PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nader, N; Ng, SSM; Wang, YH; Abel, BS; Chrousos, GP; Kino, T				Nader, Nancy; Ng, Sinnie Sin Man; Wang, Yonghong; Abel, Brent S.; Chrousos, George P.; Kino, Tomoshige			Liver X Receptors Regulate the Transcriptional Activity of the Glucocorticoid Receptor: Implications for the Carbohydrate Metabolism	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; POTENTIAL CLINICAL-IMPLICATIONS; RESPONSE ELEMENTS; ESTROGEN-RECEPTOR; NUCLEAR RECEPTORS; LIPID-METABOLISM; ACCESSORY FACTOR; LXR-ALPHA; RAT-LIVER; EXPRESSION	GLUCOCORTICOIDS are steroid hormones that strongly influence intermediary carbohydrate metabolism by increasing the transcription rate of glucose-6-phosphatase (G6Pase), a key enzyme of gluconeogenesis, and suppress the immune system through the glucocorticoid receptor (GR). The liver X receptors (LXRs), on the other hand, bind to cholesterol metabolites, heterodimerize with the retinoid X receptor (RXR), and regulate the cholesterol turnover, the hepatic glucose metabolism by decreasing the expression of G6Pase, and repress a set of inflammatory genes in immune cells. Since the actions of these receptors overlap with each other, we evaluated the crosstalk between the GR- and LXR-mediated signaling systems. Transient transfection-based reporter assays and gene silencing methods using siRNAs for LXRs showed that overexpression/ligand (GW3965) activation of LXRs/RXRs repressed GR- stimulated transactivation of certain glucocorticoid response element (GRE)-driven promoters in a gene-specific fashion. Activation of LXRs by GW3965 attenuated dexamethasone-stimulated elevation of circulating glucose in rats. It also suppressed dexamethasone-induced mRNA expression of hepatic glucose-6-phosphatase (G6Pase) in rats, mice and human hepatoma HepG2 cells, whereas endogenous, unliganded LXRs were required for dexamethasone-induced mRNA expression of phosphoenolpyruvate carboxylase. In microarray transcriptomic analysis of rat liver, GW3965 differentially regulated glucocorticoid-induced transcriptional activity of about 15% of endogenous glucocorticoid-responsive genes. To examine the mechanism through which activated LXRs attenuated GR transcriptional activity, we examined LXR alpha/RXR alpha binding to GREs. Endogenous LXR alpha/RXR alpha bound GREs and inhibited GR binding to these DNA sequences both in in vitro and in vivo chromatin immunoprecipitation assays, while their recombinant proteins did so on classic or G6Pase GREs in gel mobility shift assays. We propose that administration of LXR agonists may be beneficial in glucocorticoid treatment- or stress-associated dysmetabolic states by directly and gene-specifically attenuating the transcriptional activity of the GR on glucose and/or lipid metabolism.	[Nader, Nancy; Ng, Sinnie Sin Man; Abel, Brent S.; Kino, Tomoshige] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Mol Hormone Act, Program Reprod & Adult Endocrinol, Natl Inst Hlth, Bethesda, MD USA; [Ng, Sinnie Sin Man] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China; [Ng, Sinnie Sin Man] Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China; [Wang, Yonghong] Natl Canc Inst, Adv Technol Ctr, Natl Inst Hlth, Gaithersburg, MD USA; [Chrousos, George P.] Univ Athens, Sch Med, Dept Pediat 1, GR-11527 Athens, Greece	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Athens Medical School; National & Kapodistrian University of Athens	Nader, N (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Mol Hormone Act, Program Reprod & Adult Endocrinol, Natl Inst Hlth, Bethesda, MD USA.	nadernancy@hotmail.com	Nader, Nader/E-6358-2014	Nader, Nader/0000-0002-5744-7319	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008732] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZICBC011041, ZICBC011040] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; BOUMPAS DT, 1993, ANN INTERN MED, V119, P1198, DOI 10.7326/0003-4819-119-12-199312150-00007; Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chrousos George P, 2005, Sci STKE, V2005, ppe48, DOI 10.1126/stke.3042005pe48; Chrousos GP, 2009, ANN NY ACAD SCI, V1179, P153, DOI 10.1111/j.1749-6632.2009.04988.x; Chrousos GP, 1996, AM J RESP CRIT CARE, V154, pS39, DOI 10.1164/ajrccm/154.2_Pt_2.S39; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Chrousos GP, 2000, ENDOCR RES, V26, P513, DOI 10.3109/07435800009048562; De Rossi M, 2000, INT IMMUNOL, V12, P1329, DOI 10.1093/intimm/12.9.1329; Delvecchio CJ, 2007, MOL ENDOCRINOL, V21, P1324, DOI 10.1210/me.2007-0017; Douard V, 2008, ENDOCRINOLOGY, V149, P409, DOI 10.1210/en.2007-0906; Friedman TC, 1996, ENDOCR J, V43, P645, DOI 10.1507/endocrj.43.645; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Grempler R, 2005, BIOCHEM BIOPH RES CO, V338, P981, DOI 10.1016/j.bbrc.2005.10.030; Hallen LC, 2007, J INTERF CYTOK RES, V27, P675, DOI 10.1089/jir.2007.0021; Han JQ, 2002, RNA, V8, P512, DOI 10.1017/S1355838202020617; Hewitt KN, 2005, ENDOCRINOLOGY, V146, P2539, DOI 10.1210/en.2005-0117; Ichijo T, 2005, J BIOL CHEM, V280, P42067, DOI 10.1074/jbc.M509338200; Ichijo T, 2008, MOL CELL ENDOCRINOL, V283, P19, DOI 10.1016/j.mce.2007.10.014; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; KELLER H, 1995, MOL ENDOCRINOL, V9, P794, DOI 10.1210/me.9.7.794; Kino T, 2004, ESSAYS BIOCHEM, V40, P137, DOI 10.1042/bse0400137; Kino T, 2003, J STEROID BIOCHEM, V85, P457, DOI 10.1016/S0960-0760(03)00218-8; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; KLING MA, 1993, NEUROENDOCRINOLOGY, V57, P1082, DOI 10.1159/000126474; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Lin BC, 1998, DNA CELL BIOL, V17, P967, DOI 10.1089/dna.1998.17.967; MARKER AJ, 1989, J BIOL CHEM, V264, P7000; Mirani M, 2002, J IMMUNOL, V169, P6361, DOI 10.4049/jimmunol.169.11.6361; Nunez SB, 1997, MOL CELL ENDOCRINOL, V127, P27, DOI 10.1016/S0303-7207(96)03980-9; Ogawa H, 2002, INT J BIOCHEM CELL B, V34, P533, DOI 10.1016/S1357-2725(01)00146-7; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Patel R, 2011, J CLIN INVEST, V121, P431, DOI 10.1172/JCI41681; Peeke PM, 1995, ANN NY ACAD SCI, V771, P665, DOI 10.1111/j.1749-6632.1995.tb44719.x; PERET J, 1976, J NUTR, V106, P103, DOI 10.1093/jn/106.1.103; PETERSEN DD, 1988, MOL CELL BIOL, V8, P96, DOI 10.1128/MCB.8.1.96; Phelan CA, 2008, MOL ENDOCRINOL, V22, P2241, DOI 10.1210/me.2008-0041; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Stafford JM, 2001, J BIOL CHEM, V276, P39885, DOI 10.1074/jbc.M105370200; Stulnig TM, 2002, DIABETES, V51, P2426, DOI 10.2337/diabetes.51.8.2426; Thymiakou E, 2007, BIOCHEMISTRY-US, V46, P11473, DOI 10.1021/bi700994m; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Wiebel FF, 1997, MOL CELL BIOL, V17, P3977, DOI 10.1128/MCB.17.7.3977; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736; Wong S, 2010, ENDOCRINOLOGY, V151, P185, DOI 10.1210/en.2009-0590; Yamada K, 1999, J BIOL CHEM, V274, P5880, DOI 10.1074/jbc.274.9.5880; Yoshimura A, 2005, CLIN REV ALLERG IMMU, V28, P205, DOI 10.1385/CRIAI:28:3:205; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	56	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e26751	10.1371/journal.pone.0026751	http://dx.doi.org/10.1371/journal.pone.0026751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457708	Green Submitted, Green Published, gold			2022-12-27	WOS:000303909200001
J	Nikolic, N; Bakke, SS; Kase, ET; Rudberg, I; Halle, IF; Rustan, AC; Thoresen, GH; Aas, V				Nikolic, Natasa; Bakke, Siril Skaret; Kase, Eili Tranheim; Rudberg, Ida; Halle, Ingeborg Flo; Rustan, Arild C.; Thoresen, G. Hege; Aas, Vigdis			Electrical Pulse Stimulation of Cultured Human Skeletal Muscle Cells as an In Vitro Model of Exercise	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1; ACTIVATED PROTEIN-KINASE; GLUCOSE-TRANSPORT; GENE-EXPRESSION; ENDURANCE EXERCISE; INSULIN-RESISTANCE; C2C12 MYOTUBES; FIBER TYPE; METABOLISM; PLASTICITY	Background and Aims: Physical exercise leads to substantial adaptive responses in skeletal muscles and plays a central role in a healthy life style. Since exercise induces major systemic responses, underlying cellular mechanisms are difficult to study in vivo. It was therefore desirable to develop an in vitro model that would resemble training in cultured human myotubes. Methods: Electrical pulse stimulation (EPS) was applied to adherent human myotubes. Cellular contents of ATP, phosphocreatine (PCr) and lactate were determined. Glucose and oleic acid metabolism were studied using radio-labeled substrates, and gene expression was analyzed using real-time RT-PCR. Mitochondrial content and function were measured by live imaging and determination of citrate synthase activity, respectively. Protein expression was assessed by electrophoresis and immunoblotting. Results: High-frequency, acute EPS increased deoxyglucose uptake and lactate production, while cell contents of both ATP and PCr decreased. Chronic, low-frequency EPS increased oxidative capacity of cultured myotubes by increasing glucose metabolism (uptake and oxidation) and complete fatty acid oxidation. mRNA expression level of pyruvate dehydrogenase complex 4 (PDK4) was significantly increased in EPS-treated cells, while mRNA expressions of interleukin 6 (IL-6), cytochrome C and carnitin palmitoyl transferase b (CPT1b) also tended to increase. Intensity of MitoTracker (R) Red FM was doubled after 48 h of chronic, low-frequency EPS. Protein expression of a slow fiber type marker (MHCI) was increased in EPS-treated cells. Conclusions: Our results imply that in vitro EPS (acute, high-frequent as well as chronic, low-frequent) of human myotubes may be used to study effects of exercise.	[Nikolic, Natasa; Bakke, Siril Skaret; Kase, Eili Tranheim; Rudberg, Ida; Halle, Ingeborg Flo; Rustan, Arild C.; Thoresen, G. Hege; Aas, Vigdis] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Rudberg, Ida; Aas, Vigdis] Fac Hlth Sci, Oslo, Norway; [Rudberg, Ida; Aas, Vigdis] Akershus Univ, Coll Appl Sci, Oslo, Norway	University of Oslo; Oslo Metropolitan University (OsloMet)	Nikolic, N (corresponding author), Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway.	natasa.nikolic@farmasi.uio.no	, Natasa/X-3265-2019	, Natasa/0000-0001-9614-9050	University of Oslo, Oslo University College; Norwegian Diabetes Foundation; Freia Chocolade Fabriks Medical Foundation; Anders Jahre's Foundation; NORMIC-UiO imaging platform, Department of Molecular Biosciences, University of Oslo	University of Oslo, Oslo University College; Norwegian Diabetes Foundation; Freia Chocolade Fabriks Medical Foundation; Anders Jahre's Foundation; NORMIC-UiO imaging platform, Department of Molecular Biosciences, University of Oslo	This work was funded by the University of Oslo, Oslo University College, the Norwegian Diabetes Foundation, the Freia Chocolade Fabriks Medical Foundation and the Anders Jahre's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to Ph.D. Geir Florholmen for doing the measurements of lactate, ATP and PCr, to Dr. Gerbrand Koster and Professor Oddmund Bakke of the NORMIC-UiO imaging platform, Department of Molecular Biosciences, University of Oslo, for support and use of equipment, and to Ase-Karine Fjeldheim and Robert Smith, for excellent technical assistance.	Aas V, 2002, ANN NY ACAD SCI, V967, P506; Aas V, 2010, BIOCH BIOPHYS ACTA; Al-Khalili L, 2003, BIOCHEM BIOPH RES CO, V307, P127, DOI 10.1016/S0006-291X(03)01124-0; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Booth FW, 2007, PHYSIOL GENOMICS, V28, P146, DOI 10.1152/physiolgenomics.00174.2006; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buck MJ, 2002, PHYSIOL GENOMICS, V8, P5, DOI 10.1152/physiolgenomics.00076.2001; Burch N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010970; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Coffey VG, 2006, INT J SPORT PHYSIOL, V1, P284, DOI 10.1123/ijspp.1.3.284; Coggan AR, 2000, METABOLISM, V49, P122, DOI 10.1016/S0026-0495(00)90963-6; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; Ebeling P, 1998, FEBS LETT, V436, P301, DOI 10.1016/S0014-5793(98)01149-1; Eriksen L, 2007, DIABETOLOGIA, V50, P2245, DOI 10.1007/s00125-007-0783-0; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; Gaster M, 2004, PFLUG ARCH EUR J PHY, V448, P105, DOI 10.1007/s00424-003-1219-4; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Gaster M, 2001, APMIS, V109, P726, DOI 10.1034/j.1600-0463.2001.d01-139.x; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Harridge SDR, 2007, EXP PHYSIOL, V92, P783, DOI 10.1113/expphysiol.2006.036525; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936; Hessvik NP, 2010, J LIPID RES, V51, P2090, DOI 10.1194/jlr.M003319; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182; Kase ET, 2007, DIABETOLOGIA, V50, P2171, DOI 10.1007/s00125-007-0760-7; Kase ET, 2005, DIABETES, V54, P1108, DOI 10.2337/diabetes.54.4.1108; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nedachi T, 2009, AM J PHYSIOL-ENDOC M, V297, pE866, DOI 10.1152/ajpendo.00104.2009; Park H, 2008, J TISSUE ENG REGEN M, V2, P279, DOI 10.1002/term.93; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Pedersen BK, 2004, P NUTR SOC, V63, P263, DOI 10.1079/PNS2004338; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; PETTE D, 1992, AM J PHYSIOL, V262, pR333, DOI 10.1152/ajpregu.1992.262.3.R333; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; RICHTER EA, 1982, J CLIN INVEST, V69, P785, DOI 10.1172/JCI110517; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Ruderman NB, 2006, DIABETES, V55, pS48, DOI 10.2337/db06-S007; Santos JM, 2008, INT J SPORTS MED, V29, P785, DOI 10.1055/s-2008-1038404; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Silveira LR, 2006, BBA-MOL CELL RES, V1763, P969, DOI 10.1016/j.bbamcr.2006.06.010; Sparks LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021068; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Thelen MHM, 1997, BIOCHEM J, V321, P845, DOI 10.1042/bj3210845; Tomas E, 2002, J APPL PHYSIOL, V93, P765, DOI 10.1152/japplphysiol.00267.2002; Turcotte LP, 2008, PHYS THER, V88, P1279, DOI 10.2522/ptj.20080018; TURCOTTE LP, 1992, AM J PHYSIOL, V262, pE791; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; van Loon LJC, 2004, J APPL PHYSIOL, V97, P1170, DOI 10.1152/japplphysiol.00368.2004; WALLBERGHENRIKSSON H, 1988, J APPL PHYSIOL, V65, P909, DOI 10.1152/jappl.1988.65.2.909; Yano S, 2011, J PHARMACOL SCI, V115, P94, DOI 10.1254/jphs.10185SC	65	90	95	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33203	10.1371/journal.pone.0033203	http://dx.doi.org/10.1371/journal.pone.0033203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457744	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200023
J	Torrey, EF; Torrey, BB				Torrey, E. Fuller; Torrey, Barbara Boyle			The US Distribution of Physicians from Lower Income Countries	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HEALTH-PROFESSIONALS; BRAIN-DRAIN; DOCTORS; COST	Introduction: Since the 1960 s, the number of international medical graduates (IMGs) in the United States has increased significantly. Given concerns regarding the effects of this loss to their countries of origin, the authors undertook a study of IMGs from lower income countries currently practicing in the United States. Methods: The AMA Physician Masterfile was accessed to identify all 265,851 IMGs in active practice in the United States. These were divided by state of practice and country of origin. World Bank income classification was used to identify lower income countries. Results: 128,729 IMGs were identified from 53 lower income countries, constituting 15 percent of the US active physician workforce. As a percentage of the workforce, West Virginia (29%), New Jersey (27%), and Michigan (26%) had the most IMGs from lower income countries, and Montana, Idaho, and Alaska (all less than 2%), the least. The countries with the greatest loss of physicians to the United States per 100,000 population were the Philippines, Syria, Jordan, and Haiti. Discussion: The reliance of US medicine on physicians from lower income countries is beneficial to the United States both clinically and economically. However, it results in a loss of the lower income country's investment in the IMG's education. We discuss possible mechanisms to compensate the lower income countries for the medical education costs of their physicians who immigrate to the US.	[Torrey, E. Fuller] Stanley Med Res Inst, Chevy Chase, MD USA; [Torrey, Barbara Boyle] CNR, Bethesda, MD USA		Torrey, EF (corresponding author), Stanley Med Res Inst, Chevy Chase, MD USA.	torreyf@stanleyresearch.org						Agwu K, 2009, LANCET, V373, P1665, DOI 10.1016/S0140-6736(09)60927-2; [Anonymous], 2011, BMJ-BRIT MED J, DOI DOI 10.1136/bmj.d7031; [Anonymous], 2006, WORK TOG HLTH; [Anonymous], 2012, EX BUDG SUMM FUNCT 1, P147; [Anonymous], 2011, ECONOMIST 0528; Berhan Yifru, 2008, Ethiop Med J, V46 Suppl 1, P1; Bilateral foreign aid from the Department of State is for the President's Emergency Plan for AIDS Relief program, 2012, EX BUDG SUMM FUNCT 1, P150; Bundred PE, 2000, LANCET, V356, P245, DOI 10.1016/S0140-6736(00)02492-2; Collins FS, 2010, SCIENCE, V330, P1324, DOI 10.1126/science.1199930; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Hart LG, 2007, HEALTH AFFAIR, V26, P1159, DOI 10.1377/hlthaff.26.4.1159; Hing Esther, 2009, NCHS Data Brief, P1; Joint statement by the network of African Science Academies, 2009, BRAIN DRAIN AFR STAT; Kirigia JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-89; Lohr K, NATIONS PHYS WORKFOR, P6; Mackintosh M, 2006, J INT DEV, V18, P757; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Mullan F, 2007, NEW ENGL J MED, V356, P440, DOI 10.1056/NEJMp068267; Mullan F, 2011, LANCET, V377, P1113, DOI 10.1016/S0140-6736(10)61961-7; Nebehay S, 2010, ALLIANCE NEWS D 0528; Preston J, 2011, NY TIMES        1130; Scheffler RM, 2009, HEALTH AFFAIR, V28, pW849, DOI 10.1377/hlthaff.28.5.w849; U.S. Census Bureau, 2011, STAT ABSTR US 2012; WEST KM, 1965, J MED EDUC, V40, P1110; WHO, WHO GLOB COD PRACT I; World Bank, 2009, WORLD DEV REP 2010 D	27	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33076	10.1371/journal.pone.0033076	http://dx.doi.org/10.1371/journal.pone.0033076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457735	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100013
J	Aimola, P; Carmignani, M; Volpe, AR; Di Benedetto, A; Claudio, L; Waalkes, MP; van Bokhoven, A; Tokar, EJ; Claudio, PP				Aimola, Pierpaolo; Carmignani, Marco; Volpe, Anna Rita; Di Benedetto, Altomare; Claudio, Luigi; Waalkes, Michael P.; van Bokhoven, Adrie; Tokar, Erik J.; Claudio, Pier Paolo			Cadmium Induces p53-Dependent Apoptosis in Human Prostate Epithelial Cells	PLOS ONE			English	Article							INDUCED MALIGNANT-TRANSFORMATION; WISTAR CRL-(WI)BR RATS; DOSE-RESPONSE ANALYSIS; NOBLE NBL/CR RAT; C-JUN; PROLIFERATIVE LESIONS; TUMOR-INDUCTION; CANCER CELLS; DNA-REPAIR; P53	Cadmium, a widespread toxic pollutant of occupational and environmental concern, is a known human carcinogen. The prostate is a potential target for cadmium carcinogenesis, although the underlying mechanisms are still unclear. Furthermore, cadmium may induce cell death by apoptosis in various cell types, and it has been hypothesized that a key factor in cadmium-induced malignant transformation is acquisition of apoptotic resistance. We investigated the in vitro effects produced by cadmium exposure in normal or tumor cells derived from human prostate epithelium, including RWPE-1 and its cadmium-transformed derivative CTPE, the primary adenocarcinoma 22Rv1 and CWR-R1 cells and LNCaP, PC-3 and DU145 metastatic cancer cell lines. Cells were treated for 24 hours with different concentrations of CdCl2 and apoptosis, cell cycle distribution and expression of tumor suppressor proteins were analyzed. Subsequently, cellular response to cadmium was evaluated after siRNA-mediated p53 silencing in wild type p53-expressing RWPE-1 and LNCaP cells, and after adenoviral p53 overexpression in p53-deficient DU145 and PC-3 cell lines. The cell lines exhibited different sensitivity to cadmium, and 24-hour exposure to different CdCl2 concentrations induced dose-and cell type-dependent apoptotic response and inhibition of cell proliferation that correlated with accumulation of functional p53 and overexpression of p21 in wild type p53-expressing cell lines. On the other hand, p53 silencing was able to suppress cadmium-induced apoptosis. Our results demonstrate that cadmium can induce p53-dependent apoptosis in human prostate epithelial cells and suggest p53 mutation as a possible contributing factor for the acquisition of apoptotic resistance in cadmium prostatic carcinogenesis.	[Aimola, Pierpaolo; Di Benedetto, Altomare; Claudio, Pier Paolo] Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA; [Aimola, Pierpaolo; Carmignani, Marco; Volpe, Anna Rita; Di Benedetto, Altomare] Univ Aquila, Dept Basic & Appl Biol, I-67100 Laquila, Italy; [Claudio, Luigi] Fdn Senatore Pascale, Dept Urol, Natl Canc Inst, Naples, Italy; [Waalkes, Michael P.; Tokar, Erik J.] Natl Inst Environm Hlth Sci, Natl Toxicol Program, Res Triangle Pk, NC USA; [van Bokhoven, Adrie] Univ Colorado Denver, Dept Pathol, Aurora, CO USA; [Claudio, Pier Paolo] Marshall Univ, Dept Surg, Joan C Edwards Sch Med, Huntington, WV USA	Marshall University; University of L'Aquila; IRCCS Fondazione Pascale; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Marshall University	Aimola, P (corresponding author), Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	claudiop@marshall.edu	Claudio, Pier Paolo/AAW-7282-2021	Claudio, Pier Paolo/0000-0001-7790-1622	National Cancer Institute [CA131395, CA140024]; NIH [COBRE 5P20RR020180, WV-INBRE 5P20RR016477]; Cell Differentiation and Development Center (CDDC), Marshall University; NTP; NIEHS; Marshall University Biochemistry Department; Marshall University Microbiology & Surgery Department; NATIONAL CANCER INSTITUTE [R21CA131395, R03CA140024] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020180, P20RR016477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102925] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Differentiation and Development Center (CDDC), Marshall University; NTP; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Marshall University Biochemistry Department; Marshall University Microbiology & Surgery Department; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The present studies were supported in part by the awards number CA131395 and CA140024 from the National Cancer Institute, and in part by NIH-COBRE 5P20RR020180, WV-INBRE 5P20RR016477, and the Cell Differentiation and Development Center (CDDC), Marshall University (to PPC). These studies were also supported in part by the NTP and NIEHS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the Marshall University Biochemistry and Microbiology & Surgery Departments for their support.	Achanzar WE, 2000, TOXICOL APPL PHARM, V164, P291, DOI 10.1006/taap.1999.8907; Achanzar WE, 2002, PROSTATE, V52, P236, DOI 10.1002/pros.10106; Achanzar WE, 2001, CANCER RES, V61, P455; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; CARROLL AG, 1993, PROSTATE, V23, P123, DOI 10.1002/pros.2990230206; Claudio PP, 2002, CLIN CANCER RES, V8, P1808; Crawford ED, 2009, UROLOGY, V73, P4, DOI 10.1016/j.urology.2009.03.001; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Giaginis C, 2006, TOXICOL APPL PHARM, V213, P282, DOI 10.1016/j.taap.2006.03.008; Gregory CW, 2001, CANCER RES, V61, P2892; Guo YP, 1997, CLIN CANCER RES, V3, P2269; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hart BA, 2001, TOXICOLOGY, V160, P65, DOI 10.1016/S0300-483X(00)00436-4; Hartwig A, 2010, BIOMETALS, V23, P951, DOI 10.1007/s10534-010-9330-4; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Huff J, 2007, INT J OCCUP ENV HEAL, V13, P202, DOI 10.1179/oeh.2007.13.2.202; IARC, 1993, BER CADM MERC EXP GL, V58, P119; ISAACS WB, 1991, CANCER RES, V51, P4716; Jacob ST, 2002, ENVIRON HEALTH PERSP, V110, P827, DOI 10.1289/ehp.02110s5827; Joseph P, 2001, TOXICOL SCI, V61, P295, DOI 10.1093/toxsci/61.2.295; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; KAIGHN ME, 1979, INVEST UROL, V17, P16; Lag M, 2002, CELL BIOL TOXICOL, V18, P29, DOI 10.1023/A:1014467112463; McEleny KR, 2002, PROSTATE, V51, P133, DOI 10.1002/pros.10061; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; MICKEY DD, 1977, CANCER RES, V37, P4049; Nakamura K, 2002, INT J ONCOL, V20, P543; National Toxicology Program, 2000, 10 NAT TOX PROGR DEP, pIII; OGUNLEWE JO, 1989, CANCER, V63, P1388, DOI 10.1002/1097-0142(19890401)63:7<1388::AID-CNCR2820630725>3.0.CO;2-M; Pulido MD, 2003, MUTAT RES-FUND MOL M, V533, P227, DOI 10.1016/j.mrfmmm.2003.07.015; Qu W, 2005, INT J CANCER, V114, P346, DOI 10.1002/ijc.20736; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Tang DG, 1998, CANCER RES, V58, P3466; Templeton DM, 2010, CHEM-BIOL INTERACT, V188, P267, DOI 10.1016/j.cbi.2010.03.040; TERRACIO L, 1988, ARCH TOXICOL, V61, P450, DOI 10.1007/BF00293691; Tokumoto M, 2011, J TOXICOL SCI, V36, P191, DOI 10.2131/jts.36.191; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van Bokhoven A, 2001, PROSTATE, V47, P36; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; WAALKES MP, 1989, CANCER RES, V49, P4282; WAALKES MP, 1988, CANCER RES, V48, P4656; Waalkes MP, 1999, J TOXICOL ENV HEAL A, V58, P199, DOI 10.1080/009841099157296; Waalkes MP, 1999, TOXICOL SCI, V52, P154, DOI 10.1093/toxsci/52.2.154; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Yu XZ, 2011, TOXICOL SCI, V120, P403, DOI 10.1093/toxsci/kfr010; Zhou T, 1999, TOXICOLOGY, V142, P1, DOI 10.1016/S0300-483X(99)00115-8	53	60	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33647	10.1371/journal.pone.0033647	http://dx.doi.org/10.1371/journal.pone.0033647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448262	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700053
J	Oppenheimer, M; Valenciano, AL; Kizjakina, K; Qi, J; Sobrado, P				Oppenheimer, Michelle; Lisa Valenciano, Ana; Kizjakina, Karina; Qi, Jun; Sobrado, Pablo			Chemical Mechanism of UDP-Galactopyranose Mutase from Trypanosoma cruzi: A Potential Drug Target against Chagas' Disease	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; COMPLEX; GALACTOFURANOSE; BIOSYNTHESIS; TRANSMISSION; EXPRESSION; BINDING; CLONING; PROBES; COAT	UDP-galactopyranose mutase (UGM) is a flavoenzyme that catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, the precursor of galactofuranose (Galf). Galf is found in several pathogenic organisms, including the parasite Trypanosoma cruzi, the causative agent of Chagas' disease. Galf is important for virulence and is not present in humans, making its biosynthetic pathway an attractive target for the development of new drugs against T. cruzi. Although UGMs catalyze a non-redox reaction, the flavin must be in the reduced state for activity and the exact role of the flavin in this reaction is controversial. The kinetic and chemical mechanism of TcUGM was probed using steady state kinetics, trapping of reaction intermediates, rapid reaction kinetics, and fluorescence anisotropy. It was shown for the first time that NADPH is an effective redox partner of TcUGM. The substrate, UDP-galactopyranose, protects the enzyme from reacting with molecular oxygen allowing TcUGM to turnover similar to 1000 times for every NADPH oxidized. Spectral changes consistent with a flavin iminium ion, without the formation of a flavin semiquinone, were observed under rapid reaction conditions. These data support the proposal of the flavin acting as a nucleophile. In support of this role, a flavin-galactose adduct was isolated and characterized. A detailed kinetic and chemical mechanism for the unique non-redox reaction of UGM is presented.	[Oppenheimer, Michelle; Lisa Valenciano, Ana; Kizjakina, Karina; Qi, Jun; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Oppenheimer, Michelle; Lisa Valenciano, Ana; Kizjakina, Karina; Qi, Jun; Sobrado, Pablo] Virginia Tech, Enzyme Res & Drug Discovery Lab, Blacksburg, VA USA; [Lisa Valenciano, Ana; Sobrado, Pablo] Inst Tecnol Costa Rica, Cartago, Costa Rica; [Sobrado, Pablo] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Instituto Tecnologico de Costa Rica; Virginia Polytechnic Institute & State University	Oppenheimer, M (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	psobrado@vt.edu		Valenciano, Ana Lisa/0000-0002-5516-7452	National Institutes of Health [R01 GM094469]; American Heart Association; Ministry of Science and Technology of Costa Rica; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ministry of Science and Technology of Costa Rica; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM094469 (P.S.). M.O. was supported by a fellowship from the American Heart Association. A.L.V was supported by a fellowship from the Ministry of Science and Technology of Costa Rica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JN, 1999, J AM CHEM SOC, V121, P6968, DOI 10.1021/ja991582r; Barlow JN, 1999, ENZYMATIC MECH; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Blommel PG, 2006, PROTEIN EXPRES PURIF, V47, P562, DOI 10.1016/j.pep.2005.11.007; Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; Buekens P, 2008, MATERN CHILD HLTH J, V12, P283, DOI 10.1007/s10995-007-0246-8; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Cattiaux L, 2011, BIOORGAN MED CHEM, V19, P547, DOI 10.1016/j.bmc.2010.10.062; Chad JM, 2007, BIOCHEMISTRY-US, V46, P6723, DOI 10.1021/bi7002795; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; DACCORSO NB, 1983, CARBOHYD RES, V124, P177, DOI 10.1016/0008-6215(83)88453-5; Davis CB, 2006, DEV NOVEL CARBOHYDRA; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; DELEDERKREMER RM, 1994, J ORG CHEM, V59, P690, DOI 10.1021/jo00082a037; Dorn PL, 2007, EMERG INFECT DIS, V13, P605, DOI 10.3201/eid1304.061002; Eppe G, 2009, BIOORG MED CHEM LETT, V19, P814, DOI 10.1016/j.bmcl.2008.12.014; Fullerton SWB, 2003, BIOCHEMISTRY-US, V42, P2104, DOI 10.1021/bi027077f; Gordon RD, 2006, J MOL BIOL, V360, P67, DOI 10.1016/j.jmb.2006.04.058; Gruber TD, 2009, BIOCHEMISTRY-US, V48, P9171, DOI 10.1021/bi901437v; Gruber TD, 2009, J MOL BIOL, V391, P327, DOI 10.1016/j.jmb.2009.05.081; Hanford EJ, 2007, SOC SCI MED, V65, P60, DOI 10.1016/j.socscimed.2007.02.041; Huang ZH, 2003, BIOORG CHEM, V31, P494, DOI 10.1016/j.bioorg.2003.08.002; Lai ECK, 1996, BIOORGAN MED CHEM, V4, P1929, DOI 10.1016/S0968-0896(96)00175-7; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; Lide D, 2000, HDB CHEM PHYS 2000 2; Macheroux P, 1999, METH MOL B, V131, P1; Miller SM, 2004, NAT STRUCT MOL BIOL, V11, P497, DOI 10.1038/nsmb0604-497; Nassau PM, 1996, J BACTERIOL, V178, P1047, DOI 10.1128/jb.178.4.1047-1052.1996; NESS RK, 1951, J AM CHEM SOC, V73, P3742, DOI 10.1021/ja01152a053; Oppenheimer M, 2011, ENZYME RES, V2011; Oppenheimer M, 2011, BIOCHEM BIOPH RES CO, V407, P552, DOI 10.1016/j.bbrc.2011.03.057; Oppenheimer M, 2010, ARCH BIOCHEM BIOPHYS, V502, P31, DOI 10.1016/j.abb.2010.06.035; Partha SK, 2009, J MOL BIOL, V394, P864, DOI 10.1016/j.jmb.2009.10.013; Pereira-Chioccola VL, 2000, J CELL SCI, V113, P1299; Poulin MB, 2010, METHOD ENZYMOL, V478, P389, DOI 10.1016/S0076-6879(10)78019-8; Prata A, 1999, MEM I OSWALDO CRUZ, V94, P81, DOI 10.1590/S0074-02761999000700008; Qi J, 2011, ENZYME RES, V2011; Roper JR, 2002, P NATL ACAD SCI USA, V99, P5884, DOI 10.1073/pnas.092669999; Sanders DAR, 2001, NAT STRUCT BIOL, V8, P858, DOI 10.1038/nsb1001-858; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Sun HG, 2012, J BIOL CHEM, V287, P4602, DOI 10.1074/jbc.M111.312538; Suzuki E, 2001, CLIN DIAGN LAB IMMUN, V8, P1031, DOI 10.1128/CDLI.8.5.1031-1035.2001; Tarling CA, 2004, CARBOHYD RES, V339, P2487, DOI 10.1016/j.carres.2004.08.007; Tsvetkov YE, 2000, J CHEM SOC PERK T 1, P889, DOI 10.1039/b000210k; WHO, 2002, WORLD HTLH REP; Zhang QB, 2001, J AM CHEM SOC, V123, P6756, DOI 10.1021/ja010473l; Zhang QB, 2000, J AM CHEM SOC, V122, P9065, DOI 10.1021/ja001333z	51	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32918	10.1371/journal.pone.0032918	http://dx.doi.org/10.1371/journal.pone.0032918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448231	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700021
J	Pluess, AR; Weber, P				Pluess, Andrea R.; Weber, Pascale			Drought-Adaptation Potential in Fagus sylvatica: Linking Moisture Availability with Genetic Diversity and Dendrochronology	PLOS ONE			English	Article							BEECH ECOTYPES; CLIMATE-CHANGE; LOCI; AFLP; L.; IDENTIFICATION; POLYMORPHISM; POPULATIONS; FREQUENCY; SELECTION	Background: Microevolution is essential for species persistence especially under anticipated climate change scenarios. Species distribution projection models suggested that the dominant tree species of lowland forests in Switzerland, European beech (Fagus sylvatica L.), might disappear from most areas due to expected longer dry periods. However, if genotypes at the moisture boundary of the species climatic envelope are adapted to lower moisture availability, they can serve as seed source for the continuation of beech forests under changing climates. Methodology/Principal Findings: With an AFLP genome scan approach, we studied neutral and potentially adaptive genetic variation in Fagus sylvatica in three regions containing a dry and a mesic site each (n(ind.) = 241, n(markers) = 517). We linked this dataset with dendrochronological growth measures and local moisture availabilities based on precipitation and soil characteristics. Genetic diversity decreased slightly at dry sites. Overall genetic differentiation was low (F-st = 0.028) and Bayesian cluster analysis grouped all populations together suggesting high (historical) gene flow. The Bayesian outlier analyses indicated 13 markers with three markers differing between all dry and mesic sites and the others between the contrasting sites within individual regions. A total of 41 markers, including seven outlier loci, changed their frequency with local moisture availability. Tree height and median basal growth increments were reduced at dry sites, but marker presence/absence was not related to dendrochronological characteristics. Conclusion and Their Significance: The outlier alleles and the makers with changing frequencies in relation to moisture availability indicate microevolutionary processes occurring within short geographic distances. The general genetic similarity among sites suggests that 'preadaptive' genes can easily spread across the landscape. Yet, due to the long live span of trees, fostering saplings originating from dry sites and grown within mesic sites might increase resistance of beech forests during the anticipated longer dry periods.	[Pluess, Andrea R.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Swiss Fed Inst Technol Zurich, Zurich, Switzerland; [Weber, Pascale] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Pluess, AR (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Swiss Fed Inst Technol Zurich, Zurich, Switzerland.	andrea.pluess@env.ethz.ch	Weber, Pascale/B-4136-2008		Institute of Terrestrial Ecosystems; Professorship of Ecosystem Management; Professorship of Forest Ecology; ETH Zurich; Federal Office for the Environment; Swiss State Secretariat for Education and Research (SER) (COST E52) [C07.0113]	Institute of Terrestrial Ecosystems; Professorship of Ecosystem Management; Professorship of Forest Ecology; ETH Zurich(ETH Zurich); Federal Office for the Environment; Swiss State Secretariat for Education and Research (SER) (COST E52)	Financial support was provided by the Institute of Terrestrial Ecosystems, the Professorship of Ecosystem Management, the Professorship of Forest Ecology, ETH Zurich, the Federal Office for the Environment and the Swiss State Secretariat for Education and Research (SER) (COST E52, No. C07.0113 for the support of PW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, despite the Professorship of Forest Ecology, which was involved in the ecological study design.	*AG BOD, 1982, BOD KART; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bone E, 2001, GENETICA, V112, P165, DOI 10.1023/A:1013378014069; Brundli U.-B., 2010, SCHWEIZERISCHES LAND; Burgi M, 2003, FOREST ECOL MANAG, V176, P173, DOI 10.1016/S0378-1127(02)00270-0; Cioldi F., 2010, SCHWEIZERISCHES LAND, P31; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Dasmahapatra KK, 2008, HEREDITY, V100, P286, DOI 10.1038/sj.hdy.6801075; Ellenberg H., 1974, MITT SCHWEIZ ANST FO, V48, P587; European Environmental Agency, 2004, IMP EUR CHANG CLIM; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hess H.E., 1967, FLORA SCHWEIZ ANGREN, V1; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Meier ES, 2011, J BIOGEOGR, V38, P371, DOI 10.1111/j.1365-2699.2010.02405.x; MERZEAU D, 1994, ANN SCI FOREST, V51, P163, DOI 10.1051/forest:19940206; Oddou-Muratorio S, 2010, FOREST ECOL MANAG, V259, P2151, DOI 10.1016/j.foreco.2010.03.001; Overgaard R, 2007, FORESTRY, V80, P553, DOI 10.1093/forestry/cpm020; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perea R, 2011, FOREST ECOL MANAG, V262, P1251, DOI 10.1016/j.foreco.2011.06.022; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Peuke A, 2004, TREES-STRUCT FUNCT, V18, P639, DOI 10.1007/s00468-004-0335-x; Peuke AD, 2002, NEW PHYTOL, V154, P373, DOI 10.1046/j.1469-8137.2002.00400.x; Peuke AD, 2011, TREE PHYSIOL, V31, P196, DOI 10.1093/treephys/tpr007; R_Development_Core_Team, 2009, R LANG ENV STAT COMP; Rose L, 2009, EUR J FOREST RES, V128, P335, DOI 10.1007/s10342-009-0268-4; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; TURC L., 1961, Annales Agronomiques, V12, P13; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weber P., 2010, Communicationes Instituti Forestalis Bohemicae, V25, P248; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; Z'Graggen S, DENDROHISTOMETRISCH; Zimmermann NE, 2006, WALD KLIMAWANDEL FOR, P63; Zuur Alain F., 2009, P1	45	39	39	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33636	10.1371/journal.pone.0033636	http://dx.doi.org/10.1371/journal.pone.0033636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448260	gold, Green Published			2022-12-27	WOS:000303855700051
J	Fritsche, M; Pandey, RB; Farmer, BL; Heermann, DW				Fritsche, Miriam; Pandey, Ras B.; Farmer, Barry L.; Heermann, Dieter W.			Conformational Temperature-Dependent Behavior of a Histone H2AX: A Coarse-Grained Monte Carlo Approach Via Knowledge-Based Interaction Potentials	PLOS ONE			English	Article							MODEL; SIMULATIONS; PROTEINS; PEPTIDE	Histone proteins are not only important due to their vital role in cellular processes such as DNA compaction, replication and repair but also show intriguing structural properties that might be exploited for bioengineering purposes such as the development of nano-materials. Based on their biological and technological implications, it is interesting to investigate the structural properties of proteins as a function of temperature. In this work, we study the spatial response dynamics of the histone H2AX, consisting of 143 residues, by a coarse-grained bond fluctuating model for a broad range of normalized temperatures. A knowledge-based interaction matrix is used as input for the residue-residue Lennard-Jones potential. We find a variety of equilibrium structures including global globular configurations at low normalized temperature (T* = 0.014), combination of segmental globules and elongated chains (T* = 0.016,0.017), predominantly elongated chains (T* = 0.019,0.020), as well as universal SAW conformations at high normalized temperature (T* >= 0.023). The radius of gyration of the protein exhibits a non-monotonic temperature dependence with a maximum at a characteristic temperature (T-c* = 0.019) where a crossover occurs from a positive (stretching at T* <= T-c*) to negative (contraction at T* >= T-c*) thermal response on increasing T*.	[Fritsche, Miriam; Heermann, Dieter W.] Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany; [Pandey, Ras B.] Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA; [Farmer, Barry L.] USAF, Mat & Mfg Directorate, Res Lab, Wright Patterson AFB, OH 45433 USA; [Heermann, Dieter W.] Jackson Lab, Inst Mol Biophys, Bar Harbor, ME 04609 USA; [Heermann, Dieter W.] Interdisciplinary Ctr Sci Comp, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Southern Mississippi; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; Jackson Laboratory; Ruprecht Karls University Heidelberg	Fritsche, M (corresponding author), Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany.	fritsche@tphys.uni-heidelberg.de			Air Force Research Laboratory; Alexander von Humboldt foundation	Air Force Research Laboratory; Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	Support from the Air Force Research Laboratory and Alexander von Humboldt foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuri P, 2006, CURR OPIN BIOTECH, V17, P562, DOI 10.1016/j.copbio.2006.09.002; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Behringer H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.128101; Bewersdorf J, 2006, P NATL ACAD SCI USA, V103, P18137, DOI 10.1073/pnas.0608709103; Binder K, 2010, MONTE CARRLO SIMULAT; Bjursell J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.052904; Carbone P, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829409; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Chapagain PP, 2006, BIOPOLYMERS, V81, P167, DOI 10.1002/bip.20388; Chen CM, 2003, BIOPHYS J, V84, P1902, DOI 10.1016/S0006-3495(03)74998-4; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; Eby DM, 2011, PHYS CHEM CHEM PHYS, V13, P1123, DOI 10.1039/c0cp01364a; Eickholt J, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-38; Feng J, 2011, SOFT MATTER, V7, P2113, DOI 10.1039/c0sm01118e; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gerstman BS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1990110; Graddis T. J., 2002, Current Pharmaceutical Biotechnology, V3, P285, DOI 10.2174/1389201023378148; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Kane RS, 2007, BIOTECHNOL PROGR, V23, P316, DOI 10.1021/bp060388n; Kobsa S, 2008, PEDIATR RES, V63, P513, DOI 10.1203/PDR.0b013e318165f14d; Kongruttanachok N, 2008, SCIENCEASIA, V34, P253, DOI 10.2306/scienceasia1513-1874.2008.34.253; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Liang HK, 2005, PROTEINS, V59, P58, DOI 10.1002/prot.20386; LYUBARTSEV AP, 1995, PHYS REV E, V52, P3730, DOI 10.1103/PhysRevE.52.3730; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Pandey RB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3358340; Pandey RB, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031902; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Renugopalakrishnan V, 2005, J NANOSCI NANOTECHNO, V5, P1759, DOI 10.1166/jnn.2005.441; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shen MY, 2002, PROTEINS, V49, P439, DOI 10.1002/prot.10230; Skepo M, 2006, J PHYS CHEM B, V110, P12141, DOI 10.1021/jp056033o; SMERDON MJ, 1973, BIOCHEM BIOPH RES CO, V55, P1029, DOI 10.1016/0006-291X(73)91245-X; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Tetievsky A, 2010, J APPL PHYSIOL, V109, P1552, DOI 10.1152/japplphysiol.00469.2010; Van den Burg B, 1999, BIOTECHNOL APPL BIOC, V30, P35; Wang NY, 2010, CLIN VACCINE IMMUNOL, V17, P1781, DOI 10.1128/CVI.00277-10; Wang YT, 2009, J CHEM THEORY COMPUT, V5, P1091, DOI 10.1021/ct800548t; Wei YJ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2819679; Zhou J, 2003, LANGMUIR, V19, P3472, DOI 10.1021/la026871z; Zhou J, 2007, BIOPHYS J, V92, P4289, DOI 10.1529/biophysj.106.094425; Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43940	46	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32075	10.1371/journal.pone.0032075	http://dx.doi.org/10.1371/journal.pone.0032075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442661	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500004
J	Gao, X; Lu, X; Wu, M; Zhang, HY; Pan, RQ; Tian, J; Li, SX; Liao, H				Gao, Xiang; Lu, Xing; Wu, Man; Zhang, Haiyan; Pan, Ruqian; Tian, Jiang; Li, Shuxian; Liao, Hong			Co-Inoculation with Rhizobia and AMF Inhibited Soybean Red Crown Rot: From Field Study to Plant Defense-Related Gene Expression Analysis	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; GROWTH-PROMOTING FUNGI; GLOMUS-MOSSEAE; CYLINDROCLADIUM-PARASITICUM; PHYTOPHTHORA-PARASITICA; SYSTEMIC RESISTANCE; ALUMINUM TOLERANCE; DISEASE RESISTANCE; DAMPING-OFF; BIOCONTROL	Background: Soybean red crown rot is a major soil-borne disease all over the world, which severely affects soybean production. Efficient and sustainable methods are strongly desired to control the soil-borne diseases. Principal Findings: We firstly investigated the disease incidence and index of soybean red crown rot under different phosphorus (P) additions in field and found that the natural inoculation of rhizobia and arbuscular mycorrhizal fungi (AMF) could affect soybean red crown rot, particularly without P addition. Further studies in sand culture experiments showed that inoculation with rhizobia or AMF significantly decreased severity and incidence of soybean red crown rot, especially for co-inoculation with rhizobia and AMF at low P. The root colony forming unit (CFU) decreased over 50% when inoculated by rhizobia and/or AMF at low P. However, P addition only enhanced CFU when inoculated with AMF. Furthermore, root exudates of soybean inoculated with rhizobia and/or AMF significantly inhibited pathogen growth and reproduction. Quantitative RT-PCR results indicated that the transcripts of the most tested pathogen defense-related (PR) genes in roots were significantly increased by rhizobium and/or AMF inoculation. Among them, PR2, PR3, PR4 and PR10 reached the highest level with co-inoculation of rhizobium and AMF. Conclusions: Our results indicated that inoculation with rhizobia and AMF could directly inhibit pathogen growth and reproduction, and activate the plant overall defense system through increasing PR gene expressions. Combined with optimal P fertilization, inoculation with rhizobia and AMF could be considered as an efficient method to control soybean red crown rot in acid soils.	[Gao, Xiang; Lu, Xing; Wu, Man; Zhang, Haiyan; Pan, Ruqian; Tian, Jiang; Liao, Hong] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Root Biol Ctr, Guangzhou, Guangdong, Peoples R China; [Pan, Ruqian] S China Agr Univ, Lab Bacteria & Fungicides, Guangzhou, Guangdong, Peoples R China; [Li, Shuxian] ARS, Crop Genet Res Unit, USDA, Stoneville, MS USA	South China Agricultural University; South China Agricultural University; United States Department of Agriculture (USDA)	Gao, X (corresponding author), S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Root Biol Ctr, Guangzhou, Guangdong, Peoples R China.	hliao@scau.edu.cn	gao, xiang/AFP-7274-2022; lu, xing/N-9076-2014	gao, xiang/0000-0003-0359-9533; lu, xing/0000-0002-2962-1500	National Natural Science Foundation of China [30890132, 30890133, 31025022]; National Key Basic Research Special Funds of China [2011CB100301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Special Funds of China(National Basic Research Program of China)	This study was supported by National Natural Science Foundation of China (No. 30890132, 30890133 and 31025022) and National Key Basic Research Special Funds of China (2011CB100301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MS, 2010, TURK J BIOL, V34, P1, DOI 10.3906/biy-0809-12; Arfaoui A, 2007, PLANT PHYSIOL BIOCH, V45, P470, DOI 10.1016/j.plaphy.2007.04.004; Arfaoui A., 2005, Plant Pathology Journal, V4, P35; Arfaoui A, 2006, J PLANT PATHOL, V88, P67; Aysan E., 2009, Plant Pathology Journal (Faisalabad), V8, P74, DOI 10.3923/ppj.2009.74.78; BANWART WL, 1985, J CHEM ECOL, V11, P383, DOI 10.1007/BF01411424; BELL DK, 1966, PHYTOPATHOLOGY, V56, P1361; Berggren GT, 1989, RED CROWN ROT COMPEN, P44; Breil BT, 1996, J BACTERIOL, V178, P4150, DOI 10.1128/jb.178.14.4150-4156.1996; Chandanie WA, 2006, PLANT SOIL, V286, P209, DOI 10.1007/s11104-006-9038-y; Chandanie WA, 2009, APPL SOIL ECOL, V41, P336, DOI 10.1016/j.apsoil.2008.12.006; Clark RB, 2000, J PLANT NUTR, V23, P867, DOI 10.1080/01904160009382068; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Cordier C, 1998, MOL PLANT MICROBE IN, V11, P1017, DOI 10.1094/MPMI.1998.11.10.1017; CROUS PW, 1993, MYCOL RES, V97, P889, DOI 10.1016/S0953-7562(09)81168-4; Dar GH, 1997, MICROB ECOL, V34, P74, DOI 10.1007/s002489900036; de Jensen CE, 2002, FIELD CROP RES, V74, P107, DOI 10.1016/S0378-4290(01)00200-3; Dordas C, 2008, AGRON SUSTAIN DEV, V28, P33, DOI 10.1051/agro:2007051; Gan YT, 2006, FIELD CROP RES, V97, P121, DOI 10.1016/j.fcr.2005.10.002; GIANINAZZIPEARSON V, 1994, CURR PLANT SCI BIOT, V21, P179; Gil SV, 2008, CROP PROT, V27, P1, DOI 10.1016/j.cropro.2007.03.010; Guan M, 2010, PLANT DIS, V94, P485, DOI 10.1094/PDIS-94-4-0485B; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Handelsman J, 1996, PLANT CELL, V8, P1855, DOI 10.1105/tpc.8.10.1855; Huang HC, 2007, J PHYTOPATHOL, V155, P31, DOI 10.1111/j.1439-0434.2006.01189.x; Huber D. M., 1980, Plant Disease. An Advanced Treatise. Vol. V. How Plants Defend Themselves. (Horsfall, J.G.; Cowling, E.B., Editors)., P381; Ismail Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017990; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kosuta S, 2003, PLANT PHYSIOL, V131, P952, DOI 10.1104/pp.011882; KRAUS J, 1995, APPL ENVIRON MICROB, V61, P849, DOI 10.1128/AEM.61.3.849-854.1995; Kuruppu PU, 2004, PLANT DIS, V88, P613, DOI 10.1094/PDIS.2004.88.6.613; Li CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008049; Li S, 2008, THEOR APPL GENET, V117, P343, DOI 10.1007/s00122-008-0779-2; Liao H, 2006, PLANT PHYSIOL, V141, P674, DOI 10.1104/pp.105.076497; Liu JY, 2007, PLANT J, V50, P529, DOI 10.1111/j.1365-313X.2007.03069.x; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; Mishra RPN, 2006, CURR MICROBIOL, V52, P383, DOI 10.1007/s00284-005-0296-3; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nishi K, 1999, B NAT AGR RES, V30, P100; Parniske M, 2000, CURR OPIN PLANT BIOL, V3, P320, DOI 10.1016/S1369-5266(00)00088-1; Parniske M, 2004, CURR OPIN PLANT BIOL, V7, P414, DOI 10.1016/j.pbi.2004.05.011; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; Pozo MJ, 2002, J EXP BOT, V53, P525, DOI 10.1093/jexbot/53.368.525; Qin L, 2011, PLANT SOIL, V349, P25, DOI 10.1007/s11104-011-0947-z; Raaijmakers JM, 1997, APPL ENVIRON MICROB, V63, P881, DOI 10.1128/AEM.63.3.881-887.1997; Samac DA, 2007, PLANT PHYSIOL, V144, P582, DOI 10.1104/pp.107.096503; Siddiqui ZA, 2004, Z PFLANZENK PFLANZEN, V111, P151; SMITH SE, 1988, ANNU REV PLANT PHYS, V39, P221, DOI 10.1146/annurev.arplant.39.1.221; Song YAYA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013324; Upchurch RG, 2010, PHYSIOL MOL PLANT P, V75, P64, DOI 10.1016/j.pmpp.2010.08.007; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Vigo C, 2000, PLANT PATHOL, V49, P509, DOI 10.1046/j.1365-3059.2000.00473.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Wang XR, 2011, MYCORRHIZA, V21, P173, DOI 10.1007/s00572-010-0319-1; WELLER DM, 1983, PHYTOPATHOLOGY, V73, P1548, DOI 10.1094/Phyto-73-1548; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487; Xavier LJC, 2003, BIOL FERT SOILS, V37, P261, DOI 10.1007/s00374-003-0605-6; Yan XL, 2006, ANN BOT-LONDON, V98, P473, DOI 10.1093/aob/mcl116; Yao MK, 2003, MYCORRHIZA, V13, P333, DOI 10.1007/s00572-003-0267-0; Zhao SZ, 2008, J INTEGR PLANT BIOL, V50, P799, DOI 10.1111/j.1744-7909.2008.00702.x	61	49	53	4	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33977	10.1371/journal.pone.0033977	http://dx.doi.org/10.1371/journal.pone.0033977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442737	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500078
J	Middeljans, E; Wan, X; Jansen, PW; Sharma, V; Stunnenberg, HG; Logie, C				Middeljans, Evelien; Wan, Xi; Jansen, Pascal W.; Sharma, Vikram; Stunnenberg, Hendrik G.; Logie, Colin			SS18 Together with Animal-Specific Factors Defines Human BAF-Type SWI/SNF Complexes	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION COACTIVATOR SAYP; NUCLEAR RECEPTOR COACTIVATOR; ONCOPROTEIN SYT INTERACTS; D4 GENE FAMILY; SYNOVIAL SARCOMA; CELL-CYCLE; FREQUENT MUTATIONS; ESTROGEN-RECEPTOR; HUMAN FIBROBLASTS	Background: Nucleosome translocation along DNA is catalyzed by eukaryotic SNF2-type ATPases. One class of SNF2-ATPases is distinguished by the presence of a C-terminal bromodomain and is conserved from yeast to man and plants. This class of SNF2 enzymes forms rather large protein complexes that are collectively called SWI/SNF complexes. They are involved in transcription and DNA repair. Two broad types of SWI/SNF complexes have been reported in the literature; PBAF and BAF. These are distinguished by the inclusion or not of polybromo and several ARID subunits. Here we investigated human SS18, a protein that is conserved in plants and animals. SS18 is a putative SWI/SNF subunit which has been implicated in the etiology of synovial sarcomas by virtue of being a target for oncogenic chromosomal translocations that underlie synovial sarcomas. Methodology/Principal Findings: We pursued a proteomic approach whereby the SS18 open reading frame was fused to a tandem affinity purification tag and expressed in amenable human cells. The fusion permitted efficient and exclusive purification of so-called BAF-type SWI/SNF complexes which bear ARID1A/BAF250a or ARID1B/BAF250b subunits. This demonstrates that SS18 is a BAF subtype-specific SWI/SNF complex subunit. The same result was obtained when using the SS18-SSX1 oncogenic translocation product. Furthermore, SS18L1, DPF1, DPF2, DPF3, BRD9, BCL7A, BCL7B and BCL7C were identified. 'Complex walking' showed that they all co-purify with each other, defining human BAF-type complexes. By contrast, we demonstrate that human PHF10 is part of the PBAF complex, which harbors both ARID2/BAF200 and polybromo/BAF180 subunits, but not SS18 and nor the above BAF-specific subunits. Conclusions/Significance: SWI/SNF complexes are found in most eukaryotes and in the course of evolution new SWI/SNF subunits appeared. SS18 is found in plants as well as animals. Our results suggest that in both protostome and deuterostome animals, a class of BAF-type SWI/SNF complexes will be found that harbor SS18 or its paralogs, along with ARID1, DPF and BCL7 paralogs. Those BAF complexes are proteomically distinct from the eukaryote-wide PBAF-type SWI/SNF complexes. Finally, our results suggests that the human bromodomain factors BRD7 and BRD9 associate with PBAF and BAF, respectively.	[Middeljans, Evelien; Wan, Xi; Jansen, Pascal W.; Sharma, Vikram; Stunnenberg, Hendrik G.; Logie, Colin] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Middeljans, E (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	c.logie@ncmls.ru.nl	Logie, Colin/L-9833-2019; Logie, Colin/A-1528-2010; Stunnenberg, Hendrik G./D-6875-2012	Logie, Colin/0000-0002-8534-6582; Logie, Colin/0000-0002-8534-6582; Stunnenberg, Hendrik G./0000-0002-0066-1576	Dutch cancer research fund [KWF KUN2006-3557, KUN2006-3338]	Dutch cancer research fund	This work was supported by grants from the Dutch cancer research fund KWF KUN2006-3557 (CL) and KUN2006-3338 (HGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to Michiel Vermeulen for communicating unpublished data early on in this project and to the members of the molecular biology department for their generous help and support.	Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Biggs JR, 2001, P NATL ACAD SCI USA, V98, P3814, DOI 10.1073/pnas.071057398; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Chestkov AV, 1996, GENOMICS, V36, P174, DOI 10.1006/geno.1996.0440; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; de Bruijn DRH, 2008, ONCOGENE, V27, P653, DOI 10.1038/sj.onc.1210688; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; DELEEUW B, 1995, HUM MOL GENET, V4, P1097, DOI 10.1093/hmg/4.6.1097; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Du HS, 2008, MOL CELL, V31, P641, DOI 10.1016/j.molcel.2008.08.012; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flores-Alcantar A, 2011, CELL TISSUE RES, V345, P137, DOI 10.1007/s00441-011-1182-x; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; GABIG TG, 1994, J BIOL CHEM, V269, P29515; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gkikopoulos T, 2011, EMBO J, V30, P1919, DOI 10.1038/emboj.2011.112; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guillaumond F, 2011, FASEB J, V25, P2740, DOI 10.1096/fj.10-178616; Haldar M, 2008, CLIN ORTHOP RELAT R, V466, P2156, DOI 10.1007/s11999-008-0340-2; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Harata M, 1999, BIOSCI BIOTECH BIOCH, V63, P917, DOI 10.1271/bbb.63.917; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Huang XL, 2008, DEV BIOL, V319, P258, DOI 10.1016/j.ydbio.2008.04.020; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ichinose H, 1997, GENE, V188, P95, DOI 10.1016/S0378-1119(96)00785-8; Inoue H, 2011, BIOCHEM J, V434, P83, DOI 10.1042/BJ20101358; Ishida M, 2004, GENES CELLS, V9, P419, DOI 10.1111/j.1356-9597.2004.00737.x; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; Jadayel DM, 1998, GENE, V224, P35, DOI 10.1016/S0378-1119(98)00514-9; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Kupitz C, 2008, BIOPHYS CHEM, V136, P7, DOI 10.1016/j.bpc.2008.03.011; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Ladanyi M, 2002, CANCER RES, V62, P135; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee BH, 2009, PLANT PHYSIOL, V151, P655, DOI 10.1104/pp.109.141838; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Liu G, 2011, ONCOGENE, V30, P3295, DOI 10.1038/onc.2011.81; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Mamo A, 2011, ONCOGENE; Mohrmann L, 2004, MOL CELL BIOL, V24, P3077, DOI 10.1128/MCB.24.8.3077-3088.2004; Moshkin YM, 2007, MOL CELL BIOL, V27, P651, DOI 10.1128/MCB.01257-06; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Musselman CA, 2009, MOL INTERV, V9, P314, DOI 10.1124/mi.9.6.7; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nie ZQ, 2003, MOL CELL BIOL, V23, P2942, DOI 10.1128/MCB.23.8.2942-2952.2003; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Ninkina NN, 2001, MAMM GENOME, V12, P862, DOI 10.1007/s00335-001-3039-1; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Perani M, 2005, J BIOL CHEM, V280, P42863, DOI 10.1074/jbc.M502963200; Perani M, 2003, ONCOGENE, V22, P8156, DOI 10.1038/sj.onc.1207031; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2003, CANCER RES, V63, P560; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Ring HZ, 1998, GENOMICS, V51, P140, DOI 10.1006/geno.1998.5343; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Sansam CG, 2006, CELL CYCLE, V5, P621, DOI 10.4161/cc.5.6.2579; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Schroder M, 2011, BIOCHEM SOC T, V39, P679, DOI 10.1042/BST0390679; Shidlovskii YV, 2005, EMBO J, V24, P97, DOI 10.1038/sj.emboj.7600508; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Skytting B, 1999, J NATL CANCER I, V91, P974, DOI 10.1093/jnci/91.11.974; Smith JS, 2000, GENOMICS, V64, P44, DOI 10.1006/geno.1999.6101; Sun HB, 2007, BIOCHEM BIOPH RES CO, V358, P435, DOI 10.1016/j.bbrc.2007.04.139; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeuchi JK, 2007, P NATL ACAD SCI USA, V104, P846, DOI 10.1073/pnas.0608118104; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Thompson M, 2009, BIOCHIMIE, V91, P309, DOI 10.1016/j.biochi.2008.10.019; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; van Vugt JJFA, 2007, BBA-GENE STRUCT EXPR, V1769, P153, DOI 10.1016/j.bbaexp.2007.01.013; van Vugt JJFA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006345; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vorobyeva NE, 2009, P NATL ACAD SCI USA, V106, P11049, DOI 10.1073/pnas.0901801106; Vries RGJ, 2005, GENE DEV, V19, P665, DOI 10.1101/gad.335805; Wang S, 2002, J BIOL CHEM, V277, P11821, DOI 10.1074/jbc.M110122200; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu MH, 2009, CURR GENOMICS, V10, P216, DOI 10.2174/138920209788488481; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zani VJ, 1996, BLOOD, V87, P3124, DOI 10.1182/blood.V87.8.3124.bloodjournal8783124; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	134	85	86	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33834	10.1371/journal.pone.0033834	http://dx.doi.org/10.1371/journal.pone.0033834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442726	gold, Green Submitted, Green Published			2022-12-27	WOS:000303836500067
J	Okubo, BM; Silva, ON; Migliolo, L; Gomes, DG; Porto, WF; Batista, CL; Ramos, CS; Holanda, HHS; Dias, SC; Franco, OL; Moreno, SE				Okubo, Brunna M.; Silva, Osmar N.; Migliolo, Ludovico; Gomes, Diego G.; Porto, William F.; Batista, Carla L.; Ramos, Carmel S.; Holanda, Hortencia H. S.; Dias, Simoni C.; Franco, Octavio L.; Moreno, Susana E.			Evaluation of an Antimicrobial L-Amino Acid Oxidase and Peptide Derivatives from Bothropoides mattogrosensis Pitviper Venom	PLOS ONE			English	Article							SNAKE-VENOM; PLATELET-AGGREGATION; HOST-DEFENSE; ANTIBACTERIAL; PROTEIN; IDENTIFICATION; PURIFICATION; REVEALS; CLONING; GENE	Healthcare-associated infections (HAIs) are causes of mortality and morbidity worldwide. The prevalence of bacterial resistance to common antibiotics has increased in recent years, highlighting the need to develop novel alternatives for controlling these pathogens. Pitviper venoms are composed of a multifaceted mixture of peptides, proteins and inorganic components. L-amino oxidase (LAO) is a multifunctional enzyme that is able to develop different activities including antibacterial activity. In this study a novel LAO from Bothrops mattogrosensis (BmLAO) was isolated and biochemically characterized. Partial enzyme sequence showed full identity to Bothrops pauloensis LAO. Moreover, LAO here isolated showed remarkable antibacterial activity against Gram-positive and -negative bacteria, clearly suggesting a secondary protective function. Otherwise, no cytotoxic activities against macrophages and erythrocytes were observed. Finally, some LAO fragments (BmLAO-f1, BmLAO-f2 and BmLAO-f3) were synthesized and further evaluated, also showing enhanced antimicrobial activity. Peptide fragments, which are the key residues involved in antimicrobial activity, were also structurally studied by using theoretical models. The fragments reported here may be promising candidates in the rational design of new antibiotics that could be used to control resistant microorganisms.	[Okubo, Brunna M.; Moreno, Susana E.] Univ Catolica Dom Bosco, Programa Posgrad Biotecnol, Campo Grande, Mato Grosso Do, Brazil; [Silva, Osmar N.; Migliolo, Ludovico; Gomes, Diego G.; Porto, William F.; Batista, Carla L.; Ramos, Carmel S.; Holanda, Hortencia H. S.; Dias, Simoni C.; Franco, Octavio L.] Ctr Anal Prote & Bioquim, Brasilia, DF, Brazil; [Silva, Osmar N.; Franco, Octavio L.] Univ Fed Juiz de Fora, Programa Posgrad Ciencias Biol Biotecnol & Genet, Juiz De Fora, MG, Brazil	Universidade Catolica Dom Bosco (UCDB); Universidade Federal de Juiz de Fora	Okubo, BM (corresponding author), Univ Catolica Dom Bosco, Programa Posgrad Biotecnol, Campo Grande, Mato Grosso Do, Brazil.	ocfranco@gmail.com	MIGLIOLO, LUDOVICO/AAV-6913-2021; Franco, Octavio L/T-3020-2017; Silva, Osmar/M-3270-2019; Silva, Osmar N./B-3183-2012	MIGLIOLO, LUDOVICO/0000-0002-6606-2189; Silva, Osmar/0000-0003-2148-131X; Silva, Osmar N./0000-0003-2148-131X; Porto, William/0000-0002-4739-8250; Franco, Octavio/0000-0001-9546-0525	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); UCB (Universidade Catolica de Brasilia); FAPDF (Fundacao de Amparo a Pesquisa do Distrito Federal)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UCB (Universidade Catolica de Brasilia); FAPDF (Fundacao de Amparo a Pesquisa do Distrito Federal)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), UCB (Universidade Catolica de Brasilia) and FAPDF (Fundacao de Amparo a Pesquisa do Distrito Federal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2006, PEPTIDES, V27, P640, DOI 10.1016/j.peptides.2005.08.016; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Paiva RDA, 2011, BIOCHIMIE, V93, P941, DOI 10.1016/j.biochi.2011.01.009; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butzke D, 2005, TOXICON, V46, P479, DOI 10.1016/j.toxicon.2005.06.005; Chan W, 1999, FMOC SOLID PHASE PEP, V222; Chu CC, 1997, P NATL ACAD SCI USA, V94, P2507, DOI 10.1073/pnas.94.6.2507; Torres AFC, 2010, TOXICON, V55, P795, DOI 10.1016/j.toxicon.2009.11.013; COUDERT M, 1975, ARCH MICROBIOL, V102, P151, DOI 10.1007/BF00428360; CURTI B, 1968, J BIOL CHEM, V243, P2306; Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2; Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319; Ferreira BL, 2008, EVID-BASED COMPL ALT; Georgieva D, 2011, MOL BIOSYST, V7, P379, DOI 10.1039/c0mb00101e; Gesell J, 1997, J BIOMOL NMR, V9, P127, DOI 10.1023/A:1018698002314; Gogichaeva NV, 2007, J AM SOC MASS SPECTR, V18, P279, DOI 10.1016/j.jasms.2006.09.013; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hori Y, 2001, EUR J BIOCHEM, V268, P302, DOI 10.1046/j.1432-1033.2001.01880.x; Hughes AL, 2010, IMMUNOGENETICS, V62, P753, DOI 10.1007/s00251-010-0482-8; Isaacson T, 2002, PEPTIDES, V23, P419, DOI 10.1016/S0196-9781(01)00634-9; Izidoro LFM, 2006, BIOORGAN MED CHEM, V14, P7034, DOI 10.1016/j.bmc.2006.06.025; Jung SK, 2000, J IMMUNOL, V165, P1491, DOI 10.4049/jimmunol.165.3.1491; Kasai K, 2010, FEBS J, V277, P453, DOI 10.1111/j.1742-4658.2009.07497.x; Kitani Y, 2007, FEBS J, V274, P125, DOI 10.1111/j.1742-4658.2006.05570.x; Korndorfer IP, 2006, J MOL BIOL, V364, P678, DOI 10.1016/j.jmb.2006.08.069; Lai R, 2002, PEPTIDES, V23, P437, DOI 10.1016/S0196-9781(01)00642-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee ML, 2011, COMP BIOCHEM PHYS C, V153, P237, DOI 10.1016/j.cbpc.2010.11.001; Li JX, 2006, LIFE SCI, V78, P1953, DOI 10.1016/j.lfs.2005.08.034; Lu QM, 2002, J NAT TOXINS, V11, P345; Mandal SM, 2009, PEPTIDES, V30, P633, DOI 10.1016/j.peptides.2008.12.001; Marcotte I, 2003, CHEM PHYS LIPIDS, V122, P107, DOI 10.1016/S0009-3084(02)00182-2; MURPHY JB, 1960, BIOCHIM BIOPHYS ACTA, V45, P382, DOI 10.1016/0006-3002(60)91464-5; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nagaoka K, 2009, FASEB J, V23, P2514, DOI 10.1096/fj.08-126466; Nair DG, 2007, BIOCHEM J, V402, P93, DOI 10.1042/BJ20060318; Naumann GB, 2011, BBA-GEN SUBJECTS, V1810, P683, DOI 10.1016/j.bbagen.2011.04.003; NIEDERMANN DM, 1990, J BIOL CHEM, V265, P17246; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; Pittet D, 2008, J HOSP INFECT, V68, P285, DOI 10.1016/j.jhin.2007.12.013; Rodrigues RS, 2009, BIOCHIMIE, V91, P490, DOI 10.1016/j.biochi.2008.12.004; Salamati Payman, 2006, Indian Journal of Pediatrics, V73, P197, DOI 10.1007/BF02825479; San T. M., 2010, Journal of Applied Sciences, V10, P2328; Shiina T, 2007, J IMMUNOL, V178, P7162, DOI 10.4049/jimmunol.178.11.7162; Sigurdardottir T, 2006, ANTIMICROB AGENTS CH, V50, P2983, DOI 10.1128/AAC.01583-05; Stabeli RG, 2004, BIOORGAN MED CHEM, V12, P2881, DOI 10.1016/j.bmc.2004.03.049; Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036; Sun YP, 2002, J BIOL CHEM, V277, P19080, DOI 10.1074/jbc.M200936200; Thennarasu S, 1996, PROTEIN ENG, V9, P1219, DOI 10.1093/protein/9.12.1219; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; VALLON O, 1993, EUR J BIOCHEM, V215, P351, DOI 10.1111/j.1432-1033.1993.tb18041.x; Wang FH, 2011, FISH SHELLFISH IMMUN, V30, P1095, DOI 10.1016/j.fsi.2011.02.004; Wang GS, 2008, J BIOL CHEM, V283, P32637, DOI 10.1074/jbc.M805533200; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WELLNER D, 1961, J BIOL CHEM, V236, P2357; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yang CA, 2011, FEBS J, V278, P3381, DOI 10.1111/j.1742-4658.2011.08262.x; Zhong SR, 2009, TOXICON, V54, P763, DOI 10.1016/j.toxicon.2009.06.004	62	40	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33639	10.1371/journal.pone.0033639	http://dx.doi.org/10.1371/journal.pone.0033639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438972	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100077
J	Sun, WY; Zaboli, D; Liu, Y; Arnaoutakis, D; Khan, T; Wang, H; Koch, W; Khan, Z; Califano, JA				Sun, Wenyue; Zaboli, David; Liu, Yan; Arnaoutakis, Demetri; Khan, Tanbir; Wang, Hao; Koch, Wayne; Khan, Zubair; Califano, Joseph A.			Comparison of Promoter Hypermethylation Pattern in Salivary Rinses Collected with and without an Exfoliating Brush from Patients with HNSCC	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NECK-CANCER; ORAL-CANCER; HEAD; METHYLATION; BIOMARKERS; PROTEOMICS; DISCOVERY; AGREEMENT; MARKER	Background: Salivary rinses have been recently proposed as a valuable resource for the development of epigenetic biomarkers for detection and monitoring of head and neck squamous cell carcinoma (HNSCC). Both salivary rinses collected with and without an exfoliating brush from patients with HNSCC are used in detection of promoter hypermethylation, yet their correlation of promoter hypermethylation has not been evaluated. This study was to evaluate the concordance of promoter hypermethylation between salivary rinses collected with and without an exfoliating brush from patients with HNSCC. Methodolgy: 57 paired salivary rinses collected with or without an exfoliating brush from identical HNSCC patients were evaluated for promoter hypermethylation status using Quantitative Methylation-Specific PCR. Target tumor suppressor gene promoter regions were selected based on our previous studies describing a panel for HNSCC screening and surveillance, including P16, CCNA1, DCC, TIMP3, MGMT, DAPK and MINT31. Principal Findings: In salivary rinses collected with and without brush, frequent methylation was detected in P16 (8.8% vs. 5.2%), CCNA1 (26.3% vs. 22.8%), DCC (33.3% vs. 29.8%), TIMP3 (31.6% vs. 36.8%), MGMT (29.8% vs. 38.6%), DAPK (14.0% vs. 19.2%), and MINT31 (10.5% vs. 8.8%). Spearman's rank correlation coefficient showed a positive correlation between salivary rinses collected with and without brush for P16 (rho = 0.79), CCNA1 (rho = 0.61), DCC (rho = 0.58), TIMP3 (rho = 0.10), MGMT (rho = 0.70), DAPK (rho = 0.51) and MINT31 (rho = 0.72) (P < 0.01). The percent agreement of promoter methylation between salivary rinses with brush and without brush were 96.5% for P16, 82.5% for CCNA1, 78.9% for DCC, 59.7% for TIMP3, 84.2% for MGMT, 84.2% for DAPK, and 94.7% for MINT31. Conclusions: Our study demonstrated strong correlations of gene promoter hypermethylation between salivary rinses collected with and without an exfoliating brush. Salivary rinse collection without using an exfoliating brush may offer a cost effective, rapid, non-invasive, and reliable means for development of epigenetic salivary rinse biomarkers.	[Sun, Wenyue; Zaboli, David; Arnaoutakis, Demetri; Khan, Tanbir; Koch, Wayne; Khan, Zubair; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA; [Liu, Yan] Johns Hopkins Med Inst, Dept Surg, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA; [Wang, Hao] Johns Hopkins Med Inst, Dept Oncol, Div Oncol Biostat, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Sun, WY (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu		Sun, Wenyue/0000-0003-1673-0895	National Institute of Dental and Craniofacial Research (NIDCR); NIH [P50DE019032]; NIDCR/NIH [U54DE14257]; Early Detection Research Network [U01-CA084986]; Challenge Grant [RC1DE020324, RC2DE020789]; Damon Runyon Cancer Research Foundation; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [U01CA084986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020324, RC2DE020789, U54DE014257] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Early Detection Research Network; Challenge Grant; Damon Runyon Cancer Research Foundation; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work received Grant Support from the National Institute of Dental and Craniofacial Research (NIDCR) and NIH Specialized Program of Research Excellence grant P50DE019032, NIDCR/NIH grant U54DE14257, Early Detection Research Network grant U01-CA084986 and Challenge Grant RC1DE020324 and RC2DE020789. Dr. Califano is a Damon Runyon-Lilly Clinical Investigator supported by the Damon Runyon Cancer Research Foundation (CI- # 9), a Clinical Innovator Award from the Flight Attendant Medical Research Institute. J.A. Califano is the Director of Research of the Milton J. Dance Head and Neck Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begum S, 2011, CLIN CANCER RES, V17, P4494, DOI 10.1158/1078-0432.CCR-10-3436; Brinkmann O, 2011, ORAL ONCOL, V47, P51, DOI 10.1016/j.oraloncology.2010.10.009; Carvalho AL, 2008, CLIN CANCER RES, V14, P97, DOI 10.1158/1078-0432.CCR-07-0722; Demokan S, 2010, INT J CANCER, V127, P2351, DOI 10.1002/ijc.25248; Franzmann EJ, 2007, CANCER EPIDEM BIOMAR, V16, P1348, DOI 10.1158/1055-9965.EPI-06-0011; Guerrero-Preston R, 2011, CANCER PREV RES, V4, P1061, DOI 10.1158/1940-6207.CAPR-11-0006; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Harden SV, 2003, CLIN CANCER RES, V9, P1370; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Kaur J, 2010, INT J CANCER, V127, P2367, DOI 10.1002/ijc.25377; KVALSETH TO, 1991, EDUC PSYCHOL MEAS, V51, P95, DOI 10.1177/0013164491511008; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li Y, 2004, J DENT RES, V83, P199, DOI 10.1177/154405910408300303; Lingen MW, 2010, CANCER PREV RES, V3, P1056, DOI 10.1158/1940-6207.CAPR-10-0173; Carvalho AL, 2011, CLIN CANCER RES, V17, P4782, DOI 10.1158/1078-0432.CCR-11-0324; Nagler R, 2006, CLIN CANCER RES, V12, P3979, DOI 10.1158/1078-0432.CCR-05-2412; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pattani KM, 2011, ANN SURG ONCOL, V18, P2709, DOI 10.1245/s10434-011-1785-1; Rosas SLB, 2001, CANCER RES, V61, P939; Spafford MF, 2001, CLIN CANCER RES, V7, P607; Sun WY, 2012, CLIN CANCER RES, V18, P1082, DOI 10.1158/1078-0432.CCR-11-2392; Tavassoli M, 1998, INT J CANCER, V78, P390, DOI 10.1002/(SICI)1097-0215(19981029)78:3<390::AID-IJC23>3.0.CO;2-9; Xie HW, 2008, MOL CELL PROTEOMICS, V7, P486, DOI 10.1074/mcp.M700146-MCP200; Zhao M, 2005, INT J CANCER, V117, P605, DOI 10.1002/ijc.21216	27	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33642	10.1371/journal.pone.0033642	http://dx.doi.org/10.1371/journal.pone.0033642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438973	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100078
J	Tonan, T; Fujimoto, K; Qayyum, A; Kawaguchi, T; Kawaguchi, A; Nakashima, O; Okuda, K; Hayabuchi, N; Sata, M				Tonan, Tatsuyuki; Fujimoto, Kiminori; Qayyum, Aliya; Kawaguchi, Takumi; Kawaguchi, Atsushi; Nakashima, Osamu; Okuda, Koji; Hayabuchi, Naofumi; Sata, Michio			Quantification of Hepatic Iron Concentration in Chronic Viral Hepatitis: Usefulness of T2-weighted Single-Shot Spin-Echo Echo-Planar MR Imaging	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; FATTY LIVER-DISEASE; MAGNETIC-RESONANCE; CONTROLLED-TRIAL; AMINOTRANSFERASE LEVELS; PRELIMINARY EXPERIENCE; PHLEBOTOMY; REDUCTION; HEMOCHROMATOSIS; NORMALIZATION	Objective: To investigate the usefulness of single-shot spin-echo echo-planar imaging (SSEPI) sequence for quantifying mild degree of hepatic iron stores in patients with viral hepatitis. Methods: This retrospective study included 34 patients with chronic viral hepatitis/cirrhosis who had undergone histological investigation and magnetic resonance imaging with T2-weighted gradient-recalled echo sequence (T2-GRE) and diffusion-weighted SSEPI sequence with b-factors of 0 s/mm(2) (T2-EPI), 500 s/mm(2) (DW-EPI-500), and 1000 s/mm(2) (DW-EPI-1000). The correlation between the liver-to-muscle signal intensity ratio, which was generated by regions of interest placed in the liver and paraspinous muscles of each sequence image, and the hepatic iron concentration (mmol/g dry liver), which was assessed by spectrophotometry, was analyzed by linear regression using a spline model. Akaike information criterion (AIC) was used to select the optimal model. Results: Mean +/- standard deviation of the hepatic iron concentration quantified by spectrophotometry was 24.6+/-16.4 (range, 5.5 to 83.2) mu mol/g dry liver. DW-EPI correlated more closely with hepatic iron concentration than T2-GRE (R square values: 0.75 for T2-EPI, 0.69 for DW-EPI-500, 0.62 for DW-EPI-1000, and 0.61 for T2-GRE, respectively, all P<0.0001). Using the AIC, the regression model for T2-EPI generated by spline model was optimal because of lowest cross validation error. Conclusion: T2-EPI was sensitive to hepatic iron, and might be a more useful sequence for quantifying mild degree of hepatic iron stores in patients with chronic viral hepatitis.	[Tonan, Tatsuyuki; Fujimoto, Kiminori; Hayabuchi, Naofumi] Kurume Univ, Sch Med, Kurume Univ Hosp, Dept Radiol, Kurume, Fukuoka 830, Japan; [Fujimoto, Kiminori] Kurume Univ Hosp, Ctr Diagnost Imaging, Kurume, Fukuoka, Japan; [Qayyum, Aliya] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Kawaguchi, Takumi] Kurume Univ, Sch Med, Dept Digest Dis Informat & Res, Kurume, Fukuoka 830, Japan; [Kawaguchi, Takumi] Kurume Univ, Sch Med, Dept Internal Med, Kurume, Fukuoka 830, Japan; [Kawaguchi, Atsushi] Kurume Univ, Sch Med, Ctr Biostat, Kurume, Fukuoka 830, Japan; [Nakashima, Osamu] Kurume Univ Hosp, Dept Clin Lab Med, Kurume, Fukuoka, Japan; [Okuda, Koji] Kurume Univ, Sch Med, Dept Surg, Dept Med, Kurume, Fukuoka 830, Japan; [Sata, Michio] Kurume Univ, Sch Med, Div Gastroenterol, Dept Med, Kurume, Fukuoka 830, Japan	Kurume University; Kurume University; University of California System; University of California San Francisco; Kurume University; Kurume University; Kurume University; Kurume University; Kurume University; Kurume University	Tonan, T (corresponding author), Kurume Univ, Sch Med, Kurume Univ Hosp, Dept Radiol, Kurume, Fukuoka 830, Japan.	kimichan@med.kurume-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was partially supported by a Health and Labour Sciences Research Grants for Research on Hepatitis from the Ministry of Health, Labour and Welfare of Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alustiza JM, 2004, RADIOLOGY, V230, P479, DOI 10.1148/radiol.2302020820; Alustiza JM, 2007, EUR J RADIOL, V61, P499, DOI 10.1016/j.ejrad.2006.11.012; Asbach P, 2005, MAGN RESON IMAGING, V23, P939, DOI 10.1016/j.mri.2005.07.002; Bammer R, 2001, MAGN RESON MED, V46, P548, DOI 10.1002/mrm.1226; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonkovsky HL, 1999, RADIOLOGY, V212, P227, DOI 10.1148/radiology.212.1.r99jl35227; Bonkovsky HL, 1997, HEPATOLOGY, V25, P759, DOI 10.1002/hep.510250345; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Coenegrachts K, 2009, EUR J RADIOL, V72, P432, DOI 10.1016/j.ejrad.2008.09.005; Di Bisceglie AM, 2000, HEPATOLOGY, V32, P135, DOI 10.1053/jhep.2000.8700; Fujimoto K, 2011, RADIOLOGY, V258, P739, DOI 10.1148/radiol.10100853; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; GANDON Y, 1994, RADIOLOGY, V193, P533, DOI 10.1148/radiology.193.2.7972774; Gourtsoyianni S, 2008, EUR RADIOL, V18, P486, DOI 10.1007/s00330-007-0798-4; Griesmann GE, 2009, INT J ENVIRON HEAL R, V19, P231, DOI 10.1080/09603120802641546; HAYASHI H, 1994, AM J GASTROENTEROL, V89, P986; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kato J, 2001, CANCER RES, V61, P8697; Kawaguchi A, 2008, STAT MED, V27, P3515, DOI 10.1002/sim.3129; Kawamura Y, 2005, J GASTROENTEROL, V40, P901, DOI 10.1007/s00535-005-1636-6; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kreeftenberg HG, 2000, NETH J MED, V56, P133, DOI 10.1016/S0300-2977(00)00003-6; Lim RP, 2010, AM J ROENTGENOL, V194, P1288, DOI 10.2214/AJR.09.3036; McIntyre N, OXFORD TXB CLIN HEPA, P1379; Murtz P, 2002, RADIOLOGY, V224, P258, DOI 10.1148/radiol.2241011117; Nasu Katsuhiro, 2006, Magn Reson Med Sci, V5, P129, DOI 10.2463/mrms.5.129; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; Olthof AW, 2007, MAGN RESON IMAGING, V25, P228, DOI 10.1016/j.mri.2006.09.019; Olthof AW, 2009, EUR J RADIOL, V71, P116, DOI 10.1016/j.ejrad.2008.02.008; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Sumida Y, 2007, INTERNAL MED, V46, P637, DOI 10.2169/internalmedicine.46.6085; Tanimoto A, 2006, EUR J RADIOL, V58, P200, DOI 10.1016/j.ejrad.2005.11.040; Taouli B, 2004, AM J ROENTGENOL, V183, P677, DOI 10.2214/ajr.183.3.1830677; Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; Taouli B, 2009, J MAGN RESON IMAGING, V30, P561, DOI 10.1002/jmri.21876; Tonan T, 2011, EXP THER MED, V2, P607, DOI 10.3892/etm.2011.255; Westphalen ACA, 2007, RADIOLOGY, V242, P450, DOI 10.1148/radiol.2422052024; Yano M, 2004, J GASTROENTEROL, V39, P570, DOI 10.1007/s00535-003-1344-z; Yano M, 2002, AM J GASTROENTEROL, V97, P133, DOI 10.1111/j.1572-0241.2002.05436.x; Younossi ZM, 1999, HEPATOLOGY, V30, P847, DOI 10.1002/hep.510300407	43	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33868	10.1371/journal.pone.0033868	http://dx.doi.org/10.1371/journal.pone.0033868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439008	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100108
J	Furl, N; Gallagher, S; Averbeck, BB				Furl, Nicholas; Gallagher, Shannon; Averbeck, Bruno B.			A Selective Emotional Decision-Making Bias Elicited by Facial Expressions	PLOS ONE			English	Article							TEMPORAL PREDICTION; NEURAL BASIS; OXYTOCIN; REWARD; ERRORS; NETWORKS; BEHAVIOR; SYSTEMS	Emotional and social information can sway otherwise rational decisions. For example, when participants decide between two faces that are probabilistically rewarded, they make biased choices that favor smiling relative to angry faces. This bias may arise because facial expressions evoke positive and negative emotional responses, which in turn may motivate social approach and avoidance. We tested a wide range of pictures that evoke emotions or convey social information, including animals, words, foods, a variety of scenes, and faces differing in trustworthiness or attractiveness, but we found only facial expressions biased decisions. Our results extend brain imaging and pharmacological findings, which suggest that a brain mechanism supporting social interaction may be involved. Facial expressions appear to exert special influence over this social interaction mechanism, one capable of biasing otherwise rational choices. These results illustrate that only specific types of emotional experiences can best sway our choices.	[Furl, Nicholas; Gallagher, Shannon; Averbeck, Bruno B.] NIMH, Unit Learning & Decis Making, Neuropsychol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Furl, N (corresponding author), NIMH, Unit Learning & Decis Making, Neuropsychol Lab, Bethesda, MD 20892 USA.	nick.furl@mrc-cbu.cam.ac.uk		furl, nicholas/0000-0003-2488-1343	National Institutes of Health, National Institute of Mental Health; MRC [MC_U105579214] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002928] Funding Source: NIH RePORTER; Medical Research Council [MC_U105579214] Funding Source: researchfish	National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; [Anonymous], 1982, JUDGMENT UNCERTAINTY; Averbeck BB, 2009, EMOTION, V9, P599, DOI 10.1037/a0016509; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Evans S, 2011, J COGNITIVE NEUROSCI, V23, P2197, DOI 10.1162/jocn.2010.21584; Evans S, 2010, NEUROPSYCHOPHARMACOL, V35, P2502, DOI 10.1038/npp.2010.110; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Lang P.J., 2008, A8 U FLOR; Lundqvist D., 1998, KAROLINSKA DIRECTED; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; MEHRABIA.A, 1974, PERCEPT MOTOR SKILL, V38, P283, DOI 10.2466/pms.1974.38.1.283; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schulze L, 2011, PSYCHONEUROENDOCRINO, V36, P1378, DOI 10.1016/j.psyneuen.2011.03.011; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Sherman GD, 2009, EMOTION, V9, P282, DOI 10.1037/a0014904; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Van den Stock J, 2011, P NATL ACAD SCI USA, V108, P16188, DOI 10.1073/pnas.1107214108; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006	30	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33461	10.1371/journal.pone.0033461	http://dx.doi.org/10.1371/journal.pone.0033461			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	932RU	22438936	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309000027
J	Meinzer, M; Flaisch, T; Seeds, L; Harnish, S; Antonenko, D; Witte, V; Lindenberg, R; Crosson, B				Meinzer, Marcus; Flaisch, Tobias; Seeds, Lauren; Harnish, Stacy; Antonenko, Daria; Witte, Veronica; Lindenberg, Robert; Crosson, Bruce			Same Modulation but Different Starting Points: Performance Modulates Age Differences in Inferior Frontal Cortex Activity during Word-Retrieval	PLOS ONE			English	Article							VERBAL FLUENCY; ALZHEIMERS TYPE; CHRONIC APHASIA; ADULTS; CATEGORY; RECOVERY; OLDER; FMRI; RECRUITMENT; GENERATION	The neural basis of word-retrieval deficits in normal aging has rarely been assessed and the few previous functional imaging studies found enhanced activity in right prefrontal areas in healthy older compared to younger adults. However, more pronounced right prefrontal recruitment has primarily been observed during challenging task conditions. Moreover, increased task difficulty may result in enhanced activity in the ventral inferior frontal gyrus (vIFG) bilaterally in younger participants as well. Thus, the question arises whether increased activity in older participants represents an age-related phenomenon or reflects task difficulty effects. In the present study, we manipulated task difficulty during overt semantic and phonemic word-generation and used functional magnetic resonance imaging to assess activity patterns in the vIFG in healthy younger and older adults (N = 16/group; mean age: 24 vs. 69 years). Both groups produced fewer correct responses during the more difficult task conditions. Overall, older participants produced fewer correct responses and showed more pronounced task-related activity in the right vIFG. However, increased activity during the more difficult conditions was found in both groups. Absolute degree of activity was correlated with performance across groups, tasks and difficulty levels. Activity modulation (difficult vs. easy conditions) was correlated with the respective drop in performance across groups and tasks. In conclusion, vIFG activity levels and modulation of activity were mediated by performance accuracy in a similar way in both groups. Group differences in the right vIFG activity were explained by performance accuracy which needs to be considered in future functional imaging studies of healthy and pathological aging.	[Meinzer, Marcus; Crosson, Bruce] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Meinzer, Marcus; Antonenko, Daria; Witte, Veronica; Lindenberg, Robert] Charite, Dept Neurol, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Flaisch, Tobias] Univ Konstanz, Dept Psychol, Constance, Germany; [Seeds, Lauren; Harnish, Stacy; Crosson, Bruce] Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL USA; [Harnish, Stacy] Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL USA	State University System of Florida; University of Florida; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Konstanz; State University System of Florida; University of Florida	Meinzer, M (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.	marcus.meinzer@charite.de	Harnish, Stacy M/H-6598-2016; Witte, A. Veronica/L-7765-2017; Flaisch, Tobias/AAB-7628-2019; Antonenko, Daria/A-9326-2017; Meinzer, Marcus/I-3943-2013; Crosson, Bruce A/L-3128-2013	Harnish, Stacy M/0000-0003-4987-9653; Flaisch, Tobias/0000-0002-7485-416X; 	German Science Foundation [DFG-ME3161/21]; U.S. Department of Veterans Affairs Rehabilitation Research and Development Service [B3470S]; Career Development Award [C7175M]; National Institute on Deafness and Other Communication Disorders [R01 DC007387]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007387] Funding Source: NIH RePORTER	German Science Foundation(German Research Foundation (DFG)); U.S. Department of Veterans Affairs Rehabilitation Research and Development Service(US Department of Veterans Affairs); Career Development Award; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the German Science Foundation (DFG-ME3161/21); the U.S. Department of Veterans Affairs Rehabilitation Research and Development Service to BC (Research Career Scientist Award B3470S), SH (Career Development Award C7175M); and the National Institute on Deafness and Other Communication Disorders to BC (R01 DC007387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2009, NEUROSCI LETT, V463, P167, DOI 10.1016/j.neulet.2009.07.077; Abutalebi J, 2008, ACTA PSYCHOL, V128, P466, DOI 10.1016/j.actpsy.2008.03.014; Azuma T, 1997, NEUROPSYCHOLOGY, V11, P488, DOI 10.1037/0894-4105.11.4.488; Basho S, 2007, NEUROPSYCHOLOGIA; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Brickman AM, 2005, ARCH CLIN NEUROPSYCH, V20, P561, DOI 10.1016/j.acn.2004.12.006; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cardebat D, 1991, J NEUROLINGUIST, V6, P345; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1061, DOI 10.1017/S135561770397010X; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Diaz M, 2004, BRAIN LANG, V89, P108, DOI 10.1016/S0093-934X(03)00307-9; Fling BW, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00038; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaab N, 2007, HUM BRAIN MAPP, V28, P721, DOI 10.1002/hbm.20299; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Howard D., 1992, PYRAMID PALM TREES T; KAPLAN D, 1983, BOSTON NAMING TEST; Mayr U, 2000, PSYCHOL AGING, V15, P29, DOI 10.1037//0882-7974.15.1.29; Meinzer M, 2008, APHASIOLOGY, V22, P1251, DOI 10.1080/02687030802367998; Meinzer M, 2008, NEUROIMAGE, V39, P2038, DOI 10.1016/j.neuroimage.2007.10.008; Meinzer M, 2012, NEUROBIOL AGING, V33, P656, DOI 10.1016/j.neurobiolaging.2010.06.020; Meinzer M, 2012, J NEUROSCI, V32, P1859, DOI 10.1523/JNEUROSCI.4812-11.2012; Meinzer M, 2011, APHASIOLOGY, V25, P271, DOI 10.1080/02687038.2010.530672; Meinzer M, 2009, J COGNITIVE NEUROSCI, V21, P2007, DOI 10.1162/jocn.2009.21219; Murphy KI, 2006, J INT NEUROPSYCH SOC, V12, P570, DOI 10.1017/S1355617706060590; Nagel IE, 2009, P NATL ACAD SCI USA, V106, P22552, DOI 10.1073/pnas.0908238106; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Persson J, 2004, NEUROIMAGE, V23, P1382, DOI 10.1016/j.neuroimage.2004.08.004; Pihlajamaki M, 2000, ANN NEUROL, V47, P470, DOI 10.1002/1531-8249(200004)47:4<470::AID-ANA10>3.3.CO;2-D; Spreng RN, 2010, NEUROSCI BIOBEHAV R, V34, P1178, DOI 10.1016/j.neubiorev.2010.01.009; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Szaflarski JP, 2006, HUM BRAIN MAPP, V27, P202, DOI 10.1002/hbm.20177; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 2006, QUANTIFIED PROCESS A, P185; Wechsler D, 1987, WECHSLER MEMMORY SCA; Wierenga CE, 2008, NEUROBIOL AGING, V29, P436, DOI 10.1016/j.neurobiolaging.2006.10.024; Wierenga CE, 2010, NEUROIMAGE, V51, P1222, DOI 10.1016/j.neuroimage.2010.03.021; Wiig E.H., 1989, TEST LANGUAGE COMPET	47	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33631	10.1371/journal.pone.0033631	http://dx.doi.org/10.1371/journal.pone.0033631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	932RU	22438970	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309000035
J	Peters, JM; Wolf, N; Stricker, CA; Collier, TR; del Rio, CM				Peters, Jacob M.; Wolf, Nathan; Stricker, Craig A.; Collier, Timothy R.; del Rio, Carlos Martinez			Effects of Trophic Level and Metamorphosis on Discrimination of Hydrogen Isotopes in a Plant-Herbivore System	PLOS ONE			English	Article							COMPLEX ORGANIC MATERIALS; STABLE-ISOTOPES; FOOD WEBS; DELTA-D; COMPARATIVE EQUILIBRATION; NONEXCHANGEABLE HYDROGEN; ENVIRONMENTAL WATER; MIGRANT SONGBIRDS; DRINKING-WATER; RATIOS	The use of stable isotopes in ecological studies requires that we know the magnitude of discrimination factors between consumer and element sources. The causes of variation in discrimination factors for carbon and nitrogen have been relatively well studied. In contrast, the discrimination factors for hydrogen have rarely been measured. We grew cabbage looper caterpillars (Trichoplusia ni) on cabbage (Brassica oleracea) plants irrigated with four treatments of deuterium-enriched water (delta D = -131, -88, -48, and -2%, respectively), allowing some of them to reach adulthood as moths. Tissue dD values of plants, caterpillars, and moths were linearly correlated with the isotopic composition of irrigation water. However, the slope of these relationships was less than 1, and hence, discrimination factors depended on the dD value of irrigation water. We hypothesize that this dependence is an artifact of growing plants in an environment with a common atmospheric delta D value. Both caterpillars and moths were significantly enriched in deuterium relative to plants by, similar to 45% and 23% respectively, but the moths had lower tissue to plant discrimination factors than did the caterpillars. If the trophic enrichment documented here is universal, delta D values must be accounted for in geographic assignment studies. The isotopic value of carbon was transferred more or less faithfully across trophic levels, but delta N-15 values increased from plants to insects and we observed significant non-trophic N-15 enrichment in the metamorphosis from larvae to adult.	[Peters, Jacob M.; Wolf, Nathan; del Rio, Carlos Martinez] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Stricker, Craig A.] US Geol Survey, Denver Fed Ctr, Ft Collins Sci Ctr, Denver, CO 80225 USA; [Collier, Timothy R.] Univ Wyoming, Dept Renewable Resources, Laramie, WY 82071 USA	University of Wyoming; United States Department of the Interior; United States Geological Survey; University of Wyoming	Peters, JM (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	jpeter50@uwyo.edu		Stricker, Craig/0000-0002-5031-9437	EPSCOR/NSF; National Science Foundation (NSF) [IOS-0848028]; Division Of Integrative Organismal Systems [0848028] Funding Source: National Science Foundation	EPSCOR/NSF; National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Dr. Peters received funding from and EPSCOR/NSF Wyoming undergraduate scholarship. Dr. Martinez del Rio and Dr. Wolf were funded by National Science Foundation (NSF) grant IOS-0848028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birchall J, 2005, J ANIM ECOL, V74, P877, DOI 10.1111/j.1365-2656.2005.00979.x; Burgess SSO, 2004, PLANT CELL ENVIRON, V27, P1023, DOI 10.1111/j.1365-3040.2004.01207.x; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; Chapman R.F, 2012, INSECTS STRUCTURE FU, V5th; Chesson LA, 2009, RAPID COMMUN MASS SP, V23, P1275, DOI 10.1002/rcm.4000; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Doucett RR, 2007, ECOLOGY, V88, P1587, DOI 10.1890/06-1184; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; ESTEP MF, 1980, GEOCHIM COSMOCHIM AC, V44, P1197, DOI 10.1016/0016-7037(80)90073-3; ESTEP MF, 1980, SCIENCE, V209, P1537, DOI 10.1126/science.209.4464.1537; Finlay JC, 2010, FRESHWATER BIOL, V55, P941, DOI 10.1111/j.1365-2427.2009.02327.x; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2003, PNAS, V96, P8003; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; Hoering TC, 1977, CHEM EVOLUTION EARLY, P81; Kelly JF, 2009, RAPID COMMUN MASS SP, V23, P2316, DOI 10.1002/rcm.4150; Kelly JF, 1998, TRENDS ECOL EVOL, V13, P48, DOI 10.1016/S0169-5347(97)01299-8; Kelly JF, 2002, OECOLOGIA, V130, P216, DOI 10.1007/s004420100789; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; MACKO SA, 1983, J EXP MAR BIOL ECOL, V72, P243, DOI 10.1016/0022-0981(83)90109-0; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McKechnie AE, 2004, OECOLOGIA, V140, P191, DOI 10.1007/s00442-004-1564-9; Meehan TD, 2001, CONDOR, V103, P11, DOI 10.1650/0010-5422(2001)103[0011:UHIGTE]2.0.CO;2; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Nielson KE, 2010, GEOCHIM COSMOCHIM AC, V74, P1812, DOI 10.1016/j.gca.2009.12.025; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Roden JS, 1999, PLANT PHYSIOL, V120, P1165, DOI 10.1104/pp.120.4.1165; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Sessions AL, 1999, ORG GEOCHEM, V30, P1193, DOI 10.1016/S0146-6380(99)00094-7; SMITH BN, 1970, PLANT PHYSIOL, V46, P738, DOI 10.1104/pp.46.5.738; Solomon CT, 2009, OECOLOGIA, V161, P313, DOI 10.1007/s00442-009-1370-5; Tibbets TM, 2008, FUNCT ECOL, V22, P109, DOI 10.1111/j.1365-2435.2007.01342.x; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 2000, ENVIRON SCI TECHNOL, V34, P2354, DOI 10.1021/es990804i; West AG, 2006, RAPID COMMUN MASS SP, V20, P1317, DOI 10.1002/rcm.2456; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Wolf N, 2011, J EXP BIOL, V214, P98, DOI 10.1242/jeb.050211; Zar JH., 2010, BIOSTAT ANAL, V5th	43	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32744	10.1371/journal.pone.0032744	http://dx.doi.org/10.1371/journal.pone.0032744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470423	gold, Green Submitted, Green Published			2022-12-27	WOS:000304489000007
J	Fastman, Y; Noble, R; Recker, M; Dzikowski, R				Fastman, Yair; Noble, Robert; Recker, Mario; Dzikowski, Ron			Erasing the Epigenetic Memory and Beginning to Switch-The Onset of Antigenic Switching of var Genes in Plasmodium falciparum	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; MALARIA PARASITES; MULTIGENE FAMILY; VIRULENCE GENES; VARIANT ANTIGEN; EXPRESSION; TRANSCRIPTION; SURFACE; PFEMP1; RECOMBINATION	Antigenic variation in Plasmodium falciparum is regulated by transcriptional switches among members of the var gene family, each expressed in a mutually exclusive manner and encoding a different variant of the surface antigens collectively named PfEMP1. Antigenic switching starts when the first merozoites egress from the liver and begin their asexual proliferation within red blood cells. By erasing the epigenetic memory we created parasites with no var background, similar to merozoites that egress from the liver where no var gene is expressed. Creating a null-var background enabled us to investigate the onset of antigenic switches at the early phase of infection. At the onset of switching, var transcription pattern is heterogeneous with numerous genes transcribed at low levels including upsA vars, a subtype that was implicated in severe malaria, which are rarely activated in growing cultures. Analysis of subsequent in vitro switches shows that the probability of a gene to turn on or off is not associated with its chromosomal position or promoter type per se but on intrinsic properties of each gene. We concluded that var switching is determined by gene specific associated switch rates rather than general promoter type or locus associated switch rates. In addition, we show that fine tuned reduction in var transcription increases their switch rate, indicating that transcriptional perturbation can alter antigenic switching.	[Fastman, Yair; Dzikowski, Ron] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet,IMRIC, IL-91010 Jerusalem, Israel; [Noble, Robert; Recker, Mario] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Hebrew University of Jerusalem; University of Oxford	Fastman, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet,IMRIC, IL-91010 Jerusalem, Israel.	rond@ekmd.huji.ac.il	Dzikowski, Ron/HHZ-2430-2022; Noble, Robert/H-9124-2019	Noble, Robert/0000-0002-8057-4252; Recker, Mario/0000-0001-9489-1315	German Israeli Foundation; Marie Curie International Reintegration [203675]; United States-Israel Binational Science Foundation [2007350]; Israeli Academy for Science [660/09]; Jacob and Lena Joels Memorial Foundation Senior Lectureship for Excellence in the Life and Medical Sciences; BBSRC; Royal Society University Research Fellowship	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Marie Curie International Reintegration(European Commission); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israeli Academy for Science; Jacob and Lena Joels Memorial Foundation Senior Lectureship for Excellence in the Life and Medical Sciences; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University Research Fellowship(Royal Society of London)	This work was supported by a grant from the German Israeli Foundation [997/2008]. RD is supported by the Marie Curie International Reintegration Grant (IRG) [203675], the United States-Israel Binational Science Foundation [2007350], and the Israeli Academy for Science [660/09]. RD is also supported by the Jacob and Lena Joels Memorial Foundation Senior Lectureship for Excellence in the Life and Medical Sciences. RN is supported by a BBSRC studentship. MR is funded by a Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEY SB, 1984, J EXP MED, V160, P1585, DOI 10.1084/jem.160.5.1585; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Deitsch KW, 2004, TRENDS PARASITOL, V20, P562, DOI 10.1016/j.pt.2004.09.002; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Duffy MF, 2009, J MOL BIOL, V389, P453, DOI 10.1016/j.jmb.2009.04.032; Dzikowski R, 2008, J MOL BIOL; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Dzikowski R, 2006, CELL MICROBIOL, V8, P1371, DOI 10.1111/j.1462-5822.2006.00760.x; Enderes C, 2011, J INFECT DIS, V204, P1620, DOI 10.1093/infdis/jir594; Frank M, 2006, J BIOL CHEM, V281, P9942, DOI 10.1074/jbc.M513067200; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; HORROCKS P, 2004, P NATL ACAD SCI US; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kishore SP, 2009, J MOL EVOL, V68, P706, DOI 10.1007/s00239-009-9245-2; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Recker M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001306; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; Wang CW, 2009, PARASITOL INT, V58, P478, DOI 10.1016/j.parint.2009.07.004; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	46	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34168	10.1371/journal.pone.0034168	http://dx.doi.org/10.1371/journal.pone.0034168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461905	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000304118900023
J	Wu, XP; Wu, J; Xin, ZH; Wang, HF; Zhu, XL; Pan, LP; Li, Z; Li, H; Liu, Y				Wu, Xiaopan; Wu, Jia; Xin, Zhenhui; Wang, Huifen; Zhu, Xilin; Pan, Liping; Li, Zhuo; Li, Hui; Liu, Ying			A 3 ' UTR SNP in COL18A1 Is Associated with Susceptibility to HBV Related Hepatocellular Carcinoma in Chinese: Three Independent Case-Control Studies	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENOME-WIDE ASSOCIATION; ANGIOGENESIS INHIBITOR; BREAST-CANCER; ENDOSTATIN; POLYMORPHISM; GENE; EXPRESSION; RISK; PROGRESSION	Background: Accumulated evidences indicate that single nucleotide polymorphisms (SNP) in angiogenesis and tumorigenesis related genes are associated with risk of Hepatocellular carcinoma (HCC). COL18A1 encodes the precursor of endostatin, which is a broad-spectrum angiogenesis inhibitor, and we speculate that SNPs in COL18A1 may be associated with susceptibility to HCC. Methods and Findings: We carried out a 2-stage association study in 3 independent case-control groups in a total of 1067 chronic hepatitis B (CHB) patients and 808 hepatitis B virus (HBV) related HCC patients in Han Chinese. Four SNPs which can represent all potential functional SNPs with MAF>0.1 recorded in HapMap database were genotyped using TaqMan methods. Levels of total COL18A1 mRNA were also examined using quantitative real-time RT-PCR. We found that rs7499 located in 3'-UTR to be strongly associated with HBV related HCC (P-combined = 0.0000005, OR = 0.72, 95% CI = 0.63-0.82). COL18A1 mRNA expression was significantly decreased as the disease progressed ( P = 0.000026). Conclusion: These findings indicate that COL18A1 rs7499 may contribute to the risk of HCC in Han Chinese.	[Wu, Xiaopan; Wu, Jia; Xin, Zhenhui; Zhu, Xilin; Pan, Liping; Liu, Ying] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Wu, Xiaopan; Wu, Jia; Xin, Zhenhui; Zhu, Xilin; Pan, Liping; Li, Hui; Liu, Ying] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Wang, Huifen] 302 Hosp Peoples Liberat Army, Liver Failure Treatment & Res Ctr, Beijing, Peoples R China; [Li, Zhuo] Capital Univ Med Sci, Affiliated Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Li, Hui] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Fifth Medical Center of Chinese PLA General Hospital; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Wu, XP (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	lihui99360@sohu.com; liuyingpumc@yahoo.com			National Basic Research Program of China (973 Program) [2012CB519005]; Science Fund for Creative Research Groups [31021091]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science Fund for Creative Research Groups(Science Fund for Creative Research Groups)	This work was supported by grants from the National Basic Research Program of China (973 Program) (No. 2012CB519005) and the Science Fund for Creative Research Groups (No. 31021091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian SP, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-107; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Coulon S, 2011, LIVER INT, V31, P146, DOI 10.1111/j.1478-3231.2010.02369.x; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Deng GH, 2008, GASTROENTEROLOGY, V134, P716, DOI 10.1053/j.gastro.2007.12.044; Dhar DK, 2002, CANCER-AM CANCER SOC, V95, P2188, DOI 10.1002/cncr.10972; Dixelius J, 2000, BLOOD, V95, P3403, DOI 10.1182/blood.V95.11.3403.011k07_3403_3411; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hu TH, 2005, MODERN PATHOL, V18, P663, DOI 10.1038/modpathol.3800336; Iughetti P, 2001, CANCER RES, V61, P7375; Kong SY, 2007, HEPATOLOGY, V46, P446, DOI 10.1002/hep.21720; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Liu H, 2005, WORLD J GASTROENTERO, V11, P3331, DOI 10.3748/wjg.v11.i22.3331; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long XD, 2010, HEPATOLOGY, V52, P1301, DOI 10.1002/hep.23807; Lourenco GJ, 2006, BREAST CANCER RES TR, V100, P335, DOI 10.1007/s10549-006-9259-z; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mucci LA, 2009, INT J CANCER, V125, P1143, DOI 10.1002/ijc.24423; Musso O, 2001, CANCER RES, V61, P45; Nascimento H, 2004, INT J COLORECTAL DIS, V19, P499, DOI 10.1007/s00384-004-0590-8; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Permuth-Wey J, 2011, CANCER EPIDEM BIOMAR, V20, P1793, DOI 10.1158/1055-9965.EPI-11-0397; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Yamagata M, 2000, ANN ONCOL, V11, P761, DOI 10.1023/A:1008318526938; Yip SP, 2011, MOL VIS, V17, P810; Zambon L, 2008, LUNG CANCER, V59, P276, DOI 10.1016/j.lungcan.2007.10.018; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	31	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e33855	10.1371/journal.pone.0033855	http://dx.doi.org/10.1371/journal.pone.0033855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461898	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900016
J	Wang, K; Cui, W; Hu, G; Gao, JZ; Wu, ZH; Qiu, XY; Ruan, JS; Feng, Y; Qi, Z; Shao, YM; Tuszynski, JA				Wang, Kui; Cui, Wei; Hu, Gang; Gao, Jianzhao; Wu, Zhonghua; Qiu, Xingye; Ruan, Jishou; Feng, Yi; Qi, Zhi; Shao, Yiming; Tuszynski, Jack A.			Computable Features Required to Evaluate the Efficacy of Drugs and a Universal Algorithm to Find Optimally Effective Drug in a Drug Complex	PLOS ONE			English	Article							AUTOMATED DOCKING; MONOCLONAL-ANTIBODIES; FLEXIBLE LIGANDS; INFLUENZA; H5N1; NEURAMINIDASE; INDUCTION; PROTEINS	Background: The H1N1 pandemic in 2009 and the H5N1 pandemic in 2005 demonstrated that the drugs approved to treat influenza A viruses have low efficacy. This provided a stimulus for new studies of influenza A viruses in the context of the methods used in drug design developed over the past 100 years. Finding new universal drugs is the ultimate goal but its long time horizon is incompatible with emergency situations created by reoccurring influenza outbreaks. Therefore, we propose a computer-aided method for finding efficacious drugs and drug complexes based on the use of the DrugBank database. Methods: (1) We start by assembling a panel of target proteins. (2) We then assemble a panel of drugs. (3) This is followed by a selection of benchmark binding pockets based on the panel of target proteins and the panel of drugs. (4) We generate a set of computational features, which measure the efficacy of a drug. (5) We propose a universal program to search for drugs and drug complexes. (6) A case study we report here illustrates how to use this universal program for finding an optimal drug and a drug complex for a given target. (7) Validation of the Azirchromycin and Aspirin complex is provided mathematically. (8) Finally, we propose a simple strategy to validate our computational prediction that the Azirchromycin and Aspirin complex should prove clinically effective. Result: A set of computable features are mined and then based on these features, a universal program for finding the potential drug & drug complexes is proposed. Using this universal program, the Azirchromycin and Aspirin complex is selected and its efficacy is predicted mathematically. For clinical validation of this finding, future work is still required.	[Wang, Kui; Cui, Wei; Hu, Gang; Gao, Jianzhao; Wu, Zhonghua; Qiu, Xingye; Ruan, Jishou] Nankai Univ, Coll Math Sci, Tianjin 300071, Peoples R China; [Wang, Kui; Cui, Wei; Hu, Gang; Gao, Jianzhao; Wu, Zhonghua; Qiu, Xingye; Ruan, Jishou] Nankai Univ, LPMC, Tianjin 300071, Peoples R China; [Feng, Yi; Qi, Zhi; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Ruan, Jishou] Nankai Univ, Natl Key Lab Pharmaceut Chem & Biol, Tianjin 300071, Peoples R China; [Tuszynski, Jack A.] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Tuszynski, Jack A.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	Nankai University; Nankai University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Nankai University; University of Alberta; University of Alberta	Wang, K (corresponding author), Nankai Univ, Coll Math Sci, Tianjin 300071, Peoples R China.	jsruan@nankai.edu.cn	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429; Gao, Jianzhao/0000-0002-9943-4786	International Development Research Center, Ottawa, Canada [104519-010]; China CDC [2008SKLID203]; NSFC [10671100, 68075049, 31050110432]; project for the innovative groups [08ZCHHZ00200]	International Development Research Center, Ottawa, Canada; China CDC; NSFC(National Natural Science Foundation of China (NSFC)); project for the innovative groups	This work was carried out with the aid of a grant (No. 104519-010) from the International Development Research Center, Ottawa, Canada. All authors thank the project of the China CDC (2008SKLID203). JRuan group would like to thank the support of NSFC (10671100, 68075049 and 31050110432), the project for the innovative groups administered by China Ministry of Education and Tianjin support project 08ZCHHZ00200, especially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Michael P., 2004, COMPUTATIONAL SOFT M, V23.1, P1; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Liu YF, 2009, SCI CHINA SER C, V52, P450, DOI 10.1007/s11427-009-0060-1; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang SQ, 2009, BIOCHEM BIOPH RES CO, V386, P432, DOI 10.1016/j.bbrc.2009.06.016; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09	20	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33709	10.1371/journal.pone.0033709	http://dx.doi.org/10.1371/journal.pone.0033709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457784	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900020
J	Chen, X; Cannon, CH; Conklin-Brittan, NL				Chen, Xi; Cannon, Charles H.; Conklin-Brittan, Nancy Lou			Evidence for a Trade-Off Strategy in Stone Oak (Lithocarpus) Seeds between Physical and Chemical Defense Highlights Fiber as an Important Antifeedant	PLOS ONE			English	Article							PREDATION; TANNIN; DISPERSAL; ACORNS; NUTRIENT; FOREST	Trees in the beech or oak family (Fagaceae) have a mutualistic relationship with scatter-hoarding rodents. Rodents obtain nutrients and energy by consuming seeds, while providing seed dispersal for the tree by allowing some cached seeds to germinate. Seed predation and caching behavior of rodents is primarily affected by seed size, mechanical protection, macronutrient content, and chemical antifeedants. To enhance seed dispersal, trees must optimize trade-offs in investment between macronutrients and antifeedants. Here, we examine this important chemical balance in the seeds of tropical stone oak species with two substantially different fruit morphologies. These two distinct fruit morphologies in Lithocarpus differ in the degree of mechanical protection of the seed. For 'acorn' fruit, a thin exocarp forms a shell around the seed while for 'enclosed receptacle' (ER) fruit, the seed is embedded in a woody receptacle. We compared the chemical composition of numerous macronutrient and antifeedant in seeds from several Lithocarpus species, focusing on two pairs of sympatric species with different fruit morphologies. We found that macronutrients, particularly total non-structural carbohydrate, was more concentrated in seeds of ER fruits while antifeedants, primarily fibers, were more concentrated in seeds of acorn fruits. The trade-off in these two major chemical components was more evident between the two sympatric lowland species than between two highland species. Surprisingly, no significant difference in overall tannin concentrations in the seeds was observed between the two fruit morphologies. Instead, the major trade-off between macronutrients and antifeedants involved indigestible fibers. Future studies of this complex mutualism should carefully consider the role of indigestible fibers in the foraging behavior of scatter-hoarding rodents.	[Chen, Xi; Cannon, Charles H.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Cannon, Charles H.] Chinese Acad Sci, Key Lab Trop Ecol, Xishuangbanna Trop Bot Garden, Yunnan, Peoples R China; [Conklin-Brittan, Nancy Lou] Harvard Univ, Peabody Museum, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	Texas Tech University System; Texas Tech University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Harvard University	Cannon, CH (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	chuck.cannon@ttu.edu	Cannon, Charles/AAE-7715-2019; Cannon, Charles H/D-7186-2012	Cannon, Charles/0000-0003-1901-0420; Cannon, Charles H/0000-0003-1901-0420	Graduate School of Texas Tech University; Chinese National Fundamental Research Development Fund (973)	Graduate School of Texas Tech University; Chinese National Fundamental Research Development Fund (973)	Xi Chen received a graduate research fellowship from the Graduate School of Texas Tech University. Charles Cannon received funding from the Chinese National Fundamental Research Development Fund (973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, STAND OFF METH AN AS; BATESMITH EC, 1975, PHYTOCHEMISTRY, V14, P1107, DOI 10.1016/0031-9422(75)85197-1; Cannon CH, 2001, SYST BIOL, V50, P860, DOI 10.1080/106351501753462849; Cannon CH, 2000, BOT J LINN SOC, V133, P343, DOI 10.1111/j.1095-8339.2000.tb01550.x; Chun W, 1998, FLORA CHINA, P314; CLARKSON K, 1986, J ANIM ECOL, V55, P111, DOI 10.2307/4696; Conklin-Brittain NL, 1998, INT J PRIMATOL, V19, P971, DOI 10.1023/A:1020370119096; CRAWLEY MJ, 1995, J ECOL, V83, P683, DOI 10.2307/2261636; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FORMAN L. L., 1966, KEW BULL, V18, P385, DOI 10.2307/4115792; Goering HK, 1970, AGR RES; HAGERMAN AE, 1987, J CHEM ECOL, V13, P437, DOI 10.1007/BF01880091; JACOBS LF, 1992, ANIM BEHAV, V43, P522, DOI 10.1016/S0003-3472(05)80111-3; Jansen PA, 2001, DYNAMICS PLANT ANIMA; Jansen PA, 2002, SEED DISPERSAL FRUIG; PIERCE W, 1947, QUANTITATIVE ANAL; PORTER LJ, 1985, PHYTOCHEMISTRY, V25, P223, DOI 10.1016/S0031-9422(00)94533-3; Rey PJ, 2002, FUNCT ECOL, V16, P773, DOI 10.1046/j.1365-2435.2002.00680.x; Robbins C. T, 2001, WILDLIFE FEEDING NUT; Robertson JB, 1980, ANAL DIETARY FIBER F; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Shimada T, 2001, ECOL RES, V16, P803, DOI 10.1046/j.1440-1703.2001.00435.x; Shimada T, 2006, J CHEM ECOL, V32, P1149, DOI 10.1007/s10886-006-9077-0; SMALLWOOD PD, 1986, ECOLOGY, V67, P168, DOI 10.2307/1938515; Soepadmo E, 1972, FAGACEAE FLORE MALEN; STAPANIAN MA, 1978, ECOLOGY, V59, P884, DOI 10.2307/1938541; STEELE MA, 1993, AM MIDL NAT, V130, P229, DOI 10.2307/2426123; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Vander Wall SB, 2001, BOT REV, V67, P74, DOI 10.1007/BF02857850; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026424; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; Wood MD, 2005, NORTHEAST NAT, V12, P463, DOI 10.1656/1092-6194(2005)012[0463:TALCOA]2.0.CO;2; Xiao Zhishu, 2003, Acta Theriologica Sinica, V23, P208; Xiao ZS, 2006, ACTA OECOL, V29, P205, DOI 10.1016/j.actao.2005.10.004; Xiao ZS, 2006, FOREST ECOL MANAG, V222, P46, DOI 10.1016/j.foreco.2005.10.020; Zhang Tianshu, 2006, Yingyong Shengtai Xuebao, V17, P457	38	77	80	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e32890	10.1371/journal.pone.0032890	http://dx.doi.org/10.1371/journal.pone.0032890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457722	Green Published, Green Submitted, gold			2022-12-27	WOS:000303909200008
J	Heo, JW; Kim, JH; Cho, CS; Jun, HO; Kim, DH; Yu, YS; Kim, JH				Heo, Jang Won; Kim, Jin Hyoung; Cho, Chang Sik; Jun, Hyoung Oh; Kim, Dong Hun; Yu, Young Suk; Kim, Jeong Hun			Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells	PLOS ONE			English	Article							INTRAVITREAL BEVACIZUMAB; DIABETIC-RETINOPATHY; VEGF; INJECTION; AVASTIN; NEOVASCULARIZATION; NEUROGENESIS; MECHANISMS; RECEPTORS; TOXICITY	Vascular endothelial growth factor (VEGF) is a major regulator in retinal and choroidal angiogenesis, which are common causes of blindness in all age groups. Recently anti-VEGF treatment using anti-VEGF antibody has revolutionarily improved the visual outcome in patients with vaso-proliferative retinopathies. Herein, we demonstrated that bevacizumab as an anti-VEGF antibody could inhibit differentiation of retinoblastoma cells without affection to cellular viability, which would be mediated via blockade of extracellular signal-regulated kinase (ERK) 1/2 activation. The retinoblastoma cells expressed VEGFR-2 as well as TrkA which is a neurotrophin receptor associated with differentiation of retinoblastoma cells. TrkA in retinoblastoma cells was activated with VEGF treatment. Interestingly even in the concentration of no cellular death, bevascizumab significantly attenuated the neurite formation of differentiated retinoblastoma cells, which was accompanied by inhibition of neurofilament and shank2 expression. Furthermore, bevacizumab inhibited differentiation of retinoblastoma cells by blockade of ERK 1/2 activation. Therefore, based on that the differentiated retinoblastoma cells are mostly photoreceptors, our results suggest that anti-VEGF therapies would affect to the maintenance or function of photoreceptors in mature retina.	[Heo, Jang Won; Yu, Young Suk; Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Jin Hyoung; Cho, Chang Sik; Jun, Hyoung Oh; Yu, Young Suk; Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 110744, South Korea; [Kim, Dong Hun] Sooncheonhyang Univ, Coll Med, Dept Radiol, Puchon, South Korea; [Kim, Jeong Hun] Seoul Natl Univ, Tumor Microenvironm Res Ctr, Global Core Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Soonchunhyang University; Seoul National University (SNU)	Heo, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	steph25@snu.ac.kr	Yu, Young Suk/J-5551-2012; Kim, Jeong Hun/J-2748-2012; Heo, Jang Won/J-5717-2012	Kim, Jeong Hun/0000-0003-2957-1766	Ministry of Education, Science and Technology/National Research Foundation (MEST/NRF) [2011-0017910, 2011-0027723]; Global Core Research Center (GCRC) of MEST/NRF [2011-0030677]; Seoul National University Hospital [04-2008-0630]	Ministry of Education, Science and Technology/National Research Foundation (MEST/NRF); Global Core Research Center (GCRC) of MEST/NRF; Seoul National University Hospital	This study was supported by Mid-Career Researcher Program (2011-0017910) of the Ministry of Education, Science and Technology/National Research Foundation (MEST/NRF), the Bio-Signal Analysis Technology Innovation Program (2011-0027723) of MEST/NRF, the Global Core Research Center (GCRC) grant (2011-0030677) of MEST/NRF, and the Seoul National University Hospital Research Fund (04-2008-0630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2005, RETINA-J RET VIT DIS, V25, P111, DOI 10.1097/00006982-200502000-00001; Akil H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025097; Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Arevalo JF, 2010, CURR DIABETES REV, V6, P313, DOI 10.2174/157339910793360842; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Dorrell M, 2007, SURV OPHTHALMOL, V52, pS3, DOI 10.1016/j.survophthal.2006.10.017; Arevalo JF, 2010, OPHTHALMOLOGY, V117, P1974, DOI 10.1016/j.ophtha.2010.01.056; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Heiduschka P, 2008, RETINA-J RET VIT DIS, V28, P46, DOI 10.1097/IAE.0b013e31815e9368; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Inan UU, 2007, INVEST OPHTH VIS SCI, V48, P1773, DOI 10.1167/iovs.06-0828; Iriyama A, 2007, BRIT J OPHTHALMOL, V91, P1230, DOI 10.1136/bjo.2007.117309; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jo DH, 2010, ARCH PHARM RES, V33, P1557, DOI 10.1007/s12272-010-1007-6; Kim JH, 2007, INT J ONCOL, V31, P585; Kim JH, 2006, J BIOCHEM MOL BIOL, V39, P339; Kim JH, 2010, INVEST OPHTH VIS SCI, V51, P1783, DOI 10.1167/iovs.09-3990; Kim JH, 2009, TUMOR BIOL, V30, P233, DOI 10.1159/000243766; Kim JH, 2009, EXP MOL MED, V41, P236, DOI 10.3858/emm.2009.41.4.026; Kim JH, 2009, INVEST OPHTH VIS SCI, V50, P1819, DOI 10.1167/iovs.08-2623; Kim JH, 2008, NEUROTOXICOLOGY, V29, P1131, DOI 10.1016/j.neuro.2008.06.006; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Manzano RPA, 2006, RETINA-J RET VIT DIS, V26, P257, DOI 10.1097/00006982-200603000-00001; Miki A, 2010, J CELL PHYSIOL, V224, P262, DOI 10.1002/jcp.22129; NORK TM, 1995, ARCH OPHTHALMOL-CHIC, V113, P791, DOI 10.1001/archopht.1995.01100060117046; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321	32	22	24	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33456	10.1371/journal.pone.0033456	http://dx.doi.org/10.1371/journal.pone.0033456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457763	gold, Green Published, Green Submitted			2022-12-27	WOS:000303909200030
J	Kubo, K; Okanoya, K; Kawai, N				Kubo, Kenta; Okanoya, Kazuo; Kawai, Nobuyuki			Apology Isn't Good Enough: An Apology Suppresses an Approach Motivation but Not the Physiological and Psychological Anger	PLOS ONE			English	Article							NERVOUS-SYSTEM ACTIVITY; FRONTAL BRAIN ACTIVITY; ASYMMETRY; ACTIVATION; EMOTION; MOOD	Although studies have emphasized the multiple components of anger, little is known about the physiological and psychological mechanisms of the approach motivational component and the negative emotional component of anger. In the present study, participants wrote brief opinions about social problems (e.g., tuition hikes) and received a handwritten, insulting comment about their composition from the experimenter. Half of the participants (apology group) received a simple apologetic sentence at the end of the insulting comment. Half of the participants (no apology group) did not receive one. The physiological responses of the participants were recorded prior to, and after they read the comments. Increases in heart rate and asymmetric frontal brain activity were suppressed only in the apology group. Both groups showed an increase in skin conductance response. Our psychological scales showed that the apology suppressed self reported state anger from an approach-motivational standpoint but not from a negative emotional standpoint. The results suggest that anger is not a unitary process but has multiple components. The apology did provide a different physiological profile but did not dampen down the subjective experience of anger. Thus, providing an apology may not always be effective for alleviating the experience of anger to an insult.	[Kubo, Kenta; Okanoya, Kazuo; Kawai, Nobuyuki] Japan Sci & Technol Agcy, Okanoya Emot Informat Project, Nagoya, Aichi, Japan; [Okanoya, Kazuo] Brain Sci Inst, RIKEN Lab, Wako, Saitama, Japan; [Okanoya, Kazuo] Univ Tokyo, Dept Cognit & Behav Sci, Meguro, Japan; [Kawai, Nobuyuki] Nagoya Univ, Dept Cognit Sci, Nagoya, Aichi 4648601, Japan	Japan Science & Technology Agency (JST); RIKEN; University of Tokyo; Nagoya University	Kawai, N (corresponding author), Japan Sci & Technol Agcy, Okanoya Emot Informat Project, Nagoya, Aichi, Japan.	kawai@is.nagoya-u.ac.jp	Kawai, Nobuyuki/M-4902-2014	Kawai, Nobuyuki/0000-0003-0372-1703	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work is supported by funding from the Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2004, J EXP SOC PSYCHOL, V40, P225, DOI 10.1016/S0022-1031(03)00100-8; Anderson JC, 2006, J BEHAV MED, V29, P347, DOI 10.1007/s10865-006-9062-7; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Darwin C., 1965, EXPRESS EMOT MAN; Davidson R. J., 2000, HDB PSYCHOPHYSIOLOGY, V2nd, P27; Davidson RJ, 1998, PSYCHOPHYSIOLOGY, V35, P607, DOI 10.1017/S0048577298000134; De Cremer D, 2011, PSYCHOL SCI, V22, P45, DOI 10.1177/0956797610391101; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Harmon-Jones E, 2006, PSYCHOL SCI, V17, P434, DOI 10.1111/j.1467-9280.2006.01724.x; Harmon-Jones E, 2004, EMOTION, V4, P95, DOI 10.1037/1528-3542.4.1.95; Harmon-Jones E, 2004, COGNITION EMOTION, V18, P337, DOI 10.1080/02699930341000059; Harmon-Jones E, 1997, J ABNORM PSYCHOL, V106, P159, DOI 10.1037/0021-843X.106.1.159; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Harmon-Jones E, 2007, INT J PSYCHOPHYSIOL, V66, P154, DOI 10.1016/j.ijpsycho.2007.03.020; Harmon-Jones E, 2006, PSYCHOPHYSIOLOGY, V43, P598, DOI 10.1111/j.1469-8986.2006.00465.x; Harmon-Jones E, 2010, J RES PERS, V44, P120, DOI 10.1016/j.jrp.2009.09.001; Harmon-Jones E, 2009, PSYCHOL SCI, V20, P1209, DOI 10.1111/j.1467-9280.2009.02416.x; Harmon-Jones E, 2009, EMOTION, V9, P183, DOI 10.1037/a0014959; Hewig J, 2004, J PERS SOC PSYCHOL, V87, P926, DOI 10.1037/0022-3514.87.6.926; LEVENSON RW, 1992, J PERS SOC PSYCHOL, V62, P972, DOI 10.1037/0022-3514.62.6.972; Lindsley D.E., 1974, BIOELECTRIC RECORDIN, P3; Mayan I, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00022; OHBUCHI K, 1994, J SOC PSYCHOL, V134, P5, DOI 10.1080/00224545.1994.9710877; OHBUCHI K, 1989, J PERS SOC PSYCHOL, V56, P219, DOI 10.1037/0022-3514.56.2.219; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peterson CK, 2008, PSYCHOPHYSIOLOGY, V45, P86, DOI 10.1111/j.1469-8986.2007.00597.x; Potegal M, 2010, INTERNATIONAL HANDBOOK OF ANGER, P3, DOI 10.1007/978-0-387-89676-2_1; Rybak M, 2006, CLIN EEG NEUROSCI, V37, P16, DOI 10.1177/155005940603700105; Sato A., 2001, JAPANESE J PERSONALI, V19, P138, DOI [DOI 10.2132/jjpjspp.9.2_138, DOI 10.2132/JJPJSPP.9.2_138]; Spielberger C.D., 1988, STATE TRAIT ANGER EX; Spielberger C.D., 1983, ADV PERSONAL ASSESS, V2, P161; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	36	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33006	10.1371/journal.pone.0033006	http://dx.doi.org/10.1371/journal.pone.0033006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	940QX	22457729	Green Published, gold			2022-12-27	WOS:000303909200012
J	Marzullo, TC; Gage, GJ				Marzullo, Timothy C.; Gage, Gregory J.			The SpikerBox: A Low Cost, Open-Source BioAmplifier for Increasing Public Participation in Neuroscience Inquiry	PLOS ONE			English	Article							SCIENCE	Although people are generally interested in how the brain functions, neuroscience education for the public is hampered by a lack of low cost and engaging teaching materials. To address this, we developed an open-source tool, the SpikerBox, which is appropriate for use in middle/high school educational programs and by amateurs. This device can be used in easy experiments in which students insert sewing pins into the leg of a cockroach, or other invertebrate, to amplify and listen to the electrical activity of neurons. With the cockroach leg preparation, students can hear and see (using a smartphone oscilloscope app we have developed) the dramatic changes in activity caused by touching the mechanosensitive barbs. Students can also experiment with other manipulations such as temperature, drugs, and microstimulation that affect the neural activity. We include teaching guides and other resources in the supplemental materials. These hands-on lessons with the SpikerBox have proven to be effective in teaching basic neuroscience.	[Marzullo, Timothy C.; Gage, Gregory J.] Backyard Brains Inc, Ann Arbor, MI USA		Marzullo, TC (corresponding author), Backyard Brains Inc, Ann Arbor, MI USA.	info@backyardbrains.com	Gage, Greg/J-4467-2019	Gage, Greg/0000-0002-8672-3212	National Institutes of Mental Health [1R43MH093334-01]; Kauffman Foundation; Cell Press Anuradha Rao Memorial Travel Award; Society for Neuroscience; SquareOne Education Network; University of Michigan Center for Entrepreneurship; Kickstarter Project "Backyard Brains: Operation Publication"; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH093334, R44MH093334] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Kauffman Foundation; Cell Press Anuradha Rao Memorial Travel Award; Society for Neuroscience; SquareOne Education Network; University of Michigan Center for Entrepreneurship; Kickstarter Project "Backyard Brains: Operation Publication"; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for the SpikerBox development and outreach efforts were primarily provided by the National Institutes of Mental Health Small Business Innovation Research grant #1R43MH093334-01: "Backyard Brains: Bringing Neurophysiology into Secondary Schools" and the Kauffman Foundation Post Doctoral Entrepreneurial Fellowship. Additional support was provided by Cell Press Anuradha Rao Memorial Travel Award, the Society for Neuroscience Next Generation Award, the SquareOne Education Network, and the University of Michigan Center for Entrepreneurship "Dare to Dream" Grant. The financial support for publication in PLoS ONE was subsidized through the Kickstarter Project "Backyard Brains: Operation Publication." Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple, 2011, BACK BRAINS IOS APP; Backyard Brains, 2011, BACK BRAINS WIK; Blackawton PS, 2011, BIOL LETTERS, V7, P168, DOI 10.1098/rsbl.2010.1056; Bopp T, 1997, EARTH MOON PLANETS, V79, P307, DOI 10.1023/A:1006262006364; BREER H, 1987, J INSECT PHYSIOL, V33, P771, DOI 10.1016/0022-1910(87)90025-4; Cameron W, 2003, NAT REV NEUROSCI, V4, P763, DOI 10.1038/nrn1200; Cameron William E, 2006, CBE Life Sci Educ, V5, P91, DOI 10.1187/cbe.06-03-0151; Chang K, 2009, NY TIMES        1122, pA13; Chouinard MM, 2007, MONOGR SOC RES CHILD, V72, p[vii, 1, 113]; Fields MC, 2009, ZEBRAFISH, V6, P145, DOI 10.1089/zeb.2008.0569; Foundation D, 2011, BRAIN AWARENESS WEEK; Foy Judith G, 2006, CBE Life Sci Educ, V5, P128, DOI 10.1187/cbe.05-08-0107; Gates B, 1996, ROAD AHEAD, pxviii; Geier R, 2008, J RES SCI TEACH, V45, P922, DOI 10.1002/tea.20248; Google, 2011, BACK BRAINS ANDR APP; Guthrie JT, 2004, J EDUC PSYCHOL, V96, P403, DOI 10.1037/0022-0663.96.3.403; Kuenzi J., SCI TECHNOLOGY ENG M; Land BR, 2001, J NEUROSCI METH, V106, P47, DOI 10.1016/S0165-0270(01)00328-4; MacNabb Carrie, 2006, CBE Life Sci Educ, V5, P144, DOI 10.1187/cbe.05-08-0109; Narasimhan K, 2009, NAT NEUROSCI, V12, P665; National Research Council, 2011, SCI ED; National Research Council, 1996, NAT SCI ED STAND OBS; Pascarella E. T., 2005, COLL AFFECTS STUDENT; Rolston John D, 2009, Front Neuroeng, V2, P12, DOI 10.3389/neuro.16.012.2009; Society of Neuroscience, 2011, BRAIN AW WEEK; Society of Neuroscience, 2011, NERVE VIRT ENC; Society of Neuroscience, 2007, NEUR COR CONC ESS PR; State of Michigan, 2011, DASHB SCH REP CARD S; Yu Y.-H., 2009, 2 INT C IM SIGN PROC, P1	29	38	39	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e30837	10.1371/journal.pone.0030837	http://dx.doi.org/10.1371/journal.pone.0030837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YN	22470415	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100002
J	Vermehren, J; Lotsch, J; Susser, S; Wicker, S; Berger, A; Zeuzem, S; Sarrazin, C; Doehring, A				Vermehren, Johannes; Loetsch, Joern; Susser, Simone; Wicker, Sabine; Berger, Annemarie; Zeuzem, Stefan; Sarrazin, Christoph; Doehring, Alexandra			A Common HLA-DPA1 Variant Is Associated with Hepatitis B Virus Infection but Fails to Distinguish Active from Inactive Caucasian Carriers	PLOS ONE			English	Article							HAPLOTYPE BLOCKS; POPULATION; PREVALENCE; LINKAGE; MARKERS; HISTORY; GENOME	Background and Aims: Chronic infection with the hepatitis B virus (HBV) is a major health issue worldwide. Recently, single nucleotide polymorphisms (SNPs) within the human leukocyte antigen (HLA)-DP locus were identified to be associated with HBV infection in Asian populations. Most significant associations were observed for the A alleles of HLA-DPA1 rs3077 and HLA-DPB1 rs9277535, which conferred a decreased risk for HBV infection. We assessed the implications of these variants for HBV infection in Caucasians. Methods: Two HLA-DP gene variants (rs3077 and rs9277535) were analyzed for associations with persistent HBV infection and with different clinical outcomes, i.e., inactive HBsAg carrier status versus progressive chronic HBV (CHB) infection in Caucasian patients (n = 201) and HBsAg negative controls (n = 235). Results: The HLA-DPA1 rs3077 C allele was significantly associated with HBV infection (odds ratio, OR = 5.1, 95% confidence interval, CI: 1.9-13.7; p = 0.00093). However, no significant association was seen for rs3077 with progressive CHB infection versus inactive HBsAg carrier status (OR = 2.7, 95% CI: 0.6-11.1; p = 0.31). In contrast, HLA-DPB1 rs9277535 was not associated with HBV infection in Caucasians (OR = 0.8, 95% CI: 0.4-1.9; p = 1). Conclusions: A highly significant association of HLA-DPA1 rs3077 with HBV infection was observed in Caucasians. However, as a differentiation between different clinical courses of HBV infection was not possible, knowledge of the HLA-DPA1 genotype cannot be translated into personalized anti-HBV therapy approaches.	[Vermehren, Johannes] Klinikum JW Goethe Univ, Med Klin 1, Inst Klin Pharmakol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Wicker, Sabine] Klinikum JW Goethe Univ, Betriebsarztlicher Dienst, Frankfurt, Germany; [Berger, Annemarie] Klinikum JW Goethe Univ, Inst Med Virol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Vermehren, J (corresponding author), Klinikum JW Goethe Univ, Med Klin 1, Inst Klin Pharmakol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019	Lotsch, Jorn/0000-0002-5818-6958	J. W. Goethe University Medical School, Frankfurt, Germany	J. W. Goethe University Medical School, Frankfurt, Germany	This work was supported by the "Patenschaftsmodell" from the J. W. Goethe University Medical School, Frankfurt, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2011, J INFECT DIS, V203, P943, DOI 10.1093/infdis/jiq154; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Cornberg M, 2011, Z GASTROENTEROL, V49, P871, DOI 10.1055/s-0031-1273462; Diaz G, 2003, INT IMMUNOL, V15, P565, DOI 10.1093/intimm/dxg057; Frodsham AJ, 2005, TRANSPL IMMUNOL, V14, P183, DOI 10.1016/j.trim.2005.03.006; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; LEWONTIN RC, 1964, GENETICS, V49, P49; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; LIN TM, 1989, ANTICANCER RES, V9, P737; Lotsch J, 2007, ANESTHESIOLOGY, V107, P168; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Marschall T, 2005, DEUT MED WOCHENSCHR, V130, P2753, DOI 10.1055/s-2005-922067; O'Brien TR, 2011, GENES IMMUN, V12, P428, DOI 10.1038/gene.2011.11; Penna A, 1997, HEPATOLOGY, V25, P1022, DOI 10.1002/hep.510250438; Thierfelder W, 2001, EUR J EPIDEMIOL, V17, P429, DOI 10.1023/A:1013792013184; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; World Health Organization, 2008, HEP B FACTSHEET 204	24	36	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32605	10.1371/journal.pone.0032605	http://dx.doi.org/10.1371/journal.pone.0032605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448225	gold, Green Published			2022-12-27	WOS:000303855700015
J	Zietkiewicz, E; Bukowy-Bieryllo, Z; Voelkel, K; Klimek, B; Dmenska, H; Pogorzelski, A; Sulikowska-Rowinska, A; Rutkiewicz, E; Witt, M				Zietkiewicz, Ewa; Bukowy-Bieryllo, Zuzanna; Voelkel, Katarzyna; Klimek, Barbara; Dmenska, Hanna; Pogorzelski, Andrzej; Sulikowska-Rowinska, Anna; Rutkiewicz, Ewa; Witt, Michal			Mutations in Radial Spoke Head Genes and Ultrastructural Cilia Defects in East-European Cohort of Primary Ciliary Dyskinesia Patients	PLOS ONE			English	Article							MESSENGER-RNA; DNAI1; BRONCHIECTASIS; PREDICTION; COMPLEX; RPGR	Primary ciliary dyskinesia (PCD) is a rare (1/20,000), multisystem disease with a complex phenotype caused by the impaired motility of cilia/flagella, usually related to ultrastructural defects of these organelles. Mutations in genes encoding radial spoke head (RSPH) proteins, elements of the ciliary ultrastructure, have been recently described. However, the relative involvement of RSPH genes in PCD pathogenesis remained unknown, due to a small number of PCD families examined for mutations in these genes. The purpose of this study was to estimate the involvement of RSPH4A and RSPH9 in PCD pathogenesis among East Europeans (West Slavs), and to shed more light on ultrastructural ciliary defects caused by mutations in these genes. The coding sequences of RSPH4A and RSPH9 were screened in PCD patients from 184 families, using single strand conformational polymorphism analysis and sequencing. Two previously described (Q109X; R490X) and two new RSPH4A mutations (W356X; IVS3_2-5del), in/around exons 1 and 3, were identified; no mutations were found in RSPH9. We estimate that mutations in RSPH4A, but not in RSPH9, are responsible for 2-3% of cases in the East European PCD population (4% in PCD families without situs inversus; 11% in families preselected for microtubular defects). Analysis of the SNP-haplotype background provided insight into the ancestry of repetitively found mutations (Q109X; R490X; IVS3_2-5del), but further studies involving other PCD cohorts are required to elucidate whether these mutations are specific for Slavic people or spread among other European populations. Ultrastructural defects associated with the mutations were analyzed in the transmission electron microscope images; almost half of the ciliary cross-sections examined in patients with RSPH4A mutations had the microtubule transposition phenotype (9+0 and 8+1 pattern). While microtubule transposition was a prevalent ultrastructural defect in cilia from patients with RSPH4A mutations, similar defects were also observed in PCD patients with mutations in other genes.	[Zietkiewicz, Ewa; Bukowy-Bieryllo, Zuzanna; Voelkel, Katarzyna; Klimek, Barbara; Rutkiewicz, Ewa; Witt, Michal] Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland; [Bukowy-Bieryllo, Zuzanna; Witt, Michal] Int Inst Mol & Cell Biol, Warsaw, Poland; [Dmenska, Hanna] Childrens Mem Hlth Inst, Dept Lung Physiol, Warsaw, Poland; [Pogorzelski, Andrzej] Inst TB & Lung Dis, Dept Pneumatol & Cyst Fibrosis, Rabka, Poland; [Sulikowska-Rowinska, Anna] Med Univ Warsaw, Dept Dev Age Pathomorphol, Warsaw, Poland	Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Children's Memorial Health Institute; Medical University of Warsaw	Zietkiewicz, E (corresponding author), Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland.	zietkiee@man.poznan.pl	Zietkiewicz, Ewa/ABP-3539-2022	Zietkiewicz, Ewa/0000-0003-2437-5088; Bukowy-Bieryllo, Zuzanna/0000-0002-6945-1059; Dmenska, Hanna/0000-0002-6450-0835; Witt, Michal/0000-0003-1729-4159	Polish Scientific Committee [NN401-09-5537, NN401-0204-35]; EU [ECFP7-HEALTHPROT-GA229676]	Polish Scientific Committee; EU(European Commission)	This work was supported by grants NN401-09-5537 (MW) and NN401-0204-35 (EZ) from the Polish Scientific Committee and by the EU grant ECFP7-HEALTHPROT-GA229676 (MW, ZBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Bautista-Harris G, 2000, VIRCHOWS ARCH, V437, P325, DOI 10.1007/s004280000221; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Chilvers MA, 2003, THORAX, V58, P333, DOI 10.1136/thorax.58.4.333; DEIONGH RU, 1995, AM J RESP CRIT CARE, V151, P1559, DOI 10.1164/ajrccm.151.5.7735615; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Escudier E, 2007, PAEDIATR RESPIR REV, V10, P51; Failly M, 2009, J MED GENET, V46, P281, DOI 10.1136/jmg.2008.061176; Failly M, 2008, RESPIRATION, V76, P198, DOI 10.1159/000128567; Geremek Maciej, 2004, Journal of Applied Genetics, V45, P347; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Iannaccone A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.11.e118; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Moore A, 2006, J MED GENET, V43, P326, DOI 10.1136/jmg.2005.034868; Morillas HN, 2007, RESPIRATION, V74, P252, DOI 10.1159/000101783; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Pifferi M, 2010, EUR RESPIR J, V35, P1413, DOI 10.1183/09031936.00186209; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Skrzypczak U, 2007, J APPL GENET, V48, P85, DOI 10.1007/BF03194662; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Stannard W, 2004, AM J RESP CRIT CARE, V169, P634, DOI 10.1164/rccm.200306-782OC; Stannard WA, 2010, AM J RESP CRIT CARE, V181, P307, DOI 10.1164/rccm.200903-0459OC; STURGESS JM, 1980, NEW ENGL J MED, V303, P318, DOI 10.1056/NEJM198008073030606; Zariwala M, 2001, AM J RESP CELL MOL, V25, P577, DOI 10.1165/ajrcmb.25.5.4619; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala MA, 2006, AM J RESP CRIT CARE, V174, P858, DOI 10.1164/rccm.200603-370OC; Zietkiewicz E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-174; Zito I, 2003, J MED GENET, V40, P609, DOI 10.1136/jmg.40.8.609	45	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33667	10.1371/journal.pone.0033667	http://dx.doi.org/10.1371/journal.pone.0033667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448264	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700055
J	Alaoui, SS; Dessirier, V; de Araujo, E; Alexaki, VI; Pelekanou, V; Lkhider, M; Stathopoulos, EN; Castanas, E; Bagot, M; Bensussan, A; Tsapis, A				Alaoui, Sanaa Sabour; Dessirier, Valerie; de Araujo, Elisabeth; Alexaki, Vassilia-Ismini; Pelekanou, Vassiliki; Lkhider, Mustapha; Stathopoulos, Efstathios N.; Castanas, Elias; Bagot, Martine; Bensussan, Armand; Tsapis, Andreas			TWEAK Affects Keratinocyte G2/M Growth Arrest and Induces Apoptosis through the Translocation of the AIF Protein to the Nucleus	PLOS ONE			English	Article							FACTOR RECEPTOR FAMILY; WEAK INDUCER; CELL-DEATH; TNF-ALPHA; EPIDERMAL-KERATINOCYTES; ENDOTHELIAL-CELLS; GENOTOXIC STRESS; KAPPA-B; NECROSIS; ACTIVATION	The soluble TNF-like weak inducer of apoptosis (TWEAK, TNFSF12) binds to the fibroblast growth factor-inducible 14 receptor (FN14, TNFRSF12A) on the cell membrane and induces multiple biological responses, such as proliferation, migration, differentiation, angiogenesis and apoptosis. Previous reports show that TWEAK, which does not contain a death domain in its cytoplasmic tail, induces the apoptosis of tumor cell lines through the induction of TNF alpha secretion. TWEAK induces apoptosis in human keratinocytes. Our experiments clearly demonstrate that TWEAK does not induce the secretion of TNF alpha or TRAIL proteins. The use of specific inhibitors and the absence of procaspase-3 cleavage suggest that the apoptosis of keratinocytes follows a caspase-and cathepsin B-independent pathway. Further investigation showed that TWEAK induces a decrease in the mitochondrial membrane potential of keratinocytes. Confocal microscopy showed that TWEAK induces the cleavage and the translocation of apoptosis inducing factor (AIF) from the mitochondria to the nucleus, thus initiating caspase-independent apoptosis. Moreover, TWEAK induces FOXO3 and GADD45 expression, cdc2 phosphorylation and cdc2 and cyclinB1 degradation, resulting in the arrest of cell growth at the G2/M phase. Finally, we report that TWEAK and FN14 are normally expressed in the basal layer of the physiological epidermis and are greatly enhanced in benign (psoriasis) and malignant (squamous cell carcinoma) skin pathologies that are characterized by an inflammatory component. TWEAK might play an essential role in skin homeostasis and pathology.	[Alaoui, Sanaa Sabour; Dessirier, Valerie; de Araujo, Elisabeth; Bagot, Martine; Bensussan, Armand; Tsapis, Andreas] INSERM, U976, Paris, France; [Alaoui, Sanaa Sabour; Dessirier, Valerie; de Araujo, Elisabeth; Bagot, Martine; Bensussan, Armand; Tsapis, Andreas] Univ Paris Diderot, Paris, France; [Alaoui, Sanaa Sabour; Lkhider, Mustapha] Univ Chouaib Doukkali, Dept Biol, El Jadida, Morocco; [Alexaki, Vassilia-Ismini; Pelekanou, Vassiliki; Castanas, Elias] Univ Crete, Sch Med, Lab Expt Endocrinol, Iraklion, Greece; [Pelekanou, Vassiliki; Stathopoulos, Efstathios N.] Univ Crete, Sch Med, Pathol Lab, Iraklion, Greece; [Bagot, Martine; Bensussan, Armand] Hop St Louis, Serv Dermatol, F-75475 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Chouaib Doukkali University of El Jadida; University of Crete; University of Crete; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Alaoui, SS (corresponding author), INSERM, U976, Paris, France.	andreas.tsapis@inserm.fr	Pelekanou, Vasiliki/AAB-9735-2021; Castanas, Elias/E-7007-2010; Bensussan, Armand/E-5434-2017; Alexaki, Vasileia Ismini/K-5527-2019	Pelekanou, Vasiliki/0000-0002-8431-1927; Castanas, Elias/0000-0002-8370-1835; Alexaki, Vasileia Ismini/0000-0003-3935-8985; Bensussan, Armand/0000-0002-0409-2497	INSERM; Ligue Contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by INSERM and Ligue Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki VI, 2009, J IMMUNOL, V183, P5948, DOI 10.4049/jimmunol.0901186; Ando T, 2001, J BIOL CHEM, V276, P42971, DOI 10.1074/jbc.M106460200; Ando T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2038; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Bassoe CF, 2003, CYTOM PART B-CLIN CY, V51B, P21, DOI 10.1002/cyto.b.10003; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Dai X, 2004, J INVEST DERMATOL, V122, P1356, DOI 10.1111/j.0022-202X.2004.22522.x; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; de Araujo E, 2011, EXP DERMATOL, V20, P107, DOI 10.1111/j.1600-0625.2010.01176.x; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Jakubowski A, 2002, J CELL SCI, V115, P267; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Kaplan MJ, 2000, J IMMUNOL, V164, P2897, DOI 10.4049/jimmunol.164.6.2897; Kim DS, 2008, EXP DERMATOL, V17, P312, DOI 10.1111/j.1600-0625.2007.00646.x; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Nakayama M, 2003, BIOCHEM BIOPH RES CO, V306, P819, DOI 10.1016/S0006-291X(03)01051-9; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Notas G., 2011, J NUTR BIOCH; Pelekanou V, 2011, ANAL CELL PATHOL, V34, P49, DOI [10.3233/ACP-2011-0001, 10.1155/2011/108631]; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Segaert S, 1997, J INVEST DERMATOL, V109, P46, DOI 10.1111/1523-1747.ep12276488; Sureda FX, 1999, BRAIN RES PROTOC, V4, P280, DOI 10.1016/S1385-299X(99)00030-6; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Wilson CA, 2002, CELL DEATH DIFFER, V9, P1321, DOI 10.1038/sj.cdd.4401107; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Winkles JA, 2007, FRONT BIOSCI-LANDMRK, V12, P2761, DOI 10.2741/2270; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	48	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33609	10.1371/journal.pone.0033609	http://dx.doi.org/10.1371/journal.pone.0033609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438963	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100069
J	Bucci, MP; Nassibi, N; Gerard, CL; Bui-Quoc, E; Seassau, M				Bucci, Maria Pia; Nassibi, Naziha; Gerard, Christophe-Loic; Bui-Quoc, Emmanuel; Seassau, Magali			Immaturity of the Oculomotor Saccade and Vergence Interaction in Dyslexic Children: Evidence from a Reading and Visual Search Study	PLOS ONE			English	Article							EYE-MOVEMENTS; BINOCULAR COORDINATION; DEVELOPMENTAL DYSLEXIA; ATTENTION; ACTIVATION; DEFICIT	Studies comparing binocular eye movements during reading and visual search in dyslexic children are, at our knowledge, inexistent. In the present study we examined ocular motor characteristics in dyslexic children versus two groups of non dyslexic children with chronological/reading age-matched. Binocular eye movements were recorded by an infrared system (mobileEBT (R), e(ye) BRAIN) in twelve dyslexic children (mean age 11 years old) and a group of chronological age-matched (N = 9) and reading age-matched (N = 10) non dyslexic children. Two visual tasks were used: text reading and visual search. Independently of the task, the ocular motor behavior in dyslexic children is similar to those reported in reading age-matched non dyslexic children: many and longer fixations as well as poor quality of binocular coordination during and after the saccades. In contrast, chronological age-matched non dyslexic children showed a small number of fixations and short duration of fixations in reading task with respect to visual search task; furthermore their saccades were well yoked in both tasks. The atypical eye movement's patterns observed in dyslexic children suggest a deficiency in the visual attentional processing as well as an immaturity of the ocular motor saccade and vergence systems interaction.	[Bucci, Maria Pia; Nassibi, Naziha] Univ Paris 05, CNRS, FRE 3292, Lab Psychol & Neuropsychol Cognit, Boulogne Billancourt, France; [Gerard, Christophe-Loic] Hop Robert Debre, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France; [Bui-Quoc, Emmanuel] Hop Robert Debre, Serv Ophtalmol, F-75019 Paris, France; [Seassau, Magali] E Ye BRAI, Ivry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Bucci, MP (corresponding author), Univ Paris 05, CNRS, FRE 3292, Lab Psychol & Neuropsychol Cognit, Boulogne Billancourt, France.	maria-pia.bucci@parisdescartes.fr						Angelakis E, 2012, CLIN NEUROPHYSIOL, V121, P1792; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bucci MP, 2008, GRAEF ARCH CLIN EXP, V246, P417, DOI 10.1007/s00417-007-0723-1; Bucci MP, 2006, VISION RES, V46, P3594, DOI 10.1016/j.visres.2006.06.001; Bucci MP, 2009, J OPHTHALMOL, V2009, DOI 10.1155/2009/325214; Bucci MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023125; Bucci MP, 2006, VISION RES, V46, P457, DOI 10.1016/j.visres.2005.05.004; Bucci MP, 2002, INVEST OPHTH VIS SCI, V43, P1040; Chevrie-Muller C, 1997, BATTERIE LANGAGE ORA; De Luca M, 1999, NEUROPSYCHOLOGIA, V37, P1407, DOI 10.1016/S0028-3932(99)00038-X; Dhar M, 2010, CORTEX, V46, P800, DOI 10.1016/j.cortex.2010.02.001; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; FIORAVANTI F, 1995, VISION RES, V35, P3217, DOI 10.1016/0042-6989(95)00152-5; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Hatzidaki A, 2011, DYSLEXIA, V17, P85, DOI 10.1002/dys.416; Heller D, 1999, CURRENT OCULOMOTOR R; Hutzler F, 2006, NEUROPSYCHOLOGIA, V44, P637, DOI 10.1016/j.neuropsychologia.2005.06.006; Hutzler F, 2004, BRAIN LANG, V89, P235, DOI 10.1016/S0093-934X(03)00401-2; Iles J, 2000, Dyslexia, V6, P163, DOI 10.1002/1099-0909(200007/09)6:3<163::AID-DYS150>3.0.CO;2-U; Jainta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018694; Jainta S, 2010, J VISION, V10, DOI 10.1167/10.13.2; Kennedy A, 1998, Q J EXP PSYCHOL-A, V51, P135, DOI 10.1080/713755746; Kirkby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027105; Levy-Schoen A, 1979, PROCESSING VISIBLE L; Li XH, 2009, CHINESE MED J-PEKING, V122, P267, DOI 10.3760/cma.j.issn.0366-6999.2009.03.006; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; PAVLIDIS GT, 1981, NEUROPSYCHOLOGIA, V19, P57, DOI 10.1016/0028-3932(81)90044-0; Peyrin C, 2011, BRAIN LANG, V118, P128, DOI 10.1016/j.bandl.2010.06.005; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; Rayner K, 1985, DEV NEUROPSYCHOL, V1, P3, DOI 10.1080/87565648509540294; Simos PG, 2001, DEV NEUROPSYCHOL, V19, P191, DOI 10.1207/S15326942DN1902_4; Skottun BC, 2010, CORTEX, V46, P799, DOI 10.1016/j.cortex.2009.12.006; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Stein JF., 1993, J RES READ, V16, P30, DOI [DOI 10.1111/J.1467-9817.1993.TB00033.X, 10.1111/j.1467-9817.1993.tb00033.x]; Trauzettel-Klosinski S, 2010, ACTA OPHTHALMOL, V88, P681, DOI 10.1111/j.1755-3768.2009.01523.x; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; Wilkins AJ, 2007, PERCEPTION, V36, P1788, DOI 10.1068/p5651; Yang Q, 2003, J VISION, V3, P554, DOI 10.1167/3.8.3	41	60	60	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33458	10.1371/journal.pone.0033458	http://dx.doi.org/10.1371/journal.pone.0033458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	932RV	22438934	gold, Green Published			2022-12-27	WOS:000303309100048
J	Sun, GL; Stewart, CN; Xiao, P; Zhang, BH				Sun, Guiling; Stewart, C. Neal, Jr.; Xiao, Peng; Zhang, Baohong			MicroRNA Expression Analysis in the Cellulosic Biofuel Crop Switchgrass (Panicum virgatum) under Abiotic Stress	PLOS ONE			English	Article							MICROARRAY-BASED ANALYSIS; TRANSCRIPTION FACTORS; DIFFERENTIAL EXPRESSION; RESPONSIVE MICRORNAS; REGULATED MICRORNAS; SMALL RNAS; ARABIDOPSIS; IDENTIFICATION; SALINITY; MIRNAS	Switchgrass has increasingly been recognized as a dedicated biofuel crop for its broad adaptation to marginal lands and high biomass. However, little is known about the basic biology and the regulatory mechanisms of gene expression in switchgrass, particularly under stress conditions. In this study, we investigated the effect of salt and drought stress on switchgrass germination, growth and the expression of small regulatory RNAs. The results indicate that salt stress had a gradual but significant negative effect on switchgrass growth and development. The germination rate was significantly decreased from 82% for control to 36% under 1% NaCl treatment. However, drought stress had little effect on the germination rate but had a significant effect on the growth of switchgrass under the severest salinity stress. Both salt and drought stresses altered the expression pattern of miRNAs in a dose-dependent manner. However, each miRNA responded to drought stress in a different pattern. Salt and drought stress changed the expression level of miRNAs mainly from 0.9-fold up-regulation to 0.7-fold down-regulation. miRNAs were less sensitive to drought treatment than salinity treatment, as evidenced by the narrow fold change in expression levels. Although the range of change in expression level of miRNAs was similar under salt and drought stress, no miRNAs displayed significant change in expression level under all tested salt conditions. Two miRNAs, miR156 and miR162, showed significantly change in expression level under high drought stress. This suggests that miR156 and miR162 may attribute to the adaption of switchgrass to drought stress and are good candidates for improving switchgrass as a biofuel crop by transgenic technology.	[Sun, Guiling; Zhang, Baohong] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Stewart, C. Neal, Jr.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA; [Stewart, C. Neal, Jr.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA; [Xiao, Peng] E Carolina Univ, Dept Math, Greenville, NC 27858 USA	University of North Carolina; East Carolina University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); University of North Carolina; East Carolina University	Sun, GL (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	zhangb@ecu.edu	Zhang, Baohong/O-4948-2016; Stewart, Neal/B-4709-2009	Stewart, Neal/0000-0003-3026-9193				Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Barney JN, 2009, PLANT SCI, V177, P724, DOI 10.1016/j.plantsci.2009.09.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Covarrubias AA, 2010, PLANT CELL ENVIRON, V33, P481, DOI 10.1111/j.1365-3040.2009.02048.x; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Huang SQ, 2009, J INORG BIOCHEM, V103, P282, DOI 10.1016/j.jinorgbio.2008.10.019; Hwang EW, 2011, GENES GENOM, V33, P105, DOI 10.1007/s13258-010-0135-1; Jung JH, 2011, PLANT MOL BIOL, V76, P35, DOI 10.1007/s11103-011-9759-z; Larue CT, 2009, PLANT J, V58, P450, DOI 10.1111/j.1365-313X.2009.03796.x; Li B, 2011, J EXP BOT; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Lu XY, 2008, BIOCHEM BIOPH RES CO, V368, P458, DOI 10.1016/j.bbrc.2008.02.007; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Matts J, 2010, J PLANT PHYSIOL, V167, P896, DOI 10.1016/j.jplph.2010.02.001; McLaughlin SB, 2006, ADV AGRON, V90, P267, DOI 10.1016/S0065-2113(06)90007-8; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; SLADDEN SE, 1991, BIOMASS BIOENERG, V1, P119, DOI 10.1016/0961-9534(91)90034-A; Stroup JA, 2003, BIORESOURCE TECHNOL, V86, P65, DOI 10.1016/S0960-8524(02)00102-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wullschleger SD, 1996, CROP SCI, V36, P306, DOI 10.2135/cropsci1996.0011183X003600020016x; Xie FL, 2010, PLANTA, V232, P417, DOI 10.1007/s00425-010-1182-1; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Zhang BH, 2009, MOL BIOTECHNOL, V42, P269, DOI 10.1007/s12033-009-9163-y; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005	40	46	53	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32017	10.1371/journal.pone.0032017	http://dx.doi.org/10.1371/journal.pone.0032017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470418	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000002
J	Vis, DJ; Westerhuis, JA; Hoefsloot, HCJ; Roelfsema, F; Hendriks, MMWB; Smilde, AK				Vis, Daniel J.; Westerhuis, Johan A.; Hoefsloot, Huub C. J.; Roelfsema, Ferdinand; Hendriks, Margriet M. W. B.; Smilde, Age K.			Detecting Regulatory Mechanisms in Endocrine Time Series Measurements	PLOS ONE			English	Article							SECRETION; PULSATILE; AGE	The regulatory mechanisms underlying pulsatile secretion are complex, especially as it is partly controlled by other hormones and the combined action of multiple agents. Regulatory relations between hormones are not directly observable but may be deduced from time series measurements of plasma hormone concentrations. Variation in plasma hormone levels are the resultant of secretion and clearance from the circulation. A strategy is proposed to extract inhibition, activation, thresholds and circadian synchronicity from concentration data, using particular association methods. Time delayed associations between hormone concentrations and/or extracted secretion pulse profiles reveal the information on regulatory mechanisms. The above mentioned regulatory mechanisms are illustrated with simulated data. Additionally, data from a lean cohort of healthy control subjects is used to illustrate activation (ACTH and cortisol) and circadian synchronicity (ACTH and TSH) in real data. The simulation and the real data both consist of 145 equidistant samples per individual, matching a 24-hr time span with 10 minute intervals. The results of the simulation and the real data are in concordance.	[Vis, Daniel J.; Hendriks, Margriet M. W. B.] Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands; [Vis, Daniel J.; Westerhuis, Johan A.; Hoefsloot, Huub C. J.; Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Vis, Daniel J.; Westerhuis, Johan A.; Hoefsloot, Huub C. J.; Hendriks, Margriet M. W. B.; Smilde, Age K.] Netherlands Metab Ctr, Leiden, Netherlands; [Roelfsema, Ferdinand] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Vis, DJ (corresponding author), Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands.	science@danielvis.nl		Smilde, Age/0000-0002-3052-4644	Netherlands Metabolomics Center; Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research	Netherlands Metabolomics Center; Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research	TNO Quality of Life supported this research from the systems biology program (www.tno.nl). The Netherlands Metabolomics Center, which is part of the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research (http://www.metabolomicscentre.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grant GA, 1937, BIOCHEM J, V31, P1538, DOI 10.1042/bj0311538; Keenan DM, 2010, AM J PHYSIOL-REG I, V299, pR11, DOI 10.1152/ajpregu.00201.2010; Keenan DM, 2009, AM J PHYSIOL-REG I, V297, pR515, DOI 10.1152/ajpregu.00200.2009; Reid KJ, 2009, SEMIN NEUROL, V29, P393, DOI 10.1055/s-0029-1237120; Shirakawa T, 2001, CHRONOBIOL INT, V18, P371, DOI 10.1081/CBI-100103962; Veldhuis JD, 2009, J CLIN ENDOCR METAB, V94, P4045, DOI 10.1210/jc.2009-1143; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Vis DJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE146, DOI 10.1152/ajpendo.00048.2009; WALTERVANCAUTER E, 1981, INT J PEPT PROT RES, V17, P3	9	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e32985	10.1371/journal.pone.0032985	http://dx.doi.org/10.1371/journal.pone.0032985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461889	Green Submitted, gold, Green Published			2022-12-27	WOS:000304118900008
J	Fernandez-Barral, A; Orgaz, JL; Gomez, V; del Peso, L; Calzada, MJ; Jimenez, B				Fernandez-Barral, Asuncion; Luis Orgaz, Jose; Gomez, Valenti; del Peso, Luis; Jose Calzada, Maria; Jimenez, Benilde			Hypoxia Negatively Regulates Antimetastatic PEDF in Melanoma Cells by a Hypoxia Inducible Factor-Independent, Autophagy Dependent Mechanism	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; STRESS-INDUCED AUTOPHAGY; PROLYL HYDROXYLATION; FACTOR EXPRESSION; GENE-EXPRESSION; DOWN-REGULATION; BREAST-CANCER; TUMOR-GROWTH; HIF-ALPHA; IN-VIVO	Pigment epithelium-derived factor (PEDF), a member of the serine protease inhibitor (SERPIN) superfamily, displays a potent antiangiogenic and antimetastatic activity in a broad range of tumor types. Melanocytes and low aggressive melanoma cells secrete high levels of PEDF, while its expression is lost in highly aggressive melanomas. PEDF efficiently abrogates a number of functional properties critical for the acquisition of metastatic ability by melanoma cells, such as neovascularization, proliferation, migration, invasiveness and extravasation. In this study, we identify hypoxia as a relevant negative regulator of PEDF in melanocytes and low aggressive melanoma cells. PEDF was regulated at the protein level. Importantly, although downregulation of PEDF was induced by inhibition of 2-oxoglutarate-dependent dioxygenases, it was independent of the hypoxia inducible factor (HIF), a key mediator of the adaptation to hypoxia. Decreased PEDF protein was not mediated by inhibition of translation through untranslated regions (UTRs) in melanoma cells. Degradation by metalloproteinases, implicated on PEDF degradation in retinal pigment epithelial cells, or by the proteasome, was also excluded as regulatory mechanism in melanoma cells. Instead, we found that degradation by autophagy was critical for PEDF downregulation under hypoxia in human melanoma cells. Our findings show that hypoxic conditions encountered during primary melanoma growth downregulate antiangiogenic and antimetastasic PEDF by a posttranslational mechanism involving degradation by autophagy and could therefore contribute to the acquisition of highly metastatic potential characteristic of aggressive melanoma cells.	[Fernandez-Barral, Asuncion; Luis Orgaz, Jose; Gomez, Valenti; del Peso, Luis; Jimenez, Benilde] Univ Autonoma Madrid, Dept Biochem, Madrid, Spain; [Fernandez-Barral, Asuncion; Luis Orgaz, Jose; Gomez, Valenti; del Peso, Luis; Jose Calzada, Maria; Jimenez, Benilde] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Jose Calzada, Maria] Univ Autonoma Madrid, Inst Invest Sanitaria Princesa, Hosp Princesa, Serv Inmunol, Madrid, Spain; [Jose Calzada, Maria] Univ Autonoma Madrid, Dept Med, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Autonomous University of Madrid	Fernandez-Barral, A (corresponding author), Univ Autonoma Madrid, Dept Biochem, Madrid, Spain.	bjimenez@iib.uam.es	del Peso, Luis/K-9391-2014; Fernández-Barral, Asunión/O-8133-2015; Orgaz, Jose L./ABH-1835-2020; Cuenca, Benilde Jimenez/K-9959-2014	del Peso, Luis/0000-0003-4014-5688; Fernández-Barral, Asunión/0000-0002-1278-4645; Orgaz, Jose L./0000-0002-9776-7544; Jimenez Cuenca, Benilde/0000-0002-1806-6636; Gomez, Valenti/0000-0002-2162-6462	Ministerio de Educacion y Ciencia [SAF2007-62292, SAF2010-19256, SAF2009-11113, SAF2008-03147]; CSIC-JAE;  [S-SAL-0311_2006]	Ministerio de Educacion y Ciencia(Spanish Government); CSIC-JAE; 	This work was supported by grants Ministerio de Educacion y Ciencia SAF2007-62292 and SAF2010-19256 to BJ, SAF2009-11113 to MJC and SAF2008-03147 to LP. AFB was supported by a CSIC-JAE fellowship, JLO by a Ministerio de Educacion y Ciencia SAF2007-62292 contract and VG by S-SAL-0311_2006 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Abramson LP, 2003, J PEDIATR SURG, V38, P336, DOI 10.1053/jpsu.2003.50104; Adams AE, 2006, NAT MED, V12, P168, DOI 10.1038/nm0206-168; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Bedogni B, 2009, PIGM CELL MELANOMA R, V22, P166, DOI 10.1111/j.1755-148X.2009.00553.x; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Broadhead ML, 2009, EXPERT OPIN THER TAR, V13, P1429, DOI 10.1517/14728220903307475; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cai J, 2006, CLIN CANCER RES, V12, P3510, DOI 10.1158/1078-0432.CCR-06-0094; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chen JL, 2009, AUTOPHAGY, V5, P244, DOI 10.4161/auto.5.2.7549; Chen JL, 2008, J BIOL CHEM, V283, P34432, DOI 10.1074/jbc.M804239200; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Ek ETH, 2006, MOL CANCER THER, V5, P1641, DOI 10.1158/1535-7163.MCT-06-0107; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fernandez-Garcia NI, 2007, J MOL MED-JMM, V85, P15, DOI 10.1007/s00109-006-0111; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Garcia M, 2004, CANCER RES, V64, P5632, DOI 10.1158/0008-5472.CAN-04-0230; Garcia-Lopez MA, 2005, J INVEST DERMATOL, V125, P1001, DOI 10.1111/j.0022-202X.2005.23882.x; Gorospe M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00007; Gross C, 2007, MOL CELL BIOL, V27, P4133, DOI 10.1128/MCB.01867-06; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Guan M, 2003, J CLIN PATHOL, V56, P277, DOI 10.1136/jcp.56.4.277; Halin S, 2004, CANCER RES, V64, P5664, DOI 10.1158/0008-5472.CAN-04-0835; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoshina D, 2010, CURR MOL MED, V10, P292, DOI 10.2174/156652410791065327; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KRAGGERUD SM, 1995, ANTICANCER RES, V15, P683; Ladhani O, 2011, NEOPLASIA, V13, P633, DOI 10.1593/neo.11446; Li G, 2001, ONCOGENE, V20, P8125, DOI 10.1038/sj.onc.1205034; Masuda K, 2009, J CELL MOL MED, V13, P2759, DOI 10.1111/j.1582-4934.2009.00842.x; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; McCormick R, 2010, CURR TOP MICROBIOL, V345, P47, DOI 10.1007/82_2010_76; Michaylira CZ, 2006, CANCER BIOL THER, V5, P476, DOI 10.4161/cbt.5.5.2749; Notari L, 2005, INVEST OPHTH VIS SCI, V46, P2736, DOI 10.1167/iovs.04-1489; Orgaz JL, 2009, ONCOGENE, V28, P4147, DOI 10.1038/onc.2009.284; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Punzon I, 2004, BLOOD, V103, P580, DOI 10.1182/blood-2003-07-2298; Pursiheimo JP, 2009, ONCOGENE, V28, P334, DOI 10.1038/onc.2008.392; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Tombran-Tink J, 2005, FRONT BIOSCI-LANDMRK, V10, P2131, DOI 10.2741/1686; Tombran-Tink J, 2010, CURR MOL MED, V10, P267, DOI 10.2174/156652410791065336; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhu QY, 2009, CANCER INVEST, V27, P794, DOI 10.1080/07357900802175617	64	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e32989	10.1371/journal.pone.0032989	http://dx.doi.org/10.1371/journal.pone.0032989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457728	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900006
J	Figueiredo, AC; Clement, CC; Zakia, S; Gingold, J; Philipp, M; Pereira, PJB				Figueiredo, Ana C.; Clement, Cristina C.; Zakia, Sheuli; Gingold, Julian; Philipp, Manfred; Pereira, Pedro J. B.			Rational Design and Characterization of D-Phe-Pro-D-Arg-Derived Direct Thrombin Inhibitors	PLOS ONE			English	Article							HUMAN ALPHA-THROMBIN; ACTIVE-SITE GEOMETRY; CRYSTAL-STRUCTURE; PEPTIDE INHIBITORS; CHLOROMETHYLKETONE; ANTICOAGULANTS; DABIGATRAN; HIRUGEN; COMPLEX; FOCUS	The tremendous social and economic impact of thrombotic disorders, together with the considerable risks associated to the currently available therapies, prompt for the development of more efficient and safer anticoagulants. Novel peptide-based thrombin inhibitors were identified using in silico structure-based design and further validated in vitro. The best candidate compounds contained both L- and D-amino acids, with the general sequence D-Phe(P3)-Pro(P2)-D-Arg(P1)-P1'-CONH2. The P1' position was scanned with L-and D-isomers of natural or unnatural amino acids, covering the major chemical classes. The most potent non-covalent and proteolysis-resistant inhibitors contain small hydrophobic or polar amino acids (Gly, Ala, Ser, Cys, Thr) at the P1' position. The lead tetrapeptide, D-Phe-Pro-D-Arg-D-Thr-CONH2, competitively inhibits alpha-thrombin's cleavage of the S2238 chromogenic substrate with a K-i of 0.92 mu M. In order to understand the molecular details of their inhibitory action, the three-dimensional structure of three peptides (with P1' L-isoleucine (fPrI), L-cysteine (fPrC) or D-threonine (fPrt)) in complex with human alpha-thrombin were determined by X-ray crystallography. All the inhibitors bind in a substrate-like orientation to the active site of the enzyme. The contacts established between the D-Arg residue in position P1 and thrombin are similar to those observed for the L-isomer in other substrates and inhibitors. However, fPrC and fPrt disrupt the active site His57-Ser195 hydrogen bond, while the combination of a P1 D-Arg and a bulkier P1' residue in fPrI induce an unfavorable geometry for the nucleophilic attack of the scissile bond by the catalytic serine. The experimental models explain the observed relative potency of the inhibitors, as well as their stability to proteolysis. Moreover, the newly identified direct thrombin inhibitors provide a novel pharmacophore platform for developing antithrombotic agents by exploring the conformational constrains imposed by the D-stereochemistry of the residues at positions P1 and P1'.	[Figueiredo, Ana C.; Pereira, Pedro J. B.] Univ Porto, IBMC Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Clement, Cristina C.; Zakia, Sheuli; Philipp, Manfred] CUNY Grad Sch, Dept Chem, Lehman Coll, New York, NY USA; [Clement, Cristina C.; Zakia, Sheuli; Philipp, Manfred] CUNY Grad Sch, Biochem Program, New York, NY USA; [Gingold, Julian] Mt Sinai Sch Med, MD Program, New York, NY USA	Universidade do Porto; City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; Lehman College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; Icahn School of Medicine at Mount Sinai	Figueiredo, AC (corresponding author), Univ Porto, IBMC Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	cristina.clement@lehman.cuny.edu; manfred.philipp@lehman.cuny.edu; ppereira@ibmc.up.pt	Philipp, Manfred/R-8940-2019; Pereira, Pedro/F-8972-2011; Gingold, Julian/AAD-7321-2020; Clement, Cristina/ABG-4525-2021; Figueiredo, Ana/K-1384-2013	Pereira, Pedro/0000-0003-0969-5438; Gingold, Julian/0000-0002-0354-5933; Clement, Cristina/0000-0003-1464-407X; Figueiredo, Ana/0000-0001-8386-8216; Philipp, Manfred/0000-0002-9010-9813	Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/BIA-PRO/70627/2006]; EU [REEQ/564/B10/2005, PEst-C/SAU/LA0002/2011]; Fullbright Scholar Award; PSC-CUNY; Biochemistry Department at the Graduate Center of the City University of New York; Chemistry Department, Lehman College, CUNY;  [SFR/BPD/46722/2008]	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); EU(European Commission); Fullbright Scholar Award; PSC-CUNY; Biochemistry Department at the Graduate Center of the City University of New York; Chemistry Department, Lehman College, CUNY; 	This work was funded in part by Fundacao para a Ciencia e a Tecnologia (Portugal) through grants PTDC/BIA-PRO/70627/2006, REEQ/564/B10/2005 (EU-FEDER and POCI 2010) and PEst-C/SAU/LA0002/2011 (EU-FEDER funding through COMPETE), and a postdoctoral fellowship (SFR/BPD/46722/2008) to ACF. MP was supported by a Fullbright Scholar Award and the PSC-CUNY research awards program. CC was supported by a research grant from the Biochemistry Department at the Graduate Center of the City University of New York (2001-2003) and by an Adjunct Lecturer appointment at the Chemistry Department, Lehman College, CUNY (2001-2006). The funding bodies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andricopulo AD, 2009, CURR TOP MED CHEM, V9, P771, DOI 10.2174/156802609789207127; Babuin L, 2010, VASC HEALTH RISK MAN, V6, P813, DOI 10.2147/VHRM.S3904; BAJUSZ S, 1982, Folia Haematologica (Leipzig), V109, P16; BANNER DW, 1991, J BIOL CHEM, V266, P20085; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1992, PROTEIN SCI, V1, P426; Burke FM, 2006, CHEM BIOL DRUG DES, V68, P235, DOI 10.1111/j.1747-0285.2006.00442.x; CHEN ZG, 1995, ARCH BIOCHEM BIOPHYS, V322, P198, DOI 10.1006/abbi.1995.1452; Cuker A, 2011, J THROMB THROMBOLYS, V31, P353, DOI 10.1007/s11239-011-0569-6; DeSimone G, 1997, J MOL BIOL, V269, P558, DOI 10.1006/jmbi.1997.1037; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezekowitz MD, 2011, J INTERV CARD ELECTR, V32, P173, DOI 10.1007/s10840-011-9593-x; Figueiredo AC, 2011, ACTA CRYSTALLOGR F, V67, P54, DOI 10.1107/S1744309110043472; Friedrich R, 2002, J MOL BIOL, V316, P869, DOI 10.1006/jmbi.2001.5394; Girnys EA, 2010, CHEM BIOL DRUG DES, V75, P35, DOI 10.1111/j.1747-0285.2009.00915.x; GUICHARD G, 1994, P NATL ACAD SCI USA, V91, P9765, DOI 10.1073/pnas.91.21.9765; Hauel NH, 2002, J MED CHEM, V45, P1757, DOI 10.1021/jm0109513; Isaacs RCA, 2011, BIOORG MED CHEM LETT, V21, P1536, DOI 10.1016/j.bmcl.2010.12.105; Krishnan R, 1996, PROTEIN SCI, V5, P422; MARAGANORE JM, 1990, BIOCHEMISTRY-US, V29, P7095, DOI 10.1021/bi00482a021; Matthews JH, 1996, BIOPHYS J, V71, P2830, DOI 10.1016/S0006-3495(96)79479-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mousa SA, 2010, METHODS MOL BIOL, V663, P157, DOI 10.1007/978-1-60761-803-4_5; NEISES B, 1993, ADV EXP MED BIOL, V340, P185; Nieman MT, 2008, J THROMB HAEMOST, V6, P837, DOI 10.1111/j.1538-7836.2008.02937.x; Nieman MT, 2004, J PHARMACOL EXP THER, V311, P492, DOI 10.1124/jpet.104.069229; OKAMOTO S, 1981, BIOCHEM BIOPH RES CO, V101, P440, DOI 10.1016/0006-291X(81)91279-1; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; QIU XY, 1992, BIOCHEMISTRY-US, V31, P11689, DOI 10.1021/bi00162a004; Scharer K, 2004, HELV CHIM ACTA, V87, P2517, DOI 10.1002/hlca.200490225; Sinauridze EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019969; Sion-Usakiewicz JJ, 2000, BIOCHEMISTRY-US, V39, P2384, DOI 10.1021/bi992419b; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; Srivastava S, 2005, MED RES REV, V25, P66, DOI 10.1002/med.20016; St Charles R, 1999, J MED CHEM, V42, P1376, DOI 10.1021/jm980052n; Stangier J, 2008, CLIN PHARMACOKINET, V47, P285, DOI 10.2165/00003088-200847050-00001; Steffel J, 2011, EUR HEART J, V32, P1968, DOI 10.1093/eurheartj/ehr052; Steffel J, 2009, J CARDIOVASC MED, V10, P616, DOI 10.2459/JCM.0b013e32832edac0; Talele TT, 2010, CURR TOP MED CHEM, V10, P127, DOI 10.2174/156802610790232251; Wagner J, 1998, J MED CHEM, V41, P3664, DOI 10.1021/jm981013e	42	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34354	10.1371/journal.pone.0034354	http://dx.doi.org/10.1371/journal.pone.0034354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457833	gold, Green Published			2022-12-27	WOS:000304046900062
J	Li, J; Chu, HW; Zhang, YH; Mou, TM; Wu, CY; Zhang, QF; Xu, J				Li, Juan; Chu, Huangwei; Zhang, Yonghong; Mou, Tongmin; Wu, Changyin; Zhang, Qifa; Xu, Jian			The Rice HGW Gene Encodes a Ubiquitin-Associated (UBA) Domain Protein That Regulates Heading Date and Grain Weight	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR-1; NATURAL VARIATION; FLOWERING-TIME; 26S PROTEASOME; MAJOR QTL; ARABIDOPSIS; COP1; EXPRESSION; ORTHOLOG; SIGNAL	Heading date and grain weight are two determining agronomic traits of crop yield. To date, molecular factors controlling both heading date and grain weight have not been identified. Here we report the isolation of a hemizygous mutation, heading and grain weight (hgw), which delays heading and reduces grain weight in rice. Analysis of hgw mutant phenotypes indicate that the hemizygous hgw mutation decreases latitudinal cell number in the lemma and palea, both composing the spikelet hull that is known to determine the size and shape of brown grain. Molecular cloning and characterization of the HGW gene showed that it encodes a novel plant-specific ubiquitin-associated (UBA) domain protein localized in the cytoplasm and nucleus, and functions as a key upstream regulator to promote expressions of heading date-and grain weight-related genes. Moreover, co-expression analysis in rice and Arabidopsis indicated that HGW and its Arabidopsis homolog are co-expressed with genes encoding various components of ubiquitination machinery, implying a fundamental role for the ubiquitination pathway in heading date and grain weight control.	[Li, Juan; Zhang, Yonghong; Mou, Tongmin; Wu, Changyin; Zhang, Qifa; Xu, Jian] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Chu, Huangwei; Xu, Jian] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chu, Huangwei; Xu, Jian] Natl Univ Singapore, NUS Ctr BioImaging Sci, Singapore 117548, Singapore	Huazhong Agricultural University; National University of Singapore; National University of Singapore	Li, J (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	dbsxj@nus.edu.sg	Xu, Jian/I-2921-2012	Xu, Jian/0000-0001-6194-6316; Huangwei, Chu/0000-0001-8846-2506	Ministry of Education of Singapore [MOE2009-T2-1-060]; China National Program on Research and Development of Transgenic Plants [2008ZX08001-004]; National Key Laboratory of Crop Genetic Improvement and Huazhong Agricultural University	Ministry of Education of Singapore(Ministry of Education, Singapore); China National Program on Research and Development of Transgenic Plants; National Key Laboratory of Crop Genetic Improvement and Huazhong Agricultural University	This work was supported by the AcRF Tier 2 grant (MOE2009-T2-1-060) from the Ministry of Education of Singapore, and funds from the China National Program on Research and Development of Transgenic Plants (2008ZX08001-004), National Key Laboratory of Crop Genetic Improvement and Huazhong Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Farmer LM, 2010, PLANT CELL, V22, P124, DOI 10.1105/tpc.109.072660; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Jin JB, 2003, PLANT CELL, V15, P2357, DOI 10.1105/tpc.015222; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; Lin YL, 2011, PLANT CELL, V23, P2754, DOI 10.1105/tpc.111.086702; Liu LJ, 2008, PLANT CELL, V20, P292, DOI 10.1105/tpc.107.057281; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; MCNELLIS TW, 1994, PLANT CELL, V6, P487, DOI 10.1105/tpc.6.4.487; Mou ZL, 2000, PLANT CELL, V12, P405, DOI 10.1105/tpc.12.3.405; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tanaka N, 2011, PLANT CELL, V23, P2143, DOI 10.1105/tpc.111.083436; Todd I, 2004, IMMUNOLOGY, V113, P65, DOI 10.1111/j.1365-2567.2004.01942.x; Tseng TS, 2004, PLANT CELL, V16, P1550, DOI 10.1105/tpc.019224; Tsuji H, 2010, CURR OPIN PLANT BIOL; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wu CY, 2008, P NATL ACAD SCI USA, V105, P12915, DOI 10.1073/pnas.0806019105; Wu CY, 2003, PLANT J, V35, P418, DOI 10.1046/j.1365-313X.2003.01808.x; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yoshida S, 1981, FUNDAMENTALS RICE CR; Yu JW, 2008, MOL CELL, V32, P617, DOI 10.1016/j.molcel.2008.09.026; Zhang J, 2007, PLANT J, V49, P947, DOI 10.1111/j.1365-313X.2006.03001.x; Zhang QF, 2008, MOL PLANT, V1, P715, DOI 10.1093/mp/ssn043; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104	50	39	57	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34231	10.1371/journal.pone.0034231	http://dx.doi.org/10.1371/journal.pone.0034231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457828	Green Submitted, Green Published, gold			2022-12-27	WOS:000304046900057
J	Nicolaou, N; Hourris, S; Alexandrou, P; Georgiou, J				Nicolaou, Nicoletta; Hourris, Saverios; Alexandrou, Pandelitsa; Georgiou, Julius			EEG-Based Automatic Classification of 'Awake' versus 'Anesthetized' State in General Anesthesia Using Granger Causality	PLOS ONE			English	Article							APPROXIMATE ENTROPY; BISPECTRAL INDEX; TIME-SERIES; PERMUTATION ENTROPY; VOLUME CONDUCTION; DEPTH; CONSCIOUSNESS; CONNECTIVITY; POTENTIALS; SEPARATION	Background: General anesthesia is a reversible state of unconsciousness and depression of reflexes to afferent stimuli induced by administration of a 'cocktail'' of chemical agents. The multi-component nature of general anesthesia complicates the identification of the precise mechanisms by which anesthetics disrupt consciousness. Devices that monitor the depth of anesthesia are an important aide for the anesthetist. This paper investigates the use of effective connectivity measures from human electrical brain activity as a means of discriminating between 'awake' and 'anesthetized' state during induction and recovery of consciousness under general anesthesia. Methodology/Principal Findings: Granger Causality (GC), a linear measure of effective connectivity, is utilized in automated classification of 'awake' versus 'anesthetized' state using Linear Discriminant Analysis and Support Vector Machines (with linear and non-linear kernel). Based on our investigations, the most characteristic change of GC observed between the two states is the sharp increase of GC from frontal to posterior regions when the subject was anesthetized, and reversal at recovery of consciousness. Features derived from the GC estimates resulted in classification of 'awake' and 'anesthetized' states in 21 patients with maximum average accuracies of 0.98 and 0.95, during loss and recovery of consciousness respectively. The differences in linear and non-linear classification are not statistically significant, implying that GC features are linearly separable, eliminating the need for a complex and computationally expensive non-linear classifier. In addition, the observed GC patterns are particularly interesting in terms of a physiological interpretation of the disruption of consciousness by anesthetics. Bidirectional interaction or strong unidirectional interaction in the presence of a common input as captured by GC are most likely related to mechanisms of information flow in cortical circuits. Conclusions/Significance: GC-based features could be utilized effectively in a device for monitoring depth of anesthesia during surgery.	[Nicolaou, Nicoletta; Georgiou, Julius] Univ Cyprus, Dept Elect & Comp Engn, KIOS Res Ctr, Nicosia, Cyprus; [Nicolaou, Nicoletta; Georgiou, Julius] Univ Cyprus, Dept Elect & Comp Engn, Holist Elect Res Lab, Nicosia, Cyprus; [Hourris, Saverios; Alexandrou, Pandelitsa] Nicosia Gen Hosp, Nicosia, Cyprus	University of Cyprus; University of Cyprus	Nicolaou, N (corresponding author), Univ Cyprus, Dept Elect & Comp Engn, KIOS Res Ctr, Nicosia, Cyprus.	nicoletta.n@ucy.ac.cy	Nicolaou, Nicoletta/AFQ-7836-2022	Nicolaou, Nicoletta/0000-0002-9570-5112; Georgiou, Julius/0000-0002-7474-5449	Republic of Cyprus; European Regional Development Fund [DIDAKTOR/DISEK/0308/20]	Republic of Cyprus; European Regional Development Fund(European Commission)	This work falls under the Cyprus Research Promotion Foundation's Framework Program for Research, Technological Development and Innovation 2008 (DESMI 2008), co-funded by the Republic of Cyprus and the European Regional Development Fund (Grant number: DIDAKTOR/DISEK/0308/20). Funder's website: http://crpf.metacanvas.com/EN/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Barash P., 2009, CLIN ANESTHESIA; Barnett L, 2011, J NEUROSCI METH, V201, P404, DOI 10.1016/j.jneumeth.2011.08.010; Barr G, 1999, BRIT J ANAESTH, V82, P827, DOI 10.1093/bja/82.6.827; Bassani T, COMPUT BIOL IN PRESS; Bauerle K, 2004, BRIT J ANAESTH, V92, P841, DOI 10.1093/bja/aeh142; Becker K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008876; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Bennett C, 2009, ANESTH ANALG, V109, P539, DOI 10.1213/ane.0b013e3181a9fc38; Bressler SL, 2010, NEUROIMAGE IN PRESS; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Bruhn J, 2006, BRIT J ANAESTH, V97, P85, DOI 10.1093/bja/ael120; Bruhn J, 2000, ANESTHESIOLOGY, V92, P715, DOI 10.1097/00000542-200003000-00016; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cadotte AJ, 2010, J NEUROSCI METH, V189, P121, DOI 10.1016/j.jneumeth.2010.03.007; Cariani P, 2000, CONSCIOUS COGN, V9, P387, DOI 10.1006/ccog.1999.0420; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Ferrarelli F, 2010, PNAS; Fiset P, 1999, J NEUROSCI, V19, P5506; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Hameroff SR, 2006, ANESTHESIOLOGY, V105, P400, DOI 10.1097/00000542-200608000-00024; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; Hudetz A, 2010, SUPPRESSING THE MIND: ANESTHETIC MODULATION OF MEMORY AND CONSCIOUSNESS, P99, DOI 10.1007/978-1-60761-462-3_5; Hudetz AG, 2008, INT ANESTHESIOL CLIN, V46, P25, DOI 10.1097/AIA.0b013e3181755db5; John ER, 2001, CONSCIOUS COGN, V10, P165, DOI 10.1006/ccog.2001.0507; Jordan D, 2008, ANESTHESIOLOGY, V109, P1014, DOI 10.1097/ALN.0b013e31818d6c55; Koskinen M, 2006, IEEE T BIO-MED ENG, V53, P669, DOI 10.1109/TBME.2006.870230; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; Laureys S, 2005, TRENDS COGNITIVE SCI, V9; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Li XL, 2008, ANESTHESIOLOGY, V109, P448, DOI 10.1097/ALN.0b013e318182a91b; Li XL, 2008, CLIN NEUROPHYSIOL, V119, P2465, DOI 10.1016/j.clinph.2008.08.006; Mashour GA, 2006, ANESTH ANALG, V103, P975, DOI 10.1213/01.ane.0000232442.69757.4a; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Moca VV, 2009, COMPUT METH PROG BIO, V95, P191, DOI 10.1016/j.cmpb.2009.03.001; Myles PS, 2003, ANAESTHESIA, V58, P11, DOI 10.1046/j.1365-2044.2003.02955.x; Nicolaou N, 2011, USING GRANGER CAUSAL, P188; Nicolaou N, 2010, USE GRANGER CAUSALIT; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; PRYSROBERTS C, 1987, BRIT J ANAESTH, V59, P1341, DOI 10.1093/bja/59.11.1341; Rajagovindan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003649; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Ranta S., 2002, AWARENESS RECALL GEN; Russell IF, 2006, BRIT J ANAESTH, V96, P346, DOI 10.1093/bja/ael017; Schmidt GN, 2004, ANESTHESIOLOGY, V101, P1283; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Shahbazi F, 2010, IFMBE PROC, V28, P207; Shiavi Richard, 2007, INTRO APPL STAT SIGN, Vthird; SIGL JC, 1994, J CLIN MONITOR, V10, P392, DOI 10.1007/BF01618421; Sleigh JW, 1999, ANESTH ANALG, V88, P659, DOI 10.1097/00000539-199903000-00035; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tung Avery, 2002, J Clin Monit Comput, V17, P37, DOI 10.1023/A:1015404803637; Viertio-Oja H, 2004, ACTA ANAESTH SCAND, V48, P154, DOI 10.1111/j.0001-5172.2004.00322.x; Voss L, 2007, BEST PRACT RES-CLIN, V21, P313, DOI 10.1016/j.bpa.2007.04.003; Wang X, 2007, INT J NEURAL SYST, V17, P71, DOI 10.1142/S0129065707000944; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Wiener N, 1956, THEORY PREDICTION MO; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	65	59	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33869	10.1371/journal.pone.0033869	http://dx.doi.org/10.1371/journal.pone.0033869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457797	Green Submitted, gold, Green Published			2022-12-27	WOS:000303909200038
J	Su, FY; Alam, R; Mei, Q; Tian, YQ; Youngbull, C; Johnson, RH; Meldrum, DR				Su, Fengyu; Alam, Ruhaniyah; Mei, Qian; Tian, Yanqing; Youngbull, Cody; Johnson, Roger H.; Meldrum, Deirdre R.			Nanostructured Oxygen Sensor - Using Micelles to Incorporate a Hydrophobic Platinum Porphyrin	PLOS ONE			English	Article							DISSOLVED-OXYGEN; SENSING MATERIALS; PROBES; COMPLEXES; CELLS; LIFETIME; FILMS	Hydrophobic platinum(II)-5,10,15,20-tetrakis-(2,3,4,5,6-pentafluorophenyl)-porphyrin (PtTFPP) was physically incorporated into micelles formed from poly(epsilon-caprolactone)-block-poly(ethylene glycol) to enable the application of PtTFPP in aqueous solution. Micelles were characterized using dynamic light scattering (DLS) and atomic force microscopy (AFM) to show an average diameter of about 140 nm. PtTFPP showed higher quantum efficiency in micellar solution than in tetrahydrofuran (THF) and dichloromethane (CH2Cl2). PtTFPP in micelles also exhibited higher photostability than that of PtTFPP suspended in water. PtTFPP in micelles exhibited good oxygen sensitivity and response time. This study provided an efficient approach to enable the application of hydrophobic oxygen sensors in a biological environment.	[Su, Fengyu; Alam, Ruhaniyah; Mei, Qian; Tian, Yanqing; Youngbull, Cody; Johnson, Roger H.; Meldrum, Deirdre R.] Arizona State Univ, Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Su, FY (corresponding author), Arizona State Univ, Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ 85287 USA.	yanqing.tian@asu.edu	MLSC, Colletion/B-3912-2013; Tian, Yanqing/N-1506-2019; Tian, Yanqing/C-1423-2013; Su, Fengyu/ABE-2523-2021; Su, Fengyu/V-1014-2018	Tian, Yanqing/0000-0002-1441-2431; Tian, Yanqing/0000-0002-1441-2431; Su, Fengyu/0000-0003-1922-9182	NIH [5P50 HG002360]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work was supported by NIH, 5P50 HG002360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amao Y, 2003, MICROCHIM ACTA, V143, P1, DOI 10.1007/s00604-003-0037-x; Amao Y, 2003, SENSOR ACTUAT B-CHEM, V88, P162, DOI 10.1016/S0925-4005(02)00320-9; Borisov SM, 2008, ANAL CHEM, V80, P573, DOI 10.1021/ac071374e; Borisov SM, 2007, ANAL CHEM, V79, P7501, DOI 10.1021/ac0710836; Borisov SM, 2006, ADV FUNCT MATER, V16, P1536, DOI [10.1002/adfm.200500778, 10.1002/adfm.20050U778]; Chen CY, 2007, J AM CHEM SOC, V129, P7220, DOI 10.1021/ja071057p; CLARK LC, 1956, T AM SOC ART INT ORG, V2, P41; DeRosa MC, 2003, INORG CHEM, V42, P4864, DOI 10.1021/ic026230r; EVANS NTS, 1967, RESP PHYSIOL, V3, P38, DOI 10.1016/0034-5687(67)90021-7; Garcia-Fresnadillo D, 1999, LANGMUIR, V15, P6451, DOI 10.1021/la981689c; Han BH, 2005, ANAL CHEM, V77, P8075, DOI 10.1021/ac0511703; Hirohara S, 2009, BIOCONJUGATE CHEM, V20, P944, DOI 10.1021/bc800522y; HUCH R, 1974, ARCH DIS CHILD, V49, P213, DOI 10.1136/adc.49.3.213; Ji J, 2002, J BIOMED OPT, V7, P404, DOI 10.1117/1.1483082; Joshi HS, 1999, ANGEW CHEM INT EDIT, V38, P2722; Kimura F, 2006, MEAS SCI TECHNOL, V17, P1254, DOI 10.1088/0957-0233/17/6/S04; Koo YEL, 2004, ANAL CHEM, V76, P2498, DOI 10.1021/ac035493f; Kose ME, 2005, LANGMUIR, V21, P9121, DOI 10.1021/la050997p; Lai SW, 2004, INORG CHEM, V43, P3724, DOI 10.1021/ic049902h; Lee J, 2008, PHYS CHEM CHEM PHYS, V10, P1739, DOI 10.1039/b801317a; Lee SK, 1997, ANAL COMMUN, V34, P185, DOI 10.1039/a701130j; Lidstrom ME, 2003, NAT REV MICROBIOL, V1, P158, DOI 10.1038/nrmicro755; McDonagh C, 2008, CHEM REV, V108, P400, DOI 10.1021/cr068102g; Mcevoy AK, 1997, J SOL-GEL SCI TECHN, V8, P1121, DOI 10.1007/BF02436994; McNamara KP, 1998, ANAL CHEM, V70, P4853, DOI 10.1021/ac9803232; Mitsubayashi K, 2003, SENSOR ACTUAT B-CHEM, V95, P373, DOI 10.1016/S0925-4005(03)00441-6; Molter TW, 2009, SENSOR ACTUAT B-CHEM, V135, P678, DOI 10.1016/j.snb.2008.10.036; Nagl S, 2007, ANALYST, V132, P507, DOI 10.1039/b702753b; O'Donovan C, 2005, J MATER CHEM, V15, P2946, DOI 10.1039/b501748c; O'Riordan TC, 2007, AM J PHYSIOL-REG I, V292, pR1613, DOI 10.1152/ajpregu.00707.2006; Pang HL, 2007, SENSOR ACTUAT B-CHEM, V123, P120, DOI 10.1016/j.snb.2006.07.035; Pauly S, 1989, POLYM HDB, P435; Roche P, 2006, ANAL BIOANAL CHEM, V386, P1245, DOI 10.1007/s00216-006-0787-5; Saito T, 2007, J PORPHYR PHTHALOCYA, V11, P160, DOI 10.1142/S1088424607000205; Song HT, 2005, J AM CHEM SOC, V127, P9992, DOI 10.1021/ja051833y; Sud D, 2005, P SOC PHOTO-OPT INS, V5859; Thomas PC, 2009, ANAL CHEM, V81, P9239, DOI 10.1021/ac9013379; Tian Y, 2007, ADV FUNCT MATER, V17, P1691, DOI 10.1002/adfm.200600916; Tian YQ, 2010, SENSOR ACTUAT B-CHEM, V150, P579, DOI 10.1016/j.snb.2010.08.036; Tian YQ, 2010, SENSOR ACTUAT B-CHEM, V147, P714, DOI 10.1016/j.snb.2010.03.029; Tian YQ, 2010, J BIOMED MATER RES A, V93A, P1068, DOI 10.1002/jbm.a.32607; Tian YQ, 2010, CHEM MATER, V22, P2069, DOI 10.1021/cm903361y; Valeur B., 2002, MOL FLUORESCENCE PRI; VanderDonckt E, 1996, SENSOR ACTUAT B-CHEM, V32, P121, DOI 10.1016/0925-4005(96)80120-1; Xu H, 2001, ANAL CHEM, V73, P4124, DOI 10.1021/ac0102718; Zhang GQ, 2009, NAT MATER, V8, P747, DOI [10.1038/NMAT2509, 10.1038/nmat2509]	46	45	45	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33390	10.1371/journal.pone.0033390	http://dx.doi.org/10.1371/journal.pone.0033390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457758	Green Submitted, Green Published, gold			2022-12-27	WOS:000303909200028
J	Hu, YS; Ehli, EA; Nelson, K; Bohlen, K; Lynch, C; Huizenga, P; Kittlelsrud, J; Soundy, TJ; Davies, GE				Hu, Yueshan; Ehli, Erik A.; Nelson, Kelly; Bohlen, Krista; Lynch, Christophina; Huizenga, Patty; Kittlelsrud, Julie; Soundy, Timothy J.; Davies, Gareth E.			Genotyping Performance between Saliva and Blood-Derived Genomic DNAs on the DMET Array: A Comparison	PLOS ONE			English	Article							MICROARRAY TECHNOLOGY; LARGE-SCALE; QUALITY; PHARMACOGENETICS; POLYMORPHISM; PLATFORM; SAMPLES; COHORT	The Affymetrix Drug Metabolism Enzymes and Transporters (DMET) microarray is the first assay to offer a large representation of SNPs conferring genetic diversity across known pharmacokinetic markers. As a convenient and painless alternative to blood, saliva samples have been reported to work well for genotyping on the high density SNP arrays, but no reports to date have examined this application for saliva-derived DNA on the DMET platform. Genomic DNA extractions from saliva samples produced an ample quantity of genomic DNA for DMET arrays, however when human amplifiable DNA was measured, it was determined that a large percentage of this DNA was from bacteria or fungi. A mean of 37.3% human amplifiable DNA was determined for saliva-derived DNAs, which results in a significant decrease in the genotyping call rate (88.8%) when compared with blood-derived DNAs (99.1%). More interestingly, the percentage of human amplifiable DNA correlated with a higher genotyping call rate, and almost all samples with more than 31.3% human DNA produced a genotyping call rate of at least 96%. SNP genotyping results for saliva derived DNA (n = 39) illustrated a 98.7% concordance when compared with blood DNA. In conclusion, when compared with blood DNA and tested on the DMET array, saliva-derived DNA provided adequate genotyping quality with a significant lower number of SNP calls. Saliva-derived DNA does perform very well if it contains greater than 31.3% human amplifiable DNA.	[Hu, Yueshan; Ehli, Erik A.; Nelson, Kelly; Huizenga, Patty; Davies, Gareth E.] Avera Inst Human Genet, Sioux Falls, SD USA; [Ehli, Erik A.; Soundy, Timothy J.; Davies, Gareth E.] Univ S Dakota, Dept Psychiat, Sioux Falls, SD USA; [Bohlen, Krista; Kittlelsrud, Julie] Avera Res Inst, Sioux Falls, SD USA; [Bohlen, Krista] Avera Canc Inst, Sioux Falls, SD USA; [Lynch, Christophina; Davies, Gareth E.] S Dakota State Univ, Dept Pharmaceut Sci, Brookings, SD 57007 USA	University of South Dakota; South Dakota State University	Hu, YS (corresponding author), Avera Inst Human Genet, Sioux Falls, SD USA.	gareth.davies@avera.org			state of South Dakota	state of South Dakota	The state of South Dakota provided the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo M, 2010, CANCER EPIDEM BIOMAR, V19, P794, DOI 10.1158/1055-9965.EPI-09-0812; Basham RJ, 2009, HIV CLIN TRIALS, V10, P282, DOI 10.1310/hct1004-282; Burmester JK, 2010, METHODS MOL BIOL, V632, P99, DOI 10.1007/978-1-60761-663-4_7; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Daly TM, 2007, CLIN CHEM, V53, P1222, DOI 10.1373/clinchem.2007.086348; de Leon J, 2009, CNS SPECTRUMS, V14, P19, DOI 10.1017/S1092852900020022; Deeken JF, 2010, PHARMACOGENOMICS J, V10, P191, DOI 10.1038/tpj.2009.57; Deeken J, 2009, CURR OPIN MOL THER, V11, P260; Di Martino MT, 2011, BRIT J HAEMATOL, V154, P529, DOI 10.1111/j.1365-2141.2011.08622.x; Di Martino MT, 2011, CANCER BIOL THER, P12; Dlugos DJ, 2005, EPILEPSY BEHAV, V6, P444, DOI 10.1016/j.yebeh.2005.01.014; Dumaual C, 2007, PHARMACOGENOMICS, V8, P293, DOI 10.2217/14622416.8.3.293; Hansen TVO, 2007, CANCER EPIDEM BIOMAR, V16, P2072, DOI 10.1158/1055-9965.EPI-07-0611; Herraez DL, 2008, ANAL BIOCHEM, V383, P329, DOI 10.1016/j.ab.2008.08.015; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Philibert RA, 2008, PSYCHIAT GENET, V18, P275, DOI 10.1097/YPG.0b013e3283060f81; Polgarova K, 2010, NEW MICROBIOL, V33, P373; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Rasi S, 2011, LEUKEMIA RES, V35, P1419, DOI 10.1016/j.leukres.2011.05.024; Rylander-Rudqvist T, 2006, CANCER EPIDEM BIOMAR, V15, P1742, DOI 10.1158/1055-9965.EPI-05-0706; Sissung TM, 2010, PHARMACOGENOMICS, V11, P89, DOI 10.2217/PGS.09.154	21	32	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33968	10.1371/journal.pone.0033968	http://dx.doi.org/10.1371/journal.pone.0033968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448283	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700074
J	Cousin, FJ; Jouan-Lanhouet, S; Dimanche-Boitrel, MT; Corcos, L; Jan, G				Cousin, Fabien J.; Jouan-Lanhouet, Sandrine; Dimanche-Boitrel, Marie-Therese; Corcos, Laurent; Jan, Gwenael			Milk Fermented by Propionibacterium freudenreichii Induces Apoptosis of HGT-1 Human Gastric Cancer Cells	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; IN-VITRO; METABOLIC-ACTIVITY; SODIUM-BUTYRATE; CARCINOMA CELLS; CASPASE-8; INDUCTION; NECROSIS; ACTIVATION; RESISTANCE	Background: Gastric cancer is one of the most common cancers in the world. The "economically developed countries" life style, including diet, constitutes a risk factor favoring this cancer. Diet modulation may lower digestive cancer incidence. Among promising food components, dairy propionibacteria were shown to trigger apoptosis of human colon cancer cells, via the release of short-chain fatty acids acetate and propionate. Methodology/Principal Findings: A fermented milk, exclusively fermented by P. freudenreichii, was recently designed. In this work, the pro-apoptotic potential of this new fermented milk was demonstrated on HGT-1 human gastric cancer cells. Fermented milk supernatant induced typical features of apoptosis including chromatin condensation, formation of apoptotic bodies, DNA laddering, cell cycle arrest and emergence of a subG1 population, phosphatidylserine exposure at the plasma membrane outer leaflet, reactive oxygen species accumulation, mitochondrial transmembrane potential disruption, caspase activation and cytochrome c release. Remarkably, this new fermented milk containing P. freudenreichii enhanced the cytotoxicity of camptothecin, a drug used in gastric cancer chemotherapy. Conclusions/Significance: Such new probiotic fermented milk may thus be useful as part of a preventive diet designed to prevent gastric cancer and/or as a food supplement to potentiate cancer therapeutic treatments.	[Cousin, Fabien J.; Jan, Gwenael] INRA, Sci & Technol Lait & OEuf, F-35042 Rennes, France; [Cousin, Fabien J.; Jan, Gwenael] AGROCAMPUS OUEST, Rennes, France; [Cousin, Fabien J.] CNIEL Syndifrais, Paris, France; [Jouan-Lanhouet, Sandrine; Dimanche-Boitrel, Marie-Therese] Univ Rennes 1, IRSET, Rennes, France; [Jouan-Lanhouet, Sandrine; Dimanche-Boitrel, Marie-Therese] INSERM, Team Stress, Rennes, France; [Corcos, Laurent] Fac Med, Inserm Team, Brest, France	INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale	Cousin, FJ (corresponding author), INRA, Sci & Technol Lait & OEuf, F-35042 Rennes, France.	gwenael.jan@rennes.inra.fr	Corcos, Laurent/K-1859-2015; Corcos, Laurent/M-8915-2017; Dimanche-Boitrel, Marie-Therese M/I-4642-2015; Corcos, Laurent/AAJ-2692-2020; Jan, Gwenael/K-6767-2014	Corcos, Laurent/0000-0001-8019-2505; Corcos, Laurent/0000-0001-8019-2505; Dimanche-Boitrel, Marie-Therese/0000-0002-8038-7780; Cousin, Fabien/0000-0001-6874-387X; Jouan, Sandrine/0000-0003-3599-8416	Conseil Regional de Bretagne through the CBB; Centre National Interprofessionnel de l'Economie Laitiere (CNIEL) through the Scientific Committee of Syndifrais; Ligue Nationale Contre le Cancer (the Cote d'Armor, Ille et Vilaine, Morbihan, Vendee and Sarthe Comittees); INSERM; University of Rennes 1; Region Bretagne; CNIEL; Association pour la Recherche sur le Cancer	Conseil Regional de Bretagne through the CBB(Region Bretagne); Centre National Interprofessionnel de l'Economie Laitiere (CNIEL) through the Scientific Committee of Syndifrais; Ligue Nationale Contre le Cancer (the Cote d'Armor, Ille et Vilaine, Morbihan, Vendee and Sarthe Comittees); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Rennes 1; Region Bretagne(Region Bretagne); CNIEL; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was financed by Conseil Regional de Bretagne through the CBB developpement call for projects and by the Centre National Interprofessionnel de l'Economie Laitiere (CNIEL) through by the Scientific Committee of Syndifrais call for projects. Research in the IRSET group was supported by grants from the Ligue Nationale Contre le Cancer (the Cote d'Armor, Ille et Vilaine, Morbihan, Vendee and Sarthe Comittees), INSERM, University of Rennes 1 and the Region Bretagne. FJC received a grant from CNIEL (doctoral fellowship). SJL was supported by the Association pour la Recherche sur le Cancer (doctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune D, 2011, ANN ONCOL, P1; Baldwin C, 2010, NUTR CANCER, V62, P371, DOI 10.1080/01635580903407197; Banjerdpongchai R, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-50; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Compare D, 2010, EUR REV MED PHARMACO, V14, P302; Coradini D, 2000, CELL PROLIFERAT, V33, P139, DOI 10.1046/j.1365-2184.2000.00173.x; Cousin FJ, 2011, DAIRY SCI TECHNOL, V91, P1, DOI 10.1051/dst/2010032; de LeBlanc AD, 2010, P NUTR SOC, V69, P421, DOI 10.1017/S002966511000159X; Diaz-Ruiz C, 2001, HISTOL HISTOPATHOL, V16, P415, DOI 10.14670/HH-16.415; DIMANCHEBOITREL MT, 1992, INT J CANCER, V50, P677, DOI 10.1002/ijc.2910500502; Eggert A, 2001, CANCER RES, V61, P1314; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FAO/WHO, 2006, PROB FOOD HLTH NUTR; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; Fujita K, 2004, CARCINOGENESIS, V25, P1961, DOI 10.1093/carcin/bgh205; Fulda S, 2009, CANCER LETT, V281, P128, DOI 10.1016/j.canlet.2008.11.023; Gibot L, 2009, BIOCHEM J, V420, P473, DOI 10.1042/BJ20082057; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Herve C, 2007, INT J FOOD MICROBIOL, V113, P303, DOI 10.1016/j.ijfoodmicro.2006.08.013; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Hopkins-Donaldson S, 2000, CANCER RES, V60, P4315; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj.cdd.4400935; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaminskyy V, 2011, CARCINOGENESIS; Kim JE, 2009, BRIT J NUTR, V102, P1469, DOI 10.1017/S0007114509990432; Kim SY, 2009, ANN NY ACAD SCI, V1171, P270, DOI 10.1111/j.1749-6632.2009.04721.x; Kumar M, 2010, INT J FOOD SCI NUTR, V61, P473, DOI 10.3109/09637480903455971; Kurosaka K, 2003, J IMMUNOL, V171, P4672, DOI 10.4049/jimmunol.171.9.4672; LABOISSE CL, 1982, CANCER RES, V42, P1541; Lacour S, 2003, ONCOGENE, V22, P1807, DOI 10.1038/sj.onc.1206127; Lan A, 2008, BRIT J NUTR, V100, P1251, DOI 10.1017/S0007114508978284; Lan A, 2007, BRIT J NUTR, V97, P714, DOI 10.1017/S0007114507433001; Lan A, 2007, APOPTOSIS, V12, P573, DOI 10.1007/s10495-006-0010-3; Leverrier P, 2005, FOOD MICROBIOL, V22, P11, DOI 10.1016/j.fm.2004.05.003; Lin HH, 2007, INT J CANCER, V120, P2306, DOI 10.1002/ijc.22571; Litvak DA, 1998, SURGERY, V124, P161, DOI 10.1067/msy.1998.90365; Litvak DA, 2000, ANTICANCER RES, V20, P779; Lu Y, 2011, HEPATOB PANCREAT DIS, V10, P303, DOI 10.1016/S1499-3872(11)60050-7; Matthews GM, 2007, CANCER BIOL THER, V6, P1051, DOI 10.4161/cbt.6.7.4318; Meurette O, 2005, CLIN CANCER RES, V11, P3075, DOI 10.1158/1078-0432.CCR-04-1764; Michalski MC, 2006, J DAIRY SCI, V89, P3778, DOI 10.3168/jds.S0022-0302(06)72419-5; Myllyluoma E, 2008, CLIN VACCINE IMMUNOL, V15, P1472, DOI 10.1128/CVI.00080-08; Palli Domenico, 2000, Journal of Gastroenterology, V35, P84; Prisciandaro LD, 2011, CRIT REV FOOD SCI, V51, P239, DOI 10.1080/10408390903551747; Ran ZH, 2007, WORLD J GASTROENTERO, V13, P4255, DOI 10.3748/wjg.v13.i31.4255; Sanders ME, 2010, ANNU REV FOOD SCI T, V1, P65, DOI 10.1146/annurev.food.080708.100743; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Saxelin M, 2010, INT J FOOD MICROBIOL, V144, P293, DOI 10.1016/j.ijfoodmicro.2010.10.009; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Thiel A, 2004, ITAL J FOOD SCI, V16, P245; Thierry A, 2011, INT J FOOD MICROBIOL, V149, P19, DOI 10.1016/j.ijfoodmicro.2011.04.026; Tsai LC, 2000, ANTICANCER RES, V20, P2441; Verrier F, 2004, ONCOGENE, V23, P8049, DOI 10.1038/sj.onc.1208001; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Xu XX, 2010, J DAIRY SCI, V93, P2344, DOI 10.3168/jds.2009-2926; Yan J, 2003, WORLD J GASTROENTERO, V9, P660, DOI 10.3748/wjg.v9.i4.660; Zarate G, 2002, J FOOD PROTECT, V65, P534, DOI 10.4315/0362-028X-65.3.534	62	83	88	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e31892	10.1371/journal.pone.0031892	http://dx.doi.org/10.1371/journal.pone.0031892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442660	gold, Green Published			2022-12-27	WOS:000303836500003
J	Iyer, SC; Wang, D; Iyer, EPR; Trunnell, SA; Meduri, R; Shinwari, R; Sulkowski, MJ; Cox, DN				Iyer, Srividya Chandramouli; Wang, Dennis; Iyer, Eswar Prasad R.; Trunnell, Sarah A.; Meduri, Ramakrishna; Shinwari, Riaz; Sulkowski, Mikolaj J.; Cox, Daniel N.			The RhoGEF Trio Functions in Sculpting Class Specific Dendrite Morphogenesis in Drosophila Sensory Neurons	PLOS ONE			English	Article							RAC GTPASE; NEUROBLAST PROLIFERATION; TYROSINE KINASE; DOMAIN; MECHANISMS; RECEPTOR; GROWTH; GEF; CYTOSKELETON; MAINTENANCE	Background: As the primary sites of synaptic or sensory input in the nervous system, dendrites play an essential role in processing neuronal and sensory information. Moreover, the specification of class specific dendrite arborization is critically important in establishing neural connectivity and the formation of functional networks. Cytoskeletal modulation provides a key mechanism for establishing, as well as reorganizing, dendritic morphology among distinct neuronal subtypes. While previous studies have established differential roles for the small GTPases Rac and Rho in mediating dendrite morphogenesis, little is known regarding the direct regulators of these genes in mediating distinct dendritic architectures. Methodology/Principal Findings: Here we demonstrate that the RhoGEF Trio is required for the specification of class specific dendritic morphology in dendritic arborization (da) sensory neurons of the Drosophila peripheral nervous system (PNS). Trio is expressed in all da neuron subclasses and loss-of-function analyses indicate that Trio functions cell-autonomously in promoting dendritic branching, field coverage, and refining dendritic outgrowth in various da neuron subtypes. Moreover, overexpression studies demonstrate that Trio acts to promote higher order dendritic branching, including the formation of dendritic filopodia, through Trio GEF1-dependent interactions with Rac1, whereas Trio GEF-2-dependent interactions with Rho1 serve to restrict dendritic extension and higher order branching in da neurons. Finally, we show that de novo dendritic branching, induced by the homeodomain transcription factor Cut, requires Trio activity suggesting these molecules may act in a pathway to mediate dendrite morphogenesis. Conclusions/Significance: Collectively, our analyses implicate Trio as an important regulator of class specific da neuron dendrite morphogenesis via interactions with Rac1 and Rho1 and indicate that Trio is required as downstream effector in Cut-mediated regulation of dendrite branching and filopodia formation.	[Iyer, Srividya Chandramouli; Wang, Dennis; Iyer, Eswar Prasad R.; Trunnell, Sarah A.; Meduri, Ramakrishna; Shinwari, Riaz; Sulkowski, Mikolaj J.; Cox, Daniel N.] George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA; [Iyer, Srividya Chandramouli; Wang, Dennis; Iyer, Eswar Prasad R.; Trunnell, Sarah A.; Meduri, Ramakrishna; Shinwari, Riaz; Sulkowski, Mikolaj J.; Cox, Daniel N.] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA	George Mason University; George Mason University	Iyer, SC (corresponding author), George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA.	dcox5@gmu.edu	Cox, Daniel N/H-3036-2013; Iyer, Eswar/E-8443-2017	Cox, Daniel/0000-0001-9191-9212; Wang, Dennis/0000-0003-3955-8143; Wang, Dennis/0000-0003-0068-1005	National Institutes of Health [MH086928]; Thomas F. and Kate Miller Jeffress Memorial Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH086928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas F. and Kate Miller Jeffress Memorial Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors acknowledge the National Institutes of Health (MH086928) (http://www.nimh.nih.gov) and the Thomas F. and Kate Miller Jeffress Memorial Trust for support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Ascoli GA, 2000, NEUROCOMPUTING, V32, P1003, DOI 10.1016/S0925-2312(00)00272-1; Astigarraga S, 2010, J NEUROSCI, V30, P15358, DOI 10.1523/JNEUROSCI.1862-10.2010; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dutta D, 2002, GENESIS, V34, P146, DOI 10.1002/gene.10113; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Gao F-B, 2003, CURR OPIN NEUROBIOL, V17, P525; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Goldstein AYN, 2005, P NATL ACAD SCI USA, V102, P3834, DOI 10.1073/pnas.0500748102; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Leiss F, 2009, DEV NEUROBIOL, V69, P221, DOI 10.1002/dneu.20699; Li WJ, 2005, DEV DYNAM, V234, P512, DOI 10.1002/dvdy.20496; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Ma XM, 2011, HIPPOCAMPUS, V21, P661, DOI 10.1002/hipo.20780; Ma XM, 2008, J NEUROSCI, V28, P12368, DOI 10.1523/JNEUROSCI.4269-08.2008; Metzger F, 2010, Curr Mol Pharmacol, V3, P1; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Sato D, 2010, GENES CELLS, V15, P485, DOI 10.1111/j.1365-2443.2010.01399.x; Scott EK, 2003, J NEUROSCI, V23, P3118; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Song JK, 2011, DEV DYNAM, V240, P324, DOI 10.1002/dvdy.22525; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Sulkowski MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022611; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013	53	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33634	10.1371/journal.pone.0033634	http://dx.doi.org/10.1371/journal.pone.0033634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442703	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500044
J	Wong, C; Jones, DL				Wong, Chihunt; Jones, D. Leanne			Efficiency of Spermatogonial Dedifferentiation during Aging	PLOS ONE			English	Article							STEM-CELL MAINTENANCE; SOMATIC SUPPORT CELLS; DROSOPHILA TESTIS; SELF-RENEWAL; GERM-CELLS; IN-VIVO; NICHE; SPERMATOGENESIS; PROLIFERATION; OVARY	Background: Adult stem cells are critical for tissue homeostasis; therefore, the mechanisms utilized to maintain an adequate stem cell pool are important for the survival of an individual. In Drosophila, one mechanism utilized to replace lost germline stem cells (GSCs) is dedifferentiation of early progenitor cells. However, the average number of male GSCs decreases with age, suggesting that stem cell replacement may become compromised in older flies. Methodology/Principal Findings: Using a temperature sensitive allelic combination of Stat92E to control dedifferentiation, we found that germline dedifferentiation is remarkably efficient in older males; somatic cells are also effectively replaced. Surprisingly, although the number of somatic cyst cells also declines with age, the proliferation rate of early somatic cells, including cyst stem cells (CySCs) increases. Conclusions: These data indicate that defects in spermatogonial dedifferentiation are not likely to contribute significantly to an aging-related decline in GSCs. In addition, our findings highlight differences in the ways GSCs and CySCs age. Strategies to initiate or enhance the ability of endogenous, differentiating progenitor cells to replace lost stem cells could provide a powerful and novel strategy for maintaining tissue homeostasis and an alternative to tissue replacement therapy in older individuals.	[Wong, Chihunt; Jones, D. Leanne] Univ Calif San Diego, Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92093 USA; [Wong, Chihunt; Jones, D. Leanne] Univ Calif San Diego, Dept Biol Sci, Div Cell & Dev Biol, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Wong, C (corresponding author), Univ Calif San Diego, Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92093 USA.	ljones@salk.edu			National Institutes of Health [5R01 AG028092-04, 2T32 HD007495]; California Institute for Regenerative Medicine [RN1-00544-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health (www.nih.gov) 5R01 AG028092-04 (Jones, PI), 2T32 HD007495 (C. Kintner, PI). California Institute for Regenerative Medicine (www.cirm.ca.gov) RN1-00544-1 (Jones, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksa K, 2002, DEV BIOL, V243, P166, DOI 10.1006/dbio.2001.0539; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Cheng J, 2011, DEVELOPMENT, V138, P831, DOI 10.1242/dev.057901; Cherry CM, 2010, CELL STEM CELL, V6, P557, DOI 10.1016/j.stem.2010.04.018; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Inaba M, 2011, DEVELOPMENT, V138, P5079, DOI 10.1242/dev.072579; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kaczmarczyk AN, 2011, BIOESSAYS, V33, P5, DOI 10.1002/bies.201000085; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Mair W, 2010, AGING CELL, V9, P916, DOI 10.1111/j.1474-9726.2010.00602.x; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Matunis E, 1997, DEVELOPMENT, V124, P4383; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Michel M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1426; Monk AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028508; Monk AC, 2010, CELL STEM CELL, V6, P348, DOI 10.1016/j.stem.2010.02.016; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Schulz C, 2002, DEVELOPMENT, V129, P4523; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Sheng XR, 2009, CELL STEM CELL, V5, P191, DOI 10.1016/j.stem.2009.05.024; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Singh SR, 2010, J CELL PHYSIOL, V223, P500, DOI 10.1002/jcp.22073; Spradling AC, 1999, GENETICS, V153, P135; Straube WL, 2006, ARTIF ORGANS, V30, P743, DOI 10.1111/j.1525-1594.2006.00296.x; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Wang L, 2011, CELL CYCLE, V10, P2628, DOI 10.4161/cc.10.16.17059; Wang L, 2011, EXP GERONTOL, V46, P340, DOI 10.1016/j.exger.2010.10.005; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	45	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33635	10.1371/journal.pone.0033635	http://dx.doi.org/10.1371/journal.pone.0033635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442704	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500045
J	Yang, YY; Li, ZL; Wang, G; Zhao, XP; Crowley, DE; Zhao, YH				Yang, Yu-Yi; Li, Ze-Li; Wang, Guan; Zhao, Xiao-Ping; Crowley, David E.; Zhao, Yu-Hua			Computational Identification and Analysis of the Key Biosorbent Characteristics for the Biosorption Process of Reactive Black 5 onto Fungal Biomass	PLOS ONE			English	Article							SURFACTANT-MODIFIED ZEOLITE; AQUEOUS-SOLUTION; DYE REMOVAL; TRAMETES-VERSICOLOR; TREATED BIOMASS; TEXTILE DYES; ADSORPTION; EQUILIBRIUM; RHIZOPUS; CARBON	The performances of nine biosorbents derived from dead fungal biomass were investigated for their ability to remove Reactive Black 5 from aqueous solution. The biosorption data for removal of Reactive Black 5 were readily modeled using the Langmuir adsorption isotherm. Kinetic analysis based on both pseudo-second-order and Weber-Morris models indicated intraparticle diffusion was the rate limiting step for biosorption of Reactive Black 5 on to the biosorbents. Sorption capacities of the biosorbents were not correlated with the initial biosorption rates. Sensitivity analysis of the factors affecting biosorption examined by an artificial neural network model showed that pH was the most important parameter, explaining 22%, followed by nitrogen content of biosorbents (16%), initial dye concentration (15%) and carbon content of biosorbents (10%). The biosorption capacities were not proportional to surface areas of the sorbents, but were instead influenced by their chemical element composition. The main functional groups contributing to dye sorption were amine, carboxylic, and alcohol moieties. The data further suggest that differences in carbon and nitrogen contents of biosorbents may be used as a selection index for identifying effective biosorbents from dead fungal biomass.	[Yang, Yu-Yi; Li, Ze-Li; Wang, Guan; Zhao, Yu-Hua] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Xiao-Ping] Taizhou Municipal Hosp, Taizhou, Peoples R China; [Crowley, David E.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA	Zhejiang University; Taizhou University; University of California System; University of California Riverside	Yang, YY (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	crowley@mail.ucr.edu; yhzhao225@zju.edu.cn	Yang, Yuyi/H-6600-2015; Yang, Yuyi/N-5428-2015; Crowley, David/C-1216-2014	Yang, Yuyi/0000-0001-9807-6844; Yang, Yuyi/0000-0001-9807-6844; Crowley, David/0000-0002-1805-8599	Science and Technology Project of Zhejiang Province [2010C13G2010074, 2008C13014-3]; National Natural Science Foundation of China [31070079]; International Cooperation Project in Science and Technology of Zhejiang Province [2008C14038]	Science and Technology Project of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project in Science and Technology of Zhejiang Province	This study was supported by the Science and Technology Project of Zhejiang Province (2010C13G2010074, http://www.zjkjt.gov.cn), National Natural Science Foundation of China (31070079,http://www.nsfc.gov.cn), the Science and Technology Project of Zhejiang Province (2008C13014-3,http://www.zjkjt.gov.cn/) and the International Cooperation Project in Science and Technology of Zhejiang Province (No. 2008C14038,http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar T, 2010, BIORESOURCE TECHNOL, V101, P7271, DOI 10.1016/j.biortech.2010.04.044; Aksu Z, 2003, CHEMOSPHERE, V50, P1075, DOI 10.1016/S0045-6535(02)00623-9; Aksu Z, 2000, PROCESS BIOCHEM, V36, P431, DOI 10.1016/S0032-9592(00)00233-8; Aksu Z, 2008, BIORESOURCE TECHNOL, V99, P7730, DOI 10.1016/j.biortech.2008.01.056; Bayramoglu G, 2007, J HAZARD MATER, V143, P135, DOI 10.1016/j.jhazmat.2006.09.002; Bhatnagar A, 2010, ADV COLLOID INTERFAC, V160, P1, DOI 10.1016/j.cis.2010.06.011; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Chen BL, 2010, J HAZARD MATER, V179, P845, DOI 10.1016/j.jhazmat.2010.03.082; Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001; Das SK, 2007, ENVIRON SCI TECHNOL, V41, P8281, DOI 10.1021/es070814g; Das SK, 2006, LANGMUIR, V22, P7265, DOI 10.1021/la0526378; Eren Z, 2006, DESALINATION, V194, P1, DOI 10.1016/j.desal.2005.10.022; Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Garson G.D., 1991, AI EXPERT, V6, P46; Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326; Iscen CF, 2007, J HAZARD MATER, V143, P335, DOI 10.1016/j.jhazmat.2006.09.028; Kang Q, 2009, APPL CLAY SCI, V45, P280, DOI 10.1016/j.clay.2009.06.010; Karadag D, 2007, J CHEM ENG DATA, V52, P1615, DOI 10.1021/je7000057; Kaushik P, 2009, ENVIRON INT, V35, P127, DOI 10.1016/j.envint.2008.05.010; Khataee AR, 2010, BIORESOURCE TECHNOL, V101, P2252, DOI 10.1016/j.biortech.2009.11.079; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Mahmoodi NM, 2010, J CHEM ENG DATA, V55, P4660, DOI 10.1021/je100248m; Marquardt D., 1963, INT J COMPUT VISION, V11, P431, DOI DOI 10.1137/0111030; Mondal S, 2008, ENVIRON ENG SCI, V25, P383, DOI 10.1089/ees.2007.0049; Nadeem M, 2006, J HAZARD MATER, V138, P604, DOI 10.1016/j.jhazmat.2006.05.098; Oei BC, 2009, BIORESOURCE TECHNOL, V100, P4292, DOI 10.1016/j.biortech.2009.03.063; Osma JF, 2007, J HAZARD MATER, V147, P900, DOI 10.1016/j.jhazmat.2007.01.112; Ozdemir O, 2004, DYES PIGMENTS, V62, P49, DOI 10.1016/j.dyepig.2003.11.007; Ozer A, 2006, J HAZARD MATER, V135, P355, DOI 10.1016/j.jhazmat.2005.11.080; Patdhanagul N, 2010, MICROPOR MESOPOR MAT, V131, P97, DOI 10.1016/j.micromeso.2009.12.008; Ramsay JA, 2002, BIOTECHNOL LETT, V24, P1756; Sismanoglu T, 2010, J HAZARD MATER, V184, P164, DOI 10.1016/j.jhazmat.2010.08.019; Stavropoulos GG, 2008, J HAZARD MATER, V151, P414, DOI 10.1016/j.jhazmat.2007.06.005; Valix M, 2006, LANGMUIR, V22, P4574, DOI 10.1021/la051711j; Vijayaraghavan K, 2008, DYES PIGMENTS, V76, P726, DOI 10.1016/j.dyepig.2007.01.013; Walker GM, 2001, CHEM ENG J, V83, P201, DOI 10.1016/S1385-8947(00)00257-6; Xiong XJ, 2010, J HAZARD MATER, V175, P241, DOI 10.1016/j.jhazmat.2009.09.155; Yang YY, 2011, BIORESOURCE TECHNOL, V102, P828, DOI 10.1016/j.biortech.2010.08.125; Zarei M, 2010, J ELECTROANAL CHEM, V639, P167, DOI 10.1016/j.jelechem.2009.12.005	40	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33551	10.1371/journal.pone.0033551	http://dx.doi.org/10.1371/journal.pone.0033551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442697	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500038
J	Zhang, QR; Fisher, K				Zhang, Qianru; Fisher, Kimberly			Tight Junction-Related Barrier Contributes to the Electrophysiological Asymmetry across Vocal Fold Epithelium	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TRANSEPITHELIAL WATER TRANSPORT; INOSITOL PHOSPHATE ACCUMULATION; HUMAN-ENDOTHELIAL CELLS; ELECTRICAL-RESISTANCE; ZONULA-OCCLUDENS; IN-VITRO; HISTAMINE; ZO-1; PROTEIN	Electrophysiological homeostasis is indispensable to vocal fold hydration. We investigate tight junction (TJ)-associated components, occludin and ZO-1, and permeability with or without the challenge of a permeability-augmenting agent, histamine. Freshly excised ovine larynges are obtained from a local abattoir. TJ markers are explored via reverse transcriptase polymerase chain reaction (RT-PCR). Paracellular permeabilities are measured in an Ussing system. The gene expression of both TJ markers is detected in native ovine vocal fold epithelium. Luminal histamine treatment significantly decreases transepithelial resistance (TER) (N = 72, p < 0.01) and increases penetration of protein tracer (N = 35, p < 0.001), respectively, in a time-, and dose-dependent fashion. The present study demonstrates that histamine compromises TJ-related paracellular barrier across vocal fold epithelium. The detection of TJ markers indicates the existence of typical TJ components in non-keratinized, stratified vocal fold epithelium. The responsiveness of paracellular permeabilities to histamine would highlight the functional significance of this TJ-equivalent system to the electrophysiological homeostasis, which, in turn, regulates the vocal fold superficial hydration.	[Zhang, Qianru] China Med Univ, Coll Basic Sci, Expt Ctr Funct Subjects, Shenyang, Liaoning, Peoples R China; [Fisher, Kimberly] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA	China Medical University; Northwestern University	Zhang, QR (corresponding author), China Med Univ, Coll Basic Sci, Expt Ctr Funct Subjects, Shenyang, Liaoning, Peoples R China.	qianruzhang2008@u.northwestern.edu			Liaoning Province Doctoral Startup Fund [20101149]; Liaoning Province Science and Technology Department	Liaoning Province Doctoral Startup Fund; Liaoning Province Science and Technology Department	This work was supported by Liaoning Province Doctoral Startup Fund (No. 20101149, program funded by Liaoning Province Science and Technology Department): http://kjjh.lninfo.gov.cn/index.htm. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AndoAkatsuka Y, 1996, J CELL BIOL, V133, P43, DOI 10.1083/jcb.133.1.43; Bazzoni G, 2000, J BIOL CHEM, V275, P30970, DOI 10.1074/jbc.M003946200; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; BROCK TA, 1988, J CELL PHYSIOL, V136, P54, DOI 10.1002/jcp.1041360107; BUTT AM, 1995, BRAIN RES, V696, P145, DOI 10.1016/0006-8993(95)00811-4; BUTT AM, 1992, BRAIN RES, V569, P100, DOI 10.1016/0006-8993(92)90374-I; CARSON MR, 1989, AM J PHYSIOL, V257, pL259, DOI 10.1152/ajplung.1989.257.4.L259; DEVALIA JL, 1994, EUR RESPIR J, V7, P1958; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fisher KV, 2001, J APPL PHYSIOL, V91, P1401, DOI 10.1152/jappl.2001.91.3.1401; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gardner TW, 1997, INVEST OPHTH VIS SCI, V38, P2423; GEORGITIS JW, 1993, ANN ALLERGY, V71, P385; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hirase T, 1997, J CELL SCI, V110, P1603; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jacobi HH, 1998, CLIN EXP ALLERGY, V28, P83; Jiang J, 2000, ANN OTO RHINOL LARYN, V109, P568, DOI 10.1177/000348940010900607; Keon BH, 1996, J CELL BIOL, V134, P1003, DOI 10.1083/jcb.134.4.1003; Kevil CG, 1998, MICROCIRCULATION-LON, V5, P197, DOI 10.1038/sj.mn.7300011; KILLACKEY JJF, 1986, AM J PATHOL, V122, P50; Kim MJ, 2004, ANN OTO RHINOL LARYN, V113, P60, DOI 10.1177/000348940411300114; KRAUSE D, 1991, NEUROSCI LETT, V128, P301, DOI 10.1016/0304-3940(91)90284-Z; LO WWY, 1987, BIOCHEM BIOPH RES CO, V148, P47, DOI 10.1016/0006-291X(87)91074-6; Lodewyck D, 2007, ARCH OTOLARYNGOL, V133, P557, DOI 10.1001/archotol.133.6.557; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571; Morita K, 1998, J INVEST DERMATOL, V110, P862, DOI 10.1046/j.1523-1747.1998.00209.x; Phillips JE, 2000, J MEMBRANE BIOL, V175, P213, DOI 10.1007/s002320001069; Phillips JE, 1999, BIOPHYS J, V76, P869, DOI 10.1016/S0006-3495(99)77250-4; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; Rousseau B, LARYNGOSCOPE, V346- 351; SCHILLING L, 1994, BRAIN RES, V653, P289, DOI 10.1016/0006-8993(94)90403-0; Sivasankar M, 2002, J VOICE, V16, P172, DOI 10.1016/S0892-1997(02)00087-5; Sivasankar M, OTOLARYNGOL HEAD NEC, V142, P79; Sivasankar M, 2007, J VOICE IN PRESS; Sivasankar M, 2007, J SPEECH LANG HEAR R, V50, P886, DOI 10.1044/1092-4388(2007/063); SUGAHARA K, 1989, JPN J PHYSIOL, V39, P421, DOI 10.2170/jjphysiol.39.421; Takeuchi K, 2001, J ALLERGY CLIN IMMUN, V107, P310, DOI 10.1067/mai.2001.112127; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; VERDOLINIMARSTON K, 1990, J VOICE, V4, P142, DOI 10.1016/S0892-1997(05)80139-0; WEBER E, 1994, J CELL BIOL, V125, P583, DOI 10.1083/jcb.125.3.583; ZHONG Y, 1993, J CELL BIOL, V120, P477, DOI 10.1083/jcb.120.2.477; ZRUNEK M, 1988, ACTA OTO-LARYNGOL, V105, P155, DOI 10.3109/00016488809119460	46	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e34017	10.1371/journal.pone.0034017	http://dx.doi.org/10.1371/journal.pone.0034017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442739	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500080
J	Ida, H; Fukuhara, K; Ishii, M				Ida, Hirofumi; Fukuhara, Kazunobu; Ishii, Motonobu			Recognition of Tennis Serve Performed by a Digital Player: Comparison among Polygon, Shadow, and Stick-Figure Models	PLOS ONE			English	Article							BIOLOGICAL-MOTION; ANTICIPATORY PERFORMANCE; PERCEPTION; EXPERT; BALL; INFORMATION; KINEMATICS; HEAD; CUES	The objective of this study was to assess the cognitive effect of human character models on the observer's ability to extract relevant information from computer graphics animation of tennis serve motions. Three digital human models (polygon, shadow, and stick-figure) were used to display the computationally simulated serve motions, which were perturbed at the racket-arm by modulating the speed (slower or faster) of one of the joint rotations (wrist, elbow, or shoulder). Twenty-one experienced tennis players and 21 novices made discrimination responses about the modulated joint and also specified the perceived swing speeds on a visual analogue scale. The result showed that the discrimination accuracies of the experienced players were both above and below chance level depending on the modulated joint whereas those of the novices mostly remained at chance or guessing levels. As far as the experienced players were concerned, the polygon model decreased the discrimination accuracy as compared with the stick-figure model. This suggests that the complicated pictorial information may have a distracting effect on the recognition of the observed action. On the other hand, the perceived swing speed of the perturbed motion relative to the control was lower for the stick-figure model than for the polygon model regardless of the skill level. This result suggests that the simplified visual information can bias the perception of the motion speed toward slower. It was also shown that the increasing the joint rotation speed increased the perceived swing speed, although the resulting racket velocity had little correlation with this speed sensation. Collectively, observer's recognition of the motion pattern and perception of the motion speed can be affected by the pictorial information of the human model as well as by the perturbation processing applied to the observed motion.	[Ida, Hirofumi; Fukuhara, Kazunobu; Ishii, Motonobu] Tokyo Inst Technol, Dept Human Syst Sci, Tokyo 152, Japan; [Ida, Hirofumi] Kanagawa Inst Technol, Human Media Res Ctr, Atsugi, Kanagawa, Japan	Tokyo Institute of Technology; Kanagawa Institute Technology	Ida, H (corresponding author), Tokyo Inst Technol, Dept Human Syst Sci, Tokyo 152, Japan.	hiroida@me.com			Japan Society for the Promotion of Science [KAKENHI 22240070]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (A) of Japan Society for the Promotion of Science (KAKENHI 22240070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://www.jsps.go.jp/english/e-grants/grants.html)	ABERNETHY B, 1987, J SPORT EXERCISE PSY, V9, P326, DOI 10.1123/jsp.9.4.326; Abernethy B, 2007, J MOTOR BEHAV, V39, P353, DOI 10.3200/JMBR.39.5.353-368; Bideau B, 2004, NEUROSCI LETT, V372, P119, DOI 10.1016/j.neulet.2004.09.023; Canal-Bruland R, 2010, EXP PSYCHOL, V57, P320, DOI 10.1027/1618-3169/a000038; Craig CM, 2006, NATURWISSENSCHAFTEN, V93, P97, DOI 10.1007/s00114-005-0071-0; Dekeyser M, 2002, BEHAV RES METH INS C, V34, P375, DOI 10.3758/BF03195465; Dessing JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013161; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Farrow D, 2005, MOTOR CONTROL, V9, P332; Fink PW, 2009, J VISION, V9, DOI 10.1167/9.13.14; Fukuhara K., 2009, INT J SPORT HLTH SCI, V7, P12, DOI DOI 10.5432/IJSHS.IJSHS20090015; Gray R, 2002, J EXP PSYCHOL HUMAN, V28, P1131, DOI 10.1037//0096-1523.28.5.1131; Gray R, 2007, PSYCHON B REV, V14, P669, DOI 10.3758/BF03196819; Hodgins JK, 1998, IEEE T VIS COMPUT GR, V4, P307, DOI 10.1109/2945.765325; Huys R, 2008, PERCEPT PSYCHOPHYS, V70, P1217, DOI 10.3758/PP.70.7.1217; Ida H, 2011, PERCEPTION, V40, P1221, DOI 10.1068/p7041; Ida H, 2011, BEHAV RES METHODS, V43, P781, DOI 10.3758/s13428-011-0084-x; Jackson RC, 2007, J MOTOR BEHAV, V39, P341, DOI 10.3200/JMBR.39.5.341-352; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; McLeod P, 2008, VISION RES, V48, P1479, DOI 10.1016/j.visres.2008.03.016; Morris JP, 2005, J COGNITIVE NEUROSCI, V17, P1744, DOI 10.1162/089892905774589253; Overney LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002380; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; Pollick FE, 2001, PERCEPTION, V30, P323, DOI 10.1068/p3064; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Ranganathan R, 2007, J MOTOR BEHAV, V39, P369, DOI 10.3200/JMBR.39.5.369-380; Shim J, 2005, J MOTOR BEHAV, V37, P164, DOI 10.3200/JMBR.37.2.164-175; Sinnett S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013148; SPRIGINGS E, 1994, J BIOMECH, V27, P245, DOI 10.1016/0021-9290(94)90001-9; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; van der Kamp J, 2008, PERCEPTION, V37, P951, DOI 10.1068/p6010; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; Vignais Nicolas, 2009, International Journal of Virtual Reality, V8, P43; Vignais N, 2009, J SPORT SCI MED, V8, P501; Williams AM, 2009, HUM MOVEMENT SCI, V28, P362, DOI 10.1016/j.humov.2008.10.006; Winter D., 2005, BIOMECHANICS MOTOR C, V3rd, P13; Witt JK, 2010, PERCEPTION, V39, P1341, DOI 10.1068/p6699	38	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33879	10.1371/journal.pone.0033879	http://dx.doi.org/10.1371/journal.pone.0033879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	932RV	22439009	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100109
J	Shruti, S; Urban-Ciecko, J; Fitzpatrick, JA; Brenner, R; Bruchez, MP; Barth, AL				Shruti, Sonal; Urban-Ciecko, Joanna; Fitzpatrick, James A.; Brenner, Robert; Bruchez, Marcel P.; Barth, Alison L.			The Brain-Specific Beta4 Subunit Downregulates BK Channel Cell Surface Expression	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; ACTIVATED POTASSIUM CHANNELS; ENDOCYTIC TRAFFICKING SIGNALS; NEOCORTICAL PYRAMIDAL NEURONS; LARGE-CONDUCTANCE; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; TRANSMITTER RELEASE; NERVE-TERMINALS; SMOOTH-MUSCLE	The large-conductance K+ channel (BK channel) can control neural excitability, and enhanced channel currents facilitate high firing rates in cortical neurons. The brain-specific auxiliary subunit beta 4 alters channel Ca++- and voltage-sensitivity, and beta 4 knock-out animals exhibit spontaneous seizures. Here we investigate beta 4's effect on BK channel trafficking to the plasma membrane. Using a novel genetic tag to track the cellular location of the pore-forming BK alpha subunit in living cells, we find that beta 4 expression profoundly reduces surface localization of BK channels via a C-terminal ER retention sequence. In hippocampal CA3 neurons from C57BL/6 mice with endogenously high b4 expression, whole-cell BK channel currents display none of the characteristic properties of BK alpha+beta 4 channels observed in heterologous cells. Finally, beta 4 knock-out animals exhibit a 2.5-fold increase in whole-cell BK channel current, indicating that beta 4 also regulates current magnitude in vivo. Thus, we propose that a major function of the brain-specific beta 4 subunit in CA3 neurons is control of surface trafficking.	[Shruti, Sonal; Urban-Ciecko, Joanna; Barth, Alison L.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Fitzpatrick, James A.; Bruchez, Marcel P.] Carnegie Mellon Univ, Mol & Biosensor Imaging Ctr, Pittsburgh, PA 15213 USA; [Brenner, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	Carnegie Mellon University; Carnegie Mellon University; University of Texas System; University of Texas Health San Antonio	Shruti, S (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	bruchez@cmu.edu; barth@cmu.edu	Bruchez, Marcel P/C-2271-2009; Urban-Ciecko, Joanna/AFA-4378-2022; Fitzpatrick, James/C-2268-2009; Urban-Ciecko, Joanna/Q-3487-2016	Bruchez, Marcel P/0000-0002-7370-4848; Urban-Ciecko, Joanna/0000-0003-1676-2336; Fitzpatrick, James/0000-0002-7907-3602; Urban-Ciecko, Joanna/0000-0003-1676-2336; Brenner, Robert/0000-0002-1036-8031	Carnegie Mellon University; National Institutes of Health (NIH) [U54 RR022241]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052574] Funding Source: NIH RePORTER	Carnegie Mellon University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work was supported by start-up funds from Carnegie Mellon University and National Institutes of Health (NIH) U54 RR022241. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alle H, 2007, J NEUROSCI, V27, P942, DOI 10.1523/JNEUROSCI.4996-06.2007; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Bai JP, 2011, AM J PHYSIOL-CELL PH, V300, pC435, DOI 10.1152/ajpcell.00449.2010; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bekisz M, 2010, EUR J NEUROSCI, V32, P1715, DOI 10.1111/j.1460-9568.2010.07453.x; Benhassine N, 2005, EUR J NEUROSCI, V21, P914, DOI 10.1111/j.1460-9568.2005.03934.x; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Ghezzi A, 2010, P NATL ACAD SCI USA, V107, P16360, DOI 10.1073/pnas.1005439107; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Ha TS, 2004, BIOPHYS J, V86, P2871, DOI 10.1016/S0006-3495(04)74339-8; Hammami S, 2009, J PHYSIOL-LONDON, V587, P2225, DOI 10.1113/jphysiol.2008.163550; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; ITIN C, 1995, EMBO J, V14, P2250, DOI 10.1002/j.1460-2075.1995.tb07219.x; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jin P, 2002, J BIOL CHEM, V277, P10014, DOI 10.1074/jbc.M107682200; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; Kang J, 1996, J NEUROPHYSIOL, V76, P188, DOI 10.1152/jn.1996.76.1.188; Kaufmann WA, 2010, NEUROSCIENCE, V169, P974, DOI 10.1016/j.neuroscience.2010.05.070; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Lorenz S, 2006, AM J MED GENET B; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Matthews EA, 2009, LEARN MEMORY, V16, P106, DOI 10.1101/lm.1289809; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sheehan JJ, 2009, EPILEPSIA, V50, P711, DOI 10.1111/j.1528-1167.2008.01888.x; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; Shruti S, 2008, NEUROBIOL DIS, V30, P323, DOI 10.1016/j.nbd.2008.02.002; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Togo T, 1999, J CELL SCI, V112, P719; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang B, 2006, J GEN PHYSIOL, V127, P449, DOI 10.1085/jgp.200509436; Wang B, 2009, J GEN PHYSIOL, V133, P283, DOI 10.1085/jgp.200810141; WANG G, 1992, J PHYSIOL-LONDON, V457, P47, DOI 10.1113/jphysiol.1992.sp019364; Wang SX, 2003, J BIOL CHEM, V278, P2713, DOI 10.1074/jbc.M208411200; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x; Wynne PM, 2009, J PHARM EXP THER; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006135; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zarei MM, 2007, NEUROSCIENCE, V147, P80, DOI 10.1016/j.neuroscience.2007.04.019	65	53	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33429	10.1371/journal.pone.0033429	http://dx.doi.org/10.1371/journal.pone.0033429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438928	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100043
J	Macchia, A; Laffaye, N; Comignani, PD; Pucci, EC; Igarzabal, C; Scazziota, AS; Herrera, L; Mariani, JA; Bragagnolo, JC; Catalano, H; Tognoni, G; Nicolucci, A				Macchia, Alejandro; Laffaye, Nicolas; Comignani, Pablo D.; Cornejo Pucci, Elena; Igarzabal, Cecilia; Scazziota, Alejandra S.; Herrera, Lourdes; Mariani, Javier A.; Bragagnolo, Julio C.; Catalano, Hugo; Tognoni, Gianni; Nicolucci, Antonio			Statins but Not Aspirin Reduce Thrombotic Risk Assessed by Thrombin Generation in Diabetic Patients without Cardiovascular Events: The RATIONAL Trial	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW-DOSE ASPIRIN; PRIMARY PREVENTION; ANTIPLATELET THERAPY; FACTOR-V; METAANALYSIS; SIMVASTATIN; EFFICACY; ACTIVATION; MELLITUS	Background: The systematic use of aspirin and statins in patients with diabetes and no previous cardiovascular events is controversial. We sought to assess the effects of aspirin and statins on the thrombotic risk assessed by thrombin generation (TG) among patients with type II diabetes mellitus and no previous cardiovascular events. Methodology/Principal Findings: Prospective, randomized, open, blinded to events evaluation, controlled, 2x2 factorial clinical trial including 30 patients randomly allocated to aspirin 100 mg/d, atorvastatin 40 mg/d, both or none. Outcome measurements included changes in TG levels after treatment (8 to 10 weeks), assessed by a calibrated automated thrombogram. At baseline all groups had similar clinical and biochemical profiles, including TG levels. There was no interaction between aspirin and atorvastatin. Atorvastatin significantly reduced TG measured as peak TG with saline (85.09 +/- 55.34 nmol vs 153.26 +/- 75.55 nmol for atorvastatin and control groups, respectively; p=0.018). On the other hand, aspirin had no effect on TG (121.51 +/- 81.83 nmol vs 116.85 +/- 67.66 nmol, for aspirin and control groups, respectively; p=0.716). The effects of treatments on measurements of TG using other agonists were consistent. Conclusions/Significance: While waiting for data from ongoing large clinical randomized trials to definitively outline the role of aspirin in primary prevention, our study shows that among diabetic patients without previous vascular events, statins but not aspirin reduce thrombotic risk assessed by TG. Trial Registration: ClinicalTrials. gov NCT00793754	[Macchia, Alejandro; Laffaye, Nicolas; Comignani, Pablo D.; Catalano, Hugo] Hosp Aleman, Dept Med, Buenos Aires, DF, Argentina; [Macchia, Alejandro; Cornejo Pucci, Elena; Igarzabal, Cecilia] CEMIC, Dept Med, Buenos Aires, DF, Argentina; [Macchia, Alejandro; Tognoni, Gianni; Nicolucci, Antonio] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Chieti, Italy; [Macchia, Alejandro; Laffaye, Nicolas; Mariani, Javier A.] Fdn GESICA, Grp Estudio Invest Clin Argentina, Buenos Aires, DF, Argentina; [Scazziota, Alejandra S.; Herrera, Lourdes] Univ Buenos Aires, Fac Farm & Bioquim, RA-1113 Buenos Aires, DF, Argentina; [Bragagnolo, Julio C.] Hosp Ramos Mejia, Dept Med, Buenos Aires, DF, Argentina	Hospital Aleman; University of Buenos Aires; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Consorzio Mario Negri Sud; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires	Macchia, A (corresponding author), Hosp Aleman, Dept Med, Buenos Aires, DF, Argentina.	macchia@negrisud.it	Macchia, Alejandro/AAV-9665-2020; Mariani, Javier/P-9144-2018	Macchia, Alejandro/0000-0002-5424-5009; 	Universidad de Buenos Aires (UBA); GESICA Foundation	Universidad de Buenos Aires (UBA)(University of Buenos Aires); GESICA Foundation	This study was an independent clinical trial. Financial resources from the Universidad de Buenos Aires (UBA) (www.fmed.uba.ar) and the GESICA Foundation (www.fundaciongesica.org) were used to pay laboratory assessments and administrative cost. This trial provided no payment to investigators or institutions and fees for ethical committees have been waived. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman R, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-5; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 2005, DIABETES CARE, V28, pS4; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Bruno A, 2005, NUTR METAB CARDIOVAS, V15, P42, DOI 10.1016/j.numecd.2004.04.001; Carcaillon L, 2011, ARTERIOSCL THROM VAS, V31, P1445, DOI 10.1161/ATVBAHA.111.223453; Costa J, 2006, BMJ-BRIT MED J, V332, P1115, DOI 10.1136/bmj.38793.468449.AE; De Berardis G, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-21; DEBERARDIS G, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4531; Evangelista V, 2005, THROMB HAEMOSTASIS, V93, P8, DOI 10.1160/TH04-07-0453; Geisler T, 2010, CLIN RES CARDIOL, V99, P743, DOI 10.1007/s00392-010-0179-x; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Haffner SM, 2000, NEW ENGL J MED, V342, P1040, DOI 10.1056/NEJM200004063421408; Halushka MK, 2002, CIRCULATION, V105, P1620, DOI 10.1161/01.CIR.0000015422.86569.52; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Liao JK, 2002, INT J CARDIOL, V86, P5, DOI 10.1016/S0167-5273(02)00195-X; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451; Nicolucci A, 2011, DIABETES CARE, V34, pS150, DOI 10.2337/dc11-s210; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Undas A, 2005, ARTERIOSCL THROM VAS, V25, P1524, DOI 10.1161/01.ATV.0000168913.25278.38; Undas A, 2001, CIRCULATION, V103, P2248; Vinik AI, 2001, DIABETES CARE, V24, P1476, DOI 10.2337/diacare.24.8.1476; Wegert W, 2002, INT J CLIN PHARM TH, V40, P135; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9; Zhang CY, 2010, DIABETES RES CLIN PR, V87, P211, DOI 10.1016/j.diabres.2009.09.029	31	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32894	10.1371/journal.pone.0032894	http://dx.doi.org/10.1371/journal.pone.0032894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470429	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000011
J	Weksberg, DC; Bilton, SD; Chang, EL				Weksberg, David C.; Bilton, Stephen D.; Chang, Eric L.			Use of a Deformable Atlas to Identify Cryptic Critical Structures in the Treatment of Glioblastoma Multiforme	PLOS ONE			English	Article							RADIATION-THERAPY; ADJUVANT TEMOZOLOMIDE; BRAIN RADIOTHERAPY; PHASE-III; TRIAL; OLIGODENDROGLIOMA; CONCOMITANT; HIPPOCAMPUS; METASTASES	Dose constraints for traditional neural critical structures (e.g. optic chiasm, brain stem) are a standard component of planning radiation therapy to the central nervous system. Increasingly, investigators are becoming interested in accounting for the dose delivered to other non-target neural structures (e.g. hippocampi), which are not easily identified on axial imaging. In this pilot study, a commercially available digital atlas was used to identify cryptic neural structures (hippocampus, optic radiations, and visual cortices) in 6 patients who received intensity modulated radiation therapy (IMRT) as part of multimodal management of glioblastoma multiforme (GBM). The patient's original IMRT plans were re-optimized, with avoidance parameters for the newly identified critical structures. Re-optimization was able to reduce both mean and maximum dose to the volumes of interest, with a more pronounced effect for contralateral structures. Mean dose was reduced by 11% and 3% to contralateral and ipsilateral structures, respectively, with comparable reduction in maximum dose of 10% and 2%, respectively. Importantly, target coverage was not compromised, with an average change in coverage of 0.2%. Overall, our results demonstrate the feasibility of incorporating tools for cryptic critical structure identification into the treatment planning process for GBM.	[Weksberg, David C.; Bilton, Stephen D.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Chang, Eric L.] Univ So Calif, Keck Sch Med, Norris Canc Hosp, Dept Radiat Oncol, Los Angeles, CA 90033 USA	University of Texas System; UTMD Anderson Cancer Center; University of Southern California	Weksberg, DC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	eric.L.chang@usc.edu						Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Butler EB, 2007, CANCER INVEST, V25, P1, DOI 10.1080/07357900600970490; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; Central Brain Tumor Registry of the United States, 2011, PRIM BRAIN CENTR NER; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Chera BS, 2009, AM J CLIN ONCOL-CANC, V32, P20, DOI 10.1097/COC.0b013e318178e4e8; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Hamilton JD, J COMPUTER IN PRESS; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Marsh JC, 2011, J MED IMAG RADIAT ON, V55, P442, DOI 10.1111/j.1754-9485.2011.02282.x; Rosenschold PM, ACTA ONCOL, V50, P777; Shah GD, 2007, J CLIN ONCOL, V25, P4730, DOI 10.1200/JCO.2007.12.5062; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; van den Bent MJ, 2003, CANCER-AM CANCER SOC, V97, P1276, DOI 10.1002/cncr.11187; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497	18	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e32098	10.1371/journal.pone.0032098	http://dx.doi.org/10.1371/journal.pone.0032098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461883	Green Submitted, Green Published, gold			2022-12-27	WOS:000304118900002
J	Oviedo, HV; Reyes, AD				Oviedo, Hysell V.; Reyes, Alex D.			Integration of Subthreshold and Suprathreshold Excitatory Barrages along the Somatodendritic Axis of Pyramidal Neurons	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; INPUT-OUTPUT PROPERTIES; SYNAPTIC INTEGRATION; NEOCORTICAL NEURONS; CORTICAL-NEURONS; IN-VITRO; POSTSYNAPTIC POTENTIALS; SUPRALINEAR SUMMATION; APICAL DENDRITES; BASAL DENDRITES	Neurons integrate inputs arriving in different cellular compartments to produce action potentials that are transmitted to other neurons. Because of the voltage- and time-dependent conductances in the dendrites and soma, summation of synaptic inputs is complex. To examine summation of membrane potentials and firing rates, we performed whole-cell recordings from layer 5 cortical pyramidal neurons in acute slices of the rat's somatosensory cortex. We delivered subthreshold and suprathreshold stimuli at the soma and several sites on the apical dendrite, and injected inputs that mimic synaptic barrages at individual or distributed sites. We found that summation of subthreshold potentials differed from that of firing rates. Subthreshold summation was linear when barrages were small but became supralinear as barrages increased. When neurons were discharging repetitively the rules were more diverse. At the soma and proximal apical dendrite summation of the evoked firing rates was predominantly sublinear whereas in the distal dendrite summation ranged from supralinear to sublinear. In addition, the integration of inputs delivered at a single location differed from that of distributed inputs only for suprathreshold responses. These results indicate that convergent inputs onto the apical dendrite and soma do not simply summate linearly, as suggested previously, and that distinct presynaptic afferents that target specific sites on the dendritic tree may perform unique sets of computations.	[Oviedo, Hysell V.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Reyes, Alex D.] NYU, Ctr Neural Sci, New York, NY 10003 USA	Cold Spring Harbor Laboratory; New York University	Oviedo, HV (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	oviedo@cshl.edu			United States National Institutes of Health National Research Service Award; National Institute of Deafness and Other Communication Disorders [DC-005787-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005787] Funding Source: NIH RePORTER	United States National Institutes of Health National Research Service Award; National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the United States National Institutes of Health National Research Service Award (H.V.O.) and National Institute of Deafness and Other Communication Disorders Grant DC-005787-01A1 (A.D.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Crill WE, 1999, J PHYSIOLOGY-PARIS, V93, P17, DOI 10.1016/S0928-4257(99)80132-6; Dodt HU, 2003, NEUROREPORT, V14, P623, DOI 10.1097/00001756-200303240-00020; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Gonzalez-Burgos G, 2001, J NEUROPHYSIOL, V86, P1671, DOI 10.1152/jn.2001.86.4.1671; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larkum ME, 2004, CEREB CORTEX; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magistretti J, 1999, J PHYSIOL-LONDON, V521, P629, DOI 10.1111/j.1469-7793.1999.00629.x; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Oakley JC, 2001, J NEUROPHYSIOL, V86, P514, DOI 10.1152/jn.2001.86.1.514; Oviedo H, 2005, J NEUROSCI, V25, P4985, DOI 10.1523/JNEUROSCI.0562-05.2005; Oviedo H, 2002, NAT NEUROSCI, V5, P261, DOI 10.1038/nn807; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes AD, 1996, J NEUROSCI, V16, P993; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schwindt PC, 1998, J NEUROPHYSIOL, V79, P2432, DOI 10.1152/jn.1998.79.5.2432; SCHWINDT PC, 1995, J NEUROPHYSIOL, V74, P2220, DOI 10.1152/jn.1995.74.5.2220; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P424, DOI 10.1152/jn.1988.59.2.424; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Spadoni F, 2002, NEUROREPORT, V13, P1167, DOI 10.1097/00001756-200207020-00019; Spruston N, 2004, NAT NEUROSCI, V7, P567, DOI 10.1038/nn0604-567; Stricker C, 1996, J PHYSIOL-LONDON, V490, P419, DOI 10.1113/jphysiol.1996.sp021155; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Tamas G, 2002, J NEUROSCI, V22, P740, DOI 10.1523/JNEUROSCI.22-03-00740.2002; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; Williams SR, 2005, J NEUROSCI, V25, P5894, DOI 10.1523/JNEUROSCI.0502-05.2005; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33831	10.1371/journal.pone.0033831	http://dx.doi.org/10.1371/journal.pone.0033831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457793	Green Published, gold, Green Accepted			2022-12-27	WOS:000304046900028
J	Gaudry, KS				Gaudry, Kate S.			The Lone Inventor: Low Success Rates and Common Errors Associated with Pro-Se Patent Applications	PLOS ONE			English	Article								A pro-se patent applicant is an inventor who chooses to represent himself while pursuing ("prosecuting") a patent application. To the author's knowledge, this paper is the first empirical study addressing how applications filed by pro-se inventors fare compared to applications in which inventors were represented by patent attorneys or agents. The prosecution history of 500 patent applications filed at the United States Patent and Trademark Office were analyzed: inventors were represented by a patent professional for 250 of the applications ("represented applications") but not in the other 250 ("pro-se applications"). 76% of the pro-se applications became abandoned (not issuing as a patent), as compared to 35% of the represented applications. Further, among applications that issued as patents, pro-se patents' claims appear to be narrower and therefore of less value than claims in the represented patent set. Case-specific data suggests that a substantial portion of pro-se applicants unintentionally abandon their applications, terminate the examination process relatively early, and/or fail to take advantage of interview opportunities that may resolve issues stalling allowance of the application.	Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University	Gaudry, KS (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.	kategaudry@gmail.com						Barney JA, 2002, AIPLA Q J, V30, P317; Calvert J, 2011, PRO BONO PILOT PROGR; Hashimoto EJ, 2006, DEFENDING RIGHT SELF; Kasper AJ, 2008, STATEMENT ALAN J KAS; Kirik Cathie, 2011, WORKING PATENT PRACT; Painter CS, 2011, CAPSTONE REPORTARKAN; United States Patent and Trademark Office, 2011, INV RES	7	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33141	10.1371/journal.pone.0033141	http://dx.doi.org/10.1371/journal.pone.0033141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470439	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100016
J	Gruber, CW; Muttenthaler, M				Gruber, Christian W.; Muttenthaler, Markus			Discovery of Defense- and Neuropeptides in Social Ants by Genome-Mining	PLOS ONE			English	Article							CONSERVED SALT BRIDGE; JUMPER ANT; MOLECULAR CHARACTERIZATION; CAMPONOTUS-FLORIDANUS; INSECT DEFENSIN; AUSTRALIAN ANT; DRAFT GENOME; PEPTIDE; VENOM; IDENTIFICATION	Natural peptides of great number and diversity occur in all organisms, but analyzing their peptidome is often difficult. With natural product drug discovery in mind, we devised a genome-mining approach to identify defense- and neuropeptides in the genomes of social ants from Atta cephalotes (leaf-cutter ant), Camponotus floridanus (carpenter ant) and Harpegnathos saltator (basal genus). Numerous peptide-encoding genes of defense peptides, in particular defensins, and neuropeptides or regulatory peptide hormones, such as allatostatins and tachykinins, were identified and analyzed. Most interestingly we annotated genes that encode oxytocin/vasopressin-related peptides (inotocins) and their putative receptors. This is the first piece of evidence for the existence of this nonapeptide hormone system in ants (Formicidae) and supports recent findings in Tribolium castaneum (red flour beetle) and Nasonia vitripennis (parasitoid wasp), and therefore its confinement to some basal holometabolous insects. By contrast, the absence of the inotocin hormone system in Apis mellifera (honeybee), another closely-related member of the eusocial Hymenoptera clade, establishes the basis for future studies on the molecular evolution and physiological function of oxytocin/vasopressin-related peptides (vasotocin nonapeptide family) and their receptors in social insects. Particularly the identification of ant inotocin and defensin peptide sequences will provide a basis for future pharmacological characterization in the quest for potent and selective lead compounds of therapeutic value.	[Gruber, Christian W.] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Muttenthaler, Markus] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Muttenthaler, Markus] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Medical University of Vienna; Scripps Research Institute; Scripps Research Institute	Gruber, CW (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria.	christian.w.gruber@meduniwien.ac.at	Gruber, Christian/C-4406-2011; Muttenthaler, Markus/B-4944-2017; Muttenthaler, Markus/AAF-5944-2021	Muttenthaler, Markus/0000-0003-1996-4646; Muttenthaler, Markus/0000-0003-1996-4646; Gruber, Christian/0000-0001-6060-7048	Austrian Science Fund (FWF) [P22889-B11]; European Union [254897]; Austrian Science Fund (FWF) [P 22889] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financially supported by the Austrian Science Fund (FWF): P22889-B11 and from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. [254897]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHER R, 1995, FRONT NEUROENDOCRIN, V16, P237, DOI 10.1006/frne.1995.1009; Acher R, 1995, ADV EXP MED BIOL, V395, P615; Aikins MJ, 2008, INSECT BIOCHEM MOLEC, V38, P740, DOI 10.1016/j.ibmb.2008.04.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Bulmer MS, 2004, MOL BIOL EVOL, V21, P2256, DOI 10.1093/molbev/msh236; CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Chini B, 1996, FEBS LETT, V397, P201, DOI 10.1016/S0014-5793(96)01135-0; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Daly NL, 2007, BIOCHEMISTRY-US, V46, P9920, DOI 10.1021/bi700720e; Davies NW, 2004, TOXICON, V43, P173, DOI 10.1016/j.toxicon.2003.11.021; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Donovan GR, 1996, BIOCHEM MOL BIOL INT, V39, P877; DONOVAN GR, 1993, BIOCHIM BIOPHYS ACTA, V1171, P272, DOI 10.1016/0167-4781(93)90065-L; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Elekonich MM, 2005, COMP BIOCHEM PHYS A, V141, P362, DOI 10.1016/j.cbpb.2005.04.014; Escoubas P, 2006, TOXICON, V47, P650, DOI 10.1016/j.toxicon.2006.01.018; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; FORD SA, 1991, CLIN EXP ALLERGY, V21, P167, DOI 10.1111/j.1365-2222.1991.tb00826.x; Fujino Y, 1999, J EXP ZOOL, V284, P401, DOI 10.1002/(SICI)1097-010X(19990901)284:4<401::AID-JEZ6>3.0.CO;2-U; Gadagkar R, 2011, P NATL ACAD SCI USA, V108, P5477, DOI 10.1073/pnas.1100765108; Gade G, 2004, ANNU REV ENTOMOL, V49, P93, DOI 10.1146/annurev.ento.49.061802.123354; Goodson JL, 2008, PROG BRAIN RES, V170, P3, DOI 10.1016/S0079-6123(08)00401-9; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gruber CW, 2010, CURR PHARM DESIGN, V16, P3071; Gruber CW, 2010, BIOPOLYMERS, V94, P565, DOI 10.1002/bip.21414; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Hoyle CHV, 1999, BRAIN RES, V848, P1, DOI 10.1016/S0006-8993(99)01975-7; Inagaki H, 2004, ARCH BIOCHEM BIOPHYS, V428, P170, DOI 10.1016/j.abb.2004.05.013; Inagaki H, 2008, ARCH BIOCHEM BIOPHYS, V477, P411, DOI 10.1016/j.abb.2008.05.014; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; KIMURA T, 1994, EUR J ENDOCRINOL, V131, P385, DOI 10.1530/eje.0.1310385; Laenen B, 1999, J INSECT PHYSIOL, V45, P743, DOI 10.1016/S0022-1910(99)00053-0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landon C, 2008, PROTEINS, V72, P229, DOI 10.1002/prot.21912; Muttenthaler M, 2010, J MED CHEM, V53, P8585, DOI 10.1021/jm100989w; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Ratzka C, 2011, INSECT BIOCHEM MOLEC, V41, P529, DOI 10.1016/j.ibmb.2011.03.002; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Saito M, 1997, BIOCHEM PHARMACOL, V53, P1711, DOI 10.1016/S0006-2952(97)00070-1; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; Stay B, 2007, ANNU REV ENTOMOL, V52, P277, DOI 10.1146/annurev.ento.51.110104.151050; STREET MD, 1994, CLIN EXP ALLERGY, V24, P590, DOI 10.1111/j.1365-2222.1994.tb00957.x; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Taguchi S, 1998, BIOCHIMIE, V80, P343, DOI 10.1016/S0300-9084(98)80078-3; Ueberheide BM, 2009, P NATL ACAD SCI USA, V106, P6910, DOI 10.1073/pnas.0900745106; Viljakainen L, 2005, INSECT MOL BIOL, V14, P335, DOI 10.1111/j.1365-2583.2005.00564.x; Viljakainen L, 2008, J MOL EVOL, V67, P643, DOI 10.1007/s00239-008-9173-6; Wiese MD, 2007, ALLERGY, V62, P437, DOI 10.1111/j.1398-9995.2007.01320.x; Wiese MD, 2006, TOXICON, V47, P208, DOI 10.1016/j.toxicon.2005.10.018; Wu QX, 1998, BBA-GEN SUBJECTS, V1425, P74, DOI 10.1016/S0304-4165(98)00052-X; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108	66	48	49	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32559	10.1371/journal.pone.0032559	http://dx.doi.org/10.1371/journal.pone.0032559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448224	Green Submitted, gold, Green Published			2022-12-27	WOS:000303855700014
J	Lau, CS; Wong, DTW				Lau, Chang S.; Wong, David T. W.			Breast Cancer Exosome-like Microvesicles and Salivary Gland Cells Interplay Alters Salivary Gland Cell-Derived Exosome-like Microvesicles In Vitro	PLOS ONE			English	Article							BIOMARKERS; VESICLES; VACCINE	Saliva is a useful biofluid for the early detection of disease, but how distal tumors communicate with the oral cavity and create disease-specific salivary biomarkers remains unclear. Using an in vitro breast cancer model, we demonstrated that breast cancer-derived exosome-like microvesicles are capable of interacting with salivary gland cells, altering the composition of their secreted exosome-like microvesicles. We found that the salivary gland cells secreted exosome-like microvesicles encapsulating both protein and mRNA. We also showed that the interaction with breast cancer-derived exosome-like microvesicles communicated and activated the transcriptional machinery of the salivary gland cells. Thus, the interaction altered the composition of the salivary gland cell-derived exosome-like microvesicles on both the transcriptomically and proteomically.	[Lau, Chang S.; Wong, David T. W.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Lau, Chang S.; Wong, David T. W.] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90024 USA; [Wong, David T. W.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Wong, David T. W.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Wong, David T. W.] Univ Calif Los Angeles, Div Head & Neck Surg Otolaryngol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lau, CS (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	dtww@ucla.edu			Felix & Mildred Yip Endowed Professorship; Annie and Kevin Barnes Fund	Felix & Mildred Yip Endowed Professorship; Annie and Kevin Barnes Fund	This work was supported by the Felix & Mildred Yip Endowed Professorship and the Annie and Kevin Barnes Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2004, J IMMUNOL, V172, P2126, DOI 10.4049/jimmunol.172.4.2126; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; BRINKLEY BR, 1980, CANCER RES, V40, P3118; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Hendrix A, 2010, CANCER RES, V70, P9533, DOI 10.1158/0008-5472.CAN-10-3248; Hu S, 2010, ARTHRITIS CARE RES; Hu S, 2007, CURR OPIN MOL THER, V9, P467; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McManaman JL, 2006, J MAMMARY GLAND BIOL, V11, P249, DOI 10.1007/s10911-006-9031-3; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Schutz C, 2009, J IMMUNOL METHODS, V344, P98, DOI 10.1016/j.jim.2009.03.008; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Zhang L, 2010, PLOS ONE, V5, P1; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010; Zhou H, 2008, KIDNEY INT, V74, P613, DOI 10.1038/ki.2008.206; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	27	70	73	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33037	10.1371/journal.pone.0033037	http://dx.doi.org/10.1371/journal.pone.0033037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448232	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700022
J	Mohanta, TK; Occhipinti, A; Zebelo, SA; Foti, M; Fliegmann, J; Bossi, S; Maffei, ME; Bertea, CM				Mohanta, Tapan Kumar; Occhipinti, Andrea; Zebelo, Simon Atsbaha; Foti, Maria; Fliegmann, Judith; Bossi, Simone; Maffei, Massimo E.; Bertea, Cinzia M.			Ginkgo biloba Responds to Herbivory by Activating Early Signaling and Direct Defenses	PLOS ONE			English	Article							FEEDING SPODOPTERA-LITTORALIS; RADICAL SCAVENGING ACTIVITY; LIMA-BEAN LEAVES; SECONDARY METABOLITES; PLANT VOLATILES; CYTOCHROME B5; CELL-DEATH; EXPRESSION; EXTRACT; RESISTANCE	Background: Ginkgo biloba (Ginkgoaceae) is one of the most ancient living seed plants and is regarded as a living fossil. G. biloba has a broad spectrum of resistance or tolerance to many pathogens and herbivores because of the presence of toxic leaf compounds. Little is known about early and late events occurring in G. biloba upon herbivory. The aim of this study was to assess whether herbivory by the generalist Spodoptera littoralis was able to induce early signaling and direct defense in G. biloba by evaluating early and late responses. Methodology/Principal Findings: Early and late responses in mechanically wounded leaves and in leaves damaged by S. littoralis included plasma transmembrane potential (Vm) variations, time-course changes in both cytosolic calcium concentration ([Ca2+](cyt)) and H2O2 production, the regulation of genes correlated to terpenoid and flavonoid biosynthesis, the induction of direct defense compounds, and the release of volatile organic compounds (VOCs). The results show that G. biloba responded to hebivory with a significant Vm depolarization which was associated to significant increases in both [Ca2+](cyt) and H2O2. Several defense genes were regulated by herbivory, including those coding for ROS scavenging enzymes and the synthesis of terpenoids and flavonoids. Metabolomic analyses revealed the herbivore-induced production of several flavonoids and VOCs. Surprisingly, no significant induction by herbivory was found for two of the most characteristic G. biloba classes of bioactive compounds; ginkgolides and bilobalides. Conclusions/Significance: By studying early and late responses of G. biloba to herbivory, we provided the first evidence that this "living fossil" plant responds to herbivory with the same defense mechanisms adopted by the most recent angiosperms.	[Mohanta, Tapan Kumar; Occhipinti, Andrea; Zebelo, Simon Atsbaha; Foti, Maria; Bossi, Simone; Maffei, Massimo E.; Bertea, Cinzia M.] Univ Turin, Innovat Ctr, Dept Life Sci & Syst Biol, Plant Physiol Unit, Turin, Italy; [Fliegmann, Judith] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France	University of Turin; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Mohanta, TK (corresponding author), Govind Ballabh Pant Univ Agr & Technol, Coll Basic Sci & Humanities, Dept Biol Sci, Udham Singh Nagar, Uttarakhand, India.	massimo.maffei@unito.it	Occhipinti, Andrea/E-4607-2017; Maffei, Massimo E/K-9593-2015; Zebelo, Simon/T-7086-2017; Mohanta, Tapan Kumar/F-9907-2018; Bertea, Cinzia Margherita/AAH-6434-2019	Occhipinti, Andrea/0000-0003-2723-6374; Maffei, Massimo E/0000-0001-6814-2353; Mohanta, Tapan Kumar/0000-0002-3196-7746; Fliegmann, Judith/0000-0003-1021-8006; Bossi, Simone/0000-0003-4736-519X; Bertea, Cinzia Margherita/0000-0003-2919-0445	Centre of Excellence CEBIOVEM of the University of Turin	Centre of Excellence CEBIOVEM of the University of Turin	This work was partly supported by the Centre of Excellence CEBIOVEM of the University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Altiok N, 2006, NEUROTOXICOLOGY, V27, P158, DOI 10.1016/j.neuro.2005.08.004; Anttila U, 2010, OECOLOGIA, V164, P163, DOI 10.1007/s00442-010-1658-5; Arimura GI, 2011, INT J MOL SCI, V12, P3723, DOI 10.3390/ijms12063723; Arimura G, 2010, BIOCHEM BIOPH RES CO, V400, P455, DOI 10.1016/j.bbrc.2010.08.134; ARNOTT HJ, 1959, AM J BOT, V46, P405, DOI 10.2307/2439135; Barbehenn R, 2010, OECOLOGIA, V164, P993, DOI 10.1007/s00442-010-1733-y; Bedir E, 2002, J AGR FOOD CHEM, V50, P3150, DOI 10.1021/jf011682s; Bhattacharjee S, 2008, PLANT CELL, V20, P2661, DOI 10.1105/tpc.108.060467; Bonaventure G, 2011, TRENDS PLANT SCI, V16, P294, DOI 10.1016/j.tplants.2011.01.006; Boonkaew T, 2005, PHYTOMEDICINE, V12, P318, DOI 10.1016/j.phymed.2003.06.008; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Brenner ED, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-143; Chan WH, 2007, ANN NY ACAD SCI, V1095, P388, DOI 10.1196/annals.1397.042; Christen Y, 2002, CELL MOL BIOL, V48, P601; Dahan J, 2001, J EXP BOT, V52, P1947, DOI 10.1093/jexbot/52.362.1947; Dai SH, 2011, PLANT CELL, V23, P961, DOI 10.1105/tpc.111.084293; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Delvas N, 2011, ENTOMOL EXP APPL, V141, P35, DOI 10.1111/j.1570-7458.2011.01161.x; Ding S, 2008, PHYTOCHEMISTRY, V69, P1555, DOI 10.1016/j.phytochem.2008.01.026; Ducreux LJM, 2008, J EXP BOT, V59, P4219, DOI 10.1093/jxb/ern264; Ellnain-Wojtaszek M, 2002, FOOD CHEM, V79, P79, DOI 10.1016/S0308-8146(02)00181-4; Fan RC, 2009, PLANT PHYSIOL, V150, P1880, DOI 10.1104/pp.109.141374; Frahry G, 1998, PHYTOCHEMISTRY, V48, P223, DOI 10.1016/S0031-9422(98)00004-1; Guerrieri E, 2008, J PLANT INTERACT, V3, P223, DOI 10.1080/17429140802567173; Hasebe M., 1997, GINKGO BILOBA GLOBAL, P173; HASLER A, 1992, J CHROMATOGR, V605, P41, DOI 10.1016/0021-9673(92)85026-P; He XY, 2009, J ENVIRON SCI-CHINA, V21, P199, DOI 10.1016/S1001-0742(08)62251-2; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Imbiscuso G, 2009, J PLANT INTERACT, V4, P15, DOI 10.1080/17429140802387739; Jacobs BP, 2000, AM J MED, V108, P341, DOI 10.1016/S0002-9343(00)00290-4; Kanchiswamy CN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-97; Kang SM, 2009, J BIOTECHNOL, V139, P84, DOI 10.1016/j.jbiotec.2008.09.007; Karban R, 2011, J PLANT INTERACT, V6, P81, DOI 10.1080/17429145.2010.536589; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kugimiya S, 2011, J PLANT INTERACT, V6, P187, DOI 10.1080/17429145.2010.543475; Kumar R, 2006, PLANT J, V48, P920, DOI 10.1111/j.1365-313X.2006.02925.x; Leistner E, 2010, J NAT PROD, V73, P86, DOI 10.1021/np9005019; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; Lin XH, 2011, PHYSIOL PLANTARUM, V143, P207, DOI 10.1111/j.1399-3054.2011.01500.x; Liu N, 2005, APPL RADIAT ISOTOPES, V63, P151, DOI 10.1016/j.apradiso.2004.12.011; Maffei M, 2004, PLANT PHYSIOL, V134, P1752, DOI 10.1104/pp.103.034165; Maffei ME, 2007, PHYTOCHEMISTRY, V68, P2946, DOI 10.1016/j.phytochem.2007.07.016; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Maffei ME, 2011, NAT PROD REP, V28, P1359, DOI 10.1039/c1np00021g; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; MAITRA I, 1995, BIOCHEM PHARMACOL, V49, P1649, DOI 10.1016/0006-2952(95)00089-I; Mithofer A, 2009, ANNU PLANT REV, V34, P261, DOI 10.1111/b.9781405175326.2009.00009.x; Mithoefer Axel, 2009, V479, P79, DOI 10.1007/978-1-59745-289-2_5; Muller Walter E, 2009, Pharm Unserer Zeit, V38, P408, DOI 10.1002/pauz.200900328; Mundry M, 2004, FLORA, V199, P437, DOI 10.1078/0367-2530-00171; O'Neill BF, 2010, J CHEM ECOL, V36, P35, DOI 10.1007/s10886-009-9727-0; Olson DM, 2008, J CHEM ECOL, V34, P1341, DOI 10.1007/s10886-008-9532-1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pszczolkowski MA, 2011, J AGR FOOD CHEM, V59, P10879, DOI 10.1021/jf202386c; Ramadan A, 2011, J PLANT INTERACT, V6, P155, DOI 10.1080/17429145.2010.544775; Rasmann S, 2011, ECOL LETT, V14, P476, DOI 10.1111/j.1461-0248.2011.01609.x; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Royer DL, 2003, PALEOBIOLOGY, V29, P84, DOI 10.1666/0094-8373(2003)029&lt;0084:ECITLF&gt;2.0.CO;2; Sabelis MW, 2011, J PLANT INTERACT, V6, P71, DOI 10.1080/17429145.2011.556262; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Schepmann HG, 2001, ARCH BIOCHEM BIOPHYS, V392, P263, DOI 10.1006/abbi.2001.2438; Schwarz M, 1999, COMPREHENSIVE NATURA, V2, P367, DOI DOI 10.1016/B978-0-08-091283-7.00043-6; Shaw F. J. F., 1908, NEW PHYTOL, V7, P85; Shi C, 2010, NEUROCHEM INT, V56, P893, DOI 10.1016/j.neuint.2010.03.016; Shi C, 2010, INT J MOL SCI, V11, P107, DOI 10.3390/ijms11010107; Swanson SJ, 2011, ANNU REV PLANT BIOL, V62, P273, DOI 10.1146/annurev-arplant-042110-103832; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; van Beek TA, 2002, J CHROMATOGR A, V967, P21, DOI 10.1016/S0021-9673(02)00172-3; Van Den Boom CEM, 2004, J CHEM ECOL, V30, P69, DOI 10.1023/B:JOEC.0000013183.72915.99; van den Boom CEM, 2003, J APPL ENTOMOL, V127, P177, DOI 10.1046/j.1439-0418.2003.00726.x; Wang YQ, 2010, TREE GENET GENOMES, V6, P357, DOI 10.1007/s11295-009-0254-5; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x; Zebelo SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017195; Zhao YP, 2010, TAXON, V59, P495, DOI 10.1002/tax.592014; Zhou ZY, 2003, NATURE, V423, P821, DOI 10.1038/423821a	76	62	68	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32822	10.1371/journal.pone.0032822	http://dx.doi.org/10.1371/journal.pone.0032822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448229	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700019
J	Coste, F; Kemp, C; Bobezeau, V; Hetru, C; Kellenberger, C; Imler, JL; Roussel, A				Coste, Franck; Kemp, Cordula; Bobezeau, Vanessa; Hetru, Charles; Kellenberger, Christine; Imler, Jean-Luc; Roussel, Alain			Crystal Structure of Diedel, a Marker of the Immune Response of Drosophila melanogaster	PLOS ONE			English	Article							PROTEIN; PATHWAYS; IMD	Background: The Drosophila melanogaster gene CG11501 is up regulated after a septic injury and was proposed to act as a negative regulator of the JAK/STAT signaling pathway. Diedel, the CG11501 gene product, is a small protein of 115 residues with 10 cysteines. Methodology/Principal Findings: We have produced Diedel in Drosophila S2 cells as an extra cellular protein thanks to its own signal peptide and solved its crystal structure at 1.15 angstrom resolution by SIRAS using an iodo derivative. Diedel is composed of two sub domains SD1 and SD2. SD1 is made of an antiparallel beta-sheet covered by an alpha-helix and displays a ferredoxin-like fold. SD2 reveals a new protein fold made of loops connected by four disulfide bridges. Further structural analysis identified conserved hydrophobic residues on the surface of Diedel that may constitute a potential binding site. The existence of two conformations, cis and trans, for the proline 52 may be of interest as prolyl peptidyl isomerisation has been shown to play a role in several physiological mechanisms. The genome of D. melanogaster contains two other genes coding for proteins homologous to Diedel, namely CG43228 and CG34329. Strikingly, apart from Drosophila and the pea aphid Acyrthosiphon pisum, Diedel-related sequences were exclusively identified in a few insect DNA viruses of the Baculoviridae and Ascoviridae families. Conclusion/Significance: Diedel, a marker of the Drosophila antimicrobial/antiviral response, is a member of a small family of proteins present in drosophilids, aphids and DNA viruses infecting lepidopterans. Diedel is an extracellular protein composed of two sub-domains. Two special structural features (hydrophobic surface patch and cis/trans conformation for proline 52) may indicate a putative interaction site, and support an extra cellular signaling function for Diedel, which is in accordance with its proposed role as negative regulator of the JAK/STAT signaling pathway.	[Coste, Franck; Bobezeau, Vanessa] CNRS, Ctr Biophys Mol, UPR4301, Orleans, France; [Kemp, Cordula; Hetru, Charles; Imler, Jean-Luc] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, UPR9022, Strasbourg, France; [Roussel, Alain] CNRS, UMR6098, Marseille, France; [Kellenberger, Christine; Roussel, Alain] Aix Marseille Univ, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Coste, F (corresponding author), CNRS, Ctr Biophys Mol, UPR4301, Orleans, France.	alain.roussel@afmb.univ-mrs.fr	coste, franck/F-6832-2015; Imler, Jean-Luc/GXH-4323-2022; kellenberger, christine/AAV-9304-2020; coste, franck/ABC-1407-2020	coste, franck/0000-0002-7409-0470; coste, franck/0000-0002-7409-0470	Agence Nationale de la Recherche, France [ANR-07-MIME-023-01]; US National Institutes of Health [PO1 AI070167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Agence Nationale de la Recherche, France(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Agence Nationale de la Recherche, France, ANR-07-MIME-023-01 to AR and CH, and US National Institutes of Health, PO1 AI070167, to JLI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basbous N, 2011, EMBO REP, V12, P327, DOI 10.1038/embor.2011.19; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kellenberger C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182741; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Long CM, 2009, VIROLOGY, V388, P231, DOI 10.1016/j.virol.2009.04.006; Mallis RJ, 2002, NAT STRUCT BIOL, V9, P900, DOI 10.1038/nsb864; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Mishima Y, 2009, ACTA CRYSTALLOGR F, V65, P870, DOI 10.1107/S1744309109014997; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; ROUSSEL A, 1991, SILICON GRAPHICS GEO; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stasiak K, 2003, J GEN VIROL, V84, P2999, DOI 10.1099/vir.0.19290-0	36	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33416	10.1371/journal.pone.0033416	http://dx.doi.org/10.1371/journal.pone.0033416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442689	Green Submitted, gold, Green Published			2022-12-27	WOS:000303836500030
J	Fei, J; Li, YM; Zhu, XJ; Luo, XC				Fei, Jia; Li, Yumin; Zhu, Xuejiao; Luo, Xiaochuang			miR-181a Post-Transcriptionally Downregulates Oncogenic RalA and Contributes to Growth Inhibition and Apoptosis in Chronic Myelogenous Leukemia (CML)	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MYELOID-LEUKEMIA; MESSENGER-RNA; MICRORNA EXPRESSION; GENE-EXPRESSION; HUMAN-CELLS; TARGETS; GTPASES; PREDICTION; CARCINOMA	MicroRNAs (miRNAs) are a class of short RNAs that regulate gene expression through either translational repression or mRNA cleavage. miRNA-181a (miR-181a), one of the many miRNAs conserved among vertebrates, is differentially expressed in a variety of leukemia. However, its function in leukemia, particularly chronic myelogenous leukemia (CML), is poorly understood. Here we have reported the identification of miR-181a targets by combining TargetScan software prediction and expression profiling through overexpression of miR-181a mimic in leukemic K562 cells. Four overlapping genes were found to be the likely targets of miR-181a. Among the four genes, RalA is a downstream molecule of bcr-abl fusion protein in ras signaling pathway. However, its role in CML remains elusive. Luciferase reporter and Western blot assays confirmed that RalA is a direct target of miR-181a. overexpression of miR-181a effectively suppresses cell growth and induces G2-phase arrest and apoptosis partially by targeting RalA in leukemic K562 cells. Using the KEGG database combined with recent publications, downstream signaling pathway of RalA was graphed by cytoscape software. Therefore, our study is the first to report that RalA is directly regulated by miR-181a and plays an important role in CML. The approach of computational prediction combined with expression profiling might be valuable for the identification of miRNA targets in animal.	[Fei, Jia; Li, Yumin; Zhu, Xuejiao; Luo, Xiaochuang] Jinan Univ, Dept Biochem & Mol Biol, Coll Med, Guangzhou, Guangdong, Peoples R China	Jinan University	Fei, J (corresponding author), Jinan Univ, Dept Biochem & Mol Biol, Coll Med, Guangzhou, Guangdong, Peoples R China.	efeijia@163.com	li, yu/HGL-9518-2022; Li, yu/HHZ-5236-2022; li, Yu/HCI-9086-2022		National Natural Science Foundation of China [81170496]; Fundamental Research Funds for the Central Universities [21609406]; Natural Science Foundation of Guang Dong province [5300488]; Science and Technology Plan Projects of Guang Dong province [2006B35502010, 2005B33101005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Guang Dong province(National Natural Science Foundation of Guangdong Province); Science and Technology Plan Projects of Guang Dong province	This work was supported by grants from National Natural Science Foundation of China (81170496), the Fundamental Research Funds for the Central Universities (no. 21609406), the Natural Science Foundation of Guang Dong province (No.5300488), and Science and Technology Plan Projects of Guang Dong province (No. 2006B35502010, No.2005B33101005).(http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Calin GA, 2007, BEST PRACT RES CL HA, V20, P425, DOI 10.1016/j.beha.2007.02.003; Chang YC, 2009, ONCOGENE, V28, P4105, DOI 10.1038/onc.2009.260; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chomel JC, 2011, ONCOTARGET, V2, P713; Dufies M, 2011, ONCOTARGET, V2, P874, DOI 10.18632/oncotarget.360; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Thomas EK, 2008, LEUKEMIA, V22, P898, DOI 10.1038/leu.2008.71; Vakana E, 2011, ONCOTARGET, V2, P1322; Wang K, 2009, INT J IMMUNOPATH PH, V22, P735, DOI 10.1177/039463200902200319; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032	35	57	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32834	10.1371/journal.pone.0032834	http://dx.doi.org/10.1371/journal.pone.0032834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442671	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500013
J	Shen, ZH; Cheng, FX; Xu, Y; Fu, J; Xiao, W; Shen, J; Liu, GX; Li, WH; Tang, Y				Shen, Zhonghua; Cheng, Feixiong; Xu, You; Fu, Jing; Xiao, Wen; Shen, Jie; Liu, Guixia; Li, Weihua; Tang, Yun			Investigation of Indazole Unbinding Pathways in CYP2E1 by Molecular Dynamics Simulations	PLOS ONE			English	Article							FREE-ENERGY DIFFERENCES; BURIED ACTIVE-SITE; CYTOCHROME P450S; SUBSTRATES ENTER; ACCESS CHANNELS; PRODUCTS EXIT; BINDING; EGRESS; MECHANISMS; 3A4	Human microsomal cytochrome P450 2E1 (CYP2E1) can oxidize not only low molecular weight xenobiotic compounds such as ethanol, but also many endogenous fatty acids. The crystal structure of CYP2E1 in complex with indazole reveals that the active site is deeply buried into the protein center. Thus, the unbinding pathways and associated unbinding mechanisms remain elusive. In this study, random acceleration molecular dynamics simulations combined with steered molecular dynamics and potential of mean force calculations were performed to identify the possible unbinding pathways in CYP2E1. The results show that channel 2c and 2a are most likely the unbinding channels of CYP2E1. The former channel is located between helices G and I and the B-C loop, and the latter resides between the region formed by the F-G loop, the B-C loop and the beta 1 sheet. Phe298 and Phe478 act as the gate keeper during indazole unbinding along channel 2c and 2a, respectively. Previous site-directed mutagenesis experiments also supported these findings.	[Shen, Zhonghua; Cheng, Feixiong; Xu, You; Fu, Jing; Xiao, Wen; Shen, Jie; Liu, Guixia; Li, Weihua; Tang, Yun] E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China	East China University of Science & Technology	Shen, ZH (corresponding author), E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China.	whli@ecust.edu.cn; ytang234@ecust.edu.cn	LI, Weihua/G-7190-2011; Cheng, Feixiong/D-9922-2013; Shen, Jie/H-5258-2011	Cheng, Feixiong/0000-0002-1251-3116; Cheng, Feixiong/0000-0002-1736-2847	Shanghai Natural Science Foundation [10ZR1407000]; Fundamental Research Funds for the Central Universities [WY1014010]; Program for New Century Excellent Talents in University [NCET-08-0774]; Shanghai Supercomputer Center of China	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Supercomputer Center of China	This work was supported by Shanghai Natural Science Foundation (Grant No. 10ZR1407000); Fundamental Research Funds for the Central Universities (WY1014010); and the Program for New Century Excellent Talents in University (Grant No. NCET-08-0774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. F. Marty Ytreberg for his kindness in offering us the script for calculating the uncertainty of PMF. Usage of AMBER is gratefully acknowledged. This work was also supported by Shanghai Supercomputer Center of China.	Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Berka K, 2011, J PHYS CHEM A, V115, P11248, DOI 10.1021/jp204488j; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Fishelovitch D, 2009, J PHYS CHEM B, V113, P13018, DOI 10.1021/jp810386z; GrahamLorence S, 1996, FASEB J, V10, P206, DOI 10.1096/fasebj.10.2.8641554; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559, DOI 10.1093/oxfordjournals.jbchem.a123619; Hu Y, 1997, MOL PHARMACOL, V51, P370; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Li WH, 2007, DRUG METAB DISPOS, V35, P689, DOI 10.1124/dmd.106.014019; Li WH, 2011, PROTEINS, V79, P271, DOI 10.1002/prot.22880; Li WH, 2005, DRUG METAB DISPOS, V33, P910, DOI 10.1124/dmd.105.004200; Ludemann SK, 2000, J MOL BIOL, V303, P813, DOI 10.1006/jmbi.2000.4155; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Spatzenegger M, 2003, J PHARMACOL EXP THER, V304, P477, DOI 10.1124/jpet.102.043323; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Ytreberg FM, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3119261; Ytreberg FM, 2004, J COMPUT CHEM, V25, P1749, DOI 10.1002/jcc.20103; Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u	26	40	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33500	10.1371/journal.pone.0033500	http://dx.doi.org/10.1371/journal.pone.0033500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442693	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500034
J	Bottger, E; Multhoff, G; Kun, JFJ; Esen, M				Boettger, Evelyn; Multhoff, Gabriele; Kun, Juergen F. J.; Esen, Meral			Plasmodium falciparum-Infected Erythrocytes Induce Granzyme B by NK Cells through Expression of Host-Hsp70	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DIFFERENTIAL EXPRESSION; DENDRITIC CELLS; ACTIVATION; MALARIA; HSP70; INNATE; HEAT-SHOCK-PROTEIN-70; RESPONSES; CANCER	In the early immune response to Plasmodium falciparum-infected erythrocytes (iRBC), Natural Killer (NK) cells are activated, which suggests an important role in innate anti-parasitic immunity. However, it is not well understood whether NK cells directly recognize iRBC or whether stimulation of NK cells depends mainly on activating signals from accessory cells through cell-to-cell contact or soluble factors. In the present study, we investigated the influence of membrane-bound host Heat shock protein (Hsp) 70 in triggering cytotoxicity of NK cells from malaria-naive donors or the cell line NK92 against iRBC. Hsp70 and HLA-E membrane expression on iRBC and potential activatory NK cell receptors (NKG2C, CD94) were assessed by flow cytometry and immunoblot. Upon contact with iRBC, Granzyme B (GzmB) production and release was initiated by unstimulated and Hsp70-peptide (TKD) pre-stimulated NK cells, as determined by Western blot, RT-PCR and ELISPOT analysis. Eryptosis of iRBC was determined by Annexin V-staining. Our results suggest that presence of Hsp70 and absence of HLA-E on the membrane of iRBC prompt the infected host cells to become targets for NK cell-mediated cytotoxicity, as evidenced by impaired parasite development. Contact of iRBC with NK cells induced release of GzmB. We propose that following GzmB uptake, iRBC undergo eryptosis via a perforin-independent, GzmB-mediated mechanism. Since NK activity toward iRBC could be specifically enhanced by TKD peptide and abrogated to baseline levels by blocking Hsp70 exposure, we propose TKD as an innovative immunostimulatory agent to be tested as an adjunct to anti-parasitic treatments in vivo.	[Boettger, Evelyn; Kun, Juergen F. J.; Esen, Meral] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany; [Multhoff, Gabriele] Helmholtz Zentrum Munchen, Clin Cooperat Grp Innate Immun Tumor Biol, Munich, Germany	Eberhard Karls University of Tubingen; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Bottger, E (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	evelyn-boettger@hotmail.de	Multhoff, Gabriele/AAW-9796-2021	Multhoff, Gabriele/0000-0002-2616-3137	Deutsche Forschungsgemeinschaft [DFGKU 775/17-1, D2709082, D3109364]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft grants DFGKU 775/17-1, D2709082, and D3109364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas K, 2003, J IMMUNOL, V171, P5396, DOI 10.4049/jimmunol.171.10.5396; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Banumathy G, 2002, J BIOL CHEM, V277, P3902, DOI 10.1074/jbc.M110513200; Binder RJ, 2008, EXPERT REV VACCINES, V7, P383, DOI 10.1586/14760584.7.3.383; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Calderwood SK, 2005, EUR J IMMUNOL, V35, P2518, DOI 10.1002/eji.200535002; de Carvalho EG, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-311; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Elsner L, 2010, J CELL MOL MED, V14, P992, DOI [10.1111/j.1582-4934.2008.00677.x, 10.1111/j.1582-4934.2009.00677.x]; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Foller M, 2010, EUR J CLIN INVEST, V40, P534, DOI 10.1111/j.1365-2362.2010.02296.x; Foller M, 2009, CELL PHYSIOL BIOCHEM, V24, P133, DOI 10.1159/000233238; Giribaldi G, 2001, BRIT J HAEMATOL, V113, P492, DOI 10.1046/j.1365-2141.2001.02707.x; Gross C, 2003, CELL STRESS CHAPERON, V8, P348, DOI 10.1379/1466-1268(2003)008<0348:HSPRIA>2.0.CO;2; Gross C, 2003, J BIOL CHEM, V278, P41173, DOI 10.1074/jbc.M302644200; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; Hermsen CC, 2003, CLIN EXP IMMUNOL, V132, P467, DOI 10.1046/j.1365-2249.2003.02160.x; Horowitz A, 2010, J IMMUNOL, V184, P6043, DOI 10.4049/jimmunol.1000106; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim TD, 2011, BLOOD, V118, P5476, DOI 10.1182/blood-2011-04-347526; Korbel DS, 2005, J IMMUNOL, V175, P7466, DOI 10.4049/jimmunol.175.11.7466; Krause SW, 2004, CLIN CANCER RES, V10, P3699, DOI 10.1158/1078-0432.CCR-03-0683; Lang F, 2008, CELL PHYSIOL BIOCHEM, V22, P373, DOI 10.1159/000185448; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Multhoff G, 2009, INT J HYPERTHER, V25, P169, DOI 10.1080/02656730902902001; Multhoff G, 2009, INT J HYPERTHER, V25, P176, DOI 10.1080/02656730902835672; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; Stangl S, 2008, CELL STRESS CHAPERON, V13, P221, DOI 10.1007/s12192-007-0008-y; Stangl S, 2006, J IMMUNOL, V176, P6270, DOI 10.4049/jimmunol.176.10.6270; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687	41	81	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33774	10.1371/journal.pone.0033774	http://dx.doi.org/10.1371/journal.pone.0033774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438997	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309000039
J	Shi, ZH; Nijhawan, R				Shi, Zhuanghua; Nijhawan, Romi			Motion Extrapolation in the Central Fovea	PLOS ONE			English	Article							FLASH-LAG; NEURAL DELAYS; ATTENTION; POSITION; LOCALIZATION; SIGNALS; MECHANISMS; LATENCIES; EYE	Neural transmission latency would introduce a spatial lag when an object moves across the visual field, if the latency was not compensated. A visual predictive mechanism has been proposed, which overcomes such spatial lag by extrapolating the position of the moving object forward. However, a forward position shift is often absent if the object abruptly stops moving (motion-termination). A recent "correction-for-extrapolation'' hypothesis suggests that the absence of forward shifts is caused by sensory signals representing 'failed' predictions. Thus far, this hypothesis has been tested only for extra-foveal retinal locations. We tested this hypothesis using two foveal scotomas: scotoma to dim light and scotoma to blue light. We found that the perceived position of a dim dot is extrapolated into the fovea during motion-termination. Next, we compared the perceived position shifts of a blue versus a green moving dot. As predicted the extrapolation at motion-termination was only found with the blue moving dot. The results provide new evidence for the correction-for-extrapolation hypothesis for the region with highest spatial acuity, the fovea.	[Shi, Zhuanghua] Univ Munich, Dept Psychol, Munich, Germany; [Nijhawan, Romi] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Munich; University of Sussex	Shi, ZH (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	shi@psy.lmu.de	Shi, Zhuanghua/J-2236-2019	Shi, Zhuanghua/0000-0003-2388-6695	German research foundation (DFG) [SH166]	German research foundation (DFG)(German Research Foundation (DFG))	The present work was supported by German research foundation (DFG) project SH166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDO MVC, 1995, NATURE, V378, P565, DOI 10.1038/378565a0; Brenner E, 2000, VISION RES, V40, P1645, DOI 10.1016/S0042-6989(00)00067-5; DASSONVILLE P, 1995, EXP BRAIN RES, V106, P434; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Eagleman DM, 2007, J VISION, V7, DOI 10.1167/7.4.3; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Frohlich FW, 1923, Z SINNESPHYSIOLOGIE, V54; Hecht E., 2002, OPTICS; Holy TE, 2007, NEURON, V55, P831, DOI 10.1016/j.neuron.2007.09.002; ISOBE K, 1955, NATURE, V175, P306, DOI 10.1038/175306a0; Kerzel D, 2000, VISION RES, V40, P3703, DOI 10.1016/S0042-6989(00)00226-1; Kirschfeld K, 1999, VISION RES, V39, P3702, DOI 10.1016/S0042-6989(99)00089-9; Koch C, 1999, NAT NEUROSCI, V2, P9, DOI 10.1038/4511; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Krekelberg B, 2001, TRENDS NEUROSCI, V24, P335, DOI 10.1016/S0166-2236(00)01795-1; Magnussen S, 2001, VISION RES, V41, P2961, DOI 10.1016/S0042-6989(01)00178-X; Maus GW, 2006, VISION RES, V46, P4375, DOI 10.1016/j.visres.2006.08.028; Maus GW, 2008, PSYCHOL SCI, V19, P1087, DOI 10.1111/j.1467-9280.2008.02205.x; Maus GW, 2009, J EXP PSYCHOL HUMAN, V35, P611, DOI 10.1037/a0012317; Musseler J, 1998, PERCEPT PSYCHOPHYS, V60, P683, DOI 10.3758/BF03206055; Nijhawan R, 2003, CURR BIOL, V13, P749, DOI 10.1016/S0960-9822(03)00248-3; Nijhawan R, 2002, TRENDS COGN SCI, V6, P387, DOI 10.1016/S1364-6613(02)01963-0; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; NIJHAWAN R, 1992, INVEST OPHTHALMOL, V33, P1415; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Nijhawan R, 2009, PHILOS T R SOC A, V367, P1063, DOI 10.1098/rsta.2008.0270; Nussbaum J J, 1981, Retina, V1, P296, DOI 10.1097/00006982-198101040-00007; Ogmen H, 2004, VISION RES, V44, P2109, DOI 10.1016/j.visres.2004.04.003; Patel S S, 2000, Science, V290, P1051; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Schlag J, 2002, NAT REV NEUROSCI, V3, P191, DOI 10.1038/nrn750; Schwartz G, 2007, NEURON, V55, P958, DOI 10.1016/j.neuron.2007.07.042; Shi ZH, 2008, J VISION, V8, DOI 10.1167/8.7.24; Stevens M, 2008, P ROY SOC B-BIOL SCI, V275, P2639, DOI 10.1098/rspb.2008.0877; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Krekelberg B, 2000, Science, V289, P1107; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659	38	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33651	10.1371/journal.pone.0033651	http://dx.doi.org/10.1371/journal.pone.0033651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438976	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309000036
J	Stiasny, K; Aberle, JH; Keller, M; Grubeck-Loebenstein, B; Heinz, FX				Stiasny, Karin; Aberle, Judith H.; Keller, Michael; Grubeck-Loebenstein, Beatrix; Heinz, Franz X.			Age Affects Quantity but Not Quality of Antibody Responses after Vaccination with an Inactivated Flavivirus Vaccine against Tick-Borne Encephalitis	PLOS ONE			English	Article							MEDIATED NEUTRALIZATION; IMMUNOSENESCENCE; VIRUS; MECHANISMS; PROTECTION; INFECTION; EXTREMES	The impairment of immune functions in the elderly (immunosenescence) results in post-vaccination antibody titers that are significantly lower than in young individuals. It is, however, a controversial question whether also the quality of antibodies declines with age. In this study, we have therefore investigated the age-dependence of functional characteristics of antibody responses induced by vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis (TBE). For this purpose, we quantified TBE virus-specific IgG and neutralizing antibody titers in post-vaccination sera from groups of young and elderly healthy adults and determined antibody avidities and NT/ELISA titer ratios (functional activity). In contrast to the quantitative impairment of antibody production in the elderly, we found no age-related differences in the avidity and functional activity of antibodies induced by vaccination, which also appeared to be independent of the age at primary immunization. There was no correlation between antibody avidity and NT/ELISA ratios suggesting that additional factors affect the quality of polyclonal responses, independent of age. Our work indicates that healthy elderly people are able to produce antibodies in response to vaccination with similar avidity and functional activity as young individuals, albeit at lower titers.	[Stiasny, Karin; Aberle, Judith H.; Heinz, Franz X.] Med Univ Vienna, Dept Virol, Vienna, Austria; [Keller, Michael; Grubeck-Loebenstein, Beatrix] Austrian Acad Sci, Inst Biomed Aging Res, Innsbruck, Austria	Medical University of Vienna; Austrian Academy of Sciences	Stiasny, K (corresponding author), Med Univ Vienna, Dept Virol, Vienna, Austria.	karin.stiasny@meduniwien.ac.at		Stiasny, Karin/0000-0002-1902-8674	Medical University of Vienna	Medical University of Vienna	This work was supported by intramural funds of the Medical University of Vienna. No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle JH, 2012, AGE DORDR; Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Blomberg BB, 2011, J CLIN INVEST, V121, P2981, DOI 10.1172/JCI58406; Cancro MP, 2009, TRENDS IMMUNOL, V30, P313, DOI 10.1016/j.it.2009.04.005; Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002; de Bruijn IA, 1999, J INFECT DIS, V179, P31, DOI 10.1086/314540; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Dunn-Walters DK, 2010, CURR OPIN IMMUNOL, V22, P514, DOI 10.1016/j.coi.2010.04.009; Frasca D, 2011, AGEING RES REV, V10, P330, DOI 10.1016/j.arr.2010.08.004; Frasca D, 2009, CURR OPIN IMMUNOL, V21, P425, DOI 10.1016/j.coi.2009.06.001; Grubeck-Loebenstein B, 2009, AGING CLIN EXP RES, V21, P201, DOI 10.1007/BF03324904; Hainz U, 2005, VACCINE, V23, P3232, DOI 10.1016/j.vaccine.2005.01.085; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; HEINZ FX, 1986, J BIOL STAND, V14, P133, DOI 10.1016/0092-1157(86)90032-6; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Klasse PJ, 2002, J GEN VIROL, V83, P2091, DOI 10.1099/0022-1317-83-9-2091; Kreil TR, 1998, J VIROL, V72, P3076, DOI 10.1128/JVI.72.4.3076-3081.1998; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; Offit PA, 2008, VACCINES-BASEL, V2, P17, DOI 10.1016/b978-1-4557-0090-5.00004-5; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Rendi-Wagner P, 2007, VACCINE, V25, P5097, DOI 10.1016/j.vaccine.2007.01.116; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Sexton SA, 2008, ANN ROY COLL SURG, V90, P58, DOI 10.1308/003588408X242312; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Simmonds P, 2011, VIRUS TAXONOMY 9 REP; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Stiasny K, 2009, VACCINE, V27, P7021, DOI 10.1016/j.vaccine.2009.09.069; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Weinberger B, 2010, VACCINE, V28, P3511, DOI 10.1016/j.vaccine.2010.03.024; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; *WHO, 2011, WKLY EPIDEMIOL REC, V86, P241; Zheng B, 1997, IMMUNOL REV, V160, P63, DOI 10.1111/j.1600-065X.1997.tb01028.x; Zlatkovic J, 2011, J VIROL, V85, P1994, DOI 10.1128/JVI.01886-10	36	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34145	10.1371/journal.pone.0034145	http://dx.doi.org/10.1371/journal.pone.0034145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461903	Green Published, gold			2022-12-27	WOS:000304118900021
J	Chen, C; Chen, C; Wang, ZY; Wang, LX; Yang, LH; Ding, MJ; Ding, C; Sun, Y; Lin, Q; Huang, XY; Du, XH; Zhao, XW; Wang, CY				Chen, Chan; Chen, Chun; Wang, Zhiyi; Wang, Liangxing; Yang, Lehe; Ding, Minjiao; Ding, Cheng; Sun, Yu; Lin, Quan; Huang, Xiaoying; Du, Xiaohong; Zhao, Xiaowei; Wang, Chuangyi			Puerarin Induces Mitochondria-Dependent Apoptosis in Hypoxic Human Pulmonary Arterial Smooth Muscle Cells	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; INDUCED PROLIFERATION; GENE-EXPRESSION; HYPERTENSION; RATS; CHANNEL; GROWTH; DICHLOROACETATE; MECHANISMS; PREVENTS	Background: Pulmonary vascular medial hypertrophy in hypoxic pulmonary arterial hypertension (PAH) is caused in part by decreased apoptosis in pulmonary artery smooth muscle cells (PASMCs). Puerarin, an isoflavone purified from the Chinese medicinal herb kudzu, ameliorates chronic hypoxic PAH in animal models. Here we investigated the effects of puerarin on apoptosis of hypoxic human PASMCs (HPASMCs), and to determine the possible underlying mechanisms. Methodology/Principal Findings: HPASMCs were cultured for 24 h in normoxia or hypoxia (5% O-2) conditions with and without puerarin. Cell number and viability were determined with a hemacytometer or a cell counting kit. Apoptosis was detected with a TUNEL test, rhodamine-123 (R-123) fluorescence, a colorimetric assay, western blots, immunohistochemical staining and RT-PCR. Hypoxia inhibited mitochondria-dependent apoptosis and promoted HPASMC growth. In contrast, after puerarin (50 mu M or more) intervention, cell growth was inhibited and apoptosis was observed. Puerarin-induced apoptosis in hypoxic HPASMCs was accompanied by reduced mitochondrial membrane potential, cytochrome c release from the mitochondria, caspase-9 activation, and Bcl-2 down-regulation with concurrent Bax up-regulation. Conclusions/Significance: Puerarin promoted apoptosis in hypoxic HPASMCs by acting on the mitochondria-dependent pathway. These results suggest a new mechanism of puerarin relevant to the management of clinical hypoxic pulmonary hypertension.	[Chen, Chan; Du, Xiaohong; Zhao, Xiaowei; Wang, Chuangyi] Wenzhou Med Coll, Dept Geriatr Med, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Chen, Chun; Wang, Liangxing; Yang, Lehe; Ding, Minjiao; Ding, Cheng; Sun, Yu; Lin, Quan; Huang, Xiaoying] Wenzhou Med Coll, Dept Resp Med, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Wang, Zhiyi] Wenzhou Med Coll, Dept Emergency Med, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Chen, C (corresponding author), Wenzhou Med Coll, Dept Geriatr Med, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China.	wzyxywlx@163.com			National Natural Science Foundation of China [30670933]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 30670933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Cowan KN, 2000, NAT MED, V6, P698, DOI 10.1038/76282; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crompton M, 2000, J PHYSIOL-LONDON, V529, P11, DOI 10.1111/j.1469-7793.2000.00011.x; Fan L L, 1984, Yao Xue Xue Bao, V19, P801; [范小芳 Fan Xiaofang], 2004, [中国药理学通报, Chinese Pharmacological Bulletin], V20, P347; Gao FY, 2003, ZHONG CAO YAO, V34, P7; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Geraci MW, 2001, CIRC RES, V88, P555, DOI 10.1161/01.RES.88.6.555; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hao Li-Na, 2006, Shengli Xuebao, V58, P584; Hu Hong-Ling, 2006, Shengli Xuebao, V58, P262; Jiang B, 2003, CELL BIOL INT, V27, P1025, DOI 10.1016/j.cellbi.2003.09.007; Kang TD, 2003, ZHONG XI YI JIE HE X, V1, P703; Li Ji-Wu, 2008, Zhongguo Zhong Yao Za Zhi, V33, P544; Lin Quan, 2009, Zhongguo Yaolixue Tongbao, V25, P887; Lin YJ, 2009, BIOCHEM BIOPH RES CO, V378, P683, DOI 10.1016/j.bbrc.2008.10.178; Lu SY, 2005, LIFE SCI, V77, P28, DOI 10.1016/j.lfs.2004.11.026; Mandegar M, 2004, MICROVASC RES, V68, P75, DOI 10.1016/j.mvr.2004.06.001; Martinou JC, 2000, NAT CELL BIOL, V2, pE41, DOI 10.1038/35004069; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Schultz K, 2006, AM J PHYSIOL-HEART C, V290, pH2528, DOI 10.1152/ajpheart.01077.2005; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; SONG XP, 1988, ACTA PHARM SINIC, V9, P55; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Wang J, 2005, AM J PHYSIOL-LUNG C, V288, pL1049, DOI 10.1152/ajplung.00379.2004; Xu XH, 2005, PLANTA MED, V71, P585, DOI 10.1055/s-2005-871261; Xu Yi-Zhou, 2006, Zhongguo Zhong Yao Za Zhi, V31, P490; Yu ZL, 2006, CANCER LETT, V238, P53, DOI 10.1016/j.canlet.2005.06.022; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	35	26	30	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34181	10.1371/journal.pone.0034181	http://dx.doi.org/10.1371/journal.pone.0034181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457823	Green Submitted, Green Published, gold			2022-12-27	WOS:000304046900052
J	Ge, HF; Baribault, H; Vonderfecht, S; Lemon, B; Weiszmann, J; Gardner, J; Lee, KJ; Gupte, J; Mookherjee, P; Wang, MH; Sheng, J; Wu, XL; Li, Y				Ge, Hongfei; Baribault, Helene; Vonderfecht, Steven; Lemon, Bryan; Weiszmann, Jennifer; Gardner, Jonitha; Lee, Ki Jeong; Gupte, Jamila; Mookherjee, Paramita; Wang, Minghan; Sheng, Jackie; Wu, Xinle; Li, Yang			Characterization of a FGF19 Variant with Altered Receptor Specificity Revealed a Central Role for FGFR1c in the Regulation of Glucose Metabolism	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; BETA-KLOTHO; FIBROBLAST; FIBROBLAST-GROWTH-FACTOR-19; DETERMINES; EXPRESSION; DIETARY; OBESITY; MODE	Diabetes and associated metabolic conditions have reached pandemic proportions worldwide, and there is a clear unmet medical need for new therapies that are both effective and safe. FGF19 and FGF21 are distinctive members of the FGF family that function as endocrine hormones. Both have potent effects on normalizing glucose, lipid, and energy homeostasis, and therefore, represent attractive potential next generation therapies for combating the growing epidemics of type 2 diabetes and obesity. The mechanism responsible for these impressive metabolic effects remains unknown. While both FGF19 and FGF21 can activate FGFRs 1c, 2c, and 3c in the presence of co-receptor beta Klotho in vitro, which receptor is responsible for the metabolic activities observed in vivo remains unknown. Here we have generated a variant of FGF19, FGF19-7, that has altered receptor specificity with a strong bias toward FGFR1c. We show that FGF19-7 is equally efficacious as wild type FGF19 in regulating glucose, lipid, and energy metabolism in both diet-induced obesity and leptin-deficient mouse models. These results are the first direct demonstration of the central role of the beta Klotho/FGFR1c receptor complex in glucose and lipid regulation, and also strongly suggest that activation of this receptor complex alone might be sufficient to achieve all the metabolic functions of endocrine FGF molecules.	[Ge, Hongfei; Baribault, Helene; Lemon, Bryan; Weiszmann, Jennifer; Gardner, Jonitha; Gupte, Jamila; Wu, Xinle; Li, Yang] Amgen Inc, San Francisco, CA USA; [Vonderfecht, Steven; Lee, Ki Jeong; Wang, Minghan; Sheng, Jackie] Amgen Inc, Thousand Oaks, CA 91320 USA; [Mookherjee, Paramita] Amgen Inc, Seattle, WA USA	Amgen; Amgen; Amgen	Ge, HF (corresponding author), Amgen Inc, San Francisco, CA USA.	yangl@amgen.com		, Ki Jeong/0000-0002-8039-7436				Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Gupte J, 2011, J MOL BIOL, V408, P491, DOI 10.1016/j.jmb.2011.03.003; Hill-Baskin AE, 2009, HUM MOL GENET, V18, P2975, DOI 10.1093/hmg/ddp236; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Li XF, 2009, FEBS LETT, V583, P3230, DOI 10.1016/j.febslet.2009.09.012; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ornitz DM, 2001, GENOME BIOL, V2; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Wu X, 2011, ENDOCRINE FGFS KLOTH; Wu XL, 2007, J BIOL CHEM, V282, P29069, DOI 10.1074/jbc.C700130200; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu XL, 2010, J BIOL CHEM, V285, P5165, DOI 10.1074/jbc.M109.068783; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	31	32	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33603	10.1371/journal.pone.0033603	http://dx.doi.org/10.1371/journal.pone.0033603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457778	gold, Green Submitted, Green Published			2022-12-27	WOS:000304046900019
J	Kahner, BN; Kato, H; Banno, A; Ginsberg, MH; Shattil, SJ; Ye, F				Kahner, Bryan N.; Kato, Hisashi; Banno, Asoka; Ginsberg, Mark H.; Shattil, Sanford J.; Ye, Feng			Kindlins, Integrin Activation and the Regulation of Talin Recruitment to alpha IIb beta 3	PLOS ONE			English	Article							OUT SIGNAL-TRANSDUCTION; BETA CYTOPLASMIC DOMAIN; RECEPTOR ACTIVATION; MAMMALIAN-CELLS; COMPLEX; COACTIVATOR; PLATELETS; THROMBIN; BINDING; PHOSPHORYLATION	Talins and kindlins bind to the integrin beta 3 cytoplasmic tail and both are required for effective activation of integrin alpha IIb beta 3 and resulting high-affinity ligand binding in platelets. However, binding of the talin head domain alone to b3 is sufficient to activate purified integrin alpha IIb beta 3 in vitro. Since talin is localized to the cytoplasm of unstimulated platelets, its re-localization to the plasma membrane and to the integrin is required for activation. Here we explored the mechanism whereby kindlins function as integrin co-activators. To test whether kindlins regulate talin recruitment to plasma membranes and to alpha IIb beta 3, full-length talin and kindlin recruitment to b3 was studied using a reconstructed CHO cell model system that recapitulates agonist-induced alpha IIb beta 3 activation. Over-expression of kindlin-2, the endogenous kindlin isoform in CHO cells, promoted PAR1-mediated and talin-dependent ligand binding. In contrast, shRNA knockdown of kindlin-2 inhibited ligand binding. However, depletion of kindlin-2 by shRNA did not affect talin recruitment to the plasma membrane, as assessed by subcellular fractionation, and neither over-expression of kindlins nor depletion of kindlin-2 affected talin interaction with alpha IIb beta 3 in living cells, as monitored by bimolecular fluorescence complementation. Furthermore, talin failed to promote kindlin-2 association with alpha IIb beta 3 in CHO cells. In addition, purified talin and kindlin-3, the kindlin isoform expressed in platelets, failed to promote each other's binding to the b3 cytoplasmic tail in vitro. Thus, kindlins do not promote initial talin recruitment to alpha IIb beta 3, suggesting that they co-activate integrin through a mechanism independent of recruitment.	[Kahner, Bryan N.; Kato, Hisashi; Banno, Asoka; Ginsberg, Mark H.; Shattil, Sanford J.; Ye, Feng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kahner, BN (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	feye@ucsd.edu			National Institutes of Health [HL56595, GM098412, GM094663, T32 HL086344]; American Heart Association [09POST2180011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056595, T32HL086344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM098412, U01GM094663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants HL56595 to SJS, GM098412 and GM094663 to MHG, and T32 HL086344 to BNK, and by American Heart Association fellowship award 09POST2180011 to FY. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammoun S, 2010, NEURO-ONCOLOGY, V12, P834, DOI 10.1093/neuonc/noq012; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; BERTAGNOLLI ME, 1993, J CELL SCI, V106, P1189; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Bottcher RT, 2009, CURR OPIN CELL BIOL, V21, P670, DOI 10.1016/j.ceb.2009.05.008; Bouaouina M, 2012, J BIOL CHEM IN PRESS; Brass LF, 2009, BASIC PRINCIPLES PRA, P1793; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Choy MK, 2010, GENOME MED, V2, DOI 10.1186/gm158; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hiatt SM, 2008, METHODS, V45, P185, DOI 10.1016/j.ymeth.2008.06.003; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kalli AC, 2010, STRUCTURE, V18, P1280, DOI 10.1016/j.str.2010.07.012; KAO FT, 1968, P NATL ACAD SCI USA, V60, P1275, DOI 10.1073/pnas.60.4.1275; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; OTOOLE TE, 1989, BLOOD, V74, P14; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Roberts Gordon C. K., 2009, Biophysical Reviews, V1, P61, DOI 10.1007/s12551-009-0009-4; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Ye F, 2011, CURR OPIN HEMATOL, V18, P356, DOI 10.1097/MOH.0b013e3283497f09; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045	54	46	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34056	10.1371/journal.pone.0034056	http://dx.doi.org/10.1371/journal.pone.0034056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457811	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900042
J	Cao, Q; Mahalanabis, M; Chang, J; Carey, B; Hsieh, C; Stanley, A; Odell, CA; Mitchell, P; Feldman, J; Pollock, NR; Klapperich, CM				Cao, Qingqing; Mahalanabis, Madhumita; Chang, Jessie; Carey, Brendan; Hsieh, Christopher; Stanley, Ahjegannie; Odell, Christine A.; Mitchell, Patricia; Feldman, James; Pollock, Nira R.; Klapperich, Catherine M.			Microfluidic Chip for Molecular Amplification of Influenza A RNA in Human Respiratory Specimens	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; SYNCYTIAL VIRUS; CHEMICAL-ANALYSIS; GENETIC-ANALYSIS; H1N1 VIRUS; PCR; SENSITIVITY; PERFORMANCE; SYSTEM; INFECTION	A rapid, low cost, accurate point-of-care (POC) device to detect influenza virus is needed for effective treatment and control of both seasonal and pandemic strains. We developed a single-use microfluidic chip that integrates solid phase extraction (SPE) and molecular amplification via a reverse transcription polymerase chain reaction (RT-PCR) to amplify influenza virus type A RNA. We demonstrated the ability of the chip to amplify influenza A RNA in human nasopharyngeal aspirate (NPA) and nasopharyngeal swab (NPS) specimens collected at two clinical sites from 2008-2010. The microfluidic test was dramatically more sensitive than two currently used rapid immunoassays and had high specificity that was essentially equivalent to the rapid assays and direct fluorescent antigen (DFA) testing. We report 96% (CI 89%, 99%) sensitivity and 100% (CI 95%, 100%) specificity compared to conventional (bench top) RT-PCR based on the testing of n = 146 specimens (positive predictive value = 100%(CI 94%, 100%) and negative predictive value = 96%(CI 88%, 98%)). These results compare well with DFA performed on samples taken during the same time period (98% (CI 91%, 100%) sensitivity and 96%(CI 86%, 99%) specificity compared to our gold standard testing). Rapid immunoassay tests on samples taken during the enrollment period were less reliable (49%(CI 38%, 61%) sensitivity and 98%(CI 98%, 100%) specificity). The microfluidic test extracted and amplified influenza A RNA directly from clinical specimens with viral loads down to 10(3) copies/ml in 3 h or less. The new test represents a major improvement over viral culture in terms of turn around time, over rapid immunoassay tests in terms of sensitivity, and over bench top RT-PCR and DFA in terms of ease of use and portability.	[Cao, Qingqing; Klapperich, Catherine M.] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Mahalanabis, Madhumita; Chang, Jessie; Carey, Brendan; Hsieh, Christopher; Stanley, Ahjegannie; Klapperich, Catherine M.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Odell, Christine A.] Boston Med Ctr, Dept Pediat, Div Pediat Emergency Med, Boston, MA USA; [Odell, Christine A.; Mitchell, Patricia; Feldman, James] Boston Univ, Sch Med, Boston, MA USA; [Pollock, Nira R.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA USA	Boston University; Boston University; Boston Medical Center; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Klapperich, CM (corresponding author), Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.	catherin@bu.edu	Cao, Qingqing/G-2450-2014	Klapperich, Catherine/0000-0001-6103-849X; Feldman, James/0000-0003-3962-0189	National Institutes of Health (NIH) [R01 EB008268, 1 K23 AI074638-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI074638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008268] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by National Institutes of Health (NIH) grant R01 EB008268. NP is supported by a NIH K23 grant (1 K23 AI074638-01A2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, LAB CHIP, V11, P1166, DOI [10.1039/c0lc00519c, 10.1039/c01c00519c]; Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; AHLUWALIA G, 1987, J CLIN MICROBIOL, V25, P763, DOI 10.1128/JCM.25.5.763-767.1987; Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; [Anonymous], 2007, 1047399 QIAG; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bhattacharyya A, 2006, ANAL CHEM, V78, P788, DOI 10.1021/ac051449j; Bhattacharyya A, 2008, SENSOR ACTUAT B-CHEM, V129, P693, DOI 10.1016/j.snb.2007.09.057; Bhattacharyya A, 2007, LAB CHIP, V7, P876, DOI 10.1039/b700442g; Boddinghaus B, 2001, J CLIN MICROBIOL, V39, P3750, DOI 10.1128/JCM.39.10.3750-3752.2001; Cao Q, 2010, BIOTECHNOL J, V6, P177; Centers for Disease Control and Prevention, 2009, 100705 CDCP CDC; Centers for Disease Control and Prevention, 2010, RAP DIAGN TEST INFL; Chan KH, 2009, J CLIN VIROL, V45, P205, DOI 10.1016/j.jcv.2009.05.034; Chen ZY, 2007, ANN NY ACAD SCI, V1098, P429, DOI 10.1196/annals.1384.024; Crews N, 2008, BIOMED MICRODEVICES, V10, P187, DOI 10.1007/s10544-007-9124-9; Dettloff R, 2008, ANAL CHEM, V80, P4208, DOI 10.1021/ac800339w; Easley CJ, 2006, P NATL ACAD SCI USA, V103, P19272, DOI 10.1073/pnas.0604663103; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Ferguson BS, 2011, J AM CHEM SOC, V133, P9129, DOI 10.1021/ja203981w; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Hagan KA, 2011, LAB CHIP, V11, P957, DOI 10.1039/c01c00136h; Hawkes M, 2010, PEDIATRICS, V125, pE639, DOI 10.1542/peds.2009-2669; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; Jannetto PJ, 2010, J CLIN MICROBIOL, V48, P3997, DOI 10.1128/JCM.01118-10; Kao LTH, 2011, BIOSENS BIOELECTRON, V26, P2006, DOI 10.1016/j.bios.2010.08.076; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lien KY, 2007, BIOSENS BIOELECTRON, V22, P1739, DOI 10.1016/j.bios.2006.08.010; Liu W, 2010, CLIN INFECT DIS, V51, P1028, DOI 10.1086/656588; Mahalanabis M, 2009, LAB CHIP, V9, P2811, DOI 10.1039/b905065p; MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I; MCINTOSH K, 1993, CLIN INFECT DIS, V16, P151, DOI 10.1093/clinids/16.1.151; Motulsky H., 1995, INTUITIVE BIOSTATIST; Ngaosuwankul N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-75; Northrup MA., 1993, TRANSDUCERS, P924; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Panaro NJ, 2004, BIOMED MICRODEVICES, V6, P75, DOI 10.1023/B:BMMD.0000013369.34716.8d; Pollock NR, 2009, CLIN INFECT DIS, V49, pE66, DOI 10.1086/644502; Rouleau I, 2009, J CLIN MICROBIOL, V47, P2699, DOI 10.1128/JCM.00762-09; Ruano-Lopez JM, 2009, LAB CHIP, V9, P1495, DOI 10.1039/b902354m; Sauer-Budge AF, 2009, LAB CHIP, V9, P2803, DOI 10.1039/b904854e; Scherer JR, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3502457; Takahashi H, 2010, J INFECT CHEMOTHER, V16, P155, DOI 10.1007/s10156-010-0035-y; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Toriello NM, 2008, P NATL ACAD SCI USA, V105, P20173, DOI 10.1073/pnas.0806355106; Wang CH, 2005, BIOSENS BIOELECTRON, V21, P419, DOI 10.1016/j.bios.2004.11.004; Wang F, 2009, BIOMED MICRODEVICES, V11, P1071, DOI 10.1007/s10544-009-9324-6; World Health Organization, 2010, PAND H1N1 2009 UPD 1; World Health Organization, 2009, WORLD NOW START 2009; Yao LY, 2005, BIOMED MICRODEVICES, V7, P253, DOI 10.1007/s10544-005-3999-0; Zetti Z R, 2010, Med J Malaysia, V65, P27; Zhang CS, 2007, NUCLEIC ACIDS RES, V35, P4223, DOI 10.1093/nar/gkm389; Zhang C, 2010, CHEM REV, V110, P4910, DOI 10.1021/cr900081z; Zhang YH, 2009, ANAL CHIM ACTA, V638, P115, DOI 10.1016/j.aca.2009.02.038	57	45	50	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33176	10.1371/journal.pone.0033176	http://dx.doi.org/10.1371/journal.pone.0033176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457740	Green Published, Green Submitted, gold			2022-12-27	WOS:000303909200020
J	Yang, D; Tan, MJ; Wang, GX; Sun, Y				Yang, Dong; Tan, Mingjia; Wang, Gongxian; Sun, Yi			The p21-Dependent Radiosensitization of Human Breast Cancer Cells by MLN4924, an Investigational Inhibitor of NEDD8 Activating Enzyme	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; CULLIN-RING LIGASES; NF-KAPPA-B; NEDD8-ACTIVATING ENZYME; DNA-REPLICATION; CYCLE; APOPTOSIS; P21; SCF; ARREST	Radiotherapy is a treatment choice for local control of breast cancer. However, intrinsic radioresistance of cancer cells limits therapeutic efficacy. We have recently validated that SCF (SKP1, Cullins, and F-box protein) E3 ubiquitin ligase is an attractive radiosensitizing target. Here we tested our hypothesis that MLN4924, a newly discovered investigational small molecule inhibitor of NAE (NEDD8 Activating Enzyme) that inactivates SCF E3 ligase, could act as a novel radiosensitizing agent in breast cancer cells. Indeed, we found that MLN4924 effectively inhibited cullin neddylation, and sensitized breast cancer cells to radiation with a sensitivity enhancement ratio (SER) of 1.75 for SK-BR-3 cells and 1.32 for MCF7 cells, respectively. Mechanistically, MLN4924 significantly enhanced radiation-induced G2/M arrest in SK-BR-3 cells, but not in MCF7 cells at early time point, and enhanced radiation-induced apoptosis in both lines at later time point. However, blockage of apoptosis by Z-VAD failed to abrogate MLN4924 radiosensitization, suggesting that apoptosis was not causally related. We further showed that MLN4924 failed to enhance radiation-induced DNA damage response, but did cause minor delay in DNA damage repair. Among a number of tested SCF E3 substrates known to regulate growth arrest, apoptosis and DNA damage response, p21 was the only one showing an enhanced accumulation in MLN4924-radiation combination group, as compared to the single treatment groups. Importantly, p21 knockdown via siRNA partialy inhibited MLN4924-induced G2/M arrest and radiosensitization, indicating a causal role played by p21. Our study suggested that MLN4924 could be further developed as a novel class of radiosensitizer for the treatment of breast cancer.	[Yang, Dong; Tan, Mingjia; Sun, Yi] Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA; [Wang, Gongxian] Nanchang Univ, Affiliated Hosp 1, Dept Urol, Nanchang, Peoples R China	University of Michigan System; University of Michigan; Nanchang University	Yang, D (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Orthopaed, Nanchang, Peoples R China.	sunyi@umich.edu	Sun, Yi/K-1025-2014	Sun, Yi/0000-0002-5841-4287	NCI [CA118762, CA156744]; Nanchang University in China; NATIONAL CANCER INSTITUTE [R01CA156744, R01CA118762] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nanchang University in China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the NCI grants, CA118762 and CA156744 to YS and the Nanchang University Scholarship Fund in China to DY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chargari C, 2011, CANCER LETT, V312, P209, DOI 10.1016/j.canlet.2011.08.011; Debeb BG, 2009, J MAMMARY GLAND BIOL, V14, P11, DOI 10.1007/s10911-009-9114-z; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FERTIL B, 1984, RADIAT RES, V99, P73, DOI 10.2307/3576448; Flatmark K, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-25; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; HARPER JW, 1993, CELL, V75, P805; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Jameel JKA, 2004, BREAST, V13, P452, DOI 10.1016/j.breast.2004.08.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia L, 2011, CURR CANCER DRUG TAR, V11, P347, DOI 10.2174/156800911794519734; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Jia LJ, 2011, J BIOL CHEM, V286, P3379, DOI 10.1074/jbc.M110.188425; Jia LJ, 2010, CLIN CANCER RES, V16, P814, DOI 10.1158/1078-0432.CCR-09-1592; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kee Y, 2012, MOL CANC RES    0106; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Lyons JA, 2011, FUTURE ONCOL, V7, P915, DOI [10.2217/FON.11.61, 10.2217/fon.11.61]; Malmstrom P, 2003, EUR J CANCER, V39, P1690, DOI 10.1016/S0959-8049(03)00324-1; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Raffoul JJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-107; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun Y, 2003, CANCER BIOL THER, V2, P623; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Tan MJ, 2010, FREE RADICAL BIO MED, V49, P976, DOI 10.1016/j.freeradbiomed.2010.05.030; Tang WG, 2005, CANCER RES, V65, P1904, DOI 10.1158/0008-5472.CAN-04-2597; Wasielewski M, 2006, BREAST CANCER RES TR, V99, P97, DOI 10.1007/s10549-006-9186-z; Wei DP, 2012, CANCER RES, V72, P282, DOI 10.1158/0008-5472.CAN-11-2866; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Yang D, 2011, BREAST CANC RES 0909; Yang J, 2011, MOL CANCER THER, V10, P658, DOI 10.1158/1535-7163.MCT-10-0643; Yi S, 2005, METHOD ENZYMOL, V399, P654, DOI 10.1016/S0076-6879(05)99043-5; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	58	64	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e34079	10.1371/journal.pone.0034079	http://dx.doi.org/10.1371/journal.pone.0034079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457814	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200042
J	Zhang, C; Liu, YG; Gilthorpe, J; van der Maarel, JRC				Zhang, Ce; Liu, Yonggang; Gilthorpe, Jonathan; van der Maarel, Johan R. C.			MRP14 (S100A9) Protein Interacts with Alzheimer Beta-Amyloid Peptide and Induces Its Fibrillization	PLOS ONE			English	Article							MOLECULAR-WEIGHT; INFLAMMATION; ARTHRITIS; DISEASE; NEUROPATHOLOGY; MACROPHAGES	Increasing evidence supports the contribution of local inflammation to the development of Alzheimer's disease (AD) pathology, although the precise mechanisms are not clear. In this study, we demonstrate that the pro-inflammatory protein S100A9 interacts with the A beta 1-40 peptide and promotes the formation of fibrillar beta-amyloid structures. This interaction also results in reduced S100A9 cytotoxicity by the binding of S100A9 toxic species to A beta 1-40 amyloid structures. These results suggest that secretion of S100A9 during inflammation promotes the formation of amyloid plaques. By acting as a sink for toxic species, plaque formation may be the result of a protective response within the brain of AD patients, in part mediated by S100A9.	[Zhang, Ce] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [van der Maarel, Johan R. C.] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Liu, Yonggang] Chongqing Med Univ, Lab Stem Cell & Tissue Engn, Chongqing, Peoples R China; [Gilthorpe, Jonathan] Umea Univ, UCMM, Umea, Sweden	Umea University; National University of Singapore; Chongqing Medical University; Umea University	Zhang, C (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	phyzce@nus.edu.sg; liuyonggangcq01@yahoo.com	ZHANG, CE/G-4969-2012; Liu, Yong/GWQ-6163-2022; van der Maarel, Johan RC/E-7871-2010	van der Maarel, Johan RC/0000-0001-5560-0298; Zhang, Ce/0000-0003-1284-7279; Gilthorpe, Jonathan/0000-0002-6884-4774				Anna W, 1987, NATURE, V330, P80; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; BRUN JG, 1994, J RHEUMATOL, V21, P733; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; GOEBELER M, 1994, TRANSPLANTATION, V58, P355; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Guo JT, 2002, J NEUROSCI, V22, P5900; Heneka MT, 2001, J NEUROPATH EXP NEUR, V60, P906, DOI 10.1093/jnen/60.9.906; HESSIAN PA, 1995, FEBS LETT, V371, P271, DOI 10.1016/0014-5793(95)00905-O; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Itou H, 2002, J MOL BIOL, V316, P265, DOI 10.1006/jmbi.2001.5340; Jose LJ, 2002, P NATL ACAD SCI USA, V99, P9196; Kerkhoff C, 1998, BBA-MOL CELL RES, V1448, P200, DOI 10.1016/S0167-4889(98)00144-X; Muller R, 2007, MACROMOLECULES, V40, P5599, DOI 10.1021/ma062599e; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; ROTH J, 1992, IMMUNOBIOLOGY, V186, P304, DOI 10.1016/S0171-2985(11)80259-7; RUGTVEIT J, 1994, GUT, V35, P669, DOI 10.1136/gut.35.5.669; SOHNLE PG, 1991, J INFECT DIS, V164, P137, DOI 10.1093/infdis/164.1.137; SUNDERKOTTER C, 1991, AM J PATHOL, V138, P931; Tae YH, 2010, PLOS ONE, V5, pe8840; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Xu WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024329	24	33	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e32953	10.1371/journal.pone.0032953	http://dx.doi.org/10.1371/journal.pone.0032953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457725	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200010
J	Hegde, SR; Rajasingh, H; Das, C; Mande, SS; Mande, SC				Hegde, Shubhada R.; Rajasingh, Hannah; Das, Chandrani; Mande, Sharmila S.; Mande, Shekhar C.			Understanding Communication Signals during Mycobacterial Latency through Predicted Genome-Wide Protein Interactions and Boolean Modeling	PLOS ONE			English	Article							AMP RECEPTOR PROTEIN; GENE-EXPRESSION; ESCHERICHIA-COLI; HYPOXIC RESPONSE; BACTERIAL-GROWTH; TUBERCULOSIS; ADAPTATION; DORMANCY; SEQUENCE; SURVIVAL	About 90% of the people infected with Mycobacterium tuberculosis carry latent bacteria that are believed to get activated upon immune suppression. One of the fundamental challenges in the control of tuberculosis is therefore to understand molecular mechanisms involved in the onset of latency and/or reactivation. We have attempted to address this problem at the systems level by a combination of predicted functional protein: protein interactions, integration of functional interactions with large scale gene expression studies, predicted transcription regulatory network and finally simulations with a Boolean model of the network. Initially a prediction for genome-wide protein functional linkages was obtained based on genome-context methods using a Support Vector Machine. This set of protein functional linkages along with gene expression data of the available models of latency was employed to identify proteins involved in mediating switch signals during dormancy. We show that genes that are up and down regulated during dormancy are not only coordinately regulated under dormancy-like conditions but also under a variety of other experimental conditions. Their synchronized regulation indicates that they form a tightly regulated gene cluster and might form a latency-regulon. Conservation of these genes across bacterial species suggests a unique evolutionary history that might be associated with M. tuberculosis dormancy. Finally, simulations with a Boolean model based on the regulatory network with logical relationships derived from gene expression data reveals a bistable switch suggesting alternating latent and actively growing states. Our analysis based on the interaction network therefore reveals a potential model of M. tuberculosis latency.	[Hegde, Shubhada R.; Das, Chandrani; Mande, Shekhar C.] Ctr DNA Fingerprinting & Diagnost, Struct Biol Lab, Hyderabad, Andhra Pradesh, India; [Rajasingh, Hannah; Das, Chandrani; Mande, Sharmila S.] Tata Consultancy Serv, Biosci R&D Div, TCS Innovat Labs, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Tata Sons; Tata Consultancy Services Limited (TCS)	Hegde, SR (corresponding author), Natl Ctr Cell Sci, Struct Biol Lab, Pune, Maharashtra, India.	shekhar@nccs.res.in			Department of Biotechnology	Department of Biotechnology	The study was funded by the Department of Biotechnology under the Centre for Excellence Grant. SRH is a University Grants Commission Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 2010, WHO REP MULT EXT RES; Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Balazsi G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.63; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhardwaj N, 2005, BIOINFORMATICS, V21, P2730, DOI 10.1093/bioinformatics/bti398; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Campbell DR, 2007, J BIOL CHEM, V282, P32298, DOI 10.1074/jbc.M703451200; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Chih-Chung C, LIBSVM LIBRARY SUPPO; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cui T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-118; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Enault F, 2003, BIOINFORMATICS, V19, pi105, DOI 10.1093/bioinformatics/btg1013; Gomez JE, 2000, P NATL ACAD SCI USA, V97, P8554, DOI 10.1073/pnas.140225297; Gonzalez AG, 2006, BIOSYSTEMS, V84, P91, DOI 10.1016/j.biosystems.2005.10.003; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kim TH, 2005, BIOCHEM BIOPH RES CO, V337, P757, DOI 10.1016/j.bbrc.2005.09.115; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Kumar P, 2010, BIOPHYS J, V98, P305, DOI 10.1016/j.bpj.2009.10.016; MacLean D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009101; Manimaran P, 2009, MOL BIOSYST, V5, P1936, DOI [10.1039/b905264j, 10.1039/B905264j]; Marshall E, 2004, SCIENCE, V306, P630, DOI 10.1126/science.306.5696.630; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; Morth JP, 2004, STRUCTURE, V12, P1595, DOI 10.1016/j.str.2004.06.018; Mukamolova GV, 2002, MOL MICROBIOL, V46, P611, DOI 10.1046/j.1365-2958.2002.03183.x; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Strong M, 2003, NUCLEIC ACIDS RES, V31, P7099, DOI 10.1093/nar/gkg924; Tyagi JS, 2004, CURR SCI INDIA, V86, P93; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607; ZAMBRANO MM, 1993, J BACTERIOL, V175, P5642, DOI 10.1128/JB.175.17.5642-5647.1993	72	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33893	10.1371/journal.pone.0033893	http://dx.doi.org/10.1371/journal.pone.0033893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448278	gold, Green Published, Green Submitted			2022-12-27	WOS:000303855700069
J	Kamprath, S; Timmer, A				Kamprath, Stefan; Timmer, Antje			Prioritisation of Clinical Research by the Example of Type 2 Diabetes: A Caregiver-Survey on Perceived Relevance and Need for Evidence	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; GRADE	Background: The Cochrane Collaboration aims at providing the best available evidence for interventions in health care. We wished to examine to which extent treatments considered relevant by caregivers in type 2 diabetes are covered by Cochrane systematic reviews. Methodology/Principal Findings: 130 different interventions in type 2 diabetes were identified based on a review of clinical practice guidelines and expert opinion (Table S1). 459 members of the German Diabetes Society (diabetologists, general practitioners, diabetic nurses, nutritionists, podologists, others) were surveyed via e-mail-list to rank a) the perceived clinical relevance and b) the perceived need for evidence of interventions, based on an internet survey. In the Cochrane Library, there were, at the time of this evaluation, 56 reviews on interventions in diabetes. Generally, coverage of topics by Cochrane reviews reflected the perceived clinical relevance and perceived need for evidence. As an example, highly ranked treatments such as lifestyle changes or oral antidiabetics were well covered, while low rank treatments such as complementary approaches were not covered. Discrepancies occurred with new treatments such as amylin-analogues (low relevance, high need for evidence, review not yet completed) and interventions with immediate and dramatic effects such as treating hypoglycemia (high relevance, low need for evidence, no review). Also, there was a relative scarcity of reviews concerning specific problems, in particular, treatment of late diabetic complications. Conclusions/Significance: For most interventions, perceived relevance and perceived need for evidence are reflected by the evidence already available. Prioritizing should aim at improving immediacy and consideration of the treatment of complications.	[Kamprath, Stefan] Herz Zentrum Bodensee, Dept Cardiol, Constance, Germany; [Timmer, Antje] Bremen Inst Prevent Res & Social Med, Dept Clin Epidemiol, Bremen, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS)	Kamprath, S (corresponding author), Herz Zentrum Bodensee, Dept Cardiol, Constance, Germany.	timmer@bips.uni-bremen.de	Timmer, Antje/N-8056-2015	Timmer, Antje/0000-0001-9579-0516	German Ministry of Health (BMG); Sanofi Aventis; Novartis; Ferring; SHS	German Ministry of Health (BMG); Sanofi Aventis(Sanofi-Aventis); Novartis(Novartis); Ferring(Ferring Pharmaceuticals); SHS	There are no current external funding sources for this study. Antje Timmer was funded by the German Ministry of Health (BMG, http://www.bundesgesundheitsministerium.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Antje Timmer is currently involved in pharmacoepidemiological studies funded by Sanofi Aventis and Novartis, and has presented in educational sessions funded by Ferring and SHS. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Back-Pettersson S, 2008, J CLIN NURS, V17, P2221, DOI 10.1111/j.1365-2702.2007.02083.x; Badgett R, 2008, J CLIN EPIDEMIOL, V61, P419, DOI 10.1016/j.jclinepi.2007.11.022; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Boaz Annette, 2011, BMC Res Notes, V4, P212, DOI 10.1186/1756-0500-4-212; Buckley BS, 2010, NEUROUROL URODYNAM, V29, P708, DOI 10.1002/nau.20816; Buckley BS, 2011, J CLIN EPIDEMIOL; Caron-Flinterman JF, 2005, HEALTH EXPECT, V8, P253; CHALMERS I, 1993, ANN NY ACAD SCI, V703, P156, DOI 10.1111/j.1749-6632.1993.tb26345.x; Chalmers I, 2010, COCHRANE DB SYST REV, V8; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Doyle J, 2005, J EPIDEMIOL COMMUN H, V59, P193, DOI 10.1136/jech.2003.019547; Emond SD, 2002, ANN EMERG MED, V39, P153, DOI 10.1067/mem.2002.120795; Gillies Andrea, 2009, KEEPER; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Mallett Susan, 2003, ACP J Club, V139, pA11; Mandel D, 2006, ACTA PAEDIATR, V95, P1209, DOI 10.1080/08035250600580537; Moat K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000019; Patrick DM, 2006, CAN J PUBLIC HEALTH, V97, pS24; Sampson M, 2008, J CLIN EPIDEMIOL, V61, P531, DOI 10.1016/j.jclinepi.2008.02.004; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Stewart RJ, 2010, HLTH EXPECT; Zhang P, 2009, EC IMPACT DIABETES	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32414	10.1371/journal.pone.0032414	http://dx.doi.org/10.1371/journal.pone.0032414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448219	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700009
J	Olman, CA; Harel, N; Feinberg, DA; He, S; Zhang, P; Ugurbil, K; Yacoub, E				Olman, Cheryl A.; Harel, Noam; Feinberg, David A.; He, Sheng; Zhang, Peng; Ugurbil, Kamil; Yacoub, Essa			Layer-Specific fMRI Reflects Different Neuronal Computations at Different Depths in Human V1	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; HUMAN-BRAIN; LAMINAR SPECIFICITY; RETINOTOPIC CORTEX; ACTIVATION; RECOGNITION; PROFILES; FEEDBACK; COLUMNS; SIGNALS	Recent work has established that cerebral blood flow is regulated at a spatial scale that can be resolved by high field fMRI to show cortical columns in humans. While cortical columns represent a cluster of neurons with similar response properties (spanning from the pial surface to the white matter), important information regarding neuronal interactions and computational processes is also contained within a single column, distributed across the six cortical lamina. A basic understanding of underlying neuronal circuitry or computations may be revealed through investigations of the distribution of neural responses at different cortical depths. In this study, we used T-2-weighted imaging with 0.7 mm (isotropic) resolution to measure fMRI responses at different depths in the gray matter while human subjects observed images with either recognizable or scrambled (physically impossible) objects. Intact and scrambled images were partially occluded, resulting in clusters of activity distributed across primary visual cortex. A subset of the identified clusters of voxels showed a preference for scrambled objects over intact; in these clusters, the fMRI response in middle layers was stronger during the presentation of scrambled objects than during the presentation of intact objects. A second experiment, using stimuli targeted at either the magnocellular or the parvocellular visual pathway, shows that laminar profiles in response to parvocellular-targeted stimuli peak in more superficial layers. These findings provide new evidence for the differential sensitivity of high-field fMRI to modulations of the neural responses at different cortical depths.	[Olman, Cheryl A.; Harel, Noam; Ugurbil, Kamil; Yacoub, Essa] Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Olman, Cheryl A.; He, Sheng; Zhang, Peng] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Harel, Noam] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Feinberg, David A.] Adv MRI Technol, Sebastopol, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Olman, CA (corresponding author), Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	yacoub@cmrr.umn.edu	Ugurbil, Kamil/AAD-6058-2022; Yacoub, Essa/AAS-7757-2021; Harel, Noam/R-7391-2018	Harel, Noam/0000-0002-6034-3801; Olman, Cheryl/0000-0002-7324-6461	National Institutes of Health [R01 EY015261, R01 MH070800, R01 EB000331, R01 EB008645, 1R44NS063537, P30 NS057091, P41 RR08079, S10 RR1395]; W.M. Keck Foundation; Mind Institute; National Science Foundation [DBI-9907842]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395, P41RR008079] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008645, R01EB000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R44NS063537, P30NS057091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); Mind Institute; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health (grants, R01 EY015261 to CAO and SH, R01 MH070800 to EY, R01 EB000331 to EY, R01 EB008645 to NH, 1R44NS063537 to DF, NH, P30 NS057091, P41 RR08079), the W.M. Keck Foundation, and Mind Institute. The 7 T magnet purchase was funded in part by National Science Foundation DBI-9907842 and NIH S10 RR1395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriany G, 2001, HALF VOLUME TRANSMIT; Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Brainard DH, 1997, PSYCHOPHYSICS TOOLBO, P433; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; FEINBERG DA, 1985, RADIOLOGY, V156, P743, DOI 10.1148/radiology.156.3.4023236; Feinberg DA, 2008, SUBMILLIMETER SINGLE; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Goense JBM, 2006, MAGN RESON IMAGING, V24, P381, DOI 10.1016/j.mri.2005.12.032; Harel N, 2006, NEUROIMAGE, V29, P879, DOI 10.1016/j.neuroimage.2005.08.016; Hsieh PJ, 2010, J NEUROPHYSIOL, V103, P1501, DOI 10.1152/jn.00812.2009; Keller AL, 2011, J NEUROSCI, V31, P1246, DOI 10.1523/JNEUROSCI.2765-10.2011; Koopmans PJ, 2011, NEUROIMAGE, V56, P1276, DOI 10.1016/j.neuroimage.2011.02.042; Koopmans PJ, 2010, HUM BRAIN MAPP, V31, P1297, DOI 10.1002/hbm.20936; Larsson J, 2001, THESIS KAROLINSKA I; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; Murray SO, 2002, P NATL ACAD SCI USA, V99, P15164, DOI 10.1073/pnas.192579399; Murray SO, 2006, NATURE NEUROSCIENCE; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Olman Cheryl A, 2011, Open Neuroimag J, V5, P74, DOI 10.2174/1874440001105010074; OSHIO K, 1991, MAGNET RESON MED, V20, P344, DOI 10.1002/mrm.1910200219; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polimeni JR, 2010, NEUROIMAGE, V52, P1334, DOI 10.1016/j.neuroimage.2010.05.005; Ress D, 2007, NEUROIMAGE, V34, P74, DOI 10.1016/j.neuroimage.2006.08.020; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Shapley R, 2011, VISION RES, V51, P701, DOI 10.1016/j.visres.2011.02.012; Sherman SM, 2007, CURRENT OPINION NEUR; Siero JCW, 2011, J CEREBR BLOOD F MET, V31, P1999, DOI 10.1038/jcbfm.2011.57; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Ugurbil K, 2003, MAGN RESON IMAGING, V21, P1263, DOI 10.1016/j.mri.2003.08.027; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Zimmermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028716	37	127	127	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32536	10.1371/journal.pone.0032536	http://dx.doi.org/10.1371/journal.pone.0032536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448223	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700013
J	Secatto, A; Rodrigues, LC; Serezani, CH; Ramos, SG; Dias-Baruffi, M; Faccioli, LH; Medeiros, AI				Secatto, Adriana; Rodrigues, Lilian Cataldi; Serezani, Carlos Henrique; Ramos, Simone Gusmao; Dias-Baruffi, Marcelo; Faccioli, Lucia Helena; Medeiros, Alexandra I.			5-Lipoxygenase Deficiency Impairs Innate and Adaptive Immune Responses during Fungal Infection	PLOS ONE			English	Article							ALVEOLAR MACROPHAGE PHAGOCYTOSIS; T-CELL RECRUITMENT; HISTOPLASMA-CAPSULATUM; LEUKOTRIENE B-4; KLEBSIELLA-PNEUMONIAE; MYCOBACTERIUM-TUBERCULOSIS; FUNGISTATIC ACTIVITY; HUMAN NEUTROPHILS; HOST CONTROL; INFLAMMATION	5-lipoxygenase-derived products have been implicated in both the inhibition and promotion of chronic infection. Here, we sought to investigate the roles of endogenous 5-lipoxygenase products and exogenous leukotrienes during Histoplasma capsulatum infection in vivo and in vitro. 5-LO deficiency led to increased lung CFU, decreased nitric oxide production and a deficient primary immune response during active fungal infection. Moreover, H. capsulatum-infected 5-LO-/- mice showed an intense influx of neutrophils and an impaired ability to generate and recruit effector T cells to the lung. The fungal susceptibility of 5-LO-/- mice correlated with a lower rate of macrophage ingestion of IgG-H. capsulatum relative to WT macrophages. Conversely, exogenous LTB4 and LTC4 restored macrophage phagocytosis in 5-LO deficient mice. Our results demonstrate that leukotrienes are required to control chronic fungal infection by amplifying both the innate and adaptive immune response during histoplasmosis.	[Secatto, Adriana; Rodrigues, Lilian Cataldi; Dias-Baruffi, Marcelo; Faccioli, Lucia Helena] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, Sao Paulo, Brazil; [Serezani, Carlos Henrique] Univ Michigan Hlth Syst, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Ramos, Simone Gusmao] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Patol, Sao Paulo, Brazil; [Medeiros, Alexandra I.] Univ Estadual Paulista, Fac Ciencias Farmaceut, Dept Ciencias Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; University of Michigan System; University of Michigan; Universidade de Sao Paulo; Universidade Estadual Paulista	Secatto, A (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, Sao Paulo, Brazil.	medeirosai@fcfar.unesp.br	Faccioli, Lúcia Helena/AGH-5297-2022; Lucia, Faccioli/G-8976-2015; Baruffi, Marcelo D/I-7199-2015; Medeiros, Alexandra I. AIM/J-6103-2012; Terra, Lilian Cataldi Rodrigues/GYV-2597-2022; Fapesp, Biota/F-8655-2017; serezani, C. Henrique/H-1675-2013	Faccioli, Lúcia Helena/0000-0002-4999-8305; Lucia, Faccioli/0000-0002-4999-8305; Baruffi, Marcelo D/0000-0002-2039-1884; Medeiros, Alexandra I. AIM/0000-0001-6048-3647; Terra, Lilian Cataldi Rodrigues/0000-0002-2014-2263; Fapesp, Biota/0000-0002-9887-8449; serezani, C. Henrique/0000-0002-5363-415X; Ramos, Simone/0000-0002-1981-5248	Fundacao de Amparo a Pesquisas do Estado de Sao Paulo (FAPESP, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); National Institutes of Health (NIH) [HL-103777 01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103777, K99HL103777] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisas do Estado de Sao Paulo (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by Fundacao de Amparo a Pesquisas do Estado de Sao Paulo (FAPESP, Brazil), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and National Institutes of Health (NIH) (HL-103777 01 - C.H.S.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendoerfer R, 2000, J IMMUNOL, V165, P2657, DOI 10.4049/jimmunol.165.5.2657; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Bailie MB, 1996, J IMMUNOL, V157, P5221; BRUMMER E, 1995, CLIN EXP IMMUNOL, V102, P65; BRUMMER E, 1991, J INFECT DIS, V164, P158, DOI 10.1093/infdis/164.1.158; Canetti C, 2003, BLOOD, V102, P1877, DOI 10.1182/blood-2003-02-0534; Carlos D, 2009, INFECT IMMUN, V77, P5359, DOI 10.1128/IAI.01497-08; Chen NN, 2001, J NEUROIMMUNOL, V120, P94, DOI 10.1016/S0165-5728(01)00415-5; Clish CB, 1999, P NATL ACAD SCI USA, V96, P8247, DOI 10.1073/pnas.96.14.8247; Costa MFD, 2010, J LEUKOCYTE BIOL, V87, P323, DOI 10.1189/jlb.0809563; Deepe GS, 1999, J IMMUNOL, V163, P4985; Deepe GS, 2000, CURR OPIN MICROBIOL, V3, P359, DOI 10.1016/S1369-5274(00)00104-1; FACCIOLI LH, 1990, AGENTS ACTIONS, V30, P344, DOI 10.1007/BF01966298; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Huffman LJ, 2003, J BIOSCIENCES, V28, P29, DOI 10.1007/BF02970129; Islam SA, 2006, BLOOD, V107, P444, DOI 10.1182/blood-2005-06-2362; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; KURITA N, 1991, MYCOPATHOLOGIA, V115, P207, DOI 10.1007/BF00462229; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Mancuso P, 2001, INFECT IMMUN, V69, P2011, DOI 10.1128/IAI.69.4.2011-2016.2001; Mancuso P, 2000, AM J RESP CELL MOL, V23, P727, DOI 10.1165/ajrcmb.23.6.4246; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Medeiros AI, 1999, BRIT J PHARMACOL, V128, P1529, DOI 10.1038/sj.bjp.0702912; Medeiros AI, 2008, J IMMUNOL, V181, P8544, DOI 10.4049/jimmunol.181.12.8544; Morato-Marques M, 2011, J BIOL CHEM, V286, P28902, DOI 10.1074/jbc.M111.235309; NEWMAN SL, 1993, J CLIN INVEST, V92, P624, DOI 10.1172/JCI116630; Newman SL, 1999, TRENDS MICROBIOL, V7, P67, DOI 10.1016/S0966-842X(98)01431-0; Pavanelli WR, 2010, MICROBES INFECT, V12, P587, DOI 10.1016/j.micinf.2010.03.016; Peres CM, 2007, MICROBES INFECT, V9, P483, DOI 10.1016/j.micinf.2007.01.006; Peters-Golden M, 1998, J LAB CLIN MED, V132, P251, DOI 10.1016/S0022-2143(98)90037-3; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Sa-Nunes A, 2005, MICROBES INFECT, V7, P584, DOI 10.1016/j.micinf.2004.12.017; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Schwab JM, 2006, CURR OPIN PHARMACOL, V6, P414, DOI 10.1016/j.coph.2006.02.006; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Talvani A, 2002, INFECT IMMUN, V70, P4247, DOI 10.1128/IAI.70.8.4247-4253.2002; ZHOU P, 1995, J IMMUNOL, V155, P785	42	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e31701	10.1371/journal.pone.0031701	http://dx.doi.org/10.1371/journal.pone.0031701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448213	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700003
J	Halonen, JI; Kivimaki, M; Oksanen, T; Virtanen, P; Virtanen, MJ; Pentti, J; Vahtera, J				Halonen, Jaana I.; Kivimaeki, Mika; Oksanen, Tuula; Virtanen, Pekka; Virtanen, Mikko J.; Pentti, Jaana; Vahtera, Jussi			Waterborne Outbreak of Gastroenteritis: Effects on Sick Leaves and Cost of Lost Workdays	PLOS ONE			English	Article							DISEASE OUTBREAKS; DRINKING-WATER; UNITED-STATES; RISK; INFECTION; ARTHRITIS; SYMPTOMS	Background: In 2007, part of a drinking water distribution system was accidentally contaminated with waste water effluent causing a gastroenteritis outbreak in a Finnish town. We examined the acute and cumulative effects of this incidence on sick leaves among public sector employees residing in the clean and contaminated areas, and the additional costs of lost workdays due to the incidence. Methods: Daily information on sick leaves of 1789 Finnish Public Sector Study participants was obtained from employers' registers. Global Positioning System-coordinates were used for linking participants to the clean and contaminated areas. Prevalence ratios (PR) for weekly sickness absences were calculated using binomial regression analysis. Calculations for the costs were based on prior studies. Results: Among those living in the contaminated areas, the prevalence of participants on sick leave was 3.54 (95% confidence interval (CI) 2.97-4.22) times higher on the week following the incidence compared to the reference period. Those living and working in the clean area were basically not affected, the corresponding PR for sick leaves was 1.12, 95% CI 0.73-1.73. No cumulative effects on sick leaves were observed among the exposed. The estimated additional costs of lost workdays due to the incidence were 1.8-2.1 million euros. Conclusions: The prevalence of sickness absences among public sector employees residing in affected areas increased shortly after drinking water distribution system was contaminated, but no long-term effects were observed. The estimated costs of lost workdays were remarkable, thus, the cost-benefits of better monitoring systems for the water distribution systems should be evaluated.	[Halonen, Jaana I.; Kivimaeki, Mika; Oksanen, Tuula; Pentti, Jaana; Vahtera, Jussi] Finnish Inst Occupat Hlth, Helsinki, Finland; [Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Virtanen, Pekka] Univ Tampere, Tampere Sch Hlth Sci, FIN-33101 Tampere, Finland; [Virtanen, Mikko J.] Natl Inst Hlth & Welf, Epidemiol Surveillance & Response Unit, Helsinki, Finland; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland	Finnish Institute of Occupational Health; University of London; University College London; Tampere University; Finland National Institute for Health & Welfare; University of Turku; University of Turku	Halonen, JI (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	jaana.halonen@ttl.fi	Kivimaki, Mika/B-3607-2012; Vahtera, Jussi/J-3271-2013; Oksanen, Tuula/AAK-5599-2021	Kivimaki, Mika/0000-0002-4699-5627; Vahtera, Jussi/0000-0002-6036-061X; Halonen, Jaana/0000-0003-1142-0388	Academy of Finland [124271, 124322, 129262, 132944]; BUPA Foundation, UK; New OSH ERA	Academy of Finland(Academy of Finland); BUPA Foundation, UK; New OSH ERA	This study was funded by the Academy of Finland (projects 124271, 124322, 129262, and 132944). Mika Kivimaki is supported by the BUPA Foundation, UK; and the New OSH ERA research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Can Commun Dis Rep, V26, P170; Auld H, 2004, J TOXICOL ENV HEAL A, V67, P1879, DOI 10.1080/15287390490493475; Bekker MHJ, 2009, PSYCHOL HEALTH MED, V14, P405, DOI 10.1080/13548500903012830; Breitenmoser A, 2011, J WATER HEALTH, V9, P569, DOI 10.2166/wh.2011.158; BREMELL T, 1991, ANN RHEUM DIS, V50, P934, DOI 10.1136/ard.50.12.934; Brunkard Joan M., 2011, Morbidity and Mortality Weekly Report, V60, P38; Burdorf A, 2011, OCCUP ENVIRON MED, V68, P707, DOI 10.1136/oemed-2011-100269; Craun GF, 2010, CLIN MICROBIOL REV, V23, P507, DOI 10.1128/CMR.00077-09; Daly ER, 2010, EPIDEMIOL INFECT, V138, P491, DOI 10.1017/S0950268809990744; Garg AX, 2008, RHEUMATOLOGY, V47, P200, DOI 10.1093/rheumatology/kem339; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Hanevik K, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-27; Koroglu M, 2011, NEW MICROBIOL, V34, P17; Laine J, 2011, EPIDEMIOL INFECT, V139, P1105, DOI 10.1017/S0950268810002141; LAURSEN E, 1994, J EPIDEMIOL COMMUN H, V48, P453, DOI 10.1136/jech.48.5.453; Lehtonen V, LEHT V MIT HALL SAIR; Locht H, 2002, ANN RHEUM DIS, V61, P448, DOI 10.1136/ard.61.5.448; Mann EA, 2012, CURR OPIN GASTROEN, V28, P24, DOI 10.1097/MOG.0b013e32834c453e; Pohjola Pankki Oyj, SAIR; Riera-Montes M, 2011, EPIDEMIOL INFECT, V20, P1; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Uotila T, 2011, SCAND J RHEUMATOL, V40, P358, DOI 10.3109/03009742.2011.562533; Yang ZC, 2011, BIOMED ENVIRON SCI, V24, P275, DOI 10.3967/0895-3988.2011.03.011; Zacheus O, 2011, J WATER HEALTH, V9, P763, DOI 10.2166/wh.2011.021	24	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33307	10.1371/journal.pone.0033307	http://dx.doi.org/10.1371/journal.pone.0033307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442683	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500025
J	He, GJ; Yan, YB				He, Guang-Jun; Yan, Yong-Bin			A Deadenylase Assay by Size-Exclusion Chromatography	PLOS ONE			English	Article							HUMAN POLY(A)-SPECIFIC RIBONUCLEASE; MESSENGER-RNA STABILITY; RRM DOMAIN; METHYLENE-BLUE; CAP; PARN; EUKARYOTES; BINDING; EXONUCLEASE; INHIBITION	The shortening of the 3'-end poly(A) tail, also called deadenylation, is crucial to the regulation of mRNA processing, transportation, translation and degradation. The deadenylation process is achieved by deadenylases, which specifically catalyze the removal of the poly(A) tail at the 3'-end of eukaryotic mRNAs and release 5'-AMP as the product. To achieve their physiological functions, all deadenylases have numerous binding partners that may regulate their catalytic properties or recruit them into various protein complexes. To study the effects of various partners, it is important to develop new deadenylase assay that can be applied either in vivo or in vitro. In this research, we developed the deadenylase assay by the size-exclusion chromatography (SEC) method. The SEC analysis indicated that the poly(A) or oligo(A) substrate and the product AMP could be successfully separated and quantified. The enzymatic parameters of deadenylase could be obtained by quantifying the AMP generation. When using the commercial poly(A) as the substrate, a biphasic catalytic process was observed, which might correlate to the two distinct states of poly(A) in the commercial samples. Different lots of commercial poly(A) had dissimilar size distributions and were dissimilar in response to the degradation of deadenylase. The deadenylation pattern, processive or distributive, could also be investigated using the SEC assay by monitoring the status of the substrate and the generation kinetics of AMP and A2. The SEC assay was applicable to both simple samples using the purified enzyme and complex enzyme reaction conditions such as using protein mixtures or crude cell extracts as samples. The influence of solutes with absorption at 254 nm could be successfully eliminated by constructing the different SEC profiles.	[He, Guang-Jun; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	He, GJ (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ybyan@tsinghua.edu.cn	Yan, Yong-Bin/A-4282-2008	Yan, Yong-Bin/0000-0002-8565-3558	National Natural Science Foundation of China [30770477, 31170757]; Ministry of Education, China [NCET-07-0494]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, China(Ministry of Education, China)	This investigation was supported by grants 30770477 and 31170757 from the National Natural Science Foundation of China and grant NCET-07-0494 from the Ministry of Education, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTROM J, 1992, J BIOL CHEM, V267, P18154; Balatsos NAA, 2009, BIOCHEMISTRY-US, V48, P6044, DOI 10.1021/bi900236k; Balatsos NAA, 2009, J ENZYM INHIB MED CH, V24, P516, DOI [10.1080/14756360802218763, 10.1080/14756360802218763 ]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng YA, 2006, PROTEIN PEPTIDE LETT, V13, P125, DOI 10.2174/092986606775101580; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; GreinerStoeffele T, 1996, ANAL BIOCHEM, V240, P24, DOI 10.1006/abio.1996.0326; Henriksson N, 2010, J BIOL CHEM, V285, P163, DOI 10.1074/jbc.M109.043893; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Korner CG, 1997, J BIOL CHEM, V272, P10448; Liu WF, 2008, PROTEIN EXPRES PURIF, V60, P46, DOI 10.1016/j.pep.2008.03.008; Liu WF, 2007, BIOCHEM BIOPH RES CO, V360, P846, DOI 10.1016/j.bbrc.2007.06.139; Liu WF, 2007, FEBS LETT, V581, P1047, DOI 10.1016/j.febslet.2007.02.008; Liu WF, 2009, BIOCHEM BIOPH RES CO, V379, P341, DOI 10.1016/j.bbrc.2008.12.056; Martinez J, 2001, J BIOL CHEM, V276, P27923, DOI 10.1074/jbc.M102270200; Martinez J, 2000, J BIOL CHEM, V275, P24222, DOI 10.1074/jbc.M001705200; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Monecke T, 2008, J MOL BIOL, V382, P827, DOI 10.1016/j.jmb.2008.07.073; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; Ren YG, 2004, J BIOL CHEM, V279, P48702, DOI 10.1074/jbc.M403858200; Reverdatto SV, 2004, RNA, V10, P1200, DOI 10.1261/rna.7540204; Seal R, 2005, NUCLEIC ACIDS RES, V33, P376, DOI 10.1093/nar/gki169; Virtanen A, 2001, METHOD ENZYMOL, V342, P303, DOI 10.1016/S0076-6879(01)42554-7; Walley JW, 2010, PLANT PHYSIOL, V152, P866, DOI 10.1104/pp.109.149005; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wu MS, 2009, STRUCTURE, V17, P276, DOI 10.1016/j.str.2008.11.012; Zhang A, 2007, ARCH BIOCHEM BIOPHYS, V461, P255, DOI 10.1016/j.abb.2007.02.023; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	32	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33700	10.1371/journal.pone.0033700	http://dx.doi.org/10.1371/journal.pone.0033700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442711	gold, Green Submitted, Green Published			2022-12-27	WOS:000303836500052
J	Tsai, CY; Chan, JYH; Hsu, KS; Chang, AYW; Chan, SHH				Tsai, Ching-Yi; Chan, Julie Y. H.; Hsu, Kuei-sen; Chang, Alice Y. W.; Chan, Samuel H. H.			Brain-Derived Neurotrophic Factor Ameliorates Brain Stem Cardiovascular Dysregulation during Experimental Temporal Lobe Status Epilepticus	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; HIPPOCAMPAL CA3 SUBFIELD; NITRIC-OXIDE-SYNTHASE; OXIDATIVE STRESS; ANGIOTENSIN-II; BAROREFLEX SENSITIVITY; MOLECULAR SYNTHESIS; NEURAL REGULATION; SUPEROXIDE ANION; UP-REGULATION	Background: Status epilepticus (SE) is an acute, prolonged epileptic crisis with a mortality rate of 20-30%; the underlying mechanism is not completely understood. We assessed the hypothesis that brain stem cardiovascular dysregulation occurs during SE because of oxidative stress in rostral ventrolateral medulla (RVLM), a key nucleus of the baroreflex loop; to be ameliorated by brain-derived neurotrophic factor (BDNF) via an antioxidant action. Methodology/Principal Findings: In a clinically relevant experimental model of temporal lobe SE (TLSE) using Sprague-Dawley rats, sustained hippocampal seizure activity was accompanied by progressive hypotension that was preceded by a reduction in baroreflex-mediated sympathetic vasomotor tone; heart rate and baroreflex-mediated cardiac responses remained unaltered. Biochemical experiments further showed concurrent augmentation of superoxide anion, phosphorylated p47(phox) subunit of NADPH oxidase and mRNA or protein levels of BDNF, tropomyosin receptor kinase B (TrkB), angiotensin AT1 receptor subtype (AT1R), nitric oxide synthase II (NOS II) or peroxynitrite in RVLM. Whereas pretreatment by microinjection bilaterally into RVLM of a superoxide dismutase mimetic (tempol), a specific antagonist of NADPH oxidase (apocynin) or an AT1R antagonist (losartan) blunted significantly the augmented superoxide anion or phosphorylated p47(phox) subunit in RVLM, hypotension and the reduced baroreflex-mediated sympathetic vasomotor tone during experimental TLSE, pretreatment with a recombinant human TrkB-Fc fusion protein or an antisense bdnf oligonucleotide significantly potentiated all those events, alongside peroxynitrite. However, none of the pretreatments affected the insignificant changes in heart rate and baroreflex-mediated cardiac responses. Conclusions/Significance: We conclude that formation of peroxynitrite by a reaction between superoxide anion generated by NADPH oxidase in RVLM on activation by AT1R and NOS II-derived NO leads to a reduction in baroreflex-mediated sympathetic vasomotor tone during experimental TLSE; to be ameliorated by the upregulated BDNF/TrkB signaling via inhibition of p47(phox) phosphorylation. This information offers a new vista in devising therapeutic strategy towards minimizing mortality associated with TLSE.	[Tsai, Ching-Yi; Chan, Julie Y. H.; Chang, Alice Y. W.; Chan, Samuel H. H.] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan; [Hsu, Kuei-sen] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan	Chang Gung Memorial Hospital; National Cheng Kung University	Tsai, CY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan.	cgmf.kmc@gmail.com; shhchan@adm.cgmh.org.tw	Chan, Julie/X-5253-2019; Tsai, CY/AAV-9723-2021; Hsu, Kuei-Sen/AAV-8386-2021	Tsai, CY/0000-0002-9548-9851; 	National Science Council, Taiwan, Republic of China [NSC99-2321-B-182A-005, NSC99-2321-B-182A-007, NSC100-2321-B-182A-007, NSC100-2321-B-182A-008, NSC99-2321-B-182A-006, NSC100-2321-B-182A-006]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan, Republic of China, NSC99-2321-B-182A-005, NSC99-2321-B-182A-007, NSC100-2321-B-182A-007 and NSC100-2321-B-182A-008 (SHHC), and NSC99-2321-B-182A-006 and NSC100-2321-B-182A-006 (AYWC). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdallah DM, 2009, EUR J PHARMACOL, V603, P93, DOI 10.1016/j.ejphar.2008.11.057; Albuszies G, 2003, INTENS CARE MED, V29, P1632, DOI 10.1007/s00134-003-1861-5; AVERILL DB, 1994, BRAIN RES, V665, P245, DOI 10.1016/0006-8993(94)91344-7; Azevedo L. C. P., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P159; Bealer SL, 2010, EPILEPSY RES, V91, P66, DOI 10.1016/j.eplepsyres.2010.06.013; Boggs JG, 1998, EPILEPSY RES, V31, P199, DOI 10.1016/S0920-1211(98)00031-X; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Chan JYH, 2001, CIRCULATION, V104, P1676, DOI 10.1161/hc3901.095767; Chan SHH, 2011, BRIT J PHARMACOL, V164, P2015, DOI 10.1111/j.1476-5381.2011.01508.x; Chan SHH, 2006, FREE RADICAL BIO MED, V40, P2028, DOI 10.1016/j.freeradbiomed.2006.01.032; Chan SHH, 2010, CIRC RES, V107, P1127, DOI 10.1161/CIRCRESAHA.110.225573; Chan SHH, 2009, CIRC RES, V105, P886, DOI 10.1161/CIRCRESAHA.109.199018; Chan SHH, 2005, CIRC RES, V97, P772, DOI 10.1161/01.RES.0000185804.79157.C0; Chan SHH, 2005, FREE RADICAL BIO MED, V39, P603, DOI 10.1016/j.freeradbiomed.2005.04.012; Chan SHH, 2003, BRIT J PHARMACOL, V138, P584, DOI 10.1038/sj.bjp.0705081; Chan SHH, 2002, NEUROPHARMACOLOGY, V43, P889, DOI 10.1016/S0028-3908(02)00146-6; Chan SHH, 2001, BRIT J PHARMACOL, V133, P606, DOI 10.1038/sj.bjp.0704105; Chuang YC, 2007, NEUROPHARMACOLOGY, V52, P1263, DOI 10.1016/j.neuropharm.2007.01.010; Chuang YC, 2009, EPILEPSIA, V50, P731, DOI 10.1111/j.1528-1167.2008.01778.x; Clark CG, 2011, J NEUROSCI, V31, P12318, DOI 10.1523/JNEUROSCI.0746-11.2011; Dai KY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-72; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; DELORENZO RJ, 1992, EPILEPSIA, V33, pS15; DODSON WE, 1993, JAMA-J AM MED ASSOC, V270, P854; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Irigoyen MC, 2005, HYPERTENSION, V46, P998, DOI 10.1161/01.HYP.0000176238.90688.6b; KANTER RK, 1994, EXP NEUROL, V129, P290, DOI 10.1006/exnr.1994.1171; Kanter RK, 1996, NEUROSCIENCE, V73, P807, DOI 10.1016/0306-4522(96)00051-6; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kemp JA, 1986, BRIT J PHARMACOL, V89, P535; Kolls JK, 2006, J CLIN INVEST, V116, P860, DOI 10.1172/JCI28111; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V272, pH485, DOI 10.1152/ajpheart.1997.272.1.H485; Laude D, 2004, AM J PHYSIOL-REG I, V286, pR226, DOI 10.1152/ajpregu.00709.2002; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Legriel S, 2008, INTENS CARE MED, V34, P476, DOI 10.1007/s00134-007-0915-5; Li PL, 2001, CIRCULATION, V103, P2114; Lin YY, 1999, NEUROLOGY, V53, P885, DOI 10.1212/WNL.53.4.885; Logroscino G, 2005, EPILEPSIA, V46, P46, DOI 10.1111/j.1528-1167.2005.00409.x; Ma CHE, 2010, NEUROSCIENCE, V165, P463, DOI 10.1016/j.neuroscience.2009.10.026; Macias M, 2007, EUR J NEUROSCI, V25, P2425, DOI 10.1111/j.1460-9568.2007.05498.x; Metcalf CS, 2009, AM J PHYSIOL-HEART C, V297, pH2120, DOI 10.1152/ajpheart.00724.2009; Monahan KD, 2004, AM J PHYSIOL-HEART C, V286, pH2113, DOI 10.1152/ajpheart.01054.2003; Oh H, 2010, BIOCHEM BIOPH RES CO, V394, P691, DOI 10.1016/j.bbrc.2010.03.053; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Simonato M, 2006, TRENDS PHARMACOL SCI, V27, P631, DOI 10.1016/j.tips.2006.10.002; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Touyz RM, 2002, CIRC RES, V90, P1205, DOI 10.1161/01.RES.0000020404.01971.2F; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Walker M, 2005, BRIT MED J, V331, P673, DOI 10.1136/bmj.331.7518.673; WHITE PT, 1961, NEUROLOGY, V11, P354; WONG PC, 1992, HYPERTENSION, V19, P663, DOI 10.1161/01.HYP.19.6.663; Yan Q, 1997, J COMP NEUROL, V378, P135; Yang CH, 1995, J PHARMACOL EXP THER, V275, P1568; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zimmerman MC, 2004, PROG BIOPHYS MOL BIO, V84, P125, DOI 10.1016/j.pbiomolbio.2003.11.009	59	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33527	10.1371/journal.pone.0033527	http://dx.doi.org/10.1371/journal.pone.0033527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442695	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500036
J	Upadhyayula, SM; Mutheneni, SR; Kadiri, MR; Kumaraswamy, S; Nagalla, B				Upadhyayula, Suryanaryana Murty; Mutheneni, Srinivasa Rao; Kadiri, Madhusudhan Rao; Kumaraswamy, Sriram; Nagalla, Balakrishna			A Cohort Study of Lymphatic Filariasis on Socio Economic Conditions in Andhra Pradesh, India	PLOS ONE			English	Article							PERSONAL-PROTECTION MEASURES; PREVALENCE; MICROFILAREMIA; PROGRAM; REGION; HEALTH; COSTS	Background: To assess the impact of socioeconomic variables on lymphatic filariasis in endemic villages of Karimnagar district, Andhra Pradesh, India. Methods: A pilot scale study was conducted in 30 villages of Karimnagar district from 2004 to 2007. These villages were selected based on previous reports from department of health, Government of Andhra Pradesh, epidemiology, entomology and socioeconomic survey was conducted as per protocol. Collected data were analysed statistically by Chi square test, Principal Component Analysis, Odds ratio, Bivariate, multivariate logistic regression analysis. Results: Total of 5,394 blood samples collected and screened for microfilaria, out of which 199 were found to be positive (3.7%). The socioeconomic data of these respondents/participants were correlated with MF prevalence. The socioeconomic variables like educational status (Odds Ratio (OR) = 2.6, 95% Confidence Interval (CI) = 1.1-6.5), house structure (hut OR = 1.9, 95% CI = 1.2-3.1; tiled OR = 1.3, 95% CI = 0.8-2) and participation in mass drug administration program (OR = 1.8, 95% CI = 1.3-2.6) were found to be highly associated with the occurrence of filarial disease. The socioeconomic index was categorized into low (3.6%; OR-1.1, 95% CI: 0.7-1.5) medium (4.9%; OR-1.5, 95% CI = 1-2.1) and high (3.3%) in relation to percentage of filarial parasite prevalence. A significant difference was observed among these three groups while comparing the number of cases of filaria with the type of socioeconomic conditions of the respondents (P = 0.067). Conclusions: From this study it is inferred that age, education of family, type of house structure and awareness about the filarial disease directly influenced the disease prevalence. Beside annual mass drug administration program, such type of analysis should be undertaken by health officials to target a few socioeconomic factors to reduce the disease burden. Health education campaigns in the endemic villages and imparting of protection measures against mosquitoes using insecticide treated bed nets would substantially reduce the disease in these villages.	[Upadhyayula, Suryanaryana Murty; Mutheneni, Srinivasa Rao; Kadiri, Madhusudhan Rao; Kumaraswamy, Sriram] Indian Inst Chem Technol CSIR, Div Biol, Bioinformat Grp, Hyderabad, Andhra Pradesh, India; [Nagalla, Balakrishna] Natl Inst Nutr ICMR, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Upadhyayula, SM (corresponding author), Indian Inst Chem Technol CSIR, Div Biol, Bioinformat Grp, Hyderabad, Andhra Pradesh, India.	murty_usn@yahoo.com	Mutheneni, Srinivasa Rao/AAI-2262-2020; Nagalla, Balakrishna/GRR-4393-2022	Nagalla, Balakrishna/0000-0002-5613-0942; Mutheneni, Srinivasa Rao/0000-0003-3263-3905	Ministry of Communication and Information Technology (MC&IT), Govt. of India; Indian Institute of Chemical Technology (IICT)	Ministry of Communication and Information Technology (MC&IT), Govt. of India; Indian Institute of Chemical Technology (IICT)(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful to Ministry of Communication and Information Technology (MC&IT), Govt. of India for sponsoring the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the director of the Indian Institute of Chemical Technology (IICT) for his encouragement and support.	Albuquerque M.D.F.P., 1993, CAD SA DE P BLICA, V9, P487, DOI DOI 10.1590/S0102-311X1993000400009; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P221; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P333; [Anonymous], 1992, World Health Organ Tech Rep Ser, V821, P1; Baruah K, 2000, JPN J INFECT DIS, V53, P107; Braga C, 2001, Cad Saude Publica, V17, P1211, DOI 10.1590/S0102-311X2001000500021; CARME B, 1979, T ROY SOC TROP MED H, V73, P424, DOI 10.1016/0035-9203(79)90168-8; Chadee DD, 2002, ANN TROP MED PARASIT, V96, pS47, DOI 10.1179/000349802125002365; De Albuquerque Mde F, 1995, REV INST MED TROP SP, V37, P224; Durrheim DN, 2004, TROP MED INT HEALTH, V9, P843, DOI 10.1111/j.1365-3156.2004.01287.x; Erlanger TE, 2005, AM J TROP MED HYG, V73, P523, DOI 10.4269/ajtmh.2005.73.523; Galvez Tan Jaime Z, 2003, Filaria J, V2, P12; Gbakima AA, 2005, TROP MED INT HEALTH, V10, P387, DOI 10.1111/j.1365-3156.2005.01389.x; *ICMR, 2001, ICMR B, V31; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kumar KNV, 2008, ANN TROP MED PARASIT, V102, P391, DOI 10.1179/136485908X278892; Lee SYD, 2004, SOC SCI MED, V58, P1309, DOI 10.1016/S0277-9536(03)00329-0; Lu AG, 1988, SOCIAL EC RES PROJEC; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Molyneux David, 2003, Filaria J, V2, P13, DOI 10.1186/1475-2883-2-13; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Muhondwa EPY, 1983, 4WP8313 TDRSERSWG WH; Murty U. Suryanarayana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P583; Mwobobia IK, 1999, E AFR MED J, V76, P495; Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x; Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Perera M, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000128; Ramaiah KD, 2009, TRENDS PARASITOL, V25, P7, DOI 10.1016/j.pt.2008.10.001; Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4; Ramaiah KD, 1998, TROP MED INT HEALTH, V3, P108, DOI 10.1046/j.1365-3156.1998.00208.x; Rauyajin O, 1995, SOC SCI MED, V41, P1705, DOI 10.1016/0277-9536(95)00132-Q; RIJI H B M, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P457; Sabesan Shanmugavelu, 2006, Filaria J, V5, P12, DOI 10.1186/1475-2883-5-12; Seim A R, 1999, Rev Soc Bras Med Trop, V32, P325, DOI 10.1590/S0037-86821999000300022; Snehalatha KS, 2003, ACTA TROP, V88, P3, DOI 10.1016/S0001-706X(03)00155-4; Stolk WA, 2004, PARASITOLOGY, V129, P605, DOI 10.1017/S0031182004005980; Streit T, 2008, ANN NY ACAD SCI, V1136, P53, DOI 10.1196/annals.1425.036; Testi A, 2009, EUR J HEALTH ECON, V10, P323, DOI 10.1007/s10198-008-0136-z; Upadhayula SM, 2010, ASIAN PAC J TROP MED, V3, P647, DOI 10.1016/S1995-7645(10)60156-3; Uttah EC, 2011, J VECTOR DIS, V48, P78; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; *WHO, 1999, BUILD PARTN LYMPH FI; *WHO, 2000, P 1 M GLOB ALL EL LY	44	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33779	10.1371/journal.pone.0033779	http://dx.doi.org/10.1371/journal.pone.0033779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939TA	22442721	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500062
J	Gilbert, C; McCafferty, DJ; Giroud, S; Ancel, A; Blanc, S				Gilbert, Caroline; McCafferty, Dominic J.; Giroud, Sylvain; Ancel, Andre; Blanc, Stephane			Private Heat for Public Warmth: How Huddling Shapes Individual Thermogenic Responses of Rabbit Pups	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; SYRIAN GOLDEN-HAMSTERS; INFANT NORWAY RATS; NEWBORN DOMESTIC RABBITS; NEW-BORN RABBITS; INFRARED THERMOGRAPHY; LITTER HUDDLE; NONSHIVERING THERMOGENESIS; ULTRASONIC VOCALIZATION; ENERGETIC BENEFITS	Background: Within their litter, young altricial mammals compete for energy (constraining growth and survival) but cooperate for warmth. The aim of this study was to examine the mechanisms by which huddling in altricial infants influences individual heat production and loss, while providing public warmth. Although considered as a textbook example, it is surprising to note that physiological mechanisms underlying huddling are still not fully characterised. Methodology/Principal Findings: The brown adipose tissue (BAT) contribution to energy output was assessed as a function of the ability of rabbit (Oryctolagus cuniculus) pups to huddle (placed in groups of 6 and 2, or isolated) and of their thermoregulatory capacities (non-insulated before 5 days old and insulated at ca. 10 days old). BAT contribution of pups exposed to cold was examined by combining techniques of infrared thermography (surface temperature), indirect calorimetry (total energy expenditure, TEE) and telemetry (body temperature). Through local heating, the huddle provided each pup whatever their age with an ambient "public warmth" in the cold, which particularly benefited non-insulated pups. Huddling allowed pups facing a progressive cold challenge to buffer the decreasing ambient temperature by delaying the activation of their thermogenic response, especially when fur-insulated. In this way, huddling permitted pups to effectively shift from a non-insulated to a pseudo-insulated thermal state while continuously allocating energy to growth. The high correlation between TEE and the difference in surface temperatures between BAT and back areas of the body reveals that energy loss for non-shivering thermogenesis is the major factor constraining the amount of energy allocated to growth in non-insulated altricial pups. Conclusions/Significance: By providing public warmth with minimal individual costs at a stage of life when pups are the most vulnerable, huddling buffers cold challenges and ensures a constant allocation of energy to growth by reducing BAT activation.	[Gilbert, Caroline] Univ Paris Est, Ecole Natl Vet Alfort, UMR 7179, CNRS,MNHN, Maisons Alfort, France; [McCafferty, Dominic J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Giroud, Sylvain] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria; [Ancel, Andre; Blanc, Stephane] Univ Strasbourg, IPHC, Strasbourg, France; [Ancel, Andre; Blanc, Stephane] CNRS, UMR 7178, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ecole Nationale Veterinaire d'Alfort (ENVA); Museum National d'Histoire Naturelle (MNHN); University of Glasgow; University of Veterinary Medicine Vienna; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gilbert, C (corresponding author), Univ Paris Est, Ecole Natl Vet Alfort, UMR 7179, CNRS,MNHN, Maisons Alfort, France.	cgilbert@vet-alfort.fr	Giroud, Sylvain/AAG-6430-2019	Giroud, Sylvain/0000-0001-6621-7462; McCafferty, Dominic/0000-0002-3079-3326; Gilbert, Caroline/0000-0002-9957-405X	Centre National de la Recherche Scientifique (CNRS), France; BDI-CNRS	Centre National de la Recherche Scientifique (CNRS), France(Centre National de la Recherche Scientifique (CNRS)); BDI-CNRS	This research was funded by the Centre National de la Recherche Scientifique (CNRS), France, http://www.cnrs.fr/. CG was supported by a BDI-CNRS fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS JR, 1978, J COMP PHYSIOL PSYCH, V92, P231, DOI 10.1037/h0077459; Bautista A, 2005, ANIM BEHAV, V70, P1011, DOI 10.1016/j.anbehav.2005.01.015; Bautista A, 2003, DEV PSYCHOBIOL, V43, P208, DOI 10.1002/dev.10134; Bautista A, 2008, BEHAV ECOL SOCIOBIOL, V62, P331, DOI 10.1007/s00265-007-0420-4; Bautista A, 2010, DEV PSYCHOBIOL, V52, P35, DOI 10.1002/dev.20409; BERNARD E, 1964, BIOL NEONATORUM, V7, P172; BLUMBERG MS, 1992, DEV PSYCHOBIOL, V25, P497, DOI 10.1002/dev.420250704; Blumberg MS, 1996, BEHAV NEUROSCI, V110, P305, DOI 10.1037/0735-7044.110.2.305; Blumberg MS, 1998, DEV PSYCHOBIOL, V33, P107, DOI 10.1002/(SICI)1098-2302(199809)33:2<107::AID-DEV2>3.0.CO;2-N; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CANNON B, 1986, BIOCHEM SOC T, V14, P233, DOI 10.1042/bst0140233; Coureaud G, 2000, REPROD NUTR DEV, V40, P19, DOI 10.1051/rnd:2000117; DAWKINS MJR, 1964, J PHYSIOL-LONDON, V172, P216, DOI 10.1113/jphysiol.1964.sp007414; Drummond H, 2000, ETHOLOGY, V106, P511, DOI 10.1046/j.1439-0310.2000.00554.x; Gilbert C, 2007, AM J PHYSIOL-REG I, V293, pR867, DOI 10.1152/ajpregu.00081.2007; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Haig D, 2008, CURR BIOL, V18, pR172, DOI 10.1016/j.cub.2007.12.040; HAMMEL HT, 1955, AM J PHYSIOL, V182, P369, DOI 10.1152/ajplegacy.1955.182.2.369; HAYES JP, 1992, PHYSIOL ZOOL, V65, P742, DOI 10.1086/physzool.65.4.30158537; HEIM T, 1966, J PHYSIOL-LONDON, V186, P42, DOI 10.1113/jphysiol.1966.sp008019; HUDSON R, 1982, BEHAVIOUR, V79, P255, DOI 10.1163/156853982X00292; Hudson R, 2008, BEHAV ECOL SOCIOBIOL, V62, P299, DOI 10.1007/s00265-007-0417-z; Hudson R, 2011, DEV PSYCHOBIOL, V53, P564, DOI 10.1002/dev.20535; HULL D, 1965, J PHYSIOL-LONDON, V181, P449, DOI 10.1113/jphysiol.1965.sp007773; Jackson DM, 2001, J THERM BIOL, V26, P85, DOI 10.1016/S0306-4565(00)00023-1; JANSKY L, 1973, BIOL REV, V48, P85; Jilge B, 2000, J BIOL RHYTHM, V15, P329, DOI 10.1177/074873000129001431; Jilge B, 2001, LAB ANIM-UK, V35, P364, DOI 10.1258/0023677011911831; LINCOLN DW, 1974, PHYSIOL BEHAV, V13, P711, DOI 10.1016/0031-9384(74)90247-9; McCafferty DJ, 2011, COMP BIOCHEM PHYS A, V158, P337, DOI 10.1016/j.cbpa.2010.09.012; Mccafferty DJ, 2007, MAMMAL REV, V37, P207, DOI 10.1111/j.1365-2907.2007.00111.x; Mock D. W., 1997, EVOLUTION SIBLING RI; MOHLER FS, 1988, AM J PHYSIOL, V254, pR389, DOI 10.1152/ajpregu.1988.254.2.R389; Mucino E, 2009, DEV PSYCHOBIOL, V51, P24, DOI 10.1002/dev.20339; Nedergaard J, 2001, BIOCHEM SOC T, V29, P756; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Oya A, 1997, J PERINAT MED, V25, P447, DOI 10.1515/jpme.1997.25.5.447; Reyes-Meza V, 2011, PHYSIOL BEHAV, V104, P778, DOI 10.1016/j.physbeh.2011.07.019; Rodel HG, 2008, OECOLOGIA, V155, P677, DOI 10.1007/s00442-008-0958-5; Rodel HG, 2008, PHYSIOL BEHAV, V95, P441, DOI 10.1016/j.physbeh.2008.07.011; Rodel HG, 2008, PHYSIOL BEHAV, V93, P826, DOI 10.1016/j.physbeh.2007.11.047; Rodel HG, 2009, PHYSIOL BEHAV, V97, P495, DOI 10.1016/j.physbeh.2009.04.005; SCHMIDTNIELSEN K, 1997, ANIMAL PHYSL ADAPTAT, P241; Sokoloff G, 2000, BEHAV NEUROSCI, V114, P585; Sokoloff G, 2002, J COMP PSYCHOL, V116, P240, DOI 10.1037/0735-7036.116.3.240; Sokoloff G, 2002, J COMP PSYCHOL, V116, P228, DOI 10.1037//0735-7036.116.3.228; Sokoloff G, 2001, DEV PSYCHOBIOL, V39, P65, DOI 10.1002/dev.1030; Speakman JR, 1998, ZOOL-ANAL COMPLEX SY, V101, P224; STANIER MW, 1975, COMP BIOCHEM PHYS A, V51, P79, DOI 10.1016/0300-9629(75)90416-8; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; ZARROW MX, 1965, SCIENCE, V150, P1835, DOI 10.1126/science.150.3705.1835	52	29	29	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33553	10.1371/journal.pone.0033553	http://dx.doi.org/10.1371/journal.pone.0033553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438947	Green Published, Green Accepted, gold			2022-12-27	WOS:000303309100056
J	Huang, KH; Kuo, KL; Chen, SC; Weng, TI; Chuang, YT; Tsai, YC; Pu, YS; Chiang, CK; Liu, SH				Huang, Kuo-How; Kuo, Kuan-Lin; Chen, Shyh-Chyan; Weng, Te-I; Chuang, Yuan-Ting; Tsai, Yu-Chieh; Pu, Yeong-Shiau; Chiang, Chih-Kang; Liu, Shing-Hwa			Down-Regulation of Glucose-Regulated Protein (GRP) 78 Potentiates Cytotoxic Effect of Celecoxib in Human Urothelial Carcinoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; URINARY-BLADDER CANCER; NON-COXIB ANALOG; IN-VITRO; INDUCED APOPTOSIS; CYCLOOXYGENASE-2 INHIBITORS; COMBINATION; DEATH; VIVO; METHOTREXATE	Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that has been reported to elicit anti-proliferative response in various tumors. In this study, we aim to investigate the antitumor effect of celecoxib on urothelial carcinoma (UC) cells and the role endoplasmic reticulum (ER) stress plays in celecoxib-induced cytotoxicity. The cytotoxic effects were measured by MTT assay and flow cytometry. The cell cycle progression and ER stress-associated molecules were examined by Western blot and flow cytometry. Moreover, the cytotoxic effects of celecoxib combined with glucose-regulated protein (GRP) 78 knockdown (siRNA), (-)-epigallocatechin gallate (EGCG) or MG132 were assessed. We demonstrated that celecoxib markedly reduces the cell viability and causes apoptosis in human UC cells through cell cycle G1 arrest. Celecoxib possessed the ability to activate ER stress-related chaperones (IRE-1 alpha and GRP78), caspase-4, and CCAAT/enhancer binding protein homologous protein (CHOP), which were involved in UC cell apoptosis. Down-regulation of GRP78 by siRNA, co-treatment with EGCG (a GRP78 inhibitor) or with MG132 (a proteasome inhibitor) could enhance celecoxib-induced apoptosis. We concluded that celecoxib induces cell cycle G1 arrest, ER stress, and eventually apoptosis in human UC cells. The down-regulation of ER chaperone GRP78 by siRNA, EGCG, or proteosome inhibitor potentiated the cytotoxicity of celecoxib in UC cells. These findings provide a new treatment strategy against UC.	[Huang, Kuo-How; Chiang, Chih-Kang; Liu, Shing-Hwa] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Huang, Kuo-How; Kuo, Kuan-Lin; Chen, Shyh-Chyan; Weng, Te-I; Chuang, Yuan-Ting; Tsai, Yu-Chieh; Pu, Yeong-Shiau; Chiang, Chih-Kang; Liu, Shing-Hwa] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Huang, Kuo-How; Kuo, Kuan-Lin; Chen, Shyh-Chyan; Chuang, Yuan-Ting; Pu, Yeong-Shiau; Liu, Shing-Hwa] Natl Taiwan Univ, Coll Med, Dept Urol, Taipei 10764, Taiwan; [Weng, Te-I] Natl Taiwan Univ, Coll Med, Dept Forens Med, Taipei 10764, Taiwan; [Tsai, Yu-Chieh] Natl Taiwan Univ, Coll Med, Dept Oncol, Taipei 10764, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ, Coll Med, Dept Integrated Diagnost & Therapeut, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Huang, KH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan.	kuohowhuang@gmail.com; shinghwaliu@ntu.edu.tw		Weng, Te-I/0000-0002-8797-1672; Huang, Kuo-How/0000-0002-0989-0578; Kuo, Kuan-Lin/0000-0001-7204-3032; PU, YEONG-SHIAU/0000-0002-2859-3966; TSAI, YU-CHIEH/0000-0002-9285-7655; CHIANG, CHIH-KANG/0000-0001-9021-4616; LIU, SHING-HWA/0000-0002-9976-1197	Taiwan National Science Council [NSC 98-2314-B-002-056]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from Taiwan National Science Council (NSC 98-2314-B-002-056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhim Z, 2011, BRIT J CANCER, V105, P393, DOI 10.1038/bjc.2011.262; Chen ST, 2010, LEUKEMIA RES, V34, P250, DOI 10.1016/j.leukres.2009.09.028; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; Cusimano A, 2010, CELL CYCLE, V9, P1399, DOI 10.4161/cc.9.7.11254; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Dhawan D, 2008, MOL CANCER THER, V7, P897, DOI 10.1158/1535-7163.MCT-07-0313; Dhawan D, 2010, MOL CANCER THER, V9, P1371, DOI 10.1158/1535-7163.MCT-10-0049; Dovedi SJ, 2008, EUR UROL, V54, P621, DOI 10.1016/j.eururo.2008.01.013; Egger L, 2007, CELL DEATH DIFFER, V14, P1172, DOI 10.1038/sj.cdd.4402125; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Ferrandina G, 2003, CLIN CANCER RES, V9, P4324; Gee J, 2006, ONCOL REP, V15, P471; Gee JR, 2009, ANTICANCER RES, V29, P3769; HARKER WG, 1985, J CLIN ONCOL, V3, P1463, DOI 10.1200/JCO.1985.3.11.1463; Hour TC, 2004, ANTI-CANCER DRUG, V15, P779, DOI 10.1097/00001813-200409000-00007; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jendrossek V, 2003, FASEB J, V17, P1547, DOI 10.1096/fj.02-0947fje; Kardosh A, 2008, CANCER RES, V68, P843, DOI 10.1158/0008-5472.CAN-07-5555; Kulkarni P, 2011, J CELL BIOCHEM, V112, P1949, DOI 10.1002/jcb.23115; Kulp SK, 2004, CANCER RES, V64, P1444, DOI 10.1158/0008-5472.CAN-03-2396; Latini DM, 2010, UROLOGY, V75, P334, DOI 10.1016/j.urology.2009.09.051; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Leese PT, 2000, J CLIN PHARMACOL, V40, P124, DOI 10.1177/00912700022008766; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Mohammed SI, 2006, MOL CANCER THER, V5, P329, DOI 10.1158/1535-7163.MCT-05-0117; Mohammed SI, 2002, CANCER RES, V62, P356; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; Qin J, 2009, BIOMED PHARMACOTHER, V63, P241, DOI 10.1016/j.biopha.2008.04.007; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schonthal AH, 2009, CANCER LETT, V275, P163, DOI 10.1016/j.canlet.2008.07.005; STERNBERG CN, 1989, CANCER, V64, P2448, DOI 10.1002/1097-0142(19891215)64:12<2448::AID-CNCR2820641209>3.0.CO;2-7; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Williams CS, 2000, CANCER RES, V60, P6045; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yu Hong-Jeng, 1992, Journal of the Formosan Medical Association, V91, P608	42	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33615	10.1371/journal.pone.0033615	http://dx.doi.org/10.1371/journal.pone.0033615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438966	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100072
J	Kufoy, E; Palma, JA; Lopez, J; Alegre, M; Urrestarazu, E; Artieda, J; Iriarte, J				Kufoy, Ernesto; Palma, Jose-Alberto; Lopez, Jon; Alegre, Manuel; Urrestarazu, Elena; Artieda, Julio; Iriarte, Jorge			Changes in the Heart Rate Variability in Patients with Obstructive Sleep Apnea and Its Response to Acute CPAP Treatment	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; AUTONOMIC FUNCTION; SPECTRAL-ANALYSIS; RISK-FACTORS; SEVERITY; GENDER; EEG; MEN; ASSOCIATION; DYNAMICS	Introduction: Obstructive Sleep Apnea (OSA) is a major risk factor for cardiovascular disease. The goal of this study was to demonstrate whether the use of CPAP produces significant changes in the heart rate or in the heart rate variability of patients with OSA in the first night of treatment and whether gender and obesity play a role in these differences. Methods: Single-center transversal study including patients with severe OSA corrected with CPAP. Only patients with total correction after CPAP were included. Patients underwent two sleep studies on consecutive nights: the first night a basal study, and the second with CPAP. We also analyzed the heart rate changes and their relationship with CPAP treatment, sleep stages, sex and body mass index. Twenty-minute segments of the ECG were selected from the sleep periods of REM, no-REM and awake. Heart rate (HR) and heart rate variability (HRV) were studied by comparing the R-R interval in the different conditions. We also compared samples from the basal study and CPAP nights. Results: 39 patients (15 females, 24 males) were studied. The mean age was 50.67 years old, the mean AHI was 48.54, and mean body mass index was 33.41 kg/m(2) (31.83 males, 35.95 females). Our results showed that HRV (SDNN) decreased after the use of CPAP during the first night of treatment, especially in non-REM sleep. Gender and obesity did not have any influence on our results. Conclusions: These findings support that cardiac variability improves as an acute effect, independently of gender or weight, in the first night of CPAP use in severe OSA patients, supporting the idea of continuous use and emphasizing that noncompliance of CPAP treatment should be avoided even if it is just once.	[Kufoy, Ernesto; Palma, Jose-Alberto; Alegre, Manuel; Urrestarazu, Elena; Artieda, Julio; Iriarte, Jorge] Univ Navarra Clin, Clin Neurophysiol Serv, Pamplona, Spain; [Palma, Jose-Alberto] Univ Navarra Clin, Dept Neurol, Pamplona, Spain; [Lopez, Jon; Alegre, Manuel; Urrestarazu, Elena; Artieda, Julio] Univ Navarra, Neurophysiol Lab, Neurosci Area, CIMA, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra	Kufoy, E (corresponding author), Univ Navarra Clin, Clin Neurophysiol Serv, Pamplona, Spain.	jiriarte@unav.es	Palma, Jose-Alberto/H-7986-2019; URRESTARAZU, ELENAE/E-8640-2018; Artieda, Julio/L-4704-2014; Alegre, Manuel/F-5379-2011	Palma, Jose-Alberto/0000-0002-1345-6774; Artieda, Julio/0000-0003-0987-0873; Alegre, Manuel/0000-0003-4985-9724				*AASM, 2005, INT CLASS SLEEP DIS; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Antczak J, 2008, J PHYSIOL PHARMACOL, V59, P123; Aydin M, 2004, TEX HEART I J, V31, P132; Aytemir K, 2007, RESP MED, V101, P1277, DOI 10.1016/j.rmed.2006.10.016; Bakker JP, 2011, SLEEP BREATH, V15, P325, DOI 10.1007/s11325-010-0385-9; Baumert M, 2008, SLEEP, V31, P959; Belozeroff V, 2003, SLEEP, V26, P65, DOI 10.1093/sleep/26.1.65; Burgess HJ, 1997, AM J PHYSIOL-HEART C, V273, pH1761, DOI 10.1152/ajpheart.1997.273.4.H1761; Burgess HJ, 1999, J SLEEP RES, V8, P113, DOI 10.1046/j.1365-2869.1999.00149.x; Burr RL, 2007, SLEEP, V30, P913, DOI 10.1093/sleep/30.7.913; Chrysostomakis Stavros I, 2006, Hellenic J Cardiol, V47, P13; Chung MH, 2009, SCAND J WORK ENV HEA, V35, P180, DOI 10.5271/sjweh.1324; Cifci N, 2010, SLEEP BREATH, V14, P241, DOI 10.1007/s11325-009-0306-y; Dumont M, 2007, CLIN NEUROPHYSIOL, V118, P2752, DOI 10.1016/j.clinph.2007.08.018; Dursunoglu D, 2006, TUBERK TORAK, V54, P382; Dursunoglu D, 2007, SLEEP MED, V8, P478, DOI 10.1016/j.sleep.2006.08.002; Dursunoglu N, 2005, RESPIRATION, V72, P150, DOI 10.1159/000084045; Ferland A, 2009, EUR RESPIR J, V34, P694, DOI 10.1183/09031936.00167308; Frazier S K, 2001, Biol Res Nurs, V2, P167, DOI 10.1177/109980040100200302; Gates Gregory J, 2005, BMC Pulm Med, V5, P9, DOI 10.1186/1471-2466-5-9; Gilman MR, 2008, CLIN SCI, V114, P243, DOI 10.1042/CS20070172; Guilleminault C, 2005, SLEEP MED, V6, P451, DOI 10.1016/j.sleep.2005.03.014; Halasz P, 2004, J SLEEP RES, V13, P1, DOI 10.1111/j.1365-2869.2004.00388.x; HOFFSTEIN V, 1994, AM J RESP CRIT CARE, V150, P486, DOI 10.1164/ajrccm.150.2.8049834; Jo JA, 2007, ANN BIOMED ENG, V35, P1425, DOI 10.1007/s10439-007-9299-5; Jurysta F, 2003, CLIN NEUROPHYSIOL, V114, P2146, DOI 10.1016/S1388-2457(03)00215-3; Kandel E., 2000, PRINCIPLES NEURAL SC; Kasai T, 2008, CHEST, V133, P690, DOI 10.1378/chest.07-1901; Kesek M, 2009, CLIN PHYSIOL FUNCT I, V29, P309, DOI 10.1111/j.1475-097X.2009.00873.x; Limphanudom Pimporn, 2007, Journal of the Medical Association of Thailand, V90, P1530; Lin CM, 2008, SLEEP MED REV, V12, P481, DOI 10.1016/j.smrv.2007.11.003; MAYER J, 1991, CARDIOLOGY, V79, P84, DOI 10.1159/000174864; Pack AI, 2009, PROG CARDIOVASC DIS, V51, P434, DOI 10.1016/j.pcad.2009.01.002; Park DH, 2008, J KOREAN MED SCI, V23, P226, DOI 10.3346/jkms.2008.23.2.226; Patruno V, 2007, CHEST, V131, P1393, DOI 10.1378/chest.06-2192; Penzel T, 2003, NEUROPSYCHOPHARMACOL, V28, pS48, DOI 10.1038/sj.npp.1300146; Penzel T, 2003, EUR RESPIR J, V22, P870, DOI 10.1183/09031936.03.00102003; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Reynolds EB, 2007, SLEEP BREATH, V11, P53, DOI 10.1007/s11325-006-0083-9; Roche F, 2007, EUR RESPIR J, V29, P1206, DOI 10.1183/09031936.00042606; Roche F, 2003, PACE, V26, P669, DOI 10.1046/j.1460-9592.2003.00116.x; Silva A, 2008, BRAZ J MED BIOL RES, V41, P1067, DOI 10.1590/S0100-879X2008001200005; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101, DOI 10.1164/ajrccm.160.4.9903020; Smith R P, 1998, Sleep Med Rev, V2, P69, DOI 10.1016/S1087-0792(98)90001-6; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; Sorajja D, 2008, CHEST, V133, P927, DOI 10.1378/chest.07-2544; Sztajzel J, 2008, ANN NONINVAS ELECTRO, V13, P270, DOI 10.1111/j.1542-474X.2008.00231.x; Tabata R, 2008, AURIS NASUS LARYNX, V35, P242, DOI 10.1016/j.anl.2007.11.001; Wang W, 2008, J SLEEP RES, V17, P251, DOI 10.1111/j.1365-2869.2008.00652.x; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Ye LC, 2009, SLEEP MED, V10, P1075, DOI 10.1016/j.sleep.2009.02.006	52	60	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33769	10.1371/journal.pone.0033769	http://dx.doi.org/10.1371/journal.pone.0033769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438995	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100097
J	Li, CY; Song, YY; Luan, SH; Wan, PX; Li, NY; Tang, J; Han, Y; Xiong, CJ; Wang, ZC				Li, Chaoyang; Song, Yiyue; Luan, Shaohong; Wan, Pengxia; Li, Naiyang; Tang, Jing; Han, Yu; Xiong, Cuiju; Wang, Zhichong			Research on the Stability of a Rabbit Dry Eye Model Induced by Topical Application of the Preservative Benzalkonium Chloride	PLOS ONE			English	Article							OCULAR SURFACE; MOUSE MODEL; EPITHELIAL PROLIFERATION; INFLAMMATORY MARKERS; PREVALENCE; TIMOLOL; CELLS; VIVO	Background: Dry eye is a common disease worldwide, and animal models are critical for the study of it. At present, there is no research about the stability of the extant animal models, which may have negative implications for previous dry eye studies. In this study, we observed the stability of a rabbit dry eye model induced by the topical benzalkonium chloride (BAC) and determined the valid time of this model. Methods and Findings: Eighty white rabbits were randomly divided into four groups. One eye from each rabbit was randomly chosen to receive topical 0.1% BAC twice daily for 2 weeks (Group BAC-W2), 3 weeks (Group BAC-W3), 4 weeks (Group BAC-W4), or 5 weeks (Group BAC-W5). Fluorescein staining, Schirmer's tests, and conjunctival impression cytology were performed before BAC treatment (normal) and on days 0, 7, 14 and 21 after BAC removal. The eyeballs were collected at these time points for immunofluorescence staining, hematoxylin and eosin (HE) staining, and electron microscopy. After removing BAC, the signs of dry eye in Group BAC-W2 lasted one week. Compared with normal, there were still significant differences in the results of Schirmer's tests and fluorescein staining in Groups BAC-W3 and BAC-W4 on day 7 (P<0.05) and in Group BAC-W5 on day 14 (P<0.05). Decreases in goblet cell density remained stable in the three experimental groups at all time points (P<0.001). Decreased levels of mucin-5 subtype AC (MUC5AC), along with histopathological and ultrastructural disorders of the cornea and conjunctiva could be observed in Group BAC-W4 and particularly in Group BACW5 until day 21. Conclusions: A stable rabbit dry eye model was induced by topical 0.1% BAC for 5 weeks, and after BAC removal, the signs of dry eye were sustained for 2 weeks (for the mixed type of dry eye) or for at least 3 weeks (for mucin-deficient dry eye).	[Li, Chaoyang; Luan, Shaohong; Wan, Pengxia; Li, Naiyang; Xiong, Cuiju; Wang, Zhichong] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Jing; Han, Yu] Peoples Hosp Leshan, Dept Ophthalmol, Leshan, Peoples R China	Sun Yat Sen University	Li, CY (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	wzc001@hotmail.com	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210	National Natural Science Foundation of China [30973246]; Science and Technology Planning Project of Guangdong Province, China [2009A030200004]; Medical Science Foundation of Guangdong Province, China [B2011106]; National Science Foundation of Guangdong Province, China [S2011040004327]; state key lab.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Medical Science Foundation of Guangdong Province, China; National Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); state key lab.	This study was supported by the National Natural Science Foundation of China Grant No. 30973246 (W.Z.C.) (http://www.nsfc.gov.cn), the Science and Technology Planning Project of Guangdong Province, China, No. 2009A030200004 (W.Z.C.) (http://www.gdstc.gov.cn), the Medical Science Foundation of Guangdong Province, China, No. B2011106 (W.Z.C.) (http://www.gdwst.gov.cn), the Doctor Initiating Project of the National Science Foundation of Guangdong Province, China, No. S2011040004327 (W.Z.C.), and grant from the fundamental research funds of state key lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manscript.	Barabino S, 2005, INVEST OPHTH VIS SCI, V46, P2766, DOI 10.1167/iovs.04-1326; Barabino S, 2007, EXP EYE RES, V84, P973, DOI 10.1016/j.exer.2007.02.003; Baudouin C, 1997, INVEST OPHTH VIS SCI, V38, P1458; Baudouin C, 2004, OPHTHALMOLOGY, V111, P2186, DOI 10.1016/j.ophtha.2004.06.023; BAUDOUIN C, 1992, BRIT J OPHTHALMOL, V76, P545, DOI 10.1136/bjo.76.9.545; Baudouin C, 2008, OPHTHALMOLOGY, V115, P109, DOI 10.1016/j.ophtha.2007.01.036; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Becquet F, 1998, CURR EYE RES, V17, P419, DOI 10.1080/02713689808951223; Chen W, 2008, INVEST OPHTH VIS SCI, V49, P1386, DOI 10.1167/iovs.07-0744; Chen W, 2009, EXP EYE RES, V89, P311, DOI 10.1016/j.exer.2009.03.015; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Fabiani C, 2009, EXP EYE RES, V89, P166, DOI 10.1016/j.exer.2009.03.003; FUJIHARA T, 1995, J OCUL PHARMACOL TH, V11, P503, DOI 10.1089/jop.1995.11.503; GILBARD JP, 1988, INVEST OPHTH VIS SCI, V29, P374; GREEN K, 1987, J TOXICOL-CUTAN OCUL, V6, P89, DOI 10.3109/15569528709052168; HIKICHI T, 1995, GRAEF ARCH CLIN EXP, V233, P555, DOI 10.1007/BF00404705; Ishibashi T, 2003, J GLAUCOMA, V12, P486, DOI 10.1097/00061198-200312000-00008; Jean MD, 1999, INVEST OPHTH VIS SCI, V40, P619; KASWAN RL, 1989, ARCH OPHTHALMOL-CHIC, V107, P1210, DOI 10.1001/archopht.1989.01070020276038; Kunert KS, 2002, ARCH OPHTHALMOL-CHIC, V120, P330; Lemp Michael A., 1995, CLAO Journal, V21, P221; Lemp MA, 2007, OCUL SURF, V5, P75; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Maitchouk DY, 2000, ARCH OPHTHALMOL-CHIC, V118, P246; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Pisella PJ, 2004, INVEST OPHTH VIS SCI, V45, P1360, DOI 10.1167/iovs.03-1067; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Spurr-Michaud S, 2007, EXP EYE RES, V84, P939, DOI 10.1016/j.exer.2007.01.018; Steuhl K P, 1991, Fortschr Ophthalmol, V88, P865; Stewart Paul, 2005, Eye Contact Lens, V31, P175, DOI 10.1097/01.ICL.0000161705.19602.C9; SULLIVAN DA, 1986, EXP EYE RES, V42, P131, DOI 10.1016/0014-4835(86)90037-0; SULLIVAN DA, 1984, IMMUNOLOGY, V52, P234; Susi B, 1999, OPHTHALMIC RES, V31, P229; Uematsu M, 2007, OPHTHAL RES, V39, P308, DOI 10.1159/000109986; Watanabe Hitoshi, 2002, Cornea, V21, pS17, DOI 10.1097/00003226-200203001-00005; Wilson G, 1995, J Am Optom Assoc, V66, P435; Xiong C, 2008, INVEST OPHTH VIS SCI, V49, P1850, DOI 10.1167/iovs.07-0720; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581	39	47	52	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33688	10.1371/journal.pone.0033688	http://dx.doi.org/10.1371/journal.pone.0033688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438984	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100088
J	Martina, MA; Correa, EME; Argarana, CE; Barra, JL				Martina, Mariana A.; Correa, Elisa M. E.; Argarana, Carlos E.; Barra, Jose L.			Escherichia coli Frameshift Mutation Rate Depends on the Chromosomal Context but Not on the GATC Content Near the Mutation Site	PLOS ONE			English	Article							UV-INDUCED MUTAGENESIS; DNA MISMATCH REPAIR; D(GATC) SEQUENCES; LOCATION; REPLICATION; ASYMMETRY; TRACTS; GENE	Different studies have suggested that mutation rate varies at different positions in the genome. In this work we analyzed if the chromosomal context and/or the presence of GATC sites can affect the frameshift mutation rate in the Escherichia coli genome. We show that in a mismatch repair deficient background, a condition where the mutation rate reflects the fidelity of the DNA polymerization process, the frameshift mutation rate could vary up to four times among different chromosomal contexts. Furthermore, the mismatch repair efficiency could vary up to eight times when compared at different chromosomal locations, indicating that detection and/or repair of frameshift events also depends on the chromosomal context. Also, GATC sequences have been proved to be essential for the correct functioning of the E. coli mismatch repair system. Using bacteriophage heteroduplexes molecules it has been shown that GATC influence the mismatch repair efficiency in a distance-and number-dependent manner, being almost nonfunctional when GATC sequences are located at 1 kb or more from the mutation site. Interestingly, we found that in E. coli genomic DNA the mismatch repair system can efficiently function even if the nearest GATC sequence is located more than 2 kb away from the mutation site. The results presented in this work show that even though frameshift mutations can be efficiently generated and/or repaired anywhere in the genome, these processes can be modulated by the chromosomal context that surrounds the mutation site.	[Martina, Mariana A.; Correa, Elisa M. E.; Argarana, Carlos E.; Barra, Jose L.] Univ Nacl Cordoba, Dept Quim Biol, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC,UNC CONICET, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Martina, MA (corresponding author), Univ Nacl Cordoba, Dept Quim Biol, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC,UNC CONICET, RA-5000 Cordoba, Argentina.	jlbarra@fcq.unc.edu.ar		Barra, Jose Luis/0000-0001-6730-4357	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2005-33589]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [112-200901-00420]; Secretaria de Ciencia y Tecnica [05/C451, 05/C503]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas; Secretaria de Ciencia y Tecnica(Secretaria de Ciencia y Tecnologia (SECYT))	Agencia Nacional de Promocion Cientifica y Tecnologica GrantPICT-2005-33589 (http://www.agencia.gov.ar/), Consejo Nacional de Investigaciones Cientificas y Tecnologicas Grant112-200901-00420 (http://www.conicet.gov.ar/), and Secretaria de Ciencia y Tecnica Grant 05/C451 and 05/C503 (http://www.secyt.unc.edu.ar/) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwood JK, 2010, P NATL ACAD SCI USA, V107, P22582, DOI 10.1073/pnas.1012906108; Brown J, 2001, BIOCHEM J, V354, P627, DOI 10.1042/0264-6021:3540627; BRUNI R, 1988, NUCLEIC ACIDS RES, V16, P4875, DOI 10.1093/nar/16.11.4875; Fujii S, 1999, J MOL BIOL, V289, P835, DOI 10.1006/jmbi.1999.2802; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Gawel D, 2002, J BACTERIOL, V184, P4449, DOI 10.1128/JB.184.16.4449-4454.2002; Gawel D, 2002, MUTAT RES-FUND MOL M, V501, P129, DOI 10.1016/S0027-5107(02)00020-9; Gragg H, 2002, MOL CELL BIOL, V22, P8756, DOI 10.1128/MCB.22.24.8756-8762.2002; Hawk JD, 2005, P NATL ACAD SCI USA, V102, P8639, DOI 10.1073/pnas.0503415102; Hudson RE, 2002, MOL BIOL EVOL, V19, P85, DOI 10.1093/oxfordjournals.molbev.a003986; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Khrustalev VV, 2010, GENOMICS, V96, P173, DOI 10.1016/j.ygeno.2010.06.002; LAENGLEROUAULT F, 1986, EMBO J, V5, P2009, DOI 10.1002/j.1460-2075.1986.tb04457.x; LAHUE RS, 1987, P NATL ACAD SCI USA, V84, P1482, DOI 10.1073/pnas.84.6.1482; LANGLEROUAULT F, 1987, EMBO J, V6, P1121, DOI 10.1002/j.1460-2075.1987.tb04867.x; Lind PA, 2008, P NATL ACAD SCI USA, V105, P17878, DOI 10.1073/pnas.0804445105; LU AL, 1987, J BACTERIOL, V169, P1254, DOI 10.1128/jb.169.3.1254-1259.1987; Mak WB, 2008, MUTAT RES-FUND MOL M, V638, P154, DOI 10.1016/j.mrfmmm.2007.10.001; Makiela-Dzbenska K, 2009, MOL MICROBIOL, V74, P1114, DOI 10.1111/j.1365-2958.2009.06921.x; Marinus MG, 2010, MUTAT RES-REV MUTAT, V705, P71, DOI 10.1016/j.mrrev.2010.05.001; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Mercier R, 2009, M S-MED SCI, V25, P885, DOI 10.1051/medsci/20092511885; Mira A, 2002, MOL BIOL EVOL, V19, P1350, DOI 10.1093/oxfordjournals.molbev.a004196; Orsi RH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-102; Parkhomchuk D, 2009, P NATL ACAD SCI USA, V106, P20830, DOI 10.1073/pnas.0906681106; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; SHARP PM, 1989, SCIENCE, V246, P808, DOI 10.1126/science.2683084; Stancheva I, 1999, EMBO J, V18, P6542, DOI 10.1093/emboj/18.22.6542; STREISINGER G, 1985, GENETICS, V109, P633; Sutton MD, 2010, BBA-PROTEINS PROTEOM, V1804, P1167, DOI 10.1016/j.bbapap.2009.06.010; WAGNER R, 1976, P NATL ACAD SCI USA, V73, P4135, DOI 10.1073/pnas.73.11.4135; Zheng Q, 2002, MATH BIOSCI, V176, P237, DOI 10.1016/S0025-5564(02)00087-1	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33701	10.1371/journal.pone.0033701	http://dx.doi.org/10.1371/journal.pone.0033701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438985	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100089
J	Palusa, S; Ndaluka, C; Bowen, RA; Wilusz, CJ; Wilusz, J				Palusa, Saiprasad; Ndaluka, Christina; Bowen, Richard A.; Wilusz, Carol J.; Wilusz, Jeffrey			The 3 ' Untranslated Region of the Rabies Virus Glycoprotein mRNA Specifically Interacts with Cellular PCBP2 Protein and Promotes Transcript Stability	PLOS ONE			English	Article							AU-RICH ELEMENTS; GENE-EXPRESSION; POLY(C)-BINDING PROTEIN-2; POLY(RC)-BINDING PROTEIN; BINDING-PROTEIN; KH-DOMAIN; IN-VITRO; REPLICATION; POLIOVIRUS; DEGRADATION	Viral polymerase entry and pausing at intergenic junctions is predicted to lead to a defined polarity in the levels of rhabdovirus gene expression. Interestingly, we observed that the rabies virus glycoprotein mRNA is differentially over-expressed based on this model relative to other transcripts during infection of 293T cells. During infection, the rabies virus glycoprotein mRNA also selectively interacts with the cellular poly(rC)-binding protein 2 (PCBP2), a factor known to influence mRNA stability. Reporter assays performed both in electroporated cells and in a cell-free RNA decay system indicate that the conserved portion of the 3' UTR of the rabies virus glycoprotein mRNA contains an RNA stability element. PCBP2 specifically interacts with reporter transcripts containing this 72 base 3' UTR sequence. Furthermore, the PCBP2 interaction is directly associated with the stability of reporter transcripts. Therefore, we conclude that PCBP2 specifically and selectively interacts with the rabies virus glycoprotein mRNA and that this interaction may contribute to the post-transcriptional regulation of glycoprotein expression.	[Palusa, Saiprasad; Ndaluka, Christina; Wilusz, Carol J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Ndaluka, Christina; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Palusa, S (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	jeffrey.wilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021; Wilusz, Carol/F-7241-2017		National Institutes of Health; Rocky Mountain Regional Center of Excellence in Biodefense [AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocky Mountain Regional Center of Excellence in Biodefense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant funding associated with the Rocky Mountain Regional Center of Excellence in Biodefense awarded to JW (AI065357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini AAV, 2011, ADV VIRUS RES, V79, P1, DOI 10.1016/B978-0-12-387040-7.00001-9; Bergman N, 2007, NAT STRUCT MOL BIOL, V14, P824, DOI 10.1038/nsmb1287; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Dickson AM, 2011, TRENDS GENET, V27, P286, DOI 10.1016/j.tig.2011.04.003; Dinh PX, 2011, J VIROL, V85, P9459, DOI 10.1128/JVI.05179-11; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; Fenn S, 2007, NUCLEIC ACIDS RES, V35, P2651, DOI 10.1093/nar/gkm139; Fitzgerald KD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002127; Fontanes V, 2009, VIROLOGY, V394, P82, DOI 10.1016/j.virol.2009.08.012; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Fujimura K, 2009, BBA-MOL CELL RES, V1793, P878, DOI 10.1016/j.bbamcr.2009.02.002; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kong J, 2003, MOL CELL BIOL, V23, P1125, DOI 10.1128/MCB.23.4.1125-1134.2003; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Morris AR, 2010, WIRES SYST BIOL MED, V2, P162, DOI 10.1002/wsbm.54; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Ogram SA, 2010, VIROLOGY, V397, P14, DOI 10.1016/j.virol.2009.11.006; Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07; RAVKOV EV, 1995, VIROLOGY, V206, P718, DOI 10.1016/S0042-6822(95)80095-6; Sarmento L, 2005, J NEUROVIROL, V11, P571, DOI 10.1080/13550280500385310; Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sean P, 2009, VIROLOGY, V389, P45, DOI 10.1016/j.virol.2009.03.012; Silvera D, 1999, J BIOL CHEM, V274, P38163, DOI 10.1074/jbc.274.53.38163; Toyoda H, 2007, J VIROL, V81, P10017, DOI 10.1128/JVI.00516-07; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Wang LY, 2011, J VIROL, V85, P7954, DOI 10.1128/JVI.00339-11; Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61; WILUSZ J, 1988, CELL, V52, P221, DOI 10.1016/0092-8674(88)90510-7; Wu XF, 2007, VIRUS RES, V129, P91, DOI 10.1016/j.virusres.2007.06.022; Xu L, 2009, MOL PHARMACOL, V76, P872, DOI 10.1124/mol.109.057596; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815	41	18	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33561	10.1371/journal.pone.0033561	http://dx.doi.org/10.1371/journal.pone.0033561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438951	gold, Green Submitted, Green Published			2022-12-27	WOS:000303309100060
J	Zhang, SM; Zhou, X; Lang, RA; Guo, FK				Zhang, Shuangmin; Zhou, Xuan; Lang, Richard A.; Guo, Fukun			RhoA of the Rho Family Small GTPases Is Essential for B Lymphocyte Development	PLOS ONE			English	Article							CELL-DEVELOPMENT; CDC42 GTPASES; KAPPA-B; RECEPTOR; RAC; BAFF; CHEMOTAXIS; ACTIVATION; RESPONSES; PROTEINS	RhoA is a member of the Rho family small GTPases that are implicated in various cell functions including proliferation and survival. However, the physiological role of RhoA in vivo remains largely unknown. Here, we deleted RhoA in the B cell and hematopoietic stem cell (HSC) populations in RhoA(flox/flox) mice with CD19 and Mx promoter-driven Cre expression, respectively. Deletion of RhoA by CD19(Cre/+) significantly blocked B cell development in spleen, leading to a marked reduction in the number of transitional, marginal zone, and follicular B cells. Surprisingly, neither B cell proliferation in response to either LPS or B cell receptor (BCR) engagement nor B cell survival rate in vivo was affected by RhoA deletion. Furthermore, RhoA(-/-) B cells, like control cells, were rescued from apoptosis by BCR crosslinking in vitro. In contrast, RhoA deficiency led to a defect in B cell activating factor (BAFF)-mediated B cell survival that was associated with a dampened expression of BAFF receptor and a loss of BAFF-mediated Akt activation. Finally, HSC deletion of RhoA by Mx-Cre severely reduced proB/preB and immature B cell populations in bone marrow while common lymphoid progenitors were increased, indicating that RhoA is also required for B cell progenitor/precursor differentiation. Taken together, our results uncover an important role for RhoA at multiple stages of B cell development.	[Zhang, Shuangmin; Zhou, Xuan; Guo, Fukun] Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Lang, Richard A.] Childrens Hosp Res Fdn, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Zhang, SM (corresponding author), Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	fukun.guo@cchmc.org		Lang, Richard/0000-0002-5212-254X	Cincinnati Children's Hospital Research Foundation	Cincinnati Children's Hospital Research Foundation	The work was supported by the start-up funds from the Cincinnati Children's Hospital Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Badr G, 2008, BLOOD, V111, P2744, DOI 10.1182/blood-2007-03-081232; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Caloca MJ, 2008, J BIOL CHEM, V283, P36454, DOI 10.1074/jbc.M803814200; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; Cuesta-Mateos C, 2010, EXP HEMATOL, V38, P756, DOI 10.1016/j.exphem.2010.05.003; Debreceni B, 2004, J BIOL CHEM, V279, P3777, DOI 10.1074/jbc.M308282200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Guo FK, 2004, MOL CELL BIOL, V24, P1426, DOI 10.1128/MCB.24.3.1426-1438.2004; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Haudenschild Dominik R., 2009, Molecular & Cellular Biomechanics, V6, P135; Henderson RB, 2010, J EXP MED, V207, P837, DOI 10.1084/jem.20091489; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ollila J, 2005, INT J BIOCHEM CELL B, V37, P518, DOI 10.1016/j.biocel.2004.09.007; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Saci A, 2005, MOL CELL, V17, P205, DOI 10.1016/j.molcel.2004.12.012; Salzer U, 2007, EUR J IMMUNOL, V37, P17, DOI 10.1002/eji.200636914; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; So T, 2006, INT J HEMATOL, V83, P1, DOI 10.1532/IJH97.05120; Srivastava B, 2005, SEMIN IMMUNOL, V17, P175, DOI 10.1016/j.smim.2005.02.008; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	38	27	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33773	10.1371/journal.pone.0033773	http://dx.doi.org/10.1371/journal.pone.0033773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438996	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100098
J	Kedzierska, K; Curtis, JM; Valkenburg, SA; Hatton, LA; Kiu, H; Doherty, PC; Kedzierski, L				Kedzierska, Katherine; Curtis, Joan M.; Valkenburg, Sophie A.; Hatton, Lauren A.; Kiu, Hiu; Doherty, Peter C.; Kedzierski, Lukasz			Induction of Protective CD4(+) T Cell-Mediated Immunity by a Leishmania Peptide Delivered in Recombinant Influenza Viruses	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; A VIRUS; INFANTUM P36/LACK; CD8(+); ANTIGEN; VACCINE; MICE; REQUIREMENTS; DNA; SUSCEPTIBILITY	The available evidence suggests that protective immunity to Leishmania is achieved by priming the CD4(+) Th1 response. Therefore, we utilised a reverse genetics strategy to generate influenza A viruses to deliver an immunogenic Leishmania peptide. The single, immunodominant Leishmania-specific LACK(158-173) CD4(+) peptide was engineered into the neuraminidase stalk of H1N1 and H3N2 influenza A viruses. These recombinant viruses were used to vaccinate susceptible BALB/c mice to determine whether the resultant LACK(158-173)-specific CD4(+) T cell responses protected against live L. major infection. We show that vaccination with influenza-LACK(158-173) triggers LACK(158-173)-specific Th1-biased CD4(+) T cell responses within an appropriate cytokine milieu (IFN-gamma, IL-12), essential for the magnitude and quality of the Th1 response. A single intraperitoneal exposure (non-replicative route of immunisation) to recombinant influenza delivers immunogenic peptides, leading to a marked reduction (2-4 log) in parasite burden, albeit without reduction in lesion size. This correlated with increased numbers of IFN-gamma-producing CD4(+) T cells in vaccinated mice compared to controls. Importantly, the subsequent prime-boost approach with a serologically distinct strain of influenza (H1N1->H3N2) expressing LACK(158-173) led to a marked reduction in both lesion size and parasite burdens in vaccination trials. This protection correlated with high levels of IFN-gamma producing cells in the spleen, which were maintained for 6 weeks post-challenge indicating the longevity of this protective effector response. Thus, these experiments show that Leishmania-derived peptides delivered in the context of recombinant influenza viruses are immunogenic in vivo, and warrant investigation of similar vaccine strategies to generate parasite-specific immunity.	[Kedzierska, Katherine; Valkenburg, Sophie A.; Hatton, Lauren A.; Doherty, Peter C.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Curtis, Joan M.; Kiu, Hiu; Kedzierski, Lukasz] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Curtis, Joan M.; Kiu, Hiu; Kedzierski, Lukasz] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Doherty, Peter C.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; St Jude Children's Research Hospital	Kedzierska, K (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	kkedz@unimelb.edu.au; kedzierski@wehi.edu.au	; Doherty, Peter Charles/C-4185-2013	Kedzierska, Katherine/0000-0001-6141-335X; Doherty, Peter Charles/0000-0002-5028-3489; Kedzierski, Lukasz/0000-0003-0203-1057	Australian National Health and Medical Research Council [406631, 406601]; NHMRC [361646]; Victorian State Government; Australian Postgraduate Scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Australian Postgraduate Scholarship(Australian Government)	This work was supported by the Australian National Health and Medical Research Council, (Project Grant 406631 and Program Grant 406601), NHMRC Independent Research Institutes Infrastructure Support Scheme grant #361646, and Victorian State Government Operational Infrastructure Support grant. KK is an NHMRC RD Wright Research Fellow. LAH and HK are recipients of an NHMRC Biomedical Postgraduate Research Scholarship, and SAV is a recipient of the Australian Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdary S, 2000, INFECT IMMUN, V68, P1760, DOI 10.1128/IAI.68.4.1760-1764.2000; Ajdary S, 2009, J INFECTION, V59, P139, DOI 10.1016/j.jinf.2009.05.010; [Anonymous], FIELDS VIROLOGY; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bertholet S, 2005, INFECT IMMUN, V73, P6620, DOI 10.1128/IAI.73.10.6620-6628.2005; Bertholet S, 2006, J IMMUNOL, V177, P3525, DOI 10.4049/jimmunol.177.6.3525; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Coler RN, 2007, INFECT IMMUN, V75, P4648, DOI 10.1128/IAI.00394-07; Courret N, 1999, EUR J IMMUNOL, V29, P762, DOI 10.1002/(SICI)1521-4141(199903)29:03&lt;762::AID-IMMU762&gt;3.0.CO;2-4; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Goede AL, 2009, VACCINE, V27, P5735, DOI 10.1016/j.vaccine.2009.07.032; Gonzalo RM, 2002, VACCINE, V20, P1226, DOI 10.1016/S0264-410X(01)00427-3; Gonzalo RM, 2001, MICROBES INFECT, V3, P701, DOI 10.1016/S1286-4579(01)01426-5; Gurunathan S, 2000, J IMMUNOL, V165, P915, DOI 10.4049/jimmunol.165.2.915; Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000; HANDMAN E, 1983, MOL BIOCHEM PARASIT, V7, P111, DOI 10.1016/0166-6851(83)90039-7; Handman E, 2000, ADV PARASIT, V44, P1; Hoffmann E, 2002, P NATL ACAD SCI USA, V99, P11411, DOI 10.1073/pnas.172393399; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huber M, 1998, INFECT IMMUN, V66, P3968, DOI 10.1128/IAI.66.8.3968-3970.1998; Joseph T, 2008, VIROLOGY, V378, P123, DOI 10.1016/j.virol.2008.05.021; Julia V, 1999, INFECT IMMUN, V67, P3641, DOI 10.1128/IAI.67.7.3641-3644.1999; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kedzierska K, 2008, J IMMUNOL, V180, P7938, DOI 10.4049/jimmunol.180.12.7938; Kedzierska K, 2007, P NATL ACAD SCI USA, V104, P9782, DOI 10.1073/pnas.0703699104; Kedzierski L, 2008, EUR J IMMUNOL, V38, P3090, DOI 10.1002/eji.200838423; Kedzierski L, 2009, CURR MED CHEM, V16, P599, DOI 10.2174/092986709787458489; Kronenberg K, 2010, J INVEST DERMATOL, V130, P2602, DOI 10.1038/jid.2010.171; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Maasho K, 2001, CLIN EXP IMMUNOL, V124, P255, DOI 10.1046/j.1365-2249.2001.01538.x; Maassab HF, 1999, REV MED VIROL, V9, P237, DOI 10.1002/(SICI)1099-1654(199910/12)9:4&lt;237::AID-RMV252&gt;3.0.CO;2-G; MacLeod MKL, 2008, P NATL ACAD SCI USA, V105, P14521, DOI 10.1073/pnas.0807449105; Martina BEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018995; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Mishin VR, 2005, VACCINE, V23, P2922, DOI 10.1016/j.vaccine.2004.11.058; MITCHELL GF, 1983, AUST J EXP BIOL MED, V61, P11, DOI 10.1038/icb.1983.2; Miyahira Y, 1998, P NATL ACAD SCI USA, V95, P3954, DOI 10.1073/pnas.95.7.3954; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484; Ravkov EV, 2009, J IMMUNOL, V183, P2382, DOI 10.4049/jimmunol.0900319; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Rose K, 2004, INT J PARASITOL, V34, P655, DOI 10.1016/j.ijpara.2004.03.001; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; SCOTT P, 1989, EXP PARASITOL, V68, P369, DOI 10.1016/0014-4894(89)90120-3; Sexton A, 2009, J VIROL, V83, P7619, DOI 10.1128/JVI.00470-09; Stukova MA, 2006, TUBERCULOSIS, V86, P236, DOI 10.1016/j.tube.2006.01.010; Sun K, 2010, J VIROL, V84, P5007, DOI 10.1128/JVI.02408-09; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; TOWNSEND ARM, 1984, CELL, V39, P13, DOI 10.1016/0092-8674(84)90187-9; Uzonna JE, 2004, J EXP MED, V199, P1559, DOI 10.1084/jem.20040172; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; World Health Organization, 2008, WHO IN VACC RES; Zheng HY, 2000, CANCER RES, V60, P6972	63	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33161	10.1371/journal.pone.0033161	http://dx.doi.org/10.1371/journal.pone.0033161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470440	gold, Green Published			2022-12-27	WOS:000303857100018
J	Laksanalamai, P; Jackson, SA; Mammel, MK; Datta, AR				Laksanalamai, Pongpan; Jackson, Scott A.; Mammel, Mark K.; Datta, Atin R.			High Density Microarray Analysis Reveals New Insights into Genetic Footprints of Listeria monocytogenes Strains Involved in Listeriosis Outbreaks	PLOS ONE			English	Article							FEBRILE GASTROENTERITIS; COMPARATIVE GENOMICS; ESCHERICHIA-COLI; IDENTIFICATION; VIRULENCE; DIVERSIFICATION; ELECTROPHORESIS; RECOMBINATION; EVOLUTIONARY; DIVERSITY	Listeria monocytogenes, a foodborne bacterial pathogen, causes invasive and febrile gastroenteritis forms of listeriosis in humans. Both invasive and febrile gastroenteritis listeriosis is caused mostly by serotypes 1/2a, 1/2b and 4b strains. The outbreak strains of serotype 1/2a and 4b could be further classified into several epidemic clones but the genetic bases for the diverse pathophysiology have been unsuccessful. DNA microarray provides an important tool to scan the entire genome for genetic signatures that may distinguish the L. monocytogenes strains belonging to different outbreaks. We have designed a pan-genomic microarray chip (Listeria GeneChip) containing sequences from 24 L. monocytogenes strains. The chip was designed to identify the presence/absence of genomic sequences, analyze transcription profiles and identify SNPs. Analysis of the genomic profiles of 38 outbreak strains representing 1/2a, 1/2b and 4b serotypes, revealed that the strains formed distinct genetic clusters adhering to their serotypes and epidemic clone types. Although serologically 1/2a and 1/b strains share common antigenic markers microarray analysis revealed that 1/2a strains are further apart from the closely related 1/2b and 4b strains. Within any given serotype and epidemic clone type the febrile gastroenteritis and invasive strains can be further distinguished based on several genetic markers including large numbers of phage genome, and intergenic sequences. Our results showed that the microarray-based data can be an important tool in characterization of L. monocytogenes strains involved in both invasive and gastroenteritis outbreaks. The results for the first time showed that the serotypes and epidemic clones are based on extensive pan-genomic variability and the 1/2b and 4bstrains are more closely related to each other than the 1/2a strains. The data also supported the hypothesis that the strains causing these two diverse outbreaks are genotypically different and this finding might be important in understanding the pathophysiology of this organism.	[Laksanalamai, Pongpan; Jackson, Scott A.; Mammel, Mark K.; Datta, Atin R.] US FDA, Off Appl Res & Safety Assessment, Ctr Food Safety & Appl Nutr, Laurel, MD USA	US Food & Drug Administration (FDA)	Laksanalamai, P (corresponding author), US FDA, Off Appl Res & Safety Assessment, Ctr Food Safety & Appl Nutr, Laurel, MD USA.	atin.datta@fda.hhs.gov		Jackson, Scott/0000-0003-4891-8323				Abu-Ali GS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-296; Affymetrix Inc, 2002, STAT ALG DESCR DOC; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Barbuddhe SB, 2009, CURR TOP MICROBIOL, V337, P173, DOI 10.1007/978-3-642-01846-6_6; BIBB WF, 1989, INT J FOOD MICROBIOL, V8, P233, DOI 10.1016/0168-1605(89)90018-4; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borucki MK, 2004, J CLIN MICROBIOL, V42, P5270, DOI 10.1128/JCM.42.11.5270-5276.2004; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Call DR, 2003, J MICROBIOL METH, V53, P235, DOI 10.1016/S0167-7012(03)00027-7; Call DR, 2003, J CLIN MICROBIOL, V41, P632, DOI 10.1128/JCM.41.2.632-639.2003; Chen Y, 2008, J CLIN MICROBIOL, V46, P1478, DOI 10.1128/JCM.01873-07; Cheng Ying, 2008, P337, DOI 10.1201/9781420051414.ch11; Cheng Y, 2010, APPL ENVIRON MICROB, V76, P3061, DOI 10.1128/AEM.03064-09; Datta A. R., 2003, International handbook of foodborne pathogens, P105; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Doumith M, 2004, INFECT IMMUN, V72, P1072, DOI 10.1128/IAI.72.2.1072-1083.2004; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Franciosa G, 2005, FEMS IMMUNOL MED MIC, V43, P431, DOI 10.1016/j.femsim.2004.11.005; Franciosa G, 2001, APPL ENVIRON MICROB, V67, P1793, DOI 10.1128/AEM.67.4.1793-1799.2001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Glaser P, 2001, SCIENCE, V294, P849; Graves L. M., 2007, LISTERIA LISTERIOSIS, P283; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Huson DH, 2005, BIOINFORMATICS, V21, P159, DOI 10.1093/bioinformatics/bti1126; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-349; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Miettinen MK, 1999, J CLIN MICROBIOL, V37, P2358, DOI 10.1128/JCM.37.7.2358-2360.1999; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Norton D. M., 2007, LISTERIA LISTERIOSIS, P305; Ooi ST, 2005, CLIN INFECT DIS, V40, P1327, DOI 10.1086/429324; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; PIFFARETTI JC, 1989, P NATL ACAD SCI USA, V86, P3818, DOI 10.1073/pnas.86.10.3818; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Seeliger HP, 2011, METHOD MICROBIOL, P31; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Volokhov D, 2002, J CLIN MICROBIOL, V40, P4720, DOI 10.1128/JCM.40.12.4720-4728.2002; Ward TJ, 2004, J BACTERIOL, V186, P4994, DOI 10.1128/jb.186.15.4994-5002.2004; Zhang CM, 2003, J BACTERIOL, V185, P5573, DOI 10.1128/JB.185.18.5573-5584.2003	43	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e32896	10.1371/journal.pone.0032896	http://dx.doi.org/10.1371/journal.pone.0032896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457724	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100007
J	Chow, KPN; Qiu, JT; Lee, JM; Hsu, SL; Yang, SC; Wu, NN; Huang, W; Wu, TS				Chow, Kai-Ping N.; Qiu, Jian-Tai; Lee, Jam-Mou; Hsu, Shuo-Lun; Yang, Shan-Che; Wu, Ning-Ning; Huang, Wei; Wu, Tzong-Shoon			Selective Reduction of Post-Selection CD8 Thymocyte Proliferation in IL-15R alpha Deficient Mice	PLOS ONE			English	Article							T-CELL REPERTOIRE; RECEPTOR-ALPHA CHAIN; IN-VIVO; CYTOKINE SIGNALING-1; FUNCTIONAL-DIFFERENTIATION; IMMUNE-SYSTEM; IL-15; EXPANSION; EXPRESSION; SUPPRESSOR	Peripheral CD8(+) T cells are defective in both IL-15 and IL-15R alpha knock-out (KO) mice; however, whether IL-15/IL-15R alpha deficiency has a similar effect on CD8 single-positive (SP) thymocytes remains unclear. In this study, we investigated whether the absence of IL-15 transpresentation in IL-15R alpha KO mice results in a defect in thymic CD8 single positive (SP) TCRhi thymocytes. Comparison of CD8SP TCRhi thymocytes from IL-15R alpha KO mice with their wild type (WT) counterparts by flow cytometry showed a significant reduction in the percentage of CD69(+) CD8SP TCRhi thymocytes, which represent thymic premigrants. In addition, analysis of in vivo 5-bromo-2-deoxyuridine (BrdU) incorporation demonstrated that premigrant expansion of CD8SP TCRhi thymocytes was reduced in IL-15R alpha KO mice. The presence of IL-15 transpresentation-dependent expansion in CD8SP TCRhi thymocytes was assessed by culturing total thymocytes in IL-15R alpha-Fc fusion protein-pre-bound plates that were pre-incubated with IL-15 to mimic IL-15 transpresentation in vitro. The results demonstrated that CD8SP thymocytes selectively outgrew other thymic subsets. The contribution of the newly divided CD8SP thymocytes to the peripheral CD8(+) T cell pool was examined using double labeling with intrathymically injected FITC and intravenously injected BrdU. A marked decrease in FITC+ BrdU(+) CD8(+) T cells was observed in the IL-15R alpha KO lymph nodes. Through these experiments, we identified an IL-15 transpresentation-dependent proliferation process selective for the mature CD8SP premigrant subpopulation. Importantly, this process may contribute to the maintenance of the normal peripheral CD8(+) T cell pool.	[Chow, Kai-Ping N.] Chang Gung Univ, Sch Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan; [Chow, Kai-Ping N.; Qiu, Jian-Tai; Yang, Shan-Che; Wu, Ning-Ning; Wu, Tzong-Shoon] Chang Gung Univ, Sch Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Qiu, Jian-Tai; Hsu, Shuo-Lun; Huang, Wei; Wu, Tzong-Shoon] Chang Gung Univ, Sch Med, Dept Biomed Sci, Tao Yuan, Taiwan; [Qiu, Jian-Tai] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan; [Lee, Jam-Mou] Wellkent Biomed Technol Inc, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chow, KPN (corresponding author), Chang Gung Univ, Sch Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan.	jwtsw@mail.cgu.edu.tw	Timothy, Qiu J./AAV-3086-2020	Qiu, JT/0000-0001-7090-6906; Meir, Yaa-Jyuhn/0000-0001-6084-3446	Chang Gung Memorial Hospital [CMRPD1A0101]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from the Chang Gung Memorial Hospital (CMRPD1A0101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Baird AM, 1999, CURR OPIN IMMUNOL, V11, P157, DOI 10.1016/S0952-7915(99)80027-2; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Berzins SP, 2002, TRENDS MOL MED, V8, P469, DOI 10.1016/S1471-4914(02)02415-2; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; BHATIA SK, 1995, J EXP MED, V181, P1399, DOI 10.1084/jem.181.4.1399; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Castillo EF, 2010, BLOOD, V116, P2494, DOI 10.1182/blood-2010-03-277103; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Di Santo JP, 1998, CURR OPIN IMMUNOL, V10, P196, DOI 10.1016/S0952-7915(98)80249-5; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Gagnon J, 2008, J IMMUNOL, V180, P7958, DOI 10.4049/jimmunol.180.12.7958; Gagnon J, 2007, CELL SIGNAL, V19, P806, DOI 10.1016/j.cellsig.2006.10.003; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; Goronzy JJ, 2003, ARTHRITIS RES THER, V5, P225, DOI 10.1186/ar974; Goronzy JJ, 2001, TRENDS IMMUNOL, V22, P251, DOI 10.1016/S1471-4906(00)01841-X; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; Hare KJ, 2000, J IMMUNOL, V165, P2410, DOI 10.4049/jimmunol.165.5.2410; Hare KJ, 1998, J IMMUNOL, V160, P3666; He YW, 1997, J IMMUNOL, V158, P2592; Heng TSP, 2010, CURR OPIN PHARMACOL, V10, P425, DOI 10.1016/j.coph.2010.04.006; Hsieh CL, 2011, IMMUNOBIOLOGY, V216, P491, DOI 10.1016/j.imbio.2010.09.002; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Ilangumaran S, 2003, BLOOD, V102, P4115, DOI 10.1182/blood-2003-01-0175; Ilangumaran S, 2003, J IMMUNOL, V171, P2435, DOI 10.4049/jimmunol.171.5.2435; Ilangumaran S, 2010, IMMUNOL LETT, V132, P12, DOI 10.1016/j.imlet.2010.04.009; KELLY KA, 1993, EUR J IMMUNOL, V23, P1922, DOI 10.1002/eji.1830230829; Kokaji AI, 2008, J IMMUNOL, V180, P4391, DOI 10.4049/jimmunol.180.7.4391; Ku CC, 2001, J IMMUNOL, V166, P2186, DOI 10.4049/jimmunol.166.4.2186; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Le Campion A, 2002, J IMMUNOL, V168, P1664, DOI 10.4049/jimmunol.168.4.1664; Le Campion A, 2000, EUR J IMMUNOL, V30, P738; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; LUCAS B, 1993, J IMMUNOL, V151, P4574; LUCAS B, 1994, J IMMUNOL, V153, P53; Luttichau HR, 2000, J EXP MED, V191, P171, DOI 10.1084/jem.191.1.171; Mackall C L, 1997, Semin Immunol, V9, P339, DOI 10.1006/smim.1997.0091; Mackall CL, 1997, IMMUNOL TODAY, V18, P245, DOI 10.1016/S0167-5699(97)81664-7; MACKALL CL, 1993, BLOOD, V82, P2585; Messaoudi I, 2004, J EXP MED, V200, P1347, DOI 10.1084/jem.20040437; MOORE NC, 1993, EUR J IMMUNOL, V23, P922, DOI 10.1002/eji.1830230424; Moore TA, 1996, J IMMUNOL, V157, P2366; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; PENIT C, 1995, J IMMUNOL, V154, P5103; PENIT C, 1993, CYTOMETRY, V14, P757, DOI 10.1002/cyto.990140708; Penit C, 1997, J IMMUNOL, V159, P4848; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ramanathan S, 2006, J IMMUNOL, V176, P4029, DOI 10.4049/jimmunol.176.7.4029; Ramanathan S, 2010, J IMMUNOL, V185, P357, DOI 10.4049/jimmunol.1000066; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; SADLACK B, 1994, EUR J IMMUNOL, V24, P281, DOI 10.1002/eji.1830240144; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Thulesen S, 2000, CYTOKINE, V12, P751, DOI 10.1006/cyto.1999.0608; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wu TS, 2002, J IMMUNOL, V168, P705, DOI 10.4049/jimmunol.168.2.705; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973	71	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33152	10.1371/journal.pone.0033152	http://dx.doi.org/10.1371/journal.pone.0033152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448237	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700027
J	Hotomi, M; Togawa, A; Takei, S; Sugita, G; Sugita, R; Kono, M; Fujimaki, Y; Kamide, Y; Uchizono, A; Kanesada, K; Sawada, S; Okitsu, N; Tanaka, Y; Saijo, Y; Yamanaka, N				Hotomi, Muneki; Togawa, Akihisa; Takei, Shin; Sugita, Gen; Sugita, Rinya; Kono, Masamitsu; Fujimaki, Yutaka; Kamide, Yosuke; Uchizono, Akihiro; Kanesada, Keiko; Sawada, Shoichi; Okitsu, Naohiro; Tanaka, Yumi; Saijo, Yoko; Yamanaka, Noboru			Evaluation of a Rapid Immunochromatographic ODK-0901 Test for Detection of Pneumococcal Antigen in Middle Ear Fluids and Nasopharyngeal Secretions	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; PNEUMONIAE URINARY ANTIGEN; COMMUNITY-ACQUIRED PNEUMONIA; SPUTUM GRAM STAIN; STREPTOCOCCUS-PNEUMONIAE; C-POLYSACCHARIDE; HAEMOPHILUS-INFLUENZAE; ANTIBIOTIC-RESISTANCE; PEDIATRIC-PATIENTS; CHILDREN	Since the incidence of penicillin-resistant Streptococcus pneumoniae has been increasing at an astonishing rate throughout the world, the need for accurate and rapid identification of pneumococci has become increasingly important to determine the appropriate antimicrobial treatment. We have evaluated an immunochromatographic test (ODK-0901) that detects pneumococcal antigens using 264 middle ear fluids (MEFs) and 268 nasopharyngeal secretions (NPSs). A sample was defined to contain S. pneumoniae when optochin and bile sensitive alpha hemolytic streptococcal colonies were isolated by culture. The sensitivity and specificity of the ODK-0901 test were 81.4% and 80.5%, respectively, for MEFs from patients with acute otitis media (AOM). In addition, the sensitivity and specificity were 75.2% and 88.8%, respectively, for NPSs from patients with acute rhinosinusitis. The ODK-0901 test may provide a rapid and highly sensitive evaluation of the presence of S. pneumoniae and thus may be a promising method of identifying pneumococci in MEFs and NPSs.	[Hotomi, Muneki; Togawa, Akihisa; Takei, Shin; Sugita, Gen; Kono, Masamitsu; Yamanaka, Noboru] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan; [Sugita, Gen] Sugita ENT Clin, Chiba, Japan; [Fujimaki, Yutaka] Fujimaki ENT Clin, Chiba, Japan; [Kamide, Yosuke] Kamide ENT Clin, Shizuoka, Japan; [Uchizono, Akihiro] Sendai ENT Clin, Kagoshima, Japan; [Kanesada, Keiko] Nonohana ENT Clin, Yamaguchi, Japan; [Sawada, Shoichi] Sawada ENT Clin, Kochi, Japan; [Okitsu, Naohiro] Tohoku Rosai Hosp, Dept Otolaryngol, Tohoku, Miyagi, Japan; [Tanaka, Yumi; Saijo, Yoko] Otsuka Pharmaceut Co Ltd, Tokyo, Japan	Wakayama Medical University; Otsuka Pharmaceutical	Hotomi, M (corresponding author), Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan.	mhotomi@wakayama-med.ac.jp			Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan	Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan(Otsuka Pharmaceutical)	This study was funded by Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan, whose role, through the employment of YT and YS, involved technical assistant for performing this study.	Alonso-Tarres C, 2001, LANCET, V358, P1273, DOI 10.1016/S0140-6736(01)06368-1; BALLARD TL, 1987, PEDIATR INFECT DIS J, V6, P630, DOI 10.1097/00006454-198707000-00003; BLUESTONE CD, 1992, PEDIATR INFECT DIS J, V11, pS7, DOI 10.1097/00006454-199208001-00002; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Dagan R, 2000, PEDIATR INFECT DIS J, V19, pS57, DOI 10.1097/00006454-200005001-00009; Damoiseaux RAMJ, 2000, BRIT MED J, V320, P350, DOI 10.1136/bmj.320.7231.350; Dominguez J, 2001, CHEST, V119, P243, DOI 10.1378/chest.119.1.243; Dowell SF, 2001, CLIN INFECT DIS, V32, P824, DOI 10.1086/319205; Ehara N, 2008, J MED MICROBIOL, V57, P820, DOI 10.1099/jmm.0.47793-0; Eldan M, 2000, PEDIATR INFECT DIS J, V19, P298, DOI 10.1097/00006454-200004000-00007; Faden H, 1998, PEDIATR INFECT DIS J, V17, P1105, DOI 10.1097/00006454-199812000-00002; Faden H, 2002, PEDIATR INFECT DIS J, V21, P791, DOI 10.1097/00006454-200208000-00020; Faden H, 2002, J CLIN MICROBIOL, V40, P4748, DOI 10.1128/JCM.40.12.4748-4749.2002; Faden H, 2002, J LARYNGOL OTOL, V116, P499, DOI 10.1258/002221502760132566; FEIGIN RD, 1976, J PEDIATR-US, V89, P773, DOI 10.1016/S0022-3476(76)80802-5; Garcia-Vazquez E, 2004, ARCH INTERN MED, V164, P1807, DOI 10.1001/archinte.164.16.1807; Gehanno P, 1996, PEDIATR INFECT DIS J, V15, P329, DOI 10.1097/00006454-199604000-00009; GILLESPIE SH, 1993, INFECT IMMUN, V61, P3076, DOI 10.1128/IAI.61.7.3076-3077.1993; Gisselsson-Solen M, 2007, J CLIN MICROBIOL, V45, P3003, DOI 10.1128/JCM.00299-07; GLECKMAN R, 1988, J CLIN MICROBIOL, V26, P846, DOI 10.1128/JCM.26.5.846-849.1988; Gutierrez F, 2003, CLIN INFECT DIS, V36, P286, DOI 10.1086/345852; Hamer DH, 2002, CLIN INFECT DIS, V34, P1025, DOI 10.1086/339446; Hotomi M, 2004, ORL-J OTO-RHIN-LARYN, V66, P233, DOI 10.1159/000081119; Hotomi M, 2008, J CLIN MICROBIOL, V46, P3808, DOI 10.1128/JCM.01782-08; Izumikawa K, 2009, CLIN VACCINE IMMUNOL, V16, P672, DOI 10.1128/CVI.00308-08; Jacobs MR, 2000, PEDIATR INFECT DIS J, V19, pS47, DOI 10.1097/00006454-200005001-00008; Kolberg J, 1997, MICROB PATHOGENESIS, V22, P321, DOI 10.1006/mpat.1996.0114; Marcos MA, 2003, EUR RESPIR J, V21, P209, DOI 10.1183/09031936.03.00058802; Murdoch DR, 2003, CLIN INFECT DIS, V37, P153, DOI 10.1086/375610; Murdoch DR, 2003, J CLIN MICROBIOL, V41, P2271, DOI 10.1128/JCM.41.5.2271.2003; Murdoch DR, 2001, J CLIN MICROBIOL, V39, P3495, DOI 10.1128/JCM.39.10.3495-3498.2001; NAIMAN HL, 1980, J INFECT DIS, V142, P524, DOI 10.1093/infdis/142.4.524; Navarro D, 2004, J CLIN MICROBIOL, V42, P4853, DOI 10.1128/JCM.42.10.4853-4855.2004; Ogami M, 2010, EUR J PEDIATR, V169, P1221, DOI 10.1007/s00431-010-1208-5; Okitsu N, 2011, J MICROBIOL METH, V84, P341, DOI 10.1016/j.mimet.2010.11.011; POXTON IR, 1978, BIOCHEM J, V175, P1033, DOI 10.1042/bj1751033; Priner M, 2008, J AM GERIATR SOC, V56, P170, DOI 10.1111/j.1532-5415.2007.01451.x; Reed WW, 1996, WESTERN J MED, V165, P197; Rovers MM, 2007, PEDIATRICS, V119, P579, DOI 10.1542/peds.2006-2092; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; SJOGREN AM, 1987, DIAGN MICR INFEC DIS, V6, P239, DOI 10.1016/0732-8893(87)90018-6; Slotved HC, 2004, J CLIN MICROBIOL, V42, P2518, DOI 10.1128/JCM.42.6.2518-2522.2004; SORENSEN UBS, 1995, DAN MED BULL, V42, P47; Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; VANBUCHEM FL, 1985, BRIT MED J, V290, P1033, DOI 10.1136/bmj.290.6474.1033; Vuorenoja K, 2011, EUR J CLIN IN PRESS	47	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33620	10.1371/journal.pone.0033620	http://dx.doi.org/10.1371/journal.pone.0033620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448257	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700048
J	Liu, S; Schulze, E; Baumeister, R				Liu, Shu; Schulze, Ekkehard; Baumeister, Ralf			Temperature- and Touch-Sensitive Neurons Couple CNG and TRPV Channel Activities to Control Heat Avoidance in Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; C. ELEGANS; NERVOUS-SYSTEM; CELL LINEAGE; GENE; IDENTIFICATION; THERMOSENSATION; LOCALIZATION; ADAPTATION; EXPRESSION	Background: Any organism depends on its ability to sense temperature and avoid noxious heat. The nematode Caenorhabditis elegans responds to noxious temperatures exceeding similar to 35 degrees C and also senses changes in its environmental temperature in the range between 15 and 25 degrees C. The neural circuits and molecular mechanisms involved in thermotaxis have been successfully studied, whereas details of the thermal avoidance behavior remain elusive. In this work, we investigate neurological and molecular aspects of thermonociception using genetic, cell biological and physiological approaches. Methodology/Principal Findings: We show here that the thermosensory neurons AFD, in addition to sensing temperature within the range within which the animals can thrive, also contribute to the sensation of noxious temperatures resulting in a reflex-like escape reaction. Distinct sets of interneurons are involved in transmitting thermonociception and thermotaxis, respectively. Loss of AFD is partially compensated by the activity of a pair of multidendritic, polymodal neurons, FLP, whereas laser ablation of both types of neurons abrogated the heat response in the head of the animals almost completely. A third pair of heat sensory neurons, PHC, is situated in the tail. We find that the thermal avoidance response requires the cell autonomous function of cGMP dependent Cyclic Nucleotide-Gated (CNG) channels in AFD, and the heat-and capsaicin-sensitive Transient Receptor Potential Vanilloid (TRPV) channels in the FLP and PHC sensory neurons. Conclusions/Significance: Our results identify distinct thermal responses mediated by a single neuron, but also show that parallel nociceptor circuits and molecules may be used as back-up strategies to guarantee fast and efficient responses to potentially detrimental stimuli.	[Liu, Shu; Schulze, Ekkehard; Baumeister, Ralf] Univ Freiburg, Fac Biol, Lab Bioinformat & Mol Genet, D-79106 Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Fac Med, Ctr Biochem & Mol Cell Res, D-79106 Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Sch Life Sci FRIAS LIFENET, Freiburg Inst Adv Studies, D-79106 Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Liu, S (corresponding author), Univ Freiburg, Fac Biol, Lab Bioinformat & Mol Genet, Hugstetter Str 55, D-79106 Freiburg, Germany.	baumeister@celegans.de			German Research Foundation (DFG) [GRK1104]; Deutsche Forschungsgemeinschaft [SFB592]; German Excellence Initiative (FRIAS LIFENET and excellence cluster BIOSS)	German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Excellence Initiative (FRIAS LIFENET and excellence cluster BIOSS)	S.L. was funded by the GRK1104, a scholarship from German Research Foundation (DFG). R.B. is supported by grants from the Deutsche Forschungsgemeinschaft (SFB592) and the German Excellence Initiative (FRIAS LIFENET and excellence cluster BIOSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Bargmann CI, 1997, CHEMOTAXIS THERMOTAX; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BRENNER S, 1974, GENETICS, V77, P71; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Cho SW, 2005, MOL CELLS, V19, P149; Cho SW, 2004, BIOCHEM BIOPH RES CO, V325, P525, DOI 10.1016/j.bbrc.2004.10.060; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Glauser DA, 2011, GENETICS; HALL DH, 1991, J NEUROSCI, V11, P1; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Jose AM, 2007, GENETICS, V175, P93, DOI 10.1534/genetics.106.065516; Jurado P, 2010, GENES BRAIN BEHAV, V9, P120, DOI 10.1111/j.1601-183X.2009.00549.x; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Wei JY, 1998, PROG NEUROBIOL, V56, P37, DOI 10.1016/S0301-0082(98)00029-X; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016	52	61	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32360	10.1371/journal.pone.0032360	http://dx.doi.org/10.1371/journal.pone.0032360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448218	Green Published, gold			2022-12-27	WOS:000303855700008
J	te Marvelde, L; Visser, ME				te Marvelde, Luc; Visser, Marcel E.			Manipulation of Life-History Decisions Using Leptin in a Wild Passerine	PLOS ONE			English	Article							TITS PARUS-MAJOR; GREAT TITS; CHICKEN LEPTIN; FOOD-INTAKE; FAT DEPOSITION; EGG-PRODUCTION; BODY-WEIGHT; FEED-INTAKE; COSTS; BIRDS	Seasonal timing of reproduction and the number of clutches produced per season are two key avian life-history traits with major fitness consequences. Female condition may play an important role in these decisions. In mammals, body condition and leptin levels are correlated. In birds, the role of leptin remains unclear. We did two experiments where we implanted female great tits with a pellet releasing leptin evenly for 14 days, to manipulate their perceived body condition, or a placebo pellet. In the first experiment where females were implanted when feeding their first brood offspring we found, surprisingly, that placebo treated females were more likely to initiate a second brood compared to leptin treated females. Only one second brood fledged two chicks while five were deserted late in the incubation stage or when the first egg hatched. No difference was found in female or male return rate or in recruitment rate of fledglings of the first brood, possibly due to the desertion of the second broods. In our study population, where there is selection for early egg laying, earlier timing of reproduction might be hampered by food availability and thus nutritional state of the female before egg laying. We therefore implanted similar leptin pellets three weeks before the expected start of egg laying in an attempt to manipulate the laying dates of first clutches. However, leptin treated females did not initiate egg laying earlier compared to placebo treated females, suggesting that other variables than the perceived body condition play a major role in the timing of reproduction. Also, leptin treatment did not affect body mass, basal metabolic rate or feeding rates in captive females. Manipulating life history decisions using experimental protocols which do not alter individuals' energy balance are crucial in understanding the trade-off between costs and benefits of life history decisions.	[te Marvelde, Luc; Visser, Marcel E.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	te Marvelde, L (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	l.temarvelde@nioo.knaw.nl	Visser, Marcel E/A-9151-2009; KNAW, NIOO-KNAW/A-4320-2012	Visser, Marcel E/0000-0002-1456-1939; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research (NWO-VICI)	Netherlands Organisation for Scientific Research (NWO-VICI)(Netherlands Organization for Scientific Research (NWO))	MEV is supported by a Netherlands Organisation for Scientific Research (NWO-VICI) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY MI, 1984, IBIS, V126, P33, DOI 10.1111/j.1474-919X.1984.tb03661.x; Barb CR, 1998, DOMEST ANIM ENDOCRIN, V15, P77, DOI 10.1016/S0739-7240(97)00064-7; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Denbow DM, 2000, PHYSIOL BEHAV, V69, P359, DOI 10.1016/S0031-9384(99)00258-9; Devries JH, 2008, AUK, V125, P618, DOI 10.1525/auk.2008.07055; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Friedman-Einat M, 1999, GEN COMP ENDOCR, V115, P354, DOI 10.1006/gcen.1999.7322; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Henson M. C., 2003, LEPTIN REPROD; Houseknecht KL, 1998, J ANIM SCI, V76, P1405; Hukshorn CJ, 2004, CURR OPIN CLIN NUTR, V7, P629, DOI 10.1097/00075197-200411000-00007; Kordonowy LL, 2010, GEN COMP ENDOCR, V166, P47, DOI 10.1016/j.ygcen.2009.09.005; Kuo AY, 2005, PHYSIOL BEHAV, V84, P459, DOI 10.1016/j.physbeh.2005.01.014; Lohmus M, 2006, J EXP ZOOL PART A, V305A, P13, DOI 10.1002/jez.a.240; Lohmus M, 2003, GEN COMP ENDOCR, V131, P57, DOI 10.1016/S0016-6480(02)00643-3; Lohmus M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004602; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Monaghan P, 1998, P ROY SOC B-BIOL SCI, V265, P1731, DOI 10.1098/rspb.1998.0495; Nager RG, 1997, J ANIM ECOL, V66, P495, DOI 10.2307/5944; NILSSON JA, 1994, J ANIM ECOL, V63, P200, DOI 10.2307/5595; Ohkubo T, 2000, BBA-GENE STRUCT EXPR, V1491, P303, DOI 10.1016/S0167-4781(00)00046-4; Paczoska-Eliasiewicz HE, 2006, DOMEST ANIM ENDOCRIN, V31, P211, DOI 10.1016/j.domaniend.2005.10.005; Parejo D, 2006, BEHAV ECOL SOCIOBIOL, V60, P184, DOI 10.1007/s00265-005-0155-z; Pitel F, 2000, ANIM GENET, V31, P281, DOI 10.1046/j.1365-2052.2000.00610.x; Pitel F, 2010, GEN COMP ENDOCR, V167, P1, DOI 10.1016/j.ygcen.2009.10.006; R Core Team, 2020, R LANG ENV STAT COMP; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Roff Derek A., 1992; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Schaper S, 2011, J EXPT BIOL; Sharp PJ, 2008, GEN COMP ENDOCR, V158, P2, DOI 10.1016/j.ygcen.2008.05.018; Sharp PJ, 2005, ANN NY ACAD SCI, V1040, P189, DOI 10.1196/annals.1327.024; Shi ZD, 2006, BRIT POULTRY SCI, V47, P88, DOI 10.1080/00071660500475319; Sirotkin AV, 2007, COMP BIOCHEM PHYS A, V148, P422, DOI 10.1016/j.cbpa.2007.06.001; te Marvelde L, 2011, OECOLOGIA IN PRESS, DOI DOI 10.1111/j.1365-2435.2011.01889.x; Te Marvelde L, 2011, FUNCT ECOL, V25, P1302, DOI 10.1111/j.1365-2435.2011.01889.x; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Verboven N, 2001, ARDEA, V89, P387; Verhulst S, 1997, FUNCT ECOL, V11, P714, DOI 10.1046/j.1365-2435.1997.00145.x; Verhulst S, 1998, FUNCT ECOL, V12, P132, DOI 10.1046/j.1365-2435.1998.00165.x; Verhulst S, 1996, ANIM BEHAV, V51, P957, DOI 10.1006/anbe.1996.0099; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser M, 2012, J ORNITHOLO IN PRESS; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P1271, DOI 10.1098/rspb.2001.1661; Wingfield J. C, 1980, AVIAN ENDOCRINOLOGY, P367; Wingfield JC, 2003, GEN COMP ENDOCR, V131, P143, DOI 10.1016/S0016-6480(02)00648-2; Yosefi S, 2010, J ENDOCRINOL, V207, P113, DOI 10.1677/JOE-10-0177	49	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e34090	10.1371/journal.pone.0034090	http://dx.doi.org/10.1371/journal.pone.0034090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448288	Green Published, gold			2022-12-27	WOS:000303855700079
J	Kong, DJ; Heath, E; Chen, W; Cher, ML; Powell, I; Heilbrun, L; Li, YW; Ali, S; Sethi, S; Hassan, O; Hwang, C; Gupta, N; Chitale, D; Sakr, WA; Menon, M; Sarkar, FH				Kong, Dejuan; Heath, Elisabeth; Chen, Wei; Cher, Michael L.; Powell, Isaac; Heilbrun, Lance; Li, Yiwei; Ali, Shadan; Sethi, Seema; Hassan, Oudai; Hwang, Clara; Gupta, Nilesh; Chitale, Dhananjay; Sakr, Wael A.; Menon, Mani; Sarkar, Fazlul H.			Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM	PLOS ONE			English	Article							ACID CONDENSATION PRODUCTS; REPROGRAMMING FACTOR LIN28; GROUP PROTEIN EZH2; E-CADHERIN; GENE-EXPRESSION; HISTONE METHYLTRANSFERASE; DEVELOPMENTAL REGULATORS; RADICAL PROSTATECTOMY; MICRORNA LET-7; POLYCOMB	The emergence of castrate-resistant prostate cancer (CRPC) contributes to the high mortality of patients diagnosed with prostate cancer (PCa), which in part could be attributed to the existence and the emergence of cancer stem cells (CSCs). Recent studies have shown that deregulated expression of microRNAs (miRNAs) contributes to the initiation and progression of PCa. Among several known miRNAs, let-7 family appears to play a key role in the recurrence and progression of PCa by regulating CSCs; however, the mechanism by which let-7 family contributes to PCa aggressiveness is unclear. Enhancer of Zeste homolog 2 (EZH2), a putative target of let-7 family, was demonstrated to control stem cell function. In this study, we found loss of let-7 family with corresponding over-expression of EZH2 in human PCa tissue specimens, especially in higher Gleason grade tumors. Overexpression of let-7 by transfection of let-7 precursors decreased EZH2 expression and repressed clonogenic ability and sphere-forming capacity of PCa cells, which was consistent with inhibition of EZH2 3'UTR luciferase activity. We also found that the treatment of PCa cells with BR-DIM (formulated DIM: 3,3'-diindolylmethane by Bio Response, Boulder, CO, abbreviated as BR-DIM) up-regulated let-7 and down-regulated EZH2 expression, consistent with inhibition of self-renewal and clonogenic capacity. Moreover, BR-DIM intervention in our ongoing phase II clinical trial in patients prior to radical prostatectomy showed upregulation of let-7 consistent with down-regulation of EZH2 expression in PCa tissue specimens after BR-DIM intervention. These results suggest that the loss of let-7 mediated increased expression of EZH2 contributes to PCa aggressiveness, which could be attenuated by BR-DIM treatment, and thus BR-DIM is likely to have clinical impact.	[Kong, Dejuan; Li, Yiwei; Sethi, Seema; Hassan, Oudai; Sakr, Wael A.; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA; [Heath, Elisabeth; Chen, Wei; Heilbrun, Lance; Ali, Shadan] Wayne State Univ, Sch Med, Dept Oncol, Karmanos Canc Inst, Detroit, MI USA; [Cher, Michael L.; Powell, Isaac] Wayne State Univ, Sch Med, Dept Urol, Karmanos Canc Inst, Detroit, MI USA; [Hwang, Clara] Henry Ford Hlth Syst, Dept Oncol, Detroit, MI USA; [Gupta, Nilesh; Chitale, Dhananjay] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI USA; [Menon, Mani] Henry Ford Hlth Syst, Dept Urol, Detroit, MI USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Kong, DJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu	, Wei/AAN-6343-2020; Hwang, Clara/AFJ-8520-2022; Hwang, Clara/AAF-5302-2022	, Wei/0000-0001-6048-1860; Hwang, Clara/0000-0002-0998-323X; Hwang, Clara/0000-0002-0998-323X; Chitale, Dhananjay/0000-0002-4421-6431	National Cancer Institute, National Institutes of Health [5R01CA108535-06, 5R01CA083695-08]; NATIONAL CANCER INSTITUTE [R01CA164318, R01CA108535, R01CA083695] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Cancer Institute, National Institutes of Health (5R01CA108535-06 and 5R01CA083695-08) awarded to FHS. (http://projectreporter.nih.gov/reporter_searchresults.cfm?&new = 1&icde = 4342569&loc = 2&CFID = 28929570&CFTOKEN = 80568291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton MJ, 2004, CLIN CANCER RES, V10, P5233, DOI 10.1158/1078-0432.CCR-04-0163; Anderton MJ, 2003, J CHROMATOGR B, V787, P281, DOI 10.1016/S1570-0232(02)00923-6; Barh D, 2010, CURR ONCOL, V17, P70; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Fujii S, 2008, CANCER SCI, V99, P738, DOI 10.1111/j.1349-7006.2008.00743.x; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Heath EI, 2010, AM J TRANSL RES, V2, P402; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji JF, 2010, J HEPATOL, V53, P974, DOI 10.1016/j.jhep.2010.07.001; Kattan MW, 1999, J CLIN ONCOL, V17, P1499, DOI 10.1200/JCO.1999.17.5.1499; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li LC, 2001, J UROLOGY, V166, P705, DOI 10.1016/S0022-5347(05)66047-8; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Reinhold WC, 2007, MOL CANCER THER, V6, P391, DOI 10.1158/1535-7163.MCT-06-0609; Risk MC, 2010, CLIN CANCER RES, V16, P5414, DOI 10.1158/1078-0432.CCR-10-0272; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; Sarkar FH, 2004, MUTAT RES-FUND MOL M, V555, P53, DOI 10.1016/j.mrfmmm.2004.04.015; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sumey C, 2011, EXPERT OPIN PHARMACO, V12, P73, DOI 10.1517/14656566.2010.516252; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	49	146	151	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33729	10.1371/journal.pone.0033729	http://dx.doi.org/10.1371/journal.pone.0033729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442719	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500060
J	Trabucchi, A; Guerra, LL; Faccinetti, NI; Iacono, RF; Poskus, E; Valdez, SN				Trabucchi, Aldana; Guerra, Luciano L.; Faccinetti, Natalia I.; Iacono, Ruben F.; Poskus, Edgardo; Valdez, Silvina N.			Surface Plasmon Resonance Reveals a Different Pattern of Proinsulin Autoantibodies Concentration and Affinity in Diabetic Patients	PLOS ONE			English	Article							GENERAL-POPULATION; NATURAL-HISTORY; YOUNG-CHILDREN; ANTIBODIES; MELLITUS; ONSET; RISK; AUTOIMMUNITY; IMMUNOLOGY; APPEARANCE	Type 1 diabetes mellitus (DM) is characterized by autoimmune aggression against pancreatic beta cells resulting in absolute deficiency of insulin secretion. The first detectable sign of emerging autoimmunity during the preclinical asymptomatic period is the appearance of diabetes-related autoantibodies. In children at risk for type 1 DM, high-affinity Insulin autoantibodies reactive to proinsulin, are associated with diabetes risk. Autoantibodies are usually measured by radioligand binding assay (RBA) that provides quasi-quantitative values reflecting potency (product between concentration and affinity) of specific autoantibodies. Aiming to improve the characterization of the specific humoral immune response, we selected surface plasmon resonance (SPR) as an alternative method to measure proinsulin autoantibodies (PAA). This novel technology has allowed real time detection of antibodies interaction and kinetic analysis. Herein, we have employed SPR to characterize the PAA present in sera from 28 childhood-onset (mean age 8.31 +/- 4.20) and 23 adult-onset diabetic patients (>= 65 years old, BMI<30) in terms of concentration and affinity. When evaluating comparatively samples from both groups, childhood-onset diabetic patients presented lower PAA concentrations and higher affinities (median 67.12x10(-9) M and 3.50x10(7) M-1, respectively) than the adults (median 167.4x10(-9) M and 0.84x10(7) M-1, respectively). These results are consistent with those from the reference method RBA (Standard Deviation score median 9.49 for childhood-onset group and 5.04 for adult-onset group) where the binding can be directly related to the intrinsic affinity of the antibody, suggesting that there is a different etiopathogenic pathway between both types of clinical presentation of the disease. This technology has shown to be a useful tool for the characterization of PAAs parameters as an alternative to radioimmunoassay, with high versatility and reproducibility associated to low occupational and environmental risk. However, this technology is not eligible for routine marker screening, but this is a powerful technique for a fine description of the thermodynamic parameters of antigen-antibody interaction.	[Trabucchi, Aldana] Univ Buenos Aires, Sch Pharm & Biochem, Buenos Aires, DF, Argentina; Natl Res Council CONICET UBA, Humoral Immun Inst Prof Ricardo A Margni IDEHU, Buenos Aires, DF, Argentina	University of Buenos Aires	Trabucchi, A (corresponding author), Univ Buenos Aires, Sch Pharm & Biochem, Buenos Aires, DF, Argentina.	silval@ffyb.uba.ar			FONCYT of the Agency for Science and Technology Promotion (ANPCyT) [PICT-2008-0998]; National Research Council (CONICET) [PIP-0697]; University of Buenos Aires, Buenos Aires, Argentina [UBA 200 200 90 200 395]	FONCYT of the Agency for Science and Technology Promotion (ANPCyT); National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires, Buenos Aires, Argentina(University of Buenos Aires)	This work was supported in part by grants from FONCYT Programme of the Agency for Science and Technology Promotion (ANPCyT) PICT-2008-0998, National Research Council (CONICET) PIP-0697, and the University of Buenos Aires, Buenos Aires, Argentina (UBA 200 200 90 200 395). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Achenbach P, 2005, DIABETES, V54, pS25, DOI 10.2337/diabetes.54.suppl_2.S25; Achenbach P, 2004, J CLIN INVEST, V114, P589, DOI 10.1172/JCI200421307; [Anonymous], 1985, WHO TECH REP SER, V727, P1; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Ayela C, 2007, BIOSENS BIOELECTRON, V22, P3113, DOI 10.1016/j.bios.2007.01.020; BERZOFSKY JA, 1981, MOL IMMUNOL, V18, P751, DOI 10.1016/0161-5890(81)90067-5; Berzofsky Jay A., 1993, P421; BOHMER K, 1991, DIABETOLOGIA, V34, P830, DOI 10.1007/BF00408359; Borg H, 2002, DIABETES, V51, P1754, DOI 10.2337/diabetes.51.6.1754; BURNET FM, 1961, NEW ENGL J MED, V264, P24, DOI 10.1056/NEJM196101052640107; Caputo M, 2005, AUTOIMMUNITY, V38, P277, DOI 10.1080/08916930500158203; Carlsson J, 2008, BIOSENS BIOELECTRON, V24, P876, DOI 10.1016/j.bios.2008.07.018; Colman PG, 2000, DIABETOLOGIA, V43, P203, DOI 10.1007/s001250050030; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hummel M, 2004, ANN INTERN MED, V140, P882, DOI 10.7326/0003-4819-140-11-200406010-00009; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kimpimaki T, 2002, J CLIN ENDOCR METAB, V87, P4572, DOI 10.1210/jc.2002-020018; Kupila A, 2002, DIABETES, V51, P646, DOI 10.2337/diabetes.51.3.646; Matthews DR, 1998, DIABETIC MED, V15, P297, DOI 10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.3.CO;2-N; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; Pihoker C, 2005, DIABETES, V54, pS52, DOI 10.2337/diabetes.54.suppl_2.S52; Sabbah E, 1999, J CLIN ENDOCR METAB, V84, P1534, DOI 10.1210/jc.84.5.1534; SODOYEZGOFFAUX F, 1988, DIABETOLOGIA, V31, P694, DOI 10.1007/BF00278754; Strebelow M, 1999, DIABETOLOGIA, V42, P661, DOI 10.1007/s001250051213; Trabucchi A, 2011, AMAB IN PRESS; Valdez SN, 2003, J IMMUNOL METHODS, V279, P173, DOI 10.1016/S0022-1759(03)00197-2; Valdez SN, 2001, AUTOIMMUNITY, V33, P227, DOI 10.1080/08916934.2002.11873699; VERGE CF, 1994, DIABETOLOGIA, V37, P1113, DOI 10.1007/BF00418375; Wabl M, 1999, CURR OPIN IMMUNOL, V11, P186, DOI 10.1016/S0952-7915(99)80031-4; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Winter J, 2000, J BIOTECHNOL, V84, P175, DOI 10.1016/S0168-1656(00)00356-4; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	33	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33574	10.1371/journal.pone.0033574	http://dx.doi.org/10.1371/journal.pone.0033574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442700	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500041
J	Kapoor, M; Wang, JC; Bertelsen, S; Bucholz, K; Budde, JP; Hinrichs, A; Agrawal, A; Brooks, A; Chorlian, D; Dick, D; Hesselbrock, V; Foroud, T; Kramer, J; Kuperman, S; Manz, N; Nurnberger, J; Porjesz, B; Rice, J; Tischfield, J; Xuei, XL; Schuckit, M; Edenberg, HJ; Bierut, LJ; Goate, AM				Kapoor, Manav; Wang, Jen-Chyong; Bertelsen, Sarah; Bucholz, Kathy; Budde, John P.; Hinrichs, Anthony; Agrawal, Arpana; Brooks, Andrew; Chorlian, David; Dick, Danielle; Hesselbrock, Victor; Foroud, Tatiana; Kramer, John; Kuperman, Samuel; Manz, Niklas; Nurnberger, John, Jr.; Porjesz, Bernice; Rice, John; Tischfield, Jay; Xuei, Xiaoling; Schuckit, Marc; Edenberg, Howard J.; Bierut, Laura J.; Goate, Alison M.			Variants Located Upstream of CHRNB4 on Chromosome 15q25.1 Are Associated with Age at Onset of Daily Smoking and Habitual Smoking	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE-DEPENDENCE; LUNG-CANCER; SUSCEPTIBILITY LOCUS; ALCOHOL; RISK; INITIATION; GENETICS; GENES; ADOLESCENT	Several genome-wide association and candidate gene studies have linked chromosome 15q24-q25.1 (a region including the CHRNA5-CHRNA3-CHRNB4 gene cluster) with alcohol dependence, nicotine dependence and smoking-related illnesses such as lung cancer and chronic obstructive pulmonary disease. To further examine the impact of these genes on the development of substance use disorders, we tested whether variants within and flanking the CHRNA5-CHRNA3-CHRNB4 gene cluster affect the transition to daily smoking (individuals who smoked cigarettes 4 or more days per week) in a cross sectional sample of adolescents and young adults from the COGA (Collaborative Study of the Genetics of Alcoholism) families. Subjects were recruited from families affected with alcoholism (either as a first or second degree relative) and the comparison families. Participants completed the SSAGA interview, a comprehensive assessment of alcohol and other substance use and related behaviors. Using the Quantitative trait disequilibrium test (QTDT) significant association was detected between age at onset of daily smoking and variants located upstream of CHRNB4. Multivariate analysis using a Cox proportional hazards model further revealed that these variants significantly predict the age at onset of habitual smoking among daily smokers. These variants were not in high linkage disequilibrium (0.28<r(2)<0.56) with variants that have previously been reported to affect risk for nicotine dependence and smoking related diseases in adults. The data suggests that an age-associated relationship underlies the association of SNPs in CHRNB4 with onset of chronic smoking behaviors in adolescents and young adults and may improve genetic information that will lead to better prevention and intervention for substance use disorders among adolescents and young adults.	[Kapoor, Manav; Wang, Jen-Chyong; Bertelsen, Sarah; Bucholz, Kathy; Budde, John P.; Hinrichs, Anthony; Agrawal, Arpana; Rice, John; Bierut, Laura J.; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Brooks, Andrew; Tischfield, Jay] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Chorlian, David; Manz, Niklas; Porjesz, Bernice] Suny Downstate Med Ctr, Dept Psychiat & Behav Sci, Brooklyn, NY 11203 USA; [Dick, Danielle] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Hesselbrock, Victor] Univ Connecticut, Dept Psychiat, Farmington, CT 06107 USA; [Foroud, Tatiana; Xuei, Xiaoling; Edenberg, Howard J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Kramer, John; Kuperman, Samuel; Nurnberger, John, Jr.] Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Schuckit, Marc] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	Washington University (WUSTL); Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Virginia Commonwealth University; University of Connecticut; Indiana University System; Indiana University-Purdue University Indianapolis; University of Iowa; University of California System; University of California San Diego	Kapoor, M (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	goatea@psychiatry.wustl.edu	Xuei, Xiaoling/L-8564-2019; Bierut, Laura Jean/W-6806-2019; Manz, Niklas/A-3234-2009	Bierut, Laura Jean/0000-0002-9952-4810; Manz, Niklas/0000-0003-1483-915X; Kuperman, Samuel/0000-0002-5995-1981; Nurnberger, John/0000-0002-7674-1767; Budde, John/0000-0001-7778-7276; Edenberg, Howard/0000-0003-0344-9690; Goate, Alison/0000-0002-0576-2472; Tischfield, Jay/0000-0003-3217-8287	National Institutes of Health (NIH) from National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U10AA008401]; National Institute on Drug Abuse (NIDA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401, K02AA018755] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This national collaborative study is supported by the National Institutes of Health (NIH) Grant U10AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 1998, ARCH GEN PSYCHIAT, V55, P982, DOI 10.1001/archpsyc.55.11.982; Bruschweiler-Li L, 2010, NEUROSCIENCE, V166, P864, DOI 10.1016/j.neuroscience.2010.01.026; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Centers for Disease Control (CDC), 2010, CURR CIG SMOK AD AG, P1135; Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580; Dick DM, 2007, J ABNORM PSYCHOL, V116, P213, DOI 10.1037/0021-843X.116.1.213; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Ehringer MA, 2007, AM J MED GENET B, V144B, P596, DOI 10.1002/ajmg.b.30464; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Glick SD, 2002, EUR J PHARMACOL, V448, P185, DOI 10.1016/S0014-2999(02)01944-1; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; John U, 2004, ADDICT BEHAV, V29, P857, DOI 10.1016/j.addbeh.2004.02.053; Johnson EO, 2010, ADDICTION, V105, P2014, DOI 10.1111/j.1360-0443.2010.03074.x; Kendler KS, 1999, PSYCHOL MED, V29, P299, DOI 10.1017/S0033291798008022; Koopmans JR, 1999, BEHAV GENET, V29, P383, DOI 10.1023/A:1021618719735; Lessov CN, 2004, PSYCHOL MED, V34, P865, DOI 10.1017/S0033291703001582; Lessov-Schlaggar CN, 2008, BIOCHEM PHARMACOL, V75, P178, DOI 10.1016/j.bcp.2007.08.018; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Mokdad AH, 2004, PUBLIC HEALTH REP, V119, P356, DOI 10.1016/j.phr.2004.04.015; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Loughlin J, 2003, AM J PREV MED, V25, P219, DOI 10.1016/S0749-3797(03)00198-3; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; True WR, 1999, ARCH GEN PSYCHIAT, V56, P655, DOI 10.1001/archpsyc.56.7.655; US Department of Health and Human Services (USDHHS), 2010, TOB SMOK CAUS DIS BI; Wang JC, 2009, HUM MOL GENET, V18, P3125, DOI 10.1093/hmg/ddp231; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125	37	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33513	10.1371/journal.pone.0033513	http://dx.doi.org/10.1371/journal.pone.0033513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438940	gold, Green Published			2022-12-27	WOS:000303309100052
J	Mash, B; Fairall, L; Adejayan, O; Ikpefan, O; Kumari, J; Mathee, S; Okun, R; Yogolelo, W				Mash, Bob; Fairall, Lara; Adejayan, Olubunmi; Ikpefan, Omozuanvbo; Kumari, Jyoti; Mathee, Shaheed; Okun, Ronit; Yogolelo, Willy			A Morbidity Survey of South African Primary Care	PLOS ONE			English	Article								Background: Recent studies have described the burden of disease in South Africa. However these studies do not tell us which of these conditions commonly present to primary care providers, how these conditions may present and how providers make sense of them in terms of their diagnoses. Clinical nurse practitioners are the main primary care providers and need to be better prepared for this role. This study aimed to determine the range and prevalence of reasons for encounter and diagnoses found among ambulatory patients attending public sector primary care facilities in South Africa. Methodology/Principal Findings: The study was a multi-centre prospective cross-sectional survey of consultations in primary care in four provinces of South Africa: Western Cape, Limpopo, Northern Cape and North West. Consultations were coded prior to analysis by using the International Classification of Primary Care-Version 2 in terms of reasons for encounter (REF) and diagnoses. Altogether 18856 consultations were included in the survey and generated 31451 reasons for encounter (RFE) and 24561 diagnoses. Women accounted for 12526 (66.6%) and men 6288 (33.4%). Nurses saw 16238 (86.1%) and doctors 2612 (13.9%) of patients. The top 80 RFE and top 25 diagnoses are reported and ongoing care for hypertension was the commonest RFE and diagnosis. The 20 commonest RFE and diagnoses by age group are also reported. Conclusions/Significance: Ambulatory primary care is dominated by non-communicable chronic diseases. HIV/AIDS and TB are common, but not to the extent predicted by the burden of disease. Pneumonia and gastroenteritis are commonly seen especially in children. Women's health issues such as family planning and pregnancy related visits are also common. Injuries are not as common as expected from the burden of disease. Primary care providers did not recognise mental health problems. The results should guide the future training and assessment of primary care providers.	[Mash, Bob] Univ Stellenbosch, Div Family Med & Primary Care, Cape Town, Western Cape, South Africa; [Fairall, Lara; Adejayan, Olubunmi; Ikpefan, Omozuanvbo; Kumari, Jyoti; Mathee, Shaheed; Okun, Ronit; Yogolelo, Willy] Univ Cape Town, Knowledge Translat Unit, Lung Inst, Cape Town, Western Cape, South Africa	Stellenbosch University; University of Cape Town	Mash, B (corresponding author), Univ Stellenbosch, Div Family Med & Primary Care, Cape Town, Western Cape, South Africa.	rm@sun.ac.za		Mash, Robert/0000-0001-7373-0774; Fairall, Lara/0000-0002-7460-4670	National Research Foundation South Africa	National Research Foundation South Africa(National Research Foundation - South AfricaSouth African Medical Research Council)	This study was supported by funds from the National Research Foundation (http://nrfonline.nrf.ac.za/) of South Africa's Incentive Scheme for Rated Researchers (Prof Bob Mash) and by funds held by PALSA Plus, Lung Institute, University of Cape Town. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOOM B, 1988, S AFR MED J, V73, P166; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P438; Brueton V, 2010, SAMJ S AFR MED J, V100, P309, DOI 10.7196/SAMJ.3427; Couper I, 2006, HDB FAMILY MED, P298; De Villiers P, 1994, S AFR FAM PRACT, V15, P363; Department of Health, 2011, GOVT GAZETTE, V554, P34523; Harris M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4945; Hugo J, 2008, DOCTORS TOMORROW FAM; Joyner K, 2010, ASPECTS FORENSIC MED; Okkes IM, 2002, J FAM PRACTICE, V51, P31; Rayner B, 2010, NEPHRON CLIN PRACT, V116, pC269, DOI 10.1159/000318788; Rispel L, 2010, REVITALISING PRIMARY; Ross DA, 2006, WHO TECH REP SER, V938, P1; Silbert M, 1970, S AFR MED J, V448, P28; USTUN TB, 1995, MENTAL ILLNESS GEN H; WHO, 2008, WORLD HLTH REP PRIM; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; WONCA International Classification Committee, 1998, INT CLASS PRIM CAR I	18	97	102	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e32358	10.1371/journal.pone.0032358	http://dx.doi.org/10.1371/journal.pone.0032358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22442666	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100008
J	Zanoni, BC; Phungula, T; Zanoni, HM; France, H; Cook, EF; Feeney, ME				Zanoni, Brian C.; Phungula, Thuli; Zanoni, Holly M.; France, Holly; Cook, E. Francis; Feeney, Margaret E.			Predictors of Poor CD4 and Weight Recovery in HIV-Infected Children Initiating ART in South Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1-INFECTED CHILDREN; IMMUNE RECONSTITUTION; LYMPHOID-TISSUE; EARLY MORTALITY; T-CELLS; GROWTH; ACTIVATION; HAART; DISEASE	Objective: To identify baseline demographic and clinical risk factors associated with poor CD4 and weight response after initiation of antiretroviral therapy (ART) in a cohort of human immunodeficiency virus (HIV)-infected children in KwaZulu-Natal, South Africa. Methods: We performed a retrospective cohort study of 674 children initiating antiretroviral therapy at McCord and St. Mary's hospitals in KwaZulu-Natal, South Africa, from August 2003 to December 2008. We extracted data from paper charts and electronic medical records to assess risk factors associated with CD4 and weight response using logistic regression. Results: From the initial cohort of 901 children,10 years old initiating ART between August 2003 and December 2008, we analyzed 674 children with complete baseline data. Viral suppression rates (<400 copies/ml) were 84% after six months of therapy and 88% after 12 months of therapy. Seventy-three percent of children achieved CD4 recovery after six months and 89% after 12 months. Weight-for-age Z-score (WAZ) improvements were seen in 58% of children after six months of ART and 64% after 12 months. After six months of ART, lower baseline hemoglobin (p = 0.037), presence of chronic diarrhea (p = 0.007), and virologic failure (p = 0.046) were all associated with poor CD4 recovery by multivariate logistic regression. After 12 months of ART, poor CD4 recovery was associated with higher baseline CD4% (p = 0.005), chronic diarrhea (p = 0.02), and virologic failure (p<0.001). Age less than 3 years at ART initiation (p = 0.0003), higher baseline CD4% (p<0.001), and higher baseline WAZ (p<0.001) were all associated with poor WAZ improvements after 6 months by multivariate logistic regression. Conclusion: The presence of chronic diarrhea at baseline, independent of nutritional status and viral response, predicts poor CD4 recovery. Age at initiation of ART is an important factor in early WAZ response to ART, while viral suppression strongly predicts CD4 recovery but not WAZ improvement.	[Zanoni, Brian C.] Ragon Inst MGH MIT & Harvard, Charlestown, MA 02129 USA; [Zanoni, Brian C.] Harvard Univ, Sch Med, Boston, MA USA; [Zanoni, Brian C.; Phungula, Thuli; Zanoni, Holly M.; France, Holly; Feeney, Margaret E.] McCord Hosp, Sinikithemba Clin, Durban, South Africa; [Zanoni, Brian C.; Phungula, Thuli; Zanoni, Holly M.; France, Holly; Feeney, Margaret E.] McCord Hosp, Philani Program, Durban, South Africa; [Cook, E. Francis] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Feeney, Margaret E.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco	Zanoni, BC (corresponding author), Ragon Inst MGH MIT & Harvard, Charlestown, MA 02129 USA.	margaret.feeney@ucsf.edu	Zanoni, Brian/AAI-4916-2021		Sullivan Family Foundation; Elizabeth Glaser Pediatric AIDS Foundation; Jewelers for Children Elizabeth Glaser Scientist Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	Sullivan Family Foundation; Elizabeth Glaser Pediatric AIDS Foundation; Jewelers for Children Elizabeth Glaser Scientist Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was generously supported by the Sullivan Family Foundation and the Elizabeth Glaser Pediatric AIDS Foundation (to MEF). MEF is the recipient of the Jewelers for Children Elizabeth Glaser Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 2008, ANN TROP PAEDIATR, V28, P279, DOI 10.1179/146532808X375440; Banerjee T, 2010, ANN TROP PAEDIATR, V30, P27, DOI 10.1179/146532810X12637745451915; Barreiro P, 2002, AIDS, V16, P245, DOI 10.1097/00002030-200201250-00014; Bong CN, 2007, AIDS, V21, P1805, DOI 10.1097/QAD.0b013e3282c3a9e4; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Callens SFJ, 2009, PEDIATR INFECT DIS J, V28, P35, DOI 10.1097/INF.0b013e318184eeb9; Dillingham RA, 2009, AM J TROP MED HYG, V80, P1060, DOI 10.4269/ajtmh.2009.80.1060; Eisenhut M, 2007, AIDS, V21, P1227, DOI 10.1097/QAD.0b013e32812685d2; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guillen S, 2007, PEDIATR INFECT DIS J, V26, P334, DOI 10.1097/01.inf.0000257427.19764.ff; Hainaut M, 2003, PEDIATR INFECT DIS J, V22, P62, DOI 10.1097/00006454-200301000-00016; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kabue MM, 2008, AIDS PATIENT CARE ST, V22, P245, DOI 10.1089/apc.2007.0049; Kekitiinwa A, 2008, JAIDS-J ACQ IMM DEF, V49, P384, DOI 10.1097/QAI.0b013e31818cdef5; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Kovacs A, 2005, J INFECT DIS, V192, P296, DOI 10.1086/430922; Kugathasan S, 1998, J PEDIATR-US, V133, P675, DOI 10.1016/S0022-3476(98)70111-8; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Machado DM, 2007, BRAZ J INFECT DIS, V11, P16, DOI 10.1590/S1413-86702007000100006; Naidoo R, 2010, PEDIATR INFECT DIS J, V29, P511, DOI 10.1097/INF.0b013e3181d1e989; Newell ML, 2006, J INFECT DIS, V193, P954, DOI 10.1086/500842; Diniz LMO, 2011, J PEDIAT-BRAZIL, V87, P131, DOI [10.2223/JPED.2064, 10.1590/S0021-75572011000200008]; PENEDOPITA M, 1991, J PEDIATR GASTR NUTR, V12, P56, DOI 10.1097/00005176-199101000-00012; Rosenblatt HM, 2005, J INFECT DIS, V192, P445, DOI 10.1086/431597; Rouet F, 2006, AIDS, V20, P2315, DOI 10.1097/QAD.0b013e328010943b; Salvatore S, 2008, NUTRITION, V24, P1205, DOI 10.1016/j.nut.2008.04.011; South African National Department of Health, 2010, GUID MAN HIV CHILDR; South African National Department of Health, 2004, NAT ANT TREATM GUID; Wamalwa DC, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-33; Weigel R, 2010, TROP MED INT HEALTH, V15, P934, DOI 10.1111/j.1365-3156.2010.02561.x; World Health Organization, 2010, ANT THER HIV INF INF; World Health Organization, 2006, ANT THER HIV INF AD; Zanoni BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022706; Zulu I, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-156	34	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33611	10.1371/journal.pone.0033611	http://dx.doi.org/10.1371/journal.pone.0033611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438965	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100071
J	Cardoso, AM; Cavalcante, JJV; Vieira, RP; Lima, JL; Grieco, MAB; Clementino, MM; Vasconcelos, ATR; Garcia, ES; de Souza, W; Albano, RM; Martins, OB				Cardoso, Alexander M.; Cavalcante, Janaina J. V.; Vieira, Ricardo P.; Lima, Joyce L.; Grieco, Maria Angela B.; Clementino, Maysa M.; Vasconcelos, Ana Tereza R.; Garcia, Eloi S.; de Souza, Wanderley; Albano, Rodolpho M.; Martins, Orlando B.			Gut Bacterial Communities in the Giant Land Snail Achatina fulica and Their Modification by Sugarcane-Based Diet	PLOS ONE			English	Article							MICROBIOME; ENVIRONMENT; POPULATION; GASTROPODA; DIVERSITY; ECOLOGY; FLORA	The invasive land snail Achatina fulica is one of the most damaging agricultural pests worldwide representing a potentially serious threat to natural ecosystems and human health. This species is known to carry parasites and harbors a dense and metabolically active microbial community; however, little is known about its diversity and composition. Here, we assessed for the first time the complexity of bacterial communities occurring in the digestive tracts of field-collected snails (FC) by using culture-independent molecular analysis. Crop and intestinal bacteria in FC were then compared to those from groups of snails that were reared in the laboratory (RL) on a sugarcane-based diet. Most of the sequences recovered were novel and related to those reported for herbivorous gut. Changes in the relative abundance of Bacteroidetes and Firmicutes were observed when the snails were fed a high-sugar diet, suggesting that the snail gut microbiota can influence the energy balance equation. Furthermore, this study represents a first step in gaining a better understanding of land snail gut microbiota and shows that this is a complex holobiont system containing diverse, abundant and active microbial communities.	[Cardoso, Alexander M.; Cavalcante, Janaina J. V.; Grieco, Maria Angela B.; Garcia, Eloi S.; de Souza, Wanderley; Martins, Orlando B.] Inst Nacl Metrol Qualidade & Tecnol, Rio De Janeiro, Brazil; [Vieira, Ricardo P.; Lima, Joyce L.; Martins, Orlando B.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Clementino, Maysa M.] Fundacao Oswaldo Cruz, Inst Nacl Controle Qualidade Saude, Rio De Janeiro, Brazil; [Vasconcelos, Ana Tereza R.] Lab Nacl Comp Cient, Rio De Janeiro, Brazil; [Garcia, Eloi S.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil	Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Laboratorio Nacional de Computacao Cientifica (LNCC); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Cardoso, AM (corresponding author), Inst Nacl Metrol Qualidade & Tecnol, Rio De Janeiro, Brazil.	amcardoso@bioqmed.ufrj.br	Clementino, Maysa/C-1944-2009; Vasconcelos, Ana Tereza R/I-1011-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Cardoso, Alexander/S-6687-2017; Cardoso, Alexander/AAX-2505-2021; Cavalcante, Janaina/X-8657-2018	Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Cardoso, Alexander/0000-0003-2974-0232; Albano, Rodolpho/0000-0002-0643-901X; B. Grieco, Maria Angela/0000-0002-7099-3787; Cavalcante, Janaina/0000-0002-6059-7684	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Charrier M, 1998, CAN J MICROBIOL, V44, P20, DOI 10.1139/cjm-44-1-20; CHARRIER M, 1980, ANN NUTR ALIMENT, V34, P147; Charrier M, 2006, BIOL RES, V39, P669, DOI 10.4067/S0716-97602006000500010; Dubilier N, 2001, NATURE, V411, P298, DOI 10.1038/35077067; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GHOSE KRISHNA CHANDRA, 1963, TRANS AMER MICROSCOP SOC, V82, P149, DOI 10.2307/3223991; Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000520; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Van Horn DJ, 2011, J MOLLUS STUD, V0, P1; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Worthen PL, 2006, APPL ENVIRON MICROB, V72, P4775, DOI 10.1128/AEM.00356-06; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zanol J, 2010, BIOTA NEOTROP, V10, P447, DOI 10.1590/S1676-06032010000300038	28	45	49	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33440	10.1371/journal.pone.0033440	http://dx.doi.org/10.1371/journal.pone.0033440			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438932	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309000026
J	Kang, XJ; Xie, QD; Zhou, XL; Li, FZ; Huang, JH; Liu, DL; Huang, TH				Kang, XiangJin; Xie, QingDong; Zhou, XiaoLing; Li, FangZheng; Huang, JiHua; Liu, DongLing; Huang, TianHua			Effects of Hepatitis B Virus S Protein Exposure on Sperm Membrane Integrity and Functions	PLOS ONE			English	Article							HUMAN SPERMATOZOA; OXIDATIVE STRESS; FLOW-CYTOMETRY; FREE-RADICALS; CELL-DEATH; HBV DNA; APOPTOSIS; GENERATION; TRANSMISSION; MITOCHONDRIA	Background: Hepatitis B is a public health problem worldwide. Viral infection can affect a man's fertility, but only scant information about the influence of hepatitis B virus (HBV) infection on sperm quality is available. The purpose of this study was to investigate the effect of hepatitis B virus S protein (HBs) on human sperm membrane integrity and functions. Methods/Principal Findings: Reactive oxygen species (ROS), lipid peroxidation (LP), total antioxidant capacity (TAC) and phosphatidylserine (PS) externalization were determined. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assays and flow cytometric analyses were performed. (1) After 3 h incubation with 25 mu g/ml of HBs, the average rates of ROS positive cells, annexin V-positive/propidium iodide (PI)-negative cells, Caspases-3,-8,-9 positive cells and TUNEL-positive cells were significantly increased in the test groups as compared to those in the control groups, while TAC level was decreased when compared with the control. The level of malondialdehyde (MDA) in the sperm cells exposed to 50 mu g/ml of HBs for 3 h was significantly higher than that in the control (P<0.05-0.01). (2) HBs increased the MDA levels and the numbers of ROS positive cells, annexin V-positive/PI-negative cells, caspases-3, -8, -9 positive cells and TUNEL-positive cells in a dose-dependent manner. (3) HBs monoclonal antibody (MAb) and N-Acetylcysteine (NAC) reduced the number of ROS-positive sperm cells. (4) HBs decreased the TAC levels in sperm cells in a dose-dependent manner. Conclusion: HBs exposure could lead to ROS generation, lipid peroxidation, TAC reduction, PS externalization, activation of caspases, and DNA fragmentation, resulting in increased apoptosis of sperm cells and loss of sperm membrane integrity and causing sperm dysfunctions.	[Kang, XiangJin; Xie, QingDong; Zhou, XiaoLing; Li, FangZheng; Huang, JiHua; Liu, DongLing; Huang, TianHua] Shantou Univ, Coll Med, Res Ctr Reprod Med, Shantou, Peoples R China	Shantou University	Kang, XJ (corresponding author), Shantou Univ, Coll Med, Res Ctr Reprod Med, Shantou, Peoples R China.	thhuang@stu.edu.cn	Liu, Dongling/AAT-6385-2021	Liu, Dongling/0000-0003-1583-7682; Zhou, Xiaoling/0000-0001-5721-944X	National Nature Science Foundation of China [30972526]; Li Ka Shing Shantou University Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Shantou University Foundation	This work was financially supported by the National Nature Science Foundation of China (No. 30972526) and the Li Ka Shing Shantou University Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2006, CURR OPIN OBSTET GYN, V18, P325, DOI 10.1097/01.gco.0000193003.58158.4e; Agarwal A, 2006, UROLOGY, V67, P2, DOI 10.1016/j.urology.2005.07.012; Agarwal A, 2005, J ANDROL, V26, P654, DOI 10.2164/jandrol.05016; Aitken RJ, 2001, REPRODUCTION, V122, P497, DOI 10.1530/rep.0.1220497; AITKEN RJ, 1993, MOL REPROD DEV, V35, P302, DOI 10.1002/mrd.1080350313; ALBERTI A, 1990, SPRINGER SEMIN IMMUN, V12, P5; Ali BA, 2006, ASIAN J ANDROL, V8, P273, DOI 10.1111/j.1745-7262.2006.00141.x; Ali BA, 2005, MOL REPROD DEV, V70, P30, DOI 10.1002/mrd.20185; BELLAMY COC, 1995, SEMIN CANCER BIOL, V6, P3, DOI 10.1006/scbi.1995.0002; CROSS NL, 1991, HUM REPROD, V6, P1279, DOI 10.1093/oxfordjournals.humrep.a137526; DELAMIRANDE E, 1995, HUM REPROD, V10, P15, DOI 10.1093/humrep/10.suppl_1.15; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Ganem D., 1996, FIELDS VIROLOGY, P2703; Gravance CG, 2001, REPROD TOXICOL, V15, P5, DOI 10.1016/S0890-6238(00)00113-1; Griveau JF, 1997, INT J ANDROL, V20, P61, DOI 10.1046/j.1365-2605.1997.00044.x; Grunewald S, 2008, INT J ANDROL, V31, P325, DOI 10.1111/j.1365-2605.2007.00768.x; Grunewald S, 2005, FERTIL STERIL, V83, P1106, DOI 10.1016/j.fertnstert.2004.12.011; HADCHOUEL M, 1985, J MED VIROL, V16, P61, DOI 10.1002/jmv.1890160109; Huang JM, 2002, ASIAN J ANDROL, V4, P209; Kobayashi H, 2001, J ANDROL, V22, P568; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Lang Z W, 1993, Zhonghua Yi Xue Za Zhi, V73, P329; Lang ZW, 1993, ZHONGHUA YI XUE ZA Z, V73, P379; Makker K, 2009, INDIAN J MED RES, V129, P357; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Moretti E, 2008, ANDROLOGIA, V40, P286, DOI 10.1111/j.1439-0272.2008.00855.x; Moustafa MH, 2004, HUM REPROD, V19, P129, DOI 10.1093/humrep/deh024; Ochsendorf FR, 1999, HUM REPROD UPDATE, V5, P399, DOI 10.1093/humupd/5.5.399; Piasecka M, 2003, FOLIA HISTOCHEM CYTO, V41, P125; Richburg JH, 2000, TOXICOL LETT, V112, P79, DOI 10.1016/S0378-4274(99)00253-2; Sakkas D, 2010, FERTIL STERIL, V93, P1027, DOI 10.1016/j.fertnstert.2009.10.046; Saleh RA, 2002, FERTIL STERIL, V78, P1215, DOI 10.1016/S0015-0282(02)04237-1; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SCOTT RM, 1980, J INFECT DIS, V142, P67, DOI 10.1093/infdis/142.1.67; Shen HM, 2002, HUM REPROD, V17, P1266, DOI 10.1093/humrep/17.5.1266; Tominaga H, 2004, J RADIAT RES, V45, P181, DOI 10.1269/jrr.45.181; Venkatesh S, 2009, ANDROLOGIA, V41, P251, DOI 10.1111/j.1439-0272.2009.00943.x; Wang S, 1999, Zhonghua Liu Xing Bing Xue Za Zhi, V20, P204; Wang X, 2003, FERTIL STERIL, V80, P844, DOI 10.1016/S0015-0282(03)00983-X; World Health Organization, 2008, HEP B; Wu JN, 2008, J PHARMACOL SCI, V108, P32, DOI 10.1254/jphs.FP0072079; Zalata AA, 2004, ASIAN J ANDROL, V6, P313; Zheng BJ, 2001, VACCINE, V19, P4219, DOI 10.1016/S0264-410X(01)00158-X; Zhou XL, 2009, HUM REPROD, V24, P1575, DOI 10.1093/humrep/dep050	44	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33471	10.1371/journal.pone.0033471	http://dx.doi.org/10.1371/journal.pone.0033471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470450	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000020
J	Sharma, R; Kothapalli, R; Van Dongen, AMJ; Swaminathan, K				Sharma, Reetu; Kothapalli, Roopa; Van Dongen, Antonius M. J.; Swaminathan, Kunchithapadam			Chemoinformatic Identification of Novel Inhibitors against Mycobacterium tuberculosis L-aspartate alpha-decarboxylase	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MASS-SPECTROMETRY; BETA-ALANINE; BIOSYNTHESIS; PURIFICATION; PANTOTHENATE; SPECIFICITY; DATABASE; ENZYME	L-Aspartate a-decarboxylase (ADC) belongs to a class of pyruvoyl dependent enzymes and catalyzes the conversion of aspartate to beta-alanine in the pantothenate pathway, which is critical for the growth of several micro-organisms, including Mycobacterium tuberculosis (Mtb). Its presence only in micro-organisms, fungi and plants and its absence in animals, particularly human, make it a promising drug target. We have followed a chemoinformatics-based approach to identify potential drug-like inhibitors against Mycobacterium tuberculosis L-aspartate alpha-decarboxylase (MtbADC). The structurebased high throughput virtual screening (HTVS) mode of the Glide program was used to screen 333,761 molecules of the Maybridge, National Cancer Institute (NCI) and Food and Drug Administration (FDA) approved drugs databases. Ligands were rejected if they cross-reacted with S-adenosylmethionine (SAM) decarboxylase, a human pyruvoyl dependent enzyme. The lead molecules were further analyzed for physicochemical and pharmacokinetic parameters, based on Lipinski's rule of five, and ADMET (absorption, distribution, metabolism, excretion and toxicity) properties. This analysis resulted in eight small potential drug-like inhibitors that are in agreement with the binding poses of the crystallographic ADC: fumarate and ADC: isoasparagine complex structures and whose backbone scaffolds seem to be suitable for further experimental studies in therapeutic development against tuberculosis.	[Sharma, Reetu; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Kothapalli, Roopa] Natl Univ Singapore, Dept Obstet & Gynaecol, Singapore 117548, Singapore; [Van Dongen, Antonius M. J.] Natl Univ Singapore, Duke NUS Grad Med Sch, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Sharma, R (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsks@nus.edu.sg	mo, qin/O-7877-2014	Sharma, Reetu/0000-0002-3300-9832	Ministry of Education, Singapore [R154-000-439-112]	Ministry of Education, Singapore(Ministry of Education, Singapore)	Funding was provided by the Academic Research Fund, Tier-1 (Faculty Research Grant), Ministry of Education, Singapore. Grant: R154-000-439-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert A, 1998, NAT STRUCT BIOL, V5, P289, DOI 10.1038/nsb0498-289; Andreu N, 2012, J ANTIMICROB CHEMOTH, V67, P404, DOI 10.1093/jac/dkr472; [Anonymous], 2009, PROTEIN PREPARATION; [Anonymous], 1997, WORLD HTLH REP; Bale S, 2009, BIOCHEMISTRY-US, V48, P6423, DOI 10.1021/bi900590m; Chopra S, 2002, PROTEIN EXPRES PURIF, V25, P533, DOI 10.1016/S1046-5928(02)00039-6; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Daffe M, 1997, ENVELOPE LAYERS MYCO, P131; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gopalan G, 2006, PROTEINS, V65, P796, DOI 10.1002/prot.21126; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JACKOWSKI S, 1996, ESCHERICHIA COLI SAL; Jorgensen W.L., 2006, QIKPROP V 3 0; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Karakousis PC, 2009, INFECT DIS-SER, P271, DOI 10.1007/978-1-59745-180-2_24; Kennedy J, 2004, ANAL BIOCHEM, V327, P91, DOI 10.1016/j.ab.2003.11.027; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee B, 2004, J MOL BIOL, V340, P1, DOI 10.1016/j.jmb.2004.04.049; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Merritt EA, 1997, METHOD ENZYMOL, V277, P19; Ramjee MK, 1997, BIOCHEM J, V323, P661, DOI 10.1042/bj3230661; RAVEL JM, 1946, J BIOL CHEM, V166, P407; RECSEI PA, 1984, ANNU REV BIOCHEM, V53, P357, DOI 10.1146/annurev.bi.53.070184.002041; Saldanha SA, 2001, CHEM COMMUN, P1760, DOI 10.1039/b106090m; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Shatsky M., 2002, MULTIPROT MULTIPLE P, P235, DOI [10.1007/3-540-45784-4i8, DOI 10.1007/3-540-45784-4I8]; SHIVE W, 1946, J BIOL CHEM, V162, P451; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; Webb ME, 2004, NAT PROD REP, V21, P695, DOI 10.1039/b316419p; Webb ME, 2003, CHEM COMMUN, P2416, DOI 10.1039/b308182f; WILLIAMSON JM, 1979, J BIOL CHEM, V254, P8074; WILLIAMSON JM, 1985, METHOD ENZYMOL, V113, P589	37	12	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33521	10.1371/journal.pone.0033521	http://dx.doi.org/10.1371/journal.pone.0033521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470451	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000021
J	Giuntini, S; Beernink, PT; Reason, DC; Granoff, DM				Giuntini, Serena; Beernink, Peter T.; Reason, Donald C.; Granoff, Dan M.			Monoclonal Antibodies to Meningococcal Factor H Binding Protein with Overlapping Epitopes and Discordant Functional Activity	PLOS ONE			English	Article							B NEISSERIA-MENINGITIDIS; YEAST SURFACE DISPLAY; ESCHERICHIA-COLI K1; BACTERICIDAL ACTIVITY; VACCINE CANDIDATE; LIPOPROTEIN; STRAINS; ANTIGEN; GNA1870; REGION	Background: Meningococcal factor H binding protein (fHbp) is a promising vaccine candidate. Anti-fHbp antibodies can bind to meningococci and elicit complement-mediated bactericidal activity directly. The antibodies also can block binding of the human complement down-regulator, factor H (fH). Without bound fH, the organism would be expected to have increased susceptibility to bacteriolysis. Here we describe bactericidal activity of two anti-fHbp mAbs with overlapping epitopes in relation to their different effects on fH binding and bactericidal activity. Methods and Principal Findings: Both mAbs recognized prevalent fHbp sequence variants in variant group 1. Using yeast display and site-specific mutagenesis, binding of one of the mAbs (JAR 1, IgG3) to fHbp was eliminated by a single amino acid substitution, R204A, and was decreased by K143A but not by R204H or D142A. The JAR 1 epitope overlapped that of previously described mAb (mAb502, IgG2a) whose binding to fHbp was eliminated by R204A or R204H substitutions, and was decreased by D142A but not by K143A. Although JAR 1 and mAb502 appeared to have overlapping epitopes, only JAR 1 inhibited binding of fH to fHbp and had human complement-mediated bactericidal activity. mAb502 enhanced fH binding and lacked human complement-mediated bactericidal activity. To control for confounding effects of different mouse IgG subclasses on complement activation, we created chimeric mAbs in which the mouse mAb502 or JAR 1 paratopes were paired with human IgG1 constant regions. While both chimeric mAbs showed similar binding to fHbp, only JAR 1, which inhibited fH binding, had human complement-mediated bactericidal activity. Conclusions: The lack of human complement-mediated bactericidal activity by anti-fHbp mAb502 appeared to result from an inability to inhibit binding of fH. These results underscore the importance of inhibition of fH binding for anti-fHbp mAb bactericidal activity.	[Giuntini, Serena; Beernink, Peter T.; Reason, Donald C.; Granoff, Dan M.] Childrens Hosp Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Giuntini, S (corresponding author), Childrens Hosp Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA USA.	dgranoff@chori.org			Novartis Vaccines and Diagnostics, Siena Italy; National Institute of Allergy and Infectious Diseases, NIH [R01 AI 046464, AI 082263, AI57932, AI 070955]; Clorox Company; National Center for Research Resources, NIH [C06 RR 016226]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046464, R01AI070955, R01AI057932, R01AI082263] Funding Source: NIH RePORTER	Novartis Vaccines and Diagnostics, Siena Italy; National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Clorox Company; National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a research grant from Novartis Vaccines and Diagnostics, Siena Italy, and Public Health Service grants R01 AI 046464 and AI 082263 (to D. M. G.), AI57932 (to D. C. R.) and AI 070955 (to P. T. B.) from the National Institute of Allergy and Infectious Diseases, NIH. D. M. G. also is supported in part by an endowment established by the Clorox Company. S. G. is enrolled as a PhD student at the University Vita-Salute San Raffaele, Milan, Italy. Her work at Children's Hospital Oakland Research Institute was supported in part by a grant from Novartis Vaccines, Siena Italy. The laboratory work at Children's Hospital Oakland Research Institute was performed in a facility funded by Research Facilities Improvement Program grant C06 RR 016226 from the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZMI FH, 1994, INFECT IMMUN, V62, P1776, DOI 10.1128/IAI.62.5.1776-1786.1994; Beernink PT, 2009, J INFECT DIS, V199, P1360, DOI 10.1086/597806; Beernink PT, 2008, INFECT IMMUN, V76, P4232, DOI 10.1128/IAI.00367-08; Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Beernink PT, 2006, CLIN VACCINE IMMUNOL, V13, P758, DOI 10.1128/CVI.00097-06; Beernink PT, 2011, J IMMUNOL, V186, P3606, DOI 10.4049/jimmunol.1003470; Beernink PT, 2009, MICROBIOL-SGM, V155, P2873, DOI 10.1099/mic.0.029876-0; Beernink PT, 2009, MOL IMMUNOL, V46, P1647, DOI 10.1016/j.molimm.2009.02.021; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brehony C, 2009, MICROBIOL-SGM, V155, P4155, DOI 10.1099/mic.0.027995-0; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Dunphy KY, 2011, INFECT IMMUN, V79, P353, DOI 10.1128/IAI.00849-10; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; FINNE J, 1983, LANCET, V2, P355; FINNE J, 1987, J IMMUNOL, V138, P4402; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Gasteiger J, 2006, ANAL BIOANAL CHEM, V384, P57, DOI 10.1007/s00216-005-0065-y; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Giuntini S, 2011, INFECT IMMUN; Giuntini S, 2012, INFECT IMMUN, V80, P187, DOI 10.1128/IAI.05956-11; Giuntini S, 2011, INFECT IMMUN, V79, P3751, DOI 10.1128/IAI.05182-11; Gottfredsson M, 2011, CLIN INFECT DIS, V53, pE117, DOI 10.1093/cid/cir500; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JENNINGS HJ, 1986, J IMMUNOL, V137, P1708; Jiang H-Q, 2008, PREDICTION BROAD VAC; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mascioni A, 2009, J BIOL CHEM, V284, P8729, DOI 10.1074/jbc.M808831200; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Michaelsen TE, 2004, SCAND J IMMUNOL, V59, P34, DOI 10.1111/j.0300-9475.2004.01362.x; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Pajon R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001302; Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027; Plested JS, 2008, CLIN VACCINE IMMUNOL, V15, P799, DOI 10.1128/CVI.00036-08; Robbins JB, 2011, P NATL ACAD SCI USA, V108, P17871, DOI 10.1073/pnas.1114489108; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE71, DOI 10.1097/INF.0b013e3181f59f6d; Vu DM, 2011, INFECT IMMUN; Welsch JA, 2004, J IMMUNOL, V172, P5606, DOI 10.4049/jimmunol.172.9.5606; Welsch JA, 2008, J INFECT DIS, V197, P1053, DOI 10.1086/528994	52	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34272	10.1371/journal.pone.0034272	http://dx.doi.org/10.1371/journal.pone.0034272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461909	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900027
J	Hahn, S; Kim, D				Hahn, Seungsoo; Kim, Dongsup			Transient Protein-Protein Interaction of the SH3-Peptide Complex via Closely Located Multiple Binding Sites	PLOS ONE			English	Article							AMPHIPHYSIN-1 SH3 DOMAIN; SPOT-SYNTHESIS; PEPTIDE RECOGNITION; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; RICH REGION; DRUG DESIGN; SPECIFICITY; PROLINE; ASSOCIATION	Protein-protein interactions play an essential role in cellular processes. Certain proteins form stable complexes with their partner proteins, whereas others function by forming transient complexes. The conventional protein-protein interaction model describes an interaction between two proteins under the assumption that a protein binds to its partner protein through a single binding site. In this study, we improved the conventional interaction model by developing a Multiple-Site (MS) model in which a protein binds to its partner protein through closely located multiple binding sites on a surface of the partner protein by transiently docking at each binding site with individual binding free energies. To test this model, we used the protein-protein interaction mediated by Src homology 3 (SH3) domains. SH3 domains recognize their partners via a weak, transient interaction and are therefore promiscuous in nature. Because the MS model requires large amounts of data compared with the conventional interaction model, we used experimental data from the positionally addressable syntheses of peptides on cellulose membranes (SPOT-synthesis) technique. From the analysis of the experimental data, individual binding free energies for each binding site of peptides were extracted. A comparison of the individual binding free energies from the analysis with those from atomistic force fields gave a correlation coefficient of 0.66. Furthermore, application of the MS model to 10 SH3 domains lowers the prediction error by up to 9% compared with the conventional interaction model. This improvement in prediction originates from a more realistic description of complex formation than the conventional interaction model. The results suggested that, in many cases, SH3 domains increased the protein complex population through multiple binding sites of their partner proteins. Our study indicates that the consideration of general complex formation is important for the accurate description of protein complex formation, and especially for those of weak or transient protein complexes.	[Hahn, Seungsoo; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kim, D (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon, South Korea.	kds@kaist.ac.kr	Kim, Dongsup/C-1612-2011; Hahn, Seungsoo/C-8026-2016	Hahn, Seungsoo/0000-0002-2763-1166	National Research Foundation of Korea(NRF); Ministry of Education, Science and Technology [2011-0003972, 2008-2000220]; Korea Government (MEST) [2009-0086964]	National Research Foundation of Korea(NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology(2011-0003972) Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2008-2000220). The National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST) (2009-0086964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2008, ANGEW CHEM INT EDIT, V47, P7626, DOI 10.1002/anie.200801856; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Apgar JR, 2009, J COMPUT CHEM, V30, P2402, DOI 10.1002/jcc.21249; Case D. A., 2006, AMBER9; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; Diaz-Ortiz A, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/40/406206; Diaz-Ortiz A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.012202; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Evanics F, 2007, BBA-GEN SUBJECTS, V1770, P221, DOI 10.1016/j.bbagen.2006.10.017; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hahn S, 2010, J COMPUT CHEM, V31, P2900, DOI 10.1002/jcc.21585; Hiipakka M, 1999, J MOL BIOL, V293, P1097, DOI 10.1006/jmbi.1999.3225; Hong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012654; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hou TJ, 2009, MOL CELL PROTEOMICS, V8, P639, DOI 10.1074/mcp.M800450-MCP200; Hou TJ, 2006, J PROTEOME RES, V5, P32, DOI 10.1021/pr0502267; Janin J, 1997, PROTEINS, V28, P153, DOI 10.1002/(SICI)1097-0134(199706)28:2<153::AID-PROT4>3.0.CO;2-G; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kramer A, 1999, J PEPT RES, V54, P319, DOI 10.1034/j.1399-3011.1999.00108.x; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Marles JA, 2004, MOL CELL, V14, P813, DOI 10.1016/j.molcel.2004.05.024; Mayer BJ, 2001, J CELL SCI, V114, P1253; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; SMITHGALL TE, 1995, J PHARMACOL TOX MET, V34, P125, DOI 10.1016/1056-8719(95)00082-7; Spaar A, 2006, BIOPHYS J, V90, P1913, DOI 10.1529/biophysj.105.075507; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Wunderlich L, 1999, CELL SIGNAL, V11, P253, DOI 10.1016/S0898-6568(98)00054-0; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e32804	10.1371/journal.pone.0032804	http://dx.doi.org/10.1371/journal.pone.0032804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457720	Green Submitted, Green Published, gold			2022-12-27	WOS:000303909200006
J	Cardona, L; de Quevedo, IA; Borrell, A; Aguilar, A				Cardona, Luis; Alvarez de Quevedo, Irene; Borrell, Assumpcio; Aguilar, Alex			Massive Consumption of Gelatinous Plankton by Mediterranean Apex Predators	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; ATLANTIC BLUEFIN TUNA; THUNNUS-THYNNUS LINNAEUS; SOUTHERN TYRRHENIAN SEA; CARETTA-CARETTA; FEEDING-HABITS; BIOCHEMICAL-COMPOSITION; STENELLA-COERULEOALBA; PROXIMATE-COMPOSITION; TETRAPTURUS-BELONE	Stable isotopes of carbon and nitrogen were used to test the hypothesis that stomach content analysis has systematically overlooked the consumption of gelatinous zooplankton by pelagic mesopredators and apex predators. The results strongly supported a major role of gelatinous plankton in the diet of bluefin tuna (Thunnus thynnus), little tunny (Euthynnus alletteratus), spearfish (Tetrapturus belone) and swordfish (Xiphias gladius). Loggerhead sea turtles (Caretta caretta) in the oceanic stage and ocean sunfish (Mola mola) also primarily relied on gelatinous zooplankton. In contrast, stable isotope ratios ruled out any relevant consumption of gelatinous plankton by bluefish (Pomatomus saltatrix), blue shark (Prionace glauca), leerfish (Lichia amia), bonito (Sarda sarda), striped dolphin (Stenella caerueloalba) and loggerhead sea turtles (Caretta caretta) in the neritic stage, all of which primarily relied on fish and squid. Fin whales (Balaenoptera physalus) were confirmed as crustacean consumers. The ratios of stable isotopes in albacore (Thunnus alalunga), amberjack (Seriola dumerili), blue butterfish (Stromaeus fiatola), bullet tuna (Auxis rochei), dolphinfish (Coryphaena hyppurus), horse mackerel (Trachurus trachurus), mackerel (Scomber scombrus) and pompano (Trachinotus ovatus) were consistent with mixed diets revealed by stomach content analysis, including nekton and crustaceans, but the consumption of gelatinous plankton could not be ruled out completely. In conclusion, the jellyvorous guild in the Mediterranean integrates two specialists (ocean sunfish and loggerhead sea turtles in the oceanic stage) and several opportunists (bluefin tuna, little tunny, spearfish, swordfish and, perhaps, blue butterfish), most of them with shrinking populations due to overfishing.	[Cardona, Luis] Univ Barcelona, Fac Biol, IRBIO, Barcelona, Spain; Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain	University of Barcelona; University of Barcelona	Cardona, L (corresponding author), Univ Barcelona, Fac Biol, IRBIO, Barcelona, Spain.	alvarezdequevedo@ub.edu	Cardona, Luis/L-1680-2014; Fennell, Hannah/AAI-1408-2019; Borrell, Asunción/B-8257-2009; Cardona, Luis/AAL-1354-2021; Aguilar, Alex/L-1283-2014	Cardona, Luis/0000-0002-7892-1323; Borrell, Asunción/0000-0002-6714-0724; Cardona, Luis/0000-0002-7892-1323; Aguilar, Alex/0000-0002-5751-2512	Ministry of Science and Innovation of Spain [CGL2009-10017]; Institut Menorqui d'Estudis; University of Barcelona	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institut Menorqui d'Estudis; University of Barcelona	This project was partially funded by the Plan Nacional de I+D+i of the Ministry of Science and Innovation of Spain (project CGL2009-10017) and by the Institut Menorqui d'Estudis: http://www.ime.cat/. The economic costs of publication of this article have been funded by the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Gimenez F, 2005, AQUAC RES, V36, P610, DOI 10.1111/j.1365-2109.2005.01210.x; de Quevedo IA, 2010, ICES J MAR SCI, V67, P677, DOI 10.1093/icesjms/fsp278; Avian M, 1988, RAPP COMM INT MER ME, V31, P231; ben Salem M., 1988, Cybium, V12, P247; BENNETT BA, 1989, S AFR J ZOOL, V24, P163; Bigelow H. B., 1954, Fishery Bulletin United States, V53, P1; Bjorndal Karen A., 1997, P199; BLANCO C, 1995, J ZOOL, V237, P151, DOI 10.1111/j.1469-7998.1995.tb02753.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brodeur RD, 1999, FISH OCEANOGR, V8, P296, DOI 10.1046/j.1365-2419.1999.00115.x; Buckel JA, 1999, FISH B-NOAA, V97, P758; Campo D, 2006, FISH RES, V81, P169, DOI 10.1016/j.fishres.2006.07.006; Cardona L, 2005, MAR BIOL, V147, P583, DOI 10.1007/s00227-005-1578-9; Cardona L, 2009, MAR BIOL, V156, P2621, DOI 10.1007/s00227-009-1288-9; Castriota L, 2008, J MAR BIOL ASSOC UK, V88, P183, DOI 10.1017/S0025315408000106; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chalabi A, 1992, SCRS9291 ICCAT, V40, P162; CLARKE A, 1992, J EXP MAR BIOL ECOL, V155, P55, DOI 10.1016/0022-0981(92)90027-8; Consoli P, 2008, MAR BIOL, V155, P113, DOI 10.1007/s00227-008-1012-1; Daskalov GM, 2002, MAR ECOL PROG SER, V225, P53, DOI 10.3354/meps225053; DAUBY P, 1989, CONT SHELF RES, V9, P181, DOI 10.1016/0278-4343(89)90091-5; Doyle TK, 2007, J EXP MAR BIOL ECOL, V343, P239, DOI 10.1016/j.jembe.2006.12.010; Dubischar CD, 2012, MAR BIOL, V159, P15, DOI 10.1007/s00227-011-1785-5; Eder EB, 2005, MAR ECOL PROG SER, V291, P43, DOI 10.3354/meps291043; Estrada JA, 2005, MAR BIOL, V147, P37, DOI 10.1007/s00227-004-1541-1; Falautano M, 2007, J MAR BIOL ASSOC UK, V87, P999, DOI 10.1017/S0025315407055798; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Fulton B, 2007, SEAMOUNT ECOLOGY FIS, P296; Gili Josep-Maria, 2005, Bolleti de la Societat d'Historia Natural de les Balears, V48, P9; GNAIGER E, 1984, OECOLOGIA, V62, P289, DOI 10.1007/BF00384259; GOY J, 1989, DEEP-SEA RES, V36, P269, DOI 10.1016/0198-0149(89)90138-6; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Haedrich RL, 1986, FISHES N E ATLANTIC, V3, P1192; Harbison GR, 1993, 199 CM ICES, V199; Henderson AC, 2001, J FISH BIOL, V58, P1347, DOI 10.1111/j.1095-8649.2001.tb02291.x; Hochscheid S, 2004, PHYSIOL BIOCHEM ZOOL, V77, P209, DOI 10.1086/381472; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Kyrtatos NA, 1982, THALASSOGEOGRAPHICA, V5, P88; Laran Sophie, 2010, Journal of Cetacean Research and Management, V11, P31; Legovic T, 1991, MAP TECH REP SER, V47, P128; Lilley MKS, 2011, MAR BIOL, V158, P2429, DOI 10.1007/s00227-011-1744-1; Lloris D, 2000, RECURSOS MARINS MEDI; MALEJ A, 1989, J EXP MAR BIOL ECOL, V126, P259, DOI 10.1016/0022-0981(89)90191-3; Massuti E, 1998, B MAR SCI, V63, P329; MATALLANAS J, 1995, J MAR BIOL ASSOC UK, V75, P257, DOI 10.1017/S0025315400015356; MENARD F, 1994, MAR ECOL PROG SER, V104, P139, DOI 10.3354/meps104139; Meotti C, 1997, ATTI SOC IT SCI NAT, V137, P5; Mianzan HW, 1996, FISH RES, V27, P69, DOI 10.1016/0165-7836(95)00459-9; Molinero JC, 2005, LIMNOL OCEANOGR, V50, P1213, DOI 10.4319/lo.2005.50.4.1213; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Morovic D, 1961, P TECHNICAL PAPERS G, V6, P155; Mostarda E, 2007, J MAR BIOL ASSOC UK, V87, P1007, DOI 10.1017/S0025315407055440; Neilson JD, 2006, COL VOL SCI PAP ICCA, V61, P25; Ozturk B, 2007, VIE MILIEU, V57, P57; Orsi Relini L, 1995, SCRS 92 91 ICCAT, V44, P283; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Parsons TR, 1995, FOOD WEBS INTEGRATIO, P352; Pauly D, 2009, HYDROBIOLOGIA, V616, P67, DOI 10.1007/s10750-008-9583-x; Polunin NVC, 2001, MAR ECOL PROG SER, V220, P13; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2009, HYDROBIOLOGIA, V616, P23, DOI 10.1007/s10750-008-9585-8; Reich KJ, 2008, OECOLOGIA, V155, P651, DOI 10.1007/s00442-007-0949-y; Revelles M, 2007, J MAR BIOL ASSOC UK, V87, P805, DOI 10.1017/S0025315407054707; Revelles M, 2007, MAR BIOL, V151, P1501, DOI 10.1007/s00227-006-0602-z; Revelles M, 2007, SCI MAR, V71, P87, DOI 10.3989/scimar.2007.71n187; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Romeo T, 2009, J MAR BIOL ASSOC UK, V89, P849, DOI 10.1017/S0025315408002087; Sabates A, 2001, SCI MAR, V65, P95, DOI 10.3989/scimar.2001.65n295; Sanz Brau A, 1990, RAPP COMM INT EXPL S, V32, P274; Sara G, 2007, J APPL ICHTHYOL, V23, P122, DOI 10.1111/j.1439-0426.2006.00829.x; Sinopoli M, 2004, J APPL ICHTHYOL, V20, P310, DOI 10.1111/j.1439-0426.2004.00554.x; STILLWELL CE, 1985, MAR ECOL PROG SER, V22, P239, DOI 10.3354/meps022239; Tomas J, 2001, J ZOOL, V255, P525, DOI 10.1017/S0952836901001613; Valiela I, 1991, FUNDAMENTALS AQUATIC, P29; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1	76	146	150	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e31329	10.1371/journal.pone.0031329	http://dx.doi.org/10.1371/journal.pone.0031329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470416	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100003
J	Eriksson, A; Anfora, G; Lucchi, A; Lanzo, F; Virant-Doberlet, M; Mazzoni, V				Eriksson, Anna; Anfora, Gianfranco; Lucchi, Andrea; Lanzo, Francesco; Virant-Doberlet, Meta; Mazzoni, Valerio			Exploitation of Insect Vibrational Signals Reveals a New Method of Pest Management	PLOS ONE			English	Article							VIBRATORY SIGNALS; MATING-BEHAVIOR; HEMIPTERA; COMMUNICATION; CICADELLIDAE; VECTORS	Food production is considered to be the main source of human impact on the environment and the concerns about detrimental effects of pesticides on biodiversity and human health are likely to lead to an increasingly restricted use of chemicals in agriculture. Since the first successful field trial, pheromone based mating disruption enabled sustainable insect control, which resulted in reduced levels of pesticide use. Organic farming is one of the fastest growing segments of agriculture and with the continuously growing public concern about use of pesticides, the main remaining challenge in increasing the safety of the global food production is to identify appropriate alternative mating disruption approaches for the numerous insect pests that do not rely on chemical communication. In the present study, we show for the first time that effective mating disruption based on substrate-borne vibrational signals can be achieved in the field. When disruptive vibrational signals were applied to grapevine plants through a supporting wire, mating frequency of the leafhopper pest Scaphoideus titanus dropped to 9 % in semi-field conditions and to 4 % in a mature vineyard. The underlying mechanism of this environmentally friendly pest-control tactic is a masking of the vibrational signals used in mate recognition and location. Because vibrational communication is widespread in insects, mating disruption using substrate vibrations can transform many open field and greenhouse based farming systems.	[Eriksson, Anna; Anfora, Gianfranco; Mazzoni, Valerio] Fdn Edmund Mach, Ist Agr San Michele AllAdige Res & Innovat Ctr, San Michele All Adige, Italy; [Eriksson, Anna; Lucchi, Andrea; Lanzo, Francesco] Univ Pisa, Dept CDSL, Sect Agr Entomol, Pisa, Italy; [Virant-Doberlet, Meta] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia	Fondazione Edmund Mach; University of Pisa; National Institute of Biology - Slovenia	Eriksson, A (corresponding author), Fdn Edmund Mach, Ist Agr San Michele AllAdige Res & Innovat Ctr, San Michele All Adige, Italy.	gianfranco.anfora@fmach.it	LUCCHI, ANDREA/N-4088-2015; Virant-Doberlet, Meta/G-9251-2019; Mazzoni, Valerio/ABE-4661-2021	LUCCHI, ANDREA/0000-0002-9379-6495; Virant-Doberlet, Meta/0000-0001-7510-2392; Mazzoni, Valerio/0000-0003-4036-5322; ANFORA, Gianfranco/0000-0003-2545-1409	Autonomous Province of Trento (Accordo di Programma); Slovenian Research Agency [P1-0255, V4-0525]; Fondi Ateneo of Pisa University; CBCEurope Ltd. (Milano, Italy); CBC-Europe Ltd.	Autonomous Province of Trento (Accordo di Programma)(Autonomous Province of Trento); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Fondi Ateneo of Pisa University; CBCEurope Ltd. (Milano, Italy); CBC-Europe Ltd.	This research was supported by the Autonomous Province of Trento (Accordo di Programma 2010), Funding Research Programme P1-0255 and Research Project V4-0525 by Slovenian Research Agency, Fondi Ateneo of Pisa University, and CBCEurope Ltd. (Milano, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from a commercial source (CBC-Europe Ltd.). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Al-Wahaibi AK, 2009, ANN ENTOMOL SOC AM, V102, P249, DOI 10.1603/008.102.0207; Bressan A, 2006, ENTOMOL EXP APPL, V119, P61, DOI 10.1111/j.1570-7458.2006.00391.x; Clay J, 2011, NATURE, V475, P287, DOI 10.1038/475287a; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; Cokl AA, 2009, BIORATIONAL CONTROL OF ARTHROPOD PESTS: APPLICATION AND RESISTANCE MANAGEMENT, P279, DOI 10.1007/978-90-481-2316-2_11; Costello MJ, 2008, J ECON ENTOMOL, V101, P1287, DOI 10.1603/0022-0493(2008)101[1287:RDIADO]2.0.CO;2; Dietrich CH, 2004, SYST ENTOMOL, V29, P455, DOI 10.1111/j.0307-6970.2004.00250.x; Eriksson A, 2011, PLOS ONE, V65, pe1962; GASTON LK, 1967, NATURE, V213, P1155, DOI 10.1038/2131155a0; Greenfield MD, 2002, SIGNALERS RECEIVERS; HUNT RE, 1991, BEHAV ECOL SOCIOBIOL, V28, P315, DOI 10.1007/BF00164380; Ioriatti C, 2008, AREAWIDE PEST MANAGEMENT: THEORY AND IMPLEMENTATION, P208, DOI 10.1079/9781845933722.0208; Janse J. D., 2010, J PLANT PATHOL, V92; Kanmiya K, 2006, CONT T ENT, P365; Laumann RA, 2007, ANIM BEHAV, V73, P637, DOI 10.1016/j.anbehav.2006.09.011; Lenz MS, 2009, AM J ENOL VITICULT, V60, P2; Mazzoni V, 2010, ANN ENTOMOL SOC AM, V103, P813, DOI 10.1603/AN09145; Mazzoni V, 2009, ENTOMOL EXP APPL, V133, P174, DOI 10.1111/j.1570-7458.2009.00911.x; Mazzoni V, 2009, B ENTOMOL RES, V99, P401, DOI 10.1017/S0007485308006408; Miranda X, 2006, ANN ENTOMOL SOC AM, V99, P374, DOI 10.1603/0013-8746(2006)099[0374:SSRACJ]2.0.CO;2; Pavan F, 2009, BIOCONTROL, V54, P55, DOI 10.1007/s10526-008-9151-3; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Torres-Vila LM, 2002, B ENTOMOL RES, V92, P241, DOI 10.1079/BER2002155; Urban JM, 2007, MOL PHYLOGENET EVOL, V42, P556, DOI 10.1016/j.ympev.2006.08.009; Virant-Doberlet M, 2011, MOL ECOL, V20, P2204, DOI 10.1111/j.1365-294X.2011.05038.x; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y	29	74	73	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e32954	10.1371/journal.pone.0032954	http://dx.doi.org/10.1371/journal.pone.0032954			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457726	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100011
J	Durr, KL; Tavraz, NN; Friedrich, T				Duerr, Katharina L.; Tavraz, Neslihan N.; Friedrich, Thomas			Control of Gastric H,K-ATPase Activity by Cations, Voltage and Intracellular pH Analyzed by Voltage Clamp Fluorometry in Xenopus Oocytes	PLOS ONE			English	Article							NA+/K+-ATPASE; NA/K PUMP; SODIUM-IONS; CONFORMATIONAL REARRANGEMENT; STATE STABILIZATION; H+/K+-ATPASE; BETA-SUBUNIT; SALT BRIDGE; NA,K PUMP; CHANNEL	Whereas electrogenic partial reactions of the Na,K-ATPase have been studied in depth, much less is known about the influence of the membrane potential on the electroneutrally operating gastric H, K-ATPase. In this work, we investigated site-specifically fluorescence-labeled H, K-ATPase expressed in Xenopus oocytes by voltage clamp fluorometry to monitor the voltage-dependent distribution between E1P and E2P states and measured Rb+ uptake under various ionic and pH conditions. The steady-state E1P/E2P distribution, as indicated by the voltage-dependent fluorescence amplitudes and the Rb+ uptake activity were highly sensitive to small changes in intracellular pH, whereas even large extracellular pH changes affected neither the E1P/E2P distribution nor transport activity. Notably, intracellular acidification by approximately 0.5 pH units shifted V0.5, the voltage, at which the E1P/E2P ratio is 50:50, by 2100 mV. This was paralleled by an approximately twofold acceleration of the forward rate constant of the E1P -> E2P transition and a similar increase in the rate of steady-state cation transport. The temperature dependence of Rb+ uptake yielded an activation energy of similar to 90 kJ/mol, suggesting that ion transport is rate-limited by a major conformational transition. The pronounced sensitivity towards intracellular pH suggests that proton uptake from the cytoplasmic side controls the level of phosphoenzyme entering the E1P -> E2P conformational transition, thus limiting ion transport of the gastric H, K-ATPase. These findings highlight the significance of cellular mechanisms contributing to increased proton availability in the cytoplasm of gastric parietal cells. Furthermore, we show that extracellular Na+ profoundly alters the voltage-dependent E1P/E2P distribution indicating that Na+ ions can act as surrogates for protons regarding the E2P -> E1P transition. The complexity of the intra-and extracellular cation effects can be rationalized by a kinetic model suggesting that cations reach the binding sites through a rather high-field intra-and a rather low-field extracellular access channel, with fractional electrical distances of similar to 0.5 and similar to 0.2, respectively.	[Duerr, Katharina L.; Tavraz, Neslihan N.; Friedrich, Thomas] Tech Univ Berlin, Inst Chem, Berlin, Germany	Technical University of Berlin	Durr, KL (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	friedrich@chem.tu-berlin.de	Friedrich, Thomas/AAA-3418-2022; Duerr, Katharina/A-6975-2015	Duerr, Katharina/0000-0002-3245-4088	Max-Planck-Society for the Advancement of Sciences; German Research Foundation DFG (Cluster of Excellence "Unifying Concepts in Catalysis")	Max-Planck-Society for the Advancement of Sciences; German Research Foundation DFG (Cluster of Excellence "Unifying Concepts in Catalysis")(German Research Foundation (DFG))	This work was supported by the Max-Planck-Society for the Advancement of Sciences and the German Research Foundation DFG (Cluster of Excellence "Unifying Concepts in Catalysis"). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1154; Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; BRIVING C, 1988, BIOCHIM BIOPHYS ACTA, V946, P185, DOI 10.1016/0005-2736(88)90391-4; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Diller A, 2005, BIOPHYS J, V88, P3348, DOI 10.1529/biophysj.104.055913; Durr KL, 2010, J BIOL CHEM, V285, P39366, DOI 10.1074/jbc.M110.133470; Durr KL, 2009, J BIOL CHEM, V284, P20147, DOI 10.1074/jbc.M109.005769; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; Durr KL, 2008, BIOCHEMISTRY-US, V47, P4288, DOI 10.1021/bi800092k; GADSBY DC, 1989, J GEN PHYSIOL, V94, P511, DOI 10.1085/jgp.94.3.511; GADSBY DC, 1985, NATURE, V315, P63, DOI 10.1038/315063a0; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; Geibel S, 2003, ANN NY ACAD SCI, V986, P31, DOI 10.1111/j.1749-6632.2003.tb07136.x; Geibel S, 2003, P NATL ACAD SCI USA, V100, P964, DOI 10.1073/pnas.0337336100; GOLDSHLEGGER R, 1987, J PHYSIOL-LONDON, V387, P331, DOI 10.1113/jphysiol.1987.sp016576; HELMICHDEJONG ML, 1985, BIOCHIM BIOPHYS ACTA, V821, P377, DOI 10.1016/0005-2736(85)90041-0; HEYSE S, 1994, J GEN PHYSIOL, V104, P197, DOI 10.1085/jgp.104.2.197; HILGEMANN DW, 1994, SCIENCE, V263, P1429, DOI 10.1126/science.8128223; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; Koenderink JB, 2004, J BIOL CHEM, V279, P16417, DOI 10.1074/jbc.M400020200; LAFAIRE AV, 1986, J MEMBRANE BIOL, V91, P43, DOI 10.1007/BF01870213; LAUGER P, 1991, SOC GEN PHY, V46, P303; LAUGER P, 1979, BIOCHIM BIOPHYS ACTA, V552, P143, DOI 10.1016/0005-2736(79)90253-0; Lauger P., 1991, ELECTROGENIC ION PUM; LORENTZON P, 1988, J BIOL CHEM, V263, P10705; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MITCHELL P, 1974, FEBS LETT, V43, P189, DOI 10.1016/0014-5793(74)80997-X; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; NAKAO M, 1986, NATURE, V323, P628, DOI 10.1038/323628a0; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Or E, 1996, J BIOL CHEM, V271, P2470, DOI 10.1074/jbc.271.5.2470; Pintschovius J, 1997, ANN NY ACAD SCI, V834, P361, DOI 10.1111/j.1749-6632.1997.tb52271.x; POLVANI C, 1989, J BIOL CHEM, V264, P17854; POST RL, 1965, J BIOL CHEM, V240, P1437; RABON EC, 1990, J BIOL CHEM, V265, P19594; RAKOWSKI RF, 1991, J MEMBRANE BIOL, V121, P177, DOI 10.1007/BF01870531; RAKOWSKI RF, 1993, J GEN PHYSIOL, V101, P117, DOI 10.1085/jgp.101.1.117; Ratheal IM, 2010, P NATL ACAD SCI USA, V107, P18718, DOI 10.1073/pnas.1004214107; RAY TK, 1985, FEBS LETT, V185, P24, DOI 10.1016/0014-5793(85)80733-X; SAGAR A, 1994, J GEN PHYSIOL, V103, P869, DOI 10.1085/jgp.103.5.869; STENGELIN M, 1993, J MEMBRANE BIOL, V132, P211; STENGELIN M, 1992, ANN NY ACAD SCI, V671, P170, DOI 10.1111/j.1749-6632.1992.tb43794.x; Stewart AK, 2001, AM J PHYSIOL-CELL PH, V281, pC1344, DOI 10.1152/ajpcell.2001.281.4.C1344; SWARTS HGP, 1995, J BIOL CHEM, V270, P7890, DOI 10.1074/jbc.270.14.7890; Tavraz NN, 2009, CHANNELS, V3, P82, DOI 10.4161/chan.3.2.8085; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VANDERHIJDEN HTWM, 1990, J MEMBRANE BIOL, V114, P245, DOI 10.1007/BF01869218; WALLMARK B, 1987, J BIOL CHEM, V262, P2077; Zhang Y, 1996, J BIOL CHEM, V271, P5741, DOI 10.1074/jbc.271.10.5741	52	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33645	10.1371/journal.pone.0033645	http://dx.doi.org/10.1371/journal.pone.0033645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448261	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700052
J	Luque, EM; Gutierrez, G; Navarro-Sampedro, L; Olmedo, M; Rodriguez-Romero, J; Ruger-Herreros, C; Tagua, VG; Corrochano, LM				Luque, Eva M.; Gutierrez, Gabriel; Navarro-Sampedro, Laura; Olmedo, Maria; Rodriguez-Romero, Julio; Ruger-Herreros, Carmen; Tagua, Victor G.; Corrochano, Luis M.			A Relationship between Carotenoid Accumulation and the Distribution of Species of the Fungus Neurospora in Spain	PLOS ONE			English	Article							BLUE-LIGHT REGULATION; UV-B; NATURAL-POPULATIONS; RADIATION; MODEL; GENE; PROTECTION; DIVERSITY; SEQUENCE; DAMAGE	The ascomycete fungus Neurospora is present in many parts of the world, in particular in tropical and subtropical areas, where it is found growing on recently burned vegetation. We have sampled the Neurospora population across Spain. The sampling sites were located in the region of Galicia (northwestern corner of the Iberian peninsula), the province of Caceres, the city of Seville, and the two major islands of the Canary Islands archipelago (Tenerife and Gran Canaria, west coast of Africa). The sites covered a latitude interval between 27.88 degrees and 42.74 degrees. We have identified wild-type strains of N. discreta, N. tetrasperma, N. crassa, and N. sitophila and the frequency of each species varied from site to site. It has been shown that after exposure to light Neurospora accumulates the orange carotenoid neurosporaxanthin, presumably for protection from UV radiation. We have found that each Neurospora species accumulates a different amount of carotenoids after exposure to light, but these differences did not correlate with the expression of the carotenogenic genes al-1 or al-2. The accumulation of carotenoids in Neurospora shows a correlation with latitude, as Neurospora strains isolated from lower latitudes accumulate more carotenoids than strains isolated from higher latitudes. Since regions of low latitude receive high UV irradiation we propose that the increased carotenoid accumulation may protect Neurospora from high UV exposure. In support of this hypothesis, we have found that N. crassa, the species that accumulates more carotenoids, is more resistant to UV radiation than N. discreta or N. tetrasperma. The photoprotection provided by carotenoids and the capability to accumulate different amounts of carotenoids may be responsible, at least in part, for the distribution of Neurospora species that we have observed across a range of latitudes.	[Luque, Eva M.; Gutierrez, Gabriel; Navarro-Sampedro, Laura; Olmedo, Maria; Rodriguez-Romero, Julio; Ruger-Herreros, Carmen; Tagua, Victor G.; Corrochano, Luis M.] Univ Seville, Dept Genet, Seville, Spain	University of Sevilla	Luque, EM (corresponding author), Univ Seville, Dept Genet, Seville, Spain.	corrochano@us.es	gutierrez, gabriel/S-7646-2017; Pozo, Gabriel Gutiérrez/N-7824-2019; Olmedo, Maria/E-1824-2012; Ruger-Herreros, Carmen/AAB-2098-2020; Navarro Sampedro, Laura/H-3320-2015; Rodríguez-Romero, Julio/AAF-6421-2020; Ruger-Herreros, Carmen/D-3670-2009; Olmedo, Maria/N-3708-2019; Rodriguez-Romero, Julio/K-7972-2014; Corrochano, Luis M/F-5720-2010	gutierrez, gabriel/0000-0002-1354-2883; Pozo, Gabriel Gutiérrez/0000-0002-1354-2883; Olmedo, Maria/0000-0002-5701-2665; Ruger-Herreros, Carmen/0000-0002-3982-9962; Navarro Sampedro, Laura/0000-0003-2342-9275; Rodríguez-Romero, Julio/0000-0001-8304-4014; Olmedo, Maria/0000-0002-5701-2665; Rodriguez-Romero, Julio/0000-0001-8304-4014; Corrochano, Luis M/0000-0002-6282-6567; Tagua, Victor G/0000-0003-1494-6895	Spanish "Ministerio de Ciencia e Innovacion" [INIA RM2004-0007, BIO2009-12486]; Junta de Andalucia [P09-CVI-5027]; European Regional Development Fund	Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia); European Regional Development Fund(European Commission)	This work was supported by the Spanish "Ministerio de Ciencia e Innovacion" (INIA RM2004-0007, BIO2009-12486), and Junta de Andalucia (P09-CVI-5027). These grants are supported by the European Regional Development Fund. CRH is a research fellow of the Regional Government (Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2001, PHOTOCHEM PHOTOBIOL, V73, P551, DOI 10.1562/0031-8655(2001)073<0551:EOAKGM>2.0.CO;2; Alejandre-Duran E, 2003, FUNGAL GENET BIOL, V40, P159, DOI 10.1016/S1087-1845(03)00089-6; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARPAIA G, 1995, DEV BIOL, V170, P626, DOI 10.1006/dbio.1995.1242; Arrach N, 2002, MOL GENET GENOMICS, V266, P914, DOI 10.1007/s00438-001-0626-5; AVALOS J, 1990, FEMS MICROBIOL LETT, V66, P295; BEJARANO ER, 1991, PLANTA, V183, P1, DOI 10.1007/BF00197560; Berrocal-Tito G, 1999, J BIOL CHEM, V274, P14288, DOI 10.1074/jbc.274.20.14288; Braga GUL, 2001, J INVERTEBR PATHOL, V78, P98, DOI 10.1006/jipa.2001.5048; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; Brunner M, 2008, MOL MICROBIOL, V68, P255, DOI 10.1111/j.1365-2958.2008.06148.x; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Chen CH, 2010, FUNGAL GENET BIOL, V47, P922, DOI 10.1016/j.fgb.2010.07.005; Corrochano LM, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P417; Davis R. H., 2000, CONTRIBUTIONS MODEL; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Dettman JR, 2006, MYCOLOGIA, V98, P436, DOI 10.3852/mycologia.98.3.436; Dettman JR, 2003, EVOLUTION, V57, P2721; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Diernfellner ACR, 2011, FEBS LETT, V585, P1461, DOI 10.1016/j.febslet.2011.03.049; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellison CE, 2011, P NATL ACAD SCI USA, V108, P2831, DOI 10.1073/pnas.1014971108; Fernandes EKK, 2007, J INVERTEBR PATHOL, V96, P237, DOI 10.1016/j.jip.2007.05.007; GEIS PA, 1984, MYCOLOGIA, V76, P268, DOI 10.2307/3793103; Gotz T, 1999, PLANT PHYSIOL, V120, P599, DOI 10.1104/pp.120.2.599; Hader DP, 2007, PHOTOCHEM PHOTOBIOL, V83, P1348, DOI 10.1111/j.1751-1097.2007.00168.x; Jacobson DJ, 2006, MYCOLOGIA, V98, P550, DOI 10.3852/mycologia.98.4.550; Jacobson DJ, 2004, MYCOLOGIA, V96, P66, DOI 10.2307/3761989; Lamare MD, 2004, J EXP MAR BIOL ECOL, V312, P215, DOI 10.1016/j.jembe.2004.02.016; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebert M, 2002, J PHOTOCH PHOTOBIO B, V66, P81, DOI 10.1016/S1011-1344(01)00279-2; Li CG, 1997, FUNGAL GENET BIOL, V21, P101, DOI 10.1006/fgbi.1996.0948; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; MartinRojas V, 1996, RADIAT ENVIRON BIOPH, V35, P193, DOI 10.1007/s004110050030; MATHEWSROTH MM, 1985, PHOTOCHEM PHOTOBIOL, V42, P35, DOI 10.1111/j.1751-1097.1985.tb03544.x; Menkis A, 2009, J EVOLUTION BIOL, V22, P1923, DOI 10.1111/j.1420-9101.2009.01801.x; Moline M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1145, DOI 10.1039/c0pp00009d; Moline M, 2009, J PHOTOCH PHOTOBIO B, V95, P156, DOI 10.1016/j.jphotobiol.2009.02.006; Namitha KK, 2010, CRIT REV FOOD SCI, V50, P728, DOI 10.1080/10408398.2010.499811; Nygren K, 2011, MOL PHYLOGENET EVOL, V59, P649, DOI 10.1016/j.ympev.2011.03.023; PAGE RDM, 1993, COMPONENT TREE COMP; PERKINS DD, 1988, EXP MYCOL, V12, P91, DOI 10.1016/0147-5975(88)90001-1; Perkins DD, 2000, FUNGAL GENET BIOL, V31, P153, DOI 10.1006/fgbi.2000.1248; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell AJ, 2003, MYCOLOGIA, V95, P809, DOI 10.2307/3762009; Schafmeier T, 2011, FEBS LETT, V585, P1467, DOI 10.1016/j.febslet.2011.03.050; SCHMIDHAUSER TJ, 1994, J BIOL CHEM, V269, P12060; SCHMIDHAUSER TJ, 1990, MOL CELL BIOL, V10, P5064, DOI 10.1128/MCB.10.10.5064; Selker EU, 2011, CURR BIOL, V21, pR139, DOI 10.1016/j.cub.2011.01.006; Sies H, 2004, PHOTOCH PHOTOBIO SCI, V3, P749, DOI 10.1039/b316082c; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turner BC, 2001, FUNGAL GENET BIOL, V32, P67, DOI 10.1006/fgbi.2001.1247; Villalta CF, 2009, MYCOLOGIA, V101, P777, DOI 10.3852/08-219; ZALOKAR M, 1955, ARCH BIOCHEM BIOPHYS, V56, P318, DOI 10.1016/0003-9861(55)90252-6; ZALOKAR M, 1954, ARCH BIOCHEM BIOPHYS, V50, P71, DOI 10.1016/0003-9861(54)90010-7	57	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33658	10.1371/journal.pone.0033658	http://dx.doi.org/10.1371/journal.pone.0033658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448263	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700054
J	Shen, Y; Jiang, Z; Yao, XD; Zhang, ZM; Lin, HJ; Zhao, MJ; Liu, HL; Peng, HW; Li, SJ; Pan, GT				Shen, Yaou; Jiang, Zhou; Yao, Xiadong; Zhang, Zhiming; Lin, Haijian; Zhao, Maojun; Liu, Hailan; Peng, Huanwei; Li, Shujun; Pan, Guangtang			Genome Expression Profile Analysis of the Immature Maize Embryo during Dedifferentiation	PLOS ONE			English	Article							FALSE DISCOVERY RATE; AMINO-ACIDS; TRANSPORT; DATABASE	Maize is one of the most important cereal crops worldwide and one of the primary targets of genetic manipulation, which provides an excellent way to promote its production. However, the obvious difference of the dedifferentiation frequency of immature maize embryo among various genotypes indicates that its genetic transformation is dependence on genotype and immature embryo-derived undifferentiated cells. To identify important genes and metabolic pathways involved in forming of embryo-derived embryonic calli, in this study, DGE (differential gene expression) analysis was performed on stages I, II, and III of maize inbred line 18-599R and corresponding control during the process of immature embryo dedifferentiation. A total of similar to 21 million cDNA tags were sequenced, and 4,849,453, 5,076,030, 4,931,339, and 5,130,573 clean tags were obtained in the libraries of the samples and the control, respectively. In comparison with the control, 251, 324 and 313 differentially expressed genes (DEGs) were identified in the three stages with more than five folds, respectively. Interestingly, it is revealed that all the DEGs are related to metabolism, cellular process, and signaling and information storage and processing functions. Particularly, the genes involved in amino acid and carbohydrate transport and metabolism, cell wall/membrane/envelope biogenesis and signal transduction mechanism have been significantly changed during the dedifferentiation. To our best knowledge, this study is the first genome-wide effort to investigate the transcriptional changes in dedifferentiation immature maize embryos and the identified DEGs can serve as a basis for further functional characterization.	[Shen, Yaou; Jiang, Zhou; Yao, Xiadong; Zhang, Zhiming; Lin, Haijian; Liu, Hailan; Li, Shujun; Pan, Guangtang] Sichuan Agr Univ, Minist Agr, Maize Res Inst, Key Lab Biol & Genet Improvement Maize SW Reg, Wenjiang, Peoples R China; [Zhao, Maojun] Sichuan Agr Univ, Coll Life & Sci, Yaan, Peoples R China; [Peng, Huanwei] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Shen, Y (corresponding author), Sichuan Agr Univ, Minist Agr, Maize Res Inst, Key Lab Biol & Genet Improvement Maize SW Reg, Wenjiang, Peoples R China.	pangt1956@yahoo.com.cn			National Natural Science Foundation of China [30900901]; Project of Transgenic New Variety Cultivation [2008ZX08003-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Transgenic New Variety Cultivation	This research was supported by the National Natural Science Foundation of China (grant no: 30900901) and the Project of Transgenic New Variety Cultivation (2008ZX08003-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; FACCHINI PJ, 1995, PLANT CELL, V7, P1811, DOI 10.1105/tpc.7.11.1811; Feng Ying, 2006, Functional & Integrative Genomics, V6, P14, DOI 10.1007/s10142-005-0131-8; Fraser CM, 2005, PLANT PHYSIOL, V138, P1136, DOI 10.1104/pp.104.057950; Gene Ontology C, 2008, NUCL ACIDS RES, V36, pD440; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; hmadabadi M RS, 2010, TRANSGENIC RES, V4, P437; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Lee YH, 2004, PLANT J, V40, P60, DOI 10.1111/j.1365-313X.2004.02186.x; Li YJ FY, 2011, FEBS J, V278; Lin SH, 2008, PLANT CELL, V20, P2514, DOI 10.1105/tpc.108.060244; Ma Li, 2007, Fen Zi Xi Bao Sheng Wu Xue Bao, V40, P164; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mu GuiQin, 2003, Journal of Sichuan Agricultural University, V21, P13; Pan GuangTang, 2003, Acta Agronomica Sinica, V29, P386; Pan GuangTang, 2006, Acta Agronomica Sinica, V32, P7; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Svennerstam H, 2007, PLANT PHYSIOL, V143, P1853, DOI 10.1104/pp.106.092205; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wu J DH, 2011, PLANT MOL BIOL  0604; Xie Guangning, 2011, PLANT CELL TISS ORGA, V105; Zheng PH, 2001, J MAIZE SCI, V9, P37	25	38	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32237	10.1371/journal.pone.0032237	http://dx.doi.org/10.1371/journal.pone.0032237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448216	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700006
J	Strom, A; Kolb, H; Martin, S; Herder, C; Simon, MC; Koenig, W; Heise, T; Heinemann, L; Roden, M; Schloot, NC				Strom, Alexander; Kolb, Hubert; Martin, Stephan; Herder, Christian; Simon, Marie-Christine; Koenig, Wolfgang; Heise, Tim; Heinemann, Lutz; Roden, Michael; Schloot, Nanette C.		DIATOR Study Grp	Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial)	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; C-REACTIVE PROTEIN; STATINS; INFLAMMATION; ACTIVATION; DIAGNOSIS; REDUCTASE; RECEPTOR; DISEASE; TOLERANCE	Background: A recent randomized placebo-controlled trial of the effect of atorvastatin treatment on the progression of newly diagnosed type 1 diabetes suggested a slower decline of residual beta cell function with statin treatment. Aim of this secondary analysis was to identify patient subgroups which differ in the decline of beta cell function during treatment with atorvastatin. Methodology/Principal Findings: The randomized placebo-controlled Diabetes and Atorvastatin (DIATOR) Trial included 89 patients with newly diagnosed type 1 diabetes and detectable islet autoantibodies (mean age 30 years, 40% females), in 12 centers in Germany. Patients received placebo or 80 mg/d atorvastatin for 18 months. As primary outcome stimulated serum C-peptide levels were determined 90 min after a standardized liquid mixed meal. For this secondary analysis patients were stratified by single baseline characteristics which were considered to possibly be modified by atorvastatin treatment. Subgroups defined by age, sex or by baseline metabolic parameters like body mass index (BMI), total serum cholesterol or fasting C-peptide did not differ in C-peptide outcome after atorvastatin treatment. However, the subgroup defined by high (above median) baseline C-reactive protein (CRP) concentrations exhibited higher stimulated C-peptide secretion after statin treatment (p = 0.044). Individual baseline CRP levels correlated with C-peptide outcome in the statin group (r(2) = 0.3079, p<0.004). The subgroup with baseline CRP concentrations above median differed from the corresponding subgroup with lower CRP levels by higher median values of BMI, IL-6, IL-1RA, sICAM-1 and E-selectin. Conclusions/Significance: Atorvastatin treatment may be effective in slowing the decline of beta cell function in a patient subgroup defined by above median levels of CRP and other inflammation associated immune mediators.	[Strom, Alexander; Herder, Christian; Simon, Marie-Christine; Roden, Michael; Schloot, Nanette C.] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Kolb, Hubert] Univ Dusseldorf, Univ Hosp, Immunobiol Res Grp, D-40225 Dusseldorf, Germany; [Martin, Stephan] Verbund Katholischer Kliniken Dusseldorf, W German Ctr Diabet & Hlth, Dusseldorf, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Heise, Tim; Heinemann, Lutz] Profil Inst Metab Res, Neuss, Germany; [Roden, Michael; Schloot, Nanette C.] Univ Hosp, Dept Metab Dis, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Ulm University; Profil	Strom, A (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany.	alexander.strom@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019; Simon, Marie-Christine/AAX-7883-2020	Simon, Marie-Christine/0000-0001-6625-1265; Koenig, Wolfgang/0000-0002-2064-9603	Pfizer Pharma GmbH, Berlin, Germany; Pfizer Pharma GmbH, Berlin	Pfizer Pharma GmbH, Berlin, Germany; Pfizer Pharma GmbH, Berlin	The trial was supported by an unrestricted grant from Pfizer Pharma GmbH, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: T. Heise and L. Heinemann are employed by Profil Institute of Metabolic Research which was contracted to conduct the trial. N.C. Schloot is employed by Lilly Deutschland GmbH. The study was funded by an unrestricted grant from Pfizer Pharma GmbH, Berlin. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. No other potential conflicts of interest relevant to this article were reported.	Aktunc E, 2011, IMMUNOPHARMACOL IMMU; Amuro H, 2010, ARTHRITIS RHEUM-US, V62, P2073, DOI 10.1002/art.27478; Antoniades C, 2011, CIRCULATION, V124, P335, DOI 10.1161/CIRCULATIONAHA.110.985150; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Blank N, 2007, J IMMUNOL, V179, P3613, DOI 10.4049/jimmunol.179.6.3613; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Bot I, 2011, ATHEROSCLEROSIS, V214, P295, DOI 10.1016/j.atherosclerosis.2010.11.008; Bu DX, 2010, J CLIN INVEST, V120, P1961, DOI 10.1172/JCI41384; Carstensen M, 2010, DIABETES, V59, P1222, DOI 10.2337/db09-1199; Cartier A, 2009, ANN MED, V41, P471, DOI 10.1080/07853890903022801; Contreras JL, 2002, TRANSPLANTATION, V74, P1063, DOI 10.1097/00007890-200210270-00001; Feng B, 2011, BBA-MOL BASIS DIS, V1812, P1130, DOI 10.1016/j.bbadis.2011.05.007; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Herder C, 2009, DIABETOLOGIA, V52, P433, DOI 10.1007/s00125-008-1243-1; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Kanda Hiroko, 2007, Mod Rheumatol, V17, P364, DOI 10.1007/s10165-007-0589-4; Kim YC, 2010, IMMUNOLOGY, V130, P484, DOI 10.1111/j.1365-2567.2010.03269.x; Kotler S, 2008, ATHEROSCLEROSIS, V197, P105, DOI 10.1016/j.atherosclerosis.2007.08.005; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Lozanoska-Ochser B, 2006, DIABETES, V55, P1004, DOI 10.2337/diabetes.55.04.06.db05-1261; Wagner AM, 2011, DIABETES RES CLIN PR, V93, pE25, DOI 10.1016/j.diabres.2011.03.009; MARTIN S, 1992, DIABETES CARE, V15, P66, DOI 10.2337/diacare.15.1.66; Martin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017554; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Montecucco F, 2009, RHEUMATOLOGY, V48, P233, DOI 10.1093/rheumatology/ken466; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Palomer X, 2005, DIABETOLOGIA, V48, P1671, DOI 10.1007/s00125-005-1834-z; Rydgren T, 2007, J PHARMACOL EXP THER, V323, P180, DOI 10.1124/jpet.107.122655; Scholin A, 2004, DIABETES-METAB RES, V20, P205, DOI 10.1002/dmrr.427; Sosenko JM, 2004, DIABETES, V53, pA425; Tang TT, 2011, J LIPID RES, V52, P1023, DOI 10.1194/jlr.M010876; Torn C, 2000, J CLIN ENDOCR METAB, V85, P4619, DOI 10.1210/jc.85.12.4619; Yang J, 2010, MOL CELL BIOCHEM, V345, P189, DOI 10.1007/s11010-010-0572-9; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zhang Song, 2008, Zhonghua Yi Xue Za Zhi, V88, P568	38	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33108	10.1371/journal.pone.0033108	http://dx.doi.org/10.1371/journal.pone.0033108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448235	gold, Green Published, Green Submitted			2022-12-27	WOS:000303855700025
J	Arai, R; Tominaga, K; Wu, MH; Okura, M; Ito, K; Okamura, N; Onishi, H; Osaki, M; Sugimura, Y; Yoshiyama, M; Takamatsu, D				Arai, Rie; Tominaga, Kiyoshi; Wu, Meihua; Okura, Masatoshi; Ito, Kazutomo; Okamura, Naomi; Onishi, Hidetaka; Osaki, Makoto; Sugimura, Yuya; Yoshiyama, Mikio; Takamatsu, Daisuke			Diversity of Melissococcus plutonius from Honeybee Larvae in Japan and Experimental Reproduction of European Foulbrood with Cultured Atypical Isolates	PLOS ONE			English	Article							STREPTOCOCCUS-PLUTON; BEE LARVAE; APIS; IDENTIFICATION; HYBRIDIZATION	European foulbrood (EFB) is an important infectious disease of honeybee larvae, but its pathogenic mechanisms are still poorly understood. The causative agent, Melissococcus plutonius, is a fastidious organism, and microaerophilic to anaerobic conditions and the addition of potassium phosphate to culture media are required for growth. Although M. plutonius is believed to be remarkably homologous, in addition to M. plutonius isolates with typical cultural characteristics, M. plutonius-like organisms, with characteristics seemingly different from those of typical M. plutonius, have often been isolated from diseased larvae with clinical signs of EFB in Japan. Cultural and biochemical characterization of 14 M. plutonius and 19 M. plutonius-like strain/isolates revealed that, unlike typical M. plutonius strain/isolates, M. plutonius-like isolates were not fastidious, and the addition of potassium phosphate was not required for normal growth. Moreover, only M. plutonius-like isolates, but not typical M. plutonius strain/isolates, grew anaerobically on sodium phosphate-supplemented medium and aerobically on some potassium salt-supplemented media, were positive for beta-glucosidase activity, hydrolyzed esculin, and produced acid from L-arabinose, D-cellobiose, and salicin. Despite the phenotypic differences, 16S rRNA gene sequence analysis and DNA-DNA hybridization demonstrated that M. plutonius-like organisms were taxonomically identical to M. plutonius. However, by pulsed-field gel electrophoresis analysis, these typical and atypical (M. plutonius-like) isolates were separately grouped into two genetically distinct clusters. Although M. plutonius is known to lose virulence quickly when cultured artificially, experimental infection of representative isolates showed that atypical M. plutonius maintained the ability to cause EFB in honeybee larvae even after cultured in vitro in laboratory media. Because the rapid decrease of virulence in cultured M. plutonius was a major impediment to elucidation of the pathogenesis of EFB, atypical M. plutonius discovered in this study will be a breakthrough in EFB research.	[Arai, Rie] Saitama Prefectural Chuo Livestock Hyg Serv Ctr, Saitama, Japan; [Arai, Rie; Takamatsu, Daisuke] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Tominaga, Kiyoshi] Yamaguchi Prefectural Inst Publ Hlth & Environm, Yamaguchi, Japan; [Wu, Meihua] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Okura, Masatoshi; Osaki, Makoto; Takamatsu, Daisuke] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki, Japan; [Ito, Kazutomo] Gifu Prefectural Gifu Livestock Hyg Serv Ctr, Gifu, Japan; [Okamura, Naomi] Minist Agr Forestry & Fisheries, Anim Quarantine Serv, Yokohama, Kanagawa, Japan; [Onishi, Hidetaka] Fukushima Prefectural Kenchu Livestock Hyg Serv C, Koriyama, Fukushima, Japan; [Sugimura, Yuya; Yoshiyama, Mikio] Natl Agr & Food Res Org, Natl Inst Livestock & Grassland Sci, Anim Breeding & Reprod Res Div, Honey Bee Res Unit, Tsukuba, Ibaraki, Japan	Gifu University; University of Tsukuba; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Ministry of Agriculture Forestry & Fisheries - Japan; National Agriculture & Food Research Organization - Japan	Arai, R (corresponding author), Saitama Prefectural Chuo Livestock Hyg Serv Ctr, Saitama, Japan.	p1013dt@affrc.go.jp			Japan Society for the Promotion of Science [22580345]; Promotion of Basic Research Activities for Innovative Biosciences (PRO-BRAIN)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion of Basic Research Activities for Innovative Biosciences (PRO-BRAIN)	Parts of this study were supported by a Grant-in-Aid for Scientific Research (C) (22580345) from the Japan Society for the Promotion of Science to DT and a grant from Promotion of Basic Research Activities for Innovative Biosciences (PRO-BRAIN) to MY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MF, 1993, J APICULT RES, V32, P80, DOI 10.1080/00218839.1993.11101291; ALLEN MF, 1990, J INVERTEBR PATHOL, V55, P439, DOI 10.1016/0022-2011(90)90090-S; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BAILEY L, 1962, J GEN MICROBIOL, V28, P385, DOI 10.1099/00221287-28-3-385; BAILEY L, 1957, J GEN MICROBIOL, V17, P39, DOI 10.1099/00221287-17-1-39; BAILEY L, 1984, FEMS MICROBIOL LETT, V25, P139, DOI 10.1111/j.1574-6968.1984.tb01443.x; BAILEY L, 1982, J APPL BACTERIOL, V53, P215, DOI 10.1111/j.1365-2672.1982.tb04679.x; BAILEY L, 1974, J INVERTEBR PATHOL, V23, P246, DOI 10.1016/0022-2011(74)90192-X; BAILEY L, 1963, J INSECT PATHOL, V5, P198; BAILEY L, 1983, J APPL BACTERIOL, V55, P65, DOI 10.1111/j.1365-2672.1983.tb02648.x; BAILEY L., 1957, BEE WORLD, V38, P85; Dicks L. M. T., 2009, BERGEYS MANUAL SYSTE, V3, P607; Djordjevic SP, 1999, FEMS MICROBIOL LETT, V173, P311, DOI 10.1111/j.1574-6968.1999.tb13519.x; DORSCH M, 1992, J MICROBIOL METH, V16, P271, DOI 10.1016/0167-7012(92)90017-X; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; Giersch T, 2010, APIDOLOGIE, V41, P151, DOI 10.1051/apido/2009066; Govan VA, 1998, APPL ENVIRON MICROB, V64, P1983; KUSUNOKI S, 1991, J CLIN MICROBIOL, V29, P1596, DOI 10.1128/JCM.29.8.1596-1603.1991; McKee BA, 2004, J APICULT RES, V43, P93, DOI 10.1080/00218839.2004.11101117; Okumura K, 2011, J BACTERIOL, V193, P4029, DOI 10.1128/JB.05151-11; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; White G, 1912, 157 USDA BUR ENT	23	60	60	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33708	10.1371/journal.pone.0033708	http://dx.doi.org/10.1371/journal.pone.0033708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442715	Green Submitted, Green Published, gold			2022-12-27	WOS:000303836500056
J	Blount, BA; Weenink, T; Vasylechko, S; Ellis, T				Blount, Benjamin A.; Weenink, Tim; Vasylechko, Serge; Ellis, Tom			Rational Diversification of a Promoter Providing Fine-Tuned Expression and Orthogonal Regulation for Synthetic Biology	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; YEAST TRANSCRIPTOME; GENE-EXPRESSION; DNA; PROTEINS; DESIGN; RECOGNITION; METABOLISM; ACTIVATION	Yeast is an ideal organism for the development and application of synthetic biology, yet there remain relatively few well-characterised biological parts suitable for precise engineering of this chassis. In order to address this current need, we present here a strategy that takes a single biological part, a promoter, and re-engineers it to produce a fine-graded output range promoter library and new regulated promoters desirable for orthogonal synthetic biology applications. A highly constitutive Saccharomyces cerevisiae promoter, PFY1p, was identified by bioinformatic approaches, characterised in vivo and diversified at its core sequence to create a 36-member promoter library. TetR regulation was introduced into PFY1p to create a synthetic inducible promoter (iPFY1p) that functions in an inverter device. Orthogonal and scalable regulation of synthetic promoters was then demonstrated for the first time using customisable Transcription Activator-Like Effectors (TALEs) modified and designed to act as orthogonal repressors for specific PFY1-based promoters. The ability to diversify a promoter at its core sequences and then independently target Transcription Activator-Like Orthogonal Repressors (TALORs) to virtually any of these sequences shows great promise toward the design and construction of future synthetic gene networks that encode complex "multi-wire" logic functions.	[Blount, Benjamin A.; Weenink, Tim; Ellis, Tom] Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England; [Blount, Benjamin A.; Vasylechko, Serge; Ellis, Tom] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Imperial College London; Imperial College London	Blount, BA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England.	t.ellis@imperial.ac.uk	Blount, Benjamin A/G-6344-2012	Blount, Benjamin/0000-0003-3910-4782; Ellis, Thomas/0000-0001-5392-976X	Engineering and Physical Sciences Research Council [EP/G036004/1]; EPSRC [EP/G036004/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by Science and Innovation Award EP/G036004/1 from the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amberg DC., 2005, METHODS YEAST GENETI; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Angermayr M, 2003, J BIOL CHEM, V278, P17918, DOI 10.1074/jbc.M301806200; BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; Baker D, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0606-44; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bradley PH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000270; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen LA, 2010, YEAST, V27, P345, DOI 10.1002/yea.1757; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Daran-Lapujade P, 2004, J BIOL CHEM, V279, P9125, DOI 10.1074/jbc.M309578200; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Deng D, 2012, SCIENCE; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jensen PR, 1998, BIOTECHNOL BIOENG, V58, P191, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<191::AID-BIT11>3.0.CO;2-G; Jeppsson M, 2003, YEAST, V20, P1263, DOI 10.1002/yea.1043; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Krivoruchko A, 2011, BIOTECHNOL J, V6, P262, DOI 10.1002/biot.201000308; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Lu Timothy K, 2010, Bioeng Bugs, V1, P378, DOI 10.4161/bbug.1.6.13086; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; MAGDOLEN V, 1988, MOL CELL BIOL, V8, P5108, DOI 10.1128/MCB.8.12.5108; Mak A.N., 2012, SCIENCE; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Martens C, 2001, MOL MICROBIOL, V40, P1009, DOI 10.1046/j.1365-2958.2001.02445.x; Milias-Argeitis A, 2011, NAT BIOTECHNOL, V29, P1114, DOI 10.1038/nbt.2018; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Olesen K, 2002, FEMS YEAST RES, V2, P563, DOI 10.1111/j.1567-1364.2002.tb00123.x; Pirner HM, 2006, J BIOL CHEM, V281, P12381, DOI 10.1074/jbc.M511075200; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Rao CV, 2012, CURR OPIN BIOTECHNOL; Rintala E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-461; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Siddiqui MS, 2011, FEMS YEAST RES; SIKORSKI RS, 1989, GENETICS, V122, P19; Skrzypek MS, 2011, CURR PROTOC BIOINFOR, V20, P21, DOI DOI 10.1002/0471250953.BI0120S35; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Sorokina Oxana, 2009, J Biol Eng, V3, P15, DOI 10.1186/1754-1611-3-15; Strelkowa N, 2011, CHAOS, V21, DOI 10.1063/1.3574387; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tai SL, 2005, J BIOL CHEM, V280, P437, DOI 10.1074/jbc.M410573200; Tsai SL, 2010, APPL ENVIRON MICROB, V76, P7514, DOI 10.1128/AEM.01777-10; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	78	114	123	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33279	10.1371/journal.pone.0033279	http://dx.doi.org/10.1371/journal.pone.0033279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442681	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500023
J	Cole, SW; Yoo, DJ; Knutson, B				Cole, Steven W.; Yoo, Daniel J.; Knutson, Brian			Interactivity and Reward-Related Neural Activation during a Serious Videogame	PLOS ONE			English	Article							LONG-TERM-MEMORY; BRAIN-REGIONS; YOUNG-ADULTS; GAME; SELF; ADOLESCENTS; REFLECTION; EXPERIENCE; SYSTEMS; CANCER	This study sought to determine whether playing a "serious" interactive digital game (IDG) - the Re-Mission videogame for cancer patients - activates mesolimbic neural circuits associated with incentive motivation, and if so, whether such effects stem from the participatory aspects of interactive gameplay, or from the complex sensory/ perceptual engagement generated by its dynamic event-stream. Healthy undergraduates were randomized to groups in which they were scanned with functional magnetic resonance imaging (FMRI) as they either actively played Re-Mission or as they passively observed a gameplay audio-visual stream generated by a yoked active group subject. Onset of interactive game play robustly activated mesolimbic projection regions including the caudate nucleus and nucleus accumbens, as well as a subregion of the parahippocampal gyrus. During interactive gameplay, subjects showed extended activation of the thalamus, anterior insula, putamen, and motor-related regions, accompanied by decreased activation in parietal and medial prefrontal cortex. Offset of interactive gameplay activated the anterior insula and anterior cingulate. Between-group comparisons of within-subject contrasts confirmed that mesolimbic activation was significantly more pronounced in the active playgroup than in the passive exposure control group. Individual difference analyses also found the magnitude of parahippocampal activation following gameplay onset to correlate with positive attitudes toward chemotherapy assessed both at the end of the scanning session and at an unannounced one-month follow-up. These findings suggest that IDG-induced activation of reward-related mesolimbic neural circuits stems primarily from participatory engagement in gameplay (interactivity), rather than from the effects of vivid and dynamic sensory stimulation.	[Cole, Steven W.] HopeLab Fdn, Redwood City, CA USA; [Yoo, Daniel J.; Knutson, Brian] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Cole, SW (corresponding author), HopeLab Fdn, Redwood City, CA USA.	knutson@psych.stanford.edu		Knutson, Brian/0000-0002-7669-426X	HopeLab Foundation	HopeLab Foundation	This research was supported by an unrestricted gift from the nonprofit HopeLab Foundation to Brian Knutson. HopeLab also supplied the Re-Mission videogame used as a stimulus in this study. The design, conduct, analysis, and reporting of this study represents a scientific collaboration between Brian Knutson and Steve Cole. Steve Cole serves as Vice President for Research and Development at the HopeLab Foundation, which develops play-based behavioral interventions to improve health and seeks to optimize and better understand the mechanisms of such interventions. As such, one person employed by the funders of this research had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. None of the authors have any financial or other conflicting interest in the scientific results of this study.	Abt Clark C, 1970, SERIOUS GAMES; Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Armor DA, 2003, PERS SOC PSYCHOL B, V29, P86, DOI 10.1177/0146167202238374; Baumgartner T, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.008.2008; Beale IL, 2007, J ADOLESCENT HEALTH, V41, P263, DOI 10.1016/j.jadohealth.2007.04.006; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Brown SJ, 1997, MED INFORM, V22, P77, DOI 10.3109/14639239709089835; Chua HF, 2009, BIOL PSYCHIAT, V65, P165, DOI 10.1016/j.biopsych.2008.08.030; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Falk EB, 2011, HLTH PSYCHOL; Falk EB, 2010, J NEUROSCI, V30, P8421, DOI 10.1523/JNEUROSCI.0063-10.2010; Hoeft F, 2008, J PSYCHIATR RES, V42, P253, DOI 10.1016/j.jpsychires.2007.11.010; Hsu P. L., 1938, STATISTICAL RES MEMO, V2, P1; Jancke L, 2009, FRONT NEUROSCI-SWITZ, V3, P52, DOI 10.3389/neuro.01.006.2009; Kato PM, 2008, PEDIATRICS, V122, pE305, DOI 10.1542/peds.2007-3134; Klasen M., 2011, SOC COGN AFFECT NEUR; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Kuo WJ, 2009, SCIENCE, V324, P519, DOI 10.1126/science.1165598; Lieberman D A, 2001, J Ambul Care Manage, V24, P26; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; Mathiak KA, 2011, BMC NEUROSCI, V12, P12, DOI DOI 10.1186/1471-2202-12-66; Mayer RE., 2014, CAMBRIDGE HDB MULTIM, P345, DOI 10.1017/CBO9781139547369.017; McGonigal J., 2011, REALITY IS BROKEN WH; Mobbs D, 2007, SCIENCE, V317, P1079, DOI 10.1126/science.1144298; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Packer DJ, 2009, SOC NEUROSCI-UK, V4, P412, DOI 10.1080/17470910902750186; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Prensky M., 2001, DIGITAL GAME BASED L; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; Scheffe H, 1959, ANAL VARIANCE; Tate R., 2009, INT J LEARNING MEDIA, V1, P29, DOI [10.1162/ijlm.2009.0003, DOI 10.1162/IJLM.2009.0003]; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Vorderer P., 2006, PLAYING VIDEO GAMES; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486; ZIMMERMAN DW, 1987, J EXP EDUC, V55, P171, DOI 10.1080/00220973.1987.10806451	42	56	56	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33909	10.1371/journal.pone.0033909	http://dx.doi.org/10.1371/journal.pone.0033909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939TA	22442733	Green Submitted, Green Published, gold			2022-12-27	WOS:000303836500074
J	Sutherland, JR; Sales, KJ; Jabbour, HN; Katz, AA				Sutherland, Jason R.; Sales, Kurt J.; Jabbour, Henry N.; Katz, Arieh A.			Seminal Plasma Enhances Cervical Adenocarcinoma Cell Proliferation and Tumour Growth In Vivo	PLOS ONE			English	Article							EPITHELIAL-CELLS; CANCER CELLS; AUTOCRINE/PARACRINE REGULATION; CYCLOOXYGENASE-2 EXPRESSION; ENDOMETRIAL ADENOCARCINOMA; REPRODUCTIVE-TRACT; FACTOR RECEPTOR; ANGIOGENESIS; INTERLEUKIN-6; INFLAMMATION	Cervical cancer is one of the leading causes of cancer-related death in women in sub-Saharan Africa. Extensive evidence has shown that cervical cancer and its precursor lesions are caused by Human papillomavirus (HPV) infection. Although the vast majority of HPV infections are naturally resolved, failure to eradicate infected cells has been shown to promote viral persistence and tumorigenesis. Furthermore, following neoplastic transformation, exposure of cervical epithelial cells to inflammatory mediators either directly or via the systemic circulation may enhance progression of the disease. It is well recognised that seminal plasma contains an abundance of inflammatory mediators, which are identified as regulators of tumour growth. Here we investigated the role of seminal plasma in regulating neoplastic cervical epithelial cell growth and tumorigenesis. Using HeLa cervical adenocarcinoma cells, we found that seminal plasma (SP) induced the expression of the inflammatory enzymes, prostaglandin endoperoxide synthase (PTGS1 and PTGS2), cytokines interleukin (IL) -6, and -11 and vascular endothelial growth factor-A(VEGF-A). To investigate the role of SP on tumour cell growth in vivo, we xenografted HeLa cells subcutaneously into the dorsal flank of nude mice. Intra-peritoneal administration of SP rapidly and significantly enhanced the tumour growth rate and size of HeLa cell xenografts in nude mice. As observed in vitro, we found that SP induced expression of inflammatory PTGS enzymes, cytokines and VEGF-A in vivo. Furthermore we found that SP enhances blood vessel size in HeLa cell xenografts. Finally we show that SP-induced cytokine production, VEGF-A expression and cell proliferation are mediated via the induction of the inflammatory PTGS pathway.	[Sutherland, Jason R.; Sales, Kurt J.; Katz, Arieh A.] Univ Cape Town, MRC UCT Res Grp Receptor Biol, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Sutherland, Jason R.; Sales, Kurt J.; Katz, Arieh A.] Univ Cape Town, Fac Hlth Sci, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Jabbour, Henry N.] Univ Edinburgh, Queens Med Res Inst, MRC Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland	University of Cape Town; University of Cape Town; University of Edinburgh	Sutherland, JR (corresponding author), Univ Cape Town, MRC UCT Res Grp Receptor Biol, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	kurt.sales@uct.ac.za; arieh.katz@uct.ac.za	Katz, Arieh/F-5836-2012	Sales, Kurt/0000-0002-9880-5143	United Kingdom Medical Research Council (MRC) [U.1276.00.004.00002.01]; South African Medical Research Council (MRC); University of Cape Town (UCT)	United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town (UCT)	This study was supported by the United Kingdom Medical Research Council (MRC) core funding to HNJ (U.1276.00.004.00002.01) and by the South African Medical Research Council (MRC) and by the University of Cape Town (UCT) to AAK and KJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daraji WI, 2009, INT J CLIN EXP PATHO, V2, P48; Anorlu RI, 2008, REPROD HEALTH MATTER, V16, P41, DOI 10.1016/S0968-8080(08)32415-X; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; AUMULLER G, 1992, ANDROLOGIA, V24, P183, DOI 10.1111/j.1439-0272.1992.tb02636.x; Battersby S, 2007, HUM REPROD, V22, P36, DOI 10.1093/humrep/del328; Boccardo E, 2010, CARCINOGENESIS, V31, P1905, DOI 10.1093/carcin/bgq176; Canadas MP, 2010, J CLIN VIROL, V48, P198, DOI 10.1016/j.jcv.2010.03.023; Catalano RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019209; Chan JK, 2003, BRIT J CANCER, V89, P1062, DOI 10.1038/sj.bjc.6601196; Cheng WF, 1999, OBSTET GYNECOL, V93, P761, DOI 10.1016/S0029-7844(98)00505-5; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darai E, 1998, GYNECOL ONCOL, V71, P122, DOI 10.1006/gyno.1998.5118; Denison FC, 1999, MOL HUM REPROD, V5, P220, DOI 10.1093/molehr/5.3.220; EUSTACE D, 1993, GYNECOL ONCOL, V50, P15, DOI 10.1006/gyno.1993.1156; FREGENE TA, 1993, ANTICANCER RES, V13, P2377; Fujimoto J, 2000, CANCER RES, V60, P2632; Fung KYC, 2004, PROSTATE, V61, P171, DOI 10.1002/pros.20089; Goswami B, 2008, INT J GYNECOL CANCER, V18, P591, DOI 10.1111/j.1525-1438.2007.01089.x; GUIDI AJ, 1995, J NATL CANCER I, V87, P1237, DOI 10.1093/jnci/87.16.1237; HARLAN LC, 1991, AM J PUBLIC HEALTH, V81, P885, DOI 10.2105/AJPH.81.7.885; HORAK ER, 1992, LANCET, V340, P1120, DOI 10.1016/0140-6736(92)93150-L; Jabbour HN, 2009, REPRODUCTION, V138, P903, DOI 10.1530/REP-09-0247; Jabbour HN, 2004, TRENDS ENDOCRIN MET, V15, P398, DOI 10.1016/j.tem.2004.08.006; Jeremias J, 1997, HUM REPROD, V12, P1915, DOI 10.1093/humrep/12.9.1915; Jeremias J, 1999, AM J OBSTET GYNECOL, V181, P591, DOI 10.1016/S0002-9378(99)70497-7; Klemmt L, 2005, BIRTH DEFECTS RES B, V74, P119, DOI 10.1002/bdrb.20031; Liu L, 2011, J PATHOL, V225, P203, DOI 10.1002/path.2914; Mazibrada J, 2008, GYNECOL ONCOL, V108, P112, DOI 10.1016/j.ygyno.2007.08.095; Moldenhauer LM, 2009, J IMMUNOL, V182, P8080, DOI 10.4049/jimmunol.0804018; Muller M, 2006, ENDOCRINOLOGY, V147, P3356, DOI 10.1210/en.2005-1429; Ness RB, 2008, AM J OBSTET GYNECOL, V198, P620; NEY PG, 1986, MED HYPOTHESES, V20, P221, DOI 10.1016/0306-9877(86)90128-3; Oh JM, 2009, CARCINOGENESIS, V30, P141, DOI 10.1093/carcin/bgn236; PONTEN J, 1995, INT J CANCER, V60, P1, DOI 10.1002/ijc.2910600102; Quigley JP, 2012, FUTURE ONCOL, V8, P5, DOI [10.2217/FON.11.133, 10.2217/fon.11.133]; Rizzo MT, 2011, CLIN CHIM ACTA, V412, P671, DOI 10.1016/j.cca.2010.12.026; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Robertson SA, 1996, J REPROD FERTIL, V107, P265, DOI 10.1530/jrf.0.1070265; ROBERTSON SA, 1992, BIOL REPROD, V46, P1069, DOI 10.1095/biolreprod46.6.1069; Robertson SA, 2009, J REPROD IMMUNOL, V83, P109, DOI 10.1016/j.jri.2009.08.003; Robertson SA, 2009, BIOL REPROD, V80, P1036, DOI 10.1095/biolreprod.108.074658; Ryu HS, 2000, GYNECOL ONCOL, V76, P320, DOI 10.1006/gyno.1999.5690; Sales KJ, 2002, CANCER RES, V62, P424; Sales KJ, 2003, PROSTAG OTH LIPID M, V71, P97, DOI 10.1016/S1098-8823(03)00050-9; Sales KJ, 2002, MOL HUM REPROD, V8, P1065, DOI 10.1093/molehr/8.12.1065; Sales KJ, 2003, REPRODUCTION, V126, P559, DOI 10.1530/rep.0.1260559; Sales KJ, 2001, J CLIN ENDOCR METAB, V86, P2243, DOI 10.1210/jc.86.5.2243; Sales KJ, 2010, AM J PATHOL, V176, P435, DOI 10.2353/ajpath.2010.090403; Sales KJ, 2009, BBA-MOL CELL RES, V1793, P1917, DOI 10.1016/j.bbamcr.2009.09.018; SCHIFFMAN MH, 1995, CANCER-AM CANCER SOC, V76, P1888, DOI 10.1002/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sharkey DJ, 2012, J IMMUNOL IN PRESS; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Subbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273; Takano H, 1996, ARCH GYNECOL OBSTET, V258, P25, DOI 10.1007/BF01370929; Takehara H, 2006, DIGEST DIS SCI, V51, P2188, DOI 10.1007/s10620-006-9436-2; Toomey DP, 2009, SURG-J R COLL SURG E, V7, P174, DOI 10.1016/S1479-666X(09)80042-5; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; Wallace AE, 2009, CANCER RES, V69, P5726, DOI 10.1158/0008-5472.CAN-09-0390; WATSON JM, 1990, CANCER RES, V50, P6959; YAMAZAKI K, 1994, CANCER, V74, P2245, DOI 10.1002/1097-0142(19941015)74:8<2245::AID-CNCR2820740807>3.0.CO;2-X	61	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33848	10.1371/journal.pone.0033848	http://dx.doi.org/10.1371/journal.pone.0033848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442729	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500070
J	Gou, ZY; Liu, RR; Zhao, GP; Zheng, MQ; Li, P; Wang, HH; Zhu, Y; Chen, JL; Wen, J				Gou, Zhongyong; Liu, Ranran; Zhao, Guiping; Zheng, Maiqing; Li, Peng; Wang, Huihua; Zhu, Yun; Chen, Jilan; Wen, Jie			Epigenetic Modification of TLRs in Leukocytes Is Associated with Increased Susceptibility to Salmonella enteritidis in Chickens	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; ENTERICA SEROVAR ENTERITIDIS; GENE-EXPRESSION; INNATE IMMUNITY; UP-REGULATION; NEGATIVE REGULATION; EPITHELIAL-CELLS; MAST-CELLS; HOST; METHYLATION	Toll-like receptors (TLRs) signaling pathways are the first lines in defense against Salmonella enteritidis (S. enteritidis) infection but the molecular mechanism underlying susceptibility to S. enteritidis infection in chicken remains unclear. SPF chickens injected with S. enteritidis were partitioned into two groups, one consisted of those from Salmonella-susceptible chickens (died within 5 d after injection, n = 6), the other consisted of six Salmonella-resistant chickens that survived for 15 d after injection. The present study shows that the bacterial load in susceptible chickens was significantly higher than that in resistant chickens and TLR4, TLR2-1 and TLR21 expression was strongly diminished in the leukocytes of susceptible chickens compared with those of resistant chickens. The induction of expression of pro-inflammatory cytokine genes, IL-6 and IFN-beta, was greatly enhanced in the resistant but not in susceptible chickens. Contrasting with the reduced expression of TLR genes, those of the zinc finger protein 493 (ZNF493) gene and Toll-interacting protein (TOLLIP) gene were enhanced in the susceptible chickens. Finally, the expression of TLR4 in peripheral blood mononuclear cells (PBMCs) infected in vitro with S. enteritidis increased significantly as a result of treatment with 5-Aza-2-deoxycytidine (5-Aza-dc) while either 5-Aza-dc or trichostatin A was effective in up-regulating the expression of TLR21 and TLR2-1. DNA methylation, in the predicted promoter region of TLR4 and TLR21 genes, and an exonic CpG island of the TLR2-1 gene was significantly higher in the susceptible chickens than in resistant chickens. Taken together, the results demonstrate that ZNF493-related epigenetic modification in leukocytes probably accounts for increased susceptibility to S. enteritidis in chickens by diminishing the expression and response of TLR4, TLR21 and TLR2-1.	[Gou, Zhongyong; Liu, Ranran; Zhao, Guiping; Zheng, Maiqing; Li, Peng; Wang, Huihua; Zhu, Yun; Chen, Jilan; Wen, Jie] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Gou, ZY (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	jiewen@iascaas.net.cn		Zhao, Guiping/0000-0002-1510-6903; Wen, Jie/0000-0001-7460-4219	National Natural Science Foundation of China [30871776]; National Key Technology RD Program [2011BAD28B03]; China Agriculture Research System [CARS-42]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); China Agriculture Research System	This research was supported by National Natural Science Foundation of China (No. 30871776) and the National Key Technology R&D Program (2011BAD28B03) and the China Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2008, VET IMMUNOL IMMUNOP, V123, P314, DOI 10.1016/j.vetimm.2008.02.010; Abasht B, 2009, POULTRY SCI, V88, P744, DOI 10.3382/ps.2008-00419; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Babu S, 2006, J IMMUNOL, V176, P3885, DOI 10.4049/jimmunol.176.7.3885; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Deng SX, 2008, AVIAN DIS, V52, P88, DOI 10.1637/8102-090107-Reg; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; HALFORD S, 1995, GENOMICS, V25, P322, DOI 10.1016/0888-7543(95)80149-G; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Herman JG, 1997, CANCER RES, V57, P837; Hisano M, 2003, NUCLEIC ACIDS RES, V31, P4797, DOI 10.1093/nar/gkg670; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HUE NT, 2006, AM SOC MICROBIOL, V38, P56; Jakobsson J, 2008, NEURON, V60, P818, DOI 10.1016/j.neuron.2008.09.036; Janeway CA, 1999, CURR BIOL, V9, pR879, DOI 10.1016/S0960-9822(00)80073-1; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Li P, 2010, VET MICROBIOL, V143, P346, DOI 10.1016/j.vetmic.2009.12.008; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; LINDELL KA, 1994, POULTRY SCI, V73, P757, DOI 10.3382/ps.0730757; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Shuto T, 2006, FASEB J, V20, P782, DOI 10.1096/fj.05-4934fje; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; Werling D, 2009, TRENDS IMMUNOL, V30, P124, DOI 10.1016/j.it.2008.12.001; Wigley P, 2001, INFECT IMMUN, V69, P7873, DOI 10.1128/IAI.69.12.7873-7879.2001; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; Yang HW, 2010, CELL PHYSIOL BIOCHEM, V26, P337, DOI 10.1159/000320557; Yang HW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-37	46	43	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33627	10.1371/journal.pone.0033627	http://dx.doi.org/10.1371/journal.pone.0033627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438967	gold, Green Submitted, Green Published			2022-12-27	WOS:000303309100073
J	Morag, N; Saroya, Y; Braverman, Y; Klement, E; Gottlieb, Y				Morag, Neta; Saroya, Yonatan; Braverman, Yehuda; Klement, Eyal; Gottlieb, Yuval			Molecular Identification, Phylogenetic Status, and Geographic Distribution of Culicoides oxystoma (Diptera: Ceratopogonidae) in Israel	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; POLYMERASE-CHAIN-REACTION; BITING MIDGES DIPTERA; BLUETONGUE VIRUS; OBSOLETUS COMPLEX; SCOTICUS DIPTERA; IMICOLA; TRANSMISSION; VECTORS; INFECTION	Culicoides oxystoma (Diptera: Ceratopogonidae) is an important vector species, reported mainly from Asia, with high potential to transmit viral diseases affecting livestock. In Japan, many arboviruses have been isolated from C. oxystoma, suggesting it as a key player in the epidemiology of several Culicoides-borne diseases. Over the years, C. oxystoma has also been reported in the Middle East region, including Israel. In this region, however, C. oxystoma cannot be easily distinguished morphologically from its sibling species included in the Culicoides schultzei complex. We therefore used genomic data for species identification and phylogeny resolution. Phylogenetic analyses based on internal transcribed spacer 1 (ITS-1) of ribosomal DNA and the mitochondrial gene encoding cytochrome oxidase subunit I (COI) showed that C. oxystoma from Israel is closely related to C. oxystoma from Japan. Using differential probing PCR, we showed that C. oxystoma is distributed all over the country, especially in Mediterranean climate regions. Culicoides oxystoma is less common or even absent in arid regions, while the other genetic cluster of C. schultzei complex was found only in the east of the country (mostly arid and semiarid regions). The molecular finding of C. oxystoma in wide geographical regions, together with its high proportion in the general Culicoides population and its vectoring potential, imply that it may be an important vector species in the Middle East.	[Morag, Neta; Saroya, Yonatan; Braverman, Yehuda; Klement, Eyal; Gottlieb, Yuval] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Morag, N (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	yuvalgd@yahoo.com	Klement, Eyal/H-8388-2019; Gottlieb, Yuval/H-6461-2013	Klement, Eyal/0000-0002-2384-2345; 	BARD [IS-4185-09]	BARD(US-Israel Binational Science Foundation)	This work was funded by research grant No. IS-4185-09 from BARD, The United States-Israel Binational Agricultural Research and Development fund to YG (www.bard-isus.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, CURR TOP MICROBIOL; Boorman J., 1989, Fauna of Saudi Arabia, V10, P160; Braverman Y, 1996, J AM MOSQUITO CONTR, V12, P437; BRAVERMAN Y, 1981, INSECT SCI APPL, V2, P157, DOI 10.1017/S1742758400000953; BRAVERMAN Y, 1985, J MED ENTOMOL, V22, P476, DOI 10.1093/jmedent/22.5.476; BRAVERMAN Y, 1979, REFUAH VET, V36, P121; BRAVERMAN Y, 1985, P191; Braverman Y., 1981, Israel Journal of Entomology, V15, P13; Braverman Y, 1991, C INT AS SUD EUR PAR; BRAVERMANN Y, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P179; Callot J, 1969, Bull. Soc. Path. exot., V62, P118; Cetre-Sossah C, 2004, VET RES, V35, P325, DOI 10.1051/vetres:2004015; Cetre-Sossah C, 2008, RES VET SCI, V85, P372, DOI 10.1016/j.rvsc.2007.12.001; Cornet M., 1981, Israel Journal of Entomology, V15, P110; Cornet Michel, 1994, Bulletin de la Societe Entomologique de France, V99, P149; Dallas JF, 2003, MED VET ENTOMOL, V17, P379, DOI 10.1111/j.1365-2915.2003.00454.x; DeBlauwe I, 2012, MED VET ENTOMOL, V26, P83, DOI 10.1111/j.1365-2915.2011.00979.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; Goldreich Y., 2012, CLIMATE ISRAEL OBSER; Gomulski LM, 2006, MED VET ENTOMOL, V20, P229, DOI 10.1111/j.1365-2915.2006.00620.x; Gomulski LM, 2005, SYST ENTOMOL, V30, P619, DOI 10.1111/j.1365-3113.2005.00286.x; Kaufmann C, 2011, MED VET ENTOMOL, V25, P32, DOI 10.1111/j.1365-2915.2010.00927.x; Kedmi M, 2010, J DAIRY SCI, V93, P2486, DOI 10.3168/jds.2009-2850; Mathieu B, 2007, J MED ENTOMOL, V44, P1019, DOI 10.1603/0022-2585(2007)44[1019:MIOWES]2.0.CO;2; Mathieu B, 2011, VET PARASITOL, V182, P297, DOI 10.1016/j.vetpar.2011.05.052; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; Matsumoto Y, 2009, J MED ENTOMOL, V46, P1099, DOI 10.1603/033.046.0517; Mayo CE, 2012, VET MICROBIOL, V155, P158, DOI 10.1016/j.vetmic.2011.08.029; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MELLOR PS, 1995, ANN TROP MED PARASIT, V89, P1; MELLOR PS, 1981, ACTA VIROL, V25, P401; MELLOR PS, 1984, J HYG-CAMBRIDGE, V93, P621, DOI 10.1017/S0022172400065190; Monaco F, 2010, VET ITAL, V46, P215; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Nolan DV, 2004, VETER ITAL SER, V40, P352; Pages N, 2005, J MED ENTOMOL, V42, P1026, DOI 10.1603/0022-2585(2005)042[1026:DOCOAC]2.0.CO;2; Perrin A, 2006, MED VET ENTOMOL, V20, P219, DOI 10.1111/j.1365-2915.2006.00616.x; Stephan A, 2009, PARASITOL RES, V105, P367, DOI 10.1007/s00436-009-1407-z; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Velthuis AGJ, 2010, PREV VET MED, V93, P294, DOI 10.1016/j.prevetmed.2009.11.007; Wenk CE, 2012, VET PARASITOL, V184, P258, DOI 10.1016/j.vetpar.2011.08.034; Wirth W.W., 1985, Progress in Clinical and Biological Research, V178, P151; WIRTH WW, 1968, ANN ENTOMOL SOC AM, V61, P783, DOI 10.1093/aesa/61.3.783; Yanase T, 2005, J MED ENTOMOL, V42, P63, DOI 10.1603/0022-2585(2005)042[0063:IOBAFC]2.0.CO;2	47	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33610	10.1371/journal.pone.0033610	http://dx.doi.org/10.1371/journal.pone.0033610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438964	Green Submitted, gold, Green Published			2022-12-27	WOS:000303309100070
J	Zhang, MP; Zhang, Y; Huang, JJ; Zhang, XJ; Lee, MK; Stelly, DM; Zhang, HB				Zhang, Meiping; Zhang, Yang; Huang, James J.; Zhang, Xiaojun; Lee, Mi-Kyung; Stelly, David M.; Zhang, Hong-Bin			Genome Physical Mapping of Polyploids: A BIBAC Physical Map of Cultivated Tetraploid Cotton, Gossypium hirsutum L.	PLOS ONE			English	Article							ARTIFICIAL CHROMOSOME LIBRARIES; ARABIDOPSIS-THALIANA; FINGERPRINT ANALYSIS; FUNCTIONAL-ANALYSIS; VERTEBRATE GENOME; BAC; EVOLUTION; DNA; CONSTRUCTION; TRANSFORMATION	Polyploids account for approximately 70% of flowering plants, including many field, horticulture and forage crops. Cottons are a world-leading fiber and important oilseed crop, and a model species for study of plant polyploidization, cellulose biosynthesis and cell wall biogenesis. This study has addressed the concerns of physical mapping of polyploids with BACs and/or BIBACs by constructing a physical map of the tetraploid cotton, Gossypium hirsutum L. The physical map consists of 3,450 BIBAC contigs with an N50 contig size of 863 kb, collectively spanning 2,244 Mb. We sorted the map contigs according to their origin of subgenome, showing that we assembled physical maps for the A-and D-subgenomes of the tetraploid cotton, separately. We also identified the BIBACs in the map minimal tilling path, which consists of 15,277 clones. Moreover, we have marked the physical map with nearly 10,000 BIBAC ends (BESs), making one BES in approximately 250 kb. This physical map provides a line of evidence and a strategy for physical mapping of polyploids, and a platform for advanced research of the tetraploid cotton genome, particularly fine mapping and cloning the cotton agronomic genes and QTLs, and sequencing and assembling the cotton genome using the modern next-generation sequencing technology.	[Zhang, Meiping; Zhang, Yang; Huang, James J.; Zhang, Xiaojun; Lee, Mi-Kyung; Stelly, David M.; Zhang, Hong-Bin] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Zhang, Meiping] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China	Texas A&M University System; Texas A&M University College Station; Jilin Agricultural University	Zhang, MP (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	hbz7049@tamu.edu	Stelly, David/ABC-7400-2020	Stelly, David/0000-0002-3468-4119	Zhang laboratory [203232-86360]; Texas AgriLife Research [124475-85360, 124475-70360]	Zhang laboratory; Texas AgriLife Research	This study was supported by an internal fund of Zhang laboratory (203232-86360) and the research grants of Texas AgriLife Research (124475-85360 and 124475-70360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang YL, 2001, GENETICS, V159, P1231; Chang YL, 2011, GENOME, V54, P437, DOI [10.1139/G11-011, 10.1139/g11-011]; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Ercolano MR, 2004, MOL BREEDING, V13, P15, DOI 10.1023/B:MOLB.0000012326.01128.5d; Fujiyama A, 2002, SCIENCE, V295, P131, DOI 10.1126/science.1065199; Gonzalez VM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-339; Grant V., 1981, PLANT SPECIATION; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; Gu YQ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-496; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Hamilton CM, 1999, PLANT J, V18, P223, DOI 10.1046/j.1365-313X.1999.00433.x; Hanson RE, 1998, AM J BOT, V85, P1364, DOI 10.2307/2446394; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Katagiri T, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-89; Larkin DM, 2003, GENOME RES, V13, P1966, DOI 10.1101/gr.1560203; Lee MK, 2011, THEOR APPL GEN UNPUB; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; Li YN, 2007, GENOME, V50, P278, DOI 10.1139/G07-006; Lin LF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-395; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Luo MC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-122; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Palti Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-462; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Qin QL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-247, 10.1186/1471-2164-11-501]; Ren CW, 2003, GENOME RES, V13, P2754, DOI 10.1101/gr.1499303; Romanov MN, 2003, CYTOGENET GENOME RES, V102, P277, DOI 10.1159/000075763; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Rong Y, 2004, PHYLOGENY GENUS GOSS; Sambrook J., 2001, MOL CLONING LAB MANU; Seelanan T, 1997, SYST BOT, V22, P259, DOI 10.2307/2419457; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; Tao QZ, 2001, GENETICS, V158, P1711; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Wu CC, 2004, GENOME RES, V14, P319, DOI 10.1101/gr.1405004; Wu CC, 2005, HANDBOOK OF PLANT GENOME MAPPING: GENETIC AND PHYSICAL MAPPING, P257, DOI 10.1002/3527603514.ch11; Xia JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011974; Xu P, 2007, GENOMICS, V90, P380, DOI 10.1016/j.ygeno.2007.05.008; Xu ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni037; Xu ZY, 2004, GENOMICS, V84, P941, DOI 10.1016/j.ygeno.2004.08.014; Zhang Hong-Bin, 2008, Int J Plant Genomics, V2008, P742304, DOI 10.1155/2008/742304; Zhang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027612; Zhang XJ, 2010, MAR BIOTECHNOL, V12, P141, DOI 10.1007/s10126-009-9209-y; Zhang X, 2006, MOL PLANT MICROBE IN, V19, P1302, DOI 10.1094/MPMI-19-1302; Zhang Y, 2008, MAR BIOTECHNOL, V10, P358, DOI 10.1007/s10126-007-9071-8; Zhang Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-447; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zhebentyayeva TN, 2008, TREE GENET GENOMES, V4, P745, DOI 10.1007/s11295-008-0147-z	55	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33644	10.1371/journal.pone.0033644	http://dx.doi.org/10.1371/journal.pone.0033644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438974	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100079
J	Scartozzi, M; Faloppi, L; Bianconi, M; Giampieri, R; Maccaroni, E; Bittoni, A; Del Prete, M; Loretelli, C; Belvederesi, L; Baroni, GS; Cascinu, S				Scartozzi, Mario; Faloppi, Luca; Bianconi, Maristella; Giampieri, Riccardo; Maccaroni, Elena; Bittoni, Alessandro; Del Prete, Michela; Loretelli, Cristian; Belvederesi, Laura; Baroni, Gianluca Svegliati; Cascinu, Stefano			The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management	PLOS ONE			English	Article							UNRESECTABLE HEPATOCELLULAR-CARCINOMA; METASTATIC COLORECTAL ADENOCARCINOMA; HYPOXIA-INDUCIBLE FACTOR-1; ENDOTHELIAL GROWTH-FACTOR; LIPIODOL CHEMOEMBOLIZATION; PTK787/ZK 222584; CONTROLLED-TRIAL; PHASE-III; CANCER; EXPRESSION	In many tumor types serum lactate dehydrogenase (LDH) levels is an indirect marker of tumor hypoxia, neo-angiogenesis and worse prognosis. However data about hepatocellular carcinoma (HCC) are lacking in the clinical setting of patients undergoing transarterial-chemoembolization (TACE) in whom hypoxia and neo-angiogenesis may represent a molecular key to treatment failure. Aim of our analysis was to evaluate the role of LDH pre-treatment levels in determining clinical outcome for patients with HCC receiving TACE. One hundred and fourteen patients were available for our analysis. For all patients LDH values were collected within one month before the procedure. We divided our patients into two groups, according to LDH serum concentration registered before TACE (first: LDH <= 450 U/l 84 patients; second: LDH>450 U/l 30 patients). Patients were classified according to the variation in LDH serum levels pre- and post-treatment (increased: 62 patients vs. decreased 52 patients). No statistically significant differences were found between the groups for all clinical characteristics analyzed (gender, median age, performance status ECOG, staging systems). In patients with LDH values below 450 U/l median time to progression (TTP) was 16.3 months, whereas it was of 10.1 months in patients above the cut-off (p = 0.0085). Accordingly median overall survival (OS) was 22.4 months and 11.7 months (p = 0.0049). In patients with decreased LDH values after treatment median TTP was 12.4 months, and median OS was 22.1 months, whereas TTP was 9.1 months and OS was 9.5 in patients with increased LDH levels (TTP: p = 0.0087; OS: p<0.0001). In our experience, LDH seemed able to predict clinical outcome for HCC patients undergoing TACE. Given the correlation between LDH levels and tumor angiogenesis we can speculate that patients with high LDH pretreatment levels may be optimal candidates for clinical trial exploring a multimodality treatment approach with TACE and anti-VEGF inhibitors in order to improve TTP and OS.	[Scartozzi, Mario; Giampieri, Riccardo; Loretelli, Cristian; Belvederesi, Laura; Cascinu, Stefano] Univ Politecn Marche, Azienda Osped Univ Osped Riuniti Umberto I Lancis, Clin Oncol Med, Ancona, Italy; [Faloppi, Luca; Bianconi, Maristella; Maccaroni, Elena; Bittoni, Alessandro; Del Prete, Michela] Univ Politecn Marche, Clin Oncol Med, Scuola Specializzaz Oncol Med, Ancona, Italy; [Baroni, Gianluca Svegliati] Univ Politecn Marche, Azienda Osped Univ Osped Riuniti Umberto I Lancis, Gastroenterol Clin, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University	Scartozzi, M (corresponding author), Univ Politecn Marche, Azienda Osped Univ Osped Riuniti Umberto I Lancis, Clin Oncol Med, Ancona, Italy.	marioscartozzi@gmail.com	Loretelli, Cristian/AAO-7678-2020; Cascinu, Stefano/G-2399-2017; Faloppi, Luca/K-1030-2016; Cascinu, Stefano/AAN-1923-2020; pierantonelli, irene/B-4187-2014; Maccaroni, Elena/K-1232-2018	Cascinu, Stefano/0000-0003-2215-0731; Faloppi, Luca/0000-0003-3689-3085; Maccaroni, Elena/0000-0003-3212-4246; svegliati-baroni, gianluca/0000-0003-4399-3359; Loretelli, Cristian/0000-0002-7583-8540; SCARTOZZI, MARIO/0000-0001-5977-5546; Bianconi, Maristella/0000-0003-3475-2529				Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Bruix J, 1998, HEPATOLOGY, V27, P1578, DOI 10.1002/hep.510270617; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; CHAO Y, 2003, ANN SURG ONCOL, P55; Faloppi L, 2011, CANCER TREAT REV, V37, P169, DOI 10.1016/j.ctrv.2010.08.001; Hecht JR, 2011, J CLIN ONCOL, V29, P1997, DOI 10.1200/JCO.2010.29.4496; Holbrook JJ., 1975, ENZYMES, P191; Kohles N, 2012, TUMOR BIOL, V33, P33, DOI 10.1007/s13277-011-0237-7; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Koukourakis MI, 2011, CLIN CANCER RES, V17, P4892, DOI 10.1158/1078-0432.CCR-10-2918; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; MARKERT CL, 1963, SCIENCE, V140, P1329, DOI 10.1126/science.140.3573.1329; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Montalto G, 2002, ANN NY ACAD SCI, V963, P13, DOI 10.1111/j.1749-6632.2002.tb04090.x; O'Suilleabhain CB, 2003, BRIT J SURG, V90, P325, DOI 10.1002/bjs.4045; OBERTI F, 1995, NEW ENGL J MED, V332, P1256; Okada S, 1998, HEPATO-GASTROENTEROL, V45, P1259; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pelletier G, 1998, J HEPATOL, V29, P129, DOI 10.1016/S0168-8278(98)80187-6; Poon RTP, 2004, BRIT J SURG, V91, P1354, DOI 10.1002/bjs.4594; Scartozzi M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-164; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2004, DOI 10.1200/JCO.2010.29.5436; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu XZ, 2010, WORLD J GASTROENTERO, V16, P4084, DOI 10.3748/wjg.v16.i32.4084	29	42	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e32653	10.1371/journal.pone.0032653	http://dx.doi.org/10.1371/journal.pone.0032653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461886	Green Published, gold, Green Submitted			2022-12-27	WOS:000304118900005
J	Craddock, TJA; Tuszynski, JA; Chopra, D; Casey, N; Goldstein, LE; Hameroff, SR; Tanzi, RE				Craddock, Travis J. A.; Tuszynski, Jack A.; Chopra, Deepak; Casey, Noel; Goldstein, Lee E.; Hameroff, Stuart R.; Tanzi, Rudolph E.			The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; LONG-TERM POTENTIATION; P70 S6 KINASE; MOLECULAR-DYNAMICS SIMULATION; ALPHA-BETA-TUBULIN; A-BETA; MEMORY DEFICITS; NERVOUS-SYSTEM; RAT-BRAIN; CYTOSKELETAL PROTEINS	Alzheimer's disease (AD) is the most common form of dementia in the elderly. Hallmark AD neuropathology includes extracellular amyloid plaques composed largely of the amyloid-beta protein (A beta), intracellular neurofibrillary tangles (NFTs) composed of hyper-phosphorylated microtubule-associated protein tau (MAP-tau), and microtubule destabilization. Early-onset autosomal dominant AD genes are associated with excessive A beta accumulation, however cognitive impairment best correlates with NFTs and disrupted microtubules. The mechanisms linking A beta and NFT pathologies in AD are unknown. Here, we propose that sequestration of zinc by A beta-amyloid deposits (A beta oligomers and plaques) not only drives A beta aggregation, but also disrupts zinc homeostasis in zinc-enriched brain regions important for memory and vulnerable to AD pathology, resulting in intra-neuronal zinc levels, which are either too low, or excessively high. To evaluate this hypothesis, we 1) used molecular modeling of zinc binding to the microtubule component protein tubulin, identifying specific, high-affinity zinc binding sites that influence side-to-side tubulin interaction, the sensitive link in microtubule polymerization and stability. We also 2) performed kinetic modeling showing zinc distribution in extra-neuronal A beta deposits can reduce intra-neuronal zinc binding to microtubules, destabilizing microtubules. Finally, we 3) used metallomic imaging mass spectrometry (MIMS) to show anatomically-localized and age-dependent zinc dyshomeostasis in specific brain regions of Tg2576 transgenic, mice, a model for AD. We found excess zinc in brain regions associated with memory processing and NFT pathology. Overall, we present a theoretical framework and support for a new theory of AD linking extra-neuronal A beta amyloid to intra-neuronal NFTs and cognitive dysfunction. The connection, we propose, is based on beta-amyloid-induced alterations in zinc ion concentration inside neurons affecting stability of polymerized microtubules, their binding to MAP-tau, and molecular dynamics involved in cognition. Further, our theory supports novel AD therapeutic strategies targeting intra-neuronal zinc homeostasis and microtubule dynamics to prevent neurodegeneration and cognitive decline.	[Craddock, Travis J. A.; Tuszynski, Jack A.] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Tuszynski, Jack A.] Univ Alberta, Cross Canc Inst, Div Expt Oncol, Edmonton, AB, Canada; [Chopra, Deepak] Chopra Ctr Well Being, Carlsbad, CA USA; [Casey, Noel; Goldstein, Lee E.] Boston Univ, Sch Med, Ctr Biomet & Metall, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Hameroff, Stuart R.] Univ Arizona Hlth Sci Ctr, Ctr Consciousness Studies, Dept Anesthesiol, Tucson, AZ USA; [Hameroff, Stuart R.] Univ Arizona Hlth Sci Ctr, Ctr Consciousness Studies, Dept Psychol, Tucson, AZ USA; [Tanzi, Rudolph E.] Massachusetts Gen Hosp E, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA USA	University of Alberta; University of Alberta; Boston University; University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences	Craddock, TJA (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB, Canada.	travisc@ualberta.ca	Tuszynski, Jack/AAA-2073-2020; Tanzi, Rudolph/AAE-9622-2019	Tuszynski, Jack/0000-0001-9976-0429; Tanzi, Rudolph/0000-0002-7032-1454; Craddock, Travis/0000-0001-7244-6317; Goldstein, Lee/0000-0001-8419-9800	Natural Sciences and Engineering Research Council (NSERC) (Canada); Alberta Cancer Foundation; Allard Foundation; Alberta Advanced Education and Technology; National Institute of General Medical Sciences (National Institutes of Health (NIH)) [GM75986]; National Center for Research Resources (NIH) [S10RR026599]; National Science Foundation [0901760, 0821304]; NIH Alzheimer's Disease Center National Institute on Aging [P30AG13846]; Department of Anesthesiology, University of Arizona Medical Center; Cure Alzheimer's Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council (NSERC) (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Cancer Foundation; Allard Foundation; Alberta Advanced Education and Technology; National Institute of General Medical Sciences (National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); NIH Alzheimer's Disease Center National Institute on Aging; Department of Anesthesiology, University of Arizona Medical Center; Cure Alzheimer's Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	TJAC gratefully acknowledges PGS-D funding from Natural Sciences and Engineering Research Council (NSERC) (Canada)(www.nserc-crsng.gc.ca/Index_eng.asp). JAT gratefully acknowledges research support from NSERC (Canada)(www.nserc-crsng.gc.ca/Index_eng.asp), the Alberta Cancer Foundation (albertacancer.ca/), the Allard Foundation and Alberta Advanced Education and Technology(www.advancededucation.gov.ab.ca/). LG acknowledges funding from National Institute of General Medical Sciences (National Institutes of Health (NIH)) Grant GM75986; National Center for Research Resources (NIH) Grant S10RR026599; National Science Foundation Grants 0901760, 0821304; and NIH Alzheimer's Disease Center Grant National Institute on Aging (NIH) P30AG13846. SRH acknowledges funding from the Department of Anesthesiology, University of Arizona Medical Center. RET acknowledges funding from the Cure Alzheimer's Fund (curealz.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Adlard Paul A., 2007, P333, DOI 10.1007/978-0-387-70830-0_15; Allan CL, 2011, NEUROPSYCHOBIOLOGY, V64, P163, DOI 10.1159/000328951; Ames BN, 2006, ZINC DEFICIENCY MICR; An WL, 2005, J NEUROCHEM, V92, P1104, DOI 10.1111/j.1471-4159.2004.02948.x; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Ashford JW, 1998, J NEUROPATH EXP NEUR, V57, P972, DOI 10.1097/00005072-199810000-00009; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANERJEE A, 1982, BIOCHEM BIOPH RES CO, V105, P1503, DOI 10.1016/0006-291X(82)90958-5; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bianchi M, 2006, EUR J NEUROSCI, V24, P2894, DOI 10.1111/j.1460-9568.2006.05170.x; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Calastretti A, 2001, ONCOGENE, V20, P6172, DOI 10.1038/sj.onc.1204751; Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Chi RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016655; Craddock TJA, 2009, BIOSYSTEMS, V97, P28, DOI 10.1016/j.biosystems.2009.04.001; Craddock TJA, 2012, PLOS COMP B IN PRESS; CRONLYDILLON J, 1974, J EXP BIOL, V61, P443; Dehmelt L, 2005, GENOME BIOL, V6; DIAZ JF, 1994, J MOL BIOL, V238, P214, DOI 10.1006/jmbi.1994.1282; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; EAGLE GR, 1983, BIOCHEMISTRY-US, V22, P221, DOI 10.1021/bi00270a032; Ebert JC, 2008, PROTEIN SCI, V17, P54, DOI 10.1110/ps.073138508; EDSTROM A, 1975, BRAIN RES, V86, P162, DOI 10.1016/0006-8993(75)90650-2; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Fukunaga K, 1996, NEUROCHEM INT, V28, P343, DOI 10.1016/0197-0186(95)00097-6; GASKIN F, 1978, NEUROSCIENCE, V3, P1117, DOI 10.1016/0306-4522(78)90130-6; GASKIN F, 1981, BIOCHEMISTRY-US, V20, P1318, DOI 10.1021/bi00508a043; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gonzalez-Billault C, 2004, J NEUROBIOL, V58, P48, DOI 10.1002/neu.10283; Grabrucker AM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-65; Hagan S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061901; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hameroff S, 2002, BIOSYSTEMS, V64, P149, DOI 10.1016/S0303-2647(01)00183-6; HAMEROFF SR, 1982, J THEOR BIOL, V98, P549, DOI 10.1016/0022-5193(82)90137-0; Hameroff S, 2010, J BIOL PHYS, V36, P71, DOI 10.1007/s10867-009-9148-x; Hameroff SR, 2010, J INTEGR NEUROSCI, V9, P253, DOI 10.1142/S0219635210002482; HASKINS KM, 1980, BIOCHEM BIOPH RES CO, V95, P1703, DOI 10.1016/S0006-291X(80)80095-7; HESKETH JE, 1984, INT J BIOCHEM, V16, P1331, DOI 10.1016/0020-711X(84)90236-2; HESKETH JE, 1982, INT J BIOCHEM, V14, P983, DOI 10.1016/0020-711X(82)90059-3; HESKETH JE, 1983, INT J BIOCHEM, V15, P743, DOI 10.1016/0020-711X(83)90202-1; Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011; Hoogenraad SC, 2004, BIOESSAYS, V26, P141, DOI 10.1002/bies.10402; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Khuchua Z, 2003, NEUROSCIENCE, V119, P101, DOI 10.1016/S0306-4522(03)00094-0; Kim I, 2011, NEUROREPORT IN PRESS; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; KRESS Y, 1981, BRAIN RES, V220, P139, DOI 10.1016/0006-8993(81)90217-1; Lafay-Chebassier C, 2006, J NEUROSCI RES, V84, P1323, DOI 10.1002/jnr.21039; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lian GW, 2006, CURR OPIN PEDIATR, V18, P614, DOI 10.1097/MOP.0b013e328010542d; Liu HX, 2005, MOL BRAIN RES, V139, P169, DOI 10.1016/j.molbrainres.2005.05.014; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; MELKI R, 1993, BIOCHEMISTRY-US, V32, P3405, DOI 10.1021/bi00064a026; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Nelson TJ, 2004, HIPPOCAMPUS, V14, P46, DOI 10.1002/hipo.10152; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nunez J, 1997, J MOL NEUROSCI, V8, P207, DOI 10.1007/BF02736834; OTEIZA PI, 1990, TERATOLOGY, V41, P97, DOI 10.1002/tera.1420410110; OTEIZA PI, 1990, BIOL TRACE ELEM RES, V24, P13, DOI 10.1007/BF02789137; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; PAULABARBOSA M, 1987, BRAIN RES, V417, P139, DOI 10.1016/0006-8993(87)90188-0; Pei JJ, 2008, J ALZHEIMERS DIS, V14, P385; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PRUS K, 1983, FEBS LETT, V151, P54, DOI 10.1016/0014-5793(83)80341-X; Riederer BM, 2007, BRAIN RES BULL, V71, P541, DOI 10.1016/j.brainresbull.2006.11.012; Roberts LA, 1998, MOL BRAIN RES, V56, P38, DOI 10.1016/S0169-328X(98)00026-6; Ross JL, 2004, P NATL ACAD SCI USA, V101, P12910, DOI 10.1073/pnas.0402928101; Sabate R, 2005, INT J BIOL MACROMOL, V35, P9, DOI 10.1016/j.ijbiomac.2004.11.001; Sahu S, 2012, NATURE MAT IN PRESS; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sept D, 1999, J THEOR BIOL, V197, P77, DOI 10.1006/jtbi.1998.0861; Sept D, 2003, PROTEIN SCI, V12, P2257, DOI 10.1110/ps.03187503; Shimada A, 2006, NEUROPATH APPL NEURO, V32, P1, DOI 10.1111/j.1365-2990.2006.00632.x; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Sigurdsson EM, 2009, CURR ALZHEIMER RES, V6, P446, DOI 10.2174/156720509789207930; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tuszynski JA, 1998, PHILOS T R SOC A, V356, P1897, DOI 10.1098/rsta.1998.0255; TUSZYNSKI JA, 1995, J THEOR BIOL, V174, P371, DOI 10.1006/jtbi.1995.0105; UNGER E, 1990, ELECTRON MICROSC REV, V3, P355, DOI 10.1016/0892-0354(90)90007-F; VANDERZEE EA, 1994, CEREB CORTEX, V4, P376; Vater W, 1997, CELL MOTIL CYTOSKEL, V36, P76, DOI 10.1002/(SICI)1097-0169(1997)36:1<76::AID-CM7>3.0.CO;2-F; W DeLano, 2002, PYMOL RELEASE 0 99; WANDOSELL F, 1986, J BIOL CHEM, V261, P332; Wang F, 2000, Wei Sheng Yan Jiu, V29, P156; Wang Fu-Di, 1999, Shengli Xuebao, V51, P495; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WOOLF NJ, 1994, NEUROREPORT, V5, P1045, DOI 10.1097/00001756-199405000-00007; Woolf NJ, 1999, BRAIN RES, V821, P241, DOI 10.1016/S0006-8993(99)01064-1; WOOLF NJ, 1993, J CHEM NEUROANAT, V6, P375, DOI 10.1016/0891-0618(93)90012-S; Woolf NJ, 1998, PROG NEUROBIOL, V55, P59, DOI 10.1016/S0301-0082(97)00094-4; Woolf NJ, 2010, NANOTECHNOLOGY NANOS; Yoo SS, 2011, NEUROIMAGE, V56, P1267, DOI 10.1016/j.neuroimage.2011.02.058; Zervas M, 2005, J NEUROSCI RES, V82, P83, DOI 10.1002/jnr.20624	115	113	118	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33552	10.1371/journal.pone.0033552	http://dx.doi.org/10.1371/journal.pone.0033552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457776	Green Published, gold			2022-12-27	WOS:000304046900018
J	Zhao, ZY; Yu, RJ; Yang, JY; Liu, XF; Tan, MH; Li, HY; Chen, JS				Zhao, Zhiyi; Yu, Rongjie; Yang, Jiayin; Liu, Xiaofei; Tan, Meihua; Li, HongYang; Chen, Jiansu			Maxadilan Prevents Apoptosis in iPS Cells and Shows No Effects on the Pluripotent State or Karyotype	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; EMBRYONIC STEM-CELLS; NEURAL DIFFERENTIATION; IN-VIVO; PACAP; RECEPTOR; VIP; EXPRESSION; PROTECTS; AGONIST	Pituitary adenylate cyclase-activating polypeptide (PACAP) is a structurally endogenous peptide with many biological roles. Maxadilan, a 61-amino acid vasodilatory peptide, specifically activates the PACAP type I receptor (PAC1). Although PAC1 has been identified in embryonic stem cells, little is known about its presence or effects in human induced pluripotent stem (iPS) cells. In the present study, we investigated the expression of PAC1 in human iPS cells by reverse transcriptase polymerase chain reaction (RT-PCR) and western blot analysis. To study the physiological effects mediated by PAC1, we evaluated the role of maxadilan in preventing apoptotic cell death induced by ultraviolet C (UVC). After exposure to UVC, the iPS cells showed a marked reduction in cell viability and a parallel increase of apoptotic cells, as demonstrated by WST-8 analysis, annexin V/propidium iodide (PI) analysis and the terminal transferase dUTP nick end labeling (TUNEL) assay. The addition of 30 nM of maxadilan dramatically increased iPS cell viability and reduced the percentage of apoptotic cells. The anti-apoptotic effects of maxadilan were correlated to the downregulation of caspase-3 and caspase-9. Concomitantly, immunofluorescence, western blot analysis, real-time quantitative polymerase chain reaction (RT-qPCR) analysis and in vitro differentiation results showed that maxadilan did not affect the pluripotent state of iPS cells. Moreover, karyotype analysis showed that maxadilan did not affect the karyotype of iPS cells. In summary, these results demonstrate that PAC1 is present in iPS cells and that maxadilan effectively protects iPS cells against UVC-induced apoptotic cell death while not affecting the pluripotent state or karyotype.	[Zhao, Zhiyi; Tan, Meihua; Li, HongYang; Chen, Jiansu] Jinan Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Zhao, Zhiyi; Tan, Meihua; Li, HongYang; Chen, Jiansu] Jinan Univ, Coll Med, Inst Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Zhao, Zhiyi; Tan, Meihua; Li, HongYang; Chen, Jiansu] Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjie; Liu, Xiaofei] Jinan Univ, Bioengn Inst, Guangzhou, Guangdong, Peoples R China; [Yang, Jiayin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University; Jinan University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Zhao, ZY (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China.	chenjiansu2000@163.com		Yu, Rongjie/0000-0001-9285-5783	National Natural Science Foundation of China [30973244]; Jinan University; Fundamental Research Funds for the Central Universities of China [21609407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jinan University(Jinan University); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 30973244) and the Project 211 at Jinan University, the Fundamental Research Funds for the Central Universities of China (21609407). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINO H, 1995, GENE, V164, P301, DOI 10.1016/0378-1119(95)00391-I; Alexandre D, 2002, ENDOCRINOLOGY, V143, P2680, DOI 10.1210/en.143.7.2680; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Cazillis M, 2004, EUR J NEUROSCI, V19, P798, DOI 10.1111/j.0953-816X.2004.03138.x; Chafai M, 2006, ANN NY ACAD SCI, V1070, P185, DOI 10.1196/annals.1317.010; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Gasz B, 2006, PEPTIDES, V27, P87, DOI 10.1016/j.peptides.2005.06.022; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hirose M, 2005, REGUL PEPTIDES, V126, P109, DOI 10.1016/j.regpep.2004.08.018; Kanekar S, 2010, MOL CELL NEUROSCI, V45, P345, DOI 10.1016/j.mcn.2010.07.007; Kao CL, 2010, STEM CELLS DEV, V19, P247, DOI 10.1089/scd.2009.0186; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lerner EA, 2007, PEPTIDES, V28, P1651, DOI 10.1016/j.peptides.2007.06.021; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin SA, 2005, CANCER RES, V65, P10657, DOI 10.1158/0008-5472.CAN-05-2087; Morio H, 1996, ANN NY ACAD SCI, V805, P476; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Ohta S, 2006, J NEUROSCI RES, V84, P1177, DOI 10.1002/jnr.21026; Olmer R, 2010, STEM CELL RES, V5, P51, DOI 10.1016/j.scr.2010.03.005; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Pirger Z, 2008, J MOL NEUROSCI, V36, P105, DOI 10.1007/s12031-008-9070-x; Racz B, 2010, REGUL PEPTIDES, V160, P91, DOI 10.1016/j.regpep.2009.12.003; Scharf E, 2008, J MOL NEUROSCI, V36, P79, DOI 10.1007/s12031-008-9097-z; Shahhoseini M, 2010, BIOCHEM CELL BIOL, V88, P527, DOI [10.1139/O09-181, 10.1139/o09-181]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaudry D, 2000, PHARMACOL REV, V52, P269; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yu RJ, 2006, PEPTIDES, V27, P1359, DOI 10.1016/j.peptides.2005.11.026	31	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33953	10.1371/journal.pone.0033953	http://dx.doi.org/10.1371/journal.pone.0033953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457805	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900036
J	Landrum, ML; Hullsiek, KH; O'Connell, RJ; Chun, HM; Ganesan, A; Okulicz, JF; Lalani, T; Weintrob, AC; Crum-Cianflone, NF; Agan, BK				Landrum, Michael L.; Hullsiek, Katherine Huppler; O'Connell, Robert J.; Chun, Helen M.; Ganesan, Anuradha; Okulicz, Jason F.; Lalani, Tahaniyat; Weintrob, Amy C.; Crum-Cianflone, Nancy F.; Agan, Brian K.		HIV Working Grp	Hepatitis B Vaccine Antibody Response and the Risk of Clinical AIDS or Death	PLOS ONE			English	Article							DELAYED-TYPE HYPERSENSITIVITY; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED INDIVIDUALS; T-CELL; REPLICATIVE SENESCENCE; ANTIRETROVIRAL THERAPY; HEALTH-CARE; COUNT; NONRESPONSIVENESS; REVACCINATION	Background: Whether seroresponse to a vaccine such as hepatitis B virus (HBV) vaccine can provide a measure of the functional immune status of HIV-infected persons is unknown. This study evaluated the relationship between HBV vaccine seroresponses and progression to clinical AIDS or death. Methods and Findings: From a large HIV cohort, we evaluated those who received HBV vaccine only after HIV diagnosis and had anti-HBs determination 1-12 months after the last vaccine dose. Non-response and positive response were defined as anti-HBs <10 and >= 10 IU/L, respectively. Participants were followed from date of last vaccination to clinical AIDS, death, or last visit. Univariate and multivariable risk of progression to clinical AIDS or death were evaluated with Cox regression models. A total of 795 participants vaccinated from 1986-2010 were included, of which 41% were responders. During 3,872 person-years of observation, 122 AIDS or death events occurred (53% after 1995). Twenty-two percent of non-responders experienced clinical AIDS or death compared with 5% of responders (p<0.001). Non-response to HBV vaccine was associated with a greater than 2-fold increased risk of clinical AIDS or death (HR 2.47; 95% CI, 1.38-4.43) compared with a positive response, after adjusting for CD4 count, HIV viral load, HAART use, and delayed type hypersensitivity skin test responses (an in vivo marker of cell-mediated immunity). This association remained evident among those with CD4 count >= 500 cells/mm(3) (HR 3.40; 95% CI, 1.39-8.32). Conclusions: HBV vaccine responses may have utility in assessing functional immune status and risk stratificating HIV-infected individuals, including those with CD4 count >= 500 cells/mm(3).	[Landrum, Michael L.; Hullsiek, Katherine Huppler; Ganesan, Anuradha; Lalani, Tahaniyat; Weintrob, Amy C.; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Landrum, Michael L.; Okulicz, Jason F.] San Antonio Mil Med Ctr, Ft Sam Houston, TX USA; [Hullsiek, Katherine Huppler] Univ Minnesota, Minneapolis, MN USA; [O'Connell, Robert J.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Chun, Helen M.; Crum-Cianflone, Nancy F.] USN, Hlth Res Ctr, San Diego, CA 92152 USA; [Ganesan, Anuradha; Weintrob, Amy C.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Walter Reed National Military Medical Center	Landrum, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.	mlandrum@idcrp.org	Lalani, Tahaniyat/HCI-8313-2022	Lalani, Tahaniyat/0000-0002-9361-2991; Agan, Brian/0000-0002-5114-1669; Eberly, Lynn/0000-0003-4763-330X	Department of Defense (DoD) [IDCRP-000-25]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement [Y1-AI-5072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072] Funding Source: NIH RePORTER	Department of Defense (DoD)(United States Department of Defense); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work (IDCRP-000-25) was provided by the Infectious Disease Clinical Research Program (IDCRP, www.idcrp.org), a Department of Defense (DoD) program executed through Uniformed Services University of the Health Sciences. This project has been funded with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. The IDCRP reviewed the study design, collected the data, and provided salary support to investigators (M.L.L., A.G., T.L., A.C.W., and B.K.A.). The analyses, conclusions and decision to submit the manuscript are the independent work and decision of the authors. The content of this publication is the sole responsibility of the authors and does not necessarily reflect the views or policies of the NIH or the Department of Health and Human Services, the DoD or the Departments of the Army, Navy or Air Force. Mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government.	Aberg JA, 2004, CLIN INFECT DIS, V39, P609, DOI 10.1086/423390; Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; ALPER CA, 1989, NEW ENGL J MED, V321, P708, DOI 10.1056/NEJM198909143211103; Anastos K, 2004, JAIDS-J ACQ IMM DEF, V35, P383, DOI 10.1097/00126334-200404010-00008; Appay V, 2002, TRENDS IMMUNOLOGY, P23; Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Bauer T, 2006, VACCINE, V24, P572, DOI 10.1016/j.vaccine.2005.08.058; BIRX DL, 1993, J ACQ IMMUN DEF SYND, V6, P1248; BLATT SP, 1993, ANN INTERN MED, V119, P177, DOI 10.7326/0003-4819-119-3-199308010-00001; Brodine SK, 2003, AIDS, V17, P2521, DOI 10.1097/00002030-200311210-00016; Centers for Disease Control and Prevention, 1992, MMWR, V41; Chun HM, 2010, CLIN INFECT DIS, V50, P426, DOI 10.1086/649885; CRAVEN DE, 1986, ANN INTERN MED, V105, P356, DOI 10.7326/0003-4819-105-3-356; Balado MDD, 2010, J INFECT DIS, V202, P362, DOI 10.1086/653707; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; DOLAN MJ, 1995, J INFECT DIS, V172, P79, DOI 10.1093/infdis/172.1.79; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Effros RB, 2007, VACCINE, V25, P599, DOI 10.1016/j.vaccine.2006.08.032; EGEA E, 1991, J EXP MED, V173, P531, DOI 10.1084/jem.173.3.531; FILION LG, 1988, CLIN EXP IMMUNOL, V71, P405; Goncalves L, 2004, VIROLOGY, V326, P20, DOI 10.1016/j.virol.2004.04.042; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Holmes D, 2008, IMMUNOL RES, V41, P248, DOI 10.1007/s12026-008-8037-x; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Jones-Lopez EC, 2006, AM J TROP MED HYG, V74, P154, DOI 10.4269/ajtmh.2006.74.154; Landrum ML, 2011, AM J EPIDEMIOL, V173, P84, DOI 10.1093/aje/kwq326; Landrum ML, 2010, AIDS, V24, P545, DOI 10.1097/QAD.0b013e32832cd99e; Landrum ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008687; Landrum ML, 2009, VACCINE, V27, P4731, DOI 10.1016/j.vaccine.2009.04.016; Lange CG, 2003, AIDS, V17, P2015, DOI 10.1097/00002030-200309260-00002; LOKE RHT, 1990, J MED VIROL, V31, P109, DOI 10.1002/jmv.1890310207; Maas JJ, 1998, J INFECT DIS, V178, P1024, DOI 10.1086/515655; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Meroni L, 2003, JAIDS-J ACQ IMM DEF, V33, P277, DOI 10.1097/00126334-200306010-00027; Moir S, 2003, P NATL ACAD SCI USA, V100, P6057, DOI 10.1073/pnas.0730819100; Moir S, 2008, J ALLERGY CLIN IMMUN, V122, P12, DOI 10.1016/j.jaci.2008.04.034; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Pessoa SD, 2010, VACCINE, V28, P1606, DOI 10.1016/j.vaccine.2009.11.045; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Valdez H, 2000, AIDS, V14, P11, DOI 10.1097/00002030-200001070-00002; Wang CB, 2004, HEPATOLOGY, V39, P978, DOI 10.1002/hep.20142; Yang Z, 2008, CLIN IMMUNOL, V127, P265, DOI 10.1016/j.clim.2007.11.010	43	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33488	10.1371/journal.pone.0033488	http://dx.doi.org/10.1371/journal.pone.0033488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457767	gold, Green Published, Green Submitted			2022-12-27	WOS:000303909200032
J	Tang, ACL; Hwang, GL; Tsai, SJ; Chang, MY; Tang, ZCW; Tsai, MD; Luo, CY; Hoffman, AS; Hsieh, PCH				Tang, Alan C. L.; Hwang, Gan-Lin; Tsai, Shih-Jung; Chang, Min-Yao; Tang, Zack C. W.; Tsai, Meng-Da; Luo, Chwan-Yao; Hoffman, Allan S.; Hsieh, Patrick C. H.			Biosafety of Non-Surface Modified Carbon Nanocapsules as a Potential Alternative to Carbon Nanotubes for Drug Delivery Purposes	PLOS ONE			English	Article							STRUCTURAL DEFECTS PLAY; ACUTE LUNG TOXICITY; IN-VIVO; MAJOR ROLE; BIODISTRIBUTION; TISSUE; RATS; C-60	Background: Carbon nanotubes (CNTs) have found wide success in circuitry, photovoltaics, and other applications. In contrast, several hurdles exist in using CNTs towards applications in drug delivery. Raw, non-modified CNTs are widely known for their toxicity. As such, many have attempted to reduce CNT toxicity for intravenous drug delivery purposes by post-process surface modification. Alternatively, a novel sphere-like carbon nanocapsule (CNC) developed by the arc-discharge method holds similar electric and thermal conductivities, as well as high strength. This study investigated the systemic toxicity and biocompatibility of different non-surface modified carbon nanomaterials in mice, including multiwalled carbon nanotubes (MWCNTs), single-walled carbon nanotubes (SWCNTs), carbon nanocapsules (CNCs), and C-60 fullerene (C-60). The retention of the nanomaterials and systemic effects after intravenous injections were studied. Methodology and Principal Findings: MWCNTs, SWCNTs, CNCs, and C-60 were injected intravenously into FVB mice and then sacrificed for tissue section examination. Inflammatory cytokine levels were evaluated with ELISA. Mice receiving injection of MWCNTs or SWCNTs at 50 mu g/g b.w. died while C-60 injected group survived at a 50% rate. Surprisingly, mortality rate of mice injected with CNCs was only at 10%. Tissue sections revealed that most carbon nanomaterials retained in the lung. Furthermore, serum and lung-tissue cytokine levels did not reveal any inflammatory response compared to those in mice receiving normal saline injection. Conclusion: Carbon nanocapsules are more biocompatible than other carbon nanomaterials and are more suitable for intravenous drug delivery. These results indicate potential biomedical use of non-surface modified carbon allotrope. Additionally, functionalization of the carbon nanocapsules could further enhance dispersion and biocompatibility for intravenous injection.	[Tang, Alan C. L.; Tang, Zack C. W.; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan, Taiwan; [Hwang, Gan-Lin; Tsai, Shih-Jung] Nano Powder & Thin Film Technol Ctr, Ind Technol Res Inst, Tainan, Taiwan; [Chang, Min-Yao; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Biomed Engn, Tainan, Taiwan; [Hwang, Gan-Lin; Tsai, Shih-Jung; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Ctr Micro Nano Sci & Technol, Tainan, Taiwan; [Tsai, Meng-Da; Luo, Chwan-Yao; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Dept Surg, Tainan, Taiwan; [Hoffman, Allan S.; Hsieh, Patrick C. H.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Hsieh, Patrick C. H.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Industrial Technology Research Institute - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; University of Washington; University of Washington Seattle; Academia Sinica - Taiwan	Hsieh, PCH (corresponding author), Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan, Taiwan.	phsieh@mail.ncku.edu.tw			National Science Council [99-2627-M-006-009]; Center for Micro/Nano Science and Technology of National Cheng Kung University [99C028]	National Science Council(Ministry of Science and Technology, Taiwan); Center for Micro/Nano Science and Technology of National Cheng Kung University	This research was financially supported by the National Science Council (99-2627-M-006-009) and the Center for Micro/Nano Science and Technology of National Cheng Kung University (99C028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aillon KL, 2009, ADV DRUG DELIVER REV, V61, P457, DOI 10.1016/j.addr.2009.03.010; Baker GL, 2008, TOXICOL SCI, V101, P122, DOI 10.1093/toxsci/kfm243; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Bhirde AA, 2009, ACS NANO, V3, P307, DOI 10.1021/nn800551s; Burke AR, 2011, BIOMATERIALS, V32, P5970, DOI 10.1016/j.biomaterials.2011.04.059; Cheng WH, 2004, J LIGHTWAVE TECHNOL, V22, P2177, DOI 10.1109/JLT.2004.833250; Cheung W, 2010, ADV DRUG DELIVER REV, V62, P633, DOI 10.1016/j.addr.2010.03.007; Deng X, 2007, CARBON, V45, P1419, DOI 10.1016/j.carbon.2007.03.035; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Dobrovolskaia MA, 2009, NAT NANOTECHNOL, V4, P411, DOI [10.1038/nnano.2009.175, 10.1038/NNANO.2009.175]; Fenoglio I, 2008, CHEM RES TOXICOL, V21, P1690, DOI 10.1021/tx800100s; Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044; Huang HC, 2006, THIN SOLID FILMS, V515, P1033, DOI 10.1016/j.tsf.2006.07.071; Huang HC, 2006, THIN SOLID FILMS, V511, P203, DOI 10.1016/j.tsf.2005.12.127; Hwang GL, 2003, CHEM MATER, V15, P1353, DOI 10.1021/cm020747j; Hwang GL, 2002, US patent, Patent No. 7156958; Jeong SH, 2002, CHEM MATER, V14, P1859, DOI 10.1021/cm011620h; Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241; Kostarelos K, 2008, NAT BIOTECHNOL, V26, P774, DOI 10.1038/nbt0708-774; Kubota R, 2011, TOXICOL LETT, V206, P172, DOI 10.1016/j.toxlet.2011.07.010; Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015; LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876; Li C, 2007, J MATER CHEM, V17, P2406, DOI 10.1039/b618518e; Muller J, 2008, CHEM RES TOXICOL, V21, P1698, DOI 10.1021/tx800101p; Podesta JE, 2009, SMALL, V5, P1176, DOI 10.1002/smll.200801572; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Ryman-Rasmussen JP, 2009, NAT NANOTECHNOL, V4, P747, DOI [10.1038/nnano.2009.305, 10.1038/NNANO.2009.305]; Saito N, 2009, CHEM SOC REV, V38, P1897, DOI 10.1039/b804822n; Sato Y, 2008, ACS NANO, V2, P348, DOI 10.1021/nn700324z; Shvedova AA, 2009, PHARMACOL THERAPEUT, V121, P192, DOI 10.1016/j.pharmthera.2008.10.009; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; Su TT, 2006, IEEE C EM TECHN NAN; Tong DG, 2010, PLASMA CHEM PLASMA P, V30, P897, DOI 10.1007/s11090-010-9262-3; Xu JY, 2007, CARBON, V45, P1865, DOI 10.1016/j.carbon.2007.04.030; Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u; Yang WR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/41/412001; Zhang DY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/17/175101; Zhang Y, 2010, DRUG DISCOV TODAY, V15, P428, DOI 10.1016/j.drudis.2010.04.005	38	32	32	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e32893	10.1371/journal.pone.0032893	http://dx.doi.org/10.1371/journal.pone.0032893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457723	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200009
J	Arrive, E; Dicko, F; Amghar, H; Aka, AE; Dior, H; Bouah, B; Traore, M; Ogbo, P; Dago-Akribi, HA; Eboua, TKF; Kouakou, K; Sy, HS; Alioum, A; Dabis, F; Ekouevi, DK; Leroy, V				Arrive, Elise; Dicko, Fatoumata; Amghar, Hind; Aka, Addi Edmond; Dior, Helene; Bouah, Belinda; Traore, Mariam; Ogbo, Patricia; Dago-Akribi, Hortense Aka; Eboua, Tanoh Kassi F.; Kouakou, Kouadio; Sy, Haby Signate; Alioum, Ahmadou; Dabis, Francois; Ekouevi, Didier Koumavi; Leroy, Valeriane		Pediat IeDEA W Africa Working Grp	HIV Status Disclosure and Retention in Care in HIV-Infected Adolescents on Antiretroviral Therapy (ART) in West Africa	PLOS ONE			English	Article							SOUTHERN AFRICA; CHILDREN; HEALTH; ADHERENCE; DIAGNOSIS; WORKERS; IMPACT; UGANDA; ADULTS; YOUTH	Objective: We assessed the effect of HIV status disclosure on retention in care from initiation of antiretroviral therapy (ART) among HIV-infected children aged 10 years or more in Cote d'Ivoire, Mali and Senegal. Methods: Multi-centre cohort study within five paediatric clinics participating in the IeDEA West Africa collaboration. HIV-infected patients were included in this study if they met the following inclusion criteria: aged 10-21 years while on ART; having initiated ART >= 200 days before the closure date of the clinic database; followed >= 15 days from ART initiation in clinics with >= 10 adolescents enrolled. Routine follow-up data were merged with those collected through a standardized ad hoc questionnaire on awareness of HIV status. Probability of retention (no death or loss-to-follow-up) was estimated with Kaplan-Meier method. Cox proportional hazard model with date of ART initiation as origin and a delayed entry at date of 10th birthday was used to identify factors associated with death or loss-to-follow-up. Results: 650 adolescents were available for this analysis. Characteristics at ART initiation were: median age of 10.4 years; median CD4 count of 224 cells/mm(3) (47% with severe immunosuppression), 48% CDC stage C/WHO stage 3/4. The median follow-up on ART after the age of 10 was 23.3 months; 187 adolescents (28.8%) knew their HIV status. The overall probability of retention at 36 months after ART initiation was 74.6% (95% confidence interval [CI]: 70.5-79.0) and was higher for those disclosed compared to those not: adjusted hazard ratio for the risk of being death or loss-to-follow-up = 0.23 (95% CI: 0.13-0.39). Conclusion: About 2/3 of HIV-infected adolescents on ART were not aware of their HIV status in these ART clinics in West Africa but disclosed HIV status improved retention in care. The disclosure process should be thus systematically encouraged and organized in adolescent populations.	[Arrive, Elise; Amghar, Hind; Alioum, Ahmadou; Dabis, Francois; Leroy, Valeriane] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Arrive, Elise; Alioum, Ahmadou; Dabis, Francois; Ekouevi, Didier Koumavi; Leroy, Valeriane] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Dicko, Fatoumata; Traore, Mariam] Hop Gabriel Toure, Bamako, Mali; [Aka, Addi Edmond; Dago-Akribi, Hortense Aka] Ctr Prise Charge Rech & Format, Abidjan, Cote Ivoire; [Dior, Helene; Sy, Haby Signate] Hop Albert Royer, Dakar, Senegal; [Bouah, Belinda; Eboua, Tanoh Kassi F.] Ctr Hosp Univ Yopougon, Abidjan, Cote Ivoire; [Ogbo, Patricia; Kouakou, Kouadio] Ctr Integre Rech Bioclin, Abidjan, Cote Ivoire; [Ekouevi, Didier Koumavi] PACCI, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Arrive, E (corresponding author), INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.	elise.arrive@isped.u-bordeaux2.fr	Alioum, Ahmadou/U-3789-2019; DABIS, FRANCOIS/S-9298-2019; Leroy, Valeriane/AAO-5175-2020; Leroy, Valeriane/F-8129-2013; Leroy, Valeriane/GQB-1102-2022; EKOUEVI, Didier K/E-7960-2014; Arrivé, Elise/T-9126-2019; Anglaret, Xavier/F-7333-2013	DABIS, FRANCOIS/0000-0002-1614-8857; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Anglaret, Xavier/0000-0003-3319-8423	National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) [5U01AI069919-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases (NIAID) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The International epidemiological Database to Evaluate AIDS in West Africa (IeDEA West Africa) is supported by: the National Cancer Institute (NCI), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Allergy and Infectious Diseases (NIAID) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (grant no. 5U01AI069919-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arun S, 2009, INDIAN J PEDIATR, V76, P805, DOI 10.1007/s12098-009-0177-z; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019261; Bakeera-Kitaka S, 2008, AIDS CARE, V20, P426, DOI 10.1080/09540120701867099; Bhattacharya M, 2010, J TROP PEDIAT; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Boon-Yasidhi Vitharon, 2005, J Med Assoc Thai, V88 Suppl 8, pS100; Brown B. C, 2011, AIDS CARE, P1; Butler AM, 2009, PEDIATRICS, V123, P935, DOI 10.1542/peds.2008-1290; Charles M, 2008, B WORLD HEALTH ORGAN, V86, P970, DOI 10.2471/BLT.07.050120; De Bacts AJ, 2008, SOC SCI MED, V66, P479, DOI 10.1016/j.socscimed.2007.08.028; Ding H, 2009, ARCH PEDIAT ADOL MED, V163, P1100, DOI 10.1001/archpediatrics.2009.204; Ekouevi DK, 2011, BMC PUBLIC HEALTH, V11, pe519; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; Foster C, 2010, EXPERT REV ANTI-INFE, V8, P1403, DOI 10.1586/ERI.10.129; Foster C, 2007, CURR OPIN HIV AIDS, V2, P431, DOI 10.1097/COH.0b013e3282ced150; Grandir, 2007, ANN DIAGN INF VIH EN; Gray GE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000227; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Kallem S, 2011, AIDS BEHAV, V15, P1121, DOI 10.1007/s10461-010-9741-9; Meless D, 2010, DISCLOSURE HIV TEST; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Moodley K, 2006, SAMJ S AFR MED J, V96, pA201; Musisi S, 2009, East Afr Med J, V86, P16; Myer L, 2006, J TROP PEDIATRICS, V52, P293, DOI 10.1093/tropej/fml004; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Oberdorfer P, 2006, J PAEDIATR CHILD H, V42, P283, DOI 10.1111/j.1440-1754.2006.00855.x; Rudy BJ, 2009, AIDS PATIENT CARE ST, V23, P185, DOI 10.1089/apc.2008.0162; Rujumba J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-9; Ryscavage PA, 2011, J ACQUIR IMMUNE DEFI; Santamaria EK, 2011, AIDS PATIENT CARE ST, V25, P257, DOI 10.1089/apc.2010.0161; UNAIDS, 2011, GLOB HIV RESP; Vaz L, 2008, AIDS CARE, V20, P842, DOI 10.1080/09540120701742276; Vaz LM, 2011, J DEV BEHAV PEDIAT; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; World Health Organization, 2011, GUID HIV DISC COUNS; World Health Organization, 2010, ANT THER HIV INF INF; Yeap AD, 2010, AIDS CARE, V22, P1101, DOI 10.1080/09540121003602218	39	73	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33690	10.1371/journal.pone.0033690	http://dx.doi.org/10.1371/journal.pone.0033690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YN	22457782	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100037
J	Davies, NECG; Karstaedt, AS				Davies, Natasha E. C. G.; Karstaedt, Alan S.			Antiretroviral Outcomes in South African Prisoners: A Retrospective Cohort Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PRISONERS; THERAPY; TUBERCULOSIS; RESISTANCE; RELEASE; PREVALENCE; ADHERENCE; TREAT	Background and Methods: Little is known about antiretroviral therapy (ART) outcomes in prisoners in Africa. We conducted a retrospective review of outcomes of a large cohort of prisoners referred to a public sector, urban HIV clinic. The review included baseline characteristics, sequential CD4 cell counts and viral load results, complications and co-morbidities, mortality and loss to follow-up up to 96 weeks on ART. Findings: 148 inmates (133 male) initiated on ART were included in the study. By week 96 on ART, 73% of all inmates enrolled in the study and 92% of those still accessing care had an undetectable viral load (<400copies/ml). The median CD4 cell count increased from 122 cells/mm(3) at baseline to 356 cells/mm(3) by 96 weeks. By study end, 96 (65%) inmates had ever received tuberculosis (TB) therapy with 63 (43%) receiving therapy during the study: 28% had a history of TB prior to ART initiation, 33% were on TB therapy at ART initiation and 22% developed TB whilst on ART. Nine (6%) inmates died, 7 in the second year on ART. Loss to follow-up (LTF) was common: 14 (9%) patients were LTF whilst still incarcerated, 11 (7%) were LTF post-release and 9 (6%) whose movements could not be traced. 16 (11%) inmates had inter-correctional facility transfers and 34 (23%) were released of whom only 23 (68%) returned to the ART clinic for ongoing follow-up. Conclusions: Inmates responded well to ART, despite a high frequency of TB/HIV co-infection. Attention should be directed towards ensuring eligible prisoners access ART programs promptly and that inter-facility transfers and release procedures facilitate continuity of care. Institutional TB control measures should remain a priority.	[Davies, Natasha E. C. G.; Karstaedt, Alan S.] Univ Witwatersrand, Dept Med, Chris Hani Baragwanath Hosp, Div Infect Dis, ZA-2001 Johannesburg, South Africa; [Davies, Natasha E. C. G.] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Davies, NECG (corresponding author), Univ Witwatersrand, Dept Med, Chris Hani Baragwanath Hosp, Div Infect Dis, ZA-2001 Johannesburg, South Africa.	ndavies@wrhi.ac.za			Department of Correctional Services	Department of Correctional Services	The Department of Correctional Services, both national and provincial, is also thanked for the ongoing support given throughout the course of this study.	Abrahao RMCM, 2006, INT J TUBERC LUNG D, V10, P203; [Anonymous], WHO REP 2011 GLOB TU; Babudieri S, 2000, JAMA-J AM MED ASSOC, V284, P179, DOI 10.1001/jama.284.2.179; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Beckwith CG, 2010, JAIDS-J ACQ IMM DEF, V55, pS49, DOI 10.1097/QAI.0b013e3181f9c0f7; Berger J, 2007, AIDS LAW, P21; Centres for Disease Control and Prevention, 1999, JAMA-J AM MED ASSOC, V281, P506; Civil Society Prison Reform Initiation, 2008, DEATHS CUST MED PAR; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; DCS, 2010, DEP CORR SERV MED ST; DCS, 2011, ANN REP 2010 11 DEP; Department of Correctional Services (DCS), 2011, STAT INF 2011; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Flanigan Timothy P, 2009, Trans Am Clin Climatol Assoc, V120, P73; Ford N, 2009, LANCET, V374, P2064, DOI 10.1016/S0140-6736(09)61671-8; Habeenzu C, 2007, INT J TUBERC LUNG D, V11, P1216; Ines SM, 2008, CURR HIV RES, V6, P164, DOI 10.2174/157016208783885047; King's College London, 2011, WORLD PRES BRIEF AFR; Klein SJ, 2002, AIDS EDUC PREV, V14, P114; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Makombe SD, 2007, J INFECT DEV COUNTR, V1, P303, DOI 10.3855/jidc.368; Maru DSR, 2007, JAIDS-J ACQ IMM DEF, V46, P555, DOI 10.1097/QAI.0b013e318158c0bd; Maruschak L, 2008, NCJ222179 US DEP JUS; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Moszynski P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2225; Mphahlele M, 2008, J CLIN MICROBIOL, V46, P3459, DOI 10.1128/JCM.00973-08; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; National Department of Health, 2010, CLIN GUID MAN HIV AI; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pontali E, 2005, HIV CLIN TRIALS, V6, P25; Republic of South Africa, 2006, COMM INQ ALL INC COR; Sanne IM, 2009, AIDS, V12, P1; Scheibe A, 2011, KEY POPULATION; Spaulding A, 2002, CLIN INFECT DIS, V35, P305, DOI 10.1086/341418; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; *UNAIDS, 2009, AIDS EP UPD; UNODC, 2007, HIV PROS SUB SAH AFR; Vermeulen JH, IDENTIFYING STRUCTUR; Wang EA, 2004, TUBERCULOSIS, V52, P250; WHO, 2008, 3 1 M INT CAS FIND I; Wilson D, 2007, PLOS MED, V4, pe204, DOI [10.1371/journal.pmed.0040204, DOI 10.1371/J0URNAL.PMED.0040204]; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; World Health Organization United Nations Office on Drugs and Crime UNAIDS, 2007, INT ADDR HIV PROS HI; Zachariah R, 2011, INT J TUBERC LUNG D, V15, P933, DOI 10.5588/ijtld.10.0666	50	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33309	10.1371/journal.pone.0033309	http://dx.doi.org/10.1371/journal.pone.0033309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YN	22470448	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100025
J	Yakub, M; Moti, N; Parveen, S; Chaudhry, B; Azam, I; Iqbal, MP				Yakub, Mohsin; Moti, Naushad; Parveen, Siddiqa; Chaudhry, Bushra; Azam, Iqbal; Iqbal, Mohammad Perwaiz			Polymorphisms in MTHFR, MS and CBS Genes and Homocysteine Levels in a Pakistani Population	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; SINGLE NUCLEOTIDE POLYMORPHISMS; PLASMA HOMOCYSTEINE; ALLELE-FREQUENCIES; HEART-DISEASE; RISK-FACTOR; MUTATION; ASSOCIATION; 844INS68	Background: Hyperhomocysteinemia (>15 mu mol/L) is highly prevalent in South Asian populations including Pakistan. In order to investigate the genetic determinants of this condition, we studied 6 polymorphisms in genes of 3 enzymes methylenetetrahydrofolate reductase (MTHFR; C677T; A1298C), methionine synthase (MS; A2756G), cystathionine-beta-synthase (CBS; T833C/844ins68, G919A) involved in homocysteine metabolism and investigated their interactions with nutritional and environmental factors in a Pakistani population. Methodology/Principal Findings: In a cross-sectional survey, 872 healthy adults (355 males and 517 females; age 18-60 years) were recruited from a low-income urban population in Karachi. Fasting venous blood was obtained and assessed for plasma/serum homocysteine; folate, vitamin B12, pyridoxal phosphate and blood lead. DNA was isolated and genotyping was performed by PCR-RFLP (restriction-fragment-length- polymorphism) based assays. The average changes in homocysteine levels for MTHFR 677CT and TT genotypes were positive [beta(SE beta), 2.01(0.63) and 16.19(1.8) mu mol/L, respectively]. Contrary to MTHFR C677T polymorphism, the average changes in plasma homocysteine levels for MS 2756AG and GG variants were negative [beta(SE beta), -0.56(0.58) and -0.83(0.99) mu mol/L, respectively]. The average change occurring for CBS 844ins68 heterozygous genotype (ancestral/insertion) was -1.88(0.81) mu mol/L. The combined effect of MTHFR C677T, MS A2756G and CBS 844ins68 genotypes for plasma homocysteine levels was additive (p value <0.001). Odds of having hyperhomocysteinemia with MTHFR 677TT genotype was 10-fold compared to MTHFR 677CC genotype [OR (95%CI); 10.17(3.6-28.67)]. Protective effect towards hyperhomocysteinemia was observed with heterozygous (ancestral/insertion) genotype of CBS 844ins68 compared to homozygous ancestral type [OR (95%CI); 0.58 (0.34-0.99)]. Individuals with MTHFR 677CT or TT genotypes were at a greater risk of hyperhomocysteinemia in folate and vitamin B12 deficiencies and high blood lead (p value <0.05) level. Conclusions: Gene polymorphism (especially MTHFR C677T transition), folate and vitamin B12 deficiencies, male gender and high blood lead level appear to be contributing towards the development of hyperhomocysteinemia in a Pakistani population.	[Yakub, Mohsin; Moti, Naushad; Parveen, Siddiqa; Chaudhry, Bushra; Iqbal, Mohammad Perwaiz] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Azam, Iqbal] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University; Aga Khan University	Yakub, M (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.	perwaiz.iqbal@aku.edu	Iqbal, Mohammad Perwaiz/I-6763-2015; Iqbal, Mohammed/GYA-1556-2022	Moti, Naushad/0000-0002-8649-9919	University Research Council; Aga Khan University [IUJ (70136)]; Pakistan Science Foundation [PSF/Res/S-AKU/Med(210)]	University Research Council; Aga Khan University; Pakistan Science Foundation	This research was supported by grants from the University Research Council, Aga Khan University [IUJ (70136)] and the Pakistan Science Foundation [PSF/Res/S-AKU/Med(210)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio ACM, 2008, AM J MED GENET A, V146A, P2598, DOI 10.1002/ajmg.a.32496; Chambers JC, 2000, LANCET, V355, P523, DOI 10.1016/S0140-6736(99)93019-2; CHANARIN I, 1989, LAB HAEMATOLOGY, P131; Chen CF, 2010, DIS MARKERS, V29, P111, DOI [10.1155/2010/781507, 10.3233/DMA-2010-0741]; Dutta S, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-25; Franco RF, 1998, HUM HERED, V48, P338, DOI 10.1159/000022826; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GALLAGHER PM, 1995, HUM MUTAT, V6, P177, DOI 10.1002/humu.1380060211; Golimbet V, 2009, PSYCHIAT RES, V170, P168, DOI 10.1016/j.psychres.2008.07.007; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; Griffioen PH, 2005, CLIN CHIM ACTA, V354, P191, DOI 10.1016/j.cccn.2004.11.019; Iqbal M P, 2003, J Pak Med Assoc, V53, P33; Iqbal M Perwaiz, 2005, J Mol Genet Med, V1, P26; Iqbal MP, 2011, PAK J BIOCH MOL BIOL, V44, P32; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; Kim H, 2004, AM J PREV MED, V27, P391, DOI 10.1016/j.amepre.2004.08.008; Kluijtmans LAJ, 1997, CIRCULATION, V96, P2573, DOI 10.1161/01.CIR.96.8.2573; Koc YL, 2009, CLIN APPL THROMB-HEM, V15, P701, DOI 10.1177/1076029608320719; Kraus JP, 1999, HUM MUTAT, V13, P362; Kumar J, 2010, BIOMARKERS, V15, P283, DOI 10.3109/13547501003658106; Kumar J, 2009, CIRC-CARDIOVASC GENE, V2, P599, DOI 10.1161/CIRCGENETICS.108.841411; Li Y, 2005, ACTA BIOCH BIOPH SIN, V37, P75, DOI 10.1093/abbs/37.2.75; Lievers KJA, 2001, J MOL MED-JMM, V79, P522, DOI 10.1007/s001090100253; Matsuo K, 2001, BLOOD, V97, P3205, DOI 10.1182/blood.V97.10.3205; Mukherjee M, 2002, CLIN GENET, V61, P155, DOI 10.1034/j.1399-0004.2002.610212.x; Pepe G, 1999, HUM GENET, V104, P126, DOI 10.1007/s004390050924; QUADROS EV, 2000, MODERN ANAL METHODOL; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schafer JH, 2005, ENVIRON HEALTH PERSP, V113, P31, DOI 10.1289/ehp.7369; Senemar S, 2009, MOL BIOL REP, V36, P353, DOI 10.1007/s11033-007-9186-z; Sirachainan N, 2008, THROMB RES, V122, P33, DOI 10.1016/j.thromres.2007.09.012; Song XM, 2006, BIOMED ENVIRON SCI, V19, P452; Suzuki T, 2008, CARCINOGENESIS, V29, P356, DOI 10.1093/carcin/bgm295; Tsai MY, 2000, ATHEROSCLEROSIS, V149, P131, DOI 10.1016/S0021-9150(99)00297-X; Yakub M, 2010, PAK J MED SCI, V26, P923; Yakub M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011706; Yusuf S, 2001, J AM COLL CARDIOL, V38, P688, DOI 10.1016/S0735-1097(01)01417-6	37	50	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33222	10.1371/journal.pone.0033222	http://dx.doi.org/10.1371/journal.pone.0033222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470444	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100021
J	Yan, K; Gao, J; Yang, TT; Ma, Q; Qiu, XC; Fan, QY; Ma, BA				Yan, Kang; Gao, Jie; Yang, Tongtao; Ma, Qiong; Qiu, Xiuchun; Fan, Qingyu; Ma, Baoan			MicroRNA-34a Inhibits the Proliferation and Metastasis of Osteosarcoma Cells Both In Vitro and In Vivo	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-SUPPRESSOR GENES; MET SIGNALING PATHWAY; C-MET; DOWN-REGULATION; MURINE OSTEOSARCOMA; MOUSE OSTEOSARCOMA; IDENTIFIES MIR-34A; CANCER-CELLS; INVASION	Background: MicroRNAs (miRNAs) are a class of endogenously expressed, small noncoding RNAs, which suppress its target mRNAs at the post-transcriptional level. Studies have demonstrated that miR-34a, which is a direct target of the p53 tumor suppressor gene, functions as a tumor suppressor and is associated with the tumor growth and metastasis of various human malignances. However, the role of miR-34a in osteosarcoma has not been totally elucidated. In the present study, the effects of miR-34a on osteosarcoma and the possible mechanism by which miR-34a affected the tumor growth and metastasis of osteosarcoma were investigated. Methodology/Principal Finding: Over-expression of miR-34a partially inhibited proliferation, migration and invasion of osteosarcoma cells in vitro, as well as the tumor growth and pulmonary metastasis of osteosarcoma cells in vivo. c-Met is a target of miR-34a, and regulates the migration and invasion of osteosarcoma cells. Osteosarcoma cells over-expressing miR-34a exhibited a significant decrease in the expression levels of c-Met mRNA and protein simultaneously. Finally, the results from bioinformatics analysis demonstrated that there were multiple putative targets of miR-34a that may be associated with the proliferation and metastasis of osteosarcoma, including factors in Wnt and Notch signaling pathways. Conclusion/ Significance: The results presented in this study demonstrated that over-expression of miR-34a could inhibit the tumor growth and metastasis of osteosarcoma probably through down regulating c-Met. And there are other putative miR-34a target genes beside c-Met which could potentially be key players in the development of osteosarcoma. Since pulmonary metastases are responsible for mortality of patient carrying osteosarcoma, miR-34a may prove to be a promising gene therapeutic agent. It will be interesting to further investigate the mechanism by which miR-34a functions as a tumor suppressor gene in osteosarcoma.	[Yan, Kang; Gao, Jie; Yang, Tongtao; Ma, Qiong; Qiu, Xiuchun; Fan, Qingyu; Ma, Baoan] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthoped Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Yan, K (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Orthoped Surg, Xian 710032, Shaanxi, Peoples R China.	bonetm@fmmu.edu.cn; gukemba@fmmu.edu.cn			National Natural Science Foundation of China [81072194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (NO.81072194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; BERLIN O, 1993, CANCER RES, V53, P4890; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen X, 2009, CYTOTECHNOLOGY, V61, P37, DOI 10.1007/s10616-009-9239-3; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Chow TFF, 2010, J UROLOGY, V183, P743, DOI 10.1016/j.juro.2009.09.086; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Coltella N, 2003, FASEB J, V17, P1162, DOI 10.1096/fj.02-0576fje; Comoglio PM, 2001, SEMIN CANCER BIOL, V11, P153, DOI 10.1006/scbi.2000.0366; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Guise TA, 2009, J BONE JOINT SURG AM, V91A, P724, DOI 10.2106/JBJS.I.00012; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; He CL, 2009, BIOCHEM BIOPH RES CO, V388, P35, DOI 10.1016/j.bbrc.2009.07.101; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Ichimura A, 2010, MOL PHARM; Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Khanna C, 2001, CANCER RES, V61, P3750; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liao AT, 2007, VET COMP ONCOL, V5, P177, DOI 10.1111/j.1476-5829.2007.00137.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Ma O, 2009, CANCER RES, V69, P2559, DOI 10.1158/0008-5472.CAN-08-2929; Miretti S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001828; NAITO S, 1986, CANCER RES, V46, P4109; PANG RT, 2010, CARCINOGENESIS; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tan ML, 2009, CANCER BIOL THER, V8, P106, DOI 10.4161/cbt.8.2.7385; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang LF, 2009, CANCER INVEST, V27, P774, DOI 10.1080/07357900802427935; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Wunder JS, 2005, J CLIN ONCOL, V23, P1483, DOI 10.1200/JCO.2005.04.074; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	70	178	188	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33778	10.1371/journal.pone.0033778	http://dx.doi.org/10.1371/journal.pone.0033778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457788	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100049
J	Wong, YH; Wang, H; Ravasi, T; Qian, PY				Wong, Yue Him; Wang, Hao; Ravasi, Timothy; Qian, Pei-Yuan			Involvement of Wnt Signaling Pathways in the Metamorphosis of the Bryozoan Bugula neritina	PLOS ONE			English	Article							FRIZZLED RELATED PROTEIN; BETA-CATENIN; EXPRESSION PATTERNS; MORPHOGEN GRADIENT; SFRP GENES; POLARITY; AXIS; INVERTEBRATE; MECHANISMS; ATTACHMENT	In this study, we analyzed the metamorphosis of the marine bryozoan Bugula neritina. We observed the morphogenesis of the ancestrula. We defined three distinct pre-ancestrula stages based on the anatomy of the developing polypide and the overall morphology of pre-ancestrula. We then used an annotation based enrichment analysis tool to analyze the B. neritina transcriptome and identified over-representation of genes related to Wnt signaling pathways, suggesting its involvement in metamorphosis. Finally, we studied the temporal-spatial gene expression studies of several Wnt pathway genes. We found that one of the Wnt ligand, BnWnt10, was expressed spatially opposite to the Wnt antagonist BnsFRP within the blastemas, which is the presumptive polypide. Down-stream components of the canonical Wnt signaling pathway were exclusively expressed in the blastemas. Bn beta catenin and BnFz5/8 were exclusively expressed in the blastemas throughout the metamorphosis. Based on the genes expression patterns, we propose that BnWnt10 and BnsFRP may relate to the patterning of the polypide, in which the two genes served as positional signals and contributed to the polarization of the blastemas. Another Wnt ligand, BnWnt6, was expressed in the apical part of the pre-ancestrula epidermis. Overall, our findings suggest that the Wnt signaling pathway may be important to the pattern formation of polypide and the development of epidermis.	[Wong, Yue Him; Wang, Hao; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Kowloon, Hong Kong, Peoples R China; [Ravasi, Timothy] King Abdullah Univ Sci & Technol, Dept Computat Biosci, Res Ctr, Thuwal, Saudi Arabia	Hong Kong University of Science & Technology; King Abdullah University of Science & Technology	Wong, YH (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Kowloon, Hong Kong, Peoples R China.	boqianpy@ust.hk	Ravasi, Timothy/B-8777-2008	Qian, Pei-Yuan/0000-0003-4074-9078; Ravasi, Timothy/0000-0002-9950-465X	KAUST (King Abdullah University of Science and Technology) [SA-C0040/UK-C0016]	KAUST (King Abdullah University of Science and Technology)(King Abdullah University of Science & Technology)	This study was supported by an award (SA-C0040/UK-C0016) made by KAUST (King Abdullah University of Science and Technology) to PYQ. The webpage of KAUST GCR office: http://www.kaust.edu.sa/research/grc/sap.html?submenuheader = 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; [Anonymous], DAVID BIOINF RES 6 7; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bishop CD, 2006, INTEGR COMP BIOL, V46, P655, DOI 10.1093/icb/icl004; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Dennis S, 1999, J CELL SCI, V112, P3815; Fuchs J, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-13; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Grens A, 1996, DEV BIOL, V180, P473, DOI 10.1006/dbio.1996.0321; Heller RS, 2002, DEV DYNAM, V225, P260, DOI 10.1002/dvdy.10157; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; Hickman CP, 2003, ANIMAL DIVERSITY; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Katoh M, 2005, ONCOL REP, V14, P1583; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kikuchi A, 2008, CANCER SCI, V99, P202, DOI 10.1111/j.1349-7006.2007.00675.x; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Lickert H, 2001, MECH DEVELOP, V105, P181, DOI 10.1016/S0925-4773(01)00390-2; LILLIE RD, 1976, HISTOCHEMISTRY, V49, P23, DOI 10.1007/BF00490123; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYNCH WF, 1947, BIOL BULL, V92, P115, DOI 10.2307/1538162; Marshall DJ, 2003, MAR ECOL PROG SER, V255, P145, DOI 10.3354/meps255145; Marshall DJ, 2011, CURR BIOL, V21, pR718, DOI 10.1016/j.cub.2011.08.022; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Mukai H, 1989, BRYOZOA, P69; Nielsen C, 1971, OPHELIA, V9, P203; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; REED CG, 1982, J MORPHOL, V172, P335, DOI 10.1002/jmor.1051720308; Ryan F, 2010, METAMORPHOSIS UNMASK; Schmidt C, 2007, DEV DYNAM, V236, P2502, DOI 10.1002/dvdy.21260; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tessmar-Raible K, 2003, CURR OPIN GENET DEV, V13, P331, DOI 10.1016/S0959-437X(03)00086-8; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wiens M, 2006, DEV GENES EVOL, V216, P229, DOI 10.1007/s00427-005-0047-2; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; WOOLLACOTT RM, 1971, J MORPHOL, V134, P351, DOI 10.1002/jmor.1051340307; Woollacott RM, 1977, SETTLEMENT METAMORPH, P49; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang HM, 2011, J PROTEOME RES, V10, P349, DOI 10.1021/pr100817v; Zimmer RL, 1977, STRUCTURE CLASSIFICA, P91; Zimmer RL, 1977, METAMORPHOSIS ANCEST, P57	56	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33323	10.1371/journal.pone.0033323	http://dx.doi.org/10.1371/journal.pone.0033323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448242	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700032
J	Arvizo, RR; Giri, K; Moyano, D; Miranda, OR; Madden, B; McCormick, DJ; Bhattacharya, R; Rotello, VM; Kocher, JP; Mukherjee, P				Arvizo, Rochelle R.; Giri, Karuna; Moyano, Daniel; Miranda, Oscar R.; Madden, Benjamin; McCormick, Daniel J.; Bhattacharya, Resham; Rotello, Vincent M.; Kocher, Jean-Pierre; Mukherjee, Priyabrata			Identifying New Therapeutic Targets via Modulation of Protein Corona Formation by Engineered Nanoparticles	PLOS ONE			English	Article							MEDIATED APOPTOTIC PATHWAY; PLACE-EXCHANGE-REACTIONS; LOW-ABUNDANCE PROTEINS; GROWTH-FACTOR; MASS-SPECTROMETRY; GOLD NANOPARTICLES; STATISTICAL-MODEL; PLASMA-PROTEINS; DOWN-REGULATION; CANCER	Background: We introduce a promising methodology to identify new therapeutic targets in cancer. Proteins bind to nanoparticles to form a protein corona. We modulate this corona by using surface-engineered nanoparticles, and identify protein composition to provide insight into disease development. Methods/Principal Findings: Using a family of structurally homologous nanoparticles we have investigated the changes in the protein corona around surface-functionalized gold nanoparticles (AuNPs) from normal and malignant ovarian cell lysates. Proteomics analysis using mass spectrometry identified hepatoma-derived growth factor (HDGF) that is found exclusively on positively charged AuNPs ((+)AuNPs) after incubation with the lysates. We confirmed expression of HDGF in various ovarian cancer cells and validated binding selectivity to (+)AuNPs by Western blot analysis. Silencing of HDGF by siRNA resulted s inhibition in proliferation of ovarian cancer cells. Conclusion: We investigated the modulation of protein corona around surface-functionalized gold nanoparticles as a promising approach to identify new therapeutic targets. The potential of our method for identifying therapeutic targets was demonstrated through silencing of HDGF by siRNA, which inhibited proliferation of ovarian cancer cells. This integrated proteomics, bioinformatics, and nanotechnology strategy demonstrates that protein corona identification can be used to discover novel therapeutic targets in cancer.	[Arvizo, Rochelle R.; Giri, Karuna; Bhattacharya, Resham; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Moyano, Daniel; Miranda, Oscar R.; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Madden, Benjamin; McCormick, Daniel J.] Mayo Clin, Coll Med, Prote Res Ctr, Rochester, MN USA; [Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Mukherjee, Priyabrata] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN USA	Mayo Clinic; University of Massachusetts System; University of Massachusetts Amherst; Mayo Clinic; Mayo Clinic; Mayo Clinic	Arvizo, RR (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Mukherjee.priyabrata@mayo.edu	Moyano, Daniel/A-7306-2012; Miranda, Oscar/G-9183-2014	Moyano, Daniel/0000-0002-9213-5660; Miranda, Oscar/0000-0002-2500-2075	National Institutes of Health (NIH) [CA135011, CA136494, GM077173]; NATIONAL CANCER INSTITUTE [R01CA135011, R01CA136494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077173] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) CA135011, CA136494 (Dr. Mukherjee) and GM077173 (Dr. Rotello). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009; Arvizo RR, 2011, NANOMED-NANOTECHNOL, V7, P580, DOI 10.1016/j.nano.2011.01.011; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bast RC., 2003, J CLIN ONCOL, V21, P200, DOI [10.1200/JCO.2003.01.068, DOI 10.1200/JCO.2003.01.068]; Bergeron JJM, 2010, TRENDS CELL BIOL, V20, P337, DOI 10.1016/j.tcb.2010.02.005; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Conover CA, 1998, EXP CELL RES, V238, P439, DOI 10.1006/excr.1997.3861; De M, 2009, NAT CHEM, V1, P461, DOI [10.1038/NCHEM.334, 10.1038/nchem.334]; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; Deng ZJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455101; Dhingra V, 2005, INT J PHARMACEUT, V299, P1, DOI 10.1016/j.ijpharm.2005.04.010; Diamandis EP, 2004, J NATL CANCER I, V96, P353, DOI 10.1093/jnci/djh056; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Dobrovolskaia MA, 2009, NAT NANOTECHNOL, V4, P411, DOI [10.1038/nnano.2009.175, 10.1038/NNANO.2009.175]; Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050; Everett AD, 2000, J CLIN INVEST, V105, P567, DOI 10.1172/JCI7497; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Hong R, 2006, CHEM COMMUN, P2347, DOI 10.1039/b603988j; Hostetler MJ, 1999, LANGMUIR, V15, P3782, DOI 10.1021/la981598f; Huo Q, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-20; Jasen P, 2009, MED HIST, V53, P489, DOI 10.1017/S0025727300000521; Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o; Karmali PP, 2011, EXPERT OPIN DRUG DEL, V8, P343, DOI 10.1517/17425247.2011.554818; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; KRUK PA, 1990, LAB INVEST, V63, P132; Law WC, 2011, ACS NANO, V5, P4858, DOI 10.1021/nn2009485; Lee KH, 2010, ONCOL RES, V19, P67, DOI 10.3727/096504010X12864748215043; Liang M, 2010, ACS NANO, V4, P403, DOI 10.1021/nn9011237; Liu SJ, 2010, J PHYS CHEM C, V114, P21270, DOI 10.1021/jp1086653; Liu X, 2008, J AM CHEM SOC, V130, P2780, DOI 10.1021/ja711298b; Lundqvist M, 2008, P NATL ACAD SCI US; Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Rana S, 2012, ADV DRUG DELIVER REV, V64, P200, DOI 10.1016/j.addr.2011.08.006; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Sund J, 2011, ACS NANO, V5, P4300, DOI 10.1021/nn101492k; Tang HY, 2005, PROTEOMICS, V5, P3329, DOI 10.1002/pmic.200401275; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; Tsang TY, 2008, APOPTOSIS, V13, P1135, DOI 10.1007/s10495-008-0241-6; VANHAPEREN VWTR, 1994, CANCER RES, V54, P4138; Willmott LJ, 2010, J ONCOL, V2010, DOI 10.1155/2010/740472; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; You CC, 2005, ORG LETT, V7, P5685, DOI 10.1021/ol052367k; Zhang J, 2006, CANCER RES, V66, P18, DOI 10.1158/0008-5472.CAN-04-3905	49	84	85	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33650	10.1371/journal.pone.0033650	http://dx.doi.org/10.1371/journal.pone.0033650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442705	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500046
J	Inman, CF; Laycock, GM; Mitchard, L; Harley, R; Warwick, J; Burt, R; van Diemen, PM; Stevens, M; Bailey, M				Inman, Charlotte F.; Laycock, Georgina M.; Mitchard, Louisa; Harley, Ross; Warwick, James; Burt, Rachel; van Diemen, Pauline M.; Stevens, Mark; Bailey, Mick			Neonatal Colonisation Expands a Specific Intestinal Antigen-Presenting Cell Subset Prior to CD4 T-Cell Expansion, without Altering T-Cell Repertoire	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSES; NEWBORN PIGLETS; IN-VIVO; SP NOV.; GUT; LYMPH; BACTERIA; ALPHA; BETA	Interactions between the early-life colonising intestinal microbiota and the developing immune system are critical in determining the nature of immune responses in later life. Studies in neonatal animals in which this interaction can be examined are central to understanding the mechanisms by which the microbiota impacts on immune development and to developing therapies based on manipulation of the microbiome. The inbred piglet model represents a system that is comparable to human neonates and allows for control of the impact of maternal factors. Here we show that colonisation with a defined microbiota produces expansion of mucosal plasma cells and of T-lymphocytes without altering the repertoire of alpha beta T-cells in the intestine. Importantly, this is preceded by microbially-induced expansion of a signal regulatory protein alpha-positive (SIRP alpha(+)) antigen-presenting cell subset, whilst SIRP alpha(-)CD11R1(+) antigen-presenting cells (APCs) are unaffected by colonisation. The central role of intestinal APCs in the induction and maintenance of mucosal immunity implicates SIRP alpha(+) antigen-presenting cells as orchestrators of early-life mucosal immune development.	[Inman, Charlotte F.; Laycock, Georgina M.; Mitchard, Louisa; Harley, Ross; Warwick, James; Burt, Rachel; Bailey, Mick] Univ Bristol, Sch Clin Vet Sci, Bristol, Avon, England; [van Diemen, Pauline M.; Stevens, Mark] AFRC, Inst Anim Hlth, Newbury RG16 0NN, Berks, England	University of Bristol; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Inman, CF (corresponding author), Univ Birmingham, Sch Canc Studies, Birmingham, W Midlands, England.	C.F.Inman@bham.ac.uk		Inman, Charlotte/0000-0002-0801-4779	Department for Environment, Food, and Rural Affairs; Higher Education Funding Council for England through Veterinary Training in Research Initiative [VT0104]	Department for Environment, Food, and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Higher Education Funding Council for England through Veterinary Training in Research Initiative	The work was funded by the Department for Environment, Food, and Rural Affairs and the Higher Education Funding Council for England through the Veterinary Training in Research Initiative grant VT0104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bimczok D, 2005, EUR J IMMUNOL, V35, P1418, DOI 10.1002/eji.200425726; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; Butler JE, 2000, IMMUNOLOGY, V100, P119, DOI 10.1046/j.1365-2567.2000.00013.x; Butler JE, 2005, IMMUNOLOGY, V114, P184, DOI 10.1111/j.1365-2567.2004.02072.x; Butler JE, 2002, J IMMUNOL, V169, P6822, DOI 10.4049/jimmunol.169.12.6822; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; CRABBE PA, 1968, INT ARCH ALLER A IMM, V34, P362, DOI 10.1159/000230130; Dobber R, 1992, Dev Immunol, V2, P141, DOI 10.1155/1992/57057; Duncan SH, 2006, INT J SYST EVOL MICR, V56, P2437, DOI 10.1099/ijs.0.64098-0; Edwards AG, 2008, IMMUNOLOGY, V123, P181, DOI 10.1111/j.1365-2567.2007.02685.x; Eguchi-Ogawa T, 2009, DEV COMP IMMUNOL, V33, P1111, DOI 10.1016/j.dci.2009.06.006; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Fortin G, 2009, J EXP MED, V206, P1995, DOI 10.1084/jem.20082805; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Haverson K, 2001, VET IMMUNOL IMMUNOP, V80, P175, DOI 10.1016/S0165-2427(01)00285-9; Haverson K, 2000, IMMUNOLOGY, V101, P492, DOI 10.1046/j.1365-2567.2000.00128.x; Howard CJ, 1997, J IMMUNOL, V159, P5372; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Inman CF, 2010, CLIN EXP IMMUNOL, V160, P431, DOI 10.1111/j.1365-2249.2010.04090.x; Inman CF, 2005, J IMMUNOL METHODS, V302, P156, DOI 10.1016/j.jim.2005.05.005; Inman CF, 2010, J LEUKOCYTE BIOL, V88, P571, DOI 10.1189/jlb.0310161; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Janczyk P, 2007, FEMS MICROBIOL ECOL, V61, P132, DOI 10.1111/j.1574-6941.2007.00317.x; Jorgensen FG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-2; Konstantinov SR, 2008, FEMS MICROBIOL ECOL, V66, P599, DOI 10.1111/j.1574-6941.2008.00517.x; Konstantinov SR, 2006, INT J SYST EVOL MICR, V56, P29, DOI 10.1099/ijs.0.63508-0; Konstantinov SR, 2005, APPL ENVIRON MICROB, V71, P7578, DOI 10.1128/AEM.71.11.7578-7581.2005; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Liu LM, 1998, J IMMUNOL, V161, P1146; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Nguyen TV, 2007, VET IMMUNOL IMMUNOP, V117, P236, DOI 10.1016/j.vetimm.2007.02.013; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Orcutt RP, 1987, MICROECOLOGY THERAPY; PEREY DYE, 1968, LAB INVEST, V18, P15; Persson EK, 2010, IMMUNOBIOLOGY, V215, P692, DOI 10.1016/j.imbio.2010.05.013; Probert CSJ, 2007, DEV COMP IMMUNOL, V31, P606, DOI 10.1016/j.dci.2006.08.008; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; ROTHKOTTER HJ, 1991, PEDIATR RES, V29, P237, DOI 10.1203/00006450-199103000-00004; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Saada JI, 2004, ANN NY ACAD SCI, V1029, P379, DOI 10.1196/annals.1309.023; STEPANKOVA R, 1980, FOLIA MICROBIOL, V25, P491, DOI 10.1007/BF02897215; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Talham GL, 1999, INFECT IMMUN, V67, P1992; Thacker E, 2001, VET IMMUNOL IMMUNOP, V80, P93, DOI 10.1016/S0165-2427(01)00278-1; Thompson CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010335; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wilson S, 2005, DEV COMP IMMUNOL, V29, P977, DOI 10.1016/j.dci.2005.03.008	59	15	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33707	10.1371/journal.pone.0033707	http://dx.doi.org/10.1371/journal.pone.0033707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442714	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500055
J	Louvrou, I; Danielidis, DB; Economou-Amilli, A				Louvrou, Ioanna; Danielidis, Daniel B.; Economou-Amilli, Athena			Meloneis Gen. Nov., a New Epipsammic Genus of Rhaphoneidaceae (Bacillariophyceae)	PLOS ONE			English	Article							HELLENIC VOLCANIC ARC; MILOS ISLAND; GREECE; GEOCHEMISTRY; DIATOMS	The diatom family Rhaphoneidaceae is characterized by high generic diversity and low species diversity with most genera known to have long stratigraphic ranges. The genera within this family are neritic marine, and mostly epipsammic. A new modern and epipsammic genus, Meloneis gen. nov., is described herein and is compared to all genera within Rhaphoneidaceae and especially to Rhaphoneis Ehrenberg s.l. Within Meloneis three new species and one variety are distinguished and described herein: M. mimallis sp. nov., M. mimallis var. zephyria var. nov., M. akytos sp. nov., and M. gorgis sp. nov.	[Louvrou, Ioanna; Danielidis, Daniel B.; Economou-Amilli, Athena] Univ Athens, Dept Systemat & Ecol, Athens, Greece	National & Kapodistrian University of Athens	Louvrou, I (corresponding author), Univ Athens, Dept Systemat & Ecol, Athens, Greece.	aamilli@biol.uoa.gr			Commission of the European Community [MAS3-CT95-0021]	Commission of the European Community(European Commission)	Research was conducted as part of MAST-III projects financed by the Commission of the European Community (Contract no: MAS3-CT95-0021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS GW, 1977, NOVA HEDWIGIA S, V54, P243; ANDREWS GW, 1990, P 10 INT S LIV FOSS, P127; Andrews GW, 1987, DIATOM RES, V2, P1, DOI DOI 10.1080/0269249X.1987.9704980; Andrews GW, 1988, P 9 INT DIAT S, P197; Andrews GW, 1975, NOVA HEDWIGIA S, V53, P193; ANDREWS GW, 1981, P 6 S REC FOSS DIAT, P81; Andrews GW, 1984, P 7 INT DIAT S, P225; Blanco S, 2011, PHYCOLOGIA, V50, P327, DOI 10.2216/10-92.1; BLAZE KL, 1984, BRIT PHYCOL J, V19, P217; DANDO PR, 1995, CONT SHELF RES, V15, P913, DOI 10.1016/0278-4343(95)80002-U; Dando PR, 1995, GEOLOGICAL SOC SPECI, V87, P303; Ehrenberg C.G., 1844, MONATSBER PREUSS AKA, P57; Fitzsimons MF, 1997, MAR CHEM, V57, P325, DOI 10.1016/S0304-4203(97)00021-2; Foged N., 1987, BIBLIOTHECA DIATOMOL, V14, P1; Foged N., 1975, BIBLIOTHECA PHYCOLOG, V16, P1; Foged N., 1979, BIBLIOTECHA PHYCOLOG, V47, P1; Forti A, 1912, ATTI REALE I VENETO, V71, P677; FRENGUELLI J., 1949, DARWINIANA, V9, P97; Hajos M., 1975, Initial Rep Deep Sea Drilling Project, V29, P913; Jahn Regine, 2004, Willdenowia, V34, P577, DOI 10.3372/wi.34.34219; Kociolek JP, 2007, DIATOM RES, V22, P309; Louvrou I, 2011, TAXON, V60, P1768; Louvrou I, 2006, FESTSCHRIFT HONOUR D, P123; Pantazidou A, 2006, EUR J PHYCOL, V41, P189, DOI 10.1080/09670260600649420; Pantazidou A, 2001, P 16 INT DIAT C, P381; Peragallo M.M., 1897, DIATOMEES MARINES FR; Round F.E., 1990, DIATOMS; Sato S, 2011, PHYCOL RES, V59, P236, DOI 10.1111/j.1440-1835.2011.00621.x; Scherer Reed P., 1997, Diatom Research, V12, P83; Simonsen R, 1962, KIELER MEERESFORSCH, V20, P157; Sims PA, 1996, NOVA HEDWIGIA BEIHEF, V112, P301; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Takano H., 1982, B TOKAI REGIONAL FIS, V106, P45; Valsami-Jones E, 2005, J VOLCANOL GEOTH RES, V148, P130, DOI 10.1016/j.jvolgeores.2005.03.018; Watanabe T, 2008, 20 INT S REC FOSS DI; Wenzhofer F, 2000, MAR CHEM, V69, P43, DOI 10.1016/S0304-4203(99)00091-2	36	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32198	10.1371/journal.pone.0032198	http://dx.doi.org/10.1371/journal.pone.0032198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442663	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500006
J	Gunaydin, H; Gu, Y; Huang, X				Gunaydin, Hakan; Gu, Yan; Huang, Xin			Novel Binding Mode of a Potent and Selective Tankyrase Inhibitor	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; STI-571 INHIBITION; CATALYTIC DOMAIN; STRUCTURAL BASIS; TYROSINE KINASE; MOLECULE; CANCER	Tankyrases (TNKS1 and TNKS2) are key regulators of cellular processes such as telomere pathway and Wnt signaling. IWRs (inhibitors of Wnt response) have recently been identified as potent and selective inhibitors of tankyrases. However, it is not clear how these IWRs interact with tankyrases. Here we report the crystal structure of the catalytic domain of human TNKS1 in complex with IWR2, which reveals a novel binding site for tankyrase inhibitors. The TNKS1/IWR2 complex provides a molecular basis for their strong and specific interactions and suggests clues for further development of tankyrase inhibitors.	[Gunaydin, Hakan; Gu, Yan; Huang, Xin] Amgen Inc, Dept Mol Struct, Cambridge, MA 02142 USA	Amgen	Gunaydin, H (corresponding author), Amgen Inc, Dept Mol Struct, Cambridge, MA 02142 USA.	hxin@amgen.com	Aviyente, Viktorya/Q-2759-2015	Aviyente, Viktorya/0000-0001-9430-4096	Amgen Discovery Research	Amgen Discovery Research	This work was supported by Amgen Discovery Research. The funder had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Karlberg T, 2010, J MED CHEM, V53, P5352, DOI 10.1021/jm100249w; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Lehtio L, 2008, J MOL BIOL, V379, P136, DOI 10.1016/j.jmb.2008.03.058; Lu JM, 2009, BIOORG MED CHEM LETT, V19, P3825, DOI 10.1016/j.bmcl.2009.04.040; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Wheeler SE, 2011, J AM CHEM SOC, V133, P10262, DOI 10.1021/ja202932e; Winger JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-7	16	54	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33740	10.1371/journal.pone.0033740	http://dx.doi.org/10.1371/journal.pone.0033740			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438990	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100092
J	Miyairi, I; Ziebarth, J; Laxton, JD; Wang, XF; van Rooijen, N; Williams, RW; Lu, L; Byrne, GI; Cui, Y				Miyairi, Isao; Ziebarth, Jesse; Laxton, Jonathan D.; Wang, Xiaofei; van Rooijen, Nico; Williams, Robert W.; Lu, Lu; Byrne, Gerald I.; Cui, Yan			Host Genetics and Chlamydia Disease: Prediction and Validation of Disease Severity Mechanisms	PLOS ONE			English	Article							IRG PROTEINS; RESISTANCE; SUSCEPTIBILITY; TOLERANCE; INFECTION; TRACHOMATIS; IMMUNITY; MAP	Genetic mapping studies may provide association between sequence variants and disease susceptibility that can, with further experimental and computational analysis, lead to discovery of causal mechanisms and effective intervention. We have previously demonstrated that polymorphisms in immunity-related GTPases (IRG) confer a significant difference in susceptibility to Chlamydia psittaci infection in BXD recombinant mice. Here we combine genetic mapping and network modeling to identify causal pathways underlying this association. We infected a large panel of BXD strains with C. psittaci and assessed host genotype, IRG protein polymorphisms, pathogen load, expression of 32 cytokines, inflammatory cell populations, and weight change. Proinflammatory cytokines correlated with each other and were controlled by a novel genetic locus on chromosome 1, but did not affect disease status, as quantified by weight change 6 days after infection In contrast, weight change correlated strongly with levels of inflammatory cell populations and pathogen load that were controlled by an IRG encoding genetic locus (Ctrq3) on chromosome 11. These data provided content to generate a predictive model of infection using a Bayesian framework incorporating genotypes, immune system parameters, and weight change as a measure of disease severity. Two predictions derived from the model were tested and confirmed in a second round of experiments. First, strains with the susceptible IRG haplotype lost weight as a function of pathogen load whereas strains with the resistant haplotype were almost completely unaffected over a very wide range of pathogen load. Second, we predicted that macrophage activation by Ctrq3 would be central in conferring pathogen tolerance. We demonstrated that macrophage depletion in strains with the resistant haplotype led to neutrophil influx and greater weight loss despite a lower pathogen burden. Our results show that genetic mapping and network modeling can be combined to identify causal pathways underlying chlamydial disease susceptibility.	[Miyairi, Isao; Ziebarth, Jesse; Laxton, Jonathan D.; Wang, Xiaofei; Byrne, Gerald I.; Cui, Yan] Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN 38163 USA; [Miyairi, Isao] Univ Tennessee, Dept Pediat, Hlth Sci Ctr, Memphis, TN USA; [Williams, Robert W.; Lu, Lu] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Lu, Lu] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China; [Miyairi, Isao] Natl Ctr Child Hlth & Dev, Div Infect Dis, Tokyo, Japan	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Vrije Universiteit Amsterdam; Nantong University; National Center for Child Health & Development - Japan	Miyairi, I (corresponding author), Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN 38163 USA.	miyairi-i@ncchd.go.jp; ycui2@uthsc.edu	Van Rooijen, Nico/Z-1578-2019; Miyairi, Isao/N-9640-2018; Williams, Robert W./H-8789-2016	Cui, Yan/0000-0002-7577-6845; Williams, Robert W./0000-0001-8924-4447	Children's Infection and Defense Center;  [AI081050];  [09GBIA2050135];  [BAA08-1];  [AI19782];  [AI30040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019782, R21AI081050, N01AI030040] Funding Source: NIH RePORTER	Children's Infection and Defense Center; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by AI081050 (IM, YC, LL), 09GBIA2050135 (IM), Children's Infection and Defense Center Grant (IM), BAA08-1 (GIB, IM), AI19782 (GIB), AI30040 (GIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeltawab NF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000042; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bafica A, 2007, J IMMUNOL, V179, P5514, DOI 10.4049/jimmunol.179.8.5514; Beeckman DSA, 2009, CLIN MICROBIOL INFEC, V15, P11, DOI 10.1111/j.1469-0691.2008.02669.x; Bernstein-Hanley I, 2006, GENES IMMUN, V7, P122, DOI 10.1038/sj.gene.6364285; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Best A, 2008, P NATL ACAD SCI USA, V105, P20786, DOI 10.1073/pnas.0809558105; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Bottcher S, 2001, ARTIF INTELL, P149; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; Centers for Disease Control and Prevention, 2009, CHLAM PREV MON PROJ; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Hammerschlag M, 2009, MANDELL DOUGLAN BENN; Hartemink A J, 2001, Pac Symp Biocomput, P422; Hawkins DM, 2003, J CHEM INF COMP SCI, V43, P579, DOI 10.1021/ci025626i; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Howard J, 2008, IMMUNOBIOLOGY, V213, P367, DOI 10.1016/j.imbio.2007.11.005; Hunn JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001008; Kotb M., 2008, NOVART FDN SYMP, V293, P181; Kotb M., 2008, NOVART FDN SYMP, V293, P165; Kotb Malak, 2008, Novartis Found Symp, V293, P156; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Medzhitov R, 2009, P NATL ACAD SCI USA, V106, P15525, DOI 10.1073/pnas.0908451106; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Murphy K.P., 2001, COMPUTING SCI STAT; Neapolitan R.E., 2003, LEARNING BAYESIAN NE; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Pe'er Dana, 2005, Sci STKE, V2005, ppl4, DOI 10.1126/stke.2812005pl4; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83	42	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33781	10.1371/journal.pone.0033781	http://dx.doi.org/10.1371/journal.pone.0033781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438999	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100099
J	Mau, YS; Collins, PJ; Daglish, GJ; Nayak, MK; Ebert, PR				Mau, Yosep S.; Collins, Patrick J.; Daglish, Gregory J.; Nayak, Manoj K.; Ebert, Paul R.			The rph2 Gene Is Responsible for High Level Resistance to Phosphine in Independent Field Strains of Rhyzopertha dominica	PLOS ONE			English	Article							LESSER GRAIN BORER; MIXED-AGE CULTURES; COLEOPTERA	The lesser grain borer Rhyzopertha dominica (F.) is one of the most destructive insect pests of stored grain. This pest has been controlled successfully by fumigation with phosphine for the last several decades, though strong resistance to phosphine in many countries has raised concern about the long term usefulness of this control method. Previous genetic analysis of strongly resistant (SR) R. dominica from three widely geographically dispersed regions of Australia, Queensland (SRQLD), New South Wales (SRNSW) and South Australia (SRSA), revealed a resistance allele in the rph1 gene in all three strains. The present study confirms that the rph1 gene contributes to resistance in a fourth strongly resistant strain, SR2(QLD), also from Queensland. The previously described rph2 gene, which interacts synergistically with rph1 gene, confers strong resistance on SRQLD and SRNSW. We now provide strong circumstantial evidence that weak alleles of rph2, together with rph1, contribute to the strong resistance phenotypes of SRSA and SR2(QLD). To test the notion that rph1 and rph2 are solely responsible for the strong resistance phenotype of all resistant R. dominica, we created a strain derived by hybridising the four strongly resistant lines. Following repeated selection for survival at extreme rates of phosphine exposure, we found only slightly enhanced resistance. This suggests that a single sequence of genetic changes was responsible for the development of resistance in these insects.	[Mau, Yosep S.; Ebert, Paul R.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia; [Mau, Yosep S.] Univ Nusa Cendana, Fac Agr, Kupang, Nusa Tenggara T, Indonesia; [Collins, Patrick J.; Daglish, Gregory J.; Nayak, Manoj K.] Ecosci Precinct, Dept Employment Econ Dev & Innovat, Brisbane, Qld, Australia; [Collins, Patrick J.; Daglish, Gregory J.; Nayak, Manoj K.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT, Australia	University of Queensland; Universitas Nusa Cendana	Mau, YS (corresponding author), Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia.	p.ebert@uq.edu	Mau, Yosep Seran/GNP-4795-2022; Mau, Yosep Seran/AAC-4003-2021	Mau, Yosep Seran/0000-0001-6654-5407; Ebert, Paul/0000-0002-4435-0737; Daglish, Gregory/0000-0003-1940-2643	Grain Research Development Corporation [UQ00010]; Australian Research Council [C10027038]; AusAID; Australian government's Cooperative Research Centres Program	Grain Research Development Corporation(Grains R&D Corp); Australian Research Council(Australian Research Council); AusAID(Australian Aid (AusAID)); Australian government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Paul Ebert acknowledges financial support from the Grain Research Development Corporation (grant UQ00010) and the Australian Research Council (grant C10027038) and an AusAID scholarship for Yosep Mau. Patrick Collins, Gregory Daglish and Manoj Nayak acknowledge the support from the Australian government's Cooperative Research Centres Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Acda MA, 2000, RHYZOPERTHA DOMINICA; Ansell M. R., 1990, P 5 INT WORK C STOR, P961; Bengston M, 1999, J ECON ENTOMOL, V92, P17, DOI 10.1093/jee/92.1.17; Chaudhry MQ, 1997, PESTIC SCI, V49, P213, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;213::AID-PS516&gt;3.0.CO;2-#; Collins PJ, 2005, J STORED PROD RES, V41, P373, DOI 10.1016/j.jspr.2004.05.002; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Collins PJ, 1998, STORED GRAIN AUSTR, P55; FINNEY D J, 1971, P333; Jagadeesan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031582; Lorini I, 2007, PEST MANAG SCI, V63, P358, DOI 10.1002/ps.1344; Mau YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031541; Mills KA, 2001, P INT C CONTR ATM FU; Nayak M, 2011, P 10 INT WORK C STOR, P396; Payne RW, 2004, GENSTAT WINDOWS RELE; RAJENDRAN S, 1994, INT J PEST MANAGE, V40, P207, DOI 10.1080/09670879409371883; Rajendran S, 2002, PEST MANAG SCI, V58, P277, DOI 10.1002/ps.446; RAJENDRAN S, 1992, B ENTOMOL RES, V82, P119, DOI 10.1017/S000748530005152X; REN YL, 1994, STORED PRODUCT PROTECTION, VOLS 1 AND 2, P173; Schlipalius DI, 2008, HEREDITY, V100, P506, DOI 10.1038/hdy.2008.4; Schlipalius DI, 2002, GENETICS, V161, P773; TAYLOR R W D, 1989, International Pest Control, V31, P10; Tyler P. S., 1983, International Pest Control, V25, P10; TYLER PS, 1983, INT PEST CONTROL, V25, P21; Valmas N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000130; Wallbank BE, 2002, P STOR GRAIN AUSTR 2, P105; Zeng L., 2003, STORED PRODUCTS PROT, P642	27	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34027	10.1371/journal.pone.0034027	http://dx.doi.org/10.1371/journal.pone.0034027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461899	Green Published, gold			2022-12-27	WOS:000304118900017
J	Krid, H; Dorison, A; Salhi, A; Cheval, L; Crambert, G				Krid, Halla; Dorison, Aude; Salhi, Amel; Cheval, Lydie; Crambert, Gilles			Expression Profile of Nuclear Receptors along Male Mouse Nephron Segments Reveals a Link between ERR beta and Thick Ascending Limb Function	PLOS ONE			English	Article							GENE-EXPRESSION; RENAL-FUNCTION; KIDNEY; CLOCK; GAMMA; HYPERTENSION; OBESITY; CELLS; MICE	The nuclear receptor family orchestrates many functions related to reproduction, development, metabolism, and adaptation to the circadian cycle. The majority of these receptors are expressed in the kidney, but their exact quantitative localization in this ultrastructured organ remains poorly described, making it difficult to elucidate the renal function of these receptors. In this report, using quantitative PCR on microdissected mouse renal tubules, we established a detailed quantitative expression map of nuclear receptors along the nephron. This map can serve to identify nuclear receptors with specific localization. Thus, we unexpectedly found that the estrogen-related receptor beta (ERR beta) is expressed predominantly in the thick ascending limb (TAL) and, to a much lesser extent, in the distal convoluted tubules. In vivo treatment with an ERR inverse agonist (diethylstilbestrol) showed a link between this receptor family and the expression of the Na+, K+-2Cl(-) cotransporter type 2 (NKCC2), and resulted in phenotype presenting some similarities with the Bartter syndrom (hypokalemia, urinary Na+ loss and volume contraction). Conversely, stimulation of ERRb with a selective agonist (GSK4716) in a TAL cell line stimulated NKCC2 expression. All together, these results provide broad information regarding the renal expression of all members of the nuclear receptor family and have allowed us to identify a new regulator of ion transport in the TAL segments.	[Krid, Halla; Dorison, Aude; Salhi, Amel; Cheval, Lydie; Crambert, Gilles] UPMC Univ Paris 6, INSERM, CNRS, Ctr Rech Cordeliers,Equipe Lab Genom Physiol & Ph, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Crambert, G (corresponding author), UPMC Univ Paris 6, INSERM, CNRS, Ctr Rech Cordeliers,Equipe Lab Genom Physiol & Ph, Paris, France.	gilles.crambert@crc.jussieu.fr		Crambert, Gilles/0000-0001-7065-9124; Dorison, Aude/0000-0002-8329-8767; CHEVAL, LYDIE/0000-0003-2957-6487	Transatlantic Network on Hypertension of the Leducq Fondation	Transatlantic Network on Hypertension of the Leducq Fondation	This study was supported by the program of the Transatlantic Network on Hypertension of the Leducq Fondation (G.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bourgeois S, 2003, PFLUG ARCH EUR J PHY, V446, P672, DOI 10.1007/s00424-003-1108-x; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; Chen J, 2007, DEV CELL, V13, P325, DOI 10.1016/j.devcel.2007.07.011; Cheval L, 2006, PHYSIOL GENOMICS, V27, P271, DOI 10.1152/physiolgenomics.00069.2006; Cheval L, 2011, PHYSIOL GENOMICS, V43, P161, DOI 10.1152/physiolgenomics.00093.2010; Collin RWJ, 2008, AM J HUM GENET, V82, P125, DOI 10.1016/j.ajhg.2007.09.008; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELALOUF JM, 1993, J CLIN INVEST, V91, P264, DOI 10.1172/JCI116180; Firsov D, 2010, KIDNEY INT, V78, P640, DOI 10.1038/ki.2010.227; Grimont A, 2009, FEBS LETT, V583, P1644, DOI 10.1016/j.febslet.2009.04.032; Hall JE, 2004, ADV RENAL REPLACE TH, V11, P41, DOI 10.1053/j.arrt.2003.10.007; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Horster M, 1997, PFLUG ARCH EUR J PHY, V434, P647, DOI 10.1007/s004240050448; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; Lemale J, 2008, BBA-MOL CELL RES, V1783, P2234, DOI 10.1016/j.bbamcr.2008.07.023; Lindheimer MD, 2001, SEMIN NEPHROL, V21, P173, DOI 10.1053/snep.2001.20937; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Musselman TM, 2010, STEROIDS, V75, P760, DOI 10.1016/j.steroids.2010.05.014; Sabolic I, 2007, PFLUG ARCH EUR J PHY, V455, P397, DOI 10.1007/s00424-007-0308-1; Suh JM, 2006, MOL ENDOCRINOL, V20, P3412, DOI 10.1210/me.2006-0312; Tremblay AM, 2010, MOL ENDOCRINOL, V24, P22, DOI 10.1210/me.2009-0254; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF966, DOI 10.1152/ajprenal.1999.277.6.F966; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106; Zuercher WJ, 2005, J MED CHEM, V48, P3107, DOI 10.1021/jm050161j	29	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34223	10.1371/journal.pone.0034223	http://dx.doi.org/10.1371/journal.pone.0034223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457827	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900056
J	Sheikh, A; Saeed, Z; Jafri, SAD; Yazdani, I; Hussain, SA				Sheikh, Adil; Saeed, Zeb; Jafri, Syed Ali Danial; Yazdani, Iffat; Hussain, Syed Ather			Vitamin D Levels in Asymptomatic Adults-A Population Survey in Karachi, Pakistan	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; D DEFICIENCY; HYPOVITAMINOSIS D; D INSUFFICIENCY; HIGH PREVALENCE; PREVENTION; HEALTH; CONSEQUENCES; MORTALITY; INDIANS	Background: It is well established that low levels of 25(OH) Vitamin D (<30 ng/dL) are a common finding world over, affecting over a billion of the global population. Our primary objective was to determine the prevalence of vitamin D deficiency and insufficiency in the asymptomatic adult population of Karachi, Pakistan and the demographic, nutritional and co-morbidity characteristics associated with serum vitamin D levels. Methods: A cross-sectional population survey was conducted at two spaced out densely populated areas of the city. Serum levels of 25OHVitamin D were measured and GFR as renal function was assessed by using 4 variable MDRD formula. Results: Our sample of 300 had a median age of 48(interquartile range 38-55) years. The median level of serum vitamin D was 18.8 (IQ range 12.65-24.62) ng/dL. A total of 253 (84.3%) respondents had low levels (<30 ng/dL) of 25OH vitamin D. Serum PTH and vitamin D were negatively correlated (r = 20.176, p = 0.001). The median PTH in the vitamin D sufficiency group was 38.4(IQ range28.0-48.8) pg/mL compared with 44.4(IQ range34.3-56.8) pg/mL in the deficiency group (p = 0.011). The median serum calcium level in the sample was 9.46(IQ range 9.18-9.68) ng/dL. Low serum levels of vitamin D were not associated with hypertension (p = 0.771) or with an elevated spot blood pressure (p = 0.164). In our sample 75(26%) respondents had an eGFR corresponding to stage 2 and stage 3 CKD. There was no significant correlation between levels of vitamin D and eGFR (r = 20.127, p-value = 0.277). Respondents using daily vitamin D supplements had higher 25 OH vitamin D levels (p-value = 0.021). Conclusion: We observed a high proportion of the asymptomatic adult population having low levels of vitamin D and subclinical deterioration of eGFR. The specific cause(s) for this observed high prevalence of low 25OH vitamin D levels are not clear and need to be investigated further upon.	[Sheikh, Adil; Saeed, Zeb] Aga Khan Univ Hosp, Coll Med, Karachi, Pakistan; [Jafri, Syed Ali Danial; Yazdani, Iffat; Hussain, Syed Ather] Aga Khan Univ Hosp, Dept Med, Karachi, Pakistan	Aga Khan University; Aga Khan University	Sheikh, A (corresponding author), Aga Khan Univ Hosp, Coll Med, Karachi, Pakistan.	ather.hussain@aku.edu			Glaxo Smith Kline(R) Co., Ltd.; University Research Council [EGC-020910 MC-P]	Glaxo Smith Kline(R) Co., Ltd.; University Research Council	SAH received an independent educational grant from by Glaxo Smith Kline (R) Co., Ltd., which only covered the laboratory, logistics and equipment costs incurred. The grant was in form of local currency(Pakistan Rupees) PKR = 13,000,000. Study grant was approved by the University Research Council (EGC-020910 MC-P). Funder URL: (http://www.gsk.com.pk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JMM, 2010, RAWAL MED J, V35; Ardawi MS, 2011, OSTEOPOROS INT; Arya V, 2004, OSTEOPOROSIS INT, V15, P56, DOI 10.1007/s00198-003-1491-3; Azizi E, 2009, PHOTOCHEM PHOTOBIOL, V85, P1240, DOI 10.1111/j.1751-1097.2009.00569.x; Dusso A, BEST PRACT RES CLIN, V25, P647; Evatt ML, 2011, ARCH NEUROL-CHICAGO, V68, P314, DOI 10.1001/archneurol.2011.30; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Goswami R, 2000, AM J CLIN NUTR, V72, P472; Harinarayan CV, 2005, OSTEOPOROSIS INT, V16, P397, DOI 10.1007/s00198-004-1703-5; Harinarayan CV, 2004, ASIA PAC J CLIN NUTR, V13, P359; Hashemipour S, 2006, J BONE MINER METAB, V24, P213, DOI 10.1007/s00774-005-0674-8; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Holick MF, 2008, MOL ASPECTS MED, V29, P361, DOI 10.1016/j.mam.2008.08.008; Inaguma D, 2008, CLIN EXP NEPHROL, V12, P126, DOI 10.1007/s10157-007-0023-4; Janssens W, 2011, VITAM HORM, V86, P379, DOI 10.1016/B978-0-12-386960-9.00017-4; Kim Hyung Soo, 2011, Electrolyte Blood Press, V9, P1, DOI 10.5049/EBP.2011.9.1.1; Krishnan AV, 2010, ENDOCRIN METAB CLIN, V39, P401, DOI 10.1016/j.ecl.2010.02.011; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Mansoor S, 2010, CLIN BIOCHEM, V43, P1431, DOI 10.1016/j.clinbiochem.2010.09.022; Marcinowska-Suchowierska E, 2010, ENDOKRYNOL POL, V61, P723; Masood SH, 2008, PAK J MED SCI, V24, P891; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Ogunkolade WB, 2006, J CLIN ENDOCR METAB, V91, P2612, DOI 10.1210/jc.2005-2750; Pellicane AJ, 2010, AM J PHYS MED REHAB, V89, P899, DOI 10.1097/PHM.0b013e3181f71112; Rasmussen LB, 2000, INT J FOOD SCI NUTR, V51, P209, DOI 10.1080/09637480050029719; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; Villarreal IR, 2011, NEFROLOGIA, V31, P185, DOI 10.3265/Nefrologia.pre2011.Jan.10560; Rucker D, 2009, J NEPHROL, V22, P75; Simonelli Christine, 2005, Minn Med, V88, P34; Slatopolsky E, 2011, KIDNEY INT, V79, pS3, DOI 10.1038/ki.2011.23; Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200; Zhang R, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-65; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001; Zuberi Lubna M, 2008, J Pak Med Assoc, V58, P482; Zwerina K, 2011, ANN RHEUM DIS, V70, P1122, DOI 10.1136/ard.2010.142331	38	57	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33452	10.1371/journal.pone.0033452	http://dx.doi.org/10.1371/journal.pone.0033452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457762	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900011
J	Abdul-Careem, MF; Lee, AJ; Pek, EA; Gill, N; Gillgrass, AE; Chew, MV; Reid, S; Ashkar, AA				Abdul-Careem, Mohamed F.; Lee, Amanda J.; Pek, Elishka A.; Gill, Navkiran; Gillgrass, Amy E.; Chew, Marianne V.; Reid, Sarah; Ashkar, Ali A.			Genital HSV-2 Infection Induces Short-Term NK Cell Memory	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; SIMPLEX-VIRUS TYPE-2; ADAPTIVE IMMUNITY; INNATE; MICE; RESPONSES; VACCINATION; INTERFERON; PROTECTION; INDUCTION	NK cells are known as innate immune cells that lack immunological memory. Recently, it has been shown that NK cells remember encounters with chemical haptens that induce contact hypersensitivity and cytomegalovirus infection. Here, we show the existence of NK cell memory following HSV-2 infection. Stimulation with HSV-2 Ags led to higher IFN gamma production in NK cells that were exposed 30 days previously to HSV-2, compared to NK cells from naive mice. More importantly, this increased production of IFN gamma in NK cells was independent of B- and T-lymphocytes and specific for the HSV-2 Ags. We also showed that previously exposed NK cells in a B- and T-lymphocyte free environment mediate protection against HSV-2 infection and they are necessary for the protection of mice against HSV-2 infection. Collectively, NK cells remember prior HSV-2 encounters independent of B- and T-lymphocytes leading to protection against HSV-2 mediated morbidity and mortality upon re-exposure.	[Abdul-Careem, Mohamed F.; Lee, Amanda J.; Pek, Elishka A.; Gill, Navkiran; Gillgrass, Amy E.; Chew, Marianne V.; Reid, Sarah; Ashkar, Ali A.] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [Abdul-Careem, Mohamed F.; Lee, Amanda J.; Pek, Elishka A.; Gill, Navkiran; Gillgrass, Amy E.; Chew, Marianne V.; Reid, Sarah; Ashkar, Ali A.] McMaster Univ, Inst Infect Dis Res, Dept Pathol & Mol Med, McMaster Univ Hlth Sci Ctr, Hamilton, ON, Canada	McMaster University; McMaster University	Ashkar, AA (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada.	ashkara@mcmaster.ca	Careem, Faizal/H-8005-2019	Careem, Faizal/0000-0002-9974-7600; Ashkar, Ali/0000-0003-1139-1468	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from Canadian Institutes of Health Research (CIHR) to A.A.A. M.F. Abdul-Careem is a recipient of a postdoctoral fellowship from CIHR and A.A.A. is a recipient of career award in health sciences for RxD/CIHR.	Adams EJ, 2007, P NATL ACAD SCI USA, V104, P10128, DOI 10.1073/pnas.0703735104; Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Cooper MA, 2010, IMMUNOL REV, V235, P297, DOI 10.1111/j.0105-2896.2010.00891.x; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; DJEU JY, 1982, J EXP MED, V156, P1222, DOI 10.1084/jem.156.4.1222; Gill N, 2006, J VIROL, V80, P9943, DOI 10.1128/JVI.01036-06; Gillgrass AE, 2005, J VIROL, V79, P3117, DOI 10.1128/JVI.79.5.3117-3126.2005; Harandi AM, 2001, J GEN VIROL, V82, P845, DOI 10.1099/0022-1317-82-4-845; Horowitz A, 2010, J IMMUNOL, V185, P2808, DOI 10.4049/jimmunol.1000844; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Kwant-Mitchell A, 2009, J VIROL, V83, P10664, DOI 10.1128/JVI.02584-08; MCDERMOTT MR, 1984, J VIROL, V51, P747, DOI 10.1128/JVI.51.3.747-753.1984; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; Shimizu K, 2009, EUR J IMMUNOL, V39, P457, DOI 10.1002/eji.200838794; Sun JC, 2010, IMMUNOL REV, V236, P83, DOI 10.1111/j.1600-065X.2010.00900.x; Sun JC, 2009, EUR J IMMUNOL, V39, P2059, DOI 10.1002/eji.200939435; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478	23	64	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e32821	10.1371/journal.pone.0032821	http://dx.doi.org/10.1371/journal.pone.0032821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457721	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200007
J	Mason, P; Liang, BR; Li, LY; Fremgen, T; Murphy, E; Quinn, A; Madden, SL; Biemann, HP; Wang, B; Cohen, A; Komarnitsky, S; Jancsics, K; Hirth, B; Cooper, CGF; Lee, E; Wilson, S; Krumbholz, R; Schmid, S; Xiang, YB; Booker, M; Lillie, J; Carter, K				Mason, Paul; Liang, Beirong; Li, Lingyun; Fremgen, Trisha; Murphy, Erin; Quinn, Angela; Madden, Stephen L.; Biemann, Hans-Peter; Wang, Bing; Cohen, Aharon; Komarnitsky, Svetlana; Jancsics, Kate; Hirth, Brad; Cooper, Christopher G. F.; Lee, Edward; Wilson, Sean; Krumbholz, Roy; Schmid, Steven; Xiang, Yibin; Booker, Michael; Lillie, James; Carter, Kara			SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty Acids	PLOS ONE			English	Article							SYNTHASE; DISCOVERY; BREAST; MICE	Increased metabolism is a requirement for tumor cell proliferation. To understand the dependence of tumor cells on fatty acid metabolism, we evaluated various nodes of the fatty acid synthesis pathway. Using RNAi we have demonstrated that depletion of fatty-acid synthesis pathway enzymes SCD1, FASN, or ACC1 in HCT116 colon cancer cells results in cytotoxicity that is reversible by addition of exogenous fatty acids. This conditional phenotype is most pronounced when SCD1 is depleted. We used this fatty-acid rescue strategy to characterize several small-molecule inhibitors of fatty acid synthesis, including identification of TOFA as a potent SCD1 inhibitor, representing a previously undescribed activity for this compound. Reference FASN and ACC inhibitors show cytotoxicity that is less pronounced than that of TOFA, and fatty-acid rescue profiles consistent with their proposed enzyme targets. Two reference SCD1 inhibitors show low-nanomolar cytotoxicity that is offset by at least two orders of magnitude by exogenous oleate. One of these inhibitors slows growth of HCT116 xenograft tumors. Our data outline an effective strategy for interrogation of on-mechanism potency and pathway-node- specificity of fatty acid synthesis inhibitors, establish an unambiguous link between fatty acid synthesis and cancer cell survival, and point toward SCD1 as a key target in this pathway.	[Mason, Paul; Liang, Beirong; Li, Lingyun; Fremgen, Trisha; Murphy, Erin; Quinn, Angela; Madden, Stephen L.; Biemann, Hans-Peter; Wang, Bing; Cohen, Aharon; Komarnitsky, Svetlana; Jancsics, Kate; Hirth, Brad; Cooper, Christopher G. F.; Lee, Edward; Wilson, Sean; Krumbholz, Roy; Schmid, Steven; Xiang, Yibin; Booker, Michael; Lillie, James; Carter, Kara] Genzyme Corp, Waltham, MA USA	Sanofi-Aventis; Genzyme Corporation	Mason, P (corresponding author), Genzyme Corp, Waltham, MA USA.	paul.mason@genzyme.com						Carratu L, 1996, P NATL ACAD SCI USA, V93, P3870, DOI 10.1073/pnas.93.9.3870; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Liu G, 2007, J MED CHEM, V50, P3086, DOI 10.1021/jm070219p; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Lupu R, 2006, ENDOCRINOLOGY, V147, P4056, DOI 10.1210/en.2006-0486; MCCUNE SA, 1979, J BIOL CHEM, V254, P95; Menendez JA, 2004, ARCH IMMUNOL THER EX, V52, P414; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; OMURA S, 1976, BACTERIOL REV, V40, P681, DOI 10.1128/MMBR.40.3.681-697.1976; Pizer ES, 1998, CANCER-AM CANCER SOC, V83, P528, DOI 10.1002/(SICI)1097-0142(19980801)83:3<528::AID-CNCR22>3.0.CO;2-X; Pizer ES, 2000, CANCER RES, V60, P213; Rendina AR, 2005, BIOCHEM J, V388, P895, DOI 10.1042/BJ20041963; Rivkin A, 2006, BIOORG MED CHEM LETT, V16, P4620, DOI 10.1016/j.bmcl.2006.06.014; Zhao HY, 2007, BIOORG MED CHEM LETT, V17, P3388, DOI 10.1016/j.bmcl.2007.03.099	20	124	134	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33823	10.1371/journal.pone.0033823	http://dx.doi.org/10.1371/journal.pone.0033823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457791	gold, Green Submitted, Green Published			2022-12-27	WOS:000303909200036
J	Yu, CM; Peng, HP; Chen, IC; Lee, YC; Chen, JB; Tsai, KC; Chen, CT; Chang, JY; Yang, EW; Hsu, PC; Jian, JW; Hsu, HJ; Chang, HJ; Hsu, WL; Huang, KF; Ma, AC; Yang, AS				Yu, Chung-Ming; Peng, Hung-Pin; Chen, Ing-Chien; Lee, Yu-Ching; Chen, Jun-Bo; Tsai, Keng-Chang; Chen, Ching-Tai; Chang, Jeng-Yih; Yang, Ei-Wen; Hsu, Po-Chiang; Jian, Jhih-Wei; Hsu, Hung-Ju; Chang, Hung-Ju; Hsu, Wen-Lian; Huang, Kai-Fa; Ma, Alex Che; Yang, An-Suei			Rationalization and Design of the Complementarity Determining Region Sequences in an Antibody-Antigen Recognition Interface	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERFACE; FRAGMENTS SC-DSFV; COMPUTATIONAL DESIGN; INTEGRATED APPROACH; SYNTHETIC ANTIBODIES; HOT-SPOTS; X-RAY; BINDING; AFFINITY; SPECIFICITY	Protein-protein interactions are critical determinants in biological systems. Engineered proteins binding to specific areas on protein surfaces could lead to therapeutics or diagnostics for treating diseases in humans. But designing epitope-specific protein-protein interactions with computational atomistic interaction free energy remains a difficult challenge. Here we show that, with the antibody-VEGF (vascular endothelial growth factor) interaction as a model system, the experimentally observed amino acid preferences in the antibody-antigen interface can be rationalized with 3-dimensional distributions of interacting atoms derived from the database of protein structures. Machine learning models established on the rationalization can be generalized to design amino acid preferences in antibody-antigen interfaces, for which the experimental validations are tractable with current high throughput synthetic antibody display technologies. Leave-one-out cross validation on the benchmark system yielded the accuracy, precision, recall (sensitivity) and specificity of the overall binary predictions to be 0.69, 0.45, 0.63, and 0.71 respectively, and the overall Matthews correlation coefficient of the 20 amino acid types in the 24 interface CDR positions was 0.312. The structure-based computational antibody design methodology was further tested with other antibodies binding to VEGF. The results indicate that the methodology could provide alternatives to the current antibody technologies based on animal immune systems in engineering therapeutic and diagnostic antibodies against predetermined antigen epitopes.	[Yu, Chung-Ming; Peng, Hung-Pin; Chen, Ing-Chien; Lee, Yu-Ching; Chen, Jun-Bo; Tsai, Keng-Chang; Chen, Ching-Tai; Chang, Jeng-Yih; Yang, Ei-Wen; Hsu, Po-Chiang; Jian, Jhih-Wei; Hsu, Hung-Ju; Chang, Hung-Ju; Ma, Alex Che; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Peng, Hung-Pin; Jian, Jhih-Wei] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Jun-Bo] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Chen, Ching-Tai] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Hsu, Hung-Ju] Natl Def Univ, Grad Inst Life Sci, Taipei, Taiwan; [Chang, Hung-Ju] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Huang, Kai-Fa] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Peng, Hung-Pin; Chen, Ching-Tai; Jian, Jhih-Wei] Acad Sinica, Inst Informat Sci, Taiwan Int Grad Program, Bioinformat Program, Taipei, Taiwan; [Chang, Hung-Ju] Acad Sinica, Inst Biol Chem, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Tsing Hua University; National Yang Ming Chiao Tung University; National Defense University - Taiwan; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Yu, CM (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	yangas@gate.sinica.edu.tw	Hsu, Wen-Lian/ABB-2851-2020	Hsu, Wen-Lian/0000-0001-7061-3513; Tsai, Keng-Chang/0000-0001-8277-9174; Chang, Hung-Ju/0000-0003-2062-9212; Yang, An-Suei/0000-0002-4699-873X	National Health Research Institutes [NHRI-EX98-9802EI]; National Science Council [NSC] [99-2311-B-001-014-MY3]; Genomics Research Center at Academia Sinica [AS-100-TP2-B01]; NRPB, NSC [NSC 100-2325-B-001-009, 100IDP006-3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council [NSC](Ministry of Science and Technology, Taiwan); Genomics Research Center at Academia Sinica(Academia Sinica - Taiwan); NRPB, NSC	This work was supported by National Health Research Institutes [NHRI-EX98-9802EI to A-S. Y.], National Science Council [NSC 99-2311-B-001-014-MY3 to ASY], Genomics Research Center at Academia Sinica [AS-100-TP2-B01 to ASY], and NRPB program, NSC. [NSC 100-2325-B-001-009; 100IDP006-3 to ASY] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi L, 2010, CURR MED CHEM, V17, P1730, DOI 10.2174/092986710791111215; Adams PD, 2009, ACTA CRYSTALLOGR D, V65, P567, DOI 10.1107/S0907444909011548; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Boas FE, 2007, CURR OPIN STRUC BIOL, V17, P199, DOI 10.1016/j.sbi.2007.03.006; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Chen IC, 2010, MOL BIOSYST, V6, P1307, DOI 10.1039/b921106c; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Clark LA, 2008, PROTEINS, V70, P1540, DOI 10.1002/prot.21694; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Hsu HJ, 2006, STRUCTURE, V14, P1499, DOI 10.1016/j.str.2006.08.006; Huang YJ, 2010, J BIOL CHEM, V285, P7880, DOI 10.1074/jbc.M109.061457; Jiang L, 2005, PROTEINS, V58, P893, DOI 10.1002/prot.20347; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laskowski RA, 1996, J MOL BIOL, V259, P175, DOI 10.1006/jmbi.1996.0311; Levy ED, 2010, J MOL BIOL, V403, P660, DOI 10.1016/j.jmb.2010.09.028; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Michnick SW, 2008, NAT CHEM BIOL, V4, P326, DOI 10.1038/nchembio0608-326; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pantazes RJ, 2010, PROTEIN ENG DES SEL, V23, P849, DOI 10.1093/protein/gzq061; Papoian GA, 2003, J AM CHEM SOC, V125, P9170, DOI 10.1021/ja034729u; Ponsel D, 2011, MOLECULES, V16, P3675, DOI 10.3390/molecules16053675; Raschke TM, 2006, CURR OPIN STRUC BIOL, V16, P152, DOI 10.1016/j.sbi.2006.03.002; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Russ WP, 2002, CURR OPIN STRUC BIOL, V12, P447, DOI 10.1016/S0959-440X(02)00346-9; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; Vaezin AS, 2006, HYBRIDOMA, V25, P255; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vizcarra CL, 2005, CURR OPIN CHEM BIOL, V9, P622, DOI 10.1016/j.cbpa.2005.10.014; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Yang AS, 2000, J MOL BIOL, V301, P691, DOI 10.1006/jmbi.2000.3975; Yang AS, 2000, J MOL BIOL, V301, P679, DOI 10.1006/jmbi.2000.3974; Yang AS, 2003, BIOINFORMATICS, V19, P1267, DOI 10.1093/bioinformatics/btg151; Yang AS, 2002, BIOINFORMATICS, V18, P1650, DOI 10.1093/bioinformatics/18.12.1650	53	37	66	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33340	10.1371/journal.pone.0033340	http://dx.doi.org/10.1371/journal.pone.0033340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457753	Green Submitted, Green Published, gold			2022-12-27	WOS:000303909200027
J	Iwai, S; Kikuchi, T; Kasahara, N; Teratani, T; Yokoo, T; Sakonju, I; Okano, S; Kobayashi, E				Iwai, Satomi; Kikuchi, Takeshi; Kasahara, Naoya; Teratani, Takumi; Yokoo, Takashi; Sakonju, Iwao; Okano, Shouzou; Kobayashi, Eiji			Impact of Normothermic Preservation with Extracellular Type Solution Containing Trehalose on Rat Kidney Grafting from a Cardiac Death Donor	PLOS ONE			English	Article							COLD-STORAGE; HIGH-SODIUM; TRANSPLANTATION; ISCHEMIA; HYPOTHERMIA; PERFUSION; SURVIVAL; CELLS; LIVER; 1ST	Background: The aim of this study was to investigate factors that may improve the condition of a marginal kidney preserved with a normothermic solution following cardiac death (CD) in a model of rat kidney transplantation (RTx). Methods: Post-euthanasia, Lewis (LEW) donor rats were left for 1 h in a 23 degrees C room. These critical kidney grafts were preserved in University of Wisconsin (UW), lactate Ringer's (LR), or extracellular-trehalose-Kyoto (ETK) solution, followed by intracellular-trehalose-Kyoto (ITK) solution at 4, 23, or 37 degrees C for another 1 h, and finally transplanted into bilaterally nephrectomized LEW recipient rats (n = 4-6). Grafts of rats surviving to day 14 after RTx were evaluated by histopathological examination. The energy activity of these marginal rat kidneys was measured by high-performance liquid chromatography (HPLC; n = 4 per group) and fluorescence intensity assay (n = 6 per group) after preservation with UW or ETK solutions at each temperature. Finally, the transplanted kidney was assessed by an in vivo luciferase imaging system (n = 2). Results: Using the 1-h normothermic preservation of post-CD kidneys, five out of six recipients in the ETK group survived until 14 days, in contrast to zero out of six in the UW group (p<0.01). Preservation with ITK rather than ETK at 23 degrees C tended to have an inferior effect on recipient survival (p = 0.12). Energy activities of the fresh donor kidneys decreased in a temperature-dependent manner, while those of post-CD kidneys remained at the lower level. ETK was superior to UW in protecting against edema of the post-CD kidneys at the higher temperature. Luminescence intensity of successful grafts recovered within 1 h, while the intensity of grafts of deceased recipients did not change at 1 h post-reperfusion. Conclusions: Normothermic storage with extracellular-type solution containing trehalose might prevent reperfusion injury due to temperature-dependent tissue edema.	[Iwai, Satomi; Sakonju, Iwao] Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 1, Aomori, Japan; [Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Project Lab Kidney Regenerat,Inst DNA Med, Tokyo, Japan; [Okano, Shouzou] Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 2, Aomori, Japan	Kitasato University; Jikei University; Kitasato University	Iwai, S (corresponding author), Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 1, Aomori, Japan.	eijikoba@jichi.ac.jp			Otsuka Pharmaceutical Factory, Inc. (Naruto, Japan)	Otsuka Pharmaceutical Factory, Inc. (Naruto, Japan)(Otsuka Pharmaceutical)	This study was funded by Otsuka Pharmaceutical Factory, Inc. (Naruto, Japan, http://www.otsukakj.jp/en/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON DE, 1967, J BIOL CHEM, V242, P3239; BANDO T, 1994, J THORAC CARDIOV SUR, V108, P92; Belzer F O, 1986, Prog Clin Biol Res, V224, P291; Brasile L, 2002, TRANSPLANTATION, V73, P897, DOI 10.1097/00007890-200203270-00011; Chen TN, 2000, CRYOBIOLOGY, V40, P277, DOI 10.1006/cryo.2000.2244; CLAUSEN T, 1991, PHYSIOL REV, V71, P733, DOI 10.1152/physrev.1991.71.3.733; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; Faure JP, 2003, BIOCHEM PHARMACOL, V66, P2241, DOI 10.1016/j.bcp.2003.07.011; Fujishiro J, 2006, TRANSPLANTATION, V82, P804, DOI 10.1097/01.tp.0000232687.78242.cd; Fukuse T, 1999, TRANSPLANTATION, V68, P110, DOI 10.1097/00007890-199907150-00021; Hakamata Y, 2006, TRANSPLANTATION, V81, P1179, DOI 10.1097/01.tp.0000203137.06587.4a; Hosgood SA, 2011, J SURG RES, V171, P283, DOI 10.1016/j.jss.2010.01.027; Hosgood SA, 2011, TRANSPLANTATION, V92, P735, DOI 10.1097/TP.0b013e31822d4e04; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Kajiwara N, 1996, TRANSPLANT INT, V9, P194, DOI 10.1007/BF00335385; Kay MD, 2007, TRANSPLANT INT, V20, P88, DOI 10.1111/j.1432-2277.2006.00390.x; Kay MD, 2011, J SURG RES, V171, P275, DOI 10.1016/j.jss.2010.01.018; KLAUSNER JM, 1989, AM J PHYSIOL, V256, pF794, DOI 10.1152/ajprenal.1989.256.5.F794; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Luque P, 1999, TRANSPLANT P, V31, P2352, DOI 10.1016/S0041-1345(99)00375-9; McAnulty JF, 1998, CRYOBIOLOGY, V36, P12, DOI 10.1006/cryo.1997.2055; MOEN J, 1989, TRANSPLANTATION, V47, P940, DOI 10.1097/00007890-198906000-00004; Navarro AP, 2009, AM J TRANSPLANT, V9, P1317, DOI 10.1111/j.1600-6143.2009.02633.x; Negishi K, 2011, ISLETS, V3, P111, DOI 10.4161/isl.3.3.15626; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pomfret EA, 2008, AM J TRANSPLANT, V8, P745, DOI 10.1111/j.1600-6143.2007.02146.x; RAMELLA SG, 1995, NEPHROL DIAL TRANSPL, V10, P842; Reddy SP, 2009, TRANSPLANTATION, V87, P631, DOI 10.1097/TP.0b013e3181995e83; Renkens JJM, 2005, AM J TRANSPLANT, V5, P2704, DOI 10.1111/j.1600-6143.2005.01072.x; S ung RS, 2006, CLIN TRANSPLANTS 200, P37; Salahudeen AK, 2004, KIDNEY INT, V65, P713, DOI 10.1111/j.1523-1755.2004.00416.x; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; SCHILLING M, 1993, TRANSPLANT P, V25, P1629; Singh RP, 2011, CLIN TRANSPLANT, V25, P255, DOI 10.1111/j.1399-0012.2010.01241.x; SOUTHARD JH, 1995, ANNU REV MED, V46, P235; Takeda S, 2004, NEPHROL DIAL TRANSPL, V19, P2228, DOI 10.1093/ndt/gfh302; Treckmann J, 2011, TRANSPL INT, V24, P548, DOI 10.1111/j.1432-2277.2011.01232.x; Tveita T, 2005, APMIS, V113, P13, DOI 10.1111/j.1600-0463.2005.apm1130103.x; URBAITIS BK, 1984, RENAL PHYSIOL BIOCH, V7, P22; Vajdova K, 2002, HEPATOLOGY, V36, P1543, DOI 10.1053/jhep.2002.37189; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wolters HH, 2006, TRANSPLANT P, V38, P664, DOI 10.1016/j.transproceed.2006.01.055; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667; Yoshida H, 2002, TRANSPLANTATION, V74, P1231, DOI 10.1097/00007890-200211150-00006; Zhu B, 2007, J PHYS CHEM B, V111, P5542, DOI 10.1021/jp071974h	46	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33157	10.1371/journal.pone.0033157	http://dx.doi.org/10.1371/journal.pone.0033157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457739	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100017
J	Chen, CH; Chu, PC; Lee, L; Lien, HW; Lin, TL; Fan, CC; Chi, P; Huang, CJ; Chang, MS				Chen, Chia-Hsin; Chu, Po-Chen; Lee, Liekyeow; Lien, Huang-Wei; Lin, Tse-Ling; Fan, Chi-Chen; Chi, Peter; Huang, Chang-Jen; Chang, Mau-Sun			Disruption of Murine mp29/Syf2/Ntc31 Gene Results in Embryonic Lethality with Aberrant Checkpoint Response	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; DNA-DAMAGE RESPONSES; PHYSICAL INTERACTIONS; MICE; ATR; EXPRESSION; REGULATOR; P-29	Human p29 is a putative component of spliceosomes, but its role in pre-mRNA is elusive. By siRNA knockdown and stable overexpression, we demonstrated that human p29 is involved in DNA damage response and Fanconi anemia pathway in cultured cells. In this study, we generated p29 knockout mice (mp29(GT/GT)) using the mp29 gene trap embryonic stem cells to study the role of mp29 in DNA damage response in vivo. Interruption of mp29 at both alleles resulted in embryonic lethality. Embryonic abnormality occurred as early as E6.5 in mp29(GT/GT) mice accompanied with decreased mRNA levels of alpha-tubulin and Chk1. The reduction of alpha-tubulin and Chk1 mRNAs is likely due to an impaired post-transcriptional event. An aberrant G2/M checkpoint was found in mp29 gene trap embryos when exposed to aphidicolin and UV light. This embryonic lethality was rescued by crossing with mp29 transgenic mice. Additionally, the knockdown of zfp29 in zebrafish resulted in embryonic death at 72 hours of development postfertilization (hpf). A lower level of acetylated alpha-tubulin was also observed in zfp29 morphants. Together, these results illustrate an indispensable role of mp29 in DNA checkpoint response during embryonic development.	[Chen, Chia-Hsin; Chu, Po-Chen; Lee, Liekyeow; Chi, Peter; Huang, Chang-Jen; Chang, Mau-Sun] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 10764, Taiwan; [Lien, Huang-Wei] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei 10764, Taiwan; [Fan, Chi-Chen] Mackay Mem Hosp, Dept Physiol, Taipei, Taiwan; [Lin, Tse-Ling; Chi, Peter; Huang, Chang-Jen; Chang, Mau-Sun] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	National Taiwan University; National Taiwan University; Mackay Memorial Hospital; Academia Sinica - Taiwan	Chen, CH (corresponding author), Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 10764, Taiwan.	mschang@ntu.edu.tw	Chi, Peter/AAI-1580-2019; Huang, Wenchi/F-3981-2010	Chi, Peter/0000-0001-9229-8729; Huang, Wenchi/0000-0001-5556-1460; CHANG, MAU-SUN/0000-0002-3703-2386	National Science Council (NSC) [100-2311-B-002-013]; National Taiwan University [10R80837]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by grants from National Science Council (NSC 100-2311-B-002-013) and National Taiwan University (10R80837) to MSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Brown EJ, 2000, GENE DEV, V14, P397; Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Chang MS, 2002, BIOCHEM BIOPH RES CO, V299, P241, DOI 10.1016/S0006-291X(02)02605-0; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Chu PC, 2006, CANCER RES, V66, P8484, DOI 10.1158/0008-5472.CAN-05-3229; Chu PC, 2009, CARCINOGENESIS, V30, P1710, DOI 10.1093/carcin/bgp204; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dahan O, 2002, NUCLEIC ACIDS RES, V30, P4361, DOI 10.1093/nar/gkf563; Fortschegger K, 2007, MOL CELL BIOL, V27, P3123, DOI 10.1128/MCB.01188-06; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kleinridders A, 2009, MOL CELL BIOL, V29, P3173, DOI 10.1128/MCB.01807-08; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Legerski RJ, 2009, CELL CYCLE, V8, P3448, DOI 10.4161/cc.8.21.9760; Liu QH, 2000, GENE DEV, V14, P1448; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Russell CS, 2000, RNA, V6, P1565, DOI 10.1017/S1355838200000984; Takai H, 2000, GENE DEV, V14, P1439; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Vincent K, 2003, GENETICS, V164, P895; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122	23	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33538	10.1371/journal.pone.0033538	http://dx.doi.org/10.1371/journal.pone.0033538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448250	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700041
J	Cole, L; Polfus, L; Peters, ES				Cole, Lauren; Polfus, Linda; Peters, Edward S.			Examining the Incidence of Human Papillomavirus-Associated Head and Neck Cancers by Race and Ethnicity in the US, 1995-2005	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ORAL HUMAN-PAPILLOMAVIRUS; SEXUAL-BEHAVIOR; RISK-FACTORS; INFECTION; CAVITY; TRENDS; EPIDEMIOLOGY; SURVIVAL; ADULTS	Background: Head and neck cancer (HNC) incidence, mortality and survival rates vary by sex and race, with men and African Americans disproportionately affected. Risk factors for HNC include tobacco and alcohol exposure, with a recent implication of human papillomavirus (HPV) in the pathogenesis of HNC. This study describes the epidemiology of HNC in the United States, examining variation of rates by age, sex, race/ethnicity and potential HPV-association. Methods: We used the North American Association of Central Cancer Registries (NAACCR) Cancer in North America (CINA) Deluxe Analytic Data to analyze HNC incidence for 1995-2005 from forty population-based cancer registries. We calculated age-adjusted incidence rates and incidence trends using annual percent change by age, sex, race/ethnicity and HPV-association. Results: Males and Non-Hispanic Blacks experienced greater HNC incidence compared to women and other race/ethnicity groupings. A significant overall increase in HNC incidence was observed among HPV-associated sites during 1995-2005, while non HPV-associated sites experienced a significant decline in HNC incidence. Overall, younger age groups, Non-Hispanic Whites and Hispanics experienced greater increases in incidence for HPV-associated sites, while HNC incidence declined for Non-Hispanic Blacks independent of HPV-association. In particular, for HPV-associated sites, HNC incidence for Non-Hispanic White males aged 45-54 increased at the greatest rate, with an APC of 6.28% (p<0.05). Among non HPV-associated sites, Non-Hispanic Black males aged 0-44 years experienced the greatest reduction in incidence (APC, -8.17%, p<0.05), while a greater decline among the older, 55-64 year age group (APC, 25.44%, p<0.05) occurred in females. Conclusions: This study provides evidence that HPV-associated tumors are disproportionately affecting certain age, sex and race/ethnicity groups, representing a different disease process for HPV-associated tumors compared to non HPV-associated tumors. Our study suggests that HPV tumor status should be incorporated into treatment decisions for HNC patients to improve prognosis and survival.	[Cole, Lauren; Peters, Edward S.] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA; [Polfus, Linda] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Cole, L (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA.	lcole@lsuhsc.edu	Peters, Edward S/H-1077-2015	Peters, Edward S/0000-0003-4928-6532	North American Association of Central Cancer Registries (NAACCR) [2008-07-02]; National Cancer Institute [HHSN26120044001C]	North American Association of Central Cancer Registries (NAACCR); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funding source is the North American Association of Central Cancer Registries (NAACCR) #2008-07-02 - Counsultant Agreement. This was funded to NAACCR by: HHSN26120044001C, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse S. F., 1975, SEER CANC STAT REV 1; American Cancer Society, 2010, CANC FACTS FIG 2010; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Auluck A, CANCER, V116, P2635; BILLY JOG, 1993, FAM PLANN PERSPECT, V25, P52, DOI 10.2307/2136206; Brown LM, 2011, CANCER CAUSE CONTROL, V22, P753, DOI 10.1007/s10552-011-9748-1; Cameron JE, 2005, SEX TRANSM DIS, V32, P703, DOI 10.1097/01.olq.0000175398.34610.2e; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Coutlee F, 1997, SEX TRANSM DIS, V24, P23, DOI 10.1097/00007435-199701000-00006; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Davies L, 2006, OTOLARYNG HEAD NECK, V135, P451, DOI 10.1016/j.otohns.2006.01.029; Fritz AG., 2000, INT CLASSIFICATION D, V3rd; Furniss CS, 2007, INT J CANCER, V120, P2386, DOI 10.1002/ijc.22633; Gillison ML, 2007, HEAD NECK-J SCI SPEC, V29, P779, DOI 10.1002/hed.20573; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Goodwin WJ, 2008, HEAD NECK-J SCI SPEC, V30, P358, DOI 10.1002/hed.20710; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; Horner MJ, 2009, SEER CANC STAT REV 1; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kingsley K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-87; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Liu LH, 2008, ORAL SURG ORAL MED O, V105, P470, DOI 10.1016/j.tripleo.2007.07.007; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Morse DE, 2006, J AM DENT ASSOC, V137, P203, DOI 10.14219/jada.archive.2006.0146; NAA CCR Expert Panel in Hispanic Identification, 2003, REP NAACCR EXP PAN H; Patel SC, 2011, J CLIN ONCOL, V29, P1488, DOI 10.1200/JCO.2010.31.7883; Ragin CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/ijc.22851; Ringstrom E, 2002, CLIN CANCER RES, V8, P3187; Rodu B, 2007, ORAL SURG ORAL MED O, V104, P653, DOI 10.1016/j.tripleo.2007.03.011; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273; Ryerson AB, 2008, CANCER-AM CANCER SOC, V113, P2901, DOI 10.1002/cncr.23745; Shiboski CH, 2007, COMMUNITY DENT ORAL, V35, P233, DOI 10.1111/j.0301-5661.2007.00334.x; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Silverman S, 2001, J AM DENT ASSOC, V132, p7S, DOI 10.14219/jada.archive.2001.0382; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017	41	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32657	10.1371/journal.pone.0032657	http://dx.doi.org/10.1371/journal.pone.0032657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448226	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700016
J	Gu, TJ; Buaas, FW; Simons, AK; Ackert-Bicknell, CL; Braun, RE; Hibbs, MA				Gu, Tongjun; Buaas, Frank W.; Simons, Allen K.; Ackert-Bicknell, Cheryl L.; Braun, Robert E.; Hibbs, Matthew A.			Canonical A-to-I and C-to-U RNA Editing Is Enriched at 3 ' UTRs and microRNA Target Sites in Multiple Mouse Tissues	PLOS ONE			English	Article							PARALLEL DNA; SEQUENCES; IDENTIFICATION; MIRBASE; GENOME; ERROR; TOOLS	RNA editing is a process that modifies RNA nucleotides and changes the efficiency and fidelity of the central dogma. Enzymes that catalyze RNA editing are required for life, and defects in RNA editing are associated with many diseases. Recent advances in sequencing have enabled the genome-wide identification of RNA editing sites in mammalian transcriptomes. Here, we demonstrate that canonical RNA editing (A-to-I and C-to-U) occurs in liver, white adipose, and bone tissues of the laboratory mouse, and we show that apparent non-canonical editing (all other possible base substitutions) is an artifact of current high-throughput sequencing technology. Further, we report that high-confidence canonical RNA editing sites can cause non-synonymous amino acid changes and are significantly enriched in 3' UTRs, specifically at microRNA target sites, suggesting both regulatory and functional consequences for RNA editing.	[Gu, Tongjun; Buaas, Frank W.; Simons, Allen K.; Ackert-Bicknell, Cheryl L.; Braun, Robert E.; Hibbs, Matthew A.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Gu, TJ (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Bob.Braun@jax.org; Matt.Hibbs@jax.org	Gu, Tongjun/C-4181-2013; Ackert-Bicknell, Cheryl/AAC-6833-2019; Gu, Tongjun/AAE-4801-2020	Ackert-Bicknell, Cheryl/0000-0003-4253-4775; 	Jackson Laboratory; National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R21AR069981]; NIH/National Institute of General Medical Sciences (NIGMS) [P50GM076468]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER	Jackson Laboratory; National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by The Jackson Laboratory, National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) award R21AR069981 (MAH, CLAB), NIH/National Institute of General Medical Sciences (NIGMS) award P50GM076468 (Churchill). MAH is an Ellison Medical Foundation New Scholar in Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213, DOI 10.4161/rna.7.2.11343; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dominissini D, 2011, CARCINOGENESIS, V32, P1569, DOI 10.1093/carcin/bgr124; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hamilton CE, 2010, RNA BIOL, V7, P220, DOI 10.4161/rna.7.2.11344; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Hutchins LN, 2010, DATABASE, P8; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Liang H, 2007, RNA, V13, P463, DOI 10.1261/rna.296407; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Shendure J, 2002, GENOME BIOL, V3; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340	28	55	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33720	10.1371/journal.pone.0033720	http://dx.doi.org/10.1371/journal.pone.0033720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448268	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700059
J	Judy, BM; Taylor, K; Deeraksa, A; Johnston, RK; Endsley, JJ; Vijayakumar, S; Aronson, JF; Estes, DM; Torres, AG				Judy, Barbara M.; Taylor, Katherine; Deeraksa, Arpaporn; Johnston, R. Katie; Endsley, Janice J.; Vijayakumar, Sudhamathi; Aronson, Judith F.; Estes, D. Mark; Torres, Alfredo G.			Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; BURKHOLDERIA-PSEUDOMALLEI; MURINE MODEL; INTERFERON-GAMMA; BACTERIAL-DNA; IN-VIVO; INFECTION; MICE; RESISTANCE; CYTOKINES	Prophylactic administration of CpG oligodeoxynucleotides (CpG ODNs) is known to confer protection against lethal sepsis caused by Burkholderia pseudomallei in the mouse model. The mechanisms whereby CpG regulates the innate immune response to provide protection against B. pseudomallei, however, are poorly characterized. In the present study, we demonstrate that intranasal treatment of mice with Class C CpG, results in recruitment of inflammatory monocytes and neutrophils to the lung at 48 h post-treatment. Mice infected with B. pseudomallei 48 h post-CpG treatment had reduced organ bacterial load and significantly altered cytokine and chemokine profiles concomitant with protection as compared to control animals. CpG administration reduced the robust production of chemokines and pro-inflammatory cytokines in blood, lung and spleen, observed following infection of non-treated animals. Death of control animals coincided with the time of peak cytokine production (day 1-3), while a moderate; sustained cytokine production in CpG-treated animals was associated with survival. In general, CpG treatment resulted in diminished expression of cytokines and chemokines post-infection, though IL-12p40 was released in larger quantities in CpG treated animals. In contrast to CpG-treated animals, the lungs of infected control animals were infiltrated with leukocytes, especially neutrophils, and large numbers of necrotic lesions were observed in lung sections. Therapeutic treatment of B. pseudomallei-infected animals with CpG at 24 h post-infection did not impact survival compared to control animals. In summary, protection of CpG-treated animals was associated with recruitment of inflammatory monocytes and neutrophils into the lungs prior to infection. These responses correspond with early control of bacterial growth, a dampened inflammatory cytokine/chemokine response, reduced lung pathology, and greatly increased survival. In contrast, a delay in recruitment of inflammatory cell populations, despite a robust production of pro-inflammatory cytokines, was associated with poorly controlled bacterial growth, severe lung pathology, and death of control animals.	[Judy, Barbara M.; Taylor, Katherine; Deeraksa, Arpaporn; Aronson, Judith F.; Torres, Alfredo G.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Johnston, R. Katie; Endsley, Janice J.; Vijayakumar, Sudhamathi; Torres, Alfredo G.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Endsley, Janice J.; Torres, Alfredo G.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA; [Estes, D. Mark] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University System of Georgia; University of Georgia	Judy, BM (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.	altorres@utmb.edu		Torres, Alfredo/0000-0001-6450-0643	Western Regional Center for Excellence [U54 AI057156]; NIAID/NIH [5U01AI082103-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, U01AI082103] Funding Source: NIH RePORTER	Western Regional Center for Excellence; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant number U54 AI057156 from the Western Regional Center for Excellence supported this project along with grant number 5U01AI082103-02 from the NIAID/NIH. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the RCE Programs Office, NIAID, or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya K, 2009, VACCINE, V27, P2220, DOI 10.1016/j.vaccine.2009.02.016; Binford CH, 1976, PATHOLOGY TROPICAL E; BROWN AE, 1991, J INFECT DIS, V163, P1145, DOI 10.1093/infdis/163.5.1145; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Easton A, 2011, J INFECT DIS, V204, P636, DOI 10.1093/infdis/jir301; Elkins KL, 1999, J IMMUNOL, V162, P2291; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Goodyear A, 2012, INFECT IMMUN, V80, P110, DOI 10.1128/IAI.05819-11; Hogg AE, 2009, J LEUKOCYTE BIOL, V86, P1191, DOI 10.1189/jlb.0409222; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2003, SCAND J INFECT DIS, V35, P653, DOI 10.1080/00365540310015999; Krieg AM, 2001, CURR OPIN MOL THER, V3, P15; Krieg AM, 1998, J IMMUNOL, V161, P2428; Krieg AM, 2000, VACCINE, V19, P618, DOI 10.1016/S0264-410X(00)00249-8; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lauw FN, 1999, J INFECT DIS, V180, P1878, DOI 10.1086/315155; Leakey AK, 1998, MICROB PATHOGENESIS, V24, P269, DOI 10.1006/mpat.1997.0179; Liu BP, 2002, INFECT IMMUN, V70, P504, DOI 10.1128/IAI.70.2.504-511.2002; Mondal S, 2009, J IMMUNOL, V182, P5013, DOI 10.4049/jimmunol.0801734; Netea MG, 2003, TRENDS IMMUNOL, V24, P254, DOI 10.1016/S1471-4906(03)00079-6; Rozak David A, 2010, J Immune Based Ther Vaccines, V8, P2, DOI 10.1186/1476-8518-8-2; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Santanirand P, 1997, BIOCHEM SOC T, V25, pS287, DOI 10.1042/bst025287s; Takenaka H, 1997, J LEUKOCYTE BIOL, V61, P80, DOI 10.1002/jlb.61.1.80; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Utaisincharoen P, 2003, CLIN EXP IMMUNOL, V132, P70, DOI 10.1046/j.1365-2249.2003.02107.x; Utaisincharoen P, 2002, CLIN EXP IMMUNOL, V128, P467, DOI 10.1046/j.1365-2249.2002.01866.x; Verthelyi D, 2003, J IMMUNOL, V170, P4717, DOI 10.4049/jimmunol.170.9.4717; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Vollmer J, 2005, EXPERT OPIN BIOL TH, V5, P673, DOI 10.1517/14712598.5.5.673; Waag DM, 2006, INFECT IMMUN, V74, P1944, DOI 10.1128/IAI.74.3.1944-1948.2006; Wang J, 2009, CLIN EXP MED, V9, P37, DOI 10.1007/s10238-008-0017-x; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Whitlock GC, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-55; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x; Wongratanacheewin S, 2004, INFECT IMMUN, V72, P4494, DOI 10.1128/IAI.72.8.4494-4502.2004; Yamada H, 2004, CRIT CARE MED, V32, P2045, DOI 10.1097/01.CCM.0000142397.38134.EF	40	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e34176	10.1371/journal.pone.0034176	http://dx.doi.org/10.1371/journal.pone.0034176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448290	gold, Green Published, Green Submitted			2022-12-27	WOS:000303855700081
J	Piovesan, D; Pierobon, A; DiZio, P; Lackner, JR				Piovesan, Davide; Pierobon, Alberto; DiZio, Paul; Lackner, James R.			Measuring Multi-Joint Stiffness during Single Movements: Numerical Validation of a Novel Time-Frequency Approach	PLOS ONE			English	Article							END-POINT STIFFNESS; HUMAN ARM STIFFNESS; HILBERT TRANSFORM; IMPEDANCE CHARACTERISTICS; SYSTEM-IDENTIFICATION; VARYING STIFFNESS; LINEAR-SYSTEMS; LIMB STIFFNESS; HAND IMPEDANCE; ROBOT THERAPY	This study presents and validates a Time-Frequency technique for measuring 2-dimensional multijoint arm stiffness throughout a single planar movement as well as during static posture. It is proposed as an alternative to current regressive methods which require numerous repetitions to obtain average stiffness on a small segment of the hand trajectory. The method is based on the analysis of the reassigned spectrogram of the arm's response to impulsive perturbations and can estimate arm stiffness on a trial-by-trial basis. Analytic and empirical methods are first derived and tested through modal analysis on synthetic data. The technique's accuracy and robustness are assessed by modeling the estimation of stiffness time profiles changing at different rates and affected by different noise levels. Our method obtains results comparable with two well-known regressive techniques. We also test how the technique can identify the viscoelastic component of nonlinear and higher than second order systems with a non-parametrical approach. The technique proposed here is very impervious to noise and can be used easily for both postural and movement tasks. Estimations of stiffness profiles are possible with only one perturbation, making our method a useful tool for estimating limb stiffness during motor learning and adaptation tasks, and for understanding the modulation of stiffness in individuals with neurodegenerative diseases.	[Piovesan, Davide] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Piovesan, Davide] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Piovesan, Davide; Pierobon, Alberto; DiZio, Paul; Lackner, James R.] Brandeis Univ, Ashton Graybiel Spatial Orientat Lab, Waltham, MA USA; [DiZio, Paul; Lackner, James R.] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA USA	Shirley Ryan AbilityLab; Northwestern University; Brandeis University; Brandeis University	Piovesan, D (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	d-piovesan@northwestern.edu	Piovesan, Davide/M-8325-2017	Piovesan, Davide/0000-0002-9258-8985	NIH [2 R01AR048546-06, 5 R01 MH086053-02]; Robotics Lab at Northwestern University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086053] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robotics Lab at Northwestern University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was partially supported by NIH grants 2 R01AR048546-06 and 5 R01 MH086053-02 (www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Sandro Mussa-Ivaldi and the members of the Robotics Lab at Northwestern University for their support. We are grateful to Dr. Eric Perreault for his useful suggestions that enabled us to clarify several concepts in the paper.	ANGELES J, 1992, J SOUND VIB, V154, P556, DOI 10.1016/0022-460X(92)90787-X; AUGER F, 1995, IEEE T SIGNAL PROCES, V43, P1068, DOI 10.1109/78.382394; BEEK PJ, 1995, BIOL CYBERN, V73, P499, DOI 10.1007/BF00199542; BENNETT DJ, 1992, EXP BRAIN RES, V88, P433, DOI 10.1007/BF02259118; Boashash B., 2003, APPL TIME FREQUENCY; Bortolami SB, 2003, EXP BRAIN RES, V151, P387, DOI 10.1007/s00221-003-1481-x; Braun S, 1997, MECH SYST SIGNAL PR, V11, P611, DOI 10.1006/mssp.1997.0091; Burdet E, 2000, J BIOMECH, V33, P1705, DOI 10.1016/S0021-9290(00)00142-1; Casadio M, 2009, FUNCT NEUROL, V24, P195; Casadio M, 2009, CLIN REHABIL, V23, P217, DOI 10.1177/0269215508096759; Chandler RF., 1975, INVESTIGATION INERTI; Clauser CE, 1969, WEIGHT VOLUME CTR MA, P70; Cohen L, 2002, DIGIT SIGNAL PROCESS, V12, P429, DOI 10.1006/dspr.2002.0458; Darainy M, 2004, J NEUROPHYSIOL, V92, P3344, DOI 10.1152/jn.00596.2004; Darainy M, 2007, J NEUROPHYSIOL, V97, P2676, DOI 10.1152/jn.01081.2006; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; de Vlugt E, 2003, J NEUROSCI METH, V122, P123, DOI 10.1016/S0165-0270(02)00303-5; Dempster WT, 1955, WADC55 TECHN REP, P159; DOLAN JM, 1993, IEEE T SYST MAN CYB, V23, P698, DOI 10.1109/21.256543; Ewins D.J., 2000, MODAL TESTING THEORY; Feldman M, 2007, J SOUND VIB, V303, P357, DOI 10.1016/j.jsv.2007.01.028; Feldman M, 2011, MECH SYST SIGNAL PR, V25, P735, DOI 10.1016/j.ymssp.2010.07.018; FLASH T, 1990, EXP BRAIN RES, V82, P315; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin DW, 2003, EXP BRAIN RES, V152, P211, DOI 10.1007/s00221-003-1540-3; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Frolov AA, 2006, BIOL CYBERN, V94, P97, DOI 10.1007/s00422-005-0018-8; Frolov AA, 2000, BIOL CYBERN, V82, P499, DOI 10.1007/s004220050603; Fulop S. A., 2006, ACOUST TODAY, V2, P26; Fulop SA, 2006, J ACOUST SOC AM, V119, P360, DOI 10.1121/1.2133000; Galleani L, 2004, IEEE SIGNAL PROC LET, V11, P721, DOI 10.1109/LSP.2004.831669; Gohberg I, 2009, CLASS APPL MATH, V58, P1, DOI 10.1137/1.9780898719024; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; Hanavan Jr. E.P., 1964, MATH MODEL HUMAN BOD; Hof AL, 1998, J BIOMECH, V31, P793, DOI 10.1016/S0021-9290(98)00062-1; Huang NE, 2005, HILBET HUANG TRANSFO; Inman D., 1989, VIBRATION CONTROL ME; INMAN DJ, 1980, J APPL MECH-T ASME, V47, P927, DOI 10.1115/1.3153815; Kao I, 1997, IEEE T ROBOTIC AUTOM, V13, P557, DOI 10.1109/70.611319; Kirsch RF, 1997, EXP BRAIN RES, V114, P71, DOI 10.1007/PL00005625; Kistemaker DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019568; Kolesnikov M, 2011, IEEE ENG MED BIO, P4076, DOI 10.1109/IEMBS.2011.6091013; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; Lancaster P, 2005, J SOUND VIB, V283, P891, DOI 10.1016/j.jsv.2004.05.003; Lee GC, 1998, ENG STRUCT, V20, P503, DOI 10.1016/S0141-0296(97)00089-8; Ludvig D., 2011, IEEE T BIOMEDICAL EN; Ma F, 2009, J SOUND VIB, V324, P408, DOI 10.1016/j.jsv.2009.02.005; Mah CD, 2001, EXP BRAIN RES, V136, P492, DOI 10.1007/s002210000598; Mares T, 2008, B APPL MECH, V4, P37; McConville J. T., 1980, ANTHROPOMETRIC RELAT; MILNER TE, 1993, EXP BRAIN RES, V93, P177; Milner TE, 2005, J PHYSIOL-LONDON, V567, P651, DOI 10.1113/jphysiol.2005.090449; Mitrovic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013601; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Nelson DJ, 2001, J ACOUST SOC AM, V110, P2575, DOI 10.1121/1.1402616; Orrell D, 2005, INT J BIFURCAT CHAOS, V15, P3265, DOI 10.1142/S021812740501409X; PADOVAN J, 1988, J FRANKLIN I, V325, P247, DOI 10.1016/0016-0032(88)90086-5; Palazzolo JJ, 2007, IEEE T NEUR SYS REH, V15, P94, DOI 10.1109/TNSRE.2007.891392; Perreault EJ, 1999, BIOL CYBERN, V80, P327, DOI 10.1007/s004220050529; Perreault EJ, 2004, EXP BRAIN RES, V157, P507, DOI 10.1007/s00221-004-1864-7; Perreault EJ, 2001, EXP BRAIN RES, V141, P312, DOI 10.1007/s002210100880; Piovesan D., 2011, P IEEE INT C REH ROB, P1; Piovesan D, 2011, IEEE ENG MED BIO, P8239, DOI 10.1109/IEMBS.2011.6092031; Piovesan D, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003308; Piovesan D, 2009, IEEE ENG MED BIO, P1282, DOI 10.1109/IEMBS.2009.5333242; Popescu F, 2003, EXP BRAIN RES, V152, P17, DOI 10.1007/s00221-003-1507-4; Popescu FC, 2000, J NEUROPHYSIOL, V84, P2670, DOI 10.1152/jn.2000.84.5.2670; Press W. H., 1992, ART SCI COMPUTING; Ravichandran VJ, 2004, P ANN INT IEEE EMBS, V26, P4706; Schouten AC, 2001, BIOL CYBERN, V84, P143, DOI 10.1007/s004220000202; SCHULTZ AB, 1991, J APPL PHYSIOL, V70, P803, DOI 10.1152/jappl.1991.70.2.803; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shi ZY, 2007, J APPL MECH-T ASME, V74, P223, DOI 10.1115/1.2188538; Shi ZY, 2009, J SOUND VIB, V321, P572, DOI 10.1016/j.jsv.2008.10.005; Silva P, 2007, NEUROSCI LETT, V429, P64, DOI 10.1016/j.neulet.2007.09.066; STAREK L, 1992, J VIB ACOUST, V114, P564, DOI 10.1115/1.2930299; STEIN RB, 1995, J NEUROPHYSIOL, V73, P65, DOI 10.1152/jn.1995.73.1.65; Stroeve S, 1999, BIOL CYBERN, V81, P475, DOI 10.1007/s004220050577; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Tee KP, 2004, BIOL CYBERN, V90, P368, DOI 10.1007/s00422-004-0484-4; TomasRodriguez M, 2010, LECT NOTES CONTR INF, V400, P1; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; Westwick DT, 2011, IEEE T BIO-MED ENG, V58, P521, DOI 10.1109/TBME.2010.2096424; Wong J, 2009, J NEUROPHYSIOL, V101, P1542, DOI 10.1152/jn.91188.2008; Wong J, 2009, J NEUROPHYSIOL, V101, P246, DOI 10.1152/jn.90371.2008; Xu YM, 1999, IEEE T BIO-MED ENG, V46, P409, DOI 10.1109/10.752938; Zatsiorsky V., 1983, BIOMECHANICS 8 B, V56, P1152; Zatsiorsky VM, 2002, KINETICS HUMAN MOTIO, P600	91	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33086	10.1371/journal.pone.0033086	http://dx.doi.org/10.1371/journal.pone.0033086			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448233	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700023
J	Guasch-Ferre, M; Bullo, M; Costa, B; Martinez-Gonzalez, MA; Ibarrola-Jurado, N; Estruch, R; Barrio, F; Salas-Salvado, J				Guasch-Ferre, Marta; Bullo, Monica; Costa, Bernardo; Angel Martinez-Gonzalez, Miguel; Ibarrola-Jurado, Nuria; Estruch, Ramon; Barrio, Francisco; Salas-Salvado, Jordi		PREDI-PLAN Investigators	A Risk Score to Predict Type 2 Diabetes Mellitus in an Elderly Spanish Mediterranean Population at High Cardiovascular Risk	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; IDENTIFYING INDIVIDUALS; PHYSICAL-ACTIVITY; PREVENTION; QUESTIONNAIRE; TOOLS	Introduction: To develop and test a diabetes risk score to predict incident diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. Materials and Methods: A diabetes risk score was derived from a subset of 1381 nondiabetic individuals from three centres of the PREDIMED study (derivation sample). Multivariate Cox regression model beta-coefficients were used to weigh each risk factor. PREDIMED-personal Score included body-mass-index, smoking status, family history of type 2 diabetes, alcohol consumption and hypertension as categorical variables; PREDIMED-clinical Score included also high blood glucose. We tested the predictive capability of these scores in the DE-PLAN-CAT cohort (validation sample). The discrimination of Finnish Diabetes Risk Score (FINDRISC), German Diabetes Risk Score (GDRS) and our scores was assessed with the area under curve (AUC). Results: The PREDIMED-clinical Score varied from 0 to 14 points. In the subset of the PREDIMED study, 155 individuals developed diabetes during the 4.75-years follow-up. The PREDIMED-clinical score at a cutoff of >= 6 had sensitivity of 72.2%, and specificity of 72.5%, whereas AUC was 0.78. The AUC of the PREDIMED-clinical Score was 0.66 in the validation sample (sensitivity = 85.4%; specificity = 26.6%), and was significantly higher than the FINDRISC and the GDRS in both the derivation and validation samples. Discussion: We identified classical risk factors for diabetes and developed the PREDIMED-clinical Score to determine those individuals at high risk of developing diabetes in elderly individuals at high cardiovascular risk. The predictive capability of the PREDIMED-clinical Score was significantly higher than the FINDRISC and GDRS, and also used fewer items in the questionnaire.	[Guasch-Ferre, Marta; Bullo, Monica; Ibarrola-Jurado, Nuria; Salas-Salvado, Jordi] Univ Rovira & Virgili, Fac Med & Hlth Sci, Human Nutr Unit, IISPV, E-43201 Reus, Spain; [Guasch-Ferre, Marta; Bullo, Monica; Ibarrola-Jurado, Nuria; Estruch, Ramon; Salas-Salvado, Jordi] Inst Hlth Carlos III, CIBERobn Physiopathol Obes & Nutr, Madrid, Spain; [Angel Martinez-Gonzalez, Miguel] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Costa, Bernardo; Barrio, Francisco] Jordi Gol Primary Care Res Inst, Catalan Hlth Inst, Catalunya, Spain; [Estruch, Ramon] Univ Barcelona, Hosp Clin, Dept Internal Med, Barcelona, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra; University of Barcelona; Hospital Clinic de Barcelona	Guasch-Ferre, M (corresponding author), Univ Rovira & Virgili, Fac Med & Hlth Sci, Human Nutr Unit, IISPV, C St Llorenc 21, E-43201 Reus, Spain.	jordi.salas@urv.cat	Estruch, Ramon/AAZ-3723-2020; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Bulló, Mònica/F-2925-2016; Salas-Salvado, Jordi/C-7229-2017; Babio, Nancy/AAN-2715-2020; Guasch-Ferre, Marta/H-6680-2019; Casas, Rosa/ABD-1915-2020; Toledo, Estefania/H-6211-2014	Bulló, Mònica/0000-0002-0218-7046; Salas-Salvado, Jordi/0000-0003-2700-7459; Babio, Nancy/0000-0003-3527-5277; Guasch-Ferre, Marta/0000-0001-8525-1404; Casas, Rosa/0000-0002-0211-9166; Basora, Josep/0000-0003-0278-1149; COS CLARAMUNT, FRANCESC XAVIER/0000-0003-3943-479X; Costa, Bernardo/0000-0003-1985-8376; Barrio Torrell, Francisco Jose/0000-0001-8516-4108; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Cabre Vila, Juan Jose/0000-0003-1082-6861; Toledo, Estefania/0000-0002-6263-4434	Spanish Ministry of Health (ISCIII) [PI1001407]; Thematic Network [G03/140, RD06/0045]; FEDER (Fondo Europeo de Desarrollo Regional); Public Health Division of the Department of Health of the Autonomous Government of Catalonia; Public Health Division of the Department of Health of the Autonomous Government of Caixa Tarragona [10-1343]	Spanish Ministry of Health (ISCIII)(Instituto de Salud Carlos IIISpanish Government); Thematic Network; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Public Health Division of the Department of Health of the Autonomous Government of Catalonia; Public Health Division of the Department of Health of the Autonomous Government of Caixa Tarragona	This study was funded by the Spanish Ministry of Health (ISCIII), PI1001407, Thematic Network G03/140, RD06/0045, FEDER (Fondo Europeo de Desarrollo Regional), and the Public Health Division of the Department of Health of the Autonomous Government of Catalonia and Caixa Tarragona (10-1343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2011, DIABETES CARE, V34, P2108, DOI 10.2337/dc10-2201; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alssema M, 2008, Ned Tijdschr Geneeskd, V152, P2418; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Costa B, 2012, DIABETOLOGIA, P1; Costa B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-623; Edelstein SL, 2005, DIABETES CARE, V28, P138, DOI 10.2337/diacare.28.1.138; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Home P, 2006, DIABETIC MED, V23, P579; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Martinez-Gonzalez MA, 2010, INT J EPIDEMIOL; Narayan KMV, 2000, DIABETES RES CLIN PR, V50, pS77; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Saydah SH, 2002, DIABETES CARE, V25, P1940, DOI 10.2337/diacare.25.11.1940; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Schwarz PEH, 2008, EXP CLIN ENDOCR DIAB, V116, P167, DOI 10.1055/s-2007-992115; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	29	25	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33437	10.1371/journal.pone.0033437	http://dx.doi.org/10.1371/journal.pone.0033437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442692	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500033
J	Schroder, R; Xue, LZ; Konya, V; Martini, L; Kampitsch, N; Whistler, JL; Ulven, T; Heinemann, A; Pettipher, R; Kostenis, E				Schroeder, Ralf; Xue, Luzheng; Konya, Viktoria; Martini, Lene; Kampitsch, Nora; Whistler, Jennifer L.; Ulven, Trond; Heinemann, Akos; Pettipher, Roy; Kostenis, Evi			PGH(1), the Precursor for the Anti-Inflammatory Prostaglandins of the 1-series, Is a Potent Activator of the Pro-Inflammatory Receptor CRTH2/DP2	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; EOSINOPHILIC AIRWAY INFLAMMATION; D SYNTHASE; ENDOTHELIAL-CELLS; D-2 RECEPTOR; CHEMOATTRACTANT RECEPTOR; ALLERGIC INFLAMMATION; SELECTIVE INHIBITOR; EICOSANOID BIOLOGY; CUTTING EDGE	Prostaglandin H-1 (PGH(1)) is the cyclo-oxygenase metabolite of dihomo-gamma-linolenic acid (DGLA) and the precursor for the 1-series of prostaglandins which are often viewed as "anti-inflammatory''. Herein we present evidence that PGH(1) is a potent activator of the pro-inflammatory PGD(2) receptor CRTH2, an attractive therapeutic target to treat allergic diseases such as asthma and atopic dermatitis. Non-invasive, real time dynamic mass redistribution analysis of living human CRTH2 transfectants and Ca2+ flux studies reveal that PGH(1) activates CRTH2 as PGH(2), PGD(2) or PGD(1) do. The PGH(1) precursor DGLA and the other PGH(1) metabolites did not display such effect. PGH(1) specifically internalizes CRTH2 in stable CRTH2 transfectants as assessed by antibody feeding assays. Physiological relevance of CRTH2 ligation by PGH(1) is demonstrated in several primary human hematopoietic lineages, which endogenously express CRTH2: PGH(1) mediates migration of and Ca2+ flux in Th2 lymphocytes, shape change of eosinophils, and their adhesion to human pulmonary microvascular endothelial cells under physiological flow conditions. All these effects are abrogated in the presence of the CRTH2 specific antagonist TM30089. Together, our results identify PGH(1) as an important lipid intermediate and novel CRTH2 agonist which may trigger CRTH2 activation in vivo in the absence of functional prostaglandin D synthase.	[Schroeder, Ralf; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany; [Xue, Luzheng] Univ Oxford, Biomed Res Ctr, NDM Expt Med, Oxford, England; [Konya, Viktoria; Kampitsch, Nora; Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Martini, Lene; Whistler, Jennifer L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Ulven, Trond] Univ So Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [Pettipher, Roy] Oxagen Ltd, Abingdon, Oxon, England	University of Bonn; University of Oxford; Medical University of Graz; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of Southern Denmark; Oxagen Limited	Schroder, R (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany.	kostenis@uni-bonn.de	Ulven, Trond/H-5500-2015	Ulven, Trond/0000-0002-8135-1755; Konya, Viktoria/0000-0002-7999-9093; Heinemann, Akos/0000-0002-8554-2372	AstraZeneca; Austrian Science Fund (FWF) [P 22521] Funding Source: researchfish	AstraZeneca(AstraZeneca); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Akos Heinemann has received research funding from AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aritake K, 2006, J BIOL CHEM, V281, P15277, DOI 10.1074/jbc.M506431200; BELL JG, 1994, BBA-LIPID LIPID MET, V1211, P335, DOI 10.1016/0005-2760(94)90158-9; Bohm E, 2004, J BIOL CHEM, V279, P7663, DOI 10.1074/jbc.M310270200; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Camacho M, 1998, CIRC RES, V83, P353, DOI 10.1161/01.RES.83.4.353; Chilton FH, 2008, AM J CLIN NUTR, V87, p498S, DOI 10.1093/ajcn/87.2.498S; Clarke G, 2010, J LIPID RES, V51, P1186, DOI 10.1194/jlr.P000695; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; de Gaetano G, 2003, TRENDS PHARMACOL SCI, V24, P245, DOI 10.1016/S0165-6147(03)00077-4; Demyanets S, 2011, ARTERIOSCL THROM VAS, V31, P2080, DOI 10.1161/ATVBAHA.111.231431; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; Flower RJ, 2003, NAT REV DRUG DISCOV, V2, P179, DOI 10.1038/nrd1034; Fraile-Ramos A, 2003, TRAFFIC, V4, P243, DOI 10.1034/j.1600-0854.2003.00079.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gazi L, 2005, PROSTAG OTH LIPID M, V75, P153, DOI 10.1016/j.prostaglandins.2004.11.003; Gervais FG, 2001, J ALLERGY CLIN IMMUN, V108, P982, DOI 10.1067/mai.2001.119919; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3824, DOI 10.1073/pnas.71.10.3824; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hein L, 1997, MOL ENDOCRINOL, V11, P1266, DOI 10.1210/me.11.9.1266; Heinemann A, 2003, J IMMUNOL, V170, P4752, DOI 10.4049/jimmunol.170.9.4752; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Hirai H, 2002, J IMMUNOL, V168, P981, DOI 10.4049/jimmunol.168.3.981; Hohwy M, 2008, J MED CHEM, V51, P2178, DOI 10.1021/jm701509k; Inoue T, 2004, J BIOCHEM, V135, P279, DOI 10.1093/jb/mvh033; Irikura D, 2009, J BIOL CHEM, V284, P7623, DOI 10.1074/jbc.M808593200; Kakutani S, 2010, PROSTAG LEUKOTR ESS, V83, P23, DOI 10.1016/j.plefa.2010.02.032; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Kim HY, 2008, J MICROBIOL BIOTECHN, V18, P1170; Kompauer I, 2008, EUR J EPIDEMIOL, V23, P175, DOI 10.1007/s10654-007-9218-y; Konya V, 2011, EUR J IMMUNOL, V41, P2379, DOI 10.1002/eji.201141460; Konya V, 2010, J ALLERGY CLIN IMMUN, V125, P1105, DOI 10.1016/j.jaci.2009.12.002; Kostenis E, 2005, J PHARMACOL EXP THER, V313, P78, DOI 10.1124/jpet.104.080424; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; KUNKEL SL, 1979, J CLIN INVEST, V64, P1525, DOI 10.1172/JCI109611; Levin G, 2002, BIOCHEM J, V365, P489, DOI 10.1042/BJ20011798; Lukacs NW, 2008, AM J PHYSIOL-LUNG C, V295, pL767, DOI 10.1152/ajplung.90351.2008; Ly TW, 2005, EXPERT OPIN INV DRUG, V14, P769, DOI 10.1517/13543784.14.7.769; Mandal AK, 2005, J IMMUNOL, V175, P6271, DOI 10.4049/jimmunol.175.10.6271; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Monneret G, 2002, J IMMUNOL, V168, P3563, DOI 10.4049/jimmunol.168.7.3563; Monneret G, 2001, BLOOD, V98, P1942, DOI 10.1182/blood.V98.6.1942; Murota H, 2008, RHEUMATOL INT, V28, P1127, DOI 10.1007/s00296-008-0589-5; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; Nomiya R, 2008, J IMMUNOL, V180, P5680, DOI 10.4049/jimmunol.180.8.5680; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Powell WS, 2003, PROSTAG LEUKOTR ESS, V69, P179, DOI 10.1016/S0952-3278(03)00079-6; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sabroe I, 1999, J IMMUNOL, V162, P2946; Saito M, 2003, EUR J PHARMACOL, V467, P151, DOI 10.1016/S0014-2999(03)01569-3; SALVATORI R, 1992, ENDOCRINOLOGY, V131, P21, DOI 10.1210/en.131.1.21; Sandig H, 2006, FEBS LETT, V580, P373, DOI 10.1016/j.febslet.2005.11.052; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Schroder R, 2009, J BIOL CHEM, V284, P1324, DOI 10.1074/jbc.M806867200; Schuligoi R, 2009, J LEUKOCYTE BIOL, V85, P136, DOI 10.1189/jlb.0608387; Shichijo M, 2009, CLIN EXP ALLERGY, V39, P1404, DOI 10.1111/j.1365-2222.2009.03275.x; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shiraishi Y, 2005, J PHARMACOL EXP THER, V312, P954, DOI 10.1124/jpet.104.078212; Shiraishi Y, 2008, J IMMUNOL, V180, P541, DOI 10.4049/jimmunol.180.1.541; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Soler M, 2000, CIRC RES, V87, P504; Soler M, 2001, KIDNEY INT, V59, P1283, DOI 10.1046/j.1523-1755.2001.0590041283.x; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stebbins KJ, 2010, J PHARMACOL EXP THER, V332, P764, DOI 10.1124/jpet.109.161919; Sturm EM, 2008, J IMMUNOL, V181, P7273, DOI 10.4049/jimmunol.181.10.7273; Sturm GJ, 2005, J ALLERGY CLIN IMMUN, V116, P1014, DOI 10.1016/j.jaci.2005.08.001; SVENSSON J, 1975, ACTA PHYSIOL SCAND, V94, P222, DOI 10.1111/j.1748-1716.1975.tb05881.x; Uller L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-16; Ulven T, 2005, J MED CHEM, V48, P897, DOI 10.1021/jm049036i; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Whistler JL, 2002, TRAFFIC, V3, P866, DOI 10.1034/j.1600-0854.2002.31203.x; Woods RK, 2004, THORAX, V59, P105, DOI 10.1136/thorax.2003.009498; Xue LZ, 2005, J IMMUNOL, V175, P6531, DOI 10.4049/jimmunol.175.10.6531; ZURIER RB, 1982, ARTHRITIS RHEUM, V25, P804, DOI 10.1002/art.1780250718; ZURIER RB, 1971, NATURE, V234, P304, DOI 10.1038/234304a0	80	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33329	10.1371/journal.pone.0033329	http://dx.doi.org/10.1371/journal.pone.0033329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442685	Green Submitted, Green Published, gold			2022-12-27	WOS:000303836500026
J	Hu, C; Wang, QD; Short, LA; Fu, GY				Hu, Chao; Wang, Qiandong; Short, Lindsey A.; Fu, Genyue			Speech Spectrum's Correlation with Speakers' Eysenck Personality Traits	PLOS ONE			English	Article							VOICE; EMOTION; COMMUNICATION; EXPRESSION	The current study explored the correlation between speakers' Eysenck personality traits and speech spectrum parameters. Forty-six subjects completed the Eysenck Personality Questionnaire. They were instructed to verbally answer the questions shown on a computer screen and their responses were recorded by the computer. Spectrum parameters of /sh/ and /i/ were analyzed by Praat voice software. Formant frequencies of the consonant /sh/ in lying responses were significantly lower than that in truthful responses, whereas no difference existed on the vowel /i/ speech spectrum. The second formant bandwidth of the consonant /sh/ speech spectrum was significantly correlated with the personality traits of Psychoticism, Extraversion, and Neuroticism, and the correlation differed between truthful and lying responses, whereas the first formant frequency of the vowel /i/ speech spectrum was negatively correlated with Neuroticism in both response types. The results suggest that personality characteristics may be conveyed through the human voice, although the extent to which these effects are due to physiological differences in the organs associated with speech or to a general Pygmalion effect is yet unknown.	[Hu, Chao; Wang, Qiandong; Fu, Genyue] Zhejiang Normal Univ, Dept Psychol, Jinhua, Zhejiang, Peoples R China; [Short, Lindsey A.] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada; [Fu, Genyue] Zhejiang Normal Univ, Hangzhou Coll Kindergarten Teachers, Hangzhou, Zhejiang, Peoples R China	Zhejiang Normal University; Brock University; Zhejiang Normal University	Hu, C (corresponding author), Zhejiang Normal Univ, Dept Psychol, Jinhua, Zhejiang, Peoples R China.	fugy@zjnu.cn	Hu, Chao S./I-2666-2019	Hu, Chao S./0000-0003-3315-9651	National Natural Science Foundation of China [31070894]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Natural Science Foundation of China, No. 31070894 (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bele IV, 2006, J VOICE, V20, P555, DOI 10.1016/j.jvoice.2005.07.001; BERRY DS, 1989, PERS SOC PSYCHOL B, V15, P266, DOI 10.1177/0146167289152013; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Cichero JAY, 1998, DYSPHAGIA, V13, P39, DOI 10.1007/PL00009548; Darwin C., 2002, EXPRESSION EMOTIONS; DeGroot T, 2007, INT J SELECT ASSESS, V15, P30, DOI 10.1111/j.1468-2389.2007.00365.x; DeGroot T, 2009, J BUS PSYCHOL, V24, P179, DOI 10.1007/s10869-009-9098-0; Dmitrieva ES, 2008, INT J PSYCHOPHYSIOL, V69, P284, DOI 10.1016/j.ijpsycho.2008.05.252; Ekman P., 1976, SEMIOTICA, V16, P23, DOI [10.1515/semi.1976.16.1.23, DOI 10.1515/SEMI.1976.16.1.23]; Fant G., 1972, SPEECH TRANSM LAB Q, V13, P28; Gocsal A, 2009, POLLACK PERIODICA, V4, P155, DOI DOI 10.1556/P0LLACKA.2009.3.14; Goudbeek M, 2009, 10 ANN C INT SPEECH; Hanson HM, 2001, J PHONETICS, V29, P451, DOI 10.1006/jpho.2001.0146; [胡超 HU Chao], 2011, [心理科学进展, Advances in Psychological Science], V19, P809; JOHNSON WF, 1986, ARCH GEN PSYCHIAT, V43, P280; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kuwabara H., 1987, Electronics and Communications in Japan, Part 1 (Communications), V70, P11, DOI 10.1002/ecja.4410700902; Ladefoged P., 2005, VOWELS CONSONANTS IN; MARKEL NN, 1972, J PSYCHOLINGUIST RES, V1, P249, DOI 10.1007/BF01074441; Mingyi Q., 2000, ACTA PSYCHOL SIN, V32, P317, DOI DOI 10.1007/S11769-000-0010-0; Mohammadi G., 2010, P 2 INT WORKSH SOC S; Nesic M, 1998, INT J PSYCHOPHYSIOL, V30, P155, DOI 10.1016/S0167-8760(98)90400-7; Penton-Voak IS, 2006, SOC COGNITION, V24, P607, DOI 10.1521/soco.2006.24.5.607; Revelle W., 2009, OXFORD COMPANION EMO, P21; RUBOVITS PC, 1973, J PERS SOC PSYCHOL, V25, P210, DOI 10.1037/h0034080; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; SCHERER KR, 1978, EUR J SOC PSYCHOL, V8, P467, DOI 10.1002/ejsp.2420080405; Simon-Thomas ER, 2009, EMOTION, V9, P838, DOI 10.1037/a0017810; Stagner R, 1936, J EDUC PSYCHOL, V27, P272, DOI 10.1037/h0057086	29	4	4	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33906	10.1371/journal.pone.0033906	http://dx.doi.org/10.1371/journal.pone.0033906			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	932RV	22439014	gold, Green Submitted, Green Published			2022-12-27	WOS:000303309100114
J	Pace, E; Ferraro, M; Minervini, MI; Vitulo, P; Pipitone, L; Chiappara, G; Siena, L; Montalbano, AM; Johnson, M; Gjomarkaj, M				Pace, Elisabetta; Ferraro, Maria; Minervini, Marta Ida; Vitulo, Patrizio; Pipitone, Loredana; Chiappara, Giuseppina; Siena, Liboria; Montalbano, Angela Marina; Johnson, Malcolm; Gjomarkaj, Mark			Beta Defensin-2 Is Reduced in Central but Not in Distal Airways of Smoker COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; TOLL-LIKE RECEPTOR-4; EPITHELIAL-CELLS; HOST-DEFENSE; BETA-DEFENSIN-2; EXPRESSION; INNATE; INFLAMMATION; TOLL-LIKE-RECEPTOR-2; LIPOPOLYSACCHARIDE	Background: Altered pulmonary defenses in chronic obstructive pulmonary disease (COPD) may promote distal airways bacterial colonization. The expression/activation of Toll Like receptors (TLR) and beta 2 defensin (HBD2) release by epithelial cells crucially affect pulmonary defence mechanisms. Methods: The epithelial expression of TLR4 and of HBD2 was assessed in surgical specimens from current smokers COPD (s-COPD; n = 17), ex-smokers COPD (ex-s-COPD; n = 8), smokers without COPD (S; n = 12), and from non-smoker non-COPD subjects (C; n = 13). Results: In distal airways, s-COPD highly expressed TLR4 and HBD2. In central airways, S and s-COPD showed increased TLR4 expression. Lower HBD2 expression was observed in central airways of s-COPD when compared to S and to ex-s-COPD. s-COPD had a reduced HBD2 gene expression as demonstrated by real-time PCR on micro-dissected bronchial epithelial cells. Furthermore, HBD2 expression positively correlated with FEV1/FVC ratio and inversely correlated with the cigarette smoke exposure. In a bronchial epithelial cell line (16 HBE) IL-1 beta significantly induced the HBD2 mRNA expression and cigarette smoke extracts significantly counteracted this IL-1 mediated effect reducing both the activation of NFkB pathway and the interaction between NFkB and HBD2 promoter. Conclusions: This study provides new insights on the possible mechanisms involved in the alteration of innate immunity mechanisms in COPD.	[Pace, Elisabetta; Ferraro, Maria; Chiappara, Giuseppina; Siena, Liboria; Montalbano, Angela Marina; Gjomarkaj, Mark] CNR, Inst Biomed & Mol Immunol, Palermo, Italy; [Minervini, Marta Ida] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Vitulo, Patrizio; Pipitone, Loredana] ISMETT, Mediterranean Inst Transplantat & High Specialise, Palermo, Italy; [Johnson, Malcolm] GlaxoSmithKline Res & Dev Ltd, Uxbridge, Middx, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT); GlaxoSmithKline	Pace, E (corresponding author), CNR, Inst Biomed & Mol Immunol, Palermo, Italy.	pace@ibim.cnr.it	Pace, Elisabetta/AAL-2537-2020; Montalbano, Angela Marina/AAY-3905-2020; Ferraro, Maria/AAX-8156-2020; Vitulo, Patrizio/K-7500-2016	Pace, Elisabetta/0000-0003-1141-9010; Montalbano, Angela Marina/0000-0001-5950-4834; SIENA, LIBORIA/0000-0002-3182-9503; CHIAPPARA, GIUSEPPINA/0000-0002-7226-5660; Vitulo, Patrizio/0000-0003-1699-0208; FERRARO, MARIA/0000-0003-2533-7446	Italian National Research Council; GlaxoSmithKline [CDS014]	Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR)); GlaxoSmithKline(GlaxoSmithKline)	This work was supported by the Italian National Research Council and by a GlaxoSmithKline grant to MG for Center of Excellence in COPD (CDS014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Boodoo S, 2006, AM J PHYSIOL-LUNG C, V291, pL479, DOI 10.1152/ajplung.00518.2005; Bruno A, 2005, EUR RESPIR J, V26, P398, DOI 10.1183/09031936.05.00092404; Busacker A, 2009, CHEST, V135, P48, DOI 10.1378/chest.08-0049; Chiappara G, 2007, ALLERGY, V62, P787, DOI 10.1111/j.1398-9995.2007.01417.x; COSIO MG, 1980, AM REV RESPIR DIS, V122, P265; COZENS AL, 1992, IN VITRO CELL DEV-AN, V28A, P735; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-68; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Hamilton L M, 2001, Monaldi Arch Chest Dis, V56, P48; Herr C, 2009, THORAX, V64, P144, DOI 10.1136/thx.2008.102681; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Kanda N, 2008, ENDOCRINOLOGY, V149, P5189, DOI 10.1210/en.2008-0343; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kolble K, 2000, J MOL MED-JMM, V78, pB24; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; MacRedmond R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-116; Miotto D, 2002, THORAX, V57, P146, DOI 10.1136/thorax.57.2.146; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Pace E, 2008, J IMMUNOL, V181, P7292, DOI 10.4049/jimmunol.181.10.7292; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Pace E, 2006, EUR J CANCER, V42, P2382, DOI 10.1016/j.ejca.2006.03.022; Pace E, 2011, CELL IMMUNOL, V268, P47, DOI 10.1016/j.cellimm.2011.02.004; Pace E, 2011, HUM IMMUNOL, V72, P54, DOI 10.1016/j.humimm.2010.09.009; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; Pons J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-64; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Sullivan SD, 2000, CHEST, V117, P5; Zhang WY, 2011, RESPIROLOGY, V16, P508, DOI 10.1111/j.1440-1843.2010.01920.x; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	41	55	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33601	10.1371/journal.pone.0033601	http://dx.doi.org/10.1371/journal.pone.0033601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438960	Green Published, gold			2022-12-27	WOS:000303309100068
J	Tian, WP; Zhao, M; Li, M; Song, TB; Zhang, M; Quan, L; Li, SB; Sun, ZS				Tian, Weiping; Zhao, Mei; Li, Min; Song, Tianbao; Zhang, Min; Quan, Li; Li, Shengbin; Sun, Zhong Sheng			Reversal of Cocaine-Conditioned Place Preference through Methyl Supplementation in Mice: Altering Global DNA Methylation in the Prefrontal Cortex	PLOS ONE			English	Article							GENE-EXPRESSION; DRUG-ADDICTION; BEHAVIORAL SENSITIZATION; REWARD; BINDING; CHROMATIN; MORPHINE; MOUSE; RAT; HYPOMETHYLATION	Analysis of global methylation in cells has revealed correlations between overall DNA methylation status and some biological states. Recent studies suggest that epigenetic regulation through DNA methylation could be responsible for neuroadaptations induced by addictive drugs. However, there is no investigation to determine global DNA methylation status following repeated exposure to addictive drugs. Using mice conditioned place preference (CPP) procedure, we measured global DNA methylation level in the nucleus accumbens (NAc) and the prefrontal cortex (PFC) associated with drug rewarding effects. We found that cocaine-, but not morphine- or food-CPP training decreased global DNA methylation in the PFC. Chronic treatment with methionine, a methyl donor, for 25 consecutive days prior to and during CPP training inhibited the establishment of cocaine, but not morphine or food CPP. We also found that both mRNA and protein level of DNMT (DNA methytransferase) 3b in the PFC were downregulated following the establishment of cocaine CPP, and the downregulation could be reversed by repeated administration of methionine. Our study indicates a crucial role of global PFC DNA hypomethylation in the rewarding effects of cocaine. Reversal of global DNA hypomethylation could significantly attenuate the rewarding effects induced by cocaine. Our results suggest that methionine may have become a potential therapeutic target to treat cocaine addiction.	[Tian, Weiping; Song, Tianbao; Li, Shengbin] Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Xian 710049, Shanxi, Peoples R China; [Zhao, Mei] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Zhang, Min; Quan, Li] Capital Inst Pediat, Dept Mol Immunol, Beijing, Peoples R China; [Sun, Zhong Sheng] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China; [Li, Min; Sun, Zhong Sheng] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China	Xi'an Jiaotong University; Chinese Academy of Sciences; Institute of Psychology, CAS; Capital Institute of Pediatrics (CIP); Chinese Academy of Sciences; Wenzhou Medical University	Tian, WP (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Xian 710049, Shanxi, Peoples R China.	shbinlee@mail.xjtu.edu.cn; sunzs@psych.ac.cn	Sun, Zhongsheng/AAS-4883-2020	Sun, Zhongsheng/0000-0002-7640-5026	Natural Science Foundation of China [30870821, 81071078]; Institute of Psychology and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Psychology and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	This work was supported by Natural Science Foundation of China Grants (30870821 and 81071078), Youth Development Funding (O9KF015001) from the Institute of Psychology and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anier K, 2010, NEUROPSYCHOPHARMACOL, V35, P2450, DOI 10.1038/npp.2010.128; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Barik J, 2010, BIOL PSYCHIAT, V68, P231, DOI 10.1016/j.biopsych.2010.03.037; Barros M, 2011, ADDICT BIOL, V9, P1369; Black YD, 2006, J NEUROSCI, V26, P9656, DOI 10.1523/JNEUROSCI.2391-06.2006; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; Dunn BK, 2003, ANN NY ACAD SCI, V983, P28, DOI 10.1111/j.1749-6632.2003.tb05960.x; Feng JA, 2010, NAT NEUROSCI, V13, P1039, DOI 10.1038/nn0910-1039; Freeman WM, 2008, NEUROPSYCHOPHARMACOL, V33, P1807, DOI 10.1038/sj.npp.1301577; Gadd CA, 2003, J NEUROSCI, V23, P8271, DOI 10.1523/jneurosci.23-23-08271.2003; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; INAMDAR NM, 1991, PLANT MOL BIOL, V17, P111, DOI 10.1007/BF00036811; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levy D, 2007, J NEUROSCI, V27, P14179, DOI 10.1523/JNEUROSCI.4477-07.2007; Lin KY, 2011, BEHAV BRAIN RES, V220, P126, DOI 10.1016/j.bbr.2011.01.031; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; MUCHA RF, 1982, BRAIN RES, V243, P91, DOI 10.1016/0006-8993(82)91123-4; Muller U, 2002, ZOOLOGY, V105, P313, DOI 10.1078/0944-2006-00075; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nielsen DA, 2009, NEUROPSYCHOPHARMACOL, V34, P867, DOI 10.1038/npp.2008.108; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Pum ME, 2008, PSYCHOPHARMACOLOGY, V201, P391, DOI 10.1007/s00213-008-1296-3; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Romieu P, 2008, J NEUROSCI, V28, P9342, DOI 10.1523/JNEUROSCI.0379-08.2008; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tremolizzo L, 2002, P NATL ACAD SCI USA, V99, P17095, DOI 10.1073/pnas.262658999; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsytsykova AV, 2007, J BIOL CHEM, V282, P11629, DOI 10.1074/jbc.M611418200; Tzschentke TM, 1998, BEHAV BRAIN RES, V97, P115, DOI 10.1016/S0166-4328(98)00034-5; Tzschentke TM, 1999, EUR J NEUROSCI, V11, P4099, DOI 10.1046/j.1460-9568.1999.00834.x; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Ventura R, 2005, SYNAPSE, V58, P211, DOI 10.1002/syn.20197; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005	42	68	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33435	10.1371/journal.pone.0033435	http://dx.doi.org/10.1371/journal.pone.0033435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438930	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100045
J	Gong, ZH; Shi, YW; Zhu, Z; Li, X; Ye, Y; Zhang, JB; Li, AP; Li, G; Zhou, JW				Gong, Zhenghua; Shi, Yaowei; Zhu, Ze; Li, Xuan; Ye, Yang; Zhang, Jianbing; Li, Aiping; Li, Gang; Zhou, Jianwei			JWA Deficiency Suppresses Dimethylbenz[a]Anthracene-Phorbol Ester Induced Skin Papillomas via Inactivation of MAPK Pathway in Mice	PLOS ONE			English	Article							TRANS-RETINOIC ACID; TRANSCRIPTION FACTOR; TUMOR-DEVELOPMENT; KINASE PATHWAY; P38 MAPK; PROTEIN; CANCER; GENE; CELL; KERATINOCYTES	Our previous studies indicated that JWA plays an important role in DNA damage repair, cell migration, and regulation of MAPKs. In this study, we investigated the role of JWA in chemical carcinogenesis using conditional JWA knockout (JWA(Delta 2/Delta 2)) mice and two-stage model of skin carcinogenesis. Our results indicated that JWA(Delta 2/Delta 2) mice were resistant to the development of skin papillomas initiated by 7, 12-dimethylbenz(a) anthracene (DMBA) followed by promotion with 12-O-tetradecanoylphorbol-13-acetate (TPA). In JWA(Delta 2/Delta 2) mice, the induction of papilloma was delayed, and the tumor number and size were reduced. In primary keratinocytes from JWA(Delta 2/Delta 2) mice, DMBA exposure induced more intensive DNA damage, while TPA-promoted cell proliferation was reduced. The further mechanistic studies showed that JWA deficiency blocked TPA-induced activation of MAPKs and its downstream transcription factor Elk1 both in vitro and in vivo. JWA(Delta 2/Delta 2) mice are resistance to tumorigenesis induced by DMBA/TPA probably through inhibition of transcription factor Elk1 via MAPKs. These results highlight the importance of JWA in skin homeostasis and in the process of skin tumor development.	[Gong, Zhenghua; Shi, Yaowei; Zhu, Ze; Li, Xuan; Ye, Yang; Zhang, Jianbing; Li, Aiping; Zhou, Jianwei] Nanjing Med Univ, Minist Educ, Key Lab Modern Toxicol, Dept Mol Cell Biol & Toxicol, Nanjing, Peoples R China; [Gong, Zhenghua; Shi, Yaowei; Zhu, Ze; Li, Xuan; Ye, Yang; Zhang, Jianbing; Li, Aiping; Zhou, Jianwei] Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Peoples R China; [Gong, Zhenghua; Shi, Yaowei; Zhu, Ze; Li, Xuan; Ye, Yang; Zhang, Jianbing; Li, Aiping; Zhou, Jianwei] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Peoples R China; [Li, Gang] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; University of British Columbia; Vancouver Coastal Health Research Institute	Zhou, JW (corresponding author), Nanjing Med Univ, Minist Educ, Key Lab Modern Toxicol, Dept Mol Cell Biol & Toxicol, Nanjing, Peoples R China.	jwzhou@njmu.edu.cn		gong, zhenghua/0000-0002-4363-1043	National Natural Science Foundation of China [30930080]; Foundation of Cancer Center of Nanjing Medical University [08ZLKF08]; Jiangsu Provincial Graduates Innovative Project; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Cancer Center of Nanjing Medical University; Jiangsu Provincial Graduates Innovative Project; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This study was supported in part by the National Natural Science Foundation of China (No. 30930080), the Foundation of Cancer Center of Nanjing Medical University (No. 08ZLKF08), the Jiangsu Provincial Graduates Innovative Project (Z. Gong) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Atanasova GN, 2007, ONCOL REP, V18, P999; Bai J, 2010, ONCOGENE, V29, P1227, DOI 10.1038/onc.2009.408; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Bourcier C, 2006, CANCER RES, V66, P2700, DOI 10.1158/0008-5472.CAN-05-3129; Butchbach MER, 2002, GENE, V292, P81, DOI 10.1016/S0378-1119(02)00669-8; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; CARRANO AV, 1986, MUTAT RES, V162, P233, DOI 10.1016/0027-5107(86)90090-4; Cheepala SB, 2007, MOL CARCINOGEN, V46, P634, DOI 10.1002/mc.20346; Cheepala SB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-27; Chen HR, 2007, CELL SIGNAL, V19, P1315, DOI 10.1016/j.cellsig.2007.01.007; Chen R, 2007, FREE RADICAL BIO MED, V42, P1704, DOI 10.1016/j.freeradbiomed.2007.02.018; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dominguez I, 1998, MUTAT RES-FUND MOL M, V398, P67, DOI 10.1016/S0027-5107(97)00241-8; Ely HA, 2011, MOL ENDOCRINOL, V25, P669, DOI 10.1210/me.2010-0437; Fukuda K, 2001, HEPATOLOGY, V33, P159, DOI 10.1053/jhep.2001.20794; GREENHALGH DA, 1990, P NATL ACAD SCI USA, V87, P643, DOI 10.1073/pnas.87.2.643; Han L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-67; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao DX, 2011, MOL BIOL REP, V38, P1375, DOI 10.1007/s11033-010-0240-x; Hu Z, 2008, CANCER RES, V68, P5552, DOI 10.1158/0008-5472.CAN-07-5670; Johansen C, 2009, CARCINOGENESIS, V30, P2100, DOI 10.1093/carcin/bgp238; Kilanczyk E, 2009, BIOCHEM BIOPH RES CO, V380, P54, DOI 10.1016/j.bbrc.2009.01.026; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Murray AR, 2007, CARCINOGENESIS, V28, P1582, DOI 10.1093/carcin/bgm001; Pawelczyk T, 2003, EXP CELL RES, V286, P152, DOI 10.1016/S0014-4827(03)00090-9; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Scholl FA, 2009, CANCER RES, V69, P3772, DOI 10.1158/0008-5472.CAN-08-1963; Schweneker M, 2005, FEBS LETT, V579, P1751, DOI 10.1016/j.febslet.2005.02.037; Wang SY, 2009, NUCLEIC ACIDS RES, V37, P1936, DOI 10.1093/nar/gkp054; Wood CD, 2009, INT J BIOL SCI, V5, P428; Yacoub A, 2003, RADIAT RES, V159, P439, DOI 10.1667/0033-7587(2003)159[0439:EGFAIR]2.0.CO;2; Yung Y, 2001, J BIOL CHEM, V276, P35280, DOI 10.1074/jbc.M105995200; Zhou JW, 1999, INVESTIGATION CELL M, P110; Zhu T, 2005, J BIOMED SCI, V12, P219, DOI 10.1007/s11373-004-8186-4; Zhu T, 2006, J TOXICOL ENV HEAL A, V69, P1399, DOI 10.1080/15287390500360612; Zoumpourlis V, 2003, CARCINOGENESIS, V24, P1159, DOI 10.1093/carcin/bgg067	38	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34154	10.1371/journal.pone.0034154	http://dx.doi.org/10.1371/journal.pone.0034154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461904	Green Published, gold, Green Submitted			2022-12-27	WOS:000304118900022
J	Bohm, A; Ordelheide, AM; Machann, J; Heni, M; Ketterer, C; Machicao, F; Schick, F; Stefan, N; Fritsche, A; Haring, HU; Staiger, H				Boehm, Anja; Ordelheide, Anna-Maria; Machann, Juergen; Heni, Martin; Ketterer, Caroline; Machicao, Fausto; Schick, Fritz; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald			Common Genetic Variation in the SERPINF1 Locus Determines Overall Adiposity, Obesity-Related Insulin Resistance, and Circulating Leptin Levels	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; NEUROTROPHIC ACTIVITY; FAT; IDENTIFICATION; RECEPTOR; GLUCOSE; LIPASE; PEDF; MASS	Objective: Pigment epithelium-derived factor (PEDF) belongs to the serpin family of peptidase inhibitors (serpin F1) and is among the most abundant glycoproteins secreted by adipocytes. In vitro and mouse in vivo data revealed PEDF as a candidate mediator of obesity-induced insulin resistance. Therefore, we assessed whether common genetic variation within the SERPINF1 locus contributes to adipose tissue-related prediabetic phenotypes in humans. Subjects/Methods: A population of 1,974 White European individuals at increased risk for type 2 diabetes was characterized by an oral glucose tolerance test with glucose and insulin measurements (1,409 leptin measurements) and genotyped for five tagging SNPs covering 100% of common genetic variation (minor allele frequency >= 0.05) in the SERPINF1 locus. In addition, a subgroup of 486 subjects underwent a hyperinsulinaemic-euglycaemic clamp and a subgroup of 340 magnetic resonance imaging (MRI) and spectroscopy (MRS). Results: After adjustment for gender and age and Bonferroni correction for the number of SNPs tested, SNP rs12603825 revealed significant association with MRI-derived total adipose tissue mass (p = 0.0094) and fasting leptin concentrations (p = 0.0035) as well as nominal associations with bioelectrical impedance-derived percentage of body fat (p = 0.0182) and clamp-derived insulin sensitivity (p = 0.0251). The association with insulin sensitivity was completely abolished by additional adjustment for body fat (p = 0.8). Moreover, the fat mass-increasing allele of SNP rs12603825 was significantly associated with elevated fasting PEDF concentrations (p = 0.0436), and the PEDF levels were robustly and positively associated with all body fat parameters measured and with fasting leptin concentrations (p<0.0001, all). Conclusion: In humans at increased risk for type 2 diabetes, a functional common genetic variant in the gene locus encoding PEDF contributes to overall body adiposity, obesity-related insulin resistance, and circulating leptin levels.	[Boehm, Anja; Ordelheide, Anna-Maria; Heni, Martin; Ketterer, Caroline; Machicao, Fausto; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany; [Boehm, Anja] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Expt Genet, Grp Translat Diabetol, Munich, Germany; [Ordelheide, Anna-Maria; Machann, Juergen; Machicao, Fausto; Schick, Fritz; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, Tubingen, Germany; [Machann, Juergen; Schick, Fritz] Univ Tubingen, Sect Expt Radiol, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Fritsche, Andreas] Univ Tubingen, Dept Internal Med, Div Nutr & Prevent Med, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bohm, A (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014	Moller, Anja/0000-0002-5344-8533; Heni, Martin/0000-0002-8462-3832; Staiger, Harald/0000-0002-9507-5333; Schick, Fritz/0000-0002-4231-3406; Stefan, Norbert/0000-0002-2186-9595	German Federal Ministry of Education and Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was supported in part by a grant from the German Federal Ministry of Education and Research to the German Centre for Diabetes Research (DZD e.V.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Crowe S, 2009, CELL METAB, V10, P40, DOI 10.1016/j.cmet.2009.06.001; Famulla S, 2011, INT J OBESITY, V35, P762, DOI 10.1038/ijo.2010.212; Jenkins Alicia, 2008, Diabetes Res Clin Pract, V82, pe5, DOI 10.1016/j.diabres.2008.06.019; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nakamura K, 2010, INT J CARDIOL, V143, P96, DOI 10.1016/j.ijcard.2008.11.169; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Ogata N, 2007, J CLIN ENDOCR METAB, V92, P1176, DOI 10.1210/jc.2006-2249; Sabater M, 2010, J CLIN ENDOCR METAB, V95, P4720, DOI 10.1210/jc.2010-0630; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Thamer C, 2004, DIABETES CARE, V27, P2726, DOI 10.2337/diacare.27.11.2726; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Wang P, 2008, EUR J ENDOCRINOL, V159, P713, DOI 10.1530/EJE-08-0521; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Yang SM, 2011, J CLIN ENDOCR METAB, V96, P831, DOI 10.1210/jc.2010-2140	21	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34035	10.1371/journal.pone.0034035	http://dx.doi.org/10.1371/journal.pone.0034035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457810	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900041
J	Brolly, M; Woodhouse, IH; Niklas, KJ; Hammond, ST				Brolly, Matthew; Woodhouse, Iain H.; Niklas, Karl J.; Hammond, Sean T.			A Macroecological Analysis of SERA Derived Forest Heights and Implications for Forest Volume Remote Sensing	PLOS ONE			English	Article							PASS SAR INTERFEROMETRY; RADAR BACKSCATTER; CANOPY COVER; CARBON-CYCLE; BIOMASS; TREE; STAND; PLANTATION; PARAMETER; IMPACTS	Individual trees have been shown to exhibit strong relationships between DBH, height and volume. Often such studies are cited as justification for forest volume or standing biomass estimation through remote sensing. With resolution of common satellite remote sensing systems generally too low to resolve individuals, and a need for larger coverage, these systems rely on descriptive heights, which account for tree collections in forests. For remote sensing and allometric applications, this height is not entirely understood in terms of its location. Here, a forest growth model (SERA) analyzes forest canopy height relationships with forest wood volume. Maximum height, mean, H-100, and Lorey's height are examined for variability under plant number density, resource and species. Our findings, shown to be allometrically consistent with empirical measurements for forested communities world-wide, are analyzed for implications to forest remote sensing techniques such as LiDAR and RADAR. Traditional forestry measures of maximum height, and to a lesser extent H-100 and Lorey's, exhibit little consistent correlation with forest volume across modeled conditions. The implication is that using forest height to infer volume or biomass from remote sensing requires species and community behavioral information to infer accurate estimates using height alone. SERA predicts mean height to provide the most consistent relationship with volume of the height classifications studied and overall across forest variations. This prediction agrees with empirical data collected from conifer and angiosperm forests with plant densities ranging between 10(2)- 10(6) plants/hectare and heights 6-49 m. Height classifications investigated are potentially linked to radar scattering centers with implications for allometry. These findings may be used to advance forest biomass estimation accuracy through remote sensing. Furthermore, Lorey's height with its specific relationship to remote sensing physics is recommended as a more universal indicator of volume when using remote sensing than achieved using either maximum height or H-100.	[Brolly, Matthew] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Woodhouse, Iain H.] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Niklas, Karl J.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Hammond, Sean T.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	University System of Maryland; University of Maryland College Park; University of Edinburgh; Cornell University; University of Arizona	Brolly, M (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	M.Brolly@umd.edu	Niklas, Karl/AAV-4760-2021; Dr DPS RATHORE FRSC, Member-ACS/H-6567-2019	Dr DPS RATHORE FRSC, Member-ACS/0000-0002-1108-9982; Hammond, Sean T./0000-0003-1884-2604; Brolly, Matthew/0000-0002-3576-9675	Natural Earth Research Council (NERC)	Natural Earth Research Council (NERC)	The source of funding for this work was provided by a Natural Earth Research Council (NERC) studentship given to one of the authors over a 3 year period to fund his PhD. The website can be found at http://www.nerc.ac.uk/funding/available/postgrad/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen H.E., 2003, INT ARCH PHOTOGRAMME, V34, P211; [Anonymous], GEOSC REM SENS S 200; Askne J, 2003, IEEE T GEOSCI REMOTE, V41, P1540, DOI 10.1109/TGRS.2003.813397; BALDINI S, 1989, Annali dell'Istituto Sperimentale per la Selvicoltura, V20, P385; Balzter H, 2007, INT J REMOTE SENS, V28, P1173, DOI 10.1080/01431160600904998; Balzter H, 2003, FOREST CANOPY HEIGHT; Bergen KM, 1999, ECOL MODEL, V122, P257, DOI 10.1016/S0304-3800(99)00141-6; Brolly M, 2010, INT GEOSCI REMOTE SE, P3295, DOI 10.1109/IGARSS.2010.5649508; Cade BS, 1997, J WILDLIFE MANAGE, V61, P326, DOI 10.2307/3802588; Cannell MGR, WORLD FOREST BIOMASS; CANTIANA M, 1974, B U FIRENZE, V5; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Cloude SR, 2003, IEE P-RADAR SON NAV, V150, P125, DOI 10.1049/ip-rsn:20030449; Cloude SR, 1998, IEEE T GEOSCI REMOTE, V36, P1551, DOI 10.1109/36.718859; Cloude SR, 2003, P ESA WORKSH POLINSA; Cloude SR, 2009, STUDY FOREST VERTICA; Cramer W, 2004, PHILOS T R SOC B, V359, P331, DOI 10.1098/rstb.2003.1428; Davidson M, 2008, CANDIDATE EARTH EXPL; DOBSON MC, 1992, IEEE T GEOSCI REMOTE, V30, P412, DOI 10.1109/36.134090; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Faller NP, 2002, GEOSCIENCE REMOTE SE, V33, P1230; Floury N, 1997, GEOSC REM SENS 1997, P4; HAGBERG JO, 1995, IEEE T GEOSCI REMOTE, V33, P331, DOI 10.1109/36.377933; Hajnsek I, 2009, IEEE T GEOSCI REMOTE, V47, P481, DOI 10.1109/TGRS.2008.2009437; Hammond ST, 2009, AM J BOT, V96, P1430, DOI 10.3732/ajb.0900063; HELLRIGL B, 1974, B U FIRENZE, V5; Hyyppa J, 2000, FOREST ECOL MANAG, V128, P109, DOI 10.1016/S0378-1127(99)00278-9; IMHOFF ML, 1995, IEEE T GEOSCI REMOTE, V33, P511, DOI 10.1109/36.377953; Izzawati, 2006, IEEE T GEOSCI REMOTE, V44, P863, DOI 10.1109/TGRS.2006.870828; Jennings SB, 1999, FORESTRY, V72, P59, DOI 10.1093/forestry/72.1.59; JOKELA EJ, 1981, CAN J FOREST RES, V11, P298, DOI 10.1139/x81-040; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; Kobayashi Y, 2002, GEOSCIENCE REMOTE SE, V38, P2446; Lefsky MA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023971; Lefsky MA, 2005, REMOTE SENS ENVIRON, V95, P517, DOI 10.1016/j.rse.2005.01.004; Lin CC, 2008, EUSAR 2005; Luo TX, 1996, PATTERNS BIOL PRODUC; Madsen SN, 2002, GEOSCIENCE REMOTE SE, V31, P246; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Makela A, 1998, CAN J FOREST RES, V28, P216, DOI 10.1139/cjfr-28-2-216; Menguzzato G, 1988, ANN I SPERIMENTALE S, V17, P255; Mette T, 2002, GEOSC REM SENS S 200, P2; Mitchell JE, 1997, FOREST ECOL MANAG, V95, P45, DOI 10.1016/S0378-1127(97)00002-9; NELSON R, 1984, REMOTE SENS ENVIRON, V15, P201, DOI 10.1016/0034-4257(84)90031-2; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Pang Y, 2008, CAN J REMOTE SENS, V34, pS471, DOI 10.5589/m08-074; Papathanassiou KP, 2001, IEEE T GEOSCI REMOTE, V39, P2352, DOI 10.1109/36.964971; Parresol BR, 1999, FOREST SCI, V45, P573; Santa-Regina I, 2001, EUR J SOIL BIOL, V37, P125, DOI 10.1016/S1164-5563(01)01072-X; Santa-Regina I, 2001, ANN FOREST SCI, V58, P301, DOI 10.1051/forest:2001128; Sarabandi K, 2002, GEOSCIENCE REMOTE SE, V38, P115; Smith G, 2000, IEEE T GEOSCI REMOTE, V38, P728, DOI 10.1109/36.842002; Stebler O, 2002, ISPRS J PHOTOGRAMM, V56, P149, DOI 10.1016/S0924-2716(01)00049-1; Sun G, 2011, REMOTE SENSING ENV; Tahvanainen L, 1996, SCAND J FOREST RES, V11, P233, DOI 10.1080/02827589609382932; Taras MA, 1980, ABOVEGROUND BIOMASS; Treuhaft RN, 2004, BIOSCIENCE, V54, P561, DOI 10.1641/0006-3568(2004)054[0561:FAFRIS]2.0.CO;2; Treuhaft RN, 1999, IEEE T GEOSCI REMOTE, V37, P2620, DOI 10.1109/36.789657; Treuhaft RN, 2000, RADIO SCI, V35, P141, DOI 10.1029/1999RS900108; Vanninen P, 1996, TREES-STRUCT FUNCT, V10, P231, DOI 10.1007/BF02185674; Wang HP, 2005, INT GEOSCI REMOTE SE, P4339; WARING RH, 1995, BIOSCIENCE, V45, P715, DOI 10.2307/1312677; Wegmuller U, 2002, GEOSCIENCE REMOTE SE, V35, P18; Woodhouse IH, 2006, IEEE T GEOSCI REMOTE, V44, P871, DOI 10.1109/TGRS.2006.872356; WOODS KD, 1991, CAN J FOREST RES, V21, P974, DOI 10.1139/x91-135; WOODWELL GM, 1975, ECOLOGY, V56, P318, DOI 10.2307/1934963; Zianis D, 2004, FOREST ECOL MANAG, V187, P311, DOI 10.1016/j.foreco.2003.07.007	68	1	1	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33927	10.1371/journal.pone.0033927	http://dx.doi.org/10.1371/journal.pone.0033927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457800	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900031
J	Lee, YL; Hwang, BF; Chen, YA; Chen, JM; Wu, YF				Lee, Yungling Leo; Hwang, Bing-Fang; Chen, Yu-An; Chen, Jer-Min; Wu, Yi-Fan			Pulmonary Function and Incident Bronchitis and Asthma in Children: A Community-Based Prospective Cohort Study	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; 1ST 6 YEARS; AIR-POLLUTION; LUNG-FUNCTION; RESPIRATORY SYMPTOMS; DIAGNOSED ASTHMA; PASSIVE SMOKING; CHILDHOOD; EXPOSURE; RESPONSIVENESS	Background: Previous studies revealed that reduction of airway caliber in infancy might increase the risks for wheezing and asthma. However, the evidence for the predictive effects of pulmonary function on respiratory health in children was still inconsistent. Methods: We conducted a population-based prospective cohort study among children in 14 Taiwanese communities. There were 3,160 children completed pulmonary function tests in 2007 and follow-up questionnaire in 2009. Poisson regression models were performed to estimate the effect of pulmonary function on the development of bronchitis and asthma. Results: After adjustment for potential confounders, pulmonary function indices consistently showed protective effects on respiratory diseases in children. The incidence rate ratios of bronchitis and asthma were 0.86 (95% CI 0.79-0.95) and 0.91 (95% CI 0.82-0.99) for forced expiratory volume in 1 second (FEV1). Similar adverse effects of maximal mid-expiratory flow (MMEF) were also observed on bronchitis (RR = 0.73, 95% CI 0.67-0.81) and asthma (RR = 0.85, 95% CI 0.77-0.93). We found significant decreasing trends in categorized FEV1 (p for trend = 0.02) and categories of MMEF (p for trend = 0.01) for incident bronchitis. Significant modification effects of traffic-related air pollution were noted for FEV1 and MMEF on bronchitis and also for MMEF on asthma. Conclusions: Children with high pulmonary function would have lower risks on the development of bronchitis and asthma. The protective effect of high pulmonary function would be modified by traffic-related air pollution exposure.	[Lee, Yungling Leo; Chen, Yu-An; Chen, Jer-Min; Wu, Yi-Fan] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lee, Yungling Leo] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Hwang, Bing-Fang] China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Chen, Jer-Min; Wu, Yi-Fan] Taipei City Hosp, Renai Branch, Dept Family Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; China Medical University Taiwan; Taipei City Hospital	Lee, YL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	leolee@ntu.edu.tw	Lee, Yungling/S-7011-2018; Hwang, Bing-Fang/O-2709-2015	Lee, Yungling/0000-0002-2234-9479; Hwang, Bing-Fang/0000-0002-5951-9662; Chen, Jer-Min/0000-0003-3320-8599	Taiwan National Science Council [98-2314-B-002-138-MY3, 96-2314-B-006-053]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants #98-2314-B-002-138-MY3 and #96-2314-B-006-053 from the Taiwan National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami Lara, 2006, Adv Data, P1; [Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; Carlsen KCL, 2002, PEDIAT ALLERG IMM-UK, V13, P29, DOI 10.1034/j.1399-3038.13.s.15.2.x; Carroll KN, 2008, PEDIATRICS, V122, P58, DOI 10.1542/peds.2007-2087; Cerveri I, 2003, EUR RESPIR J, V22, P413, DOI 10.1183/09031936.03.00121103; Cheng CC, 2010, CHINESE J PHYSIOL, V53, P223, DOI 10.4077/CJP.2010.AMK050; Churg A, 2003, ENVIRON HEALTH PERSP, V111, P714, DOI 10.1289/ehp.6042; Ciprandi G, 2005, RESP MED, V99, P1606, DOI 10.1016/j.rmed.2005.03.030; Cirillo I, 2006, ANN ALLERG ASTHMA IM, V96, P692, DOI 10.1016/S1081-1206(10)61067-8; Coultas DB, 2001, AM J RESP CRIT CARE, V164, P372, DOI 10.1164/ajrccm.164.3.2004029; David GL, 2005, THORAX, V60, P1052, DOI 10.1136/thx.2005.042960; Dezateux C, 1999, AM J RESP CRIT CARE, V159, P403, DOI 10.1164/ajrccm.159.2.9712029; Gilmour M, 2006, ENVIRON HEALTH PERSP, V114, P627, DOI 10.1289/ehp.8380; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Ho SY, 2007, ANN EPIDEMIOL, V17, P126, DOI 10.1016/j.annepidem.2006.06.010; Huberman M, 1999, AM J EPIDEMIOL, V150, P1340; Hwang BF, 2010, CHEST, V138, P956, DOI 10.1378/chest.09-2600; Islam T, 2007, THORAX, V62, P957, DOI 10.1136/thx.2007.078964; Jerrett M, 2008, ENVIRON HEALTH PERSP, V116, P1433, DOI 10.1289/ehp.10968; Lee YL, 2003, PEDIATRICS, V112, pE389, DOI 10.1542/peds.112.5.e389; Litonjua AA, 1999, AM J RESP CRIT CARE, V159, P1574, DOI 10.1164/ajrccm.159.5.9803063; London SJ, 2001, EPIDEMIOLOGY, V12, P577, DOI 10.1097/00001648-200109000-00019; MacIntyre NR, 2010, RESP CARE, V55, P35; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; McConnell R, 1999, ENVIRON HEALTH PERSP, V107, P757, DOI 10.2307/3434662; McConnell R, 2010, ENVIRON HEALTH PERSP, V118, P1021, DOI 10.1289/ehp.0901232; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Reed CE, 2006, J ALLERGY CLIN IMMUN, V118, P543, DOI 10.1016/j.jaci.2006.06.020; Schwartz J, 2004, PEDIATRICS, V113, P1037; Segala C, 2004, ARCH ENVIRON HEALTH, V59, P669, DOI 10.1080/00039890409602952; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Sunyer J, 2006, OCCUP ENVIRON MED, V63, P836, DOI 10.1136/oem.2006.027995; Tong SL, 2001, ANN EPIDEMIOL, V11, P38, DOI 10.1016/S1047-2797(00)00176-9; Tsai CH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-11; Tung KY, 2011, CHEST, V139, P839, DOI 10.1378/chest.10-2479; Ulrik CS, 1998, CHEST, V113, P973, DOI 10.1378/chest.113.4.973; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x	39	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e32477	10.1371/journal.pone.0032477	http://dx.doi.org/10.1371/journal.pone.0032477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457716	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900004
J	Sundararajan, A; Huan, LF; Richards, KA; Marcelin, G; Alam, S; Joo, H; Yang, HM; Webby, RJ; Topham, DJ; Sant, AJ; Sangster, MY				Sundararajan, Aarthi; Huan, Lifang; Richards, Katherine A.; Marcelin, Glendie; Alam, Shabnam; Joo, HyeMee; Yang, Hongmei; Webby, Richard J.; Topham, David J.; Sant, Andrea J.; Sangster, Mark Y.			Host Differences in Influenza-Specific CD4 T Cell and B Cell Responses Are Modulated by Viral Strain and Route of Immunization	PLOS ONE			English	Article							CLASS SWITCH RECOMBINATION; GAMMA-SECRETING CELLS; VIRUS INFECTION; GERMINAL CENTER; TRANSGENIC MICE; LYMPH-NODES; ANTIBODY; INTERFERON; DIFFERENTIATION; IMMUNOPATHOLOGY	The antibody response to influenza infection is largely dependent on CD4 T cell help for B cells. Cognate signals and secreted factors provided by CD4 T cells drive B cell activation and regulate antibody isotype switching for optimal antiviral activity. Recently, we analyzed HLA-DR1 transgenic (DR1) mice and C57BL/10 (B10) mice after infection with influenza virus A/New Caledonia/20/99 (NC) and defined epitopes recognized by virus-specific CD4 T cells. Using this information in the current study, we demonstrate that the pattern of secretion of IL-2, IFN-gamma, and IL-4 by CD4 T cells activated by NC infection is largely independent of epitope specificity and the magnitude of the epitope-specific response. Interestingly, however, the characteristics of the virus-specific CD4 T cell and the B cell response to NC infection differed in DR1 and B10 mice. The response in B10 mice featured predominantly IFN-gamma-secreting CD4 T cells and strong IgG2b/IgG2c production. In contrast, in DR1 mice most CD4 T cells secreted IL-2 and IgG production was IgG1-biased. Infection of DR1 mice with influenza PR8 generated a response that was comparable to that in B10 mice, with predominantly IFN-gamma-secreting CD4 T cells and greater numbers of IgG2c than IgG1 antibody-secreting cells. The response to intramuscular vaccination with inactivated NC was similar in DR1 and B10 mice; the majority of CD4 T cells secreted IL-2 and most IgG antibody-secreting cells produced IgG2b or IgG2c. Our findings identify inherent host influences on characteristics of the virus-specific CD4 T cell and B cell responses that are restricted to the lung environment. Furthermore, we show that these host influences are substantially modulated by the type of infecting virus via the early induction of innate factors. Our findings emphasize the importance of immunization strategy for demonstrating inherent host differences in CD4 T cell and B cell responses.	[Sundararajan, Aarthi; Richards, Katherine A.; Alam, Shabnam; Topham, David J.; Sant, Andrea J.; Sangster, Mark Y.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Huan, Lifang] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Marcelin, Glendie; Webby, Richard J.] St Jude Childrens Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Joo, HyeMee] Baylor Univ, Med Ctr, Baylor Inst Immunol Res, Dallas, TX USA; [Yang, Hongmei] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA	University of Rochester; University of Tennessee System; University of Tennessee Knoxville; St Jude Children's Research Hospital; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; University of Rochester	Sundararajan, A (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	mark_sangster@urmc.rochester.edu	Webby, Richard J/N-5657-2018	Sangster, Mark/0000-0002-1599-5894; Sundararajan, Aarthi/0000-0002-1592-1895	National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN266200700008C]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (HHSN266200700008C) from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000567; Chang WLW, 2007, J IMMUNOL, V178, P1457, DOI 10.4049/jimmunol.178.3.1457; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; GRAHAM MB, 1993, J EXP MED, V178, P1725, DOI 10.1084/jem.178.5.1725; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Joo HM, 2008, P NATL ACAD SCI USA, V105, P3485, DOI 10.1073/pnas.0800003105; Joo HM, 2010, VACCINE, V28, P2186, DOI 10.1016/j.vaccine.2009.12.058; Kim SJ, 2008, J EXP MED, V205, P2437, DOI 10.1084/jem.20070731; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Li XF, 2006, J IMMUNOL METHODS, V313, P110, DOI 10.1016/j.jim.2006.03.016; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; McDuffie Eric, 2006, J Inflamm (Lond), V3, P15, DOI 10.1186/1476-9255-3-15; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nayak JL, 2010, VIRAL IMMUNOL, V23, P169, DOI 10.1089/vim.2009.0099; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Richards KA, 2007, J VIROL, V81, P7608, DOI 10.1128/JVI.02834-06; Richards KA, 2009, J VIROL, V83, P6566, DOI 10.1128/JVI.00302-09; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; SARAWAR SR, 1994, J VIROL, V68, P3112, DOI 10.1128/JVI.68.5.3112-3119.1994; SARAWAR SR, 1994, J IMMUNOL, V153, P1246; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Szomolanyi-Tsuda E, 1998, CURR OPIN IMMUNOL, V10, P431, DOI 10.1016/S0952-7915(98)80117-9; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; WOODS A, 1994, J EXP MED, V180, P173, DOI 10.1084/jem.180.1.173; Yoo JK, 2010, J EXP MED, V207, P1435, DOI 10.1084/jem.20091373	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34377	10.1371/journal.pone.0034377	http://dx.doi.org/10.1371/journal.pone.0034377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457834	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900063
J	Bai, L; Xia, SL; Lan, RT; Liu, LY; Ye, CY; Wang, YT; Jin, D; Cui, ZG; Jing, HQ; Xiong, YW; Bai, XM; Sun, H; Zhang, J; Wang, L; Xu, JG				Bai, Li; Xia, Shengli; Lan, Ruiting; Liu, Liyun; Ye, Changyun; Wang, Yiting; Jin, Dong; Cui, Zhigang; Jing, Huaiqi; Xiong, Yanwen; Bai, Xuemei; Sun, Hui; Zhang, Jin; Wang, Lei; Xu, Jianguo			Isolation and Characterization of Cytotoxic, Aggregative Citrobacter freundii	PLOS ONE			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; TELLURITE RESISTANCE; SALMONELLA-ENTERICA; GENOMIC SEQUENCE; EPITHELIAL-CELLS; SECRETION SYSTEM; ADHERENCE; STRAINS; TOXIN; DIARRHEA	Citrobacter freundii is an infrequent but established cause of diarrhea in humans. However, little is known of its genetic diversity and potential for virulence. We analyzed 26 isolates, including 12 from human diarrheal patients, 2 from human fecal samples of unknown diarrheal status, and 12 from animals, insects, and other sources. Pulsed field gel electrophoresis using XbaI allowed us to divide the 26 isolates into 20 pulse types, while multi-locus sequence typing using 7 housekeeping genes allowed us to divide the 26 isolates into 6 sequence types (STs) with the majority belonging to 4 STs. We analyzed adhesion and cytotoxicity to HEp-2 cells in these 26 strains. All were found to adhere to HEp-2 cells. One strain, CF74, which had been isolated from a goat, showed the strongest aggregative adhesion pattern. Lactate dehydrogenase (LDH) released from HEp-2 cells was evaluated as a measure of cytotoxicity, averaging 7.46%. Strain CF74 induced the highest level of LDH, 24.3%, and caused >50% cell rounding, detachment, and death. We named strain CF74 "cytotoxic and aggregative C. freundii." Genome sequencing of CF74 revealed that it had acquired 7 genomic islands, including 2 fimbriae islands and a type VI secretion system island, all of which are potential virulence factors. Our results show that aggregative adherence and cytotoxicity play an important role in the pathogenesis of C. freundii.	[Bai, Li; Liu, Liyun; Ye, Changyun; Wang, Yiting; Jin, Dong; Cui, Zhigang; Jing, Huaiqi; Xiong, Yanwen; Bai, Xuemei; Sun, Hui; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xia, Shengli; Zhang, Jin] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan Province, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Bai, Li] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing, Peoples R China; [Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of New South Wales Sydney; Chinese Center for Disease Control & Prevention; Nankai University	Bai, L (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xujianguo@icdc.cn	wang, yiting/GYU-5306-2022; Wang, Lei/C-5176-2009	Wang, Lei/0000-0003-4427-0881; Lan, Ruiting/0000-0001-9834-5258	Ministry of Science and Technology [2005CB522905, 2008ZX10004-001, 2008ZX10004-009, 2009ZX10004-101, 2011SKLID209]; National Key Programs for Infectious Diseases of China; State Key Laboratory for Infectious Disease Prevention and Control, People's Republic of China	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Key Programs for Infectious Diseases of China; State Key Laboratory for Infectious Disease Prevention and Control, People's Republic of China	This work was supported by grants (2005CB522905, 2008ZX10004-001, 2008ZX10004-009, 2009ZX10004-101, 2011SKLID209) from Ministry of Science and Technology, the National Key Programs for Infectious Diseases of China and by grants from the State Key Laboratory for Infectious Disease Prevention and Control, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Barros SF, 2008, J CLIN MICROBIOL, V46, P4052, DOI 10.1128/JCM.01252-08; Baumler AJ, 1996, P NATL ACAD SCI USA, V93, P279, DOI 10.1073/pnas.93.1.279; Blondel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011724; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; FAVREBONTE S, 1995, INFECT IMMUN, V63, P1318, DOI 10.1128/IAI.63.4.1318-1328.1995; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; GUARINO A, 1989, INFECT IMMUN, V57, P649, DOI 10.1128/IAI.57.2.649-652.1989; GUARINO A, 1987, J CLIN MICROBIOL, V25, P110, DOI 10.1128/JCM.25.1.110-114.1987; GUERRANT RL, 1976, J PEDIATR-US, V89, P885, DOI 10.1016/S0022-3476(76)80591-4; Herold S, 2004, INT J MED MICROBIOL, V294, P115, DOI 10.1016/j.ijmm.2004.06.023; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Hubbard AL, 1998, J CLIN MICROBIOL, V36, P2326, DOI 10.1128/JCM.36.8.2326-2330.1998; Karasawa T, 2002, INFECT IMMUN, V70, P7153, DOI 10.1128/IAI.70.12.7153-7155.2002; Kauffmann F, 1940, J HYG-CAMBRIDGE, V40, P246, DOI 10.1017/S0022172400027790; Kaur P, 2010, INTERDISCIP PERSPECT, V2010; Kobayashi M, 1999, AM J TROP MED HYG, V61, P625, DOI 10.4269/ajtmh.1999.61.625; Lacher DW, 2007, J BACTERIOL, V189, P342, DOI 10.1128/JB.01472-06; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mange JP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-58; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Navarro-Garcia F, 2011, GUT MICROBES, V2, P13, DOI 10.4161/gmic.2.1.14933; NEVES MS, 1994, J CLIN MICROBIOL, V32, P1130, DOI 10.1128/JCM.32.4.1130-1131.1994; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Nucleo E, 2010, NEW MICROBIOL, V33, P37; Okeke IN, 2003, J CLIN MICROBIOL, V41, P4525, DOI 10.1128/JCM.41.10.4525-4530.2003; Parida S N, 1980, Indian J Pediatr, V47, P81; Pereira AL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-57; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Roberts PH, 2001, J MICROBIOL METH, V43, P171, DOI 10.1016/S0167-7012(00)00222-0; Rocha SPD, 2007, FEMS IMMUNOL MED MIC, V51, P319, DOI 10.1111/j.1574-695X.2007.00308.x; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; SAUKKONEN KMJ, 1988, INFECT IMMUN, V56, P892, DOI 10.1128/IAI.56.4.892-897.1988; Scavia G, 2008, J MED MICROBIOL, V57, P1141, DOI 10.1099/jmm.0.2008/001362-0; SCHMIDT H, 1993, INFECT IMMUN, V61, P534, DOI 10.1128/IAI.61.2.534-543.1993; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Taylor DE, 2002, J BACTERIOL, V184, P4690, DOI 10.1128/JB.184.17.4690-4698.2002; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; TSCHAPE H, 1995, EPIDEMIOL INFECT, V114, P441, DOI 10.1017/S0950268800052158; Turner RJ, 1999, MICROBIOL-UK, V145, P2549, DOI 10.1099/00221287-145-9-2549; Valkova D, 2007, CENT EUR J BIOL, V2, P182, DOI 10.2478/s11535-007-0019-9; Veilleux S, 2008, COMP IMMUNOL MICROB, V31, P567, DOI 10.1016/j.cimid.2007.10.003; VIAL PA, 1988, J INFECT DIS, V158, P70, DOI 10.1093/infdis/158.1.70; Wagner C, 2011, ADV EXP MED BIOL, V715, P17, DOI 10.1007/978-94-007-0940-9_2; WARNER RD, 1991, ARCH INTERN MED, V151, P2419, DOI 10.1001/archinte.151.12.2419; YAMAMOTO T, 1992, J INFECT DIS, V166, P1295, DOI 10.1093/infdis/166.6.1295; Yin XH, 2009, APPL ENVIRON MICROB, V75, P5779, DOI 10.1128/AEM.00507-09; Zhang WL, 2002, J CLIN MICROBIOL, V40, P1441, DOI 10.1128/JCM.40.4.1441-1446.2002	61	47	50	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33054	10.1371/journal.pone.0033054	http://dx.doi.org/10.1371/journal.pone.0033054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470435	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100012
J	Subburaju, S; Benes, FM				Subburaju, Sivan; Benes, Francine M.			Induction of the GABA Cell Phenotype: An In Vitro Model for Studying Neurodevelopmental Disorders	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; STEM-CELLS; NERVOUS-SYSTEM; RAT-BRAIN; NEURONAL DIFFERENTIATION; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; COMMON PROGENITOR	Recent studies of the hippocampus have suggested that a network of genes is associated with the regulation of the GAD(67) (GAD1) expression and may play a role in gamma-amino butyric acid (GABA) dysfunction in schizophrenia (SZ) and bipolar disorder (BD). To obtain a more detailed understanding of how GAD(67) regulation may result in GABAergic dysfunction, we have developed an in vitro model in which GABA cells are differentiated from the hippocampal precursor cell line, HiB5. Growth factors, such as PDGF, and BDNF, regulate the GABA phenotype by inducing the expression of GAD(67) and stimulating the growth of cellular processes, many with growth cones that form appositions with the cell bodies and processes of other GAD(67)-positive cells. These changes are associated with increased expression of acetylated tubulin, microtubule-associated protein 2 (MAP2) and the post-synaptic density protein 95 (PSD95). The addition of BDNF, together with PDGF, increases the levels of mRNA and protein for GAD(67), as well as the high affinity GABA uptake protein, GAT1. These changes are associated with increased concentrations of GABA in the cytoplasm of "differentiated'' HiB5 neurons. In the presence of Ca2+ and K+, newly synthesized GABA is released extracellularly. When the HiB5 cells appear to be fully differentiated, they also express GAD(65), parvalbumin and calbindin, and GluR subtypes as well as HDAC1, DAXX, PAX5, Runx2, associated with GAD(67) regulation. Overall, these results suggest that the HiB5 cells can differentiate into functionally mature GABA neurons in the presence of gene products that are associated with GAD(67) regulation in the adult hippocampus.	[Subburaju, Sivan; Benes, Francine M.] McLean Hosp, Program Struct & Mol Neurosci, Belmont, MA 02178 USA; [Subburaju, Sivan; Benes, Francine M.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Benes, Francine M.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Subburaju, S (corresponding author), McLean Hosp, Program Struct & Mol Neurosci, 115 Mill St, Belmont, MA 02178 USA.	fbenes@mclean.harvard.edu			National Institutes of Health [MH42261, MH77175]; William P. and Henry B. Test Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077175, R01MH042261, R37MH042261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William P. and Henry B. Test Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by the National Institutes of Health (MH42261 and MH77175) and the William P. and Henry B. Test Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; BAYER SA, 1986, INT J DEV NEUROSCI, V4, P225, DOI 10.1016/0736-5748(86)90062-6; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Benes FM, 2009, P NATL ACAD SCI USA, V106, P11731, DOI 10.1073/pnas.0903066106; Benes FM, 2008, P NATL ACAD SCI USA, V105, P20935, DOI 10.1073/pnas.0810153105; Braun K, 2010, CEREB CORTEX; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; Conejero-Goldberg C, 2000, EXP NEUROL, V161, P453, DOI 10.1006/exnr.1999.7258; Eaton MJ, 1999, CELL TRANSPLANT, V8, P87, DOI 10.1177/096368979900800102; EVES EM, 1992, P NATL ACAD SCI USA, V89, P4373, DOI 10.1073/pnas.89.10.4373; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; GIORDANO M, 1993, EXP NEUROL, V124, P395, DOI 10.1006/exnr.1993.1213; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hardt O, 2008, MOL CELL NEUROSCI, V39, P418, DOI 10.1016/j.mcn.2008.07.021; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Iritani S, 1999, PROG NEURO-PSYCHOPH, V23, P409, DOI 10.1016/S0278-5846(99)00005-6; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; Kim G, 2002, MOL BRAIN RES, V109, P134, DOI 10.1016/S0169-328X(02)00550-8; Kim HJ, 2009, STEM CELLS, V27, P390, DOI 10.1634/stemcells.2007-1047; Lee SH, 2003, MOL CELLS, V15, P233; LENDAHL U, 1990, TRENDS NEUROSCI, V13, P132, DOI 10.1016/0166-2236(90)90004-T; Lin PY, 2007, J NEUROSCI, V27, P12787, DOI 10.1523/JNEUROSCI.3302-07.2007; Lowenstein DH, 1996, J NEUROSCI, V16, P1759; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; PinkasKramarski R, 1997, ONCOGENE, V15, P2803, DOI 10.1038/sj.onc.1201466; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Sanchez JF, 2006, CELL TISSUE RES, V324, P1, DOI 10.1007/s00441-005-0094-z; SCHLESSINGER AR, 1978, ANAT EMBRYOL, V154, P153, DOI 10.1007/BF00304660; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Sung JY, 2001, J NEUROCHEM, V78, P1044, DOI 10.1046/j.1471-4159.2001.00491.x; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; VICARIOABEJON C, 1995, J NEUROSCI, V15, P6351; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Wang BB, 2008, BRAIN RES, V1210, P63, DOI 10.1016/j.brainres.2008.02.062; Wang YQ, 2009, NEUROCHEM INT, V55, P629, DOI 10.1016/j.neuint.2009.06.007; YEN SH, 1981, J CELL BIOL, V88, P115, DOI 10.1083/jcb.88.1.115	55	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33352	10.1371/journal.pone.0033352	http://dx.doi.org/10.1371/journal.pone.0033352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457755	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100030
J	Schellekens, H; Clarke, G; Jeffery, IB; Dinan, TG; Cryan, JF				Schellekens, Harriet; Clarke, Gerard; Jeffery, Ian B.; Dinan, Timothy G.; Cryan, John F.			Dynamic 5-HT2C Receptor Editing in a Mouse Model of Obesity	PLOS ONE			English	Article							SEROTONIN 2C RECEPTOR; PRE-MESSENGER-RNA; FEEDING-BEHAVIOR; FOOD-INTAKE; MICE; PROTEIN; HYPERPHAGIA; EXPRESSION; APPETITE; SYSTEM	The central serotonergic signalling system has been shown to play an important role in appetite control and the regulation of food intake. Serotonin exerts its anorectic effects mainly through the 5-HT1B, 5-HT2C and 5-HT6 receptors and these are therefore receiving increasing attention as principal pharmacotherapeutic targets for the treatment of obesity. The 5-HT2C receptor has the distinctive ability to be modified by posttranscriptional RNA editing on 5 nucleotide positions (A, B, C, D, E), having an overall decreased receptor function. Recently, it has been shown that feeding behaviour and fat mass are altered when the 5-HT2C receptor RNA is fully edited, suggesting a potential role for 5-HT2C editing in obesity. The present studies investigate the expression of serotonin receptors involved in central regulation of food intake, appetite and energy expenditure, with particular focus on the level of 5-HT2C receptor editing. Using a leptin-deficient mouse model of obesity (ob/ob), we show increased hypothalamic 5-HT1A receptor expression as well as increased hippocampal 5-HT1A, 5-HT1B, and 5-HT6 receptor mRNA expression in obese mice compared to lean control mice. An increase in full-length 5-HT2C expression, depending on time of day, as well as differences in 5-HT2C receptor editing were found, independent of changes in total 5-HT2C receptor mRNA expression. This suggests that a dynamic regulation exists of the appetite-suppressing effects of the 5HT(2C) receptor in both the hypothalamus and the hippocampus in the ob/ob mice model of obesity. The differential 5-HT1A, 5-HT1B and 5-HT6 receptor expression and altered 5-HT2C receptor editing profile reported here is poised to have important consequences for the development of novel anti-obesity therapies.	[Schellekens, Harriet] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland; [Clarke, Gerard; Dinan, Timothy G.] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland; [Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland; [Clarke, Gerard; Dinan, Timothy G.; Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Lab Neurogastroenterol, Alimentary Pharmabiot Ctr, Cork, Ireland; [Jeffery, Ian B.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland	University College Cork; University College Cork; University College Cork; University College Cork; University College Cork	Schellekens, H (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland.	j.cryan@ucc.ie	Clarke, Gerard/Y-2551-2019; Dinan, Timothy/ABA-8284-2020; Cryan, John F./A-6950-2013; Jeffery, Ian/I-4010-2013	Clarke, Gerard/0000-0001-9771-3979; Cryan, John F./0000-0001-5887-2723; Jeffery, Ian/0000-0001-9183-7292; Schellekens, Harriet/0000-0002-6065-3797; Dinan, Timothy/0000-0002-2316-7220	Enterprise Ireland [CC20080001]; Science Foundation Ireland (SFI) (Alimentary Pharmabiotic Centre) through the Irish Government; SFI [02/CE/B124, 07/CE/B1368]; European Community [FP7/2007-2013, 201714]; American Neurogastroenterology; Motility Society	Enterprise Ireland; Science Foundation Ireland (SFI) (Alimentary Pharmabiotic Centre) through the Irish Government(Science Foundation Ireland); SFI(Science Foundation Ireland); European Community(European Commission); American Neurogastroenterology; Motility Society	The work described herein was supported by Enterprise Ireland under Grant Number CC20080001. JFC and TGD are also supported in part by Science Foundation Ireland (SFI) in the form of a centre grant (Alimentary Pharmabiotic Centre) through the Irish Government's National Development Plan. The authors and their work were supported by SFI (grant no.s 02/CE/B124 and 07/CE/B1368). JFC is funded by European Community's Seventh Framework Programme; Grant Number: FP7/2007-2013, Grant Agreement 201714. GC is in receipt of research funding from the American Neurogastroenterology and Motility Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2008, ENDOCRIN METAB CLIN, V37, P811, DOI 10.1016/j.ecl.2008.08.005; BENDOTTI C, 1986, EUR J PHARMACOL, V121, P147, DOI 10.1016/0014-2999(86)90405-X; Berg KA, 2001, BRIT J PHARMACOL, V134, P386, DOI 10.1038/sj.bjp.0704255; Berg KA, 2008, NEUROPHARMACOLOGY, V55, P969, DOI 10.1016/j.neuropharm.2008.06.014; Bloom SR, 2008, MOL INTERV, V8, P82, DOI 10.1124/mi.8.2.6; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Clifton P. G., 2006, CNS & Neurological Disorders-Drug Targets, V5, P293, DOI 10.2174/187152706777452254; Collin M, 2002, NEUROREPORT, V13, P945, DOI 10.1097/00001756-200205240-00009; Cryan JF, 2000, HUM PSYCHOPHARM CLIN, V15, P113, DOI 10.1002/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W; Dalton GL, 2006, PSYCHOPHARMACOLOGY, V185, P45, DOI 10.1007/s00213-005-0212-3; Dalton GL, 2004, NEUROPHARMACOLOGY, V46, P663, DOI 10.1016/j.neuropharm.2003.11.012; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; Dracheva S, 2008, MOL PSYCHIATR, V13, P1001, DOI 10.1038/sj.mp.4002081; Dutton A. C., 2006, DRUG DISCOV TODAY, V3, P577, DOI DOI 10.1016/J.DDSTR.2006.11.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Englander MT, 2005, J NEUROSCI, V25, P648, DOI 10.1523/JNEUROSCI.3895-04.2005; Feng Y, 2006, MOL CELL BIOL, V26, P480, DOI 10.1128/MCB.26.2.480-488.2006; Finger BC, 2011, PSYCHOPHARMACOLOGY, V216, P421, DOI 10.1007/s00213-011-2234-3; Finger BC, 2010, PSYCHOPHARMACOLOGY, V210, P559, DOI 10.1007/s00213-010-1858-z; Frassetto A, 2008, BRAIN RES, V1236, P140, DOI 10.1016/j.brainres.2008.08.012; Gardiner Katheleen, 2006, Briefings in Functional Genomics & Proteomics, V5, P37, DOI 10.1093/bfgp/ell006; Garfield AS, 2009, J PHYSIOL-LONDON, V587, P49, DOI 10.1113/jphysiol.2008.164152; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halford JCG, 2007, DRUGS, V67, P27, DOI 10.2165/00003495-200767010-00004; Heal DJ, 2008, PHARMACOL THERAPEUT, V117, P207, DOI 10.1016/j.pharmthera.2007.08.006; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Iwamoto K, 2005, NEUROSCI RES, V53, P69, DOI 10.1016/j.neures.2005.06.001; Iwamoto K, 2009, RNA BIOL, V6, P248, DOI 10.4161/rna.6.3.8370; Kanoski SE, 2011, NEUROPSYCHOPHARMACOL; Kawahara Y, 2008, J NEUROSCI, V28, P12834, DOI 10.1523/JNEUROSCI.3896-08.2008; Lam Daniel D., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000245; Lanfranco MF, 2009, J NEUROSCI METH, V179, P247, DOI 10.1016/j.jneumeth.2009.01.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; Meneses A, 1999, IDrugs, V2, P796; Miller KJ, 2005, MOL INTERV, V5, P282, DOI 10.1124/mi.5.5.8; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NEILL JC, 1988, EUR J PHARMACOL, V151, P329, DOI 10.1016/0014-2999(88)90818-7; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Nonogaki K, 2006, ENDOCRINOLOGY, V147, P5893, DOI 10.1210/en.2006-0418; O'Leary OF, 2010, HDB BEHAV NEUROBIOLO; O'Mahony S, 2008, NEUROGASTROENT MOTIL, V20, P680, DOI 10.1111/j.1365-2982.2007.01065.x; Olaghere da Silva UB, 2010, FRONTIERS NEUROPHARM; Paxinos G, 2007, MOUSE BRAIN STEREOTA; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; ROWLAND NE, 1995, PHYSIOL BEHAV, V58, P749, DOI 10.1016/0031-9384(95)00105-R; SALLER CF, 1976, SCIENCE, V192, P385, DOI 10.1126/science.1257774; Schellekens H, 2010, NEUROPHARMACOLOGY, V58, P2, DOI 10.1016/j.neuropharm.2009.06.024; Sharp T, 2007, TRENDS PHARMACOL SCI, V28, P629, DOI 10.1016/j.tips.2007.10.009; Simpson KA, 2009, ARQ BRAS ENDOCRINOL, V53, P120, DOI 10.1590/S0004-27302009000200002; Singer JM, 2009, BIOORG MED CHEM LETT, V19, P2409, DOI 10.1016/j.bmcl.2009.03.077; Somerville EM, 2007, EUR J NEUROSCI, V25, P3115, DOI 10.1111/j.1460-9568.2007.05567.x; Suzuki K, 2010, ENDOCR J, V57, P359, DOI 10.1507/endocrj.K10E-077; Tecott LH, 2007, CELL METAB, V6, P352, DOI 10.1016/j.cmet.2007.09.012; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Walker EA, 2010, BEHAV PHARMACOL, V21, P83, DOI 10.1097/FBP.0b013e328337bde7; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2000, J NEUROCHEM, V74, P1290; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012	66	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32266	10.1371/journal.pone.0032266	http://dx.doi.org/10.1371/journal.pone.0032266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448217	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700007
J	Urada, LA; Morisky, DE; Pimentel-Simbulan, N; Silverman, JG; Strathdee, SA				Urada, Lianne A.; Morisky, Donald E.; Pimentel-Simbulan, Nymia; Silverman, Jay G.; Strathdee, Steffanie A.			Condom Negotiations among Female Sex Workers in the Philippines: Environmental Influences	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; STRUCTURAL INTERVENTIONS; SOCIAL-SUPPORT; HIV RISK; PREVENTION; BEHAVIORS; HEALTH; IMPACT; WOMEN; TRAFFICKING	Background: Social and structural influences of condom negotiation among female sex workers (FSWs) remain understudied. This study assesses environmental and individual factors associated with condom negotiation among FSWs at high risk for acquiring HIV in a large urban setting of Metro Manila, Philippines. Methods: Female bar/spa workers (N = 498), aged 18 and over, underwent interview-led surveys examining their sexual health practices in the context of their risk environments. Data were collected from April 2009-January 2010 from 54 venues. Multiple logistic regressions were conducted to assess socio-behavioral factors (e. g., age, education, length of time employed as an entertainer, and alcohol/drug use) and socio-structural factors (e. g., venue-level peer/manager support, condom rule/availability, and sex trafficking) associated with condom negotiation, adjusting for individuals nested within venues. Results: Of 142 FSWs who traded sex in the previous 6 months (included in the analysis), 24% did not typically negotiate condom use with venue patrons. Factors in the physical environment - trafficked/coerced into work (AOR = 12.92, 95% CI = 3.34-49.90), economic environment - sex without a condom to make more money (AOR = 1.52, 95% CI 1.01-2.30), policy environment - sex without a condom because none was available (AOR = 2.58, 95% CI = 1.49-4.48), and individual risk - substance use (AOR = 2.36, 95% CI = 1.28-4.35) were independently associated with FSWs' lack of condom negotiation with venue patrons. Conclusions: Factors in the physical, economic, and policy environments, over individual (excepting substance use) and social level factors, were significantly associated with these FSWs' condom negotiations in the Philippines. Drawing upon Rhodes' risk environment framework, these results highlight the need for policies that support safer sex negotiations among sex workers in the context of their risk environments. Interventions should reduce barriers to condom negotiation for FSWs trafficked/coerced into their work, substance using, and impacted by economic conditions and policies that do not support condom availability.	[Urada, Lianne A.; Silverman, Jay G.; Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Morisky, Donald E.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90024 USA; [Pimentel-Simbulan, Nymia] Univ Philippines Manila, Coll Arts & Sci, Dept Behav Sci, Manila, Philippines	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of the Philippines System; University of the Philippines Manila	Urada, LA (corresponding author), Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA.	lurada@ucsd.edu	Morisky, Donald/AAU-4679-2021; Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X	University of California; University of California Los Angeles' International Institute; University of California Los Angeles' Graduate Division; National Institutes of Drug Abuse [T32 DA023356]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA023356] Funding Source: NIH RePORTER	University of California(University of California System); University of California Los Angeles' International Institute; University of California Los Angeles' Graduate Division; National Institutes of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support for this project was provided by the University of California Office of the President Pacific Rim Research Program, the University of California Los Angeles' International Institute, the University of California Los Angeles' Graduate Division to the Community Health Science Department's Doctoral Training Program in the Social and Behavioral Determinants of HIV/AIDS Prevention, and a training grant from the National Institutes of Drug Abuse (T32 DA023356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUKAL, 1997, BUKAL ANN REP; Cheng SSY, 2010, AIDS CARE, V22, P606, DOI 10.1080/09540120903311441; Choi SYP, 2007, CULT HEALTH SEX, V9, P489, DOI 10.1080/13691050701220446; Cwikel J, 2003, J EPIDEMIOL COMMUN H, V57, P809, DOI 10.1136/jech.57.10.809; Decker MR, 2011, J EPIDEMIOL COMMUN H, V65, P334, DOI 10.1136/jech.2009.096834; DKT International, 2011, PHIL 2 810 161 CYPS; Dutton L, 2008, J MIDWIFERY WOM HEAL, V53, P331, DOI 10.1016/j.jmwh.2008.02.003; Goldenberg SM, 2011, SOC SCI MED, V72, P1185, DOI 10.1016/j.socscimed.2011.02.014; Golub ET, 2004, J URBAN HEALTH, V81, P278, DOI 10.1093/jurban/jth114; Grayman JH, 2005, AIDS BEHAV, V9, P41, DOI 10.1007/s10461-005-1680-5; Gurnani V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-755; Hong Y, 2011, AIDS BEHAV; Hong Y, 2008, SEX TRANSM DIS, V35, P662, DOI 10.1097/OLQ.0b013e31816b322c; Kelly PJ, 2011, W J NURS RES; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Ko NY, 2009, AIDS CARE, V21, P1499, DOI 10.1080/09540120902923022; Krishnan AKS, 2007, AIDS EDUC PREV, V19, P334, DOI 10.1521/aeap.2007.19.4.334; Larios SE, 2009, AIDS CARE, V21, P1335, DOI 10.1080/09540120902803190; Minh TT, 2004, AIDS EDUC PREV, V16, P389, DOI 10.1521/aeap.16.5.389.48740; Morisky DE, 2002, HEALTH EDUC BEHAV, V29, P461, DOI 10.1177/109019810202900406; Morisky DE, 2010, PROSPECTS, V3, P335; Morisky DE, 2006, HEALTH PSYCHOL, V25, P595, DOI 10.1037/0278-6133.25.5.595; Morisky DE, 2011, AIDS CARE, V23, P83, DOI 10.1080/09540121.2011.554520; Morisky DE, 2010, ASIA-PAC J PUBLIC HE, V22, p151S, DOI 10.1177/1010539510373018; Nemoto T, 2011, AM J PUBLIC HEALTH, V101, P1980, DOI 10.2105/AJPH.2010.197285; NORBECK JS, 1981, NURS RES, V30, P264; NORBECK JS, 1983, NURS RES, V32, P4; Parrenas R.S., 2011, ILLICIT FLIRTATIONS; Philippines Department of Health National Epidemiology Center, 2010, HIV AIDS REG REP 201; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Santos AF, 1999, MAKING HARM VISIBLE; Sarkar K, 2008, J HEALTH POPUL NUTR, V26, P223; Seffner F, 2011, GLOB PUBLIC HEALTH, V6, pS271, DOI 10.1080/17441692.2011.602701; Shannon K, 2011, DRUG ALCOHOL DEPEN, V113, P76, DOI 10.1016/j.drugalcdep.2010.07.011; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Strathdee SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019048; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; Trinidad A, 2005, CHILD PORNOGRAPHY PH; UNAIDS, 2008, REP GLOB AIDS EP; United Nations Treaty Collection, 2000, PEN MATT S; United States Department of State, 2011, TRAFF PERS REP JUN 2; *UNODC, 2008, 2008 WORLD DRUG REP; Urada LA, 2013, AIDS BEHAV, V17, P523, DOI 10.1007/s10461-011-0113-x; Wong ML, 2005, SEX TRANSM DIS, V32, P439, DOI 10.1097/01.olq.0000168279.05452.ad	47	62	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33282	10.1371/journal.pone.0033282	http://dx.doi.org/10.1371/journal.pone.0033282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YB	22448241	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700031
J	Wu, L; Chen, H; Hu, Y; Xiang, HY; Yu, X; Zhang, T; Cao, ZQ; Wang, YJ				Wu, Li; Chen, Hui; Hu, Yang; Xiang, Huiyun; Yu, Xiang; Zhang, Tao; Cao, Zhongqiang; Wang, Youjie			Prevalence and Associated Factors of Elder Mistreatment in a Rural Community in People's Republic of China: A Cross-Sectional Study	PLOS ONE			English	Article							RISK-FACTORS; UNITED-STATES; ABUSE; NEGLECT; OLDER; SAMPLE	Background: Current knowledge about elder mistreatment is mainly derived from studies done in Western countries, which indicate that this problem is related to risk factors such as a shared living situation, social isolation, disease burden, and caregiver strain. We know little about prevalence and risk factors for elder mistreatment and mistreatment subtypes in rural China where the elder population is the most vulnerable. Methods: In 2010, we conducted a cross-sectional survey among older adults aged 60 or older in three rural communities in Macheng, a city in Hubei province, China. Of 2245 people initially identified, 2039 were available for interview and this was completed in 2000. A structured questionnaire was used to collect data regarding mistreatment and covariates. Logistic regression analysis was used to identify factors related to elder mistreatment and subtypes of mistreatment. Results: Elder mistreatment was reported by 36.2% (95% CI: 34.1%-38.3%) of the participants. Prevalence rates of psychological mistreatment, caregiver neglect, physical mistreatment, and financial mistreatment were 27.3% (95% CI: 25.3%-29.2%), 15.8% (95% CI: 14.2%-17.4%), 4.9% (95% CI: 3.9%-5.8%) and 2.0% (95% CI: 1.3%-2.6%), respectively. The multivariate logistic regression analysis revealed that depression, being widowed/divorced/single/separated, having a physical disability, having a labor intensive job, depending solely on self-made income, and living alone were risk factors for elder mistreatment. Different types of elder mistreatment were associated with different risk factors, and depression was the consistent risk factor for the three most common mistreatment subtypes. Conclusion: Older adults in rural China self-report a higher rate of mistreatment than their counterparts in Western countries. Depression is a main risk factor associated with most subtypes of mistreatment. Our findings suggest that prevention and management of elder mistreatment is a challenge facing a rapidly aging Chinese population.	[Wu, Li; Chen, Hui; Hu, Yang; Yu, Xiang; Zhang, Tao; Cao, Zhongqiang; Wang, Youjie] Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chen, Hui; Hu, Yang; Zhang, Tao; Wang, Youjie] Huazhong Univ Sci & Technol, Tongji Ctr Injury Prevent, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xiang, Huiyun] Ohio State Univ, Ctr Injury Res & Policy, Columbus, OH 43210 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Wu, L (corresponding author), Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	wangyoujie@mails.tjmu.edu.cn	Xiang, Huiyun/E-4335-2011		National Natural Science Foundation of China [30671733]; NECT Program [07-0333]; National Institutes of Health Fogarty International Center [1D43TW007257-01A2]; FOGARTY INTERNATIONAL CENTER [D43TW007257] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NECT Program; National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was funded by a grant support from National Natural Science Foundation of China, Project No: 30671733, NECT Program 07-0333, and USA-China Agricultural Injury Research Training Project, Grant #1D43TW007257-01A2, funded by the National Institutes of Health Fogarty International Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Boey KW, 2000, GERONTOLOGIST, V21, P49; Bonnie R. J., 2003, ELDER MISTREATMENT A; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; Cham G. W. M., 2000, SMJ Singapore Medical Journal, V41, P571; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Cohen M, 2007, J AM GERIATR SOC, V55, P1224, DOI 10.1111/j.1532-5415.2007.01269.x; Compton SA, 1997, INT J GERIATR PSYCH, V12, P632, DOI 10.1002/(SICI)1099-1166(199706)12:6<632::AID-GPS570>3.3.CO;2-0; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Dong X, 2007, ELDER ABUSE NEGL, V19, P79; Dong XQ, 2011, J AGING HEALTH, V23, P289, DOI 10.1177/0898264310385931; Dong XQ, 2010, ARCH GERONTOL GERIAT, V50, P202, DOI 10.1016/j.archger.2009.03.011; Dong XQ, 2008, J ELDER ABUSE NEGL, V20, P25, DOI 10.1300/J084v20n01_02; Dong XQ, 2005, CLIN GERIATR MED, V21, P293, DOI 10.1016/j.cger.2004.10.006; Fulmer Terry, 2002, Annu Rev Nurs Res, V20, P369; Garre-Olmo J, 2009, J AM GERIATR SOC, V57, P815, DOI 10.1111/j.1532-5415.2009.02221.x; Greenberg Jan R., 1990, J ELDER ABUSE NEGL, V2, P73, DOI DOI 10.1300/J084V02N01_05; Hwalek MA., 1986, J APPL GERONTOLOGY, V5, P153, DOI [DOI 10.1177/073346488600500205, DOI https://doi.org/10.1177/073346488600500205]; Lachs MS, 1997, GERONTOLOGIST, V37, P469, DOI 10.1093/geront/37.4.469; Lachs MS, 1998, JAMA-J AM MED ASSOC, V280, P428, DOI 10.1001/jama.280.5.428; Lachs MS, 2004, LANCET, V364, P1263, DOI 10.1016/S0140-6736(04)17144-4; Lam TH, 2004, ACTA PSYCHIAT SCAND, V110, P195, DOI 10.1111/j.1600-0447.2004.00342.x; Laumann EO, 2008, J GERONTOL B-PSYCHOL, V63, pS248, DOI 10.1093/geronb/63.4.S248; PAVEZA GJ, 1992, GERONTOLOGIST, V32, P493, DOI 10.1093/geront/32.4.493; Perez-Rojo G, 2009, ARCH GERONTOL GERIAT, V49, P17, DOI 10.1016/j.archger.2008.04.005; PILLEMER K, 1988, GERONTOLOGIST, V28, P51, DOI 10.1093/geront/28.1.51; Reay AMC, 2001, AGING MENT HEALTH, V5, P56, DOI 10.1080/13607860020020654; Schofield MJ, 2003, GERONTOLOGIST, V43, P110, DOI 10.1093/geront/43.1.110; Silverstein M, 2006, J GERONTOL B-PSYCHOL, V61, pS256, DOI 10.1093/geronb/61.5.S256; Thomas C, 2000, J ELDER ABUSE NEGL, V12, P1, DOI 10.1300/J084v12n01_01; Yan E, 2001, J INTERPERS VIOLENCE, V16, P1158, DOI 10.1177/088626001016011004; Yan E., 2002, TRAUMA VIOLENCE ABUS, V3, P167, DOI DOI 10.1177/15248380020033001; Zeng Y, 2003, RES AGING, V25, P65, DOI DOI 10.1177/0164027502238343	33	70	81	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33857	10.1371/journal.pone.0033857	http://dx.doi.org/10.1371/journal.pone.0033857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YB	22448276	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700067
J	Chibalin, AV; Heiny, JA; Benziane, B; Prokofiev, AV; Vasiliev, AV; Kravtsova, VV; Krivoi, II				Chibalin, Alexander V.; Heiny, Judith A.; Benziane, Boubacar; Prokofiev, Alexander V.; Vasiliev, Alexander V.; Kravtsova, Violetta V.; Krivoi, Igor I.			Chronic Nicotine Modifies Skeletal Muscle Na,K-ATPase Activity through Its Interaction with the Nicotinic Acetylcholine Receptor and Phospholemman	PLOS ONE			English	Article							NA+/K+-ATPASE; FXYD PROTEINS; ISOFORM; STIMULATION; REGULATORS; ALPHA-2; BRAIN	Our previous finding that the muscle nicotinic acetylcholine receptor (nAChR) and the Na,K-ATPase interact as a regulatory complex to modulate Na,K-ATPase activity suggested that chronic, circulating nicotine may alter this interaction, with long-term changes in the membrane potential. To test this hypothesis, we chronically exposed rats to nicotine delivered orally for 21-31 days. Chronic nicotine produced a steady membrane depolarization of similar to 3 mV in the diaphragm muscle, which resulted from a net change in electrogenic transport by the Na,K-ATPase alpha 2 and alpha 1 isoforms. Electrogenic transport by the alpha 2 isoform increased (+1.8 mV) while the activity of the alpha 1 isoform decreased (24.4 mV). Protein expression of Na,K-ATPase alpha 1 or alpha 2 isoforms and the nAChR did not change; however, the content of alpha 2 subunit in the plasma membrane decreased by 25%, indicating that its stimulated electrogenic transport is due to an increase in specific activity. The physical association between the nAChR, the Na,K-ATPase alpha 1 or alpha 2 subunits, and the regulatory subunit of the Na, K-ATPase, phospholemman (PLM), measured by co-immuno precipitation, was stable and unchanged. Chronic nicotine treatment activated PKC alpha/beta 2 and PKC delta and was accompanied by parallel increases in PLM phosphorylation at Ser(63) and Ser(68). Collectively, these results demonstrate that nicotine at chronic doses, acting through the nAChR-Na,K-ATPase complex, is able to modulate Na,K-ATPase activity in an isoform-specific manner and that the regulatory range includes both stimulation and inhibition of enzyme activity. Cholinergic modulation of Na,K-ATPase activity is achieved, in part, through activation of PKC and phosphorylation of PLM.	[Chibalin, Alexander V.; Benziane, Boubacar] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Heiny, Judith A.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH USA; [Prokofiev, Alexander V.; Vasiliev, Alexander V.; Kravtsova, Violetta V.; Krivoi, Igor I.] St Petersburg State Univ, Dept Gen Physiol, St Petersburg, Russia	Karolinska Institutet; University System of Ohio; University of Cincinnati; Saint Petersburg State University	Chibalin, AV (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	Alexander.Chibalin@ki.se; IgorKrivoi@IK4251.spb.edu	Krivoi, Igor/K-3546-2013; Vasiliev, Alexander/K-4229-2013; Kravtsova, Violetta V/K-1816-2013; Vasiliev, Alexander N/N-4742-2017	Krivoi, Igor/0000-0002-2690-9226; Vasiliev, Alexander/0000-0003-3751-7794; Kravtsova, Violetta V/0000-0002-3382-5848; Chibalin, Alexander/0000-0002-6339-6271	Russian Foundation for Basic Research [10-04-00970a]; Saint-Petersburg State University [1.37.118.2011]; Swedish Research Council; Novo-Nordisk Foundation; Hedlunds Foundation; Commission of the European Communities [LSHM-CT-2004-512013 EUGENEHEART]; University of Cincinnati	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Saint-Petersburg State University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo-Nordisk Foundation(Novo Nordisk Foundation); Hedlunds Foundation; Commission of the European Communities(European Commission); University of Cincinnati	This work was supported by the Russian Foundation for Basic Research grant #10-04-00970a and Saint-Petersburg State University research grant #1.37.118.2011, the Swedish Research Council, Novo-Nordisk Foundation, Hedlunds Foundation, and Commission of the European Communities Grants LSHM-CT-2004-512013 EUGENEHEART, and the Physiology Research Fund, University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz NL, 1997, BRIT J CLIN PHARMACO, V43, P259, DOI 10.1111/j.1365-2125.1997.00566.x; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Chibalin AV, 2001, ENDOCRINOLOGY, V142, P3474, DOI 10.1210/en.142.8.3474; Leite PEC, 2010, J NEUROIMMUNOL, V227, P44, DOI 10.1016/j.jneuroim.2010.06.005; Dey K, 2012, BIOCHIMIE, V94, P991, DOI 10.1016/j.biochi.2011.12.020; Di Angelantonio S, 2003, BRIT J PHARMACOL, V139, P1061, DOI 10.1038/sj.bjp.0705337; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2003, ANN NY ACAD SCI, V986, P388, DOI 10.1111/j.1749-6632.2003.tb07219.x; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Heiny JA, 2010, J BIOL CHEM, V285, P28614, DOI 10.1074/jbc.M110.150961; HENNING RH, 1994, BRIT J PHARMACOL, V111, P459, DOI 10.1111/j.1476-5381.1994.tb14758.x; Kragenbrink R, 1996, SYNAPSE, V23, P219, DOI 10.1002/(SICI)1098-2396(199607)23:3<219::AID-SYN11>3.0.CO;2-U; Kravtsova V V, 2008, Ross Fiziol Zh Im I M Sechenova, V94, P1181; Krivoi I, 2003, ANN NY ACAD SCI, V986, P639, DOI 10.1111/j.1749-6632.2003.tb07272.x; Krivoi II, 2006, PFLUG ARCH EUR J PHY, V452, P756, DOI 10.1007/s00424-006-0081-6; LARSSON L, 1988, ACTA PHYSIOL SCAND, V134, P519, DOI 10.1111/j.1365-201X.1988.tb10630.x; Lindstrom JM, 2003, ANN NY ACAD SCI, V998, P41, DOI 10.1196/annals.1254.007; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Rasmussen MK, 2008, ACTA PHYSIOL, V194, P67, DOI 10.1111/j.1748-1716.2008.01857.x; Reis J, 2005, J APPL PHYSIOL, V99, P1508, DOI 10.1152/japplphysiol.00375.2005; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; ROWELL PP, 1983, J PHARMACOL METHOD, V9, P249, DOI 10.1016/0160-5402(83)90064-5; RUFF RL, 1988, MUSCLE NERVE, V11, P502, DOI 10.1002/mus.880110514; Ruff RL, 2011, MUSCLE NERVE, V44, P854, DOI 10.1002/mus.22177; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Sparks JA, 1999, PSYCHOPHARMACOLOGY, V141, P145, DOI 10.1007/s002130050818; Sperelakis N, 2001, CELL PHYSL SOURCEBOO, P231; Sweadner Kathleen J., 1995, P259; Wang H, 2005, BRAIN RES REV, V48, P420, DOI 10.1016/j.brainresrev.2004.09.003; WANG L, 1994, BIOCHEM BIOPH RES CO, V199, P1422, DOI 10.1006/bbrc.1994.1389	35	28	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33719	10.1371/journal.pone.0033719	http://dx.doi.org/10.1371/journal.pone.0033719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442718	Green Submitted, Green Published, gold			2022-12-27	WOS:000303836500059
J	Lavi-Itzkovitz, A; Tcherpakov, M; Levy, Z; Itzkovitz, S; Muscatelli, F; Fainzilber, M				Lavi-Itzkovitz, Anat; Tcherpakov, Marianna; Levy, Zehava; Itzkovitz, Shalev; Muscatelli, Francoise; Fainzilber, Mike			Functional Consequences of Necdin Nucleocytoplasmic Localization	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; P75 NEUROTROPHIN RECEPTOR; SYNDROME PROTEIN NECDIN; GROWTH SUPPRESSOR NECDIN; BIOLOGICAL NETWORKS; NUCLEAR IMPORT; GENE; INTERACTS; DISRUPTION; TRANSPORT	Background: Necdin, a MAGE family protein expressed primarily in the nervous system, has been shown to interact with both nuclear and cytoplasmic proteins, but the mechanism of its nucleocytoplasmic transport are unknown. Methodology/Principal Findings: We carried out a large-scale interaction screen using necdin as a bait in the yeast RRS system, and found a wide range of potential interactors with different subcellular localizations, including over 60 new candidates for direct binding to necdin. Integration of these interactions into a comprehensive network revealed a number of coherent interaction modules, including a cytoplasmic module connecting to necdin through huntingtin-associated protein 1 (Hap1), dynactin and hip-1 protein interactor (Hippi); a nuclear P53 and Creb-binding-protein (Crebbp) module, connecting through Crebbp and WW domain-containing transcription regulator protein 1 (Wwtr1); and a nucleocytoplasmic transport module, connecting through transportins 1 and 2. We validated the necdin-transportin1 interaction and characterized a sequence motif in necdin that modulates karyopherin interaction. Surprisingly, a D234P necdin mutant showed enhanced binding to both transportin1 and importin beta 1. Finally, exclusion of necdin from the nucleus triggered extensive cell death. Conclusions/Significance: These data suggest that necdin has multiple roles within protein complexes in different subcellular compartments, and indicate that it can utilize multiple karyopherin-dependent pathways to modulate its localization.	[Lavi-Itzkovitz, Anat; Tcherpakov, Marianna; Levy, Zehava; Itzkovitz, Shalev; Fainzilber, Mike] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Muscatelli, Francoise] INSERM, Inst Neurobiol Mediterranee, U901, F-13258 Marseille, France	Weizmann Institute of Science; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lavi-Itzkovitz, A (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	mike.fainzilber@weizmann.ac.il	Muscatelli, Françoise/P-4650-2016	Muscatelli, Françoise/0000-0003-4001-6528; Fainzilber, Mike/0000-0001-8173-8557	European Union [LSHM-CT-2005-512136]; Benoziyo Center for Neurological Diseases at Weizmann Institute of Science	European Union(European Commission); Benoziyo Center for Neurological Diseases at Weizmann Institute of Science	The work was supported by the European Union Framework 6 program (Project # LSHM-CT-2005-512136) and by the Benoziyo Center for Neurological Diseases at the Weizmann Institute of Science. M. F. is the incumbent of the Chaya Professorial Chair in Molecular Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023764; Andrieu D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-56; Aronheim Ami, 2004, Methods Mol Biol, V250, P251; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bogerd HP, 1999, J BIOL CHEM, V274, P9771, DOI 10.1074/jbc.274.14.9771; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Bronfman FC, 2004, EMBO REP, V5, P867, DOI 10.1038/sj.embor.7400219; Bush JR, 2008, DIFFERENTIATION, V76, P994, DOI 10.1111/j.1432-0436.2008.00281.x; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Dunn R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-39; Friedman ER, 2007, BIOCHEM BIOPH RES CO, V363, P113, DOI 10.1016/j.bbrc.2007.08.108; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Harel L, 2010, DEV NEUROBIOL, V70, P298, DOI 10.1002/dneu.20769; Harel L, 2009, NEURON, V63, P585, DOI 10.1016/j.neuron.2009.08.020; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; Haviland R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024923; Hu ZJ, 2005, NUCLEIC ACIDS RES, V33, pW352, DOI 10.1093/nar/gki431; Iijima M, 2006, FEBS LETT, V580, P1365, DOI 10.1016/j.febslet.2006.01.058; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Kanber D, 2009, EUR J HUM GENET, V17, P582, DOI 10.1038/ejhg.2008.232; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Kaul R, 2009, J VIROL, V83, P4871, DOI 10.1128/JVI.02286-08; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; Kuwako K, 2005, J NEUROSCI, V25, P7090, DOI 10.1523/JNEUROSCI.2083-05.2005; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee S, 2005, HUM MOL GENET, V14, P627, DOI 10.1093/hmg/ddi059; Lima-Mendez G, 2009, MOL BIOSYST, V5, P1482, DOI 10.1039/b908681a; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Reimand J, 2008, NUCLEIC ACIDS RES, V36, pW452, DOI 10.1093/nar/gkn230; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 2005, J CELL BIOCHEM, V94, P804, DOI 10.1002/jcb.20345; Taniura H, 2002, J CELL BIOCHEM, V84, P545, DOI 10.1002/jcb.10047.abs; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Tennese AA, 2008, DEV DYNAM, V237, P1935, DOI 10.1002/dvdy.21615; Velichkova M, 2005, MOL CELL BIOL, V25, P4501, DOI 10.1128/MCB.25.11.4501-4513.2005; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33786	10.1371/journal.pone.0033786	http://dx.doi.org/10.1371/journal.pone.0033786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442722	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500063
J	Liang, H; Baudouin, C; Labbe, A; Riancho, L; Brignole-Baudouin, F				Liang, Hong; Baudouin, Christophe; Labbe, Antoine; Riancho, Luisa; Brignole-Baudouin, Francoise			Conjunctiva-Associated Lymphoid Tissue (CALT) Reactions to Antiglaucoma Prostaglandins with or without BAK-Preservative in Rabbit Acute Toxicity Study	PLOS ONE			English	Article							VIVO CONFOCAL MICROSCOPY; IN-VIVO; OCULAR SURFACE; BENZALKONIUM CHLORIDE; INFLAMMATORY MARKERS; FREE TAFLUPROST; LATANOPROST; TRAVOPROST; BIMATOPROST; EXPRESSION	Conjunctiva-associated lymphoid tissue (CALT) is closely associated with ocular surface immunity. This study investigated the effects of antiglaucoma prostaglandin analogs with or without benzalkonium chloride (BAK) preservative on organized CALT using an acute toxic model. A total of 48 albino rabbits were used and seven groups of treatments were constituted. Solutions (50 mu l) of PBS, 0.02% BAK, (0.02%BAK+)latanoprost, (0.015% BAK+)travoprost, (0.005%BAK+)bimatoprost, (BAK-free)travoprost preserved with the SofZia (R) system or(BAK-free) tafluprost were instilled 15 times at 5-min intervals in both eyes. CALT changes were analyzed using in vivo confocal microscopy (IVCM), immunohistology in cryosections for detecting MUC-5AC+ mucocytes and CD45+ hematopoietic cells. Antiglaucoma eye drops stimulated inflammatory cell infiltration in the CALT, and seemed to be primarily related to the concentration of their BAK content. The CALT reaction after instillation of BAK-containing eye drops was characterized by inflammatory cell infiltration in the dome and intrafollicular layers and by cell circulation inside the lymph vessels. CD45 was strongly expressed in the CALT after instillation of all BAK-containing solutions at 4 h and decreased at 24 h. The number of MUC-5AC+ mucocytes around the CALT structure decreased dramatically after instillation of BAK-containing solutions. This study showed for the first time the in vivo aspect of rabbit CALT after toxic stimuli, confirming the concentration-dependent toxic effects of BAK. IVCM-CALT analysis could be a pertinent tool in the future for understanding the immunotoxicologic challenges in the ocular surface and would provide useful criteria for evaluating newly developed eye drops.	[Liang, Hong; Baudouin, Christophe; Labbe, Antoine; Riancho, Luisa; Brignole-Baudouin, Francoise] INSERM, U968, Paris, France; [Liang, Hong; Baudouin, Christophe; Labbe, Antoine; Riancho, Luisa; Brignole-Baudouin, Francoise] Univ Paris 06, UPMC, UMR S 968, Inst Vis, Paris, France; [Liang, Hong; Baudouin, Christophe; Labbe, Antoine; Riancho, Luisa; Brignole-Baudouin, Francoise] CNRS, UMR 7210, Paris, France; [Liang, Hong; Baudouin, Christophe; Labbe, Antoine; Brignole-Baudouin, Francoise] INSERM, DHOS CIC 503, Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [Baudouin, Christophe; Brignole-Baudouin, Francoise] Hop Ambroise Pare, AP HP, Serv Ophtalmol, Boulogne, France; [Baudouin, Christophe; Labbe, Antoine] Univ Versailles St Quentin En Yvelines, Versailles, France; [Brignole-Baudouin, Francoise] Univ Paris 05, Fac Sci Pharmaceut & Biol, Toxicol Lab, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Liang, H (corresponding author), INSERM, U968, Paris, France.	frbaudouin@aol.com	Liang, Hong/V-4518-2019	Liang, Hong/0000-0002-0579-8651; Labbe, Antoine/0000-0003-3057-3558; Baudouin, Christophe/0000-0003-1743-6698; BRIGNOLE-BAUDOUIN, FRANCOISE/0000-0002-2006-5384	INSERM, UMR_S968, Institut de la Vision	INSERM, UMR_S968, Institut de la Vision	This study was supported by unrestricted academic grants from INSERM, UMR_S968, Institut de la Vision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagoz G, 2008, OPHTHALMOLOGICA, V222, P161, DOI 10.1159/000126078; Banerjee S, 2003, BRIT J OPHTHALMOL, V87, P1515, DOI 10.1136/bjo.87.12.1515; Baudouin C, 2005, J ALLERGY CLIN IMMUN, V116, P614, DOI 10.1016/j.jaci.2005.05.033; Baudouin C, 2004, OPHTHALMOLOGY, V111, P2186, DOI 10.1016/j.ophtha.2004.06.023; Baudouin C, 2008, OPHTHALMOLOGY, V115, P109, DOI 10.1016/j.ophtha.2007.01.036; Baudouin C, 2007, INVEST OPHTH VIS SCI, V48, P4123, DOI 10.1167/iovs.07-0266; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Brasnu E, 2008, CURR EYE RES, V33, P303, DOI 10.1080/02713680801971857; Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P2525; FRANKLIN RM, 1984, INVEST OPHTH VIS SCI, V25, P181; Gerberick GF, 2002, TOXICOL SCI, V68, P420, DOI 10.1093/toxsci/68.2.420; ICHIJIMA H, 1992, CORNEA, V11, P221; Jean MD, 1999, INVEST OPHTH VIS SCI, V40, P619; Knop E, 2005, OCUL SURF, V3, pS180; Knop N, 2005, J ANAT, V207, P409, DOI 10.1111/j.1469-7580.2005.00470.x; Knop N, 2010, DEV OPHTHALMOL, V45, P23, DOI 10.1159/000315017; Konstas AGP, 2005, OPHTHALMOLOGY, V112, P262, DOI 10.1016/j.ophtha.2004.08.022; Liang H, 2008, BRIT J OPHTHALMOL, V92, P1275, DOI 10.1136/bjo.2008.138768; Liang H, 2008, MOL VIS, V14, P204; Liang H, 2006, MOL VIS, V12, P1392; Liang H, 2010, INVEST OPHTH VIS SCI, V51, P1008, DOI 10.1167/iovs.09-3509; Liang H, 2009, MOL VIS, V15, P1690; Malvitte L, 2007, BRIT J OPHTHALMOL, V91, P29, DOI 10.1136/bjo.2006.101485; Martone G, 2009, AM J OPHTHALMOL, V147, P725, DOI 10.1016/j.ajo.2008.10.019; Patel DV, 2009, BRIT J OPHTHALMOL, V93, P853, DOI 10.1136/bjo.2008.150615; Pauly A, 2009, INVEST OPHTH VIS SCI, V50, P1644, DOI 10.1167/iovs.08-2992; Peebo BB, 2010, INVEST OPHTH VIS SCI, V51, P830, DOI 10.1167/iovs.09-4407; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; Steven P, 2008, INVEST OPHTH VIS SCI, V49, P1512, DOI 10.1167/iovs.07-0809; Uter W, 2008, CONTACT DERMATITIS, V58, P359, DOI 10.1111/j.1600-0536.2008.01327.x; WILLIS CM, 1990, J INVEST DERMATOL, V95, P711, DOI 10.1111/1523-1747.ep12514510	31	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33913	10.1371/journal.pone.0033913	http://dx.doi.org/10.1371/journal.pone.0033913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442734	Green Submitted, Green Published, gold			2022-12-27	WOS:000303836500075
J	Pontier-Bres, R; Prodon, F; Munro, P; Rampal, P; Lemichez, E; Peyron, JF; Czerucka, D				Pontier-Bres, Rodolphe; Prodon, Francois; Munro, Patrick; Rampal, Patrick; Lemichez, Emmanuel; Peyron, Jean Francois; Czerucka, Dorota			Modification of Salmonella Typhimurium Motility by the Probiotic Yeast Strain Saccharomyces boulardii	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; FLAGELLAR ROTATION; BACTERIAL MOTILITY; ESCHERICHIA-COLI; RAT ILEUM; T84 CELLS; ENTERICA; INTERFERES; CHEMOTAXIS; INDUCTION	Background: Motility is an important component of Salmonella enterica serovar Typhimurium (ST) pathogenesis allowing the bacteria to move into appropriate niches, across the mucus layer and invade the intestinal epithelium. In vitro, flagellum-associated motility is closely related to the invasive properties of ST. The probiotic yeast Saccharomyces boulardii BIOCODEX (S.b-B) is widely prescribed for the prophylaxis and treatment of diarrheal diseases caused by bacteria or antibiotics. In case of Salmonella infection, S.b-B has been shown to decrease ST invasion of T84 colon cell line. The present study was designed to investigate the impact of S.b-B on ST motility. Methodology/Principal Findings: Experiments were performed on human colonic T84 cells infected by the Salmonella strain 1344 alone or in the presence of S.b-B. The motility of Salmonella was recorded by time-lapse video microscopy. Next, a manual tracking was performed to analyze bacteria dynamics (MTrackJ plugin, NIH image J software). This revealed that the speed of bacterial movement was modified in the presence of S.b-B. The median curvilinear velocity (CLV) of Salmonella incubated alone with T84 decreased from 43.3 mu m/sec to 31.2 mm/sec in the presence of S.b-B. Measurement of track linearity (TL) showed similar trends: S.b-B decreased by 15% the number of bacteria with linear tract (LT) and increased by 22% the number of bacteria with rotator tract (RT). Correlation between ST motility and invasion was further established by studying a non-motile flagella-deficient ST strain. Indeed this strain that moved with a CLV of 0.5 mu m/sec, presented a majority of RT and a significant decrease in invasion properties. Importantly, we show that S.b-B modified the motility of the pathogenic strain SL1344 and significantly decreased invasion of T84 cells by this strain. Conclusions: This study reveals that S.b-B modifies Salmonella's motility and trajectory which may account for the modification of Salmonella's invasion.	[Pontier-Bres, Rodolphe; Prodon, Francois; Peyron, Jean Francois; Czerucka, Dorota] Fac Med Nice, INSERM, Ctr Mediterraneen Med Mol C3M, Equipe Inflammat,U895, F-06034 Nice, France; [Pontier-Bres, Rodolphe; Prodon, Francois; Munro, Patrick; Lemichez, Emmanuel; Peyron, Jean Francois; Czerucka, Dorota] Univ Nice Sophia Antipolis, UFR Med, IFR50, Fac Med, Nice, France; [Peyron, Jean Francois] Hop Archet, Serv Pediat, Ctr Hosp Univ, Nice, France; [Peyron, Jean Francois] Hop Archet, Serv Hematol Clin, Ctr Hosp Univ, Nice, France; [Rampal, Patrick] Ctr Hosp Princesse Grace, Serv Hepatogastroenterol, Monaco, Monaco; [Munro, Patrick; Lemichez, Emmanuel] INSERM, U895, Ctr Mediterraneen Med Mol C3M, Equipe Toxines Microbiennes Relat Hote Pathogenes, F-75654 Paris 13, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm)	Pontier-Bres, R (corresponding author), Fac Med Nice, INSERM, Ctr Mediterraneen Med Mol C3M, Equipe Inflammat,U895, U210, F-06034 Nice, France.	czerucka@unice.fr	Jean-Francois, Peyron/AAA-9496-2022; Prodon, Francois/G-2726-2017; Lemichez, Emmanuel/G-3559-2013; Peyron, Jean-Francois/M-5682-2016; Munro, Patrick/A-6579-2009	Jean-Francois, Peyron/0000-0001-6113-916X; Lemichez, Emmanuel/0000-0001-9080-7761; Peyron, Jean-Francois/0000-0001-6113-916X; Munro, Patrick/0000-0003-4283-4671; PONTIER-BRES, Rodolphe/0000-0002-4139-5913	BIOCODEX S.A. (Gentilly, France); INSERM; Region Provence-Alpes Cote d'Azur; Conseil General des Alpes Maritimes; Biocodex	BIOCODEX S.A. (Gentilly, France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Provence-Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Biocodex	This study was supported by BIOCODEX S.A. (Gentilly, France), INSERM, the Region Provence-Alpes Cote d'Azur and the Conseil General des Alpes Maritimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; DC has acted as scientific advisor to BIOCODEX S. A. (Gentilly, France); she has also received a travel grant from them. PR acts as an expert for Biocodex S. A. and received travel grant from them. RPB's and DC's salaries are paid by a non-profit association sponsored by Biocodex. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; BLAIR DF, 1995, ANNU REV MICROBIOL, V49, P489, DOI 10.1146/annurev.mi.49.100195.002421; Castagliuolo I, 1996, INFECT IMMUN, V64, P5225, DOI 10.1128/IAI.64.12.5225-5232.1996; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; CZERUCKA D, 1994, GASTROENTEROLOGY, V106, P65, DOI 10.1016/S0016-5085(94)94403-2; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Czerucka D, 2000, INFECT IMMUN, V68, P5998, DOI 10.1128/IAI.68.10.5998-6004.2000; Dahan S, 2003, INFECT IMMUN, V71, P766, DOI 10.1128/IAI.71.2.766-773.2003; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; Frenchel T, 2004, FEMS MICROBIOL ECOL, V48, P231; Hopkins KL, 2008, EMERG INFECT DIS, V14, P340, DOI 10.3201/eid1402.070573; JONES BD, 1992, INFECT IMMUN, V60, P2475, DOI 10.1128/IAI.60.6.2475-2480.1992; JONES GW, 1981, J GEN MICROBIOL, V127, P351; Karim QN, 1998, J CLIN PATHOL, V51, P623, DOI 10.1136/jcp.51.8.623; KHORAMIANFALSAFI T, 1990, MICROB PATHOGENESIS, V9, P47, DOI 10.1016/0882-4010(90)90039-S; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; Lux R, 2004, CRIT REV ORAL BIOL M, V15, P207, DOI 10.1177/154411130401500404; Macnab R. M., 1987, ESCHERICHIA COLI SAL, V1, P732; Magariyama Y, 1995, BIOPHYS J, V69, P2154, DOI 10.1016/S0006-3495(95)80089-5; Martins FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008925; MARWAN W, 1991, J BACTERIOL, V173, P1971, DOI 10.1128/jb.173.6.1971-1977.1991; Mitchell JG, 2006, FEMS MICROBIOL ECOL, V55, P3, DOI 10.1111/j.1574-6941.2005.00003.x; Mumy KL, 2008, AM J PHYSIOL-GASTR L, V294, pG599, DOI 10.1152/ajpgi.00391.2007; POOLE PS, 1988, ANAL BIOCHEM, V175, P52, DOI 10.1016/0003-2697(88)90359-4; POTHOULAKIS C, 1993, GASTROENTEROLOGY, V104, P1108, DOI 10.1016/0016-5085(93)90280-P; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; TOMITA T, 1982, INFECT IMMUN, V38, P865, DOI 10.1128/IAI.38.3.865-870.1982; Wan MB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.018102; Whichard JM, 2007, EMERG INFECT DIS, V13, P1681, DOI 10.3201/eid1311.061438	31	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33796	10.1371/journal.pone.0033796	http://dx.doi.org/10.1371/journal.pone.0033796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442723	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500064
J	Sreekumar, PG; Spee, C; Ryan, SJ; Cole, SPC; Kannan, R; Hinton, DR				Sreekumar, Parameswaran G.; Spee, Christine; Ryan, Stephen J.; Cole, Susan P. C.; Kannan, Ram; Hinton, David R.			Mechanism of RPE Cell Death in alpha-Crystallin Deficient Mice: A Novel and Critical Role for MRP1-Mediated GSH Efflux	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-1; PIGMENT EPITHELIAL-CELLS; OXIDATIVE STRESS; MACULAR DEGENERATION; GLUTATHIONE DISULFIDE; INDUCED APOPTOSIS; TUMOR-CELLS; MRP1; TRANSPORT; EXPORT	Absence of alpha-crystallins (alpha A and alpha B) in retinal pigment epithelial (RPE) cells renders them susceptible to oxidant-induced cell death. We tested the hypothesis that the protective effect of alpha-crystallin is mediated by changes in cellular glutathione (GSH) and elucidated the mechanism of GSH efflux. In alpha-crystallin overexpressing cells resistant to cell death, cellular GSH was >2 fold higher than vector control cells and this increase was seen particularly in mitochondria. The high GSH levels associated with alpha-crystallin overexpression were due to increased GSH biosynthesis. On the other hand, cellular GSH was decreased by 50% in murine retina lacking alpha A or alpha B crystallin. Multiple multidrug resistance protein (MRP) family isoforms were expressed in RPE, among which MRP1 was the most abundant. MRP1 was localized to the plasma membrane and inhibition of MRP1 markedly decreased GSH efflux. MRP1-suppressed cells were resistant to cell death and contained elevated intracellular GSH and GSSG. Increased GSH in MRP1-supressed cells resulted from a higher conversion of GSSG to GSH by glutathione reductase. In contrast, GSH efflux was significantly higher in MRP1 overexpressing RPE cells which also contained lower levels of cellular GSH and GSSG. Oxidative stress further increased GSH efflux with a decrease in cellular GSH and rendered cells apoptosis-prone. In conclusion, our data reveal for the first time that 1) MRP1 mediates GSH and GSSG efflux in RPE cells; 2) MRP1 inhibition renders RPE cells resistant to oxidative stress-induced cell death while MRP1 overexpression makes them susceptible and 3) the antiapoptotic function of alpha-crystallin in oxidatively stressed cells is mediated in part by GSH and MRP1. Our findings suggest that MRP1 and alpha crystallin are potential therapeutic targets in pathological retinal degenerative disorders linked to oxidative stress.	[Sreekumar, Parameswaran G.; Spee, Christine; Ryan, Stephen J.; Kannan, Ram; Hinton, David R.] Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Ryan, Stephen J.; Kannan, Ram] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Cole, Susan P. C.] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON, Canada; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	Doheny Eye Institute; University of Southern California; Queens University - Canada; University of Southern California	Sreekumar, PG (corresponding author), Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, 1355 San Pablo St, Los Angeles, CA 90033 USA.	dhinton@usc.edu	kannan, ram/ABB-7154-2020; Cole, Susan P.C./I-6389-2017	kannan, ram/0000-0002-1583-3414; Cole, Susan P.C./0000-0001-6571-6884; /0000-0002-9425-3986	National Eye Institute [EY03040, EY01545]; Arnold and Mabel Beckman Foundation; Research to Prevent Blindness; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY003040, R01EY001545] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Arnold and Mabel Beckman Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grants EY03040 and EY01545 from the National Eye Institute, the Arnold and Mabel Beckman Foundation and a grant to the Department of Ophthalmology from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Armstrong JS, 2008, ANTIOXID REDOX SIGN, V10, P575, DOI 10.1089/ars.2007.1929; Arrigo AP, 2005, ANTIOXID REDOX SIGN, V7, P414, DOI 10.1089/ars.2005.7.414; Aukunuru JV, 2001, PHARM RES-DORDR, V18, P565, DOI 10.1023/A:1011060705599; Balcerczyk A, 2003, FREE RADICAL RES, V37, P189, DOI 10.1080/1071576021000040989; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Cai JY, 2000, PROG RETIN EYE RES, V19, P205, DOI 10.1016/S1350-9462(99)00009-9; Cai X, 2012, FRONT BIOSCI-LANDMRK, V17, P1976, DOI 10.2741/4033; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Courtois Y, 2010, AGING-US, V2, P888, DOI 10.18632/aging.100237; DAVIDSON PC, 1994, INVEST OPHTH VIS SCI, V35, P2843; Davis MA, 2000, TOXICOL SCI, V53, P48, DOI 10.1093/toxsci/53.1.48; Devadas S, 2003, FREE RADICAL BIO MED, V35, P648, DOI 10.1016/S0891-5849(03)00391-5; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Jungsuwadee P, 2009, MOL PHARMACOL, V75, P1117, DOI 10.1124/mol.108.052209; Kannan R, 2001, INVEST OPHTH VIS SCI, V42, P409; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Laberge RM, 2007, BIOCHEM PHARMACOL, V73, P1727, DOI 10.1016/j.bcp.2007.02.005; Lash LH, 2006, CHEM-BIOL INTERACT, V163, P54, DOI 10.1016/j.cbi.2006.03.001; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; Mannermaa E, 2009, PHARM RES-DORD, V26, P1785, DOI 10.1007/s11095-009-9890-6; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Marchan R, 2008, BBA-BIOMEMBRANES, V1778, P2413, DOI 10.1016/j.bbamem.2008.06.011; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Markovets AM, 2011, AGING-US, V3, P44; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Mueller CFH, 2005, CIRC RES, V97, P637, DOI 10.1161/01.RES.0000183734.21112.b7; Mueller CFH, 2010, J MOL CELL CARDIOL, V49, P482, DOI 10.1016/j.yjmcc.2010.02.023; Picard E, 2010, AGING-US, V2, P981, DOI 10.18632/aging.100218; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Sreekumar PG, 2009, EXP EYE RES, V88, P410, DOI 10.1016/j.exer.2008.10.009; Sreekumar PG, 2005, BIOCHEM BIOPH RES CO, V334, P245, DOI 10.1016/j.bbrc.2005.06.081; Trompier D, 2004, CANCER RES, V64, P4950, DOI 10.1158/0008-5472.CAN-04-0143; Widder JD, 2007, ARTERIOSCL THROM VAS, V27, P762, DOI 10.1161/01.ATV.0000259298.11129.a2; Yang JJ, 2007, PHARM RES-DORDR, V24, P1490, DOI 10.1007/s11095-007-9267-7; Yaung J, 2008, EXP EYE RES, V86, P355, DOI 10.1016/j.exer.2007.11.007; Yaung J, 2007, MOL VIS, V13, P566; Zhao C, 2011, AGING-US, V3, P346, DOI 10.18632/aging.100303; Zhu DH, 2009, AGING-US, V1, P740, DOI 10.18632/aging.100078; Zhu DH, 2009, J BIOL CHEM, V284, P9529, DOI 10.1074/jbc.M809393200	51	50	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33420	10.1371/journal.pone.0033420	http://dx.doi.org/10.1371/journal.pone.0033420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442691	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500032
J	Vaitheesvaran, B; Yang, L; Hartil, K; Glaser, S; Yazulla, S; Bruce, JE; Kurland, IJ				Vaitheesvaran, Bhavapriya; Yang, Li; Hartil, Kirsten; Glaser, Sherrye; Yazulla, Stephen; Bruce, James E.; Kurland, Irwin J.			Peripheral Effects of FAAH Deficiency on Fuel and Energy Homeostasis: Role of Dysregulated Lysine Acetylation	PLOS ONE			English	Article							ACID-AMIDE-HYDROLASE; HEPATIC CB1 RECEPTORS; ENDOCANNABINOID SYSTEM; CHOLESTEROL-SYNTHESIS; PROTEIN-SYNTHESIS; GLUCOSE DISPOSAL; PPAR-GAMMA; METABOLISM; ACTIVATION; ANANDAMIDE	Background: FAAH (fatty acid amide hydrolase), primarily expressed in the liver, hydrolyzes the endocannabinoids fatty acid ethanolamides (FAA). Human FAAH gene mutations are associated with increased body weight and obesity. In our present study, using targeted metabolite and lipid profiling, and new global acetylome profiling methodologies, we examined the role of the liver on fuel and energy homeostasis in whole body FAAH(-/-) mice. Methodology/Principal Findings: FAAH(-/-) mice exhibit altered energy homeostasis demonstrated by decreased oxygen consumption (Indirect calorimetry). FAAH(-/-) mice are hyperinsulinemic and have adipose, skeletal and hepatic insulin resistance as indicated by stable isotope phenotyping (SIPHEN). Fed state skeletal muscle and liver triglyceride levels was increased 2-3 fold, while glycogen was decreased 42% and 57% respectively. Hepatic cholesterol synthesis was decreased 22% in FAAH(-/-) mice. Dysregulated hepatic FAAH(-/-) lysine acetylation was consistent with their metabolite profiling. Fasted to fed increases in hepatic FAAH(-/-) acetyl-CoA (85%, p<0.01) corresponded to similar increases in citrate levels (45%). Altered FAAH(-/-) mitochondrial malate dehydrogenase (MDH2) acetylation, which can affect the malate aspartate shuttle, was consistent with our observation of a 25% decrease in fed malate and aspartate levels. Decreased fasted but not fed dihydroxyacetone-P and glycerol-3-P levels in FAAH(-/-) mice was consistent with a compensating contribution from decreased acetylation of fed FAAH(-/-) aldolase B. Fed FAAH(-/-) alcohol dehydrogenase (ADH) acetylation was also decreased. Conclusions/Significance: Whole body FAAH deletion contributes to a pre-diabetic phenotype by mechanisms resulting in impairment of hepatic glucose and lipid metabolism. FAAH(-/-) mice had altered hepatic lysine acetylation, the pattern sharing similarities with acetylation changes reported with chronic alcohol treatment. Dysregulated hepatic lysine acetylation seen with impaired FAA hydrolysis could support the liver's role in fostering the pre-diabetic state, and may reflect part of the mechanism underlying the hepatic effects of endocannabinoids in alcoholic liver disease mouse models.	[Vaitheesvaran, Bhavapriya; Hartil, Kirsten; Kurland, Irwin J.] Albert Einstein Coll Med Diabet Ctr, Stable Isotope & Metabol Core Facil, Dept Med, Bronx, NY 10461 USA; [Yang, Li] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Glaser, Sherrye; Yazulla, Stephen] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Bruce, James E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Washington State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Washington; University of Washington Seattle	Vaitheesvaran, B (corresponding author), Albert Einstein Coll Med Diabet Ctr, Stable Isotope & Metabol Core Facil, Dept Med, Bronx, NY 10461 USA.	irwin.kurland@einstein.yu.edu			National Institutes of Health [R01GM- 086688, R01RR023334, S10RR025107, DK58132-01A2]; Diabetes Research and Training Center (DRTC) NIH [P60DK020541]; NIAID [U19AI091175-01, 1R21AI090473-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025107, R01RR023334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091175, R21AI090473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK058132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Training Center (DRTC) NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The present work was supported by National Institutes of Health grants R01GM- 086688, R01RR023334, and S10RR025107 to J.E.B.; DK58132-01A2 grant to I.J.K., and method development is additionally supported by Diabetes Research and Training Center (DRTC) NIH grant P60DK020541, and NIAID grants U19AI091175-01 and 1R21AI090473-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; BARANYAI JM, 1989, BIOCHEM J, V258, P121, DOI 10.1042/bj2580121; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bouaboula M, 2005, EUR J PHARMACOL, V517, P174, DOI 10.1016/j.ejphar.2005.05.032; Brunengraber DZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE917, DOI 10.1152/ajpendo.00128.2003; Cota D, 2008, FRONT HORM RES, V36, P135, DOI 10.1159/000115362; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; Das UN, 2010, NUTRITION, V26, P459, DOI 10.1016/j.nut.2009.09.020; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; Despres Jean-Pierre, 2007, Crit Pathw Cardiol, V6, P46, DOI 10.1097/HPC.0b013e318057d4b4; Di Marzo V, 1998, NEUROBIOL DIS, V5, P386, DOI 10.1006/nbdi.1998.0214; Di Marzo V, 1999, CURR MED CHEM, V6, P721; Di Marzo V, 2011, P NATL ACAD SCI USA, V108, P12567, DOI 10.1073/pnas.1109567108; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; Dufner DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE1277, DOI 10.1152/ajpendo.00580.2004; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Engeli Stefan, 2006, Clin Cornerstone, V8 Suppl 4, pS24, DOI 10.1016/S1098-3597(06)80041-4; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Friedman SL, 2008, CELL METAB, V7, P187, DOI 10.1016/j.cmet.2008.02.002; Gaetani S, 2008, Eat Weight Disord, V13, pe42; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Gatta-Cherifi B, 2011, INT J OBES LOND; Ghoshal AK, 2005, CLIN CHIM ACTA, V358, P104, DOI 10.1016/j.cccn.2005.02.011; Gilibili RR, 2011, BIOMED CHROMATOGR, V25, P1352, DOI 10.1002/bmc.1608; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Glaser ST, 2006, J PHARMACOL EXP THER, V316, P1088, DOI 10.1124/jpet.105.094748; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Karaliota S, 2009, OBESITY, V17, P1830, DOI 10.1038/oby.2009.177; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; KUPKE IR, 1978, J CHROMATOGR, V146, P261, DOI 10.1016/S0378-4347(00)81892-7; LEE WNP, 1994, AM J PHYSIOL, V266, pE699, DOI 10.1152/ajpendo.1994.266.5.E699; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Mallat A, 2008, DIABETES METAB, V34, P680, DOI 10.1016/S1262-3636(08)74604-4; Matias I, 2006, INT J OBESITY, V30, pS7, DOI 10.1038/sj.ijo.0803271; Monteleone P, 2008, PSYCHONEUROENDOCRINO, V33, P546, DOI 10.1016/j.psyneuen.2008.01.004; Muccioli GG, 2010, DRUG DISCOV TODAY; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Previs SF, 2004, AM J PHYSIOL-ENDOC M, V286, pE665, DOI 10.1152/ajpendo.00271.2003; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Shepard BD, 2010, ALCOHOL CLIN EXP RES, V34, P280, DOI 10.1111/j.1530-0277.2009.01091.x; Silvestri C, 2011, REV ENDOCR METAB DIS, V12, P153, DOI 10.1007/s11154-011-9167-3; Sipe JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008792; Snider NT, 2010, PHARMACOL REV, V62, P136, DOI 10.1124/pr.109.001081; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Tourino C, 2010, INT J OBESITY, V34, P557, DOI 10.1038/ijo.2009.262; Vaitheesvaran B, 2010, DIABETOLOGIA, V53, P2224, DOI 10.1007/s00125-010-1827-4; Vaitheesvaran B, 2010, METABOLOMICS, V6, P180, DOI 10.1007/s11306-009-0190-2; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Xu J, 2004, ENDOCRINOLOGY, V145, P1087, DOI 10.1210/en.2003-1173; Xu J, 2003, ANAL BIOCHEM, V315, P238, DOI 10.1016/S0003-2697(02)00709-1; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200; Xu J, 2006, DIABETES, V55, P3429, DOI 10.2337/db06-0260; Xu J, 2006, DIABETES, V55, P3372, DOI 10.2337/db06-0002; Xu W, 2011, METABOLISM IS REGULA, P213; Yang L, 2011, J PROTEOME RES, V10, P4134, DOI 10.1021/pr200313x; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; ZHANG Y, 1994, J BIOL CHEM, V269, P11025; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	65	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33717	10.1371/journal.pone.0033717	http://dx.doi.org/10.1371/journal.pone.0033717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442717	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500058
J	Wang, HH; Grant, WE; Gan, JB; Rogers, WE; Swannack, TM; Koralewski, TE; Miller, JH; Taylor, JW				Wang, Hsiao-Hsuan; Grant, William E.; Gan, Jianbang; Rogers, William E.; Swannack, Todd M.; Koralewski, Tomasz E.; Miller, James H.; Taylor, John W.			Integrating Spread Dynamics and Economics of Timber Production to Manage Chinese Tallow Invasions in Southern US Forestlands	PLOS ONE			English	Article							TREE SAPIUM-SEBIFERUM; SEED DISPERSAL; CONTROL STRATEGIES; TRIADICA-SEBIFERA; NATIVE HERBIVORES; UNITED-STATES; PLANT; ALIEN; IMPACTS; ERADICATION	Economic costs associated with the invasion of nonnative species are of global concern. We estimated expected costs of Chinese tallow (Triadica sebifera (L.) Small) invasions related to timber production in southern U. S. forestlands under different management strategies. Expected costs were confined to the value of timber production losses plus costs for search and control. We simulated management strategies including (1) no control (NC), and control beginning as soon as the percentage of invaded forest land exceeded (2) 60 (Low Control), (3) 25 (Medium Control), or (4) 0 (High Control) using a spatially-explicit, stochastic, bioeconomic model. With NC, simulated invasions spread northward and westward into Arkansas and along the Gulf of Mexico to occupy approximate to 1.2 million hectares within 20 years, with associated expected total costs increasing exponentially to approximate to$300 million. With LC, MC, and HC, invaded areas reached approximate to 275, 34, and 2 thousand hectares after 20 years, respectively, with associated expected costs reaching approximate to$400, $230, and $200 million. Complete eradication would not be cost-effective; the minimum expected total cost was achieved when control began as soon as the percentage of invaded land exceeded 5%. These results suggest the importance of early detection and control of Chinese tallow, and emphasize the importance of integrating spread dynamics and economics to manage invasive species.	[Wang, Hsiao-Hsuan; Grant, William E.; Swannack, Todd M.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Gan, Jianbang; Rogers, William E.; Koralewski, Tomasz E.] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX USA; [Miller, James H.] US Forest Serv, So Res Stn, Auburn, AL USA; [Taylor, John W.] US Forest Serv, Atlanta, GA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Wang, HH (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	hsuan006@tamu.edu	Wang, Hsiao-Hsuan/AAE-7933-2020	Wang, Hsiao-Hsuan/0000-0002-7850-0406	USDA Forest Service Forest Health Protection of the Southern Region; Texas AgriLife Research	USDA Forest Service Forest Health Protection of the Southern Region(United States Department of Agriculture (USDA)United States Forest Service); Texas AgriLife Research	Funding from USDA Forest Service Forest Health Protection of the Southern Region and Texas AgriLife Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia LL, 2007, J COASTAL RES, V23, P1580, DOI 10.2112/06-0766.1; Birch JC, 2010, P NATL ACAD SCI USA, V107, P21925, DOI 10.1073/pnas.1003369107; Blackwood J, 2010, ECOL ECON, V69, P519, DOI 10.1016/j.ecolecon.2009.08.029; Bogich TL, 2008, J APPL ECOL, V45, P1134, DOI 10.1111/j.1365-2664.2008.01494.x; BOWDEN J, 1971, NATURE, V229, P500, DOI 10.1038/229500b0; Bradley BA, 2006, ECOL APPL, V16, P1132, DOI 10.1890/1051-0761(2006)016[1132:CTLDOA]2.0.CO;2; Bruce KA, 1997, NAT AREA J, V17, P255; BRUCE KA, 1995, B TORREY BOT CLUB, V122, P215, DOI 10.2307/2996086; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Burczyk J, 2005, MOL ECOL, V14, P2525, DOI 10.1111/j.1365-294X.2005.02593.x; Burnett K, 2007, J FOREST ECON, V13, P151, DOI 10.1016/j.jfe.2007.02.007; Burns JH, 2004, AM MIDL NAT, V152, P410, DOI 10.1674/0003-0031(2004)152[0410:IOCTSS]2.0.CO;2; Cacho OJ, 2008, ECOL ECON, V65, P559, DOI 10.1016/j.ecolecon.2007.08.006; Cain MD, 1992, P S WEED SCI SOC, V45, P264; Carrasco LR, 2010, ECOL ECON, V69, P1303, DOI 10.1016/j.ecolecon.2010.02.001; Chapman EL, 2008, FOREST ECOL MANAG, V256, P883, DOI 10.1016/j.foreco.2008.05.057; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; Crone EE, 2009, J APPL ECOL, V46, P673, DOI 10.1111/j.1365-2664.2009.01635.x; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Dehnen-Schmutz K, 2007, DIVERS DISTRIB, V13, P527, DOI 10.1111/j.1472-4642.2007.00359.x; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; El-Sayed AM, 2006, J ECON ENTOMOL, V99, P1550, DOI 10.1603/0022-0493-99.5.1550; Epanchin-Niell RS, 2010, FRONT ECOL ENVIRON, V8, P210, DOI 10.1890/090029; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; Fenichel EP, 2010, RESOUR ENERGY ECON, V32, P500, DOI 10.1016/j.reseneeco.2010.04.002; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Furlow E., 1996, NATURE CONSERVANCY, V46, P17; Greene DF, 2004, J ECOL, V92, P758, DOI 10.1111/j.0022-0477.2004.00921.x; Greene DF, 2002, DISPERSAL ECOLOGY ME; Grevstad FS, 2005, BIOL INVASIONS, V7, P665, DOI 10.1007/s10530-004-5855-1; Hamann O, 2001, BIODIVERS CONSERV, V10, P223, DOI 10.1023/A:1008952319105; Harcombe PA, 1999, USGSBRDBSR19980002; Hester S, 2012, HUM ECOL RISK ASSESS, V18, P181, DOI 10.1080/10807039.2012.632307; Higgins A, 2007, NAT AREA J, V27, P236, DOI 10.3375/0885-8608(2007)27[236:TPOPLS]2.0.CO;2; Higgins SI, 2000, ECOL APPL, V10, P1833, DOI 10.1890/1051-0761(2000)010[1833:UADLMF]2.0.CO;2; Holmes TP, 2009, ANN NY ACAD SCI, V1162, P18, DOI 10.1111/j.1749-6632.2009.04446.x; Johnson T, 2008, USDA FOREST SERVICE; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; Keeland BD, 2009, WETLANDS, V29, P101, DOI 10.1672/08-21.1; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Klein EK, 2006, J APPL ECOL, V43, P141, DOI 10.1111/j.1365-2664.2005.01108.x; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Lankau RA, 2004, ECOL ENTOMOL, V29, P66, DOI 10.1111/j.0307-6946.2004.00575.x; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Lodge DM, 2009, BIOECONOMICS INVASIV, P1; Loewenstein Nancy J., 2005, Urban Ecosystems, V8, P79, DOI 10.1007/s11252-005-1420-7; McAusland C, 2004, J ENVIRON ECON MANAG, V48, P954, DOI 10.1016/j.jeem.2003.11.002; McNeely Jeffrey A., 2005, SCOPE, V63, P285; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Merriam Robert W., 2002, Biological Invasions, V4, P369, DOI 10.1023/A:1023668101805; Miller J.H., 2003, NONNATIVE INVASIVE P, VVolume 62; Mishkin F.S., 2007, MONETARY POLICY STRA; Moser WK, 2009, J FOREST, V107, P320; Nijjer S, 2008, APPL SOIL ECOL, V38, P1, DOI 10.1016/j.apsoil.2007.08.002; OKUBO A, 1989, ECOLOGY, V70, P329, DOI 10.2307/1937537; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Olson L. J., 2006, Agricultural and Resource Economics Review, V35, P178; Olson LJ, 2002, AM J AGR ECON, V84, P1311, DOI 10.1111/1467-8276.00395; Oswalt CM, 2007, FOREST ECOL MANAG, V242, P727, DOI 10.1016/j.foreco.2007.02.008; Pattison RR, 2008, GLOBAL CHANGE BIOL, V14, P813, DOI 10.1111/j.1365-2486.2007.01528.x; Perrings C, 2005, INVASIVE ALIEN SPECI, DOI DOI 10.1111/1365-2435.12602; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pysek P, 2002, BIOL CONSERV, V104, P13, DOI 10.1016/S0006-3207(01)00150-1; Railsback SF, 2011, ECOL MODEL, V222, P3305, DOI 10.1016/j.ecolmodel.2011.07.009; Randall JM, 1996, INVASIVE PLANTS WEED; Regan TJ, 2006, ECOL LETT, V9, P759, DOI 10.1111/j.1461-0248.2006.00920.x; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Renne IJ, 2000, AM MIDL NAT, V144, P202, DOI 10.1674/0003-0031(2000)144[0202:SDOTCT]2.0.CO;2; Rogers WE, 2005, PLANT ECOL, V181, P57, DOI 10.1007/s11258-005-3029-6; Rudis V. A., 2006, General Technical Report - USDA Forest Service, P49; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; Scoles JC, 2006, LAND MANAGERS HDB IN; Sharov AA, 1998, ECOL APPL, V8, P833, DOI 10.1890/1051-0761(1998)008[0833:BOMTSO]2.0.CO;2; Sharov AA, 2004, RISK ANAL, V24, P879, DOI 10.1111/j.0272-4332.2004.00486.x; Sheley RL, 2006, ECOL MONOGR, V76, P365, DOI 10.1890/0012-9615(2006)076[0365:PFSTTG]2.0.CO;2; Siemann E, 2003, ECOLOGY, V84, P1489, DOI 10.1890/0012-9658(2003)084[1489:HDRLAS]2.0.CO;2; Siemann E, 2001, ECOL LETT, V4, P514, DOI 10.1046/j.1461-0248.2001.00274.x; Siemann E, 2007, GLOBAL CHANGE BIOL, V13, P2184, DOI 10.1111/j.1365-2486.2007.01425.x; Siemann E, 2007, J ECOL, V95, P689, DOI 10.1111/j.1365-2745.2007.01253.x; Siemann E, 2009, FOREST ECOL MANAG, V258, P546, DOI 10.1016/j.foreco.2009.03.056; Simberloff D, 2000, SCI TOTAL ENVIRON, V262, P253, DOI 10.1016/S0048-9697(00)00527-1; Skarpaas O, 2005, J APPL ECOL, V42, P731, DOI 10.1111/j.1365-2664.2005.01056.x; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Smith GF, 1997, FOREST ECOL MANAG, V95, P275, DOI 10.1016/S0378-1127(97)00014-5; Smolik MG, 2010, J BIOGEOGR, V37, P411, DOI 10.1111/j.1365-2699.2009.02227.x; STERN, 2006, STERN REV EC CLIMATE; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Stoyan D, 2001, ECOL MODEL, V145, P35, DOI 10.1016/S0304-3800(01)00385-4; TMS, 2009, TIMB MART S S WID AV; Tobin PC, 2007, ECOL LETT, V10, P36, DOI 10.1111/j.1461-0248.2006.00991.x; USDA, 2008, FIA DAT TOOLS; USDA, 2009, TIMB PROD OUTP TPO R; USDA, 2008, NONN INV PLANT DAT T; USDA, 2009, NONN INV PLANT DAT T; Walters C., 1986, ADAPTIVE MANAGEMENT; Wang H.-H., 2009, THESIS TEXAS A M U C; Wang HH, 2011, DIVERS DISTRIB, V17, P552, DOI 10.1111/j.1472-4642.2011.00760.x; Weber JS, 2007, WEED SCI, V55, P299, DOI 10.1614/WS-06-164.1; Wilcox J, 2007, SOUTHEAST NAT, V6, P535, DOI 10.1656/1528-7092(2007)6[535:EOLSLC]2.0.CO;2; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x; Yokomizo H, 2009, ECOL APPL, V19, P376, DOI 10.1890/08-0442.1; Zavaleta E, 2000, AMBIO, V29, P462, DOI 10.1639/0044-7447(2000)029[0462:TEVOCA]2.0.CO;2; Zou JW, 2008, ECOGRAPHY, V31, P663, DOI 10.1111/j.0906-7590.2008.05540.x; Zou JW, 2009, BASIC APPL ECOL, V10, P79, DOI 10.1016/j.baae.2007.11.010	107	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33877	10.1371/journal.pone.0033877	http://dx.doi.org/10.1371/journal.pone.0033877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939TA	22442731	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500072
J	Zhang, L; Yu, W; Schroedter, I; Kong, JM; Vrontakis, M				Zhang, Lin; Yu, Wu; Schroedter, Ingo; Kong, Jiming; Vrontakis, Maria			Galanin Transgenic Mice with Elevated Circulating Galanin Levels Alleviate Demyelination in a Cuprizone-Induced MS Mouse Model	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; REMYELINATION; EXPRESSION; CELLS; NEUROGENESIS; MYELINATION; PLASTICITY; RECEPTORS	Multiple Sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system (CNS) with a presumed autoimmune etiology. Approved treatments for MS are immunoregulatory and are able to reduce the inflammatory components of the disease. However, these treatments do not suppress progressive clinical disability. Approaches that directly protect myelin-producing oligodendrocytes and enhance remyelination are likely to improve long-term outcomes and reduce the rate of axonal damage. Galanin (GAL) is a bioactive neuropeptide that is widely distributed throughout the nervous system and has diverse neuromodulatory effects. In this study, using the cuprizone (CPZ) demyelination model of MS, we demonstrate that GAL has pronounced neuroprotective effects with respect to demyelination and remyelination. Using our GAL transgenic mouse (GAL-Tg), we identified a novel attenuation of OLs against CPZ induced demyelination, which was exerted independently of progenitor cells. Alleviation of myelin breakdown in the GAL-Tg mice was observed to be significant. Furthermore, we observed changes in the expression of the GAL receptor GalR1 during the demyelination and remyelination processes. Our data strongly indicate that GAL has the capacity to influence the outcome of primary insults that directly target OLs, as opposed to cases where immune activation is the primary pathogenic event. Taken together, these results suggest that GAL is a promising next-generation target for the treatment of MS.	[Zhang, Lin; Yu, Wu; Kong, Jiming; Vrontakis, Maria] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Schroedter, Ingo] DSM Inc, Winnipeg, MB, Canada	University of Manitoba; DSM NV	Zhang, L (corresponding author), Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada.	vrontak@cc.umanitoba.ca		Vrontakis, Maria/0000-0002-4609-7624; Kong, Jiming/0000-0002-2859-9831	Health Science Foundation (Winnipeg) [310416]; Multiple Sclerosis of Canada [311859]	Health Science Foundation (Winnipeg); Multiple Sclerosis of Canada	Health Science Foundation (Winnipeg) operating grant #310416 Multiple Sclerosis of Canada operating grant# 311859. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bartfai T, 2004, P NATL ACAD SCI USA, V101, P10470, DOI 10.1073/pnas.0403802101; BEGLEY DJ, 1994, ANN NY ACAD SCI, V739, P89, DOI 10.1111/j.1749-6632.1994.tb19810.x; Blakemore WF, 1999, J NEUROIMMUNOL, V98, P69, DOI 10.1016/S0165-5728(99)00083-1; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Branchek TA, 2000, TRENDS PHARMACOL SCI, V21, P109, DOI 10.1016/S0165-6147(00)01446-2; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; Chekhonin VP, 2000, VOP MED KHIM, V46, P549; Elliott-Hunt CR, 2004, P NATL ACAD SCI USA, V101, P5105, DOI 10.1073/pnas.0304823101; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Gregg C, 2009, J NEUROL SCI, V285, P22, DOI 10.1016/j.jns.2009.06.040; Hobson SA, 2008, CELL MOL LIFE SCI, V65, P1806, DOI 10.1007/s00018-008-8154-7; Isgaard J, 2007, Minerva Endocrinol, V32, P103; Jungnickel SRF, 2005, J NEUROCHEM, V92, P1452, DOI 10.1111/j.1471-4159.2004.02992.x; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; La Mantia L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004678.pub2; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Mazarati A, 2004, NEUROSCIENCE, V128, P431, DOI 10.1016/j.neuroscience.2004.06.052; Mazarati A, 2004, EUR J NEUROSCI, V19, P3235, DOI 10.1111/j.0953-816X.2004.03449.x; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; Miron VE, 2011, BBA-MOL BASIS DIS, V1812, P184, DOI 10.1016/j.bbadis.2010.09.010; Murck H, 2004, PSYCHONEUROENDOCRINO, V29, P1205, DOI 10.1016/j.psyneuen.2004.02.006; National Institutes of Health Image J website, IM J US GUID; Perumal P, 2003, J ENDOCRINOL, V179, P145, DOI 10.1677/joe.0.1790145; Poritsanos NJ, 2009, INT J OBESITY, V33, P1381, DOI 10.1038/ijo.2009.187; PRINEAS JW, 1993, ANN NEUROL, V33, P137, DOI 10.1002/ana.410330203; Shen PJ, 2005, NEUROPEPTIDES, V39, P201, DOI 10.1016/j.npep.2004.12.021; Shen PJ, 2003, EUR J NEUROSCI, V18, P1362, DOI 10.1046/j.1460-9568.2003.02860.x; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; TANSEY FA, 1991, J NEUROCHEM, V57, P95, DOI 10.1111/j.1471-4159.1991.tb02104.x; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x; Ubink R, 2003, TRENDS NEUROSCI, V26, P604, DOI 10.1016/j.tins.2003.09.003; Vrontakis ME, 2002, CNS NEUROL DISORD-DR, V1, P533, DOI 10.2174/1568007023338914; VRONTAKIS ME, 1992, ENDOCRINOLOGY, V130, P458, DOI 10.1210/en.130.1.458; Wraith DC, 2009, P NATL ACAD SCI USA, V106, P15466, DOI 10.1073/pnas.0903360106; Zhang J, 2011, MT SINAI J MED, V78, P244, DOI 10.1002/msj.20244; Zhang YB, 2008, SCHIZOPHR RES, V106, P182, DOI 10.1016/j.schres.2008.09.013	42	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33901	10.1371/journal.pone.0033901	http://dx.doi.org/10.1371/journal.pone.0033901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442732	Green Submitted, Green Published, gold			2022-12-27	WOS:000303836500073
J	Bonvini, S; Albiero, M; Ferretto, L; Angelini, A; Battocchio, P; Fedrigo, M; Piazza, M; Thiene, G; Avogaro, A; Fadini, GP; Grego, F				Bonvini, Stefano; Albiero, Mattia; Ferretto, Luca; Angelini, Annalisa; Battocchio, Piero; Fedrigo, Marny; Piazza, Michele; Thiene, Gaetano; Avogaro, Angelo; Fadini, Gian Paolo; Grego, Franco			The Peritoneum as a Natural Scaffold for Vascular Regeneration	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; STEM-CELLS; MOBILIZATION; ALLOGRAFTS; ARTERIES; CULTURE; GRAFTS; BYPASS; TISSUE	Objective: The peritoneum has the same developmental origin as blood vessels, is highly reactive and poorly thrombogenic. We hypothesize that parietal peritoneum can sustain development and regeneration of new vessels. Methods and Results: The study comprised two experimental approaches. First, to test surgical feasibility and efficacy of the peritoneal vascular autograft, we set up an autologous transplantation procedure in pigs, where a tubularized parietal peritoneal graft was covered with a metal mesh and anastomosed end-to-end in the infrarenal aorta. Second, to dissect the contribution of graft vs host cells to the newly developed vessel wall, we performed human-to-rat peritoneal patch grafting in the abdominal aorta and examined the origin of endothelial and smooth muscle cells. In pig experiments, the graft remodeled to an apparently normal blood vessel, without thrombosis. Histology confirmed arterialization of the graft with complete endothelial coverage and neointimal hyperplasia in the absence of erosion, inflammation or thrombosis. In rats, immunostaining for human mitochondri revealed that endothelial cells and smooth muscle cells rarely were of human origin. Remodeling of the graft was mainly attributable to local cells with no clear evidence of c-kit+ endothelial progenitor cells or c-kit+ resident perivascular progenitor cells. Conclusions: The parietal peritoneum can be feasibly used as a scaffold to sustain the regeneration of blood vessels, which appears to occur through the contribution of host-derived resident mature cells.	[Bonvini, Stefano; Ferretto, Luca; Angelini, Annalisa; Battocchio, Piero; Fedrigo, Marny; Piazza, Michele; Thiene, Gaetano; Grego, Franco] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Albiero, Mattia; Avogaro, Angelo; Fadini, Gian Paolo] Univ Padua, Dept Med, Padua, Italy; [Albiero, Mattia; Avogaro, Angelo; Fadini, Gian Paolo] Venetian Inst Mol Med, Lab Expt Diabetol, Padua, Italy	University of Padua; University of Padua; Veneto Institute Molecular Medicine	Bonvini, S (corresponding author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy.	stefanobonvini@yahoo.it; gianpaolo.fadini@unipd.it	Avogaro, Angelo/S-3808-2016; Albiero, Mattia/AAG-4257-2019; Albiero, Mattia/J-4145-2012; Fadini, Gian Paolo/M-4575-2019	Albiero, Mattia/0000-0003-4142-9738; Albiero, Mattia/0000-0003-4142-9738; Fadini, Gian Paolo/0000-0002-6510-2097; AVOGARO, ANGELO/0000-0002-1177-0516; Angelini, Annalisa/0000-0002-3578-4488				Albers M, 2004, EUR J VASC ENDOVASC, V28, P462, DOI 10.1016/j.ejvs.2004.08.009; Albiero M, 2010, TRENDS CARDIOVAS MED, V20, P133, DOI 10.1016/j.tcm.2010.12.001; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Campbell JH, 1999, CIRC RES, V85, P1173; Caplice NM, 2007, AM J PHYSIOL-RENAL, V293, pF470, DOI 10.1152/ajprenal.00067.2007; Efendy JL, 2000, J PATHOL, V192, P257, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH681>3.0.CO;2-Y; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2007, ATHEROSCLEROSIS, V194, P46, DOI 10.1016/j.atherosclerosis.2007.03.046; Fahner PJ, 2006, J VASC SURG, V44, P518, DOI 10.1016/j.jvs.2006.05.037; Gotloib L, 2007, INT J ARTIF ORGANS, V30, P501, DOI 10.1177/039139880703000608; HERNANDO A, 1994, EUR J VASCULAR SURG, V8, P531, DOI 10.1016/S0950-821X(05)80586-9; Hoenig MR, 2005, ARTERIOSCL THROM VAS, V25, P1128, DOI 10.1161/01.ATV.0000158996.03867.72; Huang W, 2010, J MOL CELL CARDIOL, V48, P702, DOI 10.1016/j.yjmcc.2009.10.032; Garcia-Graz NJ, 2008, CIR CIR, V76, P229; Mirza A, 2008, J VASC SURG, V47, P1313, DOI 10.1016/j.jvs.2007.12.038; PACHOLEWICZ JK, 1994, EUR J CARDIO-THORAC, V8, P563, DOI 10.1016/1010-7940(94)90077-9; Psaltis PJ, 2011, J CARDIOVASC TRANSL, V4, P161, DOI 10.1007/s12265-010-9248-9; Rosellini A, 2007, FOLIA BIOL-PRAGUE, V53, P50; Sainz J, 2006, ARTERIOSCL THROM VAS, V26, P281, DOI 10.1161/01.ATV.0000197793.83391.91; Sarac TP, 2005, J VASC SURG, V41, P490, DOI 10.1016/j.jvs.2004.11.033; Sarac TP, 2003, J VASC SURG, V38, P1404, DOI 10.1016/S0741-5214(03)01039-5; Sparks SR, 2002, ANN VASC SURG, V16, P73, DOI 10.1007/s10016-001-0133-5; Streinchenberger R, 2000, ANN VASC SURG, V14, P553, DOI 10.1007/s100169910103; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Yung S, 2006, PERITON DIALYSIS INT, V26, P162	25	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33557	10.1371/journal.pone.0033557	http://dx.doi.org/10.1371/journal.pone.0033557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438949	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100058
J	Canals, M; Scholten, DJ; de Munnik, S; Han, MKL; Smit, MJ; Leurs, R				Canals, Meritxell; Scholten, Danny J.; de Munnik, Sabrina; Han, Mitchell K. L.; Smit, Martine J.; Leurs, Rob			Ubiquitination of CXCR7 Controls Receptor Trafficking	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; BETA-ARRESTIN; DEPENDENT INTERNALIZATION; CELL-SURVIVAL; DESENSITIZATION; ACTIVATION; MIGRATION; CHEMOTAXIS; LIGAND; CXCL12/SDF-1	The chemokine receptor CXCR7 binds CXCL11 and CXCL12 with high affinity, chemokines that were previously thought to bind exclusively to CXCR4 and CXCR3, respectively. Expression of CXCR7 has been associated with cardiac development as well as with tumor growth and progression. Despite having all the canonical features of G protein-coupled receptors (GPCRs), the signalling pathways following CXCR7 activation remain controversial, since unlike typical chemokine receptors, CXCR7 fails to activate G alpha(i)-proteins. CXCR7 has recently been shown to interact with beta-arrestins and such interaction has been suggested to be responsible for G protein-independent signals through ERK-1/2 phosphorylation. Signal transduction by CXCR7 is controlled at the membrane by the process of GPCR trafficking. In the present study we investigated the regulatory processes triggered by CXCR7 activation as well as the molecular interactions that participate in such processes. We show that, CXCR7 internalizes and recycles back to the cell surface after agonist exposure, and that internalization is not only beta-arrestin-mediated but also dependent on the Serine/Threonine residues at the C-terminus of the receptor. Furthermore we describe, for the first time, the constitutive ubiquitination of CXCR7. Such ubiquitination is a key modification responsible for the correct trafficking of CXCR7 from and to the plasma membrane. Moreover, we found that CXCR7 is reversibly de-ubiquitinated upon treatment with CXCL12. Finally, we have also identified the Lysine residues at the C-terminus of CXCR7 to be essential for receptor cell surface delivery. Together these data demonstrate the differential regulation of CXCR7 compared to the related CXCR3 and CXCR4 receptors, and highlight the importance of understanding the molecular determinants responsible for this process.	[Canals, Meritxell; Scholten, Danny J.; de Munnik, Sabrina; Han, Mitchell K. L.; Smit, Martine J.; Leurs, Rob] Vrije Univ Amsterdam, Leiden Amsterdam Ctr Drug Res, Div Med Chem, Fac Sci, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Canals, M (corresponding author), Vrije Univ Amsterdam, Leiden Amsterdam Ctr Drug Res, Div Med Chem, Fac Sci, Amsterdam, Netherlands.	meri.canals@monash.edu	Leurs, Rob/AAC-8508-2022; Leurs, Rob/ABB-4299-2021	Leurs, Rob/0000-0003-1354-2848; Scholten, Danny/0000-0001-6822-9950; Han, Mitchell/0000-0002-9243-1136; Smit, Martine/0000-0003-2713-0238; Canals, Meritxell/0000-0002-7942-5006	Dutch Top Institute Pharma (TI Pharma)	Dutch Top Institute Pharma (TI Pharma)	This study was financially supported by the Dutch Top Institute Pharma (TI Pharma) and performed within the framework of the TI Pharma project "The GPCR forum (D1-105)" (www.tipharma.com). The funder was not involved in study design, data collection, analysis and manuscript preparation. However, the TI Pharma was involved in the decision to publish.	Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Berahovich RD, 2010, IMMUNOL LETT, V133, P112, DOI 10.1016/j.imlet.2010.06.010; Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Cottrell GS, 2007, J BIOL CHEM, V282, P12260, DOI 10.1074/jbc.M606338200; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Garland AM, 1996, MOL PHARMACOL, V49, P438; Gottle P, 2010, ANN NEUROL, V68, P915, DOI 10.1002/ana.22214; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Kuhn DJ, 2011, BLOOD, V118, P421; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Monnier J, 2012, EUR J CANCER, V48, P138, DOI 10.1016/j.ejca.2011.06.044; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; NG GYK, 1995, P NATL ACAD SCI USA, V92, P10157, DOI 10.1073/pnas.92.22.10157; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Verzijl D, 2008, J PHARMACOL EXP THER, V325, P544, DOI 10.1124/jpet.107.134783; Vischer HF, 2008, BIOCHEM BIOPH RES CO, V377, P93, DOI 10.1016/j.bbrc.2008.09.082; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269	54	67	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34192	10.1371/journal.pone.0034192	http://dx.doi.org/10.1371/journal.pone.0034192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457824	Green Submitted, Green Published, gold			2022-12-27	WOS:000304046900053
J	Liu, R; Liao, J; Yang, M; Sheng, JY; Yang, H; Wang, Y; Pan, EC; Guo, W; Pu, YP; Kim, SJ; Yin, LH				Liu, Ran; Liao, Juan; Yang, Miao; Sheng, Jingyi; Yang, Hao; Wang, Yi; Pan, Enchun; Guo, Wei; Pu, Yuepu; Kim, Sun Jung; Yin, Lihong			The Cluster of miR-143 and miR-145 Affects the Risk for Esophageal Squamous Cell Carcinoma through Co-Regulating Fascin Homolog 1	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PROGNOSTIC-SIGNIFICANCE; TUMOR SUPPRESSORS; PROSTATE-CANCER; FREQUENT LOSS; EXPRESSION; MICRORNA; REGIONS; PROLIFERATION; RELEVANCE	MicroRNAs (miRNAs), 18-24 nt non-coding RNAs, are thought to play important roles in cell proliferation, differentiation, apoptosis, and development. Recent studies suggest that some of the known microRNAs map to a single genomic locale within a single polycistronic transcript. But the roles of the cluster remain to be known. In order to understand the role and mechanism of a cluster of miR-143 and miR-145 in esophageal squamous cell carcinoma (ESCC), the association of mature miR-143 and miR-145 expression with the risk for esophageal cancer was evaluated in ESCC patients with a case-control study, and target protein regulated by mature miRNA was analyzed in ESCC cell lines with 3'UTR luciferase reporter assay. The expression levels of miR-143 and miR-145 were determined in 110 pairs of esophageal cancer tissues and adjacent normal tissues using real-time reverse transcription PCR. The relative expression of miR-143 and miR-145 were statistically different between cancer tissues and matched controls. The combined expression of miR-143 and miR-145 was significantly associated with the risk for esophageal cancer. Meanwhile, the reduced expression of two miRNAs in tumor patient was supposed to have a trend of lymph node metastases. The co-expression pattern of miR-143 and miR-145 was analyzed with Pearson correlation. It showed a significant correlation between these two miRNAs expression both in tissues and tumor cell lines. 3'UTR luciferase reporter assay indicated that Fascin Homolog 1 (FSCN1) could be co-regulated by miR-143 and miR-145. The protein level of FSCN1 showed no significant linear correlation with miR-143 and miR-145 expression in ESCC cell lines with Western blotting analysis. In conclusion, since miR-143 and miR-145 could regulate oncogenic FSCN1 and take part in the modulation of metastases, the result suggested the combination variable of miR-143 and miR-145 as a potential biomarker for earlier diagnosis and prognosis of esophageal cancer.	[Liu, Ran; Liao, Juan; Yang, Miao; Sheng, Jingyi; Yang, Hao; Pu, Yuepu; Yin, Lihong] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Wang, Yi; Pan, Enchun] Huaian Ctr Dis Control & Prevent, Huaian, Peoples R China; [Guo, Wei] First Peoples Hosp Huaian, Huaian, Peoples R China; [Kim, Sun Jung] Dongguk Univ Seoul, Dept Life Sci, Seoul, South Korea	Southeast University - China; Dongguk University	Liu, R (corresponding author), Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China.	ranliu@seu.edu.cn; sunjungk@dongguk.edu	kim, sun jung/T-1013-2019	Liu, Ran/0000-0001-8150-6799	National Natural Science Foundation of China [81172747, 81072259, 30800891, 81111140396]; National Research Foundation of Korea (NRF [NRF-2011-C00056]; Research Fund for the Doctoral Program of Higher Education of China [200802861045]; Natural Science Foundation of JiangSu province, China [BK2010407]; Excellent Youth Scholars of Southeast University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation of Korea (NRF(National Research Foundation of Korea); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of JiangSu province, China(Natural Science Foundation of Jiangsu Province); Excellent Youth Scholars of Southeast University	This study is supported by the National Natural Science Foundation of China (No. 81172747, 81072259, 30800891, 81111140396; http://www.nsfc.gov.cn), the National Research Foundation of Korea (NRF) Grant (NRF-2011-C00056; http://www.nrf.re.kr), Research Fund for the Doctoral Program of Higher Education of China (No. 200802861045; http://www.cutech.edu.cn), Natural Science Foundation of JiangSu province, China (No. BK2010407; http://www.jstd.gov.cn), and Research & Teaching Fund for the Excellent Youth Scholars of Southeast University (2009; http://www.seu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang YLC, 2010, J CLIN LAB ANAL, V24, P167, DOI 10.1002/jcla.20385; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Chiyomaru T, 2011, PROSTATE; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; Darnel AD, 2009, CLIN CANCER RES, V15, P1376, DOI 10.1158/1078-0432.CCR-08-1789; Fuse M, 2011, INT J ONCOL, V38, P1093, DOI 10.3892/ijo.2011.919; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hashimoto Y, 2005, CLIN CANCER RES, V11, P2597, DOI 10.1158/1078-0432.CCR-04-1378; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Hu N, 2000, GENE CHROMOSOME CANC, V27, P217, DOI 10.1002/(SICI)1098-2264(200003)27:3<217::AID-GCC1>3.0.CO;2-A; Jayo A, 2010, INT J BIOCHEM CELL B, V42, P1614, DOI 10.1016/j.biocel.2010.06.019; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maitra A, 2002, AM J CLIN PATHOL, V118, P52; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Mayama T, 2000, INT J ONCOL, V17, P245; Montesano R, 1996, INT J CANCER, V69, P225, DOI 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6; Moskaluk CA, 1998, GENE CHROMOSOME CANC, V22, P305, DOI 10.1002/(SICI)1098-2264(199808)22:4<305::AID-GCC6>3.3.CO;2-U; Pack SD, 1999, GENE CHROMOSOME CANC, V25, P160, DOI 10.1002/(SICI)1098-2264(199906)25:2<160::AID-GCC12>3.0.CO;2-U; Pelosi G, 2003, LUNG CANCER-J IASLC, V42, P203, DOI 10.1016/S0169-5002(03)00294-0; Peralta RC, 1998, INT J CANCER, V78, P600, DOI 10.1002/(SICI)1097-0215(19981123)78:5<600::AID-IJC12>3.0.CO;2-1; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Takikita M, 2011, ANTICANCER RES, V31, P945; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Xie JJ, 2005, BIOCHEM BIOPH RES CO, V337, P355, DOI 10.1016/j.bbrc.2005.09.055; Xu B, 2011, MOL CELL BIOCHEM, V350, P207, DOI 10.1007/s11010-010-0700-6; Yen CC, 2001, CANCER, V92, P2769, DOI 10.1002/1097-0142(20011201)92:11<2769::AID-CNCR10118>3.0.CO;2-M; Zhang H, 2006, J CLIN PATHOL, V59, P958, DOI 10.1136/jcp.2005.032730; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531; Zigeuner R, 2006, UROLOGY, V68, P518, DOI 10.1016/j.urology.2006.03.032	46	85	88	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33987	10.1371/journal.pone.0033987	http://dx.doi.org/10.1371/journal.pone.0033987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457808	Green Submitted, gold, Green Published			2022-12-27	WOS:000304046900039
J	Xu, JR; DelProposto, Z; Zhou, Z; Shen, HC; Xuan, SY; Li, QH; Haacke, EM; Hu, JN				Xu, Jianrong; DelProposto, Zachary; Zhou, Zien; Shen, Huicong; Xuan, Stephanie Yang; Li, Qing Hang; Haacke, E. Mark; Hu, Jiani			In Ovo Monitoring of Smooth Muscle Fiber Development in the Chick Embryo: Diffusion Tensor Imaging with Histologic Correlation	PLOS ONE			English	Article							GIZZARD; MODEL	Background: Magnetic resonance imaging is a noninvasive method of evaluating embryonic development. Magnetic resonance diffusion tensor imaging, which is based on the measuring the directional diffusivity of water molecules, is an established method of evaluating tissue structure. Background: Prolonged imaging times have precluded the use of embryonic diffusion tensor imaging due to motion artifact. Using temperature-based motion suppression, we aimed to investigate whether diffusion tensor imaging can be used to monitor embryonic smooth muscle development in ovo, and to determine the correlation between histologically-derived muscle fiber fraction, day of incubation and diffusion tensor imaging fractional anisotropy values and length of tracked fibers. Methodology/Principal Findings: From a set of 82 normally developing fertile chicken eggs, 5 eggs were randomly chosen each day from incubation days 5 to 18 and cooled using a dual-cooling technique prior to and during magnetic resonance imaging at 3.0 Tesla. Smooth muscle fibers of the gizzard were tracked using region of interests placed over the gizzard. Following imaging, the egg was cracked and the embryo was fixated and sectioned, and a micrograph most closely corresponding to the acquired magnetic resonance image was made. Smooth muscle fiber fraction was determined using an automated computer algorithm. Conclusions/Significance: We show that diffusion tensor images of smooth muscle within the embryonic gizzard can be acquired in ovo from incubation day 11 through hatching. Length of tracked fibers and day of incubation were found to have statistical significance (p<0.05) by multiple linear regression correlation with histologic specimens of sacrificed embryos from day 11 of incubation through hatching. The morphologic pattern of development in our histologic specimens corresponds to the development of embryonic gizzard as reported in the literature. These results suggest that diffusion tensor imaging can provide a noninvasive method of evaluating in ovo development of smooth muscle tissue.	[Xu, Jianrong; Zhou, Zien] Shanghai Jiao Tong Univ, Renji Hosp, Dept Radiol, Sch Med, Shanghai 200030, Peoples R China; [DelProposto, Zachary] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Shen, Huicong] Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, Beijing, Peoples R China; [Xuan, Stephanie Yang] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada; [Li, Qing Hang] Wayne State Univ, Dept Neurosurg, Detroit, MI USA; [Haacke, E. Mark; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA	Shanghai Jiao Tong University; Henry Ford Health System; Henry Ford Hospital; Capital Medical University; University of Toronto; Wayne State University; Wayne State University	Xu, JR (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Radiol, Sch Med, Shanghai 200030, Peoples R China.	jhu@med.wayne.edu		Zhou, Zien/0000-0001-6543-7113	Key Subject Construction in Universities of Shanghai [S30203]	Key Subject Construction in Universities of Shanghai	Supported by The Project of Key Subject Construction in Universities of Shanghai (No. S30203). No further external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain MM, 2007, J MAGN RESON IMAGING, V26, P198, DOI 10.1002/jmri.20963; BENNETT T, 1969, Z ZELLFORSCH MIK ANA, V98, P599, DOI 10.1007/BF00347035; Boss A, 2008, J MAGN RESON IMAGING, V28, P1510, DOI 10.1002/jmri.21601; Coen M, 2009, MAGN RESON CHEM, V47, pS62, DOI 10.1002/mrc.2534; Fan RH, 2008, NMR BIOMED, V21, P566, DOI 10.1002/nbm.1226; GABELLA G, 1989, ANAT EMBRYOL, V180, P213, DOI 10.1007/BF00315880; Herrera JJ, 2008, J NEUROSCI RES, V86, P443, DOI 10.1002/jnr.21481; HIRAI S, 1986, CELL TISSUE RES, V243, P487; Holmes WM, 2009, NMR BIOMED, V22, P745, DOI 10.1002/nbm.1386; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Peebles DM, 2003, DEV BRAIN RES, V141, P101, DOI 10.1016/S0165-3806(03)00002-6; Rashidi H, 2009, BIOESSAYS, V31, P459, DOI 10.1002/bies.200800168; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003	14	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34009	10.1371/journal.pone.0034009	http://dx.doi.org/10.1371/journal.pone.0034009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457809	Green Submitted, Green Published, gold			2022-12-27	WOS:000304046900040
J	Zhang, DQ; Shen, DG				Zhang, Daoqiang; Shen, Dinggang		Alzheimer's Dis Neuroimagin	Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BRAIN MR-IMAGES; CSF BIOMARKERS; BASE-LINE; HIPPOCAMPAL VOLUME; ALZHEIMERS-DISEASE; ATROPHY; PATTERNS; REGISTRATION; AD	Accurate prediction of clinical changes of mild cognitive impairment (MCI) patients, including both qualitative change (i.e., conversion to Alzheimer's disease (AD)) and quantitative change (i.e., cognitive scores) at future time points, is important for early diagnosis of AD and for monitoring the disease progression. In this paper, we propose to predict future clinical changes of MCI patients by using both baseline and longitudinal multimodality data. To do this, we first develop a longitudinal feature selection method to jointly select brain regions across multiple time points for each modality. Specifically, for each time point, we train a sparse linear regression model by using the imaging data and the corresponding clinical scores, with an extra 'group regularization' to group the weights corresponding to the same brain region across multiple time points together and to allow for selection of brain regions based on the strength of multiple time points jointly. Then, to further reflect the longitudinal changes on the selected brain regions, we extract a set of longitudinal features from the original baseline and longitudinal data. Finally, we combine all features on the selected brain regions, from different modalities, for prediction by using our previously proposed multi-kernel SVM. We validate our method on 88 ADNI MCI subjects, with both MRI and FDG-PET data and the corresponding clinical scores (i.e., MMSE and ADAS-Cog) at 5 different time points. We first predict the clinical scores (MMSE and ADAS-Cog) at 24-month by using the multimodality data at previous time points, and then predict the conversion of MCI to AD by using the multimodality data at time points which are at least 6-month ahead of the conversion. The results on both sets of experiments show that our proposed method can achieve better performance in predicting future clinical changes of MCI patients than the conventional methods.	[Zhang, Daoqiang; Shen, Dinggang] Univ N Carolina Chapel Hill, Dept Radiol & Biomed Res Imaging Ctr BRIC, Chapel Hill, NC 27515 USA; [Zhang, Daoqiang] Nanjing Univ Aeronaut & Astronaut, Dept Comp Sci & Engn, Nanjing 210016, Peoples R China; [Alzheimer's Dis Neuroimagin] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	University of North Carolina; University of North Carolina Chapel Hill; Nanjing University of Aeronautics & Astronautics; University of California System; University of California Los Angeles	Shen, DG (corresponding author), Univ N Carolina Chapel Hill, Dept Radiol & Biomed Res Imaging Ctr BRIC, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020; Zhang, Daoqiang/D-3754-2011	Shen, Dinggang/0000-0002-7934-5698; Zhang, Daoqiang/0000-0002-5658-7643	NIH [EB006733, EB008374, EB009634, MH088520]; National Science Foundation of China [60875030, 61075010]; National Basic Research Program of China (973 Program) [2010CB732505]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008374, R01EB006733, R01EB009634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG010483, U01AG024904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants EB006733, EB008374, EB009634, and MH088520, by the National Science Foundation of China under grants No. 60875030 and No. 61075010, and also by the National Basic Research Program of China (973 Program) grant No. 2010CB732505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.ucla.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. The following statements were cited from ADNI: Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private-sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles.	Argyriou A, 2008, MACH LEARN, V73, P243, DOI 10.1007/s10994-007-5040-8; Bouwman FH, 2007, NEUROLOGY, V69, P1006, DOI 10.1212/01.wnl.0000271375.37131.04; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chetelat G, 2002, NEUROREPORT, V13, P1939; Cho Y, 2012, NEUROIMAGE, V59, P2217, DOI 10.1016/j.neuroimage.2011.09.085; Convit A, 2000, NEUROBIOL AGING, V21, P19, DOI 10.1016/S0197-4580(99)00107-4; Convit A, 1997, NEUROBIOL AGING, V18, P131, DOI 10.1016/S0197-4580(97)00001-8; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Davatzikos C, 2010, NEUROBIOL AGING; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; de Leon MJ, 2007, J NEUROL, V254, P1666, DOI 10.1007/s00415-007-0610-z; De Santi S, 2001, NEUROBIOL AGING, V22, P529, DOI 10.1016/S0197-4580(01)00230-5; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; Duchesne S, 2009, NEUROIMAGE, V47, P1363, DOI 10.1016/j.neuroimage.2009.04.023; Fan Y, 2005, LECT NOTES COMPUT SC, V3749, P1; Fan Y, 2010, IEEE SYS MAN CYBERN; Fan Y, 2008, BIOL PSYCHIAT, V63, P118, DOI 10.1016/j.biopsych.2007.03.015; Fjell AM, 2010, J NEUROSCI, V30, P2088, DOI 10.1523/JNEUROSCI.3785-09.2010; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; GOLOMB J, 1993, ARCH NEUROL-CHICAGO, V50, P967, DOI 10.1001/archneur.1993.00540090066012; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Leung KK, 2010, LECT NOTES COMPUT SC, V6362, P125; Li Y, 2011, NEUROBIOL A IN PRESS; Liu J., 2009, SLEP SPARSE LEARNING; MacDonald D.J., 1998, NEUROIMAGE, V7, pS717, DOI [10.1016/S1053-8119(18)31550-7, DOI 10.1016/S1053-8119(18)31550-7]; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McEvoy LK, 2011, RADIOLOGY, V259, P834, DOI 10.1148/radiol.11101975; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Obozinski G, 2006, MULTITASK FEATURE S; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shen D, 2003, P HUM BRAIN MAPP; Shen DG, 2004, NEUROIMAGE, V21, P1508, DOI 10.1016/j.neuroimage.2003.12.015; Shen DG, 2007, PATTERN RECOGN, V40, P1161, DOI 10.1016/j.patcog.2006.08.012; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang H, 2011, LECT NOTES COMPUT SC, V6893, P115, DOI 10.1007/978-3-642-23626-6_15; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Wu GR, 2006, IEEE T MED IMAGING, V25, P1145, DOI 10.1109/TMI.2006.879320; Xue Z, 2006, NEUROIMAGE, V33, P855, DOI 10.1016/j.neuroimage.2006.08.007; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhong X, 2004, IEEE T MED IMAGING, V23, P1276, DOI 10.1109/TMI.2004.834616	49	161	165	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33182	10.1371/journal.pone.0033182	http://dx.doi.org/10.1371/journal.pone.0033182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457741	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200021
J	Atkinson, W; Forghani, R; Wojtkiewicz, GR; Pulli, B; Iwamoto, Y; Ueno, T; Waterman, P; Truelove, J; Oklu, R; Chen, JW				Atkinson, Wendy; Forghani, Reza; Wojtkiewicz, Gregory R.; Pulli, Benjamin; Iwamoto, Yoshiko; Ueno, Takuya; Waterman, Peter; Truelove, Jessica; Oklu, Rahmi; Chen, John W.			Ligation of the Jugular Veins Does Not Result in Brain Inflammation or Demyelination in Mice	PLOS ONE			English	Article							CEREBROSPINAL VENOUS INSUFFICIENCY; MULTIPLE-SCLEROSIS; MEDICAL PROGRESS; IRON DEPOSITION; FLOW; ENCEPHALOMYELITIS; AGENTS	An alternative hypothesis has been proposed implicating chronic cerebrospinal venous insufficiency (CCSVI) as a potential cause of multiple sclerosis (MS). We aimed to evaluate the validity of this hypothesis in a controlled animal model. Animal experiments were approved by the institutional animal care committee. The jugular veins in SJL mice were ligated bilaterally (n = 20), and the mice were observed for up to six months after ligation. Sham-operated mice (n = 15) and mice induced with experimental autoimmune encephalomyelitis (n = 8) were used as negative and positive controls, respectively. The animals were evaluated using CT venography and Tc-99m-exametazime to assess for structural and hemodynamic changes. Imaging was performed to evaluate for signs of blood-brain barrier (BBB) breakdown and neuroinflammation. Flow cytometry and histopathology were performed to assess inflammatory cell populations and demyelination. There were both structural changes (stenosis, collaterals) in the jugular venous drainage and hemodynamic disturbances in the brain on Tc99m-exametazime scintigraphy (p = 0.024). In the JVL mice, gadolinium MRI and immunofluorescence imaging for barrier molecules did not reveal evidence of BBB breakdown (p = 0.58). Myeloperoxidase, matrix metalloproteinase, and protease molecular imaging did not reveal signs of increased neuroinflammation (all p>0.05). Flow cytometry and histopathology also did not reveal increase in inflammatory cell infiltration or population shifts. No evidence of demyelination was found, and the mice remained without clinical signs. Despite the structural and hemodynamic changes, we did not identify changes in the BBB permeability, neuroinflammation, demyelination, or clinical signs in the JVL group compared to the sham group. Therefore, our murine model does not support CCSVI as a cause of demyelinating diseases such as multiple sclerosis.	[Atkinson, Wendy; Forghani, Reza; Wojtkiewicz, Gregory R.; Pulli, Benjamin; Iwamoto, Yoshiko; Ueno, Takuya; Waterman, Peter; Truelove, Jessica; Chen, John W.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Atkinson, Wendy; Forghani, Reza; Wojtkiewicz, Gregory R.; Pulli, Benjamin; Iwamoto, Yoshiko; Ueno, Takuya; Waterman, Peter; Truelove, Jessica; Chen, John W.] Harvard Univ, Sch Med, Richard B Simches Res Ctr, Boston, MA USA; [Forghani, Reza; Chen, John W.] Massachusetts Gen Hosp, Dept Radiol, Div Neuroradiol, Boston, MA 02114 USA; [Oklu, Rahmi] Massachusetts Gen Hosp, Dept Radiol, Div Vasc Imaging & Intervent, Boston, MA 02114 USA; [Forghani, Reza] Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada; [Forghani, Reza] McGill Univ, Montreal, PQ, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; McGill University; McGill University	Atkinson, W (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	jwchen@mgh.harvard.edu	oklu, rahmi/AAY-4676-2021; Wojtkiewicz, Gregory/L-3660-2018	Pulli, Benjamin/0000-0002-1795-9897; Forghani, Reza/0000-0002-8572-1864; Wojtkiewicz, Gregory/0000-0002-3148-8411	National Institutes of Health [R01-NS070835, R01-NS072167]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070835, R01NS072167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded in part by the National Institutes of Health (R01-NS070835 and R01-NS072167 to JWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Breckwoldt MO, 2008, P NATL ACAD SCI USA, V105, P18584, DOI 10.1073/pnas.0803945105; BROWN AM, 1981, LAB INVEST, V45, P278; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Chen JW, 2008, BRAIN, V131, P1123, DOI 10.1093/brain/awn004; Chung CP, 2007, ULTRASOUND MED BIOL, V33, P1727, DOI 10.1016/j.ultrasmedbio.2007.05.018; Cortez-Retamozo V, 2008, J CLIN INVEST, V118, P4058, DOI 10.1172/JCI36335; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Haacke EM, 2010, INT ANGIOL, V29, P149; Imitola J, 2006, ARCH NEUROL-CHICAGO, V63, P25, DOI 10.1001/archneur.63.1.25; Jm C., 1868, GAZ HOPITAUX, P554; Kieseier BC, 1998, BRAIN, V121, P159, DOI 10.1093/brain/121.1.159; McCann CM, 2009, NEUROIMAGE, V45, P360, DOI 10.1016/j.neuroimage.2008.12.022; Nahrendorf M, 2008, CIRCULATION, V117, P1153, DOI 10.1161/CIRCULATIONAHA.107.756510; Nahrendorf M, 2009, ARTERIOSCL THROM VAS, V29, P1444, DOI 10.1161/ATVBAHA.109.193086; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pagenstecher A, 1998, AM J PATHOL, V152, P729; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Querol M, 2005, ORG LETT, V7, P1719, DOI 10.1021/ol050208v; Rodriguez E, 2010, J AM CHEM SOC, V132, P168, DOI 10.1021/ja905274f; Ruan S, 2000, IEEE T MED IMAGING, V19, P1179, DOI 10.1109/42.897810; Samson K, 2010, ANN NEUROL, V67, pA11, DOI 10.1002/ana.22071; Singh AV, 2009, J CEREBR BLOOD F MET, V29, P1867, DOI 10.1038/jcbfm.2009.180; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Swirski FK, 2010, J CLIN INVEST, V120, P2627, DOI 10.1172/JCI42304; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tsunoda I, 2007, BRAIN PATHOL, V17, P45, DOI 10.1111/j.1750-3639.2006.00042.x; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2006, J ROY SOC MED, V99, P589, DOI 10.1258/jrsm.99.11.589; Zamboni P, 2009, J VASC SURG, V50, P1348, DOI 10.1016/j.jvs.2009.07.096; Zivadinov R, 2010, INT ANGIOL, V29, P158	30	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33671	10.1371/journal.pone.0033671	http://dx.doi.org/10.1371/journal.pone.0033671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457780	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100035
J	Swartz, B				Swartz, Brian			A Marine Stem-Tetrapod from the Devonian of Western North America	PLOS ONE			English	Article							TIKTAALIK-ROSEAE; PECTORAL FIN; EVOLUTION; ORIGIN; SARCOPTERYGII; ANATOMY; FISH; INTERRELATIONSHIPS; PANDERICHTHYS; LOCOMOTION	The origin of terrestrial vertebrates represents one of the major evolutionary and ecological transformations in the history of life, and the established timing and environment of this transition has recently come under scrutiny. The discovery and description of a well-preserved fossil sarcopterygian (fleshy-limbed vertebrate) from the Middle Devonian of Nevada helps to refine and question aspects of the temporal and anatomical framework that underpins the tetrapod condition. This new taxon, Tinirau clackae, demonstrates that substantial parallelism pervaded the early history of stem-tetrapods, raises additional questions about when digited sarcopterygians first evolved, and further documents that incipient stages of the terrestrial appendicular condition began when sarcopterygians still retained their median fins and occupied aquatic habitats.	[Swartz, Brian] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Swartz, Brian] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Swartz, B (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	Brian.Darwin@Berkeley.edu			Gregory family	Gregory family	The work was supported by Gregory family and several generous anonymous donors. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Ahlberg PE, 1997, J VERTEBR PALEONTOL, V17, P653, DOI 10.1080/02724634.1997.10011015; Ahlberg PE, 2000, PALAEONTOLOGY, V43, P533, DOI 10.1111/j.0031-0239.2000.00138.x; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Bendix-Almgreen SE, 1990, TERRA NOVA, V2, P131, DOI 10.1111/j.1365-3121.1990.tb00053.x; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Clack JA., 2005, J SYST PALAEONTOL, V2, P311, DOI [10.1017/S1477201904001506, DOI 10.1017/S1477201904001506]; Clack JA, 2009, ANNU REV EARTH PL SC, V37, P163, DOI 10.1146/annurev.earth.36.031207.124146; Husken T.-C., 1997, Acta Universitatis Carolinae Geologica, V40, P445, DOI 10.1016/B978-012670950-6/50018-7; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Coates MI, 2002, EVOL DEV, V4, P390, DOI 10.1046/j.1525-142X.2002.02026.x; Coates Michael I., 2010, P389; Cope ED, 1887, AM NAT, V21, P1104; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Downs JP, 2008, NATURE, V455, P925, DOI 10.1038/nature07189; Eastman C. R., 1905, MAJOR PATTERNS VERTE, V13, P1; FRICKE H, 1987, NATURE, V329, P331, DOI 10.1038/329331a0; Friedman M, 2007, EVOL DEV, V9, P329, DOI 10.1111/j.1525-142X.2007.00169.x; Friedman M, 2011, P ROY SOC B-BIOL SCI, V278, P432, DOI 10.1098/rspb.2010.1321; GODFREY SJ, 1989, PHILOS T ROY SOC B, V323, P75, DOI 10.1098/rstb.1989.0002; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Greenwood P.H., 1986, J MORPHOL S, V1, P163, DOI DOI 10.1002/JMOR.1051900412; HOLMES R, 1984, PHILOS T ROY SOC B, V306, P431, DOI 10.1098/rstb.1984.0103; Holmes RB, 1998, J VERTEBR PALEONTOL, V18, P64, DOI 10.1080/02724634.1998.10011034; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Johanson Z, 2001, T ROY SOC EDIN-EARTH, V92, P43, DOI 10.1017/S0263593300000043; Johnson JG, 1988, DEVONIAN WORLD, P161; Johnson JG, 1977, W N AM DEVONIAN, P16; King HM, 2011, P NATL ACAD SCI USA, V108, P21146, DOI 10.1073/pnas.1118669109; Lebedev OA, 1995, NATURELLE C, V17, P287; Long J.A., 1997, Records of the Western Australian Museum Supplement, V53, P1; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; Maddison D. R., 2000, MACCLADE ANAL PHYLOG; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Pomare SM, 1987, LEGENDS MAORI; Reed JW, 1980, DEVONIAN FISH FAUNA; ROMER AS, 1955, NATURE, V176, P126, DOI 10.1038/176126a0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sandberg CA, 2003, 15 INT SENCK C JOINT, P187; Schultze HP, 2010, FOSS REC, V13, P285, DOI 10.1002/mmng.201000001; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P293; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Simoes Marcello Guimaraes, 2000, Revista Brasileira de Geociencias, V30, P757; Snitting D, 2008, J VERTEBR PALEONTOL, V28, P637, DOI 10.1671/0272-4634(2008)28[637:AROTAO]2.0.CO;2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Upeniece Ieva, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P101; Vorobeva E.I., 1977, Trudy Paleontologicheskogo Instituta, V163, P1; Vorobyeva E., 1991, P68; Yu X, 1997, REEXAMINATION RELATI, P1; Zhu M, 2004, NATURE, V432, P94, DOI 10.1038/nature02843	55	39	40	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33683	10.1371/journal.pone.0033683	http://dx.doi.org/10.1371/journal.pone.0033683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448265	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700056
J	Tongaonkar, P; Golji, AE; Tran, P; Ouellette, AJ; Selsted, ME				Tongaonkar, Prasad; Golji, Amir E.; Tran, Patti; Ouellette, Andre J.; Selsted, Michael E.			High Fidelity Processing and Activation of the Human alpha-Defensin HNP1 Precursor by Neutrophil Elastase and Proteinase 3	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; IN-VITRO; ANTIBACTERIAL ACTIVITY; CELL PROLIFERATION; GRANULES; NEOVASCULARIZATION; IDENTIFICATION; INHIBITION; MECHANISMS	The azurophilic granules of human neutrophils contain four a-defensins called human neutrophil peptides (HNPs 1-4). HNPs are tridisulfide-linked antimicrobial peptides involved in the intracellular killing of organisms phagocytosed by neutrophils. The peptides are produced as inactive precursors (proHNPs) which are processed to active microbicides by as yet unidentified convertases. ProHNP1 was expressed in E. coli and the affinity-purified propeptide isolated as two species, one containing mature HNP1 sequence with native disulfide linkages ("folded proHNP1") and the other containing non-native disulfide linked proHNP1 conformers (misfolded proHNP1). Native HNP1, liberated by CNBr treatment of folded proHNP1, was microbicidal against Staphylococcus aureus, but the peptide derived from misfolded proHNP1 was inactive. We hypothesized that neutrophil elastase (NE), proteinase 3 (PR3) or cathepsin G (CG), serine proteases that co-localize with HNPs in azurophil granules, are proHNP1 activating convertases. Folded proHNP1 was converted to mature HNP1 by both NE and PR3, but CG generated an HNP1 variant with an N-terminal dipeptide extension. NE and PR3 cleaved folded proHNP1 to produce a peptide indistinguishable from native HNP1 purified from neutrophils, and the microbicidal activities of in vitro derived and natural HNP1 peptides were equivalent. In contrast, misfolded proHNP1 conformers were degraded extensively under the same conditions. Thus, NE and PR3 possess proHNP1 convertase activity that requires the presence of the native HNP1 disulfide motif for high fidelity activation of the precursor in vitro.	[Tongaonkar, Prasad; Golji, Amir E.; Tran, Patti; Ouellette, Andre J.; Selsted, Michael E.] Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90033 USA; [Ouellette, Andre J.; Selsted, Michael E.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Tongaonkar, P (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90033 USA.	tongaonk@usc.edu			National Institutes of Health [AI078321, AI22931, AI58129, DE021341, DK044632, AI059346)]; University of Southern California Norris Comprehensive Cancer Center from the National Cancer Institute [P30 CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346, R01AI022931, R37AI022931, R56AI078321, R01AI058129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044632, R01DK044632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Norris Comprehensive Cancer Center from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants to P. Tongaonkar (AI078321), MES (AI22931, AI58129 and DE021341), AJO (DK044632 and AI059346) and in part by the University of Southern California Norris Comprehensive Cancer Center Support Grant (P30 CA014089) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarbiou J, 2002, J LEUKOCYTE BIOL, V72, P167; ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Chavakis T, 2004, FASEB J, V18, P1306, DOI 10.1096/fj.03-1009fje; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; DAHER KA, 1988, P NATL ACAD SCI USA, V85, P7327, DOI 10.1073/pnas.85.19.7327; Economopoulou M, 2005, BLOOD, V106, P3831, DOI 10.1182/blood-2005-03-0889; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Faurschou M, 2005, J LEUKOCYTE BIOL, V78, P785, DOI 10.1189/jlb.1104688; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Han WH, 2009, FEBS J, V276, P6603, DOI 10.1111/j.1742-4658.2009.07370.x; HARWIG SSL, 1992, BLOOD, V79, P1532; Hashimoto S, 2011, INFLAMM BOWEL DIS; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; Li J, 2006, INVEST OPHTH VIS SCI, V47, P3811, DOI 10.1167/iovs.05-1360; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mambula SS, 2000, INFECT IMMUN, V68, P6257, DOI 10.1128/IAI.68.11.6257-6264.2000; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Muller CA, 2002, AM J PATHOL, V160, P1311, DOI 10.1016/S0002-9440(10)62558-8; Newman SL, 2000, INFECT IMMUN, V68, P5668, DOI 10.1128/IAI.68.10.5668-5672.2000; Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17; PANYUTICH AV, 1993, J LAB CLIN MED, V122, P202; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Risso A, 2000, J LEUKOCYTE BIOL, V68, P785; SCOCCHI M, 1992, EUR J BIOCHEM, V209, P589, DOI 10.1111/j.1432-1033.1992.tb17324.x; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Semple F, 2010, EUR J IMMUNOL, V40, P1073, DOI 10.1002/eji.200940041; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Syeda F, 2008, J CELL PHYSIOL, V214, P820, DOI 10.1002/jcp.21279; Thomas NJ, 2002, PEDIATR INFECT DIS J, V21, P34, DOI 10.1097/00006454-200201000-00008; Tongaonkar P, 2011, J LEUKOCYTE BIOL, V89, P283, DOI 10.1189/jlb.0910535; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Varkey J, 2005, ANTIMICROB AGENTS CH, V49, P4561, DOI 10.1128/AAC.49.11.4561-4566.2005; Wanniarachchi YA, 2011, BIOCHEMISTRY-US, V50, P8005, DOI 10.1021/bi201043j; Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wohlford-Lenane CL, 2009, J VIROL, V83, P11385, DOI 10.1128/JVI.01363-09; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j	47	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32469	10.1371/journal.pone.0032469	http://dx.doi.org/10.1371/journal.pone.0032469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448222	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700012
J	Smits, M; Vanpachtenbeke, F; Horemans, B; De Wael, K; Hauchecorne, B; Van Langenhove, H; Demeestere, K; Lenaerts, S				Smits, Marianne; Vanpachtenbeke, Floris; Horemans, Benjamin; De Wael, Karolien; Hauchecorne, Birger; Van Langenhove, Herman; Demeestere, Kristof; Lenaerts, Silvia			Effect of Operating and Sampling Conditions on the Exhaust Gas Composition of Small-Scale Power Generators	PLOS ONE			English	Article							DIESEL-ENGINE; PARTICULATE-EMISSIONS; MASS MEASUREMENTS; PARTICLE MASS; AIR-POLLUTION; METALS; MORPHOLOGY; BIODIESEL; MATTER; SOOT	Small stationary diesel engines, like in generator sets, have limited emission control measures and are therefore responsible for 44% of the particulate matter (PM) emissions in the United States. The diesel exhaust composition depends on operating conditions of the combustion engine. Furthermore, the measurements are influenced by the used sampling method. This study examines the effect of engine loading and exhaust gas dilution on the composition of small-scale power generators. These generators are used in different operating conditions than road-transport vehicles, resulting in different emission characteristics. Experimental data were obtained for gaseous volatile organic compounds (VOC) and PM mass concentration, elemental composition and nitrate content. The exhaust composition depends on load condition because of its effect on fuel consumption, engine wear and combustion temperature. Higher load conditions result in lower PM concentration and sharper edged particles with larger aerodynamic diameters. A positive correlation with load condition was found for K, Ca, Sr, Mn, Cu, Zn and Pb adsorbed on PM, elements that originate from lubricating oil or engine corrosion. The nitrate concentration decreases at higher load conditions, due to enhanced nitrate dissociation to gaseous NO at higher engine temperatures. Dilution on the other hand decreases PM and nitrate concentration and increases gaseous VOC and adsorbed metal content. In conclusion, these data show that operating and sampling conditions have a major effect on the exhaust gas composition of small-scale diesel generators. Therefore, care must be taken when designing new experiments or comparing literature results.	[Smits, Marianne; Vanpachtenbeke, Floris; Hauchecorne, Birger; Lenaerts, Silvia] Univ Antwerp, Res Grp Sustainable Energy & Air Purificat, Dept Biosci Engn, B-2020 Antwerp, Belgium; [Vanpachtenbeke, Floris; Van Langenhove, Herman; Demeestere, Kristof] Univ Ghent, Res Grp EnVOC, Dept Sustainable Organ Chem & Technol, Fac Biosci Engn, B-9000 Ghent, Belgium; [Horemans, Benjamin; De Wael, Karolien] Univ Antwerp, Environm Anal Grp, Dept Chem, B-2020 Antwerp, Belgium	University of Antwerp; Ghent University; University of Antwerp	Smits, M (corresponding author), Univ Antwerp, Res Grp Sustainable Energy & Air Purificat, Dept Biosci Engn, B-2020 Antwerp, Belgium.	marianne.smits@ua.ac.be	Lenaerts, Silvia/V-1142-2019; Lenaerts, Silvia/H-1681-2011; De Wael, Karolien/U-5545-2018; Horemans, Benjamin/E-2908-2016; Horemans, Benjamin/G-2748-2011	Lenaerts, Silvia/0000-0003-4314-9676; Lenaerts, Silvia/0000-0003-4314-9676; Horemans, Benjamin/0000-0002-6532-591X; Horemans, Benjamin/0000-0003-1950-8106; De Wael, Karolien/0000-0003-4495-0748				Baird C., 2008, ENV CHEM; Betha R, 2011, ATMOS ENVIRON, V45, P5273, DOI 10.1016/j.atmosenv.2011.06.060; Chung A, 2008, ATMOS ENVIRON, V42, P2129, DOI 10.1016/j.atmosenv.2007.11.050; Demeestere K, 2008, J CHROMATOGR A, V1186, P348, DOI 10.1016/j.chroma.2007.11.036; DOCEKAL B, 1992, FRESEN J ANAL CHEM, V343, P873, DOI 10.1007/BF00321956; Dwivedi D, 2006, ATMOS ENVIRON, V40, P5586, DOI 10.1016/j.atmosenv.2006.05.005; Horemans B, 2008, J ENVIRON MONITOR, V10, P867, DOI 10.1039/b804475a; Khalek AI, 1998, DIESEL EXHAUST PARTI; Khoder MI, 2002, CHEMOSPHERE, V49, P675, DOI 10.1016/S0045-6535(02)00391-0; Kinsey JS, 2006, J AEROSOL SCI, V37, P63, DOI 10.1016/j.jaerosci.2005.03.007; Kittelson DB, 2006, J AEROSOL SCI, V37, P913, DOI 10.1016/j.jaerosci.2005.08.005; Kittelson D.B., 1999, REV DIESEL PARTICULA; Kittelson DB, 1998, J AEROSOL SCI, V29, P575, DOI 10.1016/S0021-8502(97)10037-4; Kunzli N, 2005, ENV HLTH PERSPECT, P114; Lee KO, 2002, P COMBUST INST, V29, P647, DOI 10.1016/S1540-7489(02)80083-9; Lim J, 2009, J ENVIRON MONITOR, V11, P1614, DOI 10.1039/b822514a; Lipsky EM, 2006, ENVIRON SCI TECHNOL, V40, P155, DOI 10.1021/es050319p; Mansot JL, 2004, COLLOID SURFACE A, V243, P67, DOI 10.1016/j.colsurfa.2004.02.024; Moosmuller H, 2001, ENVIRON SCI TECHNOL, V35, P781, DOI 10.1021/es0013935; Neer A, 2006, COMBUST FLAME, V146, P142, DOI 10.1016/j.combustflame.2006.04.003; OBUCHI A, 1987, COMBUST FLAME, V70, P215, DOI 10.1016/0010-2180(87)90080-0; Olfert JS, 2007, J AEROSOL SCI, V38, P69, DOI 10.1016/j.jaerosci.2006.10.002; Placet M, 2000, ATMOS ENVIRON, V34, P2183, DOI 10.1016/S1352-2310(99)00464-1; Sarvia A, 2008, FUEL PROCESS TECHNOL, V89, P510, DOI 10.1016/j.fuproc.2007.10.006; SCHWARTZ J, 1994, ENVIRON RES, V64, P26, DOI 10.1006/enrs.1994.1004; Shah SD, 2006, ATMOS ENVIRON, V40, P4199, DOI 10.1016/j.atmosenv.2005.12.063; Sharma M, 2005, ATMOS ENVIRON, V39, P3023, DOI 10.1016/j.atmosenv.2004.12.047; Singh SK, 2006, APPL THERM ENG, V26, P259, DOI 10.1016/j.applthermaleng.2005.05.004; Spolnik Z, 2005, APPL SPECTROSC, V59, P1465, DOI 10.1366/000370205775142647; Suzuki K, 2008, APPL SURF SCI, V255, P1139, DOI 10.1016/j.apsusc.2008.05.038; Tsai JH, 2003, ATMOS ENVIRON, V37, P2485, DOI 10.1016/S1352-2310(03)00177-8; United States Environmental Protection Agency, 2004, EPA420R04007; Vercauteren J, 2011, ATMOS ENVIRON, V45, P108, DOI 10.1016/j.atmosenv.2010.09.040; Verma V, 2010, ATMOS ENVIRON, V44, P5165, DOI 10.1016/j.atmosenv.2010.08.052; Vineis P, 2004, INT J CANCER, V111, P647, DOI 10.1002/ijc.20292; Wang YF, 2003, ATMOS ENVIRON, V37, P4637, DOI 10.1016/j.atmosenv.2003.07.007; Yanosky JD, 2002, ATMOS ENVIRON, V36, P107, DOI 10.1016/S1352-2310(01)00422-8; Yaroshchyk P, 2005, SPECTROCHIM ACTA B, V60, P1482, DOI 10.1016/j.sab.2005.09.002; Zhang J, 2011, FUEL, V90, P2089, DOI 10.1016/j.fuel.2011.01.039; Zhu JY, 2005, P COMBUST INST, V30, P2781, DOI 10.1016/j.proci.2004.08.232	40	5	5	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32825	10.1371/journal.pone.0032825	http://dx.doi.org/10.1371/journal.pone.0032825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442670	Green Published, gold			2022-12-27	WOS:000303836500012
J	Yang, MH; Wang, PH; Wang, SJ; Sun, WZ; Oyang, YJ; Fuh, JL				Yang, Meng-Han; Wang, Peng-Hui; Wang, Shuu-Jiun; Sun, Wei-Zen; Oyang, Yen-Jen; Fuh, Jong-Ling			Women with Endometriosis Are More Likely to Suffer from Migraines: A Population-Based Study	PLOS ONE			English	Article							INCREASED HEADACHE PREVALENCE; HORMONE REPLACEMENT THERAPY; ORAL-CONTRACEPTIVES; MAST-CELLS; COMORBIDITY; FREQUENCY; DIAGNOSIS; SYMPTOMS; TAIWAN; HUNT	Previous research suggests that a co-morbid relationship exists between migraine and endometriosis; however, results have been inconsistent. In addition, female hormones, which are important in the pathogenesis and management of endometriosis, have been reported to precipitate migraine attacks and may confound the results. The aim of this population-based cohort study was to explore the relationship between migraine and endometriosis in women of reproductive age (18-51 years). Data were derived from the National Health Insurance Research Database of Taiwan, which contains outpatient and inpatient records from 2000 to 2007. Our study cohort included 20,220 endometriosis patients and 263,767 controls without endometriosis. We analyzed the prevalence of migraine in these women as recorded during the eight years of the database. Our results found that patients with endometriosis were more likely to suffer migraine headaches compared to controls (odds ratio [OR], 1.70; 95% confidence interval [CI] [1.59, 1.82]; p < 0.001). In addition, the co-morbid association between migraine and endometriosis remained significant after the data were controlled for age and frequently utilized hormone therapies (OR, 1.37; 95% CI, [1.27, 1.47]; p < 0.001). The results of this cohort study support the existence of a co-morbid relationship between migraine and endometriosis, even after adjusting for the possible effects of female hormone therapies on migraine attacks.	[Yang, Meng-Han; Oyang, Yen-Jen] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Wang, Peng-Hui] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Wang, Peng-Hui; Wang, Shuu-Jiun; Fuh, Jong-Ling] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Wang, Shuu-Jiun; Fuh, Jong-Ling] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Wang, Shuu-Jiun; Fuh, Jong-Ling] Natl Yang Ming Univ, Sch Med, Brain Res Ctr, Taipei 112, Taiwan; [Sun, Wei-Zen] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Oyang, Yen-Jen] Natl Taiwan Univ, Grad Inst Biomed Elect, Taipei 10764, Taiwan; [Oyang, Yen-Jen] Natl Taiwan Univ, Grad Inst Bioinformat, Taipei 10764, Taiwan	National Taiwan University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Fuh, JL (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan.	jlfuh@vghtpe.gov.tw		Fuh, Jong-Ling/0000-0001-9135-3351; SUN, WEI-ZEN/0000-0001-8543-2600	National Science Council of Taiwan; Taipei Veterans General Hospital [V100C-059]; Taiwan National Science Council; Pfizer; MSD Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Pfizer(Pfizer); MSD Taiwan	This study was supported in part by grants from the National Science Council of Taiwan and Taipei Veterans General Hospital (V100C-059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; Dr. Shuu-Jiun Wang has served on the advisory boards of Pfizer, Allergan, Daichi-Sankyo and Elli Lilly Taiwan. He has received speaking honoraria from local companies (Taiwan branches) of Pfizer, Elli Lilly, Boehringer Ingelheim and GSK. He has received research grants from the Taiwan National Science Council, Taipei-Veterans General Hospital, Pfizer and MSD Taiwan.	Aegidius K, 2006, NEUROLOGY, V66, P349, DOI 10.1212/01.wnl.0000196481.57994.09; Aegidius KL, 2011, EUR J NEUROL, V18, P321, DOI 10.1111/j.1468-1331.2010.03143.x; Berkley KJ, 2005, SCIENCE, V308, P1587, DOI 10.1126/science.1111445; Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Brandes JL, 2006, JAMA-J AM MED ASSOC, V295, P1824, DOI 10.1001/jama.295.15.1824; Buse DC, 2010, J NEUROL NEUROSUR PS, V81, P428, DOI 10.1136/jnnp.2009.192492; Chacur M, 2001, PAIN, V94, P231, DOI 10.1016/S0304-3959(01)00354-2; Chu K K, 1995, Diagn Ther Endosc, V2, P35, DOI 10.1155/DTE.2.35; D'Cruz OJ, 2007, AM J REPROD IMMUNOL, V58, P75, DOI 10.1111/j.1600-0897.2007.00502.x; DAWOOD MY, 1985, J REPROD MED, V30, P154; Ferrero S, 2004, HUM REPROD, V19, P2927, DOI 10.1093/humrep/deh537; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Hagen K, 2002, EUR J NEUROL, V9, P527, DOI 10.1046/j.1468-1331.2002.00451.x; Harris M, 2009, CONTRACEPTION, V80, P417, DOI 10.1016/j.contraception.2009.04.014; Headache Classification Committee of the International Headache Society, 1988, CEPHALALGIA S7, V8, P1; JOHANNES CB, 1995, NEUROLOGY, V45, P1076, DOI 10.1212/WNL.45.6.1076; Karp BI, 2011, FERTIL STERIL, V95, P895, DOI 10.1016/j.fertnstert.2010.11.037; Kempuraj D, 2004, AM J REPROD IMMUNOL, V52, P267, DOI 10.1111/j.1600-0897.2004.00224.x; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Levy D, 2006, HEADACHE, V46, pS13, DOI 10.1111/j.1526-4610.2006.00485.x; LICHTEN EM, 1991, J REPROD MED, V36, P419; MacGregor Anne, 1999, Headache, V39, P674, DOI 10.1046/j.1526-4610.1999.3909674.x; MacGregor E Anne, 2006, J Br Menopause Soc, V12, P104, DOI 10.1258/136218006778234048; MacGregor EA, 2010, DRUGS, V70, P1799, DOI 10.2165/11538090-000000000-00000; MacGregor EA, 2000, CEPHALALGIA, V20, P170, DOI 10.1046/j.1468-2982.2000.00038.x; Misakian AL, 2003, J WOMENS HEALTH, V12, P1027, DOI 10.1089/154099903322643956; Nappi RE, 2001, MATURITAS, V38, P157, DOI 10.1016/S0378-5122(00)00215-2; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Nyholt DR, 2009, GENET EPIDEMIOL, V33, P105, DOI 10.1002/gepi.20361; RASMUSSEN BK, 1993, PAIN, V53, P65, DOI 10.1016/0304-3959(93)90057-V; Sepulcri RD, 2009, EUR J OBSTET GYN R B, V142, P53, DOI 10.1016/j.ejogrb.2008.09.003; Sinaii N, 2002, HUM REPROD, V17, P2715, DOI 10.1093/humrep/17.10.2715; Tietjen GE, 2006, HEADACHE, V46, P422, DOI 10.1111/j.1526-4610.2006.00290.x; Tietjen GE, 2007, HEADACHE, V47, P1069, DOI 10.1111/j.1526-4610.2007.00784.x; Wang SJ, 2008, J FORMOS MED ASSOC, V107, P485, DOI 10.1016/S0929-6646(08)60157-6; Wang SJ, 2000, CEPHALALGIA, V20, P566, DOI 10.1046/j.1468-2982.2000.00085.x; Wang SJ, 2001, CEPHALALGIA, V21, P25, DOI 10.1046/j.1468-2982.2001.00138.x	37	39	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33941	10.1371/journal.pone.0033941	http://dx.doi.org/10.1371/journal.pone.0033941			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442736	Green Submitted, Green Published, gold			2022-12-27	WOS:000303836500077
J	Yoo, DG; Kim, MC; Park, MK; Park, KM; Quan, FS; Song, JM; Wee, JJ; Wang, BZ; Cho, YK; Compans, RW; Kang, SM				Yoo, Dae-Goon; Kim, Min-Chul; Park, Min-Kyung; Park, Kyoung-Mi; Quan, Fu-Shi; Song, Jae-Min; Wee, Jae Joon; Wang, Bao-Zhong; Cho, Young-Keol; Compans, Richard W.; Kang, Sang-Moo			Protective Effect of Ginseng Polysaccharides on Influenza Viral Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; PANAX-GINSENG; ACIDIC POLYSACCHARIDE; VIRUS INFECTION; GINSAN; CELLS; APOPTOSIS; CYTOKINES; IMMUNOMODULATOR; IMMUNIZATION	Ginseng polysaccharide has been known to have multiple immunomodulatory effects. In this study, we investigated whether Panax ginseng polysaccharide (GP) would have a preventive effect on influenza infection. Administration of mice with GP prior to infection was found to confer a survival benefit against infection with H1N1 (A/PR/8/34) and H3N2 (A/Philippines/82) influenza viruses. Mice infected with the 2009 H1N1 virus suspended in GP solution showed moderately enhanced survival rates and lower levels of lung viral titers and the inflammatory cytokine (IL-6). Daily treatment of vaccinated mice with GP improved their survival against heterosubtypic lethal challenge. This study demonstrates the first evidence that GP can be used as a remedy against influenza viral infection.	[Yoo, Dae-Goon; Kim, Min-Chul; Park, Kyoung-Mi; Wang, Bao-Zhong; Compans, Richard W.; Kang, Sang-Moo] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Yoo, Dae-Goon] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Park, Min-Kyung; Song, Jae-Min; Kang, Sang-Moo] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Park, Min-Kyung; Song, Jae-Min; Kang, Sang-Moo] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Park, Min-Kyung] Chungwoon Univ, Dept Human Nutr & Food Sci, Hongsung Kun, Chungnam, South Korea; [Quan, Fu-Shi] Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea; [Song, Jae-Min] Sungshin Womens Univ, Dept Global Med Sci, Seoul, South Korea; [Wee, Jae Joon] Korea Ginseng Corp, Inst Res & Dev, Taejon, South Korea; [Cho, Young-Keol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Microbiol, Seoul, South Korea	Emory University; University System of Georgia; University of Georgia; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Kyung Hee University; Sungshin Women's University; Korea Ginseng Corporation; University of Ulsan; Asan Medical Center	Yoo, DG (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	skang24@gsu.edu	Compans, Richard W/I-4087-2013; Quan, Fu-Shi/V-1826-2019	Compans, Richard W/0000-0003-2360-335X; Wang, Bao-Zhong/0000-0002-1561-4318; Park, Kyoung-Mi/0000-0001-7548-8432	National Institutes of Health (NIH)/National Institute of Allergy and Infections Diseases (NIAID) [AI0680003, AI093772, AI087782]; Korean Society of Ginseng; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093772, R56AI087782] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infections Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Korean Society of Ginseng; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health (NIH)/National Institute of Allergy and Infections Diseases (NIAID) grant AI0680003 (RWC), the Korean Society of Ginseng (SMK), and NIH/NIAID grants AI093772 (SMK) and AI087782 (SMK). The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funding agents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahn JY, 2006, FEMS IMMUNOL MED MIC, V46, P187, DOI 10.1111/j.1574-695X.2005.00021.x; Ahn JY, 2006, EUR J IMMUNOL, V36, P37, DOI 10.1002/eji.200535138; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Brydon EWA, 2005, FEMS MICROBIOL REV, V29, P837, DOI 10.1016/j.femsre.2004.12.003; Chen PY, 2010, NUTR RES, V30, P191, DOI 10.1016/j.nutres.2010.03.004; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ernst E, 2010, J GINSENG RES, V34, P259, DOI 10.5142/jgr.2010.34.4.259; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Han SK, 2005, ARCH PHARM RES, V28, P343, DOI 10.1007/BF02977803; Han Y, 2005, EVID-BASED COMPL ALT, V2, P529, DOI 10.1093/ecam/neh123; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kim KH, 1998, PLANTA MED, V64, P110, DOI 10.1055/s-2006-957385; Kim MH, 2009, KOREAN J PHYSIOL PHA, V13, P169, DOI 10.4196/kjpp.2009.13.3.169; Lee YS, 1997, ANTICANCER RES, V17, P323; Lim TS, 2004, J MED FOOD, V7, P1, DOI 10.1089/109662004322984626; Lim YJ, 2009, INT ARCH ALLERGY IMM, V150, P32, DOI 10.1159/000210378; LU ZQ, 1985, BIOCHEM BIOPH RES CO, V126, P636, DOI 10.1016/0006-291X(85)90653-9; Maruoka S, 2003, BIOCHEM BIOPH RES CO, V307, P870, DOI 10.1016/S0006-291X(03)01283-X; Mok CKP, 2007, J GEN VIROL, V88, P1275, DOI 10.1099/vir.0.82423-0; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Naffakh N, 2009, MICROBES INFECT, V11, P725, DOI 10.1016/j.micinf.2009.05.002; Nakaya TA, 2004, J INTERF CYTOK RES, V24, P93, DOI 10.1089/107999004322813336; Park JD, 2006, 9 INT S GINS, P390; Quan FS, 2008, VACCINE, V26, P3352, DOI 10.1016/j.vaccine.2008.03.055; Quan FS, 2007, VACCINE, V25, P272, DOI 10.1016/j.vaccine.2006.07.041; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2010, J VIROL, V84, P7760, DOI 10.1128/JVI.01849-09; Rhule A, 2006, J ETHNOPHARMACOL, V106, P121, DOI 10.1016/j.jep.2005.12.012; Schultz-Cherry S, 2001, J VIROL, V75, P7875, DOI 10.1128/JVI.75.17.7875-7881.2001; Shin JY, 2002, IMMUNOPHARM IMMUNOT, V24, P469, DOI 10.1081/IPH-120014730; SOLOVYOV A, 2009, EURO SURVEILL, V14; Song HY, 2002, INT IMMUNOPHARMACOL, V2, P857, DOI 10.1016/S1567-5769(01)00211-9; Song JY, 2004, ARCH PHARM RES, V27, P531, DOI 10.1007/BF02980127; Song JY, 2003, RADIAT RES, V159, P768, DOI 10.1667/0033-7587(2003)159[0768:REOGAI]2.0.CO;2; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Yuan CS, 2010, J GINSENG RES, V34, P160, DOI 10.5142/jgr.2010.34.3.160	37	67	70	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33678	10.1371/journal.pone.0033678	http://dx.doi.org/10.1371/journal.pone.0033678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442708	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500049
J	Huang, CY; Chiang, SF; Lin, TY; Chiou, SH; Chow, KC				Huang, Chih-Yang; Chiang, Shu-Fen; Lin, Tze-Yi; Chiou, Shiow-Her; Chow, Kuan-Chih			HIV-1 Vpr Triggers Mitochondrial Destruction by Impairing Mfn2-Mediated ER-Mitochondria Interaction	PLOS ONE			English	Article							VIRAL PROTEIN R; VIRUS TYPE-1 VPR; TAIL-ANCHORED PROTEINS; CELL-CYCLE ARREST; CYTOMEGALOVIRUS UL37 PROTEINS; ENDOPLASMIC-RETICULUM; UBIQUITIN LIGASE; NMR STRUCTURE; SUBCELLULAR-LOCALIZATION; NUCLEAR-LOCALIZATION	Human immunodeficiency virus 1 (HIV-1) viral protein R (Vpr) has been shown to induce host cell death by increasing the permeability of mitochondrial outer membrane (MOM). The mechanism underlying the damage to the mitochondria by Vpr, however, is not clearly illustrated. In this study, Vpr that is introduced, via transient transfection or lentivirus infection, into the human embryonic kidney cell line HEK293, human CD4(+) T lymphoblast cell line SupT1, or human primary CD4+ T cells serves as the model system to study the molecular mechanism of Vpr-mediated HIV-1 pathogenesis. The results show that Vpr injures MOM and causes a loss in membrane potential (MMP) by posttranscriptionally reducing the expression of mitofusin 2 (Mfn2) via VprBP-DDB1-CUL4A ubiquitin ligase complex, gradually weakening MOM, and increasing mitochondrial deformation. Vpr also markedly decreases cytoplasmic levels of dynamin-related protein 1 (DRP1) and increases bulging in mitochondria-associated membranes (MAM), the specific regions of endoplasmic reticulum (ER) which form physical contacts with the mitochondria. Overexpression of Mfn2 and DRP1 significantly decreased the loss of MMP and apoptotic cell death caused by Vpr. Furthermore, by employing time-lapse confocal fluorescence microscopy, we identify the transport of Vpr protein from the ER, via MAM to the mitochondria. Taken together, our results suggest that Vpr-mediated cellular damage may occur on an alternative protein transport pathway from the ER, via MAM to the mitochondria, which are modulated by Mfn2 and DRP1.	[Huang, Chih-Yang; Chiang, Shu-Fen; Chiou, Shiow-Her] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan; [Lin, Tze-Yi] China Med Univ, Dept Pathol, China Med Univ Hosp, Taichung, Taiwan; [Chow, Kuan-Chih] Natl Chung Hsing Univ, Grad Inst Biomed Sci, Taichung 40227, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University	Huang, CY (corresponding author), Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan.	shchiou@dragon.nchu.edu.tw; kcchow@dragon.nchu.edu.tw	Huang, Kevin Chih-Yang/Q-4862-2016; Huang, ChinYang/O-5170-2015	Huang, Kevin Chih-Yang/0000-0002-0266-3233; Huang, ChinYang/0000-0002-0266-3233; Chow, Kuan-Chih/0000-0002-0611-0337	Ministry of Education, Taipei, Taiwan [NCHU 995002]; NSC [NSC 97-3112-B-001-016]	Ministry of Education, Taipei, Taiwan; NSC(Ministry of Science and Technology, Taiwan)	This study was supported by the Comprehensive Academic Promotion Projects, Ministry of Education, Taipei, Taiwan (NCHU 995002 to KCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RNAi for silencing DRP1 or ATAD3A gene expression was obtained from the National RNAi Core Facility in the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, Taipei, Taiwan, supported by the National Research Program for Genomic Medicine Grants of NSC (NSC 97-3112-B-001-016). We thank Drs. Benichou, Sawaya, Kyushu, Snyders, Youle, and Peruzzi for providing us HA-Vpr, Vpr-GFP, pCDNA3-Vpr, pcDNA3-FH-PSS-1, DsRed-ER, pcDNA3.1-Mfn2 and pcDNA3.1-DRP1, and DsRed-Mito plasmids.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Andersen JL, 2005, CURR HIV RES, V3, P43, DOI 10.2174/1570162052772988; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Borgese N, 2003, BIOCHEM SOC T, V31, P1238; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgne-Sanchez A, 2007, CELL DEATH DIFFER, V14, P422, DOI 10.1038/sj.cdd.4402018; Boya P, 2004, BBA-BIOENERGETICS, V1659, P178, DOI 10.1016/j.bbabio.2004.08.007; Bozidis P, 2008, J VIROL, V82, P2715, DOI 10.1128/JVI.02456-07; Bozidis P, 2010, J VIROL, V84, P7898, DOI 10.1128/JVI.00885-10; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; Bukrinsky M, 1999, REV MED VIROL, V9, P39, DOI 10.1002/(SICI)1099-1654(199901/03)9:1<39::AID-RMV235>3.0.CO;2-3; Casey L, 2010, CYTOKINE, V51, P1, DOI 10.1016/j.cyto.2010.02.018; Chen CP, 2010, EUR BIOPHYS J BIOPHY, V39, P1089, DOI 10.1007/s00249-009-0518-x; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen JT, 2008, AM J RESP CELL MOL, V38, P559, DOI 10.1165/rcmb.2007-0001OC; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chiang SF, 2012, INT J MOL MED, V29, P365, DOI 10.3892/ijmm.2011.849; Chiang YY, 2009, MODERN PATHOL, V22, P1139, DOI 10.1038/modpathol.2009.83; Conti L, 1998, J EXP MED, V187, P403, DOI 10.1084/jem.187.3.403; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; Everett H, 2000, J EXP MED, V191, P1487, DOI 10.1084/jem.191.9.1487; Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034; Ferri KF, 2000, ANN NY ACAD SCI, V926, P149; Fukumori T, 1998, FEBS LETT, V432, P17, DOI 10.1016/S0014-5793(98)00824-2; Godet AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013760; Henderson MPA, 2007, METHODS, V41, P427, DOI 10.1016/j.ymeth.2006.07.004; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; Jacquot G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007514; Jin B, 2010, MED ONCOL; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; KORCHAK HM, 1982, BIOCHEM BIOPH RES CO, V108, P1495, DOI 10.1016/S0006-291X(82)80076-4; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; Macreadie IG, 1997, FEBS LETT, V410, P145, DOI 10.1016/S0014-5793(97)00542-5; Manninen A, 2002, J EXP MED, V195, P1023, DOI 10.1084/jem.20012039; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Morgan KS, 2003, CURRENT PROTOCOLS CE; Muthumani K, 2005, CELL DEATH DIFFER, V12, P962, DOI 10.1038/sj.cdd.4401583; Muthumani K, 2003, BIOCHEM BIOPH RES CO, V304, P583, DOI 10.1016/S0006-291X(03)00631-4; Muthumani K, 2002, ONCOGENE, V21, P4613, DOI 10.1038/sj.onc.1205549; Muthumani K, 2000, DNA CELL BIOL, V19, P179, DOI 10.1089/104454900314564; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Ohta A, 2011, MITOCHONDRION, V11, P1, DOI 10.1016/j.mito.2010.08.006; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Pandey RC, 2009, CURR HIV RES, V7, P114, DOI 10.2174/157016209787581508; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Piller SC, 1996, P NATL ACAD SCI USA, V93, P111, DOI 10.1073/pnas.93.1.111; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schinzel A, 2004, BBA-MOL CELL RES, V1644, P95, DOI 10.1016/j.bbamcr.2003.09.006; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schuler W, 1999, J MOL BIOL, V285, P2105, DOI 10.1006/jmbi.1998.2381; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI [10.1042/BSE0470085, 10.1042/bse0470085]; Shah GM, 1996, BIOCHEM BIOPH RES CO, V229, P838, DOI 10.1006/bbrc.1996.1889; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Siddiqui K, 2008, ONCOGENE, V27, P32, DOI 10.1038/sj.onc.1210632; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Stewart TL, 2005, J VIROL, V79, P1084, DOI 10.1128/JVI.79.2.1084-1098.2005; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Tomohiro S, 2009, BIOCHEM J, V418, P421, DOI 10.1042/BJ20081597; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Waldhuber MG, 2003, VIROLOGY, V313, P91, DOI 10.1016/S0042-6822(03)00258-7; Wang DM, 2006, J BIOL CHEM, V281, P7384, DOI 10.1074/jbc.M509876200; Wang W, 2010, MED ONCOL; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Wecker K, 2002, EUR J BIOCHEM, V269, P3779, DOI 10.1046/j.1432-1033.2002.03067.x; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3; Williamson CD, 2010, J VIROL, V84, P6400, DOI 10.1128/JVI.00556-10; Yedavalli VSRK, 2005, J VIROL, V79, P13735, DOI 10.1128/JVI.79.21.13735-13746.2005	85	92	96	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33657	10.1371/journal.pone.0033657	http://dx.doi.org/10.1371/journal.pone.0033657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438978	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100082
J	Lopez-Martinez, G; Rodriguez-Porrata, B; Margalef-Catala, M; Cordero-Otero, R				Lopez-Martinez, Gema; Rodriguez-Porrata, Boris; Margalef-Catala, Mar; Cordero-Otero, Ricardo			The STF2p Hydrophilin from Saccharomyces cerevisiae Is Required for Dehydration Stress Tolerance	PLOS ONE			English	Article							FREEZING TOLERANCE; YEAST-CELLS; PROTEINS; ATP; GENE; IDENTIFICATION; DESICCATION; EXPRESSION; MUTATIONS; APOPTOSIS	The yeast Saccharomyces cerevisiae is able to overcome cell dehydration; cell metabolic activity is arrested during this period but restarts after rehydration. The yeast genes encoding hydrophilin proteins were characterised to determine their roles in the dehydration-resistant phenotype, and STF2p was found to be a hydrophilin that is essential for survival after the desiccation-rehydration process. Deletion of STF2 promotes the production of reactive oxygen species and apoptotic cell death during stress conditions, whereas the overexpression of STF2, whose gene product localises to the cytoplasm, results in a reduction in ROS production upon oxidative stress as the result of the antioxidant capacity of the STF2p protein.	[Lopez-Martinez, Gema; Rodriguez-Porrata, Boris; Margalef-Catala, Mar; Cordero-Otero, Ricardo] Univ Rovira & Virgili, Dept Biochem & Biotechnol, Tarragona, Spain	Universitat Rovira i Virgili	Lopez-Martinez, G (corresponding author), Univ Rovira & Virgili, Dept Biochem & Biotechnol, Tarragona, Spain.	ricardo.cordero@urv.cat		Margalef-Catala, Mar/0000-0002-6259-4348	Spanish Ministerio de Ciencia e Innovacion [AGL2009-07933]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This study was funded by grant AGL2009-07933 from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Brachmann CB, 1998, YEAST, V14, P115; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Buchhaupt M, 2007, FEMS YEAST RES, V7, P771, DOI 10.1111/j.1567-1364.2007.00230.x; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Dang NX, 2011, CRYOBIOLOGY, V62, P188, DOI 10.1016/j.cryobiol.2011.03.002; Dienhart M, 2002, J BIOL CHEM, V277, P39289, DOI 10.1074/jbc.M205720200; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hamilton CA, 2002, FEMS MICROBIOL LETT, V208, P227, DOI 10.1111/j.1574-6968.2002.tb11086.x; Hong S, 2002, ARCH BIOCHEM BIOPHYS, V405, P38, DOI 10.1016/S0003-9861(02)00303-X; Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3; Ismail AM, 1999, P NATL ACAD SCI USA, V96, P13566, DOI 10.1073/pnas.96.23.13566; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Koziol S, 2005, FREE RADICAL RES, V39, P365, DOI 10.1080/10715760500045855; Larsson C, 2000, YEAST, V16, P797, DOI 10.1002/1097-0061(20000630)16:9<797::AID-YEA553>3.3.CO;2-X; Lebowitz MS, 1996, ARCH BIOCHEM BIOPHYS, V330, P342, DOI 10.1006/abbi.1996.0261; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Mazzio EA, 2004, J APPL TOXICOL, V24, P99, DOI 10.1002/jat.954; Pina-Vaz C, 2001, CLIN MICROBIOL INFEC, V7, P609, DOI 10.1046/j.1198-743x.2001.00307.x; Reyes JL, 2005, PLANT CELL ENVIRON, V28, P709, DOI 10.1111/j.1365-3040.2005.01317.x; Rodriguez-Porrata B, 2011, WORLD J MICROB BIOT, V27, P75, DOI 10.1007/s11274-010-0428-1; Sambrook J., 2001, MOL CLONING LAB MANU; Swire-Clark GA, 1999, PLANT MOL BIOL, V39, P117, DOI 10.1023/A:1006106906345; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Zhang L, 2000, J BIOCHEM, V127, P611, DOI 10.1093/oxfordjournals.jbchem.a022648; Zhou JW, 2009, BIOTECHNOL ADV, V27, P94, DOI 10.1016/j.biotechadv.2008.10.005	34	26	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33324	10.1371/journal.pone.0033324	http://dx.doi.org/10.1371/journal.pone.0033324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22442684	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100033
J	Ma, XF; Jensen, E; Alexandrov, N; Troukhan, M; Zhang, LP; Thomas-Jones, S; Farrar, K; Clifton-Brown, J; Donnison, I; Swaller, T; Flavell, R				Ma, Xue-Feng; Jensen, Elaine; Alexandrov, Nickolai; Troukhan, Maxim; Zhang, Liping; Thomas-Jones, Sian; Farrar, Kerrie; Clifton-Brown, John; Donnison, Iain; Swaller, Timothy; Flavell, Richard			High Resolution Genetic Mapping by Genome Sequencing Reveals Genome Duplication and Tetraploid Genetic Structure of the Diploid Miscanthus sinensis	PLOS ONE			English	Article							LINKAGE MAPS; TRNL-F; ANDROPOGONEAE; GIGANTEUS; MAIZE; DNA; IDENTIFICATION; CONSTRUCTION; SACCHARINAE; DISCOVERY	We have created a high-resolution linkage map of Miscanthus sinensis, using genotyping-by-sequencing (GBS), identifying all 19 linkage groups for the first time. The result is technically significant since Miscanthus has a very large and highly heterozygous genome, but has no or limited genomics information to date. The composite linkage map containing markers from both parental linkage maps is composed of 3,745 SNP markers spanning 2,396 cM on 19 linkage groups with a 0.64 cM average resolution. Comparative genomics analyses of the M. sinensis composite linkage map to the genomes of sorghum, maize, rice, and Brachypodium distachyon indicate that sorghum has the closest syntenic relationship to Miscanthus compared to other species. The comparative results revealed that each pair of the 19 M. sinensis linkages aligned to one sorghum chromosome, except for LG8, which mapped to two sorghum chromosomes (4 and 7), presumably due to a chromosome fusion event after genome duplication. The data also revealed several other chromosome rearrangements relative to sorghum, including two telomere-centromere inversions of the sorghum syntenic chromosome 7 in LG8 of M. sinensis and two paracentric inversions of sorghum syntenic chromosome 4 in LG7 and LG8 of M. sinensis. The results clearly demonstrate, for the first time, that the diploid M. sinensis is tetraploid origin consisting of two sub-genomes. This complete and high resolution composite linkage map will not only serve as a useful resource for novel QTL discoveries, but also enable informed deployment of the wealth of existing genomics resources of other species to the improvement of Miscanthus as a high biomass energy crop. In addition, it has utility as a reference for genome sequence assembly for the forthcoming whole genome sequencing of the Miscanthus genus.	[Ma, Xue-Feng; Alexandrov, Nickolai; Troukhan, Maxim; Zhang, Liping; Swaller, Timothy; Flavell, Richard] Ceres Inc, Thousand Oaks, CA USA; [Jensen, Elaine; Thomas-Jones, Sian; Farrar, Kerrie; Clifton-Brown, John; Donnison, Iain] Aberystwyth Univ, IBERS, Gogerddan, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Ma, XF (corresponding author), Ceres Inc, Thousand Oaks, CA USA.	tswaller@ceres-inc.com	Ma, Xue-Feng/AAO-7225-2020; Donnison, Iain S/K-6138-2014	Ma, Xue-Feng/0000-0002-0942-9116; Donnison, Iain S/0000-0001-6276-555X; Alexandrov, Nickolai/0000-0003-3381-0918; TROUKHAN, MAXIM/0000-0002-2671-6002; Clifton-Brown, John/0000-0001-6477-5452; Farrar, Kerrie/0000-0002-1884-4223	"BBSRC Sustainable Bioenergy Centre (BSBEC)" (BSBEC-BioMASS) [BB/G016216/1]; BBSRC [BB/E014933/2, BBS/E/W/00003134A]; BBSRC [BB/G016216/1, BB/E024319/1, BB/E014933/1, BB/E024319/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/W/00003134A, BB/G016216/1, BB/E024319/2, BB/E014933/2, BB/E024319/1, BB/E014933/1] Funding Source: researchfish	"BBSRC Sustainable Bioenergy Centre (BSBEC)" (BSBEC-BioMASS)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work reported in this study was performed under the "BBSRC Sustainable Bioenergy Centre (BSBEC): Bioenergy from Miscanthus and Salix Species" program (BSBEC-BioMASS; http://www.bsbec-biomass.org.uk/; Grant BB/G016216/1). Aberystwyth University also wish to acknowledge BBSRC for funding from the "Optimizing the development of the energy grass Miscanthus through manipulation of flowering time" (BB/E014933/2) and "Molecular Genetics of Miscanthus" (BBS/E/W/00003134A) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Aberystwyth University designed the experiment and managed plant and field activities while Ceres, Inc. performed the genotyping and analysis which generated the map and comparative genomics as an in-kind contribution to the current study.	ADATI, 1962, Bull. Fac. Agric. Mie Univ., P1; Atienza SG, 2003, THEOR APPL GENET, V107, P857, DOI 10.1007/s00122-003-1218-z; Atienza SG, 2003, THEOR APPL GENET, V107, P123, DOI 10.1007/s00122-003-1220-5; Atienza SG, 2002, THEOR APPL GENET, V105, P946, DOI 10.1007/s00122-002-0956-7; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Chandler VL, 2002, PLANT PHYSIOL, V130, P1594, DOI 10.1104/pp.015594; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Clifton-Brown JC, 2001, AGRON J, V93, P1013, DOI 10.2134/agronj2001.9351013x; Deuter M., 1998, P INT C WURZB, P775; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Graham-Rowe D, 2011, NATURE, V474, pS6, DOI 10.1038/474S06a; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Greef JM, 1997, GENET RESOUR CROP EV, V44, P185, DOI 10.1023/A:1008693214629; GREEF JM, 1993, ANGEW BOT, V67, P87; Heaton EA, 2010, ADV BOT RES, V56, P75, DOI 10.1016/S0065-2296(10)56003-8; Hernandez P, 2001, THEOR APPL GENET, V102, P616, DOI 10.1007/s001220051688; Ho CW, 2011, AM J BOT, V98, pE201, DOI 10.3732/ajb.1100071; Hodkinson TR, 2002, ANN BOT-LONDON, V89, P627, DOI 10.1093/aob/mcf091; Hodkinson TR, 2002, AM J BOT, V89, P279, DOI 10.3732/ajb.89.2.279; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; Hung KH, 2009, CONSERV GENET, V10, P1377, DOI 10.1007/s10592-008-9699-6; Jensen E, 2011, GCB BIOENERGY, V3, P387, DOI 10.1111/j.1757-1707.2011.01097.x; JORGENSEN U, 2001, MISCANTHUS ENERGY FI, P68; LAFFERTY J, 1994, PLANT BREEDING, V113, P246, DOI 10.1111/j.1439-0523.1994.tb00730.x; LINDELAURSEN I, 1993, HEREDITAS, V119, P297, DOI 10.1111/j.1601-5223.1993.00297.x; Ma X-F, 2008, PLANT AN GEN 16 C, P357; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Rayburn AL, 2009, PLANT MOL BIOL REP, V27, P184, DOI 10.1007/s11105-008-0070-3; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Swaminathan K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r12; Van Ooijen J., 2006, SOFTWARE CALCULATION; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Zhao H, 2011, J INTEGR PLANT BIOL, V53, P232, DOI 10.1111/j.1744-7909.2010.01026.x	36	87	91	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33821	10.1371/journal.pone.0033821	http://dx.doi.org/10.1371/journal.pone.0033821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439001	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100101
J	van Dam, JW; Negri, AP; Mueller, JF; Altenburger, R; Uthicke, S				van Dam, Joost W.; Negri, Andrew P.; Mueller, Jochen F.; Altenburger, Rolf; Uthicke, Sven			Additive Pressures of Elevated Sea Surface Temperatures and Herbicides on Symbiont-Bearing Foraminifera	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; PHOTOSYSTEM-II; CORAL-REEFS; BENTHIC FORAMINIFERA; WATER-QUALITY; HEAT-STRESS; RESPONSES; EXPOSURE; PHOTOINHIBITION	Elevated ocean temperatures and agrochemical pollution individually threaten inshore coral reefs, but these pressures are likely to occur simultaneously. Experiments were conducted to evaluate the combined effects of elevated temperature and the photosystem II (PSII) inhibiting herbicide diuron on several types of symbiotic algae (diatom, dinoflagellate or rhodophyte) of benthic foraminifera in hospite. Diuron was shown to evoke a direct effect on photosynthetic efficiency (reduced effective PSII quantum yield Delta F/F-m'), while elevated temperatures (>30 degrees C, only 2 degrees C above current average summer temperatures) were observed to impact photosynthesis more indirectly by causing reductions in maximum PSII quantum yield (F-v/F-m), interpreted as photodamage. Additionally, elevated temperatures were shown to cause bleaching through loss of chlorophyll a in foraminifera hosting either diatoms or dinoflagellates. A significant linear correlation was found between reduced F-v/F-m and loss of chlorophyll a. In most cases, symbionts within foraminifera proved more sensitive to thermal stress in the presence of diuron (>= 1 mu g L-1). The mixture toxicity model of Independent Action (IA) described the combined effects of temperature and diuron on the photosystem of species hosting diatoms or dinoflagellates convincingly and in agreement with probabilistic statistics, so a response additive joint action can be assumed. We thus demonstrate that improving water quality can improve resilience of symbiotic phototrophs to projected increases in ocean temperatures. As IA described the observed combined effects from elevated temperature and diuron stress it may therefore be employed for prediction of untested mixtures and for assessing the efficacy of management measures.	[van Dam, Joost W.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [van Dam, Joost W.; Negri, Andrew P.; Uthicke, Sven] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [van Dam, Joost W.; Mueller, Jochen F.] Univ Queensland, Natl Res Ctr Environm Toxicol, Coopers Plains, Australia; [Altenburger, Rolf] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany	University of Queensland; Australian Institute of Marine Science; University of Queensland; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	van Dam, JW (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	j.vandam@aims.gov.au	Negri, Andrew P/G-9909-2017; van Dam, Joost W/B-8964-2008; Uthicke, Sven/F-1810-2010; Mueller, Jochen F/C-6241-2008	Negri, Andrew P/0000-0003-1388-7395; van Dam, Joost W/0000-0002-4033-9274; Uthicke, Sven/0000-0002-3476-6595; Altenburger, Rolf/0000-0003-2929-2978; Mueller, Jochen/0000-0002-0000-1973	Australian Government's Marine and Tropical Sciences Research Facility (MTSRF); University of Queensland	Australian Government's Marine and Tropical Sciences Research Facility (MTSRF)(Australian Government); University of Queensland(University of Queensland)	This research was supported by the Australian Government's Marine and Tropical Sciences Research Facility (MTSRF)(http://www.rrrc.org.au/mtsrf/). JvD received financial support from The University of Queensland (http://www.uq.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburger Rolf, 2009, Integrated Environmental Assessment and Management, V5, P62, DOI 10.1897/IEAM_2008-038.1; ALVE E, 1995, J FORAMIN RES, V25, P190, DOI 10.2113/gsjfr.25.3.190; [Anonymous], 2006, 10 INT CORAL REEF S; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BERENBAUM MC, 1985, J THEOR BIOL, V114, P413, DOI 10.1016/S0022-5193(85)80176-4; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; CAIRNS J, 1975, HYDROBIOLOGIA, V47, P135, DOI 10.1007/BF00036747; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Cantin NE, 2007, MAR ECOL PROG SER, V344, P81, DOI 10.3354/meps07059; Cockey E, 1996, CORAL REEFS, V15, P237, DOI 10.1007/BF01787458; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; DRESCHER K, 1995, BIOMETRICS, V51, P716, DOI 10.2307/2532957; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; FORK DC, 1986, ANNU REV PLANT PHYS, V37, P335, DOI 10.1146/annurev.pp.37.060186.002003; Furnas M., 2003, CATCHMENTS CORALS TE; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; HALLOCK P, 1986, J FORAMIN RES, V16, P224, DOI 10.2113/gsjfr.16.3.224; HALLOCK P, 1981, Journal of Foraminiferal Research, V11, P40; Hallock P, 2003, ENVIRON MONIT ASSESS, V81, P221, DOI 10.1023/A:1021337310386; HALLOCK P, 1995, J FORAMIN RES, V25, P280, DOI 10.2113/gsjfr.25.3.280; Hallock P, 2001, T GEOBIOL, V17, P387; Hallock P, 2000, MICROPALEONTOLOGY, V46, P95; Hallock P., 1993, P 7 INT COR REEF S G, V1, P44; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hohenegger J, 1999, MAR MICROPALEONTOL, V36, P109, DOI 10.1016/S0377-8398(98)00030-9; Hohenegger J, 2004, J FORAMIN RES, V34, P9, DOI 10.2113/0340009; Hohenegger J, 2000, MICROPALEONTOLOGY, V46, P127; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hutchings P, 2005, MAR POLLUT BULL, V51, P3, DOI 10.1016/j.marpolbul.2004.11.026; Iglesias-Prieto R., 1997, P1313; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jones R, 2005, MAR POLLUT BULL, V51, P495, DOI 10.1016/j.marpolbul.2005.06.027; Jones RJ, 2004, MAR ECOL PROG SER, V284, P133, DOI 10.3354/meps284133; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Jones RJ, 2003, MAR ECOL PROG SER, V261, P149, DOI 10.3354/meps261149; Jones RJ, 2003, MAR ECOL PROG SER, V251, P153, DOI 10.3354/meps251153; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; Jones RJ, 2000, MAR FRESHWATER RES, V51, P63, DOI 10.1071/MF99100; Kennedy K, 2010, FINAL REPORT MONITOR; Kerswell AP, 2003, MAR ECOL PROG SER, V253, P145, DOI 10.3354/meps253145; Lee J.J., 1991, P157; Leggat W, 2004, SYMBIOSIS, V37, P137; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; MORELAND DE, 1980, ANNU REV PLANT PHYS, V31, P597, DOI 10.1146/annurev.pp.31.060180.003121; Nagelkerken I, 2006, Rev. biol. trop, V54, P31; Negri A, 2005, MAR POLLUT BULL, V51, P370, DOI 10.1016/j.marpolbul.2004.10.053; Negri AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019703; Negri AP, 2011, LIMNOL OCEANOGR, V56, P471, DOI 10.4319/lo.2011.56.2.0471; NOAA, 2009, COR REEF CONS PROGR; Nordemar I, 2003, MAR BIOL, V142, P669, DOI 10.1007/s00227-002-0989-0; Nystrom M, 2001, MAR BIOL, V138, P1225; OECD, 2000, GUID DOC AQ TOX TEST; Pochon X, 2001, MAR BIOL, V139, P1069; R Core Team, 2018, R LANG ENV STAT COMP; Radcliffe J.C., 2002, PESTICIDE USE AUSTR; Reymond CE, 2011, MAR ECOL PROG SER, V435, P97, DOI 10.3354/meps09172; Richardson Susan L., 2009, Smithsonian Contributions to the Marine Sciences, P429; Riedl J, 2007, CHEMOSPHERE, V67, P2210, DOI 10.1016/j.chemosphere.2006.12.022; Rottger R., 1976, Maritime Sediments Spec Publ, VNo. 1,A, P75; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; RWQPP, 2009, REEF WAT QUAL PROT P; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; Shaw M, 2010, MAR POLLUT BULL, V60, P113, DOI 10.1016/j.marpolbul.2009.08.026; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Talge H.K., 1997, P589; Talge HK, 2003, J EUKARYOT MICROBIOL, V50, P324, DOI 10.1111/j.1550-7408.2003.tb00143.x; Talge HK, 1995, MAR MICROPALEONTOL, V26, P107, DOI 10.1016/0377-8398(95)00015-1; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Team CW, 2007, 4 ASSESSMENT REPORT, P1; TISCHER W, 1977, BIOCHIM BIOPHYS ACTA, V460, P113, DOI 10.1016/0005-2728(77)90157-8; Toler SK, 1998, MAR MICROPALEONTOL, V34, P107, DOI 10.1016/S0377-8398(97)00043-1; Tomlin C., 2000, PESTICIDE MANUAL WOR; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Uthicke S, 2012, ECOLOGY, V93, P111, DOI 10.1890/11-0665.1; Uthicke S, 2012, CORAL REEFS IN PRESS; Uthicke S, 2010, LIMNOL OCEANOGR, V55, P1681, DOI 10.4319/lo.2010.55.4.1681; Van Dam J., 2011, ECOL IMPACTS TOXIC C, P187, DOI DOI 10.2174/978160805121211101010187; van Dam JW, 2012, MAR POLLUT IN PRESS; Wakefield TS, 2001, BIOL BULL-US, V200, P127, DOI 10.2307/1543306; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Wilkinson C, 2008, STATUS CORAL REEFS W; Williams DE, 2004, MAR BIOL, V145, P641, DOI 10.1007/s00227-004-1351-5; Williams DE, 1997, J FORAMIN RES, V27, P264, DOI 10.2113/gsjfr.27.4.264; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1; Wooldridge SA, 2009, MAR FRESHWATER RES, V60, P483, DOI 10.1071/MF08251; Ziegler M, 2011, J EXP MAR BIOL ECOL, V407, P70, DOI 10.1016/j.jembe.2011.07.009	95	37	37	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33900	10.1371/journal.pone.0033900	http://dx.doi.org/10.1371/journal.pone.0033900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439012	gold, Green Submitted, Green Published			2022-12-27	WOS:000303309100112
J	Zhou, L; Wang, LJ; Lu, LN; Jiang, PY; Sun, H; Wang, HT				Zhou, Liang; Wang, Lijun; Lu, Leina; Jiang, Peiyong; Sun, Hao; Wang, Huating			Inhibition of miR-29 by TGF-beta-Smad3 Signaling through Dual Mechanisms Promotes Transdifferentiation of Mouse Myoblasts into Myofibroblasts	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; TGF-BETA; TRANSCRIPTION FACTORS; SKELETAL MYOGENESIS; DIFFERENTIATION; MUSCLE; MICRORNAS; FIBROSIS; REVEALS; DYSREGULATION	MicroRNAs (miRNAs) are non-coding RNAs that regulate gene expression in post-transcriptional fashion, and emerging studies support their importance in regulating many biological processes, including myogenic differentiation and muscle development. miR-29 is a promoting factor during myogenesis but its full spectrum of impact on muscle cells has yet to be explored. Here we describe an analysis of miR-29 affected transcriptome in C2C12 muscle cells using a high throughput RNA-sequencing platform. The results reveal that miR-29 not only functions to promote myogenic differentiation but also suppresses the transdifferentiation of myoblasts into myofibroblasts. miR-29 inhibits the fibrogenic differentiation through down-regulating both extracellular matrix genes and cell adhesion genes. We further demonstrate that miR-29 is under negative regulation by TGF-beta (TGF-beta)-Smad3 signaling via dual mechanisms of both inhibiting MyoD binding and enhancing Yin Yang 1 (YY1)-recruited Polycomb association. Together, these results identify miR-29 as a pleiotropic molecule in both myogenic and fibrogenic differentiation of muscle cells.	[Zhou, Liang; Wang, Lijun; Wang, Huating] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Lu, Leina; Jiang, Peiyong; Sun, Hao] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Zhou, Liang; Wang, Lijun; Lu, Leina; Jiang, Peiyong; Sun, Hao; Wang, Huating] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Zhou, L (corresponding author), Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	haosun@cuhk.edu.hk; huating.wang@cuhk.edu.hk	JIANG, Peiyong/AAZ-9898-2020; sun, hao/GRS-7732-2022; Sun, Hao/T-5576-2019; Zhou, Liang/P-4174-2015; Wang, Huating/C-6719-2014; Sun, Hao/J-9964-2013	Sun, Hao/0000-0002-5547-9501; Zhou, Liang/0000-0001-5973-7873; Wang, Huating/0000-0001-5474-2905; Sun, Hao/0000-0002-5547-9501; Jiang, Peiyong/0000-0003-4523-3476	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China [CUHK476309, 476310, 473211]; CUHK [2041492, 2041662, 2041474]	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); CUHK(Chinese University of Hong Kong)	The work described in this paper was substantially supported by three General Research Funds (GRF) from the Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China (CUHK476309 and 476310 to HW and 473211 to HS), two CUHK direct grants to HW (2041492 and 2041662) and a CUHK Direct Grant to HS (2041474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Ono Y, 2007, J CELL PHYSIOL, V210, P358, DOI 10.1002/jcp.20838; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wang H, 2009, CELL CYCLE, V8, P1833, DOI 10.4161/cc.8.12.8851; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Xu GR, 2010, RNA, V16, P1610, DOI 10.1261/rna.2194910; Yang YW, 2009, J BIOL CHEM, V284, P5836, DOI 10.1074/jbc.M805319200; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	39	35	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33766	10.1371/journal.pone.0033766	http://dx.doi.org/10.1371/journal.pone.0033766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438993	gold, Green Submitted, Green Published			2022-12-27	WOS:000303309100095
J	Zoller, B; Li, XJ; Sundquist, J; Sundquist, K				Zoller, Bengt; Li, Xinjun; Sundquist, Jan; Sundquist, Kristina			Risk of Subsequent Coronary Heart Disease in Patients Hospitalized for Immune-Mediated Diseases: A Nationwide Follow-Up Study from Sweden	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACUTE MYOCARDIAL-INFARCTION; RHEUMATOID-ARTHRITIS; ACCELERATED ATHEROSCLEROSIS; CARDIOVASCULAR MORBIDITY; INFLAMMATION; MORTALITY; REGISTER; STROKE; WOMEN	Background: Certain immune-mediated diseases (IMDs), such as rheumatoid arthritis and systemic lupus erythematosus, have been linked to cardiovascular disorders. We examined whether there is an association between 32 different IMDs and risk of subsequent hospitalization for coronary heart disease (CHD) related to coronary atherosclerosis in a nationwide follow up study in Sweden. Methods and Findings: All individuals in Sweden hospitalized with a main diagnosis of an IMD (n = 336,479) without previous or coexisting CHD, between January 1, 1964 and December 31 2008, were followed for first hospitalization for CHD. The reference population was the total population of Sweden. Standardized incidence ratios (SIRs) for CHD were calculated. Overall risk of CHD during the first year after hospitalization for an IMD was 2.92 (95% CI 2.84-2.99). Twenty-seven of the 32 IMDs studied were associated with an increased risk of CHD during the first year after hospitalization. The overall risk of CHD decreased over time, from 1.75 after 1-5 years (95% CI 1.73-1.78), to 1.43 after 5-10 years (95% CI 1.41-1.46) and 1.28 after 10+ years (95% CI 1.26-1.30). Females generally had higher SIRs than males. The IMDs for which the SIRs of CDH were highest during the first year after hospitalization included chorea minor 6.98 (95% CI 1.32-20.65), systemic lupus erythematosus 4.94 (95% CI 4.15-5.83), rheumatic fever 4.65 (95% CI 3.53-6.01), Hashimoto's thyroiditis 4.30 (95% CI 3.87-4.75), polymyositis/dermatomyositis 3.81 (95% CI 2.62-5.35), polyarteritis nodosa 3.81 (95% CI 2.72-5.19), rheumatoid arthritis 3.72 (95% CI 3.56-3.88), systemic sclerosis 3.44 (95% CI 2.86-4.09), primary biliary cirrhosis 3.32 (95% CI 2.34-4.58), and autoimmune hemolytic anemia 3.17 (95% CI 2.16-4.47). Conclusions: Most IMDs are associated with increased risk of CHD in the first year after hospital admission. Our findings suggest that many hospitalized IMDs are tightly linked to coronary atherosclerosis.	[Zoller, Bengt; Li, Xinjun; Sundquist, Jan; Sundquist, Kristina] Lund Univ Reg Skane, Clin Res Ctr, Skane Univ Hosp, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, Jan] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Lund University; Skane University Hospital; Stanford University	Zoller, B (corresponding author), Lund Univ Reg Skane, Clin Res Ctr, Skane Univ Hosp, Ctr Primary Hlth Care Res, Malmo, Sweden.	bengt.zoller@med.lu.se	Zöller, Bengt/H-8856-2012; Zöller, Bengt/M-3217-2019	Zöller, Bengt/0000-0002-8250-5613; Zöller, Bengt/0000-0002-8250-5613; Li, Xinjun/0000-0002-5559-4657	Swedish Research Council [2008-3110, 2008-2638]; Swedish Council for Working Life and Social Research [2006-0386, 2007-1754, 2007-1962]; Formas [2006-4255-6596-99, 2007-1352]; Region Skane [REGSKANE-124611]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Formas(Swedish Research Council Formas); Region Skane	This work was supported by grants from the Swedish Research Council (2008-3110 and 2008-2638), the Swedish Council for Working Life and Social Research (2006-0386, 2007-1754 and 2007-1962), and Formas (2006-4255-6596-99 and 2007-1352), and from Region Skane (REGSKANE-124611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT RIKTL HJARTSJ 20; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; El-Gabalawy H, 2010, J RHEUMATOL, V37, P2, DOI 10.3899/jrheum.091461; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Jilma B, 2005, THROMB HAEMOSTASIS, V94, P797, DOI 10.1160/T04-10-0652; Levy L, 2008, CLIN EXP RHEUMATOL, V26, P673; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; Lopez-Pedrera C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/974648; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; National Board of Health and Welfare, 1998, SWED HOSP DISCH REG; National Board of Health and Welfare, 2000, VAL DIAGN SWED IN CA; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Rosen M, 2005, HANDBOOK OF EPIDEMIOLOGY, P231; Rothman K., 1998, MODERN EPIDEMIOLOGY; Shoenfeld Y, 2005, CIRCULATION, V112, P3337, DOI 10.1161/CIRCULATIONAHA.104.507996; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; van Leuven SI, 2008, RHEUMATOLOGY, V47, P3, DOI 10.1093/rheumatology/kem202; van Leuven SI, 2007, J LIPID RES, V48, P2640, DOI 10.1194/jlr.M700176-JLR200; Vaudo G, 2005, ARTHRITIS RHEUM-US, V52, P3890, DOI 10.1002/art.21475; Vizzardi E, 2010, ACTA CARDIOL, V65, P337, DOI 10.2143/AC.65.3.2050351; Westlake SL, 2011, RHEUMATOLOGY, V50, P518, DOI 10.1093/rheumatology/keq316; Westlake SL, 2010, RHEUMATOLOGY, V49, P295, DOI 10.1093/rheumatology/kep366; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Xu J, 2010, HAMOSTASEOLOGIE, V30, P5	29	105	109	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33442	10.1371/journal.pone.0033442	http://dx.doi.org/10.1371/journal.pone.0033442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438933	gold, Green Submitted, Green Published			2022-12-27	WOS:000303309100047
J	Eshaghi, A; Duvvuri, VR; Lai, R; Nadarajah, JT; Li, AM; Patel, SN; Low, DE; Gubbay, JB				Eshaghi, AliReza; Duvvuri, Venkata R.; Lai, Rachel; Nadarajah, Jeya T.; Li, Aimin; Patel, Samir N.; Low, Donald E.; Gubbay, Jonathan B.			Genetic Variability of Human Respiratory Syncytial Virus A Strains Circulating in Ontario: A Novel Genotype with a 72 Nucleotide G Gene Duplication	PLOS ONE			English	Article							GROUP-A; GROUP-B; SUBGROUP-A; MOLECULAR EPIDEMIOLOGY; DNA-SYNTHESIS; G-PROTEIN; PHYLOGENETIC ANALYSIS; CONSECUTIVE SEASONS; ANTIGENIC STRUCTURE; HUMAN ROTAVIRUS	Human respiratory syncytial virus (HRSV) is the main cause of acute lower respiratory infections in children under 2 years of age and causes repeated infections throughout life. We investigated the genetic variability of RSV-A circulating in Ontario during 2010-2011 winter season by sequencing and phylogenetic analysis of the G glycoprotein gene. Among the 201 consecutive RSV isolates studied, RSV-A (55.7%) was more commonly observed than RSV-B (42.3%). 59.8% and 90.1% of RSV-A infections were among children <= 12 months and <= 5 years old, respectively. On phylogenetic analysis of the second hypervariable region of the 112 RSV-A strains, 110 (98.2%) clustered within or adjacent to the NA1 genotype; two isolates were GA5 genotype. Eleven (10%) NA1-related isolates clustered together phylogenetically as a novel RSV-A genotype, named ON1, containing a 72 nucleotide duplication in the C-terminal region of the attachment (G) glycoprotein. The predicted polypeptide is lengthened by 24 amino acids and includes a23 amino acid duplication. Using RNA secondary structural software, a possible mechanism of duplication occurrence was derived. The 23 amino acid ON1 G gene duplication results in a repeat of 7 potential O-glycosylation sites including three O-linked sugar acceptors at residues 270, 275, and 283. Using Phylogenetic Analysis by Maximum Likelihood analysis, a total of 19 positively selected sites were observed among Ontario NA1 isolates; six were found to be codons which reverted to the previous state observed in the prototype RSV-A2 strain. The tendency of codon regression in the G-ectodomain may infer a decreased avidity of antibody to the current circulating strains. Further work is needed to document and further understand the emergence, virulence, pathogenicity and transmissibility of this novel RSV-A genotype with a72 nucleotide G gene duplication.	[Eshaghi, AliReza; Duvvuri, Venkata R.; Lai, Rachel; Li, Aimin; Patel, Samir N.; Low, Donald E.; Gubbay, Jonathan B.] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada; [Duvvuri, Venkata R.; Low, Donald E.; Gubbay, Jonathan B.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Nadarajah, Jeya T.; Low, Donald E.; Gubbay, Jonathan B.] Univ Toronto, Toronto, ON, Canada; [Gubbay, Jonathan B.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Eshaghi, A (corresponding author), Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada.	jonathan.gubbay@oahpp.ca	Duvvuri, Venkata R/H-2728-2019; Gubbay, Jonathan/Q-8580-2019	Duvvuri, Venkata R/0000-0001-7356-338X; Gubbay, Jonathan/0000-0003-0026-3786; Eshaghi, Alireza/0000-0001-5150-483X	GSK Inc; Hoffman La Roche Inc; Wyeth Inc	GSK Inc; Hoffman La Roche Inc; Wyeth Inc(Wyeth)	This study was not supported by any external funding. Dr Gubbay has received research grants from GSK Inc., Hoffman La Roche Inc., and Wyeth Inc. for the laboratory research projects. Dr Gubbay has never been employed, held consultancy positions, patents, or has any products in development with any of these companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; BALLARD A, 1992, J GEN VIROL, V73, P633, DOI 10.1099/0022-1317-73-3-633; BEDINGER P, 1989, J BIOL CHEM, V264, P16880; BEEM M, 1967, J IMMUNOL, V98, P1115; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; Cane PA, 1997, J MED VIROL, V51, P297, DOI 10.1002/(SICI)1096-9071(199704)51:4<297::AID-JMV7>3.0.CO;2-0; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Dewhurst-Maridor G, 2004, J VIROL METHODS, V120, P41, DOI 10.1016/j.jviromet.2004.03.017; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Galiano MC, 2005, J CLIN MICROBIOL, V43, P2266, DOI 10.1128/JCM.43.5.2266-2273.2005; GARCIA O, 1994, J VIROL, V68, P5448; GarciaBeato R, 1996, VIROLOGY, V221, P301, DOI 10.1006/viro.1996.0379; Gault E, 2001, J VIROL, V75, P7305, DOI 10.1128/JVI.75.16.7305-7314.2001; GORZIGLIA M, 1989, VIROLOGY, V170, P587, DOI 10.1016/0042-6822(89)90453-4; Gupta R, 2004, PREDICTION N GLYCOSY; HALL CB, 1990, J INFECT DIS, V162, P1283, DOI 10.1093/infdis/162.6.1283; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KAGUNI LS, 1982, P NATL ACAD SCI-BIOL, V79, P983, DOI 10.1073/pnas.79.4.983; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Kojima K, 2000, VIRUS RES, V67, P163, DOI 10.1016/S0168-1702(00)00139-8; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kuroiwa Y, 2005, J MED VIROL, V76, P241, DOI 10.1002/jmv.20348; LADUCA RJ, 1983, BIOCHEMISTRY-US, V22, P5177, DOI 10.1021/bi00291a018; LAMBERT DM, 1988, VIROLOGY, V164, P458, DOI 10.1016/0042-6822(88)90560-0; Lazar I, 2006, J CLIN VIROL, V37, P168, DOI 10.1016/j.jcv.2006.07.006; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; Matthijnssens J, 2006, BIOCHEM BIOPH RES CO, V340, P140, DOI 10.1016/j.bbrc.2005.11.165; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; SCOTT GE, 1989, VIRUS RES, V14, P119, DOI 10.1016/0168-1702(89)90033-6; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Sullender WM, 1998, J INFECT DIS, V178, P925, DOI 10.1086/515697; SULLENDER WM, 1993, J CLIN MICROBIOL, V31, P1224, DOI 10.1128/JCM.31.5.1224-1231.1993; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Suo ZC, 1998, J BIOL CHEM, V273, P27259, DOI 10.1074/jbc.273.42.27259; Tamura K, 2011, MOL BIOL EV IN PRESS; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; WALSH EE, 1983, J VIROL, V47, P171, DOI 10.1128/JVI.47.1.171-177.1983; WEAVER DT, 1982, J BIOL CHEM, V257, P2075; WEAVER DT, 1984, J MOL BIOL, V180, P961, DOI 10.1016/0022-2836(84)90266-3; WILSON V, 1988, ARCH VIROL, V102, P131, DOI 10.1007/BF01315570; Wright BE, 2003, MOL MICROBIOL, V48, P429, DOI 10.1046/j.1365-2958.2003.t01-1-03436.x; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zuker M., 1999, V70, P11	61	216	230	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32807	10.1371/journal.pone.0032807	http://dx.doi.org/10.1371/journal.pone.0032807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470426	gold, Green Published			2022-12-27	WOS:000304489000009
J	Chen, H; Young, S; Berhane, TK; Williams, HN				Chen, Huan; Young, Shanterial; Berhane, Timkhite-Kulu; Williams, Henry N.			Predatory Bacteriovorax Communities Ordered by Various Prey Species	PLOS ONE			English	Article							BDELLOVIBRIO-BACTERIOVORUS; ORGANISMS BALOS; WATER COLUMN; DIVERSITY; MARINE; RECLASSIFICATION; ENVIRONMENTS; EVOLUTION; REVEALS; ESTUARY	The role of predation in altering microbial communities has been studied for decades but few examples are known for bacterial predators. Bacteriovorax are halophilic prokaryotes that prey on susceptible Gram-negative bacteria. We recently reported novel observations on the differential selection of Bacteriovorax phylotypes by two different prey, Vibrio parahaemolyticus and Vibrio vulnificus. However, the conclusion is restricted by the limited number of prey tested. In this study, we have conducted two independent investigations involving eight species of prey bacteria while using V. vulnificus and V. parahaemolytics as reference strains. Water samples collected from Dry Bar, Apalachicola Bay were used to establish microcosms which were respectively spiked with prey strains Vibrio cholerae, Escherichia coli or Pseudomonas putida to examine the response of native Bacteriovorax to freshwater bacteria. Indigenous Vibrio sp., Pseudoalteromonas sp., Photobacterium sp. and a clinical strain of V. vulnificus were also tested for the impact of saltwater prey on the Bacteriovorax community. At 24 hour intervals, optical density of the microcosm samples and the abundance of Bacteriovorax were measured over five days. The predominant Bacteriovorax plaques were selected and analyzed by 16S rRNA gene amplification and sequencing. In addition, the impacts of prey on predator population and bacterial community composition were investigated using culture independent denaturing gradient gel electrophoresis. Strikingly, Cluster IV was found consistently as the predominant phylotype produced by the freshwater prey. For all saltwater prey, subgroups of Bacteriovorax phylotype IX were the major predators recovered. The results suggest that prey is an important factor along with temperature, salinity and other environmental parameters in shaping Bacteriovorax communities in aquatic systems.	[Chen, Huan; Young, Shanterial; Berhane, Timkhite-Kulu; Williams, Henry N.] Florida A&M Univ, Sch Environm, Tallahassee, FL 32307 USA	State University System of Florida; Florida A&M University	Chen, H (corresponding author), Florida A&M Univ, Sch Environm, Tallahassee, FL 32307 USA.	henryneal.williams@famu.edu		Chen, Huan/0000-0002-6032-6569	National Science Foundation [0932137]; Division Of Human Resource Development [0932137] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Human Resource Development(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This work was financially supported by grant from the National Science Foundation under Grant Number (0932137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Chauhan A, 2008, MICROB ECOL, V55, P640, DOI 10.1007/s00248-007-9307-1; Chauhan A, 2006, CURR MICROBIOL, V53, P516, DOI 10.1007/s00284-006-0292-2; Chauhan A, 2009, P NATL ACAD SCI USA, V106, P4301, DOI 10.1073/pnas.0809671106; Chen H, 2011, ISME J, V5, P1314, DOI 10.1038/ismej.2011.4; Cottrell MT, 2003, LIMNOL OCEANOGR, V48, P168, DOI 10.4319/lo.2003.48.1.0168; Davidov Y, 2004, INT J SYST EVOL MICR, V54, P1439, DOI 10.1099/ijs.0.02978-0; Davidov Y, 2006, ENVIRON MICROBIOL, V8, P1667, DOI 10.1111/j.1462-2920.2006.01052.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Jurkevitch E, 2000, APPL ENVIRON MICROB, V66, P2365, DOI 10.1128/AEM.66.6.2365-2371.2000; MARANGER R, 1995, MAR ECOL PROG SER, V121, P217, DOI 10.3354/meps121217; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Pineiro SA, 2004, CURR MICROBIOL, V48, P113, DOI 10.1007/s00284-003-4136-z; Pineiro SA, 2008, INT J SYST EVOL MICR, V58, P1203, DOI 10.1099/ijs.0.65710-0; Pineiro SA, 2007, ENVIRON MICROBIOL, V9, P2441, DOI 10.1111/j.1462-2920.2007.01362.x; Pommier T, 2005, AQUAT MICROB ECOL, V41, P79, DOI 10.3354/ame041079; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Rice TD, 1998, MICROBIAL ECOL, V35, P256, DOI 10.1007/s002489900081; Rogosky AM, 2006, CURR MICROBIOL, V52, P81, DOI 10.1007/s00284-005-0038-6; SCHOEFFIELD AJ, 1990, APPL ENVIRON MICROB, V56, P230, DOI 10.1128/AEM.56.1.230-236.1990; STOLP H., 1962, Phytopathologische Zeitschrift, V45, P364; Wen CQ, 2009, J APPL MICROBIOL, V106, P1154, DOI 10.1111/j.1365-2672.2008.04081.x; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; WILLIAMS HN, 1984, CAN J MICROBIOL, V30, P971, DOI 10.1139/m84-152; WILLIAMS HN, 2007, PREDATORY PROKARYOTE, P213; Yair S, 2009, SUSTAINABLE AGRICULTURE, P275, DOI 10.1007/978-90-481-2666-8_18	27	28	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34174	10.1371/journal.pone.0034174	http://dx.doi.org/10.1371/journal.pone.0034174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461907	gold, Green Published, Green Submitted			2022-12-27	WOS:000304118900025
J	Perez, AR; Berbert, LR; Lepletier, A; Revelli, S; Bottasso, O; Silva-Barbosa, SD; Savino, W				Rosa Perez, Ana; Berbert, Luiz Ricardo; Lepletier, Ailin; Revelli, Silvia; Bottasso, Oscar; Silva-Barbosa, Suse Dayse; Savino, Wilson			TNF-alpha Is Involved in the Abnormal Thymocyte Migration during Experimental Trypanosoma cruzi Infection and Favors the Export of Immature Cells	PLOS ONE			English	Article							CHAGAS-DISEASE; EXTRACELLULAR-MATRIX; THYMUS ATROPHY; T-LYMPHOCYTES; C57BL/6 MICE; CHEMOKINES; RECEPTOR; EXPRESSION; DEPLETION; FIBRONECTIN	Previous studies revealed a significant production of inflammatory cytokines together with severe thymic atrophy and thymocyte migratory disturbances during experimental Chagas disease. Migratory activity of thymocytes and mature T cells seem to be finely tuned by cytokines, chemokines and extracellular matrix (ECM) components. Systemic TNF-alpha is enhanced during infection and appears to be crucial in the response against the parasite. However, it also seems to be involved in disease pathology, since it is implicated in the arrival of T cells to effector sites, including the myocardium. Herein, we analyzed the role of TNF-alpha in the migratory activity of thymocytes in Trypanosoma cruzi (T. cruzi) acutely-infected mice. We found increased expression and deposition of TNF-alpha in the thymus of infected animals compared to controls, accompanied by increased co-localization of fibronectin, a cell migration-related ECM molecule, whose contents in the thymus of infected mice is also augmented. In-vivo studies showed an enhanced export of thymocytes in T. cruzi-infected mice, as ascertained by intrathymic injection of FITC alone or in combination with TNF-alpha. The increase of immature CD4(+)CD8(+) T cells in secondary lymphoid organs was even more clear-cut when TNF-alpha was co-injected with FITC. Ex-vivo transmigration assays also revealed higher number of migrating cells when TNF-alpha was added onto fibronectin lattices, with higher input of all thymocyte subsets, including immature CD4(+)CD8(+). Infected animals also exhibit enhanced levels of expression of both mRNA TNF-alpha receptors in the CD4(+)CD8(+) subpopulation. Our findings suggest that in T. cruzi acute infection, when TNF-alpha is complexed with fibronectin, it favours the altered migration of thymocytes, promoting the release of mature and immature T cells to different compartments of the immune system. Conceptually, this work reinforces the notion that thymocyte migration is a multivectorial biological event in health and disease, and that TNF-a is a further player in the process.	[Rosa Perez, Ana; Revelli, Silvia; Bottasso, Oscar] Natl Univ Rosario, Inst Immunol, Fac Med Sci, Rosario, Santa Fe, Argentina; [Berbert, Luiz Ricardo; Lepletier, Ailin; Silva-Barbosa, Suse Dayse; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil	National University of Rosario; Fundacao Oswaldo Cruz	Perez, AR (corresponding author), Natl Univ Rosario, Inst Immunol, Fac Med Sci, Rosario, Santa Fe, Argentina.	perez.ana@conicet.gov.ar	BERBERT, LUIZ/AAT-4678-2020; Pérez, Ana/GQA-6861-2022	Perez, Ana Rosa/0000-0002-1636-7523; Lepletier, Ailin/0000-0002-1371-7313; Berbert, Luiz Ricardo/0000-0003-0541-4002	Secretariat for Science and Technology from National University of Rosario, Argentina [1MED 245, 131/2010]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq/Pro-Sul [490375/2006-5]; Fiocruz (Brazil); Faperj (Brazil)	Secretariat for Science and Technology from National University of Rosario, Argentina; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Pro-Sul(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fiocruz (Brazil); Faperj (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Secretariat for Science and Technology from National University of Rosario (1MED 245, Resol. CS No 131/2010) Argentina, as well as Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, programa Pro-Sul (CNPq/Pro-Sul) grant no 490375/2006-5, Fiocruz and Faperj (Brazil). The funders had no role in study design, data collection and analysis, decision to publish or preparation the manuscript.	Alfonso C, 2006, EUR J IMMUNOL, V36, P149, DOI 10.1002/eji.200535127; Aliberti JCS, 2001, AM J PATHOL, V158, P1433, DOI 10.1016/S0002-9440(10)64094-1; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; ALON R, 1994, J IMMUNOL, V152, P1304; Castanos-Velez E, 1998, INFECT IMMUN, V66, P2960; Chen WX, 2005, MICROB PATHOGENESIS, V39, P189, DOI 10.1016/j.micpath.2005.08.005; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; Cotta-De-Almeida V, 2003, EUR J IMMUNOL, V33, P2439, DOI 10.1002/eji.200323860; DEMORAES MCL, 1991, SCAND J IMMUNOL, V33, P267, DOI 10.1111/j.1365-3083.1991.tb01772.x; GRESSER I, 1987, AM J PATHOL, V128, P13; Holscher C, 2000, INFECT IMMUN, V68, P4075, DOI 10.1128/IAI.68.7.4075-4083.2000; Kroll-Palhares K, 2008, MEM I OSWALDO CRUZ, V103, P375, DOI 10.1590/S0074-02762008000400011; Lannes-Vieira J, 2011, ADV EXP MED BIOL, V691, P221, DOI 10.1007/978-1-4419-6612-4_23; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendes-da-Cruz DA, 2003, MICROBES INFECT, V5, P825, DOI 10.1016/S1286-4579(03)00156-4; Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639; Mendes-da-Cruz DA, 2006, EUR J IMMUNOL, V36, P1486, DOI 10.1002/eji.200535629; Morrot A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001268; Mucci J, 2005, J IMMUNOL, V174, P4545, DOI 10.4049/jimmunol.174.8.4545; Norment AM, 2000, SEMIN IMMUNOL, V12, P445, DOI 10.1006/smim.2000.0261; Perez AR, 2011, J NEUROIMMUNOL, V235, P84, DOI 10.1016/j.jneuroim.2011.03.010; Perez AR, 2007, BRAIN BEHAV IMMUN, V21, P890, DOI 10.1016/j.bbi.2007.02.004; PROBERT L, 1993, J IMMUNOL, V151, P1894; Ribeiro-Carvalho MM, 2007, SCAND J IMMUNOL, V66, P17, DOI 10.1111/j.1365-3083.2007.01928.x; RIVERA MT, 1995, INFECT IMMUN, V63, P591, DOI 10.1128/IAI.63.2.591-595.1995; Roggero E, 2004, FEMS IMMUNOL MED MIC, V41, P123, DOI 10.1016/j.femsim.2004.02.003; Roggero E, 2002, CLIN EXP IMMUNOL, V128, P421, DOI 10.1046/j.1365-2249.2002.01874.x; Roggero E, 2006, J ENDOCRINOL, V190, P495, DOI 10.1677/joe.1.06642; Savino W, 2000, Dev Immunol, V7, P279, DOI 10.1155/2000/60247; Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X; SAVINO W, 1989, EUR J IMMUNOL, V19, P1727, DOI 10.1002/eji.1830190930; Savino W, 2007, CYTOKINE GROWTH F R, V18, P107, DOI 10.1016/j.cytogfr.2007.01.010; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Silva-Barbosa S D, 2000, Dev Immunol, V7, P293, DOI 10.1155/2000/17424; Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709; TARLETON RL, 1994, INFECT IMMUN, V62, P1820, DOI 10.1128/IAI.62.5.1820-1829.1994; Vacchio MS, 2000, SEMIN IMMUNOL, V12, P475, DOI 10.1006/smim.2000.0265; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; Wang B, 1996, IMMUNOLOGY, V88, P284, DOI 10.1111/j.1365-2567.1996.tb00016.x	40	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34360	10.1371/journal.pone.0034360	http://dx.doi.org/10.1371/journal.pone.0034360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461911	Green Published, gold			2022-12-27	WOS:000304118900029
J	Jewett, LR; Hudson, M; Malcarne, VL; Baron, M; Thombs, BD				Jewett, Lisa R.; Hudson, Marie; Malcarne, Vanessa L.; Baron, Murray; Thombs, Brett D.		Canadian Scleroderma Res Grp	Sociodemographic and Disease Correlates of Body Image Distress among Patients with Systemic Sclerosis	PLOS ONE			English	Article							APPEARANCE SELF-ESTEEM; SKIN THICKNESS SCORE; SCALE; SATISFACTION; VARIABILITY; SCLERODERMA; VALIDATION; SEVERITY; MODEL	Background: Body image concerns are infrequently studied in systemic sclerosis (SSc), even though significant visible disfigurement is common. The objective of this study was to identify sociodemographic and disease-related correlates of dissatisfaction with appearance and social discomfort among people with SSc. Methods: SSc patients came from the 15-center Canadian Scleroderma Research Group Registry. Sociodemographic information was based on patient self-report. Disease characteristics were obtained via physician examinations. The Brief-SWAP was used to assess dissatisfaction with appearance and social discomfort. Structural equation models were conducted with MPlus to determine the relationship of dissatisfaction with appearance and social discomfort with age, sex, education, marital status, race/ethnicity, disease duration, skin involvement, telangiectasias, skin pigmentation changes, and hand contractures. Results: A total of 489 SSc patients (432 female, 57 male) were included. Extent of skin involvement was significantly associated with both dissatisfaction with appearance and social discomfort (standardized regression coefficients = 0.02, p = 0.001; 0.02, p = 0.020, respectively), as was skin involvement in the face (0.18, p = 0.016; 0.23, p = 0.006, respectively). Greater social discomfort was robustly associated with younger age (20.017, p < 0.001) and upper-body telangiectasias (0.32, p = 0.021). Dissatisfaction with appearance was associated with hand contractures (0.07, p = 0.036). Conclusion: This study found that dissatisfaction with appearance and social discomfort were associated with numerous disfiguring characteristics of SSc, in addition to age. These results underline that there are multiple factors contributing to body image distress in SSc, as well as the need to attend to both disease and social contexts in understanding the impact of disfigurement among patients.	[Jewett, Lisa R.; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada; [Jewett, Lisa R.; Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Div Rheumatol, Montreal, PQ H3T 1E2, Canada; [Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Dept Psychiat, Montreal, PQ H3T 1E2, Canada; [Malcarne, Vanessa L.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA	McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; California State University System; San Diego State University	Jewett, LR (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	Baron, Murray/AAF-9486-2019; Mittoo, Shikha/C-4616-2015; Pope, Janet/G-3342-2011	Pope, Janet/0000-0003-1479-5302; Malcarne, Vanessa/0000-0002-7526-9982; Thombs, Brett D./0000-0002-5644-8432	Canadian Scleroderma Research Group (Canadian Institutes of Health Research [CIHR] Strategic Training Initiative in Health Research) [SKI 83345]; CIHR; Bourses de Formation - Formation de Maitrise from the Fonds de recherche sante Quebec; Actelion Pharmaceuticals; Pfizer Inc.; Fonds de Recherche sante Quebec	Canadian Scleroderma Research Group (Canadian Institutes of Health Research [CIHR] Strategic Training Initiative in Health Research)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Bourses de Formation - Formation de Maitrise from the Fonds de recherche sante Quebec; Actelion Pharmaceuticals; Pfizer Inc.(Pfizer); Fonds de Recherche sante Quebec	LJ was supported by a Canadian Scleroderma Research Group Studentship (Canadian Institutes of Health Research [CIHR] Strategic Training Initiative in Health Research Grant, #SKI 83345), a Frederick Banting and Charles Best Canadian Graduate Scholarship - Master's Award from the CIHR, and a Bourses de Formation - Formation de Maitrise from the Fonds de recherche sante Quebec. MB is the director of the Canadian Scleroderma Research Group, which has received grant funding from the CIHR; the Scleroderma Society of Canada and its provincial chapters, Scleroderma Society of Ontario, Sclerodermie Quebec, and the Ontario Arthritis Society; and educational grants from Actelion Pharmaceuticals and Pfizer Inc. BT and MH were supported by New Investigator Awards from the Canadian Institutes of Health Research and Etablissement de Jeunes Chercheurs awards from the Fonds de Recherche sante Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MB is the director of the Canadian Scleroderma Research Group, which received educational grants from Actelion Pharmaceuticals and Pfizer Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akesson A, 2003, CLIN EXP RHEUMATOL, V21, pS5; Amin K, 2011, PSYCHOL HEALTH MED, V16, P304, DOI 10.1080/13548506.2010.540250; Benrud-Larson LM, 2003, HEALTH PSYCHOL, V22, P130, DOI 10.1037/0278-6133.22.2.130; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Browne MW, 1993, ALTERNATIVE WAYS ASS; Cash T. F., 2002, BODY IMAGES HDB THEO; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892; Fauerbach JA, 1996, PSYCHOSOMATICS, V37, P547, DOI 10.1016/S0033-3182(96)71518-9; Feingold A, 1998, PSYCHOL SCI, V9, P190, DOI 10.1111/1467-9280.00036; Gayraud Martine, 2007, Joint Bone Spine, V74, pe1, DOI 10.1016/j.jbspin.2006.07.002; Haythornthwaite JA, 2003, RHEUM DIS CLIN N AM, V29, P427, DOI 10.1016/S0889-857X(03)00020-6; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jewett LR, 2010, ARTHRIT CARE RES, V62, P1779, DOI 10.1002/acr.20307; Kline RB, 2005, PRINCIPLES PRACTICE; Lawrence JW, 1998, PSYCHOL ASSESSMENT, V10, P64; LEROY EC, 1988, J RHEUMATOL, V15, P202; Malcarne VL, 1999, COGNITIVE THER RES, V23, P197, DOI 10.1023/A:1018783329341; Mayes MD., 2008, PRIMER RHEUMATIC DIS, P343, DOI [10.1007/978-0-387-68566-3_17, DOI 10.1007/978-0-387-68566-3_17]; Medsger TA, 1999, J RHEUMATOL, V26, P2159; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; Muthen LK, 1998, MPLUS USERSGUIDE; Newell R, 2000, BRIT J PSYCHIAT, V176, P177, DOI 10.1192/bjp.176.2.177; Newell RJ, 1999, J ADV NURS, V30, P1230, DOI 10.1046/j.1365-2648.1999.01185.x; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Rumsey N., 2012, OXFORD HDB PSYCHOL A; Rumsey Nichola, 2004, Body Image, V1, P83, DOI 10.1016/S1740-1445(03)00005-6; SEIBOLD J, 2005, KELLEYS TXB RHEUMATO; Sivakumar B, 2010, J PLAST RECONSTR AES, V63, P1669, DOI 10.1016/j.bjps.2009.08.020; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Thombs BD, 2008, J PSYCHOSOM RES, V64, P205, DOI 10.1016/j.jpsychores.2007.09.003; Thombs BD, 2007, ARTHRIT RHEUM-ARTHR, V57, P1089, DOI 10.1002/art.22910; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; van Lankveld WGJM, 2007, RHEUMATOLOGY, V46, P872, DOI 10.1093/rheumatology/kem008	34	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33281	10.1371/journal.pone.0033281	http://dx.doi.org/10.1371/journal.pone.0033281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	942MA	22457749	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900007
J	Ryan, J; Canonico, M; Carcaillon, L; Carriere, I; Scali, J; Dartigues, JF; Dufouil, C; Ritchie, K; Scarabin, PY; Ancelin, ML				Ryan, Joanne; Canonico, Marianne; Carcaillon, Laure; Carriere, Isabelle; Scali, Jacqueline; Dartigues, Jean-Francois; Dufouil, Carole; Ritchie, Karen; Scarabin, Pierre-Yves; Ancelin, Marie-Laure			Hormone Treatment, Estrogen Receptor Polymorphisms and Mortality: A Prospective Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BONE-MINERAL DENSITY; BREAST-CANCER RISK; REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; CARDIOVASCULAR-DISEASE; ALPHA GENE; PLUS PROGESTIN; ASSOCIATION; TRIAL	Background: The association between hormone treatment (HT) and mortality remains controversial. This study aimed to determine whether the risk of mortality associated with HT use varies depending on the specific characteristics of treatment and genetic variability in terms of the estrogen receptor. Methodology/Principal Findings: A prospective, population-based study of 5135 women aged 65 years and older who were recruited from three cities in France and followed over six years. Detailed information related to HT use was obtained and five estrogen receptor polymorphisms were genotyped. The total follow-up was 25,436 person-years and during this time 352 women died. Cancer (36.4%) and cardiovascular disease (19.3%) were the major causes of death. Cox proportional hazards models adjusted for age, education, centre, living situation, comorbidity, depression, physical and mental incapacities, indicated no significant association between HT and mortality, regardless of the type or duration of treatment, or the age at initiation. However, the association between HT and all-cause or cancer-related mortality varied across women, with significant interactions identified with three estrogen receptor polymorphisms (p-values = 0.004 to 0.03) in adjusted analyses. Women carrying the C allele of ESR1 rs2234693 had a decreased risk of all-cause mortality with HT (HR: 0.42, 95% CI: 0.18-0.97), while in stark contrast, those homozygous for the T allele had a significantly increased risk of cancer-related mortality (HR: 3.18, 95% CI: 1.23-8.20). The findings were similar for ESR1 rs9340799 and ESR2 rs1271572. Conclusions/Significance: The risk of mortality was not associated with HT duration, type or age at initiation. It was however not equal across all women, with some women appearing genetically more vulnerable to the effects of HT in terms of their estrogen receptor genotype. These findings, if confirmed in another independent study, may help explain the differential susceptibility of women to the beneficial or adverse effects of HT.	[Ryan, Joanne; Carriere, Isabelle; Scali, Jacqueline; Ritchie, Karen; Ancelin, Marie-Laure] Univ Montpellier I, INSERM, U1061, Montpellier, France; [Canonico, Marianne; Carcaillon, Laure; Scarabin, Pierre-Yves] Univ Paris 11, INSERM, U1018, UMRS 1018, F-94807 Villejuif, France; [Carcaillon, Laure; Dartigues, Jean-Francois] Univ Bordeaux 2, INSERM, U897, F-33076 Bordeaux, France; [Dufouil, Carole] INSERM, U708, Paris, France; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Imperial College London	Ryan, J (corresponding author), Univ Montpellier I, INSERM, U1061, Montpellier, France.	joanne.ryan@inserm.fr	Beau Yon de Jonage - Canonico, Marianne/ABE-4279-2021; Carrière, Isabelle/W-8728-2019; Ancelin, Marie-Laure/F-3079-2013; Ritchie, Karen/G-3571-2013; Canonico, Marianne/F-9138-2013; Dufouil, Carole/J-4968-2012; Ryan, Joanne/AAB-8324-2019; Ancelin, Marie-Laure/L-1198-2019; DARTIGUES, Jean François/T-4513-2019; Dufouil, Carole/F-5751-2014	Beau Yon de Jonage - Canonico, Marianne/0000-0002-2843-8640; Ancelin, Marie-Laure/0000-0002-1149-4320; Ritchie, Karen/0000-0002-0688-8982; Canonico, Marianne/0000-0002-2843-8640; Ryan, Joanne/0000-0002-7039-6325; Ancelin, Marie-Laure/0000-0002-1149-4320; Dufouil, Carole/0000-0003-2442-4476; scali, jacqueline/0000-0003-2844-7499; Carriere, Isabelle/0000-0002-3617-0752	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine; Bourgogne and Languedoc-Roussillon; Fondation de France; Ministry of Research-Inserm; Agence Nationale de la Recherche [ANR 2007-LVIE-004, 2007-LVIE-005-01]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine; Bourgogne and Languedoc-Roussillon(Region Occitanie); Fondation de France(Fondation de France); Ministry of Research-Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR))	The Three-City (3C) Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale, the Victor Segalen Bordeaux II University and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and first phase of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante, the Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon and, the Fondation de France, the Ministry of Research-Inserm Programme "Cohorts and collection of biological material''. Part of this project is financed by grants from the Agence Nationale de la Recherche (projects ANR 2007-LVIE-004 and 2007-LVIE-005-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, INT J CANCER, V126, P2935, DOI 10.1002/ijc.24892; Almeida S, 2007, CURR OPIN INVEST DR, V8, P814; Alonso P, 2011, PSYCHONEUROENDOCRINO, V36, P473, DOI 10.1016/j.psyneuen.2010.07.022; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Alperovitch A, 2009, EUR J EPIDEMIOL, V24, P669, DOI 10.1007/s10654-009-9383-2; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Canonico M, 2007, CIRCULATION, V115, P840, DOI 10.1161/CIRCULATIONAHA.106.642280; Cauley JA, 1997, ARCH INTERN MED, V157, P2181, DOI 10.1001/archinte.157.19.2181; Chen GG, 2008, MED RES REV, V28, P954, DOI 10.1002/med.20131; Cherry N, 2002, LANCET, V360, P2001; Chilvers CED, 2003, EUR HEART J, V24, P2197, DOI 10.1016/j.ehj.2003.09.019; Commenges D, 1998, STAT MED, V17, P1973, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5; Domingues-Montanari S, 2008, CLIN CHEM, V54, P1183, DOI 10.1373/clinchem.2007.102400; Farquhar C, 2009, COCHRANE DB SYST REV, V15; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fournier A, 2009, J CLIN ONCOL, V27, P5138, DOI 10.1200/JCO.2008.21.6432; Freeman EW, 2007, CLIMACTERIC, V10, P197, DOI 10.1080/13697130601181486; Gompel A, 2008, MATURITAS, V61, P227, DOI 10.1016/j.maturitas.2008.10.009; Grodstein F, 2006, J WOMENS HEALTH, V15, P35, DOI 10.1089/jwh.2006.15.35; Herrington DM, 2003, CURR OPIN LIPIDOL, V14, P145, DOI 10.1097/00041433-200304000-00005; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; Hodis HN, 2009, CLIMACTERIC, V12, P71, DOI 10.1080/13697130903095178; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Ioannidis JPA, 2002, J BONE MINER RES, V17, P2048, DOI 10.1359/jbmr.2002.17.11.2048; KATZENELLENBOGEN BS, 1980, ANNU REV PHYSIOL, V42, P17, DOI 10.1146/annurev.ph.42.030180.000313; Kobayashi N, 2002, MATURITAS, V41, P193, DOI 10.1016/S0378-5122(01)00287-0; L'Hermite M, 2008, MATURITAS, V60, P185, DOI 10.1016/j.maturitas.2008.07.007; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Maruyama H, 2000, ARCH NEUROL-CHICAGO, V57, P236, DOI 10.1001/archneur.57.2.236; Paganini-Hill A, 2006, MENOPAUSE, V13, P12, DOI 10.1097/01.gme.0000172880.40831.3b; PETITTI DB, 1987, OBSTET GYNECOL, V70, P289; Prentice RL, 2005, AM J EPIDEMIOL, V162, P404, DOI 10.1093/aje/kwi223; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rexrode KM, 2007, CLIN CHEM, V53, P1749, DOI 10.1373/clinchem.2007.091454; Rodriguez C, 2001, AM J EPIDEMIOL, V153, P145, DOI 10.1093/aje/153.2.145; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Ryan J, 2008, INT PSYCHOGERIATR, V20, P1203, DOI 10.1017/S1041610208007412; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Shearman AM, 2003, JAMA-J AM MED ASSOC, V290, P2263, DOI 10.1001/jama.290.17.2263; Silvestri S, 2006, MENOPAUSE, V13, P451, DOI 10.1097/01.gme.0000182804.14385.a2; Slattery ML, 2007, BREAST CANCER RES TR, V105, P327, DOI 10.1007/s10549-006-9453-z; Sourander L, 1998, LANCET, V352, P1965, DOI 10.1016/S0140-6736(98)05066-1; Vickers MR, 2007, BMJ-BRIT MED J, V335, P239, DOI 10.1136/bmj.39266.425069.AD; Viscoli CM, 2005, AM J OBSTET GYNECOL, V192, P387, DOI 10.1016/j.ajog.2004.08.017; Welton AJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1190	47	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34112	10.1371/journal.pone.0034112	http://dx.doi.org/10.1371/journal.pone.0034112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457817	Green Published, gold			2022-12-27	WOS:000304046900046
J	Bone, A; Guthmann, JP; Assal, A; Rousset, D; Degeorges, A; Morel, P; Valette, M; Enouf, V; Jacquot, E; Pelletier, B; Le Strat, Y; Pillonel, J; Fonteneau, L; van der Werf, S; Lina, B; Tiberghien, P; Levy-Bruhl, D				Bone, Angie; Guthmann, Jean-Paul; Assal, Azzedine; Rousset, Dominique; Degeorges, Armelle; Morel, Pascal; Valette, Martine; Enouf, Vincent; Jacquot, Eric; Pelletier, Bertrand; Le Strat, Yann; Pillonel, Josiane; Fonteneau, Laure; van der Werf, Sylvie; Lina, Bruno; Tiberghien, Pierre; Levy-Bruhl, Daniel			Incidence of H1N1 2009 Virus Infection through the Analysis of Paired Plasma Specimens among Blood Donors, France	PLOS ONE			English	Article							INFLUENZA VACCINE; ANTIBODY; PROTECTION; CHALLENGE; RESPONSES; TIME	Background: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversion infection is necessary to complement clinical surveillance data and statistical models. It provides the basis for estimating the future impact of influenza A (H1N1pdm09) and implementing appropriate prevention and response strategies. Methods: Using a cross-sectional design, two-stage stratified sampling and paired plasma samples, we estimated the age-specific prevalence of a protective level of H1N1pdm09 antibodies in the French adult population before and after the 2009/10 pandemic, and the proportion of those susceptible that seroconverted due to infection, from a single sample of 1,936 blood donors aged 20-70 years in mainland France in June 2010. Samples with a haemagglutination inhibition (HI) titre >= 1:40 were considered seropositive, and seroconversion due to infection was defined as a 4-fold increase in titre in the absence of H1N1pdm09 vaccination or pre-pandemic seropositivity. Results: Out of the 1,936 donors, 1,708 were included in the analysis. Seroprevalence before the pandemic was 6.7% (95% CI 5.0, 8.9) with no significant differences by age-group (p = 0.3). Seroprevalence afterwards was 23.0% (95% CI 17.7, 29.3) with 20-29 year olds having a higher level than older groups (p < 0.001). Seroconversion due to infection was 12.2% (95% CI 6.9, 20.5). Younger age-group, vaccination against H1N1 and being seropositive before the pandemic were strongly associated with post-pandemic seropositivity. Conclusions: Before the 2009/2010 winter influenza season, only 6.7% of the French mainland population aged 20-70 had a level of antibodies usually considered protective. During the first pandemic wave, 12.2% of the population seroconverted due to infection and the seroprevalence after the wave rose to 23%, either due to prepandemic seropositivity, infection or vaccination. This relatively low latter figure contributed to an extension of target groups for influenza vaccination for the 2010/2011 season.	[Bone, Angie; Guthmann, Jean-Paul; Le Strat, Yann; Pillonel, Josiane; Fonteneau, Laure; Levy-Bruhl, Daniel] Inst Veille Sanitaire, St Maurice, France; [Bone, Angie] European Ctr Dis Control & Prevent, European Programme Intervent Epidemiol EPIET, Stockholm, Sweden; [Assal, Azzedine; Degeorges, Armelle; Morel, Pascal; Jacquot, Eric; Pelletier, Bertrand; Tiberghien, Pierre] Etab Francais Sang, La Plaine St Denis, France; [Rousset, Dominique; Enouf, Vincent; van der Werf, Sylvie] Natl Influenza Ctr No France, Inst Pasteur, Unit Mol Genet RNA Viruses, Dept Virol, Paris, France; [Valette, Martine; Lina, Bruno] Ctr Natl Reference Virus Influenzae Region Sud, Lyon, France; [Valette, Martine; Lina, Bruno] Univ Lyon, Groupement Hosp Est, Hosp Civils Lyon & EMR Virpath, Lyon, France; [van der Werf, Sylvie] Ctr Natl Rech Sci, Unite Rech Associee, F-3015 Paris, France; [van der Werf, Sylvie] Univ Paris Diderot, Paris, France	Institute of Public Health Surveillance; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Bone, A (corresponding author), Inst Veille Sanitaire, St Maurice, France.	angie.bone@hpa.org.uk	Tiberghien, Pierre/AAH-5878-2019; LINA, bruno/M-4572-2014; lina, bruno/N-3663-2019; Le Strat, Yann/C-9848-2013; Rousset, Dominique/S-5400-2019; MOREL, Pascal/ABE-1306-2021; ENOUF, Vincent/H-6494-2017	lina, bruno/0000-0002-8959-2123; Le Strat, Yann/0000-0002-6180-4200; Rousset, Dominique/0000-0002-1473-3147; Levy-Bruhl, Daniel/0000-0002-4246-0932; ENOUF, Vincent/0000-0001-7609-4742; van der WERF, Sylvie/0000-0002-1148-4456; Tiberghien, Pierre/0000-0002-9310-8322				[Anonymous], 2009, WKLY EPIDEMIOL REC, V85, P229; Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bone A, 2010, VACCINE, V28, P8157, DOI 10.1016/j.vaccine.2010.09.096; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Carrat F, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-301; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Delangue J, 2011, CLIN MICROBIOL INFEC; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; FLAHAULT A, 2009, PLOS CURR INFLUENZA, DOI DOI 10.1371/CURRENTS.RRN1140; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hardelid P, 2011, EURO SURVEILL, V16; Health Protection Agency, 2011, NAT INFL ANN REP; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Ikonen N, 2010, EURO SURVEILL, V15; Institut de Veille Sanitaire, 2009, EST NOMBR INF GRIPP; Institut de Veille Sanitaire, 2010, B HEBD GRIPP; Institut nationale de la statistique et des etudes economiques, 2011, TABL APP GEOGR COMM; Kunzel W, 1996, VACCINE, V14, P1108, DOI 10.1016/0264-410X(96)00061-8; McLeish NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020358; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Palmer DF, 1975, ADV LAB TECHNIQUES I, P25; Perruccio AV, 2007, J EPIDEMIOL COMMUN H, V61, P1056, DOI 10.1136/jech.2006.047308; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Rimmelzwaan GF, 2008, VACCINE, V26, pD41, DOI 10.1016/j.vaccine.2008.07.043; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Silvennoinen H, 2009, PEDIATR INFECT DIS J, V28, P372, DOI 10.1097/INF.0b013e318191eef7; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Zambon M., 1998, TXB INFLUENZA, P291; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; [No title captured]	42	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33056	10.1371/journal.pone.0033056	http://dx.doi.org/10.1371/journal.pone.0033056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457734	gold, Green Published, Green Submitted			2022-12-27	WOS:000303909200017
J	Toonen, EJM; Gilissen, C; Franke, B; Kievit, W; Eijsbouts, AM; den Broeder, AA; van Reijmersdal, SV; Veltman, JA; Scheffer, H; Radstake, TRDJ; van Riel, PLCM; Barrera, P; Coenen, MJH				Toonen, Erik J. M.; Gilissen, Christian; Franke, Barbara; Kievit, Wietske; Eijsbouts, Agnes M.; den Broeder, Alfons A.; van Reijmersdal, Simon V.; Veltman, Joris A.; Scheffer, Hans; Radstake, Timothy R. D. J.; van Riel, Piet L. C. M.; Barrera, Pilar; Coenen, Marieke J. H.			Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							PERIPHERAL-BLOOD CELLS; INFLIXIMAB TREATMENT; INFLAMMATION; THERAPY; RESPONSIVENESS; ADALIMUMAB; PREDICTION; EFFICACY; CRITERIA; PROFILE	So far, there are no means of identifying rheumatoid arthritis (RA) patients who will fail to respond to tumour necrosis factor blocking agents (anti-TNF), prior to treatment. We set out to validate eight previously reported gene expression signatures predicting therapy outcome. Genome-wide expression profiling using Affymetrix GeneChip Exon 1.0 ST arrays was performed on RNA isolated from whole blood of 42 RA patients starting treatment with infliximab or adalimumab. Clinical response according to EULAR criteria was determined at week 14 of therapy. Genes that have been reported to be associated with anti-TNF treatment were extracted from our dataset. K-means partition clustering was performed to assess the predictive value of the gene-sets. We performed a hypothesis-driven analysis of the dataset using eight existing gene sets predictive of anti-TNF treatment outcome. The set that performed best reached a sensitivity of 71% and a specificity of 61%, for classifying the patients in the current study. We successfully validated one of eight previously reported predictive expression profile. This replicated expression signature is a good starting point for developing a prediction model for anti-TNF treatment outcome that can be used in a daily clinical setting. Our results confirm that gene expression profiling prior to treatment is a useful tool to predict anti-TNF (non) response.	[Toonen, Erik J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Gilissen, Christian; Franke, Barbara; van Reijmersdal, Simon V.; Veltman, Joris A.; Scheffer, Hans; Coenen, Marieke J. H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Kievit, Wietske; Radstake, Timothy R. D. J.; van Riel, Piet L. C. M.; Barrera, Pilar] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Eijsbouts, Agnes M.; den Broeder, Alfons A.] St Maartens Clin, Dept Rheumatol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Sint Maartens Clinic	Toonen, EJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	m.coenen@gen.umcn.nl	Kievit, Wietske/A-5666-2015; Franke, Barbara/D-4836-2009; Broeder, Alfons A den/H-4861-2016; Toonen, Erik/G-7337-2015; Gilissen, Christian/E-5246-2012; Veltman, Joris A/F-5128-2010; van Reijmersdal, Simon V/E-9529-2016; Scheffer, Hans/E-4644-2012; Coenen, Marieke/A-2159-2010; van Riel, P.L.C.M./H-8082-2014	Franke, Barbara/0000-0003-4375-6572; Broeder, Alfons A den/0000-0002-9012-4079; Gilissen, Christian/0000-0003-1693-9699; Veltman, Joris A/0000-0002-3218-8250; Scheffer, Hans/0000-0002-2986-0915; Coenen, Marieke/0000-0001-8796-2031; Toonen, Erik/0000-0001-9039-635X	Netherlands Organisation for Scientific Research [916.76.020]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a personal grant to MJHC from the Netherlands Organisation for Scientific Research (grant 916.76.020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Badot V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2678; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Coenen MJH, 2007, PHARMACOGENOMICS, V8, P761, DOI 10.2217/14622416.8.7.761; Gerhold DL, 2002, NAT GENET, V32, P547, DOI 10.1038/ng1042; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Huang QC, 2008, RHEUMATOL INT, V28, P697, DOI 10.1007/s00296-008-0534-7; Julia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007556; Kievit W, 2008, ANN RHEUM DIS, V67, P1229, DOI 10.1136/ard.2007.083675; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; Kraan TCV, 2008, ANN RHEUM DIS, V67, P563, DOI 10.1136/ard.2007.081950; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lequerre T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1990; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2090; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1903; Lindberg J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011310; Meugnier E, 2011, PHYSIOL GENOMICS, V43, P365, DOI 10.1152/physiolgenomics.00127.2010; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sekiguchi N, 2008, RHEUMATOLOGY, V47, P780, DOI 10.1093/rheumatology/ken083; Sorensen LK, 2008, J PERIODONTOL, V79, P477, DOI [10.1902/jop.2008.070309, 10.1902/jop.2008.070309 ]; Soto H, 2008, SCAND J IMMUNOL, V68, P43, DOI 10.1111/j.1365-3083.2008.02117.x; Stuhlmuller B, 2010, CLIN PHARMACOL THER, V87, P311, DOI 10.1038/clpt.2009.244; Tanino M, 2009, BIOCHEM BIOPH RES CO, V387, P261, DOI 10.1016/j.bbrc.2009.06.149; Toonen EJM, 2008, ANN RHEUM DIS, V67, P1663, DOI 10.1136/ard.2007.076588; van Baarsen LGM, 2010, GENES IMMUN, V11, P622, DOI 10.1038/gene.2010.34; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Kraan TCTMV, 2008, GENES IMMUN, V9, P16, DOI 10.1038/sj.gene.6364438; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105	34	51	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33199	10.1371/journal.pone.0033199	http://dx.doi.org/10.1371/journal.pone.0033199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457743	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100020
J	Mussalem, JS; Squaiella-Baptistao, CC; Teixeira, D; Yendo, TM; Thies, FG; Popi, AF; Mariano, M; Longo-Maugeri, I				Mussalem, Juliana Sekeres; Squaiella-Baptistao, Carla Cristina; Teixeira, Daniela; Yendo, Tatiana Mina; Thies, Felipe Garutti; Popi, Ana Flavia; Mariano, Mario; Longo-Maugeri, Ieda			Adjuvant Effect of Killed Propionibacterium acnes on Mouse Peritoneal B-1 Lymphocytes and Their Early Phagocyte Differentiation	PLOS ONE			English	Article							PURIFIED SOLUBLE POLYSACCHARIDE; TOLL-LIKE RECEPTORS; DENDRITIC CELL PRECURSORS; LATE-PHASE REACTION; CORYNEBACTERIUM-PARVUM; TUMOR-GROWTH; B-CELLS; INDUCTION; MICE; POPULATION	B-1 lymphocytes are the predominant cells in mouse peritoneal cavity. They express macrophage and lymphocyte markers and are divided into B-1a, B-1b and B-1c subtypes. The role of B-1 cells is not completely clear, but they are responsible for natural IgM production and seem to play a regulatory role. An enriched B-1b cell population can be obtained from non-adherent peritoneal cell cultures, and we have previously demonstrated that these cells undergo differentiation to acquire a mononuclear phagocyte phenotype upon attachment to the substrate in vitro. Nevertheless, the B-1 cell response to antigens or adjuvants has been poorly investigated. Because killed Propionibacterium acnes exhibits immunomodulatory effects on both macrophages and B-2 lymphocytes, we analyzed whether a killed bacterial suspension or its soluble polysaccharide (PS) could modulate the absolute number of peritoneal B-1 cells in BALB/c mice, the activation status of these cells and their ability to differentiate into phagocytes in vitro. In vivo, P. acnes treatment elevated the absolute number of all B-1 subsets, whereas PS only increased B-1c. Moreover, the bacterium increased the number of B-1b cells that were positive for MHC II, TLR2, TLR4, TLR9, IL-4, IL-5 and IL-12, in addition to up-regulating TLR9, CD80 and CD86 expression. PS increased B-1b cell expression of TLR4, TLR9, CD40 and CD86, as well as IL-10 and IL-12 synthesis. Both of the treatments decreased the absolute number of B-1b cells in vitro, suggesting their early differentiation into B-1 cell-derived phagocytes (B-1CDP). We also observed a higher phagocytic activity from the phagocytes that were derived from B-1b cells after P. acnes and PS treatment. The adjuvant effect that P. acnes has on B-1 cells, mainly the B-1b subtype, reinforces the importance of B-1 cells in the innate and adaptive immune responses.	[Mussalem, Juliana Sekeres; Squaiella-Baptistao, Carla Cristina; Teixeira, Daniela; Yendo, Tatiana Mina; Thies, Felipe Garutti; Popi, Ana Flavia; Mariano, Mario; Longo-Maugeri, Ieda] Univ Fed Sao Paulo, Disciplina Imunol, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Squaiella-Baptistao, Carla Cristina] Inst Butantan, Lab Imunoquim, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Instituto Butantan	Mussalem, JS (corresponding author), Univ Fed Sao Paulo, Disciplina Imunol, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil.	imaugeri@unifesp.br	Squaiella-Baptistão, Carla Cristina/K-2557-2013; Popi, Ana Flavia/V-4437-2019; Mariano, Mario/L-2557-2015; Mussalem, Juliana JS/G-4084-2012; Teixeira, Daniela/A-6600-2019; Longo-Maugeri, Ieda M/B-9764-2012	Popi, Ana Flavia/0000-0001-9814-4181; Teixeira, Daniela/0000-0001-7092-2009; Longo-Maugeri, Ieda M/0000-0003-4184-8414; Squaiella-Baptistao, Carla Cristina/0000-0002-4187-798X	Sao Paulo Research Foundation (FAPESP); National Counsel of Technological and Scientific Development (CNPq); Coordination for the Improvement of Higher Education Brasil (CAPES)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Sao Paulo Research Foundation (FAPESP), National Counsel of Technological and Scientific Development (CNPq), Coordination for the Improvement of Higher Education Brasil (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abath FG, 1998, T R SOC TROP MED HYG, V82, P73; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; Ananias RZ, 2007, SCAND J IMMUNOL, V65, P538, DOI 10.1111/j.1365-3083.2007.01939.x; Askenase PW, 2001, CLIN EXP IMMUNOL, V125, P345, DOI 10.1046/j.1365-2249.2001.01619.x; Bamba H, 2005, MICROBIOL IMMUNOL, V49, P89, DOI 10.1111/j.1348-0421.2005.tb03633.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braga EG, 2003, IMMUNOL LETT, V88, P163, DOI 10.1016/S0165-2478(03)00079-8; BRENER Z, 1976, J PARASITOL, V62, P645, DOI 10.2307/3279437; Brito RRNE, 2007, LUPUS, V16, P947, DOI 10.1177/0961203307084298; Dasari P, 2005, CELL IMMUNOL, V236, P140, DOI 10.1016/j.cellimm.2005.08.020; De Lorenzo BHP, 2007, IMMUNOL LETT, V114, P110, DOI 10.1016/j.imlet.2007.09.013; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Facincone S, 1997, MEDIAT INFLAMM, V6, P127, DOI 10.1080/09629359791820; Ghosn EEB, 2008, P NATL ACAD SCI USA, V105, P5195, DOI 10.1073/pnas.0712350105; GREEN S, 1977, J NATL CANCER I, V59, P1519, DOI 10.1093/jnci/59.5.1519; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; HALPERN BN, 1966, NATURE, V212, P853, DOI 10.1038/212853a0; HALPERN BN, 1964, J RETICULOENDOTH SOC, V1, P77; Hastings WD, 2006, IMMUNOL LETT, V105, P90, DOI 10.1016/j.imlet.2006.01.002; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P450, DOI 10.1002/eji.1830160423; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kalis C, 2005, J IMMUNOL, V174, P4295, DOI 10.4049/jimmunol.174.7.4295; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Longhini ALF, 2001, SCAND J IMMUNOL S1, V54, P90; MacDonald AS, 2002, J IMMUNOL, V168, P537, DOI 10.4049/jimmunol.168.2.537; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Mussalem JS, 2006, MICROBIOL IMMUNOL, V50, P253, DOI 10.1111/j.1348-0421.2006.tb03791.x; PALMER JOHN W., 1940, SCIENCE, V92, P155, DOI 10.1126/science.92.2381.155; Parra D, 2011, J LEUKOCYTE BIOL, V20, P1; Perez EC, 2008, CANCER SCI, V99, P920, DOI 10.1111/j.1349-7006.2008.00776.x; Plytycz B, 1997, IMMUNOL TODAY, V18, P505, DOI 10.1016/S0167-5699(97)82523-6; Popi AF, 2009, IMMUNOLOGY, V126, P114, DOI 10.1111/j.1365-2567.2008.02883.x; Squaiella CC, 2008, IMMUNOL LETT, V121, P157, DOI 10.1016/j.imlet.2008.10.005; Squaiella CC, 2006, IMMUNOBIOLOGY, V211, P105, DOI 10.1016/j.imbio.2005.10.013; Staquicini FI, 2008, CANCER RES, V68, P8419, DOI 10.1158/0008-5472.CAN-08-1242; TAKAHAMA Y, 1990, ADV EXP MED BIOL, V256, P427; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THOMASVASLIN V, 1990, INT IMMUNOL, V2, P73, DOI 10.1093/intimm/2.1.73; Velayudham A, 2006, J HEPATOL, V45, P813, DOI 10.1016/j.jhep.2006.06.017; WARR GW, 1975, IMMUNOLOGY, V28, P431; WEBSTER GF, 1990, INT J DERMATOL, V29, P313, DOI 10.1111/j.1365-4362.1990.tb04749.x; WILLERS J, 1995, SCAND J IMMUNOL, V42, P345, DOI 10.1111/j.1365-3083.1995.tb03666.x; WOODRUFF MF, 1974, CLIN EXP IMMUNOL, V17, P509; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Zhang YY, 2004, JNCI-J NATL CANCER I, V96, P201, DOI 10.1093/jnci/djh024	45	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33955	10.1371/journal.pone.0033955	http://dx.doi.org/10.1371/journal.pone.0033955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448280	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700071
J	Arora, G; Shukla, J; Ghosh, S; Maulik, SK; Malhotra, A; Bandopadhyaya, G				Arora, Geetanjali; Shukla, Jaya; Ghosh, Sourabh; Maulik, Subir Kumar; Malhotra, Arun; Bandopadhyaya, Gurupad			PLGA Nanoparticles for Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: A Novel Approach towards Reduction of Renal Radiation Dose	PLOS ONE			English	Article							PARTICLE-SIZE; RELEASE; NANOPRECIPITATION; BIODISTRIBUTION; ENCAPSULATION; TOXICITY; DELIVERY; DRUGS	Background: Peptide receptor radionuclide therapy (PRRT), employed for treatment of neuroendocrine tumors (NETs) is based on over-expression of Somatostatin Receptors (SSTRs) on NETs. It is, however, limited by high uptake and retention of radiolabeled peptide in kidneys resulting in unnecessary radiation exposure thus causing nephrotoxicity. Employing a nanocarrier to deliver PRRT drugs specifically to the tumor can reduce the associated nephrotoxicity. Based on this, Lu-177-DOTATATE loaded PLGA nanoparticles (NPs) were formulated in the present study, as a potential therapeutic model for NETs. Methodology and Findings: DOTATATE was labeled with Lutetium-177 (Lu-177) (labeling efficiency 98%; R-f similar to 0.8). Polyethylene Glycol (PEG) coated Lu-177-DOTATATE-PLGA NPs (50: 50 and 75: 25) formulated, were spherical with mean size of 304.5 +/- 80.8 and 733.4 +/- 101.3 nm (uncoated) and 303.8 +/- 67.2 and 494.3 +/- 71.8 nm (coated) for PLGA(50: 50) and PLGA(75: 25) respectively. Encapsulation efficiency (EE) and In-vitro release kinetics for uncoated and coated NPs of PLGA (50: 50 & 75: 25) were assessed and compared. Mean EE was 77.375 +/- 4.98% & 67.885 +/- 5.12% (uncoated) and 65.385 +/- 5.67% & 58.495 +/- 5.35% (coated). NPs showed initial burst release between 16.64-21.65% with total 42.83-44.79% over 21days. The release increased with coating to 20.4-23.95% initially and 60.97-69.12% over 21days. In-vivo studies were done in rats injected with Lu-177-DOTATATE and Lu-177-DOTATATE-NP (uncoated and PEG-coated) by imaging and organ counting after sacrificing rats at different time points over 24 hr post-injection. With Lu-177-DOTATATE, renal uptake of 37.89 +/- 10.2% ID/g was observed, which reduced to 4.6 +/- 1.97% and 5.27 +/- 1.66% ID/g with uncoated and coated Lu-177-DOTATATE-NP. The high liver uptake with uncoated Lu-177-DOTATATE-NP (13.68 +/- 3.08% ID/g), reduced to 7.20 +/- 2.04% ID/g (p = 0.02) with PEG coating. Conclusion: PLGA NPs were easily formulated and modified for desired release properties. PLGA 50: 50 NPs were a more suitable delivery vehicle for Lu-177-DOTATATE than PLGA 75: 25 because of higher EE and slower release rate. Reduced renal retention of Lu-177-DOTATATE and reduced opsonisation strongly advocate the potential of Lu-177-DOTATATE-PLGA-PEG NPs to reduce radiation dose in PRRT.	[Arora, Geetanjali; Malhotra, Arun; Bandopadhyaya, Gurupad] All India Inst Med Sci, Dept Nucl Med, New Delhi, India; [Shukla, Jaya] Postgrad Inst Med Educ & Res, Dept Nucl Med, Chandigarh 160012, India; [Ghosh, Sourabh] Indian Inst Technol, Dept Text Technol, New Delhi 110016, India; [Maulik, Subir Kumar] All India Inst Med Sci, Dept Pharmacol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Arora, G (corresponding author), All India Inst Med Sci, Dept Nucl Med, New Delhi, India.	guru47@gmail.com			Department of Science and Technology, New Delhi, India; Sophisticated Analytical Instrument Facility (SAIF) at All India Institute of Medical Sciences (AIIMS, New Delhi, India)	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India)); Sophisticated Analytical Instrument Facility (SAIF) at All India Institute of Medical Sciences (AIIMS, New Delhi, India)	Department of Science and Technology (Nanomission scheme), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to the faculty and staff of Sophisticated Analytical Instrument Facility (SAIF) at All India Institute of Medical Sciences (AIIMS, New Delhi, India) set up by Department of Science and Technology (New Delhi, India) for the support and guidance provided for electron microscope studies.	[Anonymous], [No title captured]; [Anonymous], NANOWERK; Barichello JM, 1999, DRUG DEV IND PHARM, V25, P471, DOI 10.1081/DDC-100102197; Budhian A, 2007, INT J PHARM, V336, P367, DOI 10.1016/j.ijpharm.2006.11.061; Dadashzadeh S, 2008, INT J PHARMACEUT, V353, P251, DOI 10.1016/j.ijpharm.2007.11.030; Das T, 2011, CANCER BIOTHER RADIO, V26, P395, DOI 10.1089/cbr.2010.0881; De Sinjan, 2004, AAPS PHARMSCITECH, V5; DeNardo SJ, 2007, J NUCL MED, V48, P437; Gnanasegaran G, 2005, INDIAN J NUCL MED, V20, P55; Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; Kairemo K, 2008, CURR RADIOPHARM, V1, P30, DOI 10.2174/1874471010801010030; Kalaria DR, 2009, PHARM RES-DORDR, V26, P492, DOI 10.1007/s11095-008-9763-4; Kaul G, 2004, J DRUG TARGET, V12, P585, DOI 10.1080/10611860400013451; Lee SC, 1999, J CONTROL RELEASE, V59, P123, DOI 10.1016/S0168-3659(98)00185-0; Li YP, 2001, J CONTROL RELEASE, V71, P203, DOI 10.1016/S0168-3659(01)00218-8; Mao SR, 2007, INT J PHARM, V334, P137, DOI 10.1016/j.ijpharm.2006.10.036; Mohanraj V. J., 2006, Tropical Journal of Pharmaceutical Research, V5, P561; Muthu MS, 2009, ASIAN J PHARM, V3, P266, DOI 10.4103/0973-8398.59948; Noemi Bronstein-Sitton, 2006, PATHWAYS        SPR; Paganelli Giovanni, 2007, NEUROENDOCRINE TUMOR; Panyam J, 2004, J PHARM SCI-US, V93, P1804, DOI 10.1002/jps.20094; Park J, 2009, NANOMED-NANOTECHNOL, V5, P410, DOI 10.1016/j.nano.2009.02.002; Rossin R, 2005, J NUCL MED, V46, P1210; Sameni J, 2009, IEEE S IND EL APPL I; Shukla J, 2007, HELL J NUCL MED, V10, P9; Speer TW, 2010, TARGETED RADIONUCLID, V1st; Ting G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/953537; Tiyaboonchai W, 2003, NARESUAN U J, V11, P51; Vaidyanathan G, 2003, CLIN CANCER RES, V9, P1868; Vegt E, 2010, J NUCL MED, V51, P1049, DOI 10.2967/jnumed.110.075101; Wang Sean X., 2008, CLIN CANCER RES, V14, P3975; Wu Y, 2005, INT J PHARMACEUT, V295, P235, DOI 10.1016/j.ijpharm.2005.01.042; Xie J, 2007, ADV MATER, V19, P3163, DOI 10.1002/adma.200701975	34	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e34019	10.1371/journal.pone.0034019	http://dx.doi.org/10.1371/journal.pone.0034019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442740	gold, Green Submitted, Green Published			2022-12-27	WOS:000303836500081
J	Bijleveld, E; Scheepers, D; Ellemers, N				Bijleveld, Erik; Scheepers, Daan; Ellemers, Naomi			The Cortisol Response to Anticipated Intergroup Interactions Predicts Self-Reported Prejudice	PLOS ONE			English	Article							SOCIAL IDENTITY THREAT; SALIVARY CORTISOL; INDIVIDUAL-DIFFERENCES; EXECUTIVE FUNCTION; STRESS; REACTIVITY; SECRETION; ANXIETY; OTHERS; STABILITY	Objectives: While prejudice has often been shown to be rooted in experiences of threat, the biological underpinnings this threat-prejudice association have received less research attention. The present experiment aims to test activations of the hypothalamus-pituitary-adrenal (HPA) axis, due to anticipated interactions with out-group predict self-reported prejudice. Moreover, we explore potential moderators of this relationship (i.e., interpersonal subtle vs. blatant prejudice). Methodology/Principal findings: Participants anticipated an interaction with an out-group member who was similar dissimilar to the self. To index HPA activation, cortisol responses to this event were measured. Then, subtle and prejudices were measured via questionnaires. Findings indicated that only when people anticipated an interaction with out-group member who was dissimilar to the self, their cortisol response to this event significantly predicted subtle (r = and blatant (r = .53) prejudice. Conclusions: These findings indicate that prejudicial attitudes are linked to HPA-axis activity. Furthermore, when interactions are interpreted to be about individuals (and not so much about groups), experienced threat (or its substrate) is less likely to relate to prejudice. This conclusion is discussed in terms of recent insights from neuroscience.	[Bijleveld, Erik] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Scheepers, Daan; Ellemers, Naomi] Leiden Univ, Inst Psychol Res, Leiden Inst Brain & Cognit, Leiden, Netherlands	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bijleveld, E (corresponding author), Univ Utrecht, Dept Psychol, Utrecht, Netherlands.	e.h.bijleveld@uu.nl		Ellemers, Naomi/0000-0001-9810-1165				Allport G. W., 1954, NATURE PREJUDICE; Amodio D., 2009, HDB PREJUDICE STEREO, P347; Amodio DM, 2006, SOC COGN AFFECT NEUR, V1, P26, DOI 10.1093/scan/nsl002; Amodio DM, 2009, J EXP SOC PSYCHOL, V45, P60, DOI 10.1016/j.jesp.2008.08.009; Blair C, 2005, CHILD DEV, V76, P554, DOI 10.1111/j.1467-8624.2005.00863.x; Blascovich J, 2001, J PERS SOC PSYCHOL, V80, P253, DOI 10.1037//0022-3514.80.2.253; Branscombe N.R., 1999, SOCIAL IDENTITY CONT, P35, DOI DOI 10.4135/9781446200919.N23; Byrne D., 1971, ATTRACTION PARADIGM, V1st ed.; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Fein S, 1997, J PERS SOC PSYCHOL, V73, P31, DOI 10.1037/0022-3514.73.1.31; Franco FM, 1996, J LANG SOC PSYCHOL, V15, P335, DOI 10.1177/0261927X960153007; Gaertner S. L., 1986, PREJUDICE DISCRIMINA, P61; Het S, 2007, BEHAV NEUROSCI, V121, P11, DOI 10.1037/0735-7044.121.1.11; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Klimes-Dougan B, 2001, DEV PSYCHOPATHOL, V13, P695, DOI 10.1017/S0954579401003157; Lazarus R.S., 1984, EMOTION ADAPTATION; LIAKAKOS D, 1975, CLIN CHIM ACTA, V65, P251, DOI 10.1016/0009-8981(75)90250-8; Liviatan I, 2008, J EXP SOC PSYCHOL, V44, P1256, DOI 10.1016/j.jesp.2008.04.007; Mallett RK, 2008, J PERS SOC PSYCHOL, V94, P265, DOI 10.1037/0022-3514.94.2.94.2.265; MARKUS H, 1986, J PERS SOC PSYCHOL, V51, P858, DOI 10.1037/0022-3514.51.4.858; Matheson K, 2004, J EXP SOC PSYCHOL, V40, P777, DOI 10.1016/j.jesp.2004.04.002; Mattarella-Micke A, 2011, EMOTION, V11, P1000, DOI 10.1037/a0023224; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Oitzl MS, 2010, NEUROSCI BIOBEHAV R, V34, P853, DOI 10.1016/j.neubiorev.2009.07.006; Page-Gould E, 2008, J PERS SOC PSYCHOL, V95, P1080, DOI 10.1037/0022-3514.95.5.1080; PETTIGREW TF, 1995, EUR J SOC PSYCHOL, V25, P57, DOI 10.1002/ejsp.2420250106; Powers SI, 2006, J PERS SOC PSYCHOL, V90, P613, DOI 10.1037/0022-3514.90.4.613; Putman P, 2011, PSYCHONEUROENDOCRINO, V36, P439, DOI 10.1016/j.psyneuen.2010.12.001; Radley JJ, 2006, J NEUROSCI, V26, P12967, DOI 10.1523/JNEUROSCI.4297-06.2006; Richeson JA, 2003, NAT NEUROSCI, V6, P1323, DOI 10.1038/nn1156; Riek BM, 2006, PERS SOC PSYCHOL REV, V10, P336, DOI 10.1207/s15327957pspr1004_4; ROKEACH M, 1966, SCIENCE, V151, P167, DOI 10.1126/science.151.3707.167; Romero ML, 2007, INT J COMP PSYCHOL, V20, P89; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Scheepers D, 2009, J EXP SOC PSYCHOL, V45, P228, DOI 10.1016/j.jesp.2008.09.011; Tomaka J, 1997, J PERS SOC PSYCHOL, V73, P63, DOI 10.1037/0022-3514.73.1.63; Tormala ZL, 2009, J EXP SOC PSYCHOL, V45, P149, DOI 10.1016/j.jesp.2008.07.020; Townsend SSM, 2011, PERS SOC PSYCHOL B, V37, P151, DOI 10.1177/0146167210392384; Tull ES, 2005, J NATL MED ASSOC, V97, P206; Wirth MM, 2006, HORM BEHAV, V49, P346, DOI 10.1016/j.yhbeh.2005.08.013	43	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33681	10.1371/journal.pone.0033681	http://dx.doi.org/10.1371/journal.pone.0033681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939TA	22442709	Green Published, gold			2022-12-27	WOS:000303836500050
J	Bonde, JS; Bulow, L				Bonde, Johan Svensson; Bulow, Leif			One-Step Purification of Recombinant Human Amelogenin and Use of Amelogenin as a Fusion Partner	PLOS ONE			English	Article							ENAMEL MATRIX PROTEINS; GENE SPLICE PRODUCTS; BONE REGENERATION; IN-VITRO; CELLS; BIOMINERALIZATION; NANOSPHERES; EXPRESSION; CULTURE	Amelogenin is an extracellular protein first identified as a matrix component important for formation of dental enamel during tooth development. Lately, amelogenin has also been found to have positive effects on clinical important areas, such as treatment of periodontal defects, wound healing, and bone regeneration. Here we present a simple method for purification of recombinant human amelogenin expressed in Escherichia coli, based on the solubility properties of amelogenin. The method combines cell lysis with recovery/purification of the protein and generates a >95% pure amelogenin in one step using intact harvested cells as starting material. By using amelogenin as a fusion partner we could further demonstrate that the same method also be can explored to purify other target proteins/peptides in an effective manner. For instance, a fusion between the clinically used protein PTH (parathyroid hormone) and amelogenin was successfully expressed and purified, and the amelogenin part could be removed from PTH by using a site-specific protease.	[Bonde, Johan Svensson; Bulow, Leif] Lund Univ, Dept Pure & Appl Biochem, Ctr Chem & Chem Engn, Lund, Sweden	Lund University	Bonde, JS (corresponding author), Lund Univ, Dept Pure & Appl Biochem, Ctr Chem & Chem Engn, Lund, Sweden.	leif.bulow@tbiokem.lth.se		Bonde, Johan/0000-0001-8866-7982	Vinnova (Swedish Governmental Agency for Innovation Systems)	Vinnova (Swedish Governmental Agency for Innovation Systems)(Vinnova)	This study was supported by grants from Vinnova (Swedish Governmental Agency for Innovation Systems). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bromley KM, 2011, J BIOL CHEM, V286, P34643, DOI 10.1074/jbc.M111.250928; DEUTSCH D, 2006, EUR J ORAL SCI, V114, P381; Deutsch D, 2006, EUR J ORAL SCI, V114, P183, DOI 10.1111/j.1600-0722.2006.00301.x; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x; Gestrelius S, 2000, Clin Oral Investig, V4, P120, DOI 10.1007/s007840050127; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x; Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Kauvar AS, 2010, J PERIODONTOL, V81, P1196, DOI 10.1902/jop.2010.090441; Kawana F, 2001, ANAT RECORD, V264, P438, DOI 10.1002/ar.10016; Lakshminarayanan R, 2010, J BIOL CHEM, V285, P40593, DOI 10.1074/jbc.M110.131136; Lyngstadaas SP, 2009, ORTHOD CRANIOFAC RES, V12, P243, DOI 10.1111/j.1601-6343.2009.01459.x; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; MIDDELBERG APJ, 1995, BIOTECHNOL ADV, V13, P491, DOI 10.1016/0734-9750(95)02007-P; Mirastschijski U, 2004, WOUND REPAIR REGEN, V12, P100, DOI 10.1111/j.1524-475X.2004.tb00001.x; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; Moradian-Oldak J, 2006, EUR J ORAL SCI, V114, P289, DOI 10.1111/j.1600-0722.2006.00285.x; Nagano T, 2004, J PERIODONTAL RES, V39, P249, DOI 10.1111/j.1600-0765.2004.00733.x; Paine ML, 2000, J STRUCT BIOL, V132, P191, DOI 10.1006/jsbi.2000.4324; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; Svensson J, 2006, PROTEIN EXPRES PURIF, V48, P134, DOI 10.1016/j.pep.2006.01.005; Swanson EC, 2006, EUR J ORAL SCI, V114, P239, DOI 10.1111/j.1600-0722.2006.00321.x; Tan J, 1998, CONNECT TISSUE RES, V38, P215, DOI 10.3109/03008209809017039; Veis A, 2003, CELL MOL LIFE SCI, V60, P38, DOI 10.1007/s000180300003; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Viswanathan HL, 2003, J PERIODONTOL, V74, P1423, DOI 10.1902/jop.2003.74.10.1423; Vowden P, 2006, WOUND REPAIR REGEN, V14, P240, DOI 10.1111/j.1743-6109.2006.00117.x; Wen HB, 2003, J BIOMED MATER RES A, V64A, P483, DOI 10.1002/jbm.a.10401; Yoneda S, 2003, J PERIODONTAL RES, V38, P333, DOI 10.1034/j.1600-0765.2003.00667.x; Yuan K, 2003, J CLIN PERIODONTOL, V30, P732, DOI 10.1034/j.1600-051X.2003.00413.x; Zeichner-David M, 2001, MATRIX BIOL, V20, P307, DOI 10.1016/S0945-053X(01)00155-X; Zeichner-David M, 2006, EUR J ORAL SCI, V114, P244, DOI 10.1111/j.1600-0722.2006.00322.x; Zhu L, 2010, ARCH ORAL BIOL, V56, P331	38	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33269	10.1371/journal.pone.0033269	http://dx.doi.org/10.1371/journal.pone.0033269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442680	gold, Green Published			2022-12-27	WOS:000303836500022
J	Puzey, JR; Karger, A; Axtell, M; Kramer, EM				Puzey, Joshua R.; Karger, Amir; Axtell, Michael; Kramer, Elena M.			Deep Annotation of Populus trichocarpa microRNAs from Diverse Tissue Sets	PLOS ONE			English	Article							STRESS-RESPONSIVE MICRORNAS; TRANSCRIPTIONAL REGULATION; PLANT; EXPRESSION; MIRBASE; GENOME; GENES	Populus trichocarpa is an important woody model organism whose entire genome has been sequenced. This resource has facilitated the annotation of microRNAs (miRNAs), which are short non-coding RNAs with critical regulatory functions. However, despite their developmental importance, P. trichocarpa miRNAs have yet to be annotated from numerous important tissues. Here we significantly expand the breadth of tissue sampling and sequencing depth for miRNA annotation in P. trichocarpa using high-throughput smallRNA (sRNA) sequencing. miRNA annotation was performed using three individual next-generation sRNA sequencing runs from separate leaves, xylem, and mechanically treated xylem, as well as a fourth run using a pooled sample containing vegetative apices, male flowers, female flowers, female apical buds, and male apical and lateral buds. A total of 276 miRNAs were identified from these datasets, including 155 previously unannotated miRNAs, most of which are P. trichocarpa specific. Importantly, we identified several xylem-enriched miRNAs predicted to target genes known to be important in secondary growth, including the critical reaction wood enzyme xyloglucan endo-transglycosylase/hydrolase and vascular-related transcription factors. This study provides a thorough genome-wide annotation of miRNAs in P. trichocarpa through deep sRNA sequencing from diverse tissue sets. Our data significantly expands the P. trichocarpa miRNA repertoire, which will facilitate a broad range of research in this major model system.	[Puzey, Joshua R.; Kramer, Elena M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, England; [Karger, Amir] Harvard Univ, Div Sci, Fac Arts & Sci, Cambridge, MA 02138 USA; [Axtell, Michael] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Puzey, JR (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, England.	ekramer@oeb.harvard.edu		Puzey, Joshua/0000-0001-8019-9993; Karger, Amir/0000-0002-4561-3850	National Science Foundation (NSF) [0638525, 0718051]	National Science Foundation (NSF)(National Science Foundation (NSF))	Populus trichocarpa smallRNA sequencing databases made publicly available by Prof. Blake Meyers and Prof. Pamela Green were used. This sequencing project was supported by National Science Foundation (NSF) award 0638525 to BM and PG. This work was supported in part by NSF award 0718051 to MJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avci U, 2008, PLANT J, V56, P303, DOI 10.1111/j.1365-313X.2008.03592.x; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Du J, 2010, J INTEGR PLANT BIOL, V52, P17, DOI 10.1111/j.1744-7909.2010.00901.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Klevebring D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-620; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Li B, 2011, J EXPT BOT; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Mahalingam G, 2010, METHODS MOL BIOL, V592, P163, DOI 10.1007/978-1-60327-005-2_12; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nishikubo N, 2007, PLANT CELL PHYSIOL, V48, P843, DOI 10.1093/pcp/pcm055; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001	31	51	177	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33034	10.1371/journal.pone.0033034	http://dx.doi.org/10.1371/journal.pone.0033034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442676	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500018
J	Bar, KJ; Rachow, T; Schulz, S; Bassarab, K; Haufe, S; Berger, S; Koch, K; Voss, A				Baer, Karl-Juergen; Rachow, Tobias; Schulz, Steffen; Bassarab, Katharina; Haufe, Stefanie; Berger, Sandy; Koch, Kathrin; Voss, Andreas			The Phrenic Component of Acute Schizophrenia - A Name and Its Physiological Reality	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RESPIRATORY SINUS ARRHYTHMIA; AUTONOMIC NERVOUS-SYSTEM; BLOOD-PRESSURE; NONLINEAR COMPLEXITY; 1ST-DEGREE RELATIVES; VAGAL ACTIVITY; MODULATION; MECHANISMS; DYNAMICS	Decreased heart rate variability (HRV) was shown for unmedicated patients with schizophrenia and their first-degree relatives, implying genetic associations. This is known to be an important risk factor for increased cardiac mortality in other diseases. The interaction of cardio-respiratory function and respiratory physiology has never been investigated in the disease although it might be closely related to the pattern of autonomic dysfunction. We hypothesized that increased breathing rates and reduced cardio-respiratory coupling in patients with acute schizophrenia would be associated with low vagal function. We assessed variability of breathing rates and depth, HRV and cardio-respiratory coupling in patients, their first-degree relatives and controls at rest. Control subjects were investigated a second time by means of a stress task to identify stress-related changes of cardio-respiratory function. A total of 73 subjects were investigated, consisting of 23 unmedicated patients, 20 healthy, first-degree relatives and 30 control subjects matched for age, gender, smoking and physical fitness. The LifeShirt (R), a multi-function ambulatory device, was used for data recording (30 minutes). Patients breathe significantly faster (p < .001) and shallower (p < .001) than controls most pronouncedly during exhalation. Patients' breathing is characterized by a significantly increased amount of middle- (p < .001), high- (p < .001), and very high frequency fluctuations (p < .001). These measures correlated positively with positive symptoms as assessed by the PANSS scale (e. g., middle frequency: r = 521; p < .01). Cardio-respiratory coupling was reduced in patients only, while HRV was decreased in patients and healthy relatives in comparison to controls. Respiratory alterations might reflect arousal in acutely ill patients, which is supported by comparable physiological changes in healthy subjects during stress. Future research needs to further investigate these findings with respect to their physiological consequences for patients. These results are invaluable for researchers studying changes of biological signals prone to the influence of breathing rate and rhythm (e. g., functional imaging).	[Baer, Karl-Juergen; Rachow, Tobias; Bassarab, Katharina; Haufe, Stefanie; Berger, Sandy; Koch, Kathrin] Univ Hosp, Dept Psychiat & Psychotherapy, Jena, Germany; [Schulz, Steffen; Voss, Andreas] Univ Appl Sci, Dept Med Engn & Biotechnol, Jena, Germany	Friedrich Schiller University of Jena	Bar, KJ (corresponding author), Univ Hosp, Dept Psychiat & Psychotherapy, Jena, Germany.	Karl-Juergen.Baer@med.uni-jena.de	Schulz, Steffen/CAH-9340-2022; Koch, Kathrin/F-4870-2010	Schulz, Steffen/0000-0002-0847-6623; Voss, Andreas/0000-0002-0236-0830				Antonius D, 2011, SCHIZOPHR RES, V127, P273, DOI 10.1016/j.schres.2010.10.007; Arne M, 2010, RESP MED, V104, P550, DOI 10.1016/j.rmed.2009.10.023; Bar KJ, 2008, CLIN NEUROPHYSIOL, V119, P2209, DOI 10.1016/j.clinph.2008.06.012; Bar KJ, 2008, PSYCHIAT RES, V157, P255, DOI 10.1016/j.psychres.2007.04.021; Bar KJ, 2007, SCHIZOPHR RES, V95, P115, DOI 10.1016/j.schres.2007.05.034; Bar KJ, 2007, CLIN NEUROPHYSIOL, V118, P2009, DOI 10.1016/j.clinph.2007.06.012; Bar KJ, 2006, BIOMED TECH, V51, P237, DOI 10.1515/BMT.2006.045; Bar KJ, 2010, SCHIZOPHRENIA BULL, V36, P1050, DOI 10.1093/schbul/sbp024; Bar KJ, 2007, J APPL PHYSIOL, V102, P1051, DOI 10.1152/japplphysiol.00811.2006; Bar KJ, 2005, J PSYCHIATR RES, V39, P519, DOI 10.1016/j.jpsychires.2004.12.007; Baumert M, 2004, METHOD INFORM MED, V43, P202, DOI 10.1055/s-0038-1633859; Baumert M, 2002, MED BIOL ENG COMPUT, V40, P241, DOI 10.1007/BF02348131; BERGER RD, 1989, AM J PHYSIOL, V256, pH142, DOI 10.1152/ajpheart.1989.256.1.H142; Berger S, 2010, PROG NEURO-PSYCHOPH, V34, P1294, DOI 10.1016/j.pnpbp.2010.07.013; Berger S, 2010, PROG NEURO-PSYCHOPH, V34, P406, DOI 10.1016/j.pnpbp.2010.01.009; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; Bianciardi M, 2009, NEUROIMAGE, V45, P160, DOI 10.1016/j.neuroimage.2008.10.034; Boettger MK, 2010, ANN NONINVAS ELECTRO, V15, P165, DOI 10.1111/j.1542-474X.2010.00358.x; Boke O, 2008, INT J PSYCHIAT MED, V38, P103, DOI 10.2190/PM.38.1.j; Caminal P, 2010, ANN BIOMED ENG, V38, P2542, DOI 10.1007/s10439-010-0027-1; Camm AJ, 1996, CIRCULATION, V93, P1043; Carry PY, 1997, CHEST, V111, P910, DOI 10.1378/chest.111.4.910; Castro MN, 2009, SCHIZOPHR RES, V109, P134, DOI 10.1016/j.schres.2008.12.026; Chang JS, 2010, PROG NEURO-PSYCHOPH, V34, P924, DOI 10.1016/j.pnpbp.2010.04.017; First M. B., 1997, STRUCTURED CLIN INTE; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; GROSSMAN P, 1990, PSYCHOPHYSIOLOGY, V27, P702, DOI 10.1111/j.1469-8986.1990.tb03198.x; GROSSMAN P, 1990, PSYCHOPHYSIOLOGY, V27, P404, DOI 10.1111/j.1469-8986.1990.tb02335.x; Grossman Paul, 2004, Stud Health Technol Inform, V108, P133; Guz A, 1997, RESP PHYSIOL, V109, P197, DOI 10.1016/S0034-5687(97)00050-9; Hadziefendic S, 1999, J AUTONOM NERV SYST, V76, P135, DOI 10.1016/S0165-1838(99)00020-X; Hempel RJ, 2005, J PSYCHIATR RES, V39, P509, DOI 10.1016/j.jpsychires.2004.11.004; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; Jindal R, 2005, J PSYCHIATR NEUROSCI, V30, P393; Kabir MM, ANN BIOMED IN PRESS; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kolotylova T, 2010, PSYCHOTHER PSYCH MED, V60, P64, DOI 10.1055/s-0028-1103297; KONNO K, 1967, J APPL PHYSIOL, V22, P407, DOI 10.1152/jappl.1967.22.3.407; Koponen H, 2008, NORD J PSYCHIAT, V62, P342, DOI 10.1080/08039480801959323; Lalley PM, 2008, RESP PHYSIOL NEUROBI, V164, P160, DOI 10.1016/j.resp.2008.02.004; LeBlanc J, 2004, PHYSIOL BEHAV, V82, P647, DOI 10.1016/j.physbeh.2004.05.014; Malaspina D, 1997, BIOL PSYCHIAT, V41, P612, DOI 10.1016/S0006-3223(96)00161-8; Mujica-Parodi LR, 2005, NEUROPSYCHOBIOLOGY, V51, P10, DOI 10.1159/000082850; Nardi AE, 2009, RESP PHYSIOL NEUROBI, V167, P133, DOI 10.1016/j.resp.2008.07.011; Okada T, 2003, J CLIN PSYCHOPHARM, V23, P441, DOI 10.1097/01.jcp.0000088901.24613.b8; Paterson AS, 1935, J NEUROL PSYCHOPATHO, V16, P36; Peupelmann J, 2009, SCHIZOPHR RES, V112, P153, DOI 10.1016/j.schres.2009.03.042; Porta A, 1999, BIOL CYBERN, V81, P119, DOI 10.1007/s004220050549; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Pramanik T, 2009, J ALTERN COMPLEM MED, V15, P293, DOI 10.1089/acm.2008.0440; Rachow T, 2011, PSYCHOPHYSIOLOGY, V48, P1323, DOI 10.1111/j.1469-8986.2011.01210.x; Ramirez JM, 1996, CURR OPIN NEUROBIOL, V6, P817, DOI 10.1016/S0959-4388(96)80033-X; SACKNER MA, 1989, J APPL PHYSIOL, V66, P410, DOI 10.1152/jappl.1989.66.1.410; Shea SA, 1996, EXP PHYSIOL, V81, P1; Toichi M, 1999, INT J PSYCHOPHYSIOL, V31, P147, DOI 10.1016/S0167-8760(98)00047-6; van den Aardweg JG, 2002, AM J RESP CRIT CARE, V165, P1041, DOI 10.1164/ajrccm.165.8.2104100; Voss A, 2009, PHILOS T R SOC A, V367, P277, DOI 10.1098/rsta.2008.0232; Wilhelm FH, 2003, BEHAV MODIF, V27, P671, DOI 10.1177/0145445503256321; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480; Wittkower E, 1934, J MENT SCI, V80, P692, DOI 10.1192/bjp.80.331.692; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101; Yasui Y, 2004, BRAIN RES, V1016, P129, DOI 10.1016/j.brainres.2004.04.080; Yeragani VK, 2002, NEUROPSYCHOBIOLOGY, V46, P111, DOI 10.1159/000066388	65	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33459	10.1371/journal.pone.0033459	http://dx.doi.org/10.1371/journal.pone.0033459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	932RV	22438935	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100049
J	Wang, YJ; Chen, YH; Yang, Q				Wang, Yuanjia; Chen, Yin-Hsiu; Yang, Qiong			Joint Rare Variant Association Test of the Average and Individual Effects for Sequencing Studies	PLOS ONE			English	Article							DISEASE	For many complex traits, single nucleotide polymorphisms (SNPs) identified from genome-wide association studies (GWAS) only explain a small percentage of heritability. Next generation sequencing technology makes it possible to explore unexplained heritability by identifying rare variants (RVs). Existing tests designed for RVs look for optimal strategies to combine information across multiple variants. Many of the tests have good power when the true underlying associations are either in the same direction or in opposite directions. We propose three tests for examining the association between a phenotype and RVs, where two of them jointly consider the common association across RVs and the individual deviations from the common effect. On one hand, similar to some of the best existing methods, the individual deviations are modeled as random effects to borrow information across multiple RVs. On the other hand, unlike the existing methods which pool individual effects towards zero, we pool them towards a possibly non-zero common effect by adding a pooled variant into the model. The common effect and the individual effects are jointly tested. We show through extensive simulations that at least one of the three tests proposed here is the most powerful or very close to being the most powerful in various settings of true models. This is appealing in practice because the direction and size of the true effects of the associated RVs are unknown. Researchers can apply the developed tests to improve power under a wide range of true models.	[Wang, Yuanjia] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10027 USA; [Chen, Yin-Hsiu] Columbia Univ, Dept Stat, New York, NY USA; [Yang, Qiong] Boston Univ, Dept Biostat, Boston, MA 02215 USA	Columbia University; Columbia University; Boston University	Wang, YJ (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10027 USA.	yuanjia.wang@columbia.edu	Yang, Qiong/G-5438-2014		NIH [R03AG031113-01A2, R01NS073670-01]; National Heart, Lung and Blood Institute [N01-HC-25195]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073671, R01NS073670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG031113] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Wang's research is supported by NIH grants R03AG031113-01A2 and R01NS073670-01. Yang's research is supported by National Heart, Lung and Blood Institute N01-HC-25195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2011, GENET EPIDE IN PRESS; Crainiceanu CM, 2004, J ROY STAT SOC B, V66, P165, DOI 10.1111/j.1467-9868.2004.00438.x; Davies RB, 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Goeman JJ, 2006, J ROY STAT SOC B, V68, P477, DOI 10.1111/j.1467-9868.2006.00551.x; Hindorff LA, 2011, CATALOG PUBLISHED GE; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002	17	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e32485	10.1371/journal.pone.0032485	http://dx.doi.org/10.1371/journal.pone.0032485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22468164	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100012
J	Wilk, A; Waligorska, A; Waligorski, P; Ochoa, A; Reiss, K				Wilk, Anna; Waligorska, Agnieszka; Waligorski, Piotr; Ochoa, Augusto; Reiss, Krzysztof			Inhibition of ER beta Induces Resistance to Cisplatin by Enhancing Rad51-Mediated DNA Repair in Human Medulloblastoma Cell Lines	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; PROSTATE-CANCER CELLS; BREAST-CANCER; NUCLEAR-INTERACTION; ICI 182,780; T-ANTIGEN; HOMOLOGOUS RECOMBINATION; DIFFERENTIAL EXPRESSION; EPITHELIAL-CELLS; ALPHA	Cisplatin is one of the most widely used and effective anticancer drugs against solid tumors including cerebellar tumor of the childhood, Medulloblastoma. However, cancer cells often develop resistance to cisplatin, which limits therapeutic effectiveness of this otherwise effective genotoxic drug. In this study, we demonstrate that human medulloblastoma cell lines develop acute resistance to cisplatin in the presence of estrogen receptor (ER) antagonist, ICI182,780. This unexpected finding involves a switch from the G2/M to G1 checkpoint accompanied by decrease in ATM/Chk2 and increase in ATR/Chk1 phosphorylation. We have previously reported that ER beta, which is highly expressed in medulloblastomas, translocates insulin receptor substrate 1 (IRS-1) to the nucleus, and that nuclear IRS-1 binds to Rad51 and attenuates homologous recombination directed DNA repair (HRR). Here, we demonstrate that in the presence of ICI182,780, cisplatin-treated medulloblastoma cells show recruitment of Rad51 to the sites of damaged DNA and increase in HRR activity. This enhanced DNA repair during the S phase preserved also clonogenic potential of medulloblastoma cells treated with cisplatin. In conclusion, inhibition of ER beta considered as a supplemental anticancer therapy, has been found to interfere with cisplatin-induced cytotoxicity in human medulloblastoma cell lines.	[Wilk, Anna; Waligorska, Agnieszka; Waligorski, Piotr; Ochoa, Augusto; Reiss, Krzysztof] LSU Hlth Sci Ctr, Dept Med, Stanley S Scott Canc Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wilk, A (corresponding author), LSU Hlth Sci Ctr, Dept Med, Stanley S Scott Canc Ctr, New Orleans, LA USA.	kreiss@lsuhsc.edu	Waligórski, Piotr/AAA-1622-2020	Waligórski, Piotr/0000-0001-7511-6196; Waligorska, Agnieszka/0000-0002-7222-0550	NIH [RO1CA095518]; NATIONAL CANCER INSTITUTE [R01CA095518, R01CA107974] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant from NIH awarded to KR (RO1CA095518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SM, 2003, J LAB CLIN MED, V142, P178, DOI 10.1016/S0022-2143(03)00111-2; Batistatou A, 2004, J CANCER RES CLIN, V130, P405, DOI 10.1007/s00432-004-0548-9; Batistatou A, 2006, J NEURO-ONCOL, V77, P17, DOI 10.1007/s11060-005-9005-0; Belcher SM, 2009, ENDOCRINOLOGY, V150, P1112, DOI 10.1210/en.2008-1363; Bergner CC, 2007, ANTICANCER RES, V27, P2071; Bhattacharyya RS, 2006, MOL CANCER THER, V5, P1539, DOI 10.1158/1535-7163.MCT-06-0065; Britten RA, 1999, BRIT J CANCER, V79, P843, DOI 10.1038/sj.bjc.6690135; Brozovic A, 2009, MUTAT RES-FUND MOL M, V670, P32, DOI 10.1016/j.mrfmmm.2009.07.002; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; deVincenzo R, 1996, ANN NY ACAD SCI, V784, P517, DOI 10.1111/j.1749-6632.1996.tb16273.x; Ercoli A, 2000, INT J CANCER, V85, P98, DOI 10.1002/(SICI)1097-0215(20000101)85:1<98::AID-IJC18>3.0.CO;2-A; Fox EM, 2008, STEROIDS, V73, P1039, DOI 10.1016/j.steroids.2008.04.006; Frankenberg-Schwager M, 2005, TOXICOLOGY, V212, P175, DOI 10.1016/j.tox.2005.04.015; Garcia-Lopez P, 2004, CANCER CHEMOTH PHARM, V53, P533, DOI 10.1007/s00280-003-0760-3; Grivas PD, 2009, INT J COLORECTAL DIS, V24, P613, DOI 10.1007/s00384-009-0647-9; HE XM, 1991, LAB INVEST, V64, P833; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huang X, 2004, CYTOM PART A, V58A, P99, DOI 10.1002/cyto.a.20018; Ikeda Y, 2006, BRAIN RES, V1083, P39, DOI 10.1016/j.brainres.2006.02.025; KATSETOS CD, 1994, SEMIN DIAGN PATHOL, V11, P85; Katsetos CD, 2003, ACTA NEUROPATHOL, V105, P1, DOI 10.1007/s00401-002-0618-5; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Lau KM, 2000, CANCER RES, V60, P3175; Leung YK, 2006, NEOPLASIA, V8, P242, DOI 10.1593/neo.05853; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; MCCOMB JG, 1981, NEUROSURGERY, V9, P548; Pedram A, 2009, MOL BIOL CELL, V20, P3374, DOI 10.1091/mbc.E09-01-0085; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pujol P, 1998, CANCER RES, V58, P5367; Reiss K, 2006, J CELL PHYSIOL, V206, P295, DOI 10.1002/jcp.20455; Reiss Krzysztof, 2002, Expert Opin Ther Targets, V6, P539, DOI 10.1517/14728222.6.5.539; Ricke WA, 2007, DIFFERENTIATION, V75, P871, DOI 10.1111/j.1432-0436.2007.00224.x; Robertson JFR, 2001, J STEROID BIOCHEM, V79, P209, DOI 10.1016/S0960-0760(01)00138-8; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Schmutte C, 1999, CANCER RES, V59, P4564; Sisci D, 2007, ANN ONCOL, V18, P81, DOI 10.1093/annonc/mdm232; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Speirs V, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2140; Stefanou D, 2004, EUR J GYNAECOL ONCOL, V25, P457; Tong D, 2002, BREAST CANCER RES TR, V71, P249, DOI 10.1023/A:1014465916473; Trojanek J, 2006, J CELL PHYSIOL, V206, P35, DOI 10.1002/jcp.20425; Trojanek J, 2003, MOL CELL BIOL, V23, P7510, DOI 10.1128/MCB.23.21.7510-7524.2003; Trojanek J, 2006, INT J CANCER, V119, P539, DOI 10.1002/ijc.21828; Urbanska K, 2008, INT J CANCER, V123, P1015, DOI 10.1002/ijc.23588; Urbanska K, 2009, J CELL PHYSIOL, V219, P392, DOI 10.1002/jcp.21683; Wozniak K, 2002, ACTA BIOCHIM POL, V49, P583; Wurster M, 2010, ONCOL REP, V24, P653, DOI 10.3892/or_00000904; Xu ZY, 2005, J PHARMACOL EXP THER, V314, P495, DOI 10.1124/jpet.105.084053; YATES AJ, 1979, CHILD BRAIN, V5, P31	50	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33867	10.1371/journal.pone.0033867	http://dx.doi.org/10.1371/journal.pone.0033867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439007	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100107
J	Yang, D; Li, SY; Yeung, CM; Chang, RCC; So, KF; Wong, D; Lo, ACY				Yang, Di; Li, Suk-Yee; Yeung, Chung-Man; Chang, Raymond Chuen-Chung; So, Kwok-Fai; Wong, David; Lo, Amy C. Y.			Lycium barbarum Extracts Protect the Brain from Blood-Brain Barrier Disruption and Cerebral Edema in Experimental Stroke	PLOS ONE			English	Article							FOCAL ISCHEMIA; MATRIX-METALLOPROTEINASE; MEDICINE; INJURY; MODEL; LEADS; POLYSACCHARIDES; OVEREXPRESSION; ENDOTHELIN-1; MECHANISMS	Background and Purpose: Ischemic stroke is a destructive cerebrovascular disease and a leading cause of death. Yet, no ideal neuroprotective agents are available, leaving prevention an attractive alternative. The extracts from the fruits of Lycium barbarum (LBP), a Chinese anti-aging medicine and food supplement, showed neuroprotective function in the retina when given prophylactically. We aim to evaluate the protective effects of LBP pre-treatment in an experimental stroke model. Methods: C57BL/6N male mice were first fed with either vehicle (PBS) or LBP (1 or 10 mg/kg) daily for 7 days. Mice were then subjected to 2-hour transient middle cerebral artery occlusion (MCAO) by the intraluminal method followed by 22-hour reperfusion upon filament removal. Mice were evaluated for neurological deficits just before sacrifice. Brains were harvested for infarct size estimation, water content measurement, immunohistochemical analysis, and Western blot experiments. Evans blue (EB) extravasation was determined to assess blood-brain barrier (BBB) disruption after MCAO. Results: LBP pre-treatment significantly improved neurological deficits as well as decreased infarct size, hemispheric swelling, and water content. Fewer apoptotic cells were identified in LBP-treated brains by TUNEL assay. Reduced EB extravasation, fewer IgG-leaky vessels, and up-regulation of occludin expression were also observed in LBP-treated brains. Moreover, immunoreactivity for aquaporin-4 and glial fibrillary acidic protein were significantly decreased in LBP-treated brains. Conclusions: Seven-day oral LBP pre-treatment effectively improved neurological deficits, decreased infarct size and cerebral edema as well as protected the brain from BBB disruption, aquaporin-4 up-regulation, and glial activation. The present study suggests that LBP may be used as a prophylactic neuroprotectant in patients at high risk for ischemic stroke.	[Yang, Di; Li, Suk-Yee; Yeung, Chung-Man; Wong, David; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai; Wong, David; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Yang, D (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Hong Kong, Hong Kong, Peoples R China.	amylo@hkucc.hku.hk	Lo, Amy C. Y./C-1195-2009; Chang, Raymond Chuen-Chung/C-1107-2009	Lo, Amy C. Y./0000-0003-4239-6851; Chang, Raymond Chuen-Chung/0000-0001-8538-7993; So, Kwok-Fai/0000-0003-4039-4246	University of Hong Kong; Azalea Endowment Fund	University of Hong Kong(University of Hong Kong); Azalea Endowment Fund	This study was supported by the University Development Fund from The University of Hong Kong to the Eye Institute and by the Azalea (1972) Endowment Fund to RCC and KFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Brouns R, 2011, EUR NEUROL, V65, P23, DOI 10.1159/000321965; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Elango C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-97; Freeman WD, 2010, SEMIN NEUROL, V30, P501, DOI 10.1055/s-0030-1268863; Ho YS, 2010, J ALZHEIMERS DIS, V19, P813, DOI 10.3233/JAD-2010-1280; Hu CF, 2010, J NAT PROD, V73, P1489, DOI 10.1021/np1001847; Huang XJ, 2009, CELL MOL NEUROBIOL, V29, P1211, DOI 10.1007/s10571-009-9417-z; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kondoh T, 2011, BRAIN RES BULL, V84, P69, DOI 10.1016/j.brainresbull.2010.11.005; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Li JJ, 2011, CLIN EXP PHARMACOL P, V38, P776, DOI 10.1111/j.1440-1681.2011.05591.x; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Lo ACY, 2007, J CEREBR BLOOD F MET, V27, P1496, DOI 10.1038/sj.jcbfm.9600452; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Potterat O, 2010, PLANTA MED, V76, P7, DOI 10.1055/s-0029-1186218; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Schmerbach K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015052; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Spatz M, 2010, ACTA NEUROCHIR SUPPL, V106, P21, DOI 10.1007/978-3-211-98811-4_3; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Yeung CM, 2010, J NEUROSCI RES, V88, P2026, DOI 10.1002/jnr.22349; Yeung PKK, 2009, J CEREBR BLOOD F MET, V29, P1891, DOI 10.1038/jcbfm.2009.175; Yu MS, 2007, INT J MOL MED, V20, P261; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhou ZY, 2010, J ETHNOPHARMACOL, V131, P154, DOI 10.1016/j.jep.2010.06.023; ZIVIN JA, 1991, ARCH NEUROL-CHICAGO, V48, P1235, DOI 10.1001/archneur.1991.00530240039014	39	45	52	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33596	10.1371/journal.pone.0033596	http://dx.doi.org/10.1371/journal.pone.0033596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438957	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100065
J	Leach, RJ; O'Neill, RG; Fitzpatrick, JL; Williams, JL; Glass, EJ				Leach, Richard J.; O'Neill, Ronan G.; Fitzpatrick, Julie L.; Williams, John L.; Glass, Elizabeth J.			Quantitative Trait Loci Associated with the Immune Response to a Bovine Respiratory Syncytial Virus Vaccine	PLOS ONE			English	Article							FEEDLOT CATTLE; MOUTH-DISEASE; CALVES; REPLICATION; FORMULATION; PARAMETERS; RESISTANCE; HAPLOTYPES; PROTECTION; INDUCTION	Infectious disease is an important problem for animal breeders, farmers and governments worldwide. One approach to reducing disease is to breed for resistance. This linkage study used a Charolais-Holstein F2 cattle cross population (n = 501) which was genotyped for 165 microsatellite markers (covering all autosomes) to search for associations with phenotypes for Bovine Respiratory Syncytial Virus (BRSV) specific total-IgG, IgG1 and IgG2 concentrations at several time-points pre- and post-BRSV vaccination. Regions of the bovine genome which influenced the immune response induced by BRSV vaccination were identified, as well as regions associated with the clearance of maternally derived BRSV specific antibodies. Significant positive correlations were detected within traits across time, with negative correlations between the pre- and post-vaccination time points. The whole genome scan identified 27 Quantitative Trait Loci (QTL) on 13 autosomes. Many QTL were associated with the Thymus Helper 1 linked IgG2 response, especially at week 2 following vaccination. However the most significant QTL, which reached 5% genome-wide significance, was on BTA 17 for IgG1, also 2 weeks following vaccination. All animals had declining maternally derived BRSV specific antibodies prior to vaccination and the levels of BRSV specific antibody prior to vaccination were found to be under polygenic control with several QTL detected. Heifers from the same population (n = 195) were subsequently immunised with a 40-mer Foot-and-Mouth Disease Virus peptide (FMDV) in a previous publication. Several of these QTL associated with the FMDV traits had overlapping peak positions with QTL in the current study, including the QTL on BTA23 which included the bovine Major Histocompatibility Complex (BoLA), and QTL on BTA9 and BTA24, suggesting that the genes underlying these QTL may control responses to multiple antigens. These results lay the groundwork for future investigations to identify the genes underlying the variation in clearance of maternal antibody and response to vaccination.	[Leach, Richard J.; Williams, John L.; Glass, Elizabeth J.] Univ Edinburgh, Roslin Inst, Dept Genet & Genom, Easter Bush, Midlothian, Scotland; [Leach, Richard J.; Williams, John L.; Glass, Elizabeth J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [O'Neill, Ronan G.] Dept Agr Fisheries & Food, Celbridge, Kildare, Ireland; [Fitzpatrick, Julie L.] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Moredun Research Institute	Leach, RJ (corresponding author), ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA.	richard.j.leach@ars.usda.gov	Glass, Elizabeth J/L-4612-2016	Glass, Elizabeth J/0000-0002-6183-0185; Williams, John/0000-0001-5188-7957	Pfizer Animal Health CASE studentship; Biotechnology and Biological Sciences Research Council (Institute Strategic); Scottish government Rural and Environment Research and Analysis Directorate (RERAD); Meat and Livestock Commission (MLC); Department for Environment, Food and Rural Affairs (DEFRA) for LINK; Cariplo Foundation; BBSRC [BBS/E/D/20241863] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241863] Funding Source: researchfish	Pfizer Animal Health CASE studentship; Biotechnology and Biological Sciences Research Council (Institute Strategic); Scottish government Rural and Environment Research and Analysis Directorate (RERAD); Meat and Livestock Commission (MLC)(Meat and Livestock Australia); Department for Environment, Food and Rural Affairs (DEFRA) for LINK; Cariplo Foundation(Fondazione Cariplo); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was undertaken with a Pfizer Animal Health CASE studentship, and supported by the Biotechnology and Biological Sciences Research Council (Institute Strategic Grant funding), the Scottish government Rural and Environment Research and Analysis Directorate (RERAD), the Meat and Livestock Commission (MLC; now devolved to EBLEX, HybuCig Cymru/Meat Promotion Wales (HCC), Quality Meat Scotland (QMS)) and the Department for Environment, Food and Rural Affairs (DEFRA) for LINK funding for the animal studies. JLW acknowledges the Cariplo Foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M, 1972, HDB MAT FUNCTIONS FO; Band MR, 2000, GENOME RES, V10, P1359, DOI 10.1101/gr.145900; Baxter R, 2009, VACCINE, V28, P28, DOI 10.1016/j.vaccine.2009.09.131; Bowland SL, 2000, CAN VET J, V41, P33; Carine L, 2008, VACCINE, V26, P4840, DOI 10.1016/j.vaccine.2008.06.100; Casas E, 2006, J ANIM SCI, V84, P3180, DOI 10.2527/jas.2006-200; Casas E, 2011, ANIM GENET, V42, P571, DOI 10.1111/j.1365-2052.2011.02189.x; CHURCHILL GA, 1994, GENETICS, V138, P963; Clawson ML, 2004, MAMM GENOME, V15, P227, DOI 10.1007/s00335-003-2320-x; Davies G, 2009, ANIMAL, V3, P415, DOI 10.1017/S1751731108003522; DIMARCHI R, 1986, SCIENCE, V232, P639, DOI 10.1126/science.3008333; Ellis JA, 2001, VET CLIN N AM-FOOD A, V17, P535, DOI 10.1016/S0749-0720(15)30005-0; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fulton Robert W., 2009, Animal Health Research Reviews, V10, P131, DOI 10.1017/S146625230999017X; Gershwin Laurel J., 2007, Animal Health Research Reviews, V8, P207, DOI 10.1017/S1466252307001405; Gershwin LJ, 2000, AM J VET RES, V61, P291, DOI 10.2460/ajvr.2000.61.291; GLASS EJ, 1991, IMMUNOLOGY, V74, P594; Glass EJ, 2010, VET IMMUNOL IN PRESS; Glass Elizabeth J., 2004, Animal Health Research Reviews, V5, P197, DOI 10.1079/AHR200469; Glass EJ, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P88, DOI 10.1079/9781845935559.0088; Green P, 1990, CRIMAP 2 4; Guo YM, 2008, ANIM GENET, V39, P486, DOI 10.1111/j.1365-2052.2008.01756.x; Gutierrez-Gil B, 2008, ANIM GENET, V39, P51, DOI 10.1111/j.1365-2052.2007.01682.x; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heringstad B, 2007, J DAIRY SCI, V90, P2419, DOI 10.3168/jds.2006-805; Hung LY, 2008, CRIT REV IMMUNOL, V28, P269, DOI 10.1615/CritRevImmunol.v28.i4.10; Ihara N, 2004, GENOME RES, V14, P1987, DOI 10.1101/gr.2741704; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Kalina WV, 2005, VACCINE, V23, P4625, DOI 10.1016/j.vaccine.2005.04.032; KIMMAN TG, 1989, VET IMMUNOL IMMUNOP, V22, P145, DOI 10.1016/0165-2427(89)90057-3; Laegreid WW, 2002, MAMM GENOME, V13, P704, DOI 10.1007/s00335-002-2219-y; Leach RJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-107; Lewin HA, 1999, IMMUNOL REV, V167, P145, DOI 10.1111/j.1600-065X.1999.tb01388.x; Mapletoft JW, 2006, VIROLOGY, V353, P316, DOI 10.1016/j.virol.2006.06.001; Meyer G, 2008, COMP IMMUNOL MICROB, V31, P191, DOI 10.1016/j.cimid.2007.07.008; Minozzi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011117; Miyairi I, 2008, CLIN MICROBIOL REV, V21, P686, DOI 10.1128/CMR.00017-08; MUGGLICOCKETT NE, 1992, J ANIM SCI, V70, P2013, DOI 10.2527/1992.7072013x; NORMAN LM, 1981, J ANIM SCI, V53, P1465, DOI 10.2527/jas1982.5361465x; O'Neill RG, 2007, VET REC, V161, P269, DOI 10.1136/vr.161.8.269; O'Neill RG, 2006, VACCINE, V24, P4007, DOI 10.1016/j.vaccine.2005.11.049; Oumouna M, 2005, J VIROL, V79, P2024, DOI 10.1128/JVI.79.4.2024-2032.2005; Pamilo P, 1998, HEREDITY, V81, P381, DOI 10.1046/j.1365-2540.1998.00395.x; Platt R, 2006, AM J VET RES, V67, P1179, DOI 10.2460/ajvr.67.7.1179; ResSpecies, 2006, ROSL; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schneider MJ, 2010, J ANIM SCI, V88, P1220, DOI 10.2527/jas.2008-1755; Seaton G, 2006, P 8 WORLD C GEN APPL; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Snowder GD, 2007, J ANIM SCI, V85, P1885, DOI 10.2527/jas.2007-0008; Snowder GD, 2006, J ANIM SCI, V84, P1999, DOI 10.2527/jas.2006-046; Snowder GD, 2005, J ANIM SCI, V83, P507; Srikumaran Subramaniam, 2007, Animal Health Research Reviews, V8, P215, DOI 10.1017/S1466252307001326; STOTT EJ, 1985, ARCH VIROL, V84, P1, DOI 10.1007/BF01310552; TAYLOR G, 1995, J VIROL, V69, P6658, DOI 10.1128/JVI.69.11.6658-6664.1995; Valarcher JF, 2007, VET RES, V38, P153, DOI 10.1051/vetres:2006053; Verschoor CP, 2009, MAMM GENOME, V20, P447, DOI 10.1007/s00335-009-9198-1; Visscher PM, 1996, GENETICS, V143, P1013; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; West K, 1999, VACCINE, V18, P907, DOI 10.1016/S0264-410X(99)00324-2; Zanella Ricardo, 2011, Frontiers in Genetics, V2, P82, DOI 10.3389/fgene.2011.00082; Zhang C, 2004, GENETICS, V167, P1863, DOI 10.1534/genetics.104.026401	62	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33526	10.1371/journal.pone.0033526	http://dx.doi.org/10.1371/journal.pone.0033526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438944	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309000031
J	Conti, F; Alessandri, C; Perricone, C; Scrivo, R; Rezai, S; Ceccarelli, F; Spinelli, FR; Ortona, E; Marianetti, M; Mina, C; Valesini, G				Conti, Fabrizio; Alessandri, Cristiano; Perricone, Carlo; Scrivo, Rossana; Rezai, Soheila; Ceccarelli, Fulvia; Spinelli, Francesca Romana; Ortona, Elena; Marianetti, Massimo; Mina, Concetta; Valesini, Guido			Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage	PLOS ONE			English	Article							COGNITIVE DYSFUNCTION; NEUROPSYCHIATRIC SYNDROMES; ANTICARDIOLIPIN ANTIBODIES; RECEPTOR ANTIBODIES; ACTIVITY INDEX; PREVALENCE; MANIFESTATIONS; IMPAIRMENT; AUTOANTIBODIES; DEPRESSION	Introduction: Systemic lupus erythematosus (SLE) is characterized by frequent neuropsychiatric involvement, which includes cognitive impairment (CI). We aimed at assessing CI in a cohort of Italian SLE patients by using a wide range of neurocognitive tests specifically designed to evaluate the fronto-subcortical dysfunction. Furthermore, we aimed at testing whether CI in SLE is associated with serum autoantibodies, disease activity and chronic damage. Methods: Fifty-eight consecutive patients were enrolled. Study protocol included data collection, evaluation of serum levels of ANA, anti-dsDNA, anti-cardiolipin, anti-beta(2)-glycoprotein I, anti-P ribosomal, anti-endothelial cell, and anti-Nedd5 antibodies. SLEDAI-2000 and SLICC were used to assess disease activity and chronic damage. Patients were administered a test battery specifically designed to detect fronto-subcortical dysfunction across five domains: memory, attention, abstract reasoning, executive function and visuospatial function. For each patient, the raw scores from each test were compared with published norms, then transformed into Z scores (deviation from normal mean), and finally summed in the Global Cognitive Dysfunction score (GCDs). Results: Nineteen percent of patients had mild GCDs impairment (GCDs 2-3), 7% moderate (GCDs 4-5) and 5% severe (GCDs >= 6). The visuospatial domain was the most compromised (MDZs = -0.89 +/- 1.23). Anti-cardiolipin IgM levels were associated with visuospatial domain impairment (r = 0.331, P = 0.005). SLEDAI correlated with GCDs, and attentional and executive domains; SLICC correlated with GCDs, and with visuospatial and attentional domains impairment. Conclusions: Anti-phospholipids, disease activity, and chronic damage are associated with cognitive dysfunction in SLE. The use of a wide spectrum of tests allowed for a better selection of the relevant factors involved in SLE cognitive dysfunction, and standardized neuropsychological testing methods should be used for routine assessment of SLE patients.	[Conti, Fabrizio; Alessandri, Cristiano; Perricone, Carlo; Scrivo, Rossana; Rezai, Soheila; Ceccarelli, Fulvia; Spinelli, Francesca Romana; Valesini, Guido] Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, Lupus Clin, Rome, Italy; [Ortona, Elena] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; [Marianetti, Massimo; Mina, Concetta] Univ Roma La Sapienza, Dept Neurol, Rome, Italy; [Marianetti, Massimo; Mina, Concetta] Univ Roma La Sapienza, ORL, Rome, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome; Sapienza University Rome	Conti, F (corresponding author), Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, Lupus Clin, Rome, Italy.	carlo.perricone@gmail.com	Spinelli, Francesca Romana/AAM-7061-2020; Spinelli, Francesca Romana/F-1475-2013; ortona, elena/J-6395-2016	Spinelli, Francesca Romana/0000-0003-1969-2097; ortona, elena/0000-0001-9845-8105; Perricone, Carlo/0000-0003-4771-6981; Alessandri, Cristiano/0000-0003-4149-5321; Marianetti, Massimo/0000-0002-1402-3831				Abdel-Nasser AM, 2008, CLIN RHEUMATOL, V27, P1377, DOI 10.1007/s10067-008-0921-1; Afeltra A, 2003, NEUROLOGY, V61, P108, DOI 10.1212/01.WNL.0000058904.94330.A7; Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Alarcon GS, 2002, ARTHRIT RHEUM-ARTHR, V47, P310, DOI 10.1002/art.10457; ASHERSON RA, 1989, AM J MED, V86, P391, DOI 10.1016/0002-9343(89)90335-5; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; BUCHBINDER R, 1988, AUST NZ J MED, V18, P679, DOI 10.1111/j.1445-5994.1988.tb00150.x; CARBOTTE RM, 1995, J RHEUMATOL, V22, P863; CARBOTTE RM, 1986, J NERV MENT DIS, V174, P357, DOI 10.1097/00005053-198606000-00008; Carlesimo G. A., 1995, Archivio di Psicologia Neurologia e Psichiatria, V56, P471; Carlomagno S, 2000, J NEUROL, V247, P273, DOI 10.1007/s004150050583; Conti F, 2004, ARTHRITIS RES THER, V6, pR366, DOI 10.1186/ar1198; DENBURG JA, 1987, NEUROLOGY, V37, P464, DOI 10.1212/WNL.37.3.464; Denburg S D, 1997, J Int Neuropsychol Soc, V3, P377; Fragoso-Loyo H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003347; GINSBURG KS, 1992, ARTHRITIS RHEUM, V35, P776, DOI 10.1002/art.1780350711; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Gladman DD, 2002, J RHEUMATOL, V29, P288; Greenwood DLV, 2002, AUTOIMMUNITY, V35, P79, DOI 10.1080/08916930290016547; HAHN RC, 1988, CANCER, V61, P845, DOI 10.1002/1097-0142(19880215)61:4<845::AID-CNCR2820610434>3.0.CO;2-Q; Hanly JG, 2005, J RHEUMATOL, V32, P1459; Hanly JG, 2004, J RHEUMATOL, V31, P2156; Hanly JG, 1999, ARTHRITIS RHEUM, V42, P728, DOI 10.1002/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O; HANLY JG, 1993, BRIT J RHEUMATOL, V32, P291; Hanly JG, 2006, J RHEUMATOL, V33, P1553; HARRIS EN, 1984, CLIN EXP RHEUMATOL, V2, P47; HAY EM, 1992, ARTHRITIS RHEUM, V35, P411, DOI 10.1002/art.1780350409; Heaton R.K., 1993, WISCONSIN CARD SORTI; HERRANZ MT, 1994, ARTHRITIS RHEUM, V37, P568, DOI 10.1002/art.1780370418; JOHNSON RT, 1968, MEDICINE, V47, P337, DOI 10.1097/00005792-196807000-00002; Kozora E, 1996, ARTHRITIS RHEUM, V39, P2035, DOI 10.1002/art.1780391213; Kozora E, 2008, ARTHRITIS RHEUM-US, V58, P3286, DOI 10.1002/art.23991; Lapteva L, 2006, ARTHRITIS RHEUM, V54, P2505, DOI 10.1002/art.22031; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Margutti P, 2005, ARTHRITIS RES THER, V7, pR896, DOI 10.1186/ar1759; Mikdashi J, 2007, LUPUS, V16, P418, DOI 10.1177/0961203307079044; Mikdashi J, 2004, RHEUMATOLOGY, V43, P1555, DOI 10.1093/rheumatology/keh384; Moorthy LN, 2010, LUPUS, V19, P620, DOI 10.1177/0961203309355810; Nichelli P., 2002, NUOVA RIV NEUROLOGIA, V12, P37; Olazaran J, 2009, EUR NEUROL, V62, P49, DOI 10.1159/000215879; Perricone R, 2008, AUTOIMMUN REV, V7, P384, DOI 10.1016/j.autrev.2008.03.002; Petri M, 2008, J RHEUMATOL, V35, P1776; Sanna G, 2003, J RHEUMATOL, V30, P985; SCHMIDT R, 1995, STROKE, V26, P749, DOI 10.1161/01.STR.26.5.749; Shoenfeld Y, 2003, LUPUS, V12, P436, DOI 10.1191/0961203303lu409oa; Shrot S, 2002, LUPUS, V11, P736, DOI 10.1191/0961203302lu255oa; Spinnler H., 1987, ITAL J NEUROL SCI S8, V6, P25; Steup-Beekman GM, 2007, LUPUS, V16, P329, DOI 10.1177/0961203307078224; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; UTSET TO, 1994, J RHEUMATOL, V21, P2039; Utset TO, 2006, J RHEUMATOL, V33, P531; Valesini G, 2006, ANN NY ACAD SCI, V1069, P118, DOI 10.1196/annals.1351.010; VANDERZEE JM, 1991, CLIN EXP IMMUNOL, V84, P238; Zandman-Goddard G, 2007, SEMIN ARTHRITIS RHEU, V36, P297, DOI 10.1016/j.semarthrit.2006.11.003; Zhou HQ, 2008, LUPUS, V17, P93, DOI 10.1177/0961203307085671	56	61	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e33824	10.1371/journal.pone.0033824	http://dx.doi.org/10.1371/journal.pone.0033824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461897	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900015
J	Lin, Q; Peng, QQ; Yao, F; Pan, XF; Xiong, LW; Wang, Y; Geng, JF; Feng, JX; Han, BH; Bao, GL; Yang, Y; Wang, XT; Jin, L; Guo, WS; Wang, JC				Lin, Qiang; Peng, Qianqian; Yao, Feng; Pan, Xu-Feng; Xiong, Li-Wen; Wang, Yi; Geng, Jun-Feng; Feng, Jiu-Xian; Han, Bao-Hui; Bao, Guo-Liang; Yang, Yu; Wang, Xiaotian; Jin, Li; Guo, Wensheng; Wang, Jiu-Cun			A Classification Method Based on Principal Components of SELDI Spectra to Diagnose of Lung Adenocarcinoma	PLOS ONE			English	Article							PROTEOMIC PATTERNS; MASS-SPECTROMETRY; CANCER; SERUM; IDENTIFICATION; BENIGN	Purpose: Lung cancer is the leading cause of cancer death worldwide, but techniques for effective early diagnosis are still lacking. Proteomics technology has been applied extensively to the study of the proteins involved in carcinogenesis. In this paper, a classification method was developed based on principal components of surface-enhanced laser desorption/ionization (SELDI) spectral data. This method was applied to SELDI spectral data from 71 lung adenocarcinoma patients and 24 healthy individuals. Unlike other peak-selection-based methods, this method takes each spectrum as a unity. The aim of this paper was to demonstrate that this unity-based classification method is more robust and powerful as a method of diagnosis than peak-selection-based methods. Results: The results showed that this classification method, which is based on principal components, has outstanding performance with respect to distinguishing lung adenocarcinoma patients from normal individuals. Through leaving-one-out, 19-fold, 5-fold and 2-fold cross-validation studies, we found that this classification method based on principal components completely outperforms peak-selection-based methods, such as decision tree, classification and regression tree, support vector machine, and linear discriminant analysis. Conclusions and Clinical Relevance: The classification method based on principal components of SELDI spectral data is a robust and powerful means of diagnosing lung adenocarcinoma. We assert that the high efficiency of this classification method renders it feasible for large-scale clinical use.	[Lin, Qiang; Yao, Feng; Pan, Xu-Feng] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai 200030, Peoples R China; [Peng, Qianqian; Wang, Yi; Wang, Xiaotian; Jin, Li; Wang, Jiu-Cun] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Peng, Qianqian; Wang, Yi; Wang, Xiaotian; Jin, Li; Wang, Jiu-Cun] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Peng, Qianqian; Wang, Yi; Wang, Xiaotian; Jin, Li; Wang, Jiu-Cun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Xiong, Li-Wen; Geng, Jun-Feng; Han, Bao-Hui; Yang, Yu] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai 200030, Peoples R China; [Feng, Jiu-Xian; Bao, Guo-Liang] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Chest Canc Res Inst, Shanghai 200030, Peoples R China; [Guo, Wensheng] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	Shanghai Jiao Tong University; Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Pennsylvania	Lin, Q (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai 200030, Peoples R China.	xklinqiang@hotmail.com; jcwang@fudan.edu.cn	Wang, Jiucun/J-8744-2012; Jin, Li/C-1468-2009; Yang, Yu/GYJ-1931-2022; Jin, Li/M-5063-2019	Wang, Jiucun/0000-0003-2765-0620; Jin, Li/0000-0002-4546-2415; Yang, Yu/0000-0002-4518-3299; Peng, Qianqian/0000-0002-2018-5706; Yao, Feng/0000-0002-9635-9581	National Science Foundation of China [30971594, 30890034]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Science Foundation of China, grant number 30971594 to JC Wang and grant numbers 30890034 and 30625016 to L Jin (URL: http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BL, 2002, CANCER RES, V62, P3609; Albrethsen J, 2007, CLIN CHEM, V53, P852, DOI 10.1373/clinchem.2006.082644; Au JSK, 2007, BIOMED PHARMACOTHER, V61, P570, DOI 10.1016/j.biopha.2007.08.017; Beadsmoore CJ, 2003, EUR J RADIOL, V45, P8, DOI 10.1016/S0720-048X(02)00287-5; Bhattacharyya S, 2004, NEOPLASIA, V6, P674, DOI 10.1593/neo.04262; Brookland, 2002, AJCC CANC STAGING MA, P167; BROWNE MW, 1968, PSYCHOMETRIKA, V33, P267, DOI 10.1007/BF02289327; Caffrey RE, 2010, METHODS MOL BIOL, V641, P167, DOI 10.1007/978-1-60761-711-2_10; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cazares LH, 2002, CLIN CANCER RES, V8, P2541; Cho William C. S., 2007, Genomics Proteomics & Bioinformatics, V5, P77, DOI 10.1016/S1672-0229(07)60018-7; Cho WCS, 2007, EXPERT REV PROTEOMIC, V4, P401, DOI 10.1586/14789450.4.3.401; Cho William Chi-shing, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P871; Conrad DH, 2008, J GEN INTERN MED, V23, P78, DOI 10.1007/s11606-007-0411-1; Ginsberg RJ, 1997, NONSMALL CELL LUNG C; Granville CA, 2005, AM J RESP CELL MOL, V32, P169, DOI 10.1165/rcmb.F290; Han KQ, 2008, AM J CLIN ONCOL-CANC, V31, P133, DOI 10.1097/COC.0b013e318145b98b; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hong YJ, 2008, ACTA PHARMACOL SIN, V29, P1240, DOI 10.1111/j.1745-7254.2008.00861.x; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Koopmann J, 2004, CLIN CANCER RES, V10, P860, DOI 10.1158/1078-0432.CCR-1167-3; Kristina G, 2009, LAB CHIP, V9, P1014, DOI 10.1039/b815503h; Lilien RH, 2003, J COMPUT BIOL, V10, P925, DOI 10.1089/106652703322756159; Liu ZQ, 2005, J BIOMED BIOTECHNOL, P155, DOI 10.1155/JBB.2005.155; Lysek M, 2005, DIAGNOSTICS USING SE; Ministry of Health of the People's Republic of China, 2003, LAYOUT COMP PREV CON; Nilsen MM, 2011, MAR POLLUT BULL, V62, P2507, DOI 10.1016/j.marpolbul.2011.08.006; Paradis V, 2005, HEPATOLOGY, V41, P40, DOI 10.1002/hep.20505; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Reed MF, 2004, AM J SURG, V188, P598, DOI 10.1016/j.amjsurg.2004.07.037; Sreseli RT, 2010, ONCOL REP, V24, P263, DOI 10.3892/or_00000855; Yang SY, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-83; Yaping C, 2009, ANAL SELDI MASS SPEC	35	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34457	10.1371/journal.pone.0034457	http://dx.doi.org/10.1371/journal.pone.0034457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461913	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900031
J	Andrieux, G; Fattet, L; Le Borgne, M; Rimokh, R; Theret, N				Andrieux, Geoffroy; Fattet, Laurent; Le Borgne, Michel; Rimokh, Ruth; Theret, Nathalie			Dynamic Regulation of Tgf-B Signaling by Tif1 gamma: A Computational Approach	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; UBIQUITIN LIGASE; BETA ACTIVATION; SMAD ACTIVITY; PATHWAY; GROWTH; CANCER; TRANSDUCTION; SYSTEMS; MOUSE	TIF1 gamma (Transcriptional Intermediary Factor 1 gamma) has been implicated in Smad-dependent signaling by Transforming Growth Factor beta (TGF-beta). Paradoxically, TIF1 gamma functions both as a transcriptional repressor or as an alternative transcription factor that promotes TGF-beta signaling. Using ordinary differential-equation models, we have investigated the effect of TIF1 gamma on the dynamics of TGF-beta signaling. An integrative model that includes the formation of transient TIF1 gamma-Smad2-Smad4 ternary complexes is the only one that can account for TGF-beta signaling compatible with the different observations reported for TIF1 gamma. In addition, our model predicts that varying TIF1 gamma/Smad4 ratios play a critical role in the modulation of the transcriptional signal induced by TGF-beta, especially for short stimulation times that mediate higher threshold responses. Chromatin immunoprecipitation analyses and quantification of the expression of TGF-beta target genes as a function TIF1 gamma/Smad4 ratios fully validate this hypothesis. Our integrative model, which successfully unifies the seemingly opposite roles of TIF1 gamma, also reveals how changing TIF1 gamma/Smad4 ratios affect the cellular response to stimulation by TGF-beta, accounting for a highly graded determination of cell fate.	[Andrieux, Geoffroy; Theret, Nathalie] Univ Rennes 1, IRSET, INSERM, U1085, Rennes, France; [Andrieux, Geoffroy; Le Borgne, Michel] Univ Rennes 1, IRISA, Rennes, France; [Fattet, Laurent; Rimokh, Ruth] Ctr Rech Cancerol Lyon, CNRS 5286, INSERM, U1052, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Andrieux, G (corresponding author), Univ Rennes 1, IRSET, INSERM, U1085, Rennes, France.	nathalie.theret@univ-rennes1.fr	Theret, Nathalie/I-2871-2015; Rimokh, Ruth/G-7506-2014; FATTET, Laurent/W-8392-2019; Fattet, Laurent/ABH-5434-2020; theret, nathalie/ABG-6780-2020	Theret, Nathalie/0000-0002-5857-7828; Fattet, Laurent/0000-0001-5152-4937; theret, nathalie/0000-0002-5857-7828; ANDRIEUX, GEOFFROY/0000-0002-5389-9481	Institut National de la Sante et de la Recherche Medicale; Ligue Nationale Contre le Cancer	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (www.inserm.fr) and the Ligue Nationale Contre le Cancer (http://www.ligue-cancer.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricola E, 2011, MOL CELL, V43, P85, DOI 10.1016/j.molcel.2011.05.020; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Assmann SM, 2009, METHODS MOL BIOL, V553, P207, DOI 10.1007/978-1-60327-563-7_10; Aucagne R, 2011, J CLIN INVEST, V121, P2361, DOI 10.1172/JCI45213; Barter MJ, 2010, MATRIX BIOL, V29, P602, DOI 10.1016/j.matbio.2010.05.002; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chung SW, 2009, BIOPHYS J, V96, P1733, DOI 10.1016/j.bpj.2008.11.050; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Melke P, 2006, BIOPHYS J, V91, P4368, DOI [10.1529/biophysj.105.080408, 10.1529/biophysj.106.080408]; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Nakabayashi J, 2009, J THEOR BIOL, V259, P389, DOI 10.1016/j.jtbi.2009.03.036; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Sreenath SN, 2008, ESSAYS BIOCHEM, V45, P1, DOI 10.1042/BSE0450001; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; Vincent DF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000575; Yan KP, 2004, GENE, V334, P3, DOI 10.1016/j.gene.2004.02.056; Zi ZK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000936; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22	30	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33761	10.1371/journal.pone.0033761	http://dx.doi.org/10.1371/journal.pone.0033761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22461896	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900023
J	Hakansson, A; Branning, C; Molin, G; Adawi, D; Hagslatt, ML; Jeppsson, B; Nyman, M; Ahrne, S				Hakansson, Asa; Branning, Camilla; Molin, Goran; Adawi, Diya; Hagslatt, Marie-Louise; Jeppsson, Bengt; Nyman, Margareta; Ahrne, Siv			Blueberry Husks and Probiotics Attenuate Colorectal Inflammation and Oncogenesis, and Liver Injuries in Rats Exposed to Cycling DSS-Treatment	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; DEXTRAN SULFATE SODIUM; ULCERATIVE-COLITIS; DIETARY FIBER; BOWEL-DISEASE; ADENOMATOUS POLYPS; GAS-CHROMATOGRAPHY; ESCHERICHIA-COLI; BACTERIAL-FLORA; MOUSE COLITIS	Long-term colonic inflammation promotes carcinogenesis and histological abnormalities of the liver, and colorectal tumours frequently arise in a background of dysplasia, a precursor of adenomas. Altered colonic microbiota with an increased proportion of bacteria with pro-inflammatory characteristics, have been implicated in neoplastic progression. The composition of the microbiota can be modified by dietary components such as probiotics, polyphenols and dietary fibres. In the present study, the influence of probiotics in combination with blueberry husks on colorectal carcinogenesis and subsequent liver damage was evaluated. Colorectal tumours were induced in rats by cyclic treatment with dextran sulphate sodium (DSS). Blueberry husks and a mixture of three probiotic strains (Bifidobacterium infantis DSM 15159, Lactobacillus gasseri, DSM 16737 and Lactobacillus plantarum DSM 15313) supplemented a basic diet fortified with oats. The condition of the rats was monitored using a disease activity index (DAI). A qualitative and quantitative histological judgement was performed on segments of distal colon and rectum and the caudate lobe of the liver. The formation of short-chain fatty acids, bacterial translocation, the inflammatory reaction and viable count of lactobacilli and Enterobaceriaceae were addressed. Blueberry husks with or without probiotics significantly decreased DAI, and significantly reduced the number of colonic ulcers and dysplastic lesions. With a decreased proportion of blueberry husk in the diet, the probiotic supplement was needed to achieve a significant decrease in numbers of dysplastic lesions. Probiotics decreased faecal viable count of Enterobacteriaceae and increased that of lactobacilli. Blueberry husks with or without probiotics lowered the proportion of butyric acid in distal colon, and decreased the haptoglobin levels. Probiotics mitigated hepatic injuries by decreasing parenchymal infiltration and the incidence of stasis and translocation. The results demonstrate a dietary option for use of blueberry husks and probiotics to delay colonic carcinogenesis and hepatic injuries in the rat model.	[Hakansson, Asa; Branning, Camilla; Molin, Goran; Hagslatt, Marie-Louise; Nyman, Margareta; Ahrne, Siv] Lund Univ, Div Appl Nutr & Food Chem, Lund, Sweden; [Adawi, Diya; Jeppsson, Bengt] Lund Univ, Skane Univ Hosp, Dept Surg, Malmo, Sweden	Lund University; Lund University; Skane University Hospital	Hakansson, A (corresponding author), Lund Univ, Div Appl Nutr & Food Chem, Lund, Sweden.	asa.hakansson@appliednutrition.lth.se	Nyman, Margareta/AAY-9466-2020	Nyman, Margareta/0000-0003-3660-2364	Functional Food Science Centre at Lund University	Functional Food Science Centre at Lund University	This study was funded by the Functional Food Science Centre at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASP NG, 1983, J AGR FOOD CHEM, V31, P476, DOI 10.1021/jf00117a003; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bullock Natalie R, 2004, Curr Issues Intest Microbiol, V5, P59; CLAUSEN MR, 1991, GUT, V32, P923, DOI 10.1136/gut.32.8.923; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; COOPER HS, 1993, LAB INVEST, V69, P238; Cooper HS, 2000, CARCINOGENESIS, V21, P757, DOI 10.1093/carcin/21.4.757; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Vrese M, 2008, ADV BIOCHEM ENG BIOT, V111, P1, DOI 10.1007/10_2008_097; De-Souza DA, 2005, CRIT CARE MED, V33, P1125, DOI 10.1097/01.CCM.0000162680.52397.97; Deutschman CS, 2006, CRIT CARE MED, V34, P2613, DOI 10.1097/01.CCM.0000240229.98275.07; Drzikova B, 2005, BRIT J NUTR, V94, P1012, DOI 10.1079/bjn20051577; Eaden JA, 2000, AM J GASTROENTEROL, V95, P2710, DOI 10.1016/S0002-9270(00)01089-3; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Garcia-Lafuente A, 1998, EUR J CLIN INVEST, V28, P1019; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Hakansson A, 2009, SCAND J GASTROENTERO, V44, P1213, DOI 10.1080/00365520903171268; ILLMAN RJ, 1985, NUTR RES, V5, P839, DOI 10.1016/S0271-5317(85)80171-8; Kono H, 2003, J PHARMACOL EXP THER, V307, P74, DOI 10.1124/jpet.103.053595; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; LESCUT D, 1990, GASTROEN CLIN BIOL, V14, P811; LEWIS CM, 1990, EUR J CLIN MICROBIOL, V9, P111, DOI 10.1007/BF01963635; Ludwig T, 1981, HEPATOLOGY, V1, P632; MALKKI Y, 1992, CEREAL CHEM, V69, P647; Masubuchi Y, 2004, DRUG METAB DISPOS, V32, P437, DOI 10.1124/dmd.32.4.437; Matsuda H, 2000, J GASTROEN HEPATOL, V15, P61, DOI 10.1046/j.1440-1746.2000.02045.x; Minushkin O N, 2003, Klin Med (Mosk), V81, P55; Murthy S, 1997, INFLAMM RES, V46, P224, DOI 10.1007/s000110050177; MYERS G, 1992, SURG GYNECOL OBSTET, V174, P291; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Nagoya T, 1981, PHARMACOMETRICS, V22, P621; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Onori L, 2001, DIGEST DIS SCI, V46, P2084, DOI 10.1023/A:1011982024849; Pohl C, 2000, HEPATO-GASTROENTEROL, V47, P57; Quednau M, 1998, CURR MICROBIOL, V36, P332, DOI 10.1007/s002849900318; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; RUPPIN H, 1980, GASTROENTEROLOGY, V78, P1500; Russell WR, 2007, MOL NUTR FOOD RES, V51, P726, DOI 10.1002/mnfr.200700022; SCHEPPACH W, 1995, EUR J CANCER, V31A, P1077, DOI 10.1016/0959-8049(95)00165-F; SHEPHERD HA, 1983, Q J MED, V52, P503; Sjoqvist U, 2004, LANGENBECK ARCH SURG, V389, P354, DOI 10.1007/s00423-003-0455-6; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Theander O, 1995, J AOAC INT, V78, P1030; Vannucci L, 2009, J IMMUNOTOXICOL, V6, P217, DOI 10.3109/15476910903334343; VERNIA P, 1995, ALIMENT PHARM THERAP, V9, P309; WARD AM, 1977, BRIT J CANCER, V35, P170, DOI 10.1038/bjc.1977.24; WEAVER GA, 1988, GUT, V29, P1539, DOI 10.1136/gut.29.11.1539; Yi WG, 2005, J AGR FOOD CHEM, V53, P7320, DOI 10.1021/jf051333o; Zhao GH, 2007, J CHROMATOGR B, V846, P202, DOI 10.1016/j.jchromb.2006.09.027; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580	53	29	31	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33510	10.1371/journal.pone.0033510	http://dx.doi.org/10.1371/journal.pone.0033510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457771	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900015
J	Kwan, JL; Kluh, S; Reisen, WK				Kwan, Jennifer L.; Kluh, Susanne; Reisen, William K.			Antecedent Avian Immunity Limits Tangential Transmission of West Nile Virus to Humans	PLOS ONE			English	Article							LOUIS-ENCEPHALITIS-VIRUS; CULEX-TARSALIS; KERN COUNTY; HOUSE SPARROWS; LOS-ANGELES; CALIFORNIA; EPIDEMIOLOGY; DIPTERA; ANTIBODIES; SURVIVAL	Background: West Nile virus (WNV) is a mosquito-borne flavivirus maintained and amplified among birds and tangentially transmitted to humans and horses which may develop terminal neuroinvasive disease. Outbreaks typically have a three-year pattern of silent introduction, rapid amplification and subsidence, followed by intermittent recrudescence. Our hypothesis that amplification to outbreak levels is contingent upon antecedent seroprevalence within maintenance host populations was tested by tracking WNV transmission in Los Angeles, California from 2003 through 2011. Methods: Prevalence of antibodies against WNV was monitored weekly in House Finches and House Sparrows. Tangential or spillover transmission was measured by seroconversions in sentinel chickens and by the number of West Nile neuroinvasive disease (WNND) cases reported to the Los Angeles County Department of Public Health. Results: Elevated seroprevalence in these avian populations was associated with the subsidence of outbreaks and in the antecedent dampening of amplification during succeeding years. Dilution of seroprevalence by recruitment resulted in the progressive loss of herd immunity following the 2004 outbreak, leading to recrudescence during 2008 and 2011. WNV appeared to be a significant cause of death in these avian species, because the survivorship of antibody positive birds significantly exceeded that of antibody negative birds. Cross-correlation analysis showed that seroprevalence was negatively correlated prior to the onset of human cases and then positively correlated, peaking at 4-6 weeks after the onset of tangential transmission. Antecedent seroprevalence during winter (Jan - Mar) was negatively correlated with the number of WNND cases during the succeeding summer (Jul-Sep). Conclusions: Herd immunity levels within after hatching year avian maintenance host populations <10% during the antecedent late winter and spring period were followed on three occasions by outbreaks of WNND cases during the succeeding summer. Because mosquitoes feed almost exclusively on these avian species, amplification was directly related to the availability of receptive non-immune hosts.	[Kwan, Jennifer L.; Reisen, William K.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Ctr Vectorborne Dis, Davis, CA 95616 USA; [Kluh, Susanne] Greater Los Angeles Cty Vector Control Dist, Santa Fe Springs, CA USA	University of California System; University of California Davis	Kwan, JL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Ctr Vectorborne Dis, Davis, CA 95616 USA.	wkreisen@ucdavis.edu			National Institutes of Allergy and Infectious Diseases, National Institutes of Health [R01-AI055607]; Science and Technology Directorate; Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055607] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Science and Technology Directorate; Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grant R01-AI055607 from the National Institutes of Allergy and Infectious Diseases, National Institutes of Health; funds and resources were provided by the Greater Los Angeles County Vector Control District, and supplemental funds for Extended Laboratory Capacity from the Center for Disease Control and the California Department of Public Health. WKR acknowledges support from the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiles RE, 1998, J VECTOR ECOL, V23, P123; Ebel GD, 2002, EMERG INFECT DIS, V8, P979, DOI 10.3201/eid0809.020152; Fang Y, 2006, AM J TROP MED HYG, V75, P480, DOI 10.4269/ajtmh.2006.75.480; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Gruwell JA, 2000, J WILDLIFE DIS, V36, P13, DOI 10.7589/0090-3558-36.1.13; Hartley DM, 2011, AM J TROP M IN PRESS; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Koenig WD, 2007, ECOHEALTH, V4, P18, DOI 10.1007/s10393-007-0086-4; Kwan JL, 2010, AM J TROP MED HYG, V83, P1137, DOI 10.4269/ajtmh.2010.10-0078; Kwan JL, 2010, AM J TROP MED HYG, V83, P400, DOI 10.4269/ajtmh.2010.10-0076; Langevin SA, 2005, AM J TROP MED HYG, V72, P99, DOI 10.4269/ajtmh.2005.72.99; MCCAUGHEY K, 2003, P MOSQ VECTOR CONTRO, V71, P38; McClure HE, 1984, BIRD BANDING PACIFIC; Milby M.M., 1990, P26; MILBY MM, 1976, BIRD BANDING, V47, P119, DOI 10.2307/4512211; Molaei G, 2010, AM J TROP MED HYG, V83, P1269, DOI 10.4269/ajtmh.2010.10-0392; Nasci RS, 2002, AM J TROP MED HYG, V67, P492, DOI 10.4269/ajtmh.2002.67.492; Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; Nielsen CF, 2007, J MED ENTOMOL, V44, P1067, DOI 10.1603/0022-2585(2007)44[1067:WNVDCI]2.0.CO;2; Patiris PJ, 2008, AM J TROP MED HYG, V78, P434, DOI 10.4269/ajtmh.2008.78.434; Pellegrini AR, 2011, CONDOR, V113, P233, DOI 10.1525/cond.2011.090233; Pyle P., 1987, IDENTIFICATION GUIDE; Reisen WK, 2008, J MED ENTOMOL, V45, P1126, DOI 10.1603/0022-2585(2008)45[1126:DVICDC]2.0.CO;2; Reisen WK, 2008, J MED ENTOMOL, V45, P494, DOI 10.1603/0022-2585(2008)45[494:PWNVTA]2.0.CO;2; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; Reisen WK, 2009, J MED ENTOMOL, V46, P139, DOI 10.1603/033.046.0118; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P356, DOI 10.1603/0022-2585(2006)043[0356:ROCIEO]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Reisen WK, 1993, P CALIF MOSQ VECTOR, V61, P33; TEMPELIS CH, 1965, AM J TROP MED HYG, V14, P170, DOI 10.4269/ajtmh.1965.14.170; TEMPELIS CH, 1976, AM J TROP MED HYG, V25, P744, DOI 10.4269/ajtmh.1976.25.744; Thiemann T, 2011, THESIS U CALIFORNIA; Thiemann TC, 2011, P MOSQ VECTOR CONTRO; Wheeler SS, 2009, CONDOR, V111, P1, DOI 10.1525/cond.2009.080013; Wheeler SS, 2009, P MOSQ VECTOR CONTRO, V77, P42	39	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34127	10.1371/journal.pone.0034127	http://dx.doi.org/10.1371/journal.pone.0034127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457819	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900048
J	Minoli, S; Kauer, I; Colson, V; Party, V; Renou, M; Anderson, P; Gadenne, C; Marion-Poll, F; Anton, S				Minoli, Sebastian; Kauer, Isabella; Colson, Violaine; Party, Virginie; Renou, Michel; Anderson, Peter; Gadenne, Christophe; Marion-Poll, Frederic; Anton, Sylvia			Brief Exposure to Sensory Cues Elicits Stimulus-Nonspecific General Sensitization in an Insect	PLOS ONE			English	Article							MOTH HELIOTHIS-VIRESCENS; LONG-TERM SENSITIZATION; SEX-PHEROMONE; PROBOSCIS-EXTENSION; SPODOPTERA-LITTORALIS; EXPERIENCE; SYSTEMS; NEURONS; HABITUATION; HONEYBEES	The effect of repeated exposure to sensory stimuli, with or without reward is well known to induce stimulus-specific modifications of behaviour, described as different forms of learning. In recent studies we showed that a brief single pre-exposure to the female-produced sex pheromone or even a predator sound can increase the behavioural and central nervous responses to this pheromone in males of the noctuid moth Spodoptera littoralis. To investigate if this increase in sensitivity might be restricted to the pheromone system or is a form of general sensitization, we studied here if a brief pre-exposure to stimuli of different modalities can reciprocally change behavioural and physiological responses to olfactory and gustatory stimuli. Olfactory and gustatory pre-exposure and subsequent behavioural tests were carried out to reveal possible intra- and cross-modal effects. Attraction to pheromone, monitored with a locomotion compensator, increased after exposure to olfactory and gustatory stimuli. Behavioural responses to sucrose, investigated using the proboscis extension reflex, increased equally after pre-exposure to olfactory and gustatory cues. Pheromone-specific neurons in the brain and antennal gustatory neurons did, however, not change their sensitivity after sucrose exposure. The observed intra- and reciprocal cross-modal effects of pre-exposure may represent a new form of stimulus-nonspecific general sensitization originating from modifications at higher sensory processing levels.	[Minoli, Sebastian; Kauer, Isabella; Colson, Violaine; Party, Virginie; Renou, Michel; Gadenne, Christophe; Marion-Poll, Frederic; Anton, Sylvia] INRA, UMR Physiol Insecte 1272, F-78026 Versailles, France; [Minoli, Sebastian; Kauer, Isabella; Colson, Violaine; Party, Virginie; Renou, Michel; Gadenne, Christophe; Marion-Poll, Frederic; Anton, Sylvia] Univ Paris 06, Paris, France; [Minoli, Sebastian] Univ Buenos Aires, FCEyN, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Kauer, Isabella] MPI Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany; [Colson, Violaine] INRA, UR Lab Physiol & Genom Poissons 1037, F-35042 Rennes, France; [Anderson, Peter] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden; [Gadenne, Christophe; Anton, Sylvia] Univ Angers, Lab Recepteurs & Canaux Ion Membranaires, UPRES EA USC INRA 1330 2647, Angers, France; [Marion-Poll, Frederic] AgroParisTech, Dept Sci Vie & Sante, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; University of Buenos Aires; INRAE; Swedish University of Agricultural Sciences; INRAE; Universite d'Angers; AgroParisTech	Minoli, S (corresponding author), INRA, UMR Physiol Insecte 1272, F-78026 Versailles, France.	sylvia.anton@angers.inra.fr	Colson, Violaine/AAA-9919-2021; Frederic, Marion-Poll/I-1358-2019; Colson, Violaine/R-1761-2017; RENOU, Michel/AAT-7340-2021	Colson, Violaine/0000-0003-0934-7935; Frederic, Marion-Poll/0000-0001-6824-0180; Colson, Violaine/0000-0003-0934-7935; RENOU, Michel/0000-0001-6172-0210	French National Founding Agency [ANR-07-NEURO-037-01]; Swedish Research Council; Trygger Foundation; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)	French National Founding Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission); Trygger Foundation; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas)	This work was supported by French National Founding Agency Grant ANR-07-NEURO-037-01 to SA, FMP and MR, the Swedish Research Council (VR), Trygger Foundation and a Linnaeus Grant from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amakawa T, 2001, J INSECT PHYSIOL, V47, P195, DOI 10.1016/S0022-1910(00)00105-0; Anderson P, 2003, CHEM SENSES, V28, P285, DOI 10.1093/chemse/28.4.285; Anderson P, 2007, CHEM SENSES, V32, P483, DOI 10.1093/chemse/bjm017; Anton S, 2011, P NATL ACAD SCI USA, V108, P3401, DOI 10.1073/pnas.1008840108; Barrozo RB, 2010, J EXP BIOL, V213, P2933, DOI 10.1242/jeb.043430; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BRAUN G, 1992, J NEUROPHYSIOL, V67, P588, DOI 10.1152/jn.1992.67.3.588; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; CHAPMAN RF, 1974, B ENTOMOL RES, V64, P339, DOI 10.1017/S0007485300031230; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DAVIS EE, 1984, J INSECT PHYSIOL, V30, P179, DOI 10.1016/0022-1910(84)90124-0; DETHIER VG, 1989, PHYSIOL ENTOMOL, V14, P127, DOI 10.1111/j.1365-3032.1989.tb00944.x; Diaz-Cenzano E, 2010, DEV PSYCHOBIOL, V52, P109, DOI 10.1002/dev.20418; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; Fan RJ, 1997, J EXP BIOL, V200, P2969; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; GABEL B, 1992, J APPL ENTOMOL, V113, P153, DOI 10.1111/j.1439-0418.1992.tb00648.x; Gonzalez KM, 2008, CHEM SENSES, V33, P173, DOI 10.1093/chemse/bjm078; Grubb MS, 2004, CURR OPIN NEUROBIOL, V14, P503, DOI 10.1016/j.conb.2004.06.006; HAMMER M, 1994, BEHAV NEURAL BIOL, V62, P210, DOI 10.1016/S0163-1047(05)80019-6; Hansson BS, 1999, INSECT OLFACTION, P125; Hartlieb E, 1999, PHYSIOL BEHAV, V67, P671, DOI 10.1016/S0031-9384(99)00124-9; Hartlieb E, 1996, J CHEM ECOL, V22, P821, DOI 10.1007/BF02033589; HAYNES KF, 1991, J CHEM ECOL, V17, P637, DOI 10.1007/BF00982132; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Homberg Uwe, 1999, P181; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Jorgensen K, 2007, CHEM SENSES, V32, P863, DOI 10.1093/chemse/bjm057; Jorgensen K, 2007, J EXP BIOL, V210, P2563, DOI 10.1242/jeb.004283; KRAMER E, 1992, J INSECT BEHAV, V5, P83, DOI 10.1007/BF01049160; Kvello P, 2010, J NEUROPHYSIOL, V103, P2965, DOI 10.1152/jn.00985.2009; LeBourg E, 1996, GERONTOLOGY, V42, P235; MarionPoll F, 1996, ENTOMOL EXP APPL, V80, P113, DOI 10.1007/BF00194738; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; MONTEITH L. G., 1963, CANADIAN ENTOMOL, V95, P418; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nassel DR, 2006, CELL TISSUE RES, V326, P1, DOI 10.1007/s00441-006-0210-8; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Oboti L, 2009, EUR J NEUROSCI, V29, P679, DOI 10.1111/j.1460-9568.2009.06614.x; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487, DOI 10.1017/S0140525X00063949; Party V, 2009, CHEM SENSES, V34, P763, DOI 10.1093/chemse/bjp060; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; Popescu A, 2008, THESIS AGROPARIS TEC; RAKITIN A, 1991, PHYSIOL BEHAV, V50, P477, DOI 10.1016/0031-9384(91)90533-T; RAMASWAMY SB, 1992, ENTOMOL EXP APPL, V65, P81, DOI 10.1007/BF00189720; Reddy GVP, 2004, TRENDS PLANT SCI, V9, P253, DOI 10.1016/j.tplants.2004.03.009; Rouyar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026443; Sakuma M, 2002, COMPUT ELECTRON AGR, V35, P243, DOI 10.1016/S0168-1699(02)00021-2; Silvegren G, 2005, J INSECT PHYSIOL, V51, P277, DOI 10.1016/j.jinsphys.2004.11.013; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Walters ET, 2001, J EXP BIOL, V204, P457; Zar JH, 1999, BIOSTAT ANAL; Zhou DS, 2009, J INSECT PHYSIOL, V55, P788, DOI 10.1016/j.jinsphys.2009.04.011; [No title captured]	56	19	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34141	10.1371/journal.pone.0034141	http://dx.doi.org/10.1371/journal.pone.0034141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457821	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900050
J	Qiu, JL; Wang, WJ; Wu, JB; Zhang, H; Wang, YZ; Qiao, J; Chen, CF; Gao, GF; Allain, JP; Li, CY				Qiu, Jinlang; Wang, Wenjing; Wu, Jingbo; Zhang, Hui; Wang, Yuanzhi; Qiao, Jun; Chen, Chuangfu; Gao, Goege F.; Allain, Jean-Pierre; Li, Chengyao			Characterization of Periplasmic Protein BP26 Epitopes of Brucella melitensis Reacting with Murine Monoclonal and Sheep Antibodies	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN-31; REV.1 DELETION MUTANTS; HEPATITIS-C VIRUS; B-MELITENSIS; NUCLEOTIDE-SEQUENCE; DNA VACCINATION; REV-1 VACCINE; INFECTION; IMMUNIZATION; EXPRESSION	More than 35,000 new cases of human brucellosis were reported in 2010 by the Chinese Center for Disease Control and Prevention. An attenuated B. melitensis vaccine M5-90 is currently used for vaccination of sheep and goats in China. In the study, a periplasmic protein BP26 from M5-90 was characterized for its epitope reactivity with mouse monoclonal and sheep antibodies. A total of 29 monoclonal antibodies (mAbs) against recombinant BP26 (rBP26) were produced, which were tested for reactivity with a panel of BP26 peptides, three truncated rBP26 and native BP26 containing membrane protein extracts (NMP) of B. melitensis M5-90 in ELISA and Western-Blot. The linear, semi-conformational and conformational epitopes from native BP26 were identified. Two linear epitopes recognized by mAbs were revealed by 28 of 16mer overlapping peptides, which were accurately mapped as the core motif of amino acid residues (93)DRDLQTGGI(101) (position 93 to 101) or residues (104)QPIYVYPD(111), respectively. The reactivity of linear epitope peptides, rBP26 and NMP was tested with 137 sheep sera by ELISAs, of which the two linear epitopes had 65-70% reactivity and NMP 90% consistent with the results of a combination of two standard serological tests. The results were helpful for evaluating the reactivity of BP26 antigen in M5-90.	[Qiu, Jinlang; Wang, Wenjing; Wu, Jingbo; Allain, Jean-Pierre; Li, Chengyao] So Med Univ, Dept Transfus Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Hui; Wang, Yuanzhi; Qiao, Jun; Chen, Chuangfu] Shihezi Univ, Anim Sci & Technol Coll, Shihezi, Peoples R China; [Gao, Goege F.] Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Allain, Jean-Pierre] Univ Cambridge, Dept Haematol, Cambridge, England	Southern Medical University - China; Shihezi University; Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Cambridge	Qiu, JL (corresponding author), So Med Univ, Dept Transfus Med, Guangzhou, Guangdong, Peoples R China.	chengyaoli@hotmail.com	Wu, Jing/GZK-5063-2022		National Basic Research Program of China (973 Program) [2010CB530204, 2009CB522507]; National Science and Technology (S&T) Grand Special Program [2009ZX10004-305]; National Natural Science Foundation of China [31100657, 81071348]; Guangdong Provincial Science and Technology Foundation [2010B060500010]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science and Technology (S&T) Grand Special Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Foundation	This work was supported by the grants from National Basic Research Program of China (973 Program: No. 2010CB530204 and No. 2009CB522507), National Science and Technology (S&T) Grand Special Program (No. 2009ZX10004-305), National Natural Science Foundation of China (No. 31100657 and No. 81071348) and Guangdong Provincial Science and Technology Foundation (No. 2010B060500010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasco JM, 1997, PREV VET MED, V31, P275, DOI 10.1016/S0167-5877(96)01110-5; BLASCO JM, 1993, LANCET, V342, P805, DOI 10.1016/0140-6736(93)91571-3; Cassataro J, 2005, INFECT IMMUN, V73, P8079, DOI 10.1128/IAI.73.12.8079-8088.2005; Cassataro J, 2005, INFECT IMMUN, V73, P6537, DOI 10.1128/IAI.73.10.6537-6546.2005; Chin JContEndDis, 1991, CHINESE J CONTROL EN, V65-68; Chinese Center for Disease Control and Prevention, 2011, CHIN HLTH STAT DIG 2; Clapp B, 2011, J WILDLIFE DIS, V47, P501, DOI 10.7589/0090-3558-47.3.501; Cloeckaert A, 1996, FEMS MICROBIOL LETT, V140, P139, DOI 10.1016/0378-1097(96)00169-3; Cloeckaert A, 2004, VACCINE, V22, P2827, DOI 10.1016/j.vaccine.2004.01.001; Cloeckaert A, 2001, CLIN DIAGN LAB IMMUN, V8, P772, DOI 10.1128/CDLI.8.4.772-775.2001; ELBERG SS, 1957, J BACTERIOL, V73, P211, DOI 10.1128/JB.73.2.211-217.1957; Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058; Garin-Bastuji B, 1998, VET RES, V29, P255; Grillo MJ, 2009, VACCINE, V27, P187, DOI 10.1016/j.vaccine.2008.10.065; Gupta VK, 2010, SMALL RUMINANT RES, V93, P119, DOI 10.1016/j.smallrumres.2010.05.009; Jacques I, 2007, VACCINE, V25, P794, DOI 10.1016/j.vaccine.2006.09.051; Li CY, 2001, J VIROL, V75, P12412, DOI 10.1128/JVI.75.24.12412-12420.2001; Liu WX, 2011, BIOTECHNOL APPL BIOC, V58, P32, DOI 10.1002/bab.11; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Ndongo N, 2010, HEPATOLOGY, V52, P1531, DOI 10.1002/hep.23862; Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08; [曲勍 QU Qing], 2009, [吉林农业大学学报, Journal of Jilin Agricultural University], V31, P438; Rossetti OL, 1996, J CLIN MICROBIOL, V34, P165, DOI 10.1128/JCM.34.1.165-169.1996; Salih-Alj, 1996, VET MICROBIOL, V53, P325; SALIHALJ DH, 1996, CLIN DIAGN LAB IMMUN, V3, P305; Seco-Mediavilla P, 2003, CLIN DIAGN LAB IMMUN, V10, P647, DOI 10.1128/CDLI.10.4.647-651.2003; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Vizcaino N, 1996, INFECT IMMUN, V64, P3744; Wang Zhoujia, 2009, Weishengwu Xuebao, V49, P405; Yang XH, 2005, INFECT IMMUN, V73, P7297, DOI 10.1128/IAI.73.11.7297-7303.2005; Yang XH, 2007, VACCINE, V25, P2261, DOI 10.1016/j.vaccine.2006.12.004; Zhang WY, 2010, EMERG INFECT DIS, V16, P2001, DOI 10.3201/eid1612.091081	32	32	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34246	10.1371/journal.pone.0034246	http://dx.doi.org/10.1371/journal.pone.0034246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457830	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900059
J	Leach, MD; Tyc, KM; Brown, AJP; Klipp, E				Leach, Michelle D.; Tyc, Katarzyna M.; Brown, Alistair J. P.; Klipp, Edda			Modelling the Regulation of Thermal Adaptation in Candida albicans, a Major Fungal Pathogen of Humans	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; DNA-BINDING ACTIVITY; TRANSCRIPTION FACTOR; PROTEIN-SYNTHESIS; GENE-EXPRESSION; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ATTRIBUTABLE MORTALITY; BACTERIAL CHEMOTAXIS; PERFECT ADAPTATION	Eukaryotic cells have evolved mechanisms to sense and adapt to dynamic environmental changes. Adaptation to thermal insults, in particular, is essential for their survival. The major fungal pathogen of humans, Candida albicans, is obligately associated with warm-blooded animals and hence occupies thermally buffered niches. Yet during its evolution in the host it has retained a bona fide heat shock response whilst other stress responses have diverged significantly. Furthermore the heat shock response is essential for the virulence of C. albicans. With a view to understanding the relevance of this response to infection we have explored the dynamic regulation of thermal adaptation using an integrative systems biology approach. Our mathematical model of thermal regulation, which has been validated experimentally in C. albicans, describes the dynamic autoregulation of the heat shock transcription factor Hsf1 and the essential chaperone protein Hsp90. We have used this model to show that the thermal adaptation system displays perfect adaptation, that it retains a transient molecular memory, and that Hsf1 is activated during thermal transitions that mimic fever. In addition to providing explanations for the evolutionary conservation of the heat shock response in this pathogen and the relevant of this response to infection, our model provides a platform for the analysis of thermal adaptation in other eukaryotic cells.	[Leach, Michelle D.; Brown, Alistair J. P.] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [Tyc, Katarzyna M.; Klipp, Edda] Humboldt Univ, D-10099 Berlin, Germany	University of Aberdeen; Humboldt University of Berlin	Leach, MD (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland.	al.brown@abdn.ac.uk; edda.klipp@rz.hu-berlin.de	Brown, Alistair J.P./B-6627-2014	Leach, Michelle/0000-0002-1631-8959; Brown, Alistair JP/0000-0003-1406-4251	Carnegie Trust; European Marie Curie Initial Training Network, FINSysB [PITN-GA-2008-214004]; UK Biotechnology and Biological Research Council [BB/D009308/1, BB/F00513X/1]; Wellcome Trust [080088]; European Commission [PITN-GA-2008-214004, HEALTH-2007-201142, ERC-2009-AdG-249793]; Biotechnology and Biological Sciences Research Council [BB/F00513X/1, BB/D009308/1] Funding Source: researchfish; BBSRC [BB/F00513X/1, BB/D009308/1] Funding Source: UKRI	Carnegie Trust(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Marie Curie Initial Training Network, FINSysB; UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MDL was supported by a Carnegie/Caledonian Scholarship from The Carnegie Trust. KMT was supported by the European Marie Curie Initial Training Network, FINSysB (PITN-GA-2008-214004). This work was also supported by grants from the UK Biotechnology and Biological Research Council (BB/D009308/1; BB/F00513X/1), the Wellcome Trust (080088) and the European Commission (Unicellsys, HEALTH-2007-201142; FINSysB, PITN-GA-2008-214004; STRIFE, ERC-2009-AdG-249793). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; Arguelles JC, 1997, FEMS MICROBIOL LETT, V146, P65, DOI 10.1016/S0378-1097(96)00455-7; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bromuro C, 1998, INFECT IMMUN, V66, P2154, DOI 10.1128/IAI.66.5.2154-2162.1998; Burnie JR, 2006, FEMS MICROBIOL REV, V30, P53, DOI 10.1111/j.1574-6976.2005.00001.x; Calderone RA., 2002, CANDIDA CANDIDIASIS; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; DIDOMENICO BJ, 1982, CELL, V31, P593, DOI 10.1016/0092-8674(82)90315-4; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; El-Samad H, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P3766; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; Eroles P, 1997, MICROBIOL-SGM, V143, P313, DOI 10.1099/00221287-143-2-313; Freeman ML, 1999, FREE RADICAL BIO MED, V26, P737, DOI 10.1016/S0891-5849(98)00258-5; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gonzalez-Parraga P, 2010, FEMS YEAST RES, V10, P747, DOI 10.1111/j.1567-1364.2010.00654.x; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hauser NC, 1998, YEAST, V14, P1209, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1209::AID-YEA311>3.0.CO;2-N; HEGDE RS, 1995, J CELL PHYSIOL, V165, P186, DOI 10.1002/jcp.1041650122; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Ingalls BP, 2003, J THEOR BIOL, V222, P23, DOI 10.1016/S0022-5193(03)00011-0; Key JL, 1982, HEAT SHOCK RESPONSE; Klipp Edda, 2009, SYSTEMS BIOL TXB; KNOX BE, 1986, P NATL ACAD SCI USA, V83, P2345, DOI 10.1073/pnas.83.8.2345; Krause F, 2010, BIOINFORMATICS, V26, P421, DOI 10.1093/bioinformatics/btp642; Kurata H, 2006, PLOS COMPUT BIOL, V2, P663, DOI 10.1371/journal.pcbi.0020059; Leach MD, 2011, MOL BIOL CELL, V22, P687, DOI 10.1091/mbc.E10-07-0632; Leach MD, 2011, MOL MICROBIOL, V79, P1574, DOI 10.1111/j.1365-2958.2011.07542.x; LEPOCK JR, 1993, J CELL BIOL, V122, P1267, DOI 10.1083/jcb.122.6.1267; LI GC, 1982, INT J RADIAT ONCOL, V8, P63, DOI 10.1016/0360-3016(82)90386-8; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; LINDQUIST S, 1980, DEV BIOL, V77, P463, DOI 10.1016/0012-1606(80)90488-1; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; LOOMIS WF, 1980, DEV BIOL, V79, P399, DOI 10.1016/0012-1606(80)90125-6; MATTHEWS RC, 1991, IMMUNOLOGY, V74, P20; Matthews RC, 2003, ANTIMICROB AGENTS CH, V47, P2208, DOI 10.1128/AAC.47.7.2208-2216.2003; MCALISTER L, 1980, BIOCHEM BIOPH RES CO, V93, P819, DOI 10.1016/0006-291X(80)91150-X; MILLER MJ, 1982, J BACTERIOL, V151, P311, DOI 10.1128/JB.151.1.311-327.1982; MITCHELL HK, 1979, DEV GENET, V1, P181, DOI 10.1002/dvg.1020010206; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; NEIDHARDT FC, 1981, BIOCHEM BIOPH RES CO, V100, P894, DOI 10.1016/S0006-291X(81)80257-4; Nicholls S, 2010, FUNGAL GENET BIOL; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; ODDS FC, 1984, ZBL BAKT-INT J MED M, V257, P207, DOI 10.1016/S0174-3031(84)80073-6; Odds FC, CANDIDA CANDIDOSIS; PARKER CS, 1984, CELL, V37, P273, DOI 10.1016/0092-8674(84)90323-4; PARSELL DA, 1993, PHILOS T R SOC B, V339, P279, DOI 10.1098/rstb.1993.0026; PELHAM HRB, 1982, EMBO J, V1, P1473, DOI 10.1002/j.1460-2075.1982.tb01340.x; PETERSEN NS, 1981, P NATL ACAD SCI-BIOL, V78, P1708, DOI 10.1073/pnas.78.3.1708; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; RABINDRAN SK, 1994, MOL CELL BIOL, V14, P6552, DOI 10.1128/MCB.14.10.6552; Research W, 2008, MATH EDITION VERSION; Rieger TR, 2005, BIOPHYS J, V88, P1646, DOI 10.1529/biophysj.104.055301; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Schaber J, 2011, CURR OPIN BIOTECH, V22, P109, DOI 10.1016/j.copbio.2010.09.014; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Spiro PA, 1997, P NATL ACAD SCI USA, V94, P7263, DOI 10.1073/pnas.94.14.7263; SWOBODA R, 1993, J GEN MICROBIOL, V139, P2995, DOI 10.1099/00221287-139-12-2995; SWOBODA RK, 1995, INFECT IMMUN, V63, P4506, DOI 10.1128/IAI.63.11.4506-4514.1995; Vilaprinyo E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-184; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WEY SB, 1988, ARCH INTERN MED, V148, P2642, DOI 10.1001/archinte.148.12.2642; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; YAMAMORI T, 1982, P NATL ACAD SCI-BIOL, V79, P860, DOI 10.1073/pnas.79.3.860; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zou JY, 1998, CELL STRESS CHAPERON, V3, P130, DOI 10.1379/1466-1268(1998)003<0130:CBGOAT>2.3.CO;2; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	85	49	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32467	10.1371/journal.pone.0032467	http://dx.doi.org/10.1371/journal.pone.0032467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448221	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700011
J	Moreno, H; Tejero, H; de la Torre, JC; Domingo, E; Martin, V				Moreno, Hector; Tejero, Hector; de la Torre, Juan Carlos; Domingo, Esteban; Martin, Veronica			Mutagenesis-Mediated Virus Extinction: Virus-Dependent Effect of Viral Load on Sensitivity to Lethal Defection	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUTH-DISEASE VIRUS; VESICULAR STOMATITIS-VIRUS; NUCLEOTIDE-SEQUENCE HETEROGENEITY; RNA VIRUS; INTERFERING PARTICLES; HOMOLOGOUS INTERFERENCE; ENHANCED MUTAGENESIS; ANTIVIRAL INHIBITORS; ERROR CATASTROPHE	Background: Lethal mutagenesis is a transition towards virus extinction mediated by enhanced mutation rates during viral genome replication, and it is currently under investigation as a potential new antiviral strategy. Viral load and virus fitness are known to influence virus extinction. Here we examine the effect or the multiplicity of infection (MOI) on progeny production of several RNA viruses under enhanced mutagenesis. Results: The effect of the mutagenic base analogue 5-fluorouracil (FU) on the replication of the arenavirus lymphocytic choriomeningitis virus (LCMV) can result either in inhibition of progeny production and virus extinction in infections carried out at low multiplicity of infection (MOI), or in a moderate titer decrease without extinction at high MOI. The effect of the MOI is similar for LCMV and vesicular stomatitis virus (VSV), but minimal or absent for the picornaviruses foot-and-mouth disease virus (FMDV) and encephalomyocarditis virus (EMCV). The increase in mutation frequency and Shannon entropy (mutant spectrum complexity) as a result of virus passage in the presence of FU was more accentuated at low MOI for LCMV and VSV, and at high MOI for FMDV and EMCV. We present an extension of the lethal defection model that agrees with the experimental results. Conclusions: (i) Low infecting load favoured the extinction of negative strand viruses, LCMV or VSV, with an increase of mutant spectrum complexity. (ii) This behaviour is not observed in RNA positive strand viruses, FMDV or EMCV. (iii) The accumulation of defector genomes may underlie the MOI-dependent behaviour. (iv) LCMV coinfections are allowed but superinfection is strongly restricted in BHK-21 cells. (v) The dissimilar effects of the MOI on the efficiency of mutagenic-based extinction of different RNA viruses can have implications for the design of antiviral protocols based on lethal mutagenesis, presently under development.	[Moreno, Hector; Tejero, Hector; Domingo, Esteban; Martin, Veronica] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Tejero, Hector] Univ Complutense Madrid, Dpto Bioquim & Biol Mol 1, Madrid, Spain; [de la Torre, Juan Carlos] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; [Domingo, Esteban] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Martin, Veronica] Ctr Invest Sanidad Anim CISA INIA Inst Nacl Inves, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Complutense University of Madrid; Scripps Research Institute; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Moreno, H (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	edomingo@cbm.uam.es	Martin, Veronica/M-9641-2019; Martín, Verónica/H-2776-2015; Moreno, Hector/AAA-6283-2020; Tejero, Hector/M-1045-2014; Domingo, Esteban/K-3937-2014	Martin, Veronica/0000-0003-1486-1656; Martín, Verónica/0000-0003-1486-1656; Tejero, Hector/0000-0002-4940-700X; Moreno, Hector/0000-0002-2615-8514; Domingo, Esteban/0000-0002-0573-1676	Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-02816/BMC]; Fundacion Ramon Areces; Instituto de Salud Carlos III [FI08/00775]; MEC (Spain) [AP2006-01044, BFU2009-12895-C02-02]; MICINN (Spain) [RYC-2010-06516]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MEC (Spain)(Spanish Government); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Work at Centro de Biologia Molecular Severo Ochoa is supported by grants BFU2008-02816/BMC from Ministerio de Ciencia e Innovacion (MICINN) and Fundacion Ramon Areces. CIBERehd (Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas) is funded by Instituto de Salud Carlos III. HM is supported by FI08/00775 from Instituto de Salud Carlos III. HT is supported by AP2006-01044, from MEC (Spain) and Grant no. BFU2009-12895-C02-02 from MEC (Spain). VM is supported by a contract RYC-2010-06516 from MICINN (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo R, 2008, J MOL BIOL, V382, P652, DOI 10.1016/j.jmb.2008.07.033; Agudo R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001072; Agudo R, 2009, FUTURE MED CHEM, V1, P529, DOI 10.4155/FMC.09.26; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; BATSCHELET E, 1976, GENE, V1, P27, DOI 10.1016/0378-1119(76)90004-4; BRUNS M, 1988, VIROLOGY, V166, P133, DOI 10.1016/0042-6822(88)90154-7; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Buchmeier MJ, 2001, FIELDS VIROLOGY, P1635; Charpentier N, 1996, VIROLOGY, V223, P10, DOI 10.1006/viro.1996.0450; COLE CN, 1975, PROG MED VIROL, V20, P180; COLE CN, 1973, J MOL BIOL, V76, P345, DOI 10.1016/0022-2836(73)90509-3; Condit R. C., 2007, FIELDS VIROLOGY, V1, P25; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crowder S, 2005, NAT GENET, V37, P701, DOI 10.1038/ng1583; Crowell RL, VIRUS ATTACHMENT ENT; de la Torre JC, 2005, VIRUS RES, V107, P207, DOI 10.1016/j.virusres.2004.11.010; DELATORRE JC, 1985, VIROLOGY, V145, P24, DOI 10.1016/0042-6822(85)90198-9; Domingo E, 2005, VIRUS RES, V107, P115, DOI 10.1016/j.virusres.2004.11.001; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; DOMINGO E, 1980, GENE, V11, P333, DOI 10.1016/0378-1119(80)90073-6; Domingo E, 2007, FIELDS VIROLOGY, P389; Domingo E., 2006, CURR TOP MICROBIO, V299, P1; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; DUKE GM, 1992, J VIROL, V66, P1602, DOI 10.1128/JVI.66.3.1602-1609.1992; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M., 1988, RNA GENETICS, V3, P211; Ellenberg P, 2004, ARCH VIROL, V149, P507, DOI 10.1007/s00705-003-0227-1; Ellenberg P, 2007, J GEN VIROL, V88, P2730, DOI 10.1099/vir.0.83041-0; Emonet SF, 2009, INFECT GENET EVOL, V9, P417, DOI 10.1016/j.meegid.2009.03.005; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; Escarmis C, 1996, J MOL BIOL, V264, P255, DOI 10.1006/jmbi.1996.0639; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Fox EJ, 2010, SEMIN CANCER BIOL, V20, P353, DOI 10.1016/j.semcancer.2010.10.005; FULLERPACE FV, 1989, J VIROL, V63, P1938, DOI 10.1128/JVI.63.5.1938-1944.1989; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Garcia-Arriaza J, 2006, J MOL BIOL, V360, P558, DOI 10.1016/j.jmb.2006.05.027; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Graci JD, 2008, FUTURE VIROL, V3, P553, DOI 10.2217/17460794.3.6.553; Grande-Perez A, 2005, J VIROL, V79, P10451, DOI 10.1128/JVI.79.16.10451-10459.2005; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Grande-Perez A, 2002, P NATL ACAD SCI USA, V99, P12938, DOI 10.1073/pnas.182426999; HALL L, 1971, VIROLOGY, V43, P152, DOI 10.1016/0042-6822(71)90233-9; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; HUANG AS, 1973, ANNU REV MICROBIOL, V27, P101, DOI 10.1146/annurev.mi.27.100173.000533; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; HUANG AS, 1986, MICROB PATHOGENESIS, V1, P205, DOI 10.1016/0882-4010(86)90022-7; Iranzo J, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/18001; Iranzo J, 2011, P NATL ACAD IN PRESS; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lee KJ, 2000, J VIROL, V74, P3470, DOI 10.1128/JVI.74.8.3470-3477.2000; Lehmann-Grube F, 1971, VIROLOGY MONOGRAPHS; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Lopez N, 2001, J VIROL, V75, P12241, DOI 10.1128/JVI.75.24.12241-12251.2001; Macher AM, 2006, EMERG INFECT DIS, V12, P835, DOI 10.3201/eid1205.050052; Manrubia SC, 2010, PHILOS T R SOC B, V365, P1943, DOI 10.1098/rstb.2010.0076; Martin V, 2008, VIROLOGY, V378, P185, DOI 10.1016/j.virol.2008.05.016; Martin V, 2010, J GEN VIROL, V91, P990, DOI 10.1099/vir.0.017053-0; Mas A, 2010, J MOL BIOL, V397, P865, DOI 10.1016/j.jmb.2010.02.005; MCCLURE MA, 1980, VIROLOGY, V100, P408, DOI 10.1016/0042-6822(80)90532-2; Meyer BJ, 2002, CURR TOP MICROBIOL, V262, P139; MUDD JA, 1970, VIROLOGY, V42, P958, DOI 10.1016/0042-6822(70)90344-2; Nowak MA., 2000, VIRUS DYNAMICS MATH; Ojosnegros S, 2011, PLOS GENETI IN PRESS; Ojosnegros S, 2010, P NATL ACAD SCI USA, V107, P2108, DOI 10.1073/pnas.0909787107; PALMA EL, 1974, J INFECT DIS, V129, P402, DOI 10.1093/infdis/129.4.402; Pariente N, 2005, VIRUS RES, V107, P183, DOI 10.1016/j.virusres.2004.11.008; Pariente N, 2003, J VIROL, V77, P7131, DOI 10.1128/JVI.77.12.7131-7138.2003; Pariente N, 2001, J VIROL, V75, P9723, DOI 10.1128/JVI.75.20.9723-9730.2001; Perales C, 2011, J VIROL IN PRESS; Perales C, 2007, J MOL BIOL, V369, P985, DOI 10.1016/j.jmb.2007.03.074; Perales C, 2011, J MOL BIOL, V407, P60, DOI 10.1016/j.jmb.2011.01.026; Perales C, 2010, FUTURE VIROL, V5, P679, DOI 10.2217/FVL.10.61; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Perales C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005554; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Peters CJ, 2002, CURR TOP MICROBIOL, V262, P65; POPESCU M, 1976, J VIROL, V20, P1; PRINGLE CR, 1970, J VIROL, V5, P559, DOI 10.1128/JVI.5.5.559-567.1970; Rodriguez LL, 2002, J GEN VIROL, V83, P2475, DOI 10.1099/0022-1317-83-10-2475; ROUX L, 1991, ADV VIRUS RES, V40, P181; Ruiz-Jarabo CM, 2003, VIROLOGY, V308, P37, DOI 10.1016/S0042-6822(02)00046-6; SALVATO MS, 1992, VIRUS RES, V22, P185, DOI 10.1016/0168-1702(92)90050-J; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; SINGH MK, 1987, VIROLOGY, V161, P448, DOI 10.1016/0042-6822(87)90138-3; SOBRINO F, 1983, VIROLOGY, V128, P310, DOI 10.1016/0042-6822(83)90258-1; Southern P. J., 1996, FIELDS VIROL, V2, P1505; Spagnolo JF, 2010, RNA, V16, P382, DOI 10.1261/rna.1955410; Tapia N, 2005, VIROLOGY, V338, P1, DOI 10.1016/j.virol.2005.05.008; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Volkenstein MV., 1994, PHYS APPROACHES BIOL, DOI [10.1007/978-3-642-78788-1, DOI 10.1007/978-3-642-78788-1]; VOLKMER N, 1983, INTERVIROLOGY, V20, P108, DOI 10.1159/000149378; VONLAER DM, 1988, J VIROL, V62, P1323, DOI 10.1128/JVI.62.4.1323-1329.1988; WELSH RM, 1972, J GEN VIROL, V14, P177, DOI 10.1099/0022-1317-14-2-177; WELSH RM, 1972, J GEN VIROL, V17, P355, DOI 10.1099/0022-1317-17-3-355; Wilke CO, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-44; Wimmer E, 2010, PICORNAVIRUSES, P33	100	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32550	10.1371/journal.pone.0032550	http://dx.doi.org/10.1371/journal.pone.0032550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442668	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500010
J	Novellino, L; Rossi, RL; Bonino, F; Cavallone, D; Abrignani, S; Pagani, M; Brunetto, MR				Novellino, Luisa; Rossi, Riccardo L.; Bonino, Ferruccio; Cavallone, Daniela; Abrignani, Sergio; Pagani, Massimiliano; Brunetto, Maurizia R.			Circulating Hepatitis B Surface Antigen Particles Carry Hepatocellular microRNAs	PLOS ONE			English	Article							EXPRESSION; CELLS; RNA; QUANTIFICATION; CARCINOMA; MIR-122; SERUM	Hepatitis B virus (HBV) produces high quantities of subviral surface antigen particles (HBsAg) which circulate in the blood outnumbering virions of about 1\10(3-6) times. In individuals coinfected with the defective hepatitis Delta virus (HDV) the small HDV-RNA-genome and Delta antigen circulate as ribonucleoprotein complexes within HBsAg subviral particles. We addressed the question whether subviral HBsAg particles may carry in the same way cellular microRNAs (miRNAs) which are released into the bloodstream within different subcellular forms such as exosomes and microvescicles. Circulating HBsAg particles were isolated from sera of 11 HBsAg carriers by selective immunoprecipitation with monoclonal anti-HBs-IgG, total RNA was extracted and human miRNAs were screened by TaqMan real-time quantitative PCR Arrays. Thirty-nine human miRNAs were found to be significantly associated with the immunoprecipitated HBsAg, as determined by both comparative DDCT analysis and non-parametric tests (Mann-Whitney, p<0.05) with respect to controls. Moreover immunoprecipitated HBsAg particles contained Ago2 protein that could be revealed in ELISA only after 0.5% NP40. HBsAg associated miRNAs were liver-specific (most frequent = miR-27a, miR-30b, miR-122, miR-126 and miR-145) as well as immune regulatory (most frequent = miR-106b and miR-223). Computationally predicted target genes of HBsAg-associated miRNAs highlighted molecular pathways dealing with host-pathogen The finding that HBsAg particles carry selective pools of hepatocellular miRNAs opens new avenues of research to disentangle the complex interactions between host and HBV and provides a non invasive tool to study the physiopathology of liver epigenetics.	[Novellino, Luisa; Cavallone, Daniela; Brunetto, Maurizia R.] Univ Hosp Pisa, Hepatol Unit, Pisa, Italy; [Novellino, Luisa; Cavallone, Daniela; Brunetto, Maurizia R.] Univ Hosp Pisa, Liver Physiopathol Lab, Pisa, Italy; [Rossi, Riccardo L.; Abrignani, Sergio; Pagani, Massimiliano] INGM, Dept Integrat Biol, Milan, Italy; [Bonino, Ferruccio] Univ Hosp Pisa, Dept Internal Med, Gen Med Unit 2, Pisa, Italy	University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Novellino, L (corresponding author), Univ Hosp Pisa, Hepatol Unit, Pisa, Italy.	ferrucciobonino@ferrucciobonino.it	Bonino, Ferruccio/B-7522-2013; Cavallone, Daniela/AAB-2660-2019; Bonino, Ferruccio/C-6036-2018; Brunetto, Maurizia/AAU-2906-2020; Rossi, Riccardo/M-8999-2019	Cavallone, Daniela/0000-0001-6718-9571; Bonino, Ferruccio/0000-0001-9942-0328; Brunetto, Maurizia/0000-0001-8364-9152; Rossi, Riccardo/0000-0002-4964-3264; Pagani, Massimiliano/0000-0002-7017-9304; Abrignani, Sergio/0000-0002-0794-3285	Italian Ministry of Health; CUCCS of the University of Pisa, Italy	Italian Ministry of Health(Ministry of Health, Italy); CUCCS of the University of Pisa, Italy	This work was supported by an educational Grant of the Italian Ministry of Health "Viral Hepatitis Emergency'' [85-2006] and by 2010 CUCCS Grant of the University of Pisa, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bertoletti A, 2010, ANTIVIR THER, V15, P15, DOI 10.3851/IMP1620; BONINO F, 1981, HEPATOLOGY, V1, P127, DOI 10.1002/hep.1840010207; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Desire N, 2011, HEPATOLOGY, V54, p1090A; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Gerlich WH, 2007, J VIRAL HEPATITIS, V14, P16, DOI 10.1111/j.1365-2893.2007.00912.x; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kim N, 2011, HEPATOL RES, V41, P170, DOI 10.1111/j.1872-034X.2010.00752.x; Kogure T, 2011, HEPATOLOGY, V54, p1278A; Lakner AM, 2011, WORLD J GASTROENTERO, V17, P2536, DOI 10.3748/wjg.v17.i20.2536; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Seeger C., 2007, FIELDS VIROLOGY, V1, P2977; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Taylor JM, 2006, VIROLOGY, V344, P71, DOI 10.1016/j.virol.2005.09.033; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712	28	50	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e31952	10.1371/journal.pone.0031952	http://dx.doi.org/10.1371/journal.pone.0031952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470417	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000001
J	Maetzler, W; Mancini, M; Liepelt-Scarfone, I; Muller, K; Becker, C; van Lummel, RC; Ainsworth, E; Hobert, M; Streffer, J; Berg, D; Chiari, L				Maetzler, Walter; Mancini, Martina; Liepelt-Scarfone, Inga; Mueller, Katharina; Becker, Clemens; van Lummel, Rob C.; Ainsworth, Erik; Hobert, Markus; Streffer, Johannes; Berg, Daniela; Chiari, Lorenzo			Impaired Trunk Stability in Individuals at High Risk for Parkinson's Disease	PLOS ONE			English	Article							POSTURAL INSTABILITY; SUBSTANTIA-NIGRA; MOTOR CONTROL; BALANCE; SWAY; HYPERECHOGENICITY; ACCELEROMETRY; RELIABILITY; PROGRESSION; DIAGNOSIS	Background: The search for disease-modifying treatments for Parkinson's disease advances, however necessary markers for early detection of the disease are still lacking. There is compelling evidence that changes of postural stability occur at very early clinical stages of Parkinson's disease, making it tempting to speculate that changes in sway performance may even occur at a prodromal stage, and may have the potential to serve as a prodromal marker for the disease. Methodology/Principal Findings: Balance performance was tested in 20 individuals with an increased risk of Parkinson's disease, 12 Parkinson's disease patients and 14 controls using a cross-sectional approach. All individuals were 50 years or older. Investigated groups were similar with respect to age, gender, and height. An accelerometer at the centre of mass at the lower spine quantified sway during quiet semitandem stance with eyes open and closed, as well as with and without foam. With increasing task difficulty, individuals with an increased risk of Parkinson's disease showed an increased variability of trunk acceleration and a decrease of smoothness of sway, compared to both other groups. These differences reached significance in the most challenging condition, i.e. the eyes closed with foam condition. Conclusions/Significance: Individuals with an increased risk of Parkinson's disease have subtle signs of a balance deficit under most challenging conditions. This preliminary finding should motivate further studies on sway performance in individuals with an increased risk of Parkinson's disease, to evaluate the potential of this symptom to serve as a biological marker for prodromal Parkinson's disease.	[Maetzler, Walter; Liepelt-Scarfone, Inga; Mueller, Katharina; Hobert, Markus; Berg, Daniela] Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, Ctr Neurol, Tubingen, Germany; [Maetzler, Walter; Liepelt-Scarfone, Inga; Mueller, Katharina; Hobert, Markus; Berg, Daniela] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Maetzler, Walter; Becker, Clemens] Robert Bosch Krankenhaus, Dept Geriatr Rehabil, Stuttgart, Germany; [Mancini, Martina; Chiari, Lorenzo] Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy; [van Lummel, Rob C.; Ainsworth, Erik] McRoberts, The Hague, Netherlands; [Streffer, Johannes] Janssen, Janssen Res & Dev, Beerse, Belgium	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Bosch; Robert Bosch Krankenhaus; University of Bologna; Johnson & Johnson; Janssen Pharmaceuticals	Maetzler, W (corresponding author), Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, Ctr Neurol, Tubingen, Germany.	walter.maetzler@uni-tuebingen.de	Maetzler, Walter/A-6796-2011; Becker, Clemens/ABI-5405-2020; Maetzler, Walter/AAE-5831-2020; Chiari, Lorenzo/N-7622-2015; Hobert, Markus A./AAR-3234-2020; Berg, Daniela/A-8728-2019	Maetzler, Walter/0000-0002-5945-4694; Maetzler, Walter/0000-0002-5945-4694; Chiari, Lorenzo/0000-0002-2318-4370; Hobert, Markus A./0000-0002-7558-8107; Berg, Daniela/0000-0001-5796-5442; Mancini, Martina/0000-0002-4532-3984; Rolf Streffer, Johannes/0000-0002-9387-5951	Werner Reichardt Centre for Integrative Neuroscience, University of Tuebingen, Germany; Forschungskolleg Geriatrie Grant from the Robert Bosch Foundation, Stuttgart, Germany [32.5.1141.0019.0]	Werner Reichardt Centre for Integrative Neuroscience, University of Tuebingen, Germany; Forschungskolleg Geriatrie Grant from the Robert Bosch Foundation, Stuttgart, Germany	MH is supported by a grant from the Werner Reichardt Centre for Integrative Neuroscience, University of Tuebingen, Germany. WM is supported by a Forschungskolleg Geriatrie Grant from the Robert Bosch Foundation, Stuttgart, Germany (Nr. 32.5.1141.0019.0). The study was also kindly supported by a private financial assistance of Mr. Volker Friederich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum JHJ, 2011, HUM MOVEMENT SCI, V30, P279, DOI 10.1016/j.humov.2010.11.009; Appel-Cresswell S, 2010, CURR OPIN NEUROL, V23, P407, DOI 10.1097/WCO.0b013e32833b6019; Baldinotti I, 2010, GAIT POSTURE, V32, P667, DOI 10.1016/j.gaitpost.2010.08.011; Berg D, 2011, ARCH NEUROL-CHICAGO, V68, P932, DOI 10.1001/archneurol.2011.141; Berg D, 2010, MOVEMENT DISORD, V25, P1464, DOI 10.1002/mds.23114; Beuter A, 2008, CAN J NEUROL SCI, V35, P65, DOI 10.1017/S0317167100007575; Bloem BR, 1996, MOVEMENT DISORD, V11, P509, DOI 10.1002/mds.870110506; Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Chastan N, 2008, MOVEMENT DISORD, V23, P366, DOI 10.1002/mds.21840; Ebersbach G, 2010, MOVEMENT DISORD, V26, P241; Frenklach A, 2009, MOVEMENT DISORD, V24, P377, DOI 10.1002/mds.22358; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Lang AE, 2011, MOVEMENT DISORD, V26, P775, DOI 10.1002/mds.23609; Leentjens AFG, 2003, MOVEMENT DISORD, V18, P414, DOI 10.1002/mds.10387; LEES AJ, 1992, MOVEMENT DISORD, V7, P110, DOI 10.1002/mds.870070203; Liepelt I, 2011, NEUROBIOL AGING, V32, P1599, DOI 10.1016/j.neurobiolaging.2009.10.004; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; Marder K, 1996, NEUROLOGY, V47, P155, DOI 10.1212/WNL.47.1.155; McVey MA, 2009, GAIT POSTURE, V30, P538, DOI 10.1016/j.gaitpost.2009.08.232; Mirelman A, 2011, ANN NEUROL, V69, P193, DOI 10.1002/ana.22165; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P328, DOI 10.1016/S0268-0033(98)00090-4; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; Nicolai S, 2010, Z GERONTOL GERIATR, V43, P224, DOI 10.1007/s00391-010-0125-6; Palmer S. J., 2010, COMPENSATORY MECH PA; Palmerini L, 2011, IEEE T INF TECHNOL B, V15, P481, DOI 10.1109/TITB.2011.2107916; Postuma RB, 2010, J NEUROL NEUROSUR PS, V81, P1008, DOI 10.1136/jnnp.2009.174748; Postuma RB, 2009, BRAIN, V132, P3298, DOI 10.1093/brain/awp244; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Ross GW, 2012, PARKINSONISM RELA S1, V18, pS199, DOI DOI 10.1016/S1353-8020(11)70062-1; Siderowf A, 2012, MOV DISORD; Stern MB, 2010, MOVEMENT DISORD, V25, pS89, DOI 10.1002/mds.22719; Yan JH, 2006, AGING NEUROPSYCHOL C, V13, P385, DOI 10.1080/138255890969609	36	56	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e32240	10.1371/journal.pone.0032240	http://dx.doi.org/10.1371/journal.pone.0032240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457713	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900002
J	Parker, TJ; Sampson, DL; Broszczak, D; Chng, YL; Carter, SL; Leavesley, DI; Parker, AW; Upton, Z				Parker, Tony J.; Sampson, Dayle L.; Broszczak, Daniel; Chng, Yee L.; Carter, Shea L.; Leavesley, David I.; Parker, Anthony W.; Upton, Zee			A Fragment of the LG3 Peptide of Endorepellin Is Present in the Urine of Physically Active Mining Workers: A Potential Marker of Physical Activity	PLOS ONE			English	Article							INDUCED MUSCLE DAMAGE; MUSCULOSKELETAL DISORDERS; EXTRACELLULAR-MATRIX; CIRCADIAN-RHYTHM; SKELETAL-MUSCLE; EXERCISE; CORTISOL; PROTEINS; INJURY; ADAPTATION	Biomarker analysis has been implemented in sports research in an attempt to monitor the effects of exertion and fatigue in athletes. This study proposed that while such biomarkers may be useful for monitoring injury risk in workers, proteomic approaches might also be utilised to identify novel exertion or injury markers. We found that urinary urea and cortisol levels were significantly elevated in mining workers following a 12 hour overnight shift. These levels failed to return to baseline over 24 h in the more active maintenance crew compared to truck drivers (operators) suggesting a lack of recovery between shifts. Use of a SELDI-TOF MS approach to detect novel exertion or injury markers revealed a spectral feature which was associated with workers in both work categories who were engaged in higher levels of physical activity. This feature was identified as the LG3 peptide, a C-terminal fragment of the anti-angiogenic/anti-tumourigenic protein endorepellin. This finding suggests that urinary LG3 peptide may be a biomarker of physical activity. It is also possible that the activity mediated release of LG3/endorepellin into the circulation may represent a biological mechanism for the known inverse association between physical activity and cancer risk/survival.	[Parker, Tony J.; Sampson, Dayle L.; Broszczak, Daniel; Chng, Yee L.; Carter, Shea L.; Leavesley, David I.; Upton, Zee] Queensland Univ Technol, Tissue Repair & Regenerat Program, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Parker, Tony J.; Sampson, Dayle L.; Chng, Yee L.; Carter, Shea L.; Parker, Anthony W.] Queensland Univ Technol, Workforce Hlth Innovat Program, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Parker, TJ (corresponding author), Queensland Univ Technol, Tissue Repair & Regenerat Program, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	a.parker@qut.edu.au	Upton, Zee/I-9777-2012; Leavesley, David/C-9532-2009; Upton, Zee/ABC-4642-2021; Broszczak, Daniel/S-1626-2016	Leavesley, David/0000-0002-1033-5459; Parker, Tony/0000-0002-5118-524X; Upton, Zee/0000-0002-9928-5864; Broszczak, Daniel/0000-0001-5147-4247; Parker, Anthony/0000-0003-1745-399X	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a National Health and Medical Research Council Partnerships in Injury; Injury Prevention and Control grant. http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball D, 1998, J BODYWORK MOVEMENT, P161; BAYNE EK, 1984, J CELL BIOL, V99, P1486, DOI 10.1083/jcb.99.4.1486; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Burdorf A, 1997, SCAND J WORK ENV HEA, V23, P243, DOI 10.5271/sjweh.217; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; Chang JW, 2008, PROTEOM CLIN APPL, V2, P23, DOI 10.1002/prca.200780049; Choi WJ, 2009, J OCCUP HEALTH, V51, P273, DOI 10.1539/joh.O8025; Chung IS, 2008, ORAL ONCOL, V44, P1118, DOI 10.1016/j.oraloncology.2008.01.017; Cieniewski-Bernard C, 2008, CLIN EXP PHARMACOL P, V35, P362, DOI 10.1111/j.1440-1681.2008.04878.x; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; CLARKSON PM, 1988, J APPL PHYSIOL, V65, P1, DOI 10.1152/jappl.1988.65.1.1; Cottin V, 1998, J ALLERGY CLIN IMMUN, V101, P116, DOI 10.1016/S0091-6749(98)70202-7; Courneya KS, 2009, PSYCHO-ONCOLOGY, V18, P337, DOI 10.1002/pon.1546; Derman W, 1997, J SPORT SCI, V15, P341, DOI 10.1080/026404197367353; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; DOHM GL, 1982, J APPL PHYSIOL, V52, P27, DOI 10.1152/jappl.1982.52.1.27; EBBELING CB, 1989, SPORTS MED, V7, P207, DOI 10.2165/00007256-198907040-00001; Eckstein F, 1999, ANAT EMBRYOL, V200, P419, DOI 10.1007/s004290050291; FUJIWARA S, 1992, INT ARCH OCC ENV HEA, V63, P409, DOI 10.1007/BF00386937; Garde AH, 2006, INT ARCH OCCUP ENV H; Garde AH, 2007, INT ARCH OCC ENV HEA, V80, P404, DOI 10.1007/s00420-006-0149-9; Gierach GL, 2009, INT J CANCER, V124, P2139, DOI 10.1002/ijc.24059; Gleeson Michael, 2002, J Sports Sci Med, V1, P31; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Goto Tomoko, 2007, Allergol Int, V56, P433, DOI 10.2332/allergolint.O-07-489; Gu Jian-Wei, 2004, BMC Physiol, V4, P2, DOI 10.1186/1472-6793-4-2; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hamer M, 2009, CANCER CAUSE CONTROL, V20, P225, DOI 10.1007/s10552-008-9237-3; Hartmann U, 2000, MED SCI SPORT EXER, V32, P209, DOI 10.1097/00005768-200001000-00031; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; Hennig J, 1998, ERGONOMICS, V41, P610, DOI 10.1080/001401398186784; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Lac G, 2004, PATHOL BIOL, V52, P43, DOI 10.1016/S0369-8114(03)00049-X; Lac G, 2000, J SPORT MED PHYS FIT, V40, P139; Langberg H, 2000, CALCIFIED TISSUE INT, V67, P41, DOI 10.1007/s00223001094; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Meilhac Olivier, 2007, Methods Mol Biol, V357, P331; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; MOTOHASHI Y, 1992, ERGONOMICS, V35, P1331, DOI 10.1080/00140139208967396; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NEWHAM DJ, 1987, J APPL PHYSIOL, V63, P1381, DOI 10.1152/jappl.1987.63.4.1381; Nyberg P, 2008, EXP CELL RES, V314, P3292, DOI 10.1016/j.yexcr.2008.08.011; O'Kane JW, 2006, OSTEOARTHR CARTILAGE, V14, P71, DOI 10.1016/j.joca.2005.08.003; Oda O, 1996, CLIN CHIM ACTA, V255, P119, DOI 10.1016/0009-8981(96)06395-4; Papale M, 2007, J CHROMATOGR B; Paulsen G, 2010, MED SCI SPORT EXER, V42, P75, DOI 10.1249/MSS.0b013e3181ac7adb; Petibois C, 2002, SPORTS MED, V32, P867, DOI 10.2165/00007256-200232130-00005; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Purvis D, 2010, PM&R, V2, P442, DOI 10.1016/j.pmrj.2010.03.025; Roelofsen H, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-2; Rosenberg HF, 2008, CURR PHARM BIOTECHNO, V9, P135, DOI 10.2174/138920108784567236; Rowbottom DG, 1997, MED SCI SPORT EXER, V29, P1233, DOI 10.1097/00005768-199709000-00017; Sevier TL, 2000, WORK, V15, P203; Sorichter S, 1999, EXERC IMMUNOL REV, V5, P5; Stevens AL, 2009, MOL CELL PROTEOMICS, V8, P1475, DOI 10.1074/mcp.M800181-MCP200; Stewart Ian B, 2008, J Occup Med Toxicol, V3, P22, DOI 10.1186/1745-6673-3-22; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; SUNDARRAJ N, 1995, J CELL SCI, V108, P2663; Suzuki K, 2003, MED SCI SPORT EXER, V35, P348, DOI 10.1249/01.MSS.0000048861.57899.04; Tolson J, 2004, LAB INVEST, V84, P845, DOI 10.1038/labinvest.3700097; Urhausen A, 2002, SPORTS MED, V32, P95, DOI 10.2165/00007256-200232020-00002; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171, DOI 10.5271/sjweh.720; Vanhoutte KJA, 2007, NEPHROL DIAL TRANSPL, V22, P2932, DOI 10.1093/ndt/gfm170; VIRU A, 1987, SPORTS MED, V4, P95, DOI 10.2165/00007256-198704020-00003; Vuadens F, 2003, PROTEOMICS, V3, P1521, DOI 10.1002/pmic.200300455; Ward DG, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-19; WESTACOTT CI, 1990, ANN RHEUM DIS, V49, P676, DOI 10.1136/ard.49.9.676; Wright GL, 1999, PROSTATE CANCER P D, V2, P264, DOI 10.1038/sj.pcan.4500384	69	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33714	10.1371/journal.pone.0033714	http://dx.doi.org/10.1371/journal.pone.0033714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457785	gold, Green Published			2022-12-27	WOS:000304046900021
J	Das, M; Sahoo, SK				Das, Manasi; Sahoo, Sanjeeb K.			Folate Decorated Dual Drug Loaded Nanoparticle: Role of Curcumin in Enhancing Therapeutic Potential of Nutlin-3a by Reversing Multidrug Resistance	PLOS ONE			English	Article							P-GLYCOPROTEIN ABCB1; CELL-CYCLE ARREST; CANCER-THERAPY; RETINOBLASTOMA CELLS; IN-VIVO; ANTAGONIST NUTLIN-3; PROTEIN-1 ABCC1; TURMERIC POWDER; P53 PATHWAY; APOPTOSIS	Retinoblastoma is the most common intraocular tumor in children. Malfunctioning of many signaling pathways regulating cell survival or apoptosis, make the disease more vulnerable. Notably, resistance to chemotherapy mediated by MRP-1, lung-resistance protein (LRP) is the most challenging aspect to treat this disease. Presently, much attention has been given to the recently developed anticancer drug nutlin-3a because of its non-genotoxic nature and potency to activate tumor suppressor protein p53. However, being a substrate of multidrug resistance protein MRP1 and Pgp its application has become limited. Currently, research has step towards reversing Multi drug resistance (MDR) by using curcumin, however its clinical relevance is restricted by plasma instability and poor bioavailability. In the present investigation we tried to encapsulate nutlin-3a and curcumin in PLGA nanoparticle (NPs) surface functionalized with folate to enhance therapeutic potential of nutlin-3a by modulating MDR. We document that curcumin can inhibit the expression of MRP-1 and LRP gene/protein in a concentration dependent manner in Y79 cells. In vitro cellular cytotoxicity, cell cycle analysis and apoptosis studies were done to compare the effectiveness of native drugs (single or combined) and single or dual drug loaded nanoparticles (unconjugated/folate conjugated). The result demonstrated an augmented therapeutic efficacy of targeted dual drug loaded NPs (Fol-Nut-Cur-NPs) over other formulation. Enhanced expression or down regulation of proapoptotic/antiapoptotic proteins respectively and down-regulation of bcl2 and NF kappa B gene/protein by Fol-Nut-Cur-NPs substantiate the above findings. This is the first investigation exploring the role of curcumin as MDR modulator to enhance the therapeutic potentiality of nutlin-3a, which may opens new direction for targeting cancer with multidrug resistance phenotype.	[Das, Manasi; Sahoo, Sanjeeb K.] Inst Life Sci, Bhubaneswar, Orissa, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Das, M (corresponding author), Inst Life Sci, Bhubaneswar, Orissa, India.	sanjeebsahoo2005@gmail.com	Sanjeeb, Sahoo/ABF-3419-2020					Acharya S, 2009, BIOMATERIALS, V30, P5737, DOI 10.1016/j.biomaterials.2009.07.008; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Anuchapreeda S, 2002, BIOCHEM PHARMACOL, V64, P573, DOI 10.1016/S0006-2952(02)01224-8; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Chearwae W, 2006, CANCER CHEMOTH PHARM, V57, P376, DOI 10.1007/s00280-005-0052-1; Chearwae W, 2004, BIOCHEM PHARMACOL, V68, P2043, DOI 10.1016/j.bcp.2004.07.009; Chearwae W, 2006, MOL CANCER THER, V5, P1995, DOI 10.1158/1535-7163.MCT-06-0087; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Das M, 2011, ACTA BIOMATER, V7, P355, DOI 10.1016/j.actbio.2010.08.010; Das M, 2009, EXPERT OPIN DRUG DEL, V6, P285, DOI 10.1517/17425240902780166; Dilnawaz F, 2010, BIOMATERIALS, V31, P3694, DOI 10.1016/j.biomaterials.2010.01.057; Drago-Ferrante R, 2008, INT J ONCOL, V33, P677, DOI 10.3892/ijo_00000053; Elison JR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1269, DOI 10.1001/archopht.124.9.1269; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Ganta S, 2009, MOL PHARMACEUT, V6, P928, DOI 10.1021/mp800240j; Greco F, 2009, ADV DRUG DELIVER REV, V61, P1203, DOI 10.1016/j.addr.2009.05.006; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gu L, 2008, LEUKEMIA, V22, P730, DOI 10.1038/leu.2008.11; HARPER JW, 1993, CELL, V75, P805; Hendig D, 2009, MOL CELL BIOCHEM, V328, P85, DOI 10.1007/s11010-009-0077-6; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Jain TK, 2008, BIOMATERIALS, V29, P4012, DOI 10.1016/j.biomaterials.2008.07.004; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; Kim BS, 2008, ARCH PHARM RES, V31, P1050, DOI 10.1007/s12272-001-1267-5; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kocbek P, 2007, J CONTROL RELEASE, V120, P18, DOI 10.1016/j.jconrel.2007.03.012; Krishnakumar S, 2004, BRIT J OPHTHALMOL, V88, P1521, DOI 10.1136/bjo.2004.047928; Lee DS, 2009, ANTICANCER RES, V29, P5039; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lim KJ, 2011, CANC BIOL THER, P11; Limtrakul P, 2007, MOL CELL BIOCHEM, V296, P85, DOI 10.1007/s11010-006-9302-8; Michaelis M, 2009, CANCER RES, V69, P416, DOI 10.1158/0008-5472.CAN-08-1856; Misra R, 2010, EUR J PHARM SCI, V39, P152, DOI 10.1016/j.ejps.2009.11.010; Miyachi M, 2009, CLIN CANCER RES, V15, P4077, DOI 10.1158/1078-0432.CCR-08-2955; Mohanty C, 2010, BIOMATERIALS, V31, P6597, DOI 10.1016/j.biomaterials.2010.04.062; Mohanty C, 2010, NANOMEDICINE-UK, V5, P433, DOI 10.2217/NNM.10.9; Park JS, 2006, J CONTROL RELEASE, V115, P37, DOI 10.1016/j.jconrel.2006.07.011; Parveen S, 2008, J DRUG TARGET, V16, P108, DOI [10.1080/10611860701794353, 10.1080/10611860701794353 ]; Parveen Suphiya, 2010, Cancer Nanotechnol, V1, P47, DOI 10.1007/s12645-010-0006-0; Patil Y, 2009, J CONTROL RELEASE, V136, P21, DOI 10.1016/j.jconrel.2009.01.021; Reddy MK, 2008, CIRC-CARDIOVASC INTE, V1, P209, DOI 10.1161/CIRCINTERVENTIONS.108.830018; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Rodriguez-Galindo C, 2008, PEDIATRICS, V122, pE763, DOI 10.1542/peds.2008-0518; Roy Madhumita, 2002, Asian Pac J Cancer Prev, V3, P61; Sahoo SK, 2005, MOL PHARMACEUT, V2, P373, DOI 10.1021/mp050032z; Sahoo SK, 2004, INT J CANCER, V112, P335, DOI 10.1002/ijc.20405; Sahoo SK, 2003, DRUG DISCOV TODAY, V8, P1112, DOI 10.1016/S1359-6446(03)02903-9; Sareen D, 2006, INVEST OPHTH VIS SCI, V47, P3708, DOI 10.1167/iovs.06-0119; Thiyagarajan S, 2009, CURR EYE RES, V34, P845, DOI 10.3109/02713680903125329; Tseng CL, 2007, BIOMATERIALS, V28, P3996, DOI 10.1016/j.biomaterials.2007.05.006; Vandana M, 2010, BIOMATERIALS, V31, P9340, DOI 10.1016/j.biomaterials.2010.08.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang YZ, 2007, INT J PHARM, V337, P63, DOI 10.1016/j.ijpharm.2006.12.033; Zhang ZP, 2007, BIOMATERIALS, V28, P1889, DOI 10.1016/j.biomaterials.2006.12.018; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	57	66	67	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e32920	10.1371/journal.pone.0032920	http://dx.doi.org/10.1371/journal.pone.0032920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470431	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100009
J	Liu, HJ; Wang, EQ; Metman, LV; Larson, CR				Liu, Hanjun; Wang, Emily Q.; Metman, Leo Verhagen; Larson, Charles R.			Vocal Responses to Perturbations in Voice Auditory Feedback in Individuals with Parkinson's Disease	PLOS ONE			English	Article							BASAL GANGLIA; PITCH FEEDBACK; SUSTAINED VOCALIZATION; LOUDNESS FEEDBACK; SHIFTED FEEDBACK; SPEECH VOLUME; MOTOR CONTROL; REFLEX; FREQUENCY; F-0	Background: One of the most common symptoms of speech deficits in individuals with Parkinson's disease (PD) is significantly reduced vocal loudness and pitch range. The present study investigated whether abnormal vocalizations in individuals with PD are related to sensory processing of voice auditory feedback. Perturbations in loudness or pitch of voice auditory feedback are known to elicit short latency, compensatory responses in voice amplitude or fundamental frequency. Methodology/Principal Findings: Twelve individuals with Parkinson's disease and 13 age- and sex-matched healthy control subjects sustained a vowel sound (/alpha/) and received unexpected, brief (200 ms) perturbations in voice loudness (+/- 3 or 6 dB) or pitch (+/- 100 cents) auditory feedback. Results showed that, while all subjects produced compensatory responses in their voice amplitude or fundamental frequency, individuals with PD exhibited larger response magnitudes than the control subjects. Furthermore, for loudness-shifted feedback, upward stimuli resulted in shorter response latencies than downward stimuli in the control subjects but not in individuals with PD. Conclusions/Significance: The larger response magnitudes in individuals with PD compared with the control subjects suggest that processing of voice auditory feedback is abnormal in PD. Although the precise mechanisms of the voice feedback processing are unknown, results of this study suggest that abnormal voice control in individuals with PD may be related to dysfunctional mechanisms of error detection or correction in sensory feedback processing.	[Liu, Hanjun] Sun Yat Sen Univ Guangzhou, Affiliated Hosp 1, Dept Rehabil Med, Guangzhou, Guangdong, Peoples R China; [Wang, Emily Q.] Rush Univ, Med Ctr, Dept Commun Disorders & Sci, Chicago, IL 60612 USA; [Wang, Emily Q.] Rush Univ, Med Ctr, Dept Otolaryngol, Chicago, IL 60612 USA; [Metman, Leo Verhagen] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Larson, Charles R.] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA	Sun Yat Sen University; Rush University; Rush University; Rush University; Northwestern University	Liu, HJ (corresponding author), Sun Yat Sen Univ Guangzhou, Affiliated Hosp 1, Dept Rehabil Med, Guangzhou, Guangdong, Peoples R China.	clarson@northwestern.edu		Liu, Hanjun/0000-0003-1466-4193; Wang, Emily/0000-0001-6020-6228	NIH [1RO1DC006243]; NSFC [30970965]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported by NIH Grant No. 1RO1DC006243 and NSFC grant No. 30970965. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN H, 1991, J NEUROL NEUROSUR PS, V54, P1093, DOI 10.1136/jnnp.54.12.1093; ADAMS SG, 1992, EUR J DISORDER COMM, V27, P121; Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Basso MA, 1996, J NEUROSCI, V16, P7318; Bauer JJ, 2006, J ACOUST SOC AM, V119, P2363, DOI 10.1121/1.2173513; Bauer JJ, 2003, J ACOUST SOC AM, V114, P1048, DOI 10.1121/1.1592161; Behroozmand R, 2009, CLIN NEUROPHYSIOL, V120, P1303, DOI 10.1016/j.clinph.2009.04.022; Belin P, 2002, NEUROPSYCHOLOGIA, V40, P1956, DOI 10.1016/S0028-3932(02)00062-3; BERGUI M, 1993, ACTA NEUROL SCAND, V88, P16; Boecker H, 1999, BRAIN, V122, P1651, DOI 10.1093/brain/122.9.1651; Boersma Paul, 2002, GLOT INT, V5, P341; Booth JR, 2007, BRAIN RES, V1133, P136, DOI 10.1016/j.brainres.2006.11.074; BROOKS DJ, 1995, J NEUROL SCI, V128, P1, DOI 10.1016/0022-510X(94)00206-4; Brown P, 1998, LANCET, V351, P1801, DOI 10.1016/S0140-6736(97)11225-9; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; CALIGIURI MP, 1987, EXP NEUROL, V98, P563, DOI 10.1016/0014-4886(87)90265-2; Chen SH, 2007, J ACOUST SOC AM, V121, P1157, DOI 10.1121/1.2404624; Chen ZC, 2010, J ACOUST SOC AM, V128, pEL355, DOI 10.1121/1.3509124; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; Demirci M, 1997, ANN NEUROL, V41, P781, DOI 10.1002/ana.410410614; Donath TM, 2002, J ACOUST SOC AM, V111, P357, DOI 10.1121/1.1424870; ELMAN JL, 1981, J ACOUST SOC AM, V70, P45, DOI 10.1121/1.386580; Fahn S., 1987, RECENT DEV PARK DIS, V2, P293; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; FILION M, 1988, BRAIN RES, V444, P165, DOI 10.1016/0006-8993(88)90924-9; Greenlee JDW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014744; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Hafke HZ, 2008, J ACOUST SOC AM, V123, P273, DOI 10.1121/1.2817357; Hain TC, 2000, EXP BRAIN RES, V130, P133, DOI 10.1007/s002219900237; Hammer MJ, 2010, EXP BRAIN RES, V201, P401, DOI 10.1007/s00221-009-2048-2; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Hawco CS, 2009, PSYCHOPHYSIOLOGY, V46, P1216, DOI 10.1111/j.1469-8986.2009.00875.x; Heinks-Maldonado TH, 2006, NEUROREPORT, V17, P1375, DOI 10.1097/01.wnr.0000233102.43526.e9; Ho AK, 1999, J NEUROL NEUROSUR PS, V67, P199, DOI 10.1136/jnnp.67.2.199; Ho AK, 1999, NEUROPSYCHOLOGIA, V37, P1453, DOI 10.1016/S0028-3932(99)00067-6; HO AT, 1977, PHONETICA, V34, P446, DOI 10.1159/000259916; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jobst EE, 1997, ARCH NEUROL-CHICAGO, V54, P450, DOI 10.1001/archneur.1997.00550160080020; Jones JA, 2002, J PHONETICS, V30, P303, DOI 10.1006/jpho.2001.0160; Kaji Ryuji, 2001, Journal of Medical Investigation, V48, P142; Kawahara H., 1994, Journal of the Acoustical Society of Japan (E), V15, P201, DOI 10.1250/ast.15.201; Kiran S, 2001, J SPEECH LANG HEAR R, V44, P975, DOI 10.1044/1092-4388(2001/076); LANE H, 1971, J SPEECH HEAR RES, V14, P677, DOI 10.1044/jshr.1404.677; Larson CR, 2008, EXP BRAIN RES, V187, P613, DOI 10.1007/s00221-008-1330-z; Larson CR, 2007, J ACOUST SOC AM, V121, P2862, DOI 10.1121/1.2715657; Lee R G, 1975, Can J Neurol Sci, V2, P285; Leyden J, 2008, MED HYPOTHESES, V71, P61, DOI 10.1016/j.mehy.2008.02.013; Liu HJ, 2007, J ACOUST SOC AM, V122, P3671, DOI 10.1121/1.2800254; Liu HJ, 2011, CLIN NEUROPHYSIOL, V122, P951, DOI 10.1016/j.clinph.2010.08.010; Liu HJ, 2009, J ACOUST SOC AM, V125, P2299, DOI 10.1121/1.3081523; LOGEMANN JA, 1978, J SPEECH HEAR DISORD, V43, P47, DOI 10.1044/jshd.4301.47; Markham CH, 1987, BASAL GANGLIA BEHAVI, P161; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Morita H, 2005, CLIN NEUROPHYSIOL, V116, P769, DOI 10.1016/j.clinph.2004.11.005; MUROFUSHI T, 1992, ORL J OTO-RHINO-LARY, V54, P255, DOI 10.1159/000276309; Natke U, 2001, J SPEECH LANG HEAR R, V44, P577, DOI 10.1044/1092-4388(2001/045); Neuhoff JG, 2002, J EXP PSYCHOL-APPL, V8, P17, DOI 10.1037//1076-898X.8.1.17; Praamstra P, 2001, J COGNITIVE NEUROSCI, V13, P31, DOI 10.1162/089892901564153; Quedas Araken, 2007, Rev. Bras. Otorrinolaringol., V73, P675, DOI 10.1590/S0034-72992007000500014; Rickards C, 1997, BRAIN, V120, P977, DOI 10.1093/brain/120.6.977; RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; SCHNEIDER JS, 1987, NEUROLOGY, V37, P951, DOI 10.1212/WNL.37.6.951; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seiss E, 2004, BRAIN, V127, P330, DOI 10.1093/brain/awh043; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Strafella AP, 2000, CLIN NEUROPHYSIOL, V111, P1198, DOI 10.1016/S1388-2457(00)00316-3; TATTON WG, 1984, CAN J NEUROL SCI, V11, P136, DOI 10.1017/S0317167100046291; TATTON WG, 1975, BRAIN RES, V100, P671, DOI 10.1016/0006-8993(75)90167-5; Teo C, 1997, MOVEMENT DISORD, V12, P655, DOI 10.1002/mds.870120506; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; von Holst E, 1954, BRIT J ANIM BEHAV, V2, P89, DOI DOI 10.1016/S0950-5601(54)80044-X; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Xu Y, 2004, J ACOUST SOC AM, V116, P1168, DOI 10.1121/1.1763952; Zarate JM, 2008, NEUROIMAGE, V40, P1871, DOI 10.1016/j.neuroimage.2008.01.026	77	51	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33629	10.1371/journal.pone.0033629	http://dx.doi.org/10.1371/journal.pone.0033629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YB	22448258	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700049
J	Thompson, AR; Watson, W; McClatchie, S; Weber, ED				Thompson, Andrew R.; Watson, William; McClatchie, Sam; Weber, Edward D.			Multi-Scale Sampling to Evaluate Assemblage Dynamics in an Oceanic Marine Reserve	PLOS ONE			English	Article							LARVAL FISH ASSEMBLAGES; LONG-TERM TRENDS; CALIFORNIA CURRENT; SPATIAL-ANALYSIS; ICHTHYOPLANKTON ASSEMBLAGES; COMMUNITY STRUCTURE; ECOLOGICAL DATA; VARIABILITY; ABUNDANCE; SCALE	To resolve the capacity of Marine Protected Areas (MPA) to enhance fish productivity it is first necessary to understand how environmental conditions affect the distribution and abundance of fishes independent of potential reserve effects. Baseline fish production was examined from 2002-2004 through ichthyoplankton sampling in a large (10,878 km(2)) Southern Californian oceanic marine reserve, the Cowcod Conservation Area (CCA) that was established in 2001, and the Southern California Bight as a whole (238,000 km(2) CalCOFI sampling domain). The CCA assemblage changed through time as the importance of oceanic-pelagic species decreased between 2002 (La Nina) and 2003 (El Nino) and then increased in 2004 (El Nino), while oceanic species and rockfishes displayed the opposite pattern. By contrast, the CalCOFI assemblage was relatively stable through time. Depth, temperature, and zooplankton explained more of the variability in assemblage structure at the CalCOFI scale than they did at the CCA scale. CalCOFI sampling revealed that oceanic species impinged upon the CCA between 2002 and 2003 in association with warmer offshore waters, thus explaining the increased influence of these species in the CCA during the El Nino years. Multi-scale, spatially explicit sampling and analysis was necessary to interpret assemblage dynamics in the CCA and likely will be needed to evaluate other focal oceanic marine reserves throughout the world.	[Thompson, Andrew R.; Watson, William; McClatchie, Sam; Weber, Edward D.] NOAA, Fisheries Resources Div, SW Fisheries Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Thompson, AR (corresponding author), NOAA, Fisheries Resources Div, SW Fisheries Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA.	andrew.thompson@noaa.gov	Weber, Edward D/A-6986-2009	Weber, Edward D/0000-0002-0942-434X	National Marine Fisheries Service	National Marine Fisheries Service	This research was funded by the National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany F, 2006, J PLANKTON RES, V28, P473, DOI 10.1093/plankt/fbi123; Auth TD, 2008, FISH OCEANOGR, V17, P316, DOI 10.1111/j.1365-2419.2008.00481.x; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Boeing WJ, 2008, ECOL INDIC, V8, P292, DOI 10.1016/j.ecolind.2007.03.002; Bograd SJ, 2003, DEEP-SEA RES PT II, V50, P2355, DOI 10.1016/S0967-0645(03)00131-0; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Brodeur RD, 2008, MAR ECOL PROG SER, V366, P187, DOI 10.3354/meps07539; Butler JL, 2003, FISH B-NOAA, V101, P260; Catalan IA, 2006, DEEP-SEA RES PT II, V53, P1377, DOI 10.1016/j.dsr2.2006.04.010; COWEN RK, 1993, B MAR SCI, V53, P567; de Knegt HJ, 2010, ECOLOGY, V91, P2455, DOI 10.1890/09-1359.1; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Govoni JJ, 2005, SCI MAR, V69, P125, DOI 10.3989/scimar.2005.69s1125; Hewitt RP, 1988, CAL COOP OCEAN FISH, V22, P111; Hooff RC, 2006, LIMNOL OCEANOGR, V51, P2607, DOI 10.4319/lo.2006.51.6.2607; Hsieh CH, 2005, PROG OCEANOGR, V67, P160, DOI 10.1016/j.pocean.2005.05.002; Hsieh CH, 2009, GLOBAL CHANGE BIOL, V15, P2137, DOI 10.1111/j.1365-2486.2009.01875.x; HUNTER JR, 1993, B MAR SCI, V53, P723; JAHN AE, 1986, MAR ECOL PROG SER, V31, P223, DOI 10.3354/meps031223; Koslow JA, 2011, MAR ECOL PROG SER, V436, P207, DOI 10.3354/meps09270; Kramer D., 1972, NOAA TECHNICAL REPOR; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; McClatchie S, 2011, DEEP SEA 1 IN PRESS; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Moser HG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P269; MOSER H G, 1987, California Cooperative Oceanic Fisheries Investigations Reports, V28, P97; MOSER HG, 1993, B MAR SCI, V53, P645; Moser HG, 2000, CAL COOP OCEAN FISH, V41, P132; Nishimoto MM, 2002, MAR ECOL PROG SER, V241, P183, DOI 10.3354/meps241183; Norcross BL, 2003, J OCEANOGR, V59, P445, DOI 10.1023/A:1025588515653; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Ralston S, 2010, CAN J FISH AQUAT SCI, V67, P1005, DOI 10.1139/F10-039; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Richardson DE, 2010, PROG OCEANOGR, V86, P8, DOI 10.1016/j.pocean.2010.04.005; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Roussel E, 2010, J PLANKTON RES, V32, P1443, DOI 10.1093/plankt/fbq056; Sanvicente-Anorve L, 2000, ESTUAR COAST SHELF S, V51, P463, DOI 10.1006/ecss.2000.0692; Smith PE, 2003, DEEP-SEA RES PT II, V50, P2519, DOI 10.1016/S0967-0645(03)00133-4; Smith PE, 1977, FAO FISHERY TECHNICA; Song H, 2011, J GEOPHYS R IN PRESS; Vilchis LI, 2009, DEEP-SEA RES PT I, V56, P125, DOI 10.1016/j.dsr.2008.08.004; Wagner HH, 2005, ECOLOGY, V86, P1975, DOI 10.1890/04-0914	47	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33131	10.1371/journal.pone.0033131	http://dx.doi.org/10.1371/journal.pone.0033131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448236	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700026
J	Wang, N; Geng, LL; Zhang, SC; He, B; Wang, JD				Wang, Ning; Geng, Linlin; Zhang, Shucheng; He, Bin; Wang, Jiedong			Expression of PRB, FKBP52 and HB-EGF Relating with Ultrasonic Evaluation of Endometrial Receptivity	PLOS ONE			English	Article							LOCAL INJURY; IMMUNOPHILIN FKBP52; UTERINE RECEPTIVITY; IMPLANTATION; FERTILIZATION; RECEPTORS; CHAPERONE; MICE	Background: To explore the molecular basis of the different ultrasonic patterns of the human endometrium, and the molecular marker basis of local injury. Methodology/Principal Findings: The mRNA and protein expression of FKBP52, progesterone receptor A (PRA), progesterone receptor B (PRB), and HB-EGF were detected in different patterns of the endometrium by real-time RTPCR and immunohistochemistry. There were differences in the mRNA and protein expression of FKBP52, PRB, and HB-EGF in the triple line (Pattern A) and homogeneous (Pattern C) endometrium in the window of implantation. No difference was detected in PRA expression. After local injury, the mRNA expression of HB-EGF significantly increased. In contrast, there was no difference in the mRNA expression of FKBP52, PRB, or PRA. The protein expression of FKBP52, PRB, and HB-EGF increased after local injury. There was no difference in the PRA expression after local injury. Conclusions: PRB, FKBP52, and HB-EGF may be the molecular basis for the classification of the ultrasonic patterns. HB-EGF may be the molecular basis of local injury. Ultrasonic evaluation on the day of ovulation can be effective in predicting the outcome of implantation.	[Wang, Ning; Geng, Linlin; Zhang, Shucheng; He, Bin; Wang, Jiedong] Natl Res Inst Family Planning, Beijing, Peoples R China	National Research Institute for Family Planning - China	Wang, N (corresponding author), Natl Res Inst Family Planning, Beijing, Peoples R China.	nrifpcb-wjd@yahoo.com.cn			Fundamental Research Funds for the Central Institutes [2009GJSSJKb06]	Fundamental Research Funds for the Central Institutes	This work was supported by Fundamental Research Funds for the Central Institutes (No. 2009GJSSJKb06). The funders had no role in study design, data collection and analysis, decision to publich, or preparation of the manuscript.	Almog B, 2010, FERTIL STERIL, V94, P2026, DOI 10.1016/j.fertnstert.2009.12.075; Anckaert E, 2002, CLIN CHEM LAB MED, V40, P824, DOI 10.1515/CCLM.2002.143; Barash A, 2003, FERTIL STERIL, V79, P1317, DOI 10.1016/S0015-0282(03)00345-5; Brugger N, 2011, REPROD DOMEST ANIM, V46, P870, DOI 10.1111/j.1439-0531.2011.01757.x; Campbell KL, 2006, PAEDIATR PERINAT EP, V20, P13, DOI 10.1111/j.1365-3016.2006.00766.x; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; Gnainsky Y, 2010, FERTIL STERIL, V94, P2030, DOI 10.1016/j.fertnstert.2010.02.022; GONEN Y, 1990, J IN VITRO FERTIL EM, V7, P146, DOI 10.1007/BF01135678; Haouzi D, 2009, HUM REPROD, V24, P1436, DOI 10.1093/humrep/dep039; Jackson KS, 2007, REPROD SCI, V14, P137, DOI 10.1177/1933719106298409; Jessmon P, 2009, MOL REPROD DEV, V76, P1116, DOI 10.1002/mrd.21066; Karimzadeh MA, 2009, AUST NZ J OBSTET GYN, V49, P677, DOI 10.1111/j.1479-828X.2009.01076.x; Killick SR, 2007, REPROD BIOMED ONLINE, V15, P63, DOI 10.1016/S1472-6483(10)60693-1; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Mulac-Jericevic B, 2005, E SCHERING RES FDN W, V52, P19; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Reddy VRK, 2001, AM J REPROD IMMUNOL, V46, P188, DOI 10.1034/j.1600-0897.2001.d01-2.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shufaro Y, 2008, J ASSIST REPROD GEN, V25, P421, DOI 10.1007/s10815-008-9245-y; Simon C, 2001, ANN NY ACAD SCI, V943, P1; Tanaka M, 2003, AM J PATHOL, V163, P295, DOI 10.1016/S0002-9440(10)63653-X; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Tranguch S, 2006, REPROD BIOMED ONLINE, V13, P651, DOI 10.1016/S1472-6483(10)60655-4; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104	25	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e34010	10.1371/journal.pone.0034010	http://dx.doi.org/10.1371/journal.pone.0034010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448285	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700076
J	Fu, AQ; Genereux, DP; Stoger, R; Burden, AF; Laird, CD; Stephens, M				Fu, Audrey Q.; Genereux, Diane P.; Stoeger, Reinhard; Burden, Alice F.; Laird, Charles D.; Stephens, Matthew			Statistical Inference of In Vivo Properties of Human DNA Methyltransferases from Double-Stranded Methylation Patterns	PLOS ONE			English	Article							HAIRPIN-BISULFITE PCR; ENZYMATIC-PROPERTIES; DNMT1; PROMOTER; SITES; MOUSE; REPLICATION; PROCESSIVITY; SPECIFICITY; CLONING	DNA methyltransferases establish methylation patterns in cells and transmit these patterns over cell generations, thereby influencing each cell's epigenetic states. Three primary DNA methyltransferases have been identified in mammals: DNMT1, DNMT3A and DNMT3B. Extensive in vitro studies have investigated key properties of these enzymes, namely their substrate specificity and processivity. Here we study these properties in vivo, by applying novel statistical analysis methods to double-stranded DNA methylation patterns collected using hairpin-bisulfite PCR. Our analysis fits a novel Hidden Markov Model (HMM) to the observed data, allowing for potential bisulfite conversion errors, and yields statistical estimates of parameters that quantify enzyme processivity and substrate specificity. We apply this model to methylation patterns established in vivo at three loci in humans: two densely methylated inactive X (Xi)-linked loci (FMR1 and G6PD), and an autosomal locus (LEP), where methylation densities are tissue-specific but moderate. We find strong evidence for a high level of processivity of DNMT1 at FMR1 and G6PD, with the mean association tract length being a few hundred base pairs. Regardless of tissue types, methylation patterns at LEP are dominated by DNMT1 maintenance events, similar to the two Xi-linked loci, but are insufficiently informative regarding processivity to draw any conclusions about processivity at that locus. At all three loci we find that DNMT1 shows a strong preference for adding methyl groups to hemi-methylated CpG sites over unmethylated sites. The data at all three loci also suggest low (possibly 0) association of the de novo methyltransferases, the DNMT3s, and are consequently uninformative about processivity or preference of these enzymes. We also extend our HMM to reanalyze published data on mouse DNMT1 activities in vitro. The results suggest shorter association tracts (and hence weaker processivity), and much longer non-association tracts than human DNMT1 in vivo.	[Fu, Audrey Q.; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Genereux, Diane P.; Burden, Alice F.; Laird, Charles D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Fu, Audrey Q.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge Syst Biol Ctr, Cambridge, England	University of Chicago; University of Washington; University of Washington Seattle; University of Chicago; University of Chicago; University of Cambridge	Fu, AQ (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	audreyqyfu@uchicago.edu		Stoger, Reinhard/0000-0002-2301-0805; Genereux, Diane/0000-0001-5770-0989; Fu, Audrey/0000-0002-3479-5652	National Institutes of Health [HD002274, GM077464]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health Grants HD002274 and GM077464 to C. D. L. (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber W, 1974, PROG NUCL ACID RES M, V23, P185; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Burden AF, 2005, J BIOL CHEM, V280, P14413, DOI 10.1074/jbc.M413836200; Durbin R., 1998, BIOL SEQUENCE ANAL P; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fu AQ, 2008, THESIS U WASHINGTON; Fu AQ, 2010, ANN APPL STAT, V4, P871, DOI 10.1214/09-AOAS297; Genereux DP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn691; Genereux DP, 2005, P NATL ACAD SCI USA, V102, P5802, DOI 10.1073/pnas.0502036102; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Jeltsch A, 2006, EPIGENETICS-US, V1, P63, DOI 10.4161/epi.1.2.2767; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Jurkowska RZ, 2008, NUCLEIC ACIDS RES, V36, P6656, DOI 10.1093/nar/gkn747; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kornberg A, 2005, DNA REPLICATION, P101; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu JS, 2004, MONTE CARLO STRATEGI, P105; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miner BE, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh132; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Rajavelu A, 2011, FUNCTION DISRUPTION, DOI [10.1093/nar/gkr753, DOI 10.1093/NAR/GKR753]; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; SMITH SS, 1987, NUCLEIC ACIDS RES, V15, P6899, DOI 10.1093/nar/15.17.6899; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Stoger R, 2006, EPIGENETICS-US, V1, P155; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200	39	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32225	10.1371/journal.pone.0032225	http://dx.doi.org/10.1371/journal.pone.0032225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442664	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500007
J	Meng, ZW; Lou, SS; Tan, J; Xu, K; Jia, Q; Zheng, W				Meng, Zhaowei; Lou, Shanshan; Tan, Jian; Xu, Ke; Jia, Qiang; Zheng, Wei			Nuclear Factor-Kappa B Inhibition Can Enhance Apoptosis of Differentiated Thyroid Cancer Cells Induced by I-131	PLOS ONE			English	Article							IN-VITRO; CARCINOMA; DEHYDROXYMETHYLEPOXYQUINOMICIN; PROGRESSION; BORTEZOMIB; THERAPIES; TARGET; LINE; RNA	Objective: To evaluate changes of nuclear factor-kappa B (NF-kappa B) during radioiodine 131(I-131) therapy and whether NF-kappa B inhibition could enhance I-131-induced apoptosis in differentiated thyroid cancer (DTC) cells in a synergistic manner. Methods: Three human DTC cell lines were used. NF-kappa B inhibition was achieved by using a NF-kappa B inhibitor (Bay 11-7082) or by p65 siRNA transfection. Methyl-thiazolyl-tetrazolium assay was performed for cell viability assessment. DNA-binding assay, luciferase reporter assay, and Western blot were adopted to determine function and expression changes of NF-kappa B. Then NF-kappa B regulated anti-apoptotic factors XIAP, cIAP1, and Bcl-xL were measured. Apoptosis was analyzed by Western blot for caspase 3 and PARP, and by flow cytometry as well. An iodide uptake assay was performed to determine whether NF-kappa B inhibition could influence radioactive iodide uptake. Results: The methyl-thiazolyl-tetrazolium assay showed significant decrease of viable cells by combination therapy than by mono-therapies. The DNA-binding assay and luciferase reporter assay showed enhanced NF-kappa B function and reporter gene activities due to I-131, yet significant suppression was achieved by NF-kappa B inhibition. Western blot proved I-131 could increase nuclear NF-kappa B concentration, while NF-kappa B inhibition reduced NF-kappa B concentration. Western blot also demonstrated significant up-regulation of XIAP, cIAP1, and Bcl-xL after I-131 therapy. And inhibition of NF-kappa B could significantly down-regulate these factors. Finally, synergism induced by combined therapy was displayed by significant enhancements of cleaved caspase 3 and PARP from Western blot, and of Annexin V positively staining from flow cytometry. The iodine uptake assay did not show significant changes when NF-kappa B was inhibited. Conclusion: We demonstrated that I-131 could induce NF-kappa B activation, which would attenuate I-131 efficacy in DTC cells. NF-kappa B inhibition by Bay 11-7082 or by p65 siRNA transfection was effective in suppressing NF-kappa B regulated anti-apoptotic changes and in combined regimen apoptosis was achieved synergistically.	[Meng, Zhaowei; Lou, Shanshan; Tan, Jian; Jia, Qiang; Zheng, Wei] Tianjin Med Univ, Gen Hosp, Dept Nucl Med, Tianjin, Peoples R China; [Lou, Shanshan] Tianjin Normal Univ, Tianjin, Peoples R China; [Xu, Ke] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Normal University; Tianjin Medical University	Meng, ZW (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Nucl Med, Tianjin, Peoples R China.	james_mencius@hotmail.com	Meng, Zhaowei/AAE-4732-2022; Zheng, Wei/AAB-4413-2021	Zheng, Wei/0000-0003-1206-9243; Migliaccio, Antimo/0000-0002-4197-2055	China National Natural Science Foundation [30900376]; Tianjin Science and Technology Committee Foundation [10JCZDJC19000]; Tianjin Medical University [2008KY20]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Committee Foundation; Tianjin Medical University	This investigation was supported by China National Natural Science Foundation grant 30900376, Key Project of Tianjin Science and Technology Committee Foundation grant 10JCZDJC19000, Tianjin Medical University Scientific Research grant 2008KY20, and Tianjin Medical University New Century Excellent Talent Program (awarded to ZM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Duan JM, 2007, MOL CANCER THER, V6, P37, DOI 10.1158/1535-7163.MCT-05-0285; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Eustatia-Rutten CFA, 2006, J CLIN ENDOCR METAB, V91, P313, DOI 10.1210/jc.2005-1322; Ganti AK, 2006, REV RECENT CLIN TRIA, V1, P133, DOI 10.2174/157488706776876526; Guo J, 2004, CLIN CANCER RES, V10, P3333, DOI 10.1158/1078-0432.CCR-03-0366; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Marx K, 2006, NUCL MED COMMUN, V27, P353, DOI 10.1097/01.mnm.0000199475.08407.e2; Meng ZW, 2008, ENDOCRINOLOGY, V149, P5357, DOI 10.1210/en.2008-0279; Mitsiades CS, 2006, J CLIN ENDOCR METAB, V91, P4013, DOI 10.1210/jc.2005-2472; Namba H, 2007, ARQ BRAS ENDOCRINOL, V51, P843, DOI 10.1590/S0004-27302007000500023; O'Neill CJ, 2010, ONCOLOGIST, V15, P146, DOI 10.1634/theoncologist.2009-0190; Pacifico F, 2004, J BIOL CHEM, V279, P54610, DOI 10.1074/jbc.M403492200; Pacifico F, 2010, MOL CELL ENDOCRINOL, V321, P29, DOI 10.1016/j.mce.2009.10.010; Palona I, 2006, ENDOCRINOLOGY, V147, P5699, DOI 10.1210/en.2006-0400; Pfister DG, 2008, J CLIN ONCOL, V26, P4701, DOI 10.1200/JCO.2008.17.3682; Starenki D, 2004, J CLIN ENDOCR METAB, V89, P410, DOI 10.1210/jc.2003-031216; Starenki DV, 2004, CLIN CANCER RES, V10, P6821, DOI 10.1158/1078-0432.CCR-04-0463; Tan J, 2009, CLIN NUCL MED, V34, P615, DOI 10.1097/RLU.0b013e3181b06b2d; Visconti R, 1997, ONCOGENE, V15, P1987, DOI 10.1038/sj.onc.1201373; Wang CM, 2012, MOL CELL BIOCHEM, V359, P125, DOI 10.1007/s11010-011-1006-z; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Woyach JA, 2009, ENDOCR-RELAT CANCER, V16, P715, DOI 10.1677/ERC-08-0335; Wu W, 2010, TUMOR BIOL, V31, P605, DOI 10.1007/s13277-010-0076-y; Wu XA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-269	27	34	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33597	10.1371/journal.pone.0033597	http://dx.doi.org/10.1371/journal.pone.0033597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438958	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100066
J	Shivalkar, M; Giniger, E				Shivalkar, Madhuri; Giniger, Edward			Control of Dendritic Morphogenesis by Trio in Drosophila melanogaster	PLOS ONE			English	Article							ABL TYROSINE KINASE; SENSORY NEURONS; AXON GROWTH; RAC GTPASES; GEF TRIO; MECHANISMS; GUIDANCE; ABELSON; PROTEIN; DOMAIN	Abl tyrosine kinase and its effectors among the Rho family of GTPases each act to control dendritic morphogenesis in Drosophila. It has not been established, however, which of the many GTPase regulators in the cell link these signaling molecules in the dendrite. In axons, the bifunctional guanine exchange factor, Trio, is an essential link between the Abl tyrosine kinase signaling pathway and Rho GTPases, particularly Rac, allowing these systems to act coordinately to control actin organization. In dendritic morphogenesis, however, Abl and Rac have contrary rather than reinforcing effects, raising the question of whether Trio is involved, and if so, whether it acts through Rac, Rho or both. We now find that Trio is expressed in sensory neurons of the Drosophila embryo and regulates their dendritic arborization. trio mutants display a reduction in dendritic branching and increase in average branch length, whereas over-expression of trio has the opposite effect. We further show that it is the Rac GEF domain of Trio, and not its Rho GEF domain that is primarily responsible for the dendritic function of Trio. Thus, Trio shapes the complexity of dendritic arbors and does so in a way that mimics the effects of its target, Rac.	[Shivalkar, Madhuri; Giniger, Edward] Natl Inst Neurol Disorders & Stroke, Axon Guidance & Neural Connect Unit, Basic Neurosci Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Shivalkar, M (corresponding author), Natl Inst Neurol Disorders & Stroke, Axon Guidance & Neural Connect Unit, Basic Neurosci Program, NIH, Bethesda, MD 20892 USA.	ginigere@ninds.nih.gov	Giniger, Edward/C-1764-2015	Giniger, Edward/0000-0002-8340-6158	NINDS, NIH [Z01 NS003013]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003013, Z01NS003013] Funding Source: NIH RePORTER	NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the NINDS, NIH (Z01 NS003013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dimitrova S, 2008, DEV BIOL, V324, P18, DOI 10.1016/j.ydbio.2008.08.028; Dorsten JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009822; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Giniger E, 2002, DIFFERENTIATION, V70, P385, DOI 10.1046/j.1432-0436.2002.700801.x; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hattori Y, 2007, GENES CELLS, V12, P1011, DOI 10.1111/j.1365-2443.2007.01107.x; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Krause M, 2002, J CELL SCI, V115, P4721, DOI 10.1242/jcs.00218; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li WJ, 2005, DEV DYNAM, V234, P512, DOI 10.1002/dvdy.20496; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Moore AW, 2008, CELL ADHES MIGR, V2, P81, DOI 10.4161/cam.2.2.6395; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Singh J, 2010, ONCOGENE, V29, P4033, DOI 10.1038/onc.2010.155; Song JK, 2011, DEV DYNAM, V240, P324, DOI 10.1002/dvdy.22525; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Sugimura K, 2003, J NEUROSCI, V23, P3752; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132	38	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33737	10.1371/journal.pone.0033737	http://dx.doi.org/10.1371/journal.pone.0033737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438988	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309000037
J	Segklia, A; Seuntjens, E; Elkouris, M; Tsalavos, S; Stappers, E; Mitsiadis, TA; Huylebroeck, D; Remboutsika, E; Graf, D				Segklia, Aikaterini; Seuntjens, Eve; Elkouris, Maximilianos; Tsalavos, Sotiris; Stappers, Elke; Mitsiadis, Thimios A.; Huylebroeck, Danny; Remboutsika, Eumorphia; Graf, Daniel			Bmp7 Regulates the Survival, Proliferation, and Neurogenic Properties of Neural Progenitor Cells during Corticogenesis in the Mouse	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; RADIAL GLIA DIFFERENTIATION; CEREBRAL-CORTEX; NEURONS; EXPRESSION; BRAIN; MICE; STEM; GENERATION; MENINGES	Bone morphogenetic proteins (BMPs) are considered important regulators of neural development. However, results mainly from a wide set of in vitro gain-of-function experiments are conflicting since these show that BMPs can act either as inhibitors or promoters of neurogenesis. Here, we report a specific and non-redundant role for BMP7 in cortical neurogenesis in vivo using knockout mice. Bmp7 is produced in regions adjacent to the developing cortex; the hem, meninges, and choroid plexus, and can be detected in the cerebrospinal fluid. Bmp7 deletion results in reduced cortical thickening, impaired neurogenesis, and loss of radial glia attachment to the meninges. Subsequent in vitro analyses of E14.5 cortical cells revealed that lack of Bmp7 affects neural progenitor cells, evidenced by their reduced proliferation, survival and self-renewal capacity. Addition of BMP7 was able to rescue these proliferation and survival defects. In addition, at the developmental stage E14.5 Bmp7 was also required to maintain Ngn2 expression in the subventricular zone. These data demonstrate a novel role for Bmp7 in the embryonic mouse cortex: Bmp7 nurtures radial glia cells and regulates fundamental properties of neural progenitor cells that subsequently affect Ngn2-dependent neurogenesis.	[Segklia, Aikaterini; Tsalavos, Sotiris] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari, Hellas, Greece; [Seuntjens, Eve; Stappers, Elke; Huylebroeck, Danny] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Biol Celgen, Louvain, Belgium; [Seuntjens, Eve; Stappers, Elke; Huylebroeck, Danny] Katholieke Univ Leuven, VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Elkouris, Maximilianos; Remboutsika, Eumorphia] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Vari, Hellas, Greece; [Mitsiadis, Thimios A.; Graf, Daniel] Univ Zurich, Inst Oral Biol, Fac Med, Zurich, Switzerland	Alexander Fleming Biomedical Sciences Research Center; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Alexander Fleming Biomedical Sciences Research Center; University of Geneva; University of Zurich	Segklia, A (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari, Hellas, Greece.	remboutsika@fleming.gr; daniel.graf@zzm.uzh.ch	Mitsiadis, Thimios/B-5564-2016; Seuntjens, Eve/AAM-2478-2021; Graf, Daniel/H-1214-2011; Remboutsika, Eumorphia/L-2718-2019	Mitsiadis, Thimios/0000-0002-9812-9982; Graf, Daniel/0000-0003-1163-8117; Remboutsika, Eumorphia/0000-0002-1243-9569; Seuntjens, Eve/0000-0002-0126-461X; Huylebroeck, Danny/0000-0003-4862-1079	Greek Ministry of Development [PENED384-2005]; University of Zurich; Research Council of K.U.Leuven [GOA-11/012]; FWO-V [G.0954.11N]; Queen Elisabeth Medical Foundation [GSKE 1113]; InfraMouse by the Hercules Foundation	Greek Ministry of Development; University of Zurich; Research Council of K.U.Leuven(KU Leuven); FWO-V(FWO); Queen Elisabeth Medical Foundation; InfraMouse by the Hercules Foundation	This work was supported by the Greek Ministry of Development (PENED384-2005, to D. Graf and E. Remboutsika) and funds from the University of Zurich (to D. Graf) and the Research Council of K.U.Leuven (GOA-11/012 to D. Huylebroeck), FWO-V (project G.0954.11N to D. Huylebroeck and E. Seuntjens), the Queen Elisabeth Medical Foundation (GSKE 1113 to D. Huylebroeck), and the type 3 large-infrastructure support InfraMouse by the Hercules Foundation (to D. Huylebroeck). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2007, REV NEUROSCIENCE, V18, P311; Ortega JA, 2010, CEREB CORTEX, V20, P2132, DOI 10.1093/cercor/bhp275; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; BAYER SA, 1991, NEUROSCIENCE, V45, P391, DOI 10.1016/0306-4522(91)90236-H; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Cox S, 2004, BRAIN RES, V1010, P55, DOI 10.1016/j.brainres.2004.02.068; Creuzet SE, 2006, P NATL ACAD SCI USA, V103, P14033, DOI 10.1073/pnas.0605899103; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Elkouris M, 2011, STEM CELLS; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Fode C, 2000, GENE DEV, V14, P67; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Godin RE, 1998, DEVELOPMENT, V125, P3473; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; Hebert JM, 2003, GENESIS, V35, P214, DOI 10.1002/gene.10183; Hutton SR, 2011, DEV BIOL, V352, P40, DOI 10.1016/j.ydbio.2011.01.015; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Kolk SM, 2006, MOL CELL NEUROSCI, V32, P199, DOI 10.1016/j.mcn.2006.01.016; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Li YX, 1998, J NEUROSCI, V18, P10231; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Ota M, 2006, DEV DYNAM, V235, P646, DOI 10.1002/dvdy.20673; Park D, 2009, BIOCHEM BIOPH RES CO, V382, P588, DOI 10.1016/j.bbrc.2009.03.074; PERIDES G, 1995, NEUROSCI LETT, V187, P21, DOI 10.1016/0304-3940(95)11327-S; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; Remboutsika E, 2011, FRONTIERS PHYSL, V2, P1; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Yabe T, 2002, J NEUROSCI RES, V68, P161, DOI 10.1002/jnr.10210; Yanagisawa M, 2001, NEUROSCI RES, V41, P391, DOI 10.1016/S0168-0102(01)00297-8; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz	55	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34088	10.1371/journal.pone.0034088	http://dx.doi.org/10.1371/journal.pone.0034088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461901	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900019
J	Fleming, JM; Ginsburg, E; Goldhar, AS; Plant, J; Vonderhaar, BK				Fleming, Jodie M.; Ginsburg, Erika; Goldhar, Anita S.; Plant, Joshua; Vonderhaar, Barbara K.			Progesterone Receptor Activates Msx2 Expression by Downregulating TNAP/Akp2 and Activating the Bmp Pathway in EpH4 Mouse Mammary Epithelial Cells	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; BREAST-CANCER CELLS; MESENCHYMAL TRANSITION; GLAND; ESTROGEN; GROWTH; PROLIFERATION; ALK2; TRANSFORMATION; METASTASIS	Previously we demonstrated that EpH4 mouse mammary epithelial cells induced the homeobox transcription factor Msx2 either when transfected with the progesterone receptor (PR) or when treated with Bmp2/4. Msx2 upregulation was unaffected by Wnt inhibitors s-FRP or Dkk1, but was inhibited by the Bmp antagonist Noggin. We therefore hypothesized that PR signaling to Msx2 acts through the Bmp receptor pathway. Herein, we confirm that transcripts for Alk2/ActR1A, a non-canonical BmpR Type I, are upregulated in mammary epithelial cells overexpressing PR (EpH4-PR). Increased phosphorylation of Smads 1,5, 8, known substrates for Alk2 and other BmpR Type I proteins, was observed as was their translocation to the nucleus in EpH4-PR cells. Analysis also showed that Tissue Non-Specific Alkaline Phosphatase (TNAP/Akp2) was also found to be downregulated in EpH4-PR cells. When an Akp2 promoter-reporter construct containing a 1/2PRE site was transfected into EpH4-PR cells, its expression was downregulated. Moreover, siRNA mediated knockdown of Akp2 increased both Alk2 and Msx2 expression. Collectively these data suggest that PR inhibition of Akp2 results in increased Alk2 activity, increased phosphorylation of Smads 1,5,8, and ultimately upregulation of Msx2. These studies imply that reactivation of the Akp2 gene could be helpful in downregulating aberrant Msx2 expression in PR+ breast cancers.	[Fleming, Jodie M.; Ginsburg, Erika; Goldhar, Anita S.; Plant, Joshua; Vonderhaar, Barbara K.] NCI, Mammary Biol & Tumorigenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Fleming, Jodie M.] N Carolina Cent Univ, Dept Biol, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; North Carolina Central University	Fleming, JM (corresponding author), NCI, Mammary Biol & Tumorigenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	ginsbure@mail.nih.gov		Fleming, Jodie/0000-0003-0297-5197	NATIONAL CANCER INSTITUTE [SC2CA176585] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn K, 2001, DEVELOPMENT, V128, P4449; Aupperlee MD, 2007, ENDOCRINOLOGY, V148, P2290, DOI 10.1210/en.2006-1721; Badtke M, 2012, BREAST CANCER RES TR, V131, P75, DOI 10.1007/s10549-011-1399-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brisken C, 2000, GENE DEV, V14, P650; Carnevale RP, 2007, MOL ENDOCRINOL, V21, P1335, DOI 10.1210/me.2006-0304; Craft CS, 2007, ONCOGENE, V26, P7240, DOI 10.1038/sj.onc.1210533; de la Pena LS, 2005, J BONE MINER RES, V20, P1168, DOI 10.1359/JBMR.050305; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Di Bari MG, 2009, J CELL PHYSIOL, V219, P659, DOI 10.1002/jcp.21712; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Fialka I, 1996, J CELL BIOL, V132, P1115, DOI 10.1083/jcb.132.6.1115; Fisher JL, 2006, CANCER RES, V66, P3620, DOI 10.1158/0008-5472.CAN-05-3119; Flanders KC, 2001, DEV DYNAM, V220, P141, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1096>3.0.CO;2-4; Fleming JM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-46; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Ghosh-Choudhury N, 2006, J BIOL CHEM, V281, P20160, DOI 10.1074/jbc.M511071200; Goldhar AS, 2011, MOL CELL ENDOCRINOL, V335, P148, DOI 10.1016/j.mce.2011.01.004; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; HASLAM SZ, 1980, J CELL BIOL, V86, P730, DOI 10.1083/jcb.86.3.730; Hens JR, 2007, DEVELOPMENT, V134, P1221, DOI 10.1242/dev.000182; Herrera B, 2009, CANCER RES, V69, P9254, DOI 10.1158/0008-5472.CAN-09-2912; Hofseth LJ, 1999, J CLIN ENDOCR METAB, V84, P4559, DOI 10.1210/jc.84.12.4559; Hovey RC, 2001, DEV DYNAM, V222, P192, DOI 10.1002/dvdy.1179; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Jacobsen BM, 2002, J BIOL CHEM, V277, P27793, DOI 10.1074/jbc.M202584200; LIEBERMAN BA, 1993, MOL ENDOCRINOL, V7, P515, DOI 10.1210/me.7.4.515; Malewski T, 2005, CANCER INVEST, V23, P222, DOI 10.1081/CNV-200055958; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Na YR, 2009, CANCER SCI, V100, P2218, DOI 10.1111/j.1349-7006.2009.01301.x; Obr A, 2011, MOL CELL ENDOCRINOL; Oka H, 2006, J ORTHOP SCI, V11, P13, DOI 10.1007/s00776-005-0966-9; Phippard DJ, 1996, DEVELOPMENT, V122, P2729; Pinkas J, 2002, CANCER RES, V62, P4781; Raafat AM, 1999, ENDOCRINOLOGY, V140, P2570, DOI 10.1210/en.140.6.2570; Satoh K, 2007, ONCOGENE, V26, P7526, DOI 10.1038/sj.onc.1210555; Shyamala G, 2000, P NATL ACAD SCI USA, V97, P3044, DOI 10.1073/pnas.97.7.3044; TERAO M, 1990, BIOCHEM J, V268, P641, DOI 10.1042/bj2680641; Tylzanowski P, 2001, J BIOL CHEM, V276, P40001, DOI 10.1074/jbc.M104112200; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; WANG SQ, 1990, ENDOCRINOLOGY, V127, P2183, DOI 10.1210/endo-127-5-2183; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8	46	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e34058	10.1371/journal.pone.0034058	http://dx.doi.org/10.1371/journal.pone.0034058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457812	gold, Green Published, Green Submitted			2022-12-27	WOS:000303909200041
J	He, LJ; Zhao, XD; Wang, HM; Zhang, P; Guo, CC; Huang, C; Liu, XW; Yao, FF; Chen, Y; Lou, WJ; Sun, S; Fan, DM				He, Lijie; Zhao, Xiaodi; Wang, Hanmin; Zhang, Peng; Guo, Changcun; Huang, Chen; Liu, Xiaowei; Yao, Fangfang; Chen, Yu; Lou, Weijuan; Sun, Shiren; Fan, Daiming			RUNX3 Mediates Suppression of Tumor Growth and Metastasis of Human CCRCC by Regulating Cyclin Related Proteins and TIMP-1	PLOS ONE			English	Article							GASTRIC-CANCER CELLS; EPITHELIAL-CELLS; EXPRESSION; INHIBITION; PROLIFERATION; PROGRESSION; PHENOTYPE; CARCINOMA; PROMOTES; INVASION	Here we presented that the expression of RUNX3 was significantly decreased in 75 cases of clear cell renal cell carcinoma (CCRCC) tissues (p < 0.05). Enforced RUNX3 expression mediated 786-O cells to exhibit inhibition of growth, G1 cell-cycle arrest and metastasis in vitro, and to lost tumorigenicity in nude mouse model in vivo. RUNX3-induced growth suppression was found partially to regulate various proteins, including inhibition of cyclinD1, cyclinE, cdk2, cdk4 and p-Rb, but increase of p27(Kip1), Rb and TIMP-1. Therefore, RUNX3 had the function of inhibiting the proliferative and metastatic abilities of CCRCC cells by regulating cyclins and TIMP1.	[He, Lijie; Wang, Hanmin; Zhang, Peng; Huang, Chen; Liu, Xiaowei; Lou, Weijuan; Sun, Shiren] Fourth Mil Med Univ, Dept Nephrol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [He, Lijie; Zhao, Xiaodi; Guo, Changcun; Yao, Fangfang; Chen, Yu; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Sun, S (corresponding author), Fourth Mil Med Univ, Dept Nephrol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.	ningsun@fmmu.edu.cn; fandaim@fmmu.edu.cn			National Natural Science Foundation of China [30801330, 81030044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30801330, No. 81030044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Chen YD, 2010, ANN INFORM SYST, V9, P1, DOI 10.1145/1980534.1980540; Cho JY, 1997, CANCER, V79, P878, DOI 10.1002/(SICI)1097-0142(19970301)79:5<878::AID-CNCR2>3.3.CO;2-N; Guo CC, 2005, INT J CANCER, V116, P155, DOI 10.1002/ijc.20919; He LJ, 2009, CANCER LETT, V276, P88, DOI 10.1016/j.canlet.2008.10.044; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Jin HF, 2007, MOL CANCER RES, V5, P423, DOI 10.1158/1541-7786.MCR-06-0407; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li W, 2009, P NATL ACAD SCI USA, V106, P486, DOI 10.1073/pnas.0804177106; Liu N, 2004, CLIN CANCER RES, V10, P6239, DOI 10.1158/1078-0432.CCR-04-0242; Malumbres M, 2006, CANCER CELL, V9, P2, DOI 10.1016/j.ccr.2005.12.026; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Meng Y, 2010, CANCER LETT, V297, P9, DOI 10.1016/j.canlet.2010.04.019; Mithani SK, 2004, J SURG RES, V117, P296, DOI 10.1016/S0022-4804(03)00335-4; Okamoto T, 2003, MOL HUM REPROD, V9, P569, DOI 10.1093/molehr/gag074; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Peng ZH, 2008, INT J ONCOL, V33, P979, DOI 10.3892/ijo_00000085; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tan Xiao-yue, 2005, Zhonghua Yi Xue Za Zhi, V85, P2607; Tsunematsu T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005892; van Golen KL, 2000, CANCER RES, V60, P5832; Wang J, 2005, BIOCHEM BIOPH RES CO, V337, P386, DOI 10.1016/j.bbrc.2005.09.051; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xue Y, 2004, BIOCHEM BIOPH RES CO, V320, P1309, DOI 10.1016/j.bbrc.2004.06.088; Zbar B, 2003, ANNU REV MED, V54, P217, DOI 10.1146/annurev.med.54.101601.152514	30	10	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e32961	10.1371/journal.pone.0032961	http://dx.doi.org/10.1371/journal.pone.0032961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457727	Green Published, Green Submitted, gold			2022-12-27	WOS:000303909200011
J	Jola, C; Abedian-Amiri, A; Kuppuswamy, A; Pollick, FE; Grosbras, MH				Jola, Corinne; Abedian-Amiri, Ali; Kuppuswamy, Annapoorna; Pollick, Frank E.; Grosbras, Marie-Helene			Motor Simulation without Motor Expertise: Enhanced Corticospinal Excitability in Visually Experienced Dance Spectators	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; ACTION OBSERVATION NETWORK; CORTEX EXCITABILITY; CORTICAL EXCITABILITY; GRASP REPRESENTATIONS; BRAIN RESPONSES; MIRROR NEURONS; MODULATION; EMPATHY; FMRI	The human "mirror-system'' is suggested to play a crucial role in action observation and execution, and is characterized by activity in the premotor and parietal cortices during the passive observation of movements. The previous motor experience of the observer has been shown to enhance the activity in this network. Yet visual experience could also have a determinant influence when watching more complex actions, as in dance performances. Here we tested the impact visual experience has on motor simulation when watching dance, by measuring changes in corticospinal excitability. We also tested the effects of empathic abilities. To fully match the participants' long-term visual experience with the present experimental setting, we used three live solo dance performances: ballet, Indian dance, and non-dance. Participants were either frequent dance spectators of ballet or Indian dance, or "novices'' who never watched dance. None of the spectators had been physically trained in these dance styles. Transcranial magnetic stimulation was used to measure corticospinal excitability by means of motor-evoked potentials (MEPs) in both the hand and the arm, because the hand is specifically used in Indian dance and the arm is frequently engaged in ballet dance movements. We observed that frequent ballet spectators showed larger MEP amplitudes in the arm muscles when watching ballet compared to when they watched other performances. We also found that the higher Indian dance spectators scored on the fantasy subscale of the Interpersonal Reactivity Index, the larger their MEPs were in the arms when watching Indian dance. Our results show that even without physical training, corticospinal excitability can be enhanced as a function of either visual experience or the tendency to imaginatively transpose oneself into fictional characters. We suggest that spectators covertly simulate the movements for which they have acquired visual experience, and that empathic abilities heighten motor resonance during dance observation.	[Jola, Corinne] Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England; [Abedian-Amiri, Ali] McGill Univ, Brain Imaging Ctr, Montreal, PQ, Canada; [Kuppuswamy, Annapoorna] Univ London Imperial Coll Sci Technol & Med, Dept Clin Neurosci, London, England; [Pollick, Frank E.] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland; [Grosbras, Marie-Helene] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Surrey; McGill University; Imperial College London; University of Glasgow; University of Glasgow	Jola, C (corresponding author), Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England.	c.jola@surrey.ac.uk	Pollick, Frank/F-3186-2011; Grosbras, Marie-Helene/C-7371-2009; Jola, Corinne/G-3241-2016	Pollick, Frank/0000-0002-7212-4622; Grosbras, Marie-Helene/0000-0002-9807-6307; Jola, Corinne/0000-0001-7216-2242; Kuppuswamy, Annapoorna/0000-0002-4288-0814	Watching Dance Arts and Humanities Research Council [AH/F01229/1]; Arts and Humanities Research Council [AH/F011229/1] Funding Source: researchfish; AHRC [AH/F011229/1] Funding Source: UKRI	Watching Dance Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	Watching Dance Arts and Humanities Research Council (www.ahrc.ac.uk) funding project ID is AH/F01229/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2002, J CLIN NEUROPHYSIOL, V19, P307, DOI 10.1097/00004691-200208000-00005; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P2593, DOI 10.1016/j.neuropsychologia.2009.05.006; Binkofski F, 2006, J PHYSIOL-PARIS, V99, P396, DOI 10.1016/j.jphysparis.2006.03.005; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Calvo-Merino B, 2010, PSYCHOL RES-PSYCH FO, V74, P400, DOI 10.1007/s00426-009-0262-y; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Chen R, 2000, MUSCLE NERVE, pS26; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; Costantini M, 2008, EUR J NEUROSCI, V28, P1222, DOI 10.1111/j.1460-9568.2008.06406.x; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; Desy MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000971; Edward Bradford Titchener, 1909, LECT EXPT PSYCHOL TH; Enticott PG, 2011, BRAIN RES BULL, V85, P89, DOI 10.1016/j.brainresbull.2011.03.018; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fecteau S, 2010, EUR J NEUROSCI, V32, P172, DOI 10.1111/j.1460-9568.2010.07285.x; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Frey SH, 2006, J NEUROSCI, V26, P13194, DOI 10.1523/JNEUROSCI.3914-06.2006; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Hejmadi A, 2000, PSYCHOL SCI, V11, P183, DOI 10.1111/1467-9280.00239; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; Hewig J, 2008, J NONVERBAL BEHAV, V32, P67, DOI 10.1007/s10919-007-0043-5; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Jackson J, 2005, RES DANCE ED, V6, P25, DOI DOI 10.1080/14617890500373089; Jarvelainen J, 2001, NEUROREPORT, V12, P3493; Jastorff J, 2009, J NEUROSCI, V29, P14026, DOI 10.1523/JNEUROSCI.3070-09.2009; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Johnson-Frey SH, 2004, BRAIN COGNITION, V55, P328, DOI 10.1016/j.bandc.2004.02.032; Jola C, 2011, DANCE RES, V29, P378, DOI 10.3366/drs.2011.0025; Jola C, 2011, EXP BRAIN RES, V213, P257, DOI 10.1007/s00221-011-2743-7; Jola C, 2010, NEUROCOGNITION OF DANCE: MIND, MOVEMENT AND MOTOR SKILLS, P203; Jola C, 2012, PHENOMENOL COGN SCI, V11, P17, DOI 10.1007/s11097-010-9191-x; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Kirk U, 2009, NEUROIMAGE, V44, P1125, DOI 10.1016/j.neuroimage.2008.10.009; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Lepage JF, 2010, EUR J NEUROSCI, V31, P931, DOI 10.1111/j.1460-9568.2010.07121.x; Martin John, 1939, INTRO DANCE; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; McNamara A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003845; MEDURI A, 1988, ASIAN THEATRE J, V5, P1, DOI 10.2307/1124019; Meduri Avanthi, 2004, DANCE RES J, V36, P11; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Mottonen R, 2010, NEUROPSYCHOLOGIA, V48, P3173, DOI 10.1016/j.neuropsychologia.2010.06.033; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Newman-Norlund RD, 2009, SOC COGN AFFECT NEUR, V4, P10, DOI 10.1093/scan/nsn028; Orgs G, 2008, EUR J NEUROSCI, V27, P3380, DOI 10.1111/j.1460-9568.2008.06271.x; Orgs G, 2011, PSYCHOL SCI, V22, P712, DOI 10.1177/0956797611406446; Pascual-Leone A., 2002, HDB TRANSCRANIAL MAG; Perkins T, 2010, J CLIN NEUROSCI, V17, P1239, DOI 10.1016/j.jocn.2010.01.026; Petersen NT, 2003, EXP BRAIN RES, V152, P1, DOI 10.1007/s00221-003-1537-y; Petrosini L, 2003, BRAIN RES REV, V42, P252, DOI 10.1016/S0165-0173(03)00176-0; Puzzo I, 2009, NEUROSCI LETT, V467, P173, DOI 10.1016/j.neulet.2009.10.033; Reason M, 2010, DANCE RES J, V42, P49, DOI 10.1017/S0149767700001030; Ricciardi E, 2009, J NEUROSCI, V29, P9719, DOI 10.1523/JNEUROSCI.0274-09.2009; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Shimada S, 2006, NEUROIMAGE, V32, P930, DOI 10.1016/j.neuroimage.2006.03.044; Siebner HR, 2007, TMS BUCH, P71; Stevens Catherine, 2010, J Dance Med Sci, V14, P19; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Zentgraf K, 2011, VISION RES, V51, P827, DOI 10.1016/j.visres.2011.01.007	81	83	84	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33343	10.1371/journal.pone.0033343	http://dx.doi.org/10.1371/journal.pone.0033343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YN	22457754	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000303857100029
J	Yegorov, S; Good, S				Yegorov, Sergey; Good, Sara			Using Paleogenomics to Study the Evolution of Gene Families: Origin and Duplication History of the Relaxin Family Hormones and Their Receptors	PLOS ONE			English	Article							GENOME DUPLICATION; AMPHIOXUS GENOME; PEPTIDE FAMILY; INSULIN; 2R; VERTEBRATES; DIVERGENCE; STARFISH; INSIGHTS; REVEALS	Recent progress in the analysis of whole genome sequencing data has resulted in the emergence of paleogenomics, a field devoted to the reconstruction of ancestral genomes. Ancestral karyotype reconstructions have been used primarily to illustrate the dynamic nature of genome evolution. In this paper, we demonstrate how they can also be used to study individual gene families by examining the evolutionary history of relaxin hormones (RLN/INSL) and relaxin family peptide receptors (RXFP). Relaxin family hormones are members of the insulin superfamily, and are implicated in the regulation of a variety of primarily reproductive and neuroendocrine processes. Their receptors are G-protein coupled receptors (GPCR's) and include members of two distinct evolutionary groups, an unusual characteristic. Although several studies have tried to elucidate the origins of the relaxin peptide family, the evolutionary origin of their receptors and the mechanisms driving the diversification of the RLN/INSL-RXFP signaling systems in non-placental vertebrates has remained elusive. Here we show that the numerous vertebrate RLN/INSL and RXFP genes are products of an ancestral receptor-ligand system that originally consisted of three genes, two of which apparently trace their origins to invertebrates. Subsequently, diversification of the system was driven primarily by whole genome duplications (WGD, 2R and 3R) followed by almost complete retention of the ligand duplicates in most vertebrates but massive loss of receptor genes in tetrapods. Interestingly, the majority of 3R duplicates retained in teleosts are potentially involved in neuroendocrine regulation. Furthermore, we infer that the ancestral AncRxfp3/4 receptor may have been syntenically linked to the AncRln-like ligand in the pre-2R genome, and show that syntenic linkages among ligands and receptors have changed dynamically in different lineages. This study ultimately shows the broad utility, with some caveats, of incorporating paleogenomics data into understanding the evolution of gene families.	[Yegorov, Sergey; Good, Sara] Univ Winnipeg, Dept Biol, Winnipeg, MB R3B 2E9, Canada	University of Winnipeg	Yegorov, S (corresponding author), Univ Winnipeg, Dept Biol, Winnipeg, MB R3B 2E9, Canada.	s.good@uwinnipeg.ca	Good, Sara Victoria/R-9966-2019; Yegorov, Sergey/AAE-4856-2020	Good, Sara Victoria/0000-0003-0563-7724; Yegorov, Sergey/0000-0002-7136-7921	NSERC; province of Manitoba; University of Winnipeg	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); province of Manitoba; University of Winnipeg	This work was supported by an NSERC Discovery Grant to SVG (www.nserc.ca), and graduate fellowships to SY provided for by both the province of Manitoba and the University of Winnipeg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gloriam DE, 2009, J MED CHEM, V52, P4429, DOI 10.1021/jm900319e; Good-Avila SV, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-293; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Halls ML, 2007, BRIT J PHARMACOL, V150, P677, DOI 10.1038/sj.bjp.0707140; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hoffmann FG, 2011, J MOL EVOL, V72, P72, DOI 10.1007/s00239-010-9403-6; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Huminiecki L, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-146; Hurst LD, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-62; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kemkemer C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-84; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Liu CL, 2005, J BIOL CHEM, V280, P292, DOI 10.1074/jbc.M409916200; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Makino T, 2008, MOL BIOL EVOL, V25, P1855, DOI 10.1093/molbev/msn137; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; McGowan BM, 2008, AM J PHYSIOL-ENDOC M, V295, pE278, DOI 10.1152/ajpendo.00028.2008; McRory JE, 1997, DNA CELL BIOL, V16, P939, DOI 10.1089/dna.1997.16.939; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mita M, 2011, ZOOL SCI, V28, P764, DOI 10.2108/zsj.28.764; Mita M, 2009, P NATL ACAD SCI USA, V106, P9507, DOI 10.1073/pnas.0900243106; Muffato M, 2008, BIOESSAYS, V30, P122, DOI 10.1002/bies.20707; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Ohno S., 1970, P1; Olinski RP, 2006, PEPTIDES, V27, P2535, DOI 10.1016/j.peptides.2006.06.008; Olinski RP, 2006, MOL BIOL EVOL, V23, P10, DOI 10.1093/molbev/msj002; Park JI, 2008, GENOME RES, V18, P974, DOI 10.1101/gr.7119108; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Shiao MS, 2008, GENETICS, V178, P1683, DOI 10.1534/genetics.108.087023; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Wilkinson TN, 2007, ADV EXP MED BIOL, V612, P1; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009	45	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e32923	10.1371/journal.pone.0032923	http://dx.doi.org/10.1371/journal.pone.0032923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470432	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100010
J	Nakayama, SI; Shi, S; Tateno, M; Shimada, M; Takahasi, KR				Nakayama, Shin-Ichiro; Shi, Shoi; Tateno, Masaki; Shimada, Masakazu; Takahasi, K. Ryo			Mutation Accumulation in a Selfing Population: Consequences of Different Mutation Rates between Selfers and Outcrossers	PLOS ONE			English	Article							INBREEDING DEPRESSION; CAENORHABDITIS-ELEGANS; DELETERIOUS MUTATIONS; EVOLUTION; FERTILIZATION; DOMINANCE; SYSTEM; PLANTS; RECOMBINATION; NUCLEOTIDE	Currently existing theories predict that because deleterious mutations accumulate at a higher rate, selfing populations suffer from more intense genetic degradation relative to outcrossing populations. This prediction may not always be true when we consider a potential difference in deleterious mutation rate between selfers and outcrossers. By analyzing the evolutionary stability of selfing and outcrossing in an infinite population, we found that the genome-wide deleterious mutation rate would be lower in selfing than in outcrossing organisms. When this difference in mutation rate was included in simulations, we found that in a small population, mutations accumulated more slowly under selfing rather than outcrossing. This result suggests that under frequent and intense bottlenecks, a selfing population may have a lower risk of genetic extinction than an outcrossing population.	[Nakayama, Shin-Ichiro; Tateno, Masaki] Univ Tokyo, Grad Sch Sci, Nikko Bot Gardens, Tokyo 113, Japan; [Shi, Shoi] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 278, Japan; [Shimada, Masakazu] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan; [Takahasi, K. Ryo] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan	University of Tokyo; Tokyo University of Science; University of Tokyo; Kyoto Sangyo University	Nakayama, SI (corresponding author), Univ Tokyo, Grad Sch Sci, Nikko Bot Gardens, Tokyo 113, Japan.	shin.ichiro.nak@gmail.com						CHARLESWORTH B, 1990, NATURE, V347, P380, DOI 10.1038/347380a0; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; CHARLESWORTH D, 1990, EVOLUTION, V44, P1469, DOI 10.1111/j.1558-5646.1990.tb03839.x; Crow JF, 1983, GENET BIOL DROSOPHIL, P1; Cutter AD, 2003, J EVOLUTION BIOL, V16, P812, DOI 10.1046/j.1420-9101.2003.00596.x; Davies EK, 1999, SCIENCE, V285, P1748, DOI 10.1126/science.285.5434.1748; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; FELSENSTEIN J, 1974, GENETICS, V78, P737; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Heller J., 1979, GENET RES, V8, P269; Hollister JD, 2010, MOL BIOL EVOL, V27, P409, DOI 10.1093/molbev/msp249; Igic B, 2006, P NATL ACAD SCI USA, V103, P1359, DOI 10.1073/pnas.0506283103; JOHNSTON MO, 1995, SCIENCE, V267, P226, DOI 10.1126/science.267.5195.226; KONDRASHOV AS, 1985, GENETICS, V111, P635; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lynch M, 1995, EVOLUTION, V49, P1067, DOI [10.1111/j.1558-5646.1995.tb04434.x, 10.2307/2410432]; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; MUKAI T, 1972, GENETICS, V72, P335; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nachman MW, 2000, GENETICS, V156, P297; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; PAMILO P, 1987, GENET RES, V49, P135, DOI 10.1017/S0016672300026938; SCHEMSKE DW, 1985, EVOLUTION, V39, P41, DOI [10.2307/2408515, 10.1111/j.1558-5646.1985.tb04078.x]; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Takebayashi N, 2001, AM J BOT, V88, P1143, DOI 10.2307/3558325; Vogler DW, 2001, EVOLUTION, V55, P202, DOI 10.1111/j.0014-3820.2001.tb01285.x; Willis JH, 1999, GENETICS, V153, P1885	29	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33541	10.1371/journal.pone.0033541	http://dx.doi.org/10.1371/journal.pone.0033541			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448251	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700042
J	Shaw, SY; Lorway, RR; Deering, KN; Avery, L; Mohan, HL; Bhattacharjee, P; Reza-Paul, S; Isac, S; Ramesh, BM; Washington, R; Moses, S; Blanchard, JF				Shaw, Souradet Y.; Lorway, Robert R.; Deering, Kathleen N.; Avery, Lisa; Mohan, H. L.; Bhattacharjee, Parinita; Reza-Paul, Sushena; Isac, Shajy; Ramesh, Banadakoppa M.; Washington, Reynold; Moses, Stephen; Blanchard, James F.			Factors Associated with Sexual Violence against Men Who Have Sex with Men and Transgendered Individuals in Karnataka, India	PLOS ONE			English	Article							INJECTING DRUG-USERS; INTIMATE PARTNER VIOLENCE; GENDER-BASED VIOLENCE; HIV-INFECTION; TRANSMITTED INFECTIONS; STRUCTURAL VIOLENCE; SOUTH-INDIA; RISK; PREVALENCE; WOMEN	Objectives: There is a lack of information on sexual violence (SV) among men who have sex with men and transgendered individuals (MSM-T) in southern India. As SV has been associated with HIV vulnerability, this study examined health related behaviours and practices associated with SV among MSM-T. Design: Data were from cross-sectional surveys from four districts in Karnataka, India. Methods: Multivariable logistic regression models were constructed to examine factors related to SV. Multivariable negative binomial regression models examined the association between physician visits and SV. Results: A total of 543 MSM-T were included in the study. Prevalence of SV was 18% in the past year. HIV prevalence among those reporting SV was 20%, compared to 12% among those not reporting SV (p = .104). In multivariable models, and among sex workers, those reporting SV were more likely to report anal sex with 5+ casual sex partners in the past week (AOR: 4.1; 95% CI: 1.2-14.3, p = .029). Increased physician visits among those reporting SV was reported only for those involved in sex work (ARR: 1.7; 95% CI: 1.1-2.7, p = .012). Conclusions: These results demonstrate high levels of SV among MSM-T populations, highlighting the importance of integrating interventions to reduce violence as part of HIV prevention programs and health services.	[Shaw, Souradet Y.; Lorway, Robert R.; Avery, Lisa; Reza-Paul, Sushena; Washington, Reynold; Moses, Stephen; Blanchard, James F.] Univ Manitoba, Fac Med, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB, Canada; [Deering, Kathleen N.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Deering, Kathleen N.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Mohan, H. L.; Bhattacharjee, Parinita; Isac, Shajy; Ramesh, Banadakoppa M.; Washington, Reynold] Karnatka Hlth Promot Trust, Bangalore, Karnataka, India	University of Manitoba; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia	Shaw, SY (corresponding author), Univ Manitoba, Fac Med, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB, Canada.	umshaw@cc.umanitoba.ca	Washington, Reynold/AAD-7447-2020	Shaw, Souradet/0000-0002-0982-1302; Blanchard, James/0000-0002-4701-590X	Bill & Melinda Gates Foundation; Manitoba Health Research Council; David G. Fish Memorial Scholarship; International Infectious Disease and Global Health Training Program; Canadian Institutes of Health Research	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Manitoba Health Research Council; David G. Fish Memorial Scholarship; International Infectious Disease and Global Health Training Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Bill & Melinda Gates Foundation. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation. SYS is supported in part by doctoral awards from the Manitoba Health Research Council, David G. Fish Memorial Scholarship, the International Infectious Disease and Global Health Training Program, and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baijal Parijat, 2009, J Int AIDS Soc, V12 Suppl 1, pS6, DOI 10.1186/1758-2652-12-S1-S6; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; BERRIOS DC, 1995, ARCH PATHOL LAB MED, V119, P139; Blanchard JF, 2007, SEX TRANSM INFECT, V83, pI30, DOI 10.1136/sti.2006.023572; Boyce P, 2007, MED ANTHROPOL, V26, P175, DOI 10.1080/01459740701285582; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Chakrapani V, 2007, AIDS EDUC PREV, V19, P346, DOI 10.1521/aeap.2007.19.4.346; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Dandona L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-98; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; El-Bassel N, 2005, SOC SCI MED, V61, P171, DOI 10.1016/j.socscimed.2004.11.035; Halli SS, 2009, SEX TRANSM DIS, V36, P556, DOI 10.1097/OLQ.0b013e3181a8cdcf; Hawkes S, 2009, SEX TRANSM INFECT, V85, P8, DOI 10.1136/sti.2008.033910; Hernandez AL, 2006, AIDS BEHAV, V10, pS5, DOI 10.1007/s10461-006-9129-z; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Houston E, 2007, J URBAN HEALTH, V84, P681, DOI 10.1007/s11524-007-9188-0; Jayasree AK, 2004, REPROD HEALTH MATTER, V12, P58, DOI 10.1016/S0968-8080(04)23111-1; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Khan S, 1999, MEN WHO SELL SEX INT, P195; Lorway R, 2010, SEXUALLY TR IN PRESS; Lorway R, 2009, MED ANTHROPOL Q, V23, P142, DOI 10.1111/j.1548-1387.2009.01052.x; Mahanta J, 2008, AIDS, V22, pS59, DOI 10.1097/01.aids.0000343764.62455.9e; Misra G, 2009, REPROD HEALTH MATTER, V17, P20, DOI 10.1016/S0968-8080(09)34478-X; Moses SA, 2006, AIDS S ASIA UNDERSTA; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; Nanda S, 1999, NEITHER MAN WOMAN; National AIDS Control Organisation, 2007, HIV SENT SURV HIV ES; Newman PA, 2008, SEX TRANSM INFECT, V84, P434, DOI 10.1136/sti.2008.031484; Oelemann WMR, 2002, J CLIN MICROBIOL, V40, P881, DOI 10.1128/JCM.40.3.881-885.2002; Panchanadeswaran S, 2008, INT J DRUG POLICY, V19, P106, DOI 10.1016/j.drugpo.2007.11.013; Panda S, 2000, INT J STD AIDS, V11, P468, DOI 10.1258/0956462001916137; Parekh S, 2003, J GAY LESBIAN PSYCHO, V7, P145; Phillips AE, 2010, SEX TRANSM INFECT, V86, P187, DOI 10.1136/sti.2009.038216; Phillips A E, 2008, J LGBT Health Res, V4, P111; Ramachandran S, 2010, AIDS CARE, P1; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Reddy Gayatri, 2005, Anthropol Med, V12, P255, DOI 10.1080/13648470500291410; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Rhodes T, 2008, BMJ; Safren SA, 2006, AIDS EDUC PREV, V18, P323, DOI 10.1521/aeap.2006.18.4.323; Sahastrabuddhe S, 2011, J ACQUIR IMMUNE DEFI; Saidel T, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000343761.77702.04; Sarkar K, 2006, SUBST USE MISUSE, V41, P341, DOI 10.1080/10826080500410991; Schneider JA, 2007, AIDS CARE, V19, P1171, DOI 10.1080/09540120701336392; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Shaw SY, 2011, SEX TRANSM INFECT, V87, P73, DOI 10.1136/sti.2009.041335; Skanland Celeste A, 2009, HIV AIDS Policy Law Rev, V14, P49; Solomon SS, 2010, AIDS BEHAV; StataCorp, 2010, STAT STAT SOFTW REL; Steinbrook R, 2007, NEW ENGL J MED, V356, P1089, DOI 10.1056/NEJMp078009; UCLA: Academic Technology Services Statistical Consulting Group, 2010, CAN I CHECK COLL SUR; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Verma RK, 2004, AIDS, V18, P1845, DOI 10.1097/00002030-200409030-00014; Ward H, 2006, SEX TRANSM INFECT, V82, P345, DOI 10.1136/sti.2006.023044; WARD H, 1993, BRIT MED J, V307, P356, DOI 10.1136/bmj.307.6900.356; World Health Organization, 2002, WORLD REPORT VIOLENC	60	48	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e31705	10.1371/journal.pone.0031705	http://dx.doi.org/10.1371/journal.pone.0031705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YB	22448214	gold, Green Published			2022-12-27	WOS:000303855700004
J	Sprau, P; Roth, T; Naguib, M; Amrhein, V				Sprau, Philipp; Roth, Tobias; Naguib, Marc; Amrhein, Valentin			Communication in the Third Dimension: Song Perch Height of Rivals Affects Singing Response in Nightingales	PLOS ONE			English	Article							BROAD-BAND TRILLS; PIED FLYCATCHER; PAIRING SUCCESS; TERRITORY; DISTANCE; CHOICE; SIGNAL; SOUND; DEGRADATION; CONSTRAINTS	Many animals use long-range signals to compete over mates and resources. Optimal transmission can be achieved by choosing efficient signals, or by choosing adequate signalling perches and song posts. High signalling perches benefit sound transmission and reception, but may be more risky due to exposure to airborne predators. Perch height could thus reflect male quality, with individuals signalling at higher perches appearing as more threatening to rivals. Using playbacks on nightingales (Luscinia megarhynchos), we simulated rivals singing at the same height as residents, or singing three metres higher. Surprisingly, residents increased song output stronger, and, varying with future pairing success, overlapped more songs of the playback when rivals were singing at the same height than when they were singing higher. Other than expected, rivals singing at the same height may thus be experienced as more threatening than rivals singing at higher perches. Our study provides new evidence that territorial animals integrate information on signalling height and thus on vertical cues in their assessment of rivals.	[Sprau, Philipp; Naguib, Marc] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Roth, Tobias; Amrhein, Valentin] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Roth, Tobias; Amrhein, Valentin] Res Stn Petite Camargue Alsacienne, St Louis, France; [Naguib, Marc] Wageningen Univ, Dept Anim Sci, Behav Ecol Grp, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Basel; Wageningen University & Research	Sprau, P (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	philippsprau@gmx.de	Amrhein, Valentin/ABD-6432-2021; Naguib, Marc/C-2650-2009; Roth, Tobias/H-7927-2019; KNAW, NIOO-KNAW/A-4320-2012	Roth, Tobias/0000-0001-9742-8297; KNAW, NIOO-KNAW/0000-0002-3835-159X; Naguib, Marc/0000-0003-0494-4888	Swiss Association Pro Petite Camargue Alsacienne; Deutsche Forschungsgemeinschaft [Na 335/8]; Singenberg Stiftung; Foundation Emilia Guggenheim-Schnurr; Basler Stiftung fur biologische Forschung; Ornithologische Gesellschaft Basel; Stiftung Dreiklang	Swiss Association Pro Petite Camargue Alsacienne; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Singenberg Stiftung; Foundation Emilia Guggenheim-Schnurr; Basler Stiftung fur biologische Forschung; Ornithologische Gesellschaft Basel; Stiftung Dreiklang	Financial support was provided by the Swiss Association Pro Petite Camargue Alsacienne, by the Deutsche Forschungsgemeinschaft (Na 335/8), and by the following private non-profit funding bodies: Singenberg Stiftung, Foundation Emilia Guggenheim-Schnurr, Basler Stiftung fur biologische Forschung, Ornithologische Gesellschaft Basel, Stiftung Dreiklang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1990, ANIM BEHAV, V39, P601, DOI 10.1016/S0003-3472(05)80430-0; Amrhein V, 2004, P ROY SOC B-BIOL SCI, V271, pS167, DOI 10.1098/rsbl.2003.0133; Amrhein V, 2002, ANIM BEHAV, V64, P939, DOI 10.1006/anbe.2002.1974; Amrhein V, 2007, IBIS, V149, P237, DOI 10.1111/j.1474-919X.2006.00621.x; Amrhein V, 2010, J ANIM ECOL, V79, P82, DOI 10.1111/j.1365-2656.2009.01629.x; Birrer S, 2009, ARDEA, V97, P615, DOI 10.5253/078.097.0430; Blumenrath SH, 2004, BEHAVIOUR, V141, P935, DOI 10.1163/1568539042360152; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; Crawley M.J., 2007, R BOOK; DABELSTEEN T, 1993, J ACOUST SOC AM, V93, P2206, DOI 10.1121/1.406682; de Kort SR, 2009, P ROY SOC B-BIOL SCI, V276, P2315, DOI 10.1098/rspb.2009.0127; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; GIRALDEAU LA, 1987, AUK, V104, P535, DOI 10.2307/4087559; Glutz von Blotzheim U. N., 1988, HDB VOGEL MITTELEURO; GOTTLANDER K, 1987, ANIM BEHAV, V35, P1037, DOI 10.1016/S0003-3472(87)80160-4; Grull A., 1981, Journal fuer Ornithologie, V122, P259, DOI 10.1007/BF01645339; Haven Wiley R., 1982, P131; KIRK DA, 1992, J RAPTOR RES, V26, P239; Krams I, 2001, BEHAV ECOL, V12, P295, DOI 10.1093/beheco/12.3.295; Kunc HP, 2006, ANIM BEHAV, V72, P25, DOI 10.1016/j.anbehav.2005.08.014; Mathevon N, 1997, BEHAV PROCESS, V39, P77, DOI 10.1016/S0376-6357(96)00046-0; Mathevon N, 2005, J ACOUST SOC AM, V117, P442, DOI 10.1121/1.1828805; Mennill DJ, 2004, ANIM BEHAV, V67, P441, DOI 10.1016/j.anbehav.2003.04.010; Moller AP, 2008, BEHAV ECOL, V19, P41, DOI 10.1093/beheco/arm098; Moller AP, 2006, BEHAV ECOL, V17, P155, DOI 10.1093/beheco/arj010; Molles LE, 2001, P ROY SOC B-BIOL SCI, V268, P2013, DOI 10.1098/rspb.2001.1757; Naguib M, 2001, ANIM BEHAV, V62, P825, DOI 10.1006/anbe.2001.1860; Naguib M, 2004, BEHAV ECOL, V15, P1011, DOI 10.1093/beheco/arh108; Naguib M, 2008, BEHAV ECOL, V19, P1034, DOI 10.1093/beheco/arn065; Naguib M, 2011, ADV STUD BEHAV, V43, P239, DOI 10.1016/B978-0-12-380896-7.00005-8; Naguib M, 2010, ANIM BEHAV, V80, pE11, DOI 10.1016/j.anbehav.2010.06.001; Nolan PM, 2004, ANIM BEHAV, V67, P403, DOI 10.1016/j.anbehav.2003.03.018; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; Poesel A, 2005, ANIM BEHAV, V70, P1419, DOI 10.1016/j.anbehav.2005.04.004; RADESATER T, 1987, ANIM BEHAV, V35, P1645, DOI 10.1016/S0003-3472(87)80057-X; Roth T, 2009, P ROY SOC B-BIOL SCI, V276, P2045, DOI 10.1098/rspb.2008.1726; Saino N, 1997, BEHAV ECOL, V8, P364, DOI 10.1093/beheco/8.4.364; Schmidt R, 2008, BEHAV ECOL, V19, P635, DOI 10.1093/beheco/arn021; Schmidt R, 2006, ANIM BEHAV, V72, P1355, DOI 10.1016/j.anbehav.2006.03.022; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; SIMPSON BS, 1985, ANIM BEHAV, V33, P793, DOI 10.1016/S0003-3472(85)80012-9; Sprau P, 2010, BEHAV ECOL, V21, P1011, DOI 10.1093/beheco/arq097; Sprau P, 2010, ETHOLOGY, V116, P300, DOI 10.1111/j.1439-0310.2010.01743.x; Ward S, 2005, J AVIAN BIOL, V36, P280, DOI 10.1111/j.0908-8857.2005.03379.x; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Zuur Alain F., 2009, P1	46	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32194	10.1371/journal.pone.0032194	http://dx.doi.org/10.1371/journal.pone.0032194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448215	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700005
J	Vasquez-Rifo, A; Jannot, G; Armisen, J; Labouesse, M; Irfan, S; Bukhari, A; Rondeau, EL; Miska, EA; Simard, MJ				Vasquez-Rifo, Alejandro; Jannot, Guillaume; Armisen, Javier; Labouesse, Michel; Irfan, Syed; Bukhari, Ahmad; Rondeau, Evelyne L.; Miska, Eric A.; Simard, Martin J.			Developmental Characterization of the MicroRNA-Specific C. elegans Argonautes alg-1 and alg-2	PLOS ONE			English	Article							RNA INTERFERENCE; DEADENYLATION; BIOGENESIS; ATTACHMENT; EXPRESSION; COMPLEXES; GERMLINE; FEATURES; PATHWAY; FAMILY	The genes alg-1 and alg-2 (referred to as "alg-1/2") encode the Argonaute proteins affiliated to the microRNA (miRNA) pathway in C. elegans. Bound to miRNAs they form the effector complex that effects post-transcriptional gene silencing. In order to define biological features important to understand the mode of action of these Argonautes, we characterize aspects of these genes during development. We establish that alg-1/2 display an overlapping spatio-temporal expression profile and shared association to a miRNAs set, but with gene-specific predominant expression in various cells and increased relative association to defined miRNAs. Congruent with their spatio-temporal coincidence and regardless of alg-1/2 drastic post-embryonic differences, only loss of both genes leads to embryonic lethality. Embryos without zygotic alg-1/2 predominantly arrest during the morphogenetic process of elongation with defects in the epidermal-muscle attachment structures. Altogether our results highlight similarities and specificities of the alg-1/2 likely to be explained at different cellular and molecular levels.	[Vasquez-Rifo, Alejandro; Jannot, Guillaume; Armisen, Javier; Labouesse, Michel; Irfan, Syed; Bukhari, Ahmad; Rondeau, Evelyne L.; Miska, Eric A.; Simard, Martin J.] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec, CHUQ, Quebec City, PQ, Canada; [Armisen, Javier; Miska, Eric A.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England; [Armisen, Javier; Miska, Eric A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Labouesse, Michel] Univ Strasbourg, Dev & Stem Cells Program, IGBMC, CNRS,UMR7104,INSERM,U964, Illkirch Graffenstaden, France	Laval University; University of Cambridge; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vasquez-Rifo, A (corresponding author), Univ Laval, Canc Res Ctr, Hotel Dieu Quebec, CHUQ, Quebec City, PQ, Canada.	Martin.Simard@crhdq.ulaval.ca	Bukhari, Syed/B-2885-2017; Vasquez-Rifo, Alejandro/AAR-2908-2021	Bukhari, Syed/0000-0003-0203-0003; Vasquez-Rifo, Alejandro/0000-0003-4707-558X; Simard, Martin/0000-0002-3189-9309; Miska, Eric/0000-0002-4450-576X	Canadian Institutes of Health Research (CIHR); Cancer Research UK; ANR (Agence Nationale de la Recherche); ARC (Association pour la Recherche sur le Cancer); NIH National Center for Research Resources (NCRR); Cancer Research UK [11832] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cancer Research UK(Cancer Research UK)	The work has been funded by the Canadian Institutes of Health Research (CIHR) (M.J.S.). J.A. and E.A.M. are supported by a program grant from Cancer Research UK and the work in the lab of M.L. was supported by grants from the ANR (Agence Nationale de la Recherche) and ARC (Association pour la Recherche sur le Cancer). M.J.S. is a CIHR New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank members of our laboratories for comments on the manuscript. We would also like to thank Eric Paquet for bioinformatics advice, the DNA microarray platform of the Infectious Disease Research Centre (CHUL/CHUQ) as well as Dr Barbara Papadopoulou and Marie-Jeanne Fiola for their help and advice in making the arrays. Some nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Alisch RS, 2007, PLOS GENET, V3, P2565, DOI 10.1371/journal.pgen.0030227; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bettinger JC, 1996, DEVELOPMENT, V122, P2517; BRENNER S, 1974, GENETICS, V77, P71; Bukhari SIA, 2012, CELL RES, V22, P1034, DOI 10.1038/cr.2012.31; Chan SP, 2009, DEV BIOL, V334, P152, DOI 10.1016/j.ydbio.2009.07.011; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chisholm A. D., 2005, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.35.1; Conine CC, 2010, P NATL ACAD SCI USA, V107, P3588, DOI 10.1073/pnas.0911685107; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; HRESKO MC, 1994, J CELL BIOL, V124, P491, DOI 10.1083/jcb.124.4.491; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Isik Meltem, 2010, Silence, V1, P5, DOI 10.1186/1758-907X-1-5; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Jannot G, 2008, RNA, V14, P829, DOI 10.1261/rna.901908; Jannot G, 2011, EMBO REP, V12, P581, DOI 10.1038/embor.2011.66; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Morita S, 2007, GENOMICS, V89, P687, DOI 10.1016/j.ygeno.2007.01.004; Shaw WR, 2010, GENETICS, V185, P897, DOI 10.1534/genetics.110.117515; Siomi MC, 2008, FEBS LETT, V582, P2473, DOI 10.1016/j.febslet.2008.06.018; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tops BBJ, 2006, COLD SPRING HARB SYM, V71, P189, DOI 10.1101/sqb.2006.71.035; Wu E, 2010, MOL CELL, V40, P558, DOI 10.1016/j.molcel.2010.11.003; Zahreddine H, 2010, CURR BIOL, V20, P322, DOI 10.1016/j.cub.2009.12.061; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765; Zhang HM, 2010, DEV DYNAM, V239, P1465, DOI 10.1002/dvdy.22255; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848	47	42	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33750	10.1371/journal.pone.0033750	http://dx.doi.org/10.1371/journal.pone.0033750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448270	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700061
J	Gomez-Carballa, A; Olivieri, A; Behar, DM; Achilli, A; Torroni, A; Salas, A				Gomez-Carballa, Alberto; Olivieri, Anna; Behar, Doron M.; Achilli, Alessandro; Torroni, Antonio; Salas, Antonio			Genetic Continuity in the Franco-Cantabrian Region: New Clues from Autochthonous Mitogenomes	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; MTDNA ANALYSIS; EXPANSION; EUROPE; SOUTHWESTERN; POPULATIONS; REFUGE	Background: The Late Glacial Maximum (LGM), similar to 20 thousand years ago (kya), is thought to have forced the people inhabiting vast areas of northern and central Europe to retreat to southern regions characterized by milder climatic conditions. Archaeological records indicate that Franco-Cantabria might have been the major source for the re-peopling of Europe at the beginning of the Holocene (11.5 kya). However, genetic evidence is still scarce and has been the focus of an intense debate. Methods/Principal Findings: Based on a survey of more than 345,000 partial control region sequences and the analysis of 53 mitochondrial DNA (mtDNA) genomes, we identified an mtDNA lineage, HV4a1a, which most likely arose in the Franco-Cantabrian area about 5.4 kya and remained confined to northern Iberia. Conclusions/Significance: The HV4a1a lineage and several of its younger branches reveal for the first time genetic continuity in this region and long-term episodes of isolation. This, in turn, could at least in part explain the unique linguistic and cultural features of the Basque region.	[Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Inst Med Legal,Fac Med, Galicia, Spain; [Olivieri, Anna; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Behar, Doron M.] Rambam Hlth Care Campus, Haifa, Israel; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy	Universidade de Santiago de Compostela; University of Pavia; Rambam Health Care Campus; University of Perugia	Gomez-Carballa, A (corresponding author), Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Inst Med Legal,Fac Med, Galicia, Spain.	antonio.salas@usc.es	OLIVIERI, ANNA/I-9235-2012; Gómez-Carballa, Alberto/I-4610-2014; Torroni, Antonio/E-1557-2011; Salas, Antonio/U-2029-2019; Achilli, Alessandro/I-9236-2012; Salas, Antonio/E-3977-2012	OLIVIERI, ANNA/0000-0002-3941-8098; Gómez-Carballa, Alberto/0000-0003-0927-1272; Torroni, Antonio/0000-0002-4163-4478; Salas, Antonio/0000-0002-2336-702X; Achilli, Alessandro/0000-0001-6871-3451; Salas, Antonio/0000-0002-2336-702X	Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion [SAF2008-02971]; Progetti Ricerca Interesse Nazionale (Italian Ministry of the University); FIRB-Futuro in Ricerca (Italian Ministry of the University); Fondazione Alma Mater Ticinensis	Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Progetti Ricerca Interesse Nazionale (Italian Ministry of the University); FIRB-Futuro in Ricerca (Italian Ministry of the University); Fondazione Alma Mater Ticinensis	This research study received support from the Fundacion de Investigacion Medica Mutua Madrilena (to AS), the Ministerio de Ciencia e Innovacion (SAF2008-02971) (to AS), the Progetti Ricerca Interesse Nazionale 2009 (Italian Ministry of the University) (to AA and AT), the FIRB-Futuro in Ricerca (Italian Ministry of the University) (to AA and AO), the Fondazione Alma Mater Ticinensis (to AT). The authors would like to thank the Genographic project for providing samples for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Cerezo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007902; Garcia O, 2011, HEREDITY, V106, P37, DOI 10.1038/hdy.2010.47; Izagirre N, 1999, AM J HUM GENET, V65, P199, DOI 10.1086/302442; Laayouni H, 2010, HUM GENET, V127, P455, DOI 10.1007/s00439-010-0798-3; Moreau C, 2009, AM J PHYS ANTHROPOL, V139, P512, DOI 10.1002/ajpa.21012; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Seoane M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023327; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	15	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32851	10.1371/journal.pone.0032851	http://dx.doi.org/10.1371/journal.pone.0032851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442672	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500014
J	Sitras, V; Fenton, C; Paulssen, R; Vartun, A; Acharya, G				Sitras, Vasilis; Fenton, Christopher; Paulssen, Ruth; Vartun, Ase; Acharya, G.			Differences in Gene Expression between First and Third Trimester Human Placenta: A Microarray Study	PLOS ONE			English	Article							FETAL CARDIAC-OUTPUT; CIGARETTE-SMOKING; CHORIONIC VILLI; TOBACCO-SMOKE; EXPOSURE	Background: The human placenta is a rapidly developing organ that undergoes structural and functional changes throughout the pregnancy. Our objectives were to investigate the differences in global gene expression profile, the expression of imprinted genes and the effect of smoking in first and third trimester normal human placentas. Materials and Methods: Placental samples were collected from 21 women with uncomplicated pregnancies delivered at term and 16 healthy women undergoing termination of pregnancy at 9-12 weeks gestation. Placental gene expression profile was evaluated by Human Genome Survey Microarray v. 2.0 (Applied Biosystems) and real-time polymerase chain reaction. Results: Almost 25% of the genes spotted on the array (n = 7519) were differentially expressed between first and third trimester placentas. Genes regulating biological processes involved in cell proliferation, cell differentiation and angiogenesis were up-regulated in the first trimester; whereas cell surface receptor mediated signal transduction, G-protein mediated signalling, ion transport, neuronal activities and chemosensory perception were up-regulated in the third trimester. Pathway analysis showed that brain and placenta might share common developmental routes. Principal component analysis based on the expression of 17 imprinted genes showed a clear separation of first and third trimester placentas, indicating that epigenetic modifications occur throughout pregnancy. In smokers, a set of genes encoding oxidoreductases were differentially expressed in both trimesters. Conclusions: Differences in global gene expression profile between first and third trimester human placenta reflect temporal changes in placental structure and function. Epigenetic rearrangements in the human placenta seem to occur across gestation, indicating the importance of environmental influence in the developing feto-placental unit.	[Sitras, Vasilis] Akershus Univ Hosp, Dept Obstet & Gynecol, Lorenskog, Norway; [Sitras, Vasilis; Vartun, Ase; Acharya, G.] Univ Tromso, Womens Hlth & Perinatol Grp, Tromso, Norway; [Sitras, Vasilis; Vartun, Ase; Acharya, G.] Univ Hosp N Norway, Tromso, Norway; [Fenton, Christopher; Paulssen, Ruth] Univ Tromso, Inst Clin Med, Tromso, Norway	University of Oslo; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sitras, V (corresponding author), Akershus Univ Hosp, Dept Obstet & Gynecol, Lorenskog, Norway.	Vasilis.Sitras@ahus.no	Sitras, Vasilis/R-1287-2018	Sitras, Vasilis/0000-0003-3264-3302	Faculty of Medicine, University of Tromso; North Norway Regional Health Authority [721484]	Faculty of Medicine, University of Tromso; North Norway Regional Health Authority	The study was partially funded by the Faculty of Medicine, University of Tromso and North Norway Regional Health Authority (funding number 721484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AHERNE W, 1966, BRIT MED BULL, V22, P5, DOI 10.1093/oxfordjournals.bmb.a070437; Bainbridge SA, 2005, MED HYPOTHESES, V64, P17, DOI 10.1016/j.mehy.2004.06.019; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bruchova H, 2010, PLACENTA, V31, P186, DOI 10.1016/j.placenta.2009.12.016; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Chen HW, 2002, MOL HUM REPROD, V8, P475, DOI 10.1093/molehr/8.5.475; Dizon-Townson DS, 2000, AM J OBSTET GYNECOL, V183, P706, DOI 10.1067/mob.2000.106583; Founds SA, 2011, J PERINAT MED, V39, P361, DOI [10.1515/JPM.2011.045, 10.1515/jpm.2011.045]; Fowden AL, PROGR BIOPH IN PRESS; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Huuskonen P, 2008, CLIN PHARMACOL THER, V83, P542, DOI 10.1038/sj.clpt.6100376; JAUNIAUX E, 1992, AM J OBSTET GYNECOL, V166, P585, DOI 10.1016/0002-9378(92)91678-4; Jauniaux E, 2007, EARLY HUM DEV, V83, P699, DOI 10.1016/j.earlhumdev.2007.07.016; KAUFMANN P, 1979, CELL TISSUE RES, V200, P409; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P126, DOI 10.1002/uog.2832; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKay R, 2011, NATURE, V472, P298, DOI 10.1038/472298a; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Morrish DW, 1998, J REPROD IMMUNOL, V39, P179, DOI 10.1016/S0165-0378(98)00021-7; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; Portmann-Lanz CB, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.893; Pozharny Y, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.039; Salafia CM, 2006, CLIN OBSTET GYNECOL, V49, P236, DOI 10.1097/00003081-200606000-00007; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Vimpeli T, 2009, ULTRASOUND OBST GYN, V33, P265, DOI 10.1002/uog.6247; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Yang QY, 2006, INT J EPIDEMIOL, V35, P288, DOI 10.1093/ije/dyi247; Yokomine T, 2005, GENOME RES, V15, P154, DOI 10.1101/gr.2609605	37	55	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33294	10.1371/journal.pone.0033294	http://dx.doi.org/10.1371/journal.pone.0033294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442682	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500024
J	Ingham, CJ; Boonstra, S; Levels, S; de Lange, M; Meis, JF; Schneeberger, PM				Ingham, Colin J.; Boonstra, Sjoukje; Levels, Suzanne; de Lange, Marit; Meis, Jacques F.; Schneeberger, Peter M.			Rapid Susceptibility Testing and Microcolony Analysis of Candida spp. Cultured and Imaged on Porous Aluminum Oxide	PLOS ONE			English	Article							ANTIFUNGAL DRUG-RESISTANCE; VORICONAZOLE; FUN-1; FLUCONAZOLE; ALBICANS; GROWTH; PROBES; YEAST; ETEST	Background: Acquired resistance to antifungal agents now supports the introduction of susceptibility testing for species-drug combinations for which this was previously thought unnecessary. For pathogenic yeasts, conventional phenotypic testing needs at least 24 h. Culture on a porous aluminum oxide (PAO) support combined with microscopy offers a route to more rapid results. Methods: Microcolonies of Candida species grown on PAO were stained with the fluorogenic dyes Fun-1 and Calcofluor White and then imaged by fluorescence microscopy. Images were captured by a charge-coupled device camera and processed by publicly available software. By this method, the growth of yeasts could be detected and quantified within 2 h. Microcolony imaging was then used to assess the susceptibility of the yeasts to amphotericin B, anidulafungin and caspofungin (3.5 h culture), and voriconazole and itraconazole (7 h culture). Significance: Overall, the results showed good agreement with EUCAST (86.5% agreement; n = 170) and E-test (85.9% agreement; n = 170). The closest agreement to standard tests was found when testing susceptibility to amphotericin B and echinocandins (88.2 to 91.2%) and the least good for the triazoles (79.4 to 82.4%). Furthermore, large datasets on population variation could be rapidly obtained. An analysis of microcolonies revealed subtle effects of antimycotics on resistant strains and below the MIC of sensitive strains, particularly an increase in population heterogeneity and cell density-dependent effects of triazoles. Additionally, the method could be adapted to strain identification via germ tube extension. We suggest PAO culture is a rapid and versatile method that may be usefully adapted to clinical mycology and has research applications.	[Ingham, Colin J.; Boonstra, Sjoukje; Levels, Suzanne; de Lange, Marit; Schneeberger, Peter M.] Jeroen Bosch Hosp, Shertogenbosch, Netherlands; [Ingham, Colin J.] MicroDish BV, Utrecht, Netherlands; [Ingham, Colin J.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Meis, Jacques F.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Meis, Jacques F.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands	Jeroen Bosch Ziekenhuis; Wageningen University & Research; Radboud University Nijmegen; Canisius-Wilhelmina Hospital	Ingham, CJ (corresponding author), Jeroen Bosch Hosp, Shertogenbosch, Netherlands.	colinutrecht@gmail.com	Meis, Jacques F/A-9241-2010	Meis, Jacques F/0000-0003-3253-6080	JBZ Hospital; Astellas; Merck; Basilea; Schering-Plough; Pfizer; Janssen Pharmaceutica	JBZ Hospital; Astellas(Astellas Pharmaceuticals); Merck(Merck & Company); Basilea; Schering-Plough(Merck & CompanySchering Plough Corporation); Pfizer(Pfizer); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was funded by the JBZ Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: CI is an employee of a company that manufactures culture disposables from porous aluminum oxide, but this work is not part of the core commercial interests of MicroDish BV. JFM received grants from Astellas, Merck, Basilea and Schering-Plough. He has been a consultant to Astellas, Basilea and Merck and received speaker's fees from Merck, Pfizer, Schering-Plough and Janssen Pharmaceutica. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Bauters TGM, 2000, J CLIN MICROBIOL, V38, P3796, DOI 10.1128/JCM.38.10.3796-3799.2000; Chamilos G, 2005, DRUG RESIST UPDATE, V8, P344, DOI 10.1016/j.drup.2006.01.001; den Besten HMW, 2007, APPL ENVIRON MICROB, V73, P4797, DOI 10.1128/AEM.00404-07; den Hertog AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011008; GALGIANI JN, 1987, ANTIMICROB AGENTS CH, V31, P1343, DOI 10.1128/AAC.31.9.1343; Henry-Stanley MJ, 2004, J MICROBIOL METH, V59, P289, DOI 10.1016/j.mimet.2004.07.001; Ingham CJ, 2008, INT J TUBERC LUNG D, V12, P645; Ingham CJ, 2005, APPL ENVIRON MICROB, V71, P8978, DOI 10.1128/AEM.71.12.8978-8981.2005; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Ingham CJ, 2006, J MED MICROBIOL, V55, P1511, DOI 10.1099/jmm.0.46585-0; Jenks P, 2008, J ANTIMICROB CHEMOTH, V62, pII1, DOI 10.1093/jac/dkn419; JOHNSON EM, 1995, J ANTIMICROB CHEMOTH, V35, P103, DOI 10.1093/jac/35.1.103; Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X; London R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008609; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Meletiadis J, 2002, J CLIN MICROBIOL, V40, P2876, DOI 10.1128/JCM.40.8.2876-2885.2002; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Park BJ, 2006, ANTIMICROB AGENTS CH, V50, P1287, DOI 10.1128/AAC.50.4.1287-1292.2006; Perera THS, 1997, J MED VET MYCOL, V35, P289; Perumal P, 2007, ANTIMICROB AGENTS CH, V51, P2454, DOI 10.1128/AAC.01237-06; Pfaller MA, 2006, J CLIN MICROBIOL, V44, P819, DOI 10.1128/JCM.44.3.819-826.2006; PFALLER MA, 1994, J CLIN MICROBIOL, V32, P1992, DOI 10.1128/JCM.32.8.1992-1996.1994; Pina-Vaz C, 2005, J ANTIMICROB CHEMOTH, V56, P678, DOI 10.1093/jac/dki264; Pina-Vaz C, 2005, J CLIN MICROBIOL, V43, P4674, DOI 10.1128/JCM.43.9.4674-4679.2005; Rodriguez-Tudela JL, 2008, CLIN MICROBIOL INFEC, V14, P985, DOI 10.1111/j.1469-0691.2008.02087.x; SHERWOOD J, 1992, J MED VET MYCOL, V30, P461; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Warnock DW, 1998, J ANTIMICROB CHEMOTH, V42, P321, DOI 10.1093/jac/42.3.321; Wenisch C, 2001, J CLIN MICROBIOL, V39, P2458, DOI 10.1128/JCM.39.7.2458-2462.2001	30	35	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33818	10.1371/journal.pone.0033818	http://dx.doi.org/10.1371/journal.pone.0033818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439000	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100100
J	Van Tassell, BW; Arena, RA; Toldo, S; Mezzaroma, E; Azam, T; Seropian, IM; Shah, K; Canada, J; Voelkel, NF; Dinarello, CA; Abbate, A				Van Tassell, Benjamin W.; Arena, Ross A.; Toldo, Stefano; Mezzaroma, Eleonora; Azam, Tania; Seropian, Ignacio M.; Shah, Keyur; Canada, Justin; Voelkel, Norbert F.; Dinarello, Charles A.; Abbate, Antonio			Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BETA-ADRENERGIC RESPONSIVENESS; LEFT-VENTRICULAR FUNCTION; MICE; ECHOCARDIOGRAPHY; PERFORMANCE; STATEMENT; CAPACITY; ANAKINRA; THERAPY	Background: Heart failure (HF) is a complex clinical syndrome characterized by impaired cardiac function and poor exercise tolerance. Enhanced inflammation is associated with worsening outcomes in HF patients and may play a direct role in disease progression. Interleukin-1 beta (IL-1 beta) is a pro-inflammatory cytokine that becomes chronically elevated in HF and exerts putative negative inotropic effects. Methods and Results: We developed a model of IL-1 beta-induced left ventricular (LV) dysfunction in healthy mice that exhibited a 32% reduction in LV fractional shortening (P<0.001) and a 76% reduction in isoproterenol response (P<0.01) at 4 hours following a single dose of IL-1 beta 3 mcg/kg. This phenotype was reproducible in mice injected with plasma from HF patients and fully preventable by pretreatment with IL-1 receptor antagonist (anakinra). This led to the design and conduct of a pilot clinical to test the effect of anakinra on cardiopulmonary exercise performance in patients with HF and evidence of elevated inflammatory signaling (n = 7). The median peak oxygen consumption (VO2) improved from 12.3 [10.0, 15.2] to 15.1 [13.7, 19.3] mL.kg(-1).min(-1) (P = 0.016 vs. baseline) and median ventilator efficiency (V-E/VCO2 slope) improved from 28.1 [22.8, 31.7] to 24.9 [22.9, 28.3] (P = 0.031 vs. baseline). Conclusions: These findings suggest that IL-1 beta activity contributes to poor exercise tolerance in patients with systolic HF and identifies IL-1 beta blockade as a novel strategy for pharmacologic intervention.	[Van Tassell, Benjamin W.; Mezzaroma, Eleonora; Seropian, Ignacio M.] Virginia Commonwealth Univ, Sch Pharm, Richmond, VA 23220 USA; [Van Tassell, Benjamin W.; Toldo, Stefano; Mezzaroma, Eleonora; Seropian, Ignacio M.; Voelkel, Norbert F.; Abbate, Antonio] Virginia Commonwealth Univ, Victoria Johnson Ctr, Richmond, VA USA; [Arena, Ross A.] Univ New Mexico, Phys Therapy Program, Albuquerque, NM 87131 USA; [Toldo, Stefano; Shah, Keyur; Abbate, Antonio] Virginia Commonwealth Univ, Pauley Heart Ctr, Richmond, VA USA; [Azam, Tania; Dinarello, Charles A.] Univ Colorado, Dept Internal Med, Boulder, CO 80309 USA; [Canada, Justin] Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; University of New Mexico; Virginia Commonwealth University; University of Colorado System; University of Colorado Boulder; Virginia Commonwealth University	Van Tassell, BW (corresponding author), Virginia Commonwealth Univ, Sch Pharm, Richmond, VA 23220 USA.	bvantassell@vcu.edu	Arena, Ross/A-3141-2008; Arena, Ross/AAY-7646-2020; Dinarello, Charles/C-8524-2013; Abbate, Antonio/G-8805-2016; Abbate, Antonio/E-3405-2014	Arena, Ross/0000-0002-6675-1996; Abbate, Antonio/0000-0002-1930-785X; Seropian, Ignacio Miguel/0000-0002-6823-4001; Canada, Justin/0000-0002-1342-7463; Toldo, Stefano/0000-0002-1588-4019	National Center for Research Resources [UL1RR031990]; American Heart Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000057, UL1TR000058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031990] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by award number UL1RR031990 from the National Center for Research Resources [BVT]. This project also received support from an American Heart Association Scientist Development Grant [AA]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Abbate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027923; Abbate A, 2010, EUR J HEART FAIL, V12, P319, DOI 10.1093/eurjhf/hfq017; Abbate A, 2010, AM J CARDIOL, V105, P1371, DOI 10.1016/j.amjcard.2009.12.059; Araujo JP, 2009, J CARD FAIL, V15, P256, DOI 10.1016/j.cardfail.2008.10.030; Arena R, 2008, HEART FAIL REV, V13, P245, DOI 10.1007/s10741-007-9067-5; Arena Ross, 2003, J Cardiopulm Rehabil, V23, P183, DOI 10.1097/00008483-200305000-00004; Baba R, 1996, Nagoya J Med Sci, V59, P55; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Broberg CS, 2003, J AM SOC ECHOCARDIOG, V16, P814, DOI 10.1067/S0894-7317(03)00399-7; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Deswal A, 2001, CIRCULATION, V103, P2055; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Guazzi M, 2009, CURR VASC PHARMACOL, V7, P557, DOI 10.2174/157016109789043955; GULICK T, 1989, P NATL ACAD SCI USA, V86, P6753, DOI 10.1073/pnas.86.17.6753; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Ikonomidis I, 2008, CIRCULATION, V117, P2662, DOI 10.1161/CIRCULATIONAHA.107.731877; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Judgutt BI, 1989, CAN J CARDIOL, V5, P211; KONES RJ, 1975, ACTA CARDIOL, V30, P353; LEGAL YM, 1990, CAN J CARDIOL, V6, P405; Liu SJ, 1999, AM J PHYSIOL-HEART C, V276, pH141, DOI 10.1152/ajpheart.1999.276.1.H141; Long C S, 2001, Heart Fail Rev, V6, P81; Mann DL, 2005, AM J CARDIOL, V95, p9C, DOI 10.1016/j.amjcard.2005.03.007; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Piepoli MF, 2006, EUR J CARDIOV PREV R, V13, P485; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Syed F, 2005, J AM SOC ECHOCARDIOG, V18, P982, DOI 10.1016/j.echo.2005.05.001; Tei C, 1995, J Cardiol, V26, P357; Van Tassell BW, 2010, J CARDIOVASC PHARM, V55, P117, DOI 10.1097/FJC.0b013e3181c87e53	35	144	145	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33438	10.1371/journal.pone.0033438	http://dx.doi.org/10.1371/journal.pone.0033438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438931	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100046
J	Lundstrom, SL; Yang, J; Kallberg, HJ; Thunberg, S; Gafvelin, G; Haeggstrom, JZ; Gronneberg, R; Grunewald, J; van Hage, M; Hammock, BD; Eklund, A; Wheelock, AM; Wheelock, CE				Lundstrom, Susanna L.; Yang, Jun; Kallberg, Henrik J.; Thunberg, Sarah; Gafvelin, Guro; Haeggstrom, Jesper Z.; Gronneberg, Reidar; Grunewald, Johan; van Hage, Marianne; Hammock, Bruce D.; Eklund, Anders; Wheelock, Asa M.; Wheelock, Craig E.			Allergic Asthmatics Show Divergent Lipid Mediator Profiles from Healthy Controls Both at Baseline and following Birch Pollen Provocation	PLOS ONE			English	Article							REGULATORY T-CELLS; ARACHIDONIC-ACID; GLOBAL BURDEN; LEUKOTRIENES; INFLAMMATION; PROSTAGLANDINS; 15-LIPOXYGENASE; IDENTIFICATION; BIOSYNTHESIS; IMMUNOLOGY	Background: Asthma is a respiratory tract disorder characterized by airway hyper-reactivity and chronic inflammation. Allergic asthma is associated with the production of allergen-specific IgE and expansion of allergen-specific T-cell populations. Progression of allergic inflammation is driven by T-helper type 2 (Th2) mediators and is associated with alterations in the levels of lipid mediators. Objectives: Responses of the respiratory system to birch allergen provocation in allergic asthmatics were investigated. Eicosanoids and other oxylipins were quantified in the bronchoalveolar lumen to provide a measure of shifts in lipid mediators associated with allergen challenge in allergic asthmatics. Methods: Eighty-seven lipid mediators representing the cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP) metabolic pathways were screened via LC-MS/MS following off-line extraction of bronchoalveolar lavage fluid (BALF). Multivariate statistics using OPLS were employed to interrogate acquired oxylipin data in combination with immunological markers. Results: Thirty-two oxylipins were quantified, with baseline asthmatics possessing a different oxylipin profile relative to healthy individuals that became more distinct following allergen provocation. The most prominent differences included 15-LOX-derived omega-3 and omega-6 oxylipins. Shared-and-Unique-Structures (SUS)-plot modeling showed a correlation (R-2 = 0.7) between OPLS models for baseline asthmatics ((RY)-Y-2[cum] = 0.87, Q(2)[cum] = 0.51) and allergen-provoked asthmatics ((RY)-Y-2[cum] = 0.95, Q(2)[cum] = 0.73), with the majority of quantified lipid mediators and cytokines contributing equally to both groups. Unique structures for allergen provocation included leukotrienes (LTB4 and 6-trans-LTB4), CYP-derivatives of linoleic acid (epoxides/diols), and IL-10. Conclusions: Differences in asthmatic relative to healthy profiles suggest a role for 15-LOX products of both omega-6 and omega-3 origin in allergic inflammation. Prominent differences at baseline levels indicate that non-symptomatic asthmatics are subject to an underlying inflammatory condition not observed with other traditional mediators. Results suggest that oxylipin profiling may provide a sensitive means of characterizing low-level inflammation and that even individuals with mild disease display distinct phenotypic profiles, which may have clinical ramifications for disease.	[Lundstrom, Susanna L.; Haeggstrom, Jesper Z.; Wheelock, Craig E.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden; [Yang, Jun; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Yang, Jun; Hammock, Bruce D.] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA; [Kallberg, Henrik J.] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Thunberg, Sarah; Gafvelin, Guro; van Hage, Marianne] Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden; [Gronneberg, Reidar; Grunewald, Johan; Eklund, Anders; Wheelock, Asa M.] Karolinska Inst, Div Resp Med, Dept Med, Stockholm, Sweden	Karolinska Institutet; University of California System; University of California Davis; University of California System; University of California Davis; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Lundstrom, SL (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden.	Asa.Wheelock@ki.se; Craig.Wheelock@ki.se	Grunewald, Johan/GQZ-8122-2022; Wheelock, Åsa/B-7904-2017; Yang, Jun/B-2262-2010; van Hage, Marianne/A-9678-2017	Wheelock, Åsa/0000-0002-8013-2745; Yang, Jun/0000-0001-8126-1728; van Hage, Marianne/0000-0003-3091-1596; Thunberg, Sarah/0000-0001-6912-6048; Gafvelin, Guro/0000-0003-1618-4011; Grunewald, Johan/0000-0003-0473-3984; Lundstrom, Susanna/0000-0003-2363-4287	Center for Allergy Research; Bernard Osher Initiative for Research on Severe Asthma; Swedish Heart-Lung Foundation; Swedish Foundation for Strategic Research; VINNOVA; National Institute of Environmental Health Science (NIEHS) [R01 ES02710, R01 ES013933]; American Asthma Foundation [09-0269]; NIEHS [P42 ES002710]; Cancer and Allergy Fou'dation; The Swedish Asthma and Allergy Association's Research Foundation; The Swedish Research Council; The Torsten and Ragnar Soderberg Foundation; The Stockholm County Council; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013933, R37ES002710, R01ES002710] Funding Source: NIH RePORTER	Center for Allergy Research; Bernard Osher Initiative for Research on Severe Asthma; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); VINNOVA(Vinnova); National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Asthma Foundation; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer and Allergy Fou'dation; The Swedish Asthma and Allergy Association's Research Foundation; The Swedish Research Council(Swedish Research Council); The Torsten and Ragnar Soderberg Foundation; The Stockholm County Council(Stockholm County Council); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the following sources: 1) Center for Allergy Research (http://ki.se/ki/jsp/polopoly.jsp;jsessionid=aHsj9g2kXX-6Yd2D5x?l =en & d=4477); 2) Bernard Osher Initiative for Research on Severe Asthma (http://ki.se/ki/jsp/polopoly.jsp?l=en & d=28528); 3) Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se/HLF/In-English/); 4) Swedish Foundation for Strategic Research (http://www.stratresearch.se/en/); 5) VINNOVA (http://www.vinnova.se/en/); 6) R01 ES02710 and R01 ES013933 from the National Institute of Environmental Health Science (NIEHS) (http://www.niehs.nih.gov/); 7) American Asthma Foundation # 09-0269 (http://www.americanasthmafoundation.org/); 8) NIEHS Superfund Basic Research Program P42 ES002710 (http://www.niehs.nih.gov/); 9) Cancer and Allergy Fou'dation (http://www.cancerochallergifonden.se/); 10) The Swedish Asthma and Allergy Association's Research Foundation (http://www.astmaoallergiforbundet.se/). 11) The Swedish Research Council (http://www.vr.se/); 12) The Torsten and Ragnar Soderberg Foundation (http://www.soderbergsstiftelser.se/); 13) The Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 2002, STAT METHODS MED RES; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brown CD, 2001, INFLAMM RES, V50, P321, DOI 10.1007/PL00000251; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; Chu H. W., 2002, Clinical and Experimental Allergy, V32, P1558, DOI 10.1046/j.1365-2222.2002.01477.x; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Corry DB, 2002, NAT REV DRUG DISCOV, V1, P55, DOI 10.1038/nrd702; DAHLEN B, 1994, EUR RESPIR J, V7, P324, DOI 10.1183/09031936.94.07020324; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; EKLUND A, 1986, THORAX, V41, P629, DOI 10.1136/thx.41.8.629; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Feng CL, 2006, BLOOD, V107, P3243, DOI 10.1182/blood-2005-07-2772; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gauvreau GM, 1999, AM J RESP CRIT CARE, V159, P31, DOI 10.1164/ajrccm.159.1.9804030; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; HAMBERG M, 1993, ARCH BIOCHEM BIOPHYS, V305, P115, DOI 10.1006/abbi.1993.1400; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Holgate Stephen T., 2003, Journal of Allergy and Clinical Immunology, V111, pS18, DOI 10.1067/mai.2003.25; Hsi LC, 2001, J BIOL CHEM, V276, P34545, DOI 10.1074/jbc.M100280200; JUBIZ W, 1981, BIOCHEM BIOPH RES CO, V99, P976, DOI 10.1016/0006-291X(81)91258-4; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kay AB, 2001, NEW ENGL J MED, V344, P109, DOI 10.1056/NEJM200101113440206; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; KUMLIN M, 1990, ARCH BIOCHEM BIOPHYS, V282, P254, DOI 10.1016/0003-9861(90)90114-E; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lemanske Jr. R.F., 2003, J ALLERGY CLIN IMMUN, V111, pS502; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Lundstrom SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023864; Lundstrom SL, 2011, CURR PHARM BIOTECHNO, V12, P1026; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Maddipati KR, 2011, PROSTAG OTH LIPID M, V94, P59, DOI 10.1016/j.prostaglandins.2011.01.003; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; MCGIFF JC, 1991, ANNU REV PHARMACOL, V31, P339, DOI 10.1146/annurev.pa.31.040191.002011; Moghaddam MF, 1997, NAT MED, V3, P562, DOI 10.1038/nm0597-562; Moore ML, 2006, J ALLERGY CLIN IMMUN, V117, P1036, DOI 10.1016/j.jaci.2005.12.1314; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; Ono E, 2009, CLIN EXP ALLERGY, V39, P72, DOI 10.1111/j.1365-2222.2008.03104.x; Ono E, 2008, J ALLERGY CLIN IMMUN, V122, P768, DOI 10.1016/j.jaci.2008.06.009; OZAWA T, 1988, AM REV RESPIR DIS, V137, P535, DOI 10.1164/ajrccm/137.3.535; Park GY, 2006, AM J PHYSIOL-LUNG C, V290, pL797, DOI 10.1152/ajplung.00513.2005; PAVORD ID, 1995, LANCET, V345, P436, DOI 10.1016/S0140-6736(95)90409-3; Phipatanakul W, 2000, J ALLERGY CLIN IMMUN, V105, P704, DOI 10.1067/mai.2000.105123; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; SHANNON VR, 1993, AM REV RESPIR DIS, V147, P1024, DOI 10.1164/ajrccm/147.4.1024; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; SWEATMAN WJ, 1968, NATURE, V217, P69, DOI 10.1038/217069a0; TAYLOR IK, 1991, LANCET, V337, P690, DOI 10.1016/0140-6736(91)90277-V; Thunberg S, 2010, ALLERGY, V65, P311, DOI 10.1111/j.1398-9995.2009.02218.x; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Xue LZ, 2005, J IMMUNOL, V175, P6531, DOI 10.4049/jimmunol.175.10.6531; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n	61	46	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33780	10.1371/journal.pone.0033780	http://dx.doi.org/10.1371/journal.pone.0033780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438998	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309000040
J	Owen, LA; Uehara, H; Cahoon, J; Huang, W; Simonis, J; Ambati, BK				Owen, Leah A.; Uehara, Hironori; Cahoon, Judd; Huang, Wei; Simonis, Jacquelyn; Ambati, Balamurali K.			Morpholino-Mediated Increase in Soluble Flt-1 Expression Results in Decreased Ocular and Tumor Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; BREAST-CANCER; CHOROIDAL NEOVASCULARIZATION; RETINAL NEOVASCULARIZATION; FACTOR RECEPTOR-1; NONHUMAN PRIMATE; VEGF; ANGIOGENESIS; METASTASIS	Background: Angiogenesis is a key process in several ocular disorders and cancers. Soluble Flt-1 is an alternatively spliced form of the Flt-1 gene that retains the ligand-binding domain, but lacks the membrane-spanning and intracellular kinase domains of the full-length membrane bound Flt-1 (mbFlt-1) protein. Thus, sFlt-1 is an endogenous inhibitor of VEGF-A mediated angiogenesis. Synthetic mopholino oligomers directed against splice site targets can modulate splice variant expression. We hypothesize that morpholino-induced upregulation of sFlt-1 will suppress angiogenesis in clinically relevant models of macular degeneration and breast cancer. Methods and Findings: In vivo morpholino constructs were designed to target murine exon/intron 13 junction of the Flt-1 transcript denoted VEGFR1_MOe13; standard nonspecific morpholino was used as control. After nucleofection of endothelial and breast adenocarcinoma cell lines, total RNA was extracted and real-time RT-PCR performed for sFlt-1 and mbFlt-1. Intravitreal injections of VEGFR1_MOe13 or control were done in a model of laser-induced choroidal neovascularization and intratumoral injections were performed in MBA-MD-231 xenografts in nude mice. VEGFR1_MOe13 elevated sFlt-1 mRNA expression and suppressed mbFlt-1 mRNA expression in vitro in multiple cellular backgrounds (p<0.001). VEGFR1_MOe13 also elevated sFlt/mbFlt-1 ratio in vivo after laser choroidal injury 5.5 fold (p<0.001) and suppressed laser-induced CNV by 50% (p = 0.0179). This latter effect was reversed by RNAi of sFlt-1, confirming specificity of morpholino activity through up-regulation of sFlt-1. In the xenograft model, VEGFR1_MOe13 regressed tumor volume by 88.9%, increased sFlt-1 mRNA expression, and reduced vascular density by 50% relative to control morpholino treatment (p<0.05). Conclusions: Morpholino oligomers targeting the VEGFR1 mRNA exon/intron 13 junction promote production of soluble FLT-1 over membrane bound FLT-1, resulting in suppression of lesional volume in laser induced CNV and breast adenocarcinoma. Thus, morpholino manipulation of alternative splicing offers translational potential for therapy of angiogenic disorders.	[Owen, Leah A.; Uehara, Hironori; Cahoon, Judd; Huang, Wei; Simonis, Jacquelyn; Ambati, Balamurali K.] Univ Utah, Dept Ophthalmol, Moran Eye Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Owen, LA (corresponding author), Univ Utah, Dept Ophthalmol, Moran Eye Ctr, Salt Lake City, UT 84112 USA.	bala.ambati@utah.edu		Owen, Leah/0000-0003-3802-3868	Research to Prevent Blindness Physician-Scientist Award; National Eye Institute [5R01EY017950]; Veterans Affairs Merit Award; NATIONAL EYE INSTITUTE [R01EY017950, P30EY014800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317] Funding Source: NIH RePORTER	Research to Prevent Blindness Physician-Scientist Award(Research to Prevent Blindness (RPB)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a Research to Prevent Blindness Physician-Scientist Award, National Eye Institute 5R01EY017950, and a Veterans Affairs Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MH, 2010, EXP EYE RES, V91, P837, DOI 10.1016/j.exer.2010.10.013; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Bertin S, 2010, CANCER LETT, V298, P264, DOI 10.1016/j.canlet.2010.07.017; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Cao YH, 2008, J MOL MED, V86, P785, DOI 10.1007/s00109-008-0337-z; Elkin M, 2004, JNCI-J NATL CANCER I, V96, P875, DOI 10.1093/jnci/djh140; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Gasparini G, 2000, Oncologist, V5 Suppl 1, P37; Giovannini M, 2010, CRIT REV ONCOL HEMAT, V76, P13, DOI 10.1016/j.critrevonc.2009.12.004; GREEN WR, 1986, OPHTHALMOLOGY, V93, P1169; Hasumi Y, 2002, CANCER RES, V62, P2019; HAWKINS BS, 1991, ARCH OPHTHALMOL-CHIC, V109, P1109; Hou X, 2010, P NATL ACAD SCI USA, V107, P12216, DOI 10.1073/pnas.1004143107; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Kishuku M, 2009, J IMMUNOL, V183, P8176, DOI 10.4049/jimmunol.0803849; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; la Cour M, 2002, DRUG AGING, V19, P101, DOI 10.2165/00002512-200219020-00003; Lai CM, 2005, MOL THER, V12, P659, DOI 10.1016/j.ymthe.2005.04.022; Lukason M, 2011, MOL THER, V19, P260, DOI 10.1038/mt.2010.230; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; MILLER H, 1990, INVEST OPHTH VIS SCI, V31, P899; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Nieto Y, 2007, BRIT J CANCER, V97, P391, DOI 10.1038/sj.bjc.6603875; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Ozaki H, 1997, EXP EYE RES, V64, P505, DOI 10.1006/exer.1996.0239; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ruffini F, 2011, BRIT J DERMATOL, V164, P1061, DOI 10.1111/j.1365-2133.2010.10200.x; Sazani P, 2010, INT J TOXICOL, V29, P143, DOI 10.1177/1091581809359206; Tolentino MJ, 2002, AM J OPHTHALMOL, V133, P373, DOI 10.1016/S0002-9394(01)01381-2; Wong CG, 2001, CURR EYE RES, V22, P140, DOI 10.1076/ceyr.22.2.140.5528; Yin HF, 2010, MOL THER, V18, P1822, DOI 10.1038/mt.2010.151	36	30	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33576	10.1371/journal.pone.0033576	http://dx.doi.org/10.1371/journal.pone.0033576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438952	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309000032
J	Kozlowski, C; Weimer, RM				Kozlowski, Cleopatra; Weimer, Robby M.			An Automated Method to Quantify Microglia Morphology and Application to Monitor Activation State Longitudinally In Vivo	PLOS ONE			English	Article							EXPRESSION; DYNAMICS; BRAIN; NEUROINFLAMMATION; INFLAMMATION; PROTEIN; INJURY; CNS	Microglia are specialized immune cells of the brain. Upon insult, microglia initiate a cascade of cellular responses including a characteristic change in cell morphology. To study the dynamics of microglia immune response in situ, we developed an automated image analysis method that enables the quantitative assessment of microglia activation state within tissue based solely on cell morphology. Per cell morphometric analysis of fluorescently labeled microglia is achieved through local iterative threshold segmentation, which reduces errors caused by signal-to-noise variation across large volumes. We demonstrate, utilizing systemic application of lipopolysaccharide as a model of immune challenge, that several morphological parameters, including cell perimeter length, cell roundness and soma size, quantitatively distinguish resting versus activated populations of microglia within tissue comparable to traditional immunohistochemistry methods. Furthermore, we provide proof-of-concept data that monitoring soma size enables the longitudinal assessment of microglia activation in the mouse neocortex imaged via 2-photon in vivo microscopy. The ability to quantify microglia activation automatically by shape alone allows unbiased and rapid analysis of both fixed and in vivo central nervous system tissue.	Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Kozlowski, C (corresponding author), Genentech Inc, Dept Safety Assessment, San Francisco, CA 94080 USA.	kozlowski.cleopatra@gene.com			Genentech, inc	Genentech, inc(Roche HoldingGenentech)	The work is funded by Genentech, inc (http://www.gene.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work is funded by Genentech inc., by which CK and RMW are employed and own stocks. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Engberink RDO, 2008, J CEREBR BLOOD F MET, V28, P841, DOI 10.1038/sj.jcbfm.9600580; Girard S, 2008, NEUROREPORT, V19, P997, DOI 10.1097/WNR.0b013e3283036e88; GRAEBER MB, 1990, J NEUROIMMUNOL, V27, P121, DOI 10.1016/0165-5728(90)90061-Q; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lalancette-Hebert M, 2009, BRAIN, V132, P940, DOI 10.1093/brain/awn345; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Otsu N., 1979, IEEE T SYS MAN CYBER, VSMC-9; Palin K, 2008, NEUROBIOL DIS, V30, P19, DOI 10.1016/j.nbd.2007.11.012; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Verdijk P, 2004, EUR J IMMUNOL, V34, P156, DOI 10.1002/eji.200324241; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Zhu LY, 2004, NEUROSCI LETT, V367, P210, DOI 10.1016/j.neulet.2004.06.020	22	142	144	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31814	10.1371/journal.pone.0031814	http://dx.doi.org/10.1371/journal.pone.0031814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22457705	Green Submitted, gold, Green Published			2022-12-27	WOS:000302999600012
J	Morgan-Short, K; Finger, I; Grey, S; Ullman, MT				Morgan-Short, Kara; Finger, Ingrid; Grey, Sarah; Ullman, Michael T.			Second Language Processing Shows Increased Native-Like Neural Responses after Months of No Exposure	PLOS ONE			English	Article							BRAIN POTENTIALS; MEMORY-SYSTEMS; ELECTROPHYSIOLOGICAL EXPLORATION; MATURATIONAL CONSTRAINTS; TIME-COURSE; LANGUAGE; EXPLICIT; IMPLICIT; SLEEP; ERP	Although learning a second language (L2) as an adult is notoriously difficult, research has shown that adults can indeed attain native language-like brain processing and high proficiency levels. However, it is important to then retain what has been attained, even in the absence of continued exposure to the L2-particularly since periods of minimal or no L2 exposure are common. This event-related potential (ERP) study of an artificial language tested performance and neural processing following a substantial period of no exposure. Adults learned to speak and comprehend the artificial language to high proficiency with either explicit, classroom-like, or implicit, immersion-like training, and then underwent several months of no exposure to the language. Surprisingly, proficiency did not decrease during this delay. Instead, it remained unchanged, and there was an increase in native-like neural processing of syntax, as evidenced by several ERP changes-including earlier, more reliable, and more left-lateralized anterior negativities, and more robust P600s, in response to word-order violations. Moreover, both the explicitly and implicitly trained groups showed increased native-like ERP patterns over the delay, indicating that such changes can hold independently of L2 training type. The results demonstrate that substantial periods with no L2 exposure are not necessarily detrimental. Rather, benefits may ensue from such periods of time even when there is no L2 exposure. Interestingly, both before and after the delay the implicitly trained group showed more native-like processing than the explicitly trained group, indicating that type of training also affects the attainment of native-like processing in the brain. Overall, the findings may be largely explained by a combination of forgetting and consolidation in declarative and procedural memory, on which L2 grammar learning appears to depend. The study has a range of implications, and suggests a research program with potentially important consequences for second language acquisition and related fields.	[Morgan-Short, Kara] Univ Illinois, Dept Hispan & Italian Studies, Chicago, IL 60612 USA; [Morgan-Short, Kara] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [Finger, Ingrid; Grey, Sarah; Ullman, Michael T.] Georgetown Univ, Brain & Language Lab, Washington, DC USA; [Finger, Ingrid] Univ Fed Rio Grande do Sul, Dept Modern Languages, Porto Alegre, RS, Brazil	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Georgetown University; Universidade Federal do Rio Grande do Sul	Morgan-Short, K (corresponding author), Univ Illinois, Dept Hispan & Italian Studies, Chicago, IL 60612 USA.	michael@georgetown.edu			National Institutes of Health [RO1 MH58189, RO1 HD049347]; Georgetown University; National Institute of Mental Health (NIMH) [F31 MH67407]; National Science Foundation [0446836]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Brazil); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH067407, R01MH058189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgetown University; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this project was provided to MTU by the National Institutes of Health under RO1 MH58189 and RO1 HD049347; to KMS by a Georgetown University Dissertation Fellowship, by the National Institute of Mental Health (NIMH) under National Research Service Award (NRSA) F31 MH67407, and by the National Science Foundation under Doctoral Dissertation Improvement Grant 0446836 (formally to MTU); and to IF by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; [Anonymous], [No title captured]; [Anonymous], 1989, STUD SECOND LANG ACQ; [Anonymous], 1995, ATTENTION AWARENESS; Bahlmann J, 2006, J COGNITIVE NEUROSCI, V18, P1829, DOI 10.1162/jocn.2006.18.11.1829; BAHRICK HP, 1984, J EXP PSYCHOL GEN, V113, P1, DOI 10.1037/0096-3445.113.1.1; Bardovi-Harlig K, 2010, STUD SECOND LANG ACQ, V32, P1, DOI 10.1017/S0272263109990246; Bever TG, 1988, P 10 ANN M COGN SCI, P276; Birdsong D, 2001, J MEM LANG, V44, P235, DOI 10.1006/jmla.2000.2750; Bjork RA, 1992, ENCY LEARNING MEMORY, P283; Bowden H., 2005, MIND CONTEXT ADULT 2, P105; Brown GDA, 2010, CURR ISS MEM, P49; Carlson Robert, 1994, MOUTON GRAMMAR LIB, V14; Chen L, 2007, BILING-LANG COGN, V10, P161, DOI 10.1017/S136672890700291X; Clahsen H, 2006, APPL PSYCHOLINGUIST, V27, P3, DOI 10.1017/S0142716406060024; Clahsen H, 2006, TRENDS COGN SCI, V10, P564, DOI 10.1016/j.tics.2006.10.002; Clahsen H, 2010, LANG LEARN, V60, P21, DOI 10.1111/j.1467-9922.2009.00550.x; Clay F, 2007, J EXP PSYCHOL LEARN, V33, P970, DOI 10.1037/0278-7393.33.5.970; Davis MH, 2009, J COGNITIVE NEUROSCI, V21, P803, DOI 10.1162/jocn.2009.21059; de Graaff R., 1997, STUDIES 2 LANGUAGE A, V19, P249, DOI DOI 10.1017/S0272263197002064; DeKeyser R.M., 1995, STUDIES 2 LANGUAGE A, V17, P379, DOI [DOI 10.1017/S027226310001425X, 10.1017/S027226310001425X]; DeKeyser Robert M., 2000, STUD SECOND LANG ACQ, V22, P499, DOI 10.1017/S0272263100004022; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Dorfberger S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000240; Doughty C.J., 2003, HDB 2 LANGUAGE ACQUI, P256, DOI DOI 10.1002/9780470756492.CH10; Doughty C.J., 2005, HDB 2 LANGUAGE ACQUI; Durrant SJ, 2011, NEUROPSYCHOLOGIA, V49, P1322, DOI 10.1016/j.neuropsychologia.2011.02.015; Ellis R, 2010, NINJAL PROJECT REV, V1, P3; Ferman S, 2009, J NEUROLINGUIST, V22, P384, DOI 10.1016/j.jneuroling.2008.12.002; Fletcher PC, 2005, CEREB CORTEX, V15, P1002, DOI 10.1093/cercor/bhh201; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Foerde KE, 2007, THESIS U CALIFORNIA; Friederici AD, 2004, NEUROREPORT, V15, P165, DOI 10.1097/00001756-200401190-00032; Friederici AD, 2003, NEUROIMAGE, V20, pS8, DOI 10.1016/j.neuroimage.2003.09.003; Friederici AD, 2002, P NATL ACAD SCI USA, V99, P529, DOI 10.1073/pnas.012611199; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; GARDNER RC, 1985, LANG LEARN, V35, P519, DOI 10.1111/j.1467-1770.1985.tb00359.x; Dowens MG, 2011, NEUROPSYCHOLOGIA, V49, P1651, DOI 10.1016/j.neuropsychologia.2011.02.034; Dowens MG, 2010, J COGNITIVE NEUROSCI, V22, P1870, DOI 10.1162/jocn.2009.21304; Grendel M, 1993, THESIS U NIJMEGEN NI; Hagoort P, 1999, J PSYCHOLINGUIST RES, V28, P715, DOI 10.1023/A:1023277213129; Hahne A, 2006, J COGNITIVE NEUROSCI, V18, P121, DOI 10.1162/089892906775250067; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Hahne A., 2001, BILING-LANG COGN, V4, P123, DOI DOI 10.1017/S1366728901000232; Hancock R, 2009, LING AKT, V146, P303; Hansen L., 1999, 2 LANGUAGE ATTRITION; Hasting AS, 2008, J COGNITIVE NEUROSCI, V20, P1207, DOI 10.1162/jocn.2008.20083; Hernandez AE, 2007, NEUROIMAGE, V36, P912, DOI 10.1016/j.neuroimage.2007.02.055; Isel F, 2007, NEUROREPORT, V18, P1885, DOI 10.1097/WNR.0b013e3282f1d518; Izquierdo I, 2006, NEUROTOX RES, V10, P113, DOI 10.1007/BF03033240; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kam CLH, 2009, COGNITIVE PSYCHOL, V59, P30, DOI 10.1016/j.cogpsych.2009.01.001; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kotz SA, 2009, BRAIN LANG, V109, P68, DOI 10.1016/j.bandl.2008.06.002; Kroll J.F., 2005, HDB BILINGUALISM PSY; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Leask SJ, 2001, TRENDS COGN SCI, V5, P513, DOI 10.1016/S1364-6613(00)01795-2; Leow R. P., 2005, MIND CONTEXT ADULT 2, P179; Mackey A, 2012, HDB 2 LANGUAGE ACQUI; Macmillan NA, 2005, DETECTION THEORY USE; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Martin-Loeches M, 2005, PSYCHOPHYSIOLOGY, V42, P508, DOI 10.1111/j.1469-8986.2005.00308.x; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2000, TRENDS PHARMACOL SCI, V21, P208, DOI 10.1016/S0165-6147(00)01473-5; McLaughlin J, 2004, NAT NEUROSCI, V7, P703, DOI 10.1038/nn1264; Mehotcheva TH, 2010, THESIS RIJKSUNIVERSI; Moreno EM, 2005, COGNITIVE BRAIN RES, V22, P205, DOI 10.1016/j.cogbrainres.2004.08.010; Morgan-Short K., 2012, ROUTLEDGE HDB 2 LANG, P282; Morgan-Short K, 2012, J COGNITIVE NEUROSCI, V24, P933, DOI 10.1162/jocn_a_00119; Morgan-Short K, 2010, LANG LEARN, V60, P154, DOI 10.1111/j.1467-9922.2009.00554.x; Mueller JL, 2005, SECOND LANG RES, V21, P152, DOI 10.1191/0267658305sr256oa; Mueller JL, 2005, J COGNITIVE NEUROSCI, V17, P1229, DOI 10.1162/0898929055002463; Murtagh L., 2004, INT J BILINGUAL, V8, P279, DOI DOI 10.1177/13670069040080030701; Neath I., 2003, HUMAN MEMORY; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Norris JM, 2000, LANG LEARN, V50, P417, DOI 10.1111/0023-8333.00136; Oikkenon Soile., 1996, STUDIES 2 LANGUAGE A, V18, P495, DOI [10.1017/s0272263100015394, DOI 10.1017/S0272263100015394]; Ojima S, 2005, J COGNITIVE NEUROSCI, V17, P1212, DOI 10.1162/0898929055002436; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Opitz B, 2003, NEUROIMAGE, V19, P1730, DOI 10.1016/S1053-8119(03)00170-8; Osterhout L, 1997, MEM COGNITION, V25, P273, DOI 10.3758/BF03211283; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 2008, J NEUROLINGUIST, V21, P509, DOI 10.1016/j.jneuroling.2008.01.001; Packard MG, 1999, P NATL ACAD SCI USA, V96, P12881, DOI 10.1073/pnas.96.22.12881; Pakulak E, 2010, J COGNITIVE NEUROSCI, V22, P2728, DOI 10.1162/jocn.2009.21393; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rosa EM, 2004, MOD LANG J, V88, P192, DOI 10.1111/j.0026-7902.2004.00225.x; Saffran J, 2008, COGNITION, V107, P479, DOI 10.1016/j.cognition.2007.10.010; Saffran JR, 2001, J MEM LANG, V44, P493, DOI 10.1006/jmla.2000.2759; Sanz C, 2004, LANG LEARN, V54, P35, DOI 10.1111/j.1467-9922.2004.00248.x; Sanz C., 2005, MIND CONTEXT ADULT 2, P3; Sanz C, 2005, MIND CONTEXT ADULT 2, P234; Schmid MS, 2004, GERMAN DIASPORIC EXP, P491; Schmidt GL, 2009, SECOND LANG RES, V25, P135, DOI 10.1177/0267658308098999; Seidler RD, 2005, EXP BRAIN RES, V165, P114, DOI 10.1007/s00221-005-2284-z; Spada N, 2010, LANG LEARN, V60, P263, DOI 10.1111/j.1467-9922.2010.00562.x; Squire L.R., 2002, NEUROPSYCHOLOGY MEMO; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; Steinhauer K, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P91, DOI 10.1016/B978-0-08-045352-1.00009-4; Steinhauer K, 2009, SECOND LANG RES, V25, P13, DOI 10.1177/0267658308098995; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tokowicz N, 2005, STUD SECOND LANG ACQ, V27, P173, DOI 10.1017/S0272263105050102; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Ullman M, 2005, MIND CONTEXT ADULT 2, P141; Ullman M.T., 2001, BILING-LANG COGN, V4, P105, DOI [10.1017/S1366728901000220, DOI 10.1017/S1366728901000220]; Ullman M.T., 2008, SEX DIFFERENCES BRAI, P291; Ullman M. T., 2007, OXFORD HDB PSYCHOLIN, P267, DOI DOI 10.1093/OXFORDHB/9780198568971.013.0016; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Ullman MT, 2012, ROUTLEDGE ENCY 2 LAN; van den Brink D, 2004, J COGNITIVE NEUROSCI, V16, P1068, DOI 10.1162/0898929041502670; van Hell JG, 2010, SECOND LANG RES, V26, P43, DOI 10.1177/0267658309337637; Walenski M, 2005, LINGUIST REV, V22, P327, DOI 10.1515/tlir.2005.22.2-4.327; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; WeberFox CM, 1996, J COGNITIVE NEUROSCI, V8, P231, DOI 10.1162/jocn.1996.8.3.231; Williams D, 2008, PSYCHOL BULL, V134, P944, DOI 10.1037/a0013743; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Ye Z, 2006, BRAIN RES, V1071, P186, DOI 10.1016/j.brainres.2005.11.085	127	62	63	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32974	10.1371/journal.pone.0032974	http://dx.doi.org/10.1371/journal.pone.0032974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948FM	22470434	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000013
J	Visser, TAW; Ohan, JL				Visser, Troy A. W.; Ohan, Jeneva L.			How Does Information Processing Speed Relate to the Attentional Blink?	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; SELECTIVE ATTENTION; TEMPORAL ATTENTION; PERCEPTUAL LOAD; TASK-IRRELEVANT; T1 DIFFICULTY; NAMING SPEED; DYSLEXIA	Background: When observers are asked to identify two targets in rapid sequence, they often suffer profound performance deficits for the second target, even when the spatial location of the targets is known. This attentional blink (AB) is usually attributed to the time required to process a previous target, implying that a link should exist between individual differences in information processing speed and the AB. Methodology/Principal Findings: The present work investigated this question by examining the relationship between a rapid automatized naming task typically used to assess information-processing speed and the magnitude of the AB. The results indicated that faster processing actually resulted in a greater AB, but only when targets were presented amongst high similarity distractors. When target-distractor similarity was minimal, processing speed was unrelated to the AB. Conclusions/Significance: Our findings indicate that information-processing speed is unrelated to target processing efficiency per se, but rather to individual differences in observers' ability to suppress distractors. This is consistent with evidence that individuals who are able to avoid distraction are more efficient at deploying temporal attention, but argues against a direct link between general processing speed and efficient information selection.	[Visser, Troy A. W.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Ohan, Jeneva L.] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia	University of Queensland; Queensland University of Technology (QUT)	Visser, TAW (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	taw.visser@gmail.com		Visser, Troy/0000-0003-3960-2263; Ohan, Jeneva/0000-0002-4801-4239	UQ Early Career Research Grant; QUT Women in Research Award	UQ Early Career Research Grant; QUT Women in Research Award	This work was supported by a UQ Early Career Research Grant (TAWV) and a QUT Women in Research Award (JLO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek EG, 2007, MEM COGNITION, V35, P621, DOI 10.3758/BF03193300; Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; Arnell KM, 2006, MEM COGNITION, V34, P1472, DOI 10.3758/BF03195912; Arnell KM, 2010, PSYCHOL RES-PSYCH FO, V74, P457, DOI 10.1007/s00426-009-0265-8; BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Badcock NA, 2008, VISION RES, V48, P1497, DOI 10.1016/j.visres.2008.03.008; Catts H. W., 2002, J LEARNING DISABILIT, V32, P38; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Dux PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003330; Folk CL, 2002, PERCEPT PSYCHOPHYS, V64, P741, DOI 10.3758/BF03194741; Gillard-Crewther S, 2007, CLIN EXP OPTOM, V90, P282, DOI 10.1111/j.1444-0938.2007.00160.x; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Jolicoeur P, 1998, MEM COGNITION, V26, P1014, DOI 10.3758/BF03201180; Kail R, 1999, APPL PSYCHOLINGUIST, V20, P303, DOI 10.1017/S0142716499002076; KAIL R, 1994, DEV PSYCHOL, V30, P949, DOI 10.1037/0012-1649.30.6.949; La Roque CL, 2009, VISION RES, V49, P96, DOI 10.1016/j.visres.2008.09.027; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Li CSR, 2002, NEUROREPORT, V13, P1427, DOI 10.1097/00001756-200208070-00016; MAKI WS, 1994, PSYCHON B REV, V1, P499, DOI 10.3758/BF03210954; MARTENS S, 2008, EXPT BRAIN RES, V129, P43; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013562; Martens S, 2009, EXP PSYCHOL, V56, P33, DOI 10.1027/1618-3169.56.1.33; McLaughlin EN, 2001, Q J EXP PSYCHOL-A, V54, P169, DOI 10.1080/02724980042000075; McLean GMT, 2010, CORTEX, V46, P1317, DOI 10.1016/j.cortex.2010.06.010; Nakatani C, 2009, PROG BRAIN RES, V176, P123, DOI 10.1016/S0079-6123(09)17608-2; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; RAYMOND JE, 1995, J EXP PSYCHOL HUMAN, V21, P653, DOI 10.1037/0096-1523.21.3.653; Reinecke A, 2008, J ANXIETY DISORD, V22, P655, DOI 10.1016/j.janxdis.2007.06.004; Rizzo M, 2001, NEUROLOGY, V57, P795, DOI 10.1212/WNL.57.5.795; Seiffert AE, 1997, J EXP PSYCHOL HUMAN, V23, P1061, DOI 10.1037/0096-1523.23.4.1061; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Visser TA, 2004, PERCEPT PSYCHOPHYS, V66, P1418, DOI 10.3758/BF03195008; Visser TAW, 1999, PSYCHOL BULL, V125, P458, DOI 10.1037/0033-2909.125.4.458; Visser TAW, 2004, VISION RES, V44, P2521, DOI 10.1016/j.visres.2004.05.010; Visser TAW, 2007, CAN J EXP PSYCHOL, V61, P102, DOI 10.1037/cjep2007011; Visser TAW, 2007, J EXP PSYCHOL HUMAN, V33, P285, DOI 10.1037/0096-1523.33.2.285; Visser TAW, 2010, Q J EXP PSYCHOL, V63, P1085, DOI 10.1080/17470210903168235; Ward R, 1997, PERCEPT PSYCHOPHYS, V59, P593, DOI 10.3758/BF03211867	47	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e33265	10.1371/journal.pone.0033265	http://dx.doi.org/10.1371/journal.pone.0033265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943KB	22461892	Green Published, gold, Green Submitted			2022-12-27	WOS:000304118900011
J	Chesi, A; Kilaru, A; Fang, XD; Cooper, AA; Gitler, AD				Chesi, Alessandra; Kilaru, Austin; Fang, Xiaodong; Cooper, Antony A.; Gitler, Aaron D.			The Role of the Parkinson's Disease Gene PARK9 in Essential Cellular Pathways and the Manganese Homeostasis Network in Yeast	PLOS ONE			English	Article							ALPHA-SYNUCLEIN TOXICITY; SACCHAROMYCES-CEREVISIAE; DOPAMINERGIC-NEURONS; VACUOLAR HYDROLASES; SEPTIN CDCREL-1; BINDING PROTEIN; VTC PROTEINS; LEWY BODIES; COMPLEX; MEMBRANE	YPK9 (Yeast PARK9; also known as YOR291W) is a non-essential yeast gene predicted by sequence to encode a transmembrane P-type transport ATPase. However, its substrate specificity is unknown. Mutations in the human homolog of YPK9, ATP13A2/PARK9, have been linked to genetic forms of early onset parkinsonism. We previously described a strong genetic interaction between Ypk9 and another Parkinson's disease (PD) protein alpha-synuclein in multiple model systems, and a role for Ypk9 in manganese detoxification in yeast. In humans, environmental exposure to toxic levels of manganese causes a syndrome similar to PD and is thus an environmental risk factor for the disease. How manganese contributes to neurodegeneration is poorly understood. Here we describe multiple genome-wide screens in yeast aimed at defining the cellular function of Ypk9 and the mechanisms by which it protects cells from manganese toxicity. In physiological conditions, we found that Ypk9 genetically interacts with essential genes involved in cellular trafficking and the cell cycle. Deletion of Ypk9 sensitizes yeast cells to exposure to excess manganese. Using a library of non-essential gene deletions, we screened for additional genes involved in tolerance to excess manganese exposure, discovering several novel pathways involved in manganese homeostasis. We defined the dependence of the deletion strain phenotypes in the presence of manganese on Ypk9, and found that Ypk9 deletion modifies the manganese tolerance of only a subset of strains. These results confirm a role for Ypk9 in manganese homeostasis and illuminates cellular pathways and biological processes in which Ypk9 likely functions.	[Chesi, Alessandra; Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Chesi, Alessandra; Kilaru, Austin; Fang, Xiaodong] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cooper, Antony A.] Univ New S Wales, Garvan Inst Med Res, Sydney, NSW, Australia	Stanford University; University of Pennsylvania; Pennsylvania Medicine; Garvan Institute of Medical Research; University of New South Wales Sydney	Chesi, A (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	agitler@stanford.edu	Chesi, Alessandra/AAT-8248-2020; Chesi, Alessandra/N-7693-2017	Gitler, Aaron/0000-0001-8603-1526; Chesi, Alessandra/0000-0002-0954-7446	National Institutes of Health [1DP2OD004417]; Parkinson Disease Foundation; Pew Charitable Trusts; Rita Allen Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson Disease Foundation; Pew Charitable Trusts; Rita Allen Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Director's New Innovator Award 1DP2OD004417 awarded to ADG. By a Postdoctoral Fellowship from the Parkinson Disease Foundation to AC. ADG is a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts and a Rita Allen Foundation Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dogic D, 1999, EUR J CELL BIOL, V78, P305, DOI 10.1016/S0171-9335(99)80064-8; Dong ZZ, 2003, P NATL ACAD SCI USA, V100, P12438, DOI 10.1073/pnas.2132992100; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Field CM, 1999, TRENDS CELL BIOL, V9, P387, DOI 10.1016/S0962-8924(99)01632-3; Fujishima K, 2007, J NEUROCHEM, V102, P77, DOI 10.1111/j.1471-4159.2007.04478.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gitler AD, 2008, NEUROSIGNALS, V16, P52, DOI 10.1159/000109759; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lapinskas PJ, 1996, MOL MICROBIOL, V21, P519, DOI 10.1111/j.1365-2958.1996.tb02561.x; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; NEWMAN AP, 1990, MOL CELL BIOL, V10, P3405, DOI 10.1128/MCB.10.7.3405; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Paidhungat M, 1998, GENETICS, V148, P1787; Pal PK, 1999, NEUROTOXICOLOGY, V20, P227; Peng XR, 2002, MOL CELL BIOL, V22, P378, DOI 10.1128/MCB.22.1.378-387.2002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Portnoy ME, 2002, BIOCHEM J, V362, P119, DOI 10.1042/bj3620119; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROSSI G, 1991, NATURE, V351, P158, DOI 10.1038/351158a0; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Sigel A., 2000, METAL IONS BIOL SYST, V37; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Son JH, 2005, J NEUROCHEM, V94, P1040, DOI 10.1111/j.1471-4159.2005.03257.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Srivastava A, 1998, GENETICS, V148, P85; Tan J, 2011, J BIOL CHEM; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Uttenweiler A, 2007, MOL BIOL CELL, V18, P166, DOI 10.1091/mbc.E06-08-0664; Vilarino-Guell C, AM J HUM GENET, V89, P162; Yang M, 2005, BIOCHEM J, V386, P479, DOI 10.1042/BJ20041582; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zimprich A, AM J HUM GENET, V89, P168	61	36	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34178	10.1371/journal.pone.0034178	http://dx.doi.org/10.1371/journal.pone.0034178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457822	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900051
J	Lam, YY; Ha, CWY; Campbell, CR; Mitchell, AJ; Dinudom, A; Oscarsson, J; Cook, DI; Hunt, NH; Caterson, ID; Holmes, AJ; Storlien, LH				Lam, Yan Y.; Ha, Connie W. Y.; Campbell, Craig R.; Mitchell, Andrew J.; Dinudom, Anuwat; Oscarsson, Jan; Cook, David I.; Hunt, Nicholas H.; Caterson, Ian D.; Holmes, Andrew J.; Storlien, Len H.			Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice	PLOS ONE			English	Article							TIGHT JUNCTION PERMEABILITY; ADIPOSE-TISSUE; INSULIN-RESISTANCE; INTESTINAL PERMEABILITY; HEPATIC STEATOSIS; TNF-ALPHA; BARRIER; MOUSE; LIVER; MODULATION	We investigated the relationship between gut health, visceral fat dysfunction and metabolic disorders in diet-induced obesity. C57BL/6J mice were fed control or high saturated fat diet (HFD). Circulating glucose, insulin and inflammatory markers were measured. Proximal colon barrier function was assessed by measuring transepithelial resistance and mRNA expression of tight-junction proteins. Gut microbiota profile was determined by 16S rDNA pyrosequencing. Tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 mRNA levels were measured in proximal colon, adipose tissue and liver using RT-qPCR. Adipose macrophage infiltration (F4/80(+)) was assessed using immunohistochemical staining. HFD mice had a higher insulin/glucose ratio (P = 0.020) and serum levels of serum amyloid A3 (131%; P = 0.008) but reduced circulating adiponectin (64%; P = 0.011). In proximal colon of HFD mice compared to mice fed the control diet, transepithelial resistance and mRNA expression of zona occludens 1 were reduced by 38% (P < 0.001) and 40% (P = 0.025) respectively and TNF-alpha mRNA level was 6.6-fold higher (P = 0.037). HFD reduced Lactobacillus (75%; P < 0.001) but increased Oscillibacter (279%; P = 0.004) in fecal microbiota. Correlations were found between abundances of Lactobacillus (r = 0.52; P = 0.013) and Oscillibacter (r = -0.55; P = 0.007) with transepithelial resistance of the proximal colon. HFD increased macrophage infiltration (58%; P = 0.020), TNF-alpha (2.5-fold, P < 0.001) and IL-6 mRNA levels (2.5-fold; P = 0.008) in mesenteric fat. Increased macrophage infiltration in epididymal fat was also observed with HFD feeding (71%; P = 0.006) but neither TNF-alpha nor IL-6 was altered. Perirenal and subcutaneous adipose tissue showed no signs of inflammation in HFD mice. The current results implicate gut dysfunction, and attendant inflammation of contiguous adipose, as salient features of the metabolic dysregulation of diet-induced obesity.	[Lam, Yan Y.; Caterson, Ian D.; Storlien, Len H.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Ha, Connie W. Y.; Holmes, Andrew J.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Campbell, Craig R.; Dinudom, Anuwat; Cook, David I.] Univ Sydney, Discipline Physiol, Bosch Inst, Sydney, NSW 2006, Australia; [Mitchell, Andrew J.; Hunt, Nicholas H.] Univ Sydney, Mol Immunopathol Unit, Bosch Inst, Sydney, NSW 2006, Australia; [Mitchell, Andrew J.; Hunt, Nicholas H.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Oscarsson, Jan] AstraZeneca R&D, Molndal, Sweden	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; AstraZeneca	Lam, YY (corresponding author), Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia.	yan.lam@sydney.edu.au	Holmes, Andrew/AAI-2845-2020; Campbell, Craig R/B-5983-2012; Mitchell, Andrew/C-2714-2009	Campbell, Craig R/0000-0002-0843-7579; Mitchell, Andrew/0000-0003-4454-853X; Ha, Connie Wing Yan/0000-0003-1357-6431	National Health and Medical Research Council of Australia [633240]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a Project Grant (#633240) from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala VJ, 2011, J INFLAMM-LOND, V8, DOI [10.1186/1476-9255-8-5, 10.1186/1476-9255-9-15]; Al-Sadi R, 2010, AM J PATHOL, V177, P2310, DOI 10.2353/ajpath.2010.100371; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Anderson RC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-316; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285; Bertin B, 2010, CURR OPIN CLIN NUTR, V13, P574, DOI 10.1097/MCO.0b013e32833cf0f4; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Campbell EL, 2011, J IMMUNOL, V187, P3475, DOI 10.4049/jimmunol.1100150; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Gambero A, 2007, INFLAMM BOWEL DIS, V13, P1357, DOI 10.1002/ibd.20222; GELBMANN CM, 1995, J CLIN INVEST, V95, P2831, DOI 10.1172/JCI117988; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Kim OY, 2012, PHYTOTHER RES, V26, P432, DOI 10.1002/ptr.3570; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Lam YY, 2011, OBESITY, V19, P2113, DOI 10.1038/oby.2011.68; Lam YY, 2011, OBES RES CLIN PRACT, V5, pE43, DOI 10.1016/j.orcp.2010.12.002; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Oliveira M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/807483; Pachikian B. D., 2008, BMC Physiology, V8, P21, DOI 10.1186/1472-6793-8-21; Paolillo R, 2009, INT IMMUNOPHARMACOL, V9, P1265, DOI 10.1016/j.intimp.2009.07.008; Pond CM, 2005, PROSTAG LEUKOTR ESS, V73, P17, DOI 10.1016/j.plefa.2005.04.005; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Salazar N, 2008, APPL ENVIRON MICROB, V74, P4737, DOI 10.1128/AEM.00325-08; Sam S, 2009, DIABETES CARE, V32, P932, DOI 10.2337/dc08-1856; Schlee M, 2008, CLIN EXP IMMUNOL, V151, P528, DOI 10.1111/j.1365-2249.2007.03587.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Terra X, 2011, J NUTR BIOCHEM, V22, P380, DOI 10.1016/j.jnutbio.2010.03.006; Thomaz MA, 2009, PHARMACOL RES, V60, P341, DOI 10.1016/j.phrs.2009.05.003; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Volynets V, 2010, J LIPID RES, V51, P3414, DOI 10.1194/jlr.M007179; Vrieze A, 2010, DIABETOLOGIA, V53, P606, DOI 10.1007/s00125-010-1662-7; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Xia Y, 2011, J GASTROEN HEPATOL, V26, P405, DOI 10.1111/j.1440-1746.2010.06498.x; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zeyda M, 2010, INT J OBESITY, V34, P1684, DOI 10.1038/ijo.2010.103	66	380	399	4	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34233	10.1371/journal.pone.0034233	http://dx.doi.org/10.1371/journal.pone.0034233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457829	Green Published, gold			2022-12-27	WOS:000304046900058
J	Lavigne, JP; Vergunst, AC; Goret, L; Sotto, A; Combescure, C; Blanco, J; O'Callaghan, D; Nicolas-Chanoine, MH				Lavigne, Jean-Philippe; Vergunst, Annette C.; Goret, Lucie; Sotto, Albert; Combescure, Christophe; Blanco, Jorge; O'Callaghan, David; Nicolas-Chanoine, Marie-Helene			Virulence Potential and Genomic Mapping of the Worldwide Clone Escherichia coli ST131	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS MODEL; URINARY-TRACT-INFECTIONS; SEQUENCE TYPE ST131; PHYLOGENETIC GROUP; BETA-LACTAMASES; STRAINS; RESISTANT; COMMUNITY; EPIDEMIOLOGY; PREVALENCE	Recently, the worldwide propagation of clonal CTX-M-15-producing Escherichia coli isolates, namely ST131 and O25b:H4, has been reported. Like the majority of extra-intestinal pathogenic E. coli isolates, the pandemic clone ST131 belongs to phylogenetic group B2, and has recently been shown to be highly virulent in a mouse model, even though it lacks several genes encoding key virulence factors (Pap, Cnf1 and HlyA). Using two animal models, Caenorhabditis elegans and zebrafish embryos, we assessed the virulence of three E. coli ST131 strains (2 CTX-M-15-producing urine and 1 non-ESBL-producing faecal isolate), comparing them with five non-ST131 B2 and a group A uropathogenic E. coli (UPEC). In C. elegans, the three ST131 strains showed intermediate virulence between the non virulent group A isolate and the virulent non-ST131 B2 strains. In zebrafish, the CTX-M-15-producing ST131 UPEC isolates were also less virulent than the non-ST131 B2 strains, suggesting that the production of CTX-M-15 is not correlated with enhanced virulence. Amongst the non-ST131 B2 group isolates, variation in pathogenic potential in zebrafish embryos was observed ranging from intermediate to highly virulent. Interestingly, the ST131 strains were equally persistent in surviving embryos as the non-ST131-group B2 strains, suggesting similar mechanisms may account for development of persistent infection. Optical maps of the genome of the ST131 strains were compared with those of 24 reference E. coli strains. Although small differences were seen within the ST131 strains, the tree built on the optical maps showed that these strains belonged to a specific cluster (86% similarity) with only 45% similarity with the other group B2 strains and 25% with strains of group A and D. Thus, the ST131 clone has a genetic composition that differs from other group B2 strains, and appears to be less virulent than previously suspected.	[Lavigne, Jean-Philippe; Vergunst, Annette C.; Goret, Lucie; Sotto, Albert; O'Callaghan, David] Univ Montpellier I, Inst Natl Sante & Rech Med, UFR Med, U1047, Nimes, France; [Lavigne, Jean-Philippe] CHU Caremeau, Bacteriol Lab, Nimes, France; [Goret, Lucie] Univ Montpellier I, UFR Med, EA2992, Nimes, France; [Combescure, Christophe] Univ Geneva, Div Clin Epidemiol, Univ Hosp Geneva, Geneva, Switzerland; [Blanco, Jorge] Univ Santiago de Compostela, Lab Referencia E Coli, Dept Microbioloxia & Parasitolxia, Fac Vet, Lugo, Spain; [Nicolas-Chanoine, Marie-Helene] AP HP Beaujon, Microbiol Serv, Clichy, France; [Nicolas-Chanoine, Marie-Helene] Univ Paris 07, Inst Natl Sante & Rech Med, Ctr Rech Biomed Bichat Beaujon CRB3, Fac Med D Diderot,U773, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; University of Geneva; Universidade de Santiago de Compostela; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lavigne, JP (corresponding author), Univ Montpellier I, Inst Natl Sante & Rech Med, UFR Med, U1047, Nimes, France.	jean.philippe.lavigne@chu-nimes.fr	Lavigne, Jean-Philippe/E-1756-2014; ALVAREZ, JORGE BLANCO/C-7161-2013; Vergunst, Annette C./O-5139-2017; Sotto, Albert/AFJ-9023-2022	Lavigne, Jean-Philippe/0000-0002-9484-0304; ALVAREZ, JORGE BLANCO/0000-0003-0264-4136; Vergunst, Annette C./0000-0002-4359-1491; O'Callaghan, David/0000-0003-4350-6143; Sotto, Albert/0000-0002-6463-9386	INSERM; Universite de Montpellier 1; La Ville de Nimes; La Region Languedoc Roussillon; NIH National Center for Research Resources (NCRR)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Montpellier 1; La Ville de Nimes; La Region Languedoc Roussillon(Region Occitanie); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	INSERM U1047 is supported by INSERM, Universite de Montpellier 1, La Ville de Nimes and La Region Languedoc Roussillon. JPL and ACV are recipients of 'Chercheur d'avenir awards from La Region Languedoc Roussillon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fer-15 was provided by the Caenorhabditis Genetics Center that is funded by the NIH National Center for Research Resources (NCRR). The authors would like to thank Ivan Matic, Harry L. Mobley, Eric Oswald and Emmanuel Lemichez for providing strains. We are grateful to Alix Pantel for help with nematode experiments and Steve Renshaw for help in analysis.	Arpin C, 2007, ANTIMICROB AGENTS CH, V51, P3440, DOI 10.1128/AAC.01431-06; Avasthi TS, 2011, J BACTERIOL, V193, P4272, DOI 10.1128/JB.05413-11; Bauer ME, 1996, INFECT IMMUN, V64, P4665, DOI 10.1128/IAI.64.11.4665-4672.1996; Bialek S, 2010, ANTIMICROB AGENTS CH, V54, P4373, DOI 10.1128/AAC.01607-09; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Capo C, 1998, J IMMUNOL, V161, P4301; Cerquetti M, 2010, CLIN MICROBIOL INFEC, V16, P1555, DOI 10.1111/j.1469-0691.2010.03162.x; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Davis JM, 2005, INFECT IMMUN, V73, P5301, DOI 10.1128/IAI.73.9.5301-5310.2005; Davis JM, 2006, INFECT IMMUN, V74, P4401, DOI 10.1128/IAI.00637-06; Diard M, 2007, MICROBES INFECT, V9, P214, DOI 10.1016/j.micinf.2006.11.009; Elkharrat D, 2007, MONOG UROL, P1, DOI 10.1007/978-2-287-48617-3_1; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Gagliotti C, 2011, EURO SURVEILL, V16; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2009, ANTIMICROB AGENTS CH, V53, P2733, DOI 10.1128/AAC.00297-09; Lavigne JP, 2006, CLIN MICROBIOL INFEC, V12, P1199, DOI 10.1111/j.1469-0691.2006.01536.x; Lavigne JP, 2007, J CLIN MICROBIOL, V45, P620, DOI 10.1128/JCM.01917-06; Lavigne JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003370; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Leflon-Guibout V, 2008, J CLIN MICROBIOL, V46, P3900, DOI 10.1128/JCM.00734-08; Lemonnier M, 2007, FEMS MICROBIOL REV, V31, P515, DOI 10.1111/j.1574-6976.2007.00078.x; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; O'Callaghan D, 2010, CURR OPIN MICROBIOL, V13, P79, DOI 10.1016/j.mib.2009.12.005; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pitout JDD, 2005, J CLIN MICROBIOL, V43, P2844, DOI 10.1128/JCM.43.6.2844-2849.2005; Platell JL, 2011, VET MICROBIOL, V153, P99, DOI 10.1016/j.vetmic.2011.05.007; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Schwan WR, 2010, MICROBIOL-SGM, V156, P2124, DOI 10.1099/mic.0.033977-0; Tourret J, 2010, INT J MED MICROBIOL, V300, P435, DOI 10.1016/j.ijmm.2010.04.013; Uchida Y, 2010, INT J ANTIMICROB AG, V35, P444, DOI 10.1016/j.ijantimicag.2009.12.012; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09; Wiles TJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000697	39	64	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34294	10.1371/journal.pone.0034294	http://dx.doi.org/10.1371/journal.pone.0034294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457832	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900061
J	Byblow, WD; Stinear, CM; Smith, MC; Bjerre, L; Flaskager, BK; McCambridge, AB				Byblow, Winston D.; Stinear, Cathy M.; Smith, Marie-Claire; Bjerre, Lotte; Flaskager, Brian K.; McCambridge, Alana B.			Mirror Symmetric Bimanual Movement Priming Can Increase Corticomotor Excitability and Enhance Motor Learning	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; NONINVASIVE CORTICAL STIMULATION; CHRONIC STROKE; UPPER-LIMB; INTERHEMISPHERIC INHIBITION; BILATERAL MOVEMENTS; CORTICOCORTICAL INHIBITION; NEUROMUSCULAR STIMULATION; INTRACORTICAL INHIBITION	Repetitive mirror symmetric bilateral upper limb may be a suitable priming technique for upper limb rehabilitation after stroke. Here we demonstrate neurophysiological and behavioural after-effects in healthy participants after priming with 20 minutes of repetitive active-passive bimanual wrist flexion and extension in a mirror symmetric pattern with respect to the body midline (MIR) compared to an control priming condition with alternating flexion-extension (ALT). Transcranial magnetic stimulation (TMS) indicated that corticomotor excitability (CME) of the passive hemisphere remained elevated compared to baseline for at least 30 minutes after MIR but not ALT, evidenced by an increase in the size of motor evoked potentials in ECR and FCR. Short and long-latency intracortical inhibition (SICI, LICI), short afferent inhibition (SAI) and interhemispheric inhibition (IHI) were also examined using pairs of stimuli. LICI differed between patterns, with less LICI after MIR compared with ALT, and an effect of pattern on IHI, with reduced IHI in passive FCR 15 minutes after MIR compared with ALT and baseline. There was no effect of pattern on SAI or FCR H-reflex. Similarly, SICI remained unchanged after 20 minutes of MIR. We then had participants complete a timed manual dexterity motor learning task with the passive hand during, immediately after, and 24 hours after MIR or control priming. The rate of task completion was faster with MIR priming compared to control conditions. Finally, ECR and FCR MEPs were examined within a pre-movement facilitation paradigm of wrist extension before and after MIR. ECR, but not FCR, MEPs were consistently facilitated before and after MIR, demonstrating no degradation of selective muscle activation. In summary, mirror symmetric active-passive bimanual movement increases CME and can enhance motor learning without degradation of muscle selectivity. These findings rationalise the use of mirror symmetric bimanual movement as a priming modality in post-stroke upper limb rehabilitation.	[Byblow, Winston D.; Smith, Marie-Claire; McCambridge, Alana B.] Univ Auckland, Dept Sport & Exercise Sci, Movement Neurosci Lab, Auckland 1, New Zealand; [Bjerre, Lotte; Flaskager, Brian K.] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark; [Stinear, Cathy M.; Smith, Marie-Claire] Univ Auckland, Dept Med, Neurol Res Grp, Auckland, New Zealand; [Byblow, Winston D.; Stinear, Cathy M.] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand	University of Auckland; Aalborg University; University of Auckland; University of Auckland	Byblow, WD (corresponding author), Univ Auckland, Dept Sport & Exercise Sci, Movement Neurosci Lab, Auckland 1, New Zealand.	w.byblow@auckland.ac.nz	Byblow, Winston/D-3579-2009	Byblow, Winston/0000-0001-8347-6730; Smith, Marie-Claire/0000-0001-5218-863X; McCambridge, Alana/0000-0001-6822-4199; Stinear, Cathy/0000-0002-9404-1959				Ackerley SJ, 2010, STROKE, V41, P1568, DOI 10.1161/STROKEAHA.110.583278; Ameli M, 2009, ANN NEUROL, V66, P298, DOI 10.1002/ana.21725; Byblow WD, 2006, EXP BRAIN RES, V168, P287, DOI 10.1007/s00221-005-0205-9; Carson RG, 2004, J PHYSIOL-LONDON, V560, P929, DOI 10.1113/jphysiol.2004.069088; Carson RG, 2004, EXP BRAIN RES, V154, P267, DOI 10.1007/s00221-003-1726-8; Cauraugh JH, 2005, NEUROSCI LETT, V382, P39, DOI 10.1016/j.neulet.2005.02.060; Cauraugh JH, 2005, PROG NEUROBIOL, V75, P309, DOI 10.1016/j.pneurobio.2005.04.001; Cauraugh JH, 2002, STROKE, V33, P1589, DOI 10.1161/01.STR.0000016926.77114.A6; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Dafotakis M, 2008, EXP NEUROL, V211, P407, DOI 10.1016/j.expneurol.2008.02.018; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Di Lazzaro V, 2008, CLIN NEUROPHYSIOL, V119, P715, DOI 10.1016/j.clinph.2007.11.049; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Duque J, 2007, J COGNITIVE NEUROSCI, V19, P204, DOI 10.1162/jocn.2007.19.2.204; Eyre JA, 2007, ANN NEUROL, V62, P493, DOI 10.1002/ana.21108; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fregni F, 2006, MOV DISORD; Gilio F, 2003, J PHYSIOL-LONDON, V551, P563, DOI 10.1113/jphysiol.2003.044313; Helmich RCG, 2005, EXP BRAIN RES, V167, P211, DOI 10.1007/s00221-005-0014-1; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; KARNI A, 1995, NATURE, V377, P155; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Kim YH, 2006, STROKE, V37, P1471, DOI 10.1161/01.STR.0000221233.55497.51; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lewis GN, 2004, CLIN REHABIL, V18, P48, DOI 10.1191/0269215504cr701oa; Lewis GN, 2004, CLIN NEUROPHYSIOL, V115, P765, DOI 10.1016/j.clinph.2003.11.014; Lewis GN, 2002, BRAIN RES, V943, P263, DOI 10.1016/S0006-8993(02)02699-9; Lewis GN, 2001, BRAIN RES, V900, P282, DOI 10.1016/S0006-8993(01)02369-1; Liepert J, 2000, ACTA NEUROL SCAND, V101, P321, DOI 10.1034/j.1600-0404.2000.90337a.x; Liuzzi G, 2010, CEREB CORTEX, V20, P1323, DOI 10.1093/cercor/bhp196; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; MARIORENZI R, 1991, ELECTROEN CLIN NEURO, V81, P90, DOI 10.1016/0168-5597(91)90002-F; Mayston MJ, 1999, ANN NEUROL, V45, P583, DOI 10.1002/1531-8249(199905)45:5<583::AID-ANA6>3.0.CO;2-W; Mudie MH, 1996, J NEUROL REHABIL, V10, P167; Mudie MH, 2000, DISABIL REHABIL, V22, P23, DOI 10.1080/096382800297097; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; Nudo RJ, 1996, J NEUROSCI, V16, P785; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Perez MA, 2009, J PHYSIOL-LONDON, V587, P725, DOI 10.1113/jphysiol.2008.166926; Pyndt HS, 2004, EXP BRAIN RES, V159, P123, DOI 10.1007/s00221-004-1943-9; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Reynolds C, 1999, NEUROLOGY, V53, P730, DOI 10.1212/WNL.53.4.730; RIDDING MC, 1995, J PHYSIOL-LONDON, V487, P541, DOI 10.1113/jphysiol.1995.sp020898; ROICK H, 1993, EXP BRAIN RES, V94, P489, DOI 10.1007/BF00230207; ROM DM, 1990, BIOMETRIKA, V77, P663, DOI 10.2307/2337008; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sailer A, 2002, J PHYSIOL-LONDON, V544, P617, DOI 10.1113/jphysiol.2002.028670; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Sanger TD, 2001, J PHYSIOL-LONDON, V530, P307, DOI 10.1111/j.1469-7793.2001.0307l.x; Sawaki L, 2006, STROKE, V37, P246, DOI 10.1161/01.STR.0000195130.16843.ac; Schneider C, 2002, EXP BRAIN RES, V146, P86, DOI 10.1007/s00221-002-1137-2; Schnitzler A, 1996, EXP BRAIN RES, V112, P381; Serrien DJ, 1999, EXP BRAIN RES, V128, P250, DOI 10.1007/s002210050845; Smith AL, 2010, EXP BRAIN RES, V205, P465, DOI 10.1007/s00221-010-2381-5; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Stewart KC, 2006, J NEUROL SCI, V244, P89, DOI 10.1016/j.jns.2006.01.005; Stinear C, 2010, LANCET NEUROL, V9, P1228, DOI 10.1016/S1474-4422(10)70247-7; Stinear CM, 2008, BRAIN, V131, P1381, DOI 10.1093/brain/awn051; Stinear CM, 2003, J NEUROPHYSIOL, V89, P2014, DOI 10.1152/jn.00925.2002; Stinear JW, 2004, J CLIN NEUROPHYSIOL, V21, P124, DOI 10.1097/00004691-200403000-00008; Stinear JW, 2004, BRAIN RES, V1022, P81, DOI 10.1016/j.brainres.2004.06.062; Stinear JW, 2002, J PHYSIOL-LONDON, V543, P307, DOI 10.1113/jphysiol.2002.023986; Stoykov ME, 2010, AM J PHYS MED REHAB, V89, P873, DOI 10.1097/PHM.0b013e3181f1c31c; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Takeuchi N, 2007, STROKE; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P333, DOI 10.1016/j.clinph.2006.10.014; Thickbroom GW, 2007, EXP BRAIN RES, V180, P583, DOI 10.1007/s00221-007-0991-3; Traversa R, 1999, BRAIN RES PROTOC, V4, P44, DOI 10.1016/S1385-299X(98)00063-4; Turton A, 1996, ELECTROMYOGR MOTOR C, V101, P316, DOI 10.1016/0924-980X(96)95560-5; Vardy AN, 2007, NEUROSCI LETT, V416, P117, DOI 10.1016/j.neulet.2007.01.064; Wassermann EM, 1996, ELECTROMYOGR MOTOR C, V101, P412; Whitall J, 2000, STROKE, V31, P2390, DOI 10.1161/01.STR.31.10.2390; Yedimenko JA, 2010, J NEUROPHYSIOL, V104, P2922, DOI 10.1152/jn.00020.2010; Ziemann U, 2005, LANCET NEUROL, V4, P454, DOI 10.1016/S1474-4422(05)70126-5	82	42	42	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33882	10.1371/journal.pone.0033882	http://dx.doi.org/10.1371/journal.pone.0033882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457799	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200040
J	Liddelow, SA; Temple, S; Mollgard, K; Gehwolf, R; Wagner, A; Bauer, H; Bauer, HC; Phoenix, TN; Dziegielewska, KM; Saunders, NR				Liddelow, Shane A.; Temple, Sally; Mollgard, Kjeld; Gehwolf, Renate; Wagner, Andrea; Bauer, Hannelore; Bauer, Hans-Christian; Phoenix, Timothy N.; Dziegielewska, Katarzyna M.; Saunders, Norman R.			Molecular Characterisation of Transport Mechanisms at the Developing Mouse Blood-CSF Interface: A Transcriptome Approach	PLOS ONE			English	Article							CEREBROSPINAL-FLUID TRANSFER; CHOROID-PLEXUS; BRAIN-BARRIER; FETAL SHEEP; MEMBRANE-FUSION; PLASMA-PROTEINS; CAENORHABDITIS-ELEGANS; DEVELOPMENTAL-CHANGES; IN-VIVO; EXPRESSION	Exchange mechanisms across the blood-cerebrospinal fluid (CSF) barrier in the choroid plexuses within the cerebral ventricles control access of molecules to the central nervous system, especially in early development when the brain is poorly vascularised. However, little is known about their molecular or developmental characteristics. We examined the transcriptome of lateral ventricular choroid plexus in embryonic day 15 (E15) and adult mice. Numerous genes identified in the adult were expressed at similar levels at E15, indicating substantial plexus maturity early in development. Some genes coding for key functions (intercellular/tight junctions, influx/efflux transporters) changed expression during development and their expression patterns are discussed in the context of available physiological/permeability results in the developing brain. Three genes: Secreted protein acidic and rich in cysteine (Sparc), Glycophorin A (Gypa) and C (Gypc), were identified as those whose gene products are candidates to target plasma proteins to choroid plexus cells. These were investigated using quantitative- and single-cell-PCR on plexus epithelial cells that were albumin- or total plasma protein-immunopositive. Results showed a significant degree of concordance between plasma protein/albumin immunoreactivity and expression of the putative transporters. Immunohistochemistry identified SPARC and GYPA in choroid plexus epithelial cells in the embryo with a subcellular distribution that was consistent with transport of albumin from blood to cerebrospinal fluid. In adult plexus this pattern of immunostaining was absent. We propose a model of the cellular mechanism in which SPARC and GYPA, together with identified vesicle-associated membrane proteins (VAMPs) may act as receptors/transporters in developmentally regulated transfer of plasma proteins at the blood-CSF interface.	[Liddelow, Shane A.; Dziegielewska, Katarzyna M.; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia; [Temple, Sally; Phoenix, Timothy N.] Regenerat Res Fdn, Neural Stem Cell Inst, Rensselaer, NY USA; [Temple, Sally] SUNY Albany, Albany, NY 12222 USA; [Gehwolf, Renate; Wagner, Andrea; Bauer, Hannelore; Bauer, Hans-Christian] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria; [Mollgard, Kjeld] Univ Copenhagen, Inst Cellular & Mol Med, Copenhagen, Denmark; [Phoenix, Timothy N.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	University of Melbourne; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Salzburg University; University of Copenhagen; St Jude Children's Research Hospital	Liddelow, SA (corresponding author), Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia.	shaneal@unimelb.edu.au	Liddelow, Shane/ABE-6456-2020	Liddelow, Shane/0000-0002-0840-1437; Gehwolf, Renate/0000-0002-2620-3127; Saunders, Norman/0000-0001-6660-7639	National Health and Medical Research Council (NHMRC, Australia) as part of European Union [HEALTH-F2-2009-241778]; Company of Biologists Travelling Fellowship; American-Australian Neurological Fellowship; EU; NHMRC; Regenerative Research Foundation; NIH/NINDS [NS033529]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033529, R01NS033529] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC, Australia) as part of European Union(National Health and Medical Research Council (NHMRC) of Australia); Company of Biologists Travelling Fellowship; American-Australian Neurological Fellowship; EU(European Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Regenerative Research Foundation; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research leading to these results has received funding from the National Health and Medical Research Council (NHMRC, Australia) as part of an agreement with the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement No. HEALTH-F2-2009-241778. SL was funded by a Company of Biologists Travelling Fellowship and an American-Australian Neurological Fellowship. SL, KD, HB, H-CB, RG, AW and NS are members of the Neurobid Consortium, funded by the Seventh Framework Program (EU) and NHMRC. KM is an adviser to the Neurobid Consortium. The project was also supported by funding from the Regenerative Research Foundation and Grant Number NS033529 from NIH/NINDS to ST. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamar E, 2008, DEV BIOL, V318, P335, DOI 10.1016/j.ydbio.2008.03.040; ADINOLFI M, 1976, NATURE, V259, P140, DOI 10.1038/259140a0; ADINOLFI M, 1977, NEUROPADIATRIE, V8, P345, DOI 10.1055/s-0028-1091530; Al-Sarraf H, 2002, DEV BRAIN RES, V139, P121, DOI 10.1016/S0165-3806(02)00537-0; AlSarraf H, 1997, DEV BRAIN RES, V102, P127, DOI 10.1016/S0165-3806(97)00089-8; AMTORP O, 1974, J PHYSIOL-LONDON, V243, P387, DOI 10.1113/jphysiol.1974.sp010759; Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Balslev Y, 1997, ANAT EMBRYOL, V195, P229, DOI 10.1007/s004290050042; BANOS G, 1978, DEV MED CHILD NEUROL, V20, P335; Bauer HC, 2011, J NEURAL TRANSM, V118, P7, DOI 10.1007/s00702-010-0484-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blazejewski S, 1997, AM J PATHOL, V151, P651; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; BRADBURY MW, 1972, J PHYSIOL-LONDON, V227, P591, DOI 10.1113/jphysiol.1972.sp010049; BRAUN LD, 1980, J NEUROCHEM, V34, P147, DOI 10.1111/j.1471-4159.1980.tb04633.x; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Choudhuri S, 2003, DRUG METAB DISPOS, V31, P1337, DOI 10.1124/dmd.31.11.1337; Chowanadisai W, 2005, J NUTR, V135, P1002, DOI 10.1093/jn/135.5.1002; Chung I, 2003, NEUROSCIENCE, V116, P349, DOI 10.1016/S0306-4522(02)00720-0; COLOMBO MP, 1991, EUR J CANCER, V27, P58, DOI 10.1016/0277-5379(91)90062-I; CORNFORD EM, 1982, PEDIATR RES, V16, P324, DOI 10.1203/00006450-198204000-00017; Damkier HH, 2010, PHYSIOLOGY, V25, P239, DOI 10.1152/physiol.00011.2010; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Davson H, 1996, PHYSL CSF BLOOD BRAI; DZIEGIELEWSKA KM, 1991, J PHYSIOL-LONDON, V439, P215, DOI 10.1113/jphysiol.1991.sp018664; DZIEGIELEWSKA KM, 1980, J PHYSIOL-LONDON, V300, P457, DOI 10.1113/jphysiol.1980.sp013172; DZIEGIELEWSKA KM, 1980, J PHYSIOL-LONDON, V300, P441, DOI 10.1113/jphysiol.1980.sp013171; Dziegielewska KM, 1988, HDB HUMAN GROWTH DEV, P169; Economopoulou M, 2009, INVEST OPHTH VIS SCI, V50, P1454, DOI 10.1167/iovs.08-2129; Ek CJ, 2010, TOXICOL LETT, V197, P51, DOI 10.1016/j.toxlet.2010.04.025; Ek CJ, 2006, J COMP NEUROL, V496, P13, DOI 10.1002/cne.20885; Ek CJ, 2011, NEUROTOXICOLOGY, DOI [10.1016/j.neuro.2011.12.009, DOI 10.1016/J.NEU-RO.2011.12.009]; FURTHMAYR H, 1981, P NATL ACAD SCI-BIOL, V78, P631, DOI 10.1073/pnas.78.1.631; Grijota-Martinez C, 2011, ENDOCRINOLOGY, V152, P1136, DOI 10.1210/en.2010-0813; HABGOOD MD, 1992, J PHYSIOL-LONDON, V456, P181, DOI 10.1113/jphysiol.1992.sp019332; Hong WJ, 1998, J CELL SCI, V111, P2831; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jauniaux E, 1999, HUM REPROD, V14, P2901, DOI 10.1093/humrep/14.11.2901; Johansson PA, 2006, EUR J NEUROSCI, V24, P65, DOI 10.1111/j.1460-9568.2006.04904.x; Johansson PA, 2005, CELL TISSUE RES, V322, P353, DOI 10.1007/s00441-005-1120-x; Johansson PA, 2008, BIOESSAYS, V30, P237, DOI 10.1002/bies.20718; KEEP RF, 1990, DEV BRAIN RES, V56, P47, DOI 10.1016/0165-3806(90)90163-S; Khvotchev MV, 2004, BIOCHEMISTRY-US, V43, P15037, DOI 10.1021/bi048290+; Kimura Y, 1996, DEV DYNAM, V206, P455, DOI 10.1002/(SICI)1097-0177(199608)206:4<455::AID-AJA11>3.0.CO;2-W; Kinne A, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S7; Knott GW, 1997, J PHYSIOL-LONDON, V499, P179, DOI 10.1113/jphysiol.1997.sp021919; KOPP JB, 1992, KIDNEY INT, V41, P56, DOI 10.1038/ki.1992.8; Kramer James M, 2005, WormBook, P1; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; KROTKIEWSKI H, 1988, CARBOHYD RES, V184, P27, DOI 10.1016/0008-6215(88)80003-X; LEFAUCONNIER JM, 1983, DEV BRAIN RES, V6, P175, DOI 10.1016/0165-3806(83)90095-0; Liddelow SA, 2011, EUR J NEUROSCI, V34, P1062, DOI 10.1111/j.1460-9568.2011.07821.x; Liddelow SA, 2011, EUR J NEUROSCI, V33, P391, DOI 10.1111/j.1460-9568.2010.07509.x; Liddelow SA, 2009, EUR J NEUROSCI, V29, P253, DOI 10.1111/j.1460-9568.2008.06571.x; Marques F, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-10; Maurer P, 1997, EUR J BIOCHEM, V248, P209, DOI 10.1111/j.1432-1033.1997.t01-1-00209.x; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; MOLLGARD K, 1976, NATURE, V264, P293, DOI 10.1038/264293a0; MOLLGARD K, 1977, PROC R SOC SER B-BIO, V199, P321, DOI 10.1098/rspb.1977.0142; MOLLGARD K, 1979, J NEUROCYTOL, V8, P139, DOI 10.1007/BF01175557; Moos T, 2000, CELL MOL NEUROBIOL, V20, P77, DOI 10.1023/A:1006948027674; Morgan EH, 2002, DEV NEUROSCI-BASEL, V24, P106, DOI 10.1159/000065699; Motamed K, 1999, INT J BIOCHEM CELL B, V31, P1363, DOI 10.1016/S1357-2725(99)00090-4; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; OLNEY JW, 1970, NATURE, V227, P609, DOI 10.1038/227609b0; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PORTERFIELD SP, 1992, ENDOCRINOLOGY, V131, P195, DOI 10.1210/en.131.1.195; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Saunders NR, 2008, TRENDS NEUROSCI, V31, P279, DOI 10.1016/j.tins.2008.03.003; Saunders NR, 1992, PHYSL PHARM BLOOD BR, P327, DOI DOI 10.1007/978-3-642-76894-1_14; Saunders NR, 2010, DEV NEUROTOXICOLOGY, P50; SCHREIBER G, 1990, AM J PHYSIOL, V258, pR338; SCHWARZBAUER JE, 1993, MOL BIOL CELL, V4, P941, DOI 10.1091/mbc.4.9.941; Simonneau L, 1998, CELL ADHES COMMUN, V6, P431, DOI 10.3109/15419069809109151; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; Stephens DJ, 2001, J CELL SCI, V114, P1053; Stewart AK, 2011, BIOCHEM CELL BIOL, V89, P224, DOI [10.1139/O10-147, 10.1139/o10-147]; Stewart PA, 2000, CELL MOL NEUROBIOL, V20, P149, DOI 10.1023/A:1007026504843; Stolp HB, 2009, NEUROPATH APPL NEURO, V35, P132, DOI 10.1111/j.1365-2990.2008.01005.x; Swaroop A, 1988, GENOMICS, V2, P37, DOI 10.1016/0888-7543(88)90107-3; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vina JR, 1997, METAB BRAIN DIS, V12, P219, DOI 10.1023/B:MEBR.0000007102.78696.e3; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wong SH, 1998, MOL BIOL CELL, V9, P1549, DOI 10.1091/mbc.9.6.1549; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Zaykin DV, 2000, GENETICS, V154, P1917; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zeng Q, 2003, J BIOL CHEM, V278, P23046, DOI 10.1074/jbc.M303214200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	96	54	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33554	10.1371/journal.pone.0033554	http://dx.doi.org/10.1371/journal.pone.0033554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457777	Green Published, gold			2022-12-27	WOS:000303857100033
J	Liu, YX; Goldberg, AJ; Dennis, JE; Gronowicz, GA; Kuhn, LT				Liu, Yongxing; Goldberg, A. Jon; Dennis, James E.; Gronowicz, Gloria A.; Kuhn, Liisa T.			One-Step Derivation of Mesenchymal Stem Cell (MSC)-Like Cells from Human Pluripotent Stem Cells on a Fibrillar Collagen Coating	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; EX-VIVO; OSTEOBLAST PHENOTYPE; GENE-EXPRESSION; THIN-FILMS; GROWTH; CULTURE; SURVIVAL; ADHESION	Controlled differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) into cells that resemble adult mesenchymal stem cells (MSCs) is an attractive approach to obtain a readily available source of progenitor cells for tissue engineering. The present study reports a new method to rapidly derive MSC-like cells from hESCs and hiPSCs, in one step, based on culturing the cells on thin, fibrillar, type I collagen coatings that mimic the structure of physiological collagen. Human H9 ESCs and HDFa-YK26 iPSCs were singly dissociated in the presence of ROCK inhibitor Y-27632, plated onto fibrillar collagen coated plates and cultured in alpha minimum essential medium (alpha-MEM) supplemented with 10% fetal bovine serum, 50 uM magnesium L-ascorbic acid phosphate and 100 nM dexamethasone. While fewer cells attached on the collagen surface initially than standard tissue culture plastic, after culturing for 10 days, resilient colonies of homogenous spindle-shaped cells were obtained. Flow cytometric analysis showed that a high percentage of the derived cells expressed typical MSC surface markers including CD73, CD90, CD105, CD146 and CD166 and were negative as expected for hematopoietic markers CD34 and CD45. The MSC-like cells derived from pluripotent cells were successfully differentiated in vitro into three different lineages: osteogenic, chondrogenic, and adipogenic. Both H9 hES and YK26 iPS cells displayed similar morphological changes during the derivation process and yielded MSC-like cells with similar properties. In conclusion, this study demonstrates that bioimimetic, fibrillar, type I collagen coatings applied to cell culture plates can be used to guide a rapid, efficient derivation of MSC-like cells from both human ES and iPS cells.	[Liu, Yongxing; Goldberg, A. Jon; Kuhn, Liisa T.] Univ Connecticut, Ctr Hlth, Ctr Biomat, Dept Reconstruct Sci, Farmington, CT USA; [Dennis, James E.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Gronowicz, Gloria A.] Univ Connecticut, Ctr Hlth, Dept Surg, Farmington, CT USA	University of Connecticut; Benaroya Research Institute; Virginia Mason Medical Center; University of Connecticut	Liu, YX (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Biomat, Dept Reconstruct Sci, Farmington, CT USA.	Lkuhn@uchc.edu		Kuhn, Liisa/0000-0003-1447-0719; Gronowicz, Gloria/0000-0001-7158-3598	State of Connecticut Stem Cell Research Grants program	State of Connecticut Stem Cell Research Grants program	The authors received financial support from the State of Connecticut Stem Cell Research Grants program (PI: D. Rowe, 2007-2010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310; Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Csete M, 2010, REGEN MED, V5, P509, DOI 10.2217/RME.10.39; Dmitrieva RI, 2012, CELL CYCLE, V11, P377, DOI 10.4161/cc.11.2.18858; Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023; Elliott JT, 2008, BIOINTERPHASES, V3, P19, DOI 10.1116/1.2912936; Elliott JT, 2005, MATRIX BIOL, V24, P489, DOI 10.1016/j.matbio.2005.07.005; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Estes BT, 2006, ARTHRITIS RHEUM-US, V54, P1222, DOI 10.1002/art.21779; Fickert S, 2011, J BONE MINER METAB, V29, P224, DOI 10.1007/s00774-010-0215-y; Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Imamichi Y, 2007, CELLS TISSUES ORGANS, V185, P180, DOI 10.1159/000101319; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Karp JM, 2006, STEM CELLS, V24, P835, DOI 10.1634/stemcells.2005-0383; Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Kurth I, 2011, MACROMOL BIOSCI, V11, P739, DOI 10.1002/mabi.201000432; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; Lee SY, 2009, TISSUE ENG PT A, V15, P2491, DOI 10.1089/ten.tea.2008.0465; Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052; LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005; Makita N, 2008, GENE, V413, P8, DOI 10.1016/j.gene.2007.12.025; Mauney JR, 2006, J BIOMED MATER RES A, V79A, P464, DOI 10.1002/jbm.a.30876; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.0.CO;2-6; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trounson Alan, 2002, Reprod Biomed Online, V4 Suppl 1, P58; Valles AM, 1996, CELL ADHES COMMUN, V4, P187, DOI 10.3109/15419069609014222; Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853	43	86	96	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33225	10.1371/journal.pone.0033225	http://dx.doi.org/10.1371/journal.pone.0033225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457746	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100022
J	Jung, EM; Friedrich, C; Hoffstetter, P; Dendl, LM; Klebl, F; Agha, A; Wiggermann, P; Stroszcynski, C; Schreyer, AG				Jung, Ernst Michael; Friedrich, Chris; Hoffstetter, Patrick; Dendl, Lena Marie; Klebl, Frank; Agha, Ayman; Wiggermann, Phillipp; Stroszcynski, Christian; Schreyer, Andreas Georg			Volume Navigation with Contrast Enhanced Ultrasound and Image Fusion for Percutaneous Interventions: First Results	PLOS ONE			English	Article							FOCAL LIVER-LESIONS; GUIDED BIOPSY; HEPATOCELLULAR-CARCINOMA; METASTASES; MRI; CT; MULTICENTER; PHANTOM; PHASE; US	Objective: Assessing the feasibility and efficiency of interventions using ultrasound (US) volume navigation (V Nav) with real time needle tracking and image fusion with contrast enhanced (ce) CT, MRI or US. Methods: First an in vitro study on a liver phantom with CT data image fusion was performed, involving the puncture of a 10 mm lesion in a depth of 5 cm performed by 15 examiners with US guided freehand technique vs. V Nav for the purpose of time optimization. Then 23 patients underwent ultrasound-navigated biopsies or interventions using V Nav image fusion of live ultrasound with ceCT, ceMRI or CEUS, which were acquired before the intervention. A CEUS data set was acquired in all patients. Image fusion was established for CEUS and CT or CEUS and MRI using anatomical landmarks in the area of the targeted lesion. The definition of a virtual biopsy line with navigational axes targeting the lesion was achieved by the usage of sterile trocar with a magnetic sensor embedded in its distal tip employing a dedicated navigation software for real time needle tracking. Results: The in vitro study showed significantly less time needed for the simulated interventions in all examiners when V Nav was used (p<0.05). In the study involving patients, in all 10 biopsies of suspect lesions of the liver a histological confirmation was achieved. We also used V Nav for a breast biopsy (intraductal carcinoma), for a biopsy of the abdominal wall (metastasis of ovarial carcinoma) and for radiofrequency ablations (4 ablations). In 8 cases of inflammatory abdominal lesions 9 percutaneous drainages were successfully inserted. Conclusion: Percutaneous biopsies and drainages, even of small lesions involving complex access pathways, can be accomplished with a high success rate by using 3D real time image fusion together with real time needle tracking.	[Jung, Ernst Michael; Friedrich, Chris; Hoffstetter, Patrick; Dendl, Lena Marie; Wiggermann, Phillipp; Stroszcynski, Christian; Schreyer, Andreas Georg] Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany; [Jung, Ernst Michael; Klebl, Frank] Univ Med Ctr Regensburg, Interdisciplinary Ultrasound Ctr, Regensburg, Germany; [Agha, Ayman] Univ Med Ctr Regensburg, Dept Surg, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Jung, EM (corresponding author), Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany.	andreas.schreyer@ukr.de	Schreye, Andreas/ABC-3197-2020; Schreyer, Andreas G/A-1797-2012; Wiggermann, Philipp/AAY-6759-2021; Agha, Ayman/J-4387-2013	Schreyer, Andreas G/0000-0002-2449-4397; Schreyer, Andreas/0000-0002-2539-059X				Albrecht T, 2004, EUR RADIOL, V14, pP25, DOI 10.1007/00406-004-0088-z; Albrecht T, 2001, RADIOLOGY, V220, P269, DOI 10.1148/radiology.220.1.r01jl40269; Albrecht T, 2003, RADIOLOGY, V227, P361, DOI 10.1148/radiol.2272011833; Bhartia B, 2003, AM J ROENTGENOL, V180, P577, DOI 10.2214/ajr.180.3.1800577; Bipat S, 2005, RADIOLOGY, V237, P123, DOI 10.1148/radiol.2371042060; Cabassa P, 2010, ULTRASOUND MED BIOL, V36, P1561, DOI 10.1016/j.ultrasmedbio.2010.06.004; Ewertsen C, 2011, ULTRASCHALL MED, V32, P191, DOI 10.1055/s-0029-1245921; Ewertsen C, 2008, AM J ROENTGENOL, V190, P1671, DOI 10.2214/AJR.07.2587; Gianfelice D, 2000, J VASC INTERV RADIOL, V11, P879, DOI 10.1016/S1051-0443(07)61805-3; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Jung EM, 2009, CLIN HEMORHEOL MICRO, V43, P57, DOI 10.3233/CH-2009-1221; Loizides A, 2011, ULTRASCHALL MED, V32, P307, DOI 10.1055/s-0029-1245713; Lu Y, 2011, EUROPEAN RADIOLOGY; Mita K, 2010, WORLD J GASTROENTERO, V16, P4187, DOI 10.3748/wjg.v16.i33.4187; Seitz K, 2010, ULTRASCHALL MED, V31, P492, DOI 10.1055/s-0029-1245591; Stattaus J, 2007, CARDIOVASC INTER RAD, V30, P928, DOI 10.1007/s00270-007-9023-8; Sugimoto K, 2011, AM J ROENTGENOL, V196, pW753, DOI 10.2214/AJR.10.5552; van de Ven SMWY, 2010, J MAGN RESON IMAGING, V32, P101, DOI 10.1002/jmri.22148; Yoon SH, 2010, EUR RADIOL, V20, P2047, DOI 10.1007/s00330-010-1757-z; Zheng YL, 2010, J ULTRAS MED, V29, P1403, DOI 10.7863/jum.2010.29.10.1403	20	55	61	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33956	10.1371/journal.pone.0033956	http://dx.doi.org/10.1371/journal.pone.0033956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448281	gold, Green Published, Green Submitted			2022-12-27	WOS:000303855700072
J	Karlsson, A; Bjorkman, P; Bratt, G; Ekvall, H; Gisslen, M; Sonnerborg, A; Mild, M; Albert, J				Karlsson, Annika; Bjoerkman, Per; Bratt, Goeran; Ekvall, Hakan; Gisslen, Magnus; Soennerborg, Anders; Mild, Mattias; Albert, Jan			Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003-2010	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; VIRAL LOAD; SUBTYPE-B; TRANSMISSION; MUTATIONS; RECOMMENDATIONS; SURVEILLANCE; PHYLOGENIES; TYPE-1	Transmitted drug resistance (TDR) is a clinical and epidemiological problem because it may contribute to failure of antiretroviral treatment. The prevalence of TDR varies geographically, and its prevalence in Sweden during the last decade has not been reported. Plasma samples from 1,463 patients newly diagnosed with HIV-1 infection between 2003 and 2010, representing 44% of all patients diagnosed in Sweden during this period, were analyzed using the WHO 2009 list of mutations for surveillance of TDR. Maximum likelihood phylogenetic analyses were used to determine genetic subtype and to investigate the relatedness of the sequences. Eighty-two patients showed evidence of TDR, representing a prevalence of 5.6% (95% CI: 4.5%-6.9%) without any significant time trends or differences between patients infected in Sweden or abroad. Multivariable logistic regression showed that TDR was positively associated with men who have sex with men (MSM) and subtype B infection and negatively associated with CD4 cell counts. Among patients with TDR, 54 (68%) had single resistance mutations, whereas five patients had multi-drug resistant HIV-1. Phylogenetic analyses identified nine significantly supported clusters involving 29 of the patients with TDR, including 23 of 42 (55%) of the patients with TDR acquired in Sweden. One cluster contained 18 viruses with a M41L resistance mutation, which had spread among MSM in Stockholm over a period of at least 16 years (1994-2010). Another cluster, which contained the five multidrug resistant viruses, also involved MSM from Stockholm. The prevalence of TDR in Sweden 2003-2010 was lower than in many other European countries. TDR was concentrated among MSM, where clustering of TDR strains was observed, which highlights the need for continued and improved measures for targeted interventions.	[Karlsson, Annika; Soennerborg, Anders] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Bjoerkman, Per] Lund Univ, Dept Clin Sci, Malmo Univ Hosp, Malmo Infect Dis Res Unit, Lund, Sweden; [Bratt, Goeran] Stockholm S Gen Hosp, Stockholm, Sweden; [Ekvall, Hakan] Sundsvall Hosp, Dept Infect Dis, Sundsvall, Sweden; [Gisslen, Magnus] Univ Gothenburg, Dept Infect Dis, Sahlgrenska Acad, Gothenburg, Sweden; [Soennerborg, Anders] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Soennerborg, Anders; Albert, Jan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Mild, Mattias; Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Mild, Mattias] Swedish Inst Communicable Dis, Stockholm, Sweden	Karolinska Institutet; Lund University; Skane University Hospital; University of Gothenburg; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Swedish Institute for Infectious Disease Control	Karlsson, A (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.	jan.albert@ki.se	Sönnerborg, Anders/W-2011-2019; Karlsson, Annika/R-2255-2016; Gisslen, Magnus/D-7454-2015	Sönnerborg, Anders/0000-0001-8928-3374; Karlsson, Annika/0000-0002-2028-8393; Gisslen, Magnus/0000-0002-2357-1020	Swedish Research Council [K2008-56X-09935-17-3, K2001-56X-0095-20-6]; Swedish International Development Cooperation Agency [SWE-2006-018]; EU [QLK2-CT-2001-01344]; EHR [LSHP-CT-2006-518211]; CHAIN; Collaborative HIV and Anti-HIV Drug Resistance Network [223131]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; EU(European Commission); EHR; CHAIN; Collaborative HIV and Anti-HIV Drug Resistance Network	Grants were obtained from the Swedish Research Council (grant no. K2008-56X-09935-17-3 and K2001-56X-0095-20-6); the Swedish International Development Cooperation Agency (grant no. SWE-2006-018); as well as the EU projects: SPREAD (QLK2-CT-2001-01344); EHR (LSHP-CT-2006-518211) and CHAIN (FP7/2007-2013) "Collaborative HIV and Anti-HIV Drug Resistance Network'' grant agreement no 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Audelin AM, 2011, AIDS RES HUM RETROVI; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Burns S, 2007, AIDS, V21, P1035, DOI 10.1097/QAD.0b013e3280b07761; Descamps D, 2010, J ANTIMICROB CHEMOTH, V65, P2620, DOI 10.1093/jac/dkq380; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Frentz D, 2011, JAIDS-J ACQ IMM DEF, V58, pE135, DOI 10.1097/QAI.0b013e3182364c80; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Josephson F, 2009, SCAND J INFECT DIS, V41, P788, DOI 10.3109/00365540903214322; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lindstrom A, 2006, ANTIVIR THER, V11, P1031; Maljkovic I, 2003, AIDS RES HUM RETROV, V19, P989, DOI 10.1089/088922203322588341; Murillo W, 2010, HIV MED, V11, P95, DOI 10.1111/j.1468-1293.2009.00747.x; Pandit A, 2008, J CLIN VIROL, V43, P401, DOI 10.1016/j.jcv.2008.08.021; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Skar H, 2011, J VIROL, V85, P510, DOI 10.1128/JVI.01413-10; SONNERBORG A, 1993, AIDS, V7, P1684, DOI 10.1097/00002030-199312000-00027; Sungkanuparph S, 2011, CLIN INFECT DIS, V52, P1053, DOI 10.1093/cid/cir107; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vandamme AM, 2011, AIDS REV, V13, P77; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yebra G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026757; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	39	42	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33484	10.1371/journal.pone.0033484	http://dx.doi.org/10.1371/journal.pone.0033484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448246	gold, Green Published, Green Submitted			2022-12-27	WOS:000303855700036
J	Yao, YY; Wang, YY; Zhang, Y; Li, YF; Sheng, ZL; Wen, S; Ma, GS; Liu, NF; Fang, F; Teng, GJ				Yao, Yuyu; Wang, Yuanyuan; Zhang, Yi; Li, Yefei; Sheng, Zulong; Wen, Song; Ma, Genshan; Liu, Naifeng; Fang, Fang; Teng, Gao-Jun			In Vivo Imaging of Macrophages during the Early-Stages of Abdominal Aortic Aneurysm Using High Resolution MRI in ApoE(-/-) Mice	PLOS ONE			English	Article							E-DEFICIENT MICE; IRON-OXIDE; ATHEROSCLEROTIC LESIONS; CONTRAST AGENTS; CAROTID PLAQUE; HUMANS; MODEL	Background: Angiotensin II (ANG II) promotes vascular inflammation and induces abdominal aortic aneurysm (AAA) in hyperlipidemic apolipoprotein E knock-out (apoE(-/-)) mice. The aim of the present study was to detect macrophage activities in an ANG II-induced early-stage AAA model using superparamagnetic iron oxide (SPIO) as a marker. Methodology/Principal Findings: Twenty-six male apoE(-/-) mice received saline or ANG II (1000 or 500 ng/kg/min) infusion for 14 days. All animals underwent MRI scanning following administration of SPIO with the exception of three mice in the 1000 ng ANG II group, which were scanned without SPIO administration. MR imaging was performed using black-blood T2 to proton density - weighted multi-spin multi-echo sequence. In vivo MRI measurement of SPIO uptake and abdominal aortic diameter were obtained. Prussian blue, CD68, alpha-SMC and MAC3 immunohistological stains were used for the detection of SPIO, macrophages and smooth muscle cells. ANG II infusion with 1000 ng/kg/min induced AAA in all of the apoE(-/-) mice. ANG II infusion exhibited significantly higher degrees of SPIO uptake, which was detected using MRI as a distinct loss of signal intensity. The contrast-to-noise ratio value decreased in proportion to an increase in the number of iron-laden macrophages in the aneurysm. The aneurysmal vessel wall in both groups of ANG II treated mice contained more iron-positive macrophages than saline-treated mice. However, the presence of cells capable of phagocytosing haemosiderin in mural thrombi also induced low-signal-intensities via MRI imaging. Conclusions/Significance: SPIO is taken up by macrophages in the shoulder and the outer layer of AAA. This alters the MRI signaling properties and can be used in imaging inflammation associated with AAA. It is important to compare images of the aorta before and after SPIO injection.	[Yao, Yuyu; Li, Yefei; Sheng, Zulong; Ma, Genshan; Liu, Naifeng] Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Wang, Yuanyuan; Zhang, Yi; Wen, Song; Fang, Fang; Teng, Gao-Jun] Southeast Univ, Sch Med, Zhongda Hosp, Jiangsu Key Lab Mol & Funct Imaging,Dept Radiol, Nanjing, Peoples R China	Southeast University - China; Southeast University - China	Yao, YY (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	gjteng@vip.sina.com	Lv, Yuanjie/AER-0767-2022; Liu, Nai-feng/AAM-7836-2020		National Natural Science Foundation of China (NSFC) [90606007, 30910103905, 30871071, 81070085]; Science and Technology Commission Foundation of Jiangsu Province [BK2010424]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission Foundation of Jiangsu Province	This project is sponsored by National Natural Science Foundation of China (NSFC #90606007, #30910103905, #30871071, #81070085), and the Basic Research Programs of Science and Technology Commission Foundation of Jiangsu Province (No. BK2010424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Chu BC, 2004, STROKE, V35, P1079, DOI 10.1161/01.STR.0000125856.25309.86; Corti R, 2011, EUR HEART J, V32, P1709, DOI 10.1093/eurheartj/ehr068; DARLING RC, 1977, CIRCULATION, V56, P161; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Deng GG, 2003, CIRC RES, V92, P510, DOI 10.1161/01.RES.0000061571.49375.E1; Desai Milind Y, 2006, Curr Atheroscler Rep, V8, P131, DOI 10.1007/s11883-006-0050-8; Kawahara I, 2008, NEUROL MED-CHIR, V48, P157, DOI 10.2176/nmc.48.157; Kleinstreuer C, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-19; Litovsky S, 2003, CIRCULATION, V107, P1545, DOI 10.1161/01.CIR.0000055323.57885.88; LORENZ JN, 1997, AM J PHYSIOL-HEART C, V273, pH2826; Michel JB, 2011, CARDIOVASC RES, V90, P18, DOI 10.1093/cvr/cvq337; Morris JB, 2008, ARTERIOSCL THROM VAS, V28, P265, DOI 10.1161/ATVBAHA.107.151175; Nahrendorf M, 2011, ARTERIOSCL THROM VAS, V31, P750, DOI 10.1161/ATVBAHA.110.221499; Nchimi A, 2010, RADIOLOGY, V254, P973, DOI 10.1148/radiol.09090657; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Pande AN, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186337; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Richards JMJ, 2011, CIRC-CARDIOVASC IMAG, V4, P274, DOI 10.1161/CIRCIMAGING.110.959866; Sadat U, 2011, EUR J VASC ENDOVASC, V41, P167, DOI 10.1016/j.ejvs.2010.08.022; Sakalihasan N, 2009, EUR J VASC ENDOVASC, V37, P728, DOI 10.1016/j.ejvs.2008.12.024; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Swedenborg J, 2011, ARTERIOSCL THROM VAS, V31, P734, DOI 10.1161/ATVBAHA.110.213157; Trivedi RA, 2006, ARTERIOSCL THROM VAS, V26, P1601, DOI 10.1161/01.ATV.0000222920.59760.df; Truijers M, 2009, AM J ROENTGENOL, V193, pW437, DOI 10.2214/AJR.09.2619; Turner GH, 2009, J MAGN RESON IMAGING, V30, P455, DOI 10.1002/jmri.21843; Turner GH, 2008, CIRC-CARDIOVASC IMAG, V1, P220, DOI 10.1161/CIRCIMAGING.108.787358; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; Wassef M, 2007, J VASC SURG, V45, P192, DOI 10.1016/j.jvs.2006.09.004	31	19	19	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33523	10.1371/journal.pone.0033523	http://dx.doi.org/10.1371/journal.pone.0033523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448249	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700040
J	Kosack, CS; Page, AL; Van Hulsteijn, LT; Lentjes, EGWM				Kosack, Cara S.; Page, Anne-Laure; Van Hulsteijn, Leonie T.; Lentjes, Eef G. W. M.			TSH-CHECK-1 Test: Diagnostic Accuracy and Potential Application to Initiating Treatment for Hypothyroidism in Patients on Anti-Tuberculosis Drugs	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; COMMUNITY-BASED THERAPY; CHILDREN	Background: Thyroid-stimulating hormone (TSH) promotes expression of thyroid hormones which are essential for metabolism, growth, and development. Second-line drugs to treat tuberculosis (TB) can cause hypothyroidism by suppressing thyroid hormone synthesis. Therefore, TSH levels are routinely measured in TB patients receiving second-line drugs, and thyroxin treatment is initiated where indicated. However, standard TSH tests are technically demanding for many low-resource settings where TB is prevalent; a simple and inexpensive test is urgently needed. Methods: As a proof of concept study TSH was measured in routinely collected sera at the University Medical Center Utrecht, Netherlands, using the TSH-CHECK-1 (VEDALAB, Alenc, on, France), a lateral-flow rapid immunochromatographic assay with a TSH cut-off value of 10 mu IU/mL, the standard threshold for initiating treatment. These results were compared with TSH levels measured by a reference standard (UniCel DXi 800 imunoassay system, Beckman Coulter, USA). Sensitivity, specificity, and likelihood ratios were then calculated. Results: A total of 215 serum samples were evaluated: 107 with TSH values <10 mu IU/mL and 108 with values >= 10 mu IU/mL. TSH-CHECK-1 test sensitivity was found to be 100.0% (95% CI: 96.6-100.0) and specificity was 76.6% (95% CI: 67.5-84.3). Predictive values (PV) were modelled for different levels of prevalence. For a prevalence of 10% and 50%, the positive PV was 32.2% (95% CI: 25.0-39.7%) and 81.1% (95% CI: 75.0-85.5%), respectively; the negative PV was 100% (95% CI: 98.9-100%) and 100% (95% CI: 91.3-100%) respectively. Discussion/Conclusions: The TSH-CHECK-1 rapid test was practical and simple to perform but difficult to interpret on weak positive results. All sera with TSH >= 10 mu IU/mL were correctly identified, but the test lacked sufficient specificity. Given its excellent negative PV in this evaluation, the test shows promise for ruling out hypothyroidism. However, so far it appears that samples testing positive with TSH-CHECK-1 would require confirmation using another method.	[Kosack, Cara S.] Medecins Sans Frontieres, Amsterdam, Netherlands; [Page, Anne-Laure] Epicentre, Paris, France; [Van Hulsteijn, Leonie T.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Lentjes, Eef G. W. M.] Univ Med Ctr Utrecht, Utrecht, Netherlands	Doctors Without Borders; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Kosack, CS (corresponding author), Medecins Sans Frontieres, Amsterdam, Netherlands.	cara.kosack@amsterdam.msf.org		van Hulsteijn, Leonie/0000-0002-2617-5429				[Anonymous], 2008, GUID PROGR MAN DRUG; BECKS GP, 1988, ENDOCRINOLOGY, V123, P545, DOI 10.1210/endo-123-1-545; Biesheuvel CJ, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-48; Drobac PC, 2006, PEDIATRICS, V117, P2022, DOI 10.1542/peds.2005-2235; DRUCKER D, 1984, ANN INTERN MED, V100, P837, DOI 10.7326/0003-4819-100-6-837; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; MACGREGOR AG, 1954, LANCET, V2, P931; Medecins sans Frontieres, 2009, DRUG RES TB PROT; Munkner T, 1996, SCAND J RESPIR DIS, V50, P212; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; Organization WH, 1997, WHOTB97229; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Rutjes AWS, 2005, CLIN CHEM, V51, P1335, DOI 10.1373/clinchem.2005.048595; Snider DE, 1998, NEW ENGL J MED, V338, P1689, DOI 10.1056/NEJM199806043382309; Thee S, 2011, INT J TUBERC LUNG D, V15, P1191, DOI 10.5588/ijtld.10.0707; World Health Organization, 2000, 2 WHO	17	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33704	10.1371/journal.pone.0033704	http://dx.doi.org/10.1371/journal.pone.0033704			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442713	Green Published, gold			2022-12-27	WOS:000303836500054
J	Mushegian, A; Gurevich, VV; Gurevich, EV				Mushegian, Arcady; Gurevich, Vsevolod V.; Gurevich, Eugenia V.			The Origin and Evolution of G Protein-Coupled Receptor Kinases	PLOS ONE			English	Article							BETA-ADRENERGIC-RECEPTOR; LIGHT-DEPENDENT PHOSPHORYLATION; PLECKSTRIN HOMOLOGY DOMAIN; RHODOPSIN KINASE; GENOME DUPLICATION; GAMMA-SUBUNITS; PHOSPHODIESTERASE ACTIVATION; ADENYLATE-CYCLASE; PLASMA-MEMBRANE; CLONING	G protein-coupled receptor (GPCR) kinases (GRKs) play key role in homologous desensitization of GPCRs. GRKs phosphorylate activated receptors, promoting high affinity binding of arrestins, which precludes G protein coupling. Direct binding to active GPCRs activates GRKs, so that they selectively phosphorylate only the activated form of the receptor regardless of the accessibility of the substrate peptides within it and their Ser/Thr-containing sequence. Mammalian GRKs were classified into three main lineages, but earlier GRK evolution has not been studied. Here we show that GRKs emerged at the early stages of eukaryotic evolution via an insertion of a kinase similar to ribosomal protein S6 kinase into a loop in RGS domain. GRKs in Metazoa fall into two clades, one including GRK2 and GRK3, and the other consisting of all remaining GRKs, split into GRK1-GRK7 lineage and GRK4-GRK5-GRK6 lineage in vertebrates. One representative of each of the two ancient clades is found as early as placozoan Trichoplax adhaerens. Several protists, two oomycetes and unicellular brown algae have one GRK-like protein, suggesting that the insertion of a kinase domain into the RGS domain preceded the origin of Metazoa. The two GRK families acquired distinct structural units in the N- and C-termini responsible for membrane recruitment and receptor association. Thus, GRKs apparently emerged before animals and rapidly expanded in true Metazoa, most likely due to the need for rapid signalling adjustments in fast-moving animals.	[Mushegian, Arcady] Stowers Inst Med Res, Kansas City, MO USA; [Mushegian, Arcady] Univ Kansas, Med Ctr, Dept Microbiol, Kansas City, KS 66103 USA; [Gurevich, Vsevolod V.; Gurevich, Eugenia V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Vanderbilt University	Mushegian, A (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	eugenia.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008; Mushegian, Arcady/ABF-5387-2021	Gurevich, Vsevolod/0000-0002-3950-5351; Mushegian, Arcady/0000-0002-6809-9225	Stowers Institute for Medical Research; National Institutes of Health (NIH) [EY011500, GM077561, GM081756, NS065868, DA030103]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM077561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030103] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Stowers Institute for Medical Research (AM) and National Institutes of Health (NIH) grants EY011500, GM077561, GM081756 (VVG), and NS065868 and DA030103 (EVG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambrose Christine, 1992, Human Molecular Genetics, V1, P697, DOI 10.1093/hmg/1.9.697; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1986, NATURE, V321, P869, DOI 10.1038/321869a0; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1993, J BIOL CHEM, V268, P19521; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; BOWNDS D, 1972, NATURE-NEW BIOL, V237, P125, DOI 10.1038/newbio237125a0; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; CHEN CY, 1993, J BIOL CHEM, V268, P7825; Chen MY, 2009, J BIOL CHEM, V284, P35040, DOI 10.1074/jbc.M109.047456; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; DOWNING AK, 1994, CURR BIOL, V4, P884, DOI 10.1016/S0960-9822(00)00197-4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Furlong RF, 2004, BIOL J LINN SOC, V82, P425, DOI 10.1111/j.1095-8312.2004.00329.x; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Gurevich EV, 2011, PHARM THER IN PRESS; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; HAGA K, 1992, J BIOL CHEM, V267, P2222; Higgins MK, 2006, J BIOL CHEM, V281, P19426, DOI 10.1074/jbc.M602203200; Hisatomi O, 1998, FEBS LETT, V424, P159, DOI 10.1016/S0014-5793(98)00162-8; HOLLAND PWH, 1994, DEVELOPMENT, P125; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jiang XS, 2007, MOL BIOL CELL, V18, P2960, DOI 10.1091/mbc.E07-01-0013; Kikkawa S, 1998, J BIOL CHEM, V273, P7441, DOI 10.1074/jbc.273.13.7441; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; Li JL, 2003, J BIOL CHEM, V278, P30219, DOI 10.1074/jbc.M302385200; LIEBMAN PA, 1980, NATURE, V287, P734, DOI 10.1038/287734a0; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; Pao CS, 2009, BIOCHEMISTRY-US, V48, P7325, DOI 10.1021/bi900408g; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Trillo I, 2006, J EUKARYOT MICROBIOL, V53, P379, DOI 10.1111/j.1550-7408.2006.00118.x; SIBLEY DR, 1985, J BIOL CHEM, V260, P3883; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; STADEL JM, 1983, P NATL ACAD SCI-BIOL, V80, P3173, DOI 10.1073/pnas.80.11.3173; STOFFEL RH, 1994, J BIOL CHEM, V269, P27791; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thiyagarajan MM, 2004, J BIOL CHEM, V279, P17989, DOI 10.1074/jbc.M310738200; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; WELLER M, 1975, P NATL ACAD SCI USA, V72, P381, DOI 10.1073/pnas.72.1.381; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305	73	54	55	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33806	10.1371/journal.pone.0033806	http://dx.doi.org/10.1371/journal.pone.0033806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442725	Green Submitted, Green Published, gold			2022-12-27	WOS:000303836500066
J	Beitnes, ACR; Raki, M; Brottveit, M; Lundin, KEA; Jahnsen, FL; Sollid, LM				Beitnes, Ann-Christin Roberg; Raki, Melinda; Brottveit, Margit; Lundin, Knut Erik Aslaksen; Jahnsen, Frode Lars; Sollid, Ludvig Magne			Rapid Accumulation of CD14(+)CD11c(+) Dendritic Cells in Gut Mucosa of Celiac Disease after in vivo Gluten Challenge	PLOS ONE			English	Article							HUMAN MONOCYTE SUBSETS; REACTIVE T-CELLS; GLIADIN; ACTIVATION; TISSUE; SPRUE; STIMULATION; EOSINOPHILS; SENSITIVITY; RESPONSES	Background: Of antigen-presenting cells (APCs) expressing HLA-DQ molecules in the celiac disease (CD) lesion, CD11c(+) dendritic cells (DCs) co-expressing the monocyte marker CD14 are increased, whereas other DC subsets (CD1c(+) or CD103(+)) and CD163(+)CD11c(-) macrophages are all decreased. It is unclear whether these changes result from chronic inflammation or whether they represent early events in the gluten response. We have addressed this in a model of in vivo gluten challenge. Methods: Treated HLA-DQ2(+) CD patients (n = 12) and HLA-DQ2(+) gluten-sensitive control subjects (n = 12) on a gluten-free diet (GFD) were orally challenged with gluten for three days. Duodenal biopsies obtained before and after gluten challenge were subjected to immunohistochemistry. Single cell digests of duodenal biopsies from healthy controls (n = 4), treated CD (n = 3) and untreated CD (n = 3) patients were analyzed by flow cytometry. Results: In treated CD patients, the gluten challenge increased the density of CD14(+)CD11c(+) DCs, whereas the density of CD103(+)CD11c(+) DCs and CD163(+)CD11c(-) macrophages decreased, and the density of CD1c(+)CD11c(+) DCs remained unchanged. Most CD14(+)CD11c(+) DCs co-expressed CCR2. The density of neutrophils also increased in the challenged mucosa, but in most patients no architectural changes or increase of CD3(+) intraepithelial lymphocytes (IELs) were found. In control tissue no significant changes were observed. Conclusions: Rapid accumulation of CD14(+)CD11c(+) DCs is specific to CD and precedes changes in mucosal architecture, indicating that this DC subset may be directly involved in the immunopathology of the disease. The expression of CCR2 and CD14 on the accumulating CD11c(+) DCs indicates that these cells are newly recruited monocytes.	[Beitnes, Ann-Christin Roberg; Raki, Melinda; Lundin, Knut Erik Aslaksen; Jahnsen, Frode Lars; Sollid, Ludvig Magne] Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0027 Oslo, Norway; [Beitnes, Ann-Christin Roberg; Raki, Melinda; Lundin, Knut Erik Aslaksen; Sollid, Ludvig Magne] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0027 Oslo, Norway; [Brottveit, Margit] Oslo Univ Hosp Ulleval, Dept Med, Oslo, Norway; [Sollid, Ludvig Magne] Univ Oslo, Dept Immunol, Oslo, Norway; [Lundin, Knut Erik Aslaksen] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Med, N-0027 Oslo, Norway; [Jahnsen, Frode Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pathol, N-0027 Oslo, Norway; [Sollid, Ludvig Magne] Univ Oslo, Ctr Immune Regulat, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Beitnes, ACR (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0027 Oslo, Norway.	Ann-Christin.Beitnes@rr-research.no	Sollid, Ludvig/N-9691-2015; Lundin, Knut E. A./AAW-9519-2021	Sollid, Ludvig/0000-0001-8860-704X; Lundin, Knut E. A./0000-0003-1713-5545	Oslo University Hospital - Rikshospitalet; Research Council of Norway	Oslo University Hospital - Rikshospitalet; Research Council of Norway(Research Council of Norway)	This study was supported by grants from Oslo University Hospital - Rikshospitalet and the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Beitnes ACR, 2011, SCAND J IMMUNOL, V74, P186, DOI 10.1111/j.1365-3083.2011.02549.x; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Brottveit M, 2011, AM J GASTROENTEROL, V106, P1318, DOI 10.1038/ajg.2011.23; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; DHESI I, 1984, VIRCHOWS ARCH A, V403, P173, DOI 10.1007/BF00695233; Diosdado B, 2007, CLIN GASTROENTEROL H, V5, P574, DOI 10.1016/j.cgh.2006.11.014; HALSTENSEN TS, 1993, SCAND J IMMUNOL, V38, P581, DOI 10.1111/j.1365-3083.1993.tb03245.x; HUITFELDT HS, 1985, HISTOCHEMISTRY, V83, P381, DOI 10.1007/BF00509196; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; JAHNSEN FL, 1994, J IMMUNOL METHODS, V173, P77, DOI 10.1016/0022-1759(94)90285-2; LEIGH RJ, 1985, SCAND J GASTROENTERO, V20, P715, DOI 10.3109/00365528509089201; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; MARSH MN, 1985, GASTROENTEROLOGY, V89, P92, DOI 10.1016/0016-5085(85)90749-8; MICKLEM KJ, 1991, AM J PATHOL, V139, P1297; Molberg O, 2000, METH MOLEC MED, V41, P105, DOI 10.1385/1-59259-082-9:105; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Palova-Jelinkova L, 2005, J IMMUNOL, V175, P7038, DOI 10.4049/jimmunol.175.10.7038; Rakhimova M, 2009, J CLIN IMMUNOL, V29, P29, DOI 10.1007/s10875-008-9228-x; Raki M, 2005, CLIN EXP IMMUNOL, V142, P333, DOI 10.1111/j.1365-2249.2005.02915.x; Raki M, 2006, GASTROENTEROLOGY, V131, P428, DOI 10.1053/j.gastro.2006.06.002; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Schwartzkopff F, 2010, INNATE IMMUN; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Shantsila E, 2011, J THROMB HAEMOST, V9, P1056, DOI 10.1111/j.1538-7836.2011.04244.x; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SPITS H, 1984, EUR J IMMUNOL, V14, P299, DOI 10.1002/eji.1830140404; Tallone T, 2011, J CARDIOVASC TRANSL, V4, P211, DOI 10.1007/s12265-011-9256-4; Troncone R, 2011, J INTERN MED, V269, P582, DOI 10.1111/j.1365-2796.2011.02385.x; Walker MM, 2011, HISTOPATHOLOGY, V59, P166, DOI 10.1111/j.1365-2559.2010.03680.x; Wang JE, 2001, INFECT IMMUN, V69, P2402, DOI 10.1128/IAI.69.4.2402-2406.2001; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355	33	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33556	10.1371/journal.pone.0033556	http://dx.doi.org/10.1371/journal.pone.0033556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438948	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100057
J	Kobayashi, M; Matsumoto, T; Ryuge, S; Yanagita, K; Nagashio, R; Kawakami, Y; Goshima, N; Jiang, SX; Saegusa, M; Iyoda, A; Satoh, Y; Masuda, N; Sato, Y				Kobayashi, Makoto; Matsumoto, Toshihide; Ryuge, Shinichiro; Yanagita, Kengo; Nagashio, Ryo; Kawakami, Yoshitaka; Goshima, Naoki; Jiang, Shi-Xu; Saegusa, Makoto; Iyoda, Akira; Satoh, Yukitoshi; Masuda, Noriyuki; Sato, Yuichi			CAXII Is a Sero-Diagnostic Marker for Lung Cancer	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-XII; ISOZYME-XII; EXPRESSION; PROGNOSIS; IX	To develop sero-diagnostic markers for lung cancer, we generated monoclonal antibodies using pulmonary adenocarcinoma (AD)-derived A549 cells as antigens by employing the random immunization method. Hybridoma supernatants were immunohistochemically screened for antibodies with AMeX-fixed and paraffin-embedded A549 cell preparations. Positive clones were monocloned twice through limiting dilutions. From the obtained monoclonal antibodies, we selected an antibody designated as KU-Lu-5 which showed intense membrane staining of A549 cells. Based on immunoprecipitation and MADLI TOF/TOF-MS analysis, this antibody was recognized as carbonic anhydrase XII (CAXII). To evaluate the utility of this antibody as a sero-diagnostic marker for lung cancer, we performed dot blot analysis with a training set consisting of sera from 70 lung cancer patients and 30 healthy controls. The CAXII expression levels were significantly higher in lung cancer patients than in healthy controls in the training set (P<0.0001), and the area under the curve of ROC was 0.794, with 70.0% specificity and 82.9% sensitivity. In lung cancers, expression levels of CAXII were significantly higher in patients with squamous cell carcinoma (SCC) than with AD (P = 0.035). Furthermore, CAXII was significantly higher in well-and moderately differentiated SCCs than in poorly differentiated ones (P = 0.027). To further confirm the utility of serum CAXII levels as a sero-diagnostic marker, an additional set consisting of sera from 26 lung cancer patients and 30 healthy controls was also investigated by dot blot analysis as a validation study. Serum CAXII levels were also significantly higher in lung cancer patients than in healthy controls in the validation set (P = 0.030). Thus, the serum CAXII levels should be applicable markers discriminating lung cancer patients from healthy controls. To our knowledge, this is the first report providing evidence that CAXII may be a novel sero-diagnostic marker for lung cancer.	[Kobayashi, Makoto; Matsumoto, Toshihide; Yanagita, Kengo; Nagashio, Ryo; Sato, Yuichi] Kitasato Univ, Grad Sch Med Sci, Dept Appl Tumor Pathol, Kanagawa, Japan; [Kobayashi, Makoto; Yanagita, Kengo; Nagashio, Ryo; Sato, Yuichi] Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Kanagawa, Japan; [Kawakami, Yoshitaka; Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan; [Matsumoto, Toshihide; Jiang, Shi-Xu; Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Kanagawa, Japan; [Iyoda, Akira; Satoh, Yukitoshi] Kitasato Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Kanagawa, Japan; [Ryuge, Shinichiro; Masuda, Noriyuki] Kitasato Univ, Sch Med, Dept Resp Med, Kanagawa, Japan	Kitasato University; Kitasato University; National Institute of Advanced Industrial Science & Technology (AIST); Kitasato University; Kitasato University; Kitasato University	Kobayashi, M (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Appl Tumor Pathol, Kanagawa, Japan.	yuichi@med.kitasato-u.ac.jp		Kobayashi, Makoto/0000-0001-7176-7207	Japan Society for the Promotion of Science [23590414]; Ministry of Health, Labour and Welfare of Japan; School of Allied Health Sciences, Kitasato University [2011-1006]; Grants-in-Aid for Scientific Research [23590414] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); School of Allied Health Sciences, Kitasato University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research Council (23590414) from the Japan Society for the Promotion of Science, grants from the Third Term Comprehensive Control Research for Cancer conducted by the Ministry of Health, Labour and Welfare of Japan, as well as from the Research Project (No. 2011-1006) of the School of Allied Health Sciences, Kitasato University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akishima-Fukasawa Y, 2010, AM J CLIN PATHOL, V134, P71, DOI 10.1309/AJCPRJP39MIDSGBH; Battke C, 2011, CANCER IMMUNOL IMMUN, V60, P649, DOI 10.1007/s00262-011-0980-z; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Haapasalo J, 2008, NEURO-ONCOLOGY, V10, P131, DOI 10.1215/15228517-2007-065; HIROHASHI S, 1984, GANN, V75, P485; Hynninen P, 2006, HISTOPATHOLOGY, V49, P594, DOI 10.1111/j.1365-2559.2006.02523.x; Ilie MI, 2011, INT J CANCER, V128, P1614, DOI 10.1002/ijc.25491; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang SX, 2004, MODERN PATHOL, V17, P222, DOI 10.1038/modpathol.3800038; Kivela A, 2000, AM J PATHOL, V156, P577, DOI 10.1016/S0002-9440(10)64762-1; Kivela AJ, 2005, WORLD J GASTROENTERO, V11, P2616, DOI 10.3748/wjg.v11.i17.2616; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mazzone Peter J, 2007, Curr Oncol Rep, V9, P265, DOI 10.1007/s11912-007-0032-1; Mazzone PJ, 2010, CURR ONCOL REP, V12, P226, DOI 10.1007/s11912-010-0111-6; Nagashio R, 2010, LUNG CANCER, V69, P54, DOI 10.1016/j.lungcan.2009.09.015; Nitori N, 2005, CLIN CANCER RES, V11, P2531, DOI 10.1158/1078-0432.CCR-04-0866; Parkkila S, 2000, J HISTOCHEM CYTOCHEM, V48, P1601, DOI 10.1177/002215540004801203; Patel JL, 2010, CLIN BIOCHEM, V43, P1449, DOI 10.1016/j.clinbiochem.2010.09.014; SATO Y, 1986, AM J PATHOL, V125, P431; Watson PH, 2003, BRIT J CANCER, V88, P1065, DOI 10.1038/sj.bjc.6600796; Wykoff CC, 2001, AM J PATHOL, V158, P1011, DOI 10.1016/S0002-9440(10)64048-5	22	28	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33952	10.1371/journal.pone.0033952	http://dx.doi.org/10.1371/journal.pone.0033952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439015	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100115
J	Li, YC; Zhang, M; Jiang, Y; Wu, F				Li, Yichong; Zhang, Mei; Jiang, Yong; Wu, Fan			Co-variations and Clustering of Chronic Disease Behavioral Risk Factors in China: China Chronic Disease and Risk Factor Surveillance, 2007	PLOS ONE			English	Article							HEALTH SYSTEM REFORM; LIFE-STYLE FACTORS; PHYSICAL-ACTIVITY; WEIGHT-GAIN; OBESITY; OVERWEIGHT; ASSOCIATION; PREVALENCE; MORTALITY; SMOKING	Background: Chronic diseases have become the leading causes of mortality in China and related behavioral risk factors (BRFs) changed dramatically in past decades. We aimed to examine the prevalence, co-variations, clustering and the independent correlates of five BRFs at the national level. Methodology/Principal Findings: We used data from the 2007 China Chronic Disease and Risk Factor Surveillance, in which multistage clustering sampling was adopted to collect a nationally representative sample of 49,247 Chinese aged 15 to 69 years. We estimated the prevalence and clustering (mean number of BRFs) of five BRFs: tobacco use, excessive alcohol drinking, insufficient intake of vegetable and fruit, physical inactivity, and overweight or obesity. We conducted binary logistic regression models to examine the co-variations among five BRFs with adjustment of demographic and socioeconomic factors, chronic conditions and other BRFs. Ordinal logistic regression was constructed to investigate the independent associations between each covariate and the clustering of BRFs within individuals. Overall, 57.0% of Chinese population had at least two BRFs and the mean number of BRFs is 1.80 (95% confidence interval: 1.78-1.83). Eight of the ten pairs of bivariate associations between the five BRFs were found statistically significant. Chinese with older age, being a male, living in rural areas, having lower education level and lower yearly household income experienced increased likelihood of having more BRFs. Conclusions/Significance: Current BRFs place the majority of Chinese aged 15 to 69 years at risk for the future development of chronic disease, which calls for urgent public health programs to reduce these risk factors. Prominent correlations between BRFs imply that a combined package of interventions targeting multiple BRFs might be appropriate. These interventions should target elder population, men, and rural residents, especially those with lower SES.	[Li, Yichong; Zhang, Mei; Jiang, Yong] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Wu, Fan] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Li, YC (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China.	alexleeliyichong@gmail.com	JIANG, Yong/GYU-9887-2022; Li, Yichong/A-3559-2019	JIANG, Yong/0000-0001-7700-6054; Li, Yichong/0000-0003-3842-475X	Ministry of Health of the People's Republic of China	Ministry of Health of the People's Republic of China	This study was funded by Ministry of Health of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamian A, 2009, AM J EPIDEMIOL, V170, P1279, DOI 10.1093/aje/kwp284; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Berrigan D, 2003, PREV MED, V36, P615, DOI 10.1016/S0091-7435(02)00067-1; Bes-Rastrollo M, 2006, NUTRITION, V22, P504, DOI 10.1016/j.nut.2005.12.006; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chinese Nutrition Society, 2022, CHIN DIET GUID; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; Fine LJ, 2004, AM J PREV MED, V27, P18, DOI 10.1016/j.amepre.2004.04.017; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Hao W, 2005, ADDICTION, V100, P737, DOI 10.1111/j.1360-0443.2005.01036.x; Hou XH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-389; Jepson RG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-538; KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; LAU RR, 1990, J HEALTH SOC BEHAV, V31, P240, DOI 10.2307/2136890; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lowry R, 1996, JAMA-J AM MED ASSOC, V276, P792, DOI 10.1001/jama.276.10.792; LYTLE LA, 1995, HEALTH EDUC RES, V10, P133, DOI 10.1093/her/10.2.133; Ma GuanSheng, 2009, Acta Nutrimenta Sinica, V31, P213; Marteau TM, 2001, BMJ-BRIT MED J, V322, P1056, DOI 10.1136/bmj.322.7293.1056; Meng LX, 1999, PREV MED, V29, P296, DOI 10.1006/pmed.1999.0538; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; National Center for Chronic and Non-communicable Disease Control and Prevention Chinese Center for Disease Control and Prevention, 2009, REP CHRON DIS RISK F; NUTBEAM D, 1989, SOC SCI MED, V29, P317, DOI 10.1016/0277-9536(89)90280-3; Pan ZF, 2004, HEALTH PROMOT INT, V19, P309, DOI 10.1093/heapro/dah304; PATTERSON TL, 1989, J PEDIATR PSYCHOL, V14, P277, DOI 10.1093/jpepsy/14.2.277; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; RISSANEN AM, 1991, EUR J CLIN NUTR, V45, P419; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Serdula MK, 1996, EPIDEMIOLOGY, V7, P161, DOI 10.1097/00001648-199603000-00010; Shi Z, 2008, INT J OBESITY, V32, P975, DOI 10.1038/ijo.2008.21; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Tjepkema Michael, 2006, Health Rep, V17, P9; World Health Organization, 2005, WHO STEPS SURV MAN W; Xiao Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P30; Xu F, 2007, ASIA PAC J CLIN NUTR, V16, P240; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Zhou MaiGeng, 2010, Disease Surveillance, V25, P239	44	28	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33881	10.1371/journal.pone.0033881	http://dx.doi.org/10.1371/journal.pone.0033881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439010	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100110
J	Sun, C; Fang, H; Xie, T; Auth, RD; Patel, N; Murray, PR; Snoy, PJ; Frucht, DM				Sun, Chen; Fang, Hui; Xie, Tao; Auth, Roger D.; Patel, Nayana; Murray, Patrick R.; Snoy, Philip J.; Frucht, David M.			Anthrax Lethal Toxin Disrupts Intestinal Barrier Function and Causes Systemic Infections with Enteric Bacteria	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; KAPPA-B	A variety of intestinal pathogens have virulence factors that target mitogen activated protein kinase (MAPK) signaling pathways, including Bacillus anthracis. Anthrax lethal toxin (LT) has specific proteolytic activity against the upstream regulators of MAPKs, the MAPK kinases (MKKs). Using a murine model of intoxication, we show that LT causes the dose-dependent disruption of intestinal epithelial integrity, characterized by mucosal erosion, ulceration, and bleeding. This pathology correlates with an LT-dependent blockade of intestinal crypt cell proliferation, accompanied by marked apoptosis in the villus tips. C57BL/6J mice treated with intravenous LT nearly uniformly develop systemic infections with commensal enteric organisms within 72 hours of administration. LT-dependent intestinal pathology depends upon its proteolytic activity and is partially attenuated by co-administration of broad spectrum antibiotics, indicating that it is both a cause and an effect of infection. These findings indicate that targeting of MAPK signaling pathways by anthrax LT compromises the structural integrity of the mucosal layer, serving to undermine the effectiveness of the intestinal barrier. Combined with the well-described immunosuppressive effects of LT, this disruption of the intestinal barrier provides a potential mechanism for host invasion via the enteric route, a common portal of entry during the natural infection cycle of Bacillus anthracis.	[Sun, Chen; Fang, Hui; Xie, Tao; Auth, Roger D.; Frucht, David M.] US FDA, Cell Biol Lab, Div Monoclonal Antibodies, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA; [Patel, Nayana; Murray, Patrick R.] NIH, Dept Lab Med, Warren Magnusen Clin Ctr, Bethesda, MD 20892 USA; [Snoy, Philip J.] US FDA, Div Vet Serv, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA)	Sun, C (corresponding author), US FDA, Cell Biol Lab, Div Monoclonal Antibodies, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	david.frucht@fda.hhs.gov			United States government	United States government	The United States government provided the funding to support this work. The information presented in this manuscript reflects the work of the authors and does not necessarily represent the policy of the United States Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brook Itzhak, 2002, Mil Med, V167, P105; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; Fang H, 2010, J IMMUNOL, V185, P5463, DOI 10.4049/jimmunol.1002471; Fasanella A, 2010, VET MICROBIOL, V140, P318, DOI 10.1016/j.vetmic.2009.08.016; Franz DR, 2009, MOL ASPECTS MED, V30, P503, DOI 10.1016/j.mam.2009.07.002; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Khan S A, 2001, J Natl Cancer Inst Monogr, P31, DOI 10.1093/oxfordjournals.jncimonographs.a003437; Kiratisin P, 2003, EUR J CLIN MICROBIOL, V22, P628, DOI 10.1007/s10096-003-1003-6; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Lin SL, 2003, CELL MICROBIOL, V5, P267, DOI 10.1046/j.1462-5822.2003.t01-1-00274.x; MILLER SI, 1980, AM J MED, V68, P649, DOI 10.1016/0002-9343(80)90250-8; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Okugawa S, 2011, INFECT IMMUN, V79, P118, DOI 10.1128/IAI.00963-10; RINK RD, 1977, CIRC SHOCK, V4, P259; Schuller BW, 2006, P NATL ACAD SCI USA, V103, P3787, DOI 10.1073/pnas.0600133103; Shan L, 2007, CELL HOST MICROBE, V1, P167, DOI 10.1016/j.chom.2007.04.008; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tournier JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/j.mam.2009.06.002; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Xie T, 2011, TOXINS, V3, P591, DOI 10.3390/toxins3060591; Xu LX, 2008, J IMMUNOL, V180, P4139, DOI 10.4049/jimmunol.180.6.4139; Xu LX, 2007, INT J BIOCHEM CELL B, V39, P20, DOI 10.1016/j.biocel.2006.08.010; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	33	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33583	10.1371/journal.pone.0033583	http://dx.doi.org/10.1371/journal.pone.0033583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438953	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100061
J	Curini-Galletti, M; Artois, T; Delogu, V; De Smet, WH; Fontaneto, D; Jondelius, U; Leasi, F; Martinez, A; Meyer-Wachsmuth, I; Nilsson, KS; Tongiorgi, P; Worsaae, K; Todaro, MA				Curini-Galletti, Marco; Artois, Tom; Delogu, Valentina; De Smet, Willem H.; Fontaneto, Diego; Jondelius, Ulf; Leasi, Francesca; Martinez, Alejandro; Meyer-Wachsmuth, Inga; Nilsson, Karin Sara; Tongiorgi, Paolo; Worsaae, Katrine; Todaro, M. Antonio			Patterns of Diversity in Soft-Bodied Meiofauna: Dispersal Ability and Body Size Matter	PLOS ONE			English	Article							PLATYHELMINTHES PROSERIATA; MARINE GASTROTRICHA; LATITUDINAL GRADIENTS; GEOGRAPHIC PATTERNS; INTERSTITIAL FAUNA; MEDITERRANEAN SEA; SPECIES RICHNESS; SP-N; ROTIFERA; TURBELLARIA	Background: Biogeographical and macroecological principles are derived from patterns of distribution in large organisms, whereas microscopic ones have often been considered uninteresting, because of their supposed wide distribution. Here, after reporting the results of an intensive faunistic survey of marine microscopic animals (meiofauna) in Northern Sardinia, we test for the effect of body size, dispersal ability, and habitat features on the patterns of distribution of several groups. Methodology/Principal Findings: As a dataset we use the results of a workshop held at La Maddalena (Sardinia, Italy) in September 2010, aimed at studying selected taxa of soft-bodied meiofauna (Acoela, Annelida, Gastrotricha, Nemertodermatida, Platyhelminthes and Rotifera), in conjunction with data on the same taxa obtained during a previous workshop hosted at Tjarno (Western Sweden) in September 2007. Using linear mixed effects models and model averaging while accounting for sampling bias and potential pseudoreplication, we found evidence that: (1) meiofaunal groups with more restricted distribution are the ones with low dispersal potential; (2) meiofaunal groups with higher probability of finding new species for science are the ones with low dispersal potential; (3) the proportion of the global species pool of each meiofaunal group present in each area at the regional scale is negatively related to body size, and positively related to their occurrence in the endobenthic habitat. Conclusion/Significance: Our macroecological analysis of meiofauna, in the framework of the ubiquity hypothesis for microscopic organisms, indicates that not only body size but mostly dispersal ability and also occurrence in the endobenthic habitat are important correlates of diversity for these understudied animals, with different importance at different spatial scales. Furthermore, since the Western Mediterranean is one of the best-studied areas in the world, the large number of undescribed species (37%) highlights that the census of marine meiofauna is still very far from being complete.	[Curini-Galletti, Marco; Delogu, Valentina] Univ Sassari, Dipartimento Zool & Genet Evoluzionist, I-07100 Sassari, Italy; [Artois, Tom] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [De Smet, Willem H.] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Fontaneto, Diego; Jondelius, Ulf; Meyer-Wachsmuth, Inga; Nilsson, Karin Sara] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden; [Fontaneto, Diego; Leasi, Francesca] Imperial Coll London, Div Biol, Ascot, Berks, England; [Leasi, Francesca; Tongiorgi, Paolo; Todaro, M. Antonio] Univ Modena & Reggio Emilia, Dipartimento Biol, Modena, Italy; [Martinez, Alejandro; Worsaae, Katrine] Univ Copenhagen, Biol Sect, Helsingor, Denmark	University of Sassari; Hasselt University; University of Antwerp; Swedish Museum of Natural History; Imperial College London; Universita di Modena e Reggio Emilia; University of Copenhagen	Curini-Galletti, M (corresponding author), Univ Sassari, Dipartimento Zool & Genet Evoluzionist, I-07100 Sassari, Italy.	antonio.todaro@unimore.it	Worsaae, Katrine/L-8739-2014; Martinek, Inga Nicole/AAD-5471-2022; Jondelius, Ulf/AAF-7943-2020; Todaro, M. Antonio/H-1311-2013; Fontaneto, Diego/B-9710-2008; Leasi, Francesca/E-4361-2017; García, Alejandro Martínez/H-7190-2019; Worsaae, Katrine/AEX-9585-2022; De Smet, Willem H/C-3458-2008; Artois, Tom/O-7349-2017	Worsaae, Katrine/0000-0003-0443-4298; Martinek, Inga Nicole/0000-0001-8809-6753; Jondelius, Ulf/0000-0003-2847-2192; Todaro, M. Antonio/0000-0002-6353-7281; Fontaneto, Diego/0000-0002-5770-0353; Leasi, Francesca/0000-0001-6995-0934; García, Alejandro Martínez/0000-0003-0073-3688; Artois, Tom/0000-0002-2491-7273	Regione Sardegna - Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna; Parco Nazionale Arcipelago di La Maddalena	Regione Sardegna - Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna; Parco Nazionale Arcipelago di La Maddalena	The workshop at La Maddalena was supported by a grant from Regione Sardegna - Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna - and by contributions from Parco Nazionale Arcipelago di La Maddalena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTALE V, 1994, J GEOPHYS RES-OCEANS, V99, P14127, DOI 10.1029/94JC00284; Artois TJ, 2001, TROP ZOOL, V14, P63, DOI 10.1080/03946975.2001.10531143; Artois TJ, 2008, ZOOTAXA, P1; Ax P., 1963, Zoologischer Anzeiger, V171, P51; Ax P., 1956, Vie et Milieu Suppl, VNo. 5, P1; Barbosa AM, 2010, ANIM CONSERV, V13, P432, DOI 10.1111/j.1469-1795.2010.00363.x; Barton K., 2011, MUMIN MULTIMODEL INF; Bates D., 2011, IME4 LINEAR MIXED EF; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BRUNET M, 1973, ZOOL SCR, V2, P17; Brunet M., 1971, Annls Fac Sci Marseille, V45, P25; BRUNET M, 1968, CAH BIOL MAR, V9, P421; BRUNET M, 1969, Bulletin de la Societe Zoologique de France, V94, P207; BRUNET M, 1973, Bulletin de la Societe Zoologique de France, V98, P121; Brunet M., 1979, Biologie et Ecologie Mediterraneenne, V6, P101; BRUNET M, 1970, CAH BIOL MAR, V11, P279; BRUNET M, 1967, Bulletin de la Societe Zoologique de France, V92, P143; BRUNET M, 1972, Zoologica Scripta, V1, P157, DOI 10.1111/j.1463-6409.1972.tb00673.x; Brunet M., 1967, Bulletin de la Societe Zoologique de France, V91, P721; Brunet M, 1965, RECUEIL TRAVAUX STAT, V39, P127; Bunnefeld N, 2011, ECOGRAPHY IN PRESS; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Castelli Alberto, 2008, Biologia Marina Mediterranea, V15, P323; Casu M, 2006, BIOL J LINN SOC, V87, P553, DOI 10.1111/j.1095-8312.2006.00588.x; Casu M, 2011, BIOL J LINN SOC, V103, P117, DOI 10.1111/j.1095-8312.2011.01630.x; Ciros-Perez J, 2001, J PLANKTON RES, V23, P1311, DOI 10.1093/plankt/23.12.1311; Clausen C, 2004, SARSIA, V89, P423, DOI 10.1080/00364820410002677; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Crawley M.J., 2007, R BOOK; Curini-Galletti Marco, 2003, Biogeographia, V24, P115; Curini-Galletti Marco, 2008, Biologia Marina Mediterranea, V15, P110; CURINIGALLETTI M, 1985, CARYOLOGIA, V38, P67, DOI 10.1080/00087114.1985.10797731; CURINIGALLETTI MC, 1992, J NAT HIST, V26, P285, DOI 10.1080/00222939200770141; Dal Zotto Matteo, 2010, Meiofauna Marina, V18, P41; De Falco G, 2011, ESTUAR COAST SHELF S, V93, P14, DOI 10.1016/j.ecss.2011.03.013; De Smet WH, 2007, J MAR BIOL ASSOC UK, V87, P1105, DOI 10.1017/S0025315407057591; Delogu V, 2007, ZOOTAXA, P17; Delogu V, 2009, CONTRIB ZOOL, V78, P99, DOI 10.1163/18759866-07803002; Delogu Valentina, 2009, Meiofauna Marina, V17, P133; Derry AM, 2003, LIMNOL OCEANOGR, V48, P675, DOI 10.4319/lo.2003.48.2.0675; DUMONT HJ, 1983, HYDROBIOLOGIA, V104, P19, DOI 10.1007/BF00045948; Erseus C, 2005, HYDROBIOLOGIA, V535, P357, DOI 10.1007/s10750-004-4426-x; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; FONTANETO D, BIOGEOGRAPHY MICROSC; Fontaneto D, 2008, J MAR BIOL ASSOC UK, V88, P253, DOI 10.1017/S0025315408000544; Fontaneto D, 2006, J MAR BIOL ASSOC UK, V86, P623, DOI 10.1017/S0025315406013531; Fontaneto D, 2012, ECOGRAPHY, V35, P174, DOI 10.1111/j.1600-0587.2011.06850.x; Fontaneto Diego, 2008, Biologia Marina Mediterranea, V15, P181; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Fontaneto Diego, 2008, Meiofauna Marina, V16, P75; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Gollner S, 2011, MAR BIOL, V158, P221, DOI 10.1007/s00227-010-1553-y; Gomez A, 2002, EVOLUTION, V56, P1431; Gschwentner R, 2002, INVERTEBR BIOL, V121, P95; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillebrand H, 2001, ECOGRAPHY, V24, P251, DOI 10.1034/j.1600-0587.2001.240302.x; Hochberg R, 2010, ZOOTAXA, P1; Hochberg R, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.61.552; Hummon WD, 2010, ZOOTAXA, P1; Hummon WD, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.94.794; Hummon William D., 2010, Meiofauna Marina, V18, P11; Hummon WD, 2010, B MAR SCI, V86, P661; Hummon WD, 2009, ZOOTAXA, P47, DOI 10.11646/zootaxa.2278.1.3; Jondelius U, 2002, ZOOL SCR, V31, P201, DOI 10.1046/j.1463-6409.2002.00090.x; Karling Tor G., 1940, ACTA ZOOL FENNICA, V26, P1; Kennedy AD, 1999, ENVIRON MONIT ASSESS, V54, P47, DOI 10.1023/A:1005854731889; Kristensen Reinhardt Mobjerg, 2005, P202; KRISTENSEN RM, 1982, ZOOL SCR, V11, P265, DOI 10.1111/j.1463-6409.1982.tb00538.x; KRISTENSEN RM, 1982, ZOOL SCR, V11, P1, DOI 10.1111/j.1463-6409.1982.tb00514.x; MARTENS PM, 1984, CAH BIOL MAR, V25, P319; MARTENS PM, 1993, BIJDR DIERKD, V63, P65, DOI 10.1163/26660644-06302001; MARTENS PM, 1986, HYDROBIOLOGIA, V132, P295, DOI 10.1007/BF00046263; Meixner J., 1938, TIERWELT NORD OSTSEE, V33, P1; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Pauly D, 2010, NAT GEOSCI, V3, P662, DOI 10.1038/ngeo973; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; ROHDE K, 1993, AM NAT, V142, P1, DOI 10.1086/285526; Rohde Klaus, 2001, Systematics Association Special Volume Series, V60, P203; Rota E, 1999, POLAR BIOL, V21, P201, DOI 10.1007/s003000050354; Rothe Birgen H., 2010, Meiofauna Marina, V18, P49; Rouse G. W., 2001, POLYCHAETES; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Schroder T, 2007, HYDROBIOLOGIA, V593, P129, DOI 10.1007/s10750-007-9066-5; Segers H, 2008, BIODIVERS CONSERV, V17, P303, DOI 10.1007/s10531-007-9262-7; Segers H, 2008, HYDROBIOLOGIA, V595, P49, DOI 10.1007/s10750-007-9003-7; Sopott B., 1972, Mikrofauna Meeresbodens, VNo. 13, P1; Sorensen MV, 2006, MOL PHYLOGENET EVOL, V40, P585, DOI 10.1016/j.ympev.2006.04.001; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sterrer W, 1998, BELG J ZOOL, V128, P55; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Swanstrom J, 2011, HYDROBIOLOGIA, V662, P19, DOI 10.1007/s10750-010-0480-8; Todaro MA, 2006, J MAR BIOL ASSOC UK, V86, P1005, DOI 10.1017/S0025315406013981; Todaro M. Antonio, 2003, Biogeographia, V24, P131; Todaro MA, 2006, MAR BIOL, V149, P1079, DOI 10.1007/s00227-006-0299-z; Todaro MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017892; Todaro M. Antonio, 2008, Meiofauna Marina, V16, P3; Todaro MA, 2005, J MAR BIOL ASSOC UK, V85, P1391, DOI 10.1017/S0025315405012579; Todaro MA, 2008, BIOL MARINA MEDITE S, V15, P160; Vasileiadou K, 2009, MAR BIOTECHNOL, V11, P53, DOI 10.1007/s10126-008-9119-4; von Salvini-Plawen L., 1968, THALASSIA JUGOSLAVIC, V4, P11; VONNORDHEIM H, 1989, ZOOL SCR, V18, P245; Walsh EJ, 2008, VERH INT VER THEOR A, V30, P1046; WESTBLAD E, 1948, ARK ZOOL, V41, P191; WESTBLAD EINAR, 1940, ARKIV ZOOL, V32A, P1; Willems W. R., 2009, Meiofauna Marina, V17, P1; Willems WR, 2006, ZOOL SCR, V35, P1, DOI 10.1111/j.1463-6409.2005.00216.x; Willems WR, 2004, ZOOL J LINN SOC-LOND, V141, P271, DOI 10.1111/j.1096-3642.2004.00124.x; Worsaae K, 2005, HYDROBIOLOGIA, V535, P319, DOI 10.1007/s10750-004-4417-y; Worsaae K, 2004, P BIOL SOC WASH, V117, P346; Worsaae K, 2009, ZOOSYMPOSIA, V2, P297, DOI 10.11646/zoosymposia.2.1.20; Worsaae Katrine, 2009, Marine Biodiversity, V39, P195, DOI 10.1007/s12526-009-0027-2; Worsaae Katrine, 2005, Meiofauna Marina, V14, P49; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	122	108	110	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33801	10.1371/journal.pone.0033801	http://dx.doi.org/10.1371/journal.pone.0033801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457790	Green Published, gold			2022-12-27	WOS:000304046900026
J	Olivieri, C; Ermini, L; Rizzi, E; Corti, G; Luciani, S; Marota, I; De Bellis, G; Rollo, F				Olivieri, Cristina; Ermini, Luca; Rizzi, Ermanno; Corti, Giorgio; Luciani, Stefania; Marota, Isolina; De Bellis, Gianluca; Rollo, Franco			Phylogenetic Position of a Copper Age Sheep (Ovis aries) Mitochondrial DNA	PLOS ONE			English	Article							DOMESTIC SHEEP; HAIR SHAFTS; SEQUENCE; LINEAGES; BREEDS; WILD	Background: Sheep (Ovis aries) were domesticated in the Fertile Crescent region about 9,000-8,000 years ago. Currently, few mitochondrial (mt) DNA studies are available on archaeological sheep. In particular, no data on archaeological European sheep are available. Methodology/Principal Findings: Here we describe the first portion of mtDNA sequence of a Copper Age European sheep. DNA was extracted from hair shafts which were part of the clothes of the so-called Tyrolean Iceman or Otzi (5,350 -5,100 years before present). Mitochondrial DNA (a total of 2,429 base pairs, encompassing a portion of the control region, tRNA(Phe), a portion of the 12S rRNA gene, and the whole cytochrome B gene) was sequenced using a mixed sequencing procedure based on PCR amplification and 454 sequencing of pooled amplification products. We have compared the sequence with the corresponding sequence of 334 extant lineages. Conclusions/Significance: A phylogenetic network based on a new cladistic notation for the mitochondrial diversity of domestic sheep shows that the Otzi's sheep falls within haplogroup B, thus demonstrating that sheep belonging to this haplogroup were already present in the Alps more than 5,000 years ago. On the other hand, the lineage of the Otzi's sheep is defined by two transitions (16147, and 16440) which, assembled together, define a motif that has not yet been identified in modern sheep populations.	[Olivieri, Cristina; Luciani, Stefania; Marota, Isolina; Rollo, Franco] Univ Camerino, Scuola Biosci & Biotecnol, Lab Archeoantropol Mol DNA Ant, I-62032 Camerino, Italy; [Ermini, Luca] Inst Canc Res, Sect Haematooncol, Sutton, Surrey, England; [Rizzi, Ermanno; Corti, Giorgio; De Bellis, Gianluca] CNR, Ist Tecnol Biomed, Segrate, Italy	University of Camerino; University of London; Institute of Cancer Research - UK; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Olivieri, C (corresponding author), Univ Camerino, Scuola Biosci & Biotecnol, Lab Archeoantropol Mol DNA Ant, I-62032 Camerino, Italy.	francougo.rollo@unicam.it	De Bellis, Gianluca/H-9725-2013; Rizzi, Ermanno/J-7448-2012; Ermini, Luca/O-4813-2016; rizzi, ermanno/Q-3399-2016	De Bellis, Gianluca/0000-0002-1622-4477; Ermini, Luca/0000-0001-8109-6021; rizzi, ermanno/0000-0002-9898-2326; Olivieri, Cristina/0000-0002-2957-5452; Corti, Giorgio/0000-0001-6379-4117	Ministero per l'Istruzione, l'Universita e la Ricerca (MIUR)	Ministero per l'Istruzione, l'Universita e la Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by a Ministero per l'Istruzione, l'Universita e la Ricerca (MIUR) research project "Tecniche Biomolecolari in Archeo-Antropologia per una nuova storia delle malattie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker LE, 2001, J FORENSIC SCI, V46, P126; Bandelt HJ, 2005, EUR J HUM GENET, V13, P1106, DOI 10.1038/sj.ejhg.5201476; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BONANI G, 1994, RADIOCARBON, V36, P247, DOI 10.1017/S0033822200040534; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Cai DW, 2007, J ARCHAEOL SCI, V34, P1347, DOI 10.1016/j.jas.2006.10.020; Cai DW, 2011, J ARCHAEOL SCI, V38, P896, DOI 10.1016/j.jas.2010.11.019; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Fraser R.D.B., 1972, KERATINS THEIR COMPO; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2004, CURR BIOL, V14, pR463, DOI 10.1016/j.cub.2004.06.008; Gilbert MTP, 2006, FORENSIC SCI INT, V156, P208, DOI 10.1016/j.forsciint.2005.02.021; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Guo J, 2005, ANIM GENET, V36, P331, DOI 10.1111/j.1365-2052.2005.01310.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hiendleder S, 1998, J HERED, V89, P113, DOI 10.1093/jhered/89.2.113; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hollemeyer K, 2008, RAPID COMMUN MASS SP, V22, P2751, DOI 10.1002/rcm.3679; Horsburgh KA, 2010, J ARCHAEOL SCI, V37, P2906, DOI 10.1016/j.jas.2010.06.035; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Lange J, 1992, MANN EIS; Lari M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-32; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meadows JRS, 2011, HEREDITY, V106, P700, DOI 10.1038/hdy.2010.122; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; Olivieri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008629; Page R.D.M., 1998, MOL EVOLUTION PHYLOG; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; Puntener AG, 2010, CHIMIA, V64, P315, DOI 10.2533/chimia.2010.315; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rollo F, 2002, P NATL ACAD SCI USA, V99, P12594, DOI 10.1073/pnas.192184599; Ryder ML, 1984, EVOLUTION DOMESTICAT, P63; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Spindler K, 1994, MAN ICE; Taberlet P, 2011, CR BIOL, V334, P247, DOI 10.1016/j.crvi.2010.12.007; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Wittig M, 1992, MANN EIS, V1; Wood NJ, 1996, ANIM GENET, V27, P25, DOI 10.1111/j.1365-2052.1996.tb01173.x	44	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33792	10.1371/journal.pone.0033792	http://dx.doi.org/10.1371/journal.pone.0033792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457789	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900025
J	Huang, QL; Cheng, XJ; Cheung, MK; Kiselev, SS; Ozoline, ON; Kwan, HS				Huang, Qianli; Cheng, Xuanjin; Cheung, Man Kit; Kiselev, Sergey S.; Ozoline, Olga N.; Kwan, Hoi Shan			High-Density Transcriptional Initiation Signals Underline Genomic Islands in Bacteria	PLOS ONE			English	Article							HORIZONTALLY-TRANSFERRED GENES; CODON USAGE BIAS; ESCHERICHIA-COLI; PATHOGENICITY ISLANDS; POSTTRANSLATIONAL MODIFICATION; PROKARYOTIC GENOMES; FOREIGN GENES; WHOLE-GENOME; PROTEIN; IDENTIFICATION	Genomic islands (GIs), frequently associated with the pathogenicity of bacteria and having a substantial influence on bacterial evolution, are groups of "alien" elements which probably undergo special temporal-spatial regulation in the host genome. Are there particular hallmark transcriptional signals for these "exotic" regions? We here explore the potential transcriptional signals that underline the GIs beyond the conventional views on basic sequence composition, such as codon usage and GC property bias. It showed that there is a significant enrichment of the transcription start positions (TSPs) in the GI regions compared to the whole genome of Salmonella enterica and Escherichia coli. There was up to a four-fold increase for the 70% GIs, implying high-density TSPs profile can potentially differentiate the GI regions. Based on this feature, we developed a new sliding window method GIST, Genomic-island Identification by Signals of Transcription, to identify these regions. Subsequently, we compared the known GI-associated features of the GIs detected by GIST and by the existing method Islandviewer to those of the whole genome. Our method demonstrates high sensitivity in detecting GIs harboring genes with biased GI-like function, preferred subcellular localization, skewed GC property, shorter gene length and biased "non-optimal" codon usage. The special transcriptional signals discovered here may contribute to the coordinate expression regulation of foreign genes. Finally, by using GIST, we detected many interesting GIs in the 2011 German E. coli O104:H4 outbreak strain TY-2482, including the microcin H47 system and gene cluster ycgXEFZ-ymgABC that activates the production of biofilm matrix. The aforesaid findings highlight the power of GIST to predict GIs with distinct intrinsic features to the genome. The heterogeneity of cumulative TSPs profiles may not only be a better identity for "alien" regions, but also provide hints to the special evolutionary course and transcriptional regulation of GI regions.	[Huang, Qianli; Cheng, Xuanjin; Cheung, Man Kit; Kwan, Hoi Shan] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Kiselev, Sergey S.; Ozoline, Olga N.] Russian Acad Sci, Inst Cell Biophys, Moscow, Russia	Chinese University of Hong Kong; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS	Huang, QL (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China.	hoishankwan@cuhk.edu.hk	Cheung, Man Kit/M-6972-2019; Kwan, Hoi Shan/GOV-6863-2022; Cheung, Man Kit/E-5696-2012	Cheung, Man Kit/0000-0002-2764-2113; Cheung, Man Kit/0000-0002-2764-2113; Kwan, Hoi Shan/0000-0002-7943-2513	Food and Health Bureau of the Hong Kong SAR, China [RFCID CHP-PH-06]	Food and Health Bureau of the Hong Kong SAR, China	This work is supported by the Food and Health Bureau of the Hong Kong SAR, China (RFCID CHP-PH-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Amoros-Moya D, 2010, MOL BIOL EVOL, V27, P2141, DOI 10.1093/molbev/msq103; Archetti M, 2004, J MOL EVOL, V59, P400, DOI 10.1007/s00239-004-2634-7; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Arvey AJ, 2009, NUCLEIC ACIDS RES, V37, P5255, DOI 10.1093/nar/gkp576; Azpiroz MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026179; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Cheung Man Kit, 2011, BMC Res Notes, V4, P533, DOI 10.1186/1756-0500-4-533; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; Cortez D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r65; COWIE DB, 1957, BIOCHIM BIOPHYS ACTA, V26, P252, DOI 10.1016/0006-3002(57)90003-3; Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dorman CJ, 2009, FRONT BIOSCI-LANDMRK, V14, P4103, DOI 10.2741/3515; Doublet B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002060; Duquesne S, 2007, J MOL MICROB BIOTECH, V13, P200, DOI 10.1159/000104748; EyreWalker A, 1996, MOL BIOL EVOL, V13, P864, DOI 10.1093/oxfordjournals.molbev.a025646; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Ganesan H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-333; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; Ge YG, 1998, J BACTERIOL, V180, P2418, DOI 10.1128/JB.180.9.2418-2425.1998; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Hullo MF, 2007, J BACTERIOL, V189, P187, DOI 10.1128/JB.01273-06; Ideses D, 2005, INT J MED MICROBIOL, V295, P227, DOI 10.1016/j.ijmm.2005.04.009; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ito T, 2003, DRUG RESIST UPDATE, V6, P41, DOI 10.1016/S1368-7646(03)00003-7; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jang J, 2008, TRENDS MICROBIOL, V16, P303, DOI 10.1016/j.tim.2008.04.005; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; LAVINA M, 1990, J BACTERIOL, V172, P6585, DOI 10.1128/jb.172.11.6585-6588.1990; Lercher MJ, 2008, MOL BIOL EVOL, V25, P559, DOI 10.1093/molbev/msm283; Lima WC, 2008, FEMS MICROBIOL LETT, V281, P87, DOI 10.1111/j.1574-6968.2008.01083.x; Lloyd AL, 2009, J BACTERIOL, V191, P3469, DOI 10.1128/JB.01717-08; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Lucarelli C, 2010, J CLIN MICROBIOL, V48, P2103, DOI 10.1128/JCM.01371-09; Main-Hester KL, 2008, INFECT IMMUN, V76, P1024, DOI 10.1128/IAI.01224-07; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Marchetti M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000280; Marquordt C, 2003, J BIOL CHEM, V278, P2212, DOI 10.1074/jbc.M209435200; McQuiston JR, 2008, J BACTERIOL, V190, P7060, DOI 10.1128/JB.01552-07; Medrano-Soto A, 2004, MOL BIOL EVOL, V21, P1884, DOI 10.1093/molbev/msh202; Merkl R, 2006, J MOL EVOL, V62, P1, DOI 10.1007/s00239-004-0311-5; Muller TA, 2003, ENVIRON MICROBIOL, V5, P163, DOI 10.1046/j.1462-2920.2003.00400.x; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; Ou HY, 2007, NUCLEIC ACIDS RES, V35, pW97, DOI 10.1093/nar/gkm380; Parks AR, 2007, J BACTERIOL, V189, P2170, DOI 10.1128/JB.01536-06; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Price MN, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r4; Pundhir Sachin, 2008, In Silico Biology, V8, P223; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Rajan I, 2007, BIOINFORMATICS, V23, P2672, DOI 10.1093/bioinformatics/btm405; Rajashekara G, 2008, J BACTERIOL, V190, P6243, DOI 10.1128/JB.00520-08; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Saini S, 2010, PLOS PATHOG, V6, DOI [10.1371/annotation/df7e26bc-4c62-43b4-865f-a39274d98ab3, 10.1371/journal.ppat.1001025]; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shavkunov KS, 2009, NUCLEIC ACIDS RES, V37, P4919, DOI 10.1093/nar/gkp490; Shi QJ, 2008, GENETICS, V179, P1237, DOI 10.1534/genetics.108.088161; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Tobe T, 2008, ADV EXP MED BIOL, V631, P189, DOI 10.1007/978-0-387-78885-2_13; Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wang GQ, 2010, FEBS LETT, V584, P194, DOI 10.1016/j.febslet.2009.11.067; Wang L, 2001, GENE, V270, P231, DOI 10.1016/S0378-1119(01)00471-1; Wang QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007646; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; Willie E, 2004, TRENDS GENET, V20, P534, DOI 10.1016/j.tig.2004.08.014; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306; Yoon SH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-184; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	90	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33759	10.1371/journal.pone.0033759	http://dx.doi.org/10.1371/journal.pone.0033759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448273	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700064
J	Reuter, D; Sparwasser, T; Hunig, T; Schneider-Schaulies, J				Reuter, Dajana; Sparwasser, Tim; Huenig, Thomas; Schneider-Schaulies, Juergen			Foxp3(+) Regulatory T Cells Control Persistence of Viral CNS Infection	PLOS ONE			English	Article							VIRUS-INDUCED ENCEPHALITIS; CENTRAL-NERVOUS-SYSTEM; SUBACUTE SCLEROSING-PANENCEPHALITIS; MEASLES-VIRUS; GAMMA-INTERFERON; RETROVIRAL INFECTION; ANTIGEN PRESENTATION; MICE; BRAIN; CD4(+)	We earlier established a model of a persistent viral CNS infection using two week old immunologically normal (genetically unmodified) mice and recombinant measles virus (MV). Using this model infection we investigated the role of regulatory T cells (Tregs) as regulators of the immune response in the brain, and assessed whether the persistent CNS infection can be modulated by manipulation of Tregs in the periphery. CD4(+) CD25(+) Foxp3(+) Tregs were expanded or depleted during the persistent phase of the CNS infection, and the consequences for the virus-specific immune response and the extent of persistent infection were analyzed. Virus-specific CD8(+) T cells predominantly recognising the H-2D(b)-presented viral hemagglutinin epitope MV-H22-30 (RIVINREHL) were quantified in the brain by pentamer staining. Expansion of Tregs after intraperitoneal (i.p.) application of the superagonistic anti-CD28 antibody D665 inducing transient immunosuppression caused increased virus replication and spread in the CNS. In contrast, depletion of Tregs using diphtheria toxin (DT) in DEREG (depletion of regulatory T cells)-mice induced an increase of virus-specific CD8(+) effector T cells in the brain and caused a reduction of the persistent infection. These data indicate that manipulation of Tregs in the periphery can be utilized to regulate virus persistence in the CNS.	[Reuter, Dajana; Huenig, Thomas; Schneider-Schaulies, Juergen] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, Hannover, Germany	University of Wurzburg	Reuter, D (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, D-8700 Wurzburg, Germany.	jss@vim.uni-wuerzburg.de	Sparwasser, Tim D/AAA-4306-2022; Sparwasser, Tim/AAF-7085-2019	Sparwasser, Tim/0000-0001-5645-902X; Schneider-Schaulies, Jurgen/0000-0001-7713-5518	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank the Deutsche Forschungsgemeinschaft for financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah H, 2009, NEUROPATH APPL NEURO, V35, P473, DOI 10.1111/j.1365-2990.2009.01023.x; Anghelina D, 2009, VIROLOGY, V385, P358, DOI 10.1016/j.virol.2008.12.014; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Carsillo T, 2006, J VIROL, V80, P11031, DOI 10.1128/JVI.01438-06; de Vries RD, 2009, EUR J IMMUNOL; Dennehy KM, 2006, J IMMUNOL, V176, P5725, DOI 10.4049/jimmunol.176.10.5725; Dietze KK, 2011, P NATL ACAD SCI USA, V108, P2420, DOI 10.1073/pnas.1015148108; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; Duprex WP, 1999, J VIROL, V73, P6916, DOI 10.1128/JVI.73.8.6916-6922.1999; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; FINKE D, 1994, IMMUNOLOGY, V83, P184; FINKE D, 1995, J VIROL, V69, P5469, DOI 10.1128/JVI.69.9.5469-5474.1995; Garg RK, 2008, J NEUROL, V255, P1861, DOI 10.1007/s00415-008-0032-6; Gogishvili T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004643; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Li S, 2008, J VIROL, V82, P21, DOI 10.1128/JVI.01768-07; Liebert UG, 1995, MEASLES VIRUS, P149; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Ludlow M, 2008, NEUROPATH APPL NEURO, V34, P424, DOI 10.1111/j.1365-2990.2007.00900.x; Moeller-Ehrlich K, 2007, J GEN VIROL, V88, P3112, DOI 10.1099/vir.0.83235-0; Myers L, 2009, J IMMUNOL, V183, P1636, DOI 10.4049/jimmunol.0900350; NIEWIESK S, 1993, J VIROL, V67, P75, DOI 10.1128/JVI.67.1.75-81.1993; Oldstone MBA, 2005, J EXP MED, V202, P1185, DOI 10.1084/jem.20051376; Park SRS, 2011, J VIROL, V85, P3664, DOI 10.1128/JVI.01496-10; Patterson CE, 2002, J VIROL, V76, P4497, DOI 10.1128/JVI.76.9.4497-4506.2002; Reuter T, 2006, J VIROL, V80, P5951, DOI 10.1128/JVI.02453-05; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schubert S, 2006, J GEN VIROL, V87, P2011, DOI 10.1099/vir.0.81838-0; SCHWENDER S, 1991, IMMUNOLOGY, V74, P533; Sellin CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004948; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Tishon A, 2006, VIROLOGY, V347, P234, DOI 10.1016/j.virol.2006.01.050; Urbanska EM, 1997, J MED VIROL, V52, P362, DOI 10.1002/(SICI)1096-9071(199708)52:4<362::AID-JMV3>3.0.CO;2-#; Vahlenkamp TW, 2004, J IMMUNOL, V172, P4752, DOI 10.4049/jimmunol.172.8.4752; Weidinger G, 2000, J GEN VIROL, V81, P2707, DOI 10.1099/0022-1317-81-11-2707; Weidinger G, 2001, J VIROL, V75, P3059, DOI 10.1128/JVI.75.7.3059-3065.2001; Weissbrich B, 2003, MEASLES ITS NEUROLOG, P401; Zelinskyy G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000406; Zelinskyy G, 2009, BLOOD, V114, P3199, DOI 10.1182/blood-2009-03-208736	46	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33989	10.1371/journal.pone.0033989	http://dx.doi.org/10.1371/journal.pone.0033989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448284	Green Published, gold			2022-12-27	WOS:000303855700075
J	Royo, JL; Bessa, J; Hidalgo, C; Fernandez-Minan, A; Tena, JJ; Roncero, Y; Gomez-Skarmeta, JL; Casares, F				Royo, Jose Luis; Bessa, Jose; Hidalgo, Carmen; Fernandez-Minan, Ana; Tena, Juan J.; Roncero, Yolanda; Luis Gomez-Skarmeta, Jose; Casares, Fernando			Identification and Analysis of Conserved cis-Regulatory Regions of the MEIS1 Gene	PLOS ONE			English	Article							DNA-BINDING; ZEBRAFISH; EXPRESSION; PAX6; PROTEINS; ELEMENTS; CELLS; HOMEOPROTEINS; NEUROBLASTOMA; TRANSGENESIS	Meis1, a conserved transcription factor of the TALE-homeodomain class, is expressed in a wide variety of tissues during development. Its complex expression pattern is likely to be controlled by an equally complex regulatory landscape. Here we have scanned the Meis1 locus for regulatory elements and found 13 non-coding regions, highly conserved between humans and teleost fishes, that have enhancer activity in stable transgenic zebrafish lines. All these regions are syntenic in most vertebrates. The composite expression of all these enhancer elements recapitulate most of Meis1 expression during early embryogenesis, indicating they comprise a basic set of regulatory elements of the Meis1 gene. Using bioinformatic tools, we identify a number of potential binding sites for transcription factors that are compatible with the regulation of these enhancers. Specifically, HHc2:066650, which is expressed in the developing retina and optic tectum, harbors several predicted Pax6 sites. Biochemical, functional and transgenic assays indicate that pax6 genes directly regulate HHc2: 066650 activity.	[Royo, Jose Luis; Bessa, Jose; Hidalgo, Carmen; Fernandez-Minan, Ana; Tena, Juan J.; Roncero, Yolanda; Luis Gomez-Skarmeta, Jose; Casares, Fernando] CSIC UPO Junta Anadalucia, CABD, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Royo, JL (corresponding author), CSIC UPO Junta Anadalucia, CABD, Seville, Spain.	jlgomska@upo.es; fcasfer@upo.es	Bessa, Jose/I-8084-2013; Tena, Juan J./Q-5995-2019; Casares, Fernando/M-5451-2019; Gomez-Skarmeta, Jose Luis/B-5268-2014; Royo, Jose Luis/H-6935-2012; Tena, Juan J/M-2265-2014	Bessa, Jose/0000-0002-8591-7138; Tena, Juan J./0000-0001-8165-7984; Casares, Fernando/0000-0002-2181-3858; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Royo, Jose Luis/0000-0003-2024-4363; Tena, Juan J/0000-0001-8165-7984; Fernandez-Minan, Ana/0000-0002-9502-6785	MICINN [BFU2009-07044]; Junta de Andalucia [CVI 2658]; Proyecto de Excelencia [CVI-3488]; JAE-DOC from the Spanish National Research Council (CSIC);  [CSD2007-00008]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Junta de Andalucia(Junta de Andalucia); Proyecto de Excelencia; JAE-DOC from the Spanish National Research Council (CSIC); 	This work was funded through grantsMICINN) and Proyecto de Excelencia CVI 2658 (Junta de Andalu BFU2009-07044 (cia) to FC and BFU2010-14839 (MICINN), CSD2007-00008 and Proyecto de Excelencia CVI-3488 to JLGS. JLR is a recipient of a JAE-DOC contract from the Spanish National Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bessa J, 2008, DEVELOPMENT, V135, P799, DOI 10.1242/dev.011932; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Choe SK, 2002, DEVELOPMENT, V129, P585; Coy SE, 2003, DEV DYNAM, V239, P1234; Crijns APG, 2007, EUR J CANCER, V43, P2495, DOI 10.1016/j.ejca.2007.08.025; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duret L, 1997, CURR OPIN STRUC BIOL, V7, P399, DOI 10.1016/S0959-440X(97)80058-9; Erickson T, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-22; Fernandez P, 2004, ONCOGENE, V23, P5084, DOI 10.1038/sj.onc.1207665; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Geerts D, 2005, CANCER LETT, V228, P43, DOI 10.1016/j.canlet.2005.01.047; Jones TA, 2000, EUR J CANCER, V36, P2368, DOI 10.1016/S0959-8049(00)00332-4; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Knoepfler PS, 1999, NUCLEIC ACIDS RES, V27, P3752, DOI 10.1093/nar/27.18.3752; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Royo JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024824; Royo JL, 2011, P NATL ACAD SCI USA, V108, P14186, DOI 10.1073/pnas.1109037108; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; Moczek AP, 2009, P NATL ACAD SCI USA, V106, P8992, DOI 10.1073/pnas.0809668106; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Nakamura H, 2001, TRENDS NEUROSCI, V24, P32, DOI 10.1016/S0166-2236(00)01676-3; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Santos JS, 2010, DEV DYNAM, V239, P1010, DOI 10.1002/dvdy.22228; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Spieker N, 2001, GENOMICS, V71, P214, DOI 10.1006/geno.2000.6408; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Vavouri T, 2009, BIOESSAYS, V31, P727, DOI 10.1002/bies.200900014; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xiang P, 2010, EXP HEMATOL, V38, P798, DOI 10.1016/j.exphem.2010.06.006; Zhang X, 2002, GENE DEV, V16, P2097, DOI 10.1101/gad.1007602; Zhang X, 2006, DEV BIOL, V300, P748, DOI 10.1016/j.ydbio.2006.06.030	46	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33617	10.1371/journal.pone.0033617	http://dx.doi.org/10.1371/journal.pone.0033617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448256	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700047
J	Suzuki, A; Saba, R; Miyoshi, K; Morita, Y; Saga, Y				Suzuki, Atsushi; Saba, Rie; Miyoshi, Kei; Morita, Yoshinori; Saga, Yumiko			Interaction between NANOS2 and the CCR4-NOT Deadenylation Complex Is Essential for Male Germ Cell Development in Mouse	PLOS ONE			English	Article							SUPPRESSES MEIOSIS; GENE-EXPRESSION; MESSENGER-RNA; MICE; PROTEIN; SPECIFICATION; TRANSCRIPTION; REGULATOR; REPRESSOR; SUBUNITS	Nanos is one of the evolutionarily conserved proteins implicated in germ cell development and we have previously shown that it interacts with the CCR4-NOT deadenylation complex leading to the suppression of specific RNAs. However, the molecular mechanism and physiological significance of this interaction have remained elusive. In our present study, we identify CNOT1, a component of the CCR4-NOT deadenylation complex, as a direct factor mediating the interaction with NANOS2. We find that the first 10 amino acids (AAs) of NANOS2 are required for this binding. We further observe that a NANOS2 mutant lacking these first 10 AAs (NANOS2-DN10) fails to rescue defects in the Nanos2-null mouse. Our current data thus indicate that the interaction with the CCR4-NOT deadenylation complex is essential for NANOS2 function. In addition, we further demonstrate that NANOS2-DN10 can associate with specific mRNAs as well as wild-type NANOS2, suggesting the existence of other NANOS2-associated factor(s) that determine the specificity of RNA-binding independently of the CCR4-NOT deadenylation complex.	[Suzuki, Atsushi] Yokohama Natl Univ, Interdisciplinary Res Ctr, Yokohama, Kanagawa 240, Japan; [Suzuki, Atsushi; Miyoshi, Kei; Morita, Yoshinori] Grad Sch Environm & Informat Sci, Dept Environm & Nat Sci, Yokohama, Kanagawa, Japan; [Saba, Rie; Saga, Yumiko] Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 411, Japan	Yokohama National University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Suzuki, A (corresponding author), Yokohama Natl Univ, Interdisciplinary Res Ctr, Yokohama, Kanagawa 240, Japan.	atsuzuki@ynu.ac.jp; ysaga@lab.nig.ac.jp			"Promotion of Environmental Improvement or Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology, Japan;  [20112006]	"Promotion of Environmental Improvement or Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was partly supported through the "Promotion of Environmental Improvement or Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology and a Grant-in-Aid for Scientific Research on Innovative Areas "RNA regulation'' (No. 20112006) to A. S., and by Grants-in-Aid for Scientific Research and of the Genome Network Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan to Y.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Aslam A, 2009, MOL BIOL CELL, V20, P3840, DOI 10.1091/mbc.E09-02-0146; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bartlam M, 2010, PROTEIN CELL, V1, P443, DOI 10.1007/s13238-010-0060-8; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Cheng Y, 2007, MOL CELL BIOL, V27, P2582, DOI 10.1128/MCB.01722-06; Chuma S, 2003, MECH DEVELOP, V120, P979, DOI 10.1016/S0925-4773(03)00181-3; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Curtis D, 1997, EMBO J, V16, P834, DOI 10.1093/emboj/16.4.834; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Hanzawa H, 2001, J BIOL CHEM, V276, P10185, DOI 10.1074/jbc.M009298200; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Ito K, 2011, PROTEIN CELL, V2, P755, DOI 10.1007/s13238-011-1092-4; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kurihara Y, 2003, BIOL REPROD, V69, P261, DOI 10.1095/biolreprod.103.015677; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Mittal S, 2011, MOL BIOL CELL, V22, P748, DOI 10.1091/mbc.E10-11-0898; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Sakai Y, 2004, GENE EXPR PATTERNS, V5, P231, DOI 10.1016/j.modgep.2004.07.011; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Suzuki A, 2010, P NATL ACAD SCI USA, V107, P3594, DOI 10.1073/pnas.0908664107; Tanaka TS, 2006, DEV GROWTH DIFFER, V48, P381, DOI 10.1111/j.1440-169x.2006.00875.x; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Winkler GS, 2006, EMBO J, V25, P3089, DOI 10.1038/sj.emboj.7601194; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	32	57	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33558	10.1371/journal.pone.0033558	http://dx.doi.org/10.1371/journal.pone.0033558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448252	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700043
J	Schoo, KL; Aberle, N; Malzahn, AM; Boersma, M				Schoo, Katherina L.; Aberle, Nicole; Malzahn, Arne M.; Boersma, Maarten			Food Quality Affects Secondary Consumers Even at Low Quantities: An Experimental Test with Larval European Lobster	PLOS ONE			English	Article							NUTRIENT LIMITATION; DYNAMIC ACTION; CALANOID COPEPODS; PRIMARY PRODUCERS; JASUS-EDWARDSII; LIFE-HISTORY; GROWTH-RATE; STOICHIOMETRY; DAPHNIA; RNA	The issues of food quality and food quantity are crucial for trophic interactions. Although most research has focussed on the primary producer - herbivore link, recent studies have shown that quality effects at the bottom of the food web propagate to higher trophic levels. Negative effects of poor food quality have almost exclusively been demonstrated at higher food quantities. Whether these negative effects have the same impact at low food availability in situations where the majority if not all of the resources are channelled into routine metabolism, is under debate. In this study a tri-trophic food chain was designed, consisting of the algae Rhodomonas salina, the copepod Acartia tonsa and freshly hatched larvae of the European lobster Homarus gammarus. The lobster larvae were presented with food of two different qualities (C:P ratios) and four different quantities to investigate the combined effects of food quality and quantity. Our results show that the quality of food has an impact on the condition of lobster larvae even at very low food quantities. Food with a lower C:P content resulted in higher condition of the lobster larvae regardless of the quantity of food. These interacting effects of food quality and food quantity can have far reaching consequences for ecosystem productivity.	[Schoo, Katherina L.; Aberle, Nicole; Malzahn, Arne M.; Boersma, Maarten] Alfred Wegener Inst Polar & Marine Biol, Biol Anstalt Helgoland, Helgoland, Germany; [Malzahn, Arne M.] GKSS Forschungszentrum Geesthacht GmbH, Inst Coastal Res, Geesthacht, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Schoo, KL (corresponding author), Alfred Wegener Inst Polar & Marine Biol, Biol Anstalt Helgoland, Helgoland, Germany.	Katherina.Schoo@awi.de	Malzahn, Arne/C-5851-2013; Malzahn, Arne/AAD-6356-2022; Aberle, Nicole/C-7366-2014; Boersma, Maarten/A-5475-2013	Malzahn, Arne/0000-0002-2027-0804; Aberle, Nicole/0000-0003-3254-5710; Boersma, Maarten/0000-0003-1010-026X	German Science Foundation DFG (German Research Foundation) [AB289/2-1]	German Science Foundation DFG (German Research Foundation)	KLS was funded by the German Science Foundation DFG (German Research Foundation)(AB289/2-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma M, 2002, ECOLOGY, V83, P2552, DOI 10.1890/0012-9658(2002)083[2552:LATEIF]2.0.CO;2; Boersma M, 2008, INT REV HYDROBIOL, V93, P479, DOI 10.1002/iroh.200811066; Boersma M, 2009, MAR FRESHWATER RES, V60, P983, DOI 10.1071/MF08240; BRANFORD JR, 1978, MAR BIOL, V47, P363, DOI 10.1007/BF00388928; BUCKLEY LJ, 1979, J FISH RES BOARD CAN, V36, P1497, DOI 10.1139/f79-217; CLEMMESEN C, 1993, MAR ECOL PROG SER, V100, P177, DOI 10.3354/meps100177; Crear BJ, 2000, J EXP MAR BIOL ECOL, V252, P129, DOI 10.1016/S0022-0981(00)00243-4; Darchambeau F, 2003, OECOLOGIA, V136, P336, DOI 10.1007/s00442-003-1283-7; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Faerovig PJ, 2003, FRESHWATER BIOL, V48, P1782, DOI 10.1046/j.1365-2427.2003.01128.x; Grasshoff K., METHODS SEAWATER ANA; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Gulati RD, 1997, FRESHWATER BIOL, V38, P753, DOI 10.1046/j.1365-2427.1997.00275.x; Havinga B, 1929, HDB SEEFISCHEREI NOR; Ikeda T, 2007, AQUAT BIOL, V1, P99, DOI 10.3354/ab00011; Jensen TC, 2007, OECOLOGIA, V152, P191, DOI 10.1007/s00442-006-0652-4; Kilham SS, 1997, FRESHWATER BIOL, V38, P639, DOI 10.1046/j.1365-2427.1997.00232.x; LAMPERT W, 1977, Archiv fuer Hydrobiologie Supplement, V48, P361; LANDRY MR, 1983, LIMNOL OCEANOGR, V28, P614, DOI 10.4319/lo.1983.28.4.0614; LEPECQ JB, 1966, ANAL BIOCHEM, V17, P100, DOI 10.1016/0003-2697(66)90012-1; Malzahn AM, 2003, MAR ECOL PROG SER, V259, P285, DOI 10.3354/meps259285; Malzahn AM, 2010, OECOLOGIA, V162, P35, DOI 10.1007/s00442-009-1458-y; Malzahn AM, 2007, LIMNOL OCEANOGR, V52, P2062, DOI 10.4319/lo.2007.52.5.2062; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; McGaw IJ, 2007, PHYSIOL BIOCHEM ZOOL, V80, P335, DOI 10.1086/513083; McNamara ME, 2010, MAR BIOL, V157, P401, DOI 10.1007/s00227-009-1327-6; Mehrtens F, 2008, THESIS U HAMBURG GER; Plath K, 2001, ECOLOGY, V82, P1260, DOI 10.1890/0012-9658(2001)082[1260:MLOZSC]2.0.CO;2; Radford CA, 2004, COMP BIOCHEM PHYS A, V139, P1, DOI 10.1016/j.cbpb.2004.02.015; Rosa R, 2005, HYDROBIOLOGIA, V537, P207, DOI 10.1007/s10750-004-2841-7; Schmalenbach I, 2010, MAR BIOL, V157, P1127, DOI 10.1007/s00227-010-1394-8; Schoo KL, 2010, AQUAT ECOL, V44, P233, DOI 10.1007/s10452-009-9265-4; Schoo KL, 2012, STOICHIOMETRIC UNPUB; Sigsgaard SJ, 2003, MAR BIOL, V143, P1143, DOI 10.1007/s00227-003-1164-y; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; STERNER RW, 1994, LIMNOL OCEANOGR, V39, P1228, DOI 10.4319/lo.1994.39.5.1228; STERNER RW, 1993, LIMNOL OCEANOGR, V38, P857, DOI 10.4319/lo.1993.38.4.0857; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; Sterner RW, 1997, FRESHWATER BIOL, V38, P473, DOI 10.1046/j.1365-2427.1997.00234.x; Sterner RW, 1998, ECOL LETT, V1, P146; Trier TM, 2003, ENVIRON ENTOMOL, V32, P1, DOI 10.1603/0046-225X-32.1.1; Villar-Argaiz M, 2002, ECOLOGY, V83, P1899, DOI 10.2307/3071773; White T. C. R., 1993, INADEQUATE ENV NITRO; Whiteley NM, 2001, COMP BIOCHEM PHYS A, V128, P595, DOI 10.1016/S1095-6433(00)00337-8	46	21	22	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33550	10.1371/journal.pone.0033550	http://dx.doi.org/10.1371/journal.pone.0033550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442696	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500037
J	Leong, MK; Chen, HB; Shih, YH				Leong, Max K.; Chen, Hong-Bin; Shih, Yu-Hsuan			Prediction of Promiscuous P-Glycoprotein Inhibition Using a Novel Machine Learning Scheme	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE GENE; PHARMACOPHORE MODEL; IN-VITRO; BINDING-SITES; IDENTIFICATION; TRANSPORTERS; PHE/SVM; HSP90; FLEXIBILITY; DERIVATIVES	Background: P-glycoprotein (P-gp) is an ATP-dependent membrane transporter that plays a pivotal role in eliminating xenobiotics by active extrusion of xenobiotics from the cell. Multidrug resistance (MDR) is highly associated with the overexpression of P-gp by cells, resulting in increased efflux of chemotherapeutical agents and reduction of intracellular drug accumulation. It is of clinical importance to develop a P-gp inhibition predictive model in the process of drug discovery and development. Methodology/Principal Findings: An in silico model was derived to predict the inhibition of P-gp using the newly invented pharmacophore ensemble/support vector machine (PhE/SVM) scheme based on the data compiled from the literature. The predictions by the PhE/SVM model were found to be in good agreement with the observed values for those structurally diverse molecules in the training set (n = 31, r(2) = 0.89, q(2) = 0.86, RMSE = 0.40, s = 0.28), the test set (n = 88, r(2) = 0.87, RMSE = 0.39, s = 0.25) and the outlier set (n = 11, r(2) = 0.96, RMSE = 0.10, s = 0.05). The generated PhE/SVM model also showed high accuracy when subjected to those validation criteria generally adopted to gauge the predictivity of a theoretical model. Conclusions/Significance: This accurate, fast and robust PhE/SVM model that can take into account the promiscuous nature of P-gp can be applied to predict the P-gp inhibition of structurally diverse compounds that otherwise cannot be done by any other methods in a high-throughput fashion to facilitate drug discovery and development by designing drug candidates with better metabolism profile.	[Leong, Max K.; Chen, Hong-Bin; Shih, Yu-Hsuan] Natl Dong Hwa Univ, Dept Chem, Shoufeng, Hualien, Taiwan; [Leong, Max K.] Natl Dong Hwa Univ, Dept Life Sci, Shoufeng, Hualien, Taiwan; [Leong, Max K.] Natl Dong Hwa Univ, Inst Biotechnol, Shoufeng, Hualien, Taiwan; [Leong, Max K.] Mennonite Christian Hosp, Dept Med Res & Teaching, Hualien, Taiwan	National Dong Hwa University; National Dong Hwa University; National Dong Hwa University	Leong, MK (corresponding author), Natl Dong Hwa Univ, Dept Chem, Shoufeng, Hualien, Taiwan.	leong@mail.ndhu.edu.tw			National Science Council, Taiwan [NSC99-2113-M-259-005-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding was provided by the National Science Council, Taiwan (URL: http://web1.nsc.gov.tw/), grant number NSC99-2113-M-259-005-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bahadduri PM, 2010, METHODS MOL BIOL, V637, P65, DOI 10.1007/978-1-60761-700-6_4; Bansal T, 2009, CURR CANCER THER REV, V5, P89, DOI 10.2174/157339409788166742; Benfenati E, 2007, QUANTITATIVE STRUCTU, P185, DOI DOI 10.1016/B978-044452710-3/50008-2; Biamonte MA, 2010, J MED CHEM, V53, P3, DOI 10.1021/jm9004708; Chang C., 2006, PHARMACOPHORES PHARM, P299; Chang C, 2006, DRUG METAB DISPOS, V34, P1976, DOI 10.1124/dmd.106.012351; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; Chen CN, 2011, CHEM RES TOXICOL, V24, P1765, DOI 10.1021/tx200310j; Chen L, 2011, MOL PHARMACEUT, V8, P889, DOI 10.1021/mp100465q; Chiba P, 1998, J MED CHEM, V41, P4001, DOI 10.1021/jm980121y; Coley HM, 2010, METHODS MOL BIOL, V596, P341, DOI 10.1007/978-1-60761-416-6_15; Crowley E, 2010, METHODS MOL BIOL, V596, P405, DOI 10.1007/978-1-60761-416-6_18; Doppenschmitt S, 1999, J PHARM SCI, V88, P1067, DOI 10.1021/js980378j; Ecker GF, 2010, TRANSPORTERS DRUG CA, P195; Ekins S, 2007, BRIT J PHARMACOL, V152, P21, DOI 10.1038/sj.bjp.0707306; Ekins S, 2002, MOL PHARMACOL, V61, P964, DOI 10.1124/mol.61.5.964; Ekins S, 2002, MOL PHARMACOL, V61, P974, DOI 10.1124/mol.61.5.974; Ekins S, 2004, DRUG DISCOV TODAY, V9, P276, DOI 10.1016/S1359-6446(03)03008-3; Evans DA, 2007, J CHEM INF MODEL, V47, P1248, DOI 10.1021/ci7000082; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Foloppe N, 2009, CURR MED CHEM, V16, P3381, DOI 10.2174/092986709789057680; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gramatica P, 2007, J MOL GRAPH MODEL, V25, P755, DOI 10.1016/j.jmgm.2006.06.005; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hiessbock R, 1999, J MED CHEM, V42, P1921, DOI 10.1021/jm980517+; Jansen G, 2003, SCAND J RHEUMATOL, V32, P325, DOI 10.1080/03009740310004333; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Klein C, 2002, J COMPUT AID MOL DES, V16, P785, DOI 10.1023/A:1023828527638; Kolossvary I, 1996, J AM CHEM SOC, V118, P5011, DOI 10.1021/ja952478m; Kurogi Y, 2001, CURR MED CHEM, V8, P1035, DOI 10.2174/0929867013372481; Labrie P, 2006, BIOORGAN MED CHEM, V14, P7972, DOI 10.1016/j.bmc.2006.07.055; Labrie P, 2006, J MED CHEM, V49, P7646, DOI 10.1021/jm060239b; Langer T, 2004, ARCH PHARM, V337, P317, DOI 10.1002/ardp.200300817; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Leong MK, 2008, MED CHEM, V4, P396, DOI 10.2174/157340608784872226; Leong MK, 2007, CHEM RES TOXICOL, V20, P217, DOI 10.1021/tx060230c; Leong MK, 2009, J COMPUT CHEM, V30, P1899, DOI 10.1002/jcc.21190; Leong MK, 2009, PHARM RES-DORDR, V26, P987, DOI 10.1007/s11095-008-9807-9; Li H, 2000, IUL BIOTECH, V2, P171; Li WX, 2007, J CHEM INF MODEL, V47, P2429, DOI 10.1021/ci700284p; Lin JH, 2003, ADV DRUG DELIVER REV, V55, P53, DOI 10.1016/S0169-409X(02)00171-0; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; Mistry P, 2001, CANCER RES, V61, P749; Pajeva I, 2005, MED CHEM RES, V14, P106, DOI 10.1007/s00044-005-0127-x; Pajeva IK, 2002, J MED CHEM, V45, P5671, DOI 10.1021/jm020941h; Palmeira A, 2010, ADV INTEL SOFT COMPU, V74, P175, DOI 10.1007/978-3-642-13214-8_23; Penzotti JE, 2002, J MED CHEM, V45, P1737, DOI 10.1021/jm0255062; Pleban K, 2005, ACTA BIOCHIM POL, V52, P737; Ravna AW, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-20; Roy PP, 2008, QSAR COMB SCI, V27, P302, DOI 10.1002/qsar.200710043; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Shukla S, 2008, EXPERT OPIN DRUG MET, V4, P205, DOI 10.1517/17425255.4.2.205; Solit DB, 2006, CURR TOP MED CHEM, V6, P1205, DOI 10.2174/156802606777812068; Sprague PW, 1995, PERSPECT DRUG DISCOV, V3, P1, DOI 10.1007/BF02174464; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Stockner T, 2009, FEBS J, V276, P964, DOI 10.1111/j.1742-4658.2008.06832.x; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Varma MVS, 2003, PHARMACOL RES, V48, P347, DOI 10.1016/S1043-6618(03)00158-0; Wang YH, 2005, J COMPUT AID MOL DES, V19, P137, DOI 10.1007/s10822-005-3321-5; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zalloum HM, 2008, J MOL GRAPH MODEL, V27, P439, DOI 10.1016/j.jmgm.2008.07.005; Zhou HY, 2008, J MED CHEM, V51, P1242, DOI 10.1021/jm7012024; Zou J, 2008, J MOL GRAPH MODEL, V27, P430, DOI 10.1016/j.jmgm.2008.07.004	75	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33829	10.1371/journal.pone.0033829	http://dx.doi.org/10.1371/journal.pone.0033829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439003	Green Submitted, gold, Green Published			2022-12-27	WOS:000303309100103
J	Andasari, V; Roper, RT; Swat, MH; Chaplain, MAJ				Andasari, Vivi; Roper, Ryan T.; Swat, Maciej H.; Chaplain, Mark A. J.			Integrating Intracellular Dynamics Using CompuCell3D and Bionetsolver: Applications to Multiscale Modelling of Cancer Cell Growth and Invasion	PLOS ONE			English	Article							BETA-CATENIN EXPRESSION; TUMOR-GROWTH; MATHEMATICAL-MODEL; SIMULATION; PHENOTYPES; EXPANSION; DRIVEN	In this paper we present a multiscale, individual-based simulation environment that integrates CompuCell3D for lattice-based modelling on the cellular level and Bionetsolver for intracellular modelling. CompuCell3D or CC3D provides an implementation of the lattice-based Cellular Potts Model or CPM (also known as the Glazier-Graner-Hogeweg or GGH model) and a Monte Carlo method based on the metropolis algorithm for system evolution. The integration of CC3D for cellular systems with Bionetsolver for subcellular systems enables us to develop a multiscale mathematical model and to study the evolution of cell behaviour due to the dynamics inside of the cells, capturing aspects of cell behaviour and interaction that is not possible using continuum approaches. We then apply this multiscale modelling technique to a model of cancer growth and invasion, based on a previously published model of Ramis-Conde et al. (2008) where individual cell behaviour is driven by a molecular network describing the dynamics of E-cadherin and beta-catenin. In this model, which we refer to as the centre-based model, an alternative individual-based modelling technique was used, namely, a lattice-free approach. In many respects, the GGH or CPM methodology and the approach of the centre-based model have the same overall goal, that is to mimic behaviours and interactions of biological cells. Although the mathematical foundations and computational implementations of the two approaches are very different, the results of the presented simulations are compatible with each other, suggesting that by using individual-based approaches we can formulate a natural way of describing complex multi-cell, multiscale models. The ability to easily reproduce results of one modelling approach using an alternative approach is also essential from a model cross-validation standpoint and also helps to identify any modelling artefacts specific to a given computational approach.	[Andasari, Vivi; Chaplain, Mark A. J.] Univ Dundee, Div Math, Dundee, Scotland; [Swat, Maciej H.] Indiana Univ, Biocomplex Inst, Bloomington, IN USA; [Swat, Maciej H.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA	University of Dundee; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Andasari, V (corresponding author), Univ Dundee, Div Math, Dundee, Scotland.	vivi@maths.dundee.ac.uk	Chaplain, Mark AJ/A-5355-2010	Chaplain, Mark AJ/0000-0001-5727-2160	Somite [R01 GM076692]; CC3D [R01 GM077138]; ERC (European Research Council) [227619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	Somite; CC3D; ERC (European Research Council)(European Research Council (ERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Somite grant No. R01 GM076692 "Multiscale Studies of Segmentation in Verterbrates'', CC3D grant No. R01 GM077138 "Development and Improvement of the Tissue Simulation Environment'', and ERC (European Research Council) AdG Grant No. 227619 "From Mutations to Metastases: Multiscale Mathematical Modelling of Cancer Growth and Spread'' (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2005, MULTISCALE MODEL SIM, V3, P440, DOI 10.1137/040603760; Anderson ARA, 2009, J MATH BIOL, V58, P579, DOI 10.1007/s00285-008-0210-2; Athale CA, 2006, J THEOR BIOL, V238, P771, DOI 10.1016/j.jtbi.2005.06.029; Ayati BP, 2006, MULTISCALE MODEL SIM, V5, P1, DOI 10.1137/050629215; Balter A, 2007, SINGLE CELL BASED MO, P151, DOI [DOI 10.1007/978-3-7643-8123-3_7, 10.1007/978-3-7643-8123-3_7]; Bellomo N, 2008, MATH COMPUT MODEL, V47, P687, DOI 10.1016/j.mcm.2007.06.004; Bellomo N., 2003, J THEOR MED, V5, P111, DOI DOI 10.1080/1027336042000288633; Billy F, 2009, J THEOR BIOL, V260, P545, DOI 10.1016/j.jtbi.2009.06.026; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Glazier JA, 2007, SINGLE CELL BASED MO, P79, DOI [10.1007/978-3-7643-8123-3_4, DOI 10.1007/978-3-7643-8123-3_4]; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Machne R, 2006, BIOINFORMATICS, V22, P1406, DOI 10.1093/bioinformatics/btl086; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Martins ML, 2007, PHYS LIFE REV, V4, P128, DOI 10.1016/j.plrev.2007.04.002; Martins ML, 2010, CURR OPIN COLLOID IN, V15, P18, DOI 10.1016/j.cocis.2009.04.004; Ng TL, 2005, MODERN PATHOL, V18, P68, DOI 10.1038/modpathol.3800272; Oudar O, 2000, CRIT REV ONCOL HEMAT, V36, P99, DOI 10.1016/S1040-8428(00)00080-9; Popawski NJ, 2009, B MATH BIOL, V71, P1189, DOI 10.1007/s11538-009-9399-5; Poplawski NJ, 2008, MATH BIOSCI ENG, V5, P355; Poplawski NJ, 2007, PHYSICA A, V373, P521, DOI 10.1016/j.physa.2006.05.028; Preziosi L., 2003, CANC MODELLING SIMUL; Quaranta V, 2008, SEMIN CANCER BIOL, V18, P338, DOI 10.1016/j.semcancer.2008.03.018; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Ramis-Conde I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016008; Rejniak K.A., 2010, WILEY INTERDISCIPLIN; Ribba B, 2006, J THEOR BIOL, V243, P532, DOI 10.1016/j.jtbi.2006.07.013; Ribba B, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-7; Schnell S, 2007, AM SCI, V95, P134, DOI 10.1511/2007.64.1018; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Stamatakos GS, 2010, J THEOR BIOL, V266, P124, DOI 10.1016/j.jtbi.2010.05.019; Starruss J, 2007, J STAT PHYS, V128, P269, DOI 10.1007/s10955-007-9298-9; Suzuki H, 2008, ANTICANCER RES, V28, P1821; Swat Maciej H., 2009, V500, P361, DOI 10.1007/978-1-59745-525-1_13; Uchino M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-414; van Leeuwen IMM, 2007, WORLD J GASTROENTERO, V13, P1399, DOI 10.3748/wjg.v13.i9.1399; Zhang L, 2009, MATH COMPUT MODEL, V49, P307, DOI 10.1016/j.mcm.2008.05.011; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034	38	47	49	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e33726	10.1371/journal.pone.0033726	http://dx.doi.org/10.1371/journal.pone.0033726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461894	gold, Green Published, Green Submitted			2022-12-27	WOS:000304118900013
J	Gawthorne, JA; Beatson, SA; Srikhanta, YN; Fox, KL; Jennings, MP				Gawthorne, Jayde A.; Beatson, Scott A.; Srikhanta, Yogitha N.; Fox, Kate L.; Jennings, Michael P.			Origin of the Diversity in DNA Recognition Domains in Phasevarion Associated modA Genes of Pathogenic Neisseria and Haemophilus influenzae	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEM; PHASE VARIATION; MODIFICATION ENZYMES; MULTIPLE GENES; SEQUENCE; METHYLTRANSFERASES; ENDONUCLEASES; BACTERIA; MOTIFS; TRANSFORMATION	Phase variable restriction-modification (R-M) systems have been identified in a range of pathogenic bacteria. In some it has been demonstrated that the random switching of the mod (DNA methyltransferase) gene mediates the coordinated expression of multiple genes and constitutes a phasevarion (phase variable regulon). ModA of Neisseria and Haemophilus influenzae contain a highly variable, DNA recognition domain (DRD) that defines the target sequence that is modified by methylation and is used to define modA alleles. 18 distinct modA alleles have been identified in H. influenzae and the pathogenic Neisseria. To determine the origin of DRD variability, the 18 modA DRDs were used to search the available databases for similar sequences. Significant matches were identified between several modA alleles and mod gene from distinct bacterial species, indicating one source of the DRD variability was via horizontal gene transfer. Comparison of DRD sequences revealed significant mosaicism, indicating exchange between the Neisseria and H. influenzae modA alleles. Regions of high inter-and intra-allele similarity indicate that some modA alleles had undergone recombination more frequently than others, generating further diversity. Furthermore, the DRD from some modA alleles, such as modA12, have been transferred en bloc to replace the DRD from different modA alleles.	[Gawthorne, Jayde A.; Srikhanta, Yogitha N.; Jennings, Michael P.] Griffith Univ Gold Coast, Inst Glyc, Gold Coast, Qld, Australia; [Gawthorne, Jayde A.; Beatson, Scott A.; Fox, Kate L.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia	Griffith University; University of Queensland	Gawthorne, JA (corresponding author), Griffith Univ Gold Coast, Inst Glyc, Gold Coast, Qld, Australia.	m.jennings@griffith.edu.au	Jennings, Michael P/G-4822-2013; Beatson, Scott/B-6985-2013	Jennings, Michael P/0000-0002-1027-4684; Beatson, Scott/0000-0002-1806-3283; Srikhanta, Yogitha/0000-0002-7513-9969	National Health and Medical Research Council (Australia) [565526]; Australian Research Council [DP110101058, DP0881347]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council (Australia) Program Grant 565526 and Australian Research Council Discovery Grant DP110101058 to MPJ, National Health and Medical Research Council (Australia) Training Fellowship to YNS. SAB is the recipient of an Australian Research Council Fellowship (project DP0881347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Bayliss CD, 2006, NUCLEIC ACIDS RES, V34, P4046, DOI 10.1093/nar/gkl568; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; BOYER HW, 1971, ANNU REV MICROBIOL, V25, P153, DOI 10.1146/annurev.mi.25.100171.001101; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; De Bolle X, 2000, MOL MICROBIOL, V35, P211, DOI 10.1046/j.1365-2958.2000.01701.x; de Vries N, 2002, J BACTERIOL, V184, P6615, DOI 10.1128/JB.184.23.6615-6624.2002; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Fox KL, 2007, NUCLEIC ACIDS RES, V35, P5242, DOI 10.1093/nar/gkm571; Fox KL, 2007, MOL MICROBIOL, V65, P1375, DOI 10.1111/j.1365-2958.2007.05873.x; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; HADI SM, 1983, J MOL BIOL, V165, P19, DOI 10.1016/S0022-2836(83)80240-X; Hoskisson PA, 2007, CURR OPIN MICROBIOL, V10, P396, DOI 10.1016/j.mib.2007.04.003; HUMBELIN M, 1988, J MOL BIOL, V200, P23, DOI 10.1016/0022-2836(88)90330-0; Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x; MEISEL A, 1992, NATURE, V355, P467, DOI 10.1038/355467a0; Moxon ER, 1997, NATURE, V387, P659, DOI 10.1038/42607; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Ryan KA, 1999, NUCLEIC ACIDS RES, V27, P1505, DOI 10.1093/nar/27.6.1505; Saha S, 1998, BIOL CHEM, V379, P511, DOI 10.1515/bchm.1998.379.4-5.511; Saunders NJ, 1999, CURR BIOL, V9, pR180, DOI 10.1016/S0960-9822(99)80108-0; Seib KL, 2002, FEMS IMMUNOL MED MIC, V32, P159; Seib KL, FASEB J, V25, P3622; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027569; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; TIMINSKAS A, 1995, GENE, V157, P3, DOI 10.1016/0378-1119(94)00783-O; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	37	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e32337	10.1371/journal.pone.0032337	http://dx.doi.org/10.1371/journal.pone.0032337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457715	Green Published, gold			2022-12-27	WOS:000304046900003
J	Mathew, MD; Mathew, ND; Ebert, PR				Mathew, Mark D.; Mathew, Neal D.; Ebert, Paul R.			WormScan: A Technique for High-Throughput Phenotypic Analysis of Caenorhabditis elegans	PLOS ONE			English	Article							BEHAVIORAL-ANALYSIS; END-POINTS; C-ELEGANS; NEMATODE; TOXICITY; REPRODUCTION; LETHALITY; GENETICS; SURVIVAL	Background: There are four main phenotypes that are assessed in whole organism studies of Caenorhabditis elegans; mortality, movement, fecundity and size. Procedures have been developed that focus on the digital analysis of some, but not all of these phenotypes and may be limited by expense and limited throughput. We have developed WormScan, an automated image acquisition system that allows quantitative analysis of each of these four phenotypes on standard NGM plates seeded with E. coli. This system is very easy to implement and has the capacity to be used in high-throughput analysis. Methodology/Principal Findings: Our system employs a readily available consumer grade flatbed scanner. The method uses light stimulus from the scanner rather than physical stimulus to induce movement. With two sequential scans it is possible to quantify the induced phototactic response. To demonstrate the utility of the method, we measured the phenotypic response of C. elegans to phosphine gas exposure. We found that stimulation of movement by the light of the scanner was equivalent to physical stimulation for the determination of mortality. WormScan also provided a quantitative assessment of health for the survivors. Habituation from light stimulation of continuous scans was similar to habituation caused by physical stimulus. Conclusions/Significance: There are existing systems for the automated phenotypic data collection of C. elegans. The specific advantages of our method over existing systems are high-throughput assessment of a greater range of phenotypic endpoints including determination of mortality and quantification of the mobility of survivors. Our system is also inexpensive and very easy to implement. Even though we have focused on demonstrating the usefulness of WormScan in toxicology, it can be used in a wide range of additional C. elegans studies including lifespan determination, development, pathology and behavior. Moreover, we have even adapted the method to study other species of similar dimensions.	[Mathew, Mark D.; Mathew, Neal D.; Ebert, Paul R.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	University of Queensland	Mathew, MD (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia Campus, Brisbane, Qld, Australia.	p.ebert@uq.edu.au		Ebert, Paul/0000-0002-4435-0737	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	NDM was supported by an Australian Postgraduate Award scholarship. No other external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Bewes JM, 2008, PHYS MED BIOL, V53, P5991, DOI 10.1088/0031-9155/53/21/007; Biston MC, 2003, PHYS MED BIOL, V48, P1551, DOI 10.1088/0031-9155/48/11/305; Boyd WA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001259; Boyd WA, 2010, TOXICOL APPL PHARM, V245, P153, DOI 10.1016/j.taap.2010.02.014; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; BRENNER S, 1974, GENETICS, V77, P71; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Cheng Q, 2003, TOXICOL SCI, V73, P60, DOI 10.1093/toxsci/kfg049; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clarke ML, 2010, CYTOM PART A, V77A, P790, DOI 10.1002/cyto.a.20864; Dahle J, 2004, CYTOM PART A, V60A, P182, DOI 10.1002/cyto.a.20038; Dhawan R, 1999, J TOXICOL ENV HEAL A, V58, P451, DOI 10.1080/009841099157179; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Gems D, 2000, J GERONTOL A-BIOL, V55, pB215, DOI 10.1093/gerona/55.5.B215; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; HARRINGTON LA, 1988, MECH AGEING DEV, V43, P71, DOI 10.1016/0047-6374(88)90098-X; Herler J, 2007, CYBIUM, V31, P39; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Long FH, 2009, NAT METHODS, V6, P667, DOI [10.1038/NMETH.1366, 10.1038/nmeth.1366]; MIDDENDORF PJ, 1993, J NEMATOL, V25, P573; MIWA J, 1982, J CANCER RES CLIN, V104, P81, DOI 10.1007/BF00402056; MORGAN PG, 1985, ANESTHESIOLOGY, V62, P738, DOI 10.1097/00000542-198506000-00007; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Peng HC, 2008, BIOINFORMATICS, V24, P234, DOI 10.1093/bioinformatics/btm569; Phillips A., 1985, SIGKDD EXPLORATIONS, V31, P329, DOI DOI 10.1145/1656274.1656278; POPHAM JD, 1979, ENVIRON RES, V20, P183, DOI 10.1016/0013-9351(79)90096-3; Pulak Rock, 2006, V351, P275; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; RANKIN CH, 1992, BEHAV NEUROSCI, V106, P239, DOI 10.1037/0735-7044.106.2.239; Raviv TR, 2010, LECT NOTES COMPUT SC, V6363, P634; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Stiernagle Theresa, 2006, WormBook, P1; Sullivan K, 2012, J VIROL METHODS, V179, P81, DOI 10.1016/j.jviromet.2011.10.003; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Sznitman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011631; Traunspurger W, 1997, ENVIRON TOXICOL CHEM, V16, P245, DOI [10.1897/1551-5028(1997)016&lt;0245:EAOASW&gt;2.3.CO;2, 10.1002/etc.5620160221]; Valmas N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000130; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406; Zuryn S, 2008, TOXICOL SCI, V102, P179, DOI 10.1093/toxsci/kfm278	49	61	61	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33483	10.1371/journal.pone.0033483	http://dx.doi.org/10.1371/journal.pone.0033483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457766	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900013
J	Yu, TY; Wang, CY; Lin, JJ				Yu, Tai-Yuan; Wang, Chen-Yi; Lin, Jing-Jer			Depleting Components of the THO Complex Causes Increased Telomere Length by Reducing the Expression of the Telomere-Associated Protein Rif1p	PLOS ONE			English	Article							MESSENGER-RNA EXPORT; DNA-BINDING PROTEIN; GENOME-WIDE SCREEN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; MITOTIC RECOMBINATION; QUANTITATIVE TRAIT; CATALYTIC SUBUNIT; GENE-EXPRESSION; PIF1P HELICASE	Telomere length is regulated mostly by proteins directly associated with telomeres. However, genome-wide analysis of Saccharomyces cerevisiae mutants has revealed that deletion of Hpr1p, a component of the THO complex, also affects telomere length. The THO complex comprises four protein subunits, namely, Tho2p, Hpr1p, Mft1p, and Thp2p. These subunits interplay between transcription elongation and co-transcriptional assembly of export-competent mRNPs. Here we found that the deletion of tho2 or hpr1 caused telomere lengthening by similar to 50-100 bps, whereas that of mft1 or thp2 did not affect telomere length. Since the THO complex functions in transcription elongation, we analyzed the expression of telomere-associated proteins in mutants depleted of complex components. We found that both the mRNA and protein levels of RIF1 were decreased in tho2 and hpr1 cells. RIF1 encodes a 1917-amino acid polypeptide that is involved in regulating telomere length and the formation of telomeric heterochromatin. Hpr1p and Tho2p appeared to affect telomeres through Rif1p, as increased Rif1p levels suppressed the telomere lengthening in tho2 and hpr1 cells. Moreover, yeast cells carrying rif1 tho2 or rif1 hpr1 double mutations showed telomere lengths and telomere silencing effects similar to those observed in the rif1 mutant. Thus, we conclude that mutations of components of the THO complex affect telomere functions by reducing the expression of a telomere-associated protein, Rif1p.	[Yu, Tai-Yuan; Wang, Chen-Yi; Lin, Jing-Jer] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Lin, Jing-Jer] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University	Yu, TY (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan.	jjlin@ym.edu.tw	Lin, Jing-Jer/G-8068-2015	LIN, JING-JER/0000-0001-8250-7398	National Health Research Institute [NHRI-EX100-10050SI]; National Science Council [99-3112-B-010-001, 100-2311-B-010-001]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by the National Health Research Institute under grant NHRI-EX100-10050SI and the National Science Council under grants 99-3112-B-010-001 and 100-2311-B-010-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Bianchi A, 1999, J BIOL CHEM, V274, P21223, DOI 10.1074/jbc.274.30.21223; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; CHAN CSM, 1983, J MOL BIOL, V168, P505, DOI 10.1016/S0022-2836(83)80299-X; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; Chavez S, 2001, MOL CELL BIOL, V21, P7054, DOI 10.1128/MCB.21.20.7054-7064.2001; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Craven RJ, 2000, MOL CELL BIOL, V20, P2378, DOI 10.1128/MCB.20.7.2378-2384.2000; Fan HY, 2001, MOL CELL BIOL, V21, P5459, DOI 10.1128/MCB.21.16.5459-5470.2001; Gallardo M, 2001, GENETICS, V157, P79; Garcia-Rubio M, 2008, MOL GENET GENOMICS, V279, P123, DOI 10.1007/s00438-007-0301-6; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Krauskopf A, 1996, NATURE, V383, P354, DOI 10.1038/383354a0; Krauskopf A, 1998, P NATL ACAD SCI USA, V95, P12486, DOI 10.1073/pnas.95.21.12486; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Lahue E, 2005, YEAST, V22, P537, DOI 10.1002/yea.1231; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Marin A, 2003, YEAST, V20, P703, DOI 10.1002/yea.992; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Prado F, 1997, EMBO J, V16, P2826, DOI 10.1093/emboj/16.10.2826; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Sabourin M, 2007, YEAST, V24, P39, DOI 10.1002/yea.1431; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stellwagen AE, 2003, GENE DEV, V17, P1; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Ungar L, 2009, NUCLEIC ACIDS RES, V37, P3840, DOI 10.1093/nar/gkp259; Wang MJ, 2000, NUCLEIC ACIDS RES, V28, P4733, DOI 10.1093/nar/28.23.4733; West RW, 2002, GENE, V288, P19, DOI 10.1016/S0378-1119(02)00482-1; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Yamada M, 1998, J BIOL CHEM, V273, P33360, DOI 10.1074/jbc.273.50.33360; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	62	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33498	10.1371/journal.pone.0033498	http://dx.doi.org/10.1371/journal.pone.0033498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448247	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700038
J	Yufera, M; Moyano, FJ; Astola, A; Pousao-Ferreira, P; Martinez-Rodriguez, G				Yufera, Manuel; Moyano, Francisco J.; Astola, Antonio; Pousao-Ferreira, Pedro; Martinez-Rodriguez, Gonzalo			Acidic Digestion in a Teleost: Postprandial and Circadian Pattern of Gastric pH, Pepsin Activity, and Pepsinogen and Proton Pump mRNAs Expression	PLOS ONE			English	Article							GASTROINTESTINAL PH; LARVAL DEVELOPMENT; ENZYME-ACTIVITIES; ARTIFICIAL REEFS; WINTER FLOUNDER; GENE-EXPRESSION; SPARUS-AURATA; TRACT; PURIFICATION; STOMACH	Two different modes for regulation of stomach acid secretion have been described in vertebrates. Some species exhibit a continuous acid secretion maintaining a low gastric pH during fasting. Others, as some teleosts, maintain a neutral gastric pH during fasting while the hydrochloric acid is released only after the ingestion of a meal. Those different patterns seem to be closely related to specific feeding habits. However, our recent observations suggest that this acidification pattern could be modified by changes in daily feeding frequency and time schedule. The aim of this study was to advance in understanding the regulation mechanisms of stomach digestion and pattern of acid secretion in teleost fish. We have examined the postprandial pattern of gastric pH, pepsin activity, and mRNA expression for pepsinogen and proton pump in white seabream juveniles maintained under a light/dark 12/12 hours cycle and receiving only one morning meal. The pepsin activity was analyzed according to the standard protocol buffering at pH 2 and using the actual pH measured in the stomach. The results show how the enzyme precursor is permanently available while the hydrochloric acid, which activates the zymogen fraction, is secreted just after the ingestion of food. Results also reveal that analytical protocol at pH 2 notably overestimates true pepsin activity in fish stomach. The expression of the mRNA encoding pepsinogen and proton pump exhibited almost parallel patterns, with notable increases during the darkness period and sharp decreases just before the morning meal. These results indicate that white seabream uses the resting hours for recovering the mRNA stock that will be quickly used during the feeding process. Our data clearly shows that both daily illumination pattern and feeding time are involved at different level in the regulation of the secretion of digestive juices.	[Yufera, Manuel; Martinez-Rodriguez, Gonzalo] Inst Ciencias Marinas Andalucia ICMAN CSIC, Cadiz, Spain; [Moyano, Francisco J.] Univ Almeria, Dept Appl Biol, EPSs, Almeria, Spain; [Astola, Antonio] Univ Cadiz, Dept Biomed & Biotechnol, Fac Sci, Puerto Real, Spain; [Pousao-Ferreira, Pedro] INRB, Olhao, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Universidad de Almeria; Universidad de Cadiz	Yufera, M (corresponding author), Inst Ciencias Marinas Andalucia ICMAN CSIC, Apartado Oficial, Cadiz, Spain.	manuel.yufera@icman.csic.es	Yufera, Manuel/E-1309-2011; Moyano, Francisco Javier/K-9997-2017; Ferreira, Pedro/HDO-1346-2022; MARTINEZ-RODRIGUEZ, GONZALO/A-2564-2009; Astola, Antonio/M-6413-2014; Pousão-Ferreira, Pedro/H-3689-2014	Moyano, Francisco Javier/0000-0002-0754-1809; MARTINEZ-RODRIGUEZ, GONZALO/0000-0003-3379-580X; Astola, Antonio/0000-0002-2290-0937; Pousão-Ferreira, Pedro/0000-0001-6746-764X; Yufera, Manuel/0000-0003-2999-4611	Spanish Ministry of Science and Innovation [AGL2007-64450-C02-01/02, CSD2007-0002]; European Regional Development Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission)	Spanish Ministry of Science and Innovation (Projects AGL2007-64450-C02-01/02 and Consolider Ingenio 2010 Program (Project Aquagenomics CSD2007-0002) + European Regional Development Fund supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon FJ, 1998, FISH PHYSIOL BIOCHEM, V19, P257, DOI 10.1023/A:1007717708491; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; BAL HS, 1992, LAB ANIM, V26, P47, DOI 10.1258/002367792780809057; Bougatef A, 2008, FOOD CHEM, V107, P777, DOI 10.1016/j.foodchem.2007.08.077; Bucking C, 2009, AQUACULT NUTR, V15, P282, DOI 10.1111/j.1365-2095.2008.00593.x; Cara JB, 2003, J FISH BIOL, V63, P48, DOI 10.1046/j.1095-8649.2003.00120.x; Costa C, 2007, ENVIRON BIOL FISH, V78, P115, DOI 10.1007/s10641-006-9081-9; Cox CL, 2010, PHYSIOL BIOCHEM ZOOL, V83, P618, DOI 10.1086/648737; Darias MJ, 2007, AQUACULTURE, V270, P369, DOI 10.1016/j.aquaculture.2007.04.045; Darias MJ, 2005, AQUACULTURE, V248, P245, DOI 10.1016/j.aquaculture.2005.04.044; Deguara S, 2003, J FISH BIOL, V62, P1033, DOI 10.1046/j.1095-8649.2003.00094.x; Diaz-Lopez M, 1998, COMP BIOCHEM PHYS B, V121, P369, DOI 10.1016/S0305-0491(98)10123-2; Douglas SE, 1999, J FISH BIOL, V55, P897, DOI 10.1111/j.1095-8649.1999.tb00729.x; Falk-Petersen IB, 2005, FISH SHELLFISH IMMUN, V19, P397, DOI 10.1016/j.fsi.2005.03.006; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng SZ, 2008, COMP BIOCHEM PHYS B, V149, P275, DOI 10.1016/j.cbpb.2007.09.017; Gao C, 2013, J ANIM PHYSIOL AN N, V97, P20, DOI 10.1111/j.1439-0396.2011.01238.x; Gawlicka A, 2001, J FISH BIOL, V58, P529, DOI 10.1006/jfbi.2000.1472; Hoehne-Reitan K, 2001, MAR BIOL, V139, P1159; Holmgren S, 2011, AUTON NEUROSCI-BASIC, V165, P102, DOI 10.1016/j.autneu.2010.10.008; Holmgren S, 2009, FISH PHYSIOL, V28, P467, DOI 10.1016/S1546-5098(09)28010-1; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; Kalantzi L, 2006, PHARM RES-DORDR, V23, P165, DOI 10.1007/s11095-005-8476-1; KAPOOR BG, 1975, ADV MAR BIOL, V13, P109; Kim DH, 2004, J FISH DIS, V27, P497, DOI 10.1111/j.1365-2761.2004.00553.x; Leitao F, 2007, ICES J MAR SCI, V64, P473, DOI 10.1093/icesjms/fsm027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo MJ, 2006, AQUACULTURE, V261, P1403, DOI 10.1016/j.aquaculture.2006.09.016; Mariani S, 2002, J FISH BIOL, V61, P138, DOI 10.1006/jfbi.2002.2073; MCLAUCHLAN G, 1989, GUT, V30, P573, DOI 10.1136/gut.30.5.573; MONTGOMERY WL, 1988, MAR ECOL PROG SER, V44, P7, DOI 10.3354/meps044007; Montoya A, 2010, AQUACULTURE, V306, P315, DOI 10.1016/j.aquaculture.2010.06.023; Murray HM, 2006, AQUACULTURE, V252, P394, DOI 10.1016/j.aquaculture.2005.03.030; Nikolopoulou D, 2011, COMP BIOCHEM PHYS A, V158, P406, DOI 10.1016/j.cbpa.2010.11.021; Ortiz-Delgado JB, 2003, HISTOL HISTOPATHOL, V18, P1141, DOI 10.14670/HH-18.1141; Papastamatiou YP, 2007, COMP BIOCHEM PHYS A, V147, P37, DOI 10.1016/j.cbpa.2006.11.012; Papastamatiou YP, 2005, COMP BIOCHEM PHYS A, V141, P210, DOI 10.1016/j.cbpb.2005.05.041; Papastamatiou YP, 2004, J EXP BIOL, V207, P225, DOI 10.1242/jeb.00741; Perez-Casanova JC, 2006, AQUACULTURE, V251, P377, DOI 10.1016/j.aquaculture.2005.06.007; Perez-Jimenez A, 2009, COMP BIOCHEM PHYS A, V154, P157, DOI 10.1016/j.cbpa.2009.05.126; Ronnestad I, 2000, FISH PHYSIOL BIOCHEM, V22, P225, DOI 10.1023/A:1007801510056; Sagawa K, 2009, J PHARM SCI-US, V98, P2494, DOI 10.1002/jps.21602; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos MN, 2006, B MAR SCI, V78, P177; Secor SM, 2003, J EXP BIOL, V206, P1621, DOI 10.1242/jeb.00300; SEGNER H, 1994, MAR BIOL, V119, P471, DOI 10.1007/BF00347544; Sugiura SH, 2006, J EXP BIOL, V209, P3719, DOI 10.1242/jeb.02436; Suzuki M, 1999, COMP BIOCHEM PHYS B, V122, P453, DOI 10.1016/S0305-0491(99)00029-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANJI M, 1988, EUR J BIOCHEM, V177, P251, DOI 10.1111/j.1432-1033.1988.tb14369.x; Tanji M, 2007, COMP BIOCHEM PHYS B, V146, P412, DOI 10.1016/j.cbpb.2006.11.025; Terova G, 2007, BIOCHEM BIOPH RES CO, V363, P591, DOI 10.1016/j.bbrc.2007.09.013; Tramati C, 2005, AQUACULT INT, V13, P89, DOI 10.1007/s10499-004-9028-0; Walford J, 1993, AQUACULTURE, V109, P107; Wu XM, 2011, AQUACULTURE, V314, P165, DOI 10.1016/j.aquaculture.2011.02.002; Yufera M, 2007, AQUACULTURE, V267, P94, DOI 10.1016/j.aquaculture.2007.02.009; Yufera M, 2004, MAR BIOL, V144, P863, DOI 10.1007/s00227-003-1255-9; Yufera Manuel, 2011, P133; Zhao LiSha, 2011, Journal of Food Processing and Technology, V2, P126; Zhou QO, 2007, FOOD CHEM, V103, P795, DOI 10.1016/j.foodchem.2006.09.021; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	61	59	63	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33687	10.1371/journal.pone.0033687	http://dx.doi.org/10.1371/journal.pone.0033687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448266	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700057
J	Hayes, EK; Lechowicz, A; Petrik, JJ; Storozhuk, Y; Paez-Parent, S; Dai, Q; Samjoo, IA; Mansell, M; Gruslin, A; Holloway, AC; Raha, S				Hayes, Emily K.; Lechowicz, Anna; Petrik, Jim J.; Storozhuk, Yaryna; Paez-Parent, Sabrina; Dai, Qin; Samjoo, Imtiaz A.; Mansell, Margaret; Gruslin, Andree; Holloway, Alison C.; Raha, Sandeep			Adverse Fetal and Neonatal Outcomes Associated with a Life-Long High Fat Diet: Role of Altered Development of the Placental Vasculature	PLOS ONE			English	Article							MATERNAL OBESITY; OXIDATIVE STRESS; INSULIN-RESISTANCE; METABOLIC SYNDROME; PREGNANCY; MODEL; FEMALE; BIRTH; RISK; WEIGHT	Maternal obesity results in a number of obstetrical and fetal complications with both immediate and long-term consequences. The increased prevalence of obesity has resulted in increasing numbers of women of reproductive age in this high-risk group. Since many of these obese women have been subjected to hypercaloric diets from early childhood we have developed a rodent model of life-long maternal obesity to more clearly understand the mechanisms that contribute to adverse pregnancy outcomes in obese women. Female Sprague Dawley rats were fed a control diet (CON - 16% of calories from fat) or high fat diet (HF - 45% of calories from fat) from 3 to 19 weeks of age. Prior to pregnancy HF-fed dams exhibited significant increases in body fat, serum leptin and triglycerides. A subset of dams was sacrificed at gestational day 15 to evaluate fetal and placental development. The remaining animals were allowed to deliver normally. HF-fed dams exhibited a more than 3-fold increase in fetal death and decreased neonatal survival. These outcomes were associated with altered vascular development in the placenta, as well as increased hypoxia in the labyrinth. We propose that the altered placental vasculature may result in reduced oxygenation of the fetal tissues contributing to premature demise and poor neonatal survival.	[Hayes, Emily K.; Lechowicz, Anna; Storozhuk, Yaryna; Paez-Parent, Sabrina; Dai, Qin; Samjoo, Imtiaz A.; Mansell, Margaret; Raha, Sandeep] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Hayes, Emily K.; Lechowicz, Anna; Samjoo, Imtiaz A.; Raha, Sandeep] McMaster Univ, Grad Program Med Sci, Hamilton, ON, Canada; [Petrik, Jim J.] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Gruslin, Andree] Univ Ottawa, Ottawa Hosp Res Inst, Dept Obstet & Gynecol, Div Maternal Fetal Med, Ottawa, ON, Canada; [Gruslin, Andree] Univ Ottawa, Ottawa Hosp Res Inst, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Holloway, Alison C.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada	McMaster University; McMaster University; University of Guelph; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; McMaster University	Hayes, EK (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.	rahas@mcmaster.ca	Raha, Sandeep/AAF-3655-2020	Raha, Sandeep/0000-0001-7307-3292	Joint Funding-Sick Kids Foundation/CIHR [XG09-45R]; McMaster University [2007h00407]; Hamilton Health Sciences, New Investigator Fund [N08-175]	Joint Funding-Sick Kids Foundation/CIHR(Canadian Institutes of Health Research (CIHR)); McMaster University; Hamilton Health Sciences, New Investigator Fund	The funding sources for this submission are Joint Funding-Sick Kids Foundation/CIHR (#XG09-45R), McMaster University Start-up Funding (#2007h00407), and Hamilton Health Sciences, New Investigator Fund (#N08-175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol A, 2009, BRIT J NUTR, V102, P1601, DOI 10.1017/S0007114509990961; Amir Lisa H, 2007, BMC Pregnancy Childbirth, V7, P9, DOI 10.1186/1471-2393-7-9; Arendas K, 2008, J OBSTET GYNAECOL CA, V30, P477, DOI 10.1016/S1701-2163(16)32863-8; Arroyo JA, 2008, SEMIN PERINATOL, V32, P172, DOI 10.1053/j.semperi.2008.02.006; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Bautista CJ, 2011, REPROD SCI, V18, p205A; Becker T, 2008, J OBSTET GYNAECOL CA, V30, P1132, DOI 10.1016/S1701-2163(16)34023-3; Bellver J, 2007, FERTIL STERIL, V88, P446, DOI 10.1016/j.fertnstert.2006.11.162; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Brewer CJ, 2010, REPRODUCTION, V140, P347, DOI 10.1530/REP-09-0568; Caluwaerts S, 2005, PLACENTA, V26, P574, DOI 10.1016/j.placenta.2004.09.007; Cimpean Anca Maria, 2007, Rom J Morphol Embryol, V48, P41; Devries MC, 2008, FREE RADICAL BIO MED, V45, P503, DOI 10.1016/j.freeradbiomed.2008.04.039; Ehrenberg HM, 2002, AM J OBSTET GYNECOL, V187, P1189, DOI 10.1067/mob.2002.127125; Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697; Fujita K, 2006, CIRC J, V70, P1437, DOI 10.1253/circj.70.1437; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Furuya M, 2008, LAB INVEST, V88, P416, DOI 10.1038/labinvest.2008.7; Granger JP, 2007, HYPERTENSION; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P187, DOI 10.1111/j.1471-0528.2006.01180.x; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hung TH, 2001, AM J PATHOL, V159, P1031, DOI 10.1016/S0002-9440(10)61778-6; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Johnson JR, 2009, REPROD SCI, V16, P605, DOI 10.1177/1933719109332823; Khankin EV, 2010, SEMIN THROMB HEMOST, V36, P309, DOI 10.1055/s-0030-1253453; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Leddy Meaghan A, 2008, Rev Obstet Gynecol, V1, P170; Leung TY, 2008, BJOG-INT J OBSTET GY, V115, P1529, DOI 10.1111/j.1471-0528.2008.01931.x; Loboda A, 2006, VASC PHARMACOL, V44, P206, DOI 10.1016/j.vph.2005.11.007; Mather K, 2009, AM J PHYSIOL-ENDOC M, V296, pE398, DOI 10.1152/ajpendo.90889.2008; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Min J, 2009, PLACENTA, V30, P418, DOI 10.1016/j.placenta.2009.02.007; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Myatt L, 2002, ENDOCRINE, V19, P103, DOI 10.1385/ENDO:19:1:103; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Nama V, 2007, HYPERTENSION, V49, pE21, DOI 10.1161/01.HYP.0000259962.47982.2a; Nash P, 2005, PLACENTA, V26, P410, DOI 10.1016/j.placenta.2004.07.009; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Nommsen-Rivers LA, 2010, AM J CLIN NUTR, V92, P574, DOI 10.3945/ajcn.2010.29192; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; Raha S, 2002, FREE RADICAL BIO MED, V32, P421, DOI 10.1016/S0891-5849(01)00816-4; RAHA S, 2003, HEART AND METABOLISM, V19, P4; Ray JG, 2005, J OBSTET GYNAECOL CA, V27, P1095, DOI 10.1016/S1701-2163(16)30391-7; Robertshaw HA, 2008, MUSCLE NERVE, V37, P431, DOI 10.1002/mus.20947; Rode L, 2005, OBSTET GYNECOL, V105, P537, DOI 10.1097/01.AOG.0000152304.39492.1c; Rowlands I, 2010, SEMIN FETAL NEONAT M, V15, P94, DOI 10.1016/j.siny.2009.09.003; Said HM, 2007, J NEURO-ONCOL, V81, P27, DOI 10.1007/s11060-006-9205-2; Salihu HM, 2009, OBSTET GYNECOL, V114, P333, DOI 10.1097/AOG.0b013e3181ae9a47; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schmatz M, 2010, J PERINATOL, V30, P441, DOI 10.1038/jp.2009.182; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shen XH, 2010, EXP BIOL MED, V235, P47, DOI 10.1258/ebm.2009.009122; Smith SA, 2008, JOGNN-J OBST GYN NEO, V37, P176, DOI 10.1111/j.1552-6909.2008.00222.x; Yu Victor Y H, 2004, Semin Fetal Neonatal Med, V9, P403, DOI 10.1016/j.siny.2004.03.004; Zain MM, 2008, WOMENS HEALTH, V4, P183, DOI 10.2217/17455057.4.2.183; Zusterzeel PLM, 2001, PLACENTA, V22, P213, DOI 10.1053/plac.2000.0606	60	94	94	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33370	10.1371/journal.pone.0033370	http://dx.doi.org/10.1371/journal.pone.0033370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442686	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500027
J	Jensik, PJ; Huggenvik, JI; Collard, MW				Jensik, Philip J.; Huggenvik, Jodi I.; Collard, Michael W.			Deformed Epidermal Autoregulatory Factor-1 (DEAF1) Interacts with the Ku70 Subunit of the DNA-Dependent Protein Kinase Complex	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; PHOSPHORYLATION SITES; CELL-DEATH; BINDING; DOMAIN; PK; PROLIFERATION; TRANSCRIPTION; ACETYLATION; EXPRESSION	Deformed Epidermal Autoregulatory Factor 1 (DEAF1) is a transcription factor linked to suicide, cancer, autoimmune disorders and neural tube defects. To better understand the role of DEAF1 in protein interaction networks, a GST-DEAF1 fusion protein was used to isolate interacting proteins in mammalian cell lysates, and the XRCC6 (Ku70) and the XRCC5 (Ku80) subunits of DNA dependent protein kinase (DNA-PK) complex were identified by mass spectrometry, and the DNAPK catalytic subunit was identified by immunoblotting. Interaction of DEAF1 with Ku70 and Ku80 was confirmed to occur within cells by co-immunoprecipitation of epitope-tagged proteins, and was mediated through interaction with the Ku70 subunit. Using in vitro GST-pulldowns, interaction between DEAF1 and the Ku70 subunit was mapped to the DEAF1 DNA binding domain and the C-terminal Bax-binding region of Ku70. In transfected cells, DEAF1 and Ku70 colocalized to the nucleus, but Ku70 could not relocalize a mutant cytoplasmic form of DEAF1 to the nucleus. Using an in vitro kinase assay, DEAF1 was phosphorylated by DNA-PK in a DNA-independent manner. Electrophoretic mobility shift assays showed that DEAF1 or Ku70/Ku80 did not interfere with the DNA binding of each other, but DNA containing DEAF1 binding sites inhibited the DEAF1-Ku70 interaction. The data demonstrates that DEAF1 can interact with the DNA-PK complex through interactions of its DNA binding domain with the carboxy-terminal region of Ku70 that contains the Bax binding domain, and that DEAF1 is a potential substrate for DNA-PK.	[Jensik, Philip J.; Huggenvik, Jodi I.; Collard, Michael W.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Jensik, PJ (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.	mcollard@siumed.edu			National Institutes of Health [CA89438, CA137556, HD060122]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD060122] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA089438, R15CA137556] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA89438, CA137556, and HD060122 to JH and MC. http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Chan DW, 1999, BIOCHEMISTRY-US, V38, P1819, DOI 10.1021/bi982584b; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Goswami DB, 2010, J NEUROCHEM, V112, P397, DOI 10.1111/j.1471-4159.2009.06462.x; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Hill R, 2011, ONCOTARGET, V2, P1094, DOI 10.18632/oncotarget.378; Hill R, 2010, CELL CYCLE, V9, P3460, DOI 10.4161/cc.9.17.13043; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Jensik PJ, 2004, J BIOL CHEM, V279, P32692, DOI 10.1074/jbc.M400946200; Ko L, 2003, J BIOL CHEM, V278, P11471, DOI 10.1074/jbc.M209723200; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; Lemonde S, 2003, J NEUROSCI, V23, P8788; Li BM, 2011, AGING-US, V3, P395, DOI 10.18632/aging.100308; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Manne U, 2001, CLIN CANCER RES, V7, P3495; Song KY, 2001, J BIOL CHEM, V276, P8321, DOI 10.1074/jbc.M008779200; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773; Yoshida T, 2004, BIOCHEM BIOPH RES CO, V321, P961, DOI 10.1016/j.bbrc.2004.07.054; Yu YP, 2003, DNA REPAIR, V2, P1239, DOI 10.1016/S1568-7864(03)00143-5; Zhang ZM, 2001, J BIOL CHEM, V276, P38231	25	9	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33404	10.1371/journal.pone.0033404	http://dx.doi.org/10.1371/journal.pone.0033404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442688	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500029
J	McGowan, J; Hogg, W; Zhong, JW; Zhao, X				McGowan, Jessie; Hogg, William; Zhong, Jianwei; Zhao, Xue			A Cost-Consequences Analysis of a Primary Care Librarian Question and Answering Service	PLOS ONE			English	Article							IN-TIME INFORMATION; CLINICAL QUESTIONS; PATIENT-CARE; SEEKING; DOCTORS	Background: Cost consequences analysis was completed from randomized controlled trial (RCT) data for the Just-in-time (JIT) librarian consultation service in primary care that ran from October 2005 to April 2006. The service was aimed at providing answers to clinical questions arising during the clinical encounter while the patient waits. Cost saving and cost avoidance were also analyzed. The data comes from eighty-eight primary care providers in the Ottawa area working in Family Health Networks (FHNs) and Family Health Groups (FHGs). Methods: We conducted a cost consequences analysis based on data from the JIT project [1]. We also estimated the potential economic benefit of JIT librarian consultation service to the health care system. Results: The results show that the cost per question for the JIT service was $38.20. The cost could be as low as $5.70 per question for a regular service. Nationally, if this service was implemented and if family physicians saw additional patients when the JIT service saved them time, up to 61,100 extra patients could be seen annually. A conservative estimate of the cost savings and cost avoidance per question for JIT was $11.55. Conclusions: The cost per question, if the librarian service was used at full capacity, is quite low. Financial savings to the health care system might exceed the cost of the service. Saving physician's time during their day could potentially lead to better access to family physicians by patients. Implementing a librarian consultation service can happen quickly as the time required to train professional librarians to do this service is short.	[McGowan, Jessie; Hogg, William] Univ Ottawa, Fac Family Med, Ottawa, ON, Canada; [McGowan, Jessie] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Hogg, William] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada; [Hogg, William; Zhong, Jianwei] Elisabeth Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada; [Zhao, Xue] Carleton Univ, Dept Econ, Ottawa, ON K1S 5B6, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Carleton University	McGowan, J (corresponding author), Univ Ottawa, Fac Family Med, Ottawa, ON, Canada.	jmcgowan@uottawa.ca			Ontario Ministry of Health and Long Term Care	Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	The Ontario Ministry of Health and Long Term Care Primary Health Care Transition Fund provided funding for this research. The views expressed in this report are the views of the authors and do not necessarily reflect those of the Ontario Ministry of Health and Long Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brassey J, 2001, BRIT MED J, V322, P529, DOI 10.1136/bmj.322.7285.529; Canadian Broadcasting Corporation (CBC), 2011, NO MED PROGR RESP QU; Coumou HCH, 2006, J MED LIBR ASSOC, V94, P55; Davies K, 2007, HEALTH INFO LIBR J, V24, P78, DOI 10.1111/j.1471-1842.2007.00713.x; Del Mar CB, 2001, MED J AUSTRALIA, V175, P134, DOI 10.5694/j.1326-5377.2001.tb143060.x; Drummond M, 2007, COST ANAL METHODS EC; Ely JW, 2002, BRIT MED J, V324, P710, DOI 10.1136/bmj.324.7339.710; GORMAN PN, 1995, MED DECIS MAKING, V15, P113, DOI 10.1177/0272989X9501500203; Greenhalgh T, 2002, BRIT MED J, V324, P524, DOI 10.1136/bmj.324.7336.524; Gutkin C, 2008, CAN FAM PHYSICIAN, V54, P480; Hayward JA, 1999, MED J AUSTRALIA, V171, P547, DOI 10.5694/j.1326-5377.1999.tb123793.x; Ingolfsson AGF, 2008, QUEUEING TOOLPAK SOF; Martin P, 2001, HLTH INFORM J, V7, P66; Mauskopf JA, 1998, PHARMACOECONOMICS, V13, P277, DOI 10.2165/00019053-199813030-00002; McGowan J, 2009, JUST IN TIME INFORM; McGowan J, 2010, HEALTH INFO LIBR J, V27, P11, DOI 10.1111/j.1471-1842.2009.00861.x; McGowan J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003785; Ontario Ministry of Health and Long Term Care, 2006, ONT HLTH INS OHIP SC; Schwartz Alan, 2006, BMC Med Inform Decis Mak, V6, P16, DOI 10.1186/1472-6947-6-16; Shepherd J, 1996, BRIT MED J, V313, P1142, DOI 10.1136/bmj.313.7065.1142; Stewart M, 2009, DELIVER PRIMARY HEAL; Swinglehurst DA, 2001, QUAL HEALTH CARE, V10, P245, DOI 10.1136/qhc.0100245..; The College of Family Physicians of Canada, 2007, NAT PHYS SURV; Verhoeven Anita A H, 2004, Health Info Libr J, V21 Suppl 2, P27, DOI 10.1111/j.1740-3324.2004.00524.x; Weightman AL, 2005, HEALTH INFO LIBR J, V22, P4, DOI 10.1111/j.1471-1842.2005.00549.x	25	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33837	10.1371/journal.pone.0033837	http://dx.doi.org/10.1371/journal.pone.0033837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442727	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500068
J	Raju, SV; Wang, GS				Raju, Sammeta V.; Wang, Guoshun			Suppression of Adenosine-Activated Chloride Transport by Ethanol in Airway Epithelia	PLOS ONE			English	Article							SURFACE LIQUID VOLUME; MUCUS CLEARANCE; CYSTIC-FIBROSIS; DEFENSE; INNATE; CELLS; LUNG; RECEPTORS; CFTR; NEUTROPHILS	Alcohol abuse is associated with increased lung infections. Molecular understanding of the underlying mechanisms is not complete. Airway epithelial ion transport regulates the homeostasis of airway surface liquid, essential for airway mucosal immunity and lung host defense. Here, air-liquid interface cultures of Calu-3 epithelial cells were basolaterally exposed to physiologically relevant concentrations of ethanol (0, 25, 50 and 100 mM) for 24 hours and adenosine-stimulated ion transport was measured by Ussing chamber. The ethanol exposure reduced the epithelial short-circuit currents (I-SC) in a dose-dependent manner. The ion currents activated by adenosine were chloride conductance mediated by cystic fibrosis transmembrane conductance regulator (CFTR), a cAMP-activated chloride channel. Alloxazine, a specific inhibitor for A(2B) adenosine receptor (A(2B)AR), largely abolished the adenosine-stimulated chloride transport, suggesting that A(2B)AR is a major receptor responsible for regulating the chloride transport of the cells. Ethanol significantly reduced intracellular cAMP production upon adenosine stimulation. Moreover, ethanol-suppression of the chloride secretion was able to be restored by cAMP analogs or by inhibitors to block cAMP degradation. These results imply that ethanol exposure dysregulates CFTR-mediated chloride transport in airways by suppression of adenosine-A(2B)AR-cAMP signaling pathway, which might contribute to alcohol-associated lung infections.	[Raju, Sammeta V.; Wang, Guoshun] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Wang, Guoshun] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol, New Orleans, LA USA; [Wang, Guoshun] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Raju, SV (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA.	gwang@lsuhsc.edu			National Institutes of Health [5R21AA16118, R01AI72327]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA016118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants to GW (5R21AA16118 and R01AI72327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Gipson DS, 2011, AM J PHYSIOL-LUNG C, V301, pL171, DOI 10.1152/ajplung.00203.2010; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Bartlett Jennifer A., 2008, V15, P147, DOI 10.1159/000136349; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Braunstein Gavin M, 2004, J Cyst Fibros, V3, P99, DOI 10.1016/j.jcf.2004.01.006; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Bucheimer RE, 2004, J PHYSIOL-LONDON, V555, P311, DOI 10.1113/jphysiol.2003.056697; Burns AR, 2003, PHYSIOL REV, V83, P309, DOI 10.1152/physrev.00023.2002; Button B, 2008, RESP PHYSIOL NEUROBI, V163, P189, DOI 10.1016/j.resp.2008.04.020; Cobb BR, 2003, AM J RESP CELL MOL, V29, P410, DOI 10.1165/rcmb.2002-0247OC; Cobb BR, 2002, AM J PHYSIOL-LUNG C, V282, pL12, DOI 10.1152/ajplung.2002.282.1.L12; Com Gulnur, 2009, Handb Exp Pharmacol, P363, DOI 10.1007/978-3-540-89615-9_12; Forget MA, 2003, ALCOHOL, V31, P31, DOI 10.1016/j.alcohol.2003.06.005; Gomez M, 2010, J IMMUNOL; Happel Kyle I, 2005, Proc Am Thorac Soc, V2, P428, DOI 10.1513/pats.200507-065JS; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kolachala V, 2005, J BIOL CHEM, V280, P4048, DOI 10.1074/jbc.M409577200; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Parker D., 2011, AM J RESP CELL MOL B; Reynolds HY, 2002, CURR OPIN PULM MED, V8, P154, DOI 10.1097/00063198-200205000-00002; Rollins BM, 2008, AM J RESP CELL MOL, V39, P190, DOI 10.1165/rcmb.2007-0450OC; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Sheppard David N., 1999, Physiological Reviews, V79, pS23; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Sisson JH, 2007, ALCOHOL, V41, P293, DOI 10.1016/j.alcohol.2007.06.003; Smith DJ, 2008, RESP PHYSIOL NEUROBI, V163, P178, DOI 10.1016/j.resp.2008.03.006; Spicuzza L, 2006, EUR J PHARMACOL, V533, P77, DOI 10.1016/j.ejphar.2005.12.056; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Tarran Robert, 2004, Proc Am Thorac Soc, V1, P42, DOI 10.1513/pats.2306014; Tecle T, 2010, INNATE IMMUN-LONDON, V16, P151, DOI 10.1177/1753425910365734; Top EAV, 2005, ALCOHOL CLIN EXP RES, V29, P882, DOI 10.1097/01.ALC.0000164364.35682.86; Twigg HL, 1998, J THORAC IMAG, V13, P221, DOI 10.1097/00005382-199810000-00003; Verma M, 1997, GENE, V189, P9, DOI 10.1016/S0378-1119(96)00742-1; Wang GS, 2000, J VIROL, V74, P9234, DOI 10.1128/JVI.74.19.9234-9239.2000; Wang GS, 1998, J VIROL, V72, P9818, DOI 10.1128/JVI.72.12.9818-9826.1998; Wang XF, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-7; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; Wyatt TA, 2003, AM J PATHOL, V163, P1157, DOI 10.1016/S0002-9440(10)63475-X; Wyatt TA, 2001, AM J PHYSIOL-LUNG C, V281, pL575, DOI 10.1152/ajplung.2001.281.3.L575; Zhang Ping, 2008, Curr Drug Abuse Rev, V1, P56	45	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32112	10.1371/journal.pone.0032112	http://dx.doi.org/10.1371/journal.pone.0032112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442662	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500005
J	Sun, LL; Gu, L; Wang, ST; Yuan, JF; Yang, HM; Zhu, JW; Zhang, H				Sun, Lili; Gu, Li; Wang, Shuting; Yuan, Jifang; Yang, Huimin; Zhu, Jiawei; Zhang, Hong			N-acetylcysteine Protects against Apoptosis through Modulation of Group I Metabotropic Glutamate Receptor Activity	PLOS ONE			English	Article							REGULATED KINASE ACTIVATION; PARKINSONS-DISEASE; SIGNALING PATHWAYS; OXIDATIVE STRESS; CELLS; ERK; NEURONS; 6-HYDROXYDOPAMINE; SURVIVAL; MODELS	The activation of group I metabotropic glutamate receptor (group I mGlus) has been shown to produce neuroprotective or neurotoxic effects. In this study, we investigated the effects of N-acetylcysteine (NAC), a precursor of the antioxidant glutathione, on group I mGlus activation in apoptosis of glial C6 and MN9D cell lines, and a rat model of Parkinson's disease (PD). We demonstrated that NAC protected against apoptosis through modulation of group I mGlus activity. In glial C6 cells, NAC promoted phosphorylation of ERK induced by (s)-3,5-dihydroxy-phenylglycine (DHPG), an agonist of group I mGlus. NAC enhanced the group I mGlus-mediated protection from staurosporine (STS)-induced apoptosis following DHPG treatment. Moreover, in rotenone-treated MN9D cells and PD rat model, NAC protected against group I mGlus-induced toxicity by compromising the decrease in phosphorylation of ERK, phosphorylation or expression level of TH. Furthermore, the results showed that NAC prohibited the level of ROS and oxidation of cellular GSH/GSSG (E-h) accompanied by activated group I mGlus in the experimental models. Our results suggest that NAC might act as a regulator of group I mGlus-mediated activities in both neuroprotection and neurotoxicity via reducing the oxidative stress, eventually to protect cell survival. The study also suggests that NAC might be a potential therapeutics targeting for group I mGlus activation in the treatment of PD.	[Sun, Lili; Gu, Li; Wang, Shuting; Yuan, Jifang; Yang, Huimin; Zhu, Jiawei; Zhang, Hong] Capital Med Univ, Dept Cell Biol, Key Lab Neurodegenerat Dis, Minist Educ, Beijing, Peoples R China; [Zhang, Hong] Capital Med Univ, Dept Neurobiol, Key Lab Neurodegenerat Dis, Minist Educ, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Sun, LL (corresponding author), Capital Med Univ, Dept Cell Biol, Key Lab Neurodegenerat Dis, Minist Educ, Beijing, Peoples R China.	hzhang@ccmu.edu.cn			National Natural Science Foundation of the People's Republic of China [30873087, 30973406]; Beijing Municipal Natural Science Foundation [7082010, 5102011]; State Key Development Program of Basic Research of China [2009CB522205]; Beijing Municipal Commission of Education [KM 200910025001]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This work was supported by the National Natural Science Foundation of the People's Republic of China (No. 30873087; 30973406), Beijing Municipal Natural Science Foundation (No. 7082010; 5102011), State Key Development Program of Basic Research of China (No. 2009CB522205) and Science and Technology Development projects of Beijing Municipal Commission of Education (No. KM 200910025001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agari T, 2008, BRAIN RES, V1203, P189, DOI 10.1016/j.brainres.2008.01.051; Albasanz JL, 1997, EUR J PHARMACOL, V326, P85, DOI 10.1016/S0014-2999(97)00154-4; Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; Berkeley JL, 2003, MOL PHARMACOL, V63, P128, DOI 10.1124/mol.63.1.128; Bi J, 2009, NEUROCHEM INT, V54, P264, DOI 10.1016/j.neuint.2008.12.003; Bonsi P, 2007, AMINO ACIDS, V32, P189, DOI 10.1007/s00726-006-0320-3; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Choe ES, 2001, NEUROSCI LETT, V313, P129, DOI 10.1016/S0304-3940(01)02258-3; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dekundy A, 2006, BRAIN RES BULL, V69, P318, DOI 10.1016/j.brainresbull.2005.12.009; Deng WB, 2004, P NATL ACAD SCI USA, V101, P7751, DOI 10.1073/pnas.0307850101; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; John WH, 1992, P NATL ACAD SCI USA, V89, P2365; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; Maiese K, 2005, CURR NEUROVASC RES, V2, P425, DOI 10.2174/156720205774962692; Maiese K, 1999, NEUROSCI LETT, V264, P17, DOI 10.1016/S0304-3940(99)00199-8; Martin V, 2007, FREE RADICAL BIO MED, V42, P1715, DOI 10.1016/j.freeradbiomed.2007.02.028; Meli E, 2005, NEUROPHARMACOLOGY, V49, P80, DOI 10.1016/j.neuropharm.2005.05.017; Monti B, 2010, NEUROTOX RES, V17, P130, DOI 10.1007/s12640-009-9090-5; Morin N, 2010, NEUROPHARMACOLOGY, V58, P981, DOI 10.1016/j.neuropharm.2009.12.024; Oh-hashi K, 1999, BIOCHEM BIOPH RES CO, V263, P504, DOI 10.1006/bbrc.1999.1237; Park SW, 2004, NEUROSCI LETT, V363, P243, DOI 10.1016/j.neulet.2004.03.072; Posadas I, 2007, BRIT J PHARMACOL, V150, P577, DOI 10.1038/sj.bjp.0706993; Pshenichkin S, 2008, NEUROPHARMACOLOGY, V55, P500, DOI 10.1016/j.neuropharm.2008.06.039; Sagara Y, 1998, J NEUROSCI, V18, P6662; Szydlowska K, 2007, EUR J PHARMACOL, V554, P18, DOI 10.1016/j.ejphar.2006.09.061; Thandi S, 2002, J NEUROCHEM, V83, P1139, DOI 10.1046/j.1471-4159.2002.01217.x; Zhang XD, 2004, MOL CANCER THER, V3, P187; Zhou F, 2007, NEUROPSYCHOPHARMACOL, V32, P2570, DOI 10.1038/sj.npp.1301381	32	37	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32503	10.1371/journal.pone.0032503	http://dx.doi.org/10.1371/journal.pone.0032503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442667	gold, Green Submitted, Green Published			2022-12-27	WOS:000303836500009
J	Lim, J; Ebstein, R; Tse, CY; Monakhov, M; Lai, PS; Dinges, DF; Kwok, K				Lim, Julian; Ebstein, Richard; Tse, Chun-Yu; Monakhov, Mikhail; Lai, Poh San; Dinges, David F.; Kwok, Kenneth			Dopaminergic Polymorphisms Associated with Time-on-Task Declines and Fatigue in the Psychomotor Vigilance Test	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY-DISORDER; SUSTAINED ATTENTION; MOLECULAR-GENETICS; METHYLTRANSFERASE COMT; RESPONSE-INHIBITION; SLEEP-DEPRIVATION; TARGET DETECTION; ENZYME-ACTIVITY; PERFORMANCE; ADHD	Prolonged demands on the attention system can cause a decay in performance over time known as the time-on-task effect. The inter-subject differences in the rate of this decline are large, and recent efforts have been made to understand the biological bases of these individual differences. In this study, we investigate the genetic correlates of the time-on-task effect, as well as its accompanying changes in subjective fatigue and mood. N = 332 subjects performed a 20-minute test of sustained attention (the Psychomotor Vigilance Test) and rated their subjective states before and after the test. We observed substantial time-on-task effects on average, and large inter-individual differences in the rate of these declines. The 10-repeat allele of the variable number of tandem repeats marker (VNTR) in the dopamine transporter gene and the Met allele of the catechol-o-methyl transferase (COMT) Val158Met polymorphism were associated with greater vulnerability to time-on-task. Separately, the exon III DRD4 48 bp VNTR of the dopamine receptor gene DRD4 was associated with subjective decreases in energy. No polymorphisms were associated with task-induced changes in mood. We posit that the dopamine transporter and COMT genes exert their effects by increasing dopaminergic tone, which may induce long-term changes in the prefrontal cortex, an important mediator of sustained attention. Thus, these alleles may affect performance particularly when sustained dopamine release is necessary.	[Lim, Julian; Tse, Chun-Yu; Kwok, Kenneth] Natl Univ Singapore, Cognit Sci Lab, Temasek Labs, Singapore 117548, Singapore; [Lim, Julian; Ebstein, Richard] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Monakhov, Mikhail] Natl Univ Singapore, Dept Econ, Singapore 117548, Singapore; [Lai, Poh San] Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore; [Dinges, David F.] Univ Penn Perelman Sch Med, Dept Psychiat, Philadelphia, PA USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; University of Pennsylvania; Pennsylvania Medicine	Lim, J (corresponding author), Natl Univ Singapore, Cognit Sci Lab, Temasek Labs, Singapore 117548, Singapore.	tsllzj@nus.edu.sg	Kwok, Kenneth/P-7835-2016; Mikhail, Monakhov/J-5899-2016; Lim, Julian/E-6844-2011; Dinges, David/P-7183-2019; Lim, Julian/K-7447-2016; Tse, Chun-Yu/ABB-4344-2020	Kwok, Kenneth/0000-0002-5387-8197; Mikhail, Monakhov/0000-0003-0285-2293; Lim, Julian/0000-0002-1214-6758; Lim, Julian/0000-0002-1214-6758; Tse, Chun-Yu/0000-0002-6120-2971; Ebstein, Richard/0000-0002-3626-541X	DRTech (Defence Research and Technology) [POD9010104458]; National Space Biomedical Research Institute through NASA NCC [9-58]	DRTech (Defence Research and Technology); National Space Biomedical Research Institute through NASA NCC	This study was supported by DRTech (Defence Research and Technology) under project agreement POD9010104458 and in part by the National Space Biomedical Research Institute through NASA NCC 9-58 (to DFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Bearden CE, 2004, AM J PSYCHIAT, V161, P1700, DOI 10.1176/appi.ajp.161.9.1700; Bellgrove MA, 2005, NEUROPSYCHOLOGIA, V43, P1847, DOI 10.1016/j.neuropsychologia.2005.03.011; Bellgrove MA, 2005, EXP BRAIN RES, V163, P352, DOI 10.1007/s00221-004-2180-y; Bellgrove MA, 2008, ANN NY ACAD SCI, V1129, P200, DOI 10.1196/annals.1417.013; Bellgrove MA, 2006, CORTEX, V42, P838, DOI 10.1016/S0010-9452(08)70426-X; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Brody AL, 2004, AM J PSYCHIAT, V161, P1211, DOI 10.1176/appi.ajp.161.7.1211; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CARTER RC, 1986, HUM FACTORS, V28, P673, DOI 10.1177/001872088602800605; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; COOK EH, 1995, AM J HUM GENET, V56, P993; Cornish KM, 2005, MOL PSYCHIATR, V10, P686, DOI 10.1038/sj.mp.4001641; da Silva N, 2011, CLIN NUCL MED, V36, P656, DOI 10.1097/RLU.0b013e318219b49d; Davies DR, 1982, PSYCHOL VIGILANCE; Demeter E, 2011, NEUROIMAGE, V54, P1518, DOI 10.1016/j.neuroimage.2010.09.026; Dinges DF, 1995, J SLEEP RES, V4, P4, DOI 10.1111/j.1365-2869.1995.tb00220.x; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Dorrian J., 2005, THESIS, P39; Dreher JC, 2002, NEURAL NETWORKS, V15, P583, DOI 10.1016/S0893-6080(02)00051-5; Eisenberg J, 1999, AM J MED GENET, V88, P497, DOI 10.1002/(SICI)1096-8628(19991015)88:5<497::AID-AJMG12>3.3.CO;2-6; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; GIAMBRA LM, 1987, HUM FACTORS, V29, P635, DOI 10.1177/001872088702900603; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1984, J NEUROSCI, V4, P2866; GRACE AA, 1995, DRUG ALCOHOL DEPEN, V37, P111, DOI 10.1016/0376-8716(94)01066-T; HEIKKILA RE, 1975, BIOCHEM PHARMACOL, V24, P847, DOI 10.1016/0006-2952(75)90152-5; Helton WS, 2011, EXP BRAIN RES, V212, P429, DOI 10.1007/s00221-011-2749-1; Helton WS, 2011, HUM FACTORS, V53, P132, DOI 10.1177/0018720811401385; KAUFMAN S, 1965, PHARMACOL REV, V17, P71; KEEFE KA, 1993, J NEURAL TRANSM-GEN, V91, P223, DOI 10.1007/BF01245233; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Malyuchenko NV, 2010, B EXP BIOL MED+, V149, P226, DOI 10.1007/s10517-010-0913-4; Manor I, 2002, MOL PSYCHIATR, V7, P790, DOI 10.1038/sj.mp.4001078; MAY LJ, 1988, J NEUROCHEM, V51, P1060, DOI 10.1111/j.1471-4159.1988.tb03069.x; Ossowski U, 2011, CONSCIOUS COGN, V20, P1649, DOI 10.1016/j.concog.2011.08.015; Parasuraman R, 2008, HUM FACTORS, V50, P511, DOI 10.1518/001872008X312198; Parasuraman R, 2012, NEUROIMAGE, V59, P70, DOI 10.1016/j.neuroimage.2011.04.040; Parasuraman R, 2009, THEOR ISS ERGON SCI, V10, P399, DOI 10.1080/14639220903106403; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Posner MI, 2012, NEUROIMAGE, V59, P149, DOI 10.1016/j.neuroimage.2011.07.060; Rodriguez-Jimenez R, 2006, NEUROPSYCHOBIOLOGY, V54, P166, DOI 10.1159/000098652; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; SEE JE, 1995, PSYCHOL BULL, V117, P230, DOI 10.1037/0033-2909.117.2.230; Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7; SPENCER T, 1995, ARCH GEN PSYCHIAT, V52, P434; Stahl SM, 2002, J CLIN PSYCHIAT, V63, P7, DOI 10.4088/JCP.v63n0102; Thayer R. E, 1990, BIOPSYCHOLOGY MOOD A; THIERRY AM, 1973, SCIENCE, V182, P499, DOI 10.1126/science.182.4111.499; Verhoeff NPLG, 2003, PHARMACOL BIOCHEM BE, V74, P425, DOI 10.1016/S0091-3057(02)01028-6; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007	63	58	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33767	10.1371/journal.pone.0033767	http://dx.doi.org/10.1371/journal.pone.0033767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438994	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100096
J	Rottlaender, D; Motloch, LJ; Schmidt, D; Reda, S; Larbig, R; Wolny, M; Dumitrescu, D; Rosenkranz, S; Erdmann, E; Hoppe, UC				Rottlaender, Dennis; Motloch, Lukas J.; Schmidt, Daniela; Reda, Sara; Larbig, Robert; Wolny, Martin; Dumitrescu, Daniel; Rosenkranz, Stephan; Erdmann, Erland; Hoppe, Uta C.			Clinical Impact of Atrial Fibrillation in Patients with Pulmonary Hypertension	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; EUROPEAN-SOCIETY; PROGNOSTIC VALUE; ECHOCARDIOGRAPHY; PREVALENCE; GUIDELINES; STATEMENT; RELEVANCE; RISK	Background: Pulmonary hypertension (PH) is associated with progressive impairment of right ventricular function, reduced exercise capacity and a poor prognosis. Little is known about the prevalence, clinical manifestation and impact of atrial fibrillation (AF) on cardiac function in PH. Methods: In a four year single-centre retrospective analysis 225 patients with confirmed PH of various origins were enrolled to investigate the prevalence of AF, and to assess the clinical manifestation, 6-minute walk distance, NT-proBNP levels, echocardiographic parameters and hemodynamics obtained by right heart catheterization in PH with AF. Results: AF was prevalent in 31.1%. In patients with PH and AF, parameters of clinical deterioration (NYHA/WHO functional class, 6-minute walk distance, NT-proBNP levels) and renal function were significantly compromised compared to patients with PH and sinus rhythm (SR). In the total PH cohort and in PH not related to left heart disease occurrence of AF was associated with an increase of right atrial pressure (RAP) and right atrial dilatation. While no direct association was found between pulmonary artery pressure (PAP) and AF in these patients, right ventricular function was reduced in AF, indicating more advanced disease. In PH due to left heart failure the prevalence of AF was particularly high (57.7% vs. 23.1% in other forms of PH). In this subgroup, left atrial dilatation, increase of pulmonary capillary wedge pressure, PAP and RAP were more pronounced in AF than in SR, suggesting that more marked backward failure led to AF in this setting. Conclusion: PH is associated with increased prevalence of AF. Occurrence of AF in PH indicates clinical deterioration and more advanced disease.	[Rottlaender, Dennis; Motloch, Lukas J.; Reda, Sara; Larbig, Robert; Hoppe, Uta C.] Paracelsus Med Univ, Dept Internal Med 2, Salzburg, Austria; [Schmidt, Daniela; Dumitrescu, Daniel; Rosenkranz, Stephan; Erdmann, Erland; Hoppe, Uta C.] Univ Cologne, Dept Internal Med 3, D-50931 Cologne, Germany; [Wolny, Martin; Rosenkranz, Stephan; Hoppe, Uta C.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	Paracelsus Private Medical University; University of Cologne; University of Cologne	Rottlaender, D (corresponding author), Paracelsus Med Univ, Dept Internal Med 2, Salzburg, Austria.	dennis.rottlaender@uk-koeln.de	Dumitrescu, Daniel/ABG-3576-2020	Motloch, Lukas Jaroslaw/0000-0002-5829-6743				Aronow WS, 2001, AM J CARDIOL, V87, P224, DOI 10.1016/S0002-9149(00)01324-2; Aronow WS, 2001, AM J CARDIOL, V87, pA228; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Crijns HJGM, 2000, EUR HEART J, V21, P1238, DOI 10.1053/euhj.1999.2107; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Hoppe UC, 2006, CIRCULATION, V114, P18, DOI 10.1161/CIRCULATIONAHA.106.614560; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pozzoli M, 1998, J AM COLL CARDIOL, V32, P197, DOI 10.1016/S0735-1097(98)00221-6; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Ruo B, 2004, J AM COLL CARDIOL, V43, P429, DOI 10.1016/j.jacc.2003.09.035; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Stevenson WG, 1999, NEW ENGL J MED, V341, P910, DOI 10.1056/NEJM199909163411209; Swedberg K, 2005, EUR HEART J, V26, P1303, DOI 10.1093/eurheartj/ehi166; Tongers J, 2007, AM HEART J, V153, P127, DOI 10.1016/j.ahj.2006.09.008	26	46	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33902	10.1371/journal.pone.0033902	http://dx.doi.org/10.1371/journal.pone.0033902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439013	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100113
J	Wang, LH; Jiang, YD; Zhang, YX; Wang, YW; Huang, SH; Wang, ZH; Tian, BL; Yang, Y; Jiang, W; Pang, D				Wang, Lihong; Jiang, Yongdong; Zhang, Youxue; Wang, Yuwen; Huang, Sunhui; Wang, Zhihua; Tian, Baoling; Yang, Yue; Jiang, Wei; Pang, Da			Association Analysis of IL-17A and IL-17F Polymorphisms in Chinese Han Women with Breast Cancer	PLOS ONE			English	Article							T-CELLS; OVARIAN-CANCER; MESSENGER-RNA; TH17 CELLS; INFLAMMATION; INTERLEUKIN-17; EXPRESSION; RECEPTOR; GENES; GENERATION	Background: Research into the etiology of breast cancer has recently focused on the role of the immunity and inflammation. The proinflammatory cytokines IL-17A and IL-17F can mediate inflammation and cancer. To evaluate the influences of IL-17A and IL-17F gene polymorphisms on the risk of sporadic breast cancer, a case-control study was conducted in Chinese Han women. Methodology and Principal Findings: We genotyped three single-nucleotide polymorphisms (SNPs) in IL-17A (rs2275913, rs3819025 and rs3748067) and five SNPs in IL-17F (rs7771511, rs9382084, rs12203582, rs1266828 and rs763780) to determine the haplotypes in 491 women with breast cancer and 502 healthy individuals. The genotypes were determined using the SNaPshot technique. The differences in the genotypic distribution between breast cancer patients and healthy controls were analyzed with the Chi-square test for trends. For rs2275913 in IL-17A, the frequency of the AA genotype was higher in patients than controls (P = 0.0016). The clinical features analysis demonstrated significant associations between IL17 SNPs and tumor protein 53 (P53), progesterone receptor (PR), human epidermal growth factor receptor 2 (Her-2) and triple-negative (ER-/PR-/Her-2-)status. In addition, the haplotype analysis indicated that the frequency of the haplotype A(rs2275913)G(rs3819025)G(rs3748067), located in the IL-17A linkage disequilibrium (LD) block, was higher in patients than in controls (P = 0.0471 after correction for multiple testing). Conclusions and Significance: Our results suggested that SNPs in IL-17A but not IL-17F were associated with the risk of breast cancer. Both IL-17A and IL-17F gene polymorphisms may provide valuable information for predicting the prognosis of breast cancer in Chinese women.	[Wang, Lihong; Huang, Sunhui; Wang, Zhihua; Tian, Baoling; Yang, Yue; Pang, Da] Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China; [Jiang, Yongdong; Zhang, Youxue; Pang, Da] Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China; [Wang, Yuwen] Harbin Med Univ, Affiliated Hosp 2, Dept Lab Diagnost, Harbin, Peoples R China; [Jiang, Wei] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Wang, LH (corresponding author), Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China.	jiangwei@hrbmu.edu.cn; pangdasir@163.com			Key Science and Technology Program of Heilongjiang Province, China [GC08C501]; National Natural Science Foundation of China [30900837]; Science Foundation of China Postdoctor [20100471109]; Heilongjiang Provincial Health Department [2009-001, 2009-253]; Fund of Heilongjiang Provincial Finance Department [2008-05, 2009-05]	Key Science and Technology Program of Heilongjiang Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of China Postdoctor; Heilongjiang Provincial Health Department; Fund of Heilongjiang Provincial Finance Department	This work was supported by the Key Science and Technology Program of Heilongjiang Province, China (Grant number GC08C501), National Natural Science Foundation of China (Grant Number 30900837), Science Foundation of China Postdoctor (Grant Number 20100471109), Scientific Research Fund of Heilongjiang Provincial Health Department (Grant Numbers 2009-001 and 2009-253), and Fund of Heilongjiang Provincial Finance Department (Grant Numbers 2008-05 and 2009-05). No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Alexandrakis MG, 2006, EUR J INTERN MED, V17, P412, DOI 10.1016/j.ejim.2006.02.012; Arisawa T, 2008, J CLIN IMMUNOL, V28, P44, DOI 10.1007/s10875-007-9125-8; Arslan C, 2011, EXPERT OPIN THER TAR, V15, P21, DOI 10.1517/14656566.2011.537260; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cabodi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2563; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; Cole SW, 2009, J CLIN ONCOL, V27, P3418, DOI 10.1200/JCO.2009.21.9782; Dawood S, 2010, DRUGS, V70, P2247, DOI 10.2165/11538150-000000000-00000; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Horlock C, 2009, BRIT J CANCER, V100, P1061, DOI 10.1038/sj.bjc.6604963; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P735, DOI 10.1006/bbrc.2001.4618; Kawaguchi M, 2006, J ALLERGY CLIN IMMUN, V117, P795, DOI 10.1016/j.jaci.2005.12.1346; Kawaguchi M, 2004, J ALLERGY CLIN IMMUN, V114, P1265, DOI 10.1016/j.jaci.2004.10.019; Lialiaris TS, 2010, J BUON, V15, P79; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Shibata T, 2009, HUM IMMUNOL, V70, P547, DOI 10.1016/j.humimm.2009.04.030; Stendahl M, 2006, CLIN CANCER RES, V12, P4614, DOI 10.1158/1078-0432.CCR-06-0248; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	27	80	85	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34400	10.1371/journal.pone.0034400	http://dx.doi.org/10.1371/journal.pone.0034400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461912	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900030
J	Alhoot, MA; Wang, SM; Sekaran, SD				Alhoot, Mohammed Abdelfatah; Wang, Seok Mui; Sekaran, Shamala Devi			RNA Interference Mediated Inhibition of Dengue Virus Multiplication and Entry in HepG2 Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-REGULATED PROTEIN; ENVELOPE PROTEIN; HEMORRHAGIC-FEVER; HAEMORRHAGIC FEVER; BINDING-PROTEIN; ER CHAPERONE; FATAL DENGUE; INFECTION	Background: Dengue virus-host cell interaction initiates when the virus binds to the attachment receptors followed by endocytic internalization of the virus particle. Successful entry into the cell is necessary for infection initiation. Currently, there is no protective vaccine or antiviral treatment for dengue infection. Targeting the viral entry pathway has become an attractive therapeutic strategy to block infection. This study aimed to investigate the effect of silencing the GRP78 and clathrin-mediated endocytosis on dengue virus entry and multiplication into HepG2 cells. Methodology/Principal Findings: HepG2 cells were transfected using specific siRNAs to silence the cellular surface receptor ( GRP78) and clathrin-mediated endocytosis pathway. Gene expression analysis showed a marked down-regulation of the targeted genes (87.2%, 90.3%, and 87.8% for GRP78, CLTC, and DNM2 respectively) in transfected HepG2 cells when measured by RT-qPCR. Intracellular and extracellular viral RNA loads were quantified by RT-qPCR to investigate the effect of silencing the attachment receptor and clathrin-mediated endocytosis on dengue virus entry. Silenced cells showed a significant reduction of intracellular (92.4%) and extracellular viral RNA load (71.4%) compared to non-silenced cells. Flow cytometry analysis showed a marked reduction of infected cells (89.7%) in silenced HepG2 cells compared to non-silenced cells. Furthermore, the ability to generate infectious virions using the plaque assay was reduced 1.07 log in silenced HepG2 cells. Conclusions/Significance: Silencing the attachment receptor and clathrin-mediated endocytosis using siRNA could inhibit dengue virus entry and multiplication into HepG2 cells. This leads to reduction of infected cells as well as the viral load, which might function as a unique and promising therapeutic agent for attenuating dengue infection and prevent the development of dengue fever to the severe life-threatening DHF or DSS. Furthermore, a decrease of viremia in humans can result in the reduction of infected vectors and thus, halt of the transmission cycle.	[Alhoot, Mohammed Abdelfatah; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Wang, Seok Mui] Univ Teknol MARA, Fac Med, Inst Med Mol Biotechnol, Selangor, Malaysia	Universiti Malaya; Universiti Teknologi MARA	Alhoot, MA (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	wang, seok mui/C-3205-2011; Devi, Shamala Devi/B-9735-2010; ALHOOT, MOHAMMED A/B-7363-2012; Wang, Seok Mui/X-5856-2019; Sekaran, Shamala Devi/B-8482-2008	Devi, Shamala Devi/0000-0002-0478-0425; ALHOOT, MOHAMMED A/0000-0003-3819-2864; Wang, Seok Mui/0000-0002-3631-6504; Sekaran, Shamala Devi/0000-0002-0478-0425	Ministry of Science and Technology [02-01-03-SF0354]; University of Malaya [PS114/2009A, ps225/2010B, J0000073560]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); University of Malaya(Universiti Malaya)	This project was supported by the Ministry of Science and Technology Innovation Research Grant 02-01-03-SF0354, the University of Malaya Grant PS114/2009A and ps225/2010B, and the University of Malaya HIR grant J0000073560. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2011, VIRUS RES; Acosta EG, 2008, FUTURE VIROL, V3, P471, DOI 10.2217/17460794.3.5.471; ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Alhoot MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001410; Altmeyer R, 2004, CURR PHARM DESIGN, V10, P3701, DOI 10.2174/1381612043382729; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Arbuthnot P, 2005, LIVER INT, V25, P9, DOI 10.1111/j.1478-3231.2004.0966.x; Awe K, 2008, FEBS LETT, V582, P3179, DOI 10.1016/j.febslet.2008.07.062; Bai FW, 2005, J INFECT DIS, V191, P1148, DOI 10.1086/428507; Berkhout B, 2004, CURR OPIN MOL THER, V6, P141; BHAMARAP.N, 1967, ANN TROP MED PARASIT, V61, P500, DOI 10.1080/00034983.1967.11686519; BHAMARAPRAVATI N, 1989, REV INFECT DIS, V11, pS826; Bhattacharjee G, 2005, ARTERIOSCL THROM VAS, V25, P1737, DOI 10.1161/01.ATV.0000173419.31242.56; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; BURKE T, 1968, T ROY SOC TROP MED H, V62, P682, DOI 10.1016/0035-9203(68)90120-X; Cabrera-Hernandez A, 2007, J MED VIROL, V79, P386, DOI 10.1002/jmv.20786; Chavez-Salinas S, 2008, VIRUS RES, V138, P111, DOI 10.1016/j.virusres.2008.08.012; Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999; Chen YP, 1996, J VIROL, V70, P8765, DOI 10.1128/JVI.70.12.8765-8772.1996; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Das S, 2007, J VIS EXP; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113; Dey A, 2006, ARCH BIOCHEM BIOPHYS, V447, P155, DOI 10.1016/j.abb.2006.01.013; Dong DZ, 2005, CANCER RES, V65, P5785, DOI 10.1158/0008-5472.CAN-05-0754; Duxbury MS, 2004, J SURG RES, V117, P339, DOI 10.1016/j.jss.2003.09.010; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Ge Q, 2004, VIRUS RES, V102, P37, DOI 10.1016/j.virusres.2004.01.013; Haasnoot J, 2003, J BIOMED SCI, V10, P607, DOI 10.1007/BF02256311; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; Hendershot LM, 2004, MT SINAI J MED, V71, P289; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Hung SL, 1999, VIROLOGY, V257, P156, DOI 10.1006/viro.1999.9633; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; KURANE I, 1994, ARCH VIROL, P59; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Le Calvez H, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-12; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Mohan B, 2000, J TROP PEDIATRICS, V46, P40, DOI 10.1093/tropej/46.1.40; Neumann-Staubitz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012017; Nguyen TL, 1997, RES VIROLOGY, V148, P273, DOI 10.1016/S0923-2516(97)88364-1; Padwad YS, 2009, IMMUNOBIOLOGY, V214, P422, DOI 10.1016/j.imbio.2008.11.010; Paradkar PN, 2011, BIOSCIENCE REP, V31, P221, DOI 10.1042/BSR20100078; Peng T, 2009, CAN J MICROBIOL, V55, P139, DOI [10.1139/W08-107, 10.1139/w08-107]; Radhakrishnan SK, 2004, VIROLOGY, V323, P173, DOI 10.1016/j.virol.2004.02.021; Randall G, 2004, VIRUS RES, V102, P19, DOI 10.1016/j.virusres.2004.01.011; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosen L, 1999, AM J TROP MED HYG, V61, P720, DOI 10.4269/ajtmh.1999.61.720; ROSEN L, 1989, RES VIROLOGY, V140, P351, DOI 10.1016/S0923-2516(89)80115-3; Sandoval P, 2011, PROTEIN HALF LIVES M; SATOH M, 1993, EXP CELL RES, V205, P76, DOI 10.1006/excr.1993.1060; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Stevenson M, 2004, NEW ENGL J MED, V351, P1772, DOI 10.1056/NEJMra045004; Subramanya S, 2010, J VIROL, V84, P2490, DOI 10.1128/JVI.02105-08; SUGAWARA S, 1993, CANCER RES, V53, P6001; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Upanan S, 2008, J VIROL METHODS, V151, P325, DOI 10.1016/j.jviromet.2008.05.001; Uprichard SL, 2005, FEBS LETT, V579, P5996, DOI 10.1016/j.febslet.2005.08.004; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wahid S. Fadilah S. Abdul, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P259; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704; Wang XL, 2008, BIOMATERIALS, V29, P15, DOI 10.1016/j.biomaterials.2007.08.048; Wati S, 2009, J VIROL, V83, P12871, DOI 10.1128/JVI.01419-09; Wiebusch L, 2004, J GEN VIROL, V85, P179, DOI 10.1099/vir.0.19453-0; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	91	34	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34060	10.1371/journal.pone.0034060	http://dx.doi.org/10.1371/journal.pone.0034060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457813	Green Published, gold			2022-12-27	WOS:000304046900043
J	Dienes, Z; Baddeley, RJ; Jansari, A				Dienes, Zoltan; Baddeley, Roland J.; Jansari, Ashok			Rapidly Measuring the Speed of Unconscious Learning: Amnesics Learn Quickly and Happy People Slowly	PLOS ONE			English	Article							MOOD; RECOGNITION; INFORMATION; EXPECTANCY; MODEL	Background: We introduce a method for quickly determining the rate of implicit learning. Methodology/Principal Findings: The task involves making a binary prediction for a probabilistic sequence over 10 minutes; from this it is possible to determine the influence of events of a different number of trials in the past on the current decision. This profile directly reflects the learning rate parameter of a large class of learning algorithms including the delta and Rescorla-Wagner rules. To illustrate the use of the method, we compare a person with amnesia with normal controls and we compare people with induced happy and sad moods. Conclusions/Significance: Learning on the task is likely both associative and implicit. We argue theoretically and demonstrate empirically that both amnesia and also transient negative moods can be associated with an especially large learning rate: People with amnesia can learn quickly and happy people slowly.	[Dienes, Zoltan] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Baddeley, Roland J.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Jansari, Ashok] Univ E London, Sch Psychol, London E15 4LZ, England	University of Sussex; University of Bristol; University of East London	Dienes, Z (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	dienes@sussex.ac.uk		Dienes, Zoltan/0000-0001-7454-3161	Economic and Social Research (ESRC) [RES-062-23-1975]	Economic and Social Research (ESRC)	The work was partly supported by Economic and Social Research (ESRC) (http://www.esrc.ac.uk/) grant RES-062-23-1975 to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ayton P, 2004, MEM COGNITION, V32, P1369, DOI 10.3758/BF03206327; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Berry D. C., 1993, IMPLICIT LEARNING TH; Casper K, 2001, THEORIES MOOD COGNIT, P27; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Cleeremans A, 1993, CONNECTIONIST MODELS; Cleeremans A., 1993, MECH IMPLICIT LEARNI; Cleeremans A, 2008, CAMB HANDB PSYCHOL, P396; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; Davey GCL, 2007, BEHAV RES THER, V45, P1231, DOI 10.1016/j.brat.2006.08.024; Destrebecqz A, 2010, Q J EXP PSYCHOL, V63, P291, DOI 10.1080/17470210902888932; Dienes Z, 1998, Q J EXP PSYCHOL-A, V51, P593, DOI 10.1080/713755772; DIENES Z, 1995, J EXP PSYCHOL LEARN, V21, P848, DOI 10.1037/0278-7393.21.4.848; Dienes Z., 2008, UNDERSTANDING PSYCHO; Dienes Z., 2012, STAT LEARNING LANGUA, P337; Dienes Z, 2008, PROG BRAIN RES, V168, P49, DOI 10.1016/S0079-6123(07)68005-4; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; GABRIELI JDE, 1995, BEHAV NEUROSCI, V109, P819, DOI 10.1037/0735-7044.109.5.819; Griffiths O, 2008, J EXP PSYCHOL GEN, V137, P626, DOI 10.1037/a0013685; Jamieson RK, 2009, Q J EXP PSYCHOL, V62, P1757, DOI 10.1080/17470210802557637; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Junge JA, 2007, VIS COGN, V15, P1, DOI 10.1080/13506280600859706; Kinder A, 2001, J COGNITIVE NEUROSCI, V13, P648, DOI 10.1162/089892901750363217; Kuhn G, 2008, COGNITION, V106, P184, DOI 10.1016/j.cognition.2007.01.003; Mackintosh N. J, 1983, CONDITIONING ASS LEA; McGlincheyBerroth R, 1997, BEHAV NEUROSCI, V111, P873, DOI 10.1037/0735-7044.111.5.873; Mitchell CJ, 2010, J EXP PSYCHOL LEARN, V36, P567, DOI 10.1037/a0018433; Norman E, 2007, CONSCIOUS COGN, V16, P809, DOI 10.1016/j.concog.2007.02.004; Orban G, 2008, P NATL ACAD SCI USA, V105, P2745, DOI 10.1073/pnas.0708424105; PEARCE JM, 1994, PSYCHOL REV, V101, P587, DOI 10.1037/0033-295X.101.4.587; PERRUCHET P, 1985, PAVLOVIAN J BIOL SCI, V20, P163; Pothos EM, 2007, PSYCHOL BULL, V133, P227, DOI 10.1037/0033-2909.133.2.227; Pothos EM, 2009, BRAIN RES, V1275, P67, DOI 10.1016/j.brainres.2009.04.019; Pretz JE, 2010, LEARN INDIVID DIFFER, V20, P215, DOI 10.1016/j.lindif.2009.12.003; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; REBER AS, 1968, J EXP PSYCHOL, V77, P317, DOI 10.1037/h0025760; Roney CJR, 2003, CAN J EXP PSYCHOL, V57, P69, DOI 10.1037/h0087414; Runger D, 2010, PSYCHOL RES-PSYCH FO, V74, P121, DOI 10.1007/s00426-008-0225-8; Rumelhart D., 1986, PARALLEL DISTRIBUTED, DOI [10.7551/mitpress/5236.001.0001, DOI 10.7551/MITPRESS/5236.001.0001]; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Schwarz N, 2003, PSYCHOL INQ, V14, P296, DOI 10.1207/S15327965PLI1403&4_20; Scott RB, 2008, J EXP PSYCHOL LEARN, V34, P1264, DOI 10.1037/a0012943; Shanks D. R., 2005, HDB COGNITION, P203, DOI [10.4135/9781848608177.n8, DOI 10.4135/9781848608177.N8]; Speekenbrink M, 2008, NEUROSCI BIOBEHAV R, V32, P292, DOI 10.1016/j.neubiorev.2007.07.005; Squire LR, 2001, NAT NEUROSCI, V4, P867; Stewart N, 2005, PSYCHOL REV, V112, P881, DOI 10.1037/0033-295X.112.4.881; Wan LL, 2008, CONSCIOUS COGN, V17, P1209, DOI 10.1016/j.concog.2008.06.007; Williams JN, 2009, NEW HANDBOOK OF SECOND LANGUAGE ACQUISITION, 2ND EDITION, P319; Wills A. J., 2005, NEW DIRECTIONS HUMAN; Wilson B, 1999, CASE STUDIES NEUROPS	51	12	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33400	10.1371/journal.pone.0033400	http://dx.doi.org/10.1371/journal.pone.0033400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	942MA	22457759	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000304046900009
J	Inoue, T; Sugiyama, H; Kitagawa, M; Takiue, K; Morinaga, H; Ogawa, A; Kikumoto, Y; Kitamura, S; Maeshima, Y; Makino, H				Inoue, Tatsuyuki; Sugiyama, Hitoshi; Kitagawa, Masashi; Takiue, Keiichi; Morinaga, Hiroshi; Ogawa, Ayu; Kikumoto, Yoko; Kitamura, Shinji; Maeshima, Yohei; Makino, Hirofumi			Suppression of Adiponectin by Aberrantly Glycosylated IgA1 in Glomerular Mesangial Cells In Vitro and In Vivo	PLOS ONE			English	Article							NEPHROPATHY PATIENTS; HINGE REGION; TRANSFERRIN RECEPTOR; IMMUNE-COMPLEXES; EPITHELIAL-CELLS; RENAL FIBROSIS; URINARY LEVELS; TISSUE-INJURY; GROWTH-FACTOR; APOPTOSIS	The pathogenesis of IgA nephropathy (IgAN) may be associated with the mesangial deposition of aberrantly glycosylated IgA1. To identify mediators affected by aberrantly glycosylated IgA1 in cultured human mesangial cells (HMCs), we generated enzymatically modified desialylated and degalactosylated (deSial/deGal) IgA1. The state of deglycosylated IgA1 was confirmed by lectin binding to Helix aspersa (HAA) and Sambucus nigra (SNA). In the cytokine array analysis, 52 proteins were upregulated and 34 were downregulated in HMCs after stimulation with deSial/deGal IgA1. Among them, the secretion of adiponectin was suppressed in HMCs after stimulation with deSial/deGal IgA1. HMCs expressed mRNAs for adiponectin and its type 1 receptor, but not the type 2 receptor. Moreover, we revealed a downregulation of adiponectin expression in the glomeruli of renal biopsy specimens from patients with IgAN compared to those with lupus nephritis. We also demonstrated that aberrantly glycosylated IgA1 was deposited in the mesangium of patients with IgAN by dual staining of HAA and IgA. Moreover, the urinary HAA/SNA ratio of lectin binding was significantly higher in IgAN compared to other kidney diseases. Since adiponectin has anti-inflammatory effects, including the inhibition of adhesion molecules and cytokines, these data suggest that the local suppression of this adipokine by aberrantly glycosylated IgA1 could be involved in the regulation of glomerular inflammation and sclerosis in IgAN.	[Inoue, Tatsuyuki; Sugiyama, Hitoshi; Kitagawa, Masashi; Takiue, Keiichi; Morinaga, Hiroshi; Ogawa, Ayu; Kikumoto, Yoko; Kitamura, Shinji; Maeshima, Yohei; Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan; [Inoue, Tatsuyuki] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Ctr Chron Kidney Dis & Peritoneal Dialysis, Okayama 7008530, Japan	Okayama University; Kyoto University; Okayama University	Inoue, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan.	hitoshis@md.okayama-u.ac.jp	Sugiyama, Hitoshi/B-2252-2011	Sugiyama, Hitoshi/0000-0002-4127-6471	Ministry of Education, Culture, Sports, Science and Technology of Japan [C-19590951]; Study Group on IgA nephropathy in Japan; Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science [B-23790943]; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [23790943, 23700537] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Study Group on IgA nephropathy in Japan; Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A portion of this study was supported by a Research Grant for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (C-19590951) to HS and a Research Grant from the Study Group on IgA nephropathy in Japan, a Research Grant for Chronic Kidney Disease Award 2010, and a Grant-in-Aid for Young Scientists (B-23790943) from the Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science (to TI) and a Grant-in-Aid for Progressive Renal Diseases Research, Research on intractable disease, from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore A, 2000, AM J KIDNEY DIS, V36, P1242, DOI 10.1053/ajkd.2000.19840; Amore A, 2001, J AM SOC NEPHROL, V12, P1862, DOI 10.1681/ASN.V1291862; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Cammisotto PG, 2008, J MOL HISTOL, V39, P579, DOI 10.1007/s10735-008-9198-6; Coppo R, 2010, KIDNEY INT, V77, P417, DOI 10.1038/ki.2009.473; Crawford LJA, 2010, J LEUKOCYTE BIOL, V88, P807, DOI 10.1189/jlb.1109723; Ding JX, 2007, CLIN IMMUNOL, V125, P268, DOI 10.1016/j.clim.2007.08.009; Fukuoka N, 2008, AM J NEPHROL, V28, P661, DOI 10.1159/000121357; GALLA JH, 1985, J CLIN IMMUNOL, V5, P298, DOI 10.1007/BF00918248; Giannakakis K, 2007, J AM SOC NEPHROL, V18, P3139, DOI 10.1681/ASN.2007030259; Gomes MM, 2010, BIOCHEMISTRY-US, V49, P5671, DOI 10.1021/bi9019498; Hiki Y, 1999, J AM SOC NEPHROL, V10, P760; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Horie A, 2003, AM J KIDNEY DIS, V42, P486, DOI 10.1016/S0272-6386(03)00743-1; Inoue T, 2010, CLIN IMMUNOL, V136, P447, DOI 10.1016/j.clim.2010.05.009; Iwasa Y, 2008, NEPHRON CLIN PRACT, V108, pC226, DOI 10.1159/000119717; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kaser S, 2005, GUT, V54, P117, DOI 10.1136/gut.2003.037010; Kobayashi M, 2005, KIDNEY INT, V68, P1018, DOI 10.1111/j.1523-1755.2005.00494.x; Makino H, 2003, VIRCHOWS ARCH, V443, P67, DOI 10.1007/s00428-003-0827-x; Matousovic K, 2006, NEPHROL DIAL TRANSPL, V21, P2478, DOI 10.1093/ndt/gfl240; Miller M, 2009, J IMMUNOL, V182, P684, DOI 10.4049/jimmunol.182.1.684; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Moore JS, 2007, MOL IMMUNOL, V44, P2598, DOI 10.1016/j.molimm.2006.12.011; Moura IC, 2005, J AM SOC NEPHROL, V16, P2667, DOI 10.1681/ASN.2004111006; Moura IC, 2001, J EXP MED, V194, P417, DOI 10.1084/jem.194.4.417; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Peruzzi L, 2000, KIDNEY INT, V58, P2331, DOI 10.1046/j.1523-1755.2000.00417.x; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Saitoh A, 1998, J CLIN LAB ANAL, V12, P1, DOI 10.1002/(SICI)1098-2825(1998)12:1<1::AID-JCLA1>3.0.CO;2-F; Schalkwijk CG, 2006, J CLIN ENDOCR METAB, V91, P129, DOI 10.1210/jc.2005-1117; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Shen YY, 2008, NEPHROLOGY, V13, P528, DOI 10.1111/j.1440-1797.2008.01018.x; Shimotomai T, 2005, RENAL FAILURE, V27, P323, DOI 10.1081/JDI-200056597; Shimozato S, 2008, NEPHROL DIAL TRANSPL, V23, P1931, DOI 10.1093/ndt/gfm913; Song HJ, 2009, TRANSL RES, V154, P18, DOI 10.1016/j.trsl.2009.04.003; Sugiyama H, 1999, J BIOL CHEM, V274, P19532, DOI 10.1074/jbc.274.28.19532; Sunami R, 2004, AM J PHYSIOL-RENAL, V286, pF1030, DOI 10.1152/ajprenal.00266.2003; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Takahashi K, 2006, BIOCHEM BIOPH RES CO, V350, P580, DOI 10.1016/j.bbrc.2006.09.075; Tanabe K, 2007, KIDNEY INT, V71, P227, DOI 10.1038/sj.ki.5002040; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Torres DD, 2008, KIDNEY INT, V73, P327, DOI 10.1038/sj.ki.5002621; Uchida HA, 2006, NEPHROL DIAL TRANSPL, V21, P3475, DOI 10.1093/ndt/gfl423; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yokoyama H, 1998, J LEUKOCYTE BIOL, V63, P493, DOI 10.1002/jlb.63.4.493	48	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33965	10.1371/journal.pone.0033965	http://dx.doi.org/10.1371/journal.pone.0033965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457806	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900037
J	Quintana-Bustamante, O; Grueso, E; Garcia-Escudero, R; Arza, E; Alvarez-Barrientos, A; Fabregat, I; Garcia-Bravo, M; Meza, NW; Segovia, JC				Quintana-Bustamante, Oscar; Grueso, Esther; Garcia-Escudero, Ramon; Arza, Elvira; Alvarez-Barrientos, Alberto; Fabregat, Isabel; Garcia-Bravo, Maria; Meza, Nestor W.; Segovia, Jose C.			Cell Fusion Reprogramming Leads to a Specific Hepatic Expression Pattern during Mouse Bone Marrow Derived Hepatocyte Formation In Vivo	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; CHROMATIN-REMODELING ATPASE; DIRECT CONVERSION; GENE-EXPRESSION; HUMAN FIBROBLASTS; SOMATIC-CELLS; PLASTICITY; NUCLEI; LIVER; DNA	The fusion of bone marrow (BM) hematopoietic cells with hepatocytes to generate BM derived hepatocytes (BMDH) is a natural process, which is enhanced in damaged tissues. However, the reprogramming needed to generate BMDH and the identity of the resultant cells is essentially unknown. In a mouse model of chronic liver damage, here we identify a modification in the chromatin structure of the hematopoietic nucleus during BMDH formation, accompanied by the loss of the key hematopoietic transcription factor PU.1/Sfpi1 (SFFV proviral integration 1) and gain of the key hepatic transcriptional regulator HNF-1A homeobox A (HNF-1A/Hnf1a). Through genome-wide expression analysis of laser captured BMDH, a differential gene expression pattern was detected and the chromatin changes observed were confirmed at the level of chromatin regulator genes. Similarly, Tranforming Growth Factor-beta 1 (TGF-beta(1)) and neurotransmitter (e.g. Prostaglandin E Receptor 4 [Ptger4]) pathway genes were over-expressed. In summary, in vivo BMDH generation is a process in which the hematopoietic cell nucleus changes its identity and acquires hepatic features. These BMDHs have their own cell identity characterized by an expression pattern different from hematopoietic cells or hepatocytes. The role of these BMDHs in the liver requires further investigation.	[Quintana-Bustamante, Oscar; Grueso, Esther; Garcia-Bravo, Maria; Meza, Nestor W.; Segovia, Jose C.] Ctr Invest Energet Medioambientales & Tecnol CIEM, Hematopoiesis & Gene Therapy Div, Differentiat & Cytometry Unit, Madrid, Spain; [Quintana-Bustamante, Oscar; Grueso, Esther; Garcia-Bravo, Maria; Meza, Nestor W.; Segovia, Jose C.] Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Madrid, Spain; [Grueso, Esther] Paul Ehrlich Inst, Div Med Biotechnol, D-6070 Langen, Germany; [Garcia-Escudero, Ramon] Ctr Invest Energet Medioambientales & Tecnol CIEM, Epithelial Biomed Div, Mol Oncol Unit, Madrid, Spain; [Arza, Elvira] Ctr Nacl Invest Cardiovasc, Microscopy & Dynam Imaging Unit, Madrid, Spain; [Alvarez-Barrientos, Alberto] Univ Extremadura, Biosci Appl Tech Facil, Badajoz, Spain; [Fabregat, Isabel] Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Barcelona, Spain; [Meza, Nestor W.] Univ Los Andes, Sch Med Tachira, San Cristobal, Venezuela	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Paul Ehrlich Institute; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad de Extremadura; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Los Andes Venezuela	Quintana-Bustamante, O (corresponding author), Ctr Invest Energet Medioambientales & Tecnol CIEM, Hematopoiesis & Gene Therapy Div, Differentiat & Cytometry Unit, Madrid, Spain.	jc.segovia@ciemat.es	Garcia-Bravo, Maria/F-7560-2011; Alvarez-Barrientos, Alberto/L-9299-2014; Garcia-Escudero, Ramon/A-2735-2012; Meza, Nestor Wenceslao/ABE-2917-2021; Hierro, Esther Grueso/C-8107-2019; Segovia, Jose Carlos/L-2922-2014; Quintana, Oscar/M-1724-2014; Fabregat, Isabel/H-7038-2015	Garcia-Bravo, Maria/0000-0002-1890-1064; Alvarez-Barrientos, Alberto/0000-0003-4761-0212; Garcia-Escudero, Ramon/0000-0001-5640-6542; Segovia, Jose Carlos/0000-0003-4101-6124; Quintana, Oscar/0000-0002-6869-7006; Fabregat, Isabel/0000-0003-0136-8440; Arza, Elvira/0000-0001-9626-047X; Grueso, Esther/0000-0002-5365-5129	Ministerio de Educacion y Ciencia [SAF2008-1883]; Fondo de Investigaciones Sanitarias [RD06/0010/0015]; PERSIST European project	Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); PERSIST European project	This work was funded by grants from the Ministerio de Educacion y Ciencia (SAF2008-1883), Fondo de Investigaciones Sanitarias (RD06/0010/0015) and the PERSIST European project. The authors also thank the Fundacion Botin for promoting translational research at the Hematopoiesis and Gene Therapy Division-CIEMAT/IBERER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Anzai H, 2003, MECH DEVELOP, V120, P791, DOI 10.1016/S0925-4773(03)00071-6; Armstrong L, 2006, STEM CELLS, V24, P805, DOI 10.1634/stemcells.2005-0350; Belmonte JCI, 2009, NAT REV GENET, V10, P878, DOI 10.1038/nrg2700; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; DARZYNKIEWICZ Z, 1988, ANAL QUANT CYTOL, V10, P462; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Fujii T, 2010, J BIOL CHEM, V285, P30214, DOI 10.1074/jbc.M110.104513; Fujino H, 2007, FASEB J, V21, P3499, DOI 10.1096/fj.06-6109com; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Han J, 2008, CURR STEM CELL RES T, V3, P66; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaenisch R, 2005, NOVART FDN SYMP, V265, P118; Jaenisch Rudolf, 2005, V265, P107; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Keller R, 2002, IMMUNOL LETT, V83, P1, DOI 10.1016/S0165-2478(02)00065-2; Khurana S, 2010, J BIOL CHEM, V285, P4725, DOI 10.1074/jbc.M109.058198; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Mascetti G, 2001, CYTOMETRY, V44, P113, DOI 10.1002/1097-0320(20010601)44:2<113::AID-CYTO1089>3.0.CO;2-A; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Pomerantz JH, 2009, J CELL SCI, V122, P1045, DOI 10.1242/jcs.041376; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Prosser CC, 2006, WORLD J GASTROENTERO, V12, P509, DOI 10.3748/wjg.v12.i4.509; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Quintana-Bustamante O, 2006, HEPATOLOGY, V43, P108, DOI 10.1002/hep.21005; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Richard JP, 2011, DEVELOPMENT, V138, P1483, DOI 10.1242/dev.063115; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Stanworth SJ, 2001, CLIN MED, V1, P378, DOI 10.7861/clinmedicine.1-5-378; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Terranova R, 2006, J CELL SCI, V119, P2065, DOI 10.1242/jcs.02945; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Ueda T, 2007, GENES CELLS, V12, P581, DOI 10.1111/j.1365-2443.2007.01080.x; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104; Zhou P, 2009, HEPATOLOGY, V49, P1992, DOI 10.1002/hep.22862	63	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33945	10.1371/journal.pone.0033945	http://dx.doi.org/10.1371/journal.pone.0033945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457803	Green Published, gold			2022-12-27	WOS:000304046900034
J	Berhane, Y; Kehler, H; Handel, K; Hisanaga, T; Xu, WH; Ojkic, D; Pasick, J				Berhane, Yohannes; Kehler, Helen; Handel, Katherine; Hisanaga, Tamiko; Xu, Wanhong; Ojkic, Davor; Pasick, John			Molecular and Antigenic Characterization of Reassortant H3N2 Viruses from Turkeys with a Unique Constellation of Pandemic H1N1 Internal Genes	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; RECEPTOR-BINDING SPECIFICITY; N-LINKED GLYCOSYLATION; AMINO-ACID CHANGE; HEMAGGLUTININ; SWINE; EVOLUTION; RECOGNITION; EMERGENCE; VACCINE	Triple reassortant (TR) H3N2 influenza viruses cause varying degrees of loss in egg production in breeder turkeys. In this study we characterized TR H3N2 viruses isolated from three breeder turkey farms diagnosed with a drop in egg production. The eight gene segments of the virus isolated from the first case submission (FAV-003) were all of TR H3N2 lineage. However, viruses from the two subsequent case submissions (FAV-009 and FAV-010) were unique reassortants with PB2, PA, nucleoprotein (NP) and matrix (M) gene segments from 2009 pandemic H1N1 and the remaining gene segments from TR H3N2. Phylogenetic analysis of the HA and NA genes placed the 3 virus isolates in 2 separate clades within cluster IV of TR H3N2 viruses. Birds from the latter two affected farms had been vaccinated with a H3N4 oil emulsion vaccine prior to the outbreak. The HAl subunit of the H3N4 vaccine strain had only a predicted amino acid identity of 79% with the isolate from FAV-003 and 80% for the isolates from FAV-009 and FAV-0010. By comparison, the predicted amino acid sequence identity between a prototype TR H3N2 cluster IV virus A/Sw/ON/33853/2005 and the three turkey isolates from this study was 95% while the identity between FAV-003 and FAV-009/10 isolates was 91%. When the previously identified antigenic sites A, B, C, D and E of HA1 were examined, isolates from FAV-003 and FAV-009/10 had a total of 19 and 16 amino acid substitutions respectively when compared with the H3N4 vaccine strain. These changes corresponded with the failure of the sera collected from turkeys that received this vaccine to neutralize any of the above three isolates in vitro.	[Berhane, Yohannes; Kehler, Helen; Handel, Katherine; Hisanaga, Tamiko; Xu, Wanhong; Pasick, John] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Ojkic, Davor] Univ Guelph, Hlth Anim Lab, Guelph, ON N1G 2W1, Canada	Canadian Food Inspection Agency; University of Guelph	Berhane, Y (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	john.pasick@inspection.gc.ca			Canadian Food Inspection Agency (CFIA); Poultry Industry Council of Canada	Canadian Food Inspection Agency (CFIA); Poultry Industry Council of Canada	This project was funded by the Canadian Food Inspection Agency (CFIA) and by the Poultry Industry Council of Canada (http://www.poultryindustrycouncil.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhane Y, 2010, AVIAN DIS, V54, P1275, DOI 10.1637/9422-061410-Reg.1; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Howden KJ, 2009, CAN VET J, V50, P1153; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; Kapczynski DR, 2009, AVIAN DIS, V53, P7, DOI 10.1637/8199-122707-Reg.1; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Long JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020130; Mathieu C, 2010, EMERG INFECT DIS, V16, P709, DOI 10.3201/eid1604.091402; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Memoli MJ, 2009, J INFECT DIS, V200, P1232, DOI 10.1086/605893; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; Nakajima K, 2003, J VIROL, V77, P10088, DOI 10.1128/JVI.77.18.10088-10098.2003; Nfon C, 2011, TRANSBOUND EMERG DIS, V58, P394, DOI 10.1111/j.1865-1682.2011.01219.x; Nobusawa E, 2000, VIROLOGY, V278, P587, DOI 10.1006/viro.2000.0679; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132, DOI 10.3201/eid1207.060268; Pillai SPS, 2009, VACCINE, V27, P819, DOI 10.1016/j.vaccine.2008.11.076; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Shil P, 2011, BIOINFORMATION, V6, P266, DOI 10.6026/97320630006266; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Tang Y, 2005, AVIAN DIS, V49, P207, DOI 10.1637/7288-101304R; Tremblay D, 2011, J CLIN MICROBIOL, V49, P4386, DOI 10.1128/JCM.05676-11; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Vincent AL, 2006, VET MICROBIOL, V118, P212, DOI 10.1016/j.vetmic.2006.07.017; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weingartl HM, 2010, J VIROL, V84, P2245, DOI 10.1128/JVI.02118-09; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Yassine HM, 2008, VACCINE, V26, P966, DOI 10.1016/j.vaccine.2007.11.094; Yassine HM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-258; Young K, 2004, EMERG INFECT DIS, V10, P2156; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e32858	10.1371/journal.pone.0032858	http://dx.doi.org/10.1371/journal.pone.0032858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470427	Green Submitted, gold, Green Published			2022-12-27	WOS:000303857100006
J	Witton, MP				Witton, Mark P.			New Insights into the Skull of Istiodactylus latidens (Ornithocheiroidea, Pterodactyloidea)	PLOS ONE			English	Article							ISLE-OF-WIGHT; PTEROSAUR; VERTEBRATES	The skull of the Cretaceous pterosaur Istiodactylus latidens, a historically important species best known for its broad muzzle of interlocking, lancet-shaped teeth, is almost completely known from the broken remains of several individuals, but the length of its jaws remains elusive. Estimates of I. latidens jaw length have been exclusively based on the incomplete skull of NHMUK R3877 and, perhaps erroneously, reconstructed by assuming continuation of its broken skull pieces as preserved in situ. Here, an overlooked jaw fragment of NHMUK R3877 is redescribed and used to revise the skull reconstruction of I. latidens. The new reconstruction suggests a much shorter skull than previously supposed, along with a relatively tall orbital region and proportionally slender maxilla, a feature documented in the early 20th century but ignored by all skull reconstructions of this species. These features indicate that the skull of I. latidens is particularly distinctive amongst istiodactylids and suggests greater disparity between I. latidens and I. sinensis than previously appreciated. A cladistic analysis of istiodactylid pterosaurs incorporating new predicted I. latidens skull metrics suggests Istiodactylidae is constrained to five species (Liaoxipterus brachyognathus, Lonchengpterus zhoai, Nurhachius ignaciobritoi, Istiodactylus latidens and Istiodactylus sinensis) defined by their distinctive dentition, but excludes the putative istiodactylids Haopterus gracilis and Hongshanopterus lacustris. Istiodactylus latidens, I. sinensis and Li. brachyognathus form an unresolved clade of derived istiodactylids, and the similarity of comparable remains of I. sinensis and Li. brachyognathus suggest further work into their taxonomy and classification is required. The new skull model of I. latidens agrees with the scavenging habits proposed for these pterosaurs, with much of their cranial anatomy converging on that of habitually scavenging birds.	Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England	University of Portsmouth	Witton, MP (corresponding author), Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England.	mark.witton@port.ac.uk	Witton, Mark/B-9368-2013					Andres B, 2006, J VERTEBR PALEONTOL, V26, P70, DOI 10.1671/0272-4634(2006)26[70:ANSOIP]2.0.CO;2; Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Arbour VM, 2011, CAN J EARTH SCI, V48, P63, DOI 10.1139/E10-083; Arthaber G. von, 1922, Palaeontologische Zeitschrift Berlin, V4, P1; Bennett S. Christopher, 2003, Geological Society Special Publication, V217, P191, DOI 10.1144/GSL.SP.2003.217.01.12; Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; Chiappe Luis M., 2000, Contributions in Science (Los Angeles), V483, P1; Dalla Vecchia FM, 2009, RIV ITAL PALEONTOL S, V115, P159, DOI 10.13130/2039-4942/6377; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dong ZM, 2005, ACTA GEOL SIN-ENGL, V79, P164; FASTNACHT M, 2005, THESIS J GUTENBERG U; Fisher Harvey I., 1944, CONDOR, V46, P272, DOI 10.2307/1364013; FITE KV, 1975, BRAIN BEHAV EVOLUT, V12, P97, DOI 10.1159/000124142; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Habib M., 2010, ACTA GEOSCI SIN, V31, P24; Hertel F, 1995, AUK, V112, P890, DOI 10.2307/4089021; Hooley R. W., 1913, Quarterly Journal of the Geological Society of London, V69; Houston D.C., 1979, SERENGETI DYNAMICS E, P263; HOWSE SCB, 1993, PALAEONTOLOGY, V36, P425; Howse Stafford C.B., 2001, Palaeontological Association Field Guides to Fossils, V10, P324; Jones MP, 2007, J EXOT PET MED, V16, P69, DOI 10.1053/j.jepm.2007.03.012; Kaup J, 1834, ISIS, V3, P311; Lu J., 2006, PTEROSAURS CHINA; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Lue Junchang, 2008, Zitteliana Reihe B, V28, P229; Maddison WP, 2011, MESQUITE MODULAR SYS; Osi A, 2005, ACTA PALAEONTOL POL, V50, P777; Osi A, 2011, LETHAIA, V44, P136, DOI 10.1111/j.1502-3931.2010.00230.x; Plieninger F, 1901, PALAEONTOGRAPHICA, V48, P65; Sanchez-Hernandez B, 2007, PALAEOGEOGR PALAEOCL, V249, P180, DOI 10.1016/j.palaeo.2007.01.009; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Schumacher G. H., 1973, P101; Seeley H. G., 1901, DRAGONS AIR; Seeley HG, 1891, J NATURAL HIST SERIE, V6, P237; Seeley HG, 1891, J NATURAL HIST SERIE, V6, p[39, 237]; Sweetman SC, 2010, J IBER GEOL, V36, P225, DOI 10.5209/rev_JIGE.2010.v36.n2.9; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P189; Veldmeijer AJ, 2006, PREDATION ORGANISMS, P295; Wang Li, 2006, Dizhi Tongbao, V25, P737; Wang XL, 2006, GEOL J, V41, P405, DOI 10.1002/gj.1046; Wang XL, 2008, ZOOTAXA, P1; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Wang XL, 2001, CHINESE SCI BULL, V46, P1112; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143; Witton MP, 2008, PALAEONTOLOGY, V51, P1289, DOI 10.1111/j.1475-4983.2008.00811.x	50	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33170	10.1371/journal.pone.0033170	http://dx.doi.org/10.1371/journal.pone.0033170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470442	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100019
J	He, M; Kershaw, MJ; Soanes, DM; Xia, YX; Talbot, NJ				He, Min; Kershaw, Michael J.; Soanes, Darren M.; Xia, Yuxian; Talbot, Nicholas J.			Infection-Associated Nuclear Degeneration in the Rice Blast Fungus Magnaporthe oryzae Requires Non-Selective Macro-Autophagy	PLOS ONE			English	Article							ARMADILLO REPEAT PROTEIN; ACID ELONGATING SYSTEM; SACCHAROMYCES-CEREVISIAE; VACUOLE JUNCTIONS; PIECEMEAL MICROAUTOPHAGY; PLANT INFECTION; APPRESSORIUM TURGOR; SIGNALING PATHWAYS; YEAST VACUOLE; MEMBRANE	Background: The rice blast fungus Magnaporthe oryzae elaborates a specialized infection structure called an appressorium to breach the rice leaf surface and gain access to plant tissue. Appressorium development is controlled by cell cycle progression, and a single round of nuclear division occurs prior to appressorium formation. Mitosis is always followed by programmed cell death of the spore from which the appressorium develops. Nuclear degeneration in the spore is known to be essential for plant infection, but the precise mechanism by which it occurs is not known. Methodology/Principal Findings: In yeast, nuclear breakdown requires a specific form of autophagy, known as piecemeal microautophagy of the nucleus (PMN), and we therefore investigated whether this process occurs in the rice blast fungus. Here, we report that M. oryzae possesses two conserved components of a putative PMN pathway, MoVac8 and MoTsc13, but that both are dispensable for nuclear breakdown during plant infection. MoVAC8 encodes a vacuolar membrane protein and MoTSC13 a peri-nuclear and peripheral ER protein. Conclusions/Significance: We show that MoVAC8 is necessary for caffeine resistance, but dispensable for pathogenicity of M. oryzae, while MoTSC13 is involved in cell wall stress responses and is an important virulence determinant. By functional analysis of DMoatg1 and DMoatg4 mutants, we demonstrate that infection-associated nuclear degeneration in M. oryzae instead occurs by non-selective macroautophagy, which is necessary for rice blast disease.	[He, Min; Kershaw, Michael J.; Soanes, Darren M.; Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter, Devon, England; [He, Min; Xia, Yuxian] Chongqing Univ, Coll Bioengn, Genet Engn Res Ctr, Chongqing 630044, Peoples R China	University of Exeter; Chongqing University	He, M (corresponding author), Univ Exeter, Sch Biosci, Exeter, Devon, England.	N.J.Talbot@exeter.ac.uk	Talbot, Nicholas J/I-5618-2019; Talbot, Nicholas J/I-9584-2014	Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757	Biotechnology and Biological Sciences Research Council [BB/G013896/1]; China Scholarship Council [2009605071]; Biotechnology and Biological Sciences Research Council [BB/E022677/1] Funding Source: researchfish; BBSRC [BB/E022677/1, BB/G013896/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BB/G013896/1) and a studentship to MH from the China Scholarship Council (No. 2009605071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barelle CJ, 2006, EUKARYOT CELL, V5, P359, DOI 10.1128/EC.5.2.359-367.2006; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Dawaliby R, 2010, MOL BIOL CELL, V21, P4173, DOI 10.1091/mbc.E09-09-0782; Dean RA, 1997, ANNU REV PHYTOPATHOL, V35, P211, DOI 10.1146/annurev.phyto.35.1.211; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Fleckenstein D, 1998, J CELL SCI, V111, P3109; Fry MR, 2006, AUTOPHAGY, V2, P280, DOI 10.4161/auto.3164; Gable K, 2004, J EXP BOT, V55, P543, DOI 10.1093/jxb/erh061; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Kershaw MJ, 1998, EMBO J, V17, P3838, DOI 10.1093/emboj/17.14.3838; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Kvam E, 2006, BIOCHEM SOC T, V34, P340, DOI 10.1042/BST0340340; Kvam E, 2005, MOL BIOL CELL, V16, P3987, DOI 10.1091/mbc.e05-04-0290; Kvam E, 2004, J CELL SCI, V117, P4959, DOI 10.1242/jcs.01372; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; LEUNG H, 1988, ADV PLANT PATHOL, V6, P175; Liu TB, 2010, AUTOPHAGY, V6, P74, DOI 10.4161/auto.6.1.10438; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Lu JP, 2009, CURR GENET, V55, P461, DOI 10.1007/s00294-009-0259-5; Oku M, 2006, AUTOPHAGY, V2, P272, DOI 10.4161/auto.3135; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Pan XZ, 1998, J CELL SCI, V111, P2137; Paul S, 2007, J BIOL CHEM, V282, P19237, DOI 10.1074/jbc.M701774200; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Peng YT, 2006, TRAFFIC, V7, P1378, DOI 10.1111/j.1600-0854.2006.00472.x; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 1993, BIOCHIM BIOPHYS ACTA, V1155, P307, DOI 10.1016/0304-419X(93)90012-2; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Sambrook J., 2002, MOL CLONING LAB MANU; Saunders DGO, 2010, PLANT CELL, V22, P497, DOI 10.1105/tpc.109.072447; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shoji JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015650; Song WQ, 2009, J EXP BOT, V60, P1839, DOI 10.1093/jxb/erp057; Subramanian K, 2006, J CELL SCI, V119, P2477, DOI 10.1242/jcs.02972; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tang FS, 2006, TRAFFIC, V7, P1368, DOI 10.1111/j.1600-0854.2006.00458.x; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Veses V, 2009, MOL MICROBIOL, V71, P505, DOI 10.1111/j.1365-2958.2008.06545.x; Wang YX, 1996, MOL BIOL CELL, V7, P1375, DOI 10.1091/mbc.7.9.1375; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237	53	29	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33270	10.1371/journal.pone.0033270	http://dx.doi.org/10.1371/journal.pone.0033270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448240	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700030
J	Oreja-Guevara, C; Noval, S; Alvarez-Linera, J; Gabaldon, L; Manzano, B; Chamorro, B; Diez-Tejedor, E				Oreja-Guevara, Celia; Noval, Susana; Alvarez-Linera, Juan; Gabaldon, Laura; Manzano, Beatriz; Chamorro, Beatriz; Diez-Tejedor, Exuperio			Clinically Isolated Syndromes Suggestive of Multiple Sclerosis: An Optical Coherence Tomography Study	PLOS ONE			English	Article							NERVE-FIBER LAYER; FOLLOW-UP; DIAGNOSTIC-CRITERIA; AXONAL LOSS; PROGNOSTIC VALUE; MRI; NEURITIS; THICKNESS; DISABILITY; SPECTROSCOPY	Background: Optical coherence tomography (OCT) is a simple, high-resolution technique to quantify the thickness of retinal nerve fiber layer (RNFL), which provides an indirect measurement of axonal damage in multiple sclerosis (MS). This study aimed to evaluate RNFL thickness in patients at presentation with clinically isolated syndromes (CIS) suggestive of MS. Methodology: This was a cross-sectional study. Twenty-four patients with CIS suggestive of MS (8 optic neuritis [ON], 6 spinal cord syndromes, 5 brainstem symptoms and 5 with sensory and other syndromes) were prospectively studied. The main outcome evaluated was RNFL thickness at CIS onset. Secondary objectives were to study the relationship between RNFL thickness and MRI criteria for disease dissemination in space (DIS) as well as the presence of oligoclonal bands in the cerebrospinal fluid. Principal Findings: Thirteen patients had decreased RNFL thickness in at least one quadrant. Mean RNFL thickness was 101.67 +/- 10.72 mm in retrobulbar ON eyes and 96.93 +/- 10.54 in unaffected eyes. Three of the 6 patients with myelitis had at least one abnormal quadrant in one of the two eyes. Eight CIS patients fulfilled DIS MRI criteria. The presence of at least one quadrant of an optic nerve with a RNFL thickness at a P<5% cut-off value had a sensitivity of 75% and a specificity of 56% for predicting DIS MRI. Conclusions: The findings from this study show that axonal damage measured by OCT is present in any type of CIS; even in myelitis forms, not only in ON as seen up to now. OCT can detect axonal damage in very early stages of disease and seems to have high sensitivity and moderate specificity for predicting DIS MRI. Studies with prospective long-term follow-up would be needed to establish the prognostic value of baseline OCT findings.	[Oreja-Guevara, Celia; Chamorro, Beatriz; Diez-Tejedor, Exuperio] Univ Hosp La Paz, Neuroimmunol & Multiple Sclerosis Unit, Dept Neurol, Idipaz Hlth Res Inst, Madrid, Spain; [Noval, Susana; Manzano, Beatriz] Univ Hosp La Paz, Neuroophthalmol Unit, Dept Ophthalmol, Idipaz Hlth Res Inst, Madrid, Spain; [Alvarez-Linera, Juan] Hosp Ruber Int, Dept Radiol, Madrid, Spain; [Gabaldon, Laura] Hosp Denia, Dept Neurol, Alicante, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz	Oreja-Guevara, C (corresponding author), Univ Hosp La Paz, Neuroimmunol & Multiple Sclerosis Unit, Dept Neurol, Idipaz Hlth Res Inst, Madrid, Spain.	orejacbn@gmail.com	Oreja-Guevara, Celia/N-5151-2019	Oreja-Guevara, Celia/0000-0002-9221-5716; Noval, Susana/0000-0003-4108-2383; Diez Tejedor, Exuperio/0000-0003-2295-1707				Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Brex PA, 2001, J NEUROL NEUROSUR PS, V70, P390, DOI 10.1136/jnnp.70.3.390; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Chen HY, 2005, J FORMOS MED ASSOC, V104, P927; Cole SR, 1998, NEUROLOGY, V51, P885, DOI 10.1212/WNL.51.3.885; Contreras I, 2007, OPHTHALMOLOGY, V114, P2338, DOI 10.1016/j.ophtha.2007.05.042; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Druschky A, 1999, CLIN NEUROL NEUROSUR, V101, P189, DOI 10.1016/S0303-8467(99)00045-1; Filippi M, 2003, BRAIN, V126, P433, DOI 10.1093/brain/awg038; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Gundogan FC, 2007, INVEST OPHTH VIS SCI, V48, P5773, DOI 10.1167/iovs.07-0834; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Jacobi C, 2008, EUR J NEUROL, V15, P1359, DOI 10.1111/j.1468-1331.2008.02315.x; Jin YP, 2003, MULT SCLER, V9, P135, DOI 10.1191/1352458503ms895oa; Ignacio RJ, 2010, J NEUROL, V257, P1188, DOI 10.1007/s00415-010-5490-y; KELTNER JL, 1993, ARCH OPHTHALMOL-CHIC, V111, P231, DOI 10.1001/archopht.1993.01090020085029; Kim JS, 2009, BRIT J OPHTHALMOL, V93, P1057, DOI 10.1136/bjo.2009.157875; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Masjuan J, 2006, NEUROLOGY, V66, P576, DOI 10.1212/01.wnl.0000198253.35119.83; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Minneboo A, 2004, ARCH NEUROL-CHICAGO, V61, P217, DOI 10.1001/archneur.61.2.217; Noval S, 2007, OPHTHALMOLOGY, V114, P200, DOI 10.1016/j.ophtha.2006.10.003; Noval S, 2006, ACTA OPHTHALMOL SCAN, V84, P790, DOI 10.1111/j.1600-0420.2006.00724.x; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; Outteryck O, 2009, ARCH NEUROL-CHICAGO, V66, P1373, DOI 10.1001/archneurol.2009.265; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Pro MJ, 2006, J NEUROL SCI, V250, P114, DOI 10.1016/j.jns.2006.08.012; Pueyo V, 2008, MULT SCLER J, V14, P609, DOI 10.1177/1352458507087326; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Rocca MA, 2003, NEUROIMAGE, V18, P847, DOI 10.1016/S1053-8119(03)00043-0; Savini G, 2006, ARCH OPHTHALMOL-CHIC, V124, P1111, DOI 10.1001/archopht.124.8.1111; SMITH CH, 2005, WALSH HOYTS CLIN NEU, P293; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Tintore M, 2006, NEUROLOGY, V67, P968, DOI 10.1212/01.wnl.0000237354.10144.ec; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trip SA, 2006, NEUROIMAGE, V31, P286, DOI 10.1016/j.neuroimage.2005.11.051; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Wattjes MP, 2008, NEURORADIOLOGY, V50, P123, DOI 10.1007/s00234-007-0325-y; Wattjes MP, 2008, J NEUROL, V255, P56, DOI 10.1007/s00415-007-0666-9	41	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33907	10.1371/journal.pone.0033907	http://dx.doi.org/10.1371/journal.pone.0033907			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448279	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700070
J	Philipp, EER; Kraemer, L; Melzner, F; Poustka, AJ; Thieme, S; Findeisen, U; Schreiber, S; Rosenstiel, P				Philipp, Eva E. R.; Kraemer, Lars; Melzner, Frank; Poustka, Albert J.; Thieme, Sebastian; Findeisen, Ulrike; Schreiber, Stefan; Rosenstiel, Philip			Massively Parallel RNA Sequencing Identifies a Complex Immune Gene Repertoire in the lophotrochozoan Mytilus edulis	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEINS; MIGRATION INHIBITORY FACTOR; TNF-ALPHA FACTOR; BETA-1,3-GLUCAN BINDING-PROTEIN; SCALLOP ARGOPECTEN-IRRADIANS; PURPLE SEA-URCHIN; NF-KAPPA-B; MOLECULAR-CLONING; PACIFIC OYSTER; ZHIKONG SCALLOP	The marine mussel Mytilus edulis and its closely related sister species are distributed world-wide and play an important role in coastal ecology and economy. The diversification in different species and their hybrids, broad ecological distribution, as well as the filter feeding mode of life has made this genus an attractive model to investigate physiological and molecular adaptations and responses to various biotic and abiotic environmental factors. In the present study we investigated the immune system of Mytilus, which may contribute to the ecological plasticity of this species. We generated a large Mytilus transcriptome database from different tissues of immune challenged and stress treated individuals from the Baltic Sea using 454 pyrosequencing. Phylogenetic comparison of orthologous groups of 23 species demonstrated the basal position of lophotrochozoans within protostomes. The investigation of immune related transcripts revealed a complex repertoire of innate recognition receptors and downstream pathway members including transcripts for 27 toll-like receptors and 524 C1q domain containing transcripts. NOD-like receptors on the other hand were absent. We also found evidence for sophisticated TNF, autophagy and apoptosis systems as well as for cytokines. Gill tissue and hemocytes showed highest expression of putative immune related contigs and are promising tissues for further functional studies. Our results partly contrast with findings of a less complex immune repertoire in ecdysozoan and other lophotrochozoan protostomes. We show that bivalves are interesting candidates to investigate the evolution of the immune system from basal metazoans to deuterostomes and protostomes and provide a basis for future molecular work directed to immune system functioning in Mytilus.	[Philipp, Eva E. R.; Kraemer, Lars; Findeisen, Ulrike; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Melzner, Frank] Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Poustka, Albert J.; Thieme, Sebastian] Max Planck Inst Mol Genet, Evolut & Dev Grp, D-14195 Berlin, Germany	University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Max Planck Society	Philipp, EER (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	e.philipp@ikmb.uni-kiel.de	Melzner, Frank/X-4339-2018; Kraemer, Lars/B-9289-2017; Rosenstiel, Philip/A-5137-2009	Melzner, Frank/0000-0002-5884-1318; Kraemer, Lars/0000-0002-0586-8357; Rosenstiel, Philip/0000-0002-9692-8828	German Research Foundation; Max-Planck Gesellschaft zur Foerderung der Wissenschaft	German Research Foundation(German Research Foundation (DFG)); Max-Planck Gesellschaft zur Foerderung der Wissenschaft	This research was supported by the German Research Foundation cluster of Excellence "The Future Ocean" and "Inflammation at Interfaces". AP and ST were supported by the Max-Planck Gesellschaft zur Foerderung der Wissenschaft". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Belinda LWC, 2008, MOL IMMUNOL, V45, P1732, DOI 10.1016/j.molimm.2007.09.030; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bolcato-Bellemin AL, 2004, J ENDOTOXIN RES, V10, P15, DOI 10.1179/096805104225003780; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Canesi L, 2006, ISJ-INVERT SURVIV J, V3, P40; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; Cao XT, 2009, NAT IMMUNOL, V10, P1049, DOI 10.1038/ni1009-1049; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Castillo MG, 2009, DEV COMP IMMUNOL, V33, P69, DOI 10.1016/j.dci.2008.07.013; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clow LA, 2004, J EXP BIOL, V207, P2147, DOI 10.1242/jeb.01001; Collette Y, 2003, TRENDS IMMUNOL, V24, P387, DOI 10.1016/S1471-4906(03)00166-2; Costa MM, 2009, DEV COMP IMMUNOL, V33, P162, DOI 10.1016/j.dci.2008.08.005; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; De Zoysa M, 2010, FISH SHELLFISH IMMUN, V28, P754, DOI 10.1016/j.fsi.2010.01.024; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V26, P625, DOI 10.1016/j.fsi.2008.10.004; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V26, P500, DOI 10.1016/j.fsi.2009.02.006; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Dishaw JL, 2010, IMMUNOGENETICS, V57, P535; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gerdol M, 2011, DEV COMP IMMUNOL, V35, P635, DOI 10.1016/j.dci.2011.01.018; Gestal C, 2010, DEV COMP IMMUNOL, V34, P926, DOI 10.1016/j.dci.2010.02.012; Goetz FW, 2004, DEV COMP IMMUNOL, V28, P487, DOI 10.1016/j.dci.2003.09.008; Goto A, 2010, J BIOL CHEM, V285, P15731, DOI 10.1074/jbc.M109.082115; Hale CM, 2009, BMC GENOMICS; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hetru C, 2009, COLD SPRING HARB PER, DOI 101101/cshperspecta000232; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Hong YH, 2006, DEV COMP IMMUNOL, V30, P919, DOI 10.1016/j.dci.2005.12.007; Huan P, 2010, GENET MOL BIOL, V33, P36, DOI 10.1590/S1415-47572010005000015; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Itoh N, 2008, COMP BIOCHEM PHYS B, V150, P409, DOI 10.1016/j.cbpb.2008.04.011; Itoh N, 2010, DEV COMP IMMUNOL, V34, P445, DOI 10.1016/j.dci.2009.12.003; Itoh N, 2009, MOL IMMUNOL, V46, P1768, DOI 10.1016/j.molimm.2009.01.022; Jayaraj SS, 2008, FISH SHELLFISH IMMUN, V24, P715, DOI 10.1016/j.fsi.2007.11.012; Otero-Gonzalez AJ, 2010, FASEB J, V24, P1320, DOI 10.1096/fj.09-143388; Jiang YS, 2007, DEV COMP IMMUNOL, V31, P121, DOI 10.1016/j.dci.2006.05.014; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Lange C, 2011, MOL BIOL EVOL, V28, P1687, DOI 10.1093/molbev/msq349; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li FM, 2011, DEV COMP IMMUNOL, V35, P62, DOI 10.1016/j.dci.2010.08.009; Liu HP, 2011, DEV COMP IMMUNOL, V35, P51, DOI 10.1016/j.dci.2010.08.005; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Malagoli D, 2010, ISJ-INVERT SURVIV J, V7, P146; Mateo DR, 2010, DEV COMP IMMUNOL, V34, P710, DOI 10.1016/j.dci.2010.02.006; McFall-Ngai MJ, 1999, ANNU REV ECOL SYST, V30, P235; Mei J, 2008, J GENET GENOMICS, V35, P17, DOI 10.1016/S1673-8527(08)60003-X; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; Mogilenko DA, 2010, MOL BIOL+, V44, P67, DOI 10.1134/S0026893310010097; Montagnani C, 2004, FEBS LETT, V561, P75, DOI 10.1016/S0014-5793(04)00124-3; Moore MN, 2007, AQUAT TOXICOL, V84, P80, DOI 10.1016/j.aquatox.2007.06.007; Multerer KA, 2004, IMMUNOGENETICS, V56, P89, DOI 10.1007/s00251-004-0665-2; Mushegian A, 2001, J CELL BIOL, V155, P705, DOI 10.1083/jcb.200107040; Nehyba J, 2009, MOL BIOL EVOL, V26, P2539, DOI 10.1093/molbev/msp167; Ni DJ, 2007, DEV COMP IMMUNOL, V31, P548, DOI 10.1016/j.dci.2006.09.001; Nonaka M, 2011, ISJ-INVERT SURVIV J, V8, P21; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Oeckinghaus A., 2009, COLD SPRING HARB PER; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pallavicini A, 2008, DEV COMP IMMUNOL, V32, P213, DOI 10.1016/j.dci.2007.05.008; Park EM, 2008, FISH SHELLFISH IMMUN, V24, P11, DOI 10.1016/j.fsi.2007.07.003; Philipp EER, BIOINFORMATICS; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P305, DOI 10.1016/j.fsi.2008.11.015; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P72, DOI 10.1016/j.fsi.2008.03.002; Qiu LM, 2007, FISH SHELLFISH IMMUN, V22, P451, DOI 10.1016/j.fsi.2006.05.003; Raible F, 2004, CURR BIOL, V14, pR106, DOI 10.1016/j.cub.2004.01.015; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Roberts S, 2008, DEV COMP IMMUNOL, V32, P1099, DOI 10.1016/j.dci.2008.02.006; Robertson AJ, 2006, DEV BIOL, V300, P321, DOI 10.1016/j.ydbio.2006.08.053; Romero A, 2011, DEV COMP IMMUNOL, V35, P334, DOI 10.1016/j.dci.2010.10.007; Rosenstiel P, 2008, CELL MOL LIFE SCI, V65, P1361, DOI 10.1007/s00018-008-7502-y; Rosenstiel P, 2009, J INNATE IMMUN, V1, P291, DOI 10.1159/000211193; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Su JG, 2004, AQUACULTURE, V239, P69, DOI 10.1016/j.aquaculture.2004.03.012; Su JG, 2007, FISH SHELLFISH IMMUN, V23, P646, DOI 10.1016/j.fsi.2007.01.023; Sullivan JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007311; Takeuchi O, 2008, NAT IMMUNOL, V9, P1327, DOI 10.1038/ni1208-1327; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Venier P, 2003, GENE, V314, P29, DOI 10.1016/S0378-1119(03)00708-X; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Wanamaker AD, 2008, RADIOCARBON, V50, P399, DOI 10.1017/S0033822200053510; Wang BZ, 2009, FISH SHELLFISH IMMUN, V27, P57, DOI 10.1016/j.fsi.2009.04.004; Yu YD, 2007, FISH SHELLFISH IMMUN, V23, P419, DOI 10.1016/j.fsi.2006.12.004; Yuan SC, 2010, J IMMUNOL, V184, P6874, DOI 10.4049/jimmunol.0903675; Zhang DC, 2009, FISH SHELLFISH IMMUN, V27, P391, DOI 10.1016/j.fsi.2009.04.006; Zhang LL, 2011, FISH SHELLFISH IMMUN, V30, P653, DOI 10.1016/j.fsi.2010.12.023; Zhang Q, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r123; Zhao JM, 2007, MOL IMMUNOL, V44, P360, DOI 10.1016/j.molimm.2006.02.025; Zhao JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013480; Zheng LP, 2011, DEV COMP IMMUNOL, V35, P35, DOI 10.1016/j.dci.2010.08.002; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	121	117	121	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33091	10.1371/journal.pone.0033091	http://dx.doi.org/10.1371/journal.pone.0033091			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448234	Green Published, gold, Green Accepted			2022-12-27	WOS:000303855700024
J	Yin, GF; Gao, LB; Shu, XH; Yang, GS; Guo, SH; Li, WG				Yin, Gefen; Gao, Libo; Shu, Xianghua; Yang, Guishu; Guo, Shuhao; Li, Wengui			Genetic Diversity of the ORF5 Gene of Porcine Reproductive and Respiratory Syndrome Virus Isolates in Southwest China from 2007 to 2009	PLOS ONE			English	Article							LIVE PRRS VACCINE; NORTH-AMERICAN; GP5; PROTEINS; EVOLUTION; STRAINS; GENOME; PIGS	To gain insight into the molecular epidemiology and possible mechanisms of genetic variation of porcine reproductive and respiratory syndrome (PRRS) in Yunnan Province of China, the ORF5 gene of 32 PRRSV isolates from clinical samples collected from 2007 to 2009 were sequenced and analyzed. Nucleotide and amino acid analyses were carried out on 32 isolates and representative strains of the North American genotype, European genotype and two representative Chinese isolates. Results revealed that these isolates share 86.9-99.0% nucleotide and 87.5-98.0% amino acid identity with VR-2332 the prototypical North American PRRSV, 61.7-62.9% and 54.3-57.8% with Lelystad virus (LV) the representative strain of European genotype, 91.2-95.4% and 90.0-94.5% with CH-1a that was isolated in mainland China in 1996, 88.1-99.3% and 85.5-99.0% with JX-A1 the representative strain of High pathogenic PRRSV in China, and 86.2-99.8% and 85.5-100.0% between isolated strains of different years, respectively. Phylogenetic analysis revealed that all 32 PRRSV isolates belonged to the North American genotype and were further divided into two different subgenotypes. Subgenotype 1 comprised twenty two Yunnan isolates which divided into two branches. Subgenotype 2 comprised ten isolates which closely related to the RespPRRS vaccine and its parent strain VR-2332. The functional domains of GP5 such as the signal peptide, ectodomain, transmembrane regions and endodomain were identified and some motifs in GP5 with known functions, such as primary neutralizing epitope (PNE) and decoy epitope were also further analyzed. Our study shown the great genetic diversity of PRRSV in southwest China, rendering the guide for control and prevention of this disease.	[Yin, Gefen; Gao, Libo; Shu, Xianghua; Yang, Guishu; Guo, Shuhao; Li, Wengui] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Peoples R China	Yunnan Agricultural University	Li, WG (corresponding author), Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Peoples R China.	wenguili@yeah.net			National Natural Science Foundation of China [30860205, 31160509]; Yunnan Provincial Program for Introducing High-level Scientists [2009CI125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Program for Introducing High-level Scientists	This work was supported by the National Natural Science Foundation of China (Grant No. 30860205, 31160509) and Yunnan Provincial Program for Introducing High-level Scientists (Grant No. 2009CI125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TQ, 2007, VET MICROBIOL, V123, P43, DOI 10.1016/j.vetmic.2007.02.025; An TQ, 2011, EMERG INFECT DIS, V17, P1782, DOI 10.3201/eid1709.110411; Botner A, 1997, VET REC, V141, P497, DOI 10.1136/vr.141.19.497; Chen NH, 2011, J GEN VIROL, V92, P880, DOI 10.1099/vir.0.027995-0; Dea S, 2000, ARCH VIROL, V145, P659, DOI 10.1007/s007050050662; Faaberg KS, 2006, VIRAL IMMUNOL, V19, P294, DOI 10.1089/vim.2006.19.294; Fairbrother JM, 2006, DIS SWINE CHAPTER CO, V9th, P387, DOI [10.1186/s12866-022-02604-z, DOI 10.1186/S12866-022-02604-Z]; Indik S, 2000, J GEN VIROL, V81, P2497, DOI 10.1099/0022-1317-81-10-2497; Jiang P, 2000, J VET DIAGN INVEST, V12, P156, DOI 10.1177/104063870001200211; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Key KF, 2003, J CLIN MICROBIOL, V41, P2433, DOI 10.1128/JCM.41.6.2433-2439.2003; Li L, 2011, J CLIN MICROBIOL, V49, P3175, DOI 10.1128/JCM.00234-11; Lu JQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-172; Mardassi H, 1996, VIROLOGY, V221, P98, DOI 10.1006/viro.1996.0356; Mateu E, 2006, VIRUS RES, V115, P198, DOI 10.1016/j.virusres.2005.09.008; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; Ostrowski M, 2002, J VIROL, V76, P4241, DOI 10.1128/JVI.76.9.4241-4250.2002; PATON DJ, 1991, VET REC, V128, P617, DOI 10.1136/vr.128.26.617; Plagemann PGW, 2004, VET IMMUNOL IMMUNOP, V102, P263, DOI 10.1016/j.vetimm.2004.09.011; Storgaard T, 1999, ARCH VIROL, V144, P2389, DOI 10.1007/s007050050652; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Yang SX, 1998, ARCH VIROL, V143, P601, DOI 10.1007/s007050050316; Zhou L, 2009, VIRUS RES, V145, P97, DOI 10.1016/j.virusres.2009.06.014; Zhou YJ, 2009, VIRUS RES, V144, P136, DOI 10.1016/j.virusres.2009.04.013	26	15	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33756	10.1371/journal.pone.0033756	http://dx.doi.org/10.1371/journal.pone.0033756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448272	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700063
J	Hozumi, S; Hirabayashi, R; Yoshizawa, A; Ogata, M; Ishitani, T; Tsutsumi, M; Kuroiwa, A; Itoh, M; Kikuchi, Y				Hozumi, Shunya; Hirabayashi, Ryo; Yoshizawa, Akio; Ogata, Mitsuko; Ishitani, Tohru; Tsutsumi, Makiko; Kuroiwa, Atsushi; Itoh, Motoyuki; Kikuchi, Yutaka			DEAD-Box Protein Ddx46 Is Required for the Development of the Digestive Organs and Brain in Zebrafish	PLOS ONE			English	Article							PANCREAS DEVELOPMENT; GENE-EXPRESSION; RNA HELICASES; SPLICEOSOME; BINDING; PRP5; DIFFERENTIATION; MORPHOGENESIS; NEUROGENESIS; ENDOCRINE	Spatially and temporally controlled gene expression, including transcription, several mRNA processing steps, and the export of mature mRNA to the cytoplasm, is essential for developmental processes. It is well known that RNA helicases of the DExD/H-box protein family are involved in these gene expression processes, including transcription, pre-mRNA splicing, and rRNA biogenesis. Although one DExD/H-box protein, Prp5, a homologue of vertebrate Ddx46, has been shown to play important roles in pre-mRNA splicing in yeast, the in vivo function of Ddx46 remains to be fully elucidated in metazoans. In this study, we isolated zebrafish morendo (mor), a mutant that shows developmental defects in the digestive organs and brain, and found that it encodes Ddx46. The Ddx46 transcript is maternally supplied, and as development proceeds in zebrafish larvae, its ubiquitous expression gradually becomes restricted to those organs. The results of whole-mount in situ hybridization showed that the expression of various molecular markers in these organs is considerably reduced in the Ddx46 mutant. Furthermore, splicing status analysis with RT-PCR revealed unspliced forms of mRNAs in the digestive organ and brain tissues of the Ddx46 mutant, suggesting that Ddx46 may be required for pre-mRNA splicing during zebrafish development. Therefore, our results suggest a model in which zebrafish Ddx46 is required for the development of the digestive organs and brain, possibly through the control of pre-mRNA splicing.	[Hozumi, Shunya; Hirabayashi, Ryo; Yoshizawa, Akio; Kikuchi, Yutaka] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Hiroshima, Japan; [Yoshizawa, Akio; Ogata, Mitsuko; Ishitani, Tohru; Tsutsumi, Makiko; Kuroiwa, Atsushi; Itoh, Motoyuki] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Hiroshima University; Nagoya University	Hozumi, S (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Hiroshima, Japan.	yutaka@hiroshima-u.ac.jp	Hozumi, Shunya/Q-8610-2019; , Tohru/AAH-8979-2020; Ishitani, Tohru/E-9781-2014	, Tohru/0000-0002-6200-7043; Kikuchi, Yutaka/0000-0001-5688-7358; Kuroiwa, Atsushi/0000-0001-7710-4041	Mitsubishi foundation; Naito foundation; Novartis foundation; Yamada foundation; MEXT [KAKENHI 16027223]; Japan Society for the Promotion of Science (JSPS) [KAKENHI 15370094, 19570204]; Japan Science Society; Grants-in-Aid for Scientific Research [24710221] Funding Source: KAKEN	Mitsubishi foundation; Naito foundation(Naito Memorial Foundation); Novartis foundation(Novartis); Yamada foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Mitsubishi foundation, Naito foundation, Novartis foundation, Yamada foundation, grants from Grant-in-Aid for Scientific Research from the MEXT (KAKENHI 16027223) and from the JSPS (KAKENHI 15370094 and 19570204) to YK, and Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows and Sasakawa Scientific Research Grant from The Japan Science Society to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Andre M, 2000, INT J DEV BIOL, V44, P249; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Dichmann DS, 2008, DEV DYNAM, V237, P1755, DOI 10.1002/dvdy.21590; diIorio PJ, 2002, DEV BIOL, V244, P75, DOI 10.1006/dbio.2002.0573; Haddon C, 1998, DEVELOPMENT, V125, P359; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Linder B, 2011, HUM MOL GENET, V20, P368, DOI 10.1093/hmg/ddq473; Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Milewski WM, 1998, ENDOCRINOLOGY, V139, P1440, DOI 10.1210/en.139.3.1440; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Nadauld LD, 2004, J BIOL CHEM, V279, P51581, DOI 10.1074/jbc.M408830200; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; ONO H, 1993, IMMUNOGENETICS, V38, P1, DOI 10.1007/BF00216384; Pasini A, 2001, MECH DEVELOP, V100, P317, DOI 10.1016/S0925-4773(00)00538-4; Rios Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001271; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rosel TD, 2011, EMBO J, V30, P1965, DOI 10.1038/emboj.2011.106; RUBY SW, 1993, GENE DEV, V7, P1909, DOI 10.1101/gad.7.10.1909; Ryu S, 2005, P NATL ACAD SCI USA, V102, P18467, DOI 10.1073/pnas.0506187102; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Skromne I, 2008, DEV DYNAM, V237, P861, DOI 10.1002/dvdy.21484; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stuckenholz C, 2009, GASTROENTEROLOGY, V137, P1321, DOI 10.1053/j.gastro.2009.06.050; Trede NS, 2007, P NATL ACAD SCI USA, V104, P6608, DOI 10.1073/pnas.0701919104; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wendik B, 2004, DEV BIOL, V268, P372, DOI 10.1016/j.ydbio.2003.12.026; Westerfield M, 1995, ZEBRAFISH BOOK; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Xu YZ, 2007, MOL CELL, V28, P838, DOI 10.1016/j.molcel.2007.09.022; Xu YZ, 2004, EMBO J, V23, P376, DOI 10.1038/sj.emboj.7600050; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; Yee NS, 2007, PLOS BIOL, V5, P2484, DOI 10.1371/journal.pbio.0050312; Yee NS, 2005, DEV BIOL, V284, P84, DOI 10.1016/j.ydbio.2005.04.035; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034	50	21	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33675	10.1371/journal.pone.0033675	http://dx.doi.org/10.1371/journal.pone.0033675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442707	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500048
J	Belz, RG; Piepho, HP				Belz, Regina G.; Piepho, Hans-Peter			Modeling Effective Dosages in Hormetic Dose-Response Studies	PLOS ONE			English	Article							PARTHENIUM-HYSTEROPHORUS L; PLANT-GROWTH; HORMESIS; ALLELOPATHY; STIMULATION	Background: Two hormetic modifications of a monotonically decreasing log-logistic dose-response function are most often used to model stimulatory effects of low dosages of a toxicant in plant biology. As just one of these empirical models is yet properly parameterized to allow inference about quantities of interest, this study contributes the parameterized functions for the second hormetic model and compares the estimates of effective dosages between both models based on 23 hormetic data sets. Based on this, the impact on effective dosage estimations was evaluated, especially in case of a substantially inferior fit by one of the two models. Methodology/Principal Findings: The data sets evaluated described the hormetic responses of four different test plant species exposed to 15 different chemical stressors in two different experimental dose-response test designs. Out of the 23 data sets, one could not be described by any of the two models, 14 could be better described by one of the two models, and eight could be equally described by both models. In cases of misspecification by any of the two models, the differences between effective dosages estimates (0-1768%) greatly exceeded the differences observed when both models provided a satisfactory fit (0-26%). This suggests that the conclusions drawn depending on the model used may diverge considerably when using an improper hormetic model especially regarding effective dosages quantifying hormesis. Conclusions/Significance: The study showed that hormetic dose responses can take on many shapes and that this diversity can not be captured by a single model without risking considerable misinterpretation. However, the two empirical models considered in this paper together provide a powerful means to model, prove, and now also to quantify a wide range of hormetic responses by reparameterization. Despite this, they should not be applied uncritically, but after statistical and graphical assessment of their adequacy.	[Belz, Regina G.] Univ Hohenheim, Agroecol Unit, Inst Plant Prod & Agroecol Trop & Subtrop, D-7000 Stuttgart, Germany; [Piepho, Hans-Peter] Univ Hohenheim, Inst Crop Sci, Bioinformat Unit, D-7000 Stuttgart, Germany	University Hohenheim; University Hohenheim	Belz, RG (corresponding author), Univ Hohenheim, Agroecol Unit, Inst Plant Prod & Agroecol Trop & Subtrop, D-7000 Stuttgart, Germany.	regina.belz@uni-hohenheim.de		Piepho, Hans-Peter/0000-0001-7813-2992	German Research Foundation (DFG) [BE4189/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	RGB is supported by an Individual Grant by the German Research Foundation (DFG), project BE4189/1-1. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN M, 1993, J CHEM ECOL, V19, P2379, DOI 10.1007/BF00979671; Andresen M, 2010, HORTSCIENCE, V45, P1848, DOI 10.21273/HORTSCI.45.12.1848; Belz RG, 2008, SCI TOTAL ENVIRON, V404, P77, DOI 10.1016/j.scitotenv.2008.06.008; Belz RG, 2008, DOSE-RESPONSE, V6, P80, DOI 10.2203/dose-response.07-007.Belz; Belz RG, 2007, CROP PROT, V26, P237, DOI 10.1016/j.cropro.2005.06.009; Belz Regina G., 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P173, DOI 10.2201/nonlin.003.02.002; Belz RG, 2010, ENVIRON EXP BOT, V69, P293, DOI 10.1016/j.envexpbot.2010.04.010; Belz RG, 2004, J CHEM ECOL, V30, P175, DOI 10.1023/B:JOEC.0000013190.72062.3d; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Calabrese EJ, 2011, REGUL TOXICOL PHARM, V61, P73, DOI 10.1016/j.yrtph.2011.06.003; Calabrese EJ, 2005, ENVIRON POLLUT, V138, P378, DOI 10.1016/j.envpol.2004.10.001; Cedergreen N, 2008, WEED RES, V48, P429, DOI 10.1111/j.1365-3180.2008.00646.x; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; Cedergreen Nina, 2007, Dose-Response, V5, P150, DOI 10.2203/dose-response.06-008.Cedergreen; Cedergreen N, 2010, PESTIC BIOCHEM PHYS, V96, P140, DOI 10.1016/j.pestbp.2009.11.002; Cedergreen N, 2009, FIELD CROP RES, V114, P54, DOI 10.1016/j.fcr.2009.07.003; Dette H, 2011, RISK ANAL, V31, P1949, DOI 10.1111/j.1539-6924.2011.01625.x; Duke S. O., 2006, Outlooks on Pest Management, V17, P29; FINNEY DJ, 1976, BIOMETRICS, V32, P721, DOI 10.2307/2529258; GAGLIARDO RW, 1992, J CHEM ECOL, V18, P1683, DOI 10.1007/BF02751095; Liu YH, 2011, DOSE-RESPONSE, V9, P117, DOI 10.2203/dose-response.09-050.Liu; Petersen J, 2001, AGRON J, V93, P37, DOI 10.2134/agronj2001.93137x; Schabenberger O, 1999, AGRON J, V91, P713, DOI 10.2134/agronj1999.914713x; Schabenberger O, 2001, HUM ECOL RISK ASSESS, V7, P891, DOI 10.1080/20018091094718; Sinkkonen A, 2011, DOSE-RESPONSE, V9, P130, DOI 10.2203/dose-response.09-045.Sinkkonen; STREIBIG JC, 1980, ACTA AGR SCAND, V30, P59, DOI 10.1080/00015128009435696	27	56	58	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33432	10.1371/journal.pone.0033432	http://dx.doi.org/10.1371/journal.pone.0033432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438929	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100044
J	Piha-Gossack, A; Sossin, W; Reinhardt, DP				Piha-Gossack, Adam; Sossin, Wayne; Reinhardt, Dieter P.			The Evolution of Extracellular Fibrillins and Their Functional Domains	PLOS ONE			English	Article							MARFAN-SYNDROME; SUPRAMOLECULAR ORGANIZATION; CALCIUM DETERMINES; INTEGRIN BINDING; CELL-ADHESION; TB DOMAIN; PROTEIN; MICROFIBRILS; SEQUENCE; MATRIX	Fibrillins constitute the major backbone of multifunctional microfibrils in elastic and non-elastic extracellular matrices, and are known to interact with several binding partners including tropoelastin and integrins. Here, we study the evolution of fibrillin proteins. Following sequence collection from 39 organisms representative of the major evolutionary groups, molecular evolutionary genetics and phylogeny inference software were used to generate a series of evolutionary trees using distance-based and maximum likelihood methods. The resulting trees support the concept of gene duplication as a means of generating the three vertebrate fibrillins. Beginning with a single fibrillin sequence found in invertebrates and jawless fish, a gene duplication event, which coincides with the appearance of elastin, led to the creation of two genes. One of the genes significantly evolved to become the gene for present-day fibrillin-1, while the other underwent evolutionary changes, including a second duplication, to produce present-day fibrillin-2 and fibrillin-3. Detailed analysis of several sequences and domains within the fibrillins reveals distinct similarities and differences across various species. The RGD integrin-binding site in TB4 of all fibrillins is conserved in cephalochordates and vertebrates, while the integrin-binding site within cbEGF18 of fibrillin-3 is a recent evolutionary change. The proline-rich domain in fibrillin-1, glycine-rich domain in fibrillin-2 and proline-/glycine-rich domain in fibrillin-3 are found in all analyzed tetrapod species, whereas it is completely replaced with an EGF-like domain in cnidarians, arthropods, molluscs and urochordates. All collected sequences contain the first 9-cysteine hybrid domain, and the second 8-cysteine hybrid domain with exception of arthropods containing an atypical 10-cysteine hybrid domain 2. Furin cleavage sites within the N- and C-terminal unique domains were found for all analyzed fibrillin sequences, indicating an essential role for processing of the fibrillin pro-proteins. The four cysteines in the unique N-terminus and the two cysteines in the unique C-terminus are also highly conserved.	[Piha-Gossack, Adam; Reinhardt, Dieter P.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Sossin, Wayne] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Reinhardt, Dieter P.] McGill Univ, Fac Dent, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Piha-Gossack, A (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada.	dieter.reinhardt@mcgill.ca	Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872; Gossack, Adam/0000-0002-2249-7789	Canadian Institutes of Health Research [MOP-106494]; Natural Sciences and Engineering Research Council of Canada [RGPIN 375738-09]; Canada Foundation for Innovation; Canada Research Chairs; Fonds de la recherche en sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (MOP-106494), the Natural Sciences and Engineering Research Council of Canada (RGPIN 375738-09), the Canada Foundation for Innovation, the Canada Research Chairs, and the Fonds de la recherche en sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Cardy CM, 1998, J MOL BIOL, V276, P855, DOI 10.1006/jmbi.1997.1593; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DAVISON IG, 1995, J EXP BIOL, V198, P2185; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Hubmacher D, 2011, BIOCHEMISTRY-US, V50, P5322, DOI 10.1021/bi200183z; Hubmacher D, 2011, BIOL EXTRACELL MATR, P233, DOI 10.1007/978-3-642-16555-9_7; Jensen SA, 2009, STRUCTURE, V17, P759, DOI 10.1016/j.str.2009.03.014; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jovanovic J, 2007, J BIOL CHEM, V282, P6743, DOI 10.1074/jbc.M607008200; Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1; Lack J, 2003, J MOL BIOL, V334, P281, DOI 10.1016/j.jmb.2003.09.053; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Lonnqvist L, 1998, HUM MOL GENET, V7, P2039, DOI 10.1093/hmg/7.13.2039; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; Miller M.A., 2010, P GAT COMP ENV WORKS; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Raghunath M, 1999, J CELL SCI, V112, P1093; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; REBERMULLER S, 1995, DEV BIOL, V169, P662, DOI 10.1006/dbio.1995.1177; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; Ritty TM, 1999, J BIOL CHEM, V274, P8933, DOI 10.1074/jbc.274.13.8933; Robertson I, 2011, BIOCHEM J, V433, P263, DOI 10.1042/BJ20101320; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; SAGE H, 1979, COMP BIOCHEM PHYS B, V64, P313, DOI 10.1016/0305-0491(79)90277-3; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thurmond FA, 1996, J EXP BIOL, V199, P1817; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200; VONHEIJNE G, 1989, FEBS LETT, V244, P439, DOI 10.1016/0014-5793(89)80579-4; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wallis DD, 2003, J CELL BIOCHEM, V90, P641, DOI 10.1002/jcb.10657; Wess TJ, 1998, J CELL BIOL, V141, P829, DOI 10.1083/jcb.141.3.829; Yuan XM, 1997, EMBO J, V16, P6659, DOI 10.1093/emboj/16.22.6659; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	65	45	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33560	10.1371/journal.pone.0033560	http://dx.doi.org/10.1371/journal.pone.0033560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438950	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100059
J	Piriyapongsa, J; Bootchai, C; Ngamphiw, C; Tongsima, S				Piriyapongsa, Jittima; Bootchai, Chaiwat; Ngamphiw, Chumpol; Tongsima, Sissades			microPIR: An Integrated Database of MicroRNA Target Sites within Human Promoter Sequences	PLOS ONE			English	Article							FUNCTIONAL ANNOTATION; GENOME BROWSER; EXPRESSION; PREDICTION; SYSTEM; GENES; TOOL	Background: microRNAs are generally understood to regulate gene expression through binding to target sequences within 3'-UTRs of mRNAs. Therefore, computational prediction of target sites is usually restricted to these gene regions. Recent experimental studies though have suggested that microRNAs may alternatively modulate gene expression by interacting with promoters. A database of potential microRNA target sites in promoters would stimulate research in this field leading to more understanding of complex microRNA regulatory mechanism. Methodology: We developed a database hosting predicted microRNA target sites located within human promoter sequences and their associated genomic features, called microPIR (microRNA-Promoter Interaction Resource). microRNA seed sequences were used to identify perfect complementary matching sequences in the human promoters and the potential target sites were predicted using the RNAhybrid program. >15 million target sites were identified which are located within 5000 bp upstream of all human genes, on both sense and antisense strands. The experimentally confirmed argonaute (AGO) binding sites and EST expression data including the sequence conservation across vertebrate species of each predicted target are presented for researchers to appraise the quality of predicted target sites. The microPIR database integrates various annotated genomic sequence databases, e. g. repetitive elements, transcription factor binding sites, CpG islands, and SNPs, offering users the facility to extensively explore relationships among target sites and other genomic features. Furthermore, functional information of target genes including gene ontologies, KEGG pathways, and OMIM associations are provided. The built-in genome browser of microPIR provides a comprehensive view of multidimensional genomic data. Finally, microPIR incorporates a PCR primer design module to facilitate experimental validation. Conclusions: The proposed microPIR database is a useful integrated resource of microRNA-promoter target interactions for experimental microRNA researchers and computational biologists to study the microRNA regulation through gene promoter. The database can be freely accessed from: http://www4a.biotec.or.th/micropir.	[Piriyapongsa, Jittima; Bootchai, Chaiwat; Ngamphiw, Chumpol; Tongsima, Sissades] Natl Ctr Genet Engn & Biotechnol, Genome Inst, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Piriyapongsa, J (corresponding author), Natl Ctr Genet Engn & Biotechnol, Genome Inst, Pathum Thani, Thailand.	jittima.pir@biotec.or.th; sissades@biotec.or.th	Ngamphiw, Chumpol/ABB-6488-2021; Piriyapongsa, Jittima/F-7581-2012; Tongsima, Sissades/F-4891-2011	Ngamphiw, Chumpol/0000-0002-8581-397X; Tongsima, Sissades/0000-0002-1491-1839	Thailand Research Fund (TRF) [RSA5480026]; National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science and Technology Development Agency (NSTDA)	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science and Technology Development Agency (NSTDA)	JP is supported by the new researcher grant from the Thailand Research Fund (TRF) and National Center for Genetic Engineering and Biotechnology (BIOTEC). CB, CN, and ST were supported by the National Center for Genetic Engineering and Biotechnology (BIOTEC). ST would like to acknowledge the TRF grant number RSA5480026 and the chair professor grant by the National Science and Technology Development Agency (NSTDA), which partially support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; CONSORTIUM IH, 2005, NATURE, V437, P1299; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829; Piriyapongsa J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S4; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smit A., REPEATMASKER OPEN 3; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Younger ST, 2009, BIOORG MED CHEM LETT, V19, P3791, DOI 10.1016/j.bmcl.2009.04.032; Younger ST, 2011, NUCL ACIDS RES; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008	45	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33888	10.1371/journal.pone.0033888	http://dx.doi.org/10.1371/journal.pone.0033888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439011	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100111
J	Vranakis, I; De Bock, PJ; Papadioti, A; Tselentis, Y; Gevaert, K; Tsiotis, G; Psaroulaki, A				Vranakis, Iosif; De Bock, Pieter-Jan; Papadioti, Anastasia; Tselentis, Yannis; Gevaert, Kris; Tsiotis, Georgios; Psaroulaki, Anna			Quantitative Proteome Profiling of C. burnetii under Tetracycline Stress Conditions	PLOS ONE			English	Article							BACTERIUM COXIELLA-BURNETII; ANTIBIOTIC-RESISTANCE GENES; ESCHERICHIA-COLI; Q-FEVER; LEADER PEPTIDASE; PSEUDOMONAS-AERUGINOSA; RIBOSOMAL PROTECTION; SUBUNIT INTERFACE; SIGNAL PEPTIDASES; DRUG-RESISTANCE	The recommended antibiotic regimen against Coxiella burnetii, the etiological agent of Q fever, is based on a semi-synthetic, second-generation tetracycline, doxycycline. Here, we report on the comparison of the proteomes of a C. burnetii reference strain either cultured under control conditions or under tetracycline stress conditions. Using the MS-driven combined fractional diagonal chromatography proteomics technique, out of the 531 proteins identified, 5 and 19 proteins were found significantly up-and down-regulated respectively, under tetracycline stress. Although the predicted cellular functions of these regulated proteins did not point to known tetracycline resistance mechanisms, our data clearly reveal the plasticity of the proteome of C. burnetii to battle tetracycline stress. Finally, we raise several plausible hypotheses that could further lead to more focused experiments on studying tetracycline resistance in C. burnetii and thus reduced treatment failures of Q fever.	[Vranakis, Iosif; Tselentis, Yannis; Psaroulaki, Anna] Univ Crete, Sch Med, Dept Clin Bacteriol Parasitol Zoonoses & Geog Med, Iraklion, Greece; [Papadioti, Anastasia; Tsiotis, Georgios] Univ Crete, Dept Chem, Div Biochem, Voutes, Greece; [De Bock, Pieter-Jan; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [De Bock, Pieter-Jan; Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium	University of Crete; University of Crete; Ghent University; Flanders Institute for Biotechnology (VIB)	Vranakis, I (corresponding author), Univ Crete, Sch Med, Dept Clin Bacteriol Parasitol Zoonoses & Geog Med, Iraklion, Greece.	iosif.vranakis@gmail.com	Gevaert, Kris/D-6489-2017; Gevaert, Kris/H-3637-2013; Gevaert, Kris/AAE-4212-2019	Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283	University of Crete; Greek Ministry of Education; General Secretariat for Research and Technology [PENED-03ED863]; Ghent University [BOF07/GOA/012]; Inter University Attraction Poles [IUAP06]	University of Crete; Greek Ministry of Education(Greek Ministry of Development-GSRT); General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Ghent University(Ghent University); Inter University Attraction Poles(Belgian Federal Science Policy Office)	This research program was supported by the University of Crete, the Greek Ministry of Education, and the General Secretariat for Research and Technology PENED-03ED863. The Ghent lab acknowledges research grants from Concerted Research Actions (project BOF07/GOA/012) from Ghent University and the Inter University Attraction Poles (IUAP06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agafonov DE, 1999, P NATL ACAD SCI USA, V96, P12345, DOI 10.1073/pnas.96.22.12345; Agafonov DE, 2001, COLD SPRING HARB SYM, V66, P509, DOI 10.1101/sqb.2001.66.509; Agafonov DE, 2001, EMBO REP, V2, P399; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Black MT, 1998, CURR PHARM DESIGN, V4, P133; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Breidenstein EBM, 2008, ANTIMICROB AGENTS CH, V52, P4486, DOI 10.1128/AAC.00222-08; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Burdett V, 1996, J BACTERIOL, V178, P3246, DOI 10.1128/jb.178.11.3246-3251.1996; Chen L, 2007, J BIOL CHEM, V282, P5582, DOI 10.1074/jbc.M609273200; CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245; Colaert N, 2010, PROTEOMICS, V10, P1226, DOI 10.1002/pmic.200900379; Connell SR, 2003, ANTIMICROB AGENTS CH, V47, P3675, DOI 10.1128/AAC.47.12.3675-3681.2003; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; DATE T, 1981, P NATL ACAD SCI-BIOL, V78, P6106, DOI 10.1073/pnas.78.10.6106; DATE T, 1983, J BACTERIOL, V154, P76, DOI 10.1128/JB.154.1.76-83.1983; DERRICK E. H., 1937, Medical Journal of Australia, V2, P281; Dotsch A, 2009, ANTIMICROB AGENTS CH, V53, P2522, DOI 10.1128/AAC.00035-09; Fajardo A, 2009, CLIN MICROBIOL INFEC, V15, P14, DOI 10.1111/j.1469-0691.2008.02688.x; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Gami AS, 2004, MAYO CLIN PROC, V79, P253, DOI 10.4065/79.2.253; Gevaert K, 2002, MOL CELL PROTEOMICS, V1, P896, DOI 10.1074/mcp.M200061-MCP200; Ghesquiere B, 2009, MOL CELL PROTEOMICS, V8, P2642, DOI 10.1074/mcp.M900259-MCP200; GIMENEZ DF, 1964, STAIN TECHNOL, V39, P135, DOI 10.3109/10520296409061219; Heinzen RA, 1996, MOL MICROBIOL, V22, P9, DOI 10.1111/j.1365-2958.1996.tb02651.x; Hu XH, 2011, BIOCHEMISTRY-US, V50, P10559, DOI 10.1021/bi201008f; Iosif V, 2011, J PROTEOME RES, V10, P4241, DOI 10.1021/pr200422f; Joshi N, 1997, ARCH INTERN MED, V157, P1421, DOI 10.1001/archinte.157.13.1421; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Maki Y, 2000, GENES CELLS, V5, P965, DOI 10.1046/j.1365-2443.2000.00389.x; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Maurin M, 1997, J ANTIMICROB CHEMOTH, V39, P725, DOI 10.1093/jac/39.6.725; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Omsland A, 2011, APPL ENVIRON MICROB, V77, P3720, DOI 10.1128/AEM.02826-10; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Rolain JM, 2005, ANN NY ACAD SCI, V1063, P252, DOI 10.1196/annals.1355.039; Rolain JM, 2003, J INFECT DIS, V188, P1322, DOI 10.1086/379082; Samland AK, 2009, INT J BIOCHEM CELL B, V41, P1482, DOI 10.1016/j.biocel.2009.02.001; Samoilis G, 2007, J PROTEOME RES, V6, P3032, DOI 10.1021/pr070077n; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; STOJILJKOVIC I, 1993, FEMS MICROBIOL LETT, V108, P111; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; Tamura N, 2003, CURR OPIN CHEM BIOL, V7, P570, DOI 10.1016/j.cbpa.2003.08.014; Taylor DE, 1996, ANTIMICROB AGENTS CH, V40, P1; Thaker M, 2010, CELL MOL LIFE SCI, V67, P419, DOI 10.1007/s00018-009-0172-6; Tissot-Dupont H, 2007, CLIN INFECT DIS, V44, P232, DOI 10.1086/510389; TURCK WPG, 1976, Q J MED, V45, P193; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; VINNIKOV AI, 1989, ANTIBIOT KHIMIOTERAP, V34, P34; Vranakis I, 2011, J PROTEOME RES, V10, P756, DOI 10.1021/pr100906v; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456; Yergeau E, 2010, APPL ENVIRON MICROB, V76, P5432, DOI 10.1128/AEM.00873-10; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	63	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33599	10.1371/journal.pone.0033599	http://dx.doi.org/10.1371/journal.pone.0033599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438959	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100067
J	Nunez, PA; Soria, M; Farber, MD				Nunez, Pablo A.; Soria, Marcelo; Farber, Marisa D.			The Twin-Arginine Translocation Pathway in alpha-Proteobacteria Is Functionally Preserved Irrespective of Genomic and Regulatory Divergence	PLOS ONE			English	Article							SEC-INDEPENDENT PROTEIN; ESCHERICHIA-COLI; SIGNAL PEPTIDES; ANAPLASMA-MARGINALE; TRANSPORT-SYSTEM; TAT TRANSLOCASES; OXIDE REDUCTASE; VIRULENCE; SECRETION; EXPORT	The twin-arginine translocation (Tat) pathway exports fully folded proteins out of the cytoplasm of Gram-negative and Gram-positive bacteria. Although much progress has been made in unraveling the molecular mechanism and biochemical characterization of the Tat system, little is known concerning its functionality and biological role to confer adaptive skills, symbiosis or pathogenesis in the alpha-proteobacteria class. A comparative genomic analysis in the alpha-proteobacteria class confirmed the presence of tatA, tatB, and tatC genes in almost all genomes, but significant variations in gene synteny and rearrangements were found in the order Rickettsiales with respect to the typically described operon organization. Transcription of tat genes was confirmed for Anaplasma marginale str. St. Maries and Brucella abortus 2308, two alpha-proteobacteria with full and partial intracellular lifestyles, respectively. The tat genes of A. marginale are scattered throughout the genome, in contrast to the more generalized operon organization. Particularly, tatA showed an approximately 20-fold increase in mRNA levels relative to tatB and tatC. We showed Tat functionality in B. abortus 2308 for the first time, and confirmed conservation of functionality in A. marginale. We present the first experimental description of the Tat system in the Anaplasmataceae and Brucellaceae families. In particular, in A. marginale Tat functionality is conserved despite operon splitting as a consequence of genome rearrangements. Further studies will be required to understand how the proper stoichiometry of the Tat protein complex and its biological role are achieved. In addition, the predicted substrates might be the evidence of role of the Tat translocation system in the transition process from a free-living to a parasitic lifestyle in these alpha-proteobacteria.	[Nunez, Pablo A.; Farber, Marisa D.] Inst Nacl Tecnol Agr CICVyA INTA, Inst Biotecnol, Buenos Aires, DF, Argentina; [Soria, Marcelo] Univ Buenos Aires, Fac Agron, INBA CONICET, Catedra Microbiol Agr, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Nunez, PA (corresponding author), Inst Nacl Tecnol Agr CICVyA INTA, Inst Biotecnol, Buenos Aires, DF, Argentina.	mfarber@cnia.inta.gov.ar			European Commission [EC FP6 INCO-DEV, FP6-003713]; National Institute for Agricultural Technology - INTA- [245711]	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Agricultural Technology - INTA-	This work was supported by European Commission EC FP6 INCO-DEV grant "Epigenevac'' FP6-003713 and from the National Institute for Agricultural Technology - INTA- (Project AEBIO 245711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Bao W, 2009, J BACTERIOL, V191, P278, DOI 10.1128/JB.01031-08; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; BEGG KJ, 1985, J BACTERIOL, V163, P615, DOI 10.1128/JB.163.2.615-622.1985; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bolhuis A, 2002, MICROBIOL-SGM, V148, P3335, DOI 10.1099/00221287-148-11-3335; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Caldelari I, 2006, MOL PLANT MICROBE IN, V19, P200, DOI 10.1094/MPMI-19-0200; Chanal A, 1998, MOL MICROBIOL, V30, P674, DOI 10.1046/j.1365-2958.1998.01095.x; Cheng ZH, 2008, J BACTERIOL, V190, P2096, DOI 10.1128/JB.01813-07; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; De Buck E, 2007, FEBS LETT, V581, P259, DOI 10.1016/j.febslet.2006.12.022; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Dilks M, 2005, J BACTERIOL, V187, P8104, DOI 10.1128/JB.187.23.8104-8113.2005; Ding ZY, 2003, J BACTERIOL, V185, P760, DOI 10.1128/JB.185.3.760-771.2003; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Frutos R, 2006, J BACTERIOL, V188, P2533, DOI 10.1128/JB.188.7.2533-2542.2006; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Heikkila MP, 2001, J BACTERIOL, V183, P1663, DOI 10.1128/JB.183.5.1663-1671.2001; Hicks MG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-64; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Ignatova Z, 2002, BIOCHEM BIOPH RES CO, V291, P146, DOI 10.1006/bbrc.2002.6420; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Jenner DC, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/354649; Jiang XW, 2011, MOL BIOL EVOL, V28, P3183, DOI 10.1093/molbev/msr154; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Joshi MV, 2010, MOL MICROBIOL, V77, P252, DOI 10.1111/j.1365-2958.2010.07206.x; Krehenbrink M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-55; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavander M, 2006, INFECT IMMUN, V74, P1768, DOI 10.1128/IAI.74.3.1768-1776.2006; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Lindenstrauss U, 2006, J BACTERIOL, V188, P7807, DOI 10.1128/JB.01139-06; Massung RF, 2008, GENE, V414, P41, DOI 10.1016/j.gene.2008.02.005; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; Meloni S, 2003, MOL MICROBIOL, V48, P1195, DOI 10.1046/j.1365-2958.2003.03510.x; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pickering BS, 2010, J BACTERIOL, V192, P5173, DOI 10.1128/JB.00206-10; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Ruybal P, 2009, VET PARASITOL, V162, P176, DOI 10.1016/j.vetpar.2009.02.006; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; Sargent F, 2006, FEMS MICROBIOL LETT, V254, P198, DOI 10.1111/j.1574-6968.2005.00049.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Seleem MN, 2008, VET MICROBIOL, V129, P1, DOI 10.1016/j.vetmic.2007.11.023; Shruthi H, 2010, J MOL EVOL, V70, P359, DOI 10.1007/s00239-010-9334-2; SILVESTRO A, 1988, BIOCHIM BIOPHYS ACTA, V954, P1, DOI 10.1016/0167-4838(88)90049-0; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stanley NR, 2002, MOL MICROBIOL, V43, P1005, DOI 10.1046/j.1365-2958.2002.02797.x; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TSUI HCT, 1994, MOL MICROBIOL, V11, P189, DOI 10.1111/j.1365-2958.1994.tb00300.x; Wieser M, 2000, INT J SYST EVOL MICR, V50, P1087, DOI 10.1099/00207713-50-3-1087; Xiong YW, 2007, BIOCHIMIE, V89, P676, DOI 10.1016/j.biochi.2007.01.006; Yuan JJ, 2010, CELL MOL LIFE SCI, V67, P179, DOI 10.1007/s00018-009-0160-x; Zhang LJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-114	68	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33605	10.1371/journal.pone.0033605	http://dx.doi.org/10.1371/journal.pone.0033605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438962	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309000034
J	Gazzerro, E; Baldassari, S; Giacomini, C; Musante, V; Fruscione, F; La Padula, V; Biancheri, R; Scarfi, S; Prada, V; Sotgia, F; Duncan, ID; Zara, F; Werner, HB; Lisanti, MP; Nobbio, L; Corradi, A; Minetti, C				Gazzerro, Elisabetta; Baldassari, Simona; Giacomini, Caterina; Musante, Veronica; Fruscione, Floriana; La Padula, Veronica; Biancheri, Roberta; Scarfi, Sonia; Prada, Valeria; Sotgia, Federica; Duncan, Ian D.; Zara, Federico; Werner, Hauke B.; Lisanti, Michael P.; Nobbio, Lucilla; Corradi, Anna; Minetti, Carlo			Hyccin, the Molecule Mutated in the Leukodystrophy Hypomyelination and Congenital Cataract (HCC), Is a Neuronal Protein	PLOS ONE			English	Article							SCHWANN-CELLS; PERIPHERAL-NERVE; WHITE-MATTER; RELATIVE QUANTIFICATION; SALLA-DISEASE; MYELINATION; GENE; MICE; DYSFUNCTION; NEUROPATHY	"Hypomyelination and Congenital Cataract'', HCC (MIM #610532), is an autosomal recessive disorder characterized by congenital cataract and diffuse cerebral and peripheral hypomyelination. HCC is caused by deficiency of Hyccin, a protein whose biological role has not been clarified yet. Since the identification of the cell types expressing a protein of unknown function can contribute to define the physiological context in which the molecule is explicating its function, we analyzed the pattern of Hyccin expression in the central and peripheral nervous system (CNS and PNS). Using heterozygous mice expressing the b-galactosidase (LacZ) gene under control of the Hyccin gene regulatory elements, we show that the gene is primarily expressed in neuronal cells. Indeed, Hyccin-LacZ signal was identified in CA1 hippocampal pyramidal neurons, olfactory bulb, and cortical pyramidal neurons, while it did not colocalize with oligodendroglial or astrocytic markers. In the PNS, Hyccin was detectable only in axons isolated from newborn mice. In the brain, Hyccin transcript levels were higher in early postnatal development (postnatal days 2 and 10) and then declined in adult mice. In a model of active myelinogenesis, organotypic cultures of rat Schwann cells (SC)/Dorsal Root Ganglion (DRG) sensory neurons, Hyccin was detected along the neurites, while it was absent from SC. Intriguingly, the abundance of the molecule was upregulated at postnatal days 10 and 15, in the initial steps of myelinogenesis and then declined at 30 days when the process is complete. As Hyccin is primarily expressed in neurons and its mutation leads to hypomyelination in human patients, we suggest that the protein is involved in neuron-to-glia signalling to initiate or maintain myelination.	[Gazzerro, Elisabetta; Baldassari, Simona; Musante, Veronica; Fruscione, Floriana; Zara, Federico; Minetti, Carlo] Univ Genoa, G Gaslini Inst, Muscular & Neurodegenerat Dis Unit, Genoa, Italy; [Giacomini, Caterina; La Padula, Veronica; Corradi, Anna] Univ Genoa, Dept Expt Med, Neurosci Sect, Genoa, Italy; [Biancheri, Roberta] G Gaslini Inst Children, Dept Neurosci, Genoa, Italy; [Scarfi, Sonia] Univ Genoa, Dept Expt Med, Biochem Sect, Genoa, Italy; [Prada, Valeria; Nobbio, Lucilla] Univ Genoa, San Martino Hosp, Dept Neurol & Genet, Genoa, Italy; [Sotgia, Federica; Lisanti, Michael P.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Sotgia, Federica; Lisanti, Michael P.] Thomas Jefferson Univ, Stem Cell Biol & Regenerat Med Ctr, Philadelphia, PA 19107 USA; [Duncan, Ian D.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Werner, Hauke B.] Max Planck Inst Expt Med, Dept Neurogenet, D-3400 Gottingen, Germany	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; Jefferson University; Jefferson University; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society	Gazzerro, E (corresponding author), Univ Genoa, G Gaslini Inst, Muscular & Neurodegenerat Dis Unit, Genoa, Italy.	elisabettagazzerro@ospedale-gaslini.ge.it	Scarfi, Sonia/AAJ-2387-2020; fruscione, floriana/AAA-8747-2020; Zara, Federico/U-3477-2017; Lisanti, Michael P/C-6866-2013; Lisanti, Michael/B-6131-2018; Baldassari, Simona/AAB-2383-2019; Minetti, Carlo/K-4666-2018; Nobbio, Lucilla/J-1213-2018; Corradi, Anna/AAC-5209-2022	Scarfi, Sonia/0000-0002-7079-6919; Zara, Federico/0000-0001-9744-5222; Lisanti, Michael/0000-0003-2034-1382; Baldassari, Simona/0000-0002-5304-3608; Minetti, Carlo/0000-0002-0640-1804; Nobbio, Lucilla/0000-0003-2150-3953; Werner, Hauke/0000-0002-7710-5738; fruscione, floriana/0000-0002-4054-645X; Prada, Valeria/0000-0001-5756-0576; Sotgia, Federica/0000-0003-2826-4529	Telethon [GP2007250]; Mariani Foundation; San Paolo Foundation; European Leukodystrophy Association Foundation [2009-032I4]; Bundesministerium fuer Bildung und Forschung - BMBF (DLR-Leukonet)	Telethon(Fondazione Telethon); Mariani Foundation; San Paolo Foundation(Compagnia di San Paolo); European Leukodystrophy Association Foundation; Bundesministerium fuer Bildung und Forschung - BMBF (DLR-Leukonet)	This work was supported by the Telethon Grant GP2007250, Mariani Foundation Grant, San Paolo Foundation Grant, and European Leukodystrophy Association Foundation Grant 2009-032I4. HBW was supported by the Bundesministerium fuer Bildung und Forschung - BMBF (DLR-Leukonet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUZZI A, 1994, HISTOCHEMISTRY, V102, P477, DOI 10.1007/BF00269579; Biancheri R, 2007, ANN NEUROL, V62, P121, DOI 10.1002/ana.21175; Bizzi A, 2008, AM J NEURORADIOL, V29, P1270, DOI 10.3174/ajnr.A1106; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Corradi A, 2003, DEVELOPMENT, V130, P401, DOI 10.1242/dev.00215; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Di Rocco M, 2004, AM J MED GENET B, V129B, P85, DOI 10.1002/ajmg.b.30029; Edgar JM, 2004, ACTA NEUROPATHOL, V107, P331, DOI 10.1007/s00401-003-0808-9; Edgar JM, 2009, CURR OPIN NEUROBIOL, V19, P498, DOI 10.1016/j.conb.2009.08.003; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MITHEN FA, 1982, DEV BRAIN RES, V4, P407, DOI 10.1016/0165-3806(82)90184-5; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nobbio L, 2004, NEUROBIOL DIS, V16, P263, DOI 10.1016/j.nbd.2004.02.007; Nobbio L, 2001, ANN NEUROL, V50, P47, DOI 10.1002/ana.1034; Nobbio L, 2009, J BIOL CHEM, V284, P23146, DOI 10.1074/jbc.M109.027128; Noetzel MJ, 2004, NEUROLOGY, V62, P847, DOI 10.1212/WNL.62.6.847; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rossi A, 2008, AM J NEURORADIOL, V29, P301, DOI 10.3174/ajnr.A0792; Sawaishi Y, 2009, BRAIN DEV-JPN, V31, P493, DOI 10.1016/j.braindev.2009.03.006; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Steenweg ME, 2010, BRAIN, V133, P2971, DOI 10.1093/brain/awq257; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Tonelli DDP, 2006, BIOTECHNIQUES, V41, P727, DOI 10.2144/000112296; Ugur SA, 2008, EUR J HUM GENET, V16, P261, DOI 10.1038/sj.ejhg.5201935; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van der Knaap MS, 2010, ANN NEUROL, V68, P115, DOI 10.1002/ana.21751; van der Voorn JP, 2004, ACTA NEUROPATHOL, V107, P539, DOI 10.1007/s00401-004-0848-9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varho T, 2000, NEUROLOGY, V55, P99, DOI 10.1212/WNL.55.1.99; Varho TT, 2002, PEDIATR NEUROL, V26, P267, DOI 10.1016/S0887-8994(01)00406-4; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; WOOD PM, 1976, BRAIN RES, V115, P361, DOI 10.1016/0006-8993(76)90355-3; Woodward K, 1999, TRENDS GENET, V15, P125, DOI 10.1016/S0168-9525(99)01716-3; Zara F, 2006, NAT GENET, V38, P1111, DOI 10.1038/ng1870	42	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e32180	10.1371/journal.pone.0032180	http://dx.doi.org/10.1371/journal.pone.0032180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461884	gold, Green Published, Green Submitted			2022-12-27	WOS:000304118900003
J	Teo, J; Cai, YY; Tang, S; Lee, W; Tan, TY; Tan, TT; Kwa, ALH				Teo, Jocelyn; Cai, Yiying; Tang, Sarah; Lee, Winnie; Tan, Thean Yen; Tan, Thuan Tong; Kwa, Andrea Lay-Hoon			Risk Factors, Molecular Epidemiology and Outcomes of Ertapenem-Resistant, Carbapenem-Susceptible Enterobacteriaceae: A Case-Case-Control Study	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; RAPID DETECTION; MULTIPLEX PCR; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; GENES; ACQUISITION; INFECTIONS; EXPRESSION	Background: Increasing prevalence of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae (ERE) in Singapore presents a major therapeutic problem. Our objective was to determine risk factors associated with the acquisition of ERE in hospitalized patients; to assess associated patient outcomes; and to describe the molecular characteristics of ERE. Methods: A retrospective case-case-control study was conducted in 2009 at a tertiary care hospital. Hospitalized patients with ERE and those with ertapenem-sensitive Enterobacteriaceae (ESE) were compared with a common control group consisting of patients with no prior gram-negative infections. Risk factors analyzed included demographics; co-morbidities; instrumentation and antibiotic exposures. Two parallel multivariate logistic regression models were performed to identify independent variables associated with ERE and ESE acquisition respectively. Clinical outcomes were compared between ERE and ESE patients. Results: Twenty-nine ERE cases, 29 ESE cases and 87 controls were analyzed. Multivariate logistic regression showed that previous hospitalization (Odds ratio [OR], 10.40; 95% confidence interval [CI], 2.19-49.20) and duration of fluoroquinolones exposure (OR, 1.18 per day increase; 95% CI, 1.05-1.34) were unique independent predictors for acquiring ERE. Duration of 4 th -generation cephalosporin exposure was found to predict for ESE acquisition (OR, 1.63 per day increase; 95% CI, 1.052.54). In-hospital mortality rates and clinical response rates were significantly different between ERE and ESE groups, however ERE infection was not a predictor of mortality. ERE isolates were clonally distinct. Ertapenem resistance was likely to be mediated by the presence of extended-spectrum b-lactamases or plasmid-borne AmpC in combination with impermeability due to porin loss and/ or efflux pumps. Conclusion: Prior hospitalization and duration of fluoroquinolone treatment were predictors of ERE acquisition. ERE infections were associated with higher mortality rates and poorer clinical response rates when compared to ESE infections.	[Teo, Jocelyn; Cai, Yiying; Tang, Sarah; Lee, Winnie; Kwa, Andrea Lay-Hoon] Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore; [Tan, Thean Yen] Changi Gen Hosp, Dept Lab Med, Singapore, Singapore; [Tan, Thuan Tong] Singapore Gen Hosp, Dept Infect Dis, Singapore 0316, Singapore	Singapore General Hospital; Changi General Hospital; Singapore General Hospital	Teo, J (corresponding author), Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore.	andrea.kwa.l.h@sgh.com.sg	Teo, Jocelyn/ABA-1755-2021	Tan, Thean Yen/0000-0003-4358-1098; Teo, Jocelyn Qi-Min/0000-0003-2508-3941	SingHealth Foundation (Singapore)	SingHealth Foundation (Singapore)(SingHealth)	This study was supported in part by research grants from the SingHealth Foundation (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baran G, 2008, INT J INFECT DIS, V12, P16, DOI 10.1016/j.ijid.2007.03.005; Bradford PA, 2004, CLIN INFECT DIS, V39, P55, DOI 10.1086/421495; Bratu S, 2005, ARCH INTERN MED, V165, P1430, DOI 10.1001/archinte.165.12.1430; CLSI, 2009, M100S19 CLSI; Dombek PE, 2000, APPL ENVIRON MICROB, V66, P2572, DOI 10.1128/AEM.66.6.2572-2577.2000; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Eagye KJ, 2009, INFECT CONT HOSP EP, V30, P746, DOI 10.1086/603527; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Endimiani A, 2004, CLIN INFECT DIS, V38, P243, DOI 10.1086/380645; Falagas ME, 2007, J ANTIMICROB CHEMOTH, V60, P1124, DOI 10.1093/jac/dkm356; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Harris AD, 2001, CLIN INFECT DIS, V32, P1055, DOI 10.1086/319600; Hindiyeh M, 2008, J CLIN MICROBIOL, V46, P2879, DOI 10.1128/JCM.00661-08; Hsu LY, 2010, ANTIMICROB AGENTS CH, V54, P1173, DOI 10.1128/AAC.01076-09; Hussein K, 2009, INFECT CONT HOSP EP, V30, P666, DOI 10.1086/598244; Hyle EP, 2010, INFECT CONT HOSP EP, V31, P1242, DOI 10.1086/657138; Ikonomidis A, 2005, J CLIN MICROBIOL, V43, P5344, DOI 10.1128/JCM.43.10.5344-5347.2005; Jacoby GA, 2004, ANTIMICROB AGENTS CH, V48, P3203, DOI 10.1128/AAC.48.8.3203-3206.2004; Jeon MH, 2008, DIAGN MICR INFEC DIS, V62, P402, DOI 10.1016/j.diagmicrobio.2008.08.014; Kaye KS, 2005, INFECT CONT HOSP EP, V26, P346, DOI 10.1086/502550; Kritsotakis EI, 2011, J ANTIMICROB CHEMOTH, V66, P1383, DOI 10.1093/jac/dkr116; Leavitt A, 2009, J CLIN MICROBIOL, V47, P969, DOI 10.1128/JCM.00651-08; MacKenzie FM, 1997, LANCET, V350, P783, DOI 10.1016/S0140-6736(05)62567-6; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; Mouloudi E, 2010, INFECT CONT HOSP EP, V31, P1250, DOI 10.1086/657135; Orsi GB, 2011, J HOSP INFECT, V78, P54, DOI 10.1016/j.jhin.2011.01.014; Patel N, 2011, J ANTIMICROB CHEMOTH, V66, P1600, DOI 10.1093/jac/dkr156; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Schwaber MJ, 2008, JAMA-J AM MED ASSOC, V300, P2911, DOI 10.1001/jama.2008.896; Szabo D, 2006, ANTIMICROB AGENTS CH, V50, P2833, DOI 10.1128/AAC.01591-05; Tan TY, 2008, ANN ACAD MED SINGAP, V37, P819; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Winokur PL, 2001, CLIN INFECT DIS, V32, pS94, DOI 10.1086/320182; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Wu JJ, 2011, MICROB DRUG RESIST, V17, P259, DOI 10.1089/mdr.2010.0115	37	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34254	10.1371/journal.pone.0034254	http://dx.doi.org/10.1371/journal.pone.0034254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461908	gold, Green Submitted, Green Published			2022-12-27	WOS:000304118900026
J	Ibrahim, MM; de Angelis, R; Lima, AS; de Carvalho, GDV; Ibrahim, FM; Malki, LT; Bichuete, MD; Martins, WD; Rocha, EM				Ibrahim, Marlon Moraes; de Angelis, Rafael; Lima, Acacio Souza; Viana de Carvalho, Glauco Dreyer; Ibrahim, Fuad Moraes; Malki, Leonardo Tannus; Bichuete, Marina de Paula; Martins, Wellington de Paula; Rocha, Eduardo Melani			A New Method to Predict the Epidemiology of Fungal Keratitis by Monitoring the Sales Distribution of Antifungal Eye Drops in Brazil	PLOS ONE			English	Article							MICROBIAL KERATITIS; CORNEAL ULCERS; SOUTH-INDIA; RISK-FACTORS; PARAGUAY; SPECTRUM; FEATURES; CLIMATE	Purpose: Fungi are a major cause of keratitis, although few medications are licensed for their treatment. The aim of this study is to observe the variation in commercialisation of antifungal eye drops, and to predict the seasonal distribution of fungal keratitis in Brazil. Methods: Data from a retrospective study of antifungal eye drops sales from the only pharmaceutical ophthalmologic laboratory, authorized to dispense them in Brazil (Opthalmos) were gathered. These data were correlated with geographic and seasonal distribution of fungal keratitis in Brazil between July 2002 and June 2008. Results: A total of 26,087 antifungal eye drop units were sold, with a mean of 2.3 per patient. There was significant variation in antifungal sales during the year (p < 0.01). A linear regression model displayed a significant association between reduced relative humidity and antifungal drug sales (R-2 = 0.17, p < 0.01). Conclusions: Antifungal eye drops sales suggest that there is a seasonal distribution of fungal keratitis. A possible interpretation is that the third quarter of the year (a period when the climate is drier), when agricultural activity is more intense in Brazil, suggests a correlation with a higher incidence of fungal keratitis. A similar model could be applied to other diseases, that are managed with unique, or few, and monitorable medications to predict epidemiological aspects.	[Ibrahim, Marlon Moraes; de Angelis, Rafael; Ibrahim, Fuad Moraes; Malki, Leonardo Tannus; Bichuete, Marina de Paula; Rocha, Eduardo Melani] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ophthalmol, Ribeirao Preto, Brazil; [Lima, Acacio Souza] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil; [Lima, Acacio Souza; Viana de Carvalho, Glauco Dreyer] Ophthalmos Ind Farmaceut, Sao Paulo, Brazil; [Martins, Wellington de Paula] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, Ribeirao Preto, Brazil; [Martins, Wellington de Paula] Escola Ultra Sonog & Reciclagem Med Ribeirao Pret, Ribeirao Preto, Brazil; [Martins, Wellington de Paula] Inst Nacl Ciencia & Tecnol Hormonios & Saude da M, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Ibrahim, MM (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ophthalmol, Ribeirao Preto, Brazil.	emrocha@fmrp.usp.br	de Souza Lima Filho, Acácio Alves/C-7189-2012; Saude da mulher, Inct/J-9403-2013; Martins, Wellington/B-1284-2008; Rocha, Eduardo Melani/D-6002-2011	de Souza Lima Filho, Acácio Alves/0000-0003-1802-9592; Martins, Wellington/0000-0002-7593-5607; Rocha, Eduardo Melani/0000-0001-9888-7313	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302005/2009-9]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo	This study was supported by grants of the following Brazilian governmental institutions: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (302005/2009-9) and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharathi MJ, 2007, OPHTHAL EPIDEMIOL, V14, P61, DOI 10.1080/09286580601001347; Carvalho M, 2001, REV IBEROAMERICANA M, P76; DEKASPAR HM, 1991, MYCOSES, V34, P251, DOI 10.1111/j.1439-0507.1991.tb00653.x; DUNLOP AAS, 1994, AUST NZ J OPHTHALMOL, V22, P105, DOI 10.1111/j.1442-9071.1994.tb00775.x; Galarreta DJ, 2007, CORNEA, V26, P1082, DOI 10.1097/ICO.0b013e318142bff3; Gopinathan U, 2002, CORNEA, V21, P555, DOI 10.1097/00003226-200208000-00004; Höfling-Lima Ana Luisa, 2005, Arq. Bras. Oftalmol., V68, P21, DOI 10.1590/S0004-27492005000100005; Ibrahim MM, 2011, ARQ BRAS OFTALMOL, V74, P7, DOI 10.1590/S0004-27492011000100002; Ibrahim MM, 2009, EUR J OPHTHALMOL, V19, P355, DOI 10.1177/112067210901900305; Johnson GJ, 2004, EYE, V18, P1235, DOI 10.1038/sj.eye.6701369; Jurkunas U, 2009, CORNEA, V28, P638, DOI 10.1097/ICO.0b013e318191695b; Kaiserman I, 2005, AM J OPHTHALMOL, V139, P498, DOI 10.1016/j.ajo.2004.10.022; Kotigadde Subbannayya, 1992, Indian Journal of Ophthalmology, V40, P31; Laspina F, 2004, GRAEF ARCH CLIN EXP, V242, P204, DOI 10.1007/s00417-003-0808-4; Leck AK, 2002, BRIT J OPHTHALMOL, V86, P1211, DOI 10.1136/bjo.86.11.1211; Lin SH, 1999, OCCUP ENVIRON MED, V56, P423, DOI 10.1136/oem.56.6.423; ODAY DM, 1987, CORNEA, V6, P238, DOI 10.1097/00003226-198706040-00002; Ou Judy I, 2007, Int Ophthalmol Clin, V47, P7, DOI 10.1097/IIO.0b013e318074e727; Passos RM, 2010, ARQ BRAS OFTALMOL, V73, P315, DOI 10.1590/S0004-27492010000400002; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; ROSA RH, 1994, OPHTHALMOLOGY, V101, P1005; Saha R, 2006, INDIAN J MED RES, V123, P159; Tuft SJ, 2009, EYE, V23, P1308, DOI 10.1038/eye.2008.298; Wilhelmus KR, 2005, AM J OPHTHALMOL, V140, P1156, DOI 10.1016/j.ajo.2005.07.032; Xie LX, 2006, OPHTHALMOLOGY, V113, P1943, DOI 10.1016/j.ophtha.2006.05.035; Yilmaz Safiye, 2007, International Ophthalmology, V27, P261, DOI 10.1007/s10792-007-9069-2	26	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33775	10.1371/journal.pone.0033775	http://dx.doi.org/10.1371/journal.pone.0033775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457787	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900024
J	Marzinzik, F; Wahl, M; Kruger, D; Gentschow, L; Colla, M; Klostermann, F				Marzinzik, Frank; Wahl, Michael; Krueger, Doris; Gentschow, Laura; Colla, Michael; Klostermann, Fabian			Abnormal Distracter Processing in Adults with Attention-Deficit-Hyperactivity Disorder	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN ACTIVITY; DEFICIT/HYPERACTIVITY DISORDER; NOVELTY P3; SELECTIVE ATTENTION; ORIENTING RESPONSE; INHIBITORY CONTROL; STIMULUS DEVIANCE; VISUAL-STIMULI; RATING-SCALE	Background: Subjects with Attention-Deficit Hyperactivity Disorder (ADHD) are overdistractible by stimuli out of the intended focus of attention. This control deficit could be due to primarily reduced attentional capacities or, e. g., to overshooting orienting to unexpected events. Here, we aimed at identifying disease-related abnormalities of novelty processing and, therefore, studied event-related potentials (ERP) to respective stimuli in adult ADHD patients compared to healthy subjects. Methods: Fifteen unmedicated subjects with ADHD and fifteen matched controls engaged in a visual oddball task (OT) under simultaneous EEG recordings. A target stimulus, upon which a motor response was required, and non-target stimuli, which did not demand a specific reaction, were presented in random order. Target and most non-target stimuli were presented repeatedly, but some non-target stimuli occurred only once ('novels'). These unique stimuli were either 'relative novels' with which a meaning could be associated, or 'complete novels', if no association was available. Results: In frontal recordings, a positive component with a peak latency of some 400 ms became maximal after novels. In healthy subjects, this novelty-P3 (or 'orienting response') was of higher magnitude after complete than after relative novels, in contrast to the patients with an undifferentially high frontal responsivity. Instead, ADHD patients tended to smaller centro-parietal P3 responses after target signals and, on a behavioural level, responded slower than controls. Conclusion: The results demonstrate abnormal novelty processing in adult subjects with ADHD. In controls, the ERP pattern indicates that allocation of meaning modulates the processing of new stimuli. However, in ADHD such a modulation was not prevalent. Instead, also familiar, only context-wise new stimuli were treated as complete novels. We propose that disturbed semantic processing of new stimuli resembles a mechanism for excessive orienting to commonly negligible stimuli in ADHD.	[Marzinzik, Frank; Wahl, Michael; Krueger, Doris; Klostermann, Fabian] Charite, Dept Neurol, D-13353 Berlin, Germany; [Marzinzik, Frank; Gentschow, Laura; Colla, Michael] Charite, Dept Psychiat, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Marzinzik, F (corresponding author), Charite, Dept Neurol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	fabian.klostermann@charite.de			German Research Foundation (DFG) [KL 1276/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG KL 1276/4-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R, 2009, CHILD NEUROPSYCHOL, V15, P120, DOI 10.1080/09297040802169077; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bledowski C, 2004, NEUROIMAGE, V22, P530, DOI 10.1016/j.neuroimage.2003.12.034; Boonstra AM, 2010, NEUROPSYCHOLOGY, V24, P209, DOI 10.1037/a0017670; Booth JR, 2005, J CHILD PSYCHOL PSYC, V46, P94, DOI 10.1111/j.1469-7610.2004.00337.x; Brazdil M, 1999, NEUROPHYSIOL CLIN, V29, P339, DOI 10.1016/S0987-7053(99)90047-3; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; Cycowicz YM, 2004, CLIN NEUROPHYSIOL, V115, P1359, DOI 10.1016/j.clinph.2004.01.008; Daffner KR, 2000, J COGNITIVE NEUROSCI, V12, P393, DOI 10.1162/089892900562219; Daffner KR, 2005, NEUROBIOL AGING, V26, P1283, DOI 10.1016/j.neurobiolaging.2004.11.007; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Depue BE, 2010, NEUROPSYCHOLOGIA, V48, P3909, DOI 10.1016/j.neuropsychologia.2010.09.013; Dien J, 2003, COGNITIVE BRAIN RES, V17, P637, DOI 10.1016/S0926-6410(03)00188-5; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dopheide JA, 2009, PHARMACOTHERAPY, V29, P656, DOI 10.1592/phco.29.6.656; Ebert D., 2003, Nervenarzt, V74, P939; Escera C, 2003, EUR J NEUROSCI, V18, P2408, DOI 10.1046/j.1460-9568.2003.02937.x; Fallgatter AJ, 2005, PSYCHIAT RES-NEUROIM, V138, P157, DOI 10.1016/j.pscychresns.2004.12.002; First MB., STRUCTURED CLIN INTE; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Friedman D, 1998, PSYCHOPHYSIOLOGY, V35, P508, DOI 10.1017/S0048577298970664; Friedman D, 2009, HUM BRAIN MAPP, V30, P1144, DOI 10.1002/hbm.20587; Goldstein A, 2002, PSYCHOPHYSIOLOGY, V39, P781, DOI 10.1017/S004857720201048X; Gumenyuk V, 2005, NEUROSCI LETT, V374, P212, DOI 10.1016/j.neulet.2004.10.081; Gumenyuk V, 2004, PSYCHOPHYSIOLOGY, V41, P30, DOI 10.1111/1469-8986.00123; Gumenyuk V, 2001, NEUROSCI LETT, V314, P147, DOI 10.1016/S0304-3940(01)02308-4; He B, 2001, HUM BRAIN MAPP, V12, P120, DOI 10.1002/1097-0193(200102)12:2<120::AID-HBM1009>3.0.CO;2-V; HOLCOMB PJ, 1986, INT J PSYCHOPHYSIOL, V3, P263, DOI 10.1016/0167-8760(86)90035-8; HOLCOMB PJ, 1985, PSYCHOPHYSIOLOGY, V22, P656, DOI 10.1111/j.1469-8986.1985.tb01663.x; JOHNSON R, 1978, ELECTROEN CLIN NEURO, V44, P424, DOI 10.1016/0013-4694(78)90027-5; Kemner C, 1996, BIOL PSYCHIAT, V40, P522, DOI 10.1016/0006-3223(95)00429-7; Knight R.T., 1990, EVENT RELATED BRAIN, P3; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Liotti M, 2005, CORTEX, V41, P377, DOI 10.1016/S0010-9452(08)70274-0; Lynn R, 1966, INT SERIES MONOGRAPH, V3; Mecklinger A, 1997, NEUROSCI LETT, V235, P65, DOI 10.1016/S0304-3940(97)00712-X; Moss SB, 2007, PRIMARY CARE, V34, P445, DOI 10.1016/j.pop.2007.05.005; Nigg JT, 2002, J CONSULT CLIN PSYCH, V70, P153, DOI 10.1037/0022-006X.70.1.153; Opitz B, 1999, CEREB CORTEX, V9, P379, DOI 10.1093/cercor/9.4.379; Pavlov I.P., 1927, CONDITIONED REFLEXES; POLICH J, 1990, PSYCHOPHYSIOLOGY, V27, P396, DOI 10.1111/j.1469-8986.1990.tb02333.x; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ranganath C, 1999, J COGNITIVE NEUROSCI, V11, P598, DOI 10.1162/089892999563661; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; Rosler M, 2004, NERVENARZT, V75, P888, DOI 10.1007/s00115-003-1622-2; SATTERFIELD JH, 1990, BIOL PSYCHIAT, V28, P879, DOI 10.1016/0006-3223(90)90569-N; SOKOLOV EN, 1990, PAVLOVIAN J BIOL SCI, V25, P142; Solanto MV, 2009, J NEUROIMAGING, V19, P205, DOI 10.1111/j.1552-6569.2008.00289.x; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tamm L, 2006, AM J PSYCHIAT, V163, P1033, DOI 10.1176/appi.ajp.163.6.1033; Uebel H, 2010, J CHILD PSYCHOL PSYC, V51, P210, DOI 10.1111/j.1469-7610.2009.02139.x; VERLEGER R, 1994, COGNITIVE BRAIN RES, V2, P103, DOI 10.1016/0926-6410(94)90007-8; Vila J, 2007, INT J PSYCHOPHYSIOL, V66, P169, DOI 10.1016/j.ijpsycho.2007.07.004; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Zang YF, 2005, BRAIN DEV-JPN, V27, P544, DOI 10.1016/j.braindev.2004.11.009	60	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33691	10.1371/journal.pone.0033691	http://dx.doi.org/10.1371/journal.pone.0033691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	940QX	22457783	Green Published, Green Submitted, gold			2022-12-27	WOS:000303909200035
J	Croy, I; Negoias, S; Novakova, L; Landis, BN; Hummel, T				Croy, Ilona; Negoias, Simona; Novakova, Lenka; Landis, Basile N.; Hummel, Thomas			Learning about the Functions of the Olfactory System from People without a Sense of Smell	PLOS ONE			English	Article							QUALITY-OF-LIFE; OLDER-ADULTS; DYSFUNCTION; DISORDERS; DEPRESSION; IMPAIRMENT; ANOSMIA; IMPACT; TASTE; POPULATION	The olfactory system provides numerous functions to humans, influencing ingestive behavior, awareness of environmental hazards and social communication. Approximately 1/5 of the general population exhibit an impaired sense of smell. However, in contrast to the many affected, only few patients complain of their impairment. So how important is it for humans to have an intact sense of smell? Or is it even dispensable, at least in the Western world? To investigate this, we compared 32 patients, who were born without a sense of smell (isolated congenital anosmia - ICA) with 36 age-matched controls. A broad questionnaire was used, containing domains relevant to olfaction in daily life, along with a questionnaire about social relationships and the BDI-questionnaire. ICA-patients differed only slightly from controls in functions of daily life related to olfaction. These differences included enhanced social insecurity, increased risk for depressive symptoms and increased risk for household accidents. In these domains the sense of olfaction seems to play a key role.	[Croy, Ilona; Negoias, Simona; Novakova, Lenka; Landis, Basile N.; Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Croy, Ilona] Univ Dresden, Sch Med, Dept Psychosomat Med, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Croy, I (corresponding author), Univ Dresden, Sch Med, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany.	ilona.croy@tu-dresden.de	Martinec Nováková, Lenka/F-6474-2015	Martinec Nováková, Lenka/0000-0002-5695-2903; Croy, Ilona/0000-0002-0361-5559; Negoias, Simona/0000-0001-9435-8860	SSMBS [PASMA-119579/1]	SSMBS	BNL was supported by a Grant of the Swiss National Fund for Scientific Research (SSMBS grant no PASMA-119579/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolmaali ND, 2002, AM J NEURORADIOL, V23, P157; Asendorpf JB, 1997, DIAGNOSTICA, V43, P289; Asendorpf JB, 2000, J SOC PERS RELAT, V17, P115, DOI 10.1177/0265407500171006; Boesveldt S, 2011, RHINOLOGY, V49, P324, DOI 10.4193/Rhino10.155; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Frasnelli J, 2005, EUR ARCH OTO-RHINO-L, V262, P231, DOI 10.1007/s00405-004-0796-y; Gudziol V, 2009, J SEX MED, V6, P1924, DOI 10.1111/j.1743-6109.2009.01266.x; Hautzinger M., 1995, BECK DEPRESSIONS INV; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Lombion-Pouthier S, 2006, J AFFECT DISORDERS, V90, P187, DOI 10.1016/j.jad.2005.11.012; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Negoias S, 2010, NEUROSCIENCE, V169, P415, DOI 10.1016/j.neuroscience.2010.05.012; Pause BM, 2003, PSYCHOPHYSIOLOGY, V40, P209, DOI 10.1111/1469-8986.00023; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; Schubert CR, 2011, CHEM SENSES; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Shu CH, 2011, RHINOLOGY, V49, P337, DOI 10.4193/Rhino10.130; Smeets M, 2009, REHABIL PSYCHOL, V54; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Tennen H., 1991, SMELL TASTE HLTH DIS, P787; Van Toller S, 1999, CHEM SENSES, V24, P705, DOI 10.1093/chemse/24.6.705; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Vowles RH, 1997, INT J PEDIATR OTORHI, V41, P207, DOI 10.1016/S0165-5876(97)00075-X	32	88	93	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33365	10.1371/journal.pone.0033365	http://dx.doi.org/10.1371/journal.pone.0033365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YN	22457756	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100031
J	Sabri, F; Cole, JA; Scarbrough, MC; Leventis, N				Sabri, Firouzeh; Cole, Judith A.; Scarbrough, Michael C.; Leventis, Nicholas			Investigation of Polyurea-Crosslinked Silica Aerogels as a Neuronal Scaffold: A Pilot Study	PLOS ONE			English	Article							ACOUSTIC PROPERTIES; GROWTH	Background: Polymer crosslinked aerogels are an attractive class of materials for future implant applications particularly as a biomaterial for the support of nerve growth. The low density and nano-porous structure of this material combined with large surface area, high mechanical strength, and tunable surface properties, make aerogels materials with a high potential in aiding repair of injuries of the peripheral nervous system. However, the interaction of neurons with aerogels remains to be investigated. Methodology: In this work the attachment and growth of neurons on clear polyurea crosslinked silica aerogels (PCSA) coated with: poly-L-lysine, basement membrane extract (BME), and laminin1 was investigated by means of optical and scanning electron microscopy. After comparing the attachment and growth capability of neurons on these different coatings, laminin1 and BME were chosen for nerve cell attachment and growth on PCSA surfaces. The behavior of neurons on treated petri dish surfaces was used as the control and behavior of neurons on treated PCSA discs was compared against it. Conclusions/Significance: This study demonstrates that: 1) untreated PCSA surfaces do not support attachment and growth of nerve cells, 2) a thin application of laminin1 layer onto the PCSA discs adhered well to the PCSA surface while also supporting growth and differentiation of neurons as evidenced by the number of processes extended and b3-tubulin expression, 3) three dimensional porous structure of PCSA remains intact after fixing protocols necessary for preservation of biological samples and 4) laminin1 coating proved to be the most effective method for attaching neurons to the desired regions on PCSA discs. This work provides the basis for potential use of PCSA as a biomaterial scaffold for neural regeneration.	[Sabri, Firouzeh] Univ Memphis, Dept Phys, Memphis, TN 38152 USA; [Cole, Judith A.; Scarbrough, Michael C.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Leventis, Nicholas] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO USA	University of Memphis; University of Memphis; University of Missouri System; Missouri University of Science & Technology	Sabri, F (corresponding author), Univ Memphis, Dept Phys, Memphis, TN 38152 USA.	fsabri@memphis.edu						Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075; Alberts B., 2004, ESSENTIAL CELL BIOL; Ayers MR, 2001, J NON-CRYST SOLIDS, V285, P123, DOI 10.1016/S0022-3093(01)00442-2; Banker G., 1991, CULTURING NERVE CELL; Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7; Coradin T, 2004, COLLOID SURFACE B, V35, P53, DOI 10.1016/j.colsurfb.2004.02.008; Forest L, 1998, ULTRASONICS, V36, P477, DOI 10.1016/S0041-624X(97)00149-2; FRICKE J, 1992, INT J HEAT MASS TRAN, V35, P2305, DOI 10.1016/0017-9310(92)90073-2; Fricke J., 1986, SPRINGER P PHYS; GIBIAT V, 1995, J NON-CRYST SOLIDS, V186, P244, DOI 10.1016/0022-3093(95)00049-6; GRONAUER M, 1986, ACUSTICA, V59, P177; Hanzawa Y, 1996, LANGMUIR, V12, P6167, DOI 10.1021/la960481t; Husing N, 1998, ANGEW CHEM INT EDIT, V37, P23, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<22::AID-ANIE22>3.0.CO;2-I; Kistler SS, 1931, NATURE, V127, P741, DOI 10.1038/127741a0; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; LEIN PJ, 1989, DEV BIOL, V136, P330, DOI 10.1016/0012-1606(89)90260-1; Leventis N, 2002, NANO LETT, V2, P957, DOI 10.1021/nl025690e; Leventis N, 2007, ACCOUNTS CHEM RES, V40, P874, DOI 10.1021/ar600033s; Li Y., 2001, BIOTECHNOL BIOPROC E, V6, P311, DOI [10.1007/BF02932999, DOI 10.1007/BF02932999]; Long Y, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2896111; Lyons L, 1999, 76 ANN M SE SECT APS, V54; MCKEEHAN WL, 1976, J CELL BIOL, V71, P727, DOI 10.1083/jcb.71.3.727; Mikos Antonios G., 2000, EJB Electronic Journal of Biotechnology, V3, P1; Pierre AC, 2002, CHEM REV, V102, P4243, DOI 10.1021/cr0101306; Power M, 2001, J NON-CRYST SOLIDS, V285, P303, DOI 10.1016/S0022-3093(01)00471-9; Ren L, 2001, J NON-CRYST SOLIDS, V285, P116, DOI 10.1016/S0022-3093(01)00441-0; Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0; Sabri F, 2011, P 3 ANN ORNL BIOM SC; Smirnova I, 2004, J NON-CRYST SOLIDS, V350, P54, DOI 10.1016/j.jnoncrysol.2004.06.031; Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058; Yin W, 2010, J BIOMED MATER RES A, V92A, P1431, DOI 10.1002/jbm.a.32476	32	32	33	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33242	10.1371/journal.pone.0033242	http://dx.doi.org/10.1371/journal.pone.0033242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448239	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700029
J	Belderbos, ME; Levy, O; Stalpers, F; Kimpen, JL; Meyaard, L; Bont, L				Belderbos, Mirjam E.; Levy, Ofer; Stalpers, Femke; Kimpen, Jan L.; Meyaard, Linde; Bont, Louis			Neonatal Plasma Polarizes TLR4-Mediated Cytokine Responses towards Low IL-12p70 and High IL-10 Production via Distinct Factors	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; TNF-ALPHA PRODUCTION; DENDRITIC CELLS; INNATE IMMUNITY; HUMAN MONOCYTES; HUMAN NEWBORN; LIPOPOLYSACCHARIDE; ACTIVATION; LPS; INTERLEUKIN-12	Human neonates are highly susceptible to infection, which may be due in part to impaired innate immune function. Neonatal Toll-like receptor (TLR) responses are biased against the generation of pro-inflammatory/Th1-polarizing cytokines, yet the underlying mechanisms are incompletely defined. Here, we demonstrate that neonatal plasma polarizes TLR4-mediated cytokine production. When exposed to cord blood plasma, mononuclear cells (MCs) produced significantly lower TLR4-mediated IL-12p70 and higher IL-10 compared to MC exposed to adult plasma. Suppression by neonatal plasma of TLR4-mediated IL-12p70 production, but not induction of TLR4-mediated IL-10 production, was maintained up to the age of 1 month. Cord blood plasma conferred a similar pattern of MC cytokine responses to TLR3 and TLR8 agonists, demonstrating activity towards both MyD88-dependent and MyD88-independent agonists. The factor causing increased TLR4-mediated IL-10 production by cord blood plasma was heat-labile, lost after protein depletion and independent of lipoprotein binding protein (LBP) or soluble CD14 (sCD14). The factor causing inhibition of TLR4-mediated IL-12p70 production by cord blood plasma was resistant to heat inactivation or protein depletion and was independent of IL-10, vitamin D and prostaglandin E2. In conclusion, human neonatal plasma contains at least two distinct factors that suppress TLR4-mediated IL-12p70 production or induce IL-10 or production. Further identification of these factors will provide insight into the ontogeny of innate immune development and might identify novel targets for the prevention and treatment of neonatal infection.	[Belderbos, Mirjam E.; Stalpers, Femke; Kimpen, Jan L.; Meyaard, Linde; Bont, Louis] Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands; [Levy, Ofer] Childrens Hosp Boston, Div Infect Dis, Boston, MA USA; [Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA	Utrecht University; Utrecht University Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Belderbos, ME (corresponding author), Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands.	m.belderbos@umcutrecht.nl		Belderbos, Mirjam/0000-0002-6164-2918; Levy, Ofer/0000-0002-5859-1945; Meyaard, Linde/0000-0003-0707-4793	Netherlands Asthma Foundation [3.2.07.001]; Alexandre Suerman Foundation; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [AI067353-01A1]; American Recovery and Reinvestment Act [3R01AI067353-05S1]; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067353] Funding Source: NIH RePORTER	Netherlands Asthma Foundation; Alexandre Suerman Foundation; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Recovery and Reinvestment Act; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grants from the Netherlands Asthma Foundation (grant no. 3.2.07.001 to LB), the Alexandre Suerman Foundation (to MEB), the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID RO1 #AI067353-01A1 to OL), the American Recovery and Reinvestment Act (Supplement 3R01AI067353-05S1 to OL) and a Global Health Award from the Bill and Melinda Gates Foundation (to OL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Al-Hertani W, 2007, CLIN INVEST MED, V30, pE44; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Belderbos ME, 2011, PEDIATRICS, V127, pE1513, DOI 10.1542/peds.2010-3054; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; Chavez-Sanchez L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-117; Firth Matthew A., 2005, Animal Health Research Reviews, V6, P143, DOI 10.1079/AHR2005107; Forster-Waldl E, 2005, PEDIATR RES, V58, P121, DOI 10.1203/01.PDR.0000163397.53466.0F; Goriely S, 2001, J IMMUNOL, V166, P2141, DOI 10.4049/jimmunol.166.3.2141; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hasko G, 2000, BRIT J PHARMACOL, V129, P909, DOI 10.1038/sj.bjp.0703134; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; ISHIDA M, 1988, PEDIATR NEPHROL, V2, P166, DOI 10.1007/BF00870399; Jansen K, 2008, J IMMUNOL METHODS, V336, P183, DOI 10.1016/j.jim.2008.04.013; Kalinski P, 2001, BLOOD, V97, P3466, DOI 10.1182/blood.V97.11.3466; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Lappalainen M, 2009, PEDIAT ALLERG IMM-UK, V20, P714, DOI 10.1111/j.1399-3038.2009.00865.x; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Lee SM, 1996, BLOOD, V88, P945; LeMoine O, 1996, J IMMUNOL, V156, P4408; Levy O, 2005, J ENDOTOXIN RES, V11, P113, DOI 10.1179/096805105X37376; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Loscher CE, 2005, J IMMUNOL, V175, P4990, DOI 10.4049/jimmunol.175.8.4990; Maldonado Y, 2001, INFECT DIS FETUS NEW, P2; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; MITCHELL MD, 1978, PROSTAGLANDINS, V16, P319, DOI 10.1016/0090-6980(78)90033-3; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Okazaki N, 2011, J BIOCHEM, V149, P265, DOI 10.1093/jb/mvq136; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; Szeles L, 2009, J IMMUNOL, V182, P2074, DOI 10.4049/jimmunol.0803345; Waggoner SN, 2005, J IMMUNOL, V175, P4706, DOI 10.4049/jimmunol.175.7.4706; Wang XC, 2007, J CLIN IMMUNOL, V27, P193, DOI 10.1007/s10875-006-9068-5; Wittmann M, 1999, J IMMUNOL, V162, P6763; Wynn JL, 2010, CLIN PERINATOL, V37, P307, DOI 10.1016/j.clp.2010.04.001; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105	42	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33419	10.1371/journal.pone.0033419	http://dx.doi.org/10.1371/journal.pone.0033419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442690	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500031
J	Derrick, SC; Dao, D; Yang, A; Kolibab, K; Jacobs, WR; Morris, SL				Derrick, Steven C.; Dao, Dee; Yang, Amy; Kolibab, Kris; Jacobs, William R.; Morris, Sheldon L.			Formulation of a mmaA4 Gene Deletion Mutant of Mycobacterium bovis BCG in Cationic Liposomes Significantly Enhances Protection against Tuberculosis	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; CD4 T-CELLS; ORAL VACCINATION; CHALLENGE; INFECTION; MEMORY; INDUCTION; EFFICACY; IMMUNITY; RISK	A new vaccination strategy is urgently needed for improved control of the global tuberculosis (TB) epidemic. Using a mouse aerosol Mycobacterium tuberculosis challenge model, we investigated the protective efficacy of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG (Delta mmaA4BCG) formulated in dimethyl dioctadecyl ammonium bromide (DDA) - D(+) trehalose 6,6 dibenenate (TDB) (DDA/TDB) adjuvant. In previous studies, deletion of the mmaA4 gene was shown to reduce the suppression of IL-12 production often seen after mycobacterial infections. While the non-adjuvanted Delta mmaA4BCG strain did not protect mice substantially better than conventional BCG against a tuberculous challenge in four protection experiments, the protective responses induced by the Delta mmaA4BCG vaccine formulated in DDA/TDB adjuvant was consistently increased relative to nonadjuvanted BCG controls. Furthermore, the Delta mmaA4BCG-DDA/TDB vaccine induced significantly higher frequencies of multifunctional (MFT) CD4 T cells expressing both IFN gamma and TNF alpha (double positive) or IFN gamma, TNF alpha and IL-2 (triple positive) than CD4 T cells derived from mice vaccinated with BCG. These MFT cells were characterized by having higher IFN gamma and TNF alpha median fluorescence intensity (MFI) values than monofunctional CD4 T cells. Interestingly, both BCG/adjuvant and Delta mmaA4BCG/adjuvant formulations induced significantly higher frequencies of CD4 T cells expressing TNF alpha and IL-2 than nonadjuvanted BCG or Delta mmaA4BCG vaccines indicating that BCG/adjuvant mixtures may be more effective at inducing central memory T cells. Importantly, when either conventional BCG or the mutant were formulated in adjuvant and administered to SCID mice or immunocompromised mice depleted of IFN gamma, significantly lower vaccine-derived mycobacterial CFU were detected relative to immunodeficient mice injected with non-adjuvanted BCG. Overall, these data suggest that immunization with the Delta mmaA4BCG/adjuvant formulation may be an effective, safe, and relatively inexpensive alternative to vaccination with conventional BCG.	[Derrick, Steven C.; Yang, Amy; Kolibab, Kris; Morris, Sheldon L.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA; [Dao, Dee; Jacobs, William R.] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10467 USA	US Food & Drug Administration (FDA); Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Derrick, SC (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA.	steven.derrick@fda.hhs.gov		Jacobs, William/0000-0003-3321-3080	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aldwell FE, 2006, VACCINE, V24, P2071, DOI 10.1016/j.vaccine.2005.11.017; Aldwell FE, 2005, INFECT IMMUN, V73, P1903, DOI 10.1128/IAI.73.3.1903-1905.2005; Beresford B, 2010, CLIN INFECT DIS, V50, pS178, DOI 10.1086/651489; Buddle BM, 2005, VACCINE, V23, P3581, DOI 10.1016/j.vaccine.2005.01.150; Christensen D, 2009, J LIPOSOME RES, V19, P2, DOI 10.1080/08982100902726820; Clark S, 2008, INFECT IMMUN, V76, P3771, DOI 10.1128/IAI.00052-08; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Corner LAL, 2010, VACCINE, V28, P6265, DOI 10.1016/j.vaccine.2010.06.120; Dao D., 2008, PLOS PATHOG, V4, P1; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Dietrich J, 2007, J IMMUNOL, V178, P3721, DOI 10.4049/jimmunol.178.6.3721; Eriksen J, 2010, THORAX, V65, P1067, DOI 10.1136/thx.2010.140186; FINE PEM, 1990, LANCET, V335, P1016, DOI 10.1016/0140-6736(90)91074-K; Fine PEM, 2001, SCAND J INFECT DIS, V33, P243, DOI 10.1080/003655401300077144; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Hatherill M, 2010, VACCINE, V28, P4550, DOI 10.1016/j.vaccine.2010.04.088; Henricksen-Lacy M, 2009, J CONTROL RELEASE, V142, P180; Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Orme IM, 2010, TUBERCULOSIS, V90, P329, DOI 10.1016/j.tube.2010.06.002; Ottenhoff TH, 2010, HUM VACCINES, V6, P1007, DOI 10.4161/hv.6.12.13143; Parida SK, 2010, CURR OPIN IMMUNOL, V22, P374, DOI 10.1016/j.coi.2010.04.006; Pulickal AS, 2007, INDIAN PEDIATR, V44, P344; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Tsukamoto T, 2009, J VIROL, V83, P9339, DOI 10.1128/JVI.01120-09; UNAIDS website, 2008, GLOB REP UNAIDS; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W	37	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32959	10.1371/journal.pone.0032959	http://dx.doi.org/10.1371/journal.pone.0032959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442674	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500016
J	Huo, ZM; Bissett, SL; Giemza, R; Beddows, S; Oeser, C; Lewis, DJM				Huo, Zhiming; Bissett, Sara L.; Giemza, Raphaela; Beddows, Simon; Oeser, Clarissa; Lewis, David J. M.			Systemic and Mucosal Immune Responses to Sublingual or Intramuscular Human Papilloma Virus Antigens in Healthy Female Volunteers	PLOS ONE			English	Article							TOXIN-B-SUBUNIT; CHOLERA-TOXIN; HPV VACCINE; IMMUNIZATION; NEUTRALIZATION; ANTIBODIES; INFECTION; ADJUVANTS; EFFICACY; DISEASE	The sublingual route has been proposed as a needle-free option to induce systemic and mucosal immune protection against viral infections. In a translational study of systemic and mucosal humoral immune responses to sublingual or systemically administered viral antigens, eighteen healthy female volunteers aged 19-31 years received three immunizations with a quadravalent Human Papilloma Virus vaccine at 0, 4 and 16 weeks as sublingual drops (SL, n = 12) or intramuscular injection (IM, n = 6). IM antigen delivery induced or boosted HPV-specific serum IgG and pseudovirus-neutralizing antibodies, HPV-specific cervical and vaginal IgG, and elicited circulating IgG and IgA antibody secreting cells. SL antigens induced similar to 38-fold lower serum and similar to 2-fold lower cervical/vaginal IgG than IM delivery, and induced or boosted serum virus neutralizing antibody in only 3/12 subjects. Neither route reproducibly induced HPV-specific mucosal IgA. Alternative delivery systems and adjuvants will be required to enhance and evaluate immune responses following sublingual immunization in humans.	[Huo, Zhiming; Giemza, Raphaela; Oeser, Clarissa] St Georges Univ London, London, England; [Bissett, Sara L.; Beddows, Simon] Hlth Protect Agcy, Virus Reference Dept, London, England; [Lewis, David J. M.] Univ Surrey, Surrey Clin Res Ctr, Guildford GU2 5XH, Surrey, England	St Georges University London; Health Protection Agency; University of Surrey	Huo, ZM (corresponding author), St Georges Univ London, London, England.	d.j.lewis@surrey.ac.uk		Lewis, David JM/0000-0003-3105-9075; Beddows, Simon/0000-0002-6879-6215	European Community [201038]; MRC [G0701217] Funding Source: UKRI; Medical Research Council [G0701217] Funding Source: researchfish	European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the European Community (http://cordis.europa.eu/fp7/) Seventh Framework Programme (FP7/2002-2013) under grant agreement 201038, "EuroNeut-41". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Cho HJ, 2010, VACCINE, V28, P2598, DOI 10.1016/j.vaccine.2010.01.013; CLEMENS JD, 1986, J INFECT DIS, V154, P175, DOI 10.1093/infdis/154.1.175; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; CZERKINSKY C, 2010, CURR TOP MICROBIOL I; Czerkinsky C, 2011, HUM VACCINES, V7, P110, DOI 10.4161/hv.7.1.13739; Desai S, 2011, SEX TRANSM DIS, V38, P622, DOI 10.1097/OLQ.0b013e31820bc880; Draper E, 2011, VACCINE, V29, P8585, DOI 10.1016/j.vaccine.2011.09.021; Ferguson M, 2011, VACCINE, V29, P6520, DOI 10.1016/j.vaccine.2011.07.007; Frati F, 2007, ALLERGY ASTHMA PROC, V28, P35, DOI 10.2500/aap.2007.28.2919; Frazer I, 2007, INT J INFECT DIS, V11, pS10, DOI 10.1016/S1201-9712(07)60016-2; Hervouet C, 2010, VACCINE, V28, P5582, DOI 10.1016/j.vaccine.2010.06.033; Holmgren J, 2005, IMMUNOL LETT, V97, P181, DOI 10.1016/j.imlet.2004.11.009; Jit M, 2007, BRIT J CANCER, V97, P989, DOI 10.1038/sj.bjc.6603955; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; LEVINE MM, 1978, INFECT IMMUN, V21, P158, DOI 10.1128/IAI.21.1.158-162.1978; Lewis DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025165; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; LEWIS DJM, 1991, EUR J IMMUNOL, V21, P2087, DOI 10.1002/eji.1830210917; Mills KHG, 2003, INFECT IMMUN, V71, P726, DOI 10.1128/IAI.71.2.726-732.2003; Moingeon P, 2011, IMMUNOL ALLERGY CLIN, V31, P407, DOI 10.1016/j.iac.2011.03.001; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pomfret TC, 2011, J CLIN PHARM THER, V36, P1, DOI 10.1111/j.1365-2710.2009.01150.x; Schiller JT, 2010, ANNU REV MICROBIOL, V64, P23, DOI 10.1146/annurev.micro.112408.134019; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105	27	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33736	10.1371/journal.pone.0033736	http://dx.doi.org/10.1371/journal.pone.0033736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438987	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100091
J	Kwee, LC; Liu, YT; Haynes, C; Gibson, JR; Stone, A; Schichman, SA; Kamel, F; Nelson, LM; Topol, B; Van Den Eeden, SK; Tanner, CM; Cudkowicz, ME; Grasso, DL; Lawson, R; Muralidhar, S; Oddone, EZ; Schmidt, S; Hauser, MA				Kwee, Lydia Coulter; Liu, Yutao; Haynes, Carol; Gibson, Jason R.; Stone, Annjanette; Schichman, Steven A.; Kamel, Freya; Nelson, Lorene M.; Topol, Barbara; Van Den Eeden, Stephen K.; Tanner, Caroline M.; Cudkowicz, Merit E.; Grasso, Daniela L.; Lawson, Robert; Muralidhar, Sumitra; Oddone, Eugene Z.; Schmidt, Silke; Hauser, Michael A.			A High-Density Genome-Wide Association Screen of Sporadic ALS in US Veterans	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; RISK-FACTOR; GENE; EXPOSURE; SUSCEPTIBILITY; SURVIVAL; DIAGNOSIS; CRITERIA; SMOKING	Following reports of an increased incidence of amyotrophic lateral sclerosis (ALS) in U. S. veterans, we have conducted a high-density genome-wide association study (GWAS) of ALS outcome and survival time in a sample of U. S. veterans. We tested,1.3 million single nucleotide polymorphisms (SNPs) for association with ALS outcome in 442 incident Caucasian veteran cases diagnosed with definite or probable ALS and 348 Caucasian veteran controls. To increase power, we also included genotypes from 5909 publicly-available non-veteran controls in the analysis. In the survival analysis, we tested for association between SNPs and post-diagnosis survival time in 639 Caucasian veteran cases with definite or probable ALS. After this discovery phase, we performed follow-up genotyping of 299 SNPs in an independent replication sample of Caucasian veterans and non-veterans (ALS outcome: 183 cases and 961 controls; survival: 118 cases). Although no SNPs reached genome-wide significance in the discovery phase for either phenotype, three SNPs were statistically significant in the replication analysis of ALS outcome: rs6080539 (177 kb from PCSK2), rs7000234 (4 kb from ZNF704), and rs3113494 (13 kb from LOC100506746). Two SNPs located in genes that were implicated by previous GWA studies of ALS were marginally significant in the pooled analysis of discovery and replication samples: rs17174381 in DPP6 (p = 4.4x10(-4)) and rs6985069 near ELP3 (p = 4.8x10(-4)). Our results underscore the difficulty of identifying and convincingly replicating genetic associations with a rare and genetically heterogeneous disorder such as ALS, and suggest that common SNPs are unlikely to account for a substantial proportion of patients affected by this devastating disorder.	[Kwee, Lydia Coulter; Liu, Yutao; Gibson, Jason R.; Oddone, Eugene Z.; Schmidt, Silke; Hauser, Michael A.] Durham Vet Affairs Med Ctr, Epidemiol Res & Informat Ctr, Durham, NC 27705 USA; [Kwee, Lydia Coulter; Liu, Yutao; Haynes, Carol; Gibson, Jason R.; Schmidt, Silke; Hauser, Michael A.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA; [Kwee, Lydia Coulter; Liu, Yutao; Haynes, Carol; Gibson, Jason R.; Oddone, Eugene Z.; Schmidt, Silke; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Stone, Annjanette; Schichman, Steven A.] Cent Arkansas Vet Healthcare Syst, Pathol & Lab Med Serv, Little Rock, AR USA; [Stone, Annjanette; Schichman, Steven A.] Cent Arkansas Vet Healthcare Syst, Res Serv, Little Rock, AR USA; [Schichman, Steven A.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Kamel, Freya] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC USA; [Nelson, Lorene M.; Topol, Barbara] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA; [Van Den Eeden, Stephen K.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Tanner, Caroline M.] Parkinsons Inst, Sunnyvale, CA USA; [Cudkowicz, Merit E.; Grasso, Daniela L.; Lawson, Robert] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neurol Clin Trial Unit, Boston, MA USA; [Muralidhar, Sumitra] Dept Vet Affairs, Off Res & Dev, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Stanford University; Kaiser Permanente; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kwee, LC (corresponding author), Durham Vet Affairs Med Ctr, Epidemiol Res & Informat Ctr, Durham, NC 27705 USA.	mike.hauser@duke.edu	CUDKOWICZ, MERIT/GWM-6585-2022; Nelson, Lorene M/D-1305-2011	CUDKOWICZ, MERIT/0000-0002-7075-1681; Kamel, Freya/0000-0001-5052-6615	Office of Research and Development, Cooperative Studies Program, Department of Veterans Affairs [CSP] [500B, 500A, 478]; National Institute of Environmental Health Sciences/National Institutes of Health [R01 ES 013244]; ALS Association [ALSA 1230]; National Institutes of Health; National Institute of Environmental Health Sciences [Z01-ES049005, R01-ES08150]; National Institute of Neurological Disorders and Stroke/National Institutes of Health [R01 NS 031964]; ALS Therapy Alliance; Wellcome Trust [076113, 085475]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049005, Z01ES049005, R01ES013244, R01ES008150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031964] Funding Source: NIH RePORTER	Office of Research and Development, Cooperative Studies Program, Department of Veterans Affairs [CSP]; National Institute of Environmental Health Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ALS Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Neurological Disorders and Stroke/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Therapy Alliance; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge support for this work from the Office of Research and Development, Cooperative Studies Program, Department of Veterans Affairs [CSP #500B]. The GENEVA study was supported by National Institute of Environmental Health Sciences/National Institutes of Health [R01 ES 013244] and the ALS Association [ALSA 1230]. The National Registry of Veterans with ALS and its DNA bank were supported by the Office of Research and Development, Cooperative Studies Program, Department of Veterans Affairs [CSP #500A, CSP #478]. The study was supported in part by the intramural research program of the National Institutes of Health, by National Institute of Environmental Health Sciences [Z01-ES049005]. The GEM study was supported by the National Institute of Environmental Health Sciences [R01-ES08150] and the National Institute of Neurological Disorders and Stroke/National Institutes of Health [R01 NS 031964]. The NEALS consortium was supported by the ALS Association and the ALS Therapy Alliance. This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113 and 085475. This study was overseen by an Executive Committee appointed by the Veterns Affairs (VA): Mary Brophy, MD, MPH; MAH, PhD; Donald Humphries, PhD; LCK, PhD; EZO, MD, MHSc; SAS, MD, PhD; SS, PhD. The VA Cooperative Studies Program provided policies and requirements for conducting the research, contributed to study design, and provided administrative review of the paper but did not alter the contents. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 2008, NEUROEPIDEMIOLOGY, V30, P180, DOI 10.1159/000126910; Beghi E, 2010, AMYOTROPH LATERAL SC, V11, P289, DOI 10.3109/17482960903384283; Binazzi A, 2009, AMYOTROPH LATERAL SC, V10, P361, DOI 10.3109/17482960802382313; Bonvicini F, 2010, ANN I SUPER SANITA, V46, P284, DOI 10.4415/ANN_10_03_10; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; CAMPBELL AM, 1970, J NEUROL NEUROSUR PS, V33, P877, DOI 10.1136/jnnp.33.6.877; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2009, HUM MOL GENET, V18, P1524, DOI 10.1093/hmg/ddp059; Cronin S, 2009, EUR J HUM GENET, V17, P213, DOI 10.1038/ejhg.2008.194; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Fang F, 2010, AM J EPIDEMIOL, V171, P1126, DOI 10.1093/aje/kwq063; Fernandez-Santiago R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.04.018; Gallo V, 2009, ANN NEUROL, V65, P378, DOI 10.1002/ana.21653; GRESHAM L S, 1986, Neuroepidemiology, V5, P29, DOI 10.1159/000110810; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Horner RD, 2008, NEUROEPIDEMIOLOGY, V31, P28, DOI 10.1159/000136648; Jawaid A, 2010, AMYOTROPH LATERAL SC, V11, P542, DOI 10.3109/17482968.2010.482592; Kamel F, 2005, NEURODEGENER DIS, V2, P195, DOI 10.1159/000089625; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Leak TS, 2007, MOL GENET METAB, V92, P145, DOI 10.1016/j.ymgme.2007.05.014; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Mata IF, 2004, HUM MOL GENET, V13, pR127, DOI 10.1093/hmg/ddh089; Mattsson P, 2010, J NEUROL NEUROSURG P; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Schmidt S, 2008, NEUROEPIDEMIOLOGY, V30, P191, DOI 10.1159/000126911; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Shatunov A, 2010, LANCET NEUROL, V9, P986, DOI 10.1016/S1474-4422(10)70197-6; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Sutedja NA, 2011, J NEUROL NEUROSUR PS, V82, P638, DOI 10.1136/jnnp.2010.236752; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P302, DOI 10.3109/17482960802455416; Traynor BJ, 2010, P NATL ACAD SCI USA, V107, P12335, DOI 10.1073/pnas.0914079107; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3; Van Es MA, 2009, AMYOTROPH LATERAL SC, V10, P441, DOI 10.3109/17482960802673042; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Wang H, 2011, ARCH NEUROL-CHICAGO, V68, P207, DOI 10.1001/archneurol.2010.367; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; YOSHIDA H, 1995, DIABETES, V44, P389, DOI 10.2337/diabetes.44.4.389; Zheng X, 2011, MOL BIOL REP	50	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32768	10.1371/journal.pone.0032768	http://dx.doi.org/10.1371/journal.pone.0032768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470424	gold, Green Submitted, Green Published			2022-12-27	WOS:000304489000008
J	Montgomery, AL; Morris, SK; Bassani, DG; Kumar, R; Jotkar, R; Jha, P				Montgomery, Ann L.; Morris, Shaun K.; Bassani, Diego G.; Kumar, Rajesh; Jotkar, Raju; Jha, Prabhat			Factors Associated with Physician Agreement and Coding Choices of Cause of Death Using Verbal Autopsies for 1130 Maternal Deaths in India	PLOS ONE			English	Article							POLITICAL PRIORITY; MORTALITY	Background: The Indian Sample Registration System (SRS) with verbal autopsy methods provides estimations of cause specific mortality for maternal deaths, where the majority of deaths occur at home, unregistered. We aim to examine factors that influence physician agreement and coding choices in assigning causes of death from verbal autopsies. Methodology/Principal Findings: Among adult deaths identified in the SRS, pregnancy-related deaths recorded in 2001-2003 were assigned ICD-10 codes by two independent physicians. Inter-rater reliability was estimated using Landis Koch Kappa classification <= 4-poor to fair agreement; >0.4 <= 0.6-moderate agreement; >0.6 <= 0.8-substantial agreement; >0.8-high agreement. We identified factors associated with physician agreement using multivariate logistic regression. A central consensus panel reviewed cases for errors and reclassified as needed based on 2011 ICD-10 coding guidelines. Of 1130 pregnancy-related deaths, 1040 were assigned ICD-10 codes by two physicians. We found substantial agreement regardless of the woman's residence, whether the death was registered, religion, respondent's or deceased's education, age, hospital admission or gestational age. Physician agreement was not influenced by the above variables, with the exception of greater agreement in cases where the respondent did not live with the deceased, or early gestational age at the time of death. A central consensus panel reviewed all cases and recoded 10% of cases due to insufficient use of information in the verbal autopsy by the coding physicians and rationale for this reclassification are discussed. Conclusion: In the absence of complete vital registration and universal healthcare services, physician coded verbal autopsies continues to be heavily relied upon to ascertain pregnancy-related death. From this study, two independent physicians had good inter-rater reliability for assigning pregnancy-related causes of death in a nationally-represented sample, and physician coding does not appear to be heavily influenced by case characteristics or demographics.	[Montgomery, Ann L.; Morris, Shaun K.; Jotkar, Raju; Jha, Prabhat] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Montgomery, Ann L.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Morris, Shaun K.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Bassani, Diego G.; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kumar, Rajesh] Post Grad Inst Med Educ, Sch Publ Hlth, Chandigarh, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Montgomery, AL (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ann.montgomery@utoronto.ca	Bassani, Diego/G-2827-2015	Bassani, Diego/0000-0001-6704-3820; Jha, Prabhat/0000-0001-7067-8341	US National Institutes of Health; Canadian Institute of Health Research; International Development Research Centre; Sick Kids Foundation; Paediatric Chairs of Canada; March of Dimes	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); International Development Research Centre; Sick Kids Foundation; Paediatric Chairs of Canada; March of Dimes(March of Dimes)	This work was supported by the US National Institutes of Health, Canadian Institute of Health Research, International Development Research Centre, and Li Ka Shing Knowledge Institute. Shaun K. Morris is a Fellow of the Pediatric Scientist Development Program. The project described was also supported by grants from Sick Kids Foundation, Paediatric Chairs of Canada, and the March of Dimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Byass P, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-1; CGHR, 2003, MILL DEATH STUD; Chan M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000223; Cross S, 2010, B WORLD HEALTH ORGAN, V88, P147, DOI 10.2471/BLT.09.063537; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Fottrell Edward, 2007, Popul Health Metr, V5, P1, DOI 10.1186/1478-7954-5-1; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Ganatra BR, 1998, B WORLD HEALTH ORGAN, V76, P591; Graham WJ, 2007, AM J PUBLIC HEALTH, V97, P978, DOI 10.2105/AJPH.2005.073692; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Joshi R, 2009, B WORLD HEALTH ORGAN, V87, P678, DOI 10.2471/BLT.07.049288; Kumar R, 2006, Indian J Public Health, V50, P90; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lopez AD, 2007, LANCET, V370, P1744, DOI 10.1016/S0140-6736(07)61419-6; Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-32; Midhet F, 2008, INT J HEALTH SCI-IJH, V2, P91; Montgomery AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014637; Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583; NCCEMD, 2009, SAV MOTH 2005 2007 4; Ordi J, 2009, PLOS MED, V6, P174, DOI 10.1371/journal.pmed.1000036; Reichenheim ME, 2004, STATA J, V4, P421, DOI 10.1177/1536867X0400400404; RGI, 2009, SPEC B MAT MORT IND; RGI CGHR, 2005, PROSP STUD SRS VERB; RGI-CGHR SC, 2006, PROSP STUD ONE MILL; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Shiffman J, 2007, BJOG-INT J OBSTET GY, V114, P785, DOI 10.1111/j.1471-0528.2007.01374.x; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2010, TRENDS MAT MORT 1990	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33075	10.1371/journal.pone.0033075	http://dx.doi.org/10.1371/journal.pone.0033075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470436	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000014
J	Pellin, D; Miotto, P; Ambrosi, A; Cirillo, DM; Di Serio, C				Pellin, Danilo; Miotto, Paolo; Ambrosi, Alessandro; Cirillo, Daniela Maria; Di Serio, Clelia			A Genome-Wide Identification Analysis of Small Regulatory RNAs in Mycobacterium tuberculosis by RNA-Seq and Conservation Analysis	PLOS ONE			English	Article							HIGH-THROUGHPUT; ALIGNMENT; EXPRESSION; PREDICTION; TARGETS; GUIDE; TOOL	We propose a new method for smallRNAs (sRNAs) identification. First we build an effective target genome (ETG) by means of a strand-specific procedure. Then we propose a new bioinformatic pipeline based mainly on the combination of two types of information: the first provides an expression map based on RNA-seq data (Reads Map) and the second applies principles of comparative genomics leading to a Conservation Map. By superimposing these two maps, a robust method for the search of sRNAs is obtained. We apply this methodology to investigate sRNAs in Mycobacterium tuberculosis H37Rv. This bioinformatic procedure leads to a total list of 1948 candidate sRNAs. The size of the candidate list is strictly related to the aim of the study and to the technology used during the verification process. We provide performance measures of the algorithm in identifying annotated sRNAs reported in three recent published studies.	[Pellin, Danilo; Ambrosi, Alessandro; Di Serio, Clelia] Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci, Milan, Italy; [Miotto, Paolo; Cirillo, Daniela Maria] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Pellin, D (corresponding author), Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci, Milan, Italy.	iserio.clelia@hsr.it	Di Serio, Clelia/AAO-5494-2020; Cirillo, Daniela Maria/AAB-3646-2019; ambrosi, alessandro/H-4424-2011; Miotto, Paolo/E-3940-2017	Cirillo, Daniela Maria/0000-0001-6415-1535; ambrosi, alessandro/0000-0003-1976-5663; Miotto, Paolo/0000-0003-4610-2427; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058	European Community [FP7-223681]	European Community(European Commission)	For this publication, the research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement FP7-223681. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama T, 2009, J BACTERIOL, V191, P3321, DOI 10.1128/JB.00120-09; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Cao Y, 2009, BIOINFORMATION, V3, P364, DOI 10.6026/97320630003364; Chaisson M, 2004, BIOINFORMATICS, V20, P2067, DOI 10.1093/bioinformatics/bth205; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DiChiara JM, 2010, NUCLEIC ACIDS RES, V38, P4067, DOI 10.1093/nar/gkq101; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu JM, 2010, CURR OPIN MICROBIOL, V13, P18, DOI 10.1016/j.mib.2009.11.004; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pichon C, 2003, BIOINFORMATICS, V19, P1707, DOI 10.1093/bioinformatics/btg235; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Sridhar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011970; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Storz G, 2007, CURR OPIN MICROBIOL, V10, P93, DOI 10.1016/j.mib.2007.03.017; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170	37	34	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32723	10.1371/journal.pone.0032723	http://dx.doi.org/10.1371/journal.pone.0032723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470422	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000006
J	Sandona, D; Desaphy, JF; Camerino, GM; Bianchini, E; Ciciliot, S; Danieli-Betto, D; Dobrowolny, G; Furlan, S; Germinario, E; Goto, K; Gutsmann, M; Kawano, F; Nakai, N; Ohira, T; Ohno, Y; Picard, A; Salanova, M; Schiffl, G; Blottner, D; Musaro, A; Ohira, Y; Betto, R; Conte, D; Schiaffino, S				Sandona, Dorianna; Desaphy, Jean-Francois; Camerino, Giulia M.; Bianchini, Elisa; Ciciliot, Stefano; Danieli-Betto, Daniela; Dobrowolny, Gabriella; Furlan, Sandra; Germinario, Elena; Goto, Katsumasa; Gutsmann, Martina; Kawano, Fuminori; Nakai, Naoya; Ohira, Takashi; Ohno, Yoshitaka; Picard, Anne; Salanova, Michele; Schiffl, Gudrun; Blottner, Dieter; Musaro, Antonio; Ohira, Yoshinobu; Betto, Romeo; Conte, Diana; Schiaffino, Stefano			Adaptation of Mouse Skeletal Muscle to Long-Term Microgravity in the MDS Mission	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ATROPHIED SOLEUS MUSCLE; FAST-TWITCH MUSCLES; HEAT-STRESS; FIBER SIZE; HINDLIMB SUSPENSION; GENE-EXPRESSION; TRANSGENIC MICE; SATELLITE CELL; SPACEFLIGHT	The effect of microgravity on skeletal muscles has so far been examined in rat and mice only after short-term (5-20 day) spaceflights. The mice drawer system (MDS) program, sponsored by Italian Space Agency, for the first time aimed to investigate the consequences of long-term (91 days) exposure to microgravity in mice within the International Space Station. Muscle atrophy was present indistinctly in all fiber types of the slow-twitch soleus muscle, but was only slightly greater than that observed after 20 days of spaceflight. Myosin heavy chain analysis indicated a concomitant slow-to-fast transition of soleus. In addition, spaceflight induced translocation of sarcolemmal nitric oxide synthase-1 (NOS1) into the cytosol in soleus but not in the fast-twitch extensor digitorum longus (EDL) muscle. Most of the sarcolemmal ion channel subunits were up-regulated, more in soleus than EDL, whereas Ca2+-activated K+ channels were down-regulated, consistent with the phenotype transition. Gene expression of the atrophy-related ubiquitin-ligases was up-regulated in both spaceflown soleus and EDL muscles, whereas autophagy genes were in the control range. Muscle-specific IGF-1 and interleukin-6 were down-regulated in soleus but up-regulated in EDL. Also, various stress-related genes were up-regulated in spaceflown EDL, not in soleus. Altogether, these results suggest that EDL muscle may resist to microgravity-induced atrophy by activating compensatory and protective pathways. Our study shows the extended sensitivity of antigravity soleus muscle after prolonged exposition to microgravity, suggests possible mechanisms accounting for the resistance of EDL, and individuates some molecular targets for the development of countermeasures.	[Sandona, Dorianna; Bianchini, Elisa; Picard, Anne] Univ Padua, Dept Biomed Sci, Padua, Italy; [Desaphy, Jean-Francois; Camerino, Giulia M.; Conte, Diana] Univ Bari, Dept Pharmacobiol, Pharmacol Sect, I-70121 Bari, Italy; [Ciciliot, Stefano; Danieli-Betto, Daniela; Germinario, Elena] Univ Padua, Dept Human Anat & Physiol, Padua, Italy; [Dobrowolny, Gabriella; Musaro, Antonio] Univ Roma La Sapienza, IIM, DAHFMO Unit Histol & Med Embryol, Rome, Italy; [Furlan, Sandra; Betto, Romeo] CNR, Inst Neurosci, Padua, Italy; [Goto, Katsumasa; Ohno, Yoshitaka] Toyohashi Sozo Univ, Grad Sch Hlth Sci, Dept Physiol, Toyohashi, Aichi, Japan; [Gutsmann, Martina; Salanova, Michele; Schiffl, Gudrun; Blottner, Dieter] Charite, D-13353 Berlin, Germany; [Gutsmann, Martina; Salanova, Michele; Schiffl, Gudrun; Blottner, Dieter] Zentrum Weltraummed Berlin, Berlin, Germany; [Kawano, Fuminori; Nakai, Naoya; Ohira, Takashi; Ohira, Yoshinobu] Osaka Univ, Grad Sch Med & Frontier Biosci, Suita, Osaka 565, Japan; [Schiaffino, Stefano] Venetian Inst Mol Med, Padua, Italy	University of Padua; Universita degli Studi di Bari Aldo Moro; University of Padua; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Osaka University; Veneto Institute Molecular Medicine	Sandona, D (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	romeo.betto@bio.unipd.it; conte@farmbiol.uniba.it; stefano.schiaffino@vimm.it	Camerino, Giulia Maria/I-6896-2013; Desaphy, Jean-Francois/T-6191-2019; Goto, Katsumasa/T-6789-2019; Musaro, Antonio/P-2953-2019; Ciciliot, Stefano/L-3887-2019; sandona, dorianna/AAB-9480-2020; Musarò, Antonio/K-9598-2016	Desaphy, Jean-Francois/0000-0001-8816-9369; Goto, Katsumasa/0000-0001-5380-4561; Musaro, Antonio/0000-0002-2944-9739; Ciciliot, Stefano/0000-0002-5833-6581; Musarò, Antonio/0000-0002-2944-9739; Bianchini, Elisa/0000-0002-8341-8095; Camerino, Giulia Maria/0000-0003-1410-6327; DANIELI, DANIELA/0000-0002-6186-8327; Blottner, Dieter/0000-0003-0355-3340; Schiaffino, Stefano/0000-0002-5607-6421; Conte, Diana/0000-0003-0162-9698; Dobrowolny, Gabriella/0000-0001-8693-0724	Italian Space Agency [OSMA WP1B12, WP1B21, WP 1B23-3, WP1B51-5]; German Aerospace Center; Deutschen Zentrums fur Luft-und Raumfahrt; Bonn-Oberkassel [50WB0821]; Japan Society for the Promotion of Science [S-19100009, B-20300218]; Association Francaise contre les Myopathies [14999]; Italian Consiglio Nazionale delle Ricerche; Grants-in-Aid for Scientific Research [20300218] Funding Source: KAKEN	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR)); Deutschen Zentrums fur Luft-und Raumfahrt; Bonn-Oberkassel; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Italian Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by funds from the Italian Space Agency (OSMA WP1B12 and WP1B21, DCC; WP 1B23-3, AM; WP1B51-5, SS), German Aerospace Center, Deutschen Zentrums fur Luft-und Raumfahrt, Bonn-Oberkassel (grant #50WB0821, DB), Grant-in-Aid for Scientific Research (S-19100009, YO; B-20300218, KG) from Japan Society for the Promotion of Science, from Association Francaise contre les Myopathies (grant #14999, RB), from Italian Consiglio Nazionale delle Ricerche (RB), and from 7FP-Myoage (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Allen DL, 1996, J APPL PHYSIOL, V81, P145, DOI 10.1152/jappl.1996.81.1.145; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; CAIOZZO VJ, 1994, J APPL PHYSIOL, V76, P1764, DOI 10.1152/jappl.1994.76.4.1764; Cancedda Ranieri, 2002, J Gravit Physiol, V9, pP337; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Criswell DS, 1998, AM J PHYSIOL-ENDOC M, V275, pE373; Danieli-Betto D, 2005, AM J PHYSIOL-REG I, V289, pR1328, DOI 10.1152/ajpregu.00673.2004; Desaphy JF, 2010, PHARMACOL RES, V61, P553, DOI 10.1016/j.phrs.2010.01.012; Desaphy JF, 2005, NEUROBIOL DIS, V18, P356, DOI 10.1016/j.nbd.2004.09.016; DESPLANCHES D, 1991, EUR J APPL PHYSIOL O, V63, P288, DOI 10.1007/BF00233864; DESPLANCHES D, 1990, J APPL PHYSIOL, V68, P48, DOI 10.1152/jappl.1990.68.1.48; EDGERTON VR, 1995, J APPL PHYSIOL, V78, P1733, DOI 10.1152/jappl.1995.78.5.1733; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Fitts RH, 2001, J EXP BIOL, V204, P3201; Goto K, 2004, JPN J PHYSIOL, V54, P285, DOI 10.2170/jjphysiol.54.285; Goto K, 2003, PFLUG ARCH EUR J PHY, V447, P247, DOI 10.1007/s00424-003-1177-x; HAIDA N, 1989, EXP NEUROL, V103, P68, DOI 10.1016/0014-4886(89)90187-8; Hansen G, 2004, PFLUG ARCH EUR J PHY, V448, P239, DOI 10.1007/s00424-003-1230-9; Harrison BC, 2003, J APPL PHYSIOL, V95, P2462, DOI 10.1152/japplphysiol.00603.2003; Hikida RS, 1997, ANAT REC, V247, P350, DOI 10.1002/(SICI)1097-0185(199703)247:3<350::AID-AR6>3.0.CO;2-Y; Ishihara A, 2008, J PHYSIOL SCI, V58, P413, DOI 10.2170/physiolsci.RP000808; JIANG B, 1992, J APPL PHYSIOL, V73, pS58, DOI 10.1152/jappl.1992.73.2.S58; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; Kawano F, 2007, AM J PHYSIOL-CELL PH, V293, pC35, DOI 10.1152/ajpcell.00297.2006; Kawano F, 2008, AM J PHYSIOL-CELL PH, V295, pC458, DOI 10.1152/ajpcell.00497.2007; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V331, P1301, DOI 10.1016/j.bbrc.2005.04.096; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Kraemer WJ, 2000, HISTOCHEM CELL BIOL, V114, P349; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MARTIN TP, 1988, J APPL PHYSIOL, V65, P2318, DOI 10.1152/jappl.1988.65.5.2318; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Masuda H, 1997, BIOCHEM BIOPH RES CO, V238, P528, DOI 10.1006/bbrc.1997.7188; Miura H, 2010, GENES CELLS, V15, P843, DOI 10.1111/j.1365-2443.2010.01422.x; Morey-Holton E. R., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P17; Musaro A, 2007, EXP GERONTOL, V42, P76, DOI 10.1016/j.exger.2006.05.004; Naito H, 2000, J APPL PHYSIOL, V88, P359, DOI 10.1152/jappl.2000.88.1.359; NAKANE M, 1993, FEBS LETT, V316, P175, DOI 10.1016/0014-5793(93)81210-Q; Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje; Ohira T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021044; Ohira Y, 2002, ADV SPACE RES, V30, P777, DOI 10.1016/S0273-1177(02)00395-2; OHIRA Y, 1992, J APPL PHYSIOL, V73, pS51, DOI 10.1152/jappl.1992.73.2.S51; Ohira Y, 1999, J APPL PHYSIOL, V87, P1776, DOI 10.1152/jappl.1999.87.5.1776; Ohno Y, 2011, CELLS TISSU IN PRESS; Pierno S, 2002, BRAIN, V125, P1510, DOI 10.1093/brain/awf162; Pierno S, 2007, J PHYSIOL-LONDON, V584, P983, DOI 10.1113/jphysiol.2007.141358; Riley DA, 1996, J APPL PHYSIOL, V81, P133, DOI 10.1152/jappl.1996.81.1.133; Rudnick J, 2004, FASEB J, V18, P1228, DOI 10.1096/fj.03-0792fje; Salanova M, 2009, HISTOCHEM CELL BIOL, V132, P383, DOI 10.1007/s00418-009-0624-y; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Schuenke MD, 2009, EUR J APPL PHYSIOL, V106, P885, DOI 10.1007/s00421-009-1091-9; Scicchitano BM, 2009, AGING-US, V1, P451, DOI 10.18632/aging.100050; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; Staron RS, 1998, HISTOCHEM CELL BIOL, V110, P73, DOI 10.1007/s004180050267; Stelzer JE, 2003, J APPL PHYSIOL, V95, P2425, DOI 10.1152/japplphysiol.01091.2002; Stevens L, 2000, AM J PHYSIOL-CELL PH, V279, pC1558, DOI 10.1152/ajpcell.2000.279.5.C1558; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Takeda I, 2009, J MUSCLE RES CELL M, V30, P145, DOI 10.1007/s10974-009-9183-z; Tidball JG, 1998, AM J PHYSIOL-CELL PH, V275, pC260, DOI 10.1152/ajpcell.1998.275.1.C260; Wang XD, 2006, AM J PHYSIOL-CELL PH, V290, pC981, DOI 10.1152/ajpcell.00298.2005; Washington TA, 2011, ACTA PHYSIOL, V202, P657, DOI 10.1111/j.1748-1716.2011.02281.x; Yamashita-Goto K, 2001, J APPL PHYSIOL, V91, P417, DOI 10.1152/jappl.2001.91.1.417; Yu Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002086; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	66	114	122	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33232	10.1371/journal.pone.0033232	http://dx.doi.org/10.1371/journal.pone.0033232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470446	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000018
J	Peeters, MW				Peeters, Maarten W.			Subject Positioning in the BOD POD (R) Only Marginally Affects Measurement of Body Volume and Estimation of Percent Body Fat in Young Adult Men	PLOS ONE			English	Article							AIR-DISPLACEMENT PLETHYSMOGRAPHY; PRECISION; VALIDITY; MODELS	Introduction: The aim of the study was to evaluate whether subject positioning would affect the measurement of raw body volume, thoracic gas volume, corrected body volume and the resulting percent body fat as assessed by air displacement plethysmography (ADP). Methods: Twenty-five young adult men (20.7 +/- 1.1y, BMI = 22.5 +/- 1.4 kg/m(2)) were measured using the BOD POD (R) system using a measured thoracic gas volume sitting in a 'forward bent' position and sitting up in a straight position in random order. Results: Raw body volume was 58 +/- 124 ml (p<0.05) higher in the 'straight' position compared to the 'bent' position. The mean difference in measured thoracic gas volume (bent-straight = -71 +/- 211 ml) was not statistically significant. Corrected body volume and percent body fat in the bent position consequently were on average 86 +/- 122 ml (p<0.05) and 0.5 +/- 0.7% (p<0.05) lower than in the straight position respectively. Conclusion: Although the differences reached statistical significance, absolute differences are rather small. Subject positioning should be viewed as a factor that may contribute to between-test variability and hence contribute to (in)precision in detecting small individual changes in body composition, rather than a potential source of systematic bias. It therefore may be advisable to pay attention to standardizing subject positioning when tracking small changes in PF are of interest. The cause of the differences is shown not to be related to changes in the volume of isothermal air in the lungs. It is hypothesized and calculated that the observed direction and magnitude of these differences may arise from the surface area artifact which does not take into account that a subject in the bent position exposes more skin to the air in the device therefore potentially creating a larger underestimation of the actual body volume due to the isothermal effect of air close to the skin.	Katholieke Univ Leuven, Res Ctr Exercise & Hlth, Dept Kinesiol, Louvain, Belgium	KU Leuven	Peeters, MW (corresponding author), Katholieke Univ Leuven, Res Ctr Exercise & Hlth, Dept Kinesiol, Louvain, Belgium.	maarten.peeters@faber.kuleuven.be			Research Foundation Flanders	Research Foundation Flanders(FWO)	The author is supported by the Research Foundation Flanders (http://www.fwo.be/Default.aspx) as a post doctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SD, 2005, EUR J CLIN NUTR, V59, P996, DOI 10.1038/sj.ejcn.1602202; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Collins AL, 2004, INT J OBESITY, V28, P80, DOI 10.1038/sj.ijo.0802466; Collins AL, 2003, EUR J CLIN NUTR, V57, P770, DOI 10.1038/sj.ejcn.1601609; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Fields DA, 2000, INT J OBESITY, V24, P200, DOI 10.1038/sj.ijo.0801113; Going S, 2005, HUMAN BODY COMPOSITI, P17; Higgins PB, 2001, OBES RES, V9, P326, DOI 10.1038/oby.2001.41; Hull Holly R, 2005, Dyn Med, V4, P8, DOI 10.1186/1476-5918-4-8; Jackson J., 2006, International Journal of Body Composition Research, V4, P169; King GA, 2006, J STRENGTH COND RES, V20, P95; McCrory MA, 1998, J APPL PHYSIOL, V84, P1475, DOI 10.1152/jappl.1998.84.4.1475; Peeters MW, 2011, J SPORT SCI, V29, P191, DOI 10.1080/02640414.2010.530677; Peeters MW., 2009, INT J BODY COMPOSITI, V7, P123; Shafer KJ, 2008, NUTRITION, V24, P148, DOI 10.1016/j.nut.2007.10.015; Siri W., 1961, TECHNIQUES MEASURING, P223; Vescovi JD, 2002, MED SCI SPORT EXER, V34, P282, DOI 10.1097/00005768-200202000-00016; WANG ZM, 1992, AM J CLIN NUTR, V56, P19, DOI 10.1093/ajcn/56.1.19; Wang ZM, 2002, AM J CLIN NUTR, V76, P968, DOI 10.1093/ajcn/76.5.968; Withers RT, 1999, AM J HUM BIOL, V11, P175, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;175::AID-AJHB5&gt;3.0.CO;2-C	21	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e32722	10.1371/journal.pone.0032722	http://dx.doi.org/10.1371/journal.pone.0032722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461887	Green Published, gold, Green Submitted			2022-12-27	WOS:000304118900006
J	Mingorance, C; Duluc, L; Chalopin, M; Simard, G; Ducluzeau, PH; Herrera, MD; De Sotomayor, MA; Andriantsitohaina, R				Mingorance, Carmen; Duluc, Lucie; Chalopin, Matthieu; Simard, Gilles; Ducluzeau, Pierre-Henri; Herrera, Maria Dolores; De Sotomayor, Maria Alvarez; Andriantsitohaina, Ramaroson			Propionyl-L-carnitine Corrects Metabolic and Cardiovascular Alterations in Diet-Induced Obese Mice and Improves Liver Respiratory Chain Activity	PLOS ONE			English	Article							HIGH-FAT DIET; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; OXIDATION; ACID; SUPPRESSION; EXTRACT; GLUCOSE; MODEL	Aims: Obesity is a primary contributor to acquired insulin resistance leading to the development of type 2 diabetes and cardiovascular alterations. The carnitine derivate, propionyl-L-carnitine (PLC), plays a key role in energy control. Our aim was to evaluate metabolic and cardiovascular effects of PLC in diet-induced obese mice. Methods: C57BL/6 mice were fed a high-fat diet for 9 weeks and then divided into two groups, receiving either free( vehicle-HF) or PLC-supplemented water (200 mg/kg/day) during 4 additional weeks. Standard diet-fed animals were used as lean controls (vehicle-ST). Body weight and food intake were monitored. Glucose and insulin tolerance tests were assessed, as well as the HOMA(IR), the serum lipid profile, the hepatic and muscular mitochondrial activity and the tissue nitric oxide (NO) liberation. Systolic blood pressure, cardiac and endothelial functions were also evaluated. Results: Vehicle-HF displayed a greater increase of body weight compared to vehicle-ST that was completely reversed by PLC treatment without affecting food intake. PLC improved the insulin-resistant state and reversed the increased total cholesterol but not the increase in free fatty acid, triglyceride and HDL/LDL ratio induced by high-fat diet. Vehicle-HF exhibited a reduced cardiac output/body weight ratio, endothelial dysfunction and tissue decrease of NO production, all of them being improved by PLC treatment. Finally, the decrease of hepatic mitochondrial activity by high-fat diet was reversed by PLC. Conclusions: Oral administration of PLC improves the insulin-resistant state developed by obese animals and decreases the cardiovascular risk associated to this metabolic alteration probably via correction of mitochondrial function.	[Mingorance, Carmen; Herrera, Maria Dolores; De Sotomayor, Maria Alvarez] Univ Seville, Dept Pharmacol, Sch Pharm, Seville, Spain; [Duluc, Lucie; Chalopin, Matthieu; Simard, Gilles; Ducluzeau, Pierre-Henri; Andriantsitohaina, Ramaroson] LUNAM Univ, Anger, France; [Duluc, Lucie; Chalopin, Matthieu; Simard, Gilles; Ducluzeau, Pierre-Henri; Andriantsitohaina, Ramaroson] INSERM U1063, Angers, France; [Simard, Gilles] Univ Angers, CHU Angers, Dept Biochem, Angers, France	University of Sevilla; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Mingorance, C (corresponding author), Univ Seville, Dept Pharmacol, Sch Pharm, Seville, Spain.	ramaroson.andriantsitohaina@univ-angers.fr	ducluzeau, pierre-henri/ABE-1092-2021; Herrera, María Dolores/B-6373-2008; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; de Sotomayor, Maria Alvarez/A-3838-2008	Herrera, María Dolores/0000-0001-7231-9537; de Sotomayor, Maria Alvarez/0000-0001-8466-1698; chalopin, matthieu/0000-0002-9285-8869; andriantsitohaina, ramaroson/0000-0002-4770-3585; Duluc, Lucie/0000-0002-5952-8008	Spanish Ministry of Education and Science; INSERM; Ministry of Education and Research	Spanish Ministry of Education and Science(Spanish Government); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministry of Education and Research	The work was supported by the following: to CM: Postgraduate National Program of FPU fellowship from the Spanish Ministry of Education and Science (www.educacion.es); to LD: recipient from INSERM and the Ministry of Education and Research (www.inserm.fr,www.enseignementsup-recherche.gouv.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Agouni A, 2007, FASEB J, V21, P2735, DOI 10.1096/fj.07-8079com; Allende-Vigo MZ, 2010, ENDOCR PRACT, V16, P692, DOI 10.4158/EP09340.RA; de Sotomayor MA, 2007, J VASC RES, V44, P354, DOI 10.1159/000102303; Amin KA, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-17; Binienda Zbigniew, 2003, Current Medicinal Chemistry - Central Nervous System Agents, V3, P275, DOI 10.2174/1568015033477659; Bueno R, 2005, LIFE SCI, V77, P2082, DOI 10.1016/j.lfs.2005.01.035; Calvani M, 2000, BASIC RES CARDIOL, V95, P75, DOI 10.1007/s003950050167; Cha Youn-Soo, 2003, Journal of Medicinal Food, V6, P163, DOI 10.1089/10966200360716562; Coffey JP, 2005, J HK COLL RADIOL, V8, P226; Crescenzo R, 2008, OBESITY, V16, P958, DOI 10.1038/oby.2008.10; De Sotomayor MA, 2007, FREE RADICAL RES, V41, P884, DOI 10.1080/10715760701416467; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fang CX, 2008, AM J PHYSIOL-HEART C, V295, pH1206, DOI 10.1152/ajpheart.00319.2008; Galinier M, 2005, ARCH MAL COEUR VAISS, V98, P39; Gastaldelli A, 2010, NUTR METAB CARDIOVAS, V20, P481, DOI 10.1016/j.numecd.2010.05.005; Kashyap SR, 2005, J CLIN ENDOCR METAB, V90, P1100, DOI 10.1210/jc.2004-0745; Ketonen J, 2010, CIRC J, V74, P1479, DOI 10.1253/circj.CJ-09-0661; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lee MS, 2006, J MED FOOD, V9, P468, DOI 10.1089/jmf.2006.9.468; Malgat MLT, 1999, MITOCHONDRIAL DIS; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Micheletti R, 1996, J CARDIOVASC PHARM, V27, P52, DOI 10.1097/00005344-199601000-00009; Mingorance C, 2011, NUTR REV, V69, P279, DOI 10.1111/j.1753-4887.2011.00387.x; Mingorance C, 2009, BRIT J NUTR, V102, P1145, DOI 10.1017/S0007114509389230; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Molnar J, 2005, CIRC RES, V96, P1178, DOI 10.1161/01.RES.0000168634.74330.ed; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Mynatt RL, 2009, DIABETES-METAB RES, V25, pS45, DOI 10.1002/dmrr.987; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Ortenblad N, 2005, BBA-MOL BASIS DIS, V1741, P206, DOI 10.1016/j.bbadis.2005.04.001; Power RA, 2007, DIABETOLOGIA, V50, P824, DOI 10.1007/s00125-007-0605-4; Rodriguez WE, 2006, AM J PHYSIOL-HEART C, V291, pH81, DOI 10.1152/ajpheart.01331.2005; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Siegner R, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-66; SILIPRANDI N, 1991, CARDIOVASC DRUG THER, V5, P11, DOI 10.1007/BF00128238; Ussher JR, 2009, DIABETES, V58, P1766, DOI 10.2337/db09-0011; Vial G, 2010, ACTA BIOCHIM POL, V57, P389; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Wiseman LR, 1998, DRUG AGING, V12, P243, DOI 10.2165/00002512-199812030-00006; Yu QJ, 2011, CARDIOVASC RES, V89, P516, DOI 10.1093/cvr/cvq349	43	30	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34268	10.1371/journal.pone.0034268	http://dx.doi.org/10.1371/journal.pone.0034268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457831	Green Published, gold			2022-12-27	WOS:000304046900060
J	Xu, XL; Bai, L; Chen, WS; Padilla, MT; Liu, YS; Kim, KC; Belinsky, SA; Lin, Y				Xu, Xiuling; Bai, Lang; Chen, Wenshu; Padilla, Mabel T.; Liu, Yushi; Kim, Kwang Chul; Belinsky, Steven A.; Lin, Yong			MUC1 Contributes to BPDE-Induced Human Bronchial Epithelial Cell Transformation through Facilitating EGFR Activation	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; TRAIL-INDUCED CYTOTOXICITY; TUMOR-NECROSIS-FACTOR; LUNG-CANCER; PSEUDOMONAS-AERUGINOSA; TNF-ALPHA; C-FLIP; PROGRESSION; EXPRESSION; CARCINOMA	Although it is well known that epidermal growth factor receptor (EGFR) is involved in lung cancer progression, whether EGFR contributes to lung epithelial cell transformation is less clear. Mucin 1 (MUC1 in human and Muc1 in animals), a glycoprotein component of airway mucus, is overexpressed in lung tumors; however, its role and underlying mechanisms in early stage lung carcinogenesis is still elusive. This study provides strong evidence demonstrating that EGFR and MUC1 are involved in bronchial epithelial cell transformation. Knockdown of MUC1 expression significantly reduced transformation of immortalized human bronchial epithelial cells induced by benzo[a]pyrene diol epoxide (BPDE), the active form of the cigarette smoke (CS) carcinogen benzo(a) pyrene (BaP)s. BPDE exposure robustly activated a pathway consisting of EGFR, Akt and ERK, and blocking this pathway significantly increased BPDE-induced cell death and inhibited cell transformation. Suppression of MUC1 expression resulted in EGFR destabilization and inhibition of the BPDE-induced activation of Akt and ERK and increase of cytotoxicity. These results strongly suggest an important role for EGFR in BPDE-induced transformation, and substantiate that MUC1 is involved in lung cancer development, at least partly through mediating carcinogen-induced activation of the EGFR-mediated cell survival pathway that facilitates cell transformation.	[Xu, Xiuling; Bai, Lang; Chen, Wenshu; Padilla, Mabel T.; Liu, Yushi; Belinsky, Steven A.; Lin, Yong] Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, Albuquerque, NM USA; [Kim, Kwang Chul] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; [Kim, Kwang Chul] Temple Univ, Lung Ctr, Sch Med, Philadelphia, PA 19122 USA	Lovelace Respiratory Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Xu, XL (corresponding author), Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, Albuquerque, NM USA.	ylin@lrri.org	Liu, Yushi/A-1533-2014	Liu, Yushi/0000-0003-4185-4187	NIEHS/NIH [R01ES017328]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017328] Funding Source: NIH RePORTER	NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by a grant from NIEHS/NIH (R01ES017328). http://www.niehs.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Arteaga CL, 2006, CANCER CELL, V9, P421, DOI 10.1016/j.ccr.2006.05.014; Baldus SE, 2004, CRIT REV CL LAB SCI, V41, P189, DOI 10.1080/10408360490452040; Bearz A, 2007, INT J BIOL MARKER, V22, P307, DOI 10.1177/172460080702200411; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; Burdick AD, 2003, CANCER RES, V63, P7825; Chen WS, 2007, CARCINOGENESIS, V28, P2114, DOI 10.1093/carcin/bgm133; Chen YT, 2010, AM J PATHOL, V177, P1255, DOI 10.2353/ajpath.2010.091129; Choi S, 2011, AM J RESP CELL MOL, V44, P255, DOI 10.1165/rcmb.2009-0323OC; Cohen Roger B, 2003, Clin Colorectal Cancer, V2, P246, DOI 10.3816/CCC.2003.n.006; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Goldkorn T, 2010, AM J RESP CELL MOL, V43, P259, DOI 10.1165/rcmb.2010-0220RT; Guang W, 2010, J BIOL CHEM, V285, P20547, DOI 10.1074/jbc.M110.121319; Guddo F, 1998, J CLIN PATHOL, V51, P667, DOI 10.1136/jcp.51.9.667; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim KC, 2008, AM J RESP CELL MOL, V39, P644, DOI 10.1165/rcmb.2008-0169TR; Kishino D, 2009, LUNG CANCER, V65, P284, DOI 10.1016/j.lungcan.2008.11.021; Koga T, 2007, AM J PHYSIOL-LUNG C, V293, pL693, DOI 10.1152/ajplung.00491.2006; Kufe DV, 2008, CANC BIOL THER, V7; Li XJ, 2005, CANCER BIOL THER, V4, P968, DOI 10.4161/cbt.4.9.1913; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li Z, 2011, J BIOL CHEM, V286, P21164, DOI 10.1074/jbc.M110.207571; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Lu WJ, 2006, J IMMUNOL, V176, P3890, DOI 10.4049/jimmunol.176.7.3890; McKenzie S, 2006, J CELL BIOCHEM, V97, P18, DOI 10.1002/jcb.20634; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Pirker R, 2009, CURR PHARM DESIGN, V15, P188, DOI 10.2174/138161209787002915; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Pochampalli MR, 2007, CANCER RES, V67, P6591, DOI 10.1158/0008-5472.CAN-06-4518; Puppala D, 2007, CARCINOGENESIS, V28, P639, DOI 10.1093/carcin/bgl169; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wheatley-Price P, 2008, CURR OPIN ONCOL, V20, P162, DOI 10.1097/CCO.0b013e3282f335a3; Wingo PA, 2003, CANCER-AM CANCER SOC, V97, P3133, DOI 10.1002/cncr.11380; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yatabe Y, 2008, CANCER RES, V68, P2106, DOI 10.1158/0008-5472.CAN-07-5211; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023	48	20	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33846	10.1371/journal.pone.0033846	http://dx.doi.org/10.1371/journal.pone.0033846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457794	Green Submitted, Green Published, gold			2022-12-27	WOS:000303909200037
J	Roth, S; Bisbal, M; Brocard, J; Bugnicourt, G; Saoudi, Y; Andrieux, A; Gory-Faure, S; Villard, C				Roth, Sophie; Bisbal, Mariano; Brocard, Jacques; Bugnicourt, Ghislain; Saoudi, Yasmina; Andrieux, Annie; Gory-Faure, Sylvie; Villard, Catherine			How Morphological Constraints Affect Axonal Polarity in Mouse Neurons	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; MECHANICAL TENSION; MICROTUBULE DYNAMICS; HIPPOCAMPAL-NEURONS; IN-VIVO; GROWTH; ESTABLISHMENT; POLARIZATION; CENTROSOME; ELONGATION	Neuronal differentiation is under the tight control of both biochemical and physical information arising from neighboring cells and micro-environment. Here we wished to assay how external geometrical constraints applied to the cell body and/or the neurites of hippocampal neurons may modulate axonal polarization in vitro. Through the use of a panel of non-specific poly-L-lysine micropatterns, we manipulated the neuronal shape. By applying geometrical constraints on the cell body we provided evidence that centrosome location was not predictive of axonal polarization but rather follows axonal fate. When the geometrical constraints were applied to the neurites trajectories we demonstrated that axonal specification was inhibited by curved lines. Altogether these results indicated that intrinsic mechanical tensions occur during neuritic growth and that maximal tension was developed by the axon and expressed on straight trajectories. The strong inhibitory effect of curved lines on axon specification was further demonstrated by their ability to prevent formation of multiple axons normally induced by cytochalasin or taxol treatments. Finally we provided evidence that microtubules were involved in the tension-mediated axonal polarization, acting as curvature sensors during neuronal differentiation. Thus, biomechanics coupled to physical constraints might be the first level of regulation during neuronal development, primary to biochemical and guidance regulations.	[Roth, Sophie; Bugnicourt, Ghislain; Villard, Catherine] Univ Grenoble 1, Grenoble, France; [Roth, Sophie; Bugnicourt, Ghislain; Villard, Catherine] CNRS, Consortium Rech Emergence Technol Avancees, Grenoble, France; [Roth, Sophie; Bugnicourt, Ghislain; Villard, Catherine] CNRS, Inst Neel, Grenoble, France; [Roth, Sophie; Bisbal, Mariano; Brocard, Jacques; Bugnicourt, Ghislain; Saoudi, Yasmina; Andrieux, Annie; Gory-Faure, Sylvie] Commissariat Energie Atom, iRTSV GPC, Grenoble, France; [Roth, Sophie; Bisbal, Mariano; Brocard, Jacques; Bugnicourt, Ghislain; Saoudi, Yasmina; Andrieux, Annie; Gory-Faure, Sylvie] Inst Natl Sante & Rech Med, GIN U836, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Roth, S (corresponding author), Amolf Inst, Grp Bioassembly & Org, Amsterdam, Netherlands.	annie.andrieux@ujf-grenoble.fr; Sylvie-gory-faure@ujf-grenoble.fr; catherine.villard@grenoble.cnrs.fr	saoudi, yasmina/AAW-7354-2020; Bisbal, Mariano/AAE-9308-2021; ANDRIEUX, ANNIE/B-2134-2017; Brocard, Jacques/I-3135-2017	Bisbal, Mariano/0000-0002-3870-6151; ANDRIEUX, ANNIE/0000-0002-4022-6405; Brocard, Jacques/0000-0002-0752-5737; Gory, Sylvie/0000-0001-5743-8079	ANR 'NeuroFETs' [ANR-07-PCVI-0007]; Nanosciences foundation (Grenoble)	ANR 'NeuroFETs'(French National Research Agency (ANR)); Nanosciences foundation (Grenoble)	This work was funded by ANR 'NeuroFETs' ANR-07-PCVI-0007 and by the Nanosciences foundation (Grenoble). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anava S, 2009, BIOPHYS J, V96, P1661, DOI 10.1016/j.bpj.2008.10.058; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Blaabjerg M, 2007, PROG BRAIN RES, V163, P85, DOI 10.1016/S0079-6123(07)63005-2; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; BRAY D, 1979, J CELL SCI, V37, P391; BRAY D, 1984, DEV BIOL, V102, P379, DOI 10.1016/0012-1606(84)90202-1; Buxton GA, 2010, PROG NEUROBIOL, V92, P478, DOI 10.1016/j.pneurobio.2010.08.003; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; de Anda FC, 2008, J CELL SCI, V121, P178, DOI 10.1242/jcs.023143; de Anda FC, 2010, J NEUROSCI, V30, P10391, DOI 10.1523/JNEUROSCI.0381-10.2010; DENNERLL TJ, 1989, J CELL BIOL, V109, P3073, DOI 10.1083/jcb.109.6.3073; DENNERLL TJ, 1988, J CELL BIOL, V107, P665, DOI 10.1083/jcb.107.2.665; Dequidt C, 2007, MOL BIOL CELL, V18, P3131, DOI 10.1091/mbc.E06-12-1101; DERRY WB, 1995, BIOCHEMISTRY-US, V34, P2203, DOI 10.1021/bi00007a014; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Eilers PHC, 2004, BIOINFORMATICS, V20, P623, DOI 10.1093/bioinformatics/btg454; Francisco H, 2007, BIOMATERIALS, V28, P3398, DOI 10.1016/j.biomaterials.2007.04.015; Jang KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015966; JORDAN MA, 1992, J CELL SCI, V102, P401; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Lamoureux P, 2002, J CELL BIOL, V159, P499, DOI 10.1083/jcb.200207174; Lamoureux P, 2010, DEV NEUROBIOL, V70, P135, DOI 10.1002/dneu.20764; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; Nam Y, 2006, BIOSENS BIOELECTRON, V22, P589, DOI 10.1016/j.bios.2006.01.027; Nishio T, 2009, J NEUROL, V256, pS306, DOI 10.1007/s00415-009-5244-x; O'Toole M, 2008, BIOPHYS J, V94, P2610, DOI 10.1529/biophysj.107.117424; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Rajagopalan J, 2010, BIOPHYS J, V99, P3208, DOI 10.1016/j.bpj.2010.09.029; Ribak CE, 2007, BRAIN RES REV, V55, P390, DOI 10.1016/j.brainresrev.2006.12.005; Seetapun D, 2010, CURR BIOL, V20, P979, DOI 10.1016/j.cub.2010.04.040; Shi P, 2009, CELL MOL BIOENG, V2, P464, DOI 10.1007/s12195-009-0097-z; Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z; Steinbach K, 2000, MICROSC RES TECHNIQ, V48, P12, DOI 10.1002/(SICI)1097-0029(20000101)48:1<12::AID-JEMT3>3.0.CO;2-O; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	47	30	30	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33623	10.1371/journal.pone.0033623	http://dx.doi.org/10.1371/journal.pone.0033623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457779	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100034
J	Scharf, I; Modlmeier, AP; Fries, S; Tirard, C; Foitzik, S				Scharf, Inon; Modlmeier, Andreas P.; Fries, Stephan; Tirard, Claire; Foitzik, Susanne			Characterizing the Collective Personality of Ant Societies: Aggressive Colonies Do Not Abandon Their Home	PLOS ONE			English	Article							NEST-SITE SELECTION; BEHAVIORAL SYNDROMES; DECISION-MAKING; LIFE-HISTORY; EMIGRATION; STRATEGIES; ECOLOGY; INTERFERENCE; EVOLUTION; DEFENSE	Animal groups can show consistent behaviors or personalities just like solitary animals. We studied the collective behavior of Temnothorax nylanderi ant colonies, including consistency in behavior and correlations between different behavioral traits. We focused on four collective behaviors (aggression against intruders, nest relocation, removal of infected corpses and nest reconstruction) and also tested for links to the immune defense level of a colony and a fitness component (per-capita productivity). Behaviors leading to an increased exposure of ants to micro-parasites were expected to be positively associated with immune defense measures and indeed colonies that often relocated to other nest sites showed increased immune defense levels. Besides, colonies that responded with low aggression to intruders or failed to remove infected corpses, showed a higher likelihood to move to a new nest site. This resembles the trade-off between aggression and relocation often observed in solitary animals. Finally, one of the behaviors, nest reconstruction, was positively linked to per-capita productivity, whereas other colony-level behaviors, such as aggression against intruders, showed no association, albeit all behaviors were expected to be important for fitness under field conditions. In summary, our study shows that ant societies exhibit complex personalities that can be associated to the physiology and fitness of the colony. Some of these behaviors are linked in suites of correlated behaviors, similar to personalities of solitary animals.	[Scharf, Inon; Modlmeier, Andreas P.; Fries, Stephan; Foitzik, Susanne] Johannes Gutenberg Univ Mainz, Inst Zool, D-6500 Mainz, Germany; [Tirard, Claire] Univ Paris 06, CNRS, UMR 7625, Lab Ecol & Evolut, Paris, France	Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Scharf, I (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Saarstr 21, D-6500 Mainz, Germany.	scharfi@uni-mainz.de	Scharf, Inon/AAF-2343-2020; Modlmeier, Andreas/H-3463-2019; Foitzik, Susanne/A-6504-2019	Scharf, Inon/0000-0002-8506-7161; Modlmeier, Andreas/0000-0002-3095-488X; Foitzik, Susanne/0000-0001-8161-6306	Minerva Stiftung; Deutsche Forschungsgemeinschaft [Fo 298/11]	Minerva Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by Minerva Stiftung grant for a post-doc researcher (to IS) and A Deutsche Forschungsgemeinschaft grant (Fo 298/11) to S. Foitzik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assendorpf J. B., 1990, METHODIKA, V4, P1; BENTON TG, 1992, P ROY SOC B-BIOL SCI, V247, P199, DOI 10.1098/rspb.1992.0029; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Bocher A, 2007, J EVOLUTION BIOL, V20, P2228, DOI 10.1111/j.1420-9101.2007.01424.x; Brockmann HJ, 2001, ADV STUD BEHAV, V30, P1, DOI 10.1016/S0065-3454(01)80004-8; Cerda X, 1998, OECOLOGIA, V113, P577, DOI 10.1007/s004420050411; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chapman BB, 2011, ANIM BEHAV, V82, P391, DOI 10.1016/j.anbehav.2011.05.019; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; CROSLAND MWJ, 1990, J INSECT BEHAV, V3, P359, DOI 10.1007/BF01052114; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Diez L, 2011, ANIM BEHAV, V81, P1171, DOI 10.1016/j.anbehav.2011.02.026; Dingemanse NJ, 2010, ANIM BEHAV, V79, P439, DOI 10.1016/j.anbehav.2009.11.024; Dornhaus A, 2004, ANIM BEHAV, V67, P959, DOI 10.1016/j.anbehav.2003.09.004; Fitzpatrick Benjamin M., 2009, BMC Ecology, V9, P12, DOI 10.1186/1472-6785-9-12; Foitzik S, 1998, BEHAV ECOL, V9, P367, DOI 10.1093/beheco/9.4.367; Foitzik S, 2003, J EVOLUTION BIOL, V16, P670, DOI 10.1046/j.1420-9101.2003.00562.x; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; Gotelli NJ, 2013, ECOSIMR 1 00; Herbers Joan M., 1995, Psyche (Cambridge), V102, P13, DOI 10.1155/1995/80574; Johnson JC, 2005, BEHAV ECOL SOCIOBIOL, V58, P390, DOI 10.1007/s00265-005-0943-5; KORONA R, 1989, BEHAV ECOL SOCIOBIOL, V25, P201, DOI 10.1007/BF00302919; Kortet R, 2007, BIOL J LINN SOC, V91, P475, DOI 10.1111/j.1095-8312.2007.00812.x; Krause J, 2002, LIVING GROUPS; Markert JA, 2007, OECOLOGIA, V154, P611, DOI 10.1007/s00442-007-0853-5; Michener C. D., 1964, Insectes Sociaux Paris, V11, P317, DOI 10.1007/BF02227433; Modlmeier AP, 2012, P ROY SOC B-BIOL SCI, V279, P2142, DOI 10.1098/rspb.2011.2376; Modlmeier AP, 2011, BEHAV ECOL, V22, P1026, DOI 10.1093/beheco/arr086; Moretz JA, 2007, BEHAV ECOL, V18, P556, DOI 10.1093/beheco/arm011; Pamminger T, 2011, BEHAV ECOL, V22, P255, DOI 10.1093/beheco/arq191; Pike N, 2004, ANIM BEHAV, V67, P909, DOI 10.1016/j.anbehav.2003.08.020; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Pratt SC, 2001, ANIM BEHAV, V62, P281, DOI 10.1006/anbe.2001.1777; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sato Y, 2006, ETHOLOGY, V112, P664, DOI 10.1111/j.1439-0310.2005.01184.x; Scharf I, 2011, BIOL J LINN SOC, V103, P559, DOI 10.1111/j.1095-8312.2011.01638.x; Scharf I, 2011, ETHOLOGY, V117, P731, DOI 10.1111/j.1439-0310.2011.01926.x; SCHMIDHEMPEL P, 1998, PARASITES SOCIAL INS; Schoning C, 2005, ECOL ENTOMOL, V30, P532, DOI 10.1111/j.0307-6946.2005.00720.x; Schradin C, 2002, ETHOLOGY, V108, P237, DOI 10.1046/j.1439-0310.2002.00775.x; SEELEY TD, 1978, INSECT SOC, V25, P323, DOI 10.1007/BF02224297; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Waddington SJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1219, DOI 10.1007/s00265-010-0936-x; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; YAMAGUCHI T, 1992, INSECT SOC, V39, P117, DOI 10.1007/BF01249288; ZIRKLE DF, 1988, OIKOS, V53, P391, DOI 10.2307/3565541	50	43	43	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33314	10.1371/journal.pone.0033314	http://dx.doi.org/10.1371/journal.pone.0033314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457751	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100027
J	Christensen, SE; Coles, JM; Zelenski, NA; Furman, BD; Leddy, HA; Zauscher, S; Bonaldo, P; Guilak, F				Christensen, Susan E.; Coles, Jeffrey M.; Zelenski, Nicole A.; Furman, Bridgette D.; Leddy, Holly A.; Zauscher, Stefan; Bonaldo, Paolo; Guilak, Farshid			Altered Trabecular Bone Structure and Delayed Cartilage Degeneration in the Knees of Collagen VI Null Mice	PLOS ONE			English	Article							CHONDROCYTE PERICELLULAR MATRIX; POSTERIOR LONGITUDINAL LIGAMENT; ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; 3-DIMENSIONAL MORPHOLOGY; INTRAARTICULAR FRACTURE; OSTEOARTHRITIC CHANGES; CHONDROITIN SULFATE; ALPHA-3 CHAIN; IN-SITU	Mutation or loss of collagen VI has been linked to a variety of musculoskeletal abnormalities, particularly muscular dystrophies, tissue ossification and/or fibrosis, and hip osteoarthritis. However, the role of collagen VI in bone and cartilage structure and function in the knee is unknown. In this study, we examined the role of collagen VI in the morphology and physical properties of bone and cartilage in the knee joint of Col6a1(-/-) mice by micro-computed tomography (microCT), histology, atomic force microscopy (AFM), and scanning microphotolysis (SCAMP). Col6a1(-/-) mice showed significant differences in trabecular bone structure, with lower bone volume, connectivity density, trabecular number, and trabecular thickness but higher structure model index and trabecular separation compared to Col6a1(+/+) mice. Subchondral bone thickness and mineral content increased significantly with age in Col6a1(+/+) mice, but not in Col6a1(-/-) mice. Col6a1(-/-) mice had lower cartilage degradation scores, but developed early, severe osteophytes compared to Col6a1(+/+) mice. In both groups, cartilage roughness increased with age, but neither the frictional coefficient nor compressive modulus of the cartilage changed with age or genotype, as measured by AFM. Cartilage diffusivity, measured via SCAMP, varied minimally with age or genotype. The absence of type VI collagen has profound effects on knee joint structure and morphometry, yet minimal influences on the physical properties of the cartilage. Together with previous studies showing accelerated hip osteoarthritis in Col6a1(-/-) mice, these findings suggest different roles for collagen VI at different sites in the body, consistent with clinical data.	[Christensen, Susan E.; Zelenski, Nicole A.; Furman, Bridgette D.; Leddy, Holly A.; Guilak, Farshid] Duke Univ, Dept Orthopaed Surg, Med Ctr, Durham, NC 27708 USA; [Christensen, Susan E.; Guilak, Farshid] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Coles, Jeffrey M.; Zauscher, Stefan; Guilak, Farshid] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27706 USA; [Bonaldo, Paolo] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Padua, Italy	Duke University; Duke University; Duke University; University of Padua	Christensen, SE (corresponding author), Duke Univ, Dept Orthopaed Surg, Med Ctr, Durham, NC 27708 USA.	guilak@duke.edu	Guilak, Farshid/AAF-8558-2020	Guilak, Farshid/0000-0001-7380-0330; Bonaldo, Paolo/0000-0002-9571-8140; Leddy, Holly/0000-0002-1604-2876; Zauscher, Stefan/0000-0002-2290-7178	National Institutes of Health [AG15768, AR48182, AR48852, AR50245]; Telethon [GGP08107]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050245, R01AR048852, R01AR048182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by the National Institutes of Health grants AG15768, AR48182, AR48852, and AR50245, and by Telethon grant GGP08107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos LG, 2009, ARTHRITIS RHEUM-US, V60, P771, DOI 10.1002/art.24293; Alexopoulos LG, 2005, ACTA BIOMATER, V1, P317, DOI 10.1016/j.actbio.2005.02.001; Alexopoulos LG, 2005, J BIOMECH, V38, P509, DOI 10.1016/j.jbiomech.2004.04.012; Alexopoulos LG, 2003, J BIOMECH ENG-T ASME, V125, P323, DOI 10.1115/1.1579047; Allen DM, 2004, J STRUCT BIOL, V145, P196, DOI 10.1016/j.jsb.2003.10.003; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; Bertini Enrico, 2002, Eur J Paediatr Neurol, V6, P193, DOI 10.1053/ejpn.2002.0593; Blumbach K, 2008, MATRIX BIOL, V27, P306, DOI 10.1016/j.matbio.2007.11.007; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; BRAY DF, 1993, J ORTHOPAED RES, V11, P677, DOI 10.1002/jor.1100110510; Cao L, 2007, J ANAT, V211, P444, DOI 10.1111/j.1469-7580.2007.00784.x; Cao L, 2006, J BIOMECH ENG-T ASME, V128, P766, DOI 10.1115/1.2246237; Carlson KJ, 2008, INTEGR COMP BIOL; Chang J, 1997, J ANAT, V190, P523, DOI 10.1046/j.1469-7580.1997.19040523.x; Chevrier A, 2009, J ORTHOP RES, V27, P1197, DOI 10.1002/jor.20869; CHIPMAN SD, 1993, P NATL ACAD SCI USA, V90, P1701, DOI 10.1073/pnas.90.5.1701; Chiravarambath S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005199; Choi JB, 2007, J BIOMECH, V40, P2596, DOI 10.1016/j.jbiomech.2007.01.009; Coles J, 2009, ORTHOPAEDIC RES SOC; Coles JM, 2008, J BIOMECH, V41, P541, DOI 10.1016/j.jbiomech.2007.10.013; Damrongrungruang T, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000137293.33127.1b; Darling EM, 2010, BIOPHYS J, V98, P2848, DOI 10.1016/j.bpj.2010.03.037; Felson DT, 2005, RHEUMATOLOGY, V44, P100, DOI 10.1093/rheumatology/keh411; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Furman BD, 2007, J ORTHOP RES, V25, P578, DOI 10.1002/jor.20331; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gelse K, 2003, OSTEOARTHR CARTILAGE, V11, P141, DOI 10.1053/joca.2002.0873; Giesen EBW, 2004, J DENT RES, V83, P255, DOI 10.1177/154405910408300314; GILLQUIST J, 1990, BRIS MYER Z, P267; Glansbeek HL, 1998, LAB INVEST, V78, P133; Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008; Guilak F, 2006, ANN NY ACAD SCI, V1068, P498, DOI 10.1196/annals.1346.011; Han L, 2007, BIOPHYS J, V92, P1384, DOI 10.1529/biophysj.106.091397; Harumiya S, 2002, BIOSCI BIOTECH BIOCH, V66, P2743, DOI 10.1271/bbb.66.2743; Higashi K, 2006, MUSCLE NERVE, V33, P120, DOI 10.1002/mus.20449; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hu K, 2006, ARTHRITIS RHEUM-US, V54, P2891, DOI 10.1002/art.22040; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kennedy EA, 2007, BIOMED SCI INSTRUM, V43, P342; Kong QQ, 2007, SPINE, V32, P2834, DOI 10.1097/BRS.0b013e31815b761c; Kubitscheck U, 1998, METHOD CELL BIOL, V53, P79; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Kwan KM, 1997, J CELL BIOL, V136, P459, DOI 10.1083/jcb.136.2.459; Lam HY, 2008, BONE, V43, P1093, DOI 10.1016/j.bone.2008.07.253; Lampe AK, 2008, HUM MUTAT, V29, P809, DOI 10.1002/humu.20704; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Leddy HA, 2008, BIOPHYS J, V95, P4890, DOI 10.1529/biophysj.108.137752; Leddy HA, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979876; MARCELINO J, 1995, BBA-PROTEIN STRUCT M, V1249, P180, DOI 10.1016/0167-4838(95)00026-Q; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; MOW VC, 1994, CELL MECHANICS AND CELLULAR ENGINEERING, P345; Nieminen J, 2008, CALCIFIED TISSUE INT, V82, P229, DOI 10.1007/s00223-008-9110-0; Ogletree DF, 1996, REV SCI INSTRUM, V67, P3298, DOI 10.1063/1.1147411; Park S, 2004, J BIOMECH, V37, P1679, DOI 10.1016/j.jbiomech.2004.02.017; Pepe G, 2002, NEUROMUSCULAR DISORD, V12, P720; Petrini S, 2005, MOL CELL NEUROSCI, V30, P408, DOI 10.1016/j.mcn.2005.08.005; POOLE CA, 1988, J CELL SCI, V90, P635; POTTENGER LA, 1990, ARTHRITIS RHEUM-US, V33, P853, DOI 10.1002/art.1780330612; Setton LA, 1997, OSTEOARTHR CARTILAGE, V5, P1, DOI 10.1016/S1063-4584(97)80027-1; Smit TH, 2003, SPINE, V28, P1802, DOI 10.1097/01.BRS.0000083285.09184.7A; Soderhall C, 2007, PLOS BIOL, V5, P1952, DOI 10.1371/journal.pbio.0050242; SOKOLOFF L, 1956, ARCH PATHOL, V62, P129; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Tanaka N, 2001, Spine J, V1, P47, DOI 10.1016/S1529-9430(01)00006-7; Tanaka T, 2003, AM J HUM GENET, V73, P812, DOI 10.1086/378593; Tsukahara S, 2005, SPINE, V30, P2321, DOI 10.1097/01.brs.0000182318.47343.6d; VANOSCH GJVM, 1995, J ORTHOPAED RES, V13, P783, DOI 10.1002/jor.1100130519; Wagener R, 2009, MATRIX BIOL IN PRESS; Walters DA, 1996, REV SCI INSTRUM, V67, P3583, DOI 10.1063/1.1147177; Ward BD, 2008, ARTHRITIS RHEUM-US, V58, P744, DOI 10.1002/art.23288; Wildey GM, 2001, J ORTHOP RES, V19, P650, DOI 10.1016/S0736-0266(00)00053-X; Zeichen J, 1999, ARCH ORTHOP TRAUM SU, V119, P315, DOI 10.1007/s004020050417; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	78	42	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33397	10.1371/journal.pone.0033397	http://dx.doi.org/10.1371/journal.pone.0033397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448243	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700033
J	Klumpp, S; Faivre, D				Klumpp, Stefan; Faivre, Damien			Interplay of Magnetic Interactions and Active Movements in the Formation of Magnetosome Chains	PLOS ONE			English	Article							MAGNETOTACTIC BACTERIA; MAGNETOSPIRILLUM-GRYPHISWALDENSE; CELL-DIVISION; PROTEIN MAMK; POLYMERIZATION; DYNAMICS; BIOMINERALIZATION; SEGREGATION; PARTICLES; DELETION	Magnetotactic bacteria assemble chains of magnetosomes, organelles that contain magnetic nano-crystals. A number of genetic factors involved in the controlled biomineralization of these crystals and the assembly of magnetosome chains have been identified in recent years, but how the specific biological regulation is coordinated with general physical processes such as diffusion and magnetic interactions remains unresolved. Here, these questions are addressed by simulations of different scenarios for magnetosome chain formation, in which various physical processes and interactions are either switched on or off. The simulation results indicate that purely physical processes of magnetosome diffusion, guided by their magnetic interactions, are not sufficient for the robust chain formation observed experimentally and suggest that biologically encoded active movements of magnetosomes may be required. Not surprisingly, the chain pattern is most resembling experimental results when both magnetic interactions and active movement are coordinated. We estimate that the force such active transport has to generate is compatible with forces generated by the polymerization or depolymerization of cytoskeletal filaments. The simulations suggest that the pleiotropic phenotypes of mamK deletion strains may be due to a defect in active motility of magnetosomes and that crystal formation in magneteosome vesicles is coupled to the activation of their active motility in M. gryphiswaldense, but not in M. magneticum.	[Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany; [Faivre, Damien] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany	Max Planck Society; Max Planck Society	Klumpp, S (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany.	klumpp@mpikg.mpg.de	Klumpp, Stefan/C-2966-2008; Klumpp, Stefan/AAC-3936-2019; faivre, damien/D-3713-2009	Klumpp, Stefan/0000-0003-0584-2146; Klumpp, Stefan/0000-0003-0584-2146; faivre, damien/0000-0001-6191-3389	Max Planck Society; European Research Council [256915 MB2]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission)	Research in DF's lab is supported by the Max Planck Society, and a Starting Grant from the European Research Council (no. 256915 MB2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Carvallo C, 2009, EARTH PLANETS SPACE, V61, P143, DOI 10.1186/BF03352894; Ding Y, 2010, J BACTERIOL, V192, P1097, DOI 10.1128/JB.01292-09; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Faivre D, 2008, AM MINERAL, V93, P463, DOI 10.2138/am.2008.2678; Faivre D, 2007, ANGEW CHEM INT EDIT, V46, P8495, DOI 10.1002/anie.200700927; Faivre D, 2010, BIOPHYS J, V99, P1268, DOI 10.1016/j.bpj.2010.05.034; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Frankel R B, 2007, MICROBIOL MONOGR, V3, DOI DOI 10.1007/7171_2006_036; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Jogler C, 2009, ENVIRON MICROBIOL, V11, P1267, DOI 10.1111/j.1462-2920.2009.01854.x; Katzmann E, 2010, MOL MICROBIOL, V77, P208, DOI 10.1111/j.1365-2958.2010.07202.x; Klumpp S, 2005, BIOPHYS J, V88, P3118, DOI 10.1529/biophysj.104.056127; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komeili  A., 2006, MAGNETORECEPTION MAG, P163; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Kopp RE, 2008, EARTH-SCI REV, V86, P42, DOI 10.1016/j.earscirev.2007.08.001; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; Lefevre CT, 2011, SCIENCE, V334, P1720, DOI 10.1126/science.1212596; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Matsunaga T, 2007, TRENDS BIOTECHNOL, V25, P182, DOI 10.1016/j.tibtech.2007.02.002; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Muxworthy AR, 2009, J R SOC INTERFACE, V6, P1207, DOI 10.1098/rsif.2008.0462; OFER S, 1984, BIOPHYS J, V46, P57, DOI 10.1016/S0006-3495(84)83998-3; Philipse AP, 2002, LANGMUIR, V18, P9977, DOI 10.1021/la0205811; Pradel N, 2006, P NATL ACAD SCI USA, V103, P17485, DOI 10.1073/pnas.0603760103; Rioux JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009151; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Scheffel A, 2008, J BACTERIOL, V190, P377, DOI 10.1128/JB.01371-07; Simmons SL, 2006, SCIENCE, V311, P371, DOI 10.1126/science.1122843; Staniland SS, 2010, J BASIC MICROB, V50, P392, DOI 10.1002/jobm.200900408; Taoka A, 2007, J BACTERIOL, V189, P8737, DOI 10.1128/JB.00899-07; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Theriot JA, 2000, TRAFFIC, V1, P19, DOI 10.1034/j.1600-0854.2000.010104.x; Uebe R, 2010, J BACTERIOL, V192, P4192, DOI 10.1128/JB.00319-10; Yuan JY, 2011, CHEM SOC REV, V40, P640, DOI 10.1039/c0cs00087f	46	28	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33562	10.1371/journal.pone.0033562	http://dx.doi.org/10.1371/journal.pone.0033562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442698	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500039
J	Peng, RH; Zhang, T; Liu, F; Ling, J; Wang, CY; Li, SH; Zhang, XD; Wang, YH; Wang, KB				Peng, Renhai; Zhang, Tao; Liu, Fang; Ling, Jian; Wang, Chunying; Li, Shaohui; Zhang, Xiangdi; Wang, Yuhong; Wang, Kunbo			Preparations of Meiotic Pachytene Chromosomes and Extended DNA Fibers from Cotton Suitable for Fluorescence In Situ Hybridization	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; MOLECULAR CYTOGENETIC ANALYSIS; GOSSYPIUM-HIRSUTUM L.; HIGH-RESOLUTION FISH; ARABIDOPSIS-THALIANA; INSITU HYBRIDIZATION; REPETITIVE DNA; RICE; GENOME; SEQUENCE	Fluorescence in situ hybridization (FISH) has become one of the most important techniques applied in plant molecular cytogenetics. However, the application of this technique in cotton has lagged behind because of difficulties in chromosome preparation. The focus of this article was FISH performed not only on cotton pachytene chromosomes, but also on cotton extended DNA fibers. The cotton pollen mother cells (PMCs) instead of buds or anthers were directly digested in enzyme to completely breakdown the cell wall. Before the routine acetic acid treatment, PMCs were incubated in acetic acid and enzyme mixture to remove the cytoplasm and clear the background. The method of ice-cold Carnoy's solution spreading chromosome was adopted instead of nitrogen removed method to avoid chromosomes losing and fully stretch chromosome. With the above-improved steps, the high-quality well-differentiated pachytene chromosomes with clear background were obtained. FISH results demonstrated that a mature protocol of cotton pachytene chromosomes preparation was presented. Intact and no debris cotton nuclei were obtained by chopping from etiolation cotyledons instead of the conventional liquid nitrogen grinding method. After incubating the nuclei with nucleus lysis buffer on slide, the parallel and clear background DNA fibers were acquired along the slide. This method overcomes the twist, accumulation and fracture of DNA fibers compared with other methods. The entire process of DNA fibers preparation requires only 30 min, in contrast, it takes 3 h with routine nitrogen grinding method. The poisonous mercaptoethanol in nucleus lysis buffer is replaced by nonpoisonous dithiothreitol. PVP40 in nucleus isolation buffer is used to prevent oxidation. The probability of success in isolating nuclei for DNA fiber preparation is almost 100% tested with this method in cotton. So a rapid, safe, and efficient method for the preparation of cotton extended DNA fibers suitable for FISH was established.	[Peng, Renhai; Zhang, Tao; Liu, Fang; Ling, Jian; Wang, Chunying; Li, Shaohui; Zhang, Xiangdi; Wang, Yuhong; Wang, Kunbo] Chinese Acad Agr Sci, China & Cotton Res Inst, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Peng, Renhai] Anyang Inst Technol, Anyang, Peoples R China; [Zhang, Tao] Hubei Acad Agr Sci, Cash Crop Res Inst, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Anyang Institute of Technology; Hubei Academy of Agricultural Sciences	Peng, RH (corresponding author), Chinese Acad Agr Sci, China & Cotton Res Inst, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	wkbcri@cricaas.com.cn		Peng, Renhai/0000-0001-7916-2288	National Natural Science Foundation of China [31071466]; National High Technology Research and Development Program [2003AA207051]; State of New Varieties of GMO [2008ZX08005-003]; Chinese Universities Scientific Fund [2011JS087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); State of New Varieties of GMO; Chinese Universities Scientific Fund	This work was supported by the National Natural Science Foundation of China (Grant No. 31071466), National High Technology Research and Development Program (Grant No. 2003AA207051), State of New Varieties of GMO Cultivation in the Major Projects (Approval No. 2008ZX08005-003), and Chinese Universities Scientific Fund (Project No. 2011JS087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley JO, 1942, GENETICS, V27, P25; Cheng ZK, 2001, GENETICS, V157, P1749; Cheng ZK, 2001, GENOME RES, V11, P2133, DOI 10.1101/gr.194601; Cheng ZK, 2002, CHROMOSOME RES, V10, P379, DOI 10.1023/A:1016849618707; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; de Jong JH, 1999, TRENDS PLANT SCI, V4, P258; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; Fransz PF, 1996, PLANT J, V9, P421, DOI 10.1046/j.1365-313X.1996.09030421.x; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Fryxell P.A., 1992, RHEEDEA, V2, P108; Goel S, 2003, GENETICS, V163, P1069; HANSON RE, 1995, GENOME, V38, P646, DOI 10.1139/g95-082; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; Hiroshi M, 2006, PLANT J, V46, P206, DOI [10.1111/j.1365-313X.2006.02684.x, DOI 10.1111/J.1365-313X.2006.02684.X]; Ijdo JW, 1991, NUCLEIC ACIDS RES, V19, P478; Jackson SA, 2000, GENETICS, V156, P833; Jackson SA, 1999, PLANT J, V17, P581, DOI 10.1046/j.1365-313X.1999.00398.x; Jeffrey CZ, 2007, PLANT PHYSIOL, V145, P1304, DOI [10.1104/pp.107.107672, DOI 10.1104/PP.107.107672]; Ji YF, 1997, GENOME, V40, P34, DOI 10.1139/g97-005; Ji YF, 2007, GENETICS, V176, P115, DOI 10.1534/genetics.107.071738; Jiang JM, 2006, GENOME, V49, P1057, DOI 10.1139/G06-076; Kato S, 2003, GENES GENET SYST, V78, P155, DOI 10.1266/ggs.78.155; Kim JS, 2005, GENETICS, V171, P1963, DOI 10.1534/genetics.105.048215; Lavania UC, 2003, J HISTOCHEM CYTOCHEM, V51, P1249, DOI 10.1177/002215540305101001; Li LJ, 2005, CYTOM PART A, V63A, P114, DOI 10.1002/cyto.a.20111; Li Zong-Yun, 2005, Acta Genetica Sinica, V32, P832; Liu SH, 2005, CHINESE SCI BULL, V50, P425, DOI 10.1360/982004-582; LIU YG, 1994, NUCLEIC ACIDS RES, V22, P2168, DOI 10.1093/nar/22.11.2168; Ma N, 2006, PLANT CELL REP, V25, P1089, DOI 10.1007/s00299-006-0171-0; MUKAI Y, 1993, CHROMOSOMA, V102, P88, DOI 10.1007/BF00356025; Nagaki K, 2003, GENETICS, V163, P759; Ohmido N., 2004, Recent Research Developments in Biochemistry, V5, P267; Ohmido N, 2000, MOL GEN GENET, V263, P388, DOI 10.1007/s004380051182; Ohmido Nobuko, 1999, American Biotechnology Laboratory, V17, P58; Paterson Andrew H, 2008, COTTON SCI S, V20, P3, DOI CNKI:SUN:MHXB.0.2008-S1-003; Percival AE, 1999, COTTON ORIGIN HIST T, P33; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; SCHWARZACHER T, 1992, THEOR APPL GENET, V84, P778, DOI 10.1007/BF00227384; Shiels C, 1997, CYTOGENET CELL GENET, V76, P20, DOI 10.1159/000134504; Shishido R, 1998, THEOR APPL GENET, V97, P1013, DOI 10.1007/s001220050985; Stephens JL, 2004, GENOME, V47, P179, DOI [10.1139/g03-084, 10.1139/G03-084]; van de Rijke FM, 2000, J HISTOCHEM CYTOCHEM, V48, P743, DOI 10.1177/002215540004800602; Wang CJR, 2006, PLANT CELL, V18, P529, DOI 10.1105/tpc.105.037838; Wang K, 2006, THEOR APPL GENET, V113, P73, DOI 10.1007/s00122-006-0273-7; Wang K, 2007, THEOR APPL GENET, V115, P675, DOI 10.1007/s00122-007-0598-x; Wang K, 2010, CHROMOSOMA, V119, P255, DOI 10.1007/s00412-009-0254-0; Wang K, 2009, CHROMOSOME RES, V17, P1041, DOI 10.1007/s10577-009-9085-3; Wang Kun-Bo, 2001, Acta Genetica Sinica, V28, P69; Wang XF, 2006, GENOME, V49, P1393, DOI 10.1139/G06-113; WEIER HUG, 1995, HUM MOL GENET, V4, P1903; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; WIEGANT J, 1992, HUM MOL GENET, V1, P587, DOI 10.1093/hmg/1.8.587; Wilkins TA, 2008, COTTON SCI S, V20, P5; WINDLE B, 1995, ELECTROPHORESIS, V16, P273, DOI 10.1002/elps.1150160143; XIANG XL, 1989, CHINESE ASIAN COTTON; Yu YS, 2003, SCIENCE, V300, P1566, DOI 10.1126/science.1083523; Zhang HB, 2000, MANUAL CONSTRUCTION; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zhong XB, 1996, CHROMOSOME RES, V4, P24, DOI 10.1007/BF02254940; Zhong XB, 1998, PLANT J, V13, P507, DOI 10.1046/j.1365-313X.1998.00055.x	62	8	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33847	10.1371/journal.pone.0033847	http://dx.doi.org/10.1371/journal.pone.0033847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442728	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500069
J	Loriol, C; Parisot, J; Poupon, G; Gwizdek, C; Martin, S				Loriol, Celine; Parisot, Josephine; Poupon, Gwenola; Gwizdek, Carole; Martin, Stephane			Developmental Regulation and Spatiotemporal Redistribution of the Sumoylation Machinery in the Rat Central Nervous System	PLOS ONE			English	Article							PROTEIN SUMOYLATION; UBIQUITIN LIGASE; CELL BIOLOGY; SUMO; EXPRESSION; AGGREGATION; MECHANISMS; UBC9; RNF4	Background: Small Ubiquitin-like MOdifier protein (SUMO) is a key regulator of nuclear functions but little is known regarding the role of the post-translational modification sumoylation outside of the nucleus, particularly in the Central Nervous System (CNS). Methodology/Principal Findings: Here, we report that the expression levels of SUMO-modified substrates as well as the components of the sumoylation machinery are temporally and spatially regulated in the developing rat brain. Interestingly, while the overall sumoylation is decreasing during brain development, there are progressively more SUMO substrates localized at synapses. This increase is correlated with a differential redistribution of the sumoylation machinery into dendritic spines during neuronal maturation. Conclusions/Significance: Overall, our data clearly demonstrate that the sumoylation process is developmentally regulated in the brain with high levels of nuclear sumoylation early in the development suggesting a role for this post-translational modification during the synaptogenesis period and a redistribution of the SUMO system towards dendritic spines at a later developmental stage to modulate synaptic protein function.	[Loriol, Celine; Poupon, Gwenola; Gwizdek, Carole; Martin, Stephane] Ctr Natl Rech Sci, Inst Pharmacol Mol & Cellulaire, Valbonne, France; [Loriol, Celine; Parisot, Josephine; Poupon, Gwenola; Gwizdek, Carole; Martin, Stephane] Univ Nice Sophia Antipolis, Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Loriol, C (corresponding author), Ctr Natl Rech Sci, Inst Pharmacol Mol & Cellulaire, Valbonne, France.	martin@ipmc.cnrs.fr	POUPON, Gwénola/M-4632-2016; Martin, Stéphane/G-5954-2012	POUPON, Gwénola/0000-0001-5772-2539; Martin, Stéphane/0000-0001-6771-7645	'Federation pour la Recherche sur le Cerveau' [AOFRC2008]; 'Fondation pour la Recherche Medicale'; Bettencourt-Schueller Foundation; 'Institut National de la Sante et de la Recherche Medicale'	'Federation pour la Recherche sur le Cerveau'; 'Fondation pour la Recherche Medicale'(Fondation pour la Recherche Medicale); Bettencourt-Schueller Foundation; 'Institut National de la Sante et de la Recherche Medicale'(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from the 'Federation pour la Recherche sur le Cerveau' (AOFRC2008), the 'Fondation pour la Recherche Medicale', the Bettencourt-Schueller Foundation and the 'Institut National de la Sante et de la Recherche Medicale'. SM is a fellow from the Young Investigator 'Action Thematique et Incitative sur Programme' (ATIP) program of the 'Centre National de la Recherche Scientifique'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2011, EMBO J, V30, P1289, DOI 10.1038/emboj.2011.42; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Feligioni M, 2009, EUR J NEUROSCI, V29, P1348, DOI 10.1111/j.1460-9568.2009.06692.x; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Geoffroy MC, 2010, MOL BIOL CELL, V21, P4227, DOI 10.1091/mbc.E10-05-0449; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hashiyama K, 2009, GENE EXPR PATTERNS, V9, P50, DOI 10.1016/j.gep.2008.08.001; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huang Q, 2010, APOPTOSIS; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Krumova P, 2011, J CELL BIOL, V194, P49, DOI 10.1083/jcb.201010117; La Salle S, 2008, DEV BIOL, V321, P227, DOI 10.1016/j.ydbio.2008.06.020; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Lu H, 2009, BIOCHEM BIOPH RES CO, V390, P872, DOI 10.1016/j.bbrc.2009.10.065; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Martin S, 2009, M S-MED SCI, V25, P693, DOI 10.1051/medsci/2009258-9693; Martin S, 2008, J BIOL CHEM, V283, P36435, DOI 10.1074/jbc.M806447200; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Oh Y, 2011, BRAIN RES, V1381, P78, DOI 10.1016/j.brainres.2011.01.039; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi A, 2007, J NEUROSCI, V27, P10037, DOI 10.1523/JNEUROSCI.0361-07.2007; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; van Niekerk EA, 2007, P NATL ACAD SCI US; Watanabe M, 2008, ACTA BIOCHIM POL, V55, P681; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Zhang YQ, 2008, BIOCHEM BIOPH RES CO, V374, P673, DOI 10.1016/j.bbrc.2008.07.109	42	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33757	10.1371/journal.pone.0033757	http://dx.doi.org/10.1371/journal.pone.0033757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438991	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100093
J	Postigo, J; Iglesias, M; Cerezo-Wallis, D; Rosal-Vela, A; Garcia-Rodriguez, S; Zubiaur, M; Sancho, J; Merino, R; Merino, J				Postigo, Jorge; Iglesias, Marcos; Cerezo-Wallis, Daniela; Rosal-Vela, Antonio; Garcia-Rodriguez, Sonia; Zubiaur, Mercedes; Sancho, Jaime; Merino, Ramon; Merino, Jesus			Mice Deficient in CD38 Develop an Attenuated Form of Collagen Type II-Induced Arthritis	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; T-CELL; IFN-GAMMA; IMMUNE-RESPONSES; IN-VIVO; RECEPTOR; MOUSE; AUTOIMMUNITY; ACTIVATION; SURFACE	CD38, a type II transmembrane glycoprotein expressed in many cells of the immune system, is involved in cell signaling, migration and differentiation. Studies in CD38 deficient mice (CD38 KO mice) indicate that this molecule controls inflammatory immune responses, although its involvement in these responses depends on the disease model analyzed. Here, we explored the role of CD38 in the control of autoimmune responses using chicken collagen type II (col II) immunized C57BL/6-CD38 KO mice as a model of collagen-induced arthritis (CIA). We demonstrate that CD38 KO mice develop an attenuated CIA that is accompanied by a limited joint induction of IL-1 beta and IL-6 expression, by the lack of induction of IFN gamma expression in the joints and by a reduction in the percentages of invariant NKT (iNKT) cells in the spleen. Immunized CD38 KO mice produce high levels of circulating IgG1 and low of IgG2a anti-col II antibodies in association with reduced percentages of Th1 cells in the draining lymph nodes. Altogether, our results show that CD38 participates in the pathogenesis of CIA controlling the number of iNKT cells and promoting Th1 inflammatory responses.	[Postigo, Jorge; Iglesias, Marcos; Merino, Ramon; Merino, Jesus] Univ Cantabria, Dept Biol Mol, Inst Formac & Invest Marques Valdecilla, E-39005 Santander, Spain; [Iglesias, Marcos; Merino, Ramon] Univ Cantabria, Inst Biomed & Biotecnol Cantabria, CSIC, SODERCAN, E-39005 Santander, Spain; [Cerezo-Wallis, Daniela; Rosal-Vela, Antonio; Garcia-Rodriguez, Sonia; Zubiaur, Mercedes; Sancho, Jaime] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Postigo, J (corresponding author), Univ Cantabria, Dept Biol Mol, Inst Formac & Invest Marques Valdecilla, E-39005 Santander, Spain.	merinor@unican.es; merinoj@unican.es	Garcia-Rodriguez, Sonia/L-6932-2014; Sancho, Jaime/O-3228-2013; Zubiaur, Mercedes/AAC-5792-2021; Rosal-Vela, Antonio/K-9720-2014; Zubiaur, Mercedes/K-9390-2014; Merino, Ramón/L-1310-2014; Sancho, Jaime/K-5989-2019; Cerezo-Wallis, Daniela/L-1492-2017	Garcia-Rodriguez, Sonia/0000-0001-8959-4797; Sancho, Jaime/0000-0003-3852-7951; Zubiaur, Mercedes/0000-0002-4127-3027; Rosal-Vela, Antonio/0000-0002-5256-6634; Zubiaur, Mercedes/0000-0002-4127-3027; Merino, Ramón/0000-0002-5306-0635; Sancho, Jaime/0000-0003-3852-7951; Cerezo-Wallis, Daniela/0000-0002-4265-6898; Iglesias Lozano, Marcos/0000-0002-7523-5950	Ministerio de Ciencia e Innovacion, Spain [SAF2008-02042, SAF2011-22463, BFU2009-07206, SAF-2008-03685, SAF2011-27261]; Fundacion Marques de Valdecilla-Leonardo Torres Quevedo, Spain [FMV-UC 08/02]; European Commission [ISCIII-FIS06/1502]; Junta de Andalucia; Consejeria de Economia; Innovacion y Ciencia [CVI-226, PC08-CTS-04046]; Fundacion Eugenio Rodriguez Pascual; JAE-Doc-CSIC	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Marques de Valdecilla-Leonardo Torres Quevedo, Spain; European Commission(European CommissionEuropean Commission Joint Research Centre); Junta de Andalucia(Junta de Andalucia); Consejeria de Economia; Innovacion y Ciencia; Fundacion Eugenio Rodriguez Pascual; JAE-Doc-CSIC	This work was supported by grants from the Ministerio de Ciencia e Innovacion, Spain to RM (SAF2008-02042 and SAF2011-22463), JM (BFU2009-07206) and JS and MZ (SAF-2008-03685, SAF2011-27261), from the Fundacion Marques de Valdecilla-Leonardo Torres Quevedo, Spain to JM and RM (FMV-UC 08/02), from the European Commission-European Regional Development Fund (ERDF/FEDER), in collaboration with ISCIII-FIS06/1502 (MZ), from the Junta de Andalucia, Consejeria de Economia, Innovacion y Ciencia to JS and MZ (CVI-226, and PC08-CTS-04046) and from Fundacion Eugenio Rodriguez Pascual to RM. SGR is supported by a JAE-Doc-CSIC-Contract and ARV is recipient of a Fellowship-Contract from the Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2006, J IMMUNOL, V176, P4590, DOI 10.4049/jimmunol.176.8.4590; Chen YG, 2006, J IMMUNOL, V177, P2939, DOI 10.4049/jimmunol.177.5.2939; Chiba A, 2005, ARTHRITIS RHEUM-US, V52, P1941, DOI 10.1002/art.21056; Cho YG, 2007, AUTOIMMUN REV, V7, P65, DOI 10.1016/j.autrev.2007.08.001; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Deaglio S, 2000, CHEM IMMUNOL, V75, P99; Deterre P, 2000, CHEM IMMUNOL, V75, P146; Driver JP, 2010, DIABETES, V59, P423, DOI 10.2337/db09-1116; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Frey O, 2005, ARTHRITIS RES THER, V7, pR291, DOI 10.1186/ar1484; Gonzalez J, 2007, J IMMUNOL, V178, P2778, DOI 10.4049/jimmunol.178.5.2778; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; GRIFFITHS MM, 1992, J IMMUNOL, V149, P309; Guedes AGP, 2008, AM J PHYSIOL-LUNG C, V294, pL290, DOI 10.1152/ajplung.00367.2007; Guedez YB, 2001, ARTHRITIS RHEUM, V44, P2413, DOI 10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Kelchtermans H, 2005, ARTHRITIS RES THER, V7, pR402, DOI 10.1186/ar1500; Lamacchia C, 2010, ARTHRITIS RHEUM-US, V62, P452, DOI 10.1002/art.27235; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Munoz P, 2003, J BIOL CHEM, V278, P50791, DOI 10.1074/jbc.M308034200; Munoz P, 2008, BLOOD, V111, P3653, DOI 10.1182/blood-2007-07-101600; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Postigo J, 2011, ARTHRITIS RHEUM-US, V63, P971, DOI 10.1002/art.30220; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Vermeire K, 1997, J IMMUNOL, V158, P5507; Viegas MS, 2007, MICROBES INFECT, V9, P847, DOI 10.1016/j.micinf.2007.03.003; Yanaba K, 2007, J IMMUNOL, V179, P1369, DOI 10.4049/jimmunol.179.2.1369; Yoshiga Y, 2008, INT J MOL MED, V22, P369, DOI 10.3892/ijmm_00000032; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416; Zubiaur M, 2002, J BIOL CHEM, V277, P13, DOI 10.1074/jbc.M107474200; Zumaquero E, 2010, EXP CELL RES, V316, P2692, DOI 10.1016/j.yexcr.2010.05.032	45	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33534	10.1371/journal.pone.0033534	http://dx.doi.org/10.1371/journal.pone.0033534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438945	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100054
J	Lee, IR; Lim, JWC; Ormerod, KL; Morrow, CA; Fraser, JA				Lee, I. Russel; Lim, Jonathan W. C.; Ormerod, Kate L.; Morrow, Carl A.; Fraser, James A.			Characterization of an Nmr Homolog That Modulates GATA Factor-Mediated Nitrogen Metabolite Repression in Cryptococcus neoformans	PLOS ONE			English	Article							PUTATIVE ZINC-FINGER; N-TERMINAL REGION; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; NEUROSPORA-CRASSA; REGULATORY GENE; CANDIDA-ALBICANS; CAENORHABDITIS-ELEGANS; CATABOLITE REPRESSION; TRANSCRIPTION FACTORS	Nitrogen source utilization plays a critical role in fungal development, secondary metabolite production and pathogenesis. In both the Ascomycota and Basidiomycota, GATA transcription factors globally activate the expression of catabolic enzyme-encoding genes required to degrade complex nitrogenous compounds. However, in the presence of preferred nitrogen sources such as ammonium, GATA factor activity is inhibited in some species through interaction with co-repressor Nmr proteins. This regulatory phenomenon, nitrogen metabolite repression, enables preferential utilization of readily assimilated nitrogen sources. In the basidiomycete pathogen Cryptococcus neoformans, the GATA factor Gat1/Are1 has been co-opted into regulating multiple key virulence traits in addition to nitrogen catabolism. Here, we further characterize Gat1/Are1 function and investigate the regulatory role of the predicted Nmr homolog Tar1. While GAT1/ARE1 expression is induced during nitrogen limitation, TAR1 transcription is unaffected by nitrogen availability. Deletion of TAR1 leads to inappropriate derepression of non-preferred nitrogen catabolic pathways in the simultaneous presence of favoured sources. In addition to exhibiting its evolutionary conserved role of inhibiting GATA factor activity under repressing conditions, Tar1 also positively regulates GAT1/ARE1 transcription under non-repressing conditions. The molecular mechanism by which Tar1 modulates nitrogen metabolite repression, however, remains open to speculation. Interaction between Tar1 and Gat1/Are1 was undetectable in a yeast two-hybrid assay, consistent with Tar1 and Gat1/Are1 each lacking the conserved C-terminus regions present in ascomycete Nmr proteins and GATA factors that are known to interact with each other. Importantly, both Tar1 and Gat1/Are1 are suppressors of C. neoformans virulence, reiterating and highlighting the paradigm of nitrogen regulation of pathogenesis.	[Lee, I. Russel; Lim, Jonathan W. C.; Ormerod, Kate L.; Morrow, Carl A.; Fraser, James A.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Lee, I. Russel; Lim, Jonathan W. C.; Ormerod, Kate L.; Morrow, Carl A.; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Lee, IR (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	jafraser@uq.edu.au	Morrow, Carl/C-9821-2012; Lim, Jonathan WC/G-4220-2017; Lee, Russel/HDN-2358-2022; Bowerman, Kate/B-1908-2018; Fraser, James A/B-4918-2012	Lim, Jonathan WC/0000-0002-5074-6359; Bowerman, Kate/0000-0003-2339-114X; Fraser, James A/0000-0001-5724-5285; Morrow, Carl/0000-0002-3650-0117	University of Queensland International Research Tuition Award (UQIRTA); University of Queensland Research Scholarship (UQRS); National Health and Medical Research Council (NHMRC) [CDA 569673]	University of Queensland International Research Tuition Award (UQIRTA); University of Queensland Research Scholarship (UQRS)(University of Queensland); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the University of Queensland International Research Tuition Award (UQIRTA) and University of Queensland Research Scholarship (UQRS) awarded to RL, and the National Health and Medical Research Council (NHMRC) CDA 569673 grant awarded to JF. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrianopoulos A, 1998, J BACTERIOL, V180, P1973, DOI 10.1128/JB.180.7.1973-1977.1998; ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; BRENNER S, 1974, GENETICS, V77, P71; Bugeja HE, 2011, FUNGAL BIOL IN PRESS; Caddick MX, 1998, J BACTERIOL, V180, P5762, DOI 10.1128/JB.180.21.5762-5764.1998; CARDENAS ME, 1994, EMBO J, V13, P5944, DOI 10.1002/j.1460-2075.1994.tb06940.x; Chun CD, 2011, CELL HOST MICROBE, V9, P243, DOI 10.1016/j.chom.2011.02.003; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Conlon H, 2001, MOL MICROBIOL, V40, P361, DOI 10.1046/j.1365-2958.2001.02399.x; Cooper TG, 2004, MYCOTA, V3, P81; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Dabas N, 2007, EUKARYOT CELL, V6, P875, DOI 10.1128/EC.00307-06; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Edskes HK, 2011, GENETICS, V188, P81, DOI 10.1534/genetics.111.127217; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Fraser JA, 2001, GENETICS, V157, P119; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Fraser JA, 2002, APPL ENVIRON MICROB, V68, P2802, DOI 10.1128/AEM.68.6.2802-2808.2002; FU YH, 1990, P NATL ACAD SCI USA, V87, P5331, DOI 10.1073/pnas.87.14.5331; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; HAAS H, 1995, CURR GENET, V27, P150, DOI 10.1007/BF00313429; Hensel M, 1998, MOL GEN GENET, V258, P553, DOI 10.1007/s004380050767; HONDA S, 1993, J GERONTOL, V48, pB57, DOI 10.1093/geronj/48.2.B57; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; JACOBSON ES, 1991, J MED VET MYCOL, V29, P121; James P, 1996, GENETICS, V144, P1425; Janbon G, 2004, FEMS YEAST RES, V4, P765, DOI 10.1016/j.femsyr.2004.04.003; Jiang N, 2009, APPL ENVIRON MICROB, V75, P6777, DOI 10.1128/AEM.00708-09; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; Kmetzsch L, 2011, FUNGAL GENET BIOL, V48, P192, DOI 10.1016/j.fgb.2010.07.011; Kronstad J, 2011, EUKARYOT CE IN PRESS; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kwon-Chung KJ, 1992, MED MYCOL, P397; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P821, DOI 10.2307/3758800; Lamb HK, 1997, J BACTERIOL, V179, P6649, DOI 10.1128/jb.179.21.6649-6656.1997; Lamb HK, 2004, PROTEIN SCI, V13, P3127, DOI 10.1110/ps.04958904; Lamb HK, 2003, J BIOL CHEM, V278, P32107, DOI 10.1074/jbc.M304104200; LANGDON T, 1995, MOL MICROBIOL, V17, P877, DOI 10.1111/j.1365-2958.1995.mmi_17050877.x; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; LEUTHER KK, 1993, CELL, V72, P575, DOI 10.1016/0092-8674(93)90076-3; LEUTHER KK, 1992, SCIENCE, V256, P1333, DOI 10.1126/science.1598579; Liao WL, 2008, FUNGAL GENET BIOL, V45, P514, DOI 10.1016/j.fgb.2007.08.006; Limjindaporn T, 2003, MOL MICROBIOL, V50, P993, DOI 10.1046/j.1365-2958.2003.03747.x; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; MINEHART PL, 1991, MOL CELL BIOL, V11, P6216, DOI 10.1128/MCB.11.12.6216; Missall TA, 2005, EUKARYOT CELL, V4, P202, DOI 10.1128/EC.4.1.202-208.2005; MITCHELL AP, 1984, MOL CELL BIOL, V4, P2767, DOI 10.1128/MCB.4.12.2767; MITCHELL AP, 1984, MOL CELL BIOL, V4, P2758, DOI 10.1128/MCB.4.12.2758; Morozov IY, 2000, MOL MICROBIOL, V37, P1248, DOI 10.1046/j.1365-2958.2000.02085.x; Morrow CA, 2012, MBIO, V3, DOI 10.1128/mBio.00310-11; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Pan H, 1997, MOL MICROBIOL, V26, P721, DOI 10.1046/j.1365-2958.1997.6041979.x; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PATEMAN JA, 1982, BIOCHEM GENET, V20, P777, DOI 10.1007/BF00483973; Perfect JR., 2006, MOL PRINCIPLES FUNGA, P3; Platt A, 1996, EMBO J, V15, P2791, DOI 10.1002/j.1460-2075.1996.tb00639.x; PREMAKUMAR R, 1980, J BACTERIOL, V144, P542, DOI 10.1128/JB.144.2.542-551.1980; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; RHODES JC, 1975, J CLIN MICROBIOL, V1, P9, DOI 10.1128/JCM.1.1.9-10.1975; Rutherford JC, 2008, EUKARYOT CELL, V7, P237, DOI 10.1128/EC.00079-07; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SELLECK SB, 1987, MOL CELL BIOL, V7, P3260, DOI 10.1128/MCB.7.9.3260; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; STAIB F, 1978, MYCOPATHOLOGIA, V65, P73, DOI 10.1007/BF00447178; Stammers DK, 2001, EMBO J, V20, P6619, DOI 10.1093/emboj/20.23.6619; STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450; STEWART V, 1986, GENE, V46, P291, DOI 10.1016/0378-1119(86)90414-2; Thoden JB, 2007, J BIOL CHEM, V282, P1534, DOI 10.1074/jbc.C600285200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Wagner D, 2010, EUKARYOT CELL, V9, P1588, DOI 10.1128/EC.00146-10; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Wong KH, 2008, EUKARYOT CELL, V7, P917, DOI 10.1128/EC.00076-08; Wong KH, 2007, MOL MICROBIOL, V66, P534, DOI 10.1111/j.1365-2958.2007.05940.x; XIAO XD, 1995, BIOCHEMISTRY-US, V34, P8861, DOI 10.1021/bi00027a038; YOUNG JL, 1990, MOL GEN GENET, V222, P120, DOI 10.1007/BF00283032; Zheng XF, 2007, P NATL ACAD SCI USA, V104, P8809, DOI 10.1073/pnas.0700480104; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	94	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32585	10.1371/journal.pone.0032585	http://dx.doi.org/10.1371/journal.pone.0032585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470421	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000005
J	Toseeb, U; Keeble, DRT; Bryant, EJ				Toseeb, Umar; Keeble, David R. T.; Bryant, Eleanor J.			The Significance of Hair for Face Recognition	PLOS ONE			English	Article							INTERNAL FACIAL FEATURES; EXTERNAL FEATURES; UNFAMILIAR FACES; PERCEPTION; FAMILIAR; BIAS; INVERSION; CORTEX; MEMORY; PARTS	Hair is a feature of the head that frequently changes in different situations. For this reason much research in the area of face perception has employed stimuli without hair. To investigate the effect of the presence of hair we used faces with and without hair in a recognition task. Participants took part in trials in which the state of the hair either remained consistent (Same) or switched between learning and test (Switch). It was found that in the Same trials performance did not differ for stimuli presented with and without hair. This implies that there is sufficient information in the internal features of the face for optimal performance in this task. It was also found that performance in the Switch trials was substantially lower than in the Same trials. This drop in accuracy when the stimuli were switched suggests that faces are represented in a holistic manner and that manipulation of the hair causes disruption to this, with implications for the interpretation of some previous studies.	[Toseeb, Umar; Keeble, David R. T.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Toseeb, Umar; Keeble, David R. T.; Bryant, Eleanor J.] Univ Bradford, Div Psychol, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; University of Bradford	Toseeb, U (corresponding author), Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	umtoseeb@bradford.ac.uk	Bryant, Eleanor/C-8493-2013	Keeble, David/0000-0002-8829-6090; Toseeb, Umar/0000-0002-7536-2722	Educational Charity of the Federation of Ophthalmic and Dispensing Opticians	Educational Charity of the Federation of Ophthalmic and Dispensing Opticians	This work is supported by a studentship from the Educational Charity of the Federation of Ophthalmic and Dispensing Opticians which was provided to U Toseeb. The Educational Charity of the Federation of Ophthalmic and Dispensing Opticians is non-profit organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 2010, J NEUROSCI, V30, P3544, DOI 10.1523/JNEUROSCI.4863-09.2010; Axelrod V, 2010, NEUROIMAGE, V52, P720, DOI 10.1016/j.neuroimage.2010.04.027; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; Betts LR, 2010, J COGNITIVE NEUROSCI, V22, P2276, DOI 10.1162/jocn.2009.21346; Bonner L, 2003, VIS COGN, V10, P527, DOI 10.1080/13506280244000168; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; Buttle H, 2010, PERCEPTION, V39, P1672, DOI 10.1068/p6790; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; Frowd C, 2007, BRIT J PSYCHOL, V98, P61, DOI 10.1348/000712606X104481; Green DM, 1966, SIGNAL DETECTION THE; Johnston RA, 2009, MEMORY, V17, P577, DOI 10.1080/09658210902976969; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Leder H, 2005, Q J EXP PSYCHOL-A, V58, P235, DOI 10.1080/02724980343000936; Lewin C, 2002, BRAIN COGNITION, V50, P121, DOI 10.1016/S0278-2626(02)00016-7; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Megreya AM, 2009, PERCEPTION, V38, P1831, DOI 10.1068/p6385; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Murray JE, 2004, PERCEPTION, V33, P387, DOI 10.1068/p5188; Nachson I, 2002, ACTA PSYCHOL, V109, P227, DOI 10.1016/S0001-6918(01)00058-0; *OFF NAT STAT, 2001, CENS STAND AR STAT E; PATTERSON KE, 1977, J EXP PSYCHOL-HUM L, V3, P406, DOI 10.1037/0278-7393.3.4.406; Schneider W., 2002, E PRIME USERS GUIDE; Sinha P, 1996, NATURE, V384, P404, DOI 10.1038/384404a0; Sinha P, 2002, PERCEPTION, V31, P133, DOI 10.1068/p3101no; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Ueda S, 2010, PERCEPTION, V39, P126; University of Bradford, 2011, REP TOOL STUD DAT; Walker PM, 2008, APPL COGNITIVE PSYCH, V22, P441, DOI 10.1002/acp.1382; Walker PM, 2006, BRIT J DEV PSYCHOL, V24, P451, DOI 10.1348/026151005X51239; Walker PM, 2006, APPL COGNITIVE PSYCH, V20, P461, DOI 10.1002/acp.1191; Want SC, 2003, BRIT J DEV PSYCHOL, V21, P125, DOI 10.1348/026151003321164663; Wright DB, 2003, ACTA PSYCHOL, V114, P101, DOI 10.1016/S0001-6918(03)00052-0; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1985, PERCEPTION, V14, P737, DOI 10.1068/p140737	36	31	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34144	10.1371/journal.pone.0034144	http://dx.doi.org/10.1371/journal.pone.0034144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943KB	22461902	Green Published, gold, Green Submitted			2022-12-27	WOS:000304118900020
J	Biedler, JK; Hu, WQ; Tae, H; Tu, ZJ				Biedler, James K.; Hu, Wanqi; Tae, Hongseok; Tu, Zhijian			Identification of Early Zygotic Genes in the Yellow Fever Mosquito Aedes aegypti and Discovery of a Motif Involved in Early Zygotic Genome Activation	PLOS ONE			English	Article							DROSOPHILA; TRANSITION; CYCLE	During early embryogenesis the zygotic genome is transcriptionally silent and all mRNAs present are of maternal origin. The maternal-zygotic transition marks the time over which embryogenesis changes its dependence from maternal RNAs to zygotically transcribed RNAs. Here we present the first systematic investigation of early zygotic genes (EZGs) in a mosquito species and focus on genes involved in the onset of transcription during 2-4 hr. We used transcriptome sequencing to identify the "pure'' (without maternal expression) EZGs by analyzing transcripts from four embryonic time ranges of 0-2, 24, 4-8, and 8-12 hr, which includes the time of cellular blastoderm formation and up to the start of gastrulation. Blast of 16,789 annotated transcripts vs. the transcriptome reads revealed evidence for 63 (P<0.001) and 143 (P<0.05) nonmaternally derived transcripts having a significant increase in expression at 2-4 hr. One third of the 63 EZG transcripts do not have predicted introns compared to 10% of all Ae. aegypti genes. We have confirmed by RT-PCR that zygotic transcription starts as early as 2-3 hours. A degenerate motif VBRGGTA was found to be overrepresented in the upstream sequences of the identified EZGs using a motif identification software called SCOPE. We find evidence for homology between this motif and the TAGteam motif found in Drosophila that has been implicated in EZG activation. A 38 bp sequence in the proximal upstream sequence of a kinesin light chain EZG (KLC2.1) contains two copies of the mosquito motif. This sequence was shown to support EZG transcription by luciferase reporter assays performed on injected early embryos, and confers early zygotic activity to a heterologous promoter from a divergent mosquito species. The results of these studies are consistent with the model of early zygotic genome activation via transcriptional activators, similar to what has been found recently in Drosophila.	[Biedler, James K.; Hu, Wanqi; Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Tae, Hongseok] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Biedler, JK (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	jbiedler@vt.edu; jaketu@vt.edu	Tae, Hongseok/K-2497-2012		Foundation for the National Institutes of Health [316]; Virginia Experimental Station	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Experimental Station	The work was funded by the Foundation for the National Institutes of Health grant GC7 #316, and the Virginia Experimental Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Biedler JK, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-206; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Campos-Ortega JA, 1985, EMBRYONIC DEV DROSOP, pxi; Carlson JM, 2007, NUCLEIC ACIDS RES, V35, pW259, DOI 10.1093/nar/gkm310; Chakravarty A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-249; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; CHERBAS L, 1993, INSECT BIOCHEM MOLEC, V23, P81, DOI 10.1016/0965-1748(93)90085-7; CLEMONS A, 2010, COLD SPRING HARB PRO; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; Erickson JW, 1998, DEVELOPMENT, V125, P3259; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Hooper SD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100112; Koutsos AC, 2007, P NATL ACAD SCI USA, V104, P11304, DOI 10.1073/pnas.0703988104; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; MCKNIGHT SL, 1976, CELL, V8, P305, DOI 10.1016/0092-8674(76)90014-3; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Papatsenko D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000584; Pritchard DK, 1996, GENE DEV, V10, P1131, DOI 10.1101/gad.10.9.1131; RAMINANI L N, 1975, International Journal of Insect Morphology and Embryology, V4, P517, DOI 10.1016/0020-7322(75)90028-8; ROTHE M, 1992, NATURE, V359, P156, DOI 10.1038/359156a0; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Tsurumi A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002086; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Zheng XL, 2002, INSECT MOL BIOL, V11, P517, DOI 10.1046/j.1365-2583.2002.00360.x	33	38	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33933	10.1371/journal.pone.0033933	http://dx.doi.org/10.1371/journal.pone.0033933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457801	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900032
J	Luedeke, M; Coinac, I; Linnert, CM; Bogdanova, N; Rinckleb, AE; Schrader, M; Vogel, W; Hoegel, J; Meyer, A; Dork, T; Maier, C				Luedeke, Manuel; Coinac, Irina; Linnert, Carmen M.; Bogdanova, Natalia; Rinckleb, Antje E.; Schrader, Mark; Vogel, Walther; Hoegel, Josef; Meyer, Andreas; Doerk, Thilo; Maier, Christiane			Prostate Cancer Risk Is not Altered by TP53AIP1 Germline Mutations in a German Case-Control Series	PLOS ONE			English	Article							APOPTOSIS; VARIANTS	Prostate cancer susceptibility has previously been associated with truncating germline variants in the gene TP53AIP1 (tumor protein p53 regulated apoptosis inducing protein 1). For two apparently recurrent mutations (p.Q22fs and p.S32X) a remarkable OR of 5.1 was reported for prostate cancer risk. Since these findings have not been validated so far, we genotyped p.Q22fs and p.S32X in two German series with a total of 1,207 prostate cancer cases and 1,495 controls. The truncating variants were not significantly associated with prostate cancer in none of the two cohorts, nor in the combined analysis [odds ratio (OR) = 1.16; 95% confidence interval (CI 95%) = 0.62- 2.15; p = 0.66]. Carriers showed no significant differences in family history of prostate cancer, age at diagnosis, Gleason score or PSA at diagnosis when compared to non-carrier prostate cancer cases. The large sample size of the combined cohort rejects a high-risk effect greater than 2.2 and indicates a limited role of TP53AIP1 in prostate cancer predisposition.	[Luedeke, Manuel; Rinckleb, Antje E.; Schrader, Mark; Maier, Christiane] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Luedeke, Manuel; Linnert, Carmen M.; Rinckleb, Antje E.; Vogel, Walther; Hoegel, Josef; Maier, Christiane] Univ Hosp Ulm, Inst Human Genet, Ulm, Germany; [Coinac, Irina; Bogdanova, Natalia; Meyer, Andreas; Doerk, Thilo] Hannover Med Sch, Radiat Oncol & Gynaecol Res Unit, D-3000 Hannover, Germany	Ulm University; Ulm University; Hannover Medical School	Luedeke, M (corresponding author), Univ Hosp Ulm, Dept Urol, Ulm, Germany.	christiane.maier@uni-ulm.de	Dörk, Thilo/J-8620-2012; Bogdanova, Natalia V./Y-2205-2019	Dörk, Thilo/0000-0002-9458-0282; 	National Cancer Institute [CA089600]; Hannelore Munke fellowship; NATIONAL CANCER INSTITUTE [U01CA089600] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hannelore Munke fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Prostate Cancer Genetics Project in Ulm has been supported by a National Cancer Institute subcontract entitled "Prostate Cancer Susceptibility: The ICPCG study'' - grant #CA089600 - http://cancer.gov/. AM has been supported by the Hannelore Munke fellowship, an internal research fellowship of the Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hallstrom TMKA, 2008, PROSTATE, V68, P902, DOI 10.1002/pros.20746; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Luedeke M, 2009, CANCER EPIDEM BIOMAR, V18, P3030, DOI 10.1158/1055-9965.EPI-09-0772; Matsuda K, 2002, CANCER RES, V62, P2883; Meyer A, 2011, UROL ONCOL; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Wang XS, 2006, CANCER RES, V66, P10302, DOI 10.1158/0008-5472.CAN-06-0638	10	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34128	10.1371/journal.pone.0034128	http://dx.doi.org/10.1371/journal.pone.0034128			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457820	Green Submitted, Green Published, gold			2022-12-27	WOS:000304046900049
J	Kallendrusch, S; Hobusch, C; Ehrlich, A; Ziebell, S; Ueda, N; Geisslinger, G; Koch, M; Dehghani, F				Kallendrusch, Sonja; Hobusch, Constance; Ehrlich, Angela; Ziebell, Simone; Ueda, Natsuo; Geisslinger, Gerd; Koch, Marco; Dehghani, Faramarz			Site-Specific and Time-Dependent Activation of the Endocannabinoid System after Transection of Long-Range Projections	PLOS ONE			English	Article							HYDROLYZING ACID AMIDASE; ENTORHINAL CORTEX SLICES; FOCAL CEREBRAL-ISCHEMIA; GYRUS GRANULE CELLS; CANNABINOID RECEPTOR; MICROGLIAL CELLS; MOLECULAR CHARACTERIZATION; INTERNATIONAL UNION; NITRIC-OXIDE; PALMITOYLETHANOLAMIDE	Background: After focal neuronal injury the endocannabinioid system becomes activated and protects or harms neurons depending on cannabinoid derivates and receptor subtypes. Endocannabinoids (eCBs) play a central role in controlling local responses and influencing neural plasticity and survival. However, little is known about the functional relevance of eCBs in long-range projection damage as observed in stroke or spinal cord injury (SCI). Methods: In rat organotypic entorhino-hippocampal slice cultures (OHSC) as a relevant and suitable model for investigating projection fibers in the CNS we performed perforant pathway transection (PPT) and subsequently analyzed the spatial and temporal dynamics of eCB levels. This approach allows proper distinction of responses in originating neurons (entorhinal cortex), areas of deafferentiation/anterograde axonal degeneration (dentate gyrus) and putative changes in more distant but synaptically connected subfields (cornu ammonis (CA) 1 region). Results: Using LC-MS/MS, we measured a strong increase in arachidonoylethanolamide (AEA), oleoylethanolamide (OEA) and palmitoylethanolamide (PEA) levels in the denervation zone (dentate gyrus) 24 hours post lesion (hpl), whereas entorhinal cortex and CA1 region exhibited little if any changes. NAPE-PLD, responsible for biosynthesis of eCBs, was increased early, whereas FAAH, a catabolizing enzyme, was up-regulated 48hpl. Conclusion: Neuronal damage as assessed by transection of long-range projections apparently provides a strong time-dependent and area-confined signal for de novo synthesis of eCB, presumably to restrict neuronal damage. The present data underlines the importance of activation of the eCB system in CNS pathologies and identifies a novel site-specific intrinsic regulation of eCBs after long-range projection damage.	[Kallendrusch, Sonja; Hobusch, Constance; Ehrlich, Angela; Koch, Marco; Dehghani, Faramarz] Univ Leipzig, Inst Anat, Leipzig, Germany; [Kallendrusch, Sonja] Lipid Signaling Forschungszentrum, Frankfurt, Germany; [Ziebell, Simone; Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Pharmacol, Frankfurt, Germany; [Ueda, Natsuo] Kagawa Univ, Dept Biochem, Sch Med, Takamatsu, Kagawa 760, Japan	Leipzig University; Goethe University Frankfurt; Kagawa University	Kallendrusch, S (corresponding author), Univ Leipzig, Inst Anat, Leipzig, Germany.	Faramarz.Dehghani@medizin.uni-leipzig.de	Kallendrusch, Sonja/AAV-7179-2020; Kallendrusch, Sonja/ABG-1789-2021	Kallendrusch, Sonja/0000-0003-2474-8307	LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); Grants-in-Aid for Scientific Research [21590310] Funding Source: KAKEN	LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskaran MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010683; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; COFFEY PJ, 1990, NEUROSCIENCE, V35, P121, DOI 10.1016/0306-4522(90)90126-O; Conti S, 2002, BRIT J PHARMACOL, V135, P181, DOI 10.1038/sj.bjp.0704466; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; De Petrocellis L, 2001, FEBS LETT, V506, P253, DOI 10.1016/S0014-5793(01)02934-9; De Petrocellis L, 2004, BRIT J PHARMACOL, V143, P251, DOI 10.1038/sj.bjp.0705924; Degn M, 2007, J NEUROCHEM, V103, P1907, DOI 10.1111/j.1471-4159.2007.04892.x; Deller T, 1997, ANN ANAT, V179, P501, DOI 10.1016/S0940-9602(97)80003-9; Deller T, 2007, PROG BRAIN RES, V163, P501, DOI 10.1016/S0079-6123(07)63027-1; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Fowler CJ, 2010, EXP NEUROL, V224, P37, DOI 10.1016/j.expneurol.2010.03.021; Franklin A, 2003, J NEUROSCI, V23, P7767; Frotscher M, 1997, TRENDS NEUROSCI, V20, P218, DOI 10.1016/S0166-2236(96)01018-1; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Galan-Rodriguez B, 2009, NEUROPHARMACOLOGY, V56, P653, DOI 10.1016/j.neuropharm.2008.11.006; Goffin K, 2011, BRAIN, V134, P1033, DOI 10.1093/brain/awq385; Grabiec U, 2011, NEUROPHARMACOLOGY; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.0.CO;2-P; Koch M, 2011, HIPPOCAMPUS, V21, P554, DOI 10.1002/hipo.20772; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Kovac AD, 2004, BRAIN PATHOL, V14, P249; Kovacs R, 2009, J NEUROSCI, V29, P8565, DOI 10.1523/JNEUROSCI.5698-08.2009; Kreutz S, 2007, EXP NEUROL, V203, P246, DOI 10.1016/j.expneurol.2006.08.010; Kreutz S, 2009, GLIA, V57, P286, DOI 10.1002/glia.20756; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Maccarrone M, 2004, J NEUROCHEM, V89, P1293, DOI 10.1111/j.1471-4159.2004.02430.x; Maccarrone M, 2003, J NEUROCHEM, V85, P1018, DOI 10.1046/j.1471-4159.2003.01759.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Nunez E, 2008, NEUROSCIENCE, V151, P104, DOI 10.1016/j.neuroscience.2007.10.029; Nyilas R, 2008, J NEUROSCI, V28, P1058, DOI 10.1523/JNEUROSCI.5102-07.2008; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pisani A, 2005, ANN NEUROL, V57, P777, DOI 10.1002/ana.20462; Ramirez JJ, 2001, RESTOR NEUROL NEUROS, V19, P237; Raso GM, 2011, J NEUROENDOCRINOL, V23, P591, DOI 10.1111/j.1365-2826.2011.02152.x; de Fonseca FR, 2001, NEUROTOX RES, V3, P23, DOI 10.1007/BF03033228; Schabitz WR, 2002, STROKE, V33, P2112, DOI 10.1161/01.STR.0000023491.63693.18; Schuchmann S, 2002, NEUROBIOL DIS, V11, P96, DOI 10.1006/nbdi.2002.0533; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Suardiaz M, 2007, PAIN, V133, P99, DOI 10.1016/j.pain.2007.03.008; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sun YX, 2004, BIOCHEM J, V380, P749, DOI 10.1042/BJ20040031; Thabuis C, 2008, LIPIDS, V43, P887, DOI 10.1007/s11745-008-3217-y; Tham CS, 2007, FEBS LETT, V581, P2899, DOI 10.1016/j.febslet.2007.05.037; TOPPER R, 1993, EXP NEUROL, V123, P271, DOI 10.1006/exnr.1993.1159; Tsuboi K, 2007, BBA-MOL CELL BIOL L, V1771, P623, DOI 10.1016/j.bbalip.2007.03.005; Ueda N, 2002, PROSTAG OTH LIPID M, V68-9, P521, DOI 10.1016/S0090-6980(02)00053-9; Ueda N, 2010, PROG LIPID RES, V49, P299, DOI 10.1016/j.plipres.2010.02.003; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; ZHANG H, 2011, BRAIN PATHOL; Zhao LY, 2007, BBA-MOL CELL BIOL L, V1771, P1397, DOI 10.1016/j.bbalip.2007.10.002; Zhao Y, 2010, J CARDIOVASC PHARM, V55, P292, DOI 10.1097/FJC.0b013e3181d2644d; Zhu C, 2011, MOL PHARMACOL, V79, P786, DOI 10.1124/mol.110.070201; Ziobro JM, 2011, BRAIN RES, V1371, P110, DOI 10.1016/j.brainres.2010.11.065	72	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33537	10.1371/journal.pone.0033537	http://dx.doi.org/10.1371/journal.pone.0033537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457773	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200034
J	Rieux, A; Gras, S; Lecaille, F; Niepceron, A; Katrib, M; Smith, NC; Lalmanach, G; Brossier, F				Rieux, Anais; Gras, Simon; Lecaille, Fabien; Niepceron, Alisson; Katrib, Marilyn; Smith, Nicholas C.; Lalmanach, Gilles; Brossier, Fabien			Eimeripain, a Cathepsin B-Like Cysteine Protease, Expressed throughout Sporulation of the Apicomplexan Parasite Eimeria tenella	PLOS ONE			English	Article							TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; OOCYST PRODUCTION; CELL INVASION; LIFE-CYCLE; IN-VITRO; AMINOPEPTIDASE; TRANSFECTION; COMPARTMENT; INHIBITION	The invasion and replication of Eimeria tenella in the chicken intestine is responsible for avian coccidiosis, a disease that has major economic impacts on poultry industries worldwide. E. tenella is transmitted to naive animals via shed unsporulated oocysts that need contact with air and humidity to form the infectious sporulated oocysts, which contain the first invasive form of the parasite, the sporozoite. Cysteine proteases (CPs) are major virulence factors expressed by protozoa. In this study, we show that E. tenella expresses five transcriptionally regulated genes encoding one cathepsin L, one cathepsin B and three cathepsin Cs. Biot-LC-LVG-CHN2, a cystatin derived probe, tagged eight polypeptides in unsporulated oocysts but only one in sporulated oocysts. CP-dependant activities were found against the fluorescent substrates, Z-FR-AMC and Z-LR-AMC, throughout the sporulation process. These activities corresponded to a cathepsin B-like enzyme since they were inhibited by CA-074, a specific cathepsin B inhibitor. A 3D model of the catalytic domain of the cathepsin B-like protease, based on its sequence homology with human cathepsin B, further confirmed its classification as a papain-like protease with similar characteristics to toxopain-1 from the related apicomplexan parasite, Toxoplasma gondii; we have, therefore, named the E. tenella cathepsin B, eimeripain. Following stable transfection of E. tenella sporozoites with a plasmid allowing the expression of eimeripain fused to the fluorescent protein mCherry, we demonstrated that eimeripain is detected throughout sporulation and has a punctate distribution in the bodies of extra- and intracellular parasites. Furthermore, CA-074 Me, the membrane-permeable derivative of CA-074, impairs invasion of epithelial MDBK cells by E. tenella sporozoites. This study represents the first characterization of CPs expressed by a parasite from the Eimeria genus. Moreover, it emphasizes the role of CPs in transmission and dissemination of exogenous stages of apicomplexan parasites.	[Rieux, Anais; Gras, Simon; Niepceron, Alisson; Brossier, Fabien] INRA, UMR1282, Equipe Pathogenese Coccidioses, Nouzilly, France; [Rieux, Anais; Gras, Simon; Niepceron, Alisson; Brossier, Fabien] Univ Francois Rabelais Tours, UMR1282, Tours, France; [Lecaille, Fabien; Lalmanach, Gilles] Univ Tours, INSERM U618, Tours, France; [Katrib, Marilyn] Tech Univ, Inst Biotechnol Infect Dis, Sydney, NSW, Australia; [Smith, Nicholas C.] James Cook Univ, Fac Med Hlth & Mol Sci, Cairns, Australia	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Technology Sydney; James Cook University	Brossier, F (corresponding author), INRA, UMR1282, Equipe Pathogenese Coccidioses, Nouzilly, France.	fbrossier@tours.inra.fr	Lecaille, Fabien/GRY-5313-2022	Smith, Nicholas/0000-0002-7467-1451; Lecaille, Fabien/0000-0003-1060-4222; Lalmanach, Gilles/0000-0001-8562-4821	French National Institute for Agricultural Research	French National Institute for Agricultural Research	Funding came from the French National Institute for Agricultural Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909; Borel E, 1998, PARASITE, V5, P371, DOI 10.1051/parasite/1998054371; Bumstead JM, 1998, PARASITOLOGY, V117, P39, DOI 10.1017/S0031182098002741; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Clark JD, 2008, MOL BIOCHEM PARASIT, V162, P77, DOI 10.1016/j.molbiopara.2008.07.006; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; Eksi S, 2007, ANTIMICROB AGENTS CH, V51, P1064, DOI 10.1128/AAC.01012-06; Eksi S, 2004, MOL MICROBIOL, V53, P243, DOI 10.1111/j.1365-2958.2004.04108.x; Fetterer RH, 2007, J PARASITOL, V93, P333, DOI 10.1645/GE-824R1.1; Fetterer RH, 2005, J PARASITOL, V91, P1280, DOI 10.1645/GE-554R.1; Florent I, 2005, BIOL CHEM, V386, P401, DOI 10.1515/BC.2005.048; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; JEFFERS TK, 1975, J PARASITOL, V61, P1083, DOI 10.2307/3279381; Kinnaird JH, 2004, INT J PARASITOL, V34, P683, DOI 10.1016/j.ijpara.2004.01.003; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Lal K, 2009, PROTEOMICS, V9, P4566, DOI 10.1002/pmic.200900305; Lalmanach G, 1996, BIOCHEM J, V318, P395, DOI 10.1042/bj3180395; Larson ET, 2009, J BIOL CHEM, V284, P26839, DOI 10.1074/jbc.M109.003780; LAWN AM, 1982, J PARASITOL, V68, P1117, DOI 10.2307/3281101; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Ling KH, 2007, GENOME RES, V17, P311, DOI 10.1101/gr.5823007; Linke M, 2002, J CELL SCI, V115, P4877, DOI 10.1242/jcs.00184; Liu XY, 2008, MOL BIOCHEM PARASIT, V161, P72, DOI 10.1016/j.molbiopara.2008.06.006; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Miska KB, 2004, J PARASITOL, V90, P1245, DOI 10.1645/GE-309R; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Naudin C, J MOL BIOL, V400, P1022; Parussini F, 2010, MOL MICROBIOL, V76, P1340, DOI 10.1111/j.1365-2958.2010.07181.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Que XC, 2007, J BIOL CHEM, V282, P4994, DOI 10.1074/jbc.M606764200; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHIRLEY MW, 1995, BIOTECHNOLOGY GUIDEL, P1; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Teo CF, 2007, ANTIMICROB AGENTS CH, V51, P679, DOI 10.1128/AAC.01059-06; Tierney J, 2003, PARASITOL RES, V90, P301, DOI 10.1007/s00436-003-0846-1; Turk V, 2011, BIOCHIM BIOPHYS ACTA, V1824, P68	42	22	23	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e31914	10.1371/journal.pone.0031914	http://dx.doi.org/10.1371/journal.pone.0031914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457711	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000303909200003
J	Thalor, SK; Berberich, T; Lee, SS; Yang, SH; Zhu, XJ; Imai, R; Takahashi, Y; Kusano, T				Thalor, Sunil Kumar; Berberich, Thomas; Lee, Sung Shin; Yang, Seung Hwan; Zhu, XuJun; Imai, Ryozo; Takahashi, Yoshihiro; Kusano, Tomonobu			Deregulation of Sucrose-Controlled Translation of a bZIP-Type Transcription Factor Results in Sucrose Accumulation in Leaves	PLOS ONE			English	Article							OPEN READING FRAME; AMINO-ACID-METABOLISM; EXPRESSION; ARABIDOPSIS; PROTEIN; GENES; REPRESSION; SENESCENCE; ACTIVATORS; NETWORKS	Sucrose is known to repress the translation of Arabidopsis thaliana AtbZIP11 transcript which encodes a protein belonging to the group of S (S - stands for small) basic region-leucine zipper (bZIP)- type transcription factor. This repression is called sucrose-induced repression of translation (SIRT). It is mediated through the sucrose-controlled upstream open reading frame (SC-uORF) found in the AtbZIP11 transcript. The SIRT is reported for 4 other genes belonging to the group of S bZIP in Arabidopsis. Tobacco tbz17 is phylogenetically closely related to AtbZIP11 and carries a putative SC-uORF in its 5'-leader region. Here we demonstrate that tbz17 exhibits SIRT mediated by its SC-uORF in a manner similar to genes belonging to the S bZIP group of the Arabidopsis genus. Furthermore, constitutive transgenic expression of tbz17 lacking its 5'-leader region containing the SC-uORF leads to production of tobacco plants with thicker leaves composed of enlarged cells with 3-4 times higher sucrose content compared to wild type plants. Our finding provides a novel strategy to generate plants with high sucrose content.	[Thalor, Sunil Kumar; Berberich, Thomas; Lee, Sung Shin; Zhu, XuJun; Takahashi, Yoshihiro; Kusano, Tomonobu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Berberich, Thomas] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Yang, Seung Hwan] Myongji Univ Sci Campus, Coll Nat Sci, Div Biosci & Bioinformat, Yongin, Gyeonggi, South Korea; [Imai, Ryozo] Natl Agr Res Ctr Hokkaido Reg, Crop Cold Res Team, Sapporo, Hokkaido, Japan	Tohoku University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Myongji University; National Agriculture & Food Research Organization - Japan	Kusano, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	kusano@ige.tohoku.ac.jp	Berberich, Thomas/F-9339-2010; Berberich, Thomas/K-3351-2019; Zhu, XuJun/D-3488-2012	Berberich, Thomas/0000-0001-9442-4450; Berberich, Thomas/0000-0001-9442-4450; 	Japan Society for the Promotion of Science [19658039]; Hesse's Ministry of Higher Education, Research, and the Arts; Rural Development Administration, Republic of Korea [ADFC2011]; MEXT	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hesse's Ministry of Higher Education, Research, and the Arts; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aids from the Japan Society for the Promotion of Science to TK (19658039), the research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts to TB, and Next-Generation BioGreen 21 Program (No. ADFC2011), Rural Development Administration, Republic of Korea to SHY. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank S.P. Dinesh-Kumar, D. Baulcombe and V. Walbot for providing plasmids and bacterial strain. The initial stage of this work was performed by Kazuyuki Sugawara. We thank Anthony J. Michael and Elena Herzog for critically reading the manuscript. S.K.T. is a recipient of MEXT fellowship.	AGUAN K, 1993, MOL GEN GENET, V240, P1, DOI 10.1007/BF00276876; Alonso R, 2009, PLANT CELL, V21, P1747, DOI 10.1105/tpc.108.062968; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Berberich T, 1999, MOL GEN GENET, V262, P534, DOI 10.1007/s004380051115; Chen S, 2005, PLANT PHYSIOL, V139, P1163, DOI 10.1104/pp.105.069468; Dietrich K, 2011, PLANT CELL, V23, P381, DOI 10.1105/tpc.110.075390; Fernie AR, 2002, TRENDS PLANT SCI, V7, P35, DOI 10.1016/S1360-1385(01)02183-5; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; Hanfrey C, 2005, J BIOL CHEM, V277, P44131; Hanson J, 2008, PLANT J, V53, P935, DOI 10.1111/j.1365-313X.2007.03385.x; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang JZ, 2001, PLANT CELL PHYSIOL, V42, P1079, DOI 10.1093/pcp/pce137; Iskandar HM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-12; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; KUSANO T, 1995, MOL GEN GENET, V248, P507, DOI 10.1007/BF02423445; Kusano T, 1998, BBA-GENE STRUCT EXPR, V1395, P171, DOI 10.1016/S0167-4781(97)00161-9; Lee SS., 2006, PLANT BIOTECHNOL, V23, P249, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.23.249; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Luo ZL, 1996, J BACTERIOL, V178, P2172, DOI 10.1128/jb.178.8.2172-2177.1996; Nagy F., 1988, PLANT MOL BIOL MAN B, VB4, P1; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Raney A, 2000, J BIOL CHEM, V275, P24444, DOI 10.1074/jbc.M003364200; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rook F, 1998, PLANT J, V15, P253, DOI 10.1046/j.1365-313X.1998.00205.x; Satoh R, 2004, PLANT CELL PHYSIOL, V45, P309, DOI 10.1093/pcp/pch036; Shimizu H, 2005, PLANT CELL PHYSIOL, V46, P1623, DOI 10.1093/pcp/pci178; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Tabuchi T, 2006, BIOSCI BIOTECH BIOCH, V70, P2330, DOI 10.1271/bbb.60309; Wiese A, 2005, BIOCHEM SOC T, V33, P272, DOI 10.1042/BST0330272; Wiese A, 2004, PLANT CELL, V16, P1717, DOI 10.1105/tpc.019349; Winter H, 2000, CRIT REV BIOCHEM MOL, V35, P253, DOI 10.1080/10409230008984165; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SH, 2001, PLANT PHYSIOL, V127, P23, DOI 10.1104/pp.127.1.23; Yoshida S, 2003, CURR OPIN PLANT BIOL, V6, P79, DOI 10.1016/S1369526602000092; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	39	31	36	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33111	10.1371/journal.pone.0033111	http://dx.doi.org/10.1371/journal.pone.0033111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457737	gold, Green Submitted, Green Published			2022-12-27	WOS:000303909200019
J	Jung, BK; Pyo, KH; Shin, KY; Hwang, YS; Lim, H; Lee, SJ; Moon, JH; Lee, SH; Suh, YH; Chai, JY; Shin, EH				Jung, Bong-Kwang; Pyo, Kyoung-Ho; Shin, Ki Young; Hwang, Young Sang; Lim, Hyoungsub; Lee, Sung Joong; Moon, Jung-Ho; Lee, Sang Hyung; Suh, Yoo-Hun; Chai, Jong-Yil; Shin, Eun-Hee			Toxoplasma gondii Infection in the Brain Inhibits Neuronal Degeneration and Learning and Memory Impairments in a Murine Model of Alzheimer's Disease	PLOS ONE			English	Article							MOUSE MODEL; NITRIC-OXIDE; BETA; INFLAMMATION; EXPRESSION; CLEARANCE; MICROGLIA; PROTEIN; INTERLEUKIN-10; PATHOGENESIS	Immunosuppression is a characteristic feature of Toxoplasma gondii-infected murine hosts. The present study aimed to determine the effect of the immunosuppression induced by T. gondii infection on the pathogenesis and progression of Alzheimer's disease (AD) in Tg2576 AD mice. Mice were infected with a cyst-forming strain (ME49) of T. gondii, and levels of inflammatory mediators (IFN-gamma and nitric oxide), anti-inflammatory cytokines (IL-10 and TGF-beta), neuronal damage, and beta-amyloid plaque deposition were examined in brain tissues and/or in BV-2 microglial cells. In addition, behavioral tests, including the water maze and Y-maze tests, were performed on T. gondii-infected and uninfected Tg2576 mice. Results revealed that whereas the level of IFN-gamma was unchanged, the levels of anti-inflammatory cytokines were significantly higher in T. gondii-infected mice than in uninfected mice, and in BV-2 cells treated with T. gondii lysate antigen. Furthermore, nitrite production from primary cultured brain microglial cells and BV-2 cells was reduced by the addition of T. gondii lysate antigen (TLA), and beta-amyloid plaque deposition in the cortex and hippocampus of Tg2576 mouse brains was remarkably lower in T. gondii-infected AD mice than in uninfected controls. In addition, water maze and Y-maze test results revealed retarded cognitive capacities in uninfected mice as compared with infected mice. These findings demonstrate the favorable effects of the immunosuppression induced by T. gondii infection on the pathogenesis and progression of AD in Tg2576 mice.	[Jung, Bong-Kwang; Pyo, Kyoung-Ho; Hwang, Young Sang; Moon, Jung-Ho; Chai, Jong-Yil; Shin, Eun-Hee] Seoul Natl Univ, Coll Med, Inst Endem Dis, Dept Parasitol & Trop Med, Seoul, South Korea; [Shin, Ki Young; Lee, Sang Hyung; Suh, Yoo-Hun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Lim, Hyoungsub; Lee, Sung Joong] Seoul Natl Univ, Sch Dent, Dept Neurosci, Seoul, South Korea; [Lee, Sang Hyung] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea; [Shin, Eun-Hee] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Jung, BK (corresponding author), Seoul Natl Univ, Coll Med, Inst Endem Dis, Dept Parasitol & Trop Med, Seoul, South Korea.	ehshin@snu.ac.kr	Jung, Bong-Kwang/GYQ-6442-2022; Chai, Jong-Yil/D-5751-2012; Lee, Sang Hyung/J-5581-2012; Shin, Ki Young/AAG-4861-2020; Shin, Eun-Hee/D-5757-2012; Suh, Yoo-Hun/J-2761-2012	Jung, Bong-Kwang/0000-0001-7581-3899; 	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0076262, 2011-0013824]; Seoul National University Bunding Hospital (SNUBH) [03-2010-016]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul National University Bunding Hospital (SNUBH)	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2009-0076262 & No. 2011-0013824), and by the Seoul National University Bunding Hospital Research Fund (SNUBH No. 03-2010-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Alexander J, 1997, PHILOS T ROY SOC B, V352, P1355, DOI 10.1098/rstb.1997.0120; Bhopale GM, 2003, COMP IMMUNOL MICROB, V26, P213, DOI 10.1016/S0147-9571(02)00058-9; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; DeckertSchluter M, 1997, J NEUROIMMUNOL, V76, P167, DOI 10.1016/S0165-5728(97)00047-7; Fernandez-Vizarra P, 2004, NEUROBIOL DIS, V15, P287, DOI 10.1016/j.nbd.2003.10.010; Fischer HG, 1997, PARASITOL RES, V83, P637, DOI 10.1007/s004360050311; Gulinello M, 2010, MICROBES INFECT, V12, P528, DOI 10.1016/j.micinf.2010.03.009; Guo JT, 2002, J NEUROSCI, V22, P5900; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; Hayashi S, 1996, J IMMUNOL, V156, P1476; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang WC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-28; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; KHAN IA, 1995, PARASITE IMMUNOL, V17, P185, DOI 10.1111/j.1365-3024.1995.tb00888.x; Kusbeci OY, 2011, ALZ DIS ASSOC DIS, V25, P1, DOI 10.1097/WAD.0b013e3181f73bc2; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Miman O, 2010, NEUROSCI LETT, V475, P129, DOI 10.1016/j.neulet.2010.03.057; Miman O, 2010, PSYCHIAT RES, V177, P263, DOI 10.1016/j.psychres.2009.12.013; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Pyo KH, 2010, KOREAN J PARASITOL, V48, P171, DOI 10.3347/kjp.2010.48.2.171; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rozenfeld C, 2005, AM J PATHOL, V167, P1021, DOI 10.1016/S0002-9440(10)61191-1; Rozenfeld C, 2003, INFECT IMMUN, V71, P2047, DOI 10.1128/IAI.71.4.2047-2057.2003; Sastre M, 2003, J NEUROSCI, V23, P9796; Schluter D, 1997, AM J PATHOL, V150, P1021; Taylor S, 2011, PSYCHIAT RE IN PRESS, P178; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wille U, 2001, PARASITE IMMUNOL, V23, P291, DOI 10.1046/j.1365-3024.2001.00389.x; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945	46	70	77	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33312	10.1371/journal.pone.0033312	http://dx.doi.org/10.1371/journal.pone.0033312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470449	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100026
J	Seino, S; Watanabe, S; Ito, N; Sasaki, K; Shoji, K; Miura, S; Kozawa, K; Nakai, K; Sato, H; Kanazawa, M; Fukudo, S				Seino, Shizuka; Watanabe, Satoshi; Ito, Namiko; Sasaki, Konosuke; Shoji, Kaori; Miura, Shoko; Kozawa, Kanoko; Nakai, Kunihiko; Sato, Hiroshi; Kanazawa, Motoyori; Fukudo, Shin			Enhanced Auditory Brainstem Response and Parental Bonding Style in Children with Gastrointestinal Symptoms	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; RECURRENT ABDOMINAL-PAIN; CORTICOTROPIN-RELEASING HORMONE; VISCERAL HYPERSENSITIVITY; SOMATIZATION INVENTORY; EMOTION REGULATION; EVOKED-POTENTIALS; COMMUNITY SAMPLE; ANXIETY; PSYCHOPATHOLOGY	Background: The electrophysiological properties of the brain and influence of parental bonding in childhood irritable bowel syndrome (IBS) are unclear. We hypothesized that children with chronic gastrointestinal (GI) symptoms like IBS may show exaggerated brainstem auditory evoked potential (BAEP) responses and receive more inadequate parental bonding. Methodology/Principal Findings: Children aged seven and their mothers (141 pairs) participated. BAEP was measured by summation of 1,000 waves of the electroencephalogram triggered by 75 dB click sounds. The mothers completed their Children's Somatization Inventory (CSI) and Parental Bonding Instrument (PBI). CSI results revealed 66 (42%) children without GI symptoms (controls) and 75 (58%) children with one or more GI symptoms (GI group). The III wave in the GI group (median 4.10 interquartile range [3.95-4.24] ms right, 4.04 [3.90-4.18] ms left) had a significantly shorter peak latency than controls (4.18 [4.06-4.34] ms right, p = 0.032, 4.13 [4.02-4.24] ms left, p = 0.018). The female GI group showed a significantly shorter peak latency of the III wave (4.00 [3.90-4.18] ms) than controls (4.18 [3.97-4.31] ms, p = 0.034) in the right side. BAEP in the male GI group did not significantly differ from that in controls. GI scores showed a significant correlation with the peak latency of the III wave in the left side (rho = -0.192, p = 0.025). The maternal care PBI scores in the GI group (29 [26-33]) were significantly lower than controls (31 [28.5-33], p = 0.010), while the maternal over-protection PBI scores were significantly higher in the GI group (16 [12-17]) than controls (13 [10.5-16], p = 0.024). Multiple regression analysis in females also supported these findings. Conclusions: It is suggested that children with chronic GI symptoms have exaggerated brainstem responses to environmental stimuli and inadequate parental behaviors aggravate these symptoms.	[Seino, Shizuka; Watanabe, Satoshi; Ito, Namiko; Kanazawa, Motoyori; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan; [Nakai, Kunihiko; Sato, Hiroshi] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci, Sendai, Miyagi 980, Japan; [Miura, Shoko; Kozawa, Kanoko] Tohoku Univ Hosp, Dept Clin Physiol, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Seino, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan.	sfukudo@med.tohoku.ac.jp	Watanabe, Satoshi/AAG-4295-2020; Fukudo, Shin/J-4813-2014	Watanabe, Satoshi/0000-0001-6757-3514; Sasaki, Konosuke/0000-0002-5507-8118	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by a Grant-in-Aid for Scientific Research from Ministry of Ministry of Education, Culture, Sports, Science and Technology Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini A, 2001, NEUROSCI LETT, V306, P132, DOI 10.1016/S0304-3940(01)01871-7; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Berman SM, 2002, AM J GASTROENTEROL, V97, P2791, DOI 10.1111/j.1572-0241.2002.07024.x; Berman SM, 2008, J NEUROSCI, V28, P349, DOI 10.1523/JNEUROSCI.2500-07.2008; Blandon AY, 2008, DEV PSYCHOL, V44, P1110, DOI 10.1037/0012-1649.44.4.1110; Campo JV, 2004, PEDIATRICS, V113, P817, DOI 10.1542/peds.113.4.817; Castilloux J, 2008, J PEDIATR GASTR NUTR, V46, P272, DOI 10.1097/MPG.0b013e31814b91e7; Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071; Creed FH, 2006, ROME 3 FUNCTIONAL GA, P295; Cruz DA, 2009, J COMP NEUROL, V514, P353, DOI 10.1002/cne.22006; Di Lorenzo C, 2001, J PEDIATR-US, V139, P838, DOI 10.1067/mpd.2001.118883; Dickhaus B, 2003, AM J GASTROENTEROL, V98, P135; DROSSMAN DA, 1990, ANN INTERN MED, V113, P828, DOI 10.7326/0003-4819-113-11-828; Dufton LM, 2009, J PEDIATR PSYCHOL, V34, P176, DOI 10.1093/jpepsy/jsn064; Durno CA, 2006, J PEDIATR GASTR NUTR, V43, P5, DOI 10.1097/01.mpg.0000221889.36501.bb; Enns MW, 2002, PSYCHOL MED, V32, P997, DOI 10.1017/S0033291702005937; Faure C, 2007, J PEDIATR-US, V150, P66, DOI 10.1016/j.jpeds.2006.08.072; Feldman R, 2010, PSYCHONEUROENDOCRINO, V35, P1133, DOI 10.1016/j.psyneuen.2010.01.013; Fukudo S, 1998, GUT, V42, P845, DOI 10.1136/gut.42.6.845; FUKUDO S, 1993, J CLIN GASTROENTEROL, V17, P133, DOI 10.1097/00004836-199309000-00009; Gorski R.A., 2000, PRINCIPLES NEURAL SC, P1131; Hattori T, 2010, NEUROGASTROENT MOTIL, V22, P1284, DOI 10.1111/j.1365-2982.2010.01568.x; HODGES K, 1985, PSYCHOSOMATICS, V26, P859, DOI 10.1016/S0033-3182(85)72777-6; Howell S, 2005, AM J GASTROENTEROL, V100, P2071, DOI 10.1111/j.1572-0241.2005.41753.x; Janssens KAM, 2009, J PEDIATR-US, V154, P918, DOI 10.1016/j.jpeds.2008.12.023; Kable JA, 2009, NEUROTOXICOL TERATOL, V31, P216, DOI 10.1016/j.ntt.2009.02.002; KITAMURA T, 1993, JPN J PSYCHIAT NEUR, V47, P29; Levy RL, 2001, GASTROENTEROLOGY, V121, P799, DOI 10.1053/gast.2001.27995; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Luecken LJ, 2006, DEV PSYCHOPATHOL, V18, P295, DOI 10.1017/S0954579406060160; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; Mayey EA, 2001, J CLIN PSYCHIAT, V62, P28; Meesters C, 2003, J PEDIATR PSYCHOL, V28, P413, DOI 10.1093/jpepsy/jsg031; Munakata J, 1997, GASTROENTEROLOGY, V112, P55, DOI 10.1016/S0016-5085(97)70219-1; Murata K, 2004, INT ARCH OCC ENV HEA, V77, P571, DOI 10.1007/s00420-004-0542-1; Naliboff BD, 2006, GASTROENTEROLOGY, V131, P352, DOI 10.1053/j.gastro.2006.05.014; Nicolson NA, 2004, PSYCHONEUROENDOCRINO, V29, P1012, DOI 10.1016/j.psyneuen.2003.09.005; Ovtscharoff W, 2006, BRAIN RES, V1116, P58, DOI 10.1016/j.brainres.2006.07.106; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; Plunkett A, 2005, J ROY SOC MED, V98, P101, DOI 10.1258/jrsm.98.3.101; ROBINSON JO, 1990, J PSYCHOSOM RES, V34, P171, DOI 10.1016/0022-3999(90)90051-5; ROSENHALL U, 1985, ELECTROEN CLIN NEURO, V62, P426, DOI 10.1016/0168-5597(85)90052-8; Sato T, 2000, PSYCHIAT CLIN NEUROS, V54, P121, DOI 10.1046/j.1440-1819.2000.00647.x; Shipman KL, 2001, DEV PSYCHOPATHOL, V13, P317, DOI 10.1017/S0954579401002073; STOCKARD JJ, 1986, ELECTRODIAGNOSIS CLI, P467; Suzuki K, 2010, ENVIRON RES, V110, P699, DOI 10.1016/j.envres.2010.07.001; Tafet GE, 2004, ANN NY ACAD SCI, V1032, P276, DOI 10.1196/annals.1314.037; Valentino RJ, 1995, J COMP NEUROL, V363, P402, DOI 10.1002/cne.903630306; Valentino RJ, 1996, BRAIN RES, V732, P1, DOI 10.1016/0006-8993(96)00482-9; van der Veek PPJ, 2008, CLIN GASTROENTEROL H, V6, P321, DOI 10.1016/j.cgh.2007.12.005; Videlock EJ, 2009, GASTROENTEROLOGY, V137, P1954, DOI 10.1053/j.gastro.2009.08.058; Vila M, 2009, J PEDIATR PSYCHOL, V34, P989, DOI 10.1093/jpepsy/jsp005; Vlieger AM, 2010, AM J GASTROENTEROL, V105, P213, DOI 10.1038/ajg.2009.613; Walker LS, 1998, J PEDIATR-US, V132, P1010, DOI 10.1016/S0022-3476(98)70400-7; WALKER LS, 1995, J PEDIATR PSYCHOL, V20, P233, DOI 10.1093/jpepsy/20.2.233; Wang Ning-Yu, 2005, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V40, P279; Watanabe S, 2007, NEUROGASTROENT MOTIL, V19, P831, DOI 10.1111/j.1365-2982.2007.00959.x; Weydert JA, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e1; WHITEHEAD WE, 1990, GASTROENTEROLOGY, V98, P1187, DOI 10.1016/0016-5085(90)90332-U; ZUCKERMAN B, 1987, PEDIATRICS, V79, P677	60	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e32913	10.1371/journal.pone.0032913	http://dx.doi.org/10.1371/journal.pone.0032913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YN	22470430	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100008
J	Chakraborty, G; Kumar, S; Mishra, R; Patil, TV; Kundu, GC				Chakraborty, Goutam; Kumar, Santosh; Mishra, Rosalin; Patil, Tushar V.; Kundu, Gopal C.			Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model	PLOS ONE			English	Article							LUNG-CANCER; ANGIOGENESIS; EXPRESSION; GENE; NEUROPILIN-1; INHIBITION; PROGRESSION; CELLS; AUTOCRINE; RECEPTORS	Background: Recent understanding on cancer therapy indicated that targeting metastatic signature or angiogenic switch could be a promising and rational approach to combat cancer. Advancement in cancer research has demonstrated the potential role of various tumor suppressor proteins in inhibition of cancer progression. Current studies have shown that axonal sprouting inhibitor, semaphorin 3A (Sema 3A) acts as a potent suppressor of tumor angiogenesis in various cancer models. However, the function of Sema 3A in regulation of melanoma progression is not well studied, and yet to be the subject of intense investigation. Methodology/Principal Findings: In this study, using multiple in vitro and in vivo approaches we have demonstrated that Sema 3A acts as a potent tumor suppressor in vitro and in vivo mice (C57BL/6) models. Mouse melanoma (B16F10) cells overexpressed with Sema 3A resulted in significant inhibition of cell motility, invasiveness and proliferation as well as suppression of in vivo tumor growth, angiogenesis and metastasis in mice models. Moreover, we have observed that Sema 3A overexpressed melanoma clone showed increased sensitivity towards curcumin and Dacarbazine, anti-cancer agents. Conclusions: Our results demonstrate, at least in part, the functional approach underlying Sema 3A mediated inhibition of tumorigenesis and angiogenesis and a clear understanding of such a process may facilitate the development of novel therapeutic strategy for the treatment of cancer.	[Chakraborty, Goutam; Kumar, Santosh; Mishra, Rosalin; Kundu, Gopal C.] NCCS, Pune, Maharashtra, India; [Patil, Tushar V.] YCM Hosp, Dept Histopathol, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Chakraborty, G (corresponding author), Sloan Kettering Inst, Div Cell Biol, New York, NY 10065 USA.	kundu@nccs.res.in	Kumar, Santosh/I-9171-2019; MISHRA, ROSALIN/L-4319-2017; Chakraborty, Goutam/B-5099-2014; Chakraborty, Goutam/U-5559-2019; Kundu, Gopal C./ABA-9897-2020	Kumar, Santosh/0000-0002-4044-7005; MISHRA, ROSALIN/0000-0002-9808-8797; 	Council of Scientific and Industrial Research, Government of India; University Grant Commission, Government of India; NCCS	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, Government of India(University Grants Commission, India); NCCS	The fellowships of G. C. and R. M. were supported by the Council of Scientific and Industrial Research, Government of India, and the fellowship of S. K. was supported by the University Grant Commission, Government of India. The cost of the reagents/consumables was supported by the NCCS Core fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2003, CANCER RES, V63, P5230; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chakraborty G, 2006, J BIOL CHEM, V281, P11322, DOI 10.1074/jbc.M512546200; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Chakraborty G, 2008, J CELL MOL MED, V12, P2305, DOI 10.1111/j.1582-4934.2008.00263.x; DENIJN M, 1993, MELANOMA RES, V3, P5, DOI 10.1097/00008390-199304000-00002; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Folkman J, 1996, SCI AM, V275, P150, DOI 10.1038/scientificamerican0996-150; Gaggioli C, 2007, PIGM CELL RES, V20, P161, DOI 10.1111/j.1600-0749.2007.00378.x; Gautam A, 2002, GENE THER, V9, P353, DOI 10.1038/sj.gt.3301662; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Herman JG, 2007, INT J ONCOL, V30, P1231; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Koblinski JE, 2005, CANCER RES, V65, P7370, DOI 10.1158/0008-5472.CAN-05-0807; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lavhale MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005365; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Maione F, 2009, J CLIN INVEST, V119, P3356, DOI 10.1172/JCI36308; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Nasarre P, 2005, NEOPLASIA, V7, P180, DOI 10.1593/neo.04481; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Roche J, 1996, ONCOGENE, V12, P1289; Rolny C, 2008, J EXP MED, V205, P1155, DOI 10.1084/jem.20072509; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Serini G, 2009, ANGIOGENESIS, V12, P187, DOI 10.1007/s10456-009-9138-4; Sharma P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-178; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 2004, EMBO REP, V5, P356, DOI 10.1038/sj.embor.7400114; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Tedeschi A, 2009, J NEUROSCI, V29, P15155, DOI 10.1523/JNEUROSCI.4416-09.2009; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Xiang RH, 1996, GENOMICS, V32, P39, DOI 10.1006/geno.1996.0074; Xiang RH, 2002, CANCER RES, V62, P2637; Yacoub M, 2009, HISTOPATHOLOGY, V55, P392, DOI 10.1111/j.1365-2559.2009.03406.x	50	65	71	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33633	10.1371/journal.pone.0033633	http://dx.doi.org/10.1371/journal.pone.0033633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448259	Green Submitted, gold, Green Published			2022-12-27	WOS:000303855700050
J	Pillai, P; Guichard, F				Pillai, Pradeep; Guichard, Frederic			Competition-Colonization Trade-Offs, Competitive Uncertainty, and the Evolutionary Assembly of Species	PLOS ONE			English	Article							CHARACTER DISPLACEMENT; ASYMMETRIC COMPETITION; LIMITING SIMILARITY; DEFINE FITNESS; COEXISTENCE; DIVERSITY; HISTORY; MODELS; BIODIVERSITY; COMMUNITIES	We utilize a standard competition-colonization metapopulation model in order to study the evolutionary assembly of species. Based on earlier work showing how models assuming strict competitive hierarchies will likely lead to runaway evolution and self-extinction for all species, we adopt a continuous competition function that allows for levels of uncertainty in the outcome of competition. We then, by extending the standard patch-dynamic metapopulation model in order to include evolutionary dynamics, allow for the coevolution of species into stable communities composed of species with distinct limiting similarities. Runaway evolution towards stochastic extinction then becomes a limiting case controlled by the level of competitive uncertainty. We demonstrate how intermediate competitive uncertainty maximizes the equilibrium species richness as well as maximizes the adaptive radiation and self-assembly of species under adaptive dynamics with mutations of non-negligible size. By reconciling competition-colonization tradeoff theory with co-evolutionary dynamics, our results reveal the importance of intermediate levels of competitive uncertainty for the evolutionary assembly of species.	[Pillai, Pradeep; Guichard, Frederic] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Pillai, P (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	pradeep.research@gmail.com			Natural Science and Engineering Research Council of Canada (NSERC); James S. McDonnell Foundation	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); James S. McDonnell Foundation	F.G. is pleased to acknowledge funding from the Natural Science and Engineering Research Council of Canada (NSERC), and from the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CH, 2012, OIKOS, V121, P116, DOI 10.1111/j.1600-0706.2011.19672.x; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bonsall MB, 2004, SCIENCE, V306, P111, DOI 10.1126/science.1100680; Bonsall MB, 2004, P ROY SOC B-BIOL SCI, V271, P1143, DOI 10.1098/rspb.2004.2722; BROWN JS, 1987, THEOR POPUL BIOL, V31, P140, DOI 10.1016/0040-5809(87)90026-8; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; Clark JS, 2010, ECOL MONOGR, V80, P569, DOI 10.1890/09-1541.1; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Clark JS, 2004, ECOL MONOGR, V74, P415, DOI 10.1890/02-4093; Clark JS, 2003, ECOLOGY, V84, P17, DOI 10.1890/0012-9658(2003)084[0017:CHTITT]2.0.CO;2; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; ESHEL I, 1983, J THEOR BIOL, V103, P99, DOI 10.1016/0022-5193(83)90201-1; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Hanski I., 1990, P127; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; HASTINGS A, 1980, THEOR POPUL BIOL, V18, P363, DOI 10.1016/0040-5809(80)90059-3; Jansen VAA, 1999, ECOL LETT, V2, P379; Johansson J, 2006, AM NAT, V168, P572, DOI 10.1086/507996; Johansson J, 2010, THEOR POPUL BIOL, V77, P95, DOI 10.1016/j.tpb.2009.10.007; Kinzig AP, 1999, AM NAT, V153, P371, DOI 10.1086/303182; Kisdi E, 1999, J THEOR BIOL, V197, P149, DOI 10.1006/jtbi.1998.0864; Law R, 1997, EVOL ECOL, V11, P485, DOI 10.1023/A:1018441108982; Levine JM, 2002, AM NAT, V160, P452, DOI 10.1086/342073; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Massol F, 2009, THEOR POPUL BIOL, V75, P183, DOI 10.1016/j.tpb.2009.02.005; MATSUDA H, 1994, EVOLUTION, V48, P1764, DOI 10.1111/j.1558-5646.1994.tb02212.x; MAY RM, 1994, J THEOR BIOL, V170, P95, DOI 10.1006/jtbi.1994.1171; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Metz JAJ, 2001, P ROY SOC B-BIOL SCI, V268, P499, DOI 10.1098/rspb.2000.1373; Moen DS, 2009, EVOLUTION, V63, P195, DOI 10.1111/j.1558-5646.2008.00538.x; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Roy M, 2004, THEOR POPUL BIOL, V66, P341, DOI 10.1016/j.tpb.2004.06.012; RUMMEL JD, 1985, EVOLUTION, V39, P1009, DOI 10.1111/j.1558-5646.1985.tb00444.x; RUMMEL JD, 1983, OIKOS, V41, P477, DOI 10.2307/3544107; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; SHORROCKS B, 1991, BIOL J LINN SOC, V43, P211, DOI 10.1111/j.1095-8312.1991.tb00594.x; Stanton ML, 2002, ECOL MONOGR, V72, P347, DOI 10.1890/0012-9615(2002)072[0347:CCTOIA]2.0.CO;2; TAPER ML, 1992, EVOLUTION, V46, P317, DOI 10.1111/j.1558-5646.1992.tb02040.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tyerman JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-34	44	6	6	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33566	10.1371/journal.pone.0033566	http://dx.doi.org/10.1371/journal.pone.0033566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448253	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700044
J	Ruger, JP; Ben Abdallah, A; Luekens, C; Cottler, L				Ruger, Jennifer Prah; Ben Abdallah, Arbi; Luekens, Craig; Cottler, Linda			Cost-Effectiveness of Peer-Delivered Interventions for Cocaine and Alcohol Abuse among Women: A Randomized Controlled Trial	PLOS ONE			English	Article							EFFECTIVENESS ACCEPTABILITY CURVES; METHADONE-MAINTENANCE TREATMENT; CONTINGENCY MANAGEMENT; PRIMARY-CARE; NATIONAL EVALUATION; ECONOMIC-EVALUATION; RELAPSE PREVENTION; DEPENDENT PATIENTS; TREATMENT PROGRAMS; PREGNANT-WOMEN	Aims: To determine whether the additional interventions to standard care are cost-effective in addressing cocaine and alcohol abuse at 4 months (4 M) and 12 months (12 M) from baseline. Method: We conducted a cost-effectiveness analysis of a randomized controlled trial with three arms: (1) NIDA's Standard intervention (SI); (2) SI plus a Well Woman Exam (WWE); and, (3) SI, WWE, plus four Educational Sessions (4ES). Results: To obtain an additional cocaine abstainer, WWE compared to SI cost $7,223 at 4 M and $3,611 at 12 M. Per additional alcohol abstainer, WWE compared to SI cost $3,611 and $7,223 at 4 M and 12 M, respectively. At 12 M, 4ES was dominated (more costly and less effective) by WWE for abstinence outcomes. Conclusions: To our knowledge, this is the first cost-effectiveness analysis simultaneously examining cocaine and alcohol abuse in women. Depending on primary outcomes sought and priorities of policy makers, peer-delivered interventions can be a cost-effective way to address the needs of this growing, underserved population.	[Ruger, Jennifer Prah; Luekens, Craig] Yale Univ, Sch Med, Dept Publ Hlth, New Haven, CT 06510 USA; [Ben Abdallah, Arbi; Cottler, Linda] Washington Univ, Sch Med, St Louis, MO USA	Yale University; Washington University (WUSTL)	Ruger, JP (corresponding author), Yale Univ, Sch Med, Dept Publ Hlth, 333 Cedar St, New Haven, CT 06510 USA.	jennifer.ruger@yale.edu		cottler, linda/0000-0001-5643-8536	National Institutes of Health (NIH) National Institute on Drug Abuse [NIDA] [R01DA1162, K01DA01635810]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011622] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Drug Abuse [NIDA](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health (NIH) National Institute on Drug Abuse ([NIDA] grant R01DA11622). JR was supported by a Career Development Award from the NIH (NIDA grant K01DA01635810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JP, 2010, PEDIATRICS, V125, P554, DOI 10.1542/peds.2009-0637; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Barnett PG, 1997, HEALTH SERV RES, V32, P615; Basu A, 2008, HEALTH ECON, V17, P927, DOI 10.1002/hec.1305; Cottler L B, 1998, Public Health Rep, V113 Suppl 1, P31; Cunningham RM, 1996, J DRUG ISSUES, V26, P541, DOI 10.1177/002204269602600303; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P205, DOI 10.1038/sj.npp.1300600; Drummond C, 2009, BRIT J PSYCHIAT, V195, P448, DOI 10.1192/bjp.bp.108.056697; Echeburua E, 2009, SUBST USE MISUSE, V44, P981, DOI 10.1080/10826080802494735; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Godfrey C, 2005, BMJ-BRIT MED J, V331, P544; Gold MR, COST EFFECTIVENESS H; Gueorguieva R, 2007, BIOL PSYCHIAT, V61, P1290, DOI 10.1016/j.biopsych.2006.09.038; Harris AH, 2005, PHARMACOECONOMICS, V23, P77, DOI 10.2165/00019053-200523010-00007; Jofre-Bonet M, 2004, J SUBST ABUSE TREAT, V26, P225, DOI 10.1016/S0740-5472(04)00004-2; Lothgren M, 2000, HEALTH ECON, V9, P623, DOI 10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V; Mansdotter AM, 2007, EUR J PUBLIC HEALTH, V17, P618, DOI 10.1093/eurpub/ckm017; Mark TL, 2007, SAMHSA PUBLICATION, VSMA 07-4227; McKay JR, 1997, J CONSULT CLIN PSYCH, V65, P778, DOI 10.1037/0022-006X.65.5.778; Milby JB, 2010, AM J PUBLIC HEALTH, V100, P913, DOI 10.2105/AJPH.2008.152975; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; National Institute on Drug Abuse, 2008, EP TRENDS DRUG AB, V1; National Institute on Drug Abuse, 2011, EP TRENDS DRUG AB; Office of National Drug Control Policy, 2004, EC COSTS DRUG AB US; Olmstead TA, 2007, DRUG ALCOHOL DEPEN, V87, P175, DOI 10.1016/j.drugalcdep.2006.08.012; Olmstead TA, 2009, DRUG ALCOHOL DEPEN, V102, P108, DOI 10.1016/j.drugalcdep.2009.02.005; Penberthy Jennifer K, 2010, Curr Drug Abuse Rev, V3, P49; Rawson RA, 2002, ARCH GEN PSYCHIAT, V59, P817, DOI 10.1001/archpsyc.59.9.817; Renalbusiness.com, 2009, RENALBUSINESS; Resch S, 2005, JAIDS-J ACQ IMM DEF, V38, P163, DOI 10.1097/01.qai.0000146598.40301.e6; Ruger JP, 2008, VALUE HEALTH, V11, P191, DOI 10.1111/j.1524-4733.2007.00240.x; Ruger JP, 2010, PUBLIC HEALTH REP, V125, P83, DOI 10.1177/00333549101250S111; Ruger JenniferPrah., 2009, HLTH SOCIAL JUSTICE; Ruger JP, 2010, COST EFFECTIVENESS I; Ruger JP, 2006, CORNELL J LAW PUBLIC, V15, P101; Schadlich PK, 1998, PHARMACOECONOMICS, V13, P719, DOI 10.2165/00019053-199813060-00008; Schumacher Joseph E, 2002, J Ment Health Policy Econ, V5, P33; Shanahan MD, 2006, ADDICT BEHAV, V31, P371, DOI 10.1016/j.addbeh.2005.05.016; Simpson DD, 1999, ARCH GEN PSYCHIAT, V56, P507, DOI 10.1001/archpsyc.56.6.507; Sindelar JL, 2004, DRUG ALCOHOL DEPEN, V73, P41, DOI 10.1016/j.drugalcdep.2003.09.002; Sindelar J, 2007, ADDICTION, V102, P309, DOI 10.1111/j.1360-0443.2006.01689.x; Sindelar JL, 2007, ADDICTION, V102, P1463, DOI 10.1111/j.1360-0443.2007.01913.x; Sindelar JL, 2006, ELGAR ORIG REF, P83; Tariq L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005696; U.S. Department of Health and Human Services, 2009, NSDUH SER H; U.S. Department of Health and Human Services, 2011, NSDUH SER H; United States Renal Data System, 2009, USRDS 2009 ANN DAT R, V3; Vocci FJ, 2005, CURR OPIN PSYCHIATR, V18, P265, DOI 10.1097/01.yco.0000165596.98552.02; Warren E, 2006, DRUG ALCOHOL DEPEN, V84, P160, DOI 10.1016/j.drugalcdep.2006.01.010; Wechsberg W. M., 1997, STANDARD INTERVENTIO; Weisner C, 2000, HEALTH SERV RES, V35, P791; Zarkin GA, 2001, HEALTH SERV RES, V36, P335; Zarkin GA, 2008, ARCH GEN PSYCHIAT, V65, P1214, DOI 10.1001/archpsyc.65.10.1214	54	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33594	10.1371/journal.pone.0033594	http://dx.doi.org/10.1371/journal.pone.0033594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YB	22448255	Green Published, gold			2022-12-27	WOS:000303855700046
J	Turrini, PCG; Loveland, JL; Dorit, RL				Turrini, Paula C. G.; Loveland, Jasmine L.; Dorit, Robert L.			By Any Other Name: Heterologous Replacement of the Escherichia coli RNase P Protein Subunit Has In Vivo Fitness Consequences	PLOS ONE			English	Article							NATURALLY-OCCURRING SUBSTRATE; RIBONUCLEASE-P; BACILLUS-SUBTILIS; NEUTRAL NETWORKS; THERMOTOGA-MARITIMA; SEQUENCE ALIGNMENT; CATALYTIC RNA; EVOLUTION; SPACE; HOLOENZYME	Bacterial RNase P is an essential ribonucleoprotein composed of a catalytic RNA component (encoded by the rnpB gene) and an associated protein moiety (encoded by rnpA). We construct a system that allows for the deletion of the essential endogenous rnpA copy and for its simultaneous replacement by a heterologous version of the gene. Using growth rate as a proxy, we explore the effects on fitness of heterologous replacement by increasingly divergent versions of the RNase P protein. All of the heterologs tested complement the loss of the endogenous rnpA gene, suggesting that all existing bacterial versions of the rnpA sequence retain the elements required for functional interaction with the RNase P RNA. All replacements, however, exact a cost on organismal fitness, and particularly on the rate of growth acceleration, defined as the time required to reach maximal growth rate. Our data suggest that the similarity of the heterolog to the endogenous version - whether defined at the sequence, structure or codon usage level - does not predict the fitness costs of the replacement. The common assumption that sequence similarity predicts functional similarity requires experimental confirmation and may prove to be an oversimplification.	[Turrini, Paula C. G.; Loveland, Jasmine L.; Dorit, Robert L.] Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA	Smith College	Turrini, PCG (corresponding author), Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA.	rdorit@smith.edu	Loveland, Jasmine L/K-9582-2016	Loveland, Jasmine L/0000-0003-1866-0229	NASA [NNX08AE90G, NAG5-8813]; National Science Foundation [0196469]; Smith College	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); Smith College	This work has been supported by NASA Exobiology Grant NNX08AE90G and NAG5-8813 and by National Science Foundation award 0196469 to RLD, as well as by the Blakeslee and Tomlinson Funds at Smith College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita T, 2003, J THEOR BIOL, V221, P599, DOI 10.1006/jtbi.2003.3209; Altman S, 2005, P NATL ACAD SCI USA, V102, P11284, DOI 10.1073/pnas.0505271102; Babajide A, 1997, FOLD DES, V2, P261, DOI 10.1016/S1359-0278(97)00037-0; Bastolla U, 2003, J MOL EVOL, V56, P243, DOI 10.1007/s00239-002-2350-0; BornbergBauer E, 1997, BIOPHYS J, V73, P2393, DOI 10.1016/S0006-3495(97)78268-7; BROWN JW, 1992, NUCLEIC ACIDS RES, V20, P1451, DOI 10.1093/nar/20.7.1451; Buck AH, 2005, NAT STRUCT MOL BIOL, V12, P958, DOI 10.1038/nsmb1004; Buck AH, 2005, EMBO J, V24, P3360, DOI 10.1038/sj.emboj.7600805; Cooper VS, 2001, EVOLUTION, V55, P889, DOI 10.1554/0014-3820(2001)055[0889:EOTDOG]2.0.CO;2; Coughlin DJ, 2008, P NATL ACAD SCI USA, V105, P12218, DOI 10.1073/pnas.0801906105; Dalgaard P, 2001, J MICROBIOL METH, V43, P183, DOI 10.1016/S0167-7012(00)00219-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis JC, 2010, EVOLUTION RNASE P IT, P17; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Fontana W, 1998, J THEOR BIOL, V194, P491, DOI 10.1006/jtbi.1998.0771; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gimple O, 2001, BIOL CHEM, V382, P1421, DOI 10.1515/BC.2001.175; Gossringer M, 2007, MOL MICROBIOL, V66, P801, DOI 10.1111/j.1365-2958.2007.05962.x; Gossringer M, 2006, J BACTERIOL, V188, P6816, DOI 10.1128/JB.00756-06; Guerrier-Takada C, 1983, CELL, V35, P9; Guo X, 2006, J MOL BIOL, V360, P190, DOI 10.1016/j.jmb.2006.05.001; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P8; HANSEN FG, 1985, GENE, V38, P85, DOI 10.1016/0378-1119(85)90206-9; Hori Y, 2000, FEBS LETT, V472, P187, DOI 10.1016/S0014-5793(00)01463-0; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kazantsev AV, 2003, P NATL ACAD SCI USA, V100, P7497, DOI 10.1073/pnas.0932597100; Kim JJ, 1997, RNA, V3, P613; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Li Y, 2003, P NATL ACAD SCI USA, V100, P13213, DOI 10.1073/pnas.2235589100; Loria A, 1998, BIOCHEMISTRY-US, V37, P15466, DOI 10.1021/bi9816507; McClain WH, 2010, J MOL BIOL, V397, P627, DOI 10.1016/j.jmb.2010.01.038; MEYERLEON L, 1984, COLD SPRING HARB SYM, V49, P797, DOI 10.1101/SQB.1984.049.01.090; Mondragon A, 2010, STRUCTURAL STUDIES R, P63; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; PANAGIOTIDIS CA, 1992, INT J BIOCHEM, V24, P1625, DOI 10.1016/0020-711X(92)90180-9; PECKMILLER KA, 1991, J MOL BIOL, V221, P1; Peden JF., THESIS U NOTTINGHAM; REICH C, 1988, SCIENCE, V239, P178, DOI 10.1126/science.3122322; Reidys C, 2001, B MATH BIOL, V63, P57, DOI 10.1006/bulm.2000.0206; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Seif E, 2008, RNA, V14, P1237, DOI 10.1261/rna.833408; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Spitzfaden C, 2000, J MOL BIOL, V295, P105, DOI 10.1006/jmbi.1999.3341; Stams T, 1998, SCIENCE, V280, P752, DOI 10.1126/science.280.5364.752; Tamura K, 2011, MOL BIOL EVOLUTION; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Westhof E, 1996, J MOL BIOL, V258, P600, DOI 10.1006/jmbi.1996.0272; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32456	10.1371/journal.pone.0032456	http://dx.doi.org/10.1371/journal.pone.0032456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448220	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700010
J	Fuller, DH; Rajakumar, P; Che, JW; Narendran, A; Nyaundi, J; Michael, H; Yager, EJ; Stagnar, C; Wahlberg, B; Taber, R; Haynes, JR; Cook, FC; Ertl, P; Tite, J; Amedee, AM; Murphey-Corb, M				Fuller, Deborah Heydenburg; Rajakumar, Premeela; Che, Jenny W.; Narendran, Amithi; Nyaundi, Julia; Michael, Heather; Yager, Eric J.; Stagnar, Cristy; Wahlberg, Brendon; Taber, Rachel; Haynes, Joel R.; Cook, Fiona C.; Ertl, Peter; Tite, John; Amedee, Angela M.; Murphey-Corb, Michael			Therapeutic DNA Vaccine Induces Broad T Cell Responses in the Gut and Sustained Protection from Viral Rebound and AIDS in SIV-Infected Rhesus Macaques	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; MUCOSAL IMMUNE-RESPONSES; BLOOD MONONUCLEAR-CELLS; HEAT-LABILE ENTEROTOXIN; TRANSCUTANEOUS IMMUNIZATION; HIV-1 INFECTION; DENDRITIC CELLS; CHOLERA-TOXIN; ESCHERICHIA-COLI	Immunotherapies that induce durable immune control of chronic HIV infection may eliminate the need for life-long dependence on drugs. We investigated a DNA vaccine formulated with a novel genetic adjuvant that stimulates immune responses in the blood and gut for the ability to improve therapy in rhesus macaques chronically infected with SIV. Using the SIV-macaque model for AIDS, we show that epidermal co-delivery of plasmids expressing SIV Gag, RT, Nef and Env, and the mucosal adjuvant, heat-labile E. coli enterotoxin (LT), during antiretroviral therapy (ART) induced a substantial 2-4-log fold reduction in mean virus burden in both the gut and blood when compared to unvaccinated controls and provided durable protection from viral rebound and disease progression after the drug was discontinued. This effect was associated with significant increases in IFN-gamma T cell responses in both the blood and gut and SIV-specific CD8+ T cells with dual TNF-alpha and cytolytic effector functions in the blood. Importantly, a broader specificity in the T cell response seen in the gut, but not the blood, significantly correlated with a reduction in virus production in mucosal tissues and a lower virus burden in plasma. We conclude that immunizing with vaccines that induce immune responses in mucosal gut tissue could reduce residual viral reservoirs during drug therapy and improve long-term treatment of HIV infection in humans.	[Fuller, Deborah Heydenburg; Rajakumar, Premeela; Che, Jenny W.; Nyaundi, Julia; Michael, Heather; Wahlberg, Brendon; Taber, Rachel; Murphey-Corb, Michael] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Fuller, Deborah Heydenburg; Narendran, Amithi; Yager, Eric J.; Stagnar, Cristy] Albany Med Coll, Albany, NY 12208 USA; [Fuller, Deborah Heydenburg; Che, Jenny W.; Haynes, Joel R.] PowderJect Vaccines Inc, Madison, WI USA; [Cook, Fiona C.; Ertl, Peter; Tite, John] GlaxoSmithKline, Stevenage, Herts, England; [Amedee, Angela M.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Albany Medical College; GlaxoSmithKline; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Fuller, DH (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	fullerdh@u.washington.edu; mcorb@pitt.edu		Yager, Eric/0000-0001-6118-7487; Fuller, Deborah/0000-0001-7315-2441	National Institutes of Health [P01 A155844-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (P01 A155844-01) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; AMEDEE AM, 1995, J VIROL, V69, P7982, DOI 10.1128/JVI.69.12.7982-7990.1995; Arrington J, 2002, J VIROL, V76, P4536, DOI 10.1128/JVI.76.9.4536-4546.2002; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Belyakov IM, 2008, VIROLOGY, V381, P106, DOI 10.1016/j.virol.2008.08.019; Belyakov IM, 2007, J IMMUNOL, V178, P7211, DOI 10.4049/jimmunol.178.11.7211; Belyakov IM, 2006, BLOOD, V107, P3258, DOI 10.1182/blood-2005-11-4374; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Berry LJ, 2004, INFECT IMMUN, V72, P1019, DOI 10.1128/IAI.72.2.1019-1028.2004; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Boyer JD, 2006, VACCINE, V24, P4498, DOI 10.1016/j.vaccine.2005.08.016; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Chen DX, 2001, J VIROL, V75, P7956, DOI 10.1128/JVI.75.17.7956-7965.2001; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Daynes RA, 1996, INFECT IMMUN, V64, P1100, DOI 10.1128/IAI.64.4.1100-1109.1996; De Rose R, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000055; Donnelly JJ, 1996, LIFE SCI, V60, P163, DOI 10.1016/S0024-3205(96)00502-4; Enioutina EY, 2008, VACCINE, V26, P601, DOI 10.1016/j.vaccine.2007.11.084; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Fuller DH, 2007, VIROLOGY, V364, P245, DOI 10.1016/j.virol.2007.02.024; Fuller DH, 2006, VIROLOGY, V348, P200, DOI 10.1016/j.virol.2005.12.008; Fuller DH, 1996, J MED PRIMATOL, V25, P236, DOI 10.1111/j.1600-0684.1996.tb00021.x; Fuller DH, 2002, J VIROL, V76, P3309, DOI 10.1128/JVI.76.7.3309-3317.2002; Gallimore A, 1998, J EXP MED, V187, P1647; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Glenn GM, 1998, J IMMUNOL, V161, P3211; Haynes JR, 2006, VACCINE, V24, P5016, DOI 10.1016/j.vaccine.2006.03.046; Hel Z, 2000, NAT MED, V6, P1140, DOI 10.1038/80481; Kent SJ, 1998, J VIROL, V72, P10180, DOI 10.1128/JVI.72.12.10180-10188.1998; Kim JJ, 2001, VIROLOGY, V285, P204, DOI 10.1006/viro.2001.0958; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Knapp LA, 1997, TISSUE ANTIGENS, V50, P657, DOI 10.1111/j.1399-0039.1997.tb02927.x; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Lackner AA, 2007, ANNU REV MED, V58, P461, DOI 10.1146/annurev.med.58.082405.094316; Levy Y, 2005, AIDS, V19, P279; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Lisziewicz J, 2005, AIDS, V19, P35, DOI 10.1097/00002030-200501030-00004; Loudon PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011021; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Lu W, 2003, NAT MED, V9, P27, DOI 10.1038/nm806; MARTIN LN, 1993, J INFECT DIS, V168, P825, DOI 10.1093/infdis/168.4.825; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Mudd PA, 2011, J VIROL, V85, P7454, DOI 10.1128/JVI.00738-11; Murphey-Corb M, 1999, J IMMUNOL, V162, P540; Nakajima T, 2008, PHARMACOGENOMICS, V9, P1347, DOI 10.2217/14622416.9.9.1347; PERTMER TM, 1995, VACCINE, V13, P1427, DOI 10.1016/0264-410X(95)00069-D; Riddler SA, 1997, AIDS, V11, pS141; Robinson HL, 1999, NAT MED, V5, P526, DOI 10.1038/8406; Rollman E, 2007, J IMMUNOL, V179, P4571, DOI 10.4049/jimmunol.179.7.4571; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Seman AL, 2000, J GEN VIROL, V81, P2441, DOI 10.1099/0022-1317-81-10-2441; Staszewski S, 1998, AIDS, V12, P2360; Taber R, 2006, VIROLOGY, V354, P116, DOI 10.1016/j.virol.2006.06.025; Takeuchi H, 2008, MICROBIOL IMMUNOL, V52, P318, DOI 10.1111/j.1348-0421.2008.00040.x; Tryniszewska E, 2002, J IMMUNOL, V169, P5347, DOI 10.4049/jimmunol.169.9.5347; Tubiana R, 2005, VACCINE, V23, P4292, DOI 10.1016/j.vaccine.2005.04.013; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003; von Gegerfelt AS, 2007, J VIROL, V81, P1972, DOI 10.1128/JVI.01990-06; Wang XL, 2007, BLOOD, V109, P1174, DOI 10.1182/blood-2006-04-015172; Watson A, 1997, J VIROL, V71, P284, DOI 10.1128/JVI.71.1.284-290.1997; Wilson SJ, 2008, J VIROL, V82, P7243, DOI 10.1128/JVI.00307-08; Wu JQ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-24; zur Megede J, 2008, AIDS RES HUM RETROV, V24, P1103, DOI 10.1089/aid.2008.0055	68	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33715	10.1371/journal.pone.0033715	http://dx.doi.org/10.1371/journal.pone.0033715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442716	Green Published, Green Accepted, gold			2022-12-27	WOS:000303836500057
J	Huet, RCGG; de Vries, AJ; Cernak, V; Lisman, T				Huet, Rolf C. G. Gallandat; de Vries, Adrianus J.; Cernak, Vladimir; Lisman, Ton			Platelet Function in Stored Heparinised Autologous Blood Is Not Superior to in Patient Platelet Function during Routine Cardiopulmonary Bypass	PLOS ONE			English	Article							CARDIAC-SURGERY; WHOLE-BLOOD; PROTECTS PLATELETS; AGGREGOMETRY; ACTIVATION; TRANSFUSION	Background: In cardiac surgery, cardiopulmonary bypass (CPB) and unfractionated heparin have negative effects on blood platelet function. In acute normovolemic haemodilution autologous unfractionated heparinised blood is stored ex-vivo and retransfused at the end of the procedure to reduce (allogeneic) transfusion requirements. In this observational study we assessed whether platelet function is better preserved in ex vivo stored autologous blood compared to platelet function in the patient during CPB. Methodology/Principal Finding: We measured platelet aggregation responses pre-CPB, 5 min after the start of CPB, at the end of CPB, and after unfractionated heparin reversal, using multiple electrode aggregometry (Multiplate (R)) with adenosine diphosphate (ADP), thrombin receptor activating peptide (TRAP) and ristocetin activated test cells. We compared blood samples taken from the patient with samples taken from 100 ml ex-vivo stored blood, which we took to mimick blood storage during normovolemic haemodilution. Platelet function declined both in ex-vivo stored blood as well as in blood taken from the patient. At the end of CPB there were no differences in platelet aggregation responses between samples from the ex vivo stored blood and the patient. Conclusion/Significance: Ex vivo preservation of autologous blood in unfractionated heparin does not seem to be profitable to preserve platelet function.	[Huet, Rolf C. G. Gallandat; de Vries, Adrianus J.; Cernak, Vladimir] Univ Groningen, Dept Anesthesiol, Univ Med Ctr Groningen, Groningen, Netherlands; [Lisman, Ton] Univ Groningen, Dept Surg, Surg Res Lab, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen	Huet, RCGG (corresponding author), Univ Groningen, Dept Anesthesiol, Univ Med Ctr Groningen, Groningen, Netherlands.	r.c.g.huet@anest.umcg.nl		Lisman, Ton/0000-0002-3503-7140				Ballotta A, 2007, J THORAC CARDIOV SUR, V134, P132, DOI 10.1016/j.jtcvs.2007.01.055; Christenson JT, 1996, ANN THORAC SURG, V62, P1373, DOI 10.1016/0003-4975(96)00751-5; Dietrich GV, 1998, THROMB RES, V89, P295, DOI 10.1016/S0049-3848(98)00020-6; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Flom-Halvorsen HI, 2003, ANN THORAC SURG, V76, P744, DOI 10.1016/S0003-4975(03)00349-7; Gao CJ, 2011, BLOOD, V117, P4946, DOI 10.1182/blood-2010-09-307751; GREILICH PE, 1995, ANESTH ANALG, V80, P459, DOI 10.1097/00000539-199503000-00005; Hanke AA, 2010, EUR J MED RES, V15, P214; HARKER LA, 1980, BLOOD, V56, P824; Hartmann M, 2006, TRANSFUS MED REV, V20, P230, DOI 10.1016/j.tmrv.2006.03.003; Hiramatsu Y, 1997, J THORAC CARDIOV SUR, V113, P182, DOI 10.1016/S0022-5223(97)70414-8; IRANI MS, 1995, BLOOD COAGUL FIBRIN, V6, P428, DOI 10.1097/00001721-199507000-00009; Kalb ML, 2009, PLATELETS, V20, P7, DOI 10.1080/09537100802364076; Kamath S, 2001, EUR HEART J, V22, P1561, DOI 10.1053/euhj.2000.2515; Kondo C, 1993, ASAIO J, pM550; Laga S, 2005, ARTIF ORGANS, V29, P541, DOI 10.1111/j.1525-1594.2005.29090.x; Maurer-Spurej E, 2001, LAB INVEST, V81, P581, DOI 10.1038/labinvest.3780267; Muriithi EW, 2006, ARTIF ORGANS, V30, P488, DOI 10.1111/j.1525-1594.2006.00246.x; Rahe-Meyer N, 2010, ARTIF ORGANS, V34, P3, DOI 10.1111/j.1525-1594.2009.00792.x; Rahe-Meyer N, 2008, ANESTH ANALG, V107, P1791, DOI 10.1213/ane.0b013e3181865733; Ramnarine IR, 2006, J CARDIOTHOR VASC AN, V20, P541, DOI 10.1053/j.jvca.2005.09.008; Solomon C, 2010, PLATELETS, V21, P221, DOI 10.3109/09537100903560155; Straub A, 2006, THORAC CARDIOV SURG, V54, P162, DOI 10.1055/s-2005-872952; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; VANOEVEREN W, 1990, J THORAC CARDIOV SUR, V99, P788; Weber CF, 2011, J THORAC CARDIOV SUR, V141, P1298, DOI 10.1016/j.jtcvs.2010.09.057; Weerasinghe A, 1998, ANN THORAC SURG, V66, P2145, DOI 10.1016/S0003-4975(98)00749-8; Xiao ZH, 1998, CIRCULATION, V97, P251, DOI 10.1161/01.CIR.97.3.251	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33686	10.1371/journal.pone.0033686	http://dx.doi.org/10.1371/journal.pone.0033686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442710	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500051
J	Do, KN; Fink, LN; Jensen, TE; Gautier, L; Parlesak, A				Khoa Nguyen Do; Fink, Lisbeth Nielsen; Jensen, Thomas Elbenhardt; Gautier, Laurent; Parlesak, Alexandr			TLR2 Controls Intestinal Carcinogen Detoxication by CYP1A1	PLOS ONE			English	Article							HYDROCARBON RECEPTOR; CYTOCHROME-P450; EXPRESSION; PROTEIN; METABOLISM; INDUCTION; CANCER; MOUSE; LOCALIZATION; TOXICITY	Intestinal cytochrome P450 subclass 1A1 (CYP1A1) contributes to a metabolic "shield" protecting the host from ingested carcinogens such as polycyclic aromatic hydrocarbons (PAH). The expression of CYP1 (including CYP1A2 and CYP1B1) is considered to depend solely on a heterodimeric transcription factor consisting of the arylhydrocarbon receptor (AHR) and the AHR nuclear translocator (ARNT). So far, no interference has been noted between the regulation of CYP1 and the activation of Toll-like receptor 2 (TLR2), which modulates the inflammatory response to bacterial cell wall components in immune cells and enterocytes. Here we report that intestinal CYP1A1 is silenced in TLR2-deficient mice, even when under exposure to the carcinogenic PAH benzo[a] pyrene (BaP). In contrast, hepatic CYP1A1 was moderately induced in TLR2-deficient mice without restoring their ability to clear BaP from systemic circulation, as present in wild-type animals. After feeding of BaP for 21 days, only TLR2(-/-) mice, but not their wild type littermates developed polyps in the colon. Gene expressions and protein concentrations of AHR and ARNT in the intestine did not differ between the genotypes. In conclusion, the presence of ligands for TLR2 of bacterial origin seems to be crucial for detoxication of luminal carcinogens by CYP1A1 in the intestine. This unprecedented finding indicates a complex interplay between the immune system of the host and intestinal bacteria with detoxication mechanisms. This highlights the relevance of intestinal microbiota when trying to unravel pathways present in mammals and opens new perspectives for research in human health.	[Khoa Nguyen Do; Fink, Lisbeth Nielsen; Parlesak, Alexandr] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Khoa Nguyen Do; Gautier, Laurent] Tech Univ Denmark, DTU Multiassay Core DMAC, DK-2800 Lyngby, Denmark; [Jensen, Thomas Elbenhardt] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Parlesak, Alexandr] Metropolitan Univ Coll, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen	Do, KN (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	alpa@bio.dtu.dk	Parlesak, Alexandr/K-6310-2013; Gautier, Laurent/F-9849-2012; Jensen, Thomas/E-1215-2015; Fink, Lisbeth/AAN-7830-2020; Fink, Lisbeth N/F-8344-2010	Parlesak, Alexandr/0000-0002-8973-3467; Jensen, Thomas/0000-0001-6139-8268; Fink, Lisbeth N/0000-0003-3621-8098	"Wissenschaftsfoerderung der Deutschen Brauwirtschaft" (Research Foundation of the German Brewing Industry) [B-87]; Center for Biological Sequence Analysis	"Wissenschaftsfoerderung der Deutschen Brauwirtschaft" (Research Foundation of the German Brewing Industry); Center for Biological Sequence Analysis	The study was supported by grant B-87 from the "Wissenschaftsfoerderung der Deutschen Brauwirtschaft" (Research Foundation of the German Brewing Industry) and by institutional funds from the Center for Biological Sequence Analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov K, 2010, TOXICOL LETT, V198, P63, DOI 10.1016/j.toxlet.2010.04.009; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bergheim I, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-34; Burk O, 2004, J BIOL CHEM, V279, P38379, DOI 10.1074/jbc.M404949200; BUTLER MA, 1989, P NATL ACAD SCI USA, V86, P7696, DOI 10.1073/pnas.86.20.7696; Chiaro CR, 2007, MOL PHARMACOL, V72, P1369, DOI 10.1124/mol.107.038968; Conney AH, 2003, CANCER RES, V63, P7005; Fontana RJ, 1999, GASTROENTEROLOGY, V117, P89, DOI 10.1016/S0016-5085(99)70554-8; GROVER PL, 1968, BIOCHEM J, V110, P159, DOI 10.1042/bj1100159; Gu J, 2008, CANCER EPIDEM BIOMAR, V17, P2445, DOI 10.1158/1055-9965.EPI-07-2890; Guengerich FP, 2000, CARCINOGENESIS, V21, P345, DOI 10.1093/carcin/21.3.345; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ito SJ, 2007, J CLIN INVEST, V117, P1940, DOI 10.1172/JCI31647; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; LINDESKOG P, 1988, MUTAT RES, V204, P553, DOI 10.1016/0165-1218(88)90058-4; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mele T, 2010, INT J BIOCHEM CELL B, V42, P1066, DOI 10.1016/j.biocel.2010.03.021; Miyata Noriyuki, 2005, Journal of Smooth Muscle Research, V41, P175, DOI 10.1540/jsmr.41.175; Nebert DW, 2008, J BIOL CHEM, V283, P36061, DOI 10.1074/jbc.R800053200; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; NEBERT DW, 1989, CRIT REV TOXICOL, V20, P153, DOI 10.3109/10408448909017908; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ozaki A, 1998, CANCER LETT, V131, P153, DOI 10.1016/S0304-3835(98)00126-8; POLAND A, 1994, MOL PHARMACOL, V46, P915; Rafter J, 2004, NUTR RES REV, V17, P277, DOI 10.1079/NRR200484; Sanchez Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/505694; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Shi ZQ, 2010, MOL PHARMACOL, V78, P46, DOI 10.1124/mol.110.063438; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tahara T, 2007, CANCER SCI, V98, P1790, DOI 10.1111/j.1349-7006.2007.00590.x; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; TRABER PG, 1992, BIOCHIM BIOPHYS ACTA, V1171, P167, DOI 10.1016/0167-4781(92)90117-I; Uematsu Satoshi, 2008, V183, P1; Uno S, 2004, MOL PHARMACOL, V65, P1225, DOI 10.1124/mol.65.5.1225; Uno S, 2006, MOL PHARMACOL, V69, P1103, DOI 10.1124/mol.105.021501; Uno S, 2008, FREE RADICAL BIO MED, V44, P570, DOI 10.1016/j.freeradbiomed.2007.10.044; Wagnerberger S, 2006, ALCOHOL, V38, P37, DOI 10.1016/j.alcohol.2006.03.007; Waldman J M, 1991, J Expo Anal Environ Epidemiol, V1, P193; WATTENBERG LW, 1962, CANCER RES, V22, P1120; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zeldin DC, 1997, MOL PHARMACOL, V51, P931, DOI 10.1124/mol.51.6.931; Zhang QY, 1997, DRUG METAB DISPOS, V25, P21	47	26	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32309	10.1371/journal.pone.0032309	http://dx.doi.org/10.1371/journal.pone.0032309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442665	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500008
J	Liu, K; Warnow, T				Liu, Kevin; Warnow, Tandy			Treelength Optimization for Phylogeny Estimation	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; JOINT BAYESIAN-ESTIMATION; STATISTICAL ALIGNMENT; ALGORITHM; ACCURACY; TREE; POY; COESTIMATION; INFERENCE; INSERTION	The standard approach to phylogeny estimation uses two phases, in which the first phase produces an alignment on a set of homologous sequences, and the second phase estimates a tree on the multiple sequence alignment. POY, a method which seeks a tree/alignment pair minimizing the total treelength, is the most widely used alternative to this two-phase approach. The topological accuracy of trees computed under treelength optimization is, however, controversial. In particular, one study showed that treelength optimization using simple gap penalties produced poor trees and alignments, and suggested the possibility that if POY were used with an affine gap penalty, it might be able to be competitive with the best two-phase methods. In this paper we report on a study addressing this possibility. We present a new heuristic for treelength, called BeeTLe (Better Treelength), that is guaranteed to produce trees at least as short as POY. We then use this heuristic to analyze a large number of simulated and biological datasets, and compare the resultant trees and alignments to those produced using POY and also maximum likelihood (ML) and maximum parsimony (MP) trees computed on a number of alignments. In general, we find that trees produced by BeeTLe are shorter and more topologically accurate than POY trees, but that neither POY nor BeeTLe produces trees as topologically accurate as ML trees produced on standard alignments. These findings, taken as a whole, suggest that treelength optimization is not as good an approach to phylogenetic tree estimation as maximum likelihood based upon good alignment methods.	[Liu, Kevin; Warnow, Tandy] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Liu, K (corresponding author), Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA.	tandy@cs.utexas.edu			National Science Foundation [DEB 0733029]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by National Science Foundation DEB 0733029, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair C, 2011, J HERED, V102, P130, DOI 10.1093/jhered/esq092; Cannone J. J, 2002, BMC BIOINF, V3; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2003, BIOINFORMATICS, V19, P1404, DOI 10.1093/bioinformatics/btg158; Fleissner R, 2005, SYST BIOL, V54, P548, DOI 10.1080/10635150590950371; FOULDS LR, 1982, ADV APPL MATH, V3, P43, DOI DOI 10.1016/S0196-8858(82)80004-3; GANAPATHY G, 2003, P 3 INT WORKSH ALG B, P245; Giribet G, 2001, CLADISTICS, V17, pS60, DOI 10.1111/j.1096-0031.2001.tb00105.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagopian R, 2010, NUCLEIC ACIDS RES, V38, pW29, DOI 10.1093/nar/gkq298; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Katoh K, 2007, BIOINFORMATICS, V23, P372, DOI 10.1093/bioinformatics/btl592; Kjer KM, 2007, SYST BIOL, V56, P133, DOI 10.1080/10635150601156305; Lehtonen S, 2008, SYST BIOL, V57, P653, DOI 10.1080/10635150802302476; Litzkow M. J., 1987, Proceedings of the Summer 1987 USENIX Conference, P381; Liu K, 2011, THESIS U TEXAS AUSTI; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu K, 2009, IEEE ACM T COMPUT BI, V6, P7, DOI 10.1109/TCBB.2008.63; Liu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013057; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Lunter G, 2005, STAT BIOL HEALTH, P375, DOI 10.1007/0-387-27733-1_14; Lunter G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-83; Lunter G, 2003, LECT N BIOINFORMAT, V2812, P228; Lunter GA, 2003, J COMPUT BIOL, V10, P869, DOI 10.1089/106652703322756122; Metzler D, 2003, BIOINFORMATICS, V19, P490, DOI 10.1093/bioinformatics/btg026; Miklos I, 2004, MOL BIOL EVOL, V21, P529, DOI 10.1093/molbev.msh043; Miklos I, 2003, DISCRETE APPL MATH, V127, P79, DOI 10.1016/S0166-218X(02)00286-X; Morrison DA, 2009, SYST BIOL, V58, P150, DOI 10.1093/sysbio/syp009; Nelesen S., 2008, PAC S BIOC, V13, P15; Novak A, 2008, BIOINFORMATICS, V24, P2403, DOI 10.1093/bioinformatics/btn457; Ogden TH, 2007, SYST BIOL, V56, P182, DOI 10.1080/10635150701281102; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; Sankoff D, 1983, TIME WARPS STRING ED, P253; Stamatakis A, 2006, P IPDPS2006 HICOMB W; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoye J, 1998, BIOINFORMATICS, V14, P157, DOI 10.1093/bioinformatics/14.2.157; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Swofford DL, 1996, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varon A., 2007, POY SOFTWARE; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Wheeler WC, 2009, SEQUENCE ALIGNMENT: METHODS, MODELS, CONCEPTS, AND STRATEGIES, P95; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yoshizawa K, 2010, SYST ENTOMOL, V35, P199, DOI 10.1111/j.1365-3113.2010.00526.x; Yu J, SATE VERSION 2 1 0; Zwickl DJ., 2006, THESIS	57	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33104	10.1371/journal.pone.0033104	http://dx.doi.org/10.1371/journal.pone.0033104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442677	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500019
J	Shi, ZM; Wang, J; Yan, ZP; You, YP; Li, CY; Qian, X; Yin, Y; Zhao, P; Wang, YY; Wang, XF; Li, MN; Liu, LZ; Liu, N; Jiang, BH				Shi, Zhu-mei; Wang, Jing; Yan, Zhiping; You, Yong-ping; Li, Chong-yong; Qian, Xu; Yin, Yu; Zhao, Peng; Wang, Ying-ying; Wang, Xie-feng; Li, Ming-na; Liu, Ling-Zhi; Liu, Ning; Jiang, Bing-Hua			MiR-128 Inhibits Tumor Growth and Angiogenesis by Targeting p70S6K1	PLOS ONE			English	Article							CANCER CELLS; MICRORNAS; EXPRESSION; ACTIVATION; GLIOBLASTOMA; PATHWAY; VEGF; AKT; PCR; TUMORIGENESIS	MicroRNAs are a class of small noncoding RNAs that function as critical gene regulators through targeting mRNAs for translational repression or degradation. In this study, we showed that miR-128 expression levels were decreased in glioma, and identified p70S6K1 as a novel direct target of miR-128. Overexpression of miR-128 suppressed p70S6K1 and its downstream signaling molecules such as HIF-1 and VEGF expression, and attenuated cell proliferation, tumor growth and angiogenesis. Forced expression of p70S6K1 can partly rescue the inhibitory effect of miR-128 in the cells. Taken together, these findings will shed light to the role and mechanism of miR-128 in regulating glioma tumor angiogenesis via miR-128/p70S6K1 axis, and miR-128 may serve as a potential therapeutic target in glioma in the future.	[Shi, Zhu-mei; You, Yong-ping; Zhao, Peng; Wang, Ying-ying; Wang, Xie-feng; Liu, Ning; Jiang, Bing-Hua] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Wang, Jing; Yan, Zhiping; Li, Chong-yong; Qian, Xu; Yin, Yu; Jiang, Bing-Hua] Nanjing Med Univ, Dept Pathol, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Li, Ming-na] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Liu, Ling-Zhi; Jiang, Bing-Hua] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Jefferson University	Shi, ZM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	binghjiang@yahoo.com	wang, yingying/GRS-3058-2022	Liu, Ling-Zhi/0000-0001-9234-457X; Hartl, Carla/0000-0001-9769-7462; Jiang, Bing-Hua/0000-0003-4526-2031	National Natural Science Foundation of China [81071642, 81172389]; National Key Basic Research Program of China [2011CB504003]; Key Basic Research Program of the Jiangsu Higher Education Institutions of China [09KJA310001]; National Cancer Institute, National Institutes of Health [R01CA109460]; NATIONAL CANCER INSTITUTE [R01CA109460] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Key Basic Research Program of the Jiangsu Higher Education Institutions of China; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Natural Science Foundation of China (81071642 and 81172389), by the National Key Basic Research Program of China (2011CB504003), Key Basic Research Program of the Jiangsu Higher Education Institutions of China (09KJA310001) and by National Cancer Institute, National Institutes of Health (R01CA109460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bello L, 2004, CANC TREAT, V117, P263; Bian CX, 2010, BIOCHEM BIOPH RES CO, V398, P395, DOI 10.1016/j.bbrc.2010.06.080; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bourne TD, 2010, NAT REV NEUROL, V6, P695, DOI 10.1038/nrneurol.2010.159; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Fang J, 2005, FASEB J, V19, P342, DOI 10.1096/fj.04-2175com; Fang J, 2007, CARCINOGENESIS, V28, P713, DOI 10.1093/carcin/bgl189; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Grammer TC, 1996, CANCER SURV, V27, P271; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lim W, 2009, FEBS LETT, V583, P1314, DOI 10.1016/j.febslet.2009.03.028; Liu LZ, 2008, CANCER RES, V68, P8183, DOI 10.1158/0008-5472.CAN-08-0819; Liu LZ, 2006, FREE RADICAL BIO MED, V41, P1521, DOI 10.1016/j.freeradbiomed.2006.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mabjeesh NJ, 2007, HISTOL HISTOPATHOL, V22, P559, DOI 10.14670/HH-22.559; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Wang XW, 2009, RNA, V15, P716, DOI 10.1261/rna.1460509; Wong MLH, 2009, J CLIN NEUROSCI, V16, P1119, DOI 10.1016/j.jocn.2009.02.009; Yancopoulos GD, 2010, CELL, V143, P13, DOI 10.1016/j.cell.2010.09.028; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	36	94	103	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32709	10.1371/journal.pone.0032709	http://dx.doi.org/10.1371/journal.pone.0032709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442669	gold, Green Submitted, Green Published			2022-12-27	WOS:000303836500011
J	Verdu, JR; Alba-Tercedor, J; Jimenez-Manrique, M				Verdu, Jose R.; Alba-Tercedor, Javier; Jimenez-Manrique, Monica			Evidence of Different Thermoregulatory Mechanisms between Two Sympatric Scarabaeus Species Using Infrared Thermography and Micro-Computer Tomography	PLOS ONE			English	Article							DUNG BEETLES COLEOPTERA; TEMPERATURE REGULATION; BODY-SIZE; FLIGHT; INSECTS; ENDOTHERMY; VENTILATION; ROLES; MOTHS; BALL	In endotherms insects, the thermoregulatory mechanisms modulate heat transfer from the thorax to the abdomen to avoid overheating or cooling in order to obtain a prolonged flight performance. Scarabaeus sacer and S. cicatricosus, two sympatric species with the same habitat and food preferences, showed daily temporal segregation with S. cicatricosus being more active during warmer hours of the day in opposition to S. sacer who avoid it. In the case of S. sacer, their endothermy pattern suggested an adaptive capacity for thorax heat retention. In S. cicatricosus, an active 'heat exchanger' mechanism was suggested. However, no empirical evidence had been documented until now. Thermographic sequences recorded during flight performance showed evidence of the existence of both thermoregulatory mechanisms. In S. sacer, infrared sequences showed a possible heat insulator (passive thermal window), which prevents heat transfer from meso-and metathorax to the abdomen during flight. In S. cicatricosus, infrared sequences revealed clear and effective heat flow between the thorax and abdomen (abdominal heat transfer) that should be considered the main mechanism of thermoregulation. This was related to a subsequent increase in abdominal pumping (as a cooling mechanism) during flight. Computer microtomography scanning, anatomical dissections and internal air volume measurements showed two possible heat retention mechanisms for S. sacer; the abdominal air sacs and the development of the internal abdominal sternites that could explain the thermoregulation between thorax and abdomen. Our results suggest that interspecific interactions between sympatric species are regulated by very different mechanisms. These mechanisms create unique thermal niches for the different species, thereby preventing competition and modulating spatio-temporal distribution and the composition of dung beetle assemblages.	[Verdu, Jose R.] Univ Alicante, IUI Ctr Iberoamer Biodiversidad CIBIO, E-03080 Alicante, Spain; [Alba-Tercedor, Javier] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Jimenez-Manrique, Monica] Univ Alicante, Fac Ciencias, E-03080 Alicante, Spain	Universitat d'Alacant; University of Granada; Universitat d'Alacant	Verdu, JR (corresponding author), Univ Alicante, IUI Ctr Iberoamer Biodiversidad CIBIO, E-03080 Alicante, Spain.	jr.verdu@ua.es	Verdú, José/F-8269-2010; Alba-Tercedor, Javier/C-3679-2015	Verdú, José/0000-0002-0805-8341; 	Secretaria de Estado de Investigacion-Ministerio de Educacion, Ciencia e Innovacion [CGL2008/03878/BOS]; Spanish Secretaria de Estado de Investigacion-Ministerio de Educacion, Ciencia e Innovacion [CGL2007-61856/BOS]; Proyecto de Excelencia de la Junta de Andalucia [RNM-02654]	Secretaria de Estado de Investigacion-Ministerio de Educacion, Ciencia e Innovacion; Spanish Secretaria de Estado de Investigacion-Ministerio de Educacion, Ciencia e Innovacion; Proyecto de Excelencia de la Junta de Andalucia(Junta de Andalucia)	Financial support was provided by the Project CGL2008/03878/BOS of the Secretaria de Estado de Investigacion-Ministerio de Educacion, Ciencia e Innovacion and benefited of projects CGL2007-61856/BOS of the Spanish Secretaria de Estado de Investigacion-Ministerio de Educacion, Ciencia e Innovacion, and RNM-02654, Proyecto de Excelencia de la Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BARTHOLOMEW GA, 1984, J EXP BIOL, V111, P131; BARTHOLOMEW GA, 1978, J EXP BIOL, V73, P65; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CASEY TM, 1976, J EXP BIOL, V64, P545; CAVENEY S, 1995, OECOLOGIA, V103, P444, DOI 10.1007/BF00328682; CHOWN SL, 1993, J THERM BIOL, V18, P25, DOI 10.1016/0306-4565(93)90038-U; Cossins A. R., 1987, TEMPERATURE BIOL ANI; *FLIR SYST LTD, 2007, THERMACAM RES V 2 9; Gaston KJ, 1999, OIKOS, V86, P584, DOI 10.2307/3546663; Hanski I., 1991, P305; HEINRICH B, 1987, J EXP BIOL, V127, P313; HEINRICH B, 1979, PHYSIOL ZOOL, V52, P484, DOI 10.1086/physzool.52.4.30155939; Heinrich B, 1996, THERMAL WARRIORS, P59; Heinrich B., 1993, HOT BLOODED INSECTS; Krogh A, 1941, J EXP BIOL, V18, P1; LIGHTON JRB, 1994, PHYSIOL ZOOL, V67, P142, DOI 10.1086/physzool.67.1.30163839; May M.L., 1985, P507; MAY ML, 1979, ANNU REV ENTOMOL, V24, P313, DOI 10.1146/annurev.en.24.010179.001525; Merrick MJ, 2004, J EXP BIOL, V207, P723, DOI 10.1242/jeb.00807; PRANGE HD, 1990, J EXP BIOL, V154, P463; PROSSER CL, 1986, ADAPTATIONAL BIOL MO; Radtke MG, 2005, ANN ENTOMOL SOC AM, V98, P548, DOI 10.1603/0013-8746(2005)098[0548:VALMAP]2.0.CO;2; Rinaldi R, 2002, INFRAMATION, V3, P3; StatsDirect Ltd, STATSDIRECT STAT SOF; Tartes U, 2002, COMP BIOCHEM PHYS A, V133, P611, DOI 10.1016/S1095-6433(02)00173-3; Verdu JR, 2006, J INSECT PHYSIOL, V52, P854, DOI 10.1016/j.jinsphys.2006.05.005; Verdu J.R., 2008, INSECT ECOLOGY CONSE, P1; Verdu JR, 2007, ECOL ENTOMOL, V32, P544, DOI 10.1111/j.1365-2311.2007.00907.x; Verdu JR, 2004, PHYSIOL ENTOMOL, V29, P32, DOI 10.1111/j.0307-6962.2004.0359.x; WEISFOGH T, 1967, J EXP BIOL, V47, P561; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677	32	33	33	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33914	10.1371/journal.pone.0033914	http://dx.doi.org/10.1371/journal.pone.0033914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442735	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500076
J	Yang, L; Ji, W; Gao, P; Li, Y; Cai, H; Bai, X; Chen, Q; Zhu, YM				Yang, Liang; Ji, Wei; Gao, Peng; Li, Yong; Cai, Hua; Bai, Xi; Chen, Qin; Zhu, Yanming			GsAPK, an ABA-Activated and Calcium-Independent SnRK2-Type Kinase from G. soja, Mediates the Regulation of Plant Tolerance to Salinity and ABA Stress	PLOS ONE			English	Article							SNF1-RELATED PROTEIN-KINASES; INDUCED ANTIOXIDANT DEFENSE; RESPONSIVE GENE-EXPRESSION; ELEMENT-BINDING FACTOR; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; GLOBAL REGULATORS; ABIOTIC STRESSES; H2O2 PRODUCTION; RICE	Plant Snf1 (sucrose non-fermenting-1) related protein kinase (SnRK), a subfamily of serine/threonine kinases, has been implicated as a crucial upstream regulator of ABA and osmotic signaling as in many other signaling cascades. In this paper, we have isolated a novel plant specific ABA activated calcium independent protein kinase (GsAPK) from a highly salt tolerant plant, Glycine soja (50109), which is a member of the SnRK2 family. Subcellular localization studies using GFP fusion protein indicated that GsAPK is localized in the plasma membrane. We found that autophosphorylation and Myelin Basis Protein phosphorylation activity of GsAPK is only activated by ABA and the kinase activity also was observed when calcium was replaced by EGTA, suggesting its independence of calcium in enzyme activity. We also found that cold, salinity, drought, and ABA stress alter GsAPK gene transcripts and heterogonous overexpression of GsAPK in Arabidopsis alters plant tolerance to high salinity and ABA stress. In summary, we demonstrated that GsAPK is a Glycine soja ABA activated calcium independent SnRK-type kinase presumably involved in ABA mediated stress signal transduction.	[Yang, Liang; Ji, Wei; Gao, Peng; Li, Yong; Cai, Hua; Bai, Xi; Zhu, Yanming] NE Agr Univ, Plant Bioengn Lab, Harbin, Heilongjiang, Peoples R China; [Yang, Liang] Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Prov Key Lab Plant Virol, Fuzhou, Fujian, Peoples R China; [Chen, Qin] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada	Northeast Agricultural University - China; Fujian Agriculture & Forestry University; Agriculture & Agri Food Canada	Yang, L (corresponding author), NE Agr Univ, Plant Bioengn Lab, Harbin, Heilongjiang, Peoples R China.	ymzhu2001@gmail.com	Li, Yong/AAE-4411-2019; Barickman, Thomas/I-6993-2012	, Wei/0000-0003-2079-4736; Li, Yong/0000-0003-2609-2401	National Natural Science Foundation of China [30570990]; National Major Project for Cultivation of Transgenic Crops [2008ZX08004]; Key Research Plan of Heilongjiang Province [GA06B103]; Innovation Research Group of NEAU [CXT004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Cultivation of Transgenic Crops; Key Research Plan of Heilongjiang Province; Innovation Research Group of NEAU	This work was supported by the National Natural Science Foundation of China (30570990), the National Major Project for Cultivation of Transgenic Crops (2008ZX08004), the Key Research Plan of Heilongjiang Province (GA06B103), and the Innovation Research Group of NEAU (CXT004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2008, PLANT CELL, V20, P1964, DOI 10.1105/tpc.108.059477; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Assmann SM, 2003, TRENDS PLANT SCI, V8, P151, DOI 10.1016/S1360-1385(03)00052-9; Boisson B, 2003, J BIOL CHEM, V278, P43418, DOI 10.1074/jbc.M307321200; Burnett EC, 2000, J EXP BOT, V51, P197, DOI 10.1093/jexbot/51.343.197; Chae MJ, 2007, PLANT MOL BIOL, V63, P151, DOI 10.1007/s11103-006-9079-x; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; D'Souza JS, 2002, PLANT PHYSIOL BIOCH, V40, P17, DOI 10.1016/S0981-9428(01)01344-4; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Ding HD, 2009, PLANTA, V230, P239, DOI 10.1007/s00425-009-0938-y; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Gomez-Cadenas A, 1999, P NATL ACAD SCI USA, V96, P1767, DOI 10.1073/pnas.96.4.1767; Gong DM, 2002, J BIOL CHEM, V277, P42088, DOI 10.1074/jbc.M205504200; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; Halford NG, 2009, BIOCHEM J, V419, P247, DOI 10.1042/BJ20082408; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Holappa LD, 2005, J CEREAL SCI, V41, P333, DOI 10.1016/j.jcs.2004.11.002; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hu XL, 2007, NEW PHYTOL, V173, P27, DOI 10.1111/j.1469-8137.2006.01888.x; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Kant S, 2006, PLANT CELL ENVIRON, V29, P1220, DOI 10.1111/j.1365-3040.2006.01502.x; Kelner A, 2004, PLANT PHYSIOL, V136, P3255, DOI 10.1104/pp.104.046151; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; Kim KN, 2000, PLANT PHYSIOL, V124, P1844, DOI 10.1104/pp.124.4.1844; Knight H, 2000, INT REV CYTOL, V195, P269; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Liu HT, 2008, PLANT J, V55, P760, DOI 10.1111/j.1365-313X.2008.03544.x; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2002, P NATL ACAD SCI USA, V99, P15812, DOI 10.1073/pnas.242607499; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Ohta M, 2003, P NATL ACAD SCI USA, V100, P11771, DOI 10.1073/pnas.2034853100; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Shao HB, 2008, BIOTECHNOL ADV, V26, P503, DOI 10.1016/j.biotechadv.2008.04.004; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Thompson GA, 2000, PROG LIPID RES, V39, P19, DOI 10.1016/S0163-7827(99)00014-4; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Wang Y, 2004, BIOCHEM J, V383, P73, DOI 10.1042/BJ20031907; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Yang Liang, 2008, China Biotechnology, V28, P60; Yang TB, 2004, J BIOL CHEM, V279, P42552, DOI 10.1074/jbc.M402830200; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang AY, 2007, NEW PHYTOL, V175, P36, DOI 10.1111/j.1469-8137.2007.02071.x; Zhang AY, 2006, PLANT PHYSIOL, V141, P475, DOI 10.1104/pp.105.075416; Zhang L, 2003, TRENDS PLANT SCI, V8, P123, DOI 10.1016/S1360-1385(03)00013-X; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	66	28	37	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33838	10.1371/journal.pone.0033838	http://dx.doi.org/10.1371/journal.pone.0033838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439004	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100104
J	Barkae, ED; Scharf, I; Abramsky, Z; Ovadia, O				Barkae, Erez David; Scharf, Inon; Abramsky, Zvika; Ovadia, Ofer			Jack of All Trades, Master of All: A Positive Association between Habitat Niche Breadth and Foraging Performance in Pit-Building Antlion Larvae	PLOS ONE			English	Article							PARTICLE-SIZE; PHENOTYPIC PLASTICITY; RESCUE BEHAVIOR; MYRMELEON-BORE; PREY CAPTURE; LIFE-HISTORY; SPECIALIZATION; EVOLUTION; GENERALIST; SUBSTRATE	Species utilizing a wide range of resources are intuitively expected to be less efficient in exploiting each resource type compared to species which have developed an optimal phenotype for utilizing only one or a few resources. We report here the results of an empirical study whose aim was to test for a negative association between habitat niche breadth and foraging performance. As a model system to address this question, we used two highly abundant species of pit-building antlions varying in their habitat niche breadth: the habitat generalist Myrmeleon hyalinus, which inhabits a variety of soil types but occurs mainly in sandy soils, and the habitat specialist Cueta lineosa, which is restricted to light soils such as loess. Both species were able to discriminate between the two soils, with each showing a distinct and higher preference to the soil type providing higher prey capture success and characterizing its primary habitat-of-origin. As expected, only small differences in the foraging performances of the habitat generalist were evident between the two soils, while the performance of the habitat specialist was markedly reduced in the alternative sandy soil. Remarkably, in both soil types, the habitat generalist constructed pits and responded to prey faster than the habitat specialist, at least under the temperature range of this study. Furthermore, prey capture success of the habitat generalist was higher than that of the habitat specialist irrespective of the soil type or prey ant species encountered, implying a positive association between habitat niche-breadth and foraging performance. Alternatively, C. lineosa specialization to light soils does not necessarily confer upon its superiority in utilizing such habitats. We thus suggest that habitat specialization in C. lineosa is either an evolutionary dead-end, or, more likely, that this species' superiority in light soils can only be evident when considering additional niche axes.	[Barkae, Erez David; Scharf, Inon; Abramsky, Zvika; Ovadia, Ofer] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Scharf, Inon] Johannes Gutenberg Univ Mainz, Inst Zool, D-6500 Mainz, Germany	Ben Gurion University; Johannes Gutenberg University of Mainz	Barkae, ED (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	barkaeer@bgu.ac.il; oferovad@bgu.ac.il	Ovadia, Ofer OO/C-8292-2012; ABRAMSKY, ZVIKA/F-1123-2012; Scharf, Inon/AAF-2343-2020	Scharf, Inon/0000-0002-8506-7161; Ovadia, Ofer/0000-0002-4941-4947				Barkae ED, 2010, ZOOLOGY, V113, P308, DOI 10.1016/j.zool.2010.05.001; Bernays EA, 1999, P ROY SOC B-BIOL SCI, V266, P151, DOI 10.1098/rspb.1999.0615; Berumen ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P989, DOI 10.1007/s00265-007-0526-8; Botz JT, 2003, J KANSAS ENTOMOL SOC, V76, P426; Caley MJ, 2003, P ROY SOC B-BIOL SCI, V270, pS175, DOI 10.1098/rsbl.2003.0040; CHRISTENSEN R, 1991, LOG LINEAR MODELS; Czechowski W, 2002, ANN ZOOL, V52, P423; DANIN A, 1978, FLORA, V167, P409; Devetak D, 2005, PHYSIOL ENTOMOL, V30, P158, DOI 10.1111/j.1365-3032.2005.00443.x; Devetak D, 2008, EUR J ENTOMOL, V105, P631, DOI 10.14411/eje.2008.085; Egas M, 2005, EVOLUTION, V59, P507; Farji-Brener AG, 2003, J INSECT BEHAV, V16, P783, DOI 10.1023/B:JOIR.0000018320.99463.ee; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Futuyma Douglas J., 2001, P177; Garcia-Robledo C, 2012, J EVOLUTION BIOL, V25, P38, DOI 10.1111/j.1420-9101.2011.02401.x; Gibernau M, 2001, OECOLOGIA, V126, P53, DOI 10.1007/s004420000479; GOTELLI NJ, 1993, ECOLOGY, V74, P226, DOI 10.2307/1939517; GRIFFITHS D, 1991, ECOL ENTOMOL, V16, P193, DOI 10.1111/j.1365-2311.1991.tb00209.x; GRIFFITHS D, 1980, J ANIM ECOL, V49, P99, DOI 10.2307/4279; Hurlbert AH, 2008, ECOL ENTOMOL, V33, P144, DOI 10.1111/j.1365-2311.2007.00962.x; KAWECKI TJ, 1994, AM NAT, V144, P833, DOI 10.1086/285709; Kelley ST, 1998, EVOLUTION, V52, P1731, DOI [10.2307/2411346, 10.1111/j.1558-5646.1998.tb02253.x]; Lane DR, 1998, J VEG SCI, V9, P239, DOI 10.2307/3237123; Larsson M, 2005, OECOLOGIA, V146, P394, DOI 10.1007/s00442-005-0217-y; LAVERTY TM, 1988, ANIM BEHAV, V36, P733, DOI 10.1016/S0003-3472(88)80156-8; LUCAS JR, 1982, ANIM BEHAV, V30, P651, DOI 10.1016/S0003-3472(82)80135-8; LUCAS JR, 1989, AM MIDL NAT, V121, P84, DOI 10.2307/2425659; LYNCH M, 1987, AM NAT, V129, P283, DOI 10.1086/284635; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Matsura T, 2005, ENTOMOL SCI, V8, P347, DOI 10.1111/j.1479-8298.2005.00134.x; MATSURA T, 1987, RES POPUL ECOL, V29, P17, DOI 10.1007/BF02515422; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Ofer Y., 2000, LETS GO ANT; ROSENZWEIG ML, 1986, OIKOS, V46, P339, DOI 10.2307/3565832; Scharf I, 2008, J EVOLUTION BIOL, V21, P162, DOI 10.1111/j.1420-9101.2007.01453.x; Scharf I, 2006, J INSECT BEHAV, V19, P197, DOI 10.1007/s10905-006-9017-4; Scharf I, 2008, ANIM BEHAV, V76, P2049, DOI 10.1016/j.anbehav.2008.08.023; Scharf I, 2008, ECOL ENTOMOL, V33, P337, DOI 10.1111/j.1365-2311.2007.00967.x; Scharf I, 2011, BIOL REV, V86, P626, DOI 10.1111/j.1469-185X.2010.00163.x; Scharf I, 2010, ANIM BEHAV, V79, P153, DOI 10.1016/j.anbehav.2009.10.017; Scharf I, 2009, OECOLOGIA, V160, P453, DOI 10.1007/s00442-009-1316-y; Scharf I, 2009, ECOL ENTOMOL, V34, P26, DOI 10.1111/j.1365-2311.2008.01038.x; Scheiner SM, 1998, J EVOLUTION BIOL, V11, P303, DOI 10.1007/s000360050090; Schlichting CD, 1998, PHENOTYPIC EVOLUTION, P273; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; Segev U, 2010, J ARID ENVIRON, V74, P646, DOI 10.1016/j.jaridenv.2009.11.001; Simon D, 1988, THESIS TEL AVIV U IS; Singer A, 2007, SOILS ISRAEL, P63; Sorensen JS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P139, DOI 10.1086/378923; Strauss Sharon Y., 2002, P77; TOLLRIAN R, 1995, ECOLOGY, V76, P1691, DOI 10.2307/1940703; vanTienderen PH, 1997, EVOLUTION, V51, P1372, DOI [10.1111/j.1558-5646.1997.tb01460.x, 10.2307/2411189]; Wenninger EJ, 2008, J ARID ENVIRON, V72, P24, DOI 10.1016/j.jaridenv.2007.04.005	55	33	34	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33506	10.1371/journal.pone.0033506	http://dx.doi.org/10.1371/journal.pone.0033506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438939	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309000028
J	Wurster, T; Polzelbauer, C; Schonberger, T; Paul, A; Seizer, P; Stellos, K; Schuster, A; Botnar, RM; Gawaz, M; Bigalke, B				Wurster, Thomas; Poelzelbauer, Catharina; Schoenberger, Tanja; Paul, Angela; Seizer, Peter; Stellos, Konstantinos; Schuster, Andreas; Botnar, Rene M.; Gawaz, Meinrad; Bigalke, Boris			Green Fluorescent Protein (GFP) Color Reporter Gene Visualizes Parvovirus B19 Non-Structural Segment 1 (NS1) Transfected Endothelial Modification	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; HIGH PREVALENCE; VIRAL GENOMES; MYOCARDITIS; VIRUS; INFECTION; DISEASE; ADHESION; CELLS; MICE	Background: Human Parvovirus B19 ((PVB19) has been associated with myocarditis putative due to endothelial infection. Whether PVB19 infects endothelial cells and causes a modification of endothelial function and inflammation and, thus, disturbance of microcirculation has not been elucidated and could not be visualized so far. Methods and Findings: To examine the PVB19-induced endothelial modification, we used green fluorescent protein (GFP) color reporter gene in the non-structural segment 1 (NS1) of PVB19. NS1-GFP-PVB19 or GFP plasmid as control were transfected in an endothelial-like cell line (ECV304). The endothelial surface expression of intercellular-adhesion molecule-1 (CD54/ICAM-1) and extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) were evaluated by flow cytometry after NS-1-GFP or control-GFP transfection. To evaluate platelet adhesion on NS-1 transfected ECs, we performed a dynamic adhesion assay (flow chamber). NS-1 transfection causes endothelial activation and enhanced expression of ICAM-1 (CD54: mean +/- standard deviation: NS1-GFP vs. control-GFP: 85.3 +/- 11.2 vs. 61.6 +/- 8.1; P<0.05) and induces endothelial expression of EMMPRIN/CD147 (CD147: mean +/- SEM: NS1-GFP vs. control-GFP: 114 +/- 15.3 vs. 80 +/- 0.91; P<0.05) compared to control-GFP transfected cells. Dynamic adhesion assays showed that adhesion of platelets is significantly enhanced on NS1 transfected ECs when compared to control-GFP (P<0.05). The transfection of ECs was verified simultaneously through flow cytometry, immunofluorescence microscopy and polymerase chain reaction (PCR) analysis. Conclusions: GFP color reporter gene shows transfection of ECs and may help to visualize NS1-PVB19 induced endothelial activation and platelet adhesion as well as an enhanced monocyte adhesion directly, providing in vitro evidence of possible microcirculatory dysfunction in PVB19-induced myocarditis and, thus, myocardial tissue damage.	[Wurster, Thomas; Poelzelbauer, Catharina; Schoenberger, Tanja; Paul, Angela; Seizer, Peter; Gawaz, Meinrad; Bigalke, Boris] Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany; [Stellos, Konstantinos] Goethe Univ Frankfurt, Dept Cardiol, Frankfurt, Germany; [Schuster, Andreas; Botnar, Rene M.; Bigalke, Boris] Kings Coll London, Div Imaging Sci & Biomed Engn, Sch Med, Rayne Inst, London WC2R 2LS, England	Eberhard Karls University of Tubingen; Goethe University Frankfurt; University of London; King's College London	Wurster, T (corresponding author), Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany.	boris.bigalke@med.uni-tuebingen.de	Botnar, Rene M/E-6875-2012; Stellos, Konstantinos/ABH-1523-2021; Botnar, Rene Michael/AAZ-2112-2020; Stellos, Konstantinos/AAF-2711-2020	Botnar, Rene M/0000-0003-2811-2509; Stellos, Konstantinos/0000-0002-0194-0825; Botnar, Rene/0000-0002-9447-4367	Deutsche Forschungsgemeinschaft [MA2186/3-1GK794]; Sonderforschungsbereich/Transregio19 'Inflammatorische Kardiomyopathie - Molekulare Pathogenese und Therapie' - "Molecular Pathogenesis and Therapy''; Klinische Forschergruppe [KFO274]; German Cardiac Society;  [DFG:Li849/3-1];  [SFB:SFB-TR19-B8N]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich/Transregio19 'Inflammatorische Kardiomyopathie - Molekulare Pathogenese und Therapie' - "Molecular Pathogenesis and Therapy''; Klinische Forschergruppe; German Cardiac Society; ; 	The study was supported by grants of Deutsche Forschungsgemeinschaft (MA2186/3-1&GK794 to MG), Sonderforschungsbereich/Transregio19 'Inflammatorische Kardiomyopathie - Molekulare Pathogenese und Therapie' - "Molecular Pathogenesis and Therapy'' and Klinische Forschergruppe KFO274 - Platelets - Molecular Mechanisms and Translational Medicine) to KS, MG (DFG:Li849/3-1; SFB:SFB-TR19-B8N), and by the grant of the German Cardiac Society 'Molecular Imaging of Atherosclerotic Plaques' to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigalke B, 2009, CAN J CARDIOL, V25, pE248, DOI 10.1016/S0828-282X(09)70511-2; Bultmann BD, 2003, HUM PATHOL, V34, P92, DOI 10.1053/hupa.2003.48; Celik S, 2007, THROMB HAEMOSTASIS, V98, P798, DOI 10.1160/TH07-02-0096; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Duechting A, 2008, J VIROL, V82, P7942, DOI 10.1128/JVI.00891-08; Escher F, 2011, HEART, V97, P733, DOI 10.1136/hrt.2010.205716; Hsu TC, 2006, CLIN EXP IMMUNOL, V144, P152, DOI 10.1111/j.1365-2249.2006.03023.x; Kittel C, 2005, J VIROL, V79, P10672, DOI 10.1128/JVI.79.16.10672-10677.2005; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; Kuhl U, 2003, CIRCULATION, V108, P945, DOI 10.1161/01.CIR.0000085168.02782.2C; Kuhl U, 2003, CIRCULATION, V107, P2793, DOI 10.1161/01.CIR.0000072766.67150.51; Leardkamolkarn V, 2012, J BIOMOL SCREEN, V17, P283, DOI 10.1177/1087057111426903; Lupescu A, 2009, CELL PHYSIOL BIOCHEM, V23, P211, DOI 10.1159/000204110; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Schultheiss HP, 2011, EUR HEART J, V32, P2616, DOI 10.1093/eurheartj/ehr165; Seizer P, 2010, ATHEROSCLEROSIS, V209, P51, DOI 10.1016/j.atherosclerosis.2009.08.029; Soliman TM, 2000, J VIROL, V74, P7600, DOI 10.1128/JVI.74.16.7600-7609.2000; Toan NL, 2006, J GEN VIROL, V87, P2941, DOI 10.1099/vir.0.82037-0; Tschope C, 2005, CIRCULATION, V111, P879, DOI 10.1161/01.CIR.0000155615.68924.B3; Wooten DK, 2000, J BIOL CHEM, V275, P26566, DOI 10.1074/jbc.M003495200; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840	22	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33602	10.1371/journal.pone.0033602	http://dx.doi.org/10.1371/journal.pone.0033602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438961	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309000033
J	Ventela, S; Come, C; Makela, JA; Hobbs, RM; Mannermaa, L; Kallajoki, M; Chan, EK; Pandolfi, PP; Toppari, J; Westermarck, J				Ventela, Sami; Come, Christophe; Makela, Juho-Antti; Hobbs, Robin M.; Mannermaa, Leni; Kallajoki, Markku; Chan, Edward K.; Pandolfi, Pier Paolo; Toppari, Jorma; Westermarck, Jukka			CIP2A Promotes Proliferation of Spermatogonial Progenitor Cells and Spermatogenesis in Mice	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; PROTEIN; PLZF; DIFFERENTIATION; APOPTOSIS; HORMONE; CANCER; MTORC1; TESTIS	Protein phosphatase 2A (PP2A) is a critical regulator of protein serine/threonine phosphorylation. However, the physiological and developmental roles of different PP2A complexes are very poorly understood. Here, we show that a newly characterized PP2A inhibitory protein CIP2A is co-expressed with ki-67 and with self-renewal protein PLZF in the spermatogonial progenitor cell (SPC) population in the testis. CIP2A and PLZF expression was shown also to correlate Ki-67 expression in human testicular spermatogonia. Functionally, CIP2A mutant mouse testes exhibited smaller number of PLZF-positive SPCs and reduced sperm counts. Moreover, seminiferous tubuli cells isolated from CIP2A mutant mice showed reduced expression of Plzf and other renewal genes Oct-4 and Nanog at mRNA level. However, PLZF-deficient testes did not show altered CIP2A expression. Importantly, spermatogonia-specific restoration of CIP2A expression rescued PLZF expression and sperm production defects observed in CIP2A mutant mice. Taken together, these results reveal first physiological function for an emerging human oncoprotein CIP2A, and provide insights into maintenance of PLZF-positive progenitors. Moreover, demonstration that CIP2A expression can be systematically inhibited without severe consequences to normal mouse development and viability may have clinical relevance regarding targeting of oncogenic CIP2A for future cancer therapies.	[Ventela, Sami; Come, Christophe; Mannermaa, Leni; Westermarck, Jukka] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Ventela, Sami; Come, Christophe; Mannermaa, Leni; Westermarck, Jukka] Abo Akad Univ, Turku, Finland; [Ventela, Sami; Makela, Juho-Antti; Toppari, Jorma] Univ Turku, Dept Physiol, Turku, Finland; [Ventela, Sami] Turku Univ Hosp, Dept Otorhinolaryngol, FIN-20520 Turku, Finland; [Makela, Juho-Antti] Univ Turku, Turku Grad Sch Biomed Sci, Turku, Finland; [Hobbs, Robin M.; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Canc Genet Program, Boston, MA 02215 USA; [Hobbs, Robin M.; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol,Canc Genet Program, Boston, MA 02215 USA; [Kallajoki, Markku; Westermarck, Jukka] Univ Turku, Dept Pathol, Turku, Finland; [Chan, Edward K.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Toppari, Jorma] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Turku; State University System of Florida; University of Florida; University of Turku	Ventela, S (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	jukwes@utu.fi	Chan, Edward K. L./B-5671-2009; Westermarck, Jukka/AAL-6464-2020; Côme, Christophe/E-8395-2016; Ventela, Sami/I-7253-2018; Hobbs, Robin/I-2577-2014	Chan, Edward K. L./0000-0003-3938-9503; Westermarck, Jukka/0000-0001-7478-3018; Côme, Christophe/0000-0001-5229-4440; Pandolfi, Pier Paolo/0000-0002-5352-5295; Ventela, Sami/0000-0001-6672-6662; Hobbs, Robin/0000-0002-3853-2614	Academy of Finland [1121413, 122546]; Emil Aaltonen's foundation; Sigrid Juselius Foundation; Finnish Cancer Society; Association of International Cancer Research [08-0614]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Emil Aaltonen's foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Society; Association of International Cancer Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the Academy of Finland (projects 1121413, and 122546), Emil Aaltonen's foundation, Sigrid Juselius Foundation, the Finnish Cancer Society and Association of International Cancer Research (grant 08-0614). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carnevalli LS, 2010, DEV CELL, V19, P187, DOI 10.1016/j.devcel.2010.08.001; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Elliott DJ, 2006, REPRODUCTION, V132, P811, DOI 10.1530/REP-06-0147; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; HUHTANIEMI I, 1985, J CLIN ENDOCR METAB, V61, P698, DOI 10.1210/jcem-61-4-698; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Niemela M, 2011, ONCOGENE IN PRESS; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Snyder EM, 2010, BIOL REPROD, V83, P783, DOI 10.1095/biolreprod.110.085811; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Ventela S, 2000, INT J ANDROL, V23, P236, DOI 10.1046/j.1365-2605.2000.00237.x; Voss AK, 1998, DEV DYNAM, V212, P258; WANG J, 2011, INT J LAB HEMATOL; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001	23	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e33209	10.1371/journal.pone.0033209	http://dx.doi.org/10.1371/journal.pone.0033209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461891	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900010
J	Assaf, A; Hoang, TV; Faik, I; Aebischer, T; Kremsner, PG; Kun, JFJ; Velavan, TP				Assaf, Amal; Tong Van Hoang; Faik, Imad; Aebischer, Toni; Kremsner, Peter G.; Kun, Juergen F. J.; Velavan, T. P.			Genetic Evidence of Functional Ficolin-2 Haplotype as Susceptibility Factor in Cutaneous Leishmaniasis	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; VISCERAL LEISHMANIASIS; POLYMORPHISMS; INFECTIONS; COMPLEMENT; ACTIVATION; IMPACT; GENOTYPES; CHILDREN; PATHWAY	Background: Ficolin-2 coded by FCN2 gene is a soluble serum protein that plays an important role in innate immunity. In this study, we analyzed five functional polymorphisms of the FCN2 gene for their possible association with cutaneous leishmaniasis. Methods: Initially we screened 40 Syrian Arabs for the entire FCN2 gene. We investigated the contribution of FCN2 functional variants in 226 patients with cutaneous leishmaniasis and 286 healthy controls from Syria. Polymorphisms in the promoter regions (-986G/A, -602G/A, -4A/G) of the FCN2 gene were assessed by TaqMan real time PCR, whereas polymorphisms in exon8 (+6359C/T and +6424G/T) were assessed by DNA sequencing. We also measured serum ficolin-2 levels in 70 control Syrian Arabs and correlated the serum concentrations to FCN2 genotypes and haplotypes respectively. Results: Nine new FCN2 variants including two with non synonymous substitutions in exon6 and exon8 were observed. The homozygous genotypes +6424T/T were distributed more in controls and none in patients (P = 0.04). The AGACG haplotype were observed more in patients than in controls (OR = 2.0, 95%CI 1.2-3.4, P = 0.006). The serum ficolin-2 levels were significantly distributed among the reconstructed ficolin-2 haplotypes (P<0.008) and the haplotype AGACG was observed with higher ficolin-2 levels in 70 control individuals. Conclusion: Our results demonstrate a significant association of FCN2 AGACG haplotype with cutaneous leishmaniasis in a Syrian Arab population. These first results provide a basis for a future study that could confirm or disprove possible relationships between FCN2 gene polymorphisms with cutaneous leishmaniasis.	[Assaf, Amal; Tong Van Hoang; Faik, Imad; Kremsner, Peter G.; Kun, Juergen F. J.; Velavan, T. P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Assaf, Amal] Univ Damascus, Fac Med, Dept Lab Med, Damascus, Syria; [Aebischer, Toni] Robert Koch Inst, D-13353 Berlin, Germany	Eberhard Karls University of Tubingen; Robert Koch Institute	Assaf, A (corresponding author), Univ Tubingen, Inst Trop Med, Wilhelmstr 27, Tubingen, Germany.	velavan@medizin.uni-tuebingen.de	Velavan, Thirumalaisamy P/C-1223-2010; van Tong, Hoang/E-9448-2011	Velavan, Thirumalaisamy P/0000-0002-9809-9883; van Tong, Hoang/0000-0002-7170-8810; Aebischer, Toni/0000-0002-4875-8457				Al-Nahhas SA, 2009, SAUDI MED J, V30, P382; Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Alonso DP, 2007, J INFECT DIS, V195, P1212, DOI 10.1086/512683; Ambrosio AR, 2005, PARASITE IMMUNOL, V27, P333, DOI 10.1111/j.1365-3024.2005.00782.x; Atkinson APM, 2004, CLIN EXP IMMUNOL, V138, P517, DOI 10.1111/j.1365-2249.2004.02634.x; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084; Cedzynski M, 2007, CLIN EXP IMMUNOL, V150, P99, DOI 10.1111/j.1365-2249.2007.03471.x; Cestari ID, 2009, MOL IMMUNOL, V47, P426, DOI 10.1016/j.molimm.2009.08.030; Cotterill JA, 1997, BRIT J DERMATOL, V137, P246, DOI 10.1046/j.1365-2133.1997.18131897.x; de Messias-Reason I, 2009, J INFECT DIS, V199, P801, DOI 10.1086/597070; Faik I, 2011, HUM IMMUNOL, V72, P74, DOI 10.1016/j.humimm.2010.10.003; Gangneux JP, 2000, PARASITE IMMUNOL, V22, P515, DOI 10.1046/j.1365-3024.2000.00332.x; GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x; Gupta MA, 1998, BRIT J DERMATOL, V139, P846; Hellemann D, 2007, HUM MOL GENET, V16, P3071, DOI 10.1093/hmg/ddm265; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Jalouk L, 2007, T ROY SOC TROP MED H, V101, P360, DOI 10.1016/j.trstmh.2006.07.011; Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357; Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682; Kamali-Sarvestani E, 2006, CYTOKINE, V35, P159, DOI 10.1016/j.cyto.2006.07.016; Kassi M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000259; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Lacroix M, 2008, MOL IMMUNOL, V45, P4134, DOI 10.1016/j.molimm.2008.08.116; Lipoldova M, 2006, NAT REV GENET, V7, P294, DOI 10.1038/nrg1832; Messias-Reason IJ, 2009, CLIN EXP IMMUNOL, V157, P395, DOI 10.1111/j.1365-2249.2009.03975.x; Miller EN, 2007, PLOS GENET, V3, P679, DOI 10.1371/journal.pgen.0030071; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Reithinger R, 2005, EMERG INFECT DIS, V11, P634, DOI 10.3201/eid1104.040945; Rivas L, 2004, TRENDS PARASITOL, V20, P297, DOI 10.1016/j.pt.2004.05.005; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Sakthianandeswaren A, 2009, TRENDS PARASITOL, V25, P383, DOI 10.1016/j.pt.2009.05.004; Santos IKFD, 2001, INFECT IMMUN, V69, P5212, DOI 10.1128/IAI.69.8.5212-5215.2001; Tayeh A, 1997, T ROY SOC TROP MED H, V91, P657, DOI 10.1016/S0035-9203(97)90509-5; Tong HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028113; Yanik M, 2004, CLIN EXP DERMATOL, V29, P464, DOI 10.1111/j.1365-2230.2004.01605.x	41	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34113	10.1371/journal.pone.0034113	http://dx.doi.org/10.1371/journal.pone.0034113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457818	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900047
J	Zhang, YX				Zhang, Yunxin			Phenomenological Analysis of ATP Dependence of Motor Proteins	PLOS ONE			English	Article							HAND-OVER-HAND; MYOSIN-V PROCESSIVITY; CYTOPLASMIC DYNEIN; KINESIN MOLECULES; MODEL; MECHANISM; STEPS; DESCRIBES; KINETICS; HEAD	In this study, through phenomenological comparison of the velocity-force data of processive motor proteins, including conventional kinesin, cytoplasmic dynein and myosin V, I found that, the ratio between motor velocities of two different ATP concentrations is almost invariant for any substall, superstall or negative external loads. Therefore, the velocity of motors can be well approximated by a Michaelis-Menten like formula V = left perpendicularATPright perpendiculark(F)L/(left perpendicularATPright perpendicular + K-M), with L the step size, and k(F) the external load F dependent rate of one mechanochemical cycle of motor motion in saturated ATP solution. The difference of Michaelis-Menten constant K-M for substall, superstall and negative external load indicates, the configurations at which ATP molecule can bind to motor heads for these three cases might be different, though the expression of k(F) as a function of F might be unchanged for any external load F. Verifications of this Michaelis-Menten like formula has also been done by fitting to the recent experimental data.	Fudan Univ, Sch Math Sci, Ctr Computat Syst Biol,Lab Math Nonlinear Sci, Shanghai Key Lab Contemporary Appl Math, Shanghai 200433, Peoples R China	Fudan University	Zhang, YX (corresponding author), Fudan Univ, Sch Math Sci, Ctr Computat Syst Biol,Lab Math Nonlinear Sci, Shanghai Key Lab Contemporary Appl Math, Shanghai 200433, Peoples R China.	xyz@fudan.edu.cn			Natural Science Foundation of Shanghai [11ZR1403700]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study is funded by the Natural Science Foundation of Shanghai (under grant no. 11ZR1403700). Website: http://www.stcsm.gov.cn/structure/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chuan PY, 2011, J MOL BIOL, V405, P105, DOI 10.1016/j.jmb.2010.10.010; DERRIDA B, 1983, J STAT PHYS, V31, P433, DOI 10.1007/BF01019492; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; Gao YQ, 2006, BIOPHYS J, V90, P811, DOI 10.1529/biophysj.105.073189; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Greenberg MJ, 2010, P NATL ACAD SCI USA, V107, P17403, DOI 10.1073/pnas.1009619107; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Guydosh NR, 2009, NATURE, V461, P125, DOI 10.1038/nature08259; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Howard J., 2001, MECH MOTOR PROTEINS; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Kolomeisky AB, 2003, BIOPHYS J, V84, P1642, DOI 10.1016/S0006-3495(03)74973-X; Lipowsky R, 2000, PHYS REV LETT, V85, P4401, DOI 10.1103/PhysRevLett.85.4401; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nishikawa M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.128103; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Parrondo JMR, 1998, EUROPHYS LETT, V43, P248, DOI 10.1209/epl/i1998-00348-5; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tsygankov D, 2007, P NATL ACAD SCI USA, V104, P19321, DOI 10.1073/pnas.0709911104; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang YX, 2008, BIOPHYS CHEM, V136, P19, DOI 10.1016/j.bpc.2008.04.002; Zhang YX, 2009, J STAT PHYS, V134, P669, DOI 10.1007/s10955-009-9695-3	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e32717	10.1371/journal.pone.0032717	http://dx.doi.org/10.1371/journal.pone.0032717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457719	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900005
J	Eriksen, E; Prozorkevich, D; Trofimov, A; Howell, D				Eriksen, Elena; Prozorkevich, Dmitry; Trofimov, Aleksandr; Howell, Daniel			Biomass of Scyphozoan Jellyfish, and Its Spatial Association with 0-Group Fish in the Barents Sea	PLOS ONE			English	Article							TEMPERATE COASTAL ENVIRONMENT; CAPELIN MALLOTUS-VILLOSUS; PELAGIC CNIDARIANS; TROPHIC CASCADES; WESTERN SWEDEN; REGIME SHIFTS; GADOID FISH; BERING-SEA; NORTH-SEA; CTENOPHORES	An 0-group fish survey is conducted annually in the Barents Sea in order to estimate fish population abundance. Data on jellyfish by-catch have been recorded since 1980, although this dataset has never been analysed. In recent years, however, the ecological importance of jellyfish medusae has become widely recognized. In this paper the biomass of jellyfish (medusae) in 0-60 m depths is calculated for the period 1980-2010. During this period the climate changed from cold to warm, and changes in zooplankton and fish distribution and abundance were observed. This paper discusses the less well known ecosystem component; jellyfish medusae within the Phylum Cnidaria, and their spatial and temporal variation. The long term average was ca. 9 x 10(8) kg, with some years showing biomasses in excess of 5 x 10(9) kg. The biomasses were low during 1980s, increased during 1990s, and were highest in early 2000s with a subsequent decline. The bulk of the jellyfish were observed in the central parts of the Barents Sea, which is a core area for most 0-group fishes. Jellyfish were associated with haddock in the western area, with haddock and herring in the central and coastal area, and with capelin in the northern area of the Barents Sea. The jellyfish were present in the temperature interval 1 degrees C<T<10 degrees C, with peak densities at ca. 5.5 degrees C, and the greatest proportion of the jellyfish occurring between 4.0-7.0 degrees C. It seems that the ongoing warming trend may be favourable for Barents Sea jellyfish medusae; however their biomass has showed a recent moderate decline during years with record high temperatures in the Barents Sea. Jellyfish are undoubtedly an important component of the Barents Sea ecosystem, and the data presented here represent the best summary of jellyfish biomass and distribution yet published for the region.	[Eriksen, Elena; Howell, Daniel] Inst Marine Res, N-5024 Bergen, Norway; [Prozorkevich, Dmitry; Trofimov, Aleksandr] Polar Res Inst Marine Fisheries & Oceanog, Murmansk, Russia	Institute of Marine Research - Norway; Research lnstitute of Fisheries & Oceanography	Eriksen, E (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	elena.eriksen@imr.no	Trofimov, Alexander G./AAX-4681-2021	Trofimov, Alexander G./0000-0003-0262-1065	IMR (Institute of Marine Research), Menu II (NFR) [190286]; BarEcoRe (NFR) [200796/S41]	IMR (Institute of Marine Research), Menu II (NFR); BarEcoRe (NFR)	The authors would like to acknowledge support provided by the Barents Sea Research programme at IMR (Institute of Marine Research), Menu II (NFR contract number 190286) and BarEcoRe (NFR contract number 200796/S41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLANDSVIK B, 1991, POLAR RES, V10, P45, DOI 10.1111/j.1751-8369.1991.tb00633.x; [Anonymous], 2010, 2010ACOM14 ICES CM; Arai M.N.A.., 1997, FUNCTIONAL BIOL SCYP; Arai MN, 2009, HYDROBIOLOGIA, V616, P241, DOI 10.1007/s10750-008-9588-5; BERGSTAD OA, 1987, FISH RES, V5, P119, DOI 10.1016/0165-7836(87)90037-3; BREWER RH, 1984, BIOL BULL, V166, P11, DOI 10.2307/1541426; Brodeur RD, 1998, MAR ECOL PROG SER, V163, P11, DOI 10.3354/meps163011; Brodeur RD, 2008, PROG OCEANOGR, V77, P103, DOI 10.1016/j.pocean.2008.03.017; Dalpadado P, 2002, LAR MAR ECOSYST, P269; Dalpadado P, 2009, POLAR BIOL, V32, P1583, DOI 10.1007/s00300-009-0657-7; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Dingsor GE, 2005, FISH RES, V72, P205, DOI 10.1016/j.fishres.2004.11.001; Doyle TK, 2007, HYDROBIOLOGIA, V579, P29, DOI 10.1007/s10750-006-0362-2; Eriksen E, 2012, ICES J MAR SCI, V69, P870, DOI 10.1093/icesjms/fsr210; Eriksen E, 2011, POLAR BIOL, V34, P1399, DOI 10.1007/s00300-011-0995-0; Eriksen E, 2011, POLAR BIOL, V34, P647, DOI 10.1007/s00300-010-0920-y; Eriksen Elena, 2009, Open Fish Science Journal, V2, P6; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Gjosaeter H, 1998, SARSIA, V83, P453, DOI 10.1080/00364827.1998.10420445; GRONDAHL F, 1987, J EXP MAR BIOL ECOL, V106, P91, DOI 10.1016/0022-0981(87)90149-3; Hallfredsson EH, 2007, CAN J FISH AQUAT SCI, V64, P1710, DOI 10.1139/F07-137; HAMRE J, 1994, BIODIVERS CONSERV, V3, P473, DOI 10.1007/BF00115154; HAY SJ, 1990, NETH J SEA RES, V25, P113, DOI 10.1016/0077-7579(90)90013-7; Hay S, 2006, CURR BIOL, V16, pR679, DOI 10.1016/j.cub.2006.08.010; Hjermann DO, 2010, CAN J FISH AQUAT SCI, V67, P1363, DOI 10.1139/F10-064; Holst S, 2010, HYDROBIOLOGIA, V645, P53, DOI 10.1007/s10750-010-0214-y; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Hylen A., 2008, NORWEGIAN SPRING SPA, P83; ICES, 2011, 2011ACOM05 ICES CM; ICES, 2019, ICES SCI REPORTS, V1, DOI 10.17895/ices.pub.4982; Ingvaldsen R., 2003, ICES MAR SCI S, V219, P160; Johannesen E, 2012, ICES J SCI IN PRESS; Kogovsek T, 2010, HYDROBIOLOGIA, V645, P81, DOI 10.1007/s10750-010-0217-8; Lilley MKS, 2011, MAR BIOL, V158, P2429, DOI 10.1007/s00227-011-1744-1; LINDAHL O, 1983, MAR ECOL PROG SER, V10, P119, DOI 10.3354/meps010119; Loeng H., 1990, 1990G49 ICES CM; Lynam CP, 2011, GLOBAL CHANGE BIOL, V17, P767, DOI 10.1111/j.1365-2486.2010.02352.x; Lynam CP, 2010, J MAR BIOL ASSOC UK, V90, P1153, DOI 10.1017/S0025315409990488; Lynam CP, 2007, MAR BIOL, V150, P1397, DOI 10.1007/s00227-006-0429-7; Lynam CP, 2006, CURR BIOL, V16, pR492, DOI 10.1016/j.cub.2006.06.018; Lynam CP, 2005, J MAR BIOL ASSOC UK, V85, P435, DOI 10.1017/S0025315405011380; Mansueti R., 1963, Copeia, V1963, P40, DOI 10.2307/1441273; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Naumov DV, 1960, HYDROIDS HYDROMEDUSA, P1; Orlova EL, 2005, ICES J MAR SCI, V62, P1281, DOI 10.1016/j.icesjms.2005.05.020; Ottersen G, 2000, ICES J MAR SCI, V57, P339, DOI 10.1006/jmsc.1999.0529; Ozhigin V., 2011, BARENTS SEA ECOSYSTE, P39; Pauly D, 2009, HYDROBIOLOGIA, V616, P67, DOI 10.1007/s10750-008-9583-x; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; PURCELL JE, 1985, B MAR SCI, V37, P739; PURCELL JE, 1991, HYDROBIOLOGIA, V216, P335, DOI 10.1007/BF00026483; Purcell JE, 2000, MAR ECOL PROG SER, V195, P145, DOI 10.3354/meps195145; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 1997, ANN I OCEANOGR PARIS, V73, P125; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2009, HYDROBIOLOGIA, V616, P23, DOI 10.1007/s10750-008-9585-8; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Roohi A, 2010, BIOL INVASIONS, V12, P2343, DOI 10.1007/s10530-009-9648-4; Russell FS, 1970, SCYPHOZOA PELAGIC, VII; SAETERSDAL G, 1987, FISH RES, V5, P253; Schneider G, 1998, OPHELIA, V48, P71, DOI 10.1080/00785236.1998.10428677; Sornes TA, 2007, J PLANKTON RES, V29, P157, DOI 10.1093/plankt/fbm003; SPANGENBERG D B, 1968, Oceanography and Marine Biology an Annual Review, V6, P231; Stiansen J. E., 2009, IMR PINRO JOINT REPO, V2009; Stromberg KHP, 2009, J MARINE SYST, V78, P18, DOI 10.1016/j.jmarsys.2009.02.004; Utne-Palm AC, 2010, SCIENCE, V329, P333, DOI 10.1126/science.1190708; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; ZELICKMAN EA, 1972, MAR BIOL, V17, P256, DOI 10.1007/BF00366301; Zelickman EA, 1970, PINRO PRESS, V27, P77	70	24	25	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33050	10.1371/journal.pone.0033050	http://dx.doi.org/10.1371/journal.pone.0033050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457732	Green Published, Green Submitted, gold			2022-12-27	WOS:000303909200015
J	Petticrew, M; Smith, GD				Petticrew, Mark; Smith, George Davey			The Monkey Puzzle: A Systematic Review of Studies of Stress, Social Hierarchies, and Heart Disease in Monkeys	PLOS ONE			English	Review							CORONARY-ARTERY ATHEROSCLEROSIS; FEMALE CYNOMOLGUS MONKEYS; INCOME INEQUALITY; RISK-FACTORS; HEALTH; ENVIRONMENT; DETERMINANTS; PATHWAYS; DIET; RANK	Background: It is often suggested that psychosocial factors, such as stress, or one's social position, may play an important role in producing social gradients in human disease. Evidence in favour of this model of health inequalities has relied, in part, on studies of the health effects of the natural social hierarchies found among non-human primates. This study aimed to assess the strength of this evidence. Methodology/Principal Findings: A systematic review was carried out to identify all studies of psychosocial factors and coronary artery disease (CAD) in non-human primates. We searched databases (MEDLINE, PsycInfo, EMBASE, and Primatelit from inception to November 2010) to identify experimental and observational studies of the impact of social reorganisation, social instability, and disruption of dominance hierarchies on primate CAD outcomes. We also handsearched bibliographies and examined the citations to those studies in public health articles. Fourteen studies were found which presented evidence on CAD and social status and/or psychosocial stress. These suggested that the association between social status and disease may be sex-specific: in female monkeys dominant status may be protective, with subordinate females having a greater extent of atherosclerosis. In male monkeys the reverse may be the case. Conclusions/Significance: Overall, non-human primate studies present only limited evidence for an association between social status and CAD, Despite this, there is selective citation of individual non-human primate studies in reviews and commentaries relating to human disease aetiology. Such generalisation of data from monkey studies to human societies does not appear warranted.	[Petticrew, Mark] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Smith, George Davey] Univ Bristol, Sch Social & Community Med, Ctr Causal Anal Translat Epidemiol CAiTE, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Petticrew, M (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England.	mark.petticrew@lshtm.ac.uk	Davey Smith, George/A-7407-2013; Petticrew, Mark/AAY-6274-2021	Davey Smith, George/0000-0002-1407-8314; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	Chief Scientist Office of the Scottish Executive Department of Health; Economic and Social Research Council Evidence Network [H141251011]; Medical Research Council [G0600705]; MRC [G0600705] Funding Source: UKRI	Chief Scientist Office of the Scottish Executive Department of Health; Economic and Social Research Council Evidence Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MP was funded by the Chief Scientist Office of the Scottish Executive Department of Health (1999-2007), and the Economic and Social Research Council Evidence Network (Grant No. H141251011). GDS works in a centre that is supported by the Medical Research Council (Grant No. G0600705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; ADAMS MR, 1985, ARTERIOSCLEROSIS, V5, P192, DOI 10.1161/01.ATV.5.2.192; Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Bobak M, 1996, BRIT MED J, V312, P421; Clarkson T B, 1989, Cardiovasc Clin, V19, P147; CLARKSON TB, 1990, OBSTET GYNECOL, V75, P217; Cummins S, 2002, BRIT MED J, V325, P436, DOI 10.1136/bmj.325.7361.436; Davey Smith G., 2003, HLTH INEQUALITIES LI; Evans R, 2002, INTERPRETING ADDRESS; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; Hamm T. E. Jr., 1980, Dissertation Abstracts International, V41B, P1319; HAMM TE, 1983, ATHEROSCLEROSIS, V48, P221, DOI 10.1016/0021-9150(83)90040-0; Harris J, 2006, NO 2 ALIKE HUMAN NAT; Kaplan J, 2001, PSYCHOSOM MED, V63, P91; Kaplan JR, 2009, AM J PRIMATOL, V71, P732, DOI 10.1002/ajp.20707; Kaplan JR, 1999, ANN NY ACAD SCI, V896, P145, DOI 10.1111/j.1749-6632.1999.tb08112.x; KAPLAN JR, 1983, SCIENCE, V220, P733; KAPLAN JR, 1982, ARTERIOSCLEROSIS, V2, P359, DOI 10.1161/01.ATV.2.5.359; Kaplan JR, 2002, OBSTET GYNECOL, V99, P381, DOI 10.1016/S0029-7844(01)01659-3; KAPLAN JR, 1987, CIRCULATION, V76, P1364, DOI 10.1161/01.CIR.76.6.1364; KAPLAN JR, 1993, ARTERIOSCLER THROMB, V13, P254, DOI 10.1161/01.ATV.13.2.254; KAPLAN JR, 1995, ARTERIOSCL THROM VAS, V15, P2094, DOI 10.1161/01.ATV.15.12.2094; KAPLAN JR, 1984, ATHEROSCLEROSIS, V53, P283, DOI 10.1016/0021-9150(84)90129-1; Lapin B, 1971, SOC STRESS DIS; Lynch J, 2001, LANCET, V358, P194, DOI 10.1016/S0140-6736(01)05407-1; Macleod J, 2003, J EPIDEMIOL COMMUN H, V57, P565, DOI 10.1136/jech.57.8.565; MANUCK SB, 1983, NEUROSCI BIOBEHAV R, V7, P485, DOI 10.1016/0149-7634(83)90028-3; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; Marmot M, 2004, STATUS SYNDROME; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; MASON WA, 1990, AM J PRIMATOL, V22, P123, DOI 10.1002/ajp.1350220206; Nordstrom CK, 2001, EPIDEMIOLOGY, V12, P180, DOI 10.1097/00001648-200103000-00009; Pearce N, 2003, AM J PUBLIC HEALTH, V93, P122, DOI 10.2105/AJPH.93.1.122; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Rohde P, 2001, J AFFECT DISORDERS, V65, P221, DOI 10.1016/S0165-0327(00)00219-6; Sandercock P, 2002, LANCET, V360, P586, DOI 10.1016/S0140-6736(02)09812-4; Sapolsky R, 1999, HORMONES HLTH BEHAV; SAPOLSKY RM, 1993, RECENT PROG HORM RES, V48, P437; SHARMAN M, 1982, Primates, V23, P567, DOI 10.1007/BF02373968; SHIVELY CA, 1994, ARTERIOSCLER THROMB, V14, P721, DOI 10.1161/01.ATV.14.5.721; SHIVELY CA, 1989, ATHEROSCLEROSIS, V77, P69, DOI 10.1016/0021-9150(89)90011-7; SHIVELY CA, 1990, ARTERIOSCLEROSIS, V10, P358, DOI 10.1161/01.ATV.10.3.358; Steptoe A, 2002, EUR HEART J, V23, P13, DOI 10.1053/euhj.2001.2611; Sterne J, 2001, SYSTEMATIC REV HLTH; von Holst D, 1998, ADV STUD BEHAV, V27, P1; Wilkinson R, 1999, SOCIAL DETERMINANTS, pp256; Wilkinson R., 2009, SPIRIT LEVEL; Wilkinson RG, 1999, INT J HEALTH SERV, V29, P525, DOI 10.2190/3QXP-4N6T-N0QG-ECXP; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591; WILLIAMS JK, 1994, CIRCULATION, V90, P983, DOI 10.1161/01.CIR.90.2.983; WILLIAMS JK, 1991, CIRCULATION, V84, P2146, DOI 10.1161/01.CIR.84.5.2146; Williams JK, 2003, ARTERIOSCL THROM VAS, V23, P864, DOI 10.1161/01.ATV.0000067934.12783.6A	53	10	10	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e27939	10.1371/journal.pone.0027939	http://dx.doi.org/10.1371/journal.pone.0027939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470414	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000303857100001
J	Li, ZJ; Yu, GH; Rao, DQ; Yang, JX				Li, Zejun; Yu, Guohua; Rao, Dingqi; Yang, Junxing			Phylogeography and Demographic History of Babina pleuraden (Anura, Ranidae) in Southwestern China	PLOS ONE			English	Article							TERMINALIA-FRANCHETII COMBRETACEAE; POPULATION-GROWTH; TIBETAN PLATEAU; CONSERVATION; SEQUENCE; REGION; UPLIFT; FROG; DIVERSIFICATION; PHYLOGENIES	Factors that determine genetic structure of species in southwestern China remain largely unknown. In this study, sequences of two mitochondrial genes (COI and cyt b) were determined to investigate the phylogeography and demography of Babina pleuraden, a pond frog endemic to southwestern China. A total of 262 individuals from 22 populations across the entire range of the species were collected. Our results indicate that B. pleuraden comprises five well-supported mitochondrial lineages roughly corresponding to five geographical areas. The phylogeographic structure of B. pleuraden has been shaped primarily by the unique regional responses of the Yunnan Plateau to the rapid uplift of the Qinghai-Tibetan Plateau occurred c. 2.5 Mya (B phrase of Qingzang Movement) and climatic oscillation during middle Pleistocene (c. 0.64-0.36 Mya), rather than by the paleo-drainage systems. The present wide distribution of the species has resulted from recent population expansion (c. 0.053-0.025 Mya) from multiple refugia prior to the Last Glacial Maximum, corresponding to the scenario of "refugia within refugia".	[Li, Zejun; Yu, Guohua; Rao, Dingqi; Yang, Junxing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Li, Zejun; Yu, Guohua] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, ZJ (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	raodq@mail.kiz.ac.cn; yangjx@mail.kiz.ac.cn			Basic Research Program of China [2007CB411600]; National Natural Science Foundation of China [30730017]	Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Basic Research Program of China (No. 2007CB411600) and National Natural Science Foundation of China (No. 30730017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Axelrod D., 1996, FLORISTIC CHARACTERI, P43; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Calix M., 2018, EUROPEAN RED LIST SA; CHENG J, 2001, GEOSCIENCE, V15, P290; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fei L., 1999, ATLAS AMPHIBIANS CHI; Fu YX, 1997, GENETICS, V147, P915; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; HARPENDING HC, 1994, HUM BIOL, V66, P591; HE HS, 1993, GEOSCIENCE, V7, P31; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; LELOUP PH, 1993, J GEOPHYS RES-SOL EA, V98, P6715, DOI 10.1029/92JB02791; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Li JJ, 1996, SCI CHINA SER D, V39, P380; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Lind AJ, 2011, CONSERV GENET, V12, P269, DOI 10.1007/s10592-010-0138-0; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Luo Y., 2011, COMPARED STUDY DIET; Lymberakis P, 2007, MOL PHYLOGENET EVOL, V44, P115, DOI 10.1016/j.ympev.2007.03.009; Maddison W.P., 2010, MESQUITE MODULAR SYS; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Measey GJ, 2011, CONSERV GENET, V12, P61, DOI 10.1007/s10592-009-9989-7; Mitsui Y, 2008, ANN BOT-LONDON, V101, P111, DOI 10.1093/aob/mcm267; Monaghan MT, 2001, HEREDITY, V86, P395, DOI 10.1046/j.1365-2540.2001.00843.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; Otsuka Hiroyuki, 2000, Journal of the Geological Society of Japan, V106, P442; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Rambaut A, 2007, TRACER V 1 4; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; SLATKIN M, 1989, GENETICS, V123, P603; Stuart BL, 2004, MOL PHYLOGENET EVOL, V31, P164, DOI 10.1016/S1055-7903(03)00258-6; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; TAJIMA F, 1989, GENETICS, V123, P585; Teacher AGF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019476; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang E, 1998, GEOL S AM S; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; Zhan AB, 2011, MOL PHYLOGENET EVOL, V61, P136, DOI 10.1016/j.ympev.2011.06.009; Zhan AB, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-17; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang Rong-Zu (Yong-Zu), 2002, Acta Zoologica Sinica, V48, P141; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zhang TC, 2011, J PLANT RES, V124, P63, DOI 10.1007/s10265-010-0360-3; Zhang W, 2006, QUATERN INT, V154, P32, DOI 10.1016/j.quaint.2006.02.012; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X	65	29	33	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e34013	10.1371/journal.pone.0034013	http://dx.doi.org/10.1371/journal.pone.0034013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448286	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700077
J	Pils, S; Kopp, K; Peterson, L; Tascon, JD; Nyffenegger-Jann, NJ; Hauck, CR				Pils, Stefan; Kopp, Kathrin; Peterson, Lisa; Tascon, Julia Delgado; Nyffenegger-Jann, Naja J.; Hauck, Christof R.			The Adaptor Molecule Nck Localizes the WAVE Complex to Promote Actin Polymerization during CEACAM3-Mediated Phagocytosis of Bacteria	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; T-CELL; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; TYROSINE KINASE; HUMAN PATHOGENS; RECEPTOR; ADHESION; PROTEIN; CEACAM3	Background: CEACAM3 is a granulocyte receptor mediating the opsonin-independent recognition and phagocytosis of human-restricted CEACAM-binding bacteria. CEACAM3 function depends on an intracellular immunoreceptor tyrosine-based activation motif (ITAM)-like sequence that is tyrosine phosphorylated by Src family kinases upon receptor engagement. The phosphorylated ITAM-like sequence triggers GTP-loading of Rac by directly associating with the guanine nucleotide exchange factor (GEF) Vav. Rac stimulation in turn is critical for actin cytoskeleton rearrangements that generate lamellipodial protrusions and lead to bacterial uptake. Principal Findings: In our present study we provide biochemical and microscopic evidence that the adaptor proteins Nck1 and Nck2, but not CrkL, Grb2 or SLP-76, bind to tyrosine phosphorylated CEACAM3. The association is phosphorylation-dependent and requires the Nck SH2 domain. Overexpression of the isolated Nck1 SH2 domain, RNAi-mediated knock-down of Nck1, or genetic deletion of Nck1 and Nck2 interfere with CEACAM3-mediated bacterial internalization and with the formation of lamellipodial protrusions. Nck is constitutively associated with WAVE2 and directs the actin nucleation promoting WAVE complex to tyrosine phosphorylated CEACAM3. In turn, dominant-negative WAVE2 as well as shRNA-mediated knock-down of WAVE2 or the WAVE-complex component Nap1 reduce internalization of bacteria. Conclusions: Our results provide novel mechanistic insight into CEACAM3-initiated phagocytosis. We suggest that the CEACAM3 ITAM-like sequence is optimized to co-ordinate a minimal set of cellular factors needed to efficiently trigger actin-based lamellipodial protrusions and rapid pathogen engulfment.	[Pils, Stefan; Kopp, Kathrin; Tascon, Julia Delgado; Nyffenegger-Jann, Naja J.; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, Constance, Germany; [Peterson, Lisa] Univ Wurzburg, Zentrum Infekt Forsch, Wurzburg, Germany; [Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany	University of Konstanz; University of Wurzburg; University of Konstanz	Pils, S (corresponding author), Univ Konstanz, Lehrstuhl Zellbiol, Constance, Germany.	christof.hauck@uni-konstanz.de			Landesstiftung Baden-Wurttemberg [LS-Prot-66]; Ministry of Science, Research and the Arts of Baden-Wurttemberg	Landesstiftung Baden-Wurttemberg; Ministry of Science, Research and the Arts of Baden-Wurttemberg	This study was supported by funds from the Landesstiftung Baden-Wurttemberg (LS-Prot-66) and by a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg to C.R.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram Clare L, 2007, Sci STKE, V2007, pre2, DOI 10.1126/stke.3772007re2; Billker O, 2002, EMBO J, V21, P560, DOI 10.1093/emboj/21.4.560; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Booth JW, 2003, J BIOL CHEM, V278, P14037, DOI 10.1074/jbc.M211879200; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Buntru A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-81; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Danson CM, 2007, J CELL SCI, V120, P4144, DOI 10.1242/jcs.013714; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Frese S, 2006, J BIOL CHEM, V281, P18236, DOI 10.1074/jbc.M512917200; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; GREENBERG S, 1995, TRENDS CELL BIOL, V5, P93, DOI 10.1016/S0962-8924(00)88957-6; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Izadi KD, 1998, EXP CELL RES, V245, P330, DOI 10.1006/excr.1998.4259; Kitamura T, 1996, BIOCHEM BIOPH RES CO, V219, P509, DOI 10.1006/bbrc.1996.0264; Kitamura Y, 1997, BIOCHEM J, V322, P873, DOI 10.1042/bj3220873; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; McCaw SE, 2003, MOL MICROBIOL, V49, P623, DOI 10.1046/j.1365-2958.2003.03591.x; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muenzner P, 2008, CELL MICROBIOL, V10, P1074, DOI 10.1111/j.1462-5822.2007.01106.x; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Pils S, 2008, INT J MED MICROBIOL, V298, P553, DOI 10.1016/j.ijmm.2008.04.005; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Ruusala A, 2008, J BIOL CHEM, V283, P30034, DOI 10.1074/jbc.M800913200; Sarantis H, 2007, CELL MICROBIOL, V9, P2167, DOI 10.1111/j.1462-5822.2007.00947.x; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; Schmitter T, 2007, J IMMUNOL, V178, P3797, DOI 10.4049/jimmunol.178.6.3797; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Youssef AR, 2009, INFECT IMMUN, V77, P5170, DOI 10.1128/IAI.00355-09; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	51	29	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32808	10.1371/journal.pone.0032808	http://dx.doi.org/10.1371/journal.pone.0032808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448228	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700018
J	Ferreira, MSR; Xavier, MDTP; Tinga, ACD; Rose, TL; Fumian, TM; Fialho, AM; de Assis, RM; Costa, FAC; de Oliveira, SA; Leite, JPG; Miagostovich, MP				Rocha Ferreira, Monica Simoes; Trindade Pinheiro Xavier, Maria da Penha; De Castro Tinga, Anna Carolina; Rose, Tatiana Lundgren; Fumian, Tulio Machado; Fialho, Alexandre Madi; de Assis, Rosane Maria; Carvalho Costa, Filipe Anibal; de Oliveira, Solange Artimos; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira			Assessment of Gastroenteric Viruses Frequency in a Children's Day Care Center in Rio De Janeiro, Brazil: A Fifteen Year Study (1994-2008)	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; HUMAN ASTROVIRUSES; HOSPITALIZED CHILDREN; NOROVIRUS INFECTIONS; HUMAN CALICIVIRUSES; ROTAVIRUS STRAINS; GENETIC DIVERSITY; YOUNG-CHILDREN; VIRAL AGENTS; GENOGROUP-II	This 15-year study aimed to determine the role of the main viruses responsible for acute infantile gastroenteritis cases in a day care center in the city of Rio de Janeiro, Brazil. From 1994 to 2008, 539 fecal samples were obtained from 23 outbreaks as well as sporadic cases that occurred in this period. The detection of Rotavirus group A (RVA), norovirus (NoV) and astrovirus (AstV) was investigated both by classical and molecular methods of viral detection. RVA was detected by enzymatic immune assay and/or polyacrylamide gel electrophoresis and genotyped by using semi-nested multiplex PCR. NoV and AstV were subsequently tested by real time PCR in all RVA-negative samples and genotyped throughout genome sequencing. Three protocols for molecular characterization of NoV nucleotide sequencing were performed with the partial nucleotide sequencing of genomic regions known as region B (polymerase gen), C and D (capsid gen). Viruses were identified in 47.7% (257/539) of the cases, and the detection rates of RVA, NoV and AstV in 16.1% (87/539), 33.4% (151/452), and 6.3% (19/301), respectively. Most gastroenteritis cases were reported in autumn and winter, although NoV presented a broader monthly distribution. Viruses' detection rates were significantly higher among children aged less than 24 months old, although NoV cases were detected in all age groups. RVA genotypes as G1P[8], G9P[8], G2P[4], G3P[8] and G1+G3P[8] and RVA was no longer detected after 2005. NoV characterization revealed genotypes variability circulating in the period as GI.2, GI.3, GI.8 GII.2, GII.3, GII.4, GII.4 variants 2001 and 2006b, GII.6, GII.7, GII.12 and GII.17. AstV genotypes 1, 2, 4 and 5 were also characterized. Those data demonstrate the impact of NoV infection in cases of infantile gastroenteritis, surpassing RVA infection responsible for high morbidity rate in children under five years old.	[Rocha Ferreira, Monica Simoes; Trindade Pinheiro Xavier, Maria da Penha; De Castro Tinga, Anna Carolina; Rose, Tatiana Lundgren; Fumian, Tulio Machado; Fialho, Alexandre Madi; de Assis, Rosane Maria; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira] Fiocruz MS, Lab Virol Comparada & Ambiental, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Carvalho Costa, Filipe Anibal] Fiocruz MS, Lab Sistemat Bioquim, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [de Oliveira, Solange Artimos] Univ Fed Fluminense, Disciplina Doencas Infecciosas & Parasitarias, Fac Med, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Ferreira, MSR (corresponding author), Fiocruz MS, Lab Virol Comparada & Ambiental, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.	mosrocha@ioc.fiocruz.br	LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020; Fumian, Tulio/AAC-4724-2021	Fialho, Alexandre Madi/0000-0002-5412-3896; Xavier, Maria/0000-0001-9657-1980	National Council for Scientific and Technological Development CNPq; Instituto Oswaldo Cruz - Fiocruz; CGLAB - Ministry of Health, Brasil	National Council for Scientific and Technological Development CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Oswaldo Cruz - Fiocruz; CGLAB - Ministry of Health, Brasil	This work was supported by the National Council for Scientific and Technological Development CNPq, Instituto Oswaldo Cruz - Fiocruz, CGLAB - Ministry of Health, Brasil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akihara S, 2005, ARCH VIROL, V150, P2061, DOI 10.1007/s00705-005-0540-y; Appleton H, 1975, Lancet, V1, P1297; Atmar RL, 2010, FOOD ENVIRON VIROL, V2, P117, DOI 10.1007/s12560-010-9038-1; BARTLETT AV, 1985, J PEDIATR-US, V107, P495, DOI 10.1016/S0022-3476(85)80004-4; Bereciartu A, 2002, J CLIN VIROL, V25, P197, DOI 10.1016/S1386-6532(02)00010-0; Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002; BISHOP RF, 1973, LANCET, V2, P1281, DOI 10.1016/s0140-6736(73)92867-5; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; Buesa J, 2008, J MED VIROL, V80, P1288, DOI 10.1002/jmv.21182; Carvalho-Costa FA, 2011, PEDIATR INFECT DIS J, V30, pS35, DOI 10.1097/INF.0b013e3181fefd5f; Carvalho-Costa FA, 2009, EMERG INFECT DIS, V15, P95, DOI 10.3201/eid1501.071136; Castilho JG, 2006, J CLIN MICROBIOL, V44, P3947, DOI 10.1128/JCM.00279-06; Cilli A, 2011, J PEDIAT-BRAZIL, V87, P445, DOI [10.2223/JPED.2122, 10.1590/S0021-75572011000500013]; Cunliffe NA, 2002, J MED VIROL, V67, P563, DOI 10.1002/jmv.10139; DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994; de Paula Cardoso DD., 2002, MED SCI MONITOR, V8, pCR624; DECASTRO L, 1994, MEM I OSWALDO CRUZ, V89, P5, DOI 10.1590/S0074-02761994000100002; Ferreira MSR, 2010, J MED VIROL, V82, P1442, DOI 10.1002/jmv.21831; Fioretti J, 2011, MEM I O CRU IN PRESS; Fukuda S, 2010, ARCH VIROL, V155, P111, DOI 10.1007/s00705-009-0528-0; Gabbay YB, 2005, MEM I OSWALDO CRUZ, V100, P709, DOI 10.1590/S0074-02762005000700004; Leite JPG, 2008, MEM I OSWALDO CRUZ, V103, P745, DOI 10.1590/S0074-02762008000800001; Gallimore CI, 2004, BRAZ J MED BIOL RES, V37, P321, DOI 10.1590/S0100-879X2004000300005; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Giordano Miguel O., 2004, Rev. Inst. Med. trop. S. Paulo, V46, P93, DOI 10.1590/S0036-46652004000200007; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; Goodgame Richard, 2006, Curr Gastroenterol Rep, V8, P401, DOI 10.1007/s11894-006-0026-4; Guix S, 2002, J CLIN MICROBIOL, V40, P133, DOI 10.1128/JCM.40.1.133-139.2002; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hansman GS, 2004, ARCH VIROL, V149, P1673, DOI 10.1007/s00705-004-0345-4; HILLIS SD, 1992, PEDIATRICS, V90, P582; Kale PL, 2004, J HEALTH POPUL NUTR, V22, P27; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Le Cann P, 2004, RES MICROBIOL, V155, P11, DOI 10.1016/j.resmic.2003.09.013; Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637; Lyman WH, 2009, J PEDIATR-US, V154, P253, DOI 10.1016/j.jpeds.2008.07.057; Morillo SG, 2010, J PEDIAT-BRAZIL, V86, P155, DOI [10.2223/JPED.1981, 10.1590/S0021-75572010000200013]; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Oh DY, 2003, J MED VIROL, V71, P82, DOI 10.1002/jmv.10449; Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04; Safadi MAP, 2010, PEDIATR INFECT DIS J, V29, P1019, DOI 10.1097/INF.0b013e3181e7886a; Pang XL, 2000, J INFECT DIS, V181, pS288, DOI 10.1086/315590; Pang XLL, 2005, J CLIN VIROL, V33, P168, DOI 10.1016/j.jcv.2004.12.014; Parashar UD, 2004, J INFECT DIS, V190, P1088, DOI 10.1086/423324; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; PEREIRA HG, 1983, J HYG-CAMBRIDGE, V90, P117, DOI 10.1017/S0022172400063919; Phillips G, 2010, EPIDEMIOL INFECT, P1, DOI DOI 10.1017/S0950268810002839; Ribeiro LR, 2008, MEM I OSWALDO CRUZ, V103, P201, DOI 10.1590/S0074-02762008000200013; Rosenfeldt V, 2005, PEDIATR INFECT DIS J, V24, P962, DOI 10.1097/01.inf.0000183748.41027.a4; Shinkawa N, 2008, INTERVIROLOGY, V51, P422, DOI 10.1159/000205527; SIEBENGA J, 2008, EUROSURVEILLANCE, V13, P1; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Silva AMV, 2001, MEM I OSWALDO CRUZ, V96, P1069, DOI 10.1590/S0074-02762001000800007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tamura T, 2010, JPN J INFECT DIS, V63, P405; Taylor MB, 1997, EPIDEMIOL INFECT, V119, P227, DOI 10.1017/S0950268897007814; Tran A, 2010, J CLIN MICROBIOL, V48, P1943, DOI 10.1128/JCM.02181-09; Vega E, 2011, EMERG INFECT DIS, V17, P1516, DOI 10.3201/eid1708.110025; Victoria M, 2007, PEDIATR INFECT DIS J, V26, P602, DOI 10.1097/INF.0b013e3180618bea; Victoria M, 2007, J MED VIROL, V79, P939, DOI 10.1002/jmv.20814; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Walker CLF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S16; WHO, 2009, IN VACC RES IVR DIAR; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	67	52	56	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33754	10.1371/journal.pone.0033754	http://dx.doi.org/10.1371/journal.pone.0033754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448271	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700062
J	Hansen, HV; Christensen, EM; Dam, H; Gluud, C; Wetterslev, J; Kessing, LV				Hansen, Hanne Vibe; Christensen, Ellen Margrethe; Dam, Henrik; Gluud, Christian; Wetterslev, Jorn; Kessing, Lars Vedel		Early Intervention Affective	The Effects of Centralised and Specialised Intervention in the Early Course of Severe Unipolar Depressive Disorder: A Randomised Clinical Trial	PLOS ONE			English	Article							BIPOLAR DISORDERS; MAJOR DEPRESSION; RECURRENCE; RISK; PSYCHOTHERAPY; SATISFACTION; INVENTORY; RECOVERY; VALIDITY; DISEASE	Background: Little is known on whether centralised and specialised combined pharmacological and psychological intervention in the early phase of severe unipolar depression improve prognosis. The aim of the present study was to assess the benefits and harms of centralised and specialised secondary care intervention in the early course of severe unipolar depression. Methods: A randomised multicentre trial with central randomisation and blinding in relation to the primary outcome comparing a centralised and specialised outpatient intervention program with standard decentralised psychiatric treatment. The interventions were offered at discharge from first, second, or third hospitalisation due to a single depressive episode or recurrent depressive disorder. The primary outcome was time to readmission to psychiatric hospital. The data on rehospitalisation was obtained from the Danish Psychiatric Central Register. The secondary and tertiary outcomes were severity of depressive symptoms according to the Major Depression Inventory, adherence to medical treatment, and satisfaction with treatment according to the total score on the Verona Service Satisfaction Scale-Affective Disorder (VSSS-A). These outcomes were assessed using questionnaires one year after discharge from hospital. Results: A total of 268 patients with unipolar depression were included. There was no significant difference in the time to readmission (unadjusted hazard ratio 0.89, 95% confidence interval 0.60 to 1.32; log rank: chi(2) = 0.3, d.f. = 1, p = 0.6); severity of depressive symptoms (mood disorder clinic: median 21.6, quartiles 9.7-31.2 versus standard treatment: median 20.2, quartiles 10.0-29.8; p = 0.7); or the prevalence of patients in antidepressant treatment (73.9% versus 80.0%, p = 0.2). Centralised and specialised secondary care intervention resulted in significantly higher satisfaction with treatment (131 (SD 31.8) versus 107 (SD 25.6); p < 0.001). Conclusions: Centralised and specialised secondary care intervention in the early course of severe unipolar depression resulted in no significant effects on time to rehospitalisation, severity of symptoms, or use of antidepressants, but increased patient satisfaction.	[Hansen, Hanne Vibe; Christensen, Ellen Margrethe; Dam, Henrik; Kessing, Lars Vedel] Copenhagen Univ Hosp, Rigshosp, Mood Disorder Clin, Psychiat Ctr Copenhagen, Copenhagen, Denmark; [Gluud, Christian; Wetterslev, Jorn] Copenhagen Univ Hosp, Rigshosp, CTU, Ctr Clin Intervent Res, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Hansen, HV (corresponding author), Copenhagen Univ Hosp, Rigshosp, Mood Disorder Clin, Psychiat Ctr Copenhagen, Copenhagen, Denmark.	lars.vedel.kessing@regionh.dk	Jorgensen, Martin Balslev MBJ/K-5758-2012; Wetterslev, Jørn/ABF-1251-2020; Gluud, Christian/HGB-3191-2022; Gluud, Christian/AAY-1027-2021	Jorgensen, Martin Balslev MBJ/0000-0002-1321-8901; Wetterslev, Jørn/0000-0001-7778-1771; Gluud, Christian/0000-0002-8861-0799; Kessing, Lars/0000-0001-9377-9436	Lundbeck Foundation; Research Foundation of the Hovedstadens Sygehusfaellesskab (The Capital Hospital Corporation); Lundbeck Foundation [R44-2009-4195] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Research Foundation of the Hovedstadens Sygehusfaellesskab (The Capital Hospital Corporation); Lundbeck Foundation(Lundbeckfonden)	The study was supported by the Lundbeck Foundation and by the Research Foundation of the Hovedstadens Sygehusfaellesskab (The Capital Hospital Corporation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, INT STAT CLASSIFICAT; Badamgarav E, 2003, AM J PSYCHIAT, V160, P2080, DOI 10.1176/appi.ajp.160.12.2080; Bauer Michael, 2002, World J Biol Psychiatry, V3, P5, DOI 10.3109/15622970209150599; Bauer Michael, 2002, World J Biol Psychiatry, V3, P69, DOI 10.3109/15622970209150605; Bech P, 2001, Ugeskr Laeger, V163, P1980; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Berk M, 2007, MED J AUSTRALIA, V187, pS11; Bock Camilla, 2009, Clin Pract Epidemiol Ment Health, V5, P4, DOI 10.1186/1745-0179-5-4; Burns T, 2009, BRIT J PSYCHIAT, V195, P5, DOI 10.1192/bjp.bp.108.062968; Dam Henrik, 2010, Ugeskr Laeger, V172, P3183; Danish National Board of Health, 2007, GUID TREATM UN DIS; de Maat SM, 2007, EUR PSYCHIAT, V22, P1, DOI 10.1016/j.eurpsy.2006.10.008; Demyttenaere K, 2008, INT CLIN PSYCHOPHARM, V23, P36, DOI 10.1097/YIC.0b013e3282f1c1d8; Dietrich AJ, 2004, BMJ-BRIT MED J, V329, P602, DOI 10.1136/bmj.38219.481250.55; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Hansen Hanne Vibe, 2007, Expert Rev Neurother, V7, P57, DOI 10.1586/14737175.7.1.57; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Hirschfeld RMA, 2003, AM J PSYCHIAT, V160, P178, DOI 10.1176/appi.ajp.160.1.178; Jacobsen JC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022890., DOI 10.1371/JOURNAL.PONE.0022890]; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001; Kessing LV, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-32; Kessing LV, 2009, J AFFECT DISORDERS, V117, P24, DOI 10.1016/j.jad.2008.11.020; Kessing LV, 1998, PSYCHOL MED, V28, P1027, DOI 10.1017/S0033291798006862; Kessing LV, 2006, SOC PSYCH PSYCH EPID, V41, P148, DOI 10.1007/s00127-005-0012-4; Kessing LV, 2004, BRIT J PSYCHIAT, V185, P372, DOI 10.1192/bjp.185.5.372; Kessing LV, 2003, J AFFECT DISORDERS, V73, P261, DOI 10.1016/S0165-0327(02)00004-6; Kessing LV, 2004, ACTA PSYCHIAT SCAND, V109, P339, DOI 10.1046/j.1600-0447.2003.00266.x; Kessing LV, 2006, RESULTS HLTH TECHNOL; MAJ M, 1992, AM J PSYCHIAT, V149, P795; Melfi CA, 1998, ARCH GEN PSYCHIAT, V55, P1128, DOI 10.1001/archpsyc.55.12.1128; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; National Board of Health, 2007, REF PROGR ADULTS UN; National Institute for Health and Clinical Excellence (NICE), 2018, DEPR AD REC MAN; Olsen LR, 2003, PSYCHOL MED, V33, P351, DOI 10.1017/S0033291702006724; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Oxman TE, 2003, AM J GERIAT PSYCHIAT, V11, P507; Ruggeri M, 2003, SCHIZOPHRENIA BULL, V29, P229, DOI 10.1093/oxfordjournals.schbul.a007000; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Tohen M, 2000, AM J PSYCHIAT, V157, P220, DOI 10.1176/appi.ajp.157.2.220; van Os TWDP, 2004, J AFFECT DISORDERS, V80, P173, DOI 10.1016/S0165-0327(03)00074-0; Von Korff M, 2001, BRIT MED J, V323, P948, DOI 10.1136/bmj.323.7319.948; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Wells K, 2004, ARCH GEN PSYCHIAT, V61, P378, DOI 10.1001/archpsyc.61.4.378; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e32950	10.1371/journal.pone.0032950	http://dx.doi.org/10.1371/journal.pone.0032950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939TA	22442673	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500015
J	Saifi, B; Ferat, JL				Saifi, Boubekeur; Ferat, Jean-Luc			Replication Fork Reactivation in a dnaC2 Mutant at Non-Permissive Temperature in Escherichia coli	PLOS ONE			English	Article							CHROMOSOMAL REPLICATION; HELICASE LOADERS; SOS RESPONSE; PROTEIN; PRIA; K-12; RECOMBINATION; INACTIVATION; INITIATION; MUTATIONS	Replicative helicases unwind double-stranded DNA in front of the polymerase and ensure the processivity of DNA synthesis. In Escherichia coli, the helicase loader DnaC as well as factors involved in the formation of the open complex during the initiation of replication and primosomal proteins during the reactivation of arrested replication forks are required to recruit and deposit the replicative helicase onto single-stranded DNA prior to the formation of the replisome. dnaC2 is a thermosensitive allele of the gene specifying the helicase loader; at non-permissive temperature replication cannot initiate, but most ongoing rounds of replication continues through to completion (18% of dnaC2 cells fail to complete replication at non-permissive temperature). An assumption, which may be drawn from this observation, is that only a few replication forks are arrested under normal growth conditions. This assumption, however, is at odds with the severe and deleterious phenotypes associated with a null mutant of priA, the gene encoding a helicase implicated in the reactivation of arrested replication forks. We developed an assay that involves an abrupt inactivation of rounds of synchronized replication in a large population of cells, in order to evaluate the ability of dnaC2 cells to reactivate arrested replication forks at non-permissive temperature. We compared the rate at which arrested replication forks accumulated in dnaC2 priA(+) and dnaC2 priA2 cells and observed that this rate was lower in dnaC2 priA(+) cells. We conclude that while replication cannot initiate in a dnaC2 mutant at non-permissive temperature, a class of arrested replication forks (PriA-dependent and DnaC-independent) are reactivated within these cells.	[Saifi, Boubekeur; Ferat, Jean-Luc] CNRS, Ctr Genet Mol, Gif Sur Yvette, France; [Ferat, Jean-Luc] Univ Versailles St Quentin, Versailles, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Saifi, B (corresponding author), CNRS, Ctr Genet Mol, Gif Sur Yvette, France.	ferat@cgm.cnrs-gif.fr			Fondation Dina Surdin under aegis of the Fondation de France	Fondation Dina Surdin under aegis of the Fondation de France	This work was supported by grants from Fondation Dina Surdin to BS under aegis of the Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; COZZARELLI NR, 1980, SCIENCE, V207, P953, DOI 10.1126/science.6243420; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; Grompone G, 2003, MOL MICROBIOL, V48, P845, DOI 10.1046/j.1365-2958.2003.03480.x; HANSEN EB, 1984, MOL GEN GENET, V196, P387, DOI 10.1007/BF00436184; Heller RC, 2007, DNA REPAIR, V6, P945, DOI 10.1016/j.dnarep.2007.02.014; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Keyamura K, 2009, J BIOL CHEM, V284, P25038, DOI 10.1074/jbc.M109.002717; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kornberg A., 1992, DNA REPLICATION; Lobner-Olesen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002984; Maisnier-Patin S, 2001, MOL MICROBIOL, V42, P1371, DOI 10.1046/j.1365-2958.2001.02718.x; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; MALLORY JB, 1990, J BIOL CHEM, V265, P13297; MASAI H, 1994, EMBO J, V13, P5338, DOI 10.1002/j.1460-2075.1994.tb06868.x; MASAI H, 1988, J BIOL CHEM, V263, P15083; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 1996, GENETICS, V143, P5; SINGER M, 1989, MICROBIOL REV, V53, P1; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x; Zechiedrich EL, 1997, GENE DEV, V11, P2580, DOI 10.1101/gad.11.19.2580	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33613	10.1371/journal.pone.0033613	http://dx.doi.org/10.1371/journal.pone.0033613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442702	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500043
J	Sticozzi, C; Belmonte, G; Pecorelli, A; Arezzini, B; Gardi, C; Maioli, E; Miracco, C; Toscano, M; Forman, HJ; Valacchi, G				Sticozzi, Claudia; Belmonte, Giuseppe; Pecorelli, Alessandra; Arezzini, Beatrice; Gardi, Concetta; Maioli, Emanuela; Miracco, Clelia; Toscano, Marzia; Forman, Henry Jay; Valacchi, Giuseppe			Cigarette Smoke Affects Keratinocytes SRB1 Expression and Localization via H2O2 Production and HNE Protein Adducts Formation	PLOS ONE			English	Article							RECEPTOR CLASS-B; DENSITY-LIPOPROTEIN HDL; SCAVENGER RECEPTOR; NADPH OXIDASE; GROWTH-FACTOR; BARRIER FUNCTION; DNA-DAMAGE; CHOLESTEROL; ACTIVATION; EPIDERMIS	Scavenger Receptor B1 (SR-B1), also known as HDL receptor, is involved in cellular cholesterol uptake. Stratum corneum (SC), the outermost layer of the skin, is composed of more than 25% cholesterol. Several reports support the view that alteration of SC lipid composition may be the cause of impaired barrier function which gives rise to several skin diseases. For this reason the regulation of the genes involved in cholesterol uptake is of extreme significance for skin health. Being the first shield against external insults, the skin is exposed to several noxious substances and among these is cigarette smoke (CS), which has been recently associated with various skin pathologies. In this study we first have shown the presence of SR-B1 in murine and human skin tissue and then by using immunoblotting, immunoprecipitation, RT-PCR, and confocal microscopy we have demonstrated the translocation and the subsequent lost of SR-B1 in human keratinocytes (cell culture model) after CS exposure is driven by hydrogen peroxide (H2O2) that derives not only from the CS gas phase but mainly from the activation of cellular NADPH oxidase (NOX). This effect was reversed when the cells were pretreated with NOX inhibitors or catalase. Furthermore, CS caused the formation of SR-B1-aldheydes adducts (acrolein and 4-hydroxy-2-nonenal) and the increase of its ubiquitination, which could be one of the causes of SR-B1 loss. In conclusion, exposure to CS, through the production of H2O2, induced post-translational modifications of SR-B1 with the consequence lost of the receptor and this may contribute to the skin physiology alteration as a consequence of the variation of cholesterol uptake.	[Sticozzi, Claudia] Univ Trento, Dept Mech & Struct Engn, Trento, Italy; [Belmonte, Giuseppe] Univ Siena, Dept Biomed Sci, I-53100 Siena, Italy; [Pecorelli, Alessandra; Arezzini, Beatrice; Gardi, Concetta; Toscano, Marzia] Univ Siena, Dept Pathophysiol Expt Med & Publ Heath, I-53100 Siena, Italy; [Maioli, Emanuela] Univ Siena, Dept Physiol, I-53100 Siena, Italy; [Miracco, Clelia] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy; [Forman, Henry Jay] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Forman, Henry Jay] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Valacchi, Giuseppe] Univ Ferrara, Dept Evolutionary Biol, I-44100 Ferrara, Italy; [Valacchi, Giuseppe] Kyung Hee Univ, Dept Food & Nutr, Seoul, South Korea	University of Trento; University of Siena; University of Siena; University of Siena; University of Siena; University of Southern California; University of California System; University of California Merced; University of Ferrara; Kyung Hee University	Sticozzi, C (corresponding author), Univ Trento, Dept Mech & Struct Engn, Trento, Italy.	giuseppe.valacchi@unife.it		MAIOLI, Emanuela/0000-0002-0701-1445; Forman, Henry Jay/0000-0001-5838-2791	Flight Attendant Medical Research Institute (FAMRI) [VG062454CIA]; Italian Ministry for Education, University and Research	Flight Attendant Medical Research Institute (FAMRI); Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR))	The study was partially supported by Flight Attendant Medical Research Institute (FAMRI) [VG062454CIA] for the cigarette smoke chamber, Ministero dell'Universita e della Ricerca (MIUR) (VG "Programma Rientro Cervelli'') for the real time PCR, and by the Italian Ministry for Education, University and Research for the general management of the internationalization of scientific research as to concern the IHC antibodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Chamulitrat W, 2004, J INVEST DERMATOL, V122, P1000, DOI 10.1111/j.0022-202X.2004.22410.x; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Chodorowska Grazyna, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P535; Curtin GM, 2006, TOXICOL SCI, V89, P66, DOI 10.1093/toxsci/kfi343; Ducrocq C, 1999, CELL MOL LIFE SCI, V55, P1068, DOI 10.1007/s000180050357; Egawa M., 1999, International Journal of Cosmetic Science, V21, P83, DOI 10.1046/j.1467-2494.1999.181656.x; FEINGOLD KR, 1990, J CLIN INVEST, V86, P1738, DOI 10.1172/JCI114899; Finkelstein EI, 2005, AM J PHYSIOL-LUNG C, V289, pL1019, DOI 10.1152/ajplung.00227.2005; Forman HJ, 2007, FREE RADICAL BIO MED, V42, P926, DOI 10.1016/j.freeradbiomed.2007.01.011; Fortino V, 2007, TOXICOL LETT, V173, P73, DOI 10.1016/j.toxlet.2007.06.004; Ghadially R, 1996, J INVEST DERMATOL, V106, P1064, DOI 10.1111/1523-1747.ep12338692; Glick ZR, 2009, DERMATITIS, V20, P6, DOI 10.2310/6620.2008.08042; JACKSON SM, 1992, J LIPID RES, V33, P1307; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Li Li, 1998, Reviews on Environmental Health, V13, P99; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Longpre JM, 2008, FREE RADICAL RES, V42, P533, DOI 10.1080/10715760802126692; Mardones P, 2002, J NUTR, V132, P443, DOI 10.1093/jn/132.3.443; Mendez-Alvarez E, 1998, J APPL TOXICOL, V18, P443, DOI 10.1002/(SICI)1099-1263(199811/12)18:6<443::AID-JAT530>3.3.CO;2-G; MENON GK, 1985, J LIPID RES, V26, P418; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Morita A, 2007, J DERMATOL SCI, V48, P169, DOI 10.1016/j.jdermsci.2007.06.015; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; NAKAYAMA T, 1989, FREE RADICAL BIO MED, V7, P9, DOI 10.1016/0891-5849(89)90094-4; Nam HJ, 2010, EXP MOL MED, V42, P270, DOI 10.3858/emm.2010.42.4.026; Parathath S, 2004, J BIOL CHEM, V279, P41310, DOI 10.1074/jbc.M404952200; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; PEVERI P, 1992, P NATL ACAD SCI USA, V89, P2494, DOI 10.1073/pnas.89.6.2494; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; Ravid T, 2002, J BIOL CHEM, V277, P31214, DOI 10.1074/jbc.M204677200; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Schafer G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008448; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; SCHURER NY, 1991, ADV LIPID RES, V24, P27; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Smith CJ, 2006, FOOD CHEM TOXICOL, V44, P1699, DOI 10.1016/j.fct.2006.05.008; SPENCER JPE, 1995, FEBS LETT, V375, P179, DOI 10.1016/0014-5793(95)01199-O; Sticozzi C, 2010, INT J MOL SCI, V11, P3375, DOI 10.3390/ijms11093375; Tanaka N, 2001, ARCH DERMATOL RES, V293, P363, DOI 10.1007/s004030100239; Tomilov AA, 2010, J BIOL CHEM, V285, P1153, DOI 10.1074/jbc.M109.017491; Tsuruoka H, 2002, J BIOL CHEM, V277, P2916, DOI 10.1074/jbc.M106445200; Valacchi G, 2000, FEBS LETT, V466, P165, DOI 10.1016/S0014-5793(99)01787-1; Valacchi G, 2001, TOXICOLOGY, V165, P225, DOI 10.1016/S0300-483X(01)00430-9; Valacchi G, 2007, TOXICOL APPL PHARM, V222, P227, DOI 10.1016/j.taap.2007.04.010; Valacchi G, 2011, ANN NY ACAD SCI, V1229, pE1, DOI 10.1111/j.1749-6632.2011.06205.x; Valacchi G, 2011, INT J BIOCHEM CELL B, V43, P1065, DOI 10.1016/j.biocel.2009.05.014; van der Toorn M, 2009, AM J PHYSIOL-LUNG C, V297, pL109, DOI 10.1152/ajplung.90461.2008; Vecchio D, 2010, AM J PHYSIOL-LUNG C, V298, pL704, DOI 10.1152/ajplung.00013.2009; Weiner D, 2009, J PHYSIOL PHARMACOL, V60, P127; Wu SL, 2008, MOL IMMUNOL, V45, P2288, DOI 10.1016/j.molimm.2007.11.019; Yao H, 2007, BIOCHEM SOC T, V35, P1151, DOI 10.1042/BST0351151; Ye J, 2002, EXP DERMATOL, V11, P209, DOI 10.1034/j.1600-0625.2002.110303.x; Yun MR, 2010, FREE RADICAL RES, V44, P742, DOI 10.3109/10715761003758122; Zhu PM, 2009, J BIOL CHEM, V284, P22878, DOI 10.1074/jbc.M109.018580	58	69	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33592	10.1371/journal.pone.0033592	http://dx.doi.org/10.1371/journal.pone.0033592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442701	Green Submitted, Green Published, gold			2022-12-27	WOS:000303836500042
J	Casso, DJ; Liu, SM; Biehs, B; Kornberg, TB				Casso, David J.; Liu, Songmei; Biehs, Brian; Kornberg, Thomas B.			Expression and Characterization of Drosophila Signal Peptide Peptidase-Like (sppL), a Gene That Encodes an Intramembrane Protease	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ENDOPLASMIC-RETICULUM; INTRACELLULAR DOMAIN; PRESENILIN HOMOLOGS; LARVAL DEVELOPMENT; ASPARTIC PROTEASE; TNF-ALPHA; IDENTIFICATION; MELANOGASTER; PROTEOLYSIS	Intramembrane proteases of the Signal Peptide Peptidase (SPP) family play important roles in developmental, metabolic and signaling pathways. Although vertebrates have one SPP and four SPP-like (SPPL) genes, we found that insect genomes encode one Spp and one SppL. Characterization of the Drosophila sppL gene revealed that the predicted SppL protein is a highly conserved structural homolog of the vertebrate SPPL3 proteases, with a predicted nine-transmembrane topology, an active site containing aspartyl residues within a transmembrane region, and a carboxy-terminal PAL domain. SppL protein localized to both the Golgi and ER. Whereas spp is an essential gene that is required during early larval stages and whereas spp loss-of-function reduced the unfolded protein response (UPR), sppL loss of function had no apparent phenotype. This was unexpected given that genetic knockdown phenotypes in other organisms suggested significant roles for Spp-related proteases.	[Casso, David J.; Biehs, Brian; Kornberg, Thomas B.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Liu, Songmei; Kornberg, Thomas B.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Casso, DJ (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	tkornberg@ucsf.edu			National Institutes of Health [GM077407]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by National Institutes of Health grant #GM077407. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amarneh B, 2009, J BIOL CHEM; Ashburner M, 1989, DROSOPHILA LABORATOR, P44; Biehs B, 1998, DEVELOPMENT, V125, P4245; BRAND AH, 1993, DEVELOPMENT, V118, P401; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Chan YM, 1999, NEURON, V23, P201, DOI 10.1016/S0896-6273(00)80771-0; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; Han SW, 2009, PLANT PHYSIOL, V149, P1289, DOI 10.1104/pp.108.130252; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; Kilic A, 2010, EUR J CELL BIOL, V89, P449, DOI 10.1016/j.ejcb.2010.02.001; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Matthews KA, 2009, GENETICS, V181, P119, DOI 10.1534/genetics.108.093450; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Oh SW, 2003, GENETICS, V163, P195; Paaby AB, 2009, FLY, V3, P29, DOI 10.4161/fly.3.1.7771; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pethica R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008934; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Slack C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000881; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Spencer CC, 2003, AGING CELL, V2, P123, DOI 10.1046/j.1474-9728.2003.00044.x; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33827	10.1371/journal.pone.0033827	http://dx.doi.org/10.1371/journal.pone.0033827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439002	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100102
J	Falkenberg, LJ; Russell, BD; Connell, SD				Falkenberg, Laura J.; Russell, Bayden D.; Connell, Sean D.			Stability of Strong Species Interactions Resist the Synergistic Effects of Local and Global Pollution in Kelp Forests	PLOS ONE			English	Article							TURF-FORMING ALGAE; SUBTIDAL HABITAT; OCEAN ACIDIFICATION; CLIMATE-CHANGE; CARBONIC-ACID; LOWERED PH; NUTRIENT; MARINE; CO2; ORGANISMS	Foundation species, such as kelp, exert disproportionately strong community effects and persist, in part, by dominating taxa that inhibit their regeneration. Human activities which benefit their competitors, however, may reduce stability of communities, increasing the probability of phase-shifts. We tested whether a foundation species (kelp) would continue to inhibit a key competitor (turf-forming algae) under moderately increased local (nutrient) and near-future forecasted global pollution (CO2). Our results reveal that in the absence of kelp, local and global pollutants combined to cause the greatest cover and mass of turfs, a synergistic response whereby turfs increased more than would be predicted by adding the independent effects of treatments (kelp absence, elevated nutrients, forecasted CO2). The positive effects of nutrient and CO2 enrichment on turfs were, however, inhibited by the presence of kelp, indicating the competitive effect of kelp was stronger than synergistic effects of moderate enrichment of local and global pollutants. Quantification of physicochemical parameters within experimental mesocosms suggests turf inhibition was likely due to an effect of kelp on physical (i.e. shading) rather than chemical conditions. Such results indicate that while forecasted climates may increase the probability of phase-shifts, maintenance of intact populations of foundation species could enable the continued strength of interactions and persistence of communities.	[Falkenberg, Laura J.; Russell, Bayden D.; Connell, Sean D.] Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA 5005, Australia	University of Adelaide	Falkenberg, LJ (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA 5005, Australia.	sean.connell@adelaide.edu.au	Russell, Bayden D./A-9942-2008; Russell, Bayden D./R-9325-2019; Falkenberg, Laura/AAC-3227-2020; Connell, Sean D/A-8874-2008	Russell, Bayden D./0000-0003-1282-9978; Russell, Bayden D./0000-0003-1282-9978; Falkenberg, Laura/0000-0002-5868-2310; Connell, Sean D/0000-0002-5350-6852	Australian Research Council; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	Funding for this research was provided by an Australian Research Council grant to Sean Connell and Bayden Russell and an Australian Postgraduate Award to Laura Falkenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 2001, BIOSCIENCE, V51, P735, DOI 10.1641/0006-3568(2001)051[0735:FPAGEC]2.0.CO;2; Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Allgeier JE, 2011, J APPL ECOL, V48, P96, DOI 10.1111/j.1365-2664.2010.01894.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Callaway RM., 2007, POSITIVE INTERACTION, P179, DOI [10.1007/978-1-4020-6224-7_4, DOI 10.1007/978-1-4020-6224-7_4]; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Connell SD, 2011, J EXP MAR BIOL ECOL, V400, P296, DOI 10.1016/j.jembe.2011.02.031; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Copertino M, 2005, PHYCOLOGIA, V44, P241, DOI 10.2216/0031-8884(2005)44[241:TPAPOT]2.0.CO;2; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Davidson EA, 2007, NATURE, V449, P1000, DOI 10.1038/4491000a; DAYTON PK, 1984, ECOL MONOGR, V54, P253, DOI 10.2307/1942498; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Drummond SP, 2005, MAR FRESHWATER RES, V56, P865, DOI 10.1071/MF04270; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Eriksson BK, 2002, J PHYCOL, V38, P284, DOI 10.1046/j.1529-8817.2002.00170.x; Gattuso JP, 2000, NATURE, V407, P311, DOI 10.1038/35030280; Gorgula SK, 2004, MAR BIOL, V145, P613, DOI 10.1007/s00227-004-1335-5; Gorman D, 2009, J APPL ECOL, V46, P1258, DOI 10.1111/j.1365-2664.2009.01711.x; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Graham MH, 2001, OIKOS, V93, P505, DOI 10.1034/j.1600-0706.2001.930317.x; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; HARRISON GW, 1979, AM NAT, V113, P659, DOI 10.1086/283424; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; KENNELLY SJ, 1987, J EXP MAR BIOL ECOL, V112, P49, DOI 10.1016/S0022-0981(87)80014-X; KENNELLY SJ, 1989, MAR ECOL PROG SER, V50, P215, DOI 10.3354/meps050215; Liebig J., 1842, ANIMAL CHEM ORGANIC; Marubini F, 1999, MAR ECOL PROG SER, V188, P117, DOI 10.3354/meps188117; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; PAINE RT, 1980, J ANIM ECOL, V49, P667; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pierrot D., 2006, ORNLCDIAC105A US DEP; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; REED DC, 1984, ECOLOGY, V65, P937, DOI 10.2307/1938066; Roleda MY, 2012, GLOBAL CHANGE BIOL, V18, P854, DOI 10.1111/j.1365-2486.2011.02594.x; Russell BD, 2007, MAR FRESHWATER RES, V58, P657, DOI 10.1071/MF06194; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Tait LW, 2011, MAR ECOL PROG SER, V421, P97, DOI 10.3354/meps08909; VAUGHAN GM, 1969, PSYCHOL BULL, V72, P204, DOI 10.1037/h0027878; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Worm B, 2000, INT REV HYDROBIOL, V85, P359; Zimmerman RC, 1997, PLANT PHYSIOL, V115, P599, DOI 10.1104/pp.115.2.599	56	44	44	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33841	10.1371/journal.pone.0033841	http://dx.doi.org/10.1371/journal.pone.0033841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439005	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100105
J	Leiser, OP; Charlson, ES; Gerken, H; Misra, R				Leiser, Owen P.; Charlson, Emily S.; Gerken, Henri; Misra, Rajeev			Reversal of the Delta degP Phenotypes by a Novel rpoE Allele of Escherichia coli	PLOS ONE			English	Article							ENVZ/OMPR 2-COMPONENT REGULON; ENVELOPE-STRESS-RESPONSE; OUTER-MEMBRANE PROTEINS; EXTRACYTOPLASMIC STRESS; CHAPERONE FUNCTION; SIGMA(E) REGULON; GENETIC-EVIDENCE; HIGH-TEMPERATURE; NULL PHENOTYPE; CELL-ENVELOPE	RseA sequesters RpoE (sigma(E)) to the inner membrane of Escherichia coli when envelope stress is low. Elevated envelope stress triggers RseA cleavage by the sequential action of two membrane proteases, DegS and RseP, releasing sigma(E) to activate an envelope stress reducing pathway. Revertants of a Delta degP Delta bamB strain, which fails to grow at 37 degrees C due to high envelope stress, harbored mutations in the rseA and rpoE genes. Null and missense rseA mutations constitutively hyper-activated the sigma(E) regulon and significantly reduced the major outer membrane protein (OMP) levels. In contrast, a novel rpoE allele, rpoE3, resulting from the partial duplication of the rpoE gene, increased sigma(E) levels greater than that seen in the rseA mutant background but did not reduce OMP levels. A sigma(E)-dependent RybB::LacZ construct showed only a weak activation of the sigma(E) pathway by rpoE3. Despite this, rpoE3 fully reversed the growth and envelope vesiculation phenotypes of Delta degP. Interestingly, rpoE3 also brought down the modestly activated Cpx envelope stress pathway in the Delta degP strain to the wild type level, showing the complementary nature of the sigma(E) and Cpx pathways. Through employing a labile mutant periplasmic protein, AcrA(L222Q), it was determined that the rpoE3 mutation overcomes the Delta degP phenotypes, in part, by activating a sigma(E) dependent proteolytic pathway. Our data suggest that a reduction in the OMP levels is not intrinsic to the sigma(E)-mediated mechanism of lowering envelope stress. They also suggest that under extreme envelope stress, a tight homeostasis loop between RseA and sigma(E) may partly be responsible for cell death, and this loop can be broken by mutations that either lower RseA activity or increase sigma(E) levels.	[Leiser, Owen P.] No Arizona Univ, Microbial Genet & Genom Ctr, Flagstaff, AZ 86011 USA; [Charlson, Emily S.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Gerken, Henri; Misra, Rajeev] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Northern Arizona University; University of Pennsylvania; Arizona State University; Arizona State University-Tempe	Leiser, OP (corresponding author), No Arizona Univ, Microbial Genet & Genom Ctr, Flagstaff, AZ 86011 USA.	rajeev.misra@asu.edu	Leiser, Owen/ABA-8089-2021	Leiser, Owen/0000-0003-1190-5596	National Institutes of Health [GM048167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM048167, R01GM048167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health; GM048167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; BAIRD L, 1991, J BACTERIOL, V173, P5763, DOI 10.1128/jb.173.18.5763-5770.1991; BAIRD L, 1990, J BACTERIOL, V172, P1587, DOI 10.1128/jb.172.3.1587-1594.1990; Bennion D, 2010, MOL MICROBIOL, V77, P1153, DOI 10.1111/j.1365-2958.2010.07280.x; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CastilloKeller M, 2003, J BACTERIOL, V185, P148, DOI 10.1128/JB.185.1.148-154.2003; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Connolly L, 1997, GENE DEV, V11, P2012, DOI 10.1101/gad.11.15.2012; Costanzo A, 2008, MOL MICROBIOL, V67, P619, DOI 10.1111/j.1365-2958.2007.06072.x; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Danese PN, 1997, GENE DEV, V11, P1183, DOI 10.1101/gad.11.9.1183; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; Fontaine F, 2008, MOL MICROBIOL, V67, P2, DOI 10.1111/j.1365-2958.2007.05988.x; Gerken H, 2004, MOL MICROBIOL, V54, P620, DOI 10.1111/j.1365-2958.2004.04301.x; Gerken H, 2010, J BACTERIOL, V192, P6271, DOI 10.1128/JB.00855-10; Gerken H, 2010, MOL MICROBIOL, V75, P1033, DOI 10.1111/j.1365-2958.2009.07042.x; Gerken H, 2009, MOL MICROBIOL, V72, P1408, DOI 10.1111/j.1365-2958.2009.06728.x; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; KIINO DR, 1984, J BACTERIOL, V158, P878, DOI 10.1128/JB.158.3.878-883.1984; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; MILLER JH, 1992, SHORT COURSE BACTERI, P71; Misra R, 2000, J BACTERIOL, V182, P4882, DOI 10.1128/JB.182.17.4882-4888.2000; MISRA R, 1991, J BIOL CHEM, V266, P13592; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Silhavy T.J., 1984, EXPT GENE FUSIONS; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; Strozen TG, 2005, J BACTERIOL, V187, P6309, DOI 10.1128/JB.187.18.6309-6316.2005; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Waller PRH, 1996, J BACTERIOL, V178, P1146, DOI 10.1128/jb.178.4.1146-1153.1996; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	52	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33979	10.1371/journal.pone.0033979	http://dx.doi.org/10.1371/journal.pone.0033979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439016	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100116
J	Krakower, DS; Mimiaga, MJ; Rosenberger, JG; Novak, DS; Mitty, JA; White, JM; Mayer, KH				Krakower, Douglas S.; Mimiaga, Matthew J.; Rosenberger, Joshua G.; Novak, David S.; Mitty, Jennifer A.; White, Jaclyn M.; Mayer, Kenneth H.			Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site	PLOS ONE			English	Article							RISK BEHAVIOR; PARTNER NOTIFICATION; CAGE QUESTIONNAIRE; UNITED-STATES; HIV RISK; GAY MEN; INFECTION; KNOWLEDGE; ACCEPTABILITY; SURVEILLANCE	Background: In 2010, the iPrEx trial demonstrated that oral antiretroviral pre-exposure prophylaxis (PrEP) reduced the risk of HIV acquisition among high-risk men who have sex with men (MSM). The impact of iPrEx on PrEP knowledge and actual use among at-risk MSM is unknown. Online surveys were conducted to assess PrEP awareness, interest and experience among at-risk MSM before and after iPrEx, and to determine demographic and behavioral factors associated with these measures. Methods and Findings: Cross-sectional, national, internet-based surveys were administered to U. S. based members of the most popular American MSM social networking site 2 months before (n=398) and 1 month after (n=4 558) publication of iPrEx results. Comparisons were made between these samples with regards to PrEP knowledge, interest, and experience. Data were collected on demographics, sexual risk, and experience with post-exposure prophylaxis (PEP). Regression analyses were performed to identify factors associated with PrEP awareness, interest, and experience post-iPrEx. Most participants were white, educated, and indicated high-risk sexual behaviors. Awareness of PrEP was limited pre-and post-iPrEx (13% vs. 19%), whereas interest levels after being provided with a description of PrEP remained high (76% vs. 79%). PrEP use remained uncommon (0.7% vs. 0.9%). PrEP use was associated with PEP awareness (OR 7.46; CI 1.52-36.6) and PEP experience (OR 34.2; CI 13.3-88.4). PrEP interest was associated with older age (OR 1.01; CI 1.00-1.02), unprotected anal intercourse with >= 1 male partner in the prior 3 months (OR 1.40; CI 1.10-1.77), and perceiving oneself at increased risk for HIV acquisition (OR 1.20; CI 1.13-1.27). Conclusions: Among MSM engaged in online networking, awareness of PrEP was limited 1 month after the iPrEx data were released. Utilization was low, although some MSM who reported high-risk behaviors were interested in using PrEP. Studies are needed to understand barriers to PrEP utilization by at-risk MSM.	[Krakower, Douglas S.; Mimiaga, Matthew J.; Mitty, Jennifer A.; Mayer, Kenneth H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Krakower, Douglas S.; Mitty, Jennifer A.; Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Mimiaga, Matthew J.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Mimiaga, Matthew J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rosenberger, Joshua G.] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA; [Novak, David S.] Online Buddies Inc, OLB Res Inst, Cambridge, MA USA; [Mimiaga, Matthew J.; Mitty, Jennifer A.; White, Jaclyn M.; Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; George Mason University; Fenway Health	Krakower, DS (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	dkrakowe@bidmc.harvard.edu	Hughto, Jaclyn White/GNH-6189-2022		Gilead Sciences; Harvard T32 post-doctoral HIV Clinical Research Fellowship [NIAID AI 007433]; National Institute of Mental Health (NIMH) [1R21MH095535-01]; OLB Research Institute; Harvard Center for AIDS Research [NIAID 5P30AI06354-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, T32AI007433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH095535] Funding Source: NIH RePORTER	Gilead Sciences(Gilead Sciences); Harvard T32 post-doctoral HIV Clinical Research Fellowship; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OLB Research Institute; Harvard Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded with project support from Gilead Sciences. Douglas Krakower received support from the Harvard T32 post-doctoral HIV Clinical Research Fellowship (NIAID AI 007433). Jennifer Mitty, Matthew Mimiaga, and Jackie White received support from the National Institute of Mental Health (NIMH 1R21MH095535-01). Joshua Rosenberger received support from The OLB Research Institute, Online Buddies Incorporated. Ken Mayer received support from the Harvard Center for AIDS Research (NIAID 5P30AI06354-08).	AAPOR, 2016, STAND DEF FIN DISP C; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Chiasson MA, 2006, J URBAN HEALTH, V83, P73, DOI 10.1007/s11524-005-9008-3; Coleman E, 2010, ARCH SEX BEHAV, V39, P1045, DOI 10.1007/s10508-009-9507-5; Dean AG, 2011, OPENEPI; Elford J, 2004, JAIDS-J ACQ IMM DEF, V35, P421, DOI 10.1097/00126334-200404010-00012; Elford J, 2001, AIDS, V15, P1409, DOI 10.1097/00002030-200107270-00010; Ellen JM, 2002, J ADOLESCENT HEALTH, V31, P26, DOI 10.1016/S1054-139X(01)00404-9; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Horvath KJ, 2008, AM J PUBLIC HEALTH, V98, P1059, DOI 10.2105/AJPH.2007.111070; Johnson CV, 2009, AM J PUBLIC HEALTH, V99, pS187, DOI 10.2105/AJPH.2007.127464; Jozkowski K, 2010, AIDS PATIENT CARE ST, V24, P465, DOI 10.1089/apc.2010.0082; Kellerman SE, 2006, JAIDS-J ACQ IMM DEF, V43, P376, DOI 10.1097/01.qai.0000234085.18914.d5; Khosropour CM, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1717; KNOWLTON R, 1994, J STUD ALCOHOL, V55, P692, DOI 10.15288/jsa.1994.55.692; Leibowitz AA, 2011, AM J PUBLIC HEALTH, V101, P982, DOI 10.2105/AJPH.2010.300066; Liau A, 2006, SEX TRANSM DIS, V33, P576, DOI 10.1097/01.olq.0000204710.35332.c5; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Mayer KH, 2008, JAIDS-J ACQ IMM DEF, V47, P494, DOI 10.1097/QAI.0b013e318162afcb; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Metzger DS, 2000, AM J EPIDEMIOL, V152, P99, DOI 10.1093/aje/152.2.99; Mimiaga MJ, 2008, AM J PUBLIC HEALTH, V98, P1009, DOI 10.2105/AJPH.2006.098467; Mimiaga MJ, 2008, SEX TRANSM DIS, V35, P111, DOI 10.1097/OLQ.0b013e3181573d84; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Myers GM, 2011, AIDS PATIENT CARE ST, V25, P63, DOI 10.1089/apc.2010.0222; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rosenberger JG, 2011, J SEX MED; Rosenberger JG, 2011, ARCH SEX BEHAV; Rosenberger JG, 2011, AIDS BEHAV, V15, pS88, DOI 10.1007/s10461-011-9897-y; Rosser BRS, 2008, AIDS CARE, V20, P588, DOI 10.1080/09540120701867156; Rosser BRS, 2011, AIDS BEHAV, V15, pS91, DOI 10.1007/s10461-011-9910-5; Rosser BRS, 2010, AIDS, V24, P2099, DOI 10.1097/QAD.0b013e32833c4ac7; Rosser BRS, 2009, AIDS BEHAV, V13, P488, DOI 10.1007/s10461-009-9524-3; Safren SA, 2009, PSYCHOL HEALTH MED, V14, P705, DOI 10.1080/13548500903334754; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Taylor BS, 2011, AIDS BEHAV; van de Vijver DAMC, 2010, CURR OPIN INFECT DIS, V23, P621, DOI 10.1097/QCO.0b013e32833ff1e6	44	193	193	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33119	10.1371/journal.pone.0033119	http://dx.doi.org/10.1371/journal.pone.0033119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948FM	22470438	gold, Green Submitted, Green Published			2022-12-27	WOS:000304489000015
J	Naicker, K; Wickham, M; Colman, I				Naicker, Kiyuri; Wickham, Maeve; Colman, Ian			Timing of First Exposure to Maternal Depression and Adolescent Emotional Disorder in a National Canadian Cohort	PLOS ONE			English	Article							INFANT-MOTHER ATTACHMENT; CHILDRENS MENTAL-HEALTH; POSTPARTUM DEPRESSION; POSTNATAL DEPRESSION; COGNITIVE-DEVELOPMENT; INSECURE ATTACHMENT; BEHAVIOR PROBLEMS; MAJOR DEPRESSION; SOCIAL RISK; SYMPTOMS	Objective: Correlations have been reported between behavioral and cognitive outcomes in adolescence and exposure to maternal depression during the first postpartum year, but the effects of timing of maternal depression during subsequent exposure periods have rarely been controlled for. This study aims to methodically investigate the importance of timing of initial exposure to maternal depression with respect to adolescent mental health outcomes. Methods: This study used data on 937 children from the National Longitudinal Study of Children and Youth (NLSCY), a nationally-representative longitudinal survey established in 1994 by Statistics Canada. Ordinal logistic regression was used to confirm associations between adolescent emotional disorder (at 12-13 years) and initial exposure to maternal depression during 2-year intervals from birth to adolescence. Following their initial exposure to maternal depression, children were dropped from subsequent cycles. Stressful life events, chronic health conditions, maternal alcohol use, maternal marital status, gender, and SES were included as covariates. Results: The results indicated that adolescents who were initially exposed to maternal depression between the ages of 2-3 years and 4-5 years had a two-fold increase in odds of emotional disorder. No increase in odds was observed in those initially exposed during the first postpartum year or later in childhood. Conclusions: The results demonstrate that a sensitive period of initial exposure to maternal depression may occur between the ages of 2 and 5, and not during the first year of life indicated by previous research. These findings are congruent with the literature on emotional and behavioral development in early childhood.	[Naicker, Kiyuri; Wickham, Maeve; Colman, Ian] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Colman, Ian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Alberta; University of Ottawa	Naicker, K (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	icolman@uottawa.ca		Colman, Ian/0000-0001-5924-0277	SickKids Foundation; Canadian Institutes of Health Research [SKF 116328]; Canada Research Chairs program	SickKids Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This research was supported by a grant from the SickKids Foundation and the Canadian Institutes of Health Research (grant number SKF 116328; www.sickkidsfoundation.com). This research was undertaken, in part, thanks to funding from the Canada Research Chairs program (www.chairs-chaires.gc.ca) for IC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERN L, 1993, DEV PSYCHOPATHOL, V5, P371, DOI 10.1017/S0954579400004478; Beck CT, 1998, ARCH PSYCHIAT NURS, V12, P12, DOI 10.1016/S0883-9417(98)80004-6; BENNETT DS, 1994, J PEDIATR PSYCHOL, V19, P149, DOI 10.1093/jpepsy/19.2.149; BOWLBY J, 1958, INT J PSYCHOANAL, V39, P350; Bowlby J., 1980, LOSS SADNESS DEPRESS, V3; BOYLE MH, 1993, CAN J PSYCHIAT, V38, P397, DOI 10.1177/070674379303800605; Brennan PA, 2000, DEV PSYCHOL, V36, P759, DOI 10.1037/0012-1649.36.6.759; BRETHERTON I, 1992, DEV PSYCHOL, V28, P759, DOI 10.1037/0012-1649.28.5.759; Brown GW, 1997, PSYCHOL MED, V27, P21, DOI 10.1017/S0033291796004060; Campbell SB, 2009, J ABNORM PSYCHOL, V118, P479, DOI 10.1037/a0015923; CASSEM EH, 1995, PSYCHOSOMATICS, V36, pS2, DOI 10.1016/S0033-3182(95)71698-X; Cicchetti D, ORG APPROACH CHILDHO, P71; Colman I, 2007, BIOL PSYCHIAT, V62, P1265, DOI 10.1016/j.biopsych.2007.05.012; Dixit AR, 2000, AM J PSYCHIAT, V157, P751, DOI 10.1176/appi.ajp.157.5.751; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; Dunn J, PRETEND PLAY FAMILY, P149; Egeland B, 1996, DEV PSYCHOPATHOL, V8, P735, DOI 10.1017/S0954579400007392; Essex MJ, 2001, BRIT J PSYCHIAT, V179, P151, DOI 10.1192/bjp.179.2.151; Feldman R, 2004, CHILD DEV, V75, P1774, DOI 10.1111/j.1467-8624.2004.00816.x; FERGUSSON DM, 1995, J CHILD PSYCHOL PSYC, V36, P1161, DOI 10.1111/j.1469-7610.1995.tb01363.x; Field T, 1998, PREV MED, V27, P200, DOI 10.1006/pmed.1998.0293; Fihrer I, 2009, J AFFECT DISORDERS, V119, P116, DOI 10.1016/j.jad.2009.03.001; Franz CE, 2011, AM J GERIAT PSYCHIAT, V19, P559, DOI 10.1097/JGP.0b013e3181ef79f1; Garber J, 2010, DEV PSYCHOPATHOL, V22, P819, DOI 10.1017/S0954579410000489; Gelfand DM, 1996, J CLIN CHILD PSYCHOL, V25, P406, DOI 10.1207/s15374424jccp2504_6; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Grace SL, 2003, ARCH WOMEN MENT HLTH, V6, P9; GROSS D, 1995, NURS RES, V44, P96; Halligan SL, 2004, BIOL PSYCHIAT, V55, P376, DOI 10.1016/j.biopsych.2003.09.013; Hatch SL, 2007, SOC SCI MED, V64, P2285, DOI 10.1016/j.socscimed.2007.02.027; Hay DF, 2008, J CHILD PSYCHOL PSYC, V49, P1079, DOI 10.1111/j.1469-7610.2008.01959.x; Human Resources and Skills Development and Statistics Canada, 2007, NAT LONG SURV CHILDR; Human Resources and Skills Development and Statistics Canada, 1998, NAT LONG SURV CHILDR; Human Resources and Skills Development Canada and Statistics Canada, 1996, GROW CAN NAT LONG SU; Judd LL, 2000, PHARMACOPSYCHIATRY, V33, P3, DOI 10.1055/s-2000-7967; Karrass J, 2005, J APPL DEV PSYCHOL, V26, P133, DOI 10.1016/j.appdev.2004.12.003; Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6; Kovacs M, 1997, ARCH GEN PSYCHIAT, V54, P613; Kurstjens S, 2001, J CHILD PSYCHOL PSYC, V42, P623, DOI 10.1017/S0021963001007296; LEHTINEN V, 1994, ACTA PSYCHIAT SCAND, V89, P7, DOI 10.1111/j.1600-0447.1994.tb05794.x; LYONSRUTH K, 1990, CHILD DEV, V61, P85, DOI 10.2307/1131049; Mancini AD, 2009, J CLIN PSYCHOL, V65, P1127, DOI 10.1002/jclp.20601; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; Murray L, 1999, J CHILD PSYCHOL PSYC, V40, P1259, DOI 10.1111/1469-7610.00542; Murray L, 1996, INT REV PSYCHIATR, V8, P55, DOI 10.3109/09540269609037817; RADKEYARROW M, 1985, CHILD DEV, V56, P884, DOI 10.2307/1130100; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Righetti-Veltema M, 2002, J AFFECT DISORDERS, V70, P291, DOI 10.1016/S0165-0327(01)00367-6; Rosenstein DS, 1996, J CONSULT CLIN PSYCH, V64, P244, DOI 10.1037/0022-006X.64.2.244; SEPPA K, 1993, ADDICTION, V88, P1377, DOI 10.1111/j.1360-0443.1993.tb02024.x; Sharp D, 1995, J CHILD PSYCHOL PSYC, V36, P1315, DOI 10.1111/j.1469-7610.1995.tb01666.x; Somers MA, 2002, VULNERABLE CHILDREN, P211; Sroufe LA, 1999, DEV PSYCHOPATHOL, V11, P1, DOI 10.1017/S0954579499001923; Sroufe LA., 2003, ANN PROGR CHILD PSYC, V2000-2001, P43; Sund AM, 2002, J AM ACAD CHILD PSY, V41, P1478, DOI 10.1097/00004583-200212000-00020; To T, 2004, ARCH PEDIAT ADOL MED, V158, P643, DOI 10.1001/archpedi.158.7.643; Troisi A, 2001, J NERV MENT DIS, V189, P311, DOI 10.1097/00005053-200105000-00007; van Doesum KTM, 2008, CHILD DEV, V79, P547, DOI 10.1111/j.1467-8624.2008.01142.x; VAUGHN B, 1979, CHILD DEV, V50, P971, DOI 10.2307/1129321; Wade TJ, 2002, J AM ACAD CHILD PSY, V41, P190, DOI 10.1097/00004583-200202000-00013; Waters E, 2000, CHILD DEV, V71, P684, DOI 10.1111/1467-8624.00176; Weissman MM, 2006, AM J PSYCHIAT, V163, P1001, DOI 10.1176/appi.ajp.163.6.1001; Williamson DE, 2004, J AM ACAD CHILD PSY, V43, P291, DOI 10.1097/00004583-200403000-00010; WRATE RM, 1985, BRIT J PSYCHIAT, V146, P622, DOI 10.1192/bjp.146.6.622; Zammit S, 2004, ARCH GEN PSYCHIAT, V61, P354, DOI 10.1001/archpsyc.61.4.354	65	40	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e33422	10.1371/journal.pone.0033422	http://dx.doi.org/10.1371/journal.pone.0033422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943KB	22461893	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900012
J	Song, YX; Gao, P; Wang, ZN; Liang, JW; Sun, Z; Wang, MX; Dong, YL; Wang, XF; Xu, HM				Song, Yong-Xi; Gao, Peng; Wang, Zhen-Ning; Liang, Ji-Wang; Sun, Zhe; Wang, Mei-Xian; Dong, Yu-Lan; Wang, Xin-Fang; Xu, Hui-Mian			Can the Tumor Deposits Be Counted as Metastatic Lymph Nodes in the UICC TNM Staging System for Colorectal Cancer?	PLOS ONE			English	Article							RECTAL-CANCER; SURVIVAL; MARKERS; SPREAD; ISSUES; IMPACT	Objective: The 7th edition of AJCC staging manual implicitly states that only T1 and T2 lesions that lack regional lymph node metastasis but have tumor deposit(s) will be classified in addition as N1c, though it is not consistent in that pN1c is also an option for pT3/T4a tumors in the staging table. Nevertheless, in this TNM classification, how to classify tumor deposits (TDs) in colorectal cancer patients with lymph node metastasis (LNM) and TDs simultaneously is still not clear. The aim of this study is to investigate the possibility of counting TDs as metastatic lymph nodes in TNM classification and to indentify its prognostic value for colorectal cancer patients. Methods and Results: In this retrospective study, 513 cases of colorectal cancer with LNM were reviewed. We proposed a novel pN (npN) category in which TDs were counted as metastatic lymph nodes in the TNM classification. Cancer-specific survival according to the npN or pN category was analyzed using Kaplan-Meier survival curves. Univariate and multivariate analyses were performed to indentify significant prognostic factors. Harrell's C statistic was used to test the predictive capacity of the prognostic models. The results revealed that the TD was a significant prognostic factor in colorectal cancer. Univariate and multivariate analyses uniformly indicated that the npN category was significantly correlated with prognosis. The results of Harrell's C statistical analysis demonstrated that the npN category exhibited a superior predictive capacity compared to the pN category of the 7th edition TNM classification. Moreover, we also found no significant prognostic differences in patients with or without TD in the same npN categories. Conclusions: The counting of TDs as metastatic lymph nodes in the TNM classification system is potentially superior to the classification in the 7th edition of the TNM staging system to assess prognosis and survival for colorectal cancer patients.	[Song, Yong-Xi; Gao, Peng; Wang, Zhen-Ning; Liang, Ji-Wang; Sun, Zhe; Xu, Hui-Mian] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Wang, Mei-Xian; Dong, Yu-Lan; Wang, Xin-Fang] China Med Univ, Hosp 1, Dept Tumor Pathol & Surg Oncol, Shenyang, Peoples R China	China Medical University; China Medical University	Wang, ZN (corresponding author), China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China.	josieon826@yahoo.com.cn	wang, zhen ning/E-1878-2011; Gao, Peng/B-8031-2013	wang, zhen ning/0000-0003-0557-3097; 	National Science Foundation of China [30972879, 81172370]; Specialized Research Fund for the Doctoral Program of Higher Education [200801590006]; Natural Science Foundation of Liaoning Province [20092129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the National Science Foundation of China (No. 30972879 and No. 81172370), Specialized Research Fund for the Doctoral Program of Higher Education (No. 200801590006) and the Natural Science Foundation of Liaoning Province (No. 20092129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belt EJT, 2010, ANN SURG ONCOL, V17, P3203, DOI 10.1245/s10434-010-1152-7; Chok KSH, 2007, WORLD J SURG, V31, P1485, DOI 10.1007/s00268-007-9089-0; Compton CC, 2006, ARCH PATHOL LAB MED, V130, P318; Edge S, 2010, AJCC CANC STAGING HD; Gabriel WB, 1935, BRIT J SURG, V23, P395, DOI 10.1002/bjs.1800239017; Goldstein NS, 2000, CANCER-AM CANCER SOC, V88, P2228, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2228::AID-CNCR5>3.0.CO;2-1; Han Hong-qiu, 2006, Zhonghua Yi Xue Za Zhi, V86, P819; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kanehara &Co. LTD Tokyo, 1997, JAP SOC CANC COL REC; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Levin B, 2003, CA-CANCER J CLIN, V53, P44, DOI 10.3322/canjclin.53.1.44; Nagtegaal ID, 2007, HISTOPATHOLOGY, V51, P141, DOI 10.1111/j.1365-2559.2007.02720.x; Prabhudesai A, 2003, DIS COLON RECTUM, V46, P1531, DOI 10.1007/s10350-004-6809-5; Sobin, 2009, UICC TNM CLASSIFICAT; Sobin LH., 2010, TNM CLASSIFICATION M; Sun Z, 2009, ANN SURG, V249, P768, DOI 10.1097/SLA.0b013e3181a3df77; Tateishi S, 2005, SURG TODAY, V35, P377, DOI 10.1007/s00595-004-2950-y; Tong LL, 2012, ANN SURG, V255, P208, DOI 10.1097/SLA.0b013e31821ad8a2; Ueno H, 1997, SURG TODAY, V27, P617, DOI 10.1007/BF02388217; Ueno H, 2007, AM J CLIN PATHOL, V127, P287, DOI 10.1309/903UT10VQ3LC7B8L; Ueno H, 2011, J CLIN ONCOL, V29, P2550, DOI 10.1200/JCO.2010.33.7725; UICC, 2017, TNM CLASSIFICATION M; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019557	24	41	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34087	10.1371/journal.pone.0034087	http://dx.doi.org/10.1371/journal.pone.0034087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461900	Green Published, gold, Green Submitted			2022-12-27	WOS:000304118900018
J	Xiao, P; Li, RW; She, RP; Yin, J; Li, WG; Mao, JJ; Sun, Q				Xiao, Peng; Li, Ruiwen; She, Ruiping; Yin, Jun; Li, Wengui; Mao, Jingjing; Sun, Quan			Prevalence of Hepatitis E Virus in Swine Fed on Kitchen Residue	PLOS ONE			English	Article							BLOOD-DONORS; INFECTION; PIG; IDENTIFICATION; TRANSMISSION; ANTIBODIES; SEQUENCE; GENOME; CHINA; HEV	The aim of this study was to investigate the prevalence of swine hepatitis E virus (HEV) in pigs fed different feedstuffs (kitchen residue or mixed feeds) and genetic identification of HEV isolated in Hebei province, China. Serum and fecal samples were collected from adult swine. Anti-HEV antibody was evaluated by double sandwich antigen enzyme immunoassay. HEV RNA was extracted from fecal samples and amplified by nested RT-PCR. The reaction products were sequenced, and the sequence analyzed. Virus-like particles were distinguishable by negative staining in the electron microscope. Histopathological observation and immunohistochemical localization were used in the animal models. Overall, the anti-HEV positive percentage of serum samples from pigs fed on kitchen residue was 87.10% (27/31), and 53.06% (130/245) from pigs fed on complete feed. The HEV RNA positivity rate of fecal samples from pigs fed on kitchen residue was 61.54% (8/13), but zero for pigs fed on complete feed. Sequence analysis of these eight samples and comparison with the published sequence showed that there were eight groups that belonged to genotype 4 d and the nucleotide identity was 95.6-99.3%. swHE11 is most closely related to strain CCC220, and the other seven HEV isolates were most closely related to strains swGX40, SwCH189 and V0008ORF3, which are isolates from human and pigs. Histopathological observation showed that there was liver damage in the experimental group, and immunohistochemistry indicated that the HEV antigens were strongly positive at 7 days after infection. The results demonstrated that the prevalence of HEV in pigs fed on kitchen residue was higher than in those fed on complete feed (P < 0.05).	[Xiao, Peng; Li, Ruiwen; She, Ruiping; Yin, Jun; Mao, Jingjing; Sun, Quan] China Agr Univ, Coll Vet Med, Minist Agr, Dept Vet Pathol,Key Lab Zoonosis, Beijing 100094, Peoples R China; [Li, Ruiwen] Hebei Agr Univ, Coll Tradit Vet Med, Dingzhou, Peoples R China; [Li, Wengui] Yunnan Agr Univ, Coll Anim Sci, Kunminng, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Hebei Agricultural University; Yunnan Agricultural University	Xiao, P (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Dept Vet Pathol,Key Lab Zoonosis, Beijing 100094, Peoples R China.	sheruiping@126.com			National Natural Science Foundation of China [30871853, 31072110]; Innovative Research Teams in Chinese Universities [IRT0866]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Teams in Chinese Universities	This work was supported by the National Natural Science Foundation of China (Grant No. 30871853 and 31072110) and Innovative Research Teams in Chinese Universities (No. IRT0866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYE TT, 1992, NUCLEIC ACIDS RES, V20, P3512, DOI 10.1093/nar/20.13.3512; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Balayan MS, 1983, P NATL ACAD SCI USA, V106, P12992; Bouwknegt M, 2007, J FOOD PROTECT, V70, P2889, DOI 10.4315/0362-028X-70.12.2889; Caprioli A, 2007, VET REC, V161, P422, DOI 10.1136/vr.161.12.422; Cheng PN, 2007, J CLIN VIROL, V38, P44, DOI 10.1016/j.jcv.2006.09.003; Chobe LP, 2006, VET MICROBIOL, V114, P240, DOI 10.1016/j.vetmic.2005.12.007; Corwin AL, 1996, AM J TROP MED HYG, V54, P559, DOI 10.4269/ajtmh.1996.54.559; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2007, J GASTROEN HEPATOL, V22, P1236, DOI 10.1111/j.1440-1746.2007.04894.x; Emerson SU, 2004, NEW ENGL J MED, V351, P2367, DOI 10.1056/NEJMp048285; Emerson SU, 2004, J VIROL, V78, P4838, DOI 10.1128/JVI.78.9.4838-4846.2004; Feagins AR, 2007, J GEN VIROL, V88, P912, DOI 10.1099/vir.0.82613-0; HUANG RT, 1992, J GEN VIROL, V73, P1143, DOI 10.1099/0022-1317-73-5-1143; HYAMS KC, 1992, J MED VIROL, V37, P274, DOI 10.1002/jmv.1890370407; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Jameel S, 1996, J VIROL, V70, P207, DOI 10.1128/JVI.70.1.207-216.1996; Kumar RM, 2001, EUR J OBSTET GYN R B, V100, P9, DOI 10.1016/S0301-2115(01)00448-1; Li WG, 2009, VET MICROBIOL, V133, P75, DOI 10.1016/j.vetmic.2008.06.026; Lorenzo FR, 2007, J MED VIROL, V79, P1128, DOI 10.1002/jmv.20905; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mansuy JM, 2008, J MED VIROL, V80, P289, DOI 10.1002/jmv.21056; Mast EE, 1997, J INFECT DIS, V176, P34, DOI 10.1086/514037; Mateos ML, 1997, NEPHRON, V76, P231, DOI 10.1159/000190177; Meng J, 1997, J CLIN MICROBIOL, V35, P1373, DOI 10.1128/JCM.35.6.1373-1377.1997; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Mizuo H, 2002, J CLIN MICROBIOL, V40, P3209, DOI 10.1128/JCM.40.9.3209-3218.2002; Munne MS, 2006, J MED VIROL, V78, P1579, DOI 10.1002/jmv.20741; Ning HQ, 2007, VET MICROBIOL, V121, P125, DOI 10.1016/j.vetmic.2006.11.006; Purcell RH, 2000, LANCET, V355, P578, DOI 10.1016/S0140-6736(05)73231-1; Renou C, 2007, EMERG INFECT DIS, V13, P1094, DOI 10.3201/eid1307.070063; Shukla P, 2007, J VIRAL HEPATITIS, V14, P310, DOI 10.1111/j.1365-2893.2006.00815.x; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tei S, 2004, J MED VIROL, V74, P67, DOI 10.1002/jmv.20147; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Yazaki Y, 2003, J GEN VIROL, V84, P2351, DOI 10.1099/vir.0.19242-0; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997; Zhang G Q, 1993, Zhonghua Nei Ke Za Zhi, V32, P316	38	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33480	10.1371/journal.pone.0033480	http://dx.doi.org/10.1371/journal.pone.0033480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457765	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900012
J	Montesinos-Lopez, OA; Montesinos-Lopez, A; Crossa, J; Eskridge, K				Antonio Montesinos-Lopez, Osval; Montesinos-Lopez, Abelardo; Crossa, Jose; Eskridge, Kent			Sample Size under Inverse Negative Binomial Group Testing for Accuracy in Parameter Estimation	PLOS ONE			English	Article							CONFIDENCE-LIMITS; INFECTION-RATES; PREVALENCE; PROPORTION; MODELS	Background: The group testing method has been proposed for the detection and estimation of genetically modified plants (adventitious presence of unwanted transgenic plants, AP). For binary response variables (presence or absence), group testing is efficient when the prevalence is low, so that estimation, detection, and sample size methods have been developed under the binomial model. However, when the event is rare (low prevalence <0.1), and testing occurs sequentially, inverse (negative) binomial pooled sampling may be preferred. Methodology/Principal Findings: This research proposes three sample size procedures (two computational and one analytic) for estimating prevalence using group testing under inverse (negative) binomial sampling. These methods provide the required number of positive pools (r(m)), given a pool size (k), for estimating the proportion of AP plants using the Dorfman model and inverse (negative) binomial sampling. We give real and simulated examples to show how to apply these methods and the proposed sample-size formula. The Monte Carlo method was used to study the coverage and level of assurance achieved by the proposed sample sizes. An R program to create other scenarios is given in Appendix S2. Conclusions: The three methods ensure precision in the estimated proportion of AP because they guarantee that the width (W) of the confidence interval (CI) will be equal to, or narrower than, the desired width (v), with a probability of c. With the Monte Carlo study we found that the computational Wald procedure (method 2) produces the more precise sample size (with coverage and assurance levels very close to nominal values) and that the samples size based on the Clopper-Pearson CI (method 1) is conservative (overestimates the sample size); the analytic Wald sample size method we developed (method 3) sometimes underestimated the optimum number of pools.	[Antonio Montesinos-Lopez, Osval] Univ Colima, Fac Telemat, Colima, Colima, Mexico; [Montesinos-Lopez, Abelardo] Ctr Invest Matemat CIMAT, Dept Estadist, Guanajuato, Guanajuato, Mexico; [Crossa, Jose] Maize & Wheat Improvement Ctr CIMMYT, Biometr & Stat Unit, Mexico City, DF, Mexico; [Eskridge, Kent] Univ Nebraska, Dept Stat, Lincoln, NE USA	Universidad de Colima; CIMAT - Centro de Investigacion en Matematicas; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Nebraska System; University of Nebraska Lincoln	Montesinos-Lopez, OA (corresponding author), Univ Colima, Fac Telemat, Colima, Colima, Mexico.	oamontes1@ucol.mx; j.crossa@cgiar.org	Crossa, Jose/AAE-7898-2019	Crossa, Jose/0000-0001-9429-5855; Montesinos-Lopez, Osval Antonio/0000-0002-3973-6547				Montesinos-Lopez OA, 2011, SEED SCI RES, V21, P235, DOI 10.1017/S0960258511000055; BEAL SL, 1989, BIOMETRICS, V45, P969, DOI 10.2307/2531696; Bilder Christopher R, 2009, Chance (N Y), V22, P46; Casella G., 2002, STAT INFERENCE, V2nd; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Ebert TA, 2010, ANN ENTOMOL SOC AM, V103, P827, DOI 10.1603/AN09158; GEORGE VT, 1993, STAT MED, V12, P685, DOI 10.1002/sim.4780120707; HALDANE JBS, 1945, BIOMETRIKA, V33, P222, DOI 10.1093/biomet/33.3.222; Hernandez-Suarez CM, 2008, SEED SCI RES, V18, P77, DOI 10.1017/S0960258508975565; Katholi C., 2006, ESTIMATION PREVALENC; Katholi CR, 2006, AM J TROP MED HYG, V74, P779, DOI 10.4269/ajtmh.2006.74.779; Kelley K, 2003, PSYCHOL METHODS, V8, P305, DOI 10.1037/1082-989X.8.3.305; Kelley K, 2007, BEHAV RES METHODS, V39, P755, DOI 10.3758/BF03192966; Kelley K, 2011, PSYCHOL METHODS, V16, P391, DOI 10.1037/a0023352; LUI KJ, 1995, STAT MED, V14, P1471, DOI 10.1002/sim.4780141307; Lopez OAM, 2010, SEED SCI RES, V20, P123, DOI 10.1017/S096025851000005X; Pritchard NA, 2011, J AGR BIOL ENVIR ST, V16, P70, DOI 10.1007/s13253-010-0036-4; Pritchard NA, 2011, BIOMETRICAL J, V53, P40, DOI 10.1002/bimj.201000148; R Development Core Team, 2007, R LANG ENV STAT COMP; Remlinger KS, 2006, TECHNOMETRICS, V48, P133, DOI 10.1198/004017005000000481; SWALLOW WH, 1985, PHYTOPATHOLOGY, V75, P882, DOI 10.1094/Phyto-75-882; Tebbs JM, 2004, J AGR BIOL ENVIR ST, V9, P75, DOI 10.1198/1085711043127; Verstraeten T, 1998, TROP MED INT HEALTH, V3, P747; Wang HS, 2005, J BIOPHARM STAT, V15, P799, DOI 10.1081/BIP-200067789; Westreich DJ, 2008, J CLIN MICROBIOL, V46, P1785, DOI 10.1128/JCM.00787-07; WOLF JK, 1985, IEEE T INFORM THEORY, V31, P185, DOI 10.1109/TIT.1985.1057026; Yamamura K, 2007, COMMUN STAT-SIMUL C, V36, P949, DOI 10.1080/03610910701539278	28	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e32250	10.1371/journal.pone.0032250	http://dx.doi.org/10.1371/journal.pone.0032250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457714	Green Published, gold			2022-12-27	WOS:000303909200004
J	van Beveren, NJM; Krab, LC; Swagemakers, S; Buitendijk, G; Boot, E; van der Spek, P; Elgersma, Y; van Amelsvoort, TAMJ				van Beveren, Nico J. M.; Krab, Lianne C.; Swagemakers, Sigrid; Buitendijk, Gabriella; Boot, Erik; van der Spek, Peter; Elgersma, Ype; van Amelsvoort, Therese A. M. J.			Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; DIGEORGE-SYNDROME; PERIPHERAL-BLOOD; VELOCARDIOFACIAL SYNDROME; BIPOLAR DISORDER; OXIDATIVE STRESS; ADULTS; BRAIN; TBX1; ABNORMALITIES	22q11 Deletion Syndrome (22q11DS) is associated with dysmorphology and a high prevalence of schizophrenia-like symptoms. Several genes located on chromosome 22q11 have been linked to schizophrenia. The deletion is thought to disrupt the expression of multiple genes involved in maturation and development of neurons and neuronal circuits, and neurotransmission. We investigated whole-genome gene expression of Peripheral Blood Mononuclear Cells (PBMC's) of 8 22q11DS patients and 8 age- and gender-matched controls, to (1) investigate the expression levels of 22q11 genes and (2) to investigate whether 22q11 genes participate in functional genetic networks relevant to schizophrenia. Functional relationships between genes differentially expressed in patients (as identified by Locally Adaptive Statistical procedure (LAP) or satisfying p<0.05 and fold-change >1.5) were investigated with the Ingenuity Pathways Analysis (IPA). 14 samples (7 patients, 7 controls) passed quality controls. LAP identified 29 deregulated genes. Pathway analysis showed 262 transcripts differentially expressed between patients and controls. Functional pathways most disturbed were cell death, cell morphology, cellular assembly and organization, and cell-to-cell signaling. In addition, 10 canonical pathways were identified, among which the signal pathways for Natural Killer-cells, neurotrophin/Trk, neuregulin, axonal guidance, and Huntington's disease. Our findings support the use of 22q11DS as a research model for schizophrenia. We identified decreased expression of several genes (among which COMT, Ufd1L, PCQAP, and GNB1L) previously linked to schizophrenia as well as involvement of signaling pathways relevant to schizophrenia, of which Neurotrophin/Trk and neuregulin signaling seems to be especially notable.	[van Beveren, Nico J. M.] Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands; [van Beveren, Nico J. M.; Krab, Lianne C.; Buitendijk, Gabriella; Elgersma, Ype] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands; [Swagemakers, Sigrid; van der Spek, Peter] Erasmus Univ, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands; [van Amelsvoort, Therese A. M. J.] Mondriaan Mental Hlth Care, Heerlen, Netherlands; [van Amelsvoort, Therese A. M. J.] Maastricht Univ, Dept Psychiat & Psychol, Maastricht, Netherlands; [van Beveren, Nico J. M.] Delta Ctr Mental Hlth Care, Rotterdam, Netherlands; [van Amelsvoort, Therese A. M. J.] Virenze Mental Hlth Care, Gronsveld, Netherlands; [Boot, Erik] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	van Beveren, NJM (corresponding author), Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands.	j.m.vanbeveren@erasmusmc.nl	Elgersma, Ype/F-5164-2013; Boot, Erik/AAV-8592-2021	Elgersma, Ype/0000-0002-3758-1297; Boot, Erik/0000-0002-0593-1539	AstraZeneca Company	AstraZeneca Company(AstraZeneca)	Part of this study has been made possible by an unrestricted personal grant to NJMvB by AstraZeneca Company. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal VS, 2006, HUM MOL GENET, V15, P3219, DOI 10.1093/hmg/ddl399; Alves FD, 2011, SCHIZOPHR RES, V132, P75, DOI 10.1016/j.schres.2011.07.017; Baker K, 2011, NEUROIMAGE, V55, P491, DOI 10.1016/j.neuroimage.2010.12.041; Barnes A, 2012, NEUROIMAGE, V59, P2057, DOI 10.1016/j.neuroimage.2011.10.007; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; Callegaro A, 2006, BIOINFORMATICS, V22, P2658, DOI 10.1093/bioinformatics/btl455; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Duijff SN, 2012, BR J PSYCHI IN PRESS; Gennery AR, 2012, CELL MOL LIFE SCI, V69, P17, DOI 10.1007/s00018-011-0842-z; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Guo TW, 2011, HUM MUTAT, V32, P1278, DOI 10.1002/humu.21568; Hashimoto K, 2003, PSYCHIAT RES, V120, P211, DOI 10.1016/S0165-1781(03)00186-0; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Jawad AF, 2001, J PEDIATR-US, V139, P715, DOI 10.1067/mpd.2001.118534; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kanaya Y, 2006, CLIN EXP IMMUNOL, V144, P85, DOI 10.1111/j.1365-2249.2006.03038.x; Kasamatsu A, 2005, INT J BIOCHEM CELL B, V37, P1869, DOI 10.1016/j.biocel.2005.04.004; Klejbor I, 2006, J NEUROCHEM, V97, P1243, DOI 10.1111/j.1471-4159.2006.03754.x; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Konradi C, 2005, BRAIN RES REV, V50, P142, DOI 10.1016/j.brainresrev.2005.05.004; Kornfeld SJ, 2000, J ALLERGY CLIN IMMUN, V105, P983, DOI 10.1067/mai.2000.105527; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Maynard TM, 2003, P NATL ACAD SCI USA, V100, P14433, DOI 10.1073/pnas.2235651100; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; Meechan DW, 2007, GENE EXPRESSION, V13, P299; Meechan DW, 2006, MOL CELL NEUROSCI, V33, P412, DOI 10.1016/j.mcn.2006.09.001; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Mirnics K, 2006, BIOL PSYCHIAT, V60, P163, DOI 10.1016/j.biopsych.2006.02.003; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Prabakaran S, 2007, J PROTEOME RES, V6, P141, DOI 10.1021/pr060308a; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Shoval G, 2005, EUR NEUROPSYCHOPHARM, V15, P319, DOI 10.1016/j.euroneuro.2004.12.005; Sivagnanasundaram S, 2007, BRAIN RES, V1139, P48, DOI 10.1016/j.brainres.2007.01.014; Straub RE, 2006, BIOL PSYCHIAT, V60, P81, DOI 10.1016/j.biopsych.2006.06.002; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Amelsvoort T, 2001, BRIT J PSYCHIAT, V178, P412; van Amelsvoort T, 2004, ARCH GEN PSYCHIAT, V61, P1085, DOI 10.1001/archpsyc.61.11.1085; van Beveren NJM, 2006, EUR NEUROPSYCHOPHARM, V16, P469, DOI 10.1016/j.euroneuro.2006.02.001; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; Williams NM, 2008, HUM MOL GENET, V17, P555, DOI 10.1093/hmg/ddm330; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yovel G, 2000, BRAIN BEHAV IMMUN, V14, P153, DOI 10.1006/brbi.1999.0574	46	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33473	10.1371/journal.pone.0033473	http://dx.doi.org/10.1371/journal.pone.0033473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457764	Green Published, gold			2022-12-27	WOS:000303909200031
J	Davis, BB; Shen, YH; Tancredi, DJ; Flores, V; Davis, RP; Pinkerton, KE				Davis, Benjamin B.; Shen, Yi-Hsin; Tancredi, Daniel J.; Flores, Vanessa; Davis, Ryan P.; Pinkerton, Kent E.			Leukocytes Are Recruited through the Bronchial Circulation to the Lung in a Spontaneously Hypertensive Rat Model of COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NEUTROPHIL SEQUESTRATION; TOBACCO-SMOKE; AIRWAYS INFLAMMATION; MECHANISMS; RABBITS; INJURY; CD18; LOCALIZATION; INHIBITION	Chronic obstructive pulmonary disease (COPD) kills approximately 2.8 million people each year, and more than 80% of COPD cases can be attributed to smoking. Leukocytes recruited to the lung contribute to COPD pathology by releasing reactive oxygen metabolites and proteolytic enzymes. In this work, we investigated where leukocytes enter the lung in the early stages of COPD in order to better understand their effect as a contributor to the development of COPD. We simultaneously evaluated the parenchyma and airways for neutrophil accumulation, as well as increases in the adhesion molecules and chemokines that cause leukocyte recruitment in the early stages of tobacco smoke induced lung disease. We found neutrophil accumulation and increased expression of adhesion molecules and chemokines in the bronchial blood vessels that correlated with the accumulation of leukocytes recovered from the lung. The expression of adhesion molecules and chemokines in other vascular beds did not correlate with leukocytes recovered in bronchoalveolar lavage fluid (BALF). These data strongly suggest leukocytes are recruited in large measure through the bronchial circulation in response to tobacco smoke. Our findings have important implications for understanding the etiology of COPD and suggest that pharmaceuticals designed to reduce leukocyte recruitment through the bronchial circulation may be a potential therapy to treat COPD.	[Davis, Benjamin B.; Shen, Yi-Hsin; Tancredi, Daniel J.; Flores, Vanessa; Davis, Ryan P.; Pinkerton, Kent E.] Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA	University of California System; University of California Davis	Davis, BB (corresponding author), Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA.	bbdavis@ucdavis.edu	Tancredi, Daniel J/O-3381-2013	Tancredi, Daniel J/0000-0002-3884-7907	National Center for Research Resources (NCRR) [UL1 RR024146, R01 ES013932]; Tobacco-Related Disease Research Program (TRDRP) [18KT-0037, 18XT-0154]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013932] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Tobacco-Related Disease Research Program (TRDRP)(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grant support for this research is from the National Center for Research Resources (NCRR) UL1 RR024146, R01 ES013932, the Tobacco-Related Disease Research Program (TRDRP) 18KT-0037, and 18XT-0154. The contents of this publication are solely the responsibility of the authors and do not represent the official view of NIH, NCRR, or TRDRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Capelli A, 1999, EUR RESPIR J, V14, P160, DOI 10.1034/j.1399-3003.1999.14a27.x; Caramori G, 2002, EUR RESPIR J, V20, P556; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Davis BB, 2011, BIOCHEM BIOPH RES CO, V410, P494, DOI 10.1016/j.bbrc.2011.06.008; de Boer WI, 2000, J PATHOL, V190, P619, DOI 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6; Di Stefano A, 1994, AM J RESP CRIT CARE, P149; DOERSCHUK CM, 1990, J IMMUNOL, V144, P2327; DOERSCHUK CM, 1993, J APPL PHYSIOL, V74, P3040, DOI 10.1152/jappl.1993.74.6.3040; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; DOWNEY GP, 1993, AM REV RESPIR DIS, V147, P168, DOI 10.1164/ajrccm/147.1.168; Folkesson HG, 1997, J APPL PHYSIOL, V82, P1743, DOI 10.1152/jappl.1997.82.6.1743; FOLKESSON HG, 1995, J CLIN INVEST, V96, P107, DOI 10.1172/JCI118009; GOLDMAN G, 1995, SURGERY, V117, P83, DOI 10.1016/S0039-6060(05)80233-8; Good PI, 2004, STAT MED, V23, P857, DOI 10.1002/sim.1738; Hsin ShenYi-, THESIS; Jeffery PK, 2000, GF FILLEY LECT CHEST, V117, p251S; LIEN DC, 1987, J APPL PHYSIOL, V62, P1236, DOI 10.1152/jappl.1987.62.3.1236; Malik AB, 1996, PHARMACOL REV, V48, P213; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Ramamoorthy C, 1997, J LEUKOCYTE BIOL, V61, P167, DOI 10.1002/jlb.61.2.167; Samet JM, 2004, TOB CONTROL, V13, P57, DOI 10.1136/tc.2003.005454; Snider GL, 1996, PULMONARY CRITICAL C, P821; TEAGUE SV, 1994, INHAL TOXICOL, V6, P79, DOI 10.3109/08958379409029697; TURATO G, 1995, AM J RESP CRIT CARE, V152, P1262, DOI 10.1164/ajrccm.152.4.7551380; Wagner JG, 2000, PHARMACOL REV, V52, P349; Yu B, 2008, INHAL TOXICOL, V20, P623, DOI [10.1080/08958370701861538, 10.1080/08958370701861538 ]; Zhong CY, 2008, TOXICOL APPL PHARM, V230, P150, DOI 10.1016/j.taap.2008.02.005	30	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33304	10.1371/journal.pone.0033304	http://dx.doi.org/10.1371/journal.pone.0033304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457750	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100024
J	Song, QB; Zhu, BB; Hu, WG; Cheng, LM; Gong, HY; Xu, B; Zheng, XW; Zou, L; Zhong, R; Duan, SY; Chen, W; Rui, R; Wu, J; Miao, XP				Song, Qibin; Zhu, Beibei; Hu, Weiguo; Cheng, Liming; Gong, Hongyun; Xu, Bin; Zheng, Xiawen; Zou, Li; Zhong, Rong; Duan, Shengyu; Chen, Wei; Rui, Rui; Wu, Jing; Miao, Xiaoping			A Common SMAD7 Variant Is Associated with Risk of Colorectal Cancer: Evidence from a Case-Control Study and a Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; SCAN; ALLELES; 8Q24	Background: A common genetic variant, rs4939827, located in SMAD7, was identified by two recent genome-wide association (GWA) studies to be strongly associated with the risk of colorectal cancer (CRC). However, the following replication studies yielded conflicting results. Method and Findings: We conducted a case-control study of 641 cases and 1037 controls in a Chinese population and then performed a meta-analysis, integrating our and published data of 34313 cases and 33251 controls, to clarify the relationship between rs4939827 and CRC risk. In our case-control study, the dominant model was significant associated with increased CRC risk [Odds Ratio (OR) = 1.46; 95% confidence interval (95% CI), 1.19-1.80]. The following meta-analysis further confirmed this significant association for all genetic models but with significant between-study heterogeneity (all P for heterogeneity <0.1). By stratified analysis, we revealed that ethnicity, sample size, and tumor sites might constitute the source of heterogeneity. The cumulative analysis suggested that evident tendency to significant association was seen with adding study samples over time; whilst, sensitive analysis showed results before and after removal of each study were similar, indicating the highly stability of the current results. Conclusion: Results from our case-control study and the meta-analysis collectively confirmed the significant association of the variant rs4939827 with increased risk of colorectal cancer. Nevertheless, fine-mapping of the susceptibility loci defined by rs4939287 should be imposed to reveal causal variant.	[Song, Qibin; Zhu, Beibei; Hu, Weiguo; Gong, Hongyun; Xu, Bin] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan 430072, Peoples R China; [Zhu, Beibei; Zheng, Xiawen; Zou, Li; Zhong, Rong; Duan, Shengyu; Chen, Wei; Rui, Rui; Wu, Jing; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Zhu, Beibei; Zheng, Xiawen; Zou, Li; Zhong, Rong; Duan, Shengyu; Chen, Wei; Rui, Rui; Wu, Jing; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Cheng, Liming] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan 430074, Peoples R China	Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Song, QB (corresponding author), Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan 430072, Peoples R China.	miaoxp@mail.hust.edu.cn	Xiao, Hu/GMX-0258-2022; Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722	National Natural Science Foundation of China [NSFC-81001275, 81171878]; Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China [131038]; HUST [2011QN200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China; HUST	This work was supported by the National Natural Science Foundation of China NSFC-81001275 and 81171878 and the Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China (131038) to X.M. and the fundamental research funds for the central universities (HUST: NO. 2011QN200) to J.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cui R, 2011, GUT; Curtin K, 2009, CANCER EPIDEM BIOMAR, V18, P616, DOI 10.1158/1055-9965.EPI-08-0690; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Halder SK, 2008, BRIT J CANCER, V99, P957, DOI 10.1038/sj.bjc.6604562; He J, 2010, CANCER EPIDEM BIOMAR, V20, P70; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li X, 2011, MOL BIOL REPORTS; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Loh YH, 2010, CANC EPIDEMIOLOGY; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mates IN, 2010, CHIRURGIA-BUCHAREST, V105, P749; Mochizuki T, 2004, J BIOL CHEM, V279, P31568, DOI 10.1074/jbc.M313977200; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mullen B, 2001, PERS SOC PSYCHOL B, V27, P1450, DOI 10.1177/01461672012711006; Niittymaki I, 2010, CANCER EPIDEM BIOMAR, V19, P1478, DOI 10.1158/1055-9965.EPI-09-1320; Pabalan NA, 2010, ASIAN PAC J CANCER P, V11, P33; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Slattery ML, 2010, CANCER RES, V70, P1479, DOI 10.1158/0008-5472.CAN-08-1792; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thompson CL, 2009, CARCINOGENESIS, V30, P982, DOI 10.1093/carcin/bgp086; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	37	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33318	10.1371/journal.pone.0033318	http://dx.doi.org/10.1371/journal.pone.0033318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457752	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100028
J	Brugger, SD; Baumberger, C; Jost, M; Jenni, W; Brugger, U; Muhlemann, K				Brugger, Silvio D.; Baumberger, Christian; Jost, Marcel; Jenni, Werner; Brugger, Urs; Muehlemann, Kathrin			Automated Counting of Bacterial Colony Forming Units on Agar Plates	PLOS ONE			English	Article							PETRI DISHES; SWITZERLAND; ALGORITHM; DISTANCE; IMAGES	Manual counting of bacterial colony forming units (CFUs) on agar plates is laborious and error-prone. We therefore implemented a colony counting system with a novel segmentation algorithm to discriminate bacterial colonies from blood and other agar plates. A colony counter hardware was designed and a novel segmentation algorithm was written in MATLAB. In brief, pre-processing with Top-Hat-filtering to obtain a uniform background was followed by the segmentation step, during which the colony images were extracted from the blood agar and individual colonies were separated. A Bayes classifier was then applied to count the final number of bacterial colonies as some of the colonies could still be concatenated to form larger groups. To assess accuracy and performance of the colony counter, we tested automated colony counting of different agar plates with known CFU numbers of S. pneumoniae, P. aeruginosa and M. catarrhalis and showed excellent performance.	[Brugger, Silvio D.; Muehlemann, Kathrin] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Baumberger, Christian; Jost, Marcel; Jenni, Werner; Brugger, Urs] Bern Univ Appl Sci Engn & Informat, Burgdorf, Switzerland; [Muehlemann, Kathrin] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Brugger, SD (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	silvio.brugger@ifik.unibe.ch	Kummer, Juerg/B-3322-2011; Brugger, Silvio Daniel/AAY-7090-2020	Brugger, Silvio Daniel/0000-0001-9492-9088	Swiss National Science Foundation [320000-113912, 323500-119214]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (research grant 320000-113912 to KM and MD-PhD scholarship 323500-119214 to SDB, www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewes JM, 2008, PHYS MED BIOL, V53, P5991, DOI 10.1088/0031-9155/53/21/007; Biston MC, 2003, PHYS MED BIOL, V48, P1551, DOI 10.1088/0031-9155/48/11/305; Blodgett RJ, 2008, FOOD MICROBIOL, V25, P92, DOI 10.1016/j.fm.2007.07.006; Breed RS, 1916, J BACTERIOL, V1, P321, DOI 10.1128/JB.1.3.321-331.1916; Corkidi G, 1998, APPL ENVIRON MICROB, V64, P1400; Fisher R., ADAPTIVE THRESHOLDIN; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Kim KH, 2003, CLIN DIAGN LAB IMMUN, V10, P616, DOI 10.1128/CDLI.10.4.616-621.2003; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; Marotz J, 2001, COMPUT METH PROG BIO, V66, P183, DOI 10.1016/S0169-2607(00)00128-0; Maurer CR, 2003, IEEE T PATTERN ANAL, V25, P265, DOI 10.1109/TPAMI.2003.1177156; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Muhlemann K, 2003, J INFECT DIS, V187, P589, DOI 10.1086/367994; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Putman M, 2005, J IMMUNOL METHODS, V302, P99, DOI 10.1016/j.jim.2005.05.003; WILSON IG, 1995, APPL ENVIRON MICROB, V61, P3158, DOI 10.1128/AEM.61.8.3158-3160.1995	16	78	80	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33695	10.1371/journal.pone.0033695	http://dx.doi.org/10.1371/journal.pone.0033695			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448267	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700058
J	Chan, DD; Neu, CP				Chan, Deva D.; Neu, Corey P.			Transient and Microscale Deformations and Strains Measured under Exogenous Loading by Noninvasive Magnetic Resonance	PLOS ONE			English	Article							CARTILAGE DEFORMATION; ARTICULAR-CARTILAGE; DISPLACEMENT; MRI; SSFP; ECHOES	Characterization of spatiotemporal deformation dynamics and material properties requires non-destructive methods to visualize mechanics of materials and biological tissues. Displacement-encoded magnetic resonance imaging (MRI) has emerged as a noninvasive and non-destructive technique used to quantify deformation and strains. However, the techniques are not yet applicable to a broad range of materials and load-bearing tissues. In this paper, we visualize transient and internal material deformation through the novel synchrony of external mechanical loading with rapid displacement-encoded MRI. We achieved deformation measurements in silicone gel materials with a spatial resolution of 100 mm and a temporal resolution (of 2.25 ms), set by the repetition time (TR) of the rapid MRI acquisition. Displacement and strain precisions after smoothing were 11 mu m and 0.1%, respectively, approaching cellular length scales. Short (1/2 TR) echo times enabled visualization of in situ deformation in a human tibiofemoral joint, inclusive of multiple variable T-2 biomaterials. Moreover, the MRI acquisitions achieved a fivefold improvement in imaging time over previous technology, setting the stage for mechanical imaging in vivo. Our results provide a general approach for noninvasive and non-destructive measurement, at high spatial and temporal resolution, of the dynamic mechanical response of a broad range of load-bearing materials and biological tissues.	[Chan, Deva D.; Neu, Corey P.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chan, DD (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	cpneu@purdue.edu	Chan, Deva/F-1496-2010	Chan, Deva/0000-0003-1508-1045	NIH [S10 RR019920-01]; NSF CMMI [1100554]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019920] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CMMI(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this research was provided in part by NIH S10 RR019920-01 and NSF CMMI 1100554. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletras AH, 1999, J MAGN RESON, V137, P247, DOI 10.1006/jmre.1998.1676; Bangerter NK, 2004, MAGN RESON MED, V51, P1038, DOI 10.1002/mrm.20052; Chan DD, 2009, MAGN RESON MED, V61, P989, DOI 10.1002/mrm.21927; Elliott AM, 2007, MAGN RESON IMAGING, V25, P359, DOI 10.1016/j.mri.2006.09.013; Epstein FH, 2004, MAGN RESON MED, V52, P774, DOI 10.1002/mrm.20232; Geers MGD, 1996, INT J SOLIDS STRUCT, V33, P4293, DOI 10.1016/0020-7683(95)00240-5; Gilchrist CL, 2007, J BIOMECH, V40, P786, DOI 10.1016/j.jbiomech.2006.03.013; Lin AP, 2008, MAGN RESON MED, V60, P8, DOI 10.1002/mrm.21621; Martin KJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.2978986; Mosher TJ, 2004, SEMIN MUSCULOSKEL R, V8, P355, DOI 10.1055/s-2004-861764; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Neu CP, 2008, MAGN RESON MED, V59, P149, DOI 10.1002/mrm.21464; Neu CP, 2005, MAGNET RESON MED, V54, P1290, DOI 10.1002/mrm.20669; Neu CP, 2003, J BIOMECH ENG-T ASME, V125, P180, DOI 10.1115/1.1560141; Osman NF, 1999, MAGN RESON MED, V42, P1048, DOI 10.1002/(SICI)1522-2594(199912)42:6<1048::AID-MRM9>3.0.CO;2-M; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Wen H, 2006, J CARDIOVASC MAGN R, V8, P153	17	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33463	10.1371/journal.pone.0033463	http://dx.doi.org/10.1371/journal.pone.0033463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448245	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700035
J	Ledwaba, L; Tavel, JA; Khabo, P; Maja, P; Qin, J; Sangweni, P; Liu, X; Follmann, D; Metcalf, JA; Orsega, S; Baseler, B; Neaton, JD; Lane, HC				Ledwaba, Lotty; Tavel, Jorge A.; Khabo, Paul; Maja, Patrick; Qin, Jing; Sangweni, Phumele; Liu, Xiao; Follmann, Dean; Metcalf, Julia A.; Orsega, Susan; Baseler, Beth; Neaton, James D.; Lane, H. Clifford		Project Phidisa Biomarkers Team	Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; EARLY MORTALITY; AIDS; ADULTS; ERA; POPULATION; ACTIVATION; PROGNOSIS; SURVIVAL; TIME	Background: Levels of high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and D-dimer predict mortality in HIV patients on antiretroviral therapy (ART) with relatively preserved CD4+ T cell counts. We hypothesized that elevated pre-ART levels of these markers among patients with advanced HIV would be associated with an increased risk of death following the initiation of ART. Methods: Pre-ART plasma from patients with advanced HIV in South Africa was used to measure hsCRP, IL-6 and D-dimer. Using a nested case-control study design, the biomarkers were measured for 187 deaths and two controls matched on age, sex, clinical site, follow-up time and CD4+ cell counts. Odds ratios were estimated using conditional logistic regression. In addition, for a random sample of 100 patients, biomarkers were measured at baseline and 6 months following randomization to determine whether ART altered their levels. Results: Median baseline biomarkers levels for cases and controls, respectively, were 11.25 vs. 3.6 mg/L for hsCRP, 1.41 vs. 0.98 mg/L for D-dimer, and 9.02 vs. 4.20 pg/mL for IL-6 (all p<0.0001). Adjusted odds ratios for the highest versus lowest quartile of baseline biomarker levels were 3.5 (95% CI: 1.9-6.7) for hsCRP, 2.6 (95% CI 1.4-4.9) for D-dimer, and 3.8 (95% CI: 1.87.8) for IL-6. These associations were stronger for deaths that occurred more proximal to the biomarker measurements. Levels of D-dimer and IL-6, but not hsCRP, were significantly lower at month 6 after commencing ART compared to baseline (p<0.0001). Conclusions: Among patients with advanced HIV disease, elevated pre-ART levels of hsCRP, IL-6 and D-dimer are strongly associated with early mortality after commencing ART. Elevated levels of inflammatory and coagulation biomarkers may identify patients who may benefit from aggressive clinical monitoring after commencing ART. Further investigation of strategies to reduce biomarkers of inflammation and coagulation in patients with advanced HIV disease is warranted.	[Ledwaba, Lotty; Khabo, Paul; Maja, Patrick; Sangweni, Phumele] Project Phidisa, Pretoria, South Africa; [Tavel, Jorge A.; Qin, Jing; Liu, Xiao; Follmann, Dean; Metcalf, Julia A.; Orsega, Susan; Lane, H. Clifford] NIH, Bethesda, MD 20892 USA; [Baseler, Beth] Frederick Inc, Sci Applicat Int Corp, Frederick, MD USA; [Neaton, James D.] Univ Minnesota, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; Science Applications International Corporation (SAIC); University of Minnesota System; University of Minnesota Twin Cities	Ledwaba, L (corresponding author), Project Phidisa, Pretoria, South Africa.	lledwaba@phidisa.org	Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309	South African National Defence Force; United States National Institutes of Health; United States Department of Defense; SAIC-Frederick, Inc.; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000585] Funding Source: NIH RePORTER	South African National Defence Force; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); SAIC-Frederick, Inc.; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the Phidisa Project, the Phidisa I and II studies, and this substudy were provided by the South African National Defence Force, the United States National Institutes of Health and the United States Department of Defense. SAIC-Frederick, Inc. helped fund the study through the employment of Beth Basseler and Xiao Liu who contributed to the study. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; Clifford DB, 1999, NEUROLOGY, V52, P623, DOI 10.1212/WNL.52.3.623; Cohen HJ, 2003, AM J MED, V114, P180, DOI 10.1016/S0002-9343(02)01484-5; Correll PK, 1998, MED J AUSTRALIA, V169, P469, DOI 10.5694/j.1326-5377.1998.tb123370.x; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Gebhardt M, 1998, AIDS, V12, P1195, DOI 10.1097/00002030-199810000-00012; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Jong E, 2010, THROMB HAEMOSTASIS, V104, P1228, DOI 10.1160/TH10-04-0233; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lehohla PJ, 2009, MIDYEAR POPULATION E; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Michaels SH, 1998, NEW ENGL J MED, V339, P405, DOI 10.1056/NEJM199808063390612; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Morcroft A, 2009, P C RETR COINF SAN F; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Pezzotti P, 1999, AIDS; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Ratsela A, 2010, J INFECT DIS, V202, P1529, DOI 10.1086/656718; Sendi PP, 1999, J ACQ IMMUN DEF SYND, V20, P376, DOI 10.1097/00042560-199904010-00008; Shorr AF, 2002, CHEST, V121, P1262, DOI 10.1378/chest.121.4.1262; Spira R, 1998, J ACQ IMMUN DEF SYND, V18, P358, DOI 10.1097/00042560-199808010-00007; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Walsh JC, 1998, AIDS, V12, P613, DOI 10.1097/00002030-199806000-00010; World Health Organization, UN ACC 2010	32	71	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e24243	10.1371/journal.pone.0024243	http://dx.doi.org/10.1371/journal.pone.0024243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448211	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700001
J	Xie, J; Emenheiser, J; Kirby, M; Sreenivasan, S; Szymanski, BK; Korniss, G				Xie, Jierui; Emenheiser, Jeffrey; Kirby, Matthew; Sreenivasan, Sameet; Szymanski, Boleslaw K.; Korniss, Gyorgy			Evolution of Opinions on Social Networks in the Presence of Competing Committed Groups	PLOS ONE			English	Article								Public opinion is often affected by the presence of committed groups of individuals dedicated to competing points of view. Using a model of pairwise social influence, we study how the presence of such groups within social networks affects the outcome and the speed of evolution of the overall opinion on the network. Earlier work indicated that a single committed group within a dense social network can cause the entire network to quickly adopt the group's opinion (in times scaling logarithmically with the network size), so long as the committed group constitutes more than about 10% of the population (with the findings being qualitatively similar for sparse networks as well). Here we study the more general case of opinion evolution when two groups committed to distinct, competing opinions A and B, and constituting fractions p(A) and p(B) of the total population respectively, are present in the network. We show for stylized social networks (including Erdos-Renyi random graphs and Barabasi-Albert scale-free networks) that the phase diagram of this system in parameter space (p(A), p(B)) consists of two regions, one where two stable steady-states coexist, and the remaining where only a single stable steady-state exists. These two regions are separated by two fold-bifurcation (spinodal) lines which meet tangentially and terminate at a cusp (critical point). We provide further insights to the phase diagram and to the nature of the underlying phase transitions by investigating the model on infinite (mean-field limit), finite complete graphs and finite sparse networks. For the latter case, we also derive the scaling exponent associated with the exponential growth of switching times as a function of the distance from the critical point.	[Xie, Jierui; Sreenivasan, Sameet; Szymanski, Boleslaw K.] Rensselaer Polytechn Inst, Dept Comp Sci, Troy, NY USA; [Emenheiser, Jeffrey; Kirby, Matthew; Sreenivasan, Sameet; Korniss, Gyorgy] Rensselaer Polytechn Inst, Dept Phys Appl Phys & Astron, Troy, NY USA; [Xie, Jierui; Emenheiser, Jeffrey; Kirby, Matthew; Sreenivasan, Sameet; Szymanski, Boleslaw K.; Korniss, Gyorgy] Rensselaer Polytechn Inst, Social & Cognit Networks Acad Res Ctr, Troy, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Xie, J (corresponding author), Rensselaer Polytechn Inst, Dept Comp Sci, Troy, NY USA.	sreens@rpi.edu	Xie, Jierui/L-9068-2013; Szymanski, Boleslaw K/A-9121-2009; Szymanski, Boleslaw Karol/O-1374-2017; Korniss, Gyorgy/A-7360-2011	Szymanski, Boleslaw K/0000-0002-0307-6743; Szymanski, Boleslaw Karol/0000-0002-0307-6743; 	Army Research Laboratory [W911NF-09-2-0053]; Army Research Office [W911NF-09-1-0254]; Office of Naval Research [N00014-09-1-0607]	Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Army Research Office; Office of Naval Research(Office of Naval Research)	This work was supported in part by the Army Research Laboratory under Cooperative Agreement Number W911NF-09-2-0053, by the Army Research Office grant W911NF-09-1-0254 and by the Office of Naval Research Grant No. N00014-09-1-0607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arnold V.I., 1988, GEOMETRICAL METHODS, V2nd; Banerjee A, 2011, DIFFUSION MICROFINAN; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baronchelli A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051102; Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Biswas S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.027101; Blanco S, 2011, NY TIMES; Bollobas B., 2001, MODERN GRAPH THEORY; Bunkley N., 2011, NY TIMES; Castello X, 2009, EUR PHYS J B, V71, P557, DOI 10.1140/epjb/e2009-00284-2; Chambers N, 2011, SCI AM; Csere C, 2011, NY TIMES; Dall'Asta L, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036105; DYKMAN MI, 1994, J CHEM PHYS, V100, P5735, DOI 10.1063/1.467139; Galam S, 2007, PHYSICA A, V381, P366, DOI 10.1016/j.physa.2007.03.034; Galam S, 2010, PHYSICA A, V389, P3619, DOI 10.1016/j.physa.2010.04.039; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GRAHAM R, 1984, J STAT PHYS, V35, P729, DOI 10.1007/BF01010830; HERRMANN DW, 1982, PHYS REV LETT, V49, P1262, DOI 10.1103/PhysRevLett.49.1262; HU G, 1987, PHYS REV A, V36, P5782, DOI 10.1103/PhysRevA.36.5782; Landau D. P., 2000, GUIDE MONTE CARLO SI; Lee TB, 2011, DEATH FLASH QUIET TR; Lehmann J, 2011, ABS11111896 CORR; Leiserowitz A., 2011, POLITICS GLOBAL WARM; Lu QM, 2009, J ECON INTERACT COOR, V4, P221, DOI 10.1007/s11403-009-0057-7; Luchinsky DG, 1998, REP PROG PHYS, V61, P889, DOI 10.1088/0034-4885/61/8/001; Madan A, 2011, LECT NOTES COMPUT SC, V6696, P214, DOI 10.1007/978-3-642-21726-5_14; Maier RS, 1992, APPL COMPUTING; Mobilia M, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/08/P08029; Mobilia M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.028701; Mori T, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011135; MORRIS N, 2000, BRIDGING GAP EXAMINA; RAY TS, 1991, J STAT PHYS, V62, P463, DOI 10.1007/BF01020882; Sinclair B, 1969, TECHNOLOGY CULTURE, P10; Steels Luc, 1995, Artificial Life, V2, P319; Surowiecki J, 2002, WIRED; Takahashi Y, 2011, WALL STREET J; Tarde Gabriel, 1969, COMMUNICATION SOCIAL; Xie J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011130; Yildiz E., 2011, SSRN ELIBRARY	40	37	37	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33215	10.1371/journal.pone.0033215	http://dx.doi.org/10.1371/journal.pone.0033215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448238	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700028
J	Kanagarajan, S; Tolf, C; Lundgren, A; Waldenstrom, J; Brodelius, PE				Kanagarajan, Selvaraju; Tolf, Conny; Lundgren, Anneli; Waldenstroem, Jonas; Brodelius, Peter E.			Transient Expression of Hemagglutinin Antigen from Low Pathogenic Avian Influenza A (H7N7) in Nicotiana benthamiana	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TOXIN B-SUBUNIT; TRANSGENIC PLANTS; VIRUS-VACCINE; RELATIVE EXPRESSION; CHALLENGE INFECTION; ORAL IMMUNIZATION; PROTECTS FERRETS; MICE; GENE	The influenza A virus is of global concern for the poultry industry, especially the H5 and H7 subtypes as they have the potential to become highly pathogenic for poultry. In this study, the hemagglutinin (HA) of a low pathogenic avian influenza virus of the H7N7 subtype isolated from a Swedish mallard Anas platyrhynchos was sequenced, characterized and transiently expressed in Nicotiana benthamiana. Recently, plant expression systems have gained interest as an alternative for the production of vaccine antigens. To examine the possibility of expressing the HA protein in N. benthamiana, a cDNA fragment encoding the HA gene was synthesized de novo, modified with a Kozak sequence, a PR1a signal peptide, a C-terminal hexahistidine (6xHis) tag, and an endoplasmic retention signal (SEKDEL). The construct was cloned into a Cowpea mosaic virus (CPMV)-based vector (pEAQ-HT) and the resulting pEAQ-HT-HA plasmid, along with a vector (pJL3:p19) containing the viral gene-silencing suppressor p19 from Tomato bushy stunt virus, was agro-infiltrated into N. benthamiana. The highest gene expression of recombinant plant-produced, uncleaved HA (rHA0), as measured by quantitative real-time PCR was detected at 6 days post infiltration (dpi). Guided by the gene expression profile, rHA0 protein was extracted at 6 dpi and subsequently purified utilizing the 6xHis tag and immobilized metal ion adsorption chromatography. The yield was 0.2 g purified protein per kg fresh weight of leaves. Further molecular characterizations showed that the purified rHA0 protein was N-glycosylated and its identity confirmed by liquid chromatography-tandem mass spectrometry. In addition, the purified rHA0 exhibited hemagglutination and hemagglutination inhibition activity indicating that the rHA0 shares structural and functional properties with native HA protein of H7 influenza virus. Our results indicate that rHA0 maintained its native antigenicity and specificity, providing a good source of vaccine antigen to induce immune response in poultry species.	[Kanagarajan, Selvaraju; Lundgren, Anneli; Brodelius, Peter E.] Linnaeus Univ, Sect Biomat & Med Chem, Sch Nat Sci, Kalmar, Sweden; [Tolf, Conny; Waldenstroem, Jonas] Linnaeus Univ, Sect Zoonot Ecol & Epidemiol, Sch Nat Sci, Kalmar, Sweden	Linnaeus University; Linnaeus University	Kanagarajan, S (corresponding author), Linnaeus Univ, Sect Biomat & Med Chem, Sch Nat Sci, Kalmar, Sweden.	peter.brodelius@lnu.se	Waldenström, Jonas/E-4460-2013; Kanagarajan, Selvaraju/AAV-4239-2021; Kanagarajan, Selvaraju/F-9992-2010	Waldenström, Jonas/0000-0002-1152-4235; Kanagarajan, Selvaraju/0000-0003-4341-9322; 	Faculty of Natural Science and Engineering, Linnaeus University, Kalmar; Sparbanksstiftelsen Kronan; Swedish Research Foundation VR [2010-3067]	Faculty of Natural Science and Engineering, Linnaeus University, Kalmar; Sparbanksstiftelsen Kronan; Swedish Research Foundation VR(Swedish Research Council)	This work was supported by grants from the Faculty of Natural Science and Engineering, Linnaeus University, Kalmar, awarded to PB. SK was supported by the fund from Sparbanksstiftelsen Kronan, a non-profit foundation, to PB. CT was supported by a grant from the Swedish Research Foundation VR (2010-3067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Bulach D, 2010, J VIROL, V84, P9957, DOI 10.1128/JVI.00930-10; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Wit E, 2005, J VIROL, V79, P12401, DOI 10.1128/JVI.79.19.12401-12407.2005; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dow AgroSciences, 2006, PLANT CELL PROD VACC; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; HAQ TA, 1995, SCIENCE, V268, P714, DOI 10.1126/science.7732379; HOEKEMA A, 1983, NATURE, V303, P179, DOI 10.1038/303179a0; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Holmberg N, 2001, GENE, V275, P115, DOI 10.1016/S0378-1119(01)00635-7; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joseph T, 2008, VIROLOGY, V378, P123, DOI 10.1016/j.virol.2008.05.021; Kalthoff D, 2010, J VIROL, V84, P12002, DOI 10.1128/JVI.00940-10; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Koya V, 2005, INFECT IMMUN, V73, P8266, DOI 10.1128/IAI.73.12.8266-8274.2005; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lacorte C, 2007, VIRUS RES, V129, P80, DOI 10.1016/j.virusres.2007.06.020; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Ru A, 2010, VACCINE, V28, P3661, DOI 10.1016/j.vaccine.2010.03.029; Lindbo JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-52; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Madhun AS, 2011, VACCINE, V29, P4973, DOI 10.1016/j.vaccine.2011.04.094; Mett V, 2008, INFLUENZA OTHER RESP, V2, P33, DOI 10.1111/j.1750-2659.2008.00037.x; Musiychuk K, 2007, INFLUENZA OTHER RESP, V1, P19, DOI 10.1111/j.1750-2659.2006.00005.x; Olofsson L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-45; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9; PERLAK FJ, 1991, P NATL ACAD SCI USA, V88, P3324, DOI 10.1073/pnas.88.8.3324; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Richter LJ, 2000, NAT BIOTECHNOL, V18, P1167, DOI 10.1038/81153; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Sambrook J., 2001, MOL CLONING LAB MANU; SCHOLTHOF HB, 1993, MOL PLANT MICROBE IN, V6, P309, DOI 10.1094/MPMI-6-309; Sharma MK, 2008, PLANT CELL REP, V27, P307, DOI 10.1007/s00299-007-0464-y; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Shoji Y, 2008, VACCINE, V26, P2930, DOI 10.1016/j.vaccine.2008.03.045; Shoji Y, 2011, HUM VACCINES, V7, P41, DOI 10.4161/hv.7.0.14561; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2003, J VIROL, V77, P13399, DOI 10.1128/JVI.77.24.13399-13402.2003; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; Tamura K, 2011, MOL BIOL EV IN PRESS; Voeten JTM, 1999, VACCINE, V17, P1942, DOI 10.1016/S0264-410X(98)00464-2; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Webster R, 2002, WHO MANUAL ANIMAL IN; Wigdorovitz A, 1999, VIROLOGY, V255, P347, DOI 10.1006/viro.1998.9590; WOOD GW, 1993, ARCH VIROL, V130, P209, DOI 10.1007/BF01319010; Yusibov V, 2002, VACCINE, V20, P3155, DOI 10.1016/S0264-410X(02)00260-8; Zhang CQ, 2010, PLANT PHYSIOL, V153, P52, DOI 10.1104/pp.109.151639	65	34	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33010	10.1371/journal.pone.0033010	http://dx.doi.org/10.1371/journal.pone.0033010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442675	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500017
J	Mihic-Probst, D; Ikenberg, K; Tinguely, M; Schraml, P; Behnke, S; Seifert, B; Civenni, G; Sommer, L; Moch, H; Dummer, R				Mihic-Probst, Daniela; Ikenberg, Kristian; Tinguely, Marianne; Schraml, Peter; Behnke, Silvia; Seifert, Burkhardt; Civenni, Gianluca; Sommer, Lukas; Moch, Holger; Dummer, Reinhard			Tumor Cell Plasticity and Angiogenesis in Human Melanomas	PLOS ONE			English	Article							SENTINEL LYMPH-NODE; ENDOTHELIAL GROWTH-FACTOR; VASCULOGENIC MIMICRY; BREAST-CANCER; CUTANEOUS MELANOMA; UVEAL MELANOMA; IN-VIVO; LYMPHANGIOGENESIS; METASTASIS; VESSELS	Recent molecular studies provide evidence for a significant transcriptional plasticity of tumor cell subpopulations that facilitate an active contribution to tumor vasculature. This feature is accompanied by morphological changes both in vitro and in vivo. Herein, we investigated the morphological plasticity of tumor cells with special focus on vasculogenic mimicry and neovascularisation in human melanoma and mouse xenografts of human melanoma cell lines. In melanoma xenograft experiments, different vessel markers and green fluorescent protein expression were used to show how melanoma cells contribute to neovascularization. Additionally, we analyzed neovascularization in 49 primary melanomas and 175 melanoma metastases using immunostaining for blood (CD34) and lymphatic (D2-40) vessel-specific markers. We found significantly more lymphatic vessels in primary melanomas than in melanoma metastases (p<0.0001). In contrast to the near absence of lymphatic vessels within metastases, we found extensive blood micro-neovascularization. Blood micro-neovascularization was absent in micro metastases (less than 2 mm). A significant inverse correlation between Glut-1 expression (implying local hypoxia) and the presence of microvessels indicates their functional activity as blood vessels (p<0.0001). We suggest that the hypoxic microenvironment in metastases contributes to a phenotype switch allowing melanoma cells to physically contribute to blood vessel formation.	[Mihic-Probst, Daniela; Ikenberg, Kristian; Tinguely, Marianne; Schraml, Peter; Behnke, Silvia; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Seifert, Burkhardt] Univ Zurich, Inst Social & Prevent Med, Biostat Unit, CH-8006 Zurich, Switzerland; [Civenni, Gianluca; Sommer, Lukas] Univ Zurich, Inst Anat, Zurich, Switzerland; [Dummer, Reinhard] Univ Zurich Hosp, Dermatol Clin, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital	Mihic-Probst, D (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	daniela.mihic@usz.ch	Mihic-Probst, Daniela/AAB-6374-2021	Seifert, Burkhardt/0000-0002-5829-2478; Sommer, Lukas/0000-0002-1143-7908; Civenni, Gianluca/0000-0003-1921-161X	Gottfried and Julia Bangerter-Rhyner-Stiftung; Swiss Cancer League, Oncosuisse, Collaborative Cancer Research Project (CCRP) [KFP OCS-01972-12-2006]	Gottfried and Julia Bangerter-Rhyner-Stiftung; Swiss Cancer League, Oncosuisse, Collaborative Cancer Research Project (CCRP)	This work was supported by the Swiss Cancer League, Oncosuisse, Collaborative Cancer Research Project (CCRP), grant number KFP OCS-01972-12-2006, and the Gottfried and Julia Bangerter-Rhyner-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; BUTLER TP, 1975, CANCER RES, V35, P512; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Civenni G, 2011, CANC RES; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Dadras SS, 2005, MODERN PATHOL, V18, P1232, DOI 10.1038/modpathol.3800410; FOLBERG R, 1993, OPHTHALMOLOGY, V100, P1389; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guidi AJ, 2000, J NATL CANCER I, V92, P486, DOI 10.1093/jnci/92.6.486; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hendrix MJC, 2002, CANCER RES, V62, P665; Hess AR, 2001, CANCER RES, V61, P3250; Hirakawa S, 2005, BLOOD, V105, P2392, DOI 10.1182/blood-2004-06-2435; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LIOTTA LA, 1974, CANCER RES, V34, P997; Luan Q, 2011, CANCER LETT, V308, P100, DOI 10.1016/j.canlet.2011.04.019; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Ricci-Vitiani L, 2010, NATURE; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Seftor EA, 2002, CLIN EXP METASTAS, V19, P233, DOI 10.1023/A:1015591624171; Sharma N, 2002, PROSTATE, V50, P189, DOI 10.1002/pros.10048; Shirakawa K, 2002, CANCER RES, V62, P560; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; SOMMER L, 2005, SCI STKE, pPE42; STACKER SA, 2007, NOVART FDN SYMP, V281, P208; STACKER SA, 2007, NOVART FDN SYMP, V281, P44; Stacker Steven A, 2007, Novartis Found Symp, V281, P38; Sun BC, 2004, INT J ONCOL, V25, P1609; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; Van den Eynden GG, 2006, BRIT J CANCER, V95, P1362, DOI 10.1038/sj.bjc.6603443; Van den Eynden GG, 2007, CLIN CANCER RES, V13, P5391, DOI 10.1158/1078-0432.CCR-07-1230; Wang R, 2010, NATURE; Warso MA, 2001, CLIN CANCER RES, V7, P473; Yang L, 2011, CANC RES; Yun SJ, 2011, AM J SURG PATHOL, V35, P235, DOI 10.1097/PAS.0b013e3182036ccd; Zhang SW, 2007, CANCER LETT, V254, P157, DOI 10.1016/j.canlet.2006.12.036	46	47	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33571	10.1371/journal.pone.0033571	http://dx.doi.org/10.1371/journal.pone.0033571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442699	Green Published, gold, Green Accepted			2022-12-27	WOS:000303836500040
J	Sakamoto, RL; Ito, M; Kawakubo, N				Sakamoto, Ryota L.; Ito, Motomi; Kawakubo, Nobumitsu			Contribution of Pollinators to Seed Production as Revealed by Differential Pollinator Exclusion in Clerodendrum trichotomum (Lamiaceae)	PLOS ONE			English	Article							POLLEN DISPERSAL; WILD RADISH; NECTAR; EFFICIENCY; BEES; SPECIALIZATION; CONSEQUENCES; HUMMINGBIRDS; POPULATIONS; BUMBLEBEES	A diverse assemblage of pollinators, such as bees, beetles, flies, and butterflies, will often visit a single plant species. However, evaluating the effect of several insects on fruit and seed production is difficult in plants visited by a variety of insects. Here, we analyzed the effect of three types of pollinators, Papilio spp., Macroglossum pyrrhosticta, and Xylocopa appendiculata on fruit and seed production in Clerodendrum trichotomum by using a flower visitor barrier experiment with nets of specific mesh sizes. As a result, fruit/flower and seed/ovule ratios were significantly lower under Papilio exclusion than under natural conditions. On the other hand, ratios were not significantly different between Papilio excluded and both Papilio and M. pyrrhosticta excluded treatments. Therefore, Papilio and X. appendiculata are effective pollinators, whereas M. pyrrhosticta, which was the most frequent visitor, of C. trichotomum, is not. From our observations of visiting behaviors, we believe that because M. pyrrhosticta probably promotes self-pollination, this species is a non-effective pollinator. This is the first study to separate and compare the contribution of various visitors to the reproductive success of a plant.	[Sakamoto, Ryota L.; Ito, Motomi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Kawakubo, Nobumitsu] Gifu Univ, Grad Sch Appl Biol Sci, Gifu, Japan	University of Tokyo; Gifu University	Sakamoto, RL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.	r.l.sakamoto.7708@gmail.com			Ministry of the Environment [D-1008]	Ministry of the Environment(Ministry of the Environment, Japan)	This study was partly supported by the Environment Research and Technology Development Fund (D-1008) from the Ministry of the Environment to MI. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch D, 2006, NEW PHYTOL, V169, P699, DOI 10.1111/j.1469-8137.2006.01653.x; Botes C, 2009, INT J PLANT SCI, V170, P151, DOI 10.1086/595291; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CONNER JK, 1995, OECOLOGIA, V104, P234, DOI 10.1007/BF00328588; Ellis AG, 2009, AM J BOT, V96, P793, DOI 10.3732/ajb.0800222; Fishbein M, 1996, ECOLOGY, V77, P1061, DOI 10.2307/2265576; GILL FB, 1982, IBIS, V124, P44, DOI 10.1111/j.1474-919X.1982.tb03739.x; Gomez JM, 2005, OECOLOGIA, V143, P412, DOI 10.1007/s00442-004-1809-7; HARDER LD, 1983, OECOLOGIA, V57, P274, DOI 10.1007/BF00379591; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; Hargreaves AL, 2008, S AFR J BOT, V74, P606, DOI 10.1016/j.sajb.2008.02.009; HEINRICH B, 1975, J COMP PHYSIOL, V96, P155, DOI 10.1007/BF00706595; Herrera CM, 2000, ECOLOGY, V81, P15, DOI 10.1890/0012-9658(2000)081[0015:FTSCOD]2.0.CO;2; HODGES SA, 1995, AM J BOT, V82, P197, DOI 10.2307/2445527; INOUYE DW, 1980, ECOLOGY, V61, P1251, DOI 10.2307/1936841; Ivey CT, 2003, AM J BOT, V90, P214, DOI 10.3732/ajb.90.2.214; Jacobs JH, 2010, ARTHROPOD-PLANT INTE, V4, P19, DOI 10.1007/s11829-009-9080-9; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; KAWAKUBO N, 1994, ANN BOT-LONDON, V74, P357, DOI 10.1006/anbo.1994.1128; Kennedy BF, 2008, OECOLOGIA, V155, P469, DOI 10.1007/s00442-007-0924-7; Kessler D, 2010, CURR BIOL, V20, P237, DOI 10.1016/j.cub.2009.11.071; Maloof JE, 2000, ECOLOGY, V81, P2651, DOI 10.1890/0012-9658(2000)081[2651:ANRCOM]2.0.CO;2; Marten-Rodriguez S, 2009, J ECOL, V97, P348, DOI 10.1111/j.1365-2745.2008.01465.x; Micheneau C, 2006, ANN BOT-LONDON, V97, P965, DOI 10.1093/aob/mcl056; Miyake T, 2003, PLANT SYST EVOL, V243, P31, DOI 10.1007/s00606-003-0059-1; Miyake T, 1999, OIKOS, V86, P233, DOI 10.2307/3546441; Morinaga SI, 2003, AM J BOT, V90, P1153, DOI 10.3732/ajb.90.8.1153; Murata G, 1989, WILD FLOWERS JAPAN W, P209; Mustajarvi K, 2001, J ECOL, V89, P80, DOI 10.1046/j.1365-2745.2001.00521.x; Nitta K, 2010, AM J BOT, V97, P261, DOI 10.3732/ajb.0900001; OLESEN JM, 1989, OECOLOGIA, V79, P205, DOI 10.1007/BF00388480; Ollerton J, 2007, TAXON, V56, P717, DOI 10.2307/25065856; PETTERSSON MW, 1991, J ECOL, V79, P591, DOI 10.2307/2260655; Reynolds RJ, 2009, ECOLOGY, V90, P2077, DOI 10.1890/08-1141.1; ROBERTSON AW, 1992, BIOL J LINN SOC, V46, P333, DOI 10.1111/j.1095-8312.1992.tb00868.x; ROUBIK DW, 1982, ECOLOGY, V63, P354, DOI 10.2307/1938953; Sahli HF, 2007, AM J BOT, V94, P203, DOI 10.3732/ajb.94.2.203; Schulke B, 2001, OECOLOGIA, V127, P239, DOI 10.1007/s004420000586; Thostesen AM, 1996, OIKOS, V77, P77, DOI 10.2307/3545587; Van Rossum F, 2009, PLANT BIOLOGY, V11, P725, DOI 10.1111/j.1438-8677.2008.00176.x; VENALBES B A B, 1985, Journal of the Lepidopterists' Society, V39, P299; WATANABE M, 1988, Ecological Research, V3, P175, DOI 10.1007/BF02346938; Weiss MR, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P171, DOI 10.1017/CBO9780511542268.010; WIKLUND C, 1982, OIKOS, V38, P263, DOI 10.2307/3544031; WIKLUND C, 1979, OIKOS, V33, P358, DOI 10.2307/3544323; Wilson AL, 2009, PLANT ECOL, V203, P173, DOI 10.1007/s11258-008-9524-9; YOUNG HJ, 1990, ECOLOGY, V71, P536, DOI 10.2307/1940307	47	9	12	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33803	10.1371/journal.pone.0033803	http://dx.doi.org/10.1371/journal.pone.0033803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442724	gold, Green Published, Green Submitted			2022-12-27	WOS:000303836500065
J	Carty, CP; Cronin, NJ; Lichtwark, GA; Mills, PM; Barrett, RS				Carty, Christopher P.; Cronin, Neil J.; Lichtwark, Glen A.; Mills, Peter M.; Barrett, Rod S.			Mechanisms of Adaptation from a Multiple to a Single Step Recovery Strategy following Repeated Exposure to Forward Loss of Balance in Older Adults	PLOS ONE			English	Article							DYNAMIC STABILITY CONTROL; FALLS; COMMUNITY; RESPONSES; RISK	When released from an initial, static, forward lean angle and instructed to recover with a single step, some older adults are able to meet the task requirements, whereas others either stumble or fall. The purpose of the present study was to use the concept of margin of stability (MoS) to investigate balance recovery responses in the anterior-posterior direction exhibited by older single steppers, multiple steppers and those that are able to adapt from multiple to single steps following exposure to repeated forward loss of balance. One hundred and fifty-one healthy, community dwelling, older adults, aged 65-80 years, participated in the study. Participants performed four trials of the balance recovery task from each of three initial lean angles. Balance recovery responses in the anterior-posterior direction were quantified at three events; cable release (CR), toe-off (TO) and foot contact (FC), for trials performed at the intermediate lean angle. MoS was computed as the anterior-posterior distance between the forward boundary of the Base of Support (BoS) and the vertical projection of the velocity adjusted centre of mass position (XCoM). Approximately one-third of participants adapted from a multiple to a single step recovery strategy following repeated exposure to the task. MoS at FC for the single and multiple step trials in the adaptation group were intermediate between the exclusively single step group and the exclusively multiple step group, with the single step trials having a significant, 3.7 times higher MoS at FC than the multiple step trials. Consistent with differences between single and multiple steppers, adaptation from multiple to single steps was attributed to an increased BoS at FC, a reduced XCoM at FC and an increased rate of BoS displacement from TO to FC. Adaptations occurred within a single test session and suggest older adults that are close to the threshold of successful recovery can rapidly improve dynamic stability following repeated exposure to a forward loss of balance.	[Carty, Christopher P.; Mills, Peter M.; Barrett, Rod S.] Griffith Univ, Ctr Musculoskeletal Res, Griffith Hlth Inst, Gold Coast, Australia; [Carty, Christopher P.; Mills, Peter M.; Barrett, Rod S.] Griffith Univ, Sch Physiotherapy & Exercise Sci, Gold Coast, Australia; [Cronin, Neil J.] Univ Jyvaskyla, Dept Biol Phys Activ, SF-40100 Jyvaskyla, Finland; [Lichtwark, Glen A.] Univ Queensland, Sch Human Movement Studies, Brisbane, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University; University of Jyvaskyla; University of Queensland	Carty, CP (corresponding author), Griffith Univ, Ctr Musculoskeletal Res, Griffith Hlth Inst, Gold Coast, Australia.	c.carty@griffith.edu.au	Cronin, Neil/B-3860-2011; Lichtwark, Glen A/B-6002-2008; Cronin, Neil/AAA-8815-2022	Cronin, Neil/0000-0002-5332-1188; Lichtwark, Glen A/0000-0001-7366-3348; Barrett, Rod/0000-0002-1784-1629; Carty, Christopher/0000-0002-8969-5181	National Health and Medical Research Council [536508]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (536508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arampatzis A, 2008, J BIOMECH, V41, P1754, DOI 10.1016/j.jbiomech.2008.02.022; Arampatzis A, 2011, J BIOMECH, V44, P52, DOI 10.1016/j.jbiomech.2010.08.023; Barrett RS, 2012, J BIOMECH, V45, P183, DOI 10.1016/j.jbiomech.2011.10.005; Bierbaum S, 2010, J BIOMECH, V43, P2362, DOI 10.1016/j.jbiomech.2010.04.025; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Carty CP, 2011, GAIT POSTURE, V33, P261, DOI 10.1016/j.gaitpost.2010.11.017; Cyr MA, 2009, J BIOMECH, V42, P1566, DOI 10.1016/j.jbiomech.2009.04.003; De Witt JK, 2010, J BIOMECH, V43, P3067, DOI 10.1016/j.jbiomech.2010.07.009; DO MC, 1982, J BIOMECH, V15, P933, DOI 10.1016/0021-9290(82)90011-2; Grabiner MD, 2008, J ELECTROMYOGR KINES, V18, P197, DOI 10.1016/j.jelekin.2007.06.009; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Karamanidis K, 2008, J ELECTROMYOGR KINES, V18, P980, DOI 10.1016/j.jelekin.2007.04.003; Maki B, 2001, CONTROL POSTURE GAIT, P126; MCILROY WE, 1995, GAIT POSTURE, V3, P43; Pavol MJ, 2004, J GERONTOL A-BIOL, V59, P494; Thelen DG, 1997, J GERONTOL A-BIOL, V52, pM8, DOI 10.1093/gerona/52A.1.M8; TINETTI ME, 1989, NEW ENGL J MED, V320, P1055; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x	18	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33591	10.1371/journal.pone.0033591	http://dx.doi.org/10.1371/journal.pone.0033591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438956	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100064
J	Weston-Green, K; Huang, XF; Deng, C				Weston-Green, Katrina; Huang, Xu-Feng; Deng, Chao			Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; Y-LIKE IMMUNOREACTIVITY; GLUTAMIC-ACID DECARBOXYLASE; DORSAL VAGAL COMPLEX; LONG-TERM TREATMENT; NEUROPEPTIDE-Y; FOOD-INTAKE; ATYPICAL ANTIPSYCHOTICS; ARCUATE NUCLEUS; BODY-WEIGHT	Background/Aim: Second generation antipsychotics (SGAs) are used to treat schizophrenia but can cause serious metabolic side-effects, such as obesity and diabetes. This study examined the effects of low to high doses of olanzapine on appetite/metabolic regulatory signals in the hypothalamus and brainstem to elucidate the mechanisms underlying olanzapine-induced obesity. Methodology/Results: Levels of pro-opiomelanocortin (POMC), neuropeptide Y (NPY) and glutamic acid decarboxylase (GAD(65), enzyme for GABA synthesis) mRNA expression, and cannabinoid CB1 receptor (CB1R) binding density (using [H-3]SR-141716A) were examined in the arcuate nucleus (Arc) and dorsal vagal complex (DVC) of female Sprague Dawley rats following 0.25, 0.5, 1.0 or 2.0 mg/kg olanzapine or vehicle (3x/day, 14-days). Consistent with its weight gain liability, olanzapine significantly decreased anorexigenic POMC and increased orexigenic NPY mRNA expression in a dose-sensitive manner in the Arc. GAD(65) mRNA expression increased and CB1R binding density decreased in the Arc and DVC. Alterations to neurotransmission signals in the brain significantly correlated with body weight and adiposity. The minimum dosage threshold required to induce weight gain in the rat was 0.5 mg/kg olanzapine. Conclusions: Olanzapine-induced weight gain is associated with reduced appetite-inhibiting POMC and increased NPY. This study also supports a role for the CB1R and GABA in the mechanisms underlying weight gain side-effects, possibly by altering POMC transmission. Metabolic dysfunction can be modelled in the female rat using low, clinically-comparable olanzapine doses when administered in-line with the half-life of the drug.	[Weston-Green, Katrina; Huang, Xu-Feng; Deng, Chao] Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW, Australia; [Weston-Green, Katrina; Huang, Xu-Feng; Deng, Chao] Schizophrenia Res Inst, Darlinghurst, NSW, Australia	University of Wollongong	Weston-Green, K (corresponding author), Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW, Australia.	chao@uow.edu.au	Huang, Xu-Feng/H-7408-2015; Huang, Xu-Feng/D-6053-2013; Weston-Green, Katrina/AAQ-8280-2020; Deng, Chao/F-4417-2016	Huang, Xu-Feng/0000-0002-5895-2253; Huang, Xu-Feng/0000-0002-5895-2253; Weston-Green, Katrina/0000-0002-4521-8463; Deng, Chao/0000-0003-1147-5741	University of Wollongong University Research Centre (URC); Australian National Health and Medical Research Council (NHMRC) [635231]; Schizophrenia Research Institute (SRI); New South Wales Health	University of Wollongong University Research Centre (URC); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute (SRI); New South Wales Health	This study was supported by a University of Wollongong (www.uow.edu.au) University Research Centre (URC) grant to CD, an Australian National Health and Medical Research Council (NHMRC, www.nhmrc.gov.au) grant to XH and CD (ID 635231), and by the Schizophrenia Research Institute (SRI, www.schizophreniaresearch.org.au), utilising infrastructure funding from New South Wales Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Allison DB, 2009, AM J PREV MED, V36, P341, DOI 10.1016/j.amepre.2008.11.020; Aravagiri M, 1999, BIOPHARM DRUG DISPOS, V20, P369, DOI 10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6; Archie S, 2003, CAN J PSYCHIAT, V48, P628, DOI 10.1177/070674370304800910; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Ballard C, 2006, COCHRANE DB SYST REV, V2006, DOI [003410.001002/14651858.CD14003476.pub14651852, DOI 10.1002/14651858.CD003476.PUB2]; Baptista T, 2002, BRAIN RES, V957, P144, DOI 10.1016/S0006-8993(02)03616-8; Beasley CM, 1996, NEUROPSYCHOPHARMACOL, V14, P111, DOI 10.1016/0893-133X(95)00069-P; BECK B, 1992, INT J OBESITY, V16, P295; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; Bermudez-Silva FJ, 2010, PHARMACOL BIOCHEM BE, V95, P375, DOI 10.1016/j.pbb.2010.03.012; Berrendero F, 1998, BBA-MOL BASIS DIS, V1407, P205, DOI 10.1016/S0925-4439(98)00042-8; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Brambilla F, 2007, PSYCHONEUROENDOCRINO, V32, P402, DOI 10.1016/j.psyneuen.2007.02.005; Bridle C, 2004, Health Technol Assess, V8, piii; Broberger C, 2001, PHYSIOL BEHAV, V74, P669, DOI 10.1016/S0031-9384(01)00611-4; BRONSTEIN DM, 1992, BRAIN RES, V587, P269, DOI 10.1016/0006-8993(92)91007-2; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Budman CL, 2001, J CLIN PSYCHIAT, V62, P290, DOI 10.4088/JCP.v62n0412; Bymaster FP, 1996, PSYCHOPHARMACOLOGY, V124, P87, DOI 10.1007/BF02245608; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Cavuoto P, 2009, BEST PRACT RES CL EN, V23, P79, DOI 10.1016/j.beem.2008.10.005; Centorrino F, 2002, AM J PSYCHIAT, V159, P1932, DOI 10.1176/appi.ajp.159.11.1932; Coccurello R, 2010, PHARMACOL THERAPEUT, V127, P210, DOI 10.1016/j.pharmthera.2010.04.008; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cope MB, 2005, INT J OBESITY, V29, P607, DOI 10.1038/sj.ijo.0802928; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; CSIFFARY A, 1990, BRAIN RES, V506, P215, DOI 10.1016/0006-8993(90)91253-D; Davoodi N, 2009, PSYCHOPHARMACOLOGY, V203, P693, DOI 10.1007/s00213-008-1415-1; De Hert M, 2011, EUR PSYCHIAT, V26, P144, DOI 10.1016/j.eurpsy.2010.09.011; de Meijer VE, 2010, PHYSIOL BEHAV, V100, P387, DOI 10.1016/j.physbeh.2010.04.001; Deng C, 2007, PROG NEURO-PSYCHOPH, V31, P915, DOI 10.1016/j.pnpbp.2007.02.009; Deng C, 2010, PROG NEURO-PSYCHOPH, V34, P1, DOI 10.1016/j.pnpbp.2009.11.009; Deng Chao, 2007, Neurosci Bull, V23, P341, DOI 10.1007/s12264-007-0051-9; Derbenev AV, 2004, J PHYSIOL-LONDON, V559, P923, DOI 10.1113/jphysiol.2004.067470; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Eder U, 2001, AM J PSYCHIAT, V158, P1719, DOI 10.1176/appi.ajp.158.10.1719; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Faulconbridge LF, 2008, BRAIN RES, V1218, P151, DOI 10.1016/j.brainres.2008.04.068; FELDBLUM S, 1993, J NEUROSCI RES, V34, P689, DOI 10.1002/jnr.490340612; Ferno J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020571; Frenchman IB, 2005, DRUG AGING, V22, P257, DOI 10.2165/00002512-200522030-00006; Gamber KM, 2005, NEUROPHARMACOLOGY, V49, P646, DOI 10.1016/j.neuropharm.2005.04.017; Gomez R, 2002, J NEUROSCI, V22, P9612; Gothelf D, 2002, AM J PSYCHIAT, V159, P1055, DOI 10.1176/appi.ajp.159.6.1055; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Guan XM, 1998, MOL BRAIN RES, V59, P273, DOI 10.1016/S0169-328X(98)00150-8; Han M, 2008, PSYCHONEUROENDOCRINO, V33, P569, DOI 10.1016/j.psyneuen.2008.01.018; Harrold JA, 2003, BRIT J NUTR, V90, P729, DOI 10.1079/BJN2003942; Hartfield AW, 2003, PSYCHOPHARMACOLOGY, V167, P115, DOI 10.1007/s00213-002-1368-8; HEILIG M, 1988, EUR J PHARMACOL, V157, P205, DOI 10.1016/0014-2999(88)90384-6; HEILIG M, 1987, REGUL PEPTIDES, V19, P221, DOI 10.1016/0167-0115(87)90278-3; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hentges ST, 2005, J NEUROSCI, V25, P9746, DOI 10.1523/JNEUROSCI.2769-05.2005; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; Hollopeter G, 1998, REGUL PEPTIDES, V75-6, P383, DOI 10.1016/S0167-0115(98)00092-5; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Huang XF, 2006, NEUROPEPTIDES, V40, P213, DOI 10.1016/j.npep.2006.01.002; Huang XF, 2003, BRAIN RES, V992, P9, DOI 10.1016/j.brainres.2003.08.019; Huang XF, 2006, BEHAV BRAIN RES, V171, P355, DOI 10.1016/j.bbr.2006.03.040; Kapur S, 2000, CAN J PSYCHIAT, V45, P241, DOI 10.1177/070674370004500302; Kapur S, 2003, J PHARMACOL EXP THER, V305, P625, DOI 10.1124/jpet.102.046987; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kim EM, 2000, BRAIN RES, V862, P11, DOI 10.1016/S0006-8993(00)02060-6; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; Kirk SL, 2006, J PSYCHOPHARMACOL, V20, P577, DOI 10.1177/0269881106061199; Kirk SL, 2009, PSYCHOPHARMACOLOGY, V207, P119, DOI 10.1007/s00213-009-1639-8; Kirkham T, 2008, J NEUROENDOCRINOL, V20, P1099, DOI 10.1111/j.1365-2826.2008.01762.x; Kirkham TC, 2009, INT REV PSYCHIATR, V21, P163, DOI 10.1080/09540260902782810; Kroeze WK, 2003, NEUROPSYCHOPHARMACOL, V28, P519, DOI 10.1038/sj.npp.1300027; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kuo DY, 2006, BRIT J PHARMACOL, V148, P640, DOI 10.1038/sj.bjp.0706754; Kuo DY, 2002, J BIOMED SCI, V9, P126, DOI 10.1159/000048208; Li C, 2011, PHARMACOL THERAPEUT, V129, P307, DOI 10.1016/j.pharmthera.2010.10.006; Lin S, 2000, BRAIN RES, V875, P89, DOI 10.1016/S0006-8993(00)02580-4; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Ling LL, 2005, NEUROSCIENCE, V132, P1103, DOI 10.1016/j.neuroscience.2004.12.043; Marie LS, 2005, P NATL ACAD SCI USA, V102, P18632, DOI 10.1073/pnas.0509240102; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Martin NM, 2004, REGUL PEPTIDES, V122, P169, DOI 10.1016/j.regpep.2004.06.012; Matsui-Sakata Akiko, 2005, Drug Metab Pharmacokinet, V20, P368, DOI 10.2133/dmpk.20.368; MEEKER RB, 1980, BRAIN RES BULL, V5, P253, DOI 10.1016/0361-9230(80)90042-8; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Menzies JRW, 2010, J NEUROENDOCRINOL, V22, P585, DOI 10.1111/j.1365-2826.2010.01990.x; Minet-Ringuet J, 2005, BEHAV BRAIN RES, V163, P204, DOI 10.1016/j.bbr.2005.05.004; Minet-Ringuet J, 2006, APPETITE, V46, P254, DOI 10.1016/j.appet.2006.01.008; Nasrallah H, 2003, PSYCHONEUROENDOCRINO, V28, P83, DOI 10.1016/S0306-4530(02)00114-2; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Nemeroff CB, 1997, J CLIN PSYCHIAT, V58, P45; Newcomer JW, 2005, CNS DRUGS, V19, P1; Nguyen QH, 2006, NEUROENDOCRINOLOGY, V84, P123, DOI 10.1159/000096996; Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004; Obuchowicz E, 1998, NEUROPEPTIDES, V32, P473, DOI 10.1016/S0143-4179(98)90074-9; Obuchowicz E, 2005, NEUROPEPTIDES, V39, P515, DOI 10.1016/j.npep.2005.04.004; Obuchowicz E, 2004, NEUROSCI BIOBEHAV R, V28, P595, DOI 10.1016/j.neubiorev.2004.08.006; Obuchowicz E, 1996, NEUROPEPTIDES, V30, P471, DOI 10.1016/S0143-4179(96)90012-8; Obuchowicz E, 1999, EUR NEUROPSYCHOPHARM, V9, P329, DOI 10.1016/S0924-977X(99)00003-6; Ota M, 2002, CLIN EXP PHARMACOL P, V29, P980, DOI 10.1046/j.1440-1681.2002.t01-1-03755.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PELLETIER G, 1991, NEUROSCI LETT, V127, P96, DOI 10.1016/0304-3940(91)90903-7; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pickar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003150; Pouzet B, 2003, PHARMACOL BIOCHEM BE, V75, P133, DOI 10.1016/S0091-3057(03)00042-X; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Qiu J, 2007, MOL PHARMACOL, V72, P885, DOI 10.1124/mol.107.038083; Rader DJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.01.003; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Remington G, 2011, PHARMACOL BIOCHEM BE, V100, P86, DOI 10.1016/j.pbb.2011.07.019; Reynolds GP, 2010, PHARMACOL THERAPEUT, V125, P169, DOI 10.1016/j.pharmthera.2009.10.010; Richelson E, 2000, LIFE SCI, V68, P29, DOI 10.1016/S0024-3205(00)00911-5; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Ryan MCM, 2004, LIFE SCI, V74, P1999, DOI 10.1016/j.lfs.2003.08.044; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Secher A, 2010, NEUROENDOCRINOLOGY, V91, P155, DOI 10.1159/000245220; Sharkey Keith A, 2005, Sci STKE, V2005, ppe15, DOI 10.1126/stke.2772005pe15; STANLEY BG, 1986, PEPTIDES, V7, P1189; Starrenburg FCJ, 2009, EUR PSYCHIAT, V24, P164, DOI 10.1016/j.eurpsy.2009.01.001; Tauscher J, 2002, MOL PSYCHIATR, V7, P317, DOI 10.1038/sj.mp.4001009; Tiwari AK, 2010, NEUROPSYCHOPHARMACOL, V35, P1315, DOI 10.1038/npp.2009.235; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; van der Zwaal EM, 2008, EUR J PHARMACOL, V585, P130, DOI 10.1016/j.ejphar.2007.11.078; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wai SM, 2004, CELL MOL NEUROBIOL, V24, P667, DOI 10.1023/B:CEMN.0000036404.39432.0c; Weiden PJ, 2004, SCHIZOPHR RES, V66, P51, DOI 10.1016/S0920-9964(02)00498-X; Weston-Green K, 2008, INT J NEUROPSYCHOPH, V11, P827, DOI 10.1017/S1461145708008560; Weston-Green K, 2011, BEHAV BRAIN RES, V217, P337, DOI 10.1016/j.bbr.2010.10.039; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Xu B, 1999, ENDOCRINOLOGY, V140, P2868, DOI 10.1210/en.140.6.2868; Yoshimatsu H, 2006, PEPTIDES, V27, P326, DOI 10.1016/j.peptides.2005.02.028; Zhang Y, 2010, NEUROSCIENCE, V169, P1662, DOI 10.1016/j.neuroscience.2010.06.001; Zhang ZJ, 2004, BRIT J PSYCHIAT, V184, P58, DOI 10.1192/bjp.184.1.58	140	74	76	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33548	10.1371/journal.pone.0033548	http://dx.doi.org/10.1371/journal.pone.0033548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438946	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100055
J	Bulleri, F; Russell, BD; Connell, SD				Bulleri, Fabio; Russell, Bayden D.; Connell, Sean D.			Context-Dependency in the Effects of Nutrient Loading and Consumers on the Availability of Space in Marine Rocky Environments	PLOS ONE			English	Article							TOP-DOWN; BOTTOM-UP; SUBTIDAL HABITAT; MACROALGAL ASSEMBLAGES; LATITUDINAL VARIATION; SPECIES-DIVERSITY; SHORE COMMUNITIES; PRIMARY PRODUCERS; NEW-ZEALAND; ALGAE	Background: Enhanced nutrient loading and depletion of consumer populations interact to alter the structure of aquatic plant communities. Nonetheless, variation between adjacent habitats in the relative strength of bottom-up (i.e. nutrients) versus top-down (i.e. grazing) forces as determinants of community structure across broad spatial scales remains unexplored. We experimentally assessed the importance of grazing pressure and nutrient availability on the development of macroalgal assemblages and the maintenance of unoccupied space in habitats differing in physical conditions (i.e. intertidal versus subtidal), across regions of contrasting productivity (oligotrophic coasts of South Australia versus the more productive coasts of Eastern Australia). Methodology/Principal findings: In Eastern Australia, grazers were effective in maintaining space free of macroalgae in both intertidal and subtidal habitats, irrespective of nutrient levels. Conversely, in South Australia, grazers could not prevent colonization of space by turf-forming macroalgae in subtidal habitats regardless of nutrients levels, yet in intertidal habitats removal of grazers reduced unoccupied space when nutrients were elevated. Conclusions/Significance: Assessing the effects of eutrophication in coastal waters requires balancing our understanding between local consumer pressure and background oceanographic conditions that affect productivity. This broader-based understanding may assist in reconciling disproportionately large local-scale variation, a characteristic of ecology, with regional scale processes that are often of greater relevance to policy making and tractability to management.	[Bulleri, Fabio; Russell, Bayden D.; Connell, Sean D.] Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA 5005, Australia; [Bulleri, Fabio] Univ Pisa, CoNISMa, Dipartimento Biol, Pisa, Italy; [Bulleri, Fabio] Univ Sassari, Dipartimento Sci Bot Ecol & Geol, I-07100 Sassari, Italy	University of Adelaide; CoNISMa; University of Pisa; University of Sassari	Bulleri, F (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA 5005, Australia.	fbulleri@biologia.unipi.it	Russell, Bayden D./R-9325-2019; Connell, Sean D/A-8874-2008; Russell, Bayden D./A-9942-2008	Russell, Bayden D./0000-0003-1282-9978; Connell, Sean D/0000-0002-5350-6852; Russell, Bayden D./0000-0003-1282-9978; Bulleri, Fabio/0000-0002-7335-6791	Australian Research Council; Wildlife Conservation Fund South Australia	Australian Research Council(Australian Research Council); Wildlife Conservation Fund South Australia	The project was funded by Australian Research Council Discovery Grants to FB and SDC and a Wildlife Conservation Fund South Australia grant to BDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V215, P79, DOI 10.3354/meps215079; Bokn TL, 2003, ECOSYSTEMS, V6, P577, DOI 10.1007/s10021-002-0108-6; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Burkepile DE, 2009, MAR ECOL PROG SER, V389, P71, DOI 10.3354/meps08142; Chapman MG, 1998, J EXP MAR BIOL ECOL, V224, P265, DOI 10.1016/S0022-0981(97)00202-5; Connell J.H., 1985, P125; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; Connell Sean D., 2007, P378; Connell Sean D., 2009, P392; Connolly SR, 1998, AM NAT, V151, P311, DOI 10.1086/286121; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Eriksson BK, 2006, ECOLOGY, V87, P246, DOI 10.1890/05-0090; Eriksson BK, 2009, ECOL APPL, V19, P1975, DOI 10.1890/08-0964.1; FLETCHER WJ, 1987, ECOL MONOGR, V57, P89, DOI 10.2307/1942640; FOSTER MS, 1990, HYDROBIOLOGIA, V192, P21, DOI 10.1007/BF00006225; Fowler-Walker MJ, 2002, MAR ECOL PROG SER, V240, P49, DOI 10.3354/meps240049; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Goodsell PJ, 2004, AUSTRAL ECOL, V29, P350, DOI 10.1111/j.1442-9993.2004.01372.x; Gorgula SK, 2004, MAR BIOL, V145, P613, DOI 10.1007/s00227-004-1335-5; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Guerry AD, 2009, J EXP MAR BIOL ECOL, V369, P155, DOI 10.1016/j.jembe.2008.11.011; HEIN M, 1995, MAR ECOL PROG SER, V118, P247, DOI 10.3354/meps118247; Hillebrand H, 2000, MAR ECOL PROG SER, V204, P27, DOI 10.3354/meps204027; Hillebrand H, 2003, OIKOS, V100, P592, DOI 10.1034/j.1600-0706.2003.12045.x; Hillebrand H, 2002, ECOLOGY, V83, P2205, DOI 10.1890/0012-9658(2002)083[2205:COMCBG]2.0.CO;2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; JONES GP, 1992, J EXP MAR BIOL ECOL, V159, P217, DOI 10.1016/0022-0981(92)90038-C; Kraufvelin P, 2006, AQUAT BOT, V84, P199, DOI 10.1016/j.aquabot.2005.08.008; Kraufvelin P, 2007, AQUAT BOT, V87, P262, DOI 10.1016/j.aquabot.2007.06.011; Kraufvelin P, 2006, ECOSYSTEMS, V9, P1076, DOI 10.1007/s10021-005-0188-1; Lotze HK, 2000, MAR ECOL PROG SER, V200, P167, DOI 10.3354/meps200167; Lotze HK, 2001, LIMNOL OCEANOGR, V47, P1734; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Masterson P, 2008, J EXP MAR BIOL ECOL, V363, P12, DOI 10.1016/j.jembe.2008.06.001; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Menge BA, 2003, P NATL ACAD SCI USA, V100, P12229, DOI 10.1073/pnas.1534875100; Menge BA, 1999, ECOL MONOGR, V69, P297, DOI 10.1890/0012-9615(1999)069[0297:TDABUR]2.0.CO;2; NICOTRI ME, 1980, J EXP MAR BIOL ECOL, V42, P13, DOI 10.1016/0022-0981(80)90163-X; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; Nielsen KJ, 2001, ECOL MONOGR, V71, P187, DOI 10.1890/0012-9615(2001)071[0187:BUATDF]2.0.CO;2; PEARCE A F, 1991, Journal of the Royal Society of Western Australia, V74, P35; Pennings SC, 2005, ECOLOGY, V86, P2310, DOI 10.1890/04-1022; Rochford DJ, 1979, NUTR STATUS OCEANS A, P9; Russell BD, 2007, MAR ECOL PROG SER, V349, P73, DOI 10.3354/meps07097; Russell BD, 2005, MAR BIOL, V147, P551, DOI 10.1007/s00227-005-1571-3; Russell BD, 2005, MAR ECOL PROG SER, V289, P5, DOI 10.3354/meps289005; Sanford E, 2003, SCIENCE, V300, P1135, DOI 10.1126/science.1083437; SCHIEL DR, 1990, HYDROBIOLOGIA, V192, P59, DOI 10.1007/BF00006227; Silliman BR, 2001, ECOLOGY, V82, P2830, DOI 10.1890/0012-9658(2001)082[2830:TDCOSA]2.0.CO;2; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1981, OECOLOGIA, V48, P221, DOI 10.1007/BF00347968; UNDERWOOD AJ, 1980, OECOLOGIA, V46, P201, DOI 10.1007/BF00540127; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; WILLIAMS SL, 1993, ECOLOGY, V74, P904, DOI 10.2307/1940815; Worm B, 2000, INT REV HYDROBIOL, V85, P359; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Worm B, 2000, MAR ECOL PROG SER, V202, P283, DOI 10.3354/meps202283; Worm B, 1999, MAR ECOL PROG SER, V185, P309, DOI 10.3354/meps185309	60	29	29	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33825	10.1371/journal.pone.0033825	http://dx.doi.org/10.1371/journal.pone.0033825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457792	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900027
J	Ritari, J; Hultman, J; Fingerroos, R; Tarkkanen, J; Pullat, J; Paulin, L; Kivi, N; Auvinen, P; Auvinen, E				Ritari, Jarmo; Hultman, Jenni; Fingerroos, Rita; Tarkkanen, Jussi; Pullat, Janne; Paulin, Lars; Kivi, Niina; Auvinen, Petri; Auvinen, Eeva			Detection of Human Papillomaviruses by Polymerase Chain Reaction and Ligation Reaction on Universal Microarray	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; DNA MICROARRAY; AMPLIFICATION; CYTOLOGY; PRIMERS; ARRAY; PCR; ABUNDANCE; CELLS	Sensitive and specific detection of human papillomaviruses (HPV) in cervical samples is a useful tool for the early diagnosis of epithelial neoplasia and anogenital lesions. Recent studies support the feasibility of HPV DNA testing instead of cytology (Pap smear) as a primary test in population screening for cervical cancer. This is likely to be an option in the near future in many countries, and it would increase the efficiency of screening for cervical abnormalities. We present here a microarray test for the detection and typing of 15 most important high-risk HPV types and two low risk types. The method is based on type specific multiplex PCR amplification of the L1 viral genomic region followed by ligation detection reaction where two specific ssDNA probes, one containing a fluorescent label and the other a flanking ZipCode sequence, are joined by enzymatic ligation in the presence of the correct HPV PCR product. Human beta-globin is amplified in the same reaction to control for sample quality and adequacy. The genotyping capacity of our approach was evaluated against Linear Array test using cervical samples collected in transport medium. Altogether 14 out of 15 valid samples (93%) gave concordant results between our test and Linear Array. One sample was HPV56 positive in our test and high-risk positive in Hybrid Capture 2 but remained negative in Linear Array. The preliminary results suggest that our test has accurate multiple HPV genotyping capability with the additional advantages of generic detection format, and potential for high-throughput screening.	[Ritari, Jarmo; Hultman, Jenni; Paulin, Lars; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Fingerroos, Rita; Kivi, Niina; Auvinen, Eeva] Helsinki Univ Hosp Lab, Dept Virol, Helsinki, Finland; [Fingerroos, Rita; Kivi, Niina; Auvinen, Eeva] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Tarkkanen, Jussi] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland; [Pullat, Janne] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany	University of Helsinki; University of Helsinki; University of Helsinki; Helmholtz Association; German Cancer Research Center (DKFZ)	Ritari, J (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	jarmo.ritari@helsinki.fi	Auvinen, Petri/D-5044-2009; Ritari, Jarmo/G-4245-2016; Auvinen, Petri/AAP-8117-2021; Hultman, Jenni/K-1990-2015	Auvinen, Petri/0000-0002-3947-4778; Ritari, Jarmo/0000-0002-3458-9314; Hultman, Jenni/0000-0002-3431-1785; Auvinen, Eeva/0000-0002-2094-985X	Helsinki University Hospital Laboratory; Finnish Cultural Foundation	Helsinki University Hospital Laboratory; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was financially supported by the Helsinki University Hospital Laboratory and the Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2006, J VIROL METHODS, V137, P236, DOI 10.1016/j.jviromet.2006.06.023; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anttila A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1804; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Candela M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-116; Choi JJ, 2009, J CLIN MICROBIOL, V47, P1785, DOI 10.1128/JCM.01398-08; CHOO KB, 1987, VIROLOGY, V161, P259, DOI 10.1016/0042-6822(87)90195-4; Coutlee F, 2002, J CLIN MICROBIOL, V40, P902, DOI 10.1128/JCM.40.3.902-907.2002; Delrio-Lafreniere SA, 2004, DIAGN MICR INFEC DIS, V48, P23, DOI 10.1016/j.diagmicrobio.2003.09.007; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Gemignani F, 2004, J VIROL METHODS, V119, P95, DOI 10.1016/j.jviromet.2004.02.018; Gerry NP, 1999, J MOL BIOL, V292, P251, DOI 10.1006/jmbi.1999.3063; Gheit T, 2006, J CLIN MICROBIOL, V44, P2025, DOI 10.1128/JCM.02305-05; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Gupta R, 2007, MOL CELL PROBE, V21, P321, DOI 10.1016/j.mcp.2007.03.006; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Hultman J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-237; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Iqbal J, 2008, INDIAN J MED MICROBI, V26, P13, DOI 10.4103/0255-0857.38851; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kim CJ, 2003, GYNECOL ONCOL, V89, P210, DOI 10.1016/S0090-8258(02)00069-0; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; Lee JK, 2009, INT J GYNECOL CANCER, V19, P266, DOI 10.1111/IGC.0b013e31819bcd0a; Leinonen M, 2009, JNCI-J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Perrons C, 2002, J MED VIROL, V67, P246, DOI 10.1002/jmv.2214; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; R Core Team, 2020, R LANG ENV STAT COMP; RESNICK RM, 1990, JNCI-J NATL CANCER I, V82, P1477, DOI 10.1093/jnci/82.18.1477; Ritari Jarmo, 2009, BMC Res Notes, V2, P249, DOI 10.1186/1756-0500-2-249; Scarinci IC, 2010, CANCER-AM CANCER SOC, V116, P2531, DOI 10.1002/cncr.25065; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P930; Schlecht NF, 2003, JNCI-J NATL CANCER I, V95, P1336, DOI 10.1093/jnci/djg037; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2010, J CLIN MICROBIOL, V48, P143, DOI 10.1128/JCM.00991-09; Staden R, 2000, Methods Mol Biol, V132, P115; Tarkkanen J, 2007, ACTA OBSTET GYN SCAN, V86, P367, DOI 10.1080/00016340601185343; Tempfer C, 2007, ANTICANCER RES, V27, P1721; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Wolffs PFG, 2009, J CLIN MICROBIOL, V47, P2620, DOI 10.1128/JCM.02436-08	43	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34211	10.1371/journal.pone.0034211	http://dx.doi.org/10.1371/journal.pone.0034211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457826	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900055
J	Seppala, EH; Koskinen, LLE; Gullov, CH; Jokinen, P; Karlskov-Mortensen, P; Bergamasco, L; Korberg, IB; Cizinauskas, S; Oberbauer, AM; Berendt, M; Fredholm, M; Lohi, H				Seppala, Eija H.; Koskinen, Lotta L. E.; Gullov, Christina H.; Jokinen, Paivi; Karlskov-Mortensen, Peter; Bergamasco, Luciana; Korberg, Izabella Baranowska; Cizinauskas, Sigitas; Oberbauer, Anita M.; Berendt, Mette; Fredholm, Merete; Lohi, Hannes			Identification of a Novel Idiopathic Epilepsy Locus in Belgian Shepherd Dogs	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; FAMILIAL PARTIAL EPILEPSY; GENOME-WIDE ASSOCIATION; FINNISH SPITZ DOGS; VARIABLE FOCI; CLINICAL CHARACTERISTICS; CHROMOSOME 22Q12; NERVOUS-SYSTEM; MUTATION; SEIZURES	Epilepsy is the most common neurological disorder in dogs, with an incidence ranging from 0.5% to up to 20% in particular breeds. Canine epilepsy can be etiologically defined as idiopathic or symptomatic. Epileptic seizures may be classified as focal with or without secondary generalization, or as primary generalized. Nine genes have been identified for symptomatic (storage diseases) and one for idiopathic epilepsy in different breeds. However, the genetic background of common canine epilepsies remains unknown. We have studied the clinical and genetic background of epilepsy in Belgian Shepherds. We collected 159 cases and 148 controls and confirmed the presence of epilepsy through epilepsy questionnaires and clinical examinations. The MRI was normal while interictal EEG revealed abnormalities and variable foci in the clinically examined affected dogs. A genome-wide association study using Affymetrix 50K SNP arrays in 40 cases and 44 controls mapped the epilepsy locus on CFA37, which was replicated in an independent cohort (81 cases and 88 controls; combined p = 9.70x10(-10), OR = 3.3). Fine mapping study defined a similar to 1 Mb region including 12 genes of which none are known epilepsy genes or encode ion channels. Exonic sequencing was performed for two candidate genes, KLF7 and ADAM23. No variation was found in KLF7 but a highly-associated non-synonymous variant, G1203A (R387H) was present in the ADAM23 gene (p = 3.7x10(-8), OR = 3.9 for homozygosity). Homozygosity for a two-SNP haplotype within the ADAM23 gene conferred the highest risk for epilepsy (p = 6.28x10(-11), OR = 7.4). ADAM23 interacts with known epilepsy proteins LGI1 and LGI2. However, our data suggests that the ADAM23 variant is a polymorphism and we have initiated a targeted re-sequencing study across the locus to identify the causative mutation. It would establish the affected breed as a novel therapeutic model, help to develop a DNA test for breeding purposes and introduce a novel candidate gene for human idiopathic epilepsies.	[Seppala, Eija H.; Koskinen, Lotta L. E.; Jokinen, Paivi; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Seppala, Eija H.; Koskinen, Lotta L. E.; Jokinen, Paivi; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Seppala, Eija H.; Koskinen, Lotta L. E.; Jokinen, Paivi; Lohi, Hannes] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Seppala, Eija H.; Koskinen, Lotta L. E.; Jokinen, Paivi; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Gullov, Christina H.; Berendt, Mette] Univ Copenhagen, Dept Small Anim Clin Sci, Copenhagen, Denmark; [Karlskov-Mortensen, Peter; Fredholm, Merete] Univ Copenhagen, Dept Basic Anim & Vet Sci, Copenhagen, Denmark; [Bergamasco, Luciana] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Korberg, Izabella Baranowska] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden; [Cizinauskas, Sigitas] Referral Anim Neurol Hosp Aisti, Vantaa, Finland; [Oberbauer, Anita M.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of Helsinki; University of Helsinki; University of Helsinki; University of Copenhagen; University of Copenhagen; Kansas State University; Swedish University of Agricultural Sciences; University of California System; University of California Davis	Seppala, EH (corresponding author), Univ Helsinki, Res Programs Unit, Helsinki, Finland.	hannes.lohi@helsinki.fi	Fiumefreddo, Andrea/T-2977-2019; Lohi, Hannes/F-4596-2011; Karlskov-Mortensen, Peter/C-3030-2013	Lohi, Hannes/0000-0003-1087-5532; Karlskov-Mortensen, Peter/0000-0002-2491-2763; Fredholm, Merete/0000-0002-3563-7648; Berendt, Mette/0000-0003-0636-449X	European Commission [GA-201370]; Academy of Finland; Sigrid Juselius Foundation; Morris Animal Foundation; Canine Health Foundation; Biocentrum Helsinki; Jane and Aatos Erkko Foundation; University of Helsinki; Finnish Belgian Shepherd Breed Club; Folkhalsan Research Foundation; Danish Kennel Club	European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Morris Animal Foundation; Canine Health Foundation; Biocentrum Helsinki; Jane and Aatos Erkko Foundation; University of Helsinki; Finnish Belgian Shepherd Breed Club; Folkhalsan Research Foundation; Danish Kennel Club	This study was supported by the European Commission (FP7-LUPA, GA-201370), the Academy of Finland, the Sigrid Juselius Foundation, the Morris Animal Foundation, the Canine Health Foundation, Biocentrum Helsinki, the Jane and Aatos Erkko Foundation, the University of Helsinki Research Funds, The Finnish Belgian Shepherd Breed Club, Folkhalsan Research Foundation, and the Danish Kennel Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol M, 2010, P NATL ACAD SCI USA, V107, P14775, DOI 10.1073/pnas.0914206107; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Awano T, 2006, MOL GENET METAB, V87, P341, DOI 10.1016/j.ymgme.2005.11.005; Awano T, 2006, MOL GENET METAB, V89, P254, DOI 10.1016/j.ymgme.2006.02.016; Berendt M, 2004, EPILEPSY RES, V61, P167, DOI 10.1016/j.eplepsyres.2004.07.009; Berendt M, 2009, J SMALL ANIM PRACT, V50, P655, DOI 10.1111/j.1748-5827.2009.00849.x; Berendt M, 2007, J VET INTERN MED, V21, P754, DOI 10.1892/0891-6640(2007)21[754:PDRFAL]2.0.CO;2; Berendt M, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-51; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bergamasco L, 2003, VET J, V166, P58, DOI 10.1016/S1090-0233(02)00254-X; Berkovic SF, 2004, EPILEPSIA, V45, P1054, DOI 10.1111/j.0013-9580.2004.30502.x; BIELFELT SW, 1971, AM J VET RES, V32, P2039; Caiazzo M, 2011, EXP CELL RES, V317, P464, DOI 10.1016/j.yexcr.2010.11.006; Callenbach PMC, 2003, EPILEPSIA, V44, P1298, DOI 10.1046/j.1528-1157.2003.62302.x; Casal ML, 2006, J VET INTERN MED, V20, P131, DOI 10.1892/0891-6640(2006)20[131:EIIW]2.0.CO;2; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Ekenstedt KJ, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-38; Engel J, 2001, EPILEPSIA, V42, P3, DOI 10.1046/j.1528-1157.2001.0420s6003.x; Famula TR, 1997, J SMALL ANIM PRACT, V38, P349, DOI 10.1111/j.1748-5827.1997.tb03483.x; Farias FHG, 2011, NEUROBIOL DIS, V42, P468, DOI 10.1016/j.nbd.2011.02.009; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; Gauguier D, 2004, EPILEPSIA, V45, P908, DOI 10.1111/j.0013-9580.2004.13104.x; Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009; Goldsmith AP, 2004, J NEUROSCI RES, V78, P647, DOI 10.1002/jnr.20320; Hoefs SJG, 2010, MOL GENET METAB, V100, P251, DOI 10.1016/j.ymgme.2010.03.015; Hulsmeyer V, 2010, J VET INTERN MED, V24, P171, DOI 10.1111/j.1939-1676.2009.0438.x; Jabbari B, 2000, CLIN NEUROPHYSIOL, V111, P102, DOI 10.1016/S1388-2457(99)00189-3; Jaggy A, 1998, J SMALL ANIM PRACT, V39, P275, DOI 10.1111/j.1748-5827.1998.tb03650.x; Jeserevics J, 2007, J VET INTERN MED, V21, P1299, DOI 10.1892/06-285.1; Jin H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-19; Jokinen TS, 2007, J VET INTERN MED, V21, P464, DOI 10.1892/0891-6640(2007)21[464:BFJEIL]2.0.CO;2; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kathmann I, 1999, J SMALL ANIM PRACT, V40, P319, DOI 10.1111/j.1748-5827.1999.tb03089.x; Katz ML, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/198042; Katz ML, 2005, BIOCHEM BIOPH RES CO, V327, P541, DOI 10.1016/j.bbrc.2004.12.038; Knowles K, 1998, CLIN TECH SMALL AN P, V13, P144, DOI 10.1016/S1096-2867(98)80035-2; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Licht BG, 2002, EPILEPSY BEHAV, V3, P460, DOI 10.1016/S1525-5050(02)00523-1; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lohi H, 2005, SCIENCE, V307, P81, DOI 10.1126/science.1102832; Melville SA, 2005, GENOMICS, V86, P287, DOI 10.1016/j.ygeno.2005.06.005; Morales-Corraliza J, 2010, EPILEPSIA, V51, P1910, DOI 10.1111/j.1528-1167.2010.02680.x; Noachtar S, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P21; Nygard Ann-Britt, 2010, BMC Res Notes, V3, P123, DOI 10.1186/1756-0500-3-123; Oberbauer AM, 2003, J HERED, V94, P57, DOI 10.1093/jhered/esg010; Oberbauer AM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-35; Owuor K, 2009, MOL CELL NEUROSCI, V42, P448, DOI 10.1016/j.mcn.2009.09.008; Pal DK, 2008, EPILEPSIA, V49, P386, DOI 10.1111/j.1528-1167.2007.01416.x; Patterson EE, 2005, JAVMA-J AM VET MED A, V226, P54, DOI 10.2460/javma.2005.226.54; Patterson EE, 2003, J VET INTERN MED, V17, P319, DOI 10.1892/0891-6640(2003)017&lt;0319:CCAIOI&gt;2.3.CO;2; Pescucci C, 2007, EUR J MED GENET, V50, P21, DOI 10.1016/j.ejmg.2006.09.001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pillai J, 2006, EPILEPSIA, V47, P14, DOI 10.1111/j.1528-1167.2006.00654.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sander JWAS, 1997, BRIT MED J, V314, P158, DOI 10.1136/bmj.314.7075.158; Sanders DN, 2010, MOL GENET METAB, V100, P349, DOI 10.1016/j.ymgme.2010.04.009; Scheffer IE, 1998, ANN NEUROL, V44, P890, DOI 10.1002/ana.410440607; Schwartz-Porsche D., 1994, CLIN SYNDROMES VET N, P234; Seppala EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002194; Stern JM, 2005, ATLAS EEG PATTERNS, P161; Stern JM, 2005, ATLAS EEG PATTERNS, P93; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Turnbull J, 2005, HUM MOL GENET, V14, P2491, DOI 10.1093/hmg/ddi250; Viitmaa R, 2006, J VET INTERN MED, V20, P305, DOI 10.1892/0891-6640(2006)20[305:MRIFIF]2.0.CO;2; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Xiong L, 1999, AM J HUM GENET, V65, P1698, DOI 10.1086/302649	67	32	32	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33549	10.1371/journal.pone.0033549	http://dx.doi.org/10.1371/journal.pone.0033549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457775	gold, Green Published			2022-12-27	WOS:000304046900017
J	Toobiak, S; Shaklai, M; Shaklai, N				Toobiak, Shlomi; Shaklai, Mati; Shaklai, Nurith			Carbon Monoxide Induced Erythroid Differentiation of K562 Cells Mimics the Central Macrophage Milieu in Erythroblastic Islands	PLOS ONE			English	Article							BONE-MARROW; HEME OXYGENASE-1; ELECTRON-MICROSCOPY; MYELOID-LEUKEMIA; FREEZE-FRACTURE; STEM-CELLS; ERYTHROPOIETIN; HEMOGLOBIN; IRON; IDENTIFICATION	Growing evidence supports the role of erythroblastic islands (EI) as microenvironmental niches within bone marrow (BM), where cell-cell attachments are suggested as crucial for erythroid maturation. The inducible form of the enzyme heme oxygenase, HO-1, which conducts heme degradation, is absent in erythroblasts where hemoglobin (Hb) is synthesized. Yet, the central macrophage, which retains high HO-1 activity, might be suitable to take over degradation of extra, harmful, Hb heme. Of these enzymatic products, only the hydrophobic gas molecule - CO can transfer from the macrophage to surrounding erythroblasts directly via their tightly attached membranes in the terminal differentiation stage. Based on the above, the study hypothesized CO to have a role in erythroid maturation. Thus, the effect of CO gas as a potential erythroid differentiation inducer on the common model for erythroid progenitors, K562 cells, was explored. Cells were kept under oxygen lacking environment to mimic BM conditions. Nitrogen anaerobic atmosphere (N(2)A) served as control for CO atmosphere (COA). Under both atmospheres cells proliferation ceased: in N(2)A due to cell death, while in COA as a result of erythroid differentiation. Maturation was evaluated by increased glycophorin A expression and Hb concentration. Addition of 1%CO only to N(2)A, was adequate for maintaining cell viability. Yet, the average Hb concentration was low as compared to COA. This was validated to be the outcome of diversified maturation stages of the progenitor's population. In fact, the above scenario mimics the in vivo EI conditions, where at any given moment only a minute portion of the progenitors proceeds into terminal differentiation. Hence, this model might provide a basis for further molecular investigations of the EI structure/function relationship.	[Toobiak, Shlomi; Shaklai, Nurith] Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Biochem, IL-69978 Tel Aviv, Israel; [Shaklai, Mati] Tel Aviv Univ, Sackler Fac Med, Dept Hematol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Toobiak, S (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Biochem, IL-69978 Tel Aviv, Israel.	nshaklai@post.tau.ac.il			Krawitz fund for hematology	Krawitz fund for hematology	This study was supported by Krawitz fund for hematology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021358; AOKI M, 1981, BRIT J HAEMATOL, V49, P337, DOI 10.1111/j.1365-2141.1981.tb07235.x; BESSIS M, 1958, Rev Hematol, V13, P8; BESSIS MC, 1962, BLOOD, V19, P635, DOI 10.1182/blood.V19.6.635.635; Calo LA, 2006, NEPHRON PHYSIOL, V103, P107, DOI 10.1159/000092213; Cao YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020634; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chou CC, 2009, N-S ARCH PHARMACOL, V379, P1, DOI 10.1007/s00210-008-0347-y; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; DAVIDSON WF, 1975, J IMMUNOL METHODS, V7, P291, DOI 10.1016/0022-1759(75)90026-5; Guitart AV, 2010, EXP HEMATOL, V38, P847, DOI 10.1016/j.exphem.2010.06.002; Huang M, 2002, MOL PHARMACOL, V62, P463, DOI 10.1124/mol.62.3.463; Immenschuh S, 2010, CURR DRUG TARGETS, V11, P1541, DOI 10.2174/1389450111009011541; ISOYAMA K, 1992, AM J HEMATOL, V39, P65, DOI 10.1002/ajh.2830390115; Katavetin P, 2007, BIOCHEM BIOPH RES CO, V359, P928, DOI 10.1016/j.bbrc.2007.05.207; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; Manwani D, 2008, CURR TOP DEV BIOL, V82, P23, DOI 10.1016/S0070-2153(07)00002-6; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; Moosavi MA, 2006, J BIOCHEM MOL BIOL, V39, P492; Nystul TG, 2004, P NATL ACAD SCI USA, V101, P9133, DOI 10.1073/pnas.0403312101; Panzenbock B, 1998, BLOOD, V92, P3658, DOI 10.1182/blood.V92.10.3658.422k18_3658_3668; QIU LB, 1995, BLOOD, V85, P1630, DOI 10.1182/blood.V85.6.1630.bloodjournal8561630; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; RAY TL, 1988, INFECT IMMUN, V56, P1942, DOI 10.1128/IAI.56.8.1942-1949.1988; Rhodes MM, 2008, BLOOD, V111, P1700, DOI 10.1182/blood-2007-06-098178; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; SCHMIDT H, 1993, CANCER GENET CYTOGEN, V71, P139, DOI 10.1016/0165-4608(93)90019-I; SHAKLAI M, 1979, J ULTRA MOL STRUCT R, V69, P343, DOI 10.1016/S0022-5320(79)80052-0; Shaklai M, 1989, HDB HEMOPOIETIC MICR, P219; SHAKLAI N, 1986, BIOCHEM INT, V13, P467; TAVASSOLI M, 1979, BRIT J HAEMATOL, V43, P235, DOI 10.1111/j.1365-2141.1979.tb03746.x; Toobiak S, 2011, INT J LAB HEMATOL, V33, P645, DOI 10.1111/j.1751-553X.2011.01338.x; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Woessmann W, 2001, EXP CELL RES, V264, P193, DOI 10.1006/excr.2000.5124; Wojda U, 2002, BLOOD, V99, P3005, DOI 10.1182/blood.V99.8.3005.h8003005_3005_3013; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131; YOSHIDA T, 1988, EUR J BIOCHEM, V171, P457, DOI 10.1111/j.1432-1033.1988.tb13811.x; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200	41	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33940	10.1371/journal.pone.0033940	http://dx.doi.org/10.1371/journal.pone.0033940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457802	Green Submitted, gold, Green Published			2022-12-27	WOS:000304046900033
J	Beyerlein, A; Nehring, I; Rzehak, P; Heinrich, J; Mluler, MJ; Plachta-Danielzik, S; Wabitsch, M; Weck, M; Brenner, H; Rothenbacher, D; von Kries, R				Beyerlein, Andreas; Nehring, Ina; Rzehak, Peter; Heinrich, Joachim; Mueller, Manfred J.; Plachta-Danielzik, Sandra; Wabitsch, Martin; Weck, Melanie; Brenner, Hermann; Rothenbacher, Dietrich; von Kries, Ruediger			Gestational Weight Gain and Body Mass Index in Children: Results from Three German Cohort Studies	PLOS ONE			English	Article							KIEL OBESITY PREVENTION; HELICOBACTER-PYLORI INFECTION; PHYSICAL-ACTIVITY; BIRTH COHORT; CHILDHOOD; OVERWEIGHT; PREGNANCY; RISK; METAANALYSIS; KOPS	Introduction: Previous studies suggested potential priming effects of gestational weight gain (GWG) on offspring's body composition in later life. However, consistency of these effects in normal weight, overweight and obese mothers is less clear. Methods: We combined the individual data of three German cohorts and assessed associations of total and excessive GWG (as defined by criteria of the Institute of Medicine) with offspring's mean body mass index (BMI) standard deviation scores (SDS) and overweight at the age of 5-6 years (total: n = 6,254). Quantile regression was used to examine potentially different effects on different parts of the BMI SDS distribution. All models were adjusted for birth weight, maternal age and maternal smoking during pregnancy and stratified by maternal pre-pregnancy weight status. Results: In adjusted models, positive associations of total and excessive GWG with mean BMI SDS and overweight were observed only in children of non-overweight mothers. For example, excessive GWG was associated with a mean increase of 0.08 (95% CI: 0.01, 0.15) units of BMI SDS (0.13 (0.02, 0.24) kg/m(2) of 'real' BMI) in children of normal-weight mothers. The effects of total and excessive GWG on BMI SDS increased for higher- BMI children of normal-weight mothers. Discussion: Increased GWG is likely to be associated with overweight in offspring of non-overweight mothers.	[Beyerlein, Andreas; Nehring, Ina; von Kries, Ruediger] Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany; [Rzehak, Peter; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Mueller, Manfred J.; Plachta-Danielzik, Sandra] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany; [Wabitsch, Martin] Univ Hosp Ulm, Ulm, Germany; [Weck, Melanie; Brenner, Hermann; Rothenbacher, Dietrich] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University	Nehring, I (corresponding author), Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany.	ina.streuling@med.uni-muenchen.de	Heinrich, Joachim/N-1720-2013; Brenner, Hermann/ABE-6383-2020; Beyerlein, Andreas/I-7504-2019; Brenner, Hermann/B-4627-2017	Heinrich, Joachim/0000-0002-9620-1629; Brenner, Hermann/0000-0002-6129-1572; Beyerlein, Andreas/0000-0001-6603-5036; Brenner, Hermann/0000-0002-6129-1572; Nehring, Ina/0000-0002-8190-687X	Ludwig-Maximilians-University; Perinatal Prevention of Obesity Development (PEPO) project; "Interdisciplinary Consortium on Obesity Prevention in Children and Adolescents" (PreVENT); German Federal Ministry of education and research (BMBF) [FKZ: 01GI0841, FKZ: 01GI0821]	Ludwig-Maximilians-University; Perinatal Prevention of Obesity Development (PEPO) project; "Interdisciplinary Consortium on Obesity Prevention in Children and Adolescents" (PreVENT); German Federal Ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Ludwig-Maximilians-University innovative research priority project MC-Health (subproject I), the Perinatal Prevention of Obesity Development (PEPO) project and the "Interdisciplinary Consortium on Obesity Prevention in Children and Adolescents" (PreVENT). PEPO (FKZ: 01GI0841) and PreVENT (FKZ: 01GI0821) are part of the German obesity network funded by the German Federal Ministry of education and research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim AR, 2007, OBESITY, V15, P1278, DOI 10.1038/oby.2007.149; Bergmann RL, 2003, PAEDIATR PERINAT EP, V17, P244, DOI 10.1046/j.1365-3016.2003.00496.x; Beyerlein A, 2010, INT J OBESITY, V34, P642, DOI 10.1038/ijo.2009.301; Beyerlein A, 2009, AM J CLIN NUTR, V90, P1552, DOI 10.3945/ajcn.2009.28026; Beyerlein A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-59; Chen CM, 2007, J ALLERGY CLIN IMMUN, V119, P1148, DOI 10.1016/j.jaci.2007.02.017; Danielzik S, 2005, INT J OBESITY, V29, pS78, DOI 10.1038/sj.ijo.0803099; Heude B, 2005, INT J OBESITY, V29, P1222, DOI 10.1038/sj.ijo.0802920; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; Institute of Medicine, 1990, NUTR PREGN; Mamun AA, 2010, AM J CLIN NUTR, V91, P1336, DOI 10.3945/ajcn.2009.28950; McClure CK, 2011, OBESITY, V19, P1047, DOI 10.1038/oby.2010.300; Moreira P, 2007, INT J OBESITY, V31, P608, DOI 10.1038/sj.ijo.0803582; Muller MJ, 2001, INT J OBESITY, V25, pS66, DOI 10.1038/sj.ijo.0801703; Nehring I, 2011, AM J CLIN NUTR, V94, P1225, DOI 10.3945/ajcn.111.015289; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Nohr EA, 2009, AM J CLIN NUTR, V90, P1288, DOI 10.3945/ajcn.2009.27919; Oken E, 2008, OBSTET GYNECOL, V112, P999, DOI 10.1097/AOG.0b013e31818a5d50; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Plachta-Danielzik S, 2008, OBESITY FACTS, V1, P325, DOI 10.1159/000176609; POSKITT EME, 1995, ACTA PAEDIATR, V84, P961, DOI 10.1111/j.1651-2227.1995.tb13806.x; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Schiessl B, 2009, J PERINAT MED, V37, P374, DOI 10.1515/JPM.2009.068; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; STEVENSSIMON C, 1992, J AM DIET ASSOC, V92, P1348; Streuling I, 2011, BJOG-INT J OBSTET GY, V118, P278, DOI 10.1111/j.1471-0528.2010.02801.x; Streuling I, 2010, AM J CLIN NUTR, V92, P678, DOI 10.3945/ajcn.2010.29363; VONKRIES R, 2010, INT J PEDIAT OBES; Weyermann M, 2006, INT J OBESITY, V30, P1281, DOI 10.1038/sj.ijo.0803260; Weyermann M, 2005, PEDIATR RES, V58, P897, DOI 10.1203/01.PDR.0000181370.67474.FD; Weyermann M, 2009, AM J GASTROENTEROL, V104, P182, DOI 10.1038/ajg.2008.61; World Health Organization (WHO), WHO GROWTH REF DAT 5; Wrotniak BH, 2008, AM J CLIN NUTR, V87, P1818, DOI 10.1093/ajcn/87.6.1818; Zilko CEM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.007; Zutavern A, 2007, ACTA PAEDIATR, V96, P1494, DOI 10.1111/j.1651-2227.2007.00412.x	35	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33205	10.1371/journal.pone.0033205	http://dx.doi.org/10.1371/journal.pone.0033205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457745	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200024
J	Garrido-Sanchez, L; Garcia-Fuentes, E; Fernandez-Garcia, D; Escote, X; Alcaide, J; Perez-Martinez, P; Vendrell, J; Tinahones, FJ				Garrido-Sanchez, Lourdes; Garcia-Fuentes, Eduardo; Fernandez-Garcia, Diego; Escote, Xavier; Alcaide, Juan; Perez-Martinez, Pablo; Vendrell, Joan; Tinahones, Francisco J.			Zinc-Alpha 2-Glycoprotein Gene Expression in Adipose Tissue Is Related with Insulin Resistance and Lipolytic Genes in Morbidly Obese Patients	PLOS ONE			English	Article							LIPID-MOBILIZING FACTOR; CANCER CACHEXIA; ZINC-ALPHA(2)-GLYCOPROTEIN; ZINC-ALPHA-2-GLYCOPROTEIN; MICE; INFLAMMATION; ADIPOCYTES; METABOLISM; INDUCTION; ADIPOKINE	Objective: Zinc-alpha(2) glycoprotein (ZAG) stimulates lipid loss by adipocytes and may be involved in the regulation of adipose tissue metabolism. However, to date no studies have been made in the most extreme of obesity. The aims of this study are to analyze ZAG expression levels in adipose tissue from morbidly obese patients, and their relationship with lipogenic and lipolytic genes and with insulin resistance (IR). Methods: mRNA expression levels of PPAR gamma, IRS-1, IRS-2, lipogenic and lipolytic genes and ZAG were quantified in visceral (VAT) and subcutaneous adipose tissue (SAT) of 25 nondiabetic morbidly obese patients, 11 with low IR and 14 with high IR. Plasma ZAG was also analyzed. Results: The morbidly obese patients with low IR had a higher VAT ZAG expression as compared with the patients with high IR (p = 0.023). In the patients with low IR, the VAT ZAG expression was greater than that in SAT (p = 0.009). ZAG expression correlated between SAT and VAT (r = 0.709, p < 0.001). VAT ZAG expression was mainly predicted by insulin, HOMA-IR, plasma adiponectin and expression of adiponectin and ACSS2. SAT ZAG expression was only predicted by expression of ATGL. Conclusions: ZAG could be involved in modulating lipid metabolism in adipose tissue and is associated with insulin resistance. These findings suggest that ZAG may be a useful target in obesity and related disorders, such as diabetes.	[Garrido-Sanchez, Lourdes; Escote, Xavier; Vendrell, Joan] Hosp Univ Joan XXIII, Pere Virgili Inst, CIBERDEM, Tarragona, Spain; [Garcia-Fuentes, Eduardo; Alcaide, Juan] Fdn IMABIS, Malaga, Spain; [Garcia-Fuentes, Eduardo; Fernandez-Garcia, Diego; Perez-Martinez, Pablo; Tinahones, Francisco J.] Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Malaga, Spain; [Fernandez-Garcia, Diego; Alcaide, Juan; Tinahones, Francisco J.] Hosp Clin Virgen de la Victoria, Serv Endocrinol & Nutr, Malaga, Spain; [Perez-Martinez, Pablo] Hosp Univ Reina Sofia, Med Interna Serv, Cordoba, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); FIMABIS; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Hospital Virgen de la Victoria; Hospital Universitario Reina Sofia - Cordoba	Garrido-Sanchez, L (corresponding author), Hosp Univ Joan XXIII, Pere Virgili Inst, CIBERDEM, Tarragona, Spain.	lourgarrido@gmail.com; edugf1@gmail.com	Escote, Xavier/G-3440-2015; Tinahones, Francisco José/AAB-2882-2020; Escoté, Xavier/AAH-2973-2020; Vendrell, Joan j/V-4034-2018; Escote, Xavier/AAC-6335-2019; Garcia-Fuentes, Eduardo/AAB-1607-2020	Escote, Xavier/0000-0003-1172-3995; Vendrell, Joan j/0000-0002-6994-6115; Escote, Xavier/0000-0003-1172-3995; Perez Martinez, Pablo/0000-0001-7716-8117; GARCIA-FUENTES, EDUARDO/0000-0002-3491-2724; Tinahones, Francisco J/0000-0001-6871-4403	Programa Juan de la Cierva [JCI-2009-04086]; Instituto de Salud Carlos III [CP04/00133, PS09/01060, PS09/00997]; Servicio Andaluz de Salud [PI0255/2007]	Programa Juan de la Cierva; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Servicio Andaluz de Salud	This work was supported in part by grants from the Programa Juan de la Cierva (JCI-2009-04086), Instituto de Salud Carlos III (CP04/00133, PS09/01060, PS09/00997), Servicio Andaluz de Salud (PI0255/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne GH, 2005, OBES SURG, V15, P692, DOI 10.1381/0960892053923789; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Bing C, 2002, BRIT J CANCER, V86, P612, DOI 10.1038/sj.bjc.6600101; Bing C, 2008, CURR OPIN CLIN NUTR, V11, P201, DOI 10.1097/MCO.0b013e3282f948e2; Ceperuelo-Mallafre V, 2009, J CLIN ENDOCR METAB, V94, P5062, DOI 10.1210/jc.2009-0764; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Garcia-Fuentes E, 2010, OBESITY, V18, P952, DOI 10.1038/oby.2009.314; Garrido-Sanchez Lourdes, 2012, PLOS ONE IN PRESS; Gohda T, 2003, DIABETES, V52, P2175, DOI 10.2337/diabetes.52.8.2175; Gong FY, 2009, INT J OBESITY, V33, P1023, DOI 10.1038/ijo.2009.141; Guerre-Millo M, 2002, J ENDOCRINOL INVEST, V25, P855, DOI 10.1007/BF03344048; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hirai K, 1998, CANCER RES, V58, P2359; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Large V, 1998, DIABETES METAB, V24, P409; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Marrades MP, 2008, J PHYSIOL BIOCHEM, V64, P61, DOI 10.1007/BF03168235; Mracek T, 2010, CLIN ENDOCRINOL, V72, P334, DOI 10.1111/j.1365-2265.2009.03658.x; Rolli V, 2007, FEBS LETT, V581, P394, DOI 10.1016/j.febslet.2006.12.047; Russell ST, 2005, BRIT J CANCER, V92, P876, DOI 10.1038/sj.bjc.6602404; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Russell ST, 2002, BRIT J CANCER, V86, P424, DOI 10.1038/sj.bjc.6600086; Selva DM, 2009, J CLIN ENDOCR METAB, V94, P4499, DOI 10.1210/jc.2009-0758; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Smith U, 2002, INT J OBESITY, V26, P897, DOI 10.1038/sj.ijo.0802028; Stejskal D, 2008, CLIN BIOCHEM, V41, P313, DOI 10.1016/j.clinbiochem.2007.11.010; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940; Tinahones FJ, 2010, OBES SURG, V20, P1559, DOI 10.1007/s11695-010-0194-z; Todorov PT, 1998, CANCER RES, V58, P2353; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Tzanavari T, 2007, MOL CELL ENDOCRINOL, V279, P26, DOI 10.1016/j.mce.2007.08.015; WHITE MF, 1994, J BIOL CHEM, V269, P1	34	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33264	10.1371/journal.pone.0033264	http://dx.doi.org/10.1371/journal.pone.0033264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442679	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500021
J	Orlando, RA; Gonzales, AM; Royer, RE; Deck, LM; Vander Jagt, DL				Orlando, Robert A.; Gonzales, Amanda M.; Royer, Robert E.; Deck, Lorraine M.; Vander Jagt, David L.			A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization	PLOS ONE			English	Article							CHEMOPREVENTIVE AGENT CURCUMIN; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; IN-VIVO; PROTEIN; BIOAVAILABILITY; FIBRILS; STRATEGIES; PATHOLOGY	Amyloid-like plaques are characteristic lesions defining the neuropathology of Alzheimer's disease (AD). The size and density of these plaques are closely associated with cognitive decline. To combat this disease, the few therapies that are available rely on drugs that increase neurotransmission; however, this approach has had limited success as it has simply slowed an imminent decline and failed to target the root cause of AD. Amyloid-like deposits result from aggregation of the A beta peptide, and thus, reducing amyloid burden by preventing A beta aggregation represents an attractive approach to improve the therapeutic arsenal for AD. Recent studies have shown that the natural product curcumin is capable of crossing the blood-brain barrier in the CNS in sufficient quantities so as to reduce amyloid plaque burden. Based upon this bioactivity, we hypothesized that curcumin presents molecular features that make it an excellent lead compound for the development of more effective inhibitors of A beta aggregation. To explore this hypothesis, we screened a library of curcumin analogs and identified structural features that contribute to the anti-oligomerization activity of curcumin and its analogs. First, at least one enone group in the spacer between aryl rings is necessary for measureable anti-A beta aggregation activity. Second, an unsaturated carbon spacer between aryl rings is essential for inhibitory activity, as none of the saturated carbon spacers showed any margin of improvement over that of native curcumin. Third, methoxyl and hydroxyl substitutions in the meta- and para-positions on the aryl rings appear necessary for some measure of improved inhibitory activity. The best lead inhibitors have either their meta-and para-substituted methoxyl and hydroxyl groups reversed from that of curcumin or methoxyl or hydroxyl groups placed in both positions. The simple substitution of the para-hydroxy group on curcumin with a methoxy substitution improved inhibitor function by 6-7-fold over that measured for curcumin.	[Orlando, Robert A.; Gonzales, Amanda M.; Royer, Robert E.; Vander Jagt, David L.] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Deck, Lorraine M.] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Orlando, RA (corresponding author), Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA.	rorlando@salud.unm.edu			National Institutes of Health [AG027794]; NATIONAL INSTITUTE ON AGING [R21AG027794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health Grant AG027794 to RAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Asai A, 2000, LIFE SCI, V67, P2785, DOI 10.1016/S0024-3205(00)00868-7; Barclay LRC, 2000, ORG LETT, V2, P2841, DOI 10.1021/ol000173t; Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Byeon SR, 2007, BIOORG MED CHEM LETT, V17, P1466, DOI 10.1016/j.bmcl.2006.10.090; DaSilva KA, 2010, EXP NEUROL, V223, P311, DOI 10.1016/j.expneurol.2009.08.032; DYRKS T, 1993, FEBS LETT, V335, P89, DOI 10.1016/0014-5793(93)80446-2; Estrada LD, 2007, CURR TOP MED CHEM, V7, P115, DOI 10.2174/156802607779318262; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Frautschy SA, 2010, MOL NEUROBIOL, V41, P392, DOI 10.1007/s12035-010-8137-1; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Glenner G G, 1984, Appl Pathol, V2, P357; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; GONZALES AM, 2009, OPEN BIOTECHNOL J, V3, P108; Habgood MD, 1998, CLIN EXP PHARMACOL P, V25, P361, DOI 10.1111/j.1440-1681.1998.tb02364.x; Habgood MD, 2000, CELL MOL NEUROBIOL, V20, P231, DOI 10.1023/A:1007001923498; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Ireson C, 2001, CANCER RES, V61, P1058; Ireson CR, 2002, CANCER EPIDEM BIOMAR, V11, P105; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; KLUNK WE, 1994, NEUROBIOL AGING, V15, P691, DOI 10.1016/0197-4580(94)90050-7; LeVine H, 2004, ANAL BIOCHEM, V335, P81, DOI 10.1016/j.ab.2004.08.014; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Markesbery WR, 2010, J ALZHEIMERS DIS, V19, P221, DOI 10.3233/JAD-2010-1220; Mayeux R, 1999, NEW ENGL J MED, V341, P1670, DOI 10.1056/NEJM199911253412207; Mendonca LM, 2009, MUTAT RES-GEN TOX EN, V675, P29, DOI 10.1016/j.mrgentox.2009.02.003; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Narlawar R, 2008, CHEMMEDCHEM, V3, P165, DOI 10.1002/cmdc.200700218; Narlawar R, 2007, BIOORG MED CHEM LETT, V17, P5428, DOI 10.1016/j.bmcl.2007.07.044; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Ng TP, 2006, AM J EPIDEMIOL, V164, P898, DOI 10.1093/aje/kwj267; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Park SY, 2002, J NAT PROD, V65, P1227, DOI 10.1021/np010039x; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Riviere C, 2007, BIOORGAN MED CHEM, V15, P1160, DOI 10.1016/j.bmc.2006.09.069; Rodrigue KM, 2009, NEUROPSYCHOL REV, V19, P436, DOI 10.1007/s11065-009-9118-x; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Soto C, 1999, MOL MED TODAY, V5, P343, DOI 10.1016/S1357-4310(99)01508-7; Talaga Patrice, 2001, Mini-Reviews in Medicinal Chemistry, V1, P175, DOI 10.2174/1389557013407098; Tamaoka A, 1997, J NEUROL SCI, V148, P41, DOI 10.1016/S0022-510X(96)00314-0; Terry RD, 2000, ANN NEUROL, V47, P421, DOI 10.1002/1531-8249(200004)47:4<421::AID-ANA3>3.3.CO;2-D; Thomas P, 2009, MUTAT RES-FUND MOL M, V661, P25, DOI 10.1016/j.mrfmmm.2008.10.016; Weber WM, 2005, BIOORGAN MED CHEM, V13, P3811, DOI 10.1016/j.bmc.2005.03.035; Yamin G, 2008, CURR PHARM DESIGN, V14, P3231, DOI 10.2174/138161208786404137; Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	49	55	57	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e31869	10.1371/journal.pone.0031869	http://dx.doi.org/10.1371/journal.pone.0031869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442659	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500002
J	Yang, CF; Jin, CL; Li, XK; Wang, F; McKeehan, WL; Luo, YD				Yang, Chaofeng; Jin, Chengliu; Li, Xiaokun; Wang, Fen; McKeehan, Wallace L.; Luo, Yongde			Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-19; ACTIVATED-RECEPTOR-GAMMA; TRANSCRIPTS ENCODING MEMBRANE; INCREASES ENERGY-EXPENDITURE; BILE-ACID SYNTHESIS; MOUSE KLOTHO GENE; PPAR-ALPHA; BETA-KLOTHO; HEPARAN-SULFATE; INSULIN SENSITIVITY	Background: Recent studies suggest that betaKlotho (KLB) and endocrine FGF19 and FGF21 redirect FGFR signaling to regulation of metabolic homeostasis and suppression of obesity and diabetes. However, the identity of the predominant metabolic tissue in which a major FGFR-KLB resides that critically mediates the differential actions and metabolism effects of FGF19 and FGF21 remain unclear. Methodology/Principal Findings: We determined the receptor and tissue specificity of FGF21 in comparison to FGF19 by using direct, sensitive and quantitative binding kinetics, and downstream signal transduction and expression of early response gene upon administration of FGF19 and FGF21 in mice. We found that FGF21 binds FGFR1 with much higher affinity than FGFR4 in presence of KLB; while FGF19 binds both FGFR1 and FGFR4 in presence of KLB with comparable affinity. The interaction of FGF21 with FGFR4-KLB is very weak even at high concentration and could be negligible at physiological concentration. Both FGF19 and FGF21 but not FGF1 exhibit binding affinity to KLB. The binding of FGF1 is dependent on where FGFRs are present. Both FGF19 and FGF21 are unable to displace the FGF1 binding, and conversely FGF1 cannot displace FGF19 and FGF21 binding. These results indicate that KLB is an indispensable mediator for the binding of FGF19 and FGF21 to FGFRs that is not required for FGF1. Although FGF19 can predominantly activate the responses of the liver and to a less extent the adipose tissue, FGF21 can do so significantly only in the adipose tissue and adipocytes. Among several metabolic and endocrine tissues, the response of adipose tissue to FGF21 is predominant, and can be blunted by the ablation of KLB or FGFR1. Conclusions: Our results indicate that unlike FGF19, FGF21 is unable to bind FGFR4-KLB complex with affinity comparable to FGFR1-KLB, and therefore, at physiological concentration less likely to directly and significantly target the liver where FGFR4-KLB predominantly resides. However, both FGF21 and FGF19 have the potential to activate responses of primarily the adipose tissue where FGFR1-KLB resides.	[Yang, Chaofeng; Jin, Chengliu; Wang, Fen; McKeehan, Wallace L.; Luo, Yongde] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX USA; [McKeehan, Wallace L.; Luo, Yongde] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, IBT Prote & Nanotechnol Lab, Houston, TX USA; [Li, Xiaokun] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wenzhou Medical University	Yang, CF (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX USA.	yluo@ibt.tamhsc.edu			U.S. Public Health Service [DK56338]; Texas A&M Health Science Center; Susan Komen Breast Cancer grant; John S. Dunn Research Foundations; Alliance of NanoHealth;  [P50 CA140388]; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Texas A&M Health Science Center; Susan Komen Breast Cancer grant; John S. Dunn Research Foundations; Alliance of NanoHealth; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. Public Health Service grants DK56338 (Texas Medical Center Digestive Diseases Center) and an Enhancement Grant of the Texas A&M Health Science Center to YL, P50 CA140388 to WLM, the Susan Komen Breast Cancer grant, and the John S. Dunn Research Foundations and the Alliance of NanoHealth to YL and WLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Gupte J, 2011, J MOL BIOL, V408, P491, DOI 10.1016/j.jmb.2011.03.003; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Huang XQ, 2009, MOL CARCINOGEN, V48, P553, DOI 10.1002/mc.20494; Huang XQ, 2006, CANCER RES, V66, P1481, DOI 10.1158/0008-5472.CAN-05-2412; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; KAN M, 1991, METHOD ENZYMOL, V198, P158; KAN M, 1991, BIOCHEM BIOPH RES CO, V174, P331, DOI 10.1016/0006-291X(91)90524-B; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; Li XF, 2009, FEBS LETT, V583, P3230, DOI 10.1016/j.febslet.2009.09.012; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Luo YD, 2006, J CELL BIOCHEM, V97, P1241, DOI 10.1002/jcb.20724; Luo YD, 1998, BIOCHEMISTRY-US, V37, P16506, DOI 10.1021/bi9816599; Luo YD, 2006, J BIOL CHEM, V281, P21052, DOI 10.1074/jbc.M601559200; Luo YD, 2010, J BIOL CHEM, V285, P30069, DOI 10.1074/jbc.M110.148288; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Mashili FL, 2011, DIABETES-METAB RES, V27, P286, DOI 10.1002/dmrr.1177; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Moore DD, 2007, SCIENCE, V316, P1436, DOI 10.1126/science.1144837; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Wu XL, 2007, J BIOL CHEM, V282, P29069, DOI 10.1074/jbc.C700130200; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	74	89	95	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33870	10.1371/journal.pone.0033870	http://dx.doi.org/10.1371/journal.pone.0033870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442730	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500071
J	Gleicher, N; Weghofer, A; Kim, A; Barad, DH				Gleicher, Norbert; Weghofer, Andrea; Kim, Ann; Barad, David H.			The Impact in Older Women of Ovarian FMR1 Genotypes and Sub-Genotypes on Ovarian Reserve	PLOS ONE			English	Article							CGG REPEAT; REPRODUCTION; HORMONE; COUNTS; GENE	We recently associated ovarian FMR1 genotypes and sub-genotypes with distinct ovarian aging patterns. How they impact older females is, however, unknown. We, therefore, investigated 217 consecutive first in vitro fertilization (IVF) cycles in women >= 40 assessing oocyte yields, stratified for better (anti-Mullerian hormone, AMH.1.05 ng/mL) or poorer (AMH <= 1.05 ng/mL) functional reserve (FOR)). Mean age was 42.4+/-2.0 years, mean AMH 0.76+/-0.92 ng/mL and mean oocyte yield 5.3+/-5.4. Overall, and in women with better FOR, FMR1 did not affect oocyte yields. With poorer FOR (AMH <= 1.05 ng/mL) women with het-norm/high, however, demonstrated higher oocyte yields (5.0+/-3.8) than those with het-norm/low sub-genotype 3.1+/-2.5; P = 0.03), confirmed after log conversion. Known associated with low FOR at young age, het-norm/high, thus, appears to preserve FOR into older age, and both het sub-genotypes appear to expand female reproductive lifespan into opposite directions.	[Gleicher, Norbert; Weghofer, Andrea; Kim, Ann; Barad, David H.] Ctr Human Reprod, New York, NY 10021 USA; [Gleicher, Norbert; Weghofer, Andrea; Kim, Ann; Barad, David H.] Fdn Reprod Med, New York, NY USA; [Weghofer, Andrea] Med Univ Vienna, Dept Gynecol Endocrinol & Reprod Med, Vienna, Austria; [Barad, David H.] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA; [Barad, David H.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA	Medical University of Vienna; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gleicher, N (corresponding author), Ctr Human Reprod, New York, NY 10021 USA.	ngleicher@thechr.com; dbarad@thechr.com	Barad, David/AAF-4332-2021		CHR	CHR	NG is owner of CHR, a for-profit infertility center, where this research was conducted. NG and DHB are listed as co-inventors on a number of pending, and one already awarded, U. S. patents claiming diagnostic benefits from dehydroepiandrosterone (DHEA)/androgen supplementation in women with diminished ovarian reserve (DOR). CHR recently received notice that a second U. S. DHEA patent, including the claim that DHEA/androgen supplementation reduces embryo aneuploidy in women with DOR, would be issued in the near future. NG and DHB are also co-inventors on a number of pending U. S. patent applications, claiming diagnostic relevance for the assessment of CGG triple repeats on the FMR1 gene in determining risk toward DOR and related issues. NG, AW, and DHB have in the past received research support, travel funds and speakers' honoraria from different pharma and medical device companies, none, however, in any way related to the here presented research data. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. At the time of this submission only one U. S. user patent with any relevance to this manuscript has been awarded (November 10, 2009; # 7615544). It claims benefits from supplementation with DHEA/Androgens on ovarian reserve and pregnancy rates in women with DOR. Above noted second user patent (# 12/123,877) is expected within weeks from this submission, claiming expanded benefits on pregnancy chances and decreased embryo aneuploidy (and, therefore, miscarriage risk) from DHEA/androgen supplementation. Among patent applications pending in regards to the FMR1 gene, one describes ovarian genotypes and sub-genotypes used in this manuscript, and claims that they reflect different ovarian aging patterns. All patent applications filed by researchers at CHR are 50% owned by CHR and 50% by the investigators who did the research that led to the application. A full list of all patent information can be provided on request. This study was partially funded by CHR.	Barad DH, 2007, OBSTET GYNECOL, V109, P1404, DOI 10.1097/01.AOG.0000264065.37661.a0; Barad DH, 2011, REPROD BIOMED ONLINE, V22, P284, DOI 10.1016/j.rbmo.2010.12.002; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Gleicher N, 2012, J AUTOIMMUN, V38, pJ74, DOI 10.1016/j.jaut.2011.05.016; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-67; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; Gleicher N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015303; Gleicher N, 2010, FERTIL STERIL, V94, P2824, DOI 10.1016/j.fertnstert.2010.04.067; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P485, DOI 10.1016/j.rbmo.2009.12.017; Holte J, 2011, FERTIL STERIL, V96, P594, DOI 10.1016/j.fertnstert.2011.06.071; Ledger WL, 2010, J CLIN ENDOCR METAB, V95, P5144, DOI 10.1210/jc.2010-0701; Willemsen R, 2011, CLIN GENET, V80, P214, DOI 10.1111/j.1399-0004.2011.01723.x; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004	16	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33638	10.1371/journal.pone.0033638	http://dx.doi.org/10.1371/journal.pone.0033638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438971	gold, Green Submitted, Green Published			2022-12-27	WOS:000303309100076
J	Kim, Y; Remacle, AG; Chernov, AV; Liu, HQ; Shubayev, I; Lai, C; Dolkas, J; Shiryaev, SA; Golubkov, VS; Mizisin, AP; Strongin, AY; Shubayev, VI				Kim, Youngsoon; Remacle, Albert G.; Chernov, Andrei V.; Liu, Huaqing; Shubayev, Igor; Lai, Calvin; Dolkas, Jennifer; Shiryaev, Sergey A.; Golubkov, Vladislav S.; Mizisin, Andrew P.; Strongin, Alex Y.; Shubayev, Veronica I.			The MMP-9/TIMP-1 Axis Controls the Status of Differentiation and Function of Myelin-Forming Schwann Cells in Nerve Regeneration	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; DORSAL-ROOT GANGLION; RAT SCIATIC-NERVE; PERIPHERAL-NERVE; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; NEUROPATHIC PAIN; WALLERIAN DEGENERATION; NEUTROPHIL GELATINASE; AXONAL REGENERATION	Background: Myelinating Schwann cells (mSCs) form myelin in the peripheral nervous system. Because of the works by us and others, matrix metalloproteinase-9 (MMP-9) has recently emerged as an essential component of the Schwann cell signaling network during sciatic nerve regeneration. Methodology/Principal Findings: In the present study, using the genome-wide transcriptional profiling of normal and injured sciatic nerves in mice followed by extensive bioinformatics analyses of the data, we determined that an endogenous, specific MMP-9 inhibitor [tissue inhibitor of metalloproteinases (TIMP)-1] was a top up-regulated gene in the injured nerve. MMP-9 capture followed by gelatin zymography and Western blotting of the isolated samples revealed the presence of the MMP-9/TIMP-1 heterodimers and the activated MMP-9 enzyme in the injured nerve within the first 24 h post-injury. MMP-9 and TIMP-1 co-localized in mSCs. Knockout of the MMP-9 gene in mice resulted in elevated numbers of de-differentiated/immature mSCs in the damaged nerve. Our comparative studies using MMP-9 knockout and wild-type mice documented an aberrantly enhanced proliferative activity and, accordingly, an increased number of post-mitotic Schwann cells, short internodes and additional nodal abnormalities in remyelinated nerves of MMP-9 knockout mice. These data imply that during the first days post-injury MMP-9 exhibits a functionally important anti-mitogenic activity in the wildtype mice. Pharmacological inhibition of MMP activity suppressed the expression of Na(v)1.7/1.8 channels in the crushed nerves. Conclusion/Significance: Collectively, our data established an essential role of the MMP-9/TIMP-1 axis in guiding the mSC differentiation and the molecular assembly of myelin domains in the course of the nerve repair process. Our findings of the MMP-dependent regulation of Na-v channels, which we document here for the first time, provide a basis for therapeutic intervention in sensorimotor pathologies and pain.	[Kim, Youngsoon; Liu, Huaqing; Lai, Calvin; Dolkas, Jennifer; Shubayev, Veronica I.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Mizisin, Andrew P.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Remacle, Albert G.; Chernov, Andrei V.; Shiryaev, Sergey A.; Golubkov, Vladislav S.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Kim, Youngsoon; Liu, Huaqing; Shubayev, Igor; Lai, Calvin; Dolkas, Jennifer; Shubayev, Veronica I.] VA San Diego Healthcare Syst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Kim, Y (corresponding author), Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA.	vshubayev@ucsd.edu	Chernov, Andrei/I-1623-2019; Golubkov, Vladislav/L-6828-2017; Strongin, Alex/R-6609-2019	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016	VA Merit Review Award; NIH/NINDS [R21NS060307]; NIH/NCI [R01CA83017, R01CA157328]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA157328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060307] Funding Source: NIH RePORTER	VA Merit Review Award(US Department of Veterans Affairs); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The funders (VA Merit Review Award (VIS), NIH/NINDS R21NS060307 (VIS), NIH/NCI R01CA83017 and R01CA157328 (AYS) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided the funding to support the studies.	ALVAREZ J, 1995, EUR J NEUROSCI, V7, P152, DOI 10.1111/j.1460-9568.1995.tb01029.x; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Ardi VC, 2009, J BIOL CHEM, V284, P25854, DOI 10.1074/jbc.M109.033472; Arroyo EJ, 2000, HISTOCHEM CELL BIOL, V113, P1, DOI 10.1007/s004180050001; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Bosse F, 2006, J NEUROCHEM, V96, P1441, DOI 10.1111/j.1471-4159.2005.03635.x; Burg-Roderfeld M, 2007, INT J ONCOL, V30, P985; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Chattopadhyay S, 2007, BRAIN BEHAV IMMUN, V21, P561, DOI 10.1016/j.bbi.2006.10.015; Chattopadhyay S, 2009, GLIA, V57, P1316, DOI 10.1002/glia.20851; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; Chernousov MA, 2008, GLIA, V56, P1498, DOI 10.1002/glia.20740; CLEMENCE A, 1989, J NEUROCYTOL, V18, P185, DOI 10.1007/BF01206661; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Court FA, 2006, CURR OPIN NEUROBIOL, V16, P501, DOI 10.1016/j.conb.2006.08.005; Court FA, 2011, J NEUROSCI, V31, P12208, DOI 10.1523/JNEUROSCI.0141-11.2011; Court FA, 2009, J NEUROSCI, V29, P3908, DOI 10.1523/JNEUROSCI.5672-08.2009; D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Griffin JW, 1984, DEV REGENERATION PER, P361; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Hall SM, 1999, ANN NY ACAD SCI, V883, P215, DOI 10.1111/j.1749-6632.1999.tb08584.x; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; Hartung HP, 2000, J NEUROIMMUNOL, V107, P140, DOI 10.1016/S0165-5728(00)00225-3; Henry MA, 2009, J PAIN, V10, P750, DOI 10.1016/j.jpain.2009.01.264; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kieseier BC, 2006, CURR OPIN NEUROL, V19, P437, DOI 10.1097/01.wco.0000245365.51823.72; Kim CF, 2011, BRAIN RES, V1405, P95, DOI 10.1016/j.brainres.2011.06.022; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kobayashi H, 2008, MOL CELL NEUROSCI, V39, P619, DOI 10.1016/j.mcn.2008.08.008; Krekoski CA, 2002, J NEUROSCI, V22, P10408; Kubo T, 2002, J NEUROCHEM, V82, P1129, DOI 10.1046/j.1471-4159.2002.01060.x; LaFleur M, 1996, J EXP MED, V184, P2311; Lambert E, 2009, INT J BIOCHEM CELL B, V41, P1102, DOI 10.1016/j.biocel.2008.10.017; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Lehmann HC, 2009, GLIA, V57, P479, DOI 10.1002/glia.20774; Liu H, 2011, EXP NEUROL; Liu HQ, 2010, J NEUROPATH EXP NEUR, V69, P386, DOI 10.1097/NEN.0b013e3181d68d12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mcdonald D, 2006, NEURON GLIA BIOL, V2, P139, DOI 10.1017/S1740925X05000347; Milward E, 2008, J NEUROIMMUNOL, V193, P140, DOI 10.1016/j.jneuroim.2007.11.001; Mizisin AP, 1997, J NEUROPATH EXP NEUR, V56, P1290, DOI 10.1097/00005072-199712000-00004; Moore CS, 2011, J NEUROSCI, V31, P6247, DOI 10.1523/JNEUROSCI.5474-10.2011; Morello N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020173; MUIR D, 1994, EXP CELL RES, V210, P243, DOI 10.1006/excr.1994.1036; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nunes GLC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021525; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; Oh LYS, 1999, J NEUROSCI, V19, P8464; Ould-yahoui A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008289; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Persson AK, 2011, EXP NEUROL, V230, P273, DOI 10.1016/j.expneurol.2011.05.005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Platt CI, 2003, J NEUROSCI RES, V74, P417, DOI 10.1002/jnr.10783; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Roeb E, 2002, J BIOL CHEM, V277, P50326, DOI 10.1074/jbc.M207446200; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Shubayev VI, 2002, J PERIPHER NERV SYST, V7, P28, DOI 10.1046/j.1529-8027.2002.02003.x; SIRI A, 1995, J BIOL CHEM, V270, P8650, DOI 10.1074/jbc.270.15.8650; Stoll G, 1999, BRAIN PATHOL, V9, P313; TAPIA M, 1995, EXP NEUROL, V131, P124, DOI 10.1016/0014-4886(95)90014-4; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Udalova IA, 2011, CRIT REV IMMUNOL, V31, P115, DOI 10.1615/CritRevImmunol.v31.i2.30; Uhm JH, 1998, GLIA, V22, P53, DOI 10.1002/(SICI)1098-1136(199801)22:1<53::AID-GLIA5>3.0.CO;2-9; Valder CR, 2003, J NEUROCHEM, V87, P560, DOI 10.1046/j.1471-4159.2003.02016.x; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vega-Avelaira D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-70; Wei Y, 2010, CELL PROLIFERAT, V43, P606, DOI 10.1111/j.1365-2184.2010.00710.x; Werner SR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-83; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Xu QG, 2008, NEUROSCIENCE, V152, P877, DOI 10.1016/j.neuroscience.2008.01.060; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhao XL, 2010, BIOCHEM BIOPH RES CO, V392, P551, DOI 10.1016/j.bbrc.2010.01.062; Zujovic V, 2010, STEM CELLS, V28, P470, DOI 10.1002/stem.290; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	95	73	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33664	10.1371/journal.pone.0033664	http://dx.doi.org/10.1371/journal.pone.0033664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438979	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100083
J	Palipudi, KM; Gupta, PC; Sinha, DN; Andes, LJ; Asma, S; McAfee, T				Palipudi, Krishna M.; Gupta, Prakash C.; Sinha, Dhirendra N.; Andes, Linda J.; Asma, Samira; McAfee, Tim		GATS Collaborative Grp	Social Determinants of Health and Tobacco Use in Thirteen Low and Middle Income Countries: Evidence from Global Adult Tobacco Survey	PLOS ONE			English	Article							SMOKING; MUMBAI; WOMEN; DISPARITIES; STILLBIRTH; COHORT; DEATH; RISK	Background: Tobacco use has been identified as the single biggest cause of inequality in morbidity. The objective of this study is to examine the role of social determinants on current tobacco use in thirteen low-and-middle income countries. Methodology/Principal Findings: We used nationally representative data from the Global Adult Tobacco Survey (GATS) conducted during 2008-2010 in 13 low-and-middle income countries: Bangladesh, China, Egypt, India, Mexico, Philippines, Poland, Russian Federation, Thailand, Turkey, Ukraine, Uruguay, and Viet Nam. These surveys provided information on 209,027 respondent's aged 15 years and above and the country datasets were analyzed individually for estimating current tobacco use across various socio-demographic factors (gender, age, place of residence, education, wealth index, and knowledge on harmful effects of smoking). Multiple logistic regression analysis was used to predict the impact of these determinants on current tobacco use status. Current tobacco use was defined as current smoking or use of smokeless tobacco, either daily or occasionally. Former smokers were excluded from the analysis. Adjusted odds ratios for current tobacco use after controlling other cofactors, was significantly higher for males across all countries and for urban areas in eight of the 13 countries. For educational level, the trend was significant in Bangladesh, Egypt, India, Philippines and Thailand demonstrating decreasing prevalence of tobacco use with increasing levels of education. For wealth index, the trend of decreasing prevalence of tobacco use with increasing wealth was significant for Bangladesh, India, Philippines, Thailand, Turkey, Ukraine, Uruguay and Viet Nam. The trend of decreasing prevalence with increasing levels of knowledge on harmful effects of smoking was significant in China, India, Philippines, Poland, Russian Federation, Thailand, Ukraine and Viet Nam. Conclusions/Significance: These findings demonstrate a significant but varied role of social determinants on current tobacco use within and across countries.	[Palipudi, Krishna M.; Andes, Linda J.; Asma, Samira; McAfee, Tim] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Gupta, Prakash C.] Healis Sekhsaria Inst Publ Hlth, Mumbai, Maharashtra, India; [Sinha, Dhirendra N.] WHO, SE Asia Reg Off, New Delhi, India	Centers for Disease Control & Prevention - USA; World Health Organization	Palipudi, KM (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	kpalipudi@cdc.gov	Andreeva, Tatiana I/G-6306-2010; PAN, ZEQIANG/X-6341-2018; McAfee, Tim/GXG-1246-2022; Zaman, M Mostafa/H-5155-2019	Andreeva, Tatiana I/0000-0001-5663-6225; Reynales - Shigematsu, Luz Myriam/0000-0002-5350-0928; Jha, Prabhat/0000-0001-7067-8341; Hoang Van, Minh/0000-0002-4749-5536; Zaman, M Mostafa/0000-0002-1736-1342; Kim Bao, Giang/0000-0003-2290-0205	Bloomberg Initiative to Reduce Tobacco Use; Bill and Melinda Gates Foundation	Bloomberg Initiative to Reduce Tobacco Use; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for the Global Adult Tobacco Survey (GATS) is provided by the Bloomberg Initiative to Reduce Tobacco Use, a program of Bloomberg Philanthropies. Government of India contributed to GATS implementation in India. Bill and Melinda Gates Foundation provided additional funding for GATS implementation in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; [Anonymous], MILL DEV GOALS TOB C; [Anonymous], 2010, WORLD POP PROSP 2010; Barbeau EM, 2004, TOB CONTROL, V13, P115, DOI 10.1136/tc.2003.006098; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Centers for Disease Control and Prevention, 1965, MORBIDITY MORTALIT S, V60, P109; CSDH, 2008, CLOS GAP GEN HLTH EQ, P25; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; England LJ, 2010, ACTA OBSTET GYN SCAN, V89, P454, DOI 10.3109/00016341003605719; GAT'S China, 2010, GLOB AD TOB SURV CHI; GATS Philippines, 2009, PHIL GLOB AD TOB SUR; GATS Russian Federation, 2009, GLOB AD TOB SURV RUS; GATS Ukraine, 2010, UKR GLOB AD TOB SURV; GATS Uruguay, 2009, GLOB AD TOB SURV UR; Global Tobacco Surveillance System, 2009, GLOB AD TOB SURV IND; Gupta PC, 2006, EPIDEMIOLOGY, V17, P47, DOI 10.1097/01.ede.0000190545.19168.c4; Gupta PC, 2004, BMJ-BRIT MED J, V328, P1538, DOI 10.1136/bmj.38113.687882.EB; Hacettepe University Institute of Population Studies Ankara Turkey, 2003, DEM HLTH SURV; Hosseinpoor AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020331; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jarvis MJ., 2006, SOCIAL DETERMINANTS, P224; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Johnson N W, 2011, Adv Dent Res, V23, P237, DOI 10.1177/0022034511402082; Ministry of Health and Family Welfare, 2016, NATL FAMILY HLTH SUR; Ministry of Health Egypt, 2008, DEM HLTH SURV; Ministry of Health Mexico, 2009, GATS ENC GLOB TAB AD; Ministry of Health Warsaw, 2010, GLOB AD TOB SURV POL; National Committee for Population Family and Children Population, 2005, VIETN DEM HLTH SURV; National Statistics Office Manila Philippines, 2008, NAT DEM HLTH SURV; Norberg M, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.5613; Pednekar MS, 2007, PREV MED, V44, P496, DOI 10.1016/j.ypmed.2007.02.017; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Rutstein S, 1999, WEALTH VERSUS EXPEND; Sorensen G, 2005, AM J PUBLIC HEALTH, V95, P1003, DOI 10.2105/AJPH.2004.045039; Subramoney S, 2010, ACTA OBSTET GYN SCAN, V89, P572, DOI 10.3109/00016341003801656; The Central Agency for Public Mobilization and Statistics (CAPMAS), 2009, GATS EG COUNTR REP; The Ministry of Health of Turkey, 2010, GLOB AD TOB SURV GAT; Ukrainian Center for Social Reforms Kyiv Ukraine, 2007, UKR DEM HLTH SURV; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2009, GLOB AD TOB SURV BAN; World Health Organization Regional office for south-east Asia, 2011, WHO FCTC IND GLOB HL; Zatonski W, 2011, CLOSING HLTH GAP EUR	43	154	156	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33466	10.1371/journal.pone.0033466	http://dx.doi.org/10.1371/journal.pone.0033466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438937	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100050
J	Quilliam, RS; Williams, AP; Jones, DL				Quilliam, Richard S.; Williams, A. Prysor; Jones, Davey L.			Lettuce Cultivar Mediates Both Phyllosphere and Rhizosphere Activity of Escherichia coli O157:H7	PLOS ONE			English	Article							LACTUCA-SATIVA L.; SALMONELLA-ENTERICA; CONTAMINATED MANURE; IRRIGATION WATER; FOOD SAFETY; INTERNALIZATION; COLONIZATION; O157-H7; TRANSMISSION; O157H7	Plant roots and leaves can be colonized by human pathogenic bacteria, and accordingly some of the largest outbreaks of foodborne illness have been associated with salad leaves contaminated by E. coli O157. Integrated disease management strategies often exploit cultivar resistance to provide a level of protection from economically important plant pathogens; however, there is limited evidence of whether the genotype of the plant can also influence the extent of E. coli O157 colonization. To determine cultivar-specific effects on colonization by E. coli O157, we used 12 different cultivars of lettuce inoculated with a chromosomally lux-marked strain of E. coli O157:H7. Lettuce seedlings grown gnotobiotically in vitro did exhibit a differential cultivar-specific response to E. coli O157 colonization, although importantly there was no relationship between metabolic activity (measured as bioluminescence) and cell numbers. Metabolic activity was highest and lowest on the cultivars Vaila-winter gem and Dazzle respectively, and much higher in endophytic and tightly bound cells than in epiphytic and loosely bound cells. The cultivar effect was also evident in the rhizosphere of plants grown in compost, which suggests that cultivar-specific root exudate influences E. coli O157 activity. However, the influence of cultivar in the rhizosphere was the opposite to that in the phyllosphere, and the higher number and activity of E. coli O157 cells in the rhizosphere may be a consequence of them not being able to gain entry to the plant as effectively. If metabolic activity in the phyllosphere corresponds to a more prepared state of infectivity during human consumption, leaf internalization of E. coli O157 may pose more of a public health risk than leaf surface contamination alone.	[Quilliam, Richard S.; Williams, A. Prysor; Jones, Davey L.] Bangor Univ, Coll Nat Sci, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales	Bangor University	Quilliam, RS (corresponding author), Bangor Univ, Coll Nat Sci, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	R.S.Quilliam@bangor.ac.uk	Jones, Davey/AAD-6037-2020; jones, davey/AAN-5606-2020; Quilliam, Richard S/E-6920-2011; Jones, Davey L/C-7411-2011	Jones, Davey/0000-0002-1482-4209; Quilliam, Richard S/0000-0001-7020-4410; Jones, Davey L/0000-0002-1482-4209	Rural Economy & Land Use (RELU) [RES-229-25-0012]	Rural Economy & Land Use (RELU)	This work was funded by the Rural Economy & Land Use (RELU programme) project 'Reducing E. coli O157 risk in rural communities' (award number: RES-229-25-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon CW, 2006, PLANT-ASSOCIATED BACTERIA, P155; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P5285, DOI 10.1128/AEM.01073-08; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; Dinu LD, 2011, APPL ENVIRON MICROB, V77, P8295, DOI 10.1128/AEM.05020-11; Erickson MC, 2010, J FOOD PROTECT, V73, P500, DOI 10.4315/0362-028X-73.3.500; HALE TL, 1979, INFECT IMMUN, V24, P879, DOI 10.1128/IAI.24.3.879-886.1979; Hudson J. A., 2009, Microbial safety of fresh produce, P205, DOI 10.1002/9781444319347.ch11; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Islam M, 2004, J FOOD PROTECT, V67, P1365, DOI 10.4315/0362-028X-67.7.1365; Jablasone J, 2005, INT J FOOD MICROBIOL, V99, P7, DOI 10.1016/j.ijfoodmicro.2004.06.011; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Nadwodnik J, 2008, PLANTA, V227, P1079, DOI 10.1007/s00425-007-0682-0; Nicola S, 2004, ACTA HORTIC, P217, DOI 10.17660/ActaHortic.2004.659.27; Ritchie JM, 2003, APPL ENVIRON MICROB, V69, P3359, DOI 10.1128/AEM.69.6.3359-3367.2003; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Scott JC, 2010, PLANT PATHOL, V59, P139, DOI 10.1111/j.1365-3059.2009.02179.x; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Someya Nobutaka, 2008, Environmental Control in Biology, V46, P139; Zhang GD, 2009, J FOOD PROTECT, V72, P2028, DOI 10.4315/0362-028X-72.10.2028	27	46	46	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33842	10.1371/journal.pone.0033842	http://dx.doi.org/10.1371/journal.pone.0033842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22439006	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100106
J	Sauert, K; Kahnert, S; Roose, M; Gull, M; Brandli, AW; Ryffel, GU; Waldner, C				Sauert, Kathrin; Kahnert, Stefan; Roose, Magdalena; Gull, Mazhar; Braendli, Andre W.; Ryffel, Gerhart U.; Waldner, Christoph			Heat-Shock Mediated Overexpression of HNF1 beta Mutations Has Differential Effects on Gene Expression in the Xenopus Pronephric Kidney	PLOS ONE			English	Article							NUCLEAR FACTOR-1-BETA GENE; AMINO-ACID TRANSPORTERS; TRANSCRIPTION FACTOR; DEVELOPMENTAL EXPRESSION; CHLORIDE CHANNELS; MICE LACKING; DISEASE; NEPHROGENESIS; VHNF1; SPECIFICATION	The transcription factor HNF1B, encoded by the TCF2 gene, plays an important role in the organogenesis of vertebrates. In humans, heterozygous mutations of HNF1B are associated with several diseases, such as pancreatic beta-cell dysfunction leading to maturity-onset diabetes of the young (MODY5), defective kidney development, disturbed liver function, pancreas atrophy, and malformations of the genital tract. The African claw frog Xenopus laevis is an excellent model to study the processes involved in embryogenesis and organogenesis, as it can be manipulated easily with a series of methods. In the present study, we overexpressed HNF1 beta mutants in the developing Xenopus embryo to assess their roles during organogenesis, particularly in the developing pronephric kidney. Towards this goal, we developed a heat-shock inducible binary Cre/loxP system with activator and effector strains. Heat-shock activation of the mutant HNF1B variants P328L329del and A263insGG resulted in malformations of various organs and the affected larvae developed large edemas. Defects in the pronephros were primarily confined to malformed proximal tubules. Furthermore, the expression of the proximal tubule marker genes tmem27 and slc3a1, both involved in amino acid transport, was affected. Both P328L329del and A263insGG downregulated expression of slc3a1. In addition, P328L329del reduced tmem27 expression while A263insGG overexpression decreased expression of the chloride channel clcnk and the transcription factor pax2. Overexpression of two mutant HNF1B derivatives resulted in distinct phenotypes reflected by either a reduction or an enlargement of pronephros size. The expression of selected pronephric marker genes was differentially affected upon overexpression of HNF1B mutations. Based on our findings, we postulate that HNF1B mutations influence gene regulation upon overexpression in specific and distinct manners. Furthermore, our study demonstrates that the newly established Cre/loxP system for Xenopus embryos is an attractive alternative to examine the gene regulatory potential of transcription factors in developing pronephric kidney as exemplified here for HNF1B.	[Sauert, Kathrin; Kahnert, Stefan; Roose, Magdalena; Ryffel, Gerhart U.; Waldner, Christoph] Univ Klinikum Essen, Inst Zellbiol Tumorforsch, Essen, Germany; [Gull, Mazhar; Braendli, Andre W.] Univ Munich, Walter Brendel Zentrum Expt Med, Munich, Germany	University of Duisburg Essen; University of Munich	Sauert, K (corresponding author), Univ Klinikum Essen, Inst Zellbiol Tumorforsch, Essen, Germany.	christoph.waldner@uni-due.de	Brandli, Andre/N-1620-2013	Brandli, Andre/0000-0002-8932-3644				Alsina B, 2009, INT J DEV BIOL, V53, P1503, DOI 10.1387/ijdb.072422ba; Barbacci E, 1999, DEVELOPMENT, V126, P4795; Bingham C, 2001, AM J HUM GENET, V68, P219, DOI 10.1086/316945; Bisceglia L, 2010, MOL GENET METAB, V99, P42, DOI 10.1016/j.ymgme.2009.09.001; Bohn S, 2003, J AM SOC NEPHROL, V14, P2033, DOI 10.1097/01.ASN.0000078808.70309.C4; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Coffinier C, 1999, DEVELOPMENT, V126, P4785; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; DEMARTIS A, 1994, MECH DEVELOP, V47, P19, DOI 10.1016/0925-4773(94)90092-2; Dudziak K, 2008, KIDNEY INT, V74, P210, DOI 10.1038/ki.2008.149; Edghill EL, 2008, NEPHROL DIAL TRANSPL, V23, P627, DOI 10.1093/ndt/gfm603; Fernandez E, 2002, AM J PHYSIOL-RENAL, V283, pF540, DOI 10.1152/ajprenal.00071.2002; Fernandez E, 2006, J BIOL CHEM, V281, P26552, DOI 10.1074/jbc.M604049200; Fischer E, 2008, KIDNEY INT, V74, P145, DOI 10.1038/ki.2008.250; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Kalin RE, 2009, BLOOD, V114, P1110, DOI 10.1182/blood-2009-03-211771; Kramer BK, 2008, NAT CLIN PRACT NEPHR, V4, P38, DOI 10.1038/ncpneph0689; Lecaudey V, 2007, DEV BIOL, V303, P134, DOI 10.1016/j.ydbio.2006.10.041; Lockwood CR, 2003, MOL GENET METAB, V78, P145, DOI 10.1016/S1096-7192(02)00225-1; Lokmane L, 2008, DEVELOPMENT, V135, P2777, DOI 10.1242/dev.023010; Lokmane L, 2010, DEVELOPMENT, V137, P347, DOI 10.1242/dev.042226; Malakauskas SM, 2007, AM J PHYSIOL-RENAL, V292, pF533, DOI 10.1152/ajprenal.00325.2006; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; Mccoy KE, 2008, GENE EXPR PATTERNS, V8, P271, DOI 10.1016/j.gep.2007.12.002; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; Nishigori H, 1998, DIABETES, V47, P1354, DOI 10.2337/diabetes.47.8.1354; Pontoglio M, 2000, J AM SOC NEPHROL, V11, pS140; Raciti D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r84; Roose M, 2009, TRANSGENIC RES, V18, P595, DOI 10.1007/s11248-009-9253-4; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; Urban AE, 2006, DEV BIOL, V297, P103, DOI 10.1016/j.ydbio.2006.04.469; Verdeguer F, 2010, NAT MED, V16, P106, DOI 10.1038/nm.2068; VONSTRANDMANN EP, 1995, DEVELOPMENT, V121, P1217; Wang L, 2004, ENDOCRINOLOGY, V145, P3941, DOI 10.1210/en.2004-0281; Werdien D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e53; Wild W, 2000, P NATL ACAD SCI USA, V97, P4695, DOI 10.1073/pnas.080010897; Wu GZ, 2004, EUR J BIOCHEM, V271, P3715, DOI 10.1111/j.1432-1033.2004.04312.x	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33522	10.1371/journal.pone.0033522	http://dx.doi.org/10.1371/journal.pone.0033522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438943	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309000030
J	Forster, S; Thumser, AE; Hood, SR; Plant, N				Forster, Samantha; Thumser, Alfred E.; Hood, Steve R.; Plant, Nick			Characterization of Rhodamine-123 as a Tracer Dye for Use In In vitro Drug Transport Assays	PLOS ONE			English	Article							LASER-SCANNING MICROSCOPY; P-GLYCOPROTEIN; CACO-2 CELLS; MULTIDRUG-RESISTANCE; ABC TRANSPORTERS; RAT HEPATOCYTES; PROTEIN-BINDING; TUMOR-CELLS; EFFLUX; METABOLISM	Fluorescent tracer dyes represent an important class of sub-cellular probes and allow the examination of cellular processes in real-time with minimal impact upon these processes. Such tracer dyes are becoming increasingly used for the examination of membrane transport processes, as they are easy-to-use, cost effective probe substrates for a number of membrane protein transporters. Rhodamine 123, a member of the rhodamine family of flurone dyes, has been used to examine membrane transport by the ABCB1 gene product, MDR1. MDR1 is viewed as the archetypal drug transport protein, and is able to efflux a large number of clinically relevant drugs. In addition, ectopic activity of MDR1 has been associated with the development of multiple drug resistance phenotype, which results in a poor patient response to therapeutic intervention. It is thus important to be able to examine the potential for novel compounds to be MDR1 substrates. Given the increasing use rhodamine 123 as a tracer dye for MDR1, a full characterisation of its spectral properties in a range of in vitro assay-relevant media is warranted. Herein, we determine lambda max for excitation and emission or rhodamine 123 and its metabolite rhodamine 110 in commonly used solvents and extraction buffers, demonstrating that fluorescence is highly dependent on the chemical environment: Optimal parameters are 1% (v/v) methanol in HBSS, with lambda ex=505 nm, lambda em=525 nm. We characterise the uptake of rhodamine 123 into cells, via both passive and active processes, and demonstrate that this occurs primarily through OATP1A2-mediated facilitated transport at concentrations below 2 mu M, and via micelle-mediated passive diffusion above this. Finally, we quantify the intracellular sequestration and metabolism of rhodamine 123, demonstrating that these are both cell line-dependent factors that may influence the interpretation of transport assays.	[Forster, Samantha; Thumser, Alfred E.; Plant, Nick] Univ Surrey, Ctr Toxicol, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Hood, Steve R.] GlaxoSmithKline, PCD DMPK, Ware, Herts, England	University of Surrey; GlaxoSmithKline	Forster, S (corresponding author), Univ Surrey, Ctr Toxicol, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	N.Plant@Surrey.ac.uk	Plant, Nick/E-4510-2011	Plant, Nick/0000-0003-4332-8308; Thumser, Alfred/0000-0003-0256-8006	UK Biotechnology; Biological Sciences Research Council (BBSRC); GlaxoSmithKline	UK Biotechnology; Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline)	Dr. Plant and Dr. Forster received joint funding from the UK Biotechnology and Biological Sciences Research Council (BBSRC) and GlaxoSmithKline to undertake this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ando H, 2001, ANTIMICROB AGENTS CH, V45, P3462, DOI 10.1128/AAC.45.12.3462-3467.2001; Annaert PP, 2005, DRUG METAB DISPOS, V33, P388, DOI 10.1124/dmd.104.001669; Aouabdi S, 2006, DRUG METAB DISPOS, V34, P138, DOI 10.1124/dmd.105.006064; Baker M, 2007, XENOBIOTICA, V37, P1110, DOI 10.1080/00498250701658296; Baldes C, 2006, EUR J PHARM BIOPHARM, V62, P39, DOI 10.1016/j.ejpb.2005.06.001; CHATTOPADHYAY A, 1984, ANAL BIOCHEM, V139, P408, DOI 10.1016/0003-2697(84)90026-5; Chuang VTG, 2009, DRUG METAB PHARMACOK, V24, P358, DOI 10.2133/dmpk.24.358; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Coley HM, 2008, CANCER TREAT REV, V34, P378, DOI 10.1016/j.ctrv.2008.01.007; Cosa G, 2001, PHOTOCHEM PHOTOBIOL, V73, P585, DOI 10.1562/0031-8655(2001)073<0585:PPOFDD>2.0.CO;2; Di L, 2011, J PHARM SCI-US, V100, P4974, DOI 10.1002/jps.22674; Dobson PD, 2009, CURR TOP MED CHEM, V9, P163, DOI 10.2174/156802609787521616; Donnenberg VS, 2009, METHODS MOL BIOL, V568, P261, DOI 10.1007/978-1-59745-280-9_17; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hilgendorf C, 2007, DRUG METAB DISPOS, V35, P1333, DOI 10.1124/dmd.107.014902; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Howe K, 2009, DRUG METAB DISPOS, V37, P391, DOI 10.1124/dmd.108.022921; Huang M, 2007, ANN BIOMED ENG, V35, P1276, DOI 10.1007/s10439-007-9265-2; Jager W, 1997, HEPATOLOGY, V26, P1467; JANCIS EM, 1993, MOL PHARMACOL, V43, P51; Kis O, 2010, TRENDS PHARMACOL SCI, V31, P22, DOI 10.1016/j.tips.2009.10.001; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kolodkin AN, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.102; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu XR, 1999, AM J PHYSIOL-GASTR L, V277, pG12, DOI 10.1152/ajpgi.1999.277.1.G12; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Parasrampuria R, 2010, J PHARM SCI-US, V99, P455, DOI 10.1002/jps.21831; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Perriere N, 2007, BRAIN RES, V1150, P1, DOI 10.1016/j.brainres.2007.02.091; Plant N, 2004, DRUG DISCOV TODAY, V9, P328, DOI 10.1016/S1359-6446(03)03019-8; Prochazkova J, 2011, FREE RADICAL RES, V45, P779, DOI 10.3109/10715762.2011.579120; Qi J, 2004, BIOCHEM BIOPH RES CO, V319, P1124, DOI 10.1016/j.bbrc.2004.05.099; Sakai M, 1997, J PHARM SCI, V86, P779, DOI 10.1021/js960529n; Stormer E, 2001, DRUG METAB DISPOS, V29, P954; SVENNEVIG K, 1995, BIOCHEM J, V311, P881, DOI 10.1042/bj3110881; SWEATMAN TW, 1990, CANCER CHEMOTH PHARM, V27, P205, DOI 10.1007/BF00685714; Troutman MD, 2003, PHARMACEUT RES, V20, P1192, DOI 10.1023/A:1025096930604; Wakuda H, 2011, J PHARM PHARMACOL, V63, P1015, DOI 10.1111/j.2042-7158.2011.01294.x; Wessels JT, 2010, CYTOM PART A, V77A, P667, DOI 10.1002/cyto.a.20931; Yu JY, 2010, PHARM RES-DORDR, V27, P457, DOI 10.1007/s11095-009-0034-9; Zhu SJ, 2009, EUR J PHARM SCI, V37, P573, DOI 10.1016/j.ejps.2009.05.001	48	111	111	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33253	10.1371/journal.pone.0033253	http://dx.doi.org/10.1371/journal.pone.0033253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470447	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000019
J	Loov, C; Hillered, L; Ebendal, T; Erlandsson, A				Loov, Camilla; Hillered, Lars; Ebendal, Ted; Erlandsson, Anna			Engulfing Astrocytes Protect Neurons from Contact-Induced Apoptosis following Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; DENTATE GYRUS; WHITE-MATTER; GLIAL-CELLS; ADULT RAT; C-ELEGANS; OLIGODENDROCYTES; ENGULFMENT	Clearing of dead cells is a fundamental process to limit tissue damage following brain injury. Engulfment has classically been believed to be performed by professional phagocytes, but recent data show that non-professional phagocytes are highly involved in the removal of cell corpses in various situations. The role of astrocytes in cell clearance following trauma has however not been studied in detail. We have found that astrocytes actively collect and engulf whole dead cells in an in vitro model of brain injury and thereby protect healthy neurons from bystander cell death. Time-lapse experiments showed that migrating neurons that come in contact with free-floating cell corpses induced apoptosis, while neurons that migrate through groups of dead cells, garnered by astrocytes, remain unaffected. Furthermore, apoptotic cells are present within astrocytes in the mouse brain following traumatic brain injury (TBI), indicating a possible role for astrocytes in engulfment of apoptotic cells in vivo. qRT-PCR analysis showed that members of both ced pathways and Megf8 are expressed in the cell culture, indicating their possible involvement in astrocytic engulfment. Moreover, addition of dead cells had a positive effect on the protein expression of MEGF10, an ortholog to CED1, known to initiate phagocytosis by binding to phosphatidylserine. Although cultured astrocytes have an immense capacity for engulfment, seemingly without adverse effects, the ingested material is stored rather than degraded. This finding might explain the multinuclear astrocytes that are found at the lesion site in patients with various brain disorders.	[Loov, Camilla; Hillered, Lars; Ebendal, Ted; Erlandsson, Anna] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Loov, C (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	anna.erlandsson@neuro.uu.se		Hillered, Lars/0000-0002-2808-9292	Swedish Research Council; Uppsala University Hospital; Tore Nilssons Foundation; Jeanssons Foundation; Magnus Bergvall Foundation; Swedish Society of Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University Hospital; Tore Nilssons Foundation; Jeanssons Foundation; Magnus Bergvall Foundation; Swedish Society of Medicine	This study was supported by grants from the Swedish Research Council, the Uppsala University Hospital, Tore Nilssons Foundation, Jeanssons Foundation, Magnus Bergvall Foundation and The Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang GHF, 2000, NEURO-ONCOLOGY, V2, P174, DOI 10.1093/neuonc/2.3.174; Colodner KJ, 2005, J NEUROPATH EXP NEUR, V64, P163, DOI 10.1093/jnen/64.2.163; Cusato K, 2003, J NEUROSCI, V23, P6413; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fullard JF, 2009, APOPTOSIS, V14, P1029, DOI 10.1007/s10495-009-0335-9; GALL C, 1979, J COMP NEUROL, V183, P539, DOI 10.1002/cne.901830306; GHATAK NR, 1992, J NEUROPATH EXP NEUR, V51, P40, DOI 10.1097/00005072-199201000-00006; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hirt UA, 2003, CELL DEATH DIFFER, V10, P1156, DOI 10.1038/sj.cdd.4401286; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; LEE KS, 1977, EXP BRAIN RES, V29, P475; LEMKEYJOHNSTON N, 1976, J COMP NEUROL, V167, P481, DOI 10.1002/cne.901670406; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Magnus T, 2002, J NEUROPATH EXP NEUR, V61, P760, DOI 10.1093/jnen/61.9.760; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MATTHEWS DA, 1976, BRAIN RES, V115, P23, DOI 10.1016/0006-8993(76)90820-9; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Mothersill C, 1998, RADIAT RES, V149, P256, DOI 10.2307/3579958; Nakanishi Y, 2004, BIOL PHARM BULL, V27, P13, DOI 10.1248/bpb.27.13; Nishie M, 2006, NEUROPATHOLOGY, V26, P62, DOI 10.1111/j.1440-1789.2006.00633.x; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; RAINE CS, 1976, J NEUROL SCI, V30, P13, DOI 10.1016/0022-510X(76)90251-3; RONNEVI LO, 1978, CELL TISSUE RES, V189, P203; Shintaku M, 2004, ACTA NEUROPATHOL, V108, P201, DOI 10.1007/s00401-004-0880-9; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Song JH, 2006, J NEUROSCI, V26, P3299, DOI 10.1523/JNEUROSCI.5572-05.2006; Suzuki E, 2007, EXP CELL RES, V313, P3729, DOI 10.1016/j.yexcr.2007.06.015; TRAPP BD, 1975, NEUROBIOLOGY, V5, P235; Venegas V, 2007, MOL BIOL CELL, V18, P3180, DOI 10.1091/mbc.E07-02-0138; WU E, 1992, LAB INVEST, V67, P88; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	45	90	91	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e33090	10.1371/journal.pone.0033090	http://dx.doi.org/10.1371/journal.pone.0033090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461890	Green Submitted, Green Published, gold			2022-12-27	WOS:000304118900009
J	Ronninger, M; Seddighzadeh, M; Eike, MC; Plant, D; Daha, NA; Skinningsrud, B; Worthington, J; Kvien, TK; Toes, REM; Lie, BA; Alfredsson, L; Padyukov, L				Ronninger, Marcus; Seddighzadeh, Maria; Eike, Morten Christoph; Plant, Darren; Daha, Nina A.; Skinningsrud, Beate; Worthington, Jane; Kvien, Tore K.; Toes, Rene E. M.; Lie, Benedicte A.; Alfredsson, Lars; Padyukov, Leonid			Interaction Analysis between HLA-DRB1 Shared Epitope Alleles and MHC Class II Transactivator CIITA Gene with Regard to Risk of Rheumatoid Arthritis	PLOS ONE			English	Article							BARE LYMPHOCYTE SYNDROME; MULTIPLE-SCLEROSIS; SUSCEPTIBILITY; POLYMORPHISMS; EXPRESSION; COMPLEX; CLASSIFICATION; METAANALYSIS; ASSOCIATION; POPULATIONS	HLA-DRB1 shared epitope (SE) alleles are the strongest genetic determinants for autoantibody positive rheumatoid arthritis (RA). One of the key regulators in expression of HLA class II receptors is MHC class II transactivator (CIITA). A variant of the CIITA gene has been found to associate with inflammatory diseases. We wanted to explore whether the risk variant rs3087456 in the CIITA gene interacts with the HLA-DRB1 SE alleles regarding the risk of developing RA. We tested this hypothesis in a case-control study with 11767 individuals from four European Caucasian populations (6649 RA cases and 5118 controls). We found no significant additive interaction for risk alleles among Swedish Caucasians with RA (n = 3869, attributable proportion due to interaction (AP) = 0.2, 95% CI: -0.2-0.5) or when stratifying for anti-citrullinated protein antibodies (ACPA) presence (ACPA positive disease: n = 2945, AP = 0.3, 95% CI: -0.05-0.6, ACPA negative: n = 2268, AP = -0.2, 95% CI: -1.0-0.6). We further found no significant interaction between the main subgroups of SE alleles (DRB1*01, DRB1*04 or DRB1*10) and CIITA. Similar analysis of three independent RA cohorts from British, Dutch and Norwegian populations also indicated an absence of significant interaction between genetic variants in CIITA and SE alleles with regard to RA risk. Our data suggest that risk from the CIITA locus is independent of the major risk for RA from HLA-DRB1 SE alleles, given that no significant interaction between rs3087456 and SE alleles was observed. Since a biological link between products of these genes is evident, the genetic contribution from CIITA and class II antigens in the autoimmune process may involve additional unidentified factors.	[Ronninger, Marcus; Seddighzadeh, Maria; Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Ronninger, Marcus; Seddighzadeh, Maria; Padyukov, Leonid] Karolinska Univ Hosp, Stockholm, Sweden; [Eike, Morten Christoph; Skinningsrud, Beate; Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Eike, Morten Christoph; Skinningsrud, Beate; Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Plant, Darren; Worthington, Jane] Univ Manchester, Epidemiol Unit 1Arc, Manchester, Lancs, England; [Daha, Nina A.; Toes, Rene E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Kvien, Tore K.] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Oslo; University of Oslo; University of Manchester; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Diakonhjemmet Hospital; Karolinska Institutet	Ronninger, M (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	marcus.ronninger@ki.se	Worthington, Jane/M-9770-2014; emery, paul/B-3560-2013; Alfredsson, Lars/AAC-9007-2019; Padyukov, Leonid/A-4890-2009	Worthington, Jane/0000-0003-0544-042X; Alfredsson, Lars/0000-0003-1688-6697; Padyukov, Leonid/0000-0003-2950-5670; Toes, Rene/0000-0002-9618-6414	Swedish Research Council [K2010-52X-20312-04-3, K2007-52X-20312-01-3]; Autocure EU; COMBINE (Vinnova); King Gustaf V Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Autocure EU; COMBINE (Vinnova)(Vinnova); King Gustaf V Foundation	This study was supported by grants K2010-52X-20312-04-3 and K2007-52X-20312-01-3 from the Swedish Research Council, from Autocure EU project, from COMBINE (Vinnova) and King Gustaf V Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bronson PG, 2008, ANN RHEUM DIS, V67, P933, DOI 10.1136/ard.2007.077099; Bronson PG, 2011, GENES IMMUN, V12, P235, DOI 10.1038/gene.2010.67; Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101; Eike MC, 2012, CIITA GENE VAR UNPUB; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Eyre S, 2006, ARTHRITIS RHEUM, V54, P3417, DOI 10.1002/art.22166; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Guillemin F, 2003, J RHEUMATOL, V30, P2585; Harrison P, 2007, RHEUMATOLOGY, V46, P409, DOI 10.1093/rheumatology/kel300; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Iikuni N, 2007, ANN RHEUM DIS, V66, P274, DOI 10.1136/ard.2006.063347; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Koizumi K, 2005, ANN RHEUM DIS, V64, P947, DOI 10.1136/ard.2004.025767; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Kvien TK, 2003, CLIN EXP RHEUMATOL, V21, pS118; MACGREGOR AJ, 1994, J RHEUMATOL, V21, P1420; Martin J, 2009, INT J IMMUNOGENET, V36, P235, DOI 10.1111/j.1744-313X.2009.00854.x; Martinez A, 2007, HUM IMMUNOL, V68, P685, DOI 10.1016/j.humimm.2007.05.005; Martinez A, 2007, ANN RHEUM DIS, V66, P325, DOI 10.1136/ard.2006.059428; Orozco G, 2006, RHEUMATOLOGY, V45, P1442, DOI 10.1093/rheumatology/kel272; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Sayer DC, 2004, TISSUE ANTIGENS, V63, P412, DOI 10.1111/j.0001-2815.2004.00214.x; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Stolt P, 2005, ANN RHEUM DIS, V64, P582, DOI 10.1136/ard.2004.022053; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; Zuvich RL, 2011, HUM MOL GENET, V20, P3517, DOI 10.1093/hmg/ddr250	36	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e32861	10.1371/journal.pone.0032861	http://dx.doi.org/10.1371/journal.pone.0032861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461888	Green Submitted, Green Published, gold			2022-12-27	WOS:000304118900007
J	Hwang, BF; Jaakkola, JJK				Hwang, Bing-Fang; Jaakkola, Jouni J. K.			Risk of Stillbirth in the Relation to Water Disinfection By-Products: A Population-Based Case-Control Study in Taiwan	PLOS ONE			English	Article							RESIDENTIAL-MOBILITY; BIRTH OUTCOMES; DRINKING-WATER; SUPPLIES; PREGNANCY; TRIHALOMETHANES; METAANALYSIS; QUALITY	Background: Few epidemiological studies that have assessed the relation between water disinfection by-products (DBPs) and the risk of stillbirth provide inconsistent results. The objective was to assess the relation between exposure to water disinfection by-products and the risk of stillbirth. Methods: We conducted a population-based case-control study of 3,289 cases of stillbirth and a random sample of 32,890 control subjects from 396,049 Taiwanese newborns in 2001-2003 using information from the Birth Registry and Waterworks Registry in Taiwan. We compared the risk of stillbirth in four disinfection by-product exposure categories based on the levels of total trihalomethanes (TTHMs) representing high (TTHMs 20+ mu g/L), medium (TTHMs 10-19 mu g/L), low exposure (TTHMs 5-9 mu g/L), and 0-4 mu g/L as the reference category. In addition, we conducted a meta-analysis of the results from the present and 5 previous studies focusing on stillbirth. Findings: In logistic regression analysis adjusting for gender, maternal age, plurality, conception of season and population density of the municipality where the mother lived during pregnancy, the odds ratio (OR) for stillbirth was 1.10 (95% CI 1.00-1.21) for medium exposure and 1.06 (95% 0.96-1.17) for high exposure compared to reference category. In the meta-analysis, the summary odds ratio for stillbirth (1.11, 95% CI: 1.03, 1.19) was consistently elevated. Conclusions: The present study is consistent with the hypothesis that the risk of stillbirth is related to prenatal exposure to disinfection by-products. This finding on stillbirth is consistent with previous epidemiologic studies, which strengthens the weight of evidence.	[Hwang, Bing-Fang] China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Hwang, Bing-Fang] China Med Univ, Coll Publ Hlth, Grad Inst Occupat Safety & Hlth, Taichung, Taiwan; [Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Ctr Environm & Resp Hlth Res, Oulu, Finland	China Medical University Taiwan; China Medical University Taiwan; University of Oulu	Hwang, BF (corresponding author), China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, Taichung, Taiwan.	bfhwang@mail.cmu.edu.tw	Hwang, Bing-Fang/O-2709-2015; Jaakkola, Jouni J.K./G-4314-2012	Hwang, Bing-Fang/0000-0002-5951-9662; Jaakkola, Jouni/0000-0003-4168-4683	National Science Council [NSC 98-2815-C-039-033-B]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was partially supported by grant # NSC 98-2815-C-039-033-B from the National Science Council. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHENGRAU A, 1993, ARCH ENVIRON HEALTH, V48, P105, DOI 10.1080/00039896.1993.9938403; Booker SM, 2000, ENVIRON HEALTH PERSP, V108, pA64, DOI 10.2307/3454496; BOVE FJ, 1995, AM J EPIDEMIOL, V141, P850, DOI 10.1093/oxfordjournals.aje.a117521; Brown-Woodman PDC, 1998, TERATOLOGY, V57, P321, DOI 10.1002/(SICI)1096-9926(199806)57:6<321::AID-TERA5>3.0.CO;2-Z; Chen JG, 2004, TOXICOL SCI, V78, P166, DOI 10.1093/toxsci/kfh046; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dodds L, 1999, EPIDEMIOLOGY, V10, P233, DOI 10.1097/00001648-199905000-00007; Dodds L, 2004, EPIDEMIOLOGY, V15, P179, DOI 10.1097/01.ede.0000112209.47765.d9; KHOURY MJ, 1988, J CLIN EPIDEMIOL, V41, P15, DOI 10.1016/0895-4356(88)90004-2; King WD, 2000, ENVIRON HEALTH PERSP, V108, P883, DOI 10.2307/3434997; Lin CM, 2004, J FORMOS MED ASSOC, V103, P297; Mayeno AN, 2005, ENVIRON SCI TECHNOL, V39, P5363, DOI 10.1021/es0479991; Nieuwenhuijsen MJ, 2000, OCCUP ENVIRON MED, V57, P73, DOI 10.1136/oem.57.2.73; Petitti DB, 1994, METAANALYSIS DECISIO, P119; Rook JJ, 1974, WATER TREATMENT EXAM, V23, P90; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P115; SHAW GM, 1992, ARCH ENVIRON HEALTH, V47, P236, DOI 10.1080/00039896.1992.9938355; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; TIBBETTS J, 1995, ENVIRON HEALTH PERSP, V103, P30, DOI 10.2307/3432252; Toledano MB, 2005, ENVIRON HEALTH PERSP, V113, P225, DOI 10.1289/ehp.7111; World Medical Assembly, 1990, B PAN AM HLTH ORG, V24, P606; Xie SH, 2011, ENVIRON RES, V111, P295, DOI 10.1016/j.envres.2010.12.010	22	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33949	10.1371/journal.pone.0033949	http://dx.doi.org/10.1371/journal.pone.0033949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457804	Green Submitted, Green Published, gold			2022-12-27	WOS:000304046900035
J	Wittig, D; Wang, X; Walter, C; Gerdes, HH; Funk, RHW; Roehlecke, C				Wittig, Dierk; Wang, Xiang; Walter, Cindy; Gerdes, Hans-Hermann; Funk, Richard H. W.; Roehlecke, Cora			Multi-Level Communication of Human Retinal Pigment Epithelial Cells via Tunneling Nanotubes	PLOS ONE			English	Article							MEMBRANE NANOTUBES; GAP-JUNCTIONS; CUTTING EDGE; ANIMAL-CELLS; IMMUNE CELLS; DEATH; PROPAGATION; CYTONEMES; EXCHANGE; NEURONS	Background: Tunneling nanotubes (TNTs) may offer a very specific and effective way of intercellular communication. Here we investigated TNTs in the human retinal pigment epithelial (RPE) cell line ARPE-19. Morphology of TNTs was examined by immunostaining and scanning electron microscopy. To determine the function of TNTs between cells, we studied the TNT-dependent intercellular communication at different levels including electrical and calcium signalling, small molecular diffusion as well as mitochondrial re-localization. Further, intercellular organelles transfer was assayed by FACS analysis. Methodology and Principal Findings: Microscopy showed that cultured ARPE-19 cells are frequently connected by TNTs, which are not attached to the substratum. The TNTs were straight connections between cells, had a typical diameter of 50 to 300 nm and a length of up to 120 mu m. We observed de novo formation of TNTs by diverging from migrating cells after a short time of interaction. Scanning electron microscopy confirmed characteristic features of TNTs. Fluorescence microscopy revealed that TNTs between ARPE-19 cells contain F-actin but no microtubules. Depolymerisation of F-actin, induced by addition of latrunculin-B, led to disappearance of TNTs. Importantly, these TNTs could function as channels for the diffusion of small molecules such as Lucifer Yellow, but not for large molecules like Dextran Red. Further, organelle exchange between cells via TNTs was observed by microscopy. Using Ca2+ imaging we show the intercellular transmission of calcium signals through TNTs. Mechanical stimulation led to membrane depolarisation, which expand through TNT connections between ARPE-19 cells. We further demonstrate that TNTs can mediate electrical coupling between distant cells. Immunolabelling for Cx43 showed that this gap junction protein is interposed at one end of 44% of TNTs between ARPE-19 cells. Conclusions and Significance: Our observations indicate that human RPE cell line ARPE-19 cells communicate by tunneling nanotubes and can support different types of intercellular traffic.	[Wittig, Dierk; Walter, Cindy; Funk, Richard H. W.; Roehlecke, Cora] Tech Univ Dresden, Inst Anat, Dresden, Germany; [Wang, Xiang; Gerdes, Hans-Hermann] Univ Bergen, Dept Biomed, Bergen, Norway; [Funk, Richard H. W.] CRTD DFG Ctr Regenerat Therapies Dresden Cluster, Ctr Biotechnol, Dresden, Germany	Technische Universitat Dresden; University of Bergen; Technische Universitat Dresden	Roehlecke, C (corresponding author), Tech Univ Dresden, Inst Anat, Dresden, Germany.	cora.roehlecke@tu-dresden.de	Funk, Richard HW/I-1780-2013					Bazan NG, 2009, PROSTAG LEUKOTR ESS, V81, P205, DOI 10.1016/j.plefa.2009.05.024; Becker DL, 2002, J NEUROBIOL, V52, P280, DOI 10.1002/neu.10088; CHEN HM, 1993, EXP EYE RES, V57, P369, DOI 10.1006/exer.1993.1136; Chiba C, 2006, J COMP NEUROL, V495, P391, DOI 10.1002/cne.20880; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; COOK JE, 1995, MICROSC RES TECHNIQ, V31, P408, DOI 10.1002/jemt.1070310510; Cusato K, 2003, J NEUROSCI, V23, P6413; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Frank DK, 2005, HEAD NECK-J SCI SPEC, V27, P794, DOI 10.1002/hed.20235; FREEMAN SM, 1993, CANCER RES, V53, P5274; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Himpens B, 1999, FASEB J, V13, pS63; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Hurtig J, 2010, WIRES NANOMED NANOBI, V2, P260, DOI 10.1002/wnan.80; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; Krutovskikh VA, 2002, ONCOGENE, V21, P1989, DOI 10.1038/sj.onc.1205187; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Pearson RA, 2004, EUR J NEUROSCI, V19, P2435, DOI 10.1111/j.0953-816X.2004.03338.x; Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Smith IF, 2011, BIOPHYS J, V100, pL37, DOI 10.1016/j.bpj.2011.03.007; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Tovell VE, 2008, INVEST OPHTH VIS SCI, V49, P350, DOI 10.1167/iovs.07-1040; Vaney DI, 2002, PROG BRAIN RES, V136, P239; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; Wang X., 2011, BIOCH BIOPHYS ACTA; Wang X, 2010, P NATL ACAD SCI USA, V107, P17194, DOI 10.1073/pnas.1006785107; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507	40	65	67	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33195	10.1371/journal.pone.0033195	http://dx.doi.org/10.1371/journal.pone.0033195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457742	gold, Green Submitted, Green Published			2022-12-27	WOS:000303909200022
J	Ayoub, MA; Angelicheva, D; Vile, D; Chandler, D; Morar, B; Cavanaugh, JA; Visscher, PM; Jablensky, A; Pfleger, KDG; Kalaydjieva, L				Ayoub, Mohammed Akli; Angelicheva, Dora; Vile, David; Chandler, David; Morar, Bharti; Cavanaugh, Juleen A.; Visscher, Peter M.; Jablensky, Assen; Pfleger, Kevin D. G.; Kalaydjieva, Luba			Deleterious GRM1 Mutations in Schizophrenia	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; LONG-TERM POTENTIATION; GROUP-I; PROTEIN-SYNTHESIS; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; GENE-EXPRESSION; MESSENGER-RNA; RAT-BRAIN; MGLUR1	We analysed a phenotypically well-characterised sample of 450 schziophrenia patients and 605 controls for rare non-synonymous single nucleotide polymorphisms (nsSNPs) in the GRM1 gene, their functional effects and family segregation. GRM1 encodes the metabotropic glutamate receptor 1 (mGluR1), whose documented role as a modulator of neuronal signalling and synaptic plasticity makes it a plausible schizophrenia candidate. In a recent study, this gene was shown to harbour a cluster of deleterious nsSNPs within a functionally important domain of the receptor, in patients with schizophrenia and bipolar disorder. Our Sanger sequencing of the GRM1 coding regions detected equal numbers of nsSNPs in cases and controls, however the two groups differed in terms of the potential effects of the variants on receptor function: 6/6 case-specific and only 1/6 control-specific nsSNPs were predicted to be deleterious. Our in-vitro experimental follow-up of the case-specific mutants showed that 4/6 led to significantly reduced inositol phosphate production, indicating impaired function of the major mGluR1 signalling pathway; 1/6 had reduced cell membrane expression; inconclusive results were obtained in 1/6. Family segregation analysis indicated that these deleterious nsSNPs were inherited. Interestingly, four of the families were affected by multiple neuropsychiatric conditions, not limited to schizophrenia, and the mutations were detected in relatives with schizophrenia, depression and anxiety, drug and alcohol dependence, and epilepsy. Our findings suggest a possible mGluR1 contribution to diverse psychiatric conditions, supporting the modulatory role of the receptor in such conditions as proposed previously on the basis of in vitro experiments and animal studies.	[Ayoub, Mohammed Akli; Angelicheva, Dora; Chandler, David; Morar, Bharti; Pfleger, Kevin D. G.; Kalaydjieva, Luba] Univ Western Australia, UWA Ctr Med Res, Western Australian Inst Med Res, Perth, WA 6009, Australia; [Vile, David; Jablensky, Assen] Univ Western Australia, Ctr Clin Res Neuropsychiat, Perth, WA 6009, Australia; [Cavanaugh, Juleen A.] Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia; [Visscher, Peter M.] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Jablensky, Assen] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; Australian National University; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Western Australia	Ayoub, MA (corresponding author), Univ Western Australia, UWA Ctr Med Res, Western Australian Inst Med Res, Perth, WA 6009, Australia.	kpfleger@waimr.uwa.edu.au; luba.kalaydjieva@uwa.edu.au	Pfleger, Kevin/H-5629-2014; Visscher, Peter/ABB-6151-2020; Jablensky, Assen/H-5116-2014; Morar, Bharti/O-8697-2014	Visscher, Peter/0000-0002-2143-8760; Jablensky, Assen/0000-0003-0602-6810; Morar, Bharti/0000-0003-3897-1403; AYOUB, Mohammed Akli/0000-0003-0022-578X; Pfleger, Kevin/0000-0001-8261-9189	National Health and Medical Research Council [37580400, 37580900]; Australian Research Council [FT100100271]; Australian National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by the National Health and Medical Research Council project grants #37580400 and #37580900 to AJ and LK. KDGP is supported by an Australian Research Council Future Fellowship (FT100100271). PMV is supported by the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Benquet P, 2002, J NEUROSCI, V22, P9679; Brody SA, 2003, EUR J NEUROSCI, V18, P3361, DOI 10.1111/j.1460-9568.2003.03073.x; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Castle DJ, 2006, PSYCHOL MED, V36, P69, DOI 10.1017/S0033291705005969; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Enz R, 2007, BIOESSAYS, V29, P60, DOI 10.1002/bies.20518; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Frank RAW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019011; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Gil-Sanz C, 2008, CEREB CORTEX, V18, P1653, DOI 10.1093/cercor/bhm193; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Grueter BA, 2007, MOL NEUROBIOL, V36, P232, DOI 10.1007/s12035-007-0037-7; Gupta DS, 2005, SYNAPSE, V57, P123, DOI 10.1002/syn.20164; Hallmayer JF, 2005, AM J HUM GENET, V77, P468, DOI 10.1086/432816; Heidinger V, 2002, J NEUROSCI, V22, P5452; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Karchin R, 2009, BRIEF BIOINFORM, V10, P35, DOI 10.1093/bib/bbn047; Kenakin T, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P21, DOI 10.1016/B978-0-12-374585-9.00002-5; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lavreysen H, 2004, NEUROPHARMACOLOGY, V46, P609, DOI 10.1016/j.neuropharm.2003.11.014; Lesage A, 2010, EUR J PHARMACOL, V639, P2, DOI 10.1016/j.ejphar.2009.12.043; Lindemeyer K, 2006, CEREB CORTEX, V16, P1662, DOI 10.1093/cercor/bhj103; MANTON KG, 1994, PSYCHOL MED, V24, P133, DOI 10.1017/S0033291700026908; Marsman A, 2011, SCHIZOPHRENIA B; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; Merlin LR, 1998, J NEUROPHYSIOL, V80, P989, DOI 10.1152/jn.1998.80.2.989; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Neyman S, 2008, EUR J NEUROSCI, V27, P1345, DOI 10.1111/j.1460-9568.2008.06109.x; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; Paul IA, 2003, ANN NY ACAD SCI, V1003, P250, DOI 10.1196/annals.1300.016; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Ronesi JA, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.15pe6; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sato T, 2003, J BIOL CHEM, V278, P4314, DOI 10.1074/jbc.M210278200; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; Simonyi A, 2005, BRAIN RES, V1043, P95, DOI 10.1016/j.brainres.2005.02.046; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Volk DW, 2010, AM J PSYCHIAT, V167, P1489, DOI 10.1176/appi.ajp.2010.10030318; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; WOODBURY MA, 1978, COMPUT BIOMED RES, V11, P277, DOI 10.1016/0010-4809(78)90012-5; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	58	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32849	10.1371/journal.pone.0032849	http://dx.doi.org/10.1371/journal.pone.0032849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448230	gold, Green Submitted, Green Published			2022-12-27	WOS:000303855700020
J	Boccitto, M; Lamitina, T; Kalb, RG				Boccitto, Marco; Lamitina, Todd; Kalb, Robert G.			Daf-2 Signaling Modifies Mutant SOD1 Toxicity in C. elegans	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; LIFE-SPAN; PROTEIN AGGREGATION; HEXANUCLEOTIDE REPEAT; MUTATIONS; INSULIN/IGF-1; LONGEVITY; ALS	The DAF-2 Insulin/IGF-1 signaling (IIS) pathway is a strong modifier of Caenorhabditis elegans longevity and healthspan. As aging is the greatest risk factor for developing neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), we were interested in determining if DAF-2 signaling modifies disease pathology in mutant superoxide dismutase 1 (SOD1) expressing C. elegans. Worms with pan-neuronal G85R SOD1 expression demonstrate significantly impaired locomotion as compared to WT SOD1 expressing controls and they develop insoluble SOD1 aggregates. Reductions in DAF-2 signaling, either through a hypomorphic allele or neuronally targeted RNAi, decreases the abundance of aggregated SOD1 and results in improved locomotion in a DAF-16 dependant manner. These results suggest that manipulation of the DAF-2 Insulin/IGF-1 signaling pathway may have therapeutic potential for the treatment of ALS.	[Boccitto, Marco; Kalb, Robert G.] Childrens Hosp Philadelphia Res Inst, Div Neurol, Dept Pediat, Philadelphia, PA USA; [Boccitto, Marco; Kalb, Robert G.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Lamitina, Todd] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Kalb, Robert G.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Boccitto, M (corresponding author), Childrens Hosp Philadelphia Res Inst, Div Neurol, Dept Pediat, Philadelphia, PA USA.	boccitto@mail.med.upenn.edu		Boccitto, Marco/0000-0002-5722-9186	National Institutes of Health [R21NS060754, RO1NS052325]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060754, R01NS052325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the National Institutes of Health R21NS060754 and RO1NS052325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Artal-Sanz M, 2010, AGING-US, V2, P1004, DOI 10.18632/aging.100246; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; BRENNER S, 1974, GENETICS, V77, P71; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Morton E, 2010, BIOTECHNIQUES, V48, pXXV, DOI 10.2144/000113427; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Reis RJS, 2011, AGING-US, V3, P125, DOI 10.18632/aging.100275; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schymick JC, 2007, J NEUROL NEUROSUR PS, V78, P754, DOI 10.1136/jnnp.2006.109553; Ticozzi N, 2010, CNS NEUROL DISORD-DR, V9, P285, DOI 10.2174/187152710791292585; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000350; Williams TW, 2010, AGING-US, V2, P742, DOI 10.18632/aging.100214; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367	35	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33494	10.1371/journal.pone.0033494	http://dx.doi.org/10.1371/journal.pone.0033494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22457769	Green Submitted, gold, Green Published			2022-12-27	WOS:000303855700037
J	Conway, BN; Shu, XO; Zhang, XL; Xiang, YB; Cai, H; Li, HL; Yang, G; Gao, YT; Zheng, W				Conway, Baqiyyah N.; Shu, Xiao-Ou; Zhang, Xianglan; Xiang, Yong-Bing; Cai, Hui; Li, Honglan; Yang, Gong; Gao, Yu-Tang; Zheng, Wei			Age at Menarche, the Leg Length to Sitting Height Ratio, and Risk of Diabetes in Middle-Aged and Elderly Chinese Men and Women	PLOS ONE			English	Article							GROWTH-FACTOR-I; INSULIN-RESISTANCE; REPLACEMENT THERAPY; GLUCOSE-TOLERANCE; CHILDHOOD; PUBERTY; ASSOCIATION; ADOLESCENTS; COMPONENTS; ADIPOSITY	Aims: To evaluate the associations of age at menarche and the leg length-to-sitting-height ratio, markers of adolescent growth, with risk of diabetes in later life. Materials and Methods: Information from 69,385 women and 55,311 men, aged 40-74 years from the Shanghai Women's Health Study and Shanghai Men's Health Study, were included in the current analyses. Diabetes status was ascertained through biennial in person follow-up. Cox models, with age as the time scale, were used. Results: There were 2369 cases of diabetes (1831 women; 538 men) during an average of 7.3 and 3.6 years of follow-up of the women and men, respectively. In females, menarche age was inversely associated with diabetes risk after adjustment for birth cohort, education, and income (HR = 0.95, 0.92-0.98). In both genders, leg length-to-sitting-height ratio was inversely related to diabetes (HR = 0.88, 0.80-0.97 for men; HR = 0.91, 0.86-0.96 for women) after adjustment for birth cohort, education, and income. Further adjustment for adult BMI at study enrollment completely eliminated the associations of age at menarche (HR = 0.99, 0.96-1.02) and the leg length-to-sitting-height ratio (HR = 1.00, 0.91-1.10 for men; HR = 1.01, 0.96-1.07 for women) with diabetes risk. Conclusions: Our study suggests that markers of an early age at peak height velocity, i.e. early menarche age and low leg-length- to-sitting height ratio, may be associated with diabetes risk later in life and this association is likely to be mediated through obesity.	[Conway, Baqiyyah N.; Shu, Xiao-Ou; Zhang, Xianglan; Cai, Hui; Yang, Gong; Zheng, Wei] Vanderbilt Univ, Dept Med, Div Epidemiol, Nashville, TN 37203 USA; [Xiang, Yong-Bing; Li, Honglan; Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China	Vanderbilt University; Shanghai Jiao Tong University	Conway, BN (corresponding author), Vanderbilt Univ, Dept Med, Div Epidemiol, Nashville, TN 37203 USA.	xiao-ou.shu@vanderbilt.edu	zhang, weihua/GXV-1334-2022; gao, yi/HCI-8298-2022; Zheng, Wei/O-3351-2013; Gao, Yu/HGE-1937-2022; Gao, Y./GWZ-3665-2022	Zheng, Wei/0000-0003-1226-070X; 	Public Health Services from United States National Institutes of Health, National Cancer Institute [R37 CA070867, R01 CA082729]; NATIONAL CANCER INSTITUTE [U54CA163069, R01CA082729, R37CA070867] Funding Source: NIH RePORTER	Public Health Services from United States National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Public Health Services grants from the United States National Institutes of Health, National Cancer Institute (R37 CA070867 to WZ and R01 CA082729 to XOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asao K, 2006, DIABETES CARE, V29, P1632, DOI 10.2337/dc05-1997; BROWN DC, 1991, DIABETOLOGIA, V34, P531, DOI 10.1007/BF00403292; Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900; Cheng JCY, 1996, CLIN ORTHOP RELAT R, P22; Cooper GS, 2000, J CLIN EPIDEMIOL, V53, P1170, DOI 10.1016/S0895-4356(00)00240-7; Cutler GB, 1997, J STEROID BIOCHEM, V61, P141; Ding E, JAMA, V295, P1288; Ding E, 2006, JAMA-J AM MED ASSOC, V296, P168; Feng Y, 2008, ATHEROSCLEROSIS, V196, P590, DOI 10.1016/j.atherosclerosis.2007.06.016; Fowden AL, 2001, BRIT MED BULL, V60, P123, DOI 10.1093/bmb/60.1.123; Gambineri A, 2004, DIABETES, V53, P2353, DOI 10.2337/diabetes.53.9.2353; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; Ibanez L, 1997, J CLIN ENDOCR METAB, V82, P2283, DOI 10.1210/jc.82.7.2283; Ji Cheng-ye, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P126; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Law CM, 1996, DIABETIC MED, V13, pS49; Lawlor DA, 2002, DIABETOLOGIA, V45, P1097, DOI 10.1007/s00125-002-0887-5; Liao L, 2006, ENDOCRINOLOGY, V147, P3877, DOI 10.1210/en.2005-1537; Lorentzon M, 2011, J PEDIATR-US, V158, P452, DOI 10.1016/j.jpeds.2010.09.009; McCarthy TL, 1997, J BIOL CHEM, V272, P18132, DOI 10.1074/jbc.272.29.18132; McIntyre M, 2011, ANN HUM BIOL; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; O'Loughlin J, 2008, ANN EPIDEMIOL, V18, P395, DOI 10.1016/j.annepidem.2007.12.010; O'Sullivan AJ, 1998, J CLIN INVEST, V102, P1035, DOI 10.1172/JCI2773; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Robertson K, 2008, AM J PHYSIOL-ENDOC M, V294, pE928, DOI 10.1152/ajpendo.00606.2007; Rooman RPA, 2005, EUR J ENDOCRINOL, V152, P597, DOI 10.1530/eje.1.01880; Sandhu J, 2006, INT J OBESITY, V30, P14, DOI 10.1038/sj.ijo.0803156; Saquib N, 2005, CLIMACTERIC, V8, P76, DOI 10.1080/13697130500062688; Schooling CM, 2008, J EPIDEMIOL COMMUN H, V62, P160, DOI 10.1136/jech.2006.058917; Schooling CM, 2010, AM J HUM BIOL, V22, P683, DOI 10.1002/ajhb.21067; Schwitzgebel VM, 2009, MOL CELL ENDOCRINOL, V304, P78, DOI 10.1016/j.mce.2009.02.019; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Strandberg TE, 2003, AM J CARDIOL, V92, P212, DOI 10.1016/S0002-9149(03)00542-3; Yang DT, 2008, COMP ECON STUD, V50, P1, DOI 10.1057/ces.2008.4; Teppala S, 2010, DIABETES CARE, V33, P2257, DOI 10.2337/dc10-0770; Tortora GJ, 2011, PRINCIPLES ANATOMY P, V3rd; Wadsworth M, 2005, DIABETOLOGIA, V48, P2505, DOI 10.1007/s00125-005-0007-4; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	40	27	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e30625	10.1371/journal.pone.0030625	http://dx.doi.org/10.1371/journal.pone.0030625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448212	Green Submitted, gold, Green Published			2022-12-27	WOS:000303855700002
J	Hrda, S; Fousek, J; Szabova, J; Hampl, VV; Vlcek, C				Hrda, Stepanka; Fousek, Jan; Szabova, Jana; Hampl, Vladimir V.; Vlcek, Cestmir			The Plastid Genome of Eutreptiella Provides a Window into the Process of Secondary Endosymbiosis of Plastid in Euglenids	PLOS ONE			English	Article							DID TRYPANOSOMATID PARASITES; OSMOTROPHIC EUGLENIDS; CHLOROPLAST DNA; REPLICATION; PHYLOGENY; SEQUENCE; INTRONS; ORIGIN; EVOLUTION	Euglenids are a group of protists that comprises species with diverse feeding modes. One distinct and diversified clade of euglenids is photoautotrophic, and its members bear green secondary plastids. In this paper we present the plastid genome of the euglenid Eutreptiella, which we assembled from 454 sequencing of Eutreptiella gDNA. Comparison of this genome and the only other available plastid genomes of photosynthetic euglenid, Euglena gracilis, revealed that they contain a virtually identical set of 57 protein coding genes, 24 genes fewer than the genome of Pyramimonas parkeae, the closest extant algal relative of the euglenid plastid. Searching within the transcriptomes of Euglena and Eutreptiella showed that 6 of the missing genes were transferred to the nucleus of the euglenid host while 18 have been probably lost completely. Euglena and Eutreptiella represent the deepest bifurcation in the photosynthetic clade, and therefore all these gene transfers and losses must have happened before the last common ancestor of all known photosynthetic euglenids. After the split of Euglena and Eutreptiella only one additional gene loss took place. The conservation of gene content in the two lineages of euglenids is in contrast to the variability of gene order and intron counts, which diversified dramatically. Our results show that the early secondary plastid of euglenids was much more susceptible to gene losses and endosymbiotic gene transfers than the established plastid, which is surprisingly resistant to changes in gene content.	[Hrda, Stepanka; Szabova, Jana; Hampl, Vladimir V.] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Fousek, Jan; Vlcek, Cestmir] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Hrda, S (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic.	vlada@natur.cuni.cz; vlcek@img.cas.cz	Hrdá, Štěpánka/R-4426-2017; Vlcek, Cestmir/I-8820-2014; Hampl, Vladimir/A-4339-2008; Fousek, Jan/F-8213-2014	Hrdá, Štěpánka/0000-0002-9753-1312; Hampl, Vladimir/0000-0002-5430-7564; 	Ministry of Education, Youth and Sport of the Czech Republic [MSM0021620828]; Czech Science Foundation [P506/11/1320]; Grant Agency of the Charles University [63409]	Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Charles University	This work was supported by Ministry of Education, Youth and Sport of the Czech Republic (project MSM0021620828), by Czech Science Foundation P506/11/1320 to VH, and by the Grant Agency of the Charles University 63409 to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendich AJ, 2004, PLANT CELL, V16, P1661, DOI 10.1105/tpc.160771; Bock R, 2008, BIOESSAYS, V30, P556, DOI 10.1002/bies.20761; Bodyl A, 2010, J PARASITOL, V96, P465, DOI 10.1645/GE-1810.1; Busse I, 2003, INT J SYST EVOL MICR, V53, P617, DOI 10.1099/ijs.0.02295-0; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Doetsch NA, 1998, MOL BIOL EVOL, V15, P76, DOI 10.1093/oxfordjournals.molbev.a025850; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Geimer S, 2009, CURR GENET, V55, P425, DOI 10.1007/s00294-009-0256-8; GIBBS SP, 1978, CAN J BOT, V56, P2883, DOI 10.1139/b78-345; Gockel G, 2000, PROTIST, V151, P347, DOI 10.1078/S1434-4610(04)70033-4; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Hannaert V, 2003, P NATL ACAD SCI USA, V100, P1067, DOI 10.1073/pnas.0335769100; HEINHORST S, 1993, J CELL SCI, V104, P1; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; KOLLER B, 1982, EMBO J, V1, P995, DOI 10.1002/j.1460-2075.1982.tb01283.x; Krajcovic J, 2002, CELL OR EX, V4, P185; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leander BS, 2007, BIOESSAYS, V29, P987, DOI 10.1002/bies.20645; Leander BS, 2004, TRENDS MICROBIOL, V12, P251, DOI 10.1016/j.tim.2004.04.001; Leander BS, 2001, EUR J PROTISTOL, V37, P337, DOI 10.1078/0932-4739-00842; Linton EW, 1999, J EUKARYOT MICROBIOL, V46, P217, DOI 10.1111/j.1550-7408.1999.tb04606.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marin B, 2004, PROTIST, V155, P13, DOI 10.1078/1434461000159; Marin B, 2003, PROTIST, V154, P99, DOI 10.1078/143446103764928521; Maruyama S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-105; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Morton BR, 1999, P NATL ACAD SCI USA, V96, P5123, DOI 10.1073/pnas.96.9.5123; Muellner AN, 2001, INT J SYST EVOL MICR, V51, P783; Preisfeld A, 2001, INT J SYST EVOL MICR, V51, P751, DOI 10.1099/00207713-51-3-751; RAVELCHAPUIS P, 1982, NATURE, V300, P78, DOI 10.1038/300078a0; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sheveleva EV, 2004, NUCLEIC ACIDS RES, V32, P803, DOI 10.1093/nar/gkh225; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thompson MD, 1996, NUCLEIC ACIDS RES, V24, P542; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Vesteg M, 2010, DNA RES, V17, P223, DOI 10.1093/dnares/dsq015; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	40	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33746	10.1371/journal.pone.0033746	http://dx.doi.org/10.1371/journal.pone.0033746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448269	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700060
J	Ferrer, PE; Frederick, P; Gulbis, JM; Dewson, G; Kluck, RM				Ferrer, Pedro Eitz; Frederick, Paul; Gulbis, Jacqueline M.; Dewson, Grant; Kluck, Ruth M.			Translocation of a Bak C-Terminus Mutant from Cytosol to Mitochondria to Mediate Cytochrome c Release: Implications for Bak and Bax Apoptotic Function	PLOS ONE			English	Article							PROSURVIVAL BCL-2 PROTEINS; TAIL-ANCHORED PROTEINS; BH3-ONLY PROTEINS; OUTER-MEMBRANE; BH3 DOMAINS; CELL-DEATH; OLIGOMERIZATION; ACTIVATION; INSERTION; LOCALIZATION	Background: One of two proapoptotic Bcl-2 proteins, Bak or Bax, is required to permeabilize the mitochondrial outer membrane during apoptosis. While Bax is mostly cytosolic and translocates to mitochondria following an apoptotic stimulus, Bak is constitutively integrated within the outer membrane. Membrane anchorage occurs via a C-terminal transmembrane domain that has been studied in Bax but not in Bak, therefore what governs their distinct subcellular distribution is uncertain. In addition, whether the distinct subcellular distributions of Bak and Bax contributes to their differential regulation during apoptosis remains unclear. Methodology/Principal Findings: To gain insight into Bak and Bax targeting to mitochondria, elements of the Bak C-terminus were mutated, or swapped with those of Bax. Truncation of the C-terminal six residues (C-segment) or substitution of three basic residues within the C-segment destabilized Bak. Replacing the Bak C-segment with that from Bax rescued stability and function, but unexpectedly resulted in a semi-cytosolic protein, termed Bak/BaxCS. When in the cytosol, both Bax and Bak/BaxCS sequestered their hydrophobic transmembrane domains in their hydrophobic surface groove. Upon apoptotic signalling, Bak/BaxCS translocated to the mitochondrial outer membrane, inserted its transmembrane domain, oligomerized, and released cytochrome c. Despite this Bax-like subcellular distribution, Bak/BaxCS retained Bak-like regulation following targeting of Mcl-1. Conclusions/Significance: Residues in the C-segment of Bak and of Bax contribute to their distinct subcellular localizations. That a semi-cytosolic form of Bak, Bak/BaxCS, could translocate to mitochondria and release cytochrome c indicates that Bak and Bax share a conserved mode of activation. In addition, the differential regulation of Bak and Bax by Mcl-1 is predominantly independent of the initial subcellular localizations of Bak and Bax.	[Ferrer, Pedro Eitz; Frederick, Paul; Gulbis, Jacqueline M.; Dewson, Grant; Kluck, Ruth M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Gulbis, Jacqueline M.; Dewson, Grant; Kluck, Ruth M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Ferrer, PE (corresponding author), Tech Univ Munich, Inst Microbiol Immunol & Hyg, Munich, Germany.	kluck@wehi.edu.au	dewson, grant/C-7646-2013; Kluck, Ruth M/C-8413-2013	dewson, grant/0000-0003-4251-8898; Kluck, Ruth M/0000-0002-7101-1925	AICR [10-230]; National Health and Medical Research Council [637335, 637337]; Australian Research Council	AICR; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grant #10-230 from the AICR http://www.aicr.org.uk and grants #637335 and #637337 from the National Health and Medical Research Council www.nhmrc.gov.au, as well as Future Fellowships (GD and RK) from the Australian Research Council http://www.arc.gov.au, and was made possible through Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Ausili A, 2008, J STRUCT BIOL, V164, P146, DOI 10.1016/j.jsb.2008.07.004; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Dewson G, 2011, CELL DEATH IN PRESS; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Martinez-Senac MD, 2002, BIOPHYS J, V82, P233, DOI 10.1016/S0006-3495(02)75390-3; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; Oliver L, 2000, FEBS LETT, V487, P161, DOI 10.1016/S0014-5793(00)02330-9; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Valentijn AJ, 2008, BIOCHEM J, V412, P347, DOI 10.1042/BJ20071548; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456	48	44	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e31510	10.1371/journal.pone.0031510	http://dx.doi.org/10.1371/journal.pone.0031510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442658	Green Published, gold			2022-12-27	WOS:000303836500001
J	Ke, JY; Zhang, CH; Harikumar, KG; Zylstra-Diegel, CR; Wang, LR; Mowry, LE; Miller, LJ; Williams, BO; Xu, HE				Ke, Jiyuan; Zhang, Chenghai; Harikumar, Kaleeckal G.; Zylstra-Diegel, Cassandra R.; Wang, Liren; Mowry, Laura E.; Miller, Laurence J.; Williams, Bart O.; Xu, H. Eric			Modulation of beta-Catenin Signaling by Glucagon Receptor Activation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; PARATHYROID-HORMONE; CELL-GROWTH; WNT; PATHWAY; METABOLISM; MECHANISMS; MEMBRANE; DISEASE; FAMILY	The glucagon receptor (GCGR) is a member of the class B G protein-coupled receptor family. Activation of GCGR by glucagon leads to increased glucose production by the liver. Thus, glucagon is a key component of glucose homeostasis by counteracting the effect of insulin. In this report, we found that in addition to activation of the classic cAMP/protein kinase A (PKA) pathway, activation of GCGR also induced beta-catenin stabilization and activated beta-catenin-mediated transcription. Activation of beta-catenin signaling was PKA-dependent, consistent with previous reports on the parathyroid hormone receptor type 1 (PTH1R) and glucagon-like peptide 1 (GLP-1R) receptors. Since low-density-lipoprotein receptor-related protein 5 (Lrp5) is an essential co-receptor required for Wnt protein mediated beta-catenin signaling, we examined the role of Lrp5 in glucagon-induced beta-catenin signaling. Cotransfection with Lrp5 enhanced the glucagon-induced beta-catenin stabilization and TCF promoter-mediated transcription. Inhibiting Lrp5/6 function using Dickkopf-1(DKK1) or by expression of the Lrp5 extracellular domain blocked glucagon-induced beta-catenin signaling. Furthermore, we showed that Lrp5 physically interacted with GCGR by immunoprecipitation and bioluminescence resonance energy transfer assays. Together, these results reveal an unexpected crosstalk between glucagon and beta-catenin signaling, and may help to explain the metabolic phenotypes of Lrp5/6 mutations.	[Ke, Jiyuan; Zhang, Chenghai; Wang, Liren; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Zylstra-Diegel, Cassandra R.; Mowry, Laura E.; Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, VARI SIMM Ctr, Ctr Struct & Funct Drug Targets, Shanghai 200031, Peoples R China; [Harikumar, Kaleeckal G.; Miller, Laurence J.] Mayo Clin Scottsdale, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ USA	Van Andel Institute; Van Andel Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Mayo Clinic; Mayo Clinic Phoenix	Ke, JY (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA.	jiyuan.ke@vai.org; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021; Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health (NIH) [R21RR024887, R01DK46577, 5R01GM087413]; Jay and Betty Van Andel Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087413] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants R21RR024887 to BOW, R01DK46577 to LJM, and 5R01GM087413 to HEX. This work was also supported in part by the Jay and Betty Van Andel Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barnes MR, 1998, TRENDS PHARMACOL SCI, V19, P399, DOI 10.1016/S0165-6147(98)01246-2; Burcelin R, 1998, J BIOL CHEM, V273, P8088, DOI 10.1074/jbc.273.14.8088; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Holmen SL, 2005, BIOCHEM BIOPH RES CO, V328, P533, DOI 10.1016/j.bbrc.2005.01.009; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Ke JY, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-132; Kulkarni NH, 2005, J CELL BIOCHEM, V95, P1178, DOI 10.1002/jcb.20506; Li XC, 2007, CLIN SCI, V113, P183, DOI 10.1042/CS20070040; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Romero G, 2010, J BIOL CHEM, V285, P14756, DOI 10.1074/jbc.M110.102970; Shevtsov SP, 2006, CELL CYCLE, V5, P2295, DOI 10.4161/cc.5.20.3357; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Unson CG, 2002, BIOPOLYMERS, V66, P218, DOI 10.1002/bip.10259; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wan M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001464; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	36	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33676	10.1371/journal.pone.0033676	http://dx.doi.org/10.1371/journal.pone.0033676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438981	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100085
J	Liu, WG; Huang, XD; Lin, JS; He, MX				Liu, Wenguang; Huang, Xiande; Lin, Jianshi; He, Maoxian			Seawater Acidification and Elevated Temperature Affect Gene Expression Patterns of the Pearl Oyster Pinctada fucata	PLOS ONE			English	Article							OCEAN ACIDIFICATION; THERMAL TOLERANCE; EPITHELIAL-CELLS; CARBON-DIOXIDE; SEA-WATER; CO2; CALCIFICATION; SHELL; IMPACT; DISSOCIATION	Oceanic uptake of anthropogenic carbon dioxide results in decrease in seawater pH and increase in temperature. In this study, we demonstrated the synergistic effects of elevated seawater temperature and declined seawater pH on gene expression patterns of aspein, calmodulin, nacrein, she-7-F10 and hsp70 in the pearl oyster Pinctada fucata. Under 'business-as-usual' scenarios, four treatments were examined: (1) ambient pH (8.10) and ambient temperature (27 degrees C) (control condition), (2) ambient pH and elevated temperature (+3 degrees C), (3) declined pH (7.70) and ambient temperature, (4) declined pH and elevated temperature. The results showed that under warming and acidic seawater conditions, expression of aspein and calmodulin showed no significant differences among different time point in condition 8.10 T. But the levels of aspein and calmodulin in conditions 8.10 T+3, 7.70 T and 7.70 T+3, and levels of nacrein, she-7-F10 in all the four treatments changed significantly. Low pH and pH x temperature interaction influenced the expression of aspein and calmodulin significantly after hours 48 and 96. Significant effects of low pH and pH x temperature interaction on the expression of nacrein were observed at hour 96. The expression level of she-7-F10 was affected significantly by pH after hours 48 and 96. The expression of hsp70 was significantly affected by temperature, pH, temperature x pH interaction at hour 6, and by temperature x pH interaction at hour 24. This study suggested that declined pH and pH x temperature interaction induced down regulation of calcification related genes, and the interaction between declined seawater pH and elevated temperature caused up regulation of hsp70 in P. facata. These results demonstrate that the declined seawater pH and elevated temperature will impact the physiological process, and potentially the adaptability of P. fucata to future warming and acidified ocean.	[Liu, Wenguang; Huang, Xiande; Lin, Jianshi; He, Maoxian] Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Liu, WG (corresponding author), Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.	hmx@scsio.ac.cn			Natural Science Foundation of China [41006090]; NSFC-Guangdong [U0831001]; Chinese Academy of Sciences [KZCX2-YW-Q07-03, ZCX2-EW-Q21]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong(National Natural Science Foundation of Guangdong Province); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study is supported by national Natural Science Foundation of China (41006090), the Joint Program of NSFC-Guangdong (U0831001) and the funds of knowledge innovation program of Chinese Academy of Sciences (KZCX2-YW-Q07-03 and ZCX2-EW-Q21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; BRADSHAW AL, 1981, EARTH PLANET SC LETT, V55, P99, DOI 10.1016/0012-821X(81)90090-X; Byrne M., 2010, P R SOC B, V282, P1; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gong NP, 2008, CELL TISSUE RES, V333, P493, DOI 10.1007/s00441-008-0609-5; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; Guan YY, 2011, CHIN J OCEANOL LIMN, V29, P616, DOI 10.1007/s00343-011-0200-x; Gutowska MA, 2010, MAR BIOL, V157, P1653, DOI 10.1007/s00227-010-1438-0; He MX, 2005, MAR BIOTECHNOL, V7, P40, DOI 10.1007/s10126-004-0003-6; Hofmann GE, 1999, AM ZOOL, V39, P889; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Liu WG, 2011, CHIN J OCEA IN PRESS; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Metzger R, 2007, J THERM BIOL, V32, P144, DOI 10.1016/j.jtherbio.2007.01.010; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; O'Donnell M, 2009, MAR BIOL, V156, P439, DOI 10.1007/s00227-008-1097-6; Ohsumi T, 2004, J OCEANOGR, V60, P693, DOI 10.1007/s10872-004-0971-1; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pierrot D., 2006, ORNLCDIAC105A US DEP; Place SP, 2008, MAR ECOL PROG SER, V356, P1, DOI 10.3354/meps07354; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Solomon S., 2007, PHYS SCI BASIS WORKI; Southgate P, 2008, PEARL OYSTER, pVII; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Turley C., 2006, AVOIDING DANGEROUS C, V8, P65; Twitchett R.J., 2009, BIOGEOSCIENCES DISCU, V6, P2267, DOI [DOI 10.5194/BGD-6-2267-2009, 10.5194/bgd-6-2267-2009]; Wang N, 2009, COMP BIOCHEM PHYS B, V154, P346, DOI 10.1016/j.cbpb.2009.07.012; Wang ZL, 2009, FISH SHELLFISH IMMUN, V26, P639, DOI 10.1016/j.fsi.2008.10.011; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Zayzafoon M, 2005, J BIOL CHEM, V280, P7049, DOI 10.1074/jbc.M412680200; Zhang LJ, 2011, AQUACULTURE, V314, P73, DOI 10.1016/j.aquaculture.2011.01.039; Zippay ML, 2010, J SHELLFISH RES, V29, P429, DOI 10.2983/035.029.0220	50	56	61	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33679	10.1371/journal.pone.0033679	http://dx.doi.org/10.1371/journal.pone.0033679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438983	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100087
J	Tasneem, A; Aberle, L; Ananth, H; Chakraborty, S; Chiswell, K; McCourt, BJ; Pietrobon, R				Tasneem, Asba; Aberle, Laura; Ananth, Hari; Chakraborty, Swati; Chiswell, Karen; McCourt, Brian J.; Pietrobon, Ricardo			The Database for Aggregate Analysis of ClinicalTrials.gov (AACT) and Subsequent Regrouping by Clinical Specialty	PLOS ONE			English	Article							REGISTRATION; ISSUES; TRIALS	Background: The ClinicalTrials.gov registry provides information regarding characteristics of past, current, and planned clinical studies to patients, clinicians, and researchers; in addition, registry data are available for bulk download. However, issues related to data structure, nomenclature, and changes in data collection over time present challenges to the aggregate analysis and interpretation of these data in general and to the analysis of trials according to clinical specialty in particular. Improving usability of these data could enhance the utility of ClinicalTrials.gov as a research resource. Methods/Principal Results: The purpose of our project was twofold. First, we sought to extend the usability of ClinicalTrials.gov for research purposes by developing a database for aggregate analysis of ClinicalTrials.gov (AACT) that contains data from the 96,346 clinical trials registered as of September 27, 2010. Second, we developed and validated a methodology for annotating studies by clinical specialty, using a custom taxonomy employing Medical Subject Heading (MeSH) terms applied by an NLM algorithm, as well as MeSH terms and other disease condition terms provided by study sponsors. Clinical specialists reviewed and annotated MeSH and non-MeSH disease condition terms, and an algorithm was created to classify studies into clinical specialties based on both MeSH and non-MeSH annotations. False positives and false negatives were evaluated by comparing algorithmic classification with manual classification for three specialties. Conclusions/Significance: The resulting AACT database features study design attributes parsed into discrete fields, integrated metadata, and an integrated MeSH thesaurus, and is available for download as Oracle extracts (.dmp file and text format). This publicly-accessible dataset will facilitate analysis of studies and permit detailed characterization and analysis of the U. S. clinical trials enterprise as a whole. In addition, the methodology we present for creating specialty datasets may facilitate other efforts to analyze studies by specialty groups.	[Tasneem, Asba; Aberle, Laura; Ananth, Hari; Chakraborty, Swati; Chiswell, Karen; McCourt, Brian J.; Pietrobon, Ricardo] Duke Clin Res Inst, Durham, NC 27715 USA; [Pietrobon, Ricardo] Duke Univ, Sch Med, Dept Surg, Durham, NC USA	Duke University; Duke University	Tasneem, A (corresponding author), Duke Clin Res Inst, Durham, NC 27715 USA.	asba.tasneem@duke.edu		Pietrobon, Ricardo/0000-0003-2996-2193	U.S. Food and Drug Administration [U19 FD003800]; Clinical Trials Transformation Initiative; FOOD AND DRUG ADMINISTRATION [U19FD003800] Funding Source: NIH RePORTER	U.S. Food and Drug Administration; Clinical Trials Transformation Initiative; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	Financial support for this work was provided by cooperative agreement U19 FD003800 awarded by the U.S. Food and Drug Administration to Duke University in support of the Clinical Trials Transformation Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Codd E. F., 1972, DATA BASE SYSTEMS, P33; CODD EF, 1970, COMMUN ACM, V13, P377, DOI 10.1145/357980.358007; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; U. S. Department of Health and Human Services - Public Health Service, 2009, IT 14 FIELDS TRAIN C, P4; World Health Organization, HLTH TOP GLOB BURD D; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	8	81	82	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33677	10.1371/journal.pone.0033677	http://dx.doi.org/10.1371/journal.pone.0033677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438982	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100086
J	Zhang, L; Yokoi, F; Parsons, DS; Standaert, DG; Li, YQ				Zhang, Lin; Yokoi, Fumiaki; Parsons, Dee S.; Standaert, David G.; Li, Yuqing			Alteration of Striatal Dopaminergic Neurotransmission in a Mouse Model of DYT11 Myoclonus-Dystonia	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE GENE; EPSILON-SARCOGLYCAN GENE; RECEPTOR-BINDING; DEFICIENT MICE; MOTOR DEFICITS; MESSENGER-RNA; MUTATIONS; IDENTIFICATION; MINOCYCLINE; EXPRESSION	Background: DYT11 myoclonus-dystonia (M-D) syndrome is a neurological movement disorder characterized by myoclonic jerks and dystonic postures or movement that can be alleviated by alcohol. It is caused by mutations in SGCE encoding epsilon-sarcoglycan (epsilon-SG); the mouse homolog of this gene is Sgce. Paternally-inherited Sgce heterozygous knockout (Sgce KO) mice exhibit myoclonus, motor impairment and anxiety-and depression-like behaviors, modeling several clinical symptoms observed in DYT11 M-D patients. The behavioral deficits are accompanied by abnormally high levels of dopamine and its metabolites in the striatum of Sgce KO mice. Neuroimaging studies of DYT11 M-D patients show reduced dopamine D2 receptor (D2R) availability, although the possibility of increased endogenous dopamine, and consequently, competitive D2R occupancy cannot be ruled out. Methodology/Principal Findings: The protein levels of striatal D2R, dopamine transporter (DAT), and dopamine D1 receptor (D1R) in Sgce KO mice were analyzed by Western blot. The striatal dopamine release after amphetamine injection in Sgce KO mice were analyzed by microdialysis in vivo. The striatal D2R was significantly decreased in Sgce KO mice without altering DAT and D1R. Sgce KO mice also exhibited a significant increase of dopamine release after amphetamine injection in comparison to wild-type (WT) littermates. Conclusion/Significance: The results suggest epsilon-SG may have a role in the regulation of D2R expression. The loss of epsilon-SG results in decreased striatal D2R, and subsequently leads to increased discharge of dopamine which could contribute to the behavioral impairment observed in DYT11 dystonia patients and in Sgce KO mice. The results suggest that reduction of striatal D2R and enhanced striatal dopamine release may contribute to the pathophysiology of DYT11 M-D patients.	[Zhang, Lin; Yokoi, Fumiaki; Li, Yuqing] Univ Florida, Sch Med, Dept Neurol, Gainesville, FL 32610 USA; [Parsons, Dee S.; Standaert, David G.] Univ Alabama Birmingham, Dept Neurol, Sch Med, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham	Li, YQ (corresponding author), Univ Florida, Sch Med, Dept Neurol, Gainesville, FL 32610 USA.	yuqing.li@neurology.ufl.edu	Li, Yuqing/G-1596-2011; Li, Yuqing/AAR-9383-2021	Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; Standaert, David/0000-0003-2921-8348	Tyler's Hope for a Dystonia Cure, Inc.; National Institutes of Health [NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, NS74423]; Department of Neurology (UAB); University of Florida; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037409, R21NS072872, R03NS074423, R01NS054246, P30NS047466, P30NS057098, R21NS065273, R21NS047692, P50NS037409] Funding Source: NIH RePORTER	Tyler's Hope for a Dystonia Cure, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurology (UAB); University of Florida(University of Florida); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Tyler's Hope for a Dystonia Cure, Inc., the National Institutes of Health grants (NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, and NS74423), and a startup fund from the Department of Neurology (UAB). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arinami T, 1997, HUM MOL GENET, V6, P577, DOI 10.1093/hmg/6.4.577; Asanuma K, 2005, NEUROLOGY, V64, P347, DOI 10.1212/01.WNL.0000149764.34953.BF; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Beukers RJ, 2009, EUR J NUCL MED MOL I, V36, P269, DOI 10.1007/s00259-008-0924-9; Chan P, 2005, J COMP NEUROL, V482, P50, DOI 10.1002/cne.20377; Dang MT, 2012, BEHAV BRAIN RES, V226, P465, DOI 10.1016/j.bbr.2011.10.002; Doheny DO, 2002, NEUROLOGY, V59, P1187, DOI 10.1212/WNL.59.8.1187; du Montcel ST, 2006, J MED GENET, V43, P394, DOI 10.1136/jmg.2005.036780; Esapa CT, 2007, HUM MOL GENET, V16, P327, DOI 10.1093/hmg/ddl472; Fahn S, 1988, Adv Neurol, V50, P1; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Grabowski M, 2003, EUR J HUM GENET, V11, P138, DOI 10.1038/sj.ejhg.5200938; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Klein C, 1999, P NATL ACAD SCI USA, V96, P5173, DOI 10.1073/pnas.96.9.5173; KNAPPSKOG PM, 1995, HUM MOL GENET, V4, P1209, DOI 10.1093/hmg/4.7.1209; LUDECKE B, 1995, HUM GENET, V95, P716; Magalhaes AC, 2011, BR J PHARM; Misbahuddin A, 2007, MOVEMENT DISORD, V22, P1173, DOI 10.1002/mds.21297; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Naumann M, 1998, MOVEMENT DISORD, V13, P319, DOI 10.1002/mds.870130219; Nishiyama A, 2004, MOL BRAIN RES, V125, P1, DOI 10.1016/j.molbrainres.2004.01.012; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Paladini CA, 2003, P NATL ACAD SCI USA, V100, P2866, DOI 10.1073/pnas.0138018100; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Ritz K, 2011, EUR J HUM GENET, V19, P438, DOI 10.1038/ejhg.2010.206; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Skidmore Frank, 2005, Curr Treat Options Neurol, V7, P231, DOI 10.1007/s11940-005-0016-0; STAEDT J, 1995, EUR ARCH PSY CLIN N, V245, P8, DOI 10.1007/BF02191538; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Wang YY, 2000, J NEUROSCI, V20, P8305, DOI 10.1523/JNEUROSCI.20-22-08305.2000; WOLF ME, 1990, ANN NY ACAD SCI, V604, P323, DOI 10.1111/j.1749-6632.1990.tb32003.x; Xiao JF, 2003, MOL BRAIN RES, V119, P132, DOI 10.1016/j.molbrainres.2003.09.004; Yokoi F, 2005, FEBS LETT, V579, P4822, DOI 10.1016/j.febslet.2005.07.065; Yokoi F, 2006, J BIOCHEM, V140, P141, DOI 10.1093/jb/mvj138; Yokoi F, 2012, HUM MOL GENET, V21, P916, DOI 10.1093/hmg/ddr528; Yokoi F, 2012, BEHAV BRAIN RES, V227, P12, DOI 10.1016/j.bbr.2011.10.024; Yokoi F, 2010, J BIOCHEM, V148, P459, DOI 10.1093/jb/mvq078; Zhang L, 2007, NEUROPSYCHOPHARMACOL, V32, P2004, DOI 10.1038/sj.npp.1301313; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015; Zhang L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/831092; Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709	43	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33669	10.1371/journal.pone.0033669	http://dx.doi.org/10.1371/journal.pone.0033669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438980	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100084
J	Zhang, YM; Shi, CY; Yu, JF; Ren, JJ; Sun, DC				Zhang, Yanmei; Shi, Chunyu; Yu, Jiafei; Ren, Jingjing; Sun, Dongchang			RpoS Regulates a Novel Type of Plasmid DNA Transfer in Escherichia coli	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; STREPTOCOCCUS-PNEUMONIAE; GENETIC-TRANSFORMATION; SIGMA(S)-DEPENDENT GENES; BACILLUS-SUBTILIS; COMPETENCE GENES; EXPRESSION; BACTERIA; RESISTANCE; PHEROMONE	Spontaneous plasmid transformation of Escherichia coli is independent of the DNA uptake machinery for single-stranded DNA (ssDNA) entry. The one-hit kinetic pattern of plasmid transformation indicates that double-stranded DNA (dsDNA) enters E. coli cells on agar plates. However, DNA uptake and transformation regulation remain unclear in this new type of plasmid transformation. In this study, we developed our previous plasmid transformation system and induced competence at early stationary phase. Despite of inoculum size, the development of competence was determined by optical cell density. DNase I interruption experiment showed that DNA was taken up exponentially within the initial 2 minutes and most transforming DNA entered E. coli cells within 10 minutes on LB-agar plates. A half-order kinetics between recipient cells and transformants was identified when cell density was high on plates. To determine whether the stationary phase master regulator RpoS plays roles in plasmid transformation, we investigated the effects of inactivating and over-expressing its encoding gene rpoS on plasmid transformation. The inactivation of rpoS systematically reduced transformation frequency, while over-expressing rpoS increased plasmid transformation. Normally, RpoS recognizes promoters by its lysine 173 (K173). We found that the K173E mutation caused RpoS unable to promote plasmid transformation, further confirming a role of RpoS in regulating plasmid transformation. In classical transformation, DNA was transferred across membranes by DNA uptake proteins and integrated by DNA processing proteins. At stationary growth phase, RpoS regulates some genes encoding membrane/periplasmic proteins and DNA processing proteins. We quantified transcription of 22 of them and found that transcription of only 4 genes (osmC, yqjC, ygiW and ugpC) encoding membrane/periplasmic proteins showed significant differential expression when wildtype RpoS and RpoS(K173E) mutant were expressed. Further investigation showed that inactivation of any one of these genes did not significantly reduce transformation, suggesting that RpoS may regulate plasmid transformation through other/multiple target genes.	[Zhang, Yanmei; Shi, Chunyu; Yu, Jiafei; Ren, Jingjing; Sun, Dongchang] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yanmei; Shi, Chunyu; Yu, Jiafei; Ren, Jingjing; Sun, Dongchang] Zhejiang Acad Agr Sci, Inst Plant Protect & Micriobiol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yanmei] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; University of Virginia	Sun, DC (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.	sundongchang@yahoo.com	sun, dongchang/X-1148-2019		Natural Science Foudation of China [31100071]; Natural Science Foundation of Zhejiang province [Y3110237]; Zhejiang Academy of Agricultural Sciences; Zhejiang Open Foundation of the Most Important Subjects	Natural Science Foudation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Zhejiang Academy of Agricultural Sciences; Zhejiang Open Foundation of the Most Important Subjects	This work is supported by the Natural Science Foudation of China (31100071), the Natural Science Foundation of Zhejiang province (Y3110237), the Doctor's Start-up Grant from Zhejiang Academy of Agricultural Sciences, the Foresight Program from Zhejiang Academy of Agricultural Sciences, and the Zhejiang Open Foundation of the Most Important Subjects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Becker G, 1999, P NATL ACAD SCI USA, V96, P6439, DOI 10.1073/pnas.96.11.6439; Becker G, 2001, MOL MICROBIOL, V39, P1153, DOI 10.1046/j.1365-2958.2001.02313.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Claverys JP, 2003, TRENDS MICROBIOL, V11, P161, DOI 10.1016/S0966-842X(03)00064-7; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; DUBNAU D, 1991, MICROBIOL REV, V55, P395, DOI 10.1128/MMBR.55.3.395-424.1991; Etchuuya R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016355; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Maeda S, 2004, FEMS MICROBIOL LETT, V236, P61, DOI 10.1111/j.1574-6968.2004.tb09627.x; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; MULVEY MR, 1989, NUCLEIC ACIDS RES, V17, P9979, DOI 10.1093/nar/17.23.9979; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; SAUNDERS CW, 1981, MOL GEN GENET, V181, P57, DOI 10.1007/BF00339005; Sauvonnet N, 2000, J BACTERIOL, V182, P848, DOI 10.1128/JB.182.3.848-854.2000; Sinha S, 2009, J BACTERIOL, V191, P5180, DOI 10.1128/JB.00476-09; Sledjeski DD, 1996, EMBO J, V15, P3993, DOI 10.1002/j.1460-2075.1996.tb00773.x; SMITH HO, 1981, ANNU REV BIOCHEM, V50, P41, DOI 10.1146/annurev.bi.50.070181.000353; Solomon JM, 1996, TRENDS GENET, V12, P150, DOI 10.1016/0168-9525(96)10014-7; Subbarayan PR, 2004, MOL GENET GENOMICS, V270, P533, DOI 10.1007/s00438-003-0944-x; Sun DC, 2006, FEMS MICROBIOL LETT, V265, P249, DOI 10.1111/j.1574-6968.2006.00503.x; Sun DC, 2009, J BACTERIOL, V191, P713, DOI 10.1128/JB.01130-08; Tsen SD, 2002, J BIOMED SCI, V9, P246, DOI 10.1159/000059425; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; Vijayakumar SRV, 2004, J BACTERIOL, V186, P8499, DOI 10.1128/JB.186.24.8499-8507.2004; Wang XJ, 2007, CURR MICROBIOL, V54, P450, DOI 10.1007/s00284-006-0617-1; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang YM, 2011, MOL BIOL REP, V38, P275, DOI 10.1007/s11033-010-0105-3	38	20	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33514	10.1371/journal.pone.0033514	http://dx.doi.org/10.1371/journal.pone.0033514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438941	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100053
J	Metzger, GJ; Dankbar, SC; Henriksen, J; Rizzardi, AE; Rosener, NK; Schmechel, SC				Metzger, Gregory J.; Dankbar, Stephen C.; Henriksen, Jonathan; Rizzardi, Anthony E.; Rosener, Nikolaus K.; Schmechel, Stephen C.			Development of Multigene Expression Signature Maps at the Protein Level from Digitized Immunohistochemistry Slides	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; LASER-CAPTURE MICRODISSECTION; PROSTATE-CANCER; GENE-EXPRESSION; BREAST-CANCER; INTRATUMORAL HETEROGENEITY; AMPLIFICATION STATUS; PREDICTING RESPONSE; MICROVESSEL DENSITY; ACID-PHOSPHATASE	Molecular classification of diseases based on multigene expression signatures is increasingly used for diagnosis, prognosis, and prediction of response to therapy. Immunohistochemistry (IHC) is an optimal method for validating expression signatures obtained using high-throughput genomics techniques since IHC allows a pathologist to examine gene expression at the protein level within the context of histologically interpretable tissue sections. Additionally, validated IHC assays may be readily implemented as clinical tests since IHC is performed on routinely processed clinical tissue samples. However, methods have not been available for automated n-gene expression profiling at the protein level using IHC data. We have developed methods to compute expression level maps (signature maps) of multiple genes from IHC data digitized on a commercial whole slide imaging system. Areas of cancer for these expression level maps are defined by a pathologist on adjacent, co-registered H&E slides, allowing assessment of IHC statistics and heterogeneity within the diseased tissue. This novel way of representing multiple IHC assays as signature maps will allow the development of n-gene expression profiling databases in three dimensions throughout virtual whole organ reconstructions.	[Metzger, Gregory J.] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA; [Dankbar, Stephen C.; Henriksen, Jonathan; Rizzardi, Anthony E.; Rosener, Nikolaus K.; Schmechel, Stephen C.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Henriksen, Jonathan; Schmechel, Stephen C.] Univ Minnesota, BioNet, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Metzger, GJ (corresponding author), Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA.	schme004@umn.edu		Metzger, Gregory/0000-0002-3187-6529	National Cancer Institute (NCI) [R01 CA131013, R01 CA131013-02S1, P30 CA77598, P50 CA101955]; Minnesota Medical Foundation [3824-9202-08]; University of Minnesota Academic Health Center; NATIONAL CANCER INSTITUTE [P50CA101955, R01CA131013, P30CA077598] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Minnesota Medical Foundation; University of Minnesota Academic Health Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (NCI) grants R01 CA131013 and R01 CA131013-02S1 (Dr. Metzger) and Minnesota Medical Foundation grant 3824-9202-08 (Dr. Schmechel). BioNet facilities are supported by NCI grants P30 CA77598 (Dr. Yee) and P50 CA101955 (Dr. Buchsbaum) and the University of Minnesota Academic Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Adams H, 2008, HUM PATHOL, V39, P1323, DOI 10.1016/j.humpath.2008.01.004; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; ALLRED DC, 1990, ARCH SURG-CHICAGO, V125, P107; Aperio, 2008, AP IMAGESERVER PROGR; BATES RJ, 1982, J UROLOGY, V127, P574, DOI 10.1016/S0022-5347(17)53915-4; Bettencourt MC, 1996, J UROLOGY, V156, P1064, DOI 10.1016/S0022-5347(01)65703-3; Bismar TA, 2006, NEOPLASIA, V8, P59, DOI 10.1593/neo.05664; Bono AV, 2002, PROSTATE CANCER P D, V5, P123, DOI 10.1038/sj.pcan.4500572; Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4; Chang CC, 2004, AM J SURG PATHOL, V28, P464, DOI 10.1097/00000478-200404000-00005; Charpin C, 2009, INT J CANCER, V124, P2124, DOI 10.1002/ijc.24177; Ciocca DR, 2000, ENDOCRINE, V13, P1, DOI 10.1385/ENDO:13:1:1; COHEN RJ, 1990, BRIT J UROL, V66, P405, DOI 10.1111/j.1464-410X.1990.tb14963.x; COHEN RJ, 1992, ARCH PATHOL LAB MED, V116, P65; Cooper L, 2009, COMPUT METH PROG BIO, V96, P182, DOI 10.1016/j.cmpb.2009.04.012; Cummings M, 2009, CELL ONCOL, V31, P467, DOI 10.3233/CLO-2009-0495; de la Taille A, 2000, AM J CLIN PATHOL, V113, P555, DOI 10.1309/02W2-KE50-PKEF-G2G4; Dolled-Filhart M, 2010, METHODS MOL BIOL, V664, P151, DOI 10.1007/978-1-60761-806-5_15; Febbo PG, 2003, J UROLOGY, V170, pS11, DOI 10.1097/01.ju.0000095567.03807.a1; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Fritzsche FR, 2010, AM J SURG PATHOL, V34, P1180, DOI 10.1097/PAS.0b013e3181e70e15; Gilbertson JR, 2006, BMC CLIN PATHOL, V6, DOI 10.1186/1472-6890-6-4; Giusiano S, 2010, INT J ONCOL, V36, P889, DOI 10.3892/ijo_00000567; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gunia S, 2009, VIRCHOWS ARCH, V454, P573, DOI 10.1007/s00428-009-0759-1; Haedicke W, 2003, BIOTECHNIQUES, V35, P164, DOI 10.2144/03351md04; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hanna W, 2007, BREAST J, V13, P122, DOI 10.1111/j.1524-4741.2007.00396.x; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Ho J, 2006, HUM PATHOL, V37, P322, DOI 10.1016/j.humpath.2005.11.005; Jiang J, 2010, CRYOBIOLOGY, V61, P280, DOI 10.1016/j.cryobiol.2010.09.006; Kapur K, 2008, BIOINFORMATICS, V24, P2887, DOI 10.1093/bioinformatics/btn571; Laakso M, 2006, J PATHOL, V210, P3, DOI 10.1002/path.2022; Landemaine T, 2008, CANCER RES, V68, P6092, DOI 10.1158/0008-5472.CAN-08-0436; Lee CK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r23; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis JT, 2005, AM J CLIN PATHOL, V124, P273, DOI 10.1309/J9VXABUGKC4Y07DL; Li L, 2010, J PATHOL INFORM, V1, P2; Li RL, 2004, CLIN CANCER RES, V10, P4118, DOI 10.1158/1078-0432.CCR-1052-03; Makretsov NA, 2004, CLIN CANCER RES, V10, P6143, DOI 10.1158/1078-0432.CCR-04-0429; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Moul JV, 1999, EUR UROL, V35, P399, DOI 10.1159/000019916; Muris JJF, 2006, J PATHOL, V208, P714, DOI 10.1002/path.1924; Nassar A, 2010, APPL IMMUNOHISTO M M, V18, P433, DOI 10.1097/PAI.0b013e3181dddb20; Norris AW, 2006, P NATL ACAD SCI USA, V103, P649, DOI 10.1073/PNAS.0510115103; Pedro RN, 2010, UROLOGY, V76, P494, DOI 10.1016/j.urology.2010.01.085; Poulsen CB, 2005, EUR J HAEMATOL, V74, P453, DOI 10.1111/j.1600-0609.2005.00429.x; Rexhepaj E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2187; Schmechel SC, 2004, LEUKEMIA, V18, P841, DOI 10.1038/sj.leu.2403293; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Shukla CJ, 2008, BJU INT, V101, P765, DOI 10.1111/j.1464-410X.2007.07372.x; Simon R, 2001, J NATL CANCER I, V93, P1141, DOI 10.1093/jnci/93.15.1141; Simone NL, 1998, TRENDS GENET, V14, P272, DOI 10.1016/S0168-9525(98)01489-9; Stephenson AJ, 2005, CANCER-AM CANCER SOC, V104, P290, DOI 10.1002/cncr.21157; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Sun YJ, 2009, PROSTATE, V69, P1119, DOI 10.1002/pros.20961; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tu IP, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-64; van Niekerk CG, 2009, PROSTATE, V69, P62, DOI 10.1002/pros.20855; Vance GH, 2009, ARCH PATHOL LAB MED, V133, P611, DOI 10.1043/1543-2165-133.4.611; Vendrell JA, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2158; Wilbur DC, 2009, ARCH PATHOL LAB MED, V133, P1949, DOI 10.1043/1543-2165-133.12.1949; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yagi Y, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-S1-S12	69	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33520	10.1371/journal.pone.0033520	http://dx.doi.org/10.1371/journal.pone.0033520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438942	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309000029
J	Sim, K; Cox, MJ; Wopereis, H; Martin, R; Knol, J; Li, MS; Cookson, WOCM; Moffatt, MF; Kroll, JS				Sim, Kathleen; Cox, Michael J.; Wopereis, Harm; Martin, Rocio; Knol, Jan; Li, Ming-Shi; Cookson, William O. C. M.; Moffatt, Miriam F.; Kroll, J. Simon			Improved Detection of Bifidobacteria with Optimised 16S rRNA-Gene Based Pyrosequencing	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE-CHAIN-REACTION; IN-SITU HYBRIDIZATION; FECAL MICROBIOTA; GUT MICROBIOTA; DEEP-SEA; INFANTS; DIVERSITY; BACTERIAL; DNA	The 16S rRNA gene is conserved across all bacteria and as such is routinely targeted in PCR surveys of bacterial diversity. PCR primer design aims to amplify as many different 16S rRNA gene sequences from as wide a range of organisms as possible, though there are no suitable 100% conserved regions of the gene, leading to bias. In the gastrointestinal tract, bifidobacteria are a key genus, but are often under-represented in 16S rRNA surveys of diversity. We have designed modified, 'bifidobacteria-optimised' universal primers, which we have demonstrated detection of bifidobacterial sequence present in DNA mixtures at 2% abundance, the lowest proportion tested. Optimisation did not compromise the detection of other organisms in infant faecal samples. Separate validation using fluorescence in situ hybridisation (FISH) shows that the proportions of bifidobacteria detected in faecal samples were in agreement with those obtained using 16S rRNA based pyrosequencing. For future studies looking at faecal microbiota, careful selection of primers will be key in order to ensure effective detection of bifidobacteria.	[Sim, Kathleen; Cox, Michael J.; Cookson, William O. C. M.; Moffatt, Miriam F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Wopereis, Harm; Martin, Rocio; Knol, Jan] Danone Res, Ctr Specialised Nutr, Wageningen, Netherlands	Imperial College London; Danone Nutricia	Sim, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, St Marys Campus, London, England.	k.sim@imperial.ac.uk	Knol, Jan/A-2178-2010; Cookson, William/HHC-1790-2022; Knol, Jan/AAL-6487-2020; Martin, Rocio/A-5846-2011	Knol, Jan/0000-0002-2103-5961; Knol, Jan/0000-0002-2103-5961; Cox, Michael/0000-0002-4002-1506	Winnicott Foundation [WMNP_ P26859]; Medical Research Council [G1000758, G0801056B, G1000758B] Funding Source: researchfish; National Institute for Health Research [ACF-2009-21-027] Funding Source: researchfish	Winnicott Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by The Winnicott Foundation, grant number WMNP_ P26859 (http://www.winnicott.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boehm G, 2005, ACTA PAEDIATR, V94, P18, DOI 10.1080/08035320510043493; Boesten R, 2011, MICROB BIOTECHNOL, V4, P417, DOI 10.1111/j.1751-7915.2010.00216.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Boer R, 2010, J MICROBIOL METH, V80, P209, DOI 10.1016/j.mimet.2009.11.009; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Forno Erick, 2008, Clin Mol Allergy, V6, P11, DOI 10.1186/1476-7961-6-11; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gilliland S, HLTH NUTR PROPERTIES; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hong PY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009964; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; Knol J, 2005, J PEDIATR GASTR NUTR, V40, P36, DOI 10.1097/00005176-200501000-00007; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Metchnikoff, 1907, PROLONGATION LIFE OP, P161; Meyer AF, 2004, APPL ENVIRON MICROB, V70, P483, DOI 10.1128/AEM.70.1.483-489.2004; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ouwehand AC, 2007, J NUTR, V137, p794S, DOI 10.1093/jn/137.3.794S; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Roger LC, 2010, MICROBIOL-SGM, V156, P3317, DOI 10.1099/mic.0.041913-0; Sambrook J., 2001, MOL CLONING LAB MANU; Satokari RM, 2001, SYST APPL MICROBIOL, V24, P227, DOI 10.1078/0723-2020-00035; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Thiel R, 2005, J MICROBIOL METH, V61, P369, DOI 10.1016/j.mimet.2004.12.014; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van der Aa LB, 2011, ALLERGY, V66, P170, DOI 10.1111/j.1398-9995.2010.02416.x; van Limpt C, 2004, PEDIATR RES, V56, P487, DOI 10.1203/00006450-200409000-00157; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhu YM, 2011, CANCER LETT, V309, P119, DOI 10.1016/j.canlet.2011.06.004	47	143	146	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32543	10.1371/journal.pone.0032543	http://dx.doi.org/10.1371/journal.pone.0032543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470420	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000004
J	Wacleche, VS; Chomont, N; Gosselin, A; Monteiro, P; Goupil, M; Kared, H; Tremblay, C; Bernard, N; Boulassel, MR; Routy, JP; Ancuta, P				Wacleche, Vanessa Sue; Chomont, Nicolas; Gosselin, Annie; Monteiro, Patricia; Goupil, Mathieu; Kared, Hassen; Tremblay, Cecile; Bernard, Nicole; Boulassel, Mohamed-Rachid; Routy, Jean-Pierre; Ancuta, Petronela			The Colocalization Potential of HIV-Specific CD8(+) and CD4(+) T-Cells is Mediated by Integrin beta 7 but Not CCR6 and Regulated by Retinoic Acid	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; LYMPHOID-TISSUE; MICROBIAL TRANSLOCATION; TYPE-1 INFECTION; TH17 CELLS; MEMORY; RECEPTOR; DISEASE; DEPLETION	CD4(+) T-cells from gut-associated lymphoid tissues (GALT) are major targets for HIV-1 infection. Recruitment of excess effector CD8(+) T-cells in the proximity of target cells is critical for the control of viral replication. Here, we investigated the colocalization potential of HIV-specific CD8(+) and CD4(+) T-cells into the GALT and explored the role of retinoic acid (RA) in regulating this process in a cohort of HIV-infected subjects with slow disease progression. The expression of the gut-homing molecules integrin beta 7, CCR6, and CXCR3 was identified as a "signature" for HIV-specific but not CMV-specific CD4(+) T-cells thus providing a new explanation for their enhanced permissiveness to infection in vivo. HIV-specific CD8(+) T-cells also expressed high levels of integrin b7 and CXCR3; however CCR6 was detected at superior levels on HIV-specific CD4(+) versus CD8(+) T-cells. All trans RA (ATRA) upregulated the expression of integrin beta 7 but not CCR6 on HIV-specific T-cells. Together, these results suggest that HIV-specific CD8(+) T-cells may colocalize in excess with CD4+ T-cells into the GALT via integrin beta 7 and CXCR3, but not via CCR6. Considering our previous findings that CCR6(+)CD4(+) T-cells are major cellular targets for HIV-DNA integration in vivo, a limited ability of CD8(+) T-cells to migrate in the vicinity of CCR6(+)CD4(+) T-cells may facilitate HIV replication and dissemination at mucosal sites.	[Wacleche, Vanessa Sue; Monteiro, Patricia; Goupil, Mathieu; Kared, Hassen; Tremblay, Cecile; Ancuta, Petronela] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Wacleche, Vanessa Sue; Gosselin, Annie; Monteiro, Patricia; Kared, Hassen; Tremblay, Cecile; Ancuta, Petronela] Hop St Luc, CHUM, Res Ctr, Montreal, PQ H2X 1P1, Canada; [Chomont, Nicolas] VGTI Florida, Port St Lucie, FL USA; [Monteiro, Patricia; Routy, Jean-Pierre; Ancuta, Petronela] INSERM, U743, Montreal, PQ, Canada; [Bernard, Nicole] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Boulassel, Mohamed-Rachid; Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Div Hematol, Montreal, PQ, Canada; [Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Montreal Chest Inst, Immunodeficiency Serv, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Vaccine & Gene Therapy Institute of Florida; Institut National de la Sante et de la Recherche Medicale (Inserm); McGill University; McGill University; McGill University	Wacleche, VS (corresponding author), Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada.	petronela.ancuta@umontreal.ca	Kared, Hassen/AAD-7247-2020; Chomont, Nicolas/ABG-2545-2020	Chomont, Nicolas/0000-0001-9747-5018	Canadian Institutes of Health [MOP-82849, HBF-82849]; Fondation du CHUM; Fonds de la Recherche en Sante Que bec (FRSQ); French Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de Recherche sur le SIDA (ANRS); Fondation de France; Universite de Montreal; CIHR [HOP-103230, MOP-93770]; ANRS/FRSQ; FRSQ; INSERM; FRSQ-SIDA Infectious Diseases Network; Canadian HIV Trials Network-CIHR [CTN 257]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Fondation du CHUM; Fonds de la Recherche en Sante Que bec (FRSQ)(Fonds de la Recherche en Sante du Quebec); French Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Fondation de France(Fondation de France); Universite de Montreal; CIHR(Canadian Institutes of Health Research (CIHR)); ANRS/FRSQ; FRSQ(Fonds de la Recherche en Sante du Quebec); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FRSQ-SIDA Infectious Diseases Network; Canadian HIV Trials Network-CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants to PA from the Canadian Institutes of Health Research (CIHR; MOP-82849 and HBF-82849), Fondation du CHUM, Fonds de la Recherche en Sante Que bec (FRSQ) and the French Institut National de la Sante et de la Recherche Medicale (INSERM), Agence Nationale de Recherche sur le SIDA (ANRS), and Fondation de France. VSW was supported by Doctoral Awards from the Universite de Montreal and CIHR. PM and HK were supported by Post-Doctoral Fellowships from ANRS/FRSQ and CIHR, respectively. JPR is a FRSQ Senior Clinician-Scientist. PA received salary support from FRSQ and INSERM. Core facilities were supported by the Fondation du CHUM and the FRSQ-SIDA Infectious Diseases Network. The HIV Primo Infection cohort is funded by the FRSQ-SIDA Infectious Diseases Network, the CIHR (#HOP-103230 to JPR), and the Canadian HIV Trials Network-CIHR (CTN-CIHR #CTN 257 to JPR). The Canadian Cohort of HIV+ Slow Progressors is funded by the CIHR (#MOP-93770 to CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; Ancuta P, 2010, CURR OPIN HIV AIDS, V5, P158, DOI 10.1097/COH.0b013e3283364733; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Barre-Sinoussi F, 2010, VIROLOGY, V397, P255, DOI 10.1016/j.virol.2009.08.033; Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Boulassel MR, 2003, J CLIN APHERESIS, V18, P55, DOI 10.1002/jca.10051; Brainard DM, 2007, J VIROL, V81, P8439, DOI 10.1128/JVI.00199-07; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Casazza JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000646; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Chomont N, 2011, CURR OPIN HIV AIDS, V6, P30, DOI 10.1097/COH.0b013e3283413775; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dwinell MB, 2001, GASTROENTEROLOGY, V120, P49, DOI 10.1053/gast.2001.20914; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2011, CLIN INFECT DIS, V52, P681, DOI 10.1093/cid/ciq202; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Killian MS, 2011, J VIROL, V85, P1696, DOI 10.1128/JVI.01120-10; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Lackner AA, 2007, ANNU REV MED, V58, P461, DOI 10.1146/annurev.med.58.082405.094316; Lackner AA, 2009, GASTROENTEROLOGY, V136, P1966, DOI 10.1053/j.gastro.2008.12.071; Lecureuil C, 2007, BLOOD, V109, P3649, DOI 10.1182/blood-2006-01-035717; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Luscinskas FW, 2001, NAT IMMUNOL, V2, P478, DOI 10.1038/88663; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Monteiro P, 2011, J IMMUNOL, V186, P4618, DOI 10.4049/jimmunol.1004151; Mora JR, 2004, IMMUNITY, V21, P458, DOI 10.1016/j.immuni.2004.10.002; NAPOLI JL, 1986, METHOD ENZYMOL, V123, P112, DOI 10.1016/S0076-6879(86)23015-3; Olsson J, 2000, J INFECT DIS, V182, P1625, DOI 10.1086/317625; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sallusto F, 2004, CURR OPIN IMMUNOL, V16, P724, DOI 10.1016/j.coi.2004.09.012; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Sauce D, 2011, BLOOD, V117, P5142, DOI 10.1182/blood-2011-01-331306; Shacklett BL, 2003, J VIROL, V77, P5621, DOI 10.1128/JVI.77.10.5621-5631.2003; Sheth PM, 2008, MUCOSAL IMMUNOL, V1, P382, DOI 10.1038/mi.2008.23; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Veazey RS, 2004, J EXP MED, V200, P697, DOI 10.1084/jem.20041464; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Westphal S, 2008, AM J PATHOL, V172, P671, DOI 10.2353/ajpath.2008.070393; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Yue FY, 2008, J VIROL, V82, P6767, DOI 10.1128/JVI.02550-07; Zaunders JJ, 2005, BLOOD, V106, P1660, DOI 10.1182/blood-2005-01-0206; Zaunders JJ, 2006, J VIROL, V80, P10162, DOI 10.1128/JVI.00249-06	83	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32964	10.1371/journal.pone.0032964	http://dx.doi.org/10.1371/journal.pone.0032964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470433	gold, Green Submitted, Green Published			2022-12-27	WOS:000304489000012
J	Tijsseling, D; Wijnberger, LDE; Derks, JB; van Velthoven, CTJ; de Vries, WB; van Bel, F; Nikkels, PGJ; Visser, GHA				Tijsseling, Deodata; Wijnberger, Lia D. E.; Derks, Jan B.; van Velthoven, Cindy T. J.; de Vries, Willem B.; van Bel, Frank; Nikkels, Peter G. J.; Visser, Gerard H. A.			Effects of Antenatal Glucocorticoid Therapy on Hippocampal Histology of Preterm Infants	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RESPIRATORY-DISTRESS-SYNDROME; MULTIPLE COURSES; RAT HIPPOCAMPUS; FETAL-GROWTH; FOLLOW-UP; CORTICOSTEROIDS; BRAIN; SINGLE; BETAMETHASONE	Objective: To investigate if antenatal glucocorticoid treatment has an effect on hippocampal histology of the human preterm newborn. Patients and Methods: Included were consecutive neonates with a gestational age between 24 and 32 weeks, who were born between 1991 to 2009, who had died within 4 days after delivery and underwent brain autopsy. Excluded were neonates with congenital malformations and neonates treated postnatally with glucocorticoids. The brains were routinely fixed, samples of the hippocampus were stained with haematoxylin and eosin and sections were examined for presence or absence of large and small neurons in regions of the hippocampus. Additional staining with GFAP, neurofilament and vimentin was performed to evaluate gliosis and myelination. The proliferation marker Ki67 was used to evaluate neuronal proliferation. Staining with acid fuchsin-thionin was performed to evaluate ischemic damage. Results: The hippocampi of ten neonates who had been treated with antenatal glucocorticoids showed a lower density of large neurons (p = 0.01) and neurons irrespective of size (p = 0.02) as compared to eleven neonates who had not been treated with glucocorticoids. No difference was found in density of small neurons, in myelination, gliosis, proliferation or ischemic damage. Conclusion: We found a significantly lower density of neurons in the hippocampus of neonates after antenatal glucocorticoid treatment. Although the pathophysiological and clinical interpretations of these findings are not clear, they are consistent with those from experiments in mice and rhesus monkeys.	[Tijsseling, Deodata; Derks, Jan B.; de Vries, Willem B.; van Bel, Frank; Visser, Gerard H. A.] Univ Med Ctr, Perinatal Ctr, Utrecht, Netherlands; [Wijnberger, Lia D. E.] Rijnstate Hosp, Dept Obstet & Gynaecol, Arnhem, Netherlands; [van Velthoven, Cindy T. J.] Univ Med Ctr, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Nikkels, Peter G. J.] Univ Med Ctr, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Rijnstate Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Tijsseling, D (corresponding author), Univ Med Ctr, Perinatal Ctr, Utrecht, Netherlands.	d.tijsseling-2@umcutrecht.nl		van Velthoven, Cindy/0000-0001-5120-4546				Abbasi S, 2000, AM J OBSTET GYNECOL, V182, P1243, DOI 10.1067/mob.2000.104789; Aberg MAI, 2000, J NEUROSCI, V20, P2896; ADAMO M, 1988, ENDOCRINOLOGY, V123, P2526; Barrington K J, 2001, BMC Pediatr, V1, P1, DOI 10.1186/1471-2431-1-1; Crowther CA, 2006, LANCET, V367, P1913, DOI 10.1016/S0140-6736(06)68846-6; Dalziel SR, 2006, THORAX, V61, P678, DOI 10.1136/thx.2005.051763; Dalziel SR, 2005, BMJ-BRIT MED J, V331, P665, DOI 10.1136/bmj.38576.494363.E0; DEKLOET ER, 1988, PROG BRAIN RES, V73, P101; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Dirnberger DR, 2001, AM J PERINAT, V18, P267, DOI 10.1055/s-2001-16989; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; EPSTEIN MF, 1977, AM J OBSTET GYNECOL, V127, P261, DOI 10.1016/0002-9378(77)90465-3; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Groenendaal F, 2006, ARCH DIS CHILD-FETAL, V91, pF429, DOI 10.1136/adc.2005.092114; Guinn DA, 2001, JAMA-J AM MED ASSOC, V286, P1581, DOI 10.1001/jama.286.13.1581; Huang WL, 1999, OBSTET GYNECOL, V94, P213, DOI 10.1016/S0029-7844(99)00265-3; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Kanagawa T, 2006, AM J OBSTET GYNECOL, V194, P231, DOI 10.1016/j.ajog.2005.06.015; Korteweg FJ, 2006, BJOG-INT J OBSTET GY, V113, P393, DOI 10.1111/j.1471-0528.2006.00881.x; LIGGINS GC, 1994, REPROD FERT DEVELOP, V6, P141, DOI 10.1071/RD9940141; MACARTHUR BA, 1982, PEDIATRICS, V70, P99; Meijer OC, 1998, CRIT REV NEUROBIOL, V12, P1; Molteni R, 2001, BRAIN RES REV, V37, P249, DOI 10.1016/S0165-0173(01)00128-X; Murphy DJ, 2001, EARLY HUM DEV, V63, P113, DOI 10.1016/S0378-3782(01)00144-X; Murphy KE, 2008, LANCET, V372, P2143, DOI 10.1016/S0140-6736(08)61929-7; Noorlander CW, 2005, ANTENATAL GLUCOCORTI, P72; Noorlandler CW, 2008, DEV NEUROBIOL, V68, P237, DOI 10.1002/dneu.20583; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.0.CO;2-C; Scheepens A, 2003, J PHYSIOL-LONDON, V552, P163, DOI 10.1113/jphysiol.2003.043414; SCHMAND B, 1990, PEDIATRICS, V86, P58; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SUMI SM, 1984, PEDIATR RES, V18, P440, DOI 10.1203/00006450-198405000-00010; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Wapner RJ, 2006, AM J OBSTET GYNECOL, V195, P633, DOI 10.1016/j.ajog.2006.03.087	39	44	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33369	10.1371/journal.pone.0033369	http://dx.doi.org/10.1371/journal.pone.0033369			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457757	Green Submitted, gold, Green Published			2022-12-27	WOS:000304046900008
J	Anbalagan, M; Moroz, K; Ali, A; Carrier, L; Glodowski, S; Rowan, BG				Anbalagan, Muralidharan; Moroz, Krzysztof; Ali, Alaa; Carrier, Latonya; Glodowski, Seth; Rowan, Brian G.			Subcellular Localization of Total and Activated Src Kinase in African American and Caucasian Breast Cancer	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; C-SRC; FAMILY KINASES; PROTEIN EXPRESSION; TARGETING SRC; CELLS; IDENTIFICATION; PATHWAYS; TUMORS; CHEMOSENSITIVITY	Background: Src, a non-receptor tyrosine kinase is elevated in cancer with expression and activity correlated with cell proliferation, adhesion, survival, motility, metastasis and angiogenesis. There is limited data on Src expression and subcellular localization in breast cancer and no information about expression in racial/ethnic groups. Methodology/Principal Findings: The present study evaluated Src expression, activity, and subcellular localization in triple negative breast cancer (TNBC) and ER alpha positive breast cancer (ER+BC), cancer tissue and adjacent normal epithelial ducts, and Caucasian and African American cases. 79 paraffin embedded breast carcinoma cases were obtained from Tulane University Hospital between 2007-2009. 39 cases represented TNBC (33-African Americans, 4-Caucasians, 2-unknowns) and 40 cases represented ER+BC (21-African Americans, 16-Caucasians, 3-unknowns). Immunohistochemistry was used to measure staining distribution and intensity of total Src and activated phospho-SrcY416 (p-Y416Src) in carcinoma tissue and adjacent normal mammary ducts. In TNBC and ER+BC, total Src was significantly higher in cancer compared to adjacent normal ducts (P < 0.0001) in both cell membrane and cytoplasm. In membranes, p-Y416Src was elevated in cancer compared to normal ducts. Total Src in the tumor cytoplasm was significantly higher in TNBC compared to ER+BC (P = 0.0028); conversely, p-Y416Src in the tumor cell membranes was higher in TNBC compared to ER+BC (P = 0.0106). Comparison between African American (n = 21) and Caucasian ER+BC (n = 16) revealed no significant difference in expression and localization of total Src and p-Y416Src. TNBC cases positive for lymph node metastasis showed elevated membrane p-Y416Src compared to lymph node negative TNBC (P = 0.027). Conclusion/Significance: Total Src and p-Y416Src were expressed higher in cancer compared to adjacent normal ducts. Cytoplasmic total Src and membrane p-Y416Src were significantly higher in TNBC compared to ER+BC. TNBC cases with lymph node metastasis showed elevated membrane p-Y416Src. Taken together, Src was elevated in the membrane and cytoplasm of more aggressive TNBC.	[Anbalagan, Muralidharan; Ali, Alaa; Carrier, Latonya; Glodowski, Seth; Rowan, Brian G.] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, New Orleans, LA 70112 USA; [Moroz, Krzysztof] Tulane Univ, Sch Med, Sect Surg Pathol & Cytopathol, New Orleans, LA 70112 USA	Tulane University; Tulane University	Rowan, BG (corresponding author), Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	browan@tulane.edu		Ali, Alaa/0000-0003-1813-515X; Anbalagan, Muralidharan/0000-0001-5797-7558	National Institutes of Health (NIH) [RO1DK068432]; Breast Cancer Relief Foundation, New Orleans, LA; Tulane University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Relief Foundation, New Orleans, LA; Tulane University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a grant to BGR from the National Institutes of Health (NIH) (RO1DK068432), the Breast Cancer Relief Foundation, New Orleans, LA, and Translational Research, Education and Commercialization Project Tulane University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Anbalagan M, 2011, BREAST CANC RES TREA; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Brower V, 2009, J NATL CANCER I, V101, P1536, DOI 10.1093/jnci/djp422; Campbell EJ, 2008, BRIT J CANCER, V99, P1769, DOI 10.1038/sj.bjc.6604768; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Elsberger B, 2010, BRIT J CANCER, V103, P899, DOI 10.1038/sj.bjc.6605829; Elsberger B, 2009, AM J PATHOL, V175, P1389, DOI 10.2353/ajpath.2009.090273; Fincham VJ, 1996, J CELL BIOL, V135, P1551, DOI 10.1083/jcb.135.6.1551; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Gucalp A, 2011, CLIN BREAST CANC; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Herynk MH, 2006, MOL CANCER THER, V5, P3023, DOI 10.1158/1535-7163.MCT-06-0394; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Jackson JG, 2000, CLIN CANCER RES, V6, P1135; Kanomata N, 2011, J CLIN PATHOL, V64, P578, DOI 10.1136/jclinpath-2011-200042; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Maitra A, 2002, AM J CLIN PATHOL, V118, P194, DOI 10.1309/TPG4-CK1C-9V8V-8AWC; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; Planas-Silva MD, 2006, BIOCHEM BIOPH RES CO, V341, P73, DOI 10.1016/j.bbrc.2005.12.164; Reissig D, 2001, J CANCER RES CLIN, V127, P226, DOI 10.1007/s004320000197; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; TRYFONOPOULOS D, 2011, ANN ONCOL; Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zou DH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2332	41	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33017	10.1371/journal.pone.0033017	http://dx.doi.org/10.1371/journal.pone.0033017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457730	Green Submitted, Green Published, gold			2022-12-27	WOS:000303909200013
J	Cooper, RM; Wingreen, NS; Cox, EC				Cooper, Robert M.; Wingreen, Ned S.; Cox, Edward C.			An Excitable Cortex and Memory Model Successfully Predicts New Pseudopod Dynamics	PLOS ONE			English	Article							CELL POLARITY; LEADING-EDGE; SIGNALING PATHWAYS; CHEMOTACTIC CELLS; TRAVELING-WAVES; MEMBRANE; PROTEIN; FLUCTUATIONS; SUPPRESSION; ROBUSTNESS	Motile eukaryotic cells migrate with directional persistence by alternating left and right turns, even in the absence of external cues. For example, Dictyostelium discoideum cells crawl by extending distinct pseudopods in an alternating right-left pattern. The mechanisms underlying this zig-zag behavior, however, remain unknown. Here we propose a new Excitable Cortex and Memory (EC&M) model for understanding the alternating, zig-zag extension of pseudopods. Incorporating elements of previous models, we consider the cell cortex as an excitable system and include global inhibition of new pseudopods while a pseudopod is active. With the novel hypothesis that pseudopod activity makes the local cortex temporarily more excitable - thus creating a memory of previous pseudopod locations - the model reproduces experimentally observed zig-zag behavior. Furthermore, the EC&M model makes four new predictions concerning pseudopod dynamics. To test these predictions we develop an algorithm that detects pseudopods via hierarchical clustering of individual membrane extensions. Data from cell-tracking experiments agrees with all four predictions of the model, revealing that pseudopod placement is a non-Markovian process affected by the dynamics of previous pseudopods. The model is also compatible with known limits of chemotactic sensitivity. In addition to providing a predictive approach to studying eukaryotic cell motion, the EC&M model provides a general framework for future models, and suggests directions for new research regarding the molecular mechanisms underlying directional persistence.	[Cooper, Robert M.; Wingreen, Ned S.; Cox, Edward C.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Cooper, RM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ecox@Princeton.EDU			National Institutes of Health [R01 GM082938, R01 GM078591, NIGMS P50GM071508, NHGRI T32HG003284]; Princeton University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078591, P50GM071508, R01GM082938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Princeton University(Princeton University); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (www.nih.gov) grants R01 GM082938, R01 GM078591, NIGMS P50GM071508, NHGRI T32HG003284, and funds from Princeton University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Asano Y, 2008, CELL MOTIL, V65; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Bretschneider T, 2004, CURR BIOL, V14, P1, DOI 10.1016/j.cub.2003.12.005; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Dormann D, 2002, CELL MOTIL CYTOSKEL, V52, P221, DOI 10.1002/cm.10048; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; Gaudet P, 2011, NUCLEIC ACIDS RES, V39, pD620, DOI 10.1093/nar/gkq1103; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Meinhardt H, 1999, J CELL SCI, V112, P2867; Merkel R, 2000, BIOPHYS J, V79, P707, DOI 10.1016/S0006-3495(00)76329-6; Moores SL, 1996, P NATL ACAD SCI USA, V93, P443, DOI 10.1073/pnas.93.1.443; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Otsuji M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001056; Postma M, 2003, MOL BIOL CELL, V14, P5019, DOI 10.1091/mbc.E03-08-0566; Postma M, 2004, J CELL SCI, V117, P2925, DOI 10.1242/jcs.01143; POTEL MJ, 1979, J CELL SCI, V36, P281; Samadani A, 2006, P NATL ACAD SCI USA, V103, P11549, DOI 10.1073/pnas.0601909103; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Schroth-Diez B, 2009, HFSP J, V3, P412, DOI 10.2976/1.3239407; Shina MC, 2011, CELL MOL LIFE SCI, V68, P303, DOI 10.1007/s00018-010-0455-y; Traynor D, 2007, J CELL SCI, V120, P2318, DOI 10.1242/jcs.007732; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; TYSON JJ, 1988, PHYSICA D, V32, P327, DOI 10.1016/0167-2789(88)90062-0; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; van Haastert PJM, 2007, BIOPHYS J, V93, P1787, DOI 10.1529/biophysj.107.104356; Van Haastert PJM, 2010, J CELL SCI, V123, P3031, DOI 10.1242/jcs.071118; Van Haastert PJM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000874; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Veltman DM, 2006, MOL BIOL CELL, V17, P3921, DOI 10.1091/mbc.E06-05-0381; Vicker MG, 2002, EXP CELL RES, V275, P54, DOI 10.1006/excr.2001.5466; Wessels D, 2007, J CELL SCI, V120, P2517, DOI 10.1242/jcs.010876; Wessels DJ, 2000, MOL BIOL CELL, V11, P2803, DOI 10.1091/mbc.11.8.2803; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Xu X, 2007, J CELL BIOL, V178, P141, DOI 10.1083/jcb.200611096; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152	55	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33528	10.1371/journal.pone.0033528	http://dx.doi.org/10.1371/journal.pone.0033528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457772	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200033
J	Midgley, DJ; Greenfield, P; Shaw, JM; Oytam, Y; Li, DM; Kerr, CA; Hendry, P				Midgley, David J.; Greenfield, Paul; Shaw, Janet M.; Oytam, Yalchin; Li, Dongmei; Kerr, Caroline A.; Hendry, Philip			Reanalysis and Simulation Suggest a Phylogenetic Microarray Does Not Accurately Profile Microbial Communities	PLOS ONE			English	Article							CLONE LIBRARY; DIVERSITY	The second generation (G2) PhyloChip is designed to detect over 8700 bacteria and archaeal and has been used over 50 publications and conference presentations. Many of those publications reveal that the PhyloChip measures of species richness greatly exceed statistical estimates of richness based on other methods. An examination of probes downloaded from Greengenes suggested that the system may have the potential to distort the observed community structure. This may be due to the sharing of probes by taxa; more than 21% of the taxa in that downloaded data have no unique probes. Insilico simulations using these data showed that a population of 64 taxa representing a typical anaerobic subterranean community returned 96 different taxa, including 15 families incorrectly called present and 19 families incorrectly called absent. A study of nasal and oropharyngeal microbial communities by Lemon et al (2010) found some 1325 taxa using the G2 PhyloChip, however, about 950 of these taxa have, in the downloaded data, no unique probes and cannot be definitively called present. Finally, data from Brodie et al (2007), when re-examined, indicate that the abundance of the majority of detected taxa, are highly correlated with one another, suggesting that many probe sets do not act independently. Based on our analyses of downloaded data, we conclude that outputs from the G2 PhyloChip should be treated with some caution, and that the presence of taxa represented solely by non-unique probes be independently verified.	[Midgley, David J.; Shaw, Janet M.; Oytam, Yalchin; Li, Dongmei; Kerr, Caroline A.; Hendry, Philip] CSIRO, Div Food & Nutr Sci, N Ryde, NSW 2113, Australia; [Greenfield, Paul] CSIRO, Div Math Informat & Stat, N Ryde, NSW 2113, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Midgley, DJ (corresponding author), CSIRO, Div Food & Nutr Sci, N Ryde, NSW 2113, Australia.	Phil.Hendry@csiro.au	Hendry, Philip/D-5795-2011; Greenfield, Paul/A-9132-2010; Midgley, David/GOV-4218-2022; Biology, Transformational/D-5787-2011	Greenfield, Paul/0000-0003-4028-9243; 				Andersen GL, 2010, ENVIRONMENTAL MOLECULAR MICROBIOLOGY, P87; [Anonymous], POLLUTION MAGAZINES; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; La Duc MT, 2009, APPL ENVIRON MICROB, V75, P6559, DOI 10.1128/AEM.01073-09; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Maldonado-Contreras A, 2010, ISME J, V5, P574; R&D global funding forecast, 2017, R D MAGAZINE; Rastogi G, 2010, MICROB ECOL, V60, P539, DOI 10.1007/s00248-010-9657-y; Rastogi G, 2010, MICROB ECOL, V59, P94, DOI 10.1007/s00248-009-9598-5; Sagaram US, 2009, APPL ENVIRON MICROB, V75, P1566, DOI 10.1128/AEM.02404-08; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; Tsiamis G, 2008, RES MICROBIOL, V159, P609, DOI 10.1016/j.resmic.2008.09.007; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	22	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33875	10.1371/journal.pone.0033875	http://dx.doi.org/10.1371/journal.pone.0033875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457798	Green Published, gold, Green Submitted			2022-12-27	WOS:000303909200039
J	Gao, Y; He, ZM; Wang, ZL; Luo, YM; Sun, HY; Zhou, Y; Huang, LH; Li, MC; Fang, Q; Jiang, SW				Gao, Yu; He, Zhiming; Wang, Zilian; Luo, Yanmin; Sun, Hongyu; Zhou, Yi; Huang, Linhuan; Li, Manchao; Fang, Qun; Jiang, Shiwen			Increased Expression and Altered Methylation of HERVWE1 in the Human Placentas of Smaller Fetuses from Monozygotic, Dichorionic, Discordant Twins	PLOS ONE			English	Article							EPIGENETIC DIFFERENCES; DNA METHYLATION; MULTIPLE-SCLEROSIS; GROWTH RESTRICTION; SYNCYTIN; MAINTENANCE; PREGNANCY; PROMOTER; PATTERN; TISSUES	Background: The human endogenous retroviral family W, Env(C7), member 1 gene (HERVWE1) is thought to participate in trophoblast cell fusion, and its expression is diminished in the placentas of singleton intrauterine growth-retarded pregnancies. However, there is limited information about the role of HERVWE1 in discordant fetal growth in twins. This study was to compare HERVWE1 gene expression between the placentas of discordant monozygotic twins and to identify its regulation by methylation. Methodology/Principal Findings: Fetuses from twenty-one pairs of monozygotic, dichorionic, discordant twins were marked as "smaller'' or "larger'' according to birth weight. Placental HERVWE1 mRNA and protein expression profiles were analyzed using quantitative RT-PCR and immunohistochemistry (IHC) staining. Methylation profiles of the HERVWE1 promoter region were analyzed using a pyrosequencing assay. DNA methyltransferase (DNMT) transcript levels were analyzed by RT-PCR. 5-methyl cytosine (5-MC) was stained using an immunohistochemical assay. There was a significant negative correlation between HERVWE1 mRNA levels and birth weight in twins (P<0.01). Whereas the mean methylation level of the HERVWE1 promoter region was diminished in the smaller group in discordant twins(P<0.01), increased mRNA and protein levels of HERVWE1 were found in smaller fetuses compared with larger fetuses in discordant twins(P<0.01). There was no significant difference in 5-MC staining intensity between discordant twins (P>0.05). The DNMT3b3 mRNA levels in the smaller group were significantly downregulated compared with the larger group in discordant twins(P<0.05), whereas the DNMT3b7 mRNA levels in the smaller group were significantly upregulated compared with the larger group in discordant twins(P<0.05). Conclusions/Significance: In discordant, monozygotic, dichorionic twins, HERVWE1 expression was higher in smaller fetuses and lower in larger fetuses. Methylation of the HERVWE1 gene promoter region may participate in the regulation of HERVWE1 gene expression in discordant twin pregnancies.	[Gao, Yu; He, Zhiming; Wang, Zilian; Luo, Yanmin; Zhou, Yi; Huang, Linhuan; Li, Manchao; Fang, Qun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Fetal Med Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Yu; He, Zhiming; Jiang, Shiwen] Mercer Univ, Sch Med, Dept Biol Sci, Hoskins Ctr, Savannah, GA USA; [Sun, Hongyu] Sun Yat Sen Univ, Dept Forens Med, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Shiwen] Mayo Coll Med, Dept Obstet & Gynecol, Rochester, MN USA	Sun Yat Sen University; Mercer University; Sun Yat Sen University; Mayo Clinic	Gao, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Fetal Med Ctr, Guangzhou 510275, Guangdong, Peoples R China.	fangqun_sums@126.com; jiang_s@mercer.edu	gao, yu/J-3061-2014; Sun, 宏钰/H-7885-2018	Sun, 宏钰/0000-0002-5926-4495				Alexander GR, 1998, CLIN OBSTET GYNECOL, V41, P115, DOI 10.1097/00003081-199803000-00017; Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Benirschke K, 2006, PATHOLOGY HUMAN PLAC, V5th; Blickstein I, 2003, TWIN RES, V6, P526, DOI 10.1375/136905203322686536; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cheng YH, 2004, BIOL REPROD, V70, P694, DOI 10.1095/biolreprod.103.023473; De Paepe ME, 2010, PLACENTA, V31, P380, DOI 10.1016/j.placenta.2010.02.018; Dupressoir A, 2011, M S-MED SCI, V27, P163, DOI 10.1051/medsci/2011272163; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Freemark M, 2010, J CLIN ENDOCR METAB, V95, P2054, DOI 10.1210/jc.2010-0517; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; Guller S, 2008, ANN NY ACAD SCI, V1127, P129, DOI 10.1196/annals.1434.015; Hall JG, 2003, LANCET, V362, P735, DOI 10.1016/S0140-6736(03)14237-7; Handunnetthi L, 2010, EXPERT REV NEUROTHER, V10, P1379, DOI [10.1586/ern.10.116, 10.1586/ERN.10.116]; Haque FN, 2009, AM J MED GENET C, V151C, P136, DOI 10.1002/ajmg.c.30206; Huppertz B, 2009, J ANAT, V215, P14, DOI 10.1111/j.1469-7580.2008.01036.x; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Kingdom JCP, 2005, PRENATAL DIAG, V25, P759, DOI 10.1002/pd.1262; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Machin G, 2009, AM J MED GENET C, V151C, P110, DOI 10.1002/ajmg.c.30212; Mastroeni D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006617; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; Mill J, 2006, AM J MED GENET B, V141B, P421, DOI 10.1002/ajmg.b.30316; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Noorali S, 2009, APPL IMMUNOHISTO M M, V17, P319, DOI 10.1097/PAI.0b013e31819640f9; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Petronis A, 2003, SCHIZOPHRENIA BULL, V29, P169, DOI 10.1093/oxfordjournals.schbul.a006988; Potgens AJG, 2004, HUM REPROD UPDATE, V10, P487, DOI 10.1093/humupd/dmh039; Robins JC, 2007, PLACENTA, V28, P1141, DOI 10.1016/j.placenta.2007.05.006; Ruebner M, 2010, J MOL MED, V88, P1143, DOI 10.1007/s00109-010-0656-8; Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Su XW, 2010, ONCOL REP, V23, P819, DOI 10.3892/or_00000703; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Yinon Y, 2005, OBSTET GYNECOL, V105, P80, DOI 10.1097/01.AOG.0000146634.28459.e8	37	48	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33503	10.1371/journal.pone.0033503	http://dx.doi.org/10.1371/journal.pone.0033503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457770	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100032
J	Hahn, MW; Scheuerl, T; Jezberova, J; Koll, U; Jezbera, J; Simek, K; Vannini, C; Petroni, G; Wu, QLL				Hahn, Martin W.; Scheuerl, Thomas; Jezberova, Jitka; Koll, Ulrike; Jezbera, Jan; Simek, Karel; Vannini, Claudia; Petroni, Giulio; Wu, Qinglong L.			The Passive Yet Successful Way of Planktonic Life: Genomic and Experimental Analysis of the Ecology of a Free-Living Polynucleobacter Population	PLOS ONE			English	Article							BACTERIAL COMMUNITY COMPOSITION; RNA GENE-SEQUENCES; SINGLET OXYGEN; TEMPORAL PATTERNS; NICHE SEPARATION; ORGANIC-MATTER; WATER HABITATS; BACTERIOPLANKTON; LAKE; NECESSARIUS	Background: The bacterial taxon Polynucleobacter necessarius subspecies asymbioticus represents a group of planktonic freshwater bacteria with cosmopolitan and ubiquitous distribution in standing freshwater habitats. These bacteria comprise <1% to 70% (on average about 20%) of total bacterioplankton cells in various freshwater habitats. The ubiquity of this taxon was recently explained by intra-taxon ecological diversification, i.e. specialization of lineages to specific environmental conditions; however, details on specific adaptations are not known. Here we investigated by means of genomic and experimental analyses the ecological adaptation of a persistent population dwelling in a small acidic pond. Findings: The investigated population (F10 lineage) contributed on average 11% to total bacterioplankton in the pond during the vegetation periods (ice-free period, usually May to November). Only a low degree of genetic diversification of the population could be revealed. These bacteria are characterized by a small genome size (2.1 Mb), a relatively small number of genes involved in transduction of environmental signals, and the lack of motility and quorum sensing. Experiments indicated that these bacteria live as chemoorganotrophs by mainly utilizing low-molecular-weight substrates derived from photooxidation of humic substances. Conclusions: Evolutionary genome streamlining resulted in a highly passive lifestyle so far only known among free-living bacteria from pelagic marine taxa dwelling in environmentally stable nutrient-poor off-shore systems. Surprisingly, such a lifestyle is also successful in a highly dynamic and nutrient-richer environment such as the water column of the investigated pond, which was undergoing complete mixis and pronounced stratification in diurnal cycles. Obviously, metabolic and ecological versatility is not a prerequisite for long-lasting establishment of abundant bacterial populations under highly dynamic environmental conditions. Caution should be exercised when generalizing the obtained insights into the ecology and adaptation of the investigated lineage to other Polynucleobacter lineages.	[Hahn, Martin W.; Scheuerl, Thomas; Jezberova, Jitka; Koll, Ulrike; Jezbera, Jan; Wu, Qinglong L.] Austrian Acad Sci, Inst Limnol, A-5310 Mondsee, Austria; [Jezberova, Jitka; Jezbera, Jan; Simek, Karel] AS CR, Vvi, Ctr Biol, Inst Hydrobiol, Ceske Budejovice, Czech Republic; [Vannini, Claudia; Petroni, Giulio] Univ Pisa, Dept Biol, Protistol Zool Unit, Pisa, Italy; [Wu, Qinglong L.] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China	Austrian Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Pisa; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS	Hahn, MW (corresponding author), Austrian Acad Sci, Inst Limnol, A-5310 Mondsee, Austria.	martin.hahn@oeaw.ac.at	Petroni, Giulio/B-6086-2008; Jezbera, Jan/B-5657-2015; Simek, Karel/F-8930-2014; Hahn, Martin W./B-9998-2008; Scheuerl, Thomas/AAC-6358-2020; Šimek, Karel/AAB-1956-2021; Jezberova, Jitka/G-1024-2014; Wu, Qinglong L/B-7625-2011	Petroni, Giulio/0000-0001-9572-9897; Hahn, Martin W./0000-0003-0501-2556; Scheuerl, Thomas/0000-0001-5216-5630; Šimek, Karel/0000-0002-7058-9063; Jezberova, Jitka/0000-0001-5000-9319; VANNINI, CLAUDIA/0000-0002-6195-695X	JGI; Austrian Science Fund (FWF) [P19853, I482-B09]; Austrian Science Fund (FWF) [I 482] Funding Source: researchfish	JGI; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was supported by the JGI Community Sequencing Program (CSP) and the Austrian Science Fund (FWF, grants P19853 and I482-B09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anesio AM, 2005, APPL ENVIRON MICROB, V71, P6267, DOI 10.1128/AEM.71.10.6267-6275.2005; [Anonymous], [No title captured]; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; BAXTER RM, 1983, NATURE, V306, P575, DOI 10.1038/306575a0; Boenigk J, 2004, APPL ENVIRON MICROB, V70, P5787, DOI 10.1128/AEM.70.10.5787-5793.2004; Briviba K, 1997, BIOL CHEM, V378, P1259; Buck U, 2009, ENVIRON MICROBIOL, V11, P1854, DOI 10.1111/j.1462-2920.2009.01910.x; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Colwell RK, 2009, ESTIMATES STAT ESTIM; Cooper W.J., 1989, ADV CHEM SER, P333; COOPER WJ, 1989, CAN J FISH AQUAT SCI, V46, P1227, DOI 10.1139/f89-158; COVENEY MF, 1989, HYDROBIOLOGIA, V173, P141, DOI 10.1007/BF00015524; Crump BC, 2003, APPL ENVIRON MICROB, V69, P2253, DOI 10.1128/AEM.69.4.2253-2268.2003; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; Fry JC, 1988, METHODS AQUATIC BACT, P27; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glaeser SP, 2010, ENVIRON MICROBIOL, V12, P3124, DOI 10.1111/j.1462-2920.2010.02285.x; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P2911, DOI 10.1111/j.1462-2920.2007.01461.x; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hahn MW, 2005, APPL ENVIRON MICROB, V71, P4539, DOI 10.1128/AEM.71.8.4539-4547.2005; Hahn MW, 2005, APPL ENVIRON MICROB, V71, P766, DOI 10.1128/AEM.71.2.766-773.2005; Hahn MW, 2004, RES MICROBIOL, V155, P688, DOI 10.1016/j.resmic.2004.05.003; Hahn MW, 2004, J MICROBIOL METH, V57, P379, DOI 10.1016/j.mimet.2004.02.004; Hahn MW, 2001, FEMS MICROBIOL ECOL, V35, P113, DOI 10.1111/j.1574-6941.2001.tb00794.x; Hervas A, 2009, ENVIRON MICROBIOL, V11, P1612, DOI 10.1111/j.1462-2920.2009.01926.x; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; Jaspers E, 2004, APPL ENVIRON MICROB, V70, P4831, DOI 10.1128/AEM.70.8.4831-4839.2004; Jezbera J, 2005, FEMS MICROBIOL ECOL, V52, P351, DOI 10.1016/j.femsec.2004.12.001; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Jezberova J, 2010, ENVIRON MICROBIOL, V12, P658, DOI 10.1111/j.1462-2920.2009.02106.x; Jogler M, 2011, APPL ENVIRON MICROB, V77, P7355, DOI 10.1128/AEM.05832-11; Kasalicky V, 2010, INT J SYST EVOL MICR, V60, P2710, DOI 10.1099/ijs.0.018952-0; KIEBER DJ, 1989, NATURE, V341, P637, DOI 10.1038/341637a0; Lau WWY, 2006, ENVIRON MICROBIOL, V8, P1688, DOI 10.1111/j.1462-2920.2006.01092.x; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; Masuda S, 2010, APPL ENVIRON MICROB, V76, P2402, DOI 10.1128/AEM.02783-09; Meincke L, 2012, STAND GENOM IN PRESS, V6; Miller W. L., 1998, AQUATIC HUMIC SUBSTA, P125, DOI DOI 10.1007/978-3-662-03736-2_7; MOPPER K, 1991, NATURE, V353, P60, DOI 10.1038/353060a0; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307, DOI 10.4319/lo.1997.42.6.1307; Myklestad SM, 2000, HANDB ENVIRON CHEM, V5, P111; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Paver SF, 2010, MICROB ECOL, V60, P406, DOI 10.1007/s00248-010-9722-6; Pearce DA, 2003, FEMS MICROBIOL ECOL, V45, P59, DOI 10.1016/S0168-6496(03)00110-7; Perez MT, 2006, LIMNOL OCEANOGR, V51, P2527, DOI 10.4319/lo.2006.51.6.2527; Pernthaler J, 2005, MICROBIOL MOL BIOL R, V69, P440, DOI 10.1128/MMBR.69.3.440-461.2005; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Salcher MM, 2008, ENVIRON MICROBIOL, V10, P2074, DOI 10.1111/j.1462-2920.2008.01628.x; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; SHERR EB, 1993, HDB METHODS AQUATIC, P695; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Simek K, 2008, AQUAT MICROB ECOL, V51, P249, DOI 10.3354/ame01193; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Simek K, 2011, APPL ENVIRON MICROB, V77, P7307, DOI 10.1128/AEM.05107-11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tranvik L.J., 1998, AQUATIC HUMIC SUBSTA, P259, DOI [DOI 10.1007/978-3-662-03736-2_11, 10.1007/978-3-662-03736-2_11]; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Vannini C, 2007, ENVIRON MICROBIOL, V9, P347, DOI 10.1111/j.1462-2920.2006.01144.x; Watanabe K, 2009, FEMS MICROBIOL ECOL, V67, P57, DOI 10.1111/j.1574-6941.2008.00606.x; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wu QLL, 2006, ENVIRON MICROBIOL, V8, P1660, DOI 10.1111/j.1462-2920.2006.01049.x; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; ZEPP RG, 1977, NATURE, V267, P421, DOI 10.1038/267421a0; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	75	68	69	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e32772	10.1371/journal.pone.0032772	http://dx.doi.org/10.1371/journal.pone.0032772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448227	Green Published, gold			2022-12-27	WOS:000303855700017
J	Hoesli, CA; Johnson, JD; Piret, JM				Hoesli, Corinne A.; Johnson, James D.; Piret, James M.			Purified Human Pancreatic Duct Cell Culture Conditions Defined by Serum-Free High-Content Growth Factor Screening	PLOS ONE			English	Article							INSULIN-SECRETING CELLS; MESENCHYMAL STEM-CELLS; ADULT-MOUSE PANCREAS; IN-VITRO; BETA-CELLS; PROGENITOR CELLS; HUMAN ISLETS; EPITHELIAL-CELLS; ANIMAL-MODELS; ACINAR-CELLS	The proliferation of pancreatic duct-like CK19+ cells has implications for multiple disease states including pancreatic cancer and diabetes mellitus. The in vitro study of this important cell type has been hampered by their limited expansion compared to fibroblast-like vimentin+ cells that overgrow primary cultures. We aimed to develop a screening platform for duct cell mitogens after depletion of the vimentin+ population. The CD90 cell surface marker was used to remove the vimentin+ cells from islet-depleted human pancreas cell cultures by magnetic-activated cell sorting. Cell sorting decreased CD90+ cell contamination of the cultures from 34 +/- 20% to 1.3 +/- 0.6%, yielding purified CK19+ cultures with epithelial morphology. A full-factorial experimental design was then applied to test the mitogenic effects of bFGF, EGF, HGF, KGF and VEGF. After 6 days in test conditions, the cells were labelled with BrdU, stained and analyzed by high-throughput imaging. This screening assay confirmed the expected mitogenic effects of bFGF, EGF, HGF and KGF on CK19+ cells and additionally revealed interactions between these factors and VEGF. A serum-free medium containing bFGF, EGF, HGF and KGF led to CK19+ cell expansion comparable to the addition of 10% serum. The methods developed in this work should advance pancreatic cancer and diabetes research by providing effective cell culture and high-throughput screening platforms to study purified primary pancreatic CK19+ cells.	[Hoesli, Corinne A.; Piret, James M.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Hoesli, Corinne A.; Piret, James M.] Univ British Columbia, Dept Biol & Chem Engn, Vancouver, BC V5Z 1M9, Canada; [Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Hoesli, CA (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada.	corinne.hoesli@gmail.com	Hoesli, Corinne/A-6643-2019; Piret, James Michael/B-4554-2008	Hoesli, Corinne/0000-0002-5629-7128; Piret, James Michael/0000-0001-7934-9675	Michael Smith Foundation for Health Research Centre for Human Islet Transplantation and Beta-cell Regeneration (CHITBR); Canadian Stem Cell Network [PA5]; Michael Smith Foundation for Health Research; Le Fonds quebecois de la recherche sur la nature et les technologies; Natural Sciences and Engineering Research Council of Canada	Michael Smith Foundation for Health Research Centre for Human Islet Transplantation and Beta-cell Regeneration (CHITBR); Canadian Stem Cell Network; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Le Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Michael Smith Foundation for Health Research Centre for Human Islet Transplantation and Beta-cell Regeneration (CHITBR) and the Canadian Stem Cell Network (#PA5). CAH was supported by fellowships from the Michael Smith Foundation for Health Research, Le Fonds quebecois de la recherche sur la nature et les technologies and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2005, SEMIN RADIAT ONCOL, V15, P254, DOI 10.1016/j.semradonc.2005.04.001; Audet J, 2002, BIOTECHNOL BIOENG, V80, P393, DOI 10.1002/bit.10399; Banerjee M, 2009, DIABETOLOGIA, V52, P621, DOI 10.1007/s00125-009-1259-1; Beattie GM, 1996, DIABETES, V45, P1223, DOI 10.2337/diabetes.45.9.1223; Berry CC, 2004, BIOMATERIALS, V25, P5405, DOI 10.1016/j.biomaterials.2003.12.046; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Butler AE, 2010, DIABETOLOGIA, V53, P21, DOI 10.1007/s00125-009-1556-8; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Chen TW, 2009, BIOCHEM BIOPH RES CO, V378, P112, DOI 10.1016/j.bbrc.2008.11.019; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Elghazi L, 2002, P NATL ACAD SCI USA, V99, P3884, DOI 10.1073/pnas.062321799; Fan XB, 2009, BIOTECHNOL PROGR, V25, P499, DOI 10.1002/btpr.68; Gao R, 2005, DIABETOLOGIA, V48, P2296, DOI 10.1007/s00125-005-1935-8; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Gmyr V, 2004, BIOCHEM BIOPH RES CO, V320, P27, DOI 10.1016/j.bbrc.2004.05.125; Gstraunthaler G, 2003, ALTEX-ALTERN TIEREXP, V20, P275; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Inchovska M, 2006, CELL PROLIFERAT, V39, P537, DOI 10.1111/j.1365-2184.2006.00410.x; Jacquemin P, 2006, DEV BIOL, V290, P189, DOI 10.1016/j.ydbio.2005.11.023; Kikugawa R, 2009, DIABETOLOGIA, V52, P645, DOI 10.1007/s00125-009-1260-8; Klein T, 2009, PANCREAS, V38, P36, DOI 10.1097/MPA.0b013e3181816547; Kopp JL, 2011, CELL CYCLE, V10, P1921, DOI 10.4161/cc.10.12.16010; Luu M, 2004, PROCESS DEV PRODUCTI; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Miettinen P, 2008, BIOCHEM SOC T, V36, P280, DOI 10.1042/BST0360280; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Nguyen TD, 1999, J CLIN INVEST, V103, P261, DOI 10.1172/JCI2539; ObergWelsh C, 1997, MOL CELL ENDOCRINOL, V126, P125, DOI 10.1016/S0303-7207(96)03977-9; Ogneva V, 2002, DIABETES RES CLIN PR, V57, P11, DOI 10.1016/S0168-8227(02)00008-6; Okuno M, 2007, AM J PHYSIOL-ENDOC M, V292, pE158, DOI 10.1152/ajpendo.00180.2006; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Pulkkinen MA, 2003, MECH DEVELOP, V120, P167, DOI 10.1016/S0925-4773(02)00440-9; Ramiya VK, 2000, NAT MED, V6, P278; Reichert M, 2011, J CLIN INVEST, V121, P4572, DOI 10.1172/JCI57131; Rescan C, 2005, LAB INVEST, V85, P65, DOI 10.1038/labinvest.3700204; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Rooman I, 2000, DIABETOLOGIA, V43, P907, DOI 10.1007/s001250051468; Rooman I, 1997, LAB INVEST, V76, P225; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sakaguchi Y, 2006, PANCREAS, V33, P371, DOI 10.1097/01.mpa.0000236734.39241.99; Scharfmann R, 2000, DIABETOLOGIA, V43, P1083, DOI 10.1007/s001250051498; Seeberger KL, 2006, LAB INVEST, V86, P141, DOI 10.1038/labinvest.3700377; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Stevenson KS, 2009, STEM CELLS DEV, V18, P1389, DOI 10.1089/scd.2008.0301; Street C, 2004, ENRICHED HUMAN PANCR; Szabat M, 2010, DIABETOLOGIA; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Todorov I, 2006, PANCREAS, V32, P130, DOI 10.1097/01.mpa.0000202945.78331.93; TRAUTMANN B, 1993, PANCREAS, V8, P248, DOI 10.1097/00006676-199303000-00017; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; VILA MR, 1995, LAB INVEST, V73, P409; VinterJensen L, 1997, GASTROENTEROLOGY, V113, P1367, DOI 10.1053/gast.1997.v113.pm9322532; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yang F, 2009, COMB CHEM HIGH T SCR, V12, P554, DOI 10.2174/138620709788681916; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670; Ye F, 2005, DIABETOLOGIA, V48, P277, DOI 10.1007/s00125-004-1638-6; YI ES, 1994, AM J PATHOL, V145, P80; Zhao M, 2005, DIABETOLOGIA, V48, P2051, DOI 10.1007/s00125-005-1888-y	64	10	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33999	10.1371/journal.pone.0033999	http://dx.doi.org/10.1371/journal.pone.0033999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442738	gold, Green Submitted, Green Published			2022-12-27	WOS:000303836500079
J	Siddiqi, S; Terry, M; Matushansky, I				Siddiqi, Sara; Terry, Melissa; Matushansky, Igor			Hiwi Mediated Tumorigenesis Is Associated with DNA Hypermethylation	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; TUMOR-RELATED DEATH; PIRNA CLUSTERS; CANCER-CELLS; STEM-CELLS; PIWI; EXPRESSION; GENE; PATHWAY; METHYLATION	Expression of Piwi proteins is confined to early development and stem cells during which they suppress transposon migration via DNA methylation to ensure genomic stability. Piwi's genomic protective function conflicts with reports that its human ortholog, Hiwi, is expressed in numerous cancers and prognosticates shorter survival. However, the role of Hiwi in tumorigenesis has not been examined. Here we demonstrate that (1) over-expressing Hiwi in sarcoma precursors inhibits their differentiation in vitro and generates sarcomas in vivo; (2) transgenic mice expressing Hiwi (mesodermally restricted) develop sarcomas; and (3) inducible down-regulation of Hiwi in human sarcomas inhibits growth and re-establishes differentiation. Our data indicates that Hiwi is directly tumorigenic and Hiwi-expressing cancers may be addicted to Hiwi expression. We further show that Hiwi associated DNA methylation and cyclin-dependent kinase inhibitor (CDKI) silencing is reversible along with Hiwi-induced tumorigenesis, via DNA-methyltransferase inhibitors. Our studies reveal for the first time not only a novel oncogenic role for Hiwi as a driver of tumorigenesis, but also suggest that the use of epigenetic agents may be clinically beneficial for treatment of tumors that express Hiwi. Additionally, our data showing that Hiwi-associated DNA hyper-methylation with subsequent genetic and epigenetic changes favoring a tumorigenic state reconciles the conundrum of how Hiwi may act appropriately to promote genomic integrity during early development (via transposon silencing) and inappropriately in adult tissues with subsequent tumorigenesis.	[Siddiqi, Sara; Terry, Melissa; Matushansky, Igor] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA	Columbia University	Siddiqi, S (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA.	im17@columbia.edu			National Cancer Institute; Damon Runyon Cancer Research Fund; Gerstner Development Award; Sarcoma Foundation of America	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Fund; Gerstner Development Award; Sarcoma Foundation of America	This work was supported by funding from the National Cancer Institute, Damon Runyon Cancer Research Fund, Gerstner Development Award, and Sarcoma Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Assis R, 2009, P NATL ACAD SCI USA, V106, P7079, DOI 10.1073/pnas.0900523106; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Clark SJ, 2007, HUM MOL GENET, V16, pR88, DOI 10.1093/hmg/ddm051; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Easwaran HP, 2010, CANCER RES, V70, P8015, DOI 10.1158/0008-5472.CAN-10-0765; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Estecio MRH, 2011, FEBS LETT, V585, P2078, DOI 10.1016/j.febslet.2010.12.001; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; He W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-426; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Lin PP, 2009, CARCINOGENESIS, V30, P1789, DOI 10.1093/carcin/bgp180; Liu XY, 2006, INT J CANCER, V118, P1922, DOI 10.1002/ijc.21575; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Martin JF, 2000, GENESIS, V26, P225, DOI 10.1002/(SICI)1526-968X(200004)26:4<225::AID-GENE10>3.0.CO;2-F; Matushansky I, 2008, AM J PATHOL, V172, P1069, DOI 10.2353/ajpath.2008.070284; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Meltzer Paul S, 2007, Cell Stem Cell, V1, P13, DOI 10.1016/j.stem.2007.05.011; Mills J, 2011, MOL CANCER THER, V10, P313, DOI 10.1158/1535-7163.MCT-10-0724; Mills J, 2009, HUM CELL, V22, P85, DOI 10.1111/j.1749-0774.2009.00073.x; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Sabah M, 2006, APPL IMMUNOHISTO M M, V14, P397, DOI 10.1097/01.pai.0000190176.06200.68; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Stojadinovic A, 2002, J CLIN ONCOL, V20, P4344, DOI 10.1200/JCO.2002.07.154; Sugimoto K, 2007, BIOCHEM BIOPH RES CO, V359, P497, DOI 10.1016/j.bbrc.2007.05.136; Taubert H, 2007, ONCOGENE, V26, P1098, DOI 10.1038/sj.onc.1209880	37	62	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33711	10.1371/journal.pone.0033711	http://dx.doi.org/10.1371/journal.pone.0033711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438986	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100090
J	Lazar, C; Macovei, A; Petrescu, S; Branza-Nichita, N				Lazar, Catalin; Macovei, Alina; Petrescu, Stefana; Branza-Nichita, Norica			Activation of ERAD Pathway by Human Hepatitis B Virus Modulates Viral and Subviral Particle Production	PLOS ONE			English	Article							RETICULUM-ASSOCIATED-DEGRADATION; UNFOLDED PROTEIN RESPONSE; ENVELOPE PROTEINS; QUALITY-CONTROL; AUTOPHAGY; STRESS; IMPAIRMENT; DELIVERY; DISEASE; VARIANT	Hepatitis B virus (HBV) belongs to the Hepadnaviridae family of enveloped DNA viruses. It was previously shown that HBV can induce endoplasmic reticulum (ER) stress and activate the IRE1-XBP1 pathway of the unfolded protein response (UPR), through the expression of the viral regulatory protein X (HBx). However, it remained obscure whether or not this activation had any functional consequences on the target genes of the UPR pathway. Of these targets, the ER degradation-enhancing, mannosidase-like proteins (EDEMs) are thought to play an important role in relieving the ER stress during UPR, by recognizing terminally misfolded glycoproteins and delivering them to the ER-associated degradation (ERAD). In this study, we investigated the role of EDEMs in the HBV life-cycle. We found that synthesis of EDEMs (EDEM1 and its homologues, EDEM2 and EDEM3) is significantly up-regulated in cells with persistent or transient HBV replication. Co-expression of the wild-type HBV envelope proteins with EDEM1 resulted in their massive degradation, a process reversed by EDEM1 silencing. Surprisingly, the autophagy/lysosomes, rather than the proteasome were involved in disposal of the HBV envelope proteins. Importantly, inhibition of the endogenous EDEM1 expression in HBV replicating cells significantly increased secretion of both, enveloped virus and subviral particles. This is the first report showing that HBV activates the ERAD pathway, which, in turn, reduces the amount of envelope proteins, possibly as a mechanism to control the level of virus particles in infected cells and facilitate the establishment of chronic infections.	[Lazar, Catalin; Macovei, Alina; Petrescu, Stefana; Branza-Nichita, Norica] Romanian Acad, Inst Biochem, Dept Viral Glycoprot, Bucharest, Romania	Romanian Academy of Sciences; Institute of Biochemistry, Bucharest	Lazar, C (corresponding author), Romanian Acad, Inst Biochem, Dept Viral Glycoprot, Bucharest, Romania.	norica70@yahoo.co.uk	Lazar, Catalin/A-4896-2012; Petrescu, Stefana M/I-9240-2012; Macovei, Alina/B-9270-2012; Petrescu, Stefana/AAJ-9505-2021	Lazar, Catalin/0000-0001-5994-5533; Petrescu, Stefana M/0000-0002-4047-0811; Petrescu, Stefana/0000-0002-4047-0811	National Council of Scientific Research in Higher Education (CNCSIS) [PD-126]; Institute of Biochemistry;  [POSDRU/89/1.5/S/60746]	National Council of Scientific Research in Higher Education (CNCSIS)(Consiliul National al Cercetarii Stiintifice (CNCS)); Institute of Biochemistry; 	This work was supported by the PD-126 grant awarded by the National Council of Scientific Research in Higher Education (CNCSIS) to Dr. Catalin Lazar and the Romanian Academy project 3, of the Institute of Biochemistry. Catalin Lazar and Alina Macovei were also supported by POSDRU/89/1.5/S/60746 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Branza-Nichita N, 2001, J VIROL, V75, P3527, DOI 10.1128/JVI.75.8.3527-3536.2001; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; GERLICH WH, 1992, ARCH VIROL, P129; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lazar C, 2007, ANTIVIR RES, V76, P30, DOI 10.1016/j.antiviral.2007.04.004; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Liu YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024477; Macovei A, 2010, J VIROL, V84, P243, DOI 10.1128/JVI.01207-09; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Momoi T, 2006, CURR MOL MED, V6, P111, DOI 10.2174/156652406775574596; Nassal M, 1996, CURR TOP MICROBIOL, V214, P297; Patient R, 2007, J VIROL, V81, P3842, DOI 10.1128/JVI.02741-06; Popescu CI, 2005, J BIOL CHEM, V280, P13833, DOI 10.1074/jbc.M413087200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Trujillo-Alonso V, 2011, J VIROL, V85, P12594, DOI 10.1128/JVI.05620-11; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	34	61	68	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34169	10.1371/journal.pone.0034169	http://dx.doi.org/10.1371/journal.pone.0034169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461906	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900024
J	Qi, YJ; Oja, M; Weston, J; Noble, WS				Qi, Yanjun; Oja, Merja; Weston, Jason; Noble, William Stafford			A Unified Multitask Architecture for Predicting Local Protein Properties	PLOS ONE			English	Article							COMBINED TRANSMEMBRANE TOPOLOGY; SEQUENCE ALIGNMENT PROFILES; SIGNAL PEPTIDE PREDICTION; SECONDARY STRUCTURE; SOLVENT ACCESSIBILITY; COILED COILS; INTERACTION SITES; BINDING RESIDUES; IDENTIFICATION; DATABASE	A variety of functionally important protein properties, such as secondary structure, transmembrane topology and solvent accessibility, can be encoded as a labeling of amino acids. Indeed, the prediction of such properties from the primary amino acid sequence is one of the core projects of computational biology. Accordingly, a panoply of approaches have been developed for predicting such properties; however, most such approaches focus on solving a single task at a time. Motivated by recent, successful work in natural language processing, we propose to use multitask learning to train a single, joint model that exploits the dependencies among these various labeling tasks. We describe a deep neural network architecture that, given a protein sequence, outputs a host of predicted local properties, including secondary structure, solvent accessibility, transmembrane topology, signal peptides and DNA-binding residues. The network is trained jointly on all these tasks in a supervised fashion, augmented with a novel form of semi-supervised learning in which the model is trained to distinguish between local patterns from natural and synthetic protein sequences. The task-independent architecture of the network obviates the need for task-specific feature engineering. We demonstrate that, for all of the tasks that we considered, our approach leads to statistically significant improvements in performance, relative to a single task neural network approach, and that the resulting model achieves state-of-the-art performance.	[Qi, Yanjun] NEC Labs Amer, Machine Learning Dept, Princeton, NJ USA; [Oja, Merja; Noble, William Stafford] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Weston, Jason] Google, New York, NY USA	NEC Corporation; University of Washington; University of Washington Seattle; Google Incorporated	Qi, YJ (corresponding author), NEC Labs Amer, Machine Learning Dept, Princeton, NJ USA.	william-noble@uw.edu			NIH [R01 GM074257, P41 RR0011823]; Academy of Finland; Finnish Cultural Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH awards R01 GM074257 and P41 RR0011823, and by the Academy of Finland and the Finnish Cultural Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Yanjun Qi is an employee of NEC Labs America and Jason Weston an employee of Google, New York City. These authors contributed to all aspects of the study.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1987, COMPUT SPEECH LANG, DOI DOI 10.1016/0885-2308(87)90026-X; Bartoli L, 2009, BIOINFORMATICS, V25, P2757, DOI 10.1093/bioinformatics/btp539; Bassnett S, 2009, MOL VIS, V15, P2448; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bengio Y, 2003, J MACH LEARN RES, V3, P1137, DOI 10.1162/153244303322533223; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Chu W, 2006, IEEE ACM T COMPUT BI, V3, P98, DOI 10.1109/TCBB.2006.17; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Collobert R, 2007, P 45 ANN M ASS COMP, P25; Collobert R., 2008, MACH LEARN P 25 INT; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Fagerberg L, 2010, PROTEOMICS, V10, P1141, DOI 10.1002/pmic.200900258; Gallet X, 2000, J MOL BIOL, V302, P917, DOI 10.1006/jmbi.2000.4092; Gianese G, 2006, J COMPUT CHEM, V27, P621, DOI 10.1002/jcc.20370; Glorot X., 2010, P 13 INT C ARTIFICIA, V9, P249, DOI DOI 10.1.1/207.2059; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Katzman S, 2008, BIOINFORMATICS, V24, P2453, DOI 10.1093/bioinformatics/btn438; Khanna MR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-302; Kim H, 2003, PROTEIN ENG, V16, P553, DOI 10.1093/protein/gzg072; Kountouris P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-437; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mika S, 2003, NUCLEIC ACIDS RES, V31, P3789, DOI 10.1093/nar/gkg620; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Qian N, 1988, J MOL BIOL, V202, P865, DOI 10.1016/0022-2836(88)90564-5; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Richardson CJ, 1999, PROTEIN ENG, V12, P1051, DOI 10.1093/protein/12.12.1051; Riis SK, 1996, J COMPUT BIOL, V3, P163, DOI 10.1089/cmb.1996.3.163; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Styczynski MP, 2008, NAT BIOTECHNOL, V26, P274, DOI 10.1038/nbt0308-274; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD222, DOI 10.1093/nar/gkm800; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yan CH, 2004, BIOINFORMATICS, V20, P371, DOI 10.1093/bioinformatics/bth920; Yao XQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-49; Yuan Z, 2002, PROTEINS, V48, P566, DOI 10.1002/prot.10176; Zhou Z, 2010, EXPERT SYSTEMS APPL	57	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e32235	10.1371/journal.pone.0032235	http://dx.doi.org/10.1371/journal.pone.0032235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461885	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900004
J	Eloualid, A; Abidi, O; Charif, M; El Houate, B; Benrahma, H; Louanjli, N; Chadli, E; Ajjemami, M; Barakat, A; Bashamboo, A; McElreavey, K; Rhaissi, H; Rouba, H				Eloualid, Abdelmajid; Abidi, Omar; Charif, Majida; El Houate, Brahim; Benrahma, Houda; Louanjli, Noureddine; Chadli, Elbakkay; Ajjemami, Maria; Barakat, Abdelhamid; Bashamboo, Anu; McElreavey, Ken; Rhaissi, Houria; Rouba, Hassan			Association of the MTHFR A1298C Variant with Unexplained Severe Male Infertility	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; IDIOPATHIC MALE-INFERTILITY; COMMON MUTATION; RISK-FACTORS; SEVERE OLIGOZOOSPERMIA; C677T; POLYMORPHISMS; FOLATE; SPERM; HYPERHOMOCYSTEINEMIA	The methylenetetrahydrofolate reductase (MTHFR) gene is one of the main regulatory enzymes involved in folate metabolism, DNA synthesis and remethylation reactions. The influence of MTHFR variants on male infertility is not completely understood. The objective of this study was to analyze the distribution of the MTHFR C677T and A1298C variants using PCR-Restriction Fragment Length Polymorphism (RFLP) in a case group consisting of 344 men with unexplained reduced sperm counts compared to 617 ancestry-matched fertile or normozoospermic controls. The Chi square test was used to analyze the genotype distributions of MTHFR polymorphisms. Our data indicated a lack of association of the C677T variant with infertility. However, the homozygous (C/C) A1298C polymorphism of the MTHFR gene was present at a statistically high significance in severe oligozoospermia group compared with controls (OR = 3.372, 95% confidence interval CI = 1.27-8.238; p = 0.01431). The genotype distribution of the A1298C variants showed significant deviation from the expected Hardy-Weinberg equilibrium, suggesting that purifying selection may be acting on the 1298CC genotype. Further studies are necessary to determine the influence of the environment, especially the consumption of diet folate on sperm counts of men with different MTHFR variants.	[Eloualid, Abdelmajid; Abidi, Omar; Charif, Majida; El Houate, Brahim; Benrahma, Houda; Ajjemami, Maria; Barakat, Abdelhamid; Rouba, Hassan] Inst Pasteur, Res Dept, Human Genet Unit, Casablanca, Morocco; [Chadli, Elbakkay] Inst Pasteur, Cytogenet Unit, Casablanca, Morocco; [Louanjli, Noureddine] In Vitro Fecondat Ctr, Casablanca, Morocco; [Bashamboo, Anu; McElreavey, Ken] Inst Pasteur, Human Dev Genet Unit, Paris, France; [Eloualid, Abdelmajid; Rhaissi, Houria] Fac Sci Ben Msik, Casablanca, Morocco	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Hassan II University of Casablanca	Eloualid, A (corresponding author), Inst Pasteur, Res Dept, Human Genet Unit, Casablanca, Morocco.	abdelmajideloualid@yahoo.fr	Abidi, Omar/AAM-5088-2020	Benrahma, Houda/0000-0002-7523-2581; Brahim, EL HOUATE/0000-0002-7781-426X				A ZC, 2007, ASIAN J ANDROL, V9, P57, DOI 10.1111/j.1745-7262.2007.00225.x; Austin RC, 2004, CELL DEATH DIFFER, V11, pS56, DOI 10.1038/sj.cdd.4401451; Bashamboo A, 2010, AM J HUM GENET, V87, P505, DOI 10.1016/j.ajhg.2010.09.009; Bezold G, 2001, NEW ENGL J MED, V344, P1172, DOI 10.1056/NEJM200104123441517; Chan D, 2010, ENDOCRINOLOGY, V151, P3363, DOI 10.1210/en.2009-1340; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Dohle GR, 2002, HUM REPROD, V17, P13, DOI 10.1093/humrep/17.1.13; Ebisch IMW, 2007, HUM REPROD UPDATE, V13, P163, DOI 10.1093/humupd/dml054; Ebisch IMW, 2003, FERTIL STERIL, V80, P1190, DOI 10.1016/S0015-0282(03)02157-5; Esfahani ST, 2003, J AM DIET ASSOC, V103, P200, DOI 10.1053/jada.2003.50030; Ferlin A, 2007, REPROD BIOMED ONLINE, V14, P734, DOI 10.1016/S1472-6483(10)60677-3; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Forges T, 2008, GYNECOL OBSTET FERTI, V36, P930, DOI 10.1016/j.gyobfe.2008.07.004; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gava MM, 2011, GENET TEST MOL BIOMA, V15, P153, DOI 10.1089/gtmb.2010.0128; Gueant JL, 2003, CLIN CHEM LAB MED, V41, P1473, DOI 10.1515/CCLM.2003.226; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Lee HC, 2006, HUM REPROD, V21, P3162, DOI 10.1093/humrep/del280; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lu CC, 2009, HUM MOL GENET, V18, P1122, DOI 10.1093/hmg/ddn427; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Montjean D, 2011, FERTIL STERIL, V95, P635, DOI 10.1016/j.fertnstert.2010.08.054; Mtiraoui N, 2007, DIABETES RES CLIN PR, V75, P99, DOI 10.1016/j.diabres.2006.05.018; Paluku They-Theys THK, 2009, ANTROPO, V20, P11; Paracchini V, 2006, BIOMARKERS, V11, P53, DOI 10.1080/13547500500442050; Ravel C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006540; Safarinejad MR, 2011, REPROD SCI, V18, P304, DOI 10.1177/1933719110385135; Shen OX, 2012, ANN HUM GENET, V76, P25, DOI 10.1111/j.1469-1809.2011.00691.x; Singh K, 2005, INT J ANDROL, V28, P115, DOI 10.1111/j.1365-2605.2004.00513.x; Singh K, 2010, J POSTGRAD MED, V56, P267, DOI 10.4103/0022-3859.70935; Steegers-Theunissen RP, 2004, OBSTET GYNECOL, V104, P336, DOI 10.1097/01.AOG.0000129955.47943.2a; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wei BB, 2012, MOL BIOL REP, V39, P1997, DOI 10.1007/s11033-011-0946-4; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wu W, 2011, INT J ANDROL, DOI [101111/j.1365-2605..01147.x., DOI 10.1111/J.1365-2605..01147.X]; Wu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013884	37	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34111	10.1371/journal.pone.0034111	http://dx.doi.org/10.1371/journal.pone.0034111			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457816	Green Submitted, Green Published, gold			2022-12-27	WOS:000304046900045
J	Wen, FS; Zhou, RY; Shen, A; Choi, A; Uribe, D; Shi, JQ				Wen, Fushi; Zhou, Renyuan; Shen, Alex; Choi, Andrew; Uribe, Diana; Shi, Jiaqi			The Tumor Suppressive Role of eIF3f and Its Function in Translation Inhibition and rRNA Degradation	PLOS ONE			English	Article							INITIATION-FACTOR 3F; NUCLEAR RIBONUCLEOPROTEIN K; MESSENGER-RNA; INDUCED APOPTOSIS; CELL-GROWTH; EXPRESSION; PROTEIN; TRANSCRIPTION; INTERACTS; IDENTIFICATION	Deregulated translation plays an important role in human cancer. We previously reported decreased eukaryotic initiation factor 3 subunit f (eIF3f) expression in pancreatic cancer. Whether decreased eIF3f expression can transform normal epithelial cells is not known. In our current study, we found evidence that stable knockdown of eIF3f in normal human pancreatic ductal epithelial cells increased cell size, nuclear pleomorphism, cytokinesis defects, cell proliferation, clonogenicity, apoptotic resistance, migration, and formation of 3-dimensional irregular masses. Our findings support the tumor suppressive role of eIF3f in pancreatic cancer. Mechanistically, we found that eIF3f inhibited both cap-dependent and cap-independent translation. An increase in the ribosomal RNA (rRNA) level was suggested to promote the generation of cancer. The regulatory mechanism of rRNA degradation in mammals is not well understood. We demonstrated here that eIF3f promotes rRNA degradation through direct interaction with heterogeneous nuclear ribonucleoprotein (hnRNP) K. We showed that hnRNP K is required for maintaining rRNA stability: under stress conditions, eIF3f dissociates hnRNP K from rRNA, thereby preventing it from protecting rRNA from degradation. We also demonstrated that rRNA degradation occurred in non-P body, non-stress granule cytoplasmic foci that contain eIF3f. Our findings established a new mechanism of rRNA decay regulation mediated by hnRNP K/eIF3f and suggest that the tumor suppressive function of eIF3f may link to impaired rRNA degradation and translation.	[Wen, Fushi; Shen, Alex; Choi, Andrew; Uribe, Diana; Shi, Jiaqi] Univ Arizona, Dept Pathol, Dept Surg, Ctr Canc, Tucson, AZ 85719 USA; [Zhou, Renyuan] Fifth Peoples Hosp Shanghai, Dept Urol, Shanghai, Peoples R China	University of Arizona	Wen, FS (corresponding author), Univ Arizona, Dept Pathol, Dept Surg, Ctr Canc, Tucson, AZ 85719 USA.	sjq@email.arizona.edu		Shi, Jiaqi/0000-0003-4893-1587; Zhou, Renyuan/0000-0001-6914-342X	NCI/United States National Institutes of Health (NIH) [CA133449]; GI SPORE [CA95060]; NIH Arizona Cancer Center [CA023074]; NATIONAL CANCER INSTITUTE [R03CA158895, P30CA023074, P50CA095060, R03CA133449] Funding Source: NIH RePORTER	NCI/United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GI SPORE; NIH Arizona Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI/United States National Institutes of Health (NIH) grant CA133449, GI SPORE CA95060, and NIH Arizona Cancer Center Support Grant CA023074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza ME, 1999, J BIOL CHEM, V274, P28505, DOI 10.1074/jbc.274.40.28505; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Clemens MJ, 1998, ONCOGENE, V17, P2921, DOI 10.1038/sj.onc.1202227; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008994; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Doldan A, 2008, MOL CARCINOGEN, V47, P806, DOI 10.1002/mc.20436; Doldan A, 2008, MOL CARCINOGEN, V47, P235, DOI 10.1002/mc.20379; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Fukuda T, 2009, GENES CELLS, V14, P113, DOI 10.1111/j.1365-2443.2008.01256.x; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2007, J CELL BIOL, V179, P1105, DOI 10.1083/jcb.200709044; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Joseph P, 2002, CANCER RES, V62, P703; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Marchetti A, 2001, INT J ONCOL, V18, P175; Mikolajczyk M, 2004, BIOCHEM J, V384, P461, DOI 10.1042/BJ20040848; Morley SJ, 1998, FEBS LETT, V438, P41, DOI 10.1016/S0014-5793(98)01269-1; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Paziewska A, 2005, CELL MOL BIOL LETT, V10, P227; Peng XH, 2005, CANCER RES, V65, P1909, DOI 10.1158/0008-5472.CAN-04-3196; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Rodriguez AJ, 2007, SEMIN CELL DEV BIOL, V18, P202, DOI 10.1016/j.semcdb.2007.02.002; Sheikh MS, 1999, ONCOGENE, V18, P6121, DOI 10.1038/sj.onc.1203131; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Shi JQ, 2009, FEBS LETT, V583, P971, DOI 10.1016/j.febslet.2009.02.028; Shi JQ, 2003, J BIOL CHEM, V278, P5062, DOI 10.1074/jbc.M206427200; Skalweit A, 2003, CIRC RES, V92, P419, DOI 10.1161/01.RES.0000059300.67152.4E; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tyagi S, 2004, BIOPHYS J, V87, P4153, DOI 10.1529/biophysj.104.045153; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; Wallach D, 1997, TRENDS BIOCHEM SCI, V22, P107, DOI 10.1016/S0968-0004(97)01015-3; Watkins SJ, 2002, BRIT J CANCER, V86, P1023, DOI 10.1038/sj/bjc/6600222; Wen FS, 2010, ANN SURG ONCOL, V17, P2619, DOI 10.1245/s10434-010-1121-1; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744; Zhu YH, 2005, ONCOGENE, V24, P6555, DOI 10.1038/sj.onc.1208800	46	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34194	10.1371/journal.pone.0034194	http://dx.doi.org/10.1371/journal.pone.0034194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457825	Green Submitted, Green Published, gold			2022-12-27	WOS:000304046900054
J	Yuan, SQ; Cohen, DB; Ravel, J; Abdo, Z; Forney, LJ				Yuan, Sanqing; Cohen, Dora B.; Ravel, Jacques; Abdo, Zaid; Forney, Larry J.			Evaluation of Methods for the Extraction and Purification of DNA from the Human Microbiome	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; BACTERIAL VAGINOSIS; GUT MICROBIOTA; GARDNERELLA-VAGINALIS; METAGENOMIC ANALYSIS; BACTERIOLYTIC AGENT; MOLECULAR ANALYSIS; ATOPOBIUM-VAGINAE; HUMAN INTESTINE; PCR	Background: DNA extraction is an essential step in all cultivation-independent approaches to characterize microbial diversity, including that associated with the human body. A fundamental challenge in using these approaches has been to isolate DNA that is representative of the microbial community sampled. Methodology/Principal Findings: In this study, we statistically evaluated six commonly used DNA extraction procedures using eleven human-associated bacterial species and a mock community that contained equal numbers of those eleven species. These methods were compared on the basis of DNA yield, DNA shearing, reproducibility, and most importantly representation of microbial diversity. The analysis of 16S rRNA gene sequences from a mock community showed that the observed species abundances were significantly different from the expected species abundances for all six DNA extraction methods used. Conclusions/Significance: Protocols that included bead beating and/or mutanolysin produced significantly better bacterial community structure representation than methods without both of them. The reproducibility of all six methods was similar, and results from different experimenters and different times were in good agreement. Based on the evaluations done it appears that DNA extraction procedures for bacterial community analysis of human associated samples should include bead beating and/or mutanolysin to effectively lyse cells.	[Yuan, Sanqing; Cohen, Dora B.; Forney, Larry J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Abdo, Zaid] Univ Idaho, Dept Math, Moscow, ID 83843 USA; [Abdo, Zaid] Univ Idaho, Dept Stat, Moscow, ID 83843 USA; [Yuan, Sanqing; Cohen, Dora B.; Abdo, Zaid; Forney, Larry J.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; University System of Maryland; University of Maryland Baltimore	Yuan, SQ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	lforney@uidaho.edu	Ravel, Jacques/D-2530-2009; Abdo, Zaid/E-5176-2017	Abdo, Zaid/0000-0002-8272-7734; Ravel, Jacques/0000-0002-0851-2233	National Institutes of Health [U01-AI070921]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health under grant U01-AI070921. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Anderson KL, 2003, J APPL MICROBIOL, V94, P988, DOI 10.1046/j.1365-2672.2003.01917.x; Ariefdjohan MW, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-23; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bertrand H, 2005, J MICROBIOL METH, V62, P1, DOI 10.1016/j.mimet.2005.01.003; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; BROWDER HP, 1965, BIOCHEM BIOPH RES CO, V19, P383, DOI 10.1016/0006-291X(65)90473-0; Burgmann H, 2001, J MICROBIOL METH, V45, P7, DOI 10.1016/S0167-7012(01)00213-5; Cabrol L, 2010, APPL MICROBIOL BIOT, V85, P779, DOI 10.1007/s00253-009-2253-8; Carrigg C, 2007, APPL MICROBIOL BIOT, V77, P955, DOI 10.1007/s00253-007-1219-y; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Donachie WD, 2001, MOL MICROBIOL, V40, P779, DOI 10.1046/j.1365-2958.2001.02439.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; Ferris MJ, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-5; Forney LJ, 2004, CURR OPIN MICROBIOL, V7, P210, DOI 10.1016/j.mib.2004.04.015; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; Gabor EM, 2003, FEMS MICROBIOL ECOL, V44, P153, DOI 10.1016/S0168-6496(02)00462-2; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3378, DOI 10.1128/AEM.02715-09; Kaser M, 2009, APPL ENVIRON MICROB, V75, P414, DOI 10.1128/AEM.01358-08; Krsek M, 1999, J MICROBIOL METH, V39, P1, DOI 10.1016/S0167-7012(99)00093-7; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; LaMontagne MG, 2002, J MICROBIOL METH, V49, P255, DOI 10.1016/S0167-7012(01)00377-3; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li F, 2007, J MICROBIOL METH, V68, P303, DOI 10.1016/j.mimet.2006.09.006; LIESACK W, 1991, MICROBIAL ECOL, V21, P191, DOI 10.1007/BF02539153; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Morita H, 2007, MICROBES ENVIRON, V22, P214, DOI 10.1264/jsme2.22.214; Nylund L, 2010, J MICROBIOL METH, V83, P231, DOI 10.1016/j.mimet.2010.09.003; Oehlert G. W., 1 COURSE DESIGN ANAL; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; RAVEL J, 2010, P NATL ACAD SCI US; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schutte UME, 2009, ISME J, V3, P1258, DOI 10.1038/ismej.2009.71; Scupham AJ, 2007, J APPL MICROBIOL, V102, P401, DOI 10.1111/j.1365-2672.2006.03094.x; Shiba T, 2000, ACTA CRYSTALLOGR D, V56, P1462, DOI 10.1107/S0907444900010374; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Team RDC, 2019, R LANG ENV STAT COMP; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vanysacker L, 2010, APPL MICROBIOL BIOT, V88, P299, DOI 10.1007/s00253-010-2770-5; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Watts DH, 2005, J INFECT DIS, V191, P1129, DOI 10.1086/427777; Williams ML, 2008, J APPL MICROBIOL, V104, P1790, DOI 10.1111/j.1365-2672.2007.03704.x; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	71	325	332	8	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33865	10.1371/journal.pone.0033865	http://dx.doi.org/10.1371/journal.pone.0033865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457796	Green Submitted, gold, Green Published			2022-12-27	WOS:000304046900030
J	Zhao, XH; Liu, Y; Wang, XB; Liu, B; Xi, Q; Guo, QH; Jiang, H; Jiang, TZ; Wang, PJ				Zhao, Xiaohu; Liu, Yong; Wang, Xiangbin; Liu, Bing; Xi, Qian; Guo, Qihao; Jiang, Hong; Jiang, Tianzi; Wang, Peijun			Disrupted Small-World Brain Networks in Moderate Alzheimer's Disease: A Resting-State fMRI Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; GRAPH-THEORETICAL ANALYSIS; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; CLINICAL-FEATURES; CORTICAL NETWORKS; EPISODIC MEMORY; APOE GENOTYPE; DEMENTIA; FREQUENCY	The small-world organization has been hypothesized to reflect a balance between local processing and global integration in the human brain. Previous multimodal imaging studies have consistently demonstrated that the topological architecture of the brain network is disrupted in Alzheimer's disease (AD). However, these studies have reported inconsistent results regarding the topological properties of brain alterations in AD. One potential explanation for these inconsistent results lies with the diverse homogeneity and distinct progressive stages of the AD involved in these studies, which are thought to be critical factors that might affect the results. We investigated the topological properties of brain functional networks derived from resting functional magnetic resonance imaging (fMRI) of carefully selected moderate AD patients and normal controls (NCs). Our results showed that the topological properties were found to be disrupted in AD patients, which showing increased local efficiency but decreased global efficiency. We found that the altered brain regions are mainly located in the default mode network, the temporal lobe and certain subcortical regions that are closely associated with the neuropathological changes in AD. Of note, our exploratory study revealed that the ApoE genotype modulates brain network properties, especially in AD patients.	[Zhao, Xiaohu; Wang, Xiangbin; Xi, Qian; Jiang, Hong; Wang, Peijun] Tongji Univ, TongJi Hosp Shanghai, Dept Imaging, Shanghai, Peoples R China; [Liu, Yong; Liu, Bing; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, LIAMA Ctr Computat Med, Beijing, Peoples R China; [Guo, Qihao] Fudan Univ, Shanghai Med Coll, Huashan Hosp,State Key Lab Med Neurobiol, Dept Neurol,Inst Neurol, Shanghai 200433, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Jiang, Tianzi] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Tongji University; Chinese Academy of Sciences; Institute of Automation, CAS; Fudan University; University of Electronic Science & Technology of China; University of Queensland	Zhao, XH (corresponding author), Tongji Univ, TongJi Hosp Shanghai, Dept Imaging, Shanghai, Peoples R China.	jiangtz@nlpr.ia.ac.cn; tongjipjwang@vip.sina.com	Liu, Yong/F-2682-2011; Jiang, Tianzi/I-4256-2012	Liu, Yong/0000-0002-1862-3121; Jiang, Tianzi/0000-0001-9531-291X	National High Technology Research and Development Program of China (863 Program) [2009AA02Z302]; National Key Basic Research and Development Program (973) [2011CBA00408]; Natural Science Foundation of China [60831004, 30970818, 30770615, 30970770]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Basic Research and Development Program (973)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the National High Technology Research and Development Program of China (863 Program, Grant No. 2009AA02Z302), the National Key Basic Research and Development Program (973, Grant 2011CBA00408), the Natural Science Foundation of China (Grant Nos. 60831004, 30970818, 30770615, 30970770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Adamson MM, 2011, NEUROPSYCHOLOGIA, V49, P2448, DOI 10.1016/j.neuropsychologia.2011.04.022; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Alexander GE, 2002, AM J PSYCHIAT, V159, P738, DOI 10.1176/appi.ajp.159.5.738; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; AZARI NP, 1993, J CEREBR BLOOD F MET, V13, P438, DOI 10.1038/jcbfm.1993.58; Bokde ALW, 2001, ARCH NEUROL-CHICAGO, V58, P480, DOI 10.1001/archneur.58.3.480; Borenstein AR, 2010, AM J ALZHEIMERS DIS, V25, P233, DOI 10.1177/1533317509357736; Brainerd CJ, 2011, NEUROPSYCHOLOGY, V25, P679, DOI 10.1037/a0024483; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; CARLESIMO GA, 1992, NEUROPSYCHOL REV, V3, P119, DOI 10.1007/BF01108841; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; Delbeuck X, 2007, NEUROPSYCHOLOGIA, V45, P3315, DOI 10.1016/j.neuropsychologia.2007.05.001; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Di Paola M, 2007, J NEUROL, V254, P774, DOI 10.1007/s00415-006-0435-1; Dickerson Bradford C, 2005, NeuroRx, V2, P348, DOI 10.1007/BF03206676; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Filippini N, 2011, NEUROIMAGE, V54, P602, DOI 10.1016/j.neuroimage.2010.08.009; Forstl H, 1999, EUR ARCH PSY CLIN N, V249, P288, DOI 10.1007/s004060050101; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Halliday GM, 2003, NEUROBIOL AGING, V24, P797, DOI 10.1016/S0197-4580(02)00227-0; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Horwitz B, 1995, NEUROREPORT, V6, P2287, DOI 10.1097/00001756-199511270-00005; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Johnson MD, 2000, BRAIN COGNITION, V42, P218, DOI 10.1006/brcg.1999.1101; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lind J, 2006, BRAIN, V129, P1240, DOI 10.1093/brain/awl054; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salmon E, 2006, HUM BRAIN MAPP, V27, P588, DOI 10.1002/hbm.20203; Salvador R, 2007, NEUROIMAGE, V35, P83, DOI 10.1016/j.neuroimage.2006.12.001; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schmidt C, 2010, DEMENT GERIATR COGN, V29, P371, DOI 10.1159/000278692; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O., 2010, NETWORKS BRAIN; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stenset V, 2007, ACTA NEUROL SCAND, V115, P68, DOI 10.1111/j.1600-0404.2007.00851.x; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Thompson PM, 2003, J NEUROSCI, V23, P994; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Trachtenberg AJ, 2012, NEUROIMAGE, V59, P565, DOI 10.1016/j.neuroimage.2011.07.059; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603; Wolk DA, 2011, NEUROIMAGE, V54, P1530, DOI 10.1016/j.neuroimage.2010.09.005; Wolk DA, 2010, P NATL ACAD SCI USA, V107, P10256, DOI 10.1073/pnas.1001412107; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yoneoka Y, 2004, AM J NEURORADIOL, V25, P964; Zarei M, 2010, NEUROIMAGE, V49, P1, DOI 10.1016/j.neuroimage.2009.09.001; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049	92	151	166	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33540	10.1371/journal.pone.0033540	http://dx.doi.org/10.1371/journal.pone.0033540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457774	Green Submitted, gold, Green Published			2022-12-27	WOS:000304046900016
J	Diaz, A; Zikhali, M; Turner, AS; Isaac, P; Laurie, DA				Diaz, Aurora; Zikhali, Meluleki; Turner, Adrian S.; Isaac, Peter; Laurie, David A.			Copy Number Variation Affecting the Photoperiod-B1 and Vernalization-A1 Genes Is Associated with Altered Flowering Time in Wheat (Triticum aestivum)	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; FREEZING TOLERANCE; BARLEY; PPD-B1; VRN-1; LINES	The timing of flowering during the year is an important adaptive character affecting reproductive success in plants and is critical to crop yield. Flowering time has been extensively manipulated in crops such as wheat (Triticum aestivum L.) during domestication, and this enables them to grow productively in a wide range of environments. Several major genes controlling flowering time have been identified in wheat with mutant alleles having sequence changes such as insertions, deletions or point mutations. We investigated genetic variants in commercial varieties of wheat that regulate flowering by altering photoperiod response (Ppd-B1 alleles) or vernalization requirement (Vrn-A1 alleles) and for which no candidate mutation was found within the gene sequence. Genetic and genomic approaches showed that in both cases alleles conferring altered flowering time had an increased copy number of the gene and altered gene expression. Alleles with an increased copy number of Ppd-B1 confer an early flowering day neutral phenotype and have arisen independently at least twice. Plants with an increased copy number of Vrn-A1 have an increased requirement for vernalization so that longer periods of cold are required to potentiate flowering. The results suggest that copy number variation (CNV) plays a significant role in wheat adaptation.	[Diaz, Aurora; Zikhali, Meluleki; Turner, Adrian S.; Laurie, David A.] John Innes Ctr, Norfolk, VA USA; [Isaac, Peter] IDNA Genet Ltd, Norwich BioIncubator, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Laurie, DA (corresponding author), John Innes Ctr, Norwich Res Pk, Norfolk, VA USA.	david.laurie@jic.ac.uk	Díaz, Aurora/AGY-7093-2022; Bermúdez, Aurora Díaz/AFB-9080-2022	Díaz, Aurora/0000-0001-7297-1699; 	Spanish Foundation Alfonso Martin Escudero; Chevening Scholarship Programme; UK Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Foundation; John Innes Centre; Sainsbury Laboratory; BBSRC;  [BB/F014031/1]; Biotechnology and Biological Sciences Research Council [BB/F014031/1] Funding Source: researchfish; BBSRC [BB/F014031/1] Funding Source: UKRI	Spanish Foundation Alfonso Martin Escudero; Chevening Scholarship Programme; UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; John Innes Centre; Sainsbury Laboratory; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AD was supported by a postdoctoral grant from the Spanish Foundation Alfonso Martin Escudero. MZ was supported during an MSc project by the Chevening Scholarship Programme administered by the British Council, and during a Rotation Ph.D. project by the UK Biotechnology and Biological Sciences Research Council (BBSRC), John Innes Foundation, John Innes Centre and the Sainsbury Laboratory. This work was also supported by grant number BB/F014031/1 and by grant-in-aid to the John Innes Centre from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouis S, 2003, CEREAL RES COMMUN, V31, P331; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bentley AR, 2011, PLANT BREEDING, V130, P10, DOI 10.1111/j.1439-0523.2010.01802.x; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; Butterworth KJ, 2000, THESIS U E ANGLIA; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen YH, 2009, THEOR APPL GENET, V118, P881, DOI 10.1007/s00122-008-0946-5; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Eagles HA, 2011, PLANT BREEDING, V130, P413, DOI 10.1111/j.1439-0523.2011.01856.x; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Hanocq E, 2004, THEOR APPL GENET, V110, P106, DOI 10.1007/s00122-004-1799-1; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Keim DL, P 4 INT WHEAT GEN S, P879; Knox AK, 2010, THEOR APPL GENET, V121, P21, DOI 10.1007/s00122-010-1288-7; MCINTOSH RA, 2003, CATALOGUE GENE SYMBO; Mohler V, 2004, EUPHYTICA, V138, P33, DOI 10.1023/B:EUPH.0000047056.58938.76; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; SCARTH R, 1984, Z PFLANZENZUCHT, V92, P140; SCARTH R, 1983, HEREDITY, V51, P607, DOI 10.1038/hdy.1983.73; Schrider DR, 2010, P ROY SOC B-BIOL SCI, V277, P3213, DOI 10.1098/rspb.2010.1180; Sourdille P, 2000, GENOME, V43, P487, DOI 10.1139/g00-013; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Tanio M, 2007, BREEDING SCI, V57, P65, DOI 10.1270/jsbbs.57.65; Thomas B., 1997, PHOTOPERIODISM PLANT; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; WORLAND AJ, 1994, EUPHYTICA, V80, P219, DOI 10.1007/BF00039653; Worland T., 2001, WORLD WHEAT BOOK HIS, P59; Xue SL, 2008, THEOR APPL GENET, V117, P181, DOI 10.1007/s00122-008-0764-9; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	40	271	284	11	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33234	10.1371/journal.pone.0033234	http://dx.doi.org/10.1371/journal.pone.0033234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457747	gold, Green Published, Green Submitted			2022-12-27	WOS:000303909200025
J	Blythe, MJ; Malla, S; Everall, R; Shih, YH; Lemay, V; Moreton, J; Wilson, R; Aboobaker, AA				Blythe, Martin J.; Malla, Sunir; Everall, Richard; Shih, Yu-huan; Lemay, Virginie; Moreton, Joanna; Wilson, Raymond; Aboobaker, A. Aziz			High Through-Put Sequencing of the Parhyale hawaiensis mRNAs and microRNAs to Aid Comparative Developmental Studies	PLOS ONE			English	Article							AMPHIPOD CRUSTACEAN; EMBRYONIC-DEVELOPMENT; RAPID TRANSCRIPTOME; EXPRESSION; EVOLUTION; RESOURCE; REVEALS; LINEAGE; CLUSTER; GENOME	Understanding the genetic and evolutionary basis of animal morphological diversity will require comparative developmental studies that use new model organisms. This necessitates development of tools for the study of genetics and also the generation of sequence information of the organism to be studied. The development of next generation sequencing technology has enabled quick and cost effective generation of sequence information. Parhyale hawaiensis has emerged as a model organism of choice due to the development of advanced molecular tools, thus P. hawaiensis genetic information will help drive functional studies in this organism. Here we present a transcriptome and miRNA collection generated using next generation sequencing platforms. We generated approximately 1.7 million reads from a P. hawaiensis cDNA library constructed from embryos up to the germ band stage. These reads were assembled into a dataset comprising 163,501 transcripts. Using the combined annotation of Annot8r and pfam2go, Gene Ontology classifications was assigned to 20,597 transcripts. Annot8r was used to provide KEGG orthology to our transcript dataset. A total of 25,292 KEGG pathway assignments were defined and further confirmed with reciprocal blast against the NCBI nr protein database. This has identified many P. hawaiensis gene orthologs of key conserved signalling pathways involved in development. We also generated small RNA sequences from P. hawaiensis, identifying 55 conserved miRNAs. Sequenced small RNAs that were not annotated by stringent comparison to mirBase were used to search the Daphnia pulex for possible novel miRNAs. Using a conservative approach, we have identified 51 possible miRNA candidates conserved in the Daphnia pulex genome, which could be potential crustacean/arthropod specific miRNAs. Our study presents gene and miRNA discovery in a new model organism that does not have a sequenced genome. The data provided by our work will be valuable for the P. hawaiensis community as well as the wider evolutionary developmental biology community.	[Blythe, Martin J.; Malla, Sunir; Moreton, Joanna; Wilson, Raymond; Aboobaker, A. Aziz] Univ Nottingham, Fac Med & Hlth Sci, Queens Med Ctr, Nottingham NG7 2RD, England; [Everall, Richard; Shih, Yu-huan; Lemay, Virginie; Aboobaker, A. Aziz] Univ Nottingham, Evolutionary Dev Biol Lab, Ctr Genet & Genom, Queens Med Ctr, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Blythe, MJ (corresponding author), Univ Nottingham, Fac Med & Hlth Sci, Queens Med Ctr, Nottingham NG7 2RD, England.	Aziz.Aboobaker@nottingham.ac.uk		Moreton, Joanna/0000-0003-3193-1812; Aboobaker, Aziz/0000-0003-4902-5797	University of Nottingham	University of Nottingham	This work was funded by project grants from the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Al-Nakhle H, 2010, CANCER RES, V70, P4778, DOI 10.1158/0008-5472.CAN-09-4104; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Browne WE, 2005, GENESIS, V42, P124, DOI 10.1002/gene.20145; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Extavour CG, 2005, DEV BIOL, V277, P387, DOI 10.1016/j.ydbio.2004.09.030; Finn R. D., 2008, NUCLEIC ACIDS RES, V38, pD211; Gerberding M, 2002, DEVELOPMENT, V129, P5789, DOI 10.1242/dev.00155; Guerra-Assuncao JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-133; He PA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-248; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jenner RA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-21; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kontarakis Z, 2011, DEVELOPMENT, V138, P2625, DOI 10.1242/dev.066324; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liubicich DM, 2009, P NATL ACAD SCI USA, V106, P13892, DOI 10.1073/pnas.0903105106; Marco A, 2010, GENOME BIOL EVOL, V2, P686, DOI 10.1093/gbe/evq053; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Ozhan-Kizil G, 2009, DEV BIOL, V327, P230, DOI 10.1016/j.ydbio.2008.10.028; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Parchem RJ, 2010, GENOMICS, V95, P261, DOI 10.1016/j.ygeno.2010.03.005; Pavlopoulos A, 2005, P NATL ACAD SCI USA, V102, P7888, DOI 10.1073/pnas.0501101102; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Prpic NM, 2008, DEV GENES EVOL, V218, P333, DOI 10.1007/s00427-008-0221-4; Rehm EJ, 2009, COLD SPRING HARB PRO; Rehm EJ, 2009, COLD SPRING HARB PRO, P114; Schmid R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-180; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581	44	28	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33784	10.1371/journal.pone.0033784	http://dx.doi.org/10.1371/journal.pone.0033784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448274	gold, Green Published, Green Submitted			2022-12-27	WOS:000303855700065
J	Minguez, L; Buronfosse, T; Giamberini, L				Minguez, Laetitia; Buronfosse, Thierry; Giamberini, Laure			Different Host Exploitation Strategies in Two Zebra Mussel-Trematode Systems: Adjustments of Host Life History Traits	PLOS ONE			English	Article							CLAM PISIDIUM-AMNICUM; FRESH-WATER MUSSEL; DREISSENA-POLYMORPHA; DIGESTIVE GLAND; ENERGY ALLOCATION; PATHOGENIC ORGANISMS; LYSOSOMAL RESPONSES; METAL CONTAMINATION; CERASTODERMA-EDULE; GAMMARUS-PULEX	The zebra mussel is the intermediate host for two digenean trematodes, Phyllodistomum folium and Bucephalus polymorphus, infecting gills and the gonad respectively. Many gray areas exist relating to the host physiological disturbances associated with these infections, and the strategies used by these parasites to exploit their host without killing it. The aim of this study was to examine the host exploitation strategies of these trematodes and the associated host physiological disturbances. We hypothesized that these two parasite species, by infecting two different organs (gills or gonads), do not induce the same physiological changes. Four cellular responses (lysosomal and peroxisomal defence systems, lipidic peroxidation and lipidic reserves) in the host digestive gland were studied by histochemistry and stereology, as well as the energetic reserves available in gonads. Moreover, two indices were calculated related to the reproductive status and the physiological condition of the organisms. Both parasites induced adjustments of zebra mussel life history traits. The host-exploitation strategy adopted by P. folium would occur during a short-term period due to gill deformation, and could be defined as "virulent." Moreover, this parasite had significant host gender-dependent effects: infected males displayed a slowed-down metabolism and energetic reserves more allocated to growth, whereas females displayed better defences and would allocate more energy to reproduction and maintenance. In contrast, B. polymorphus would be a more "prudent" parasite, exploiting its host during a long-term period through the consumption of reserves allocated to reproduction.	[Minguez, Laetitia; Giamberini, Laure] Univ Lorraine, CNRS UMR 7146, LIEBE, Metz, France; [Buronfosse, Thierry] Univ Lyon, Ecole Natl Vet Lyon, Lab Endocrinol, Marcy Letoile, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; VetAgro Sup	Minguez, L (corresponding author), Univ Lorraine, CNRS UMR 7146, LIEBE, Campus Bridoux, Metz, France.	giamb@univ-metz.fr		Minguez, Laetitia/0000-0003-4840-1607	CNRS-INSU	CNRS-INSU(Centre National de la Recherche Scientifique (CNRS))	Financial support was provided by CNRS-INSU (programme EC2CO 2008 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RS, 1995, J INVERTEBR PATHOL, V66, P82, DOI 10.1006/jipa.1995.1065; Benesh DP, 2007, J PARASITOL, V93, P735, DOI 10.1645/GE-1093R.1; Burtis CA, 2001, TIETZ FUNDAMENTALS C; CAJARAVILLE MP, 1993, HISTOL HISTOPATHOL, V8, P537; CHU KH, 1990, ENVIRON INT, V16, P31, DOI 10.1016/0160-4120(90)90202-H; Davids Cees, 1993, P749; De Kinkelin P., 1969, Bulletin Francais de Pisciculture, VNo. 234, P5; Fearman JA, 2009, J SHELLFISH RES, V28, P305, DOI 10.2983/035.028.0212; Gabbott PA, 1976, THEIR ECOLOGY PHYSL, P293; Gandon S, 2001, EVOLUTION, V55, P1056, DOI 10.1554/0014-3820(2001)055[1056:HLHATE]2.0.CO;2; Giamberini L, 2005, ENVIRON RES, V98, P210, DOI 10.1016/j.envres.2004.11.003; Guerlet E, 2006, AQUAT TOXICOL, V77, P19, DOI 10.1016/j.aquatox.2005.10.012; Guerlet E, 2007, AQUAT TOXICOL, V81, P377, DOI 10.1016/j.aquatox.2006.12.016; Heinonen J, 2000, ARCH ENVIRON CON TOX, V39, P352, DOI 10.1007/s002440010115; Heinonen J, 2001, ENVIRON TOXICOL CHEM, V20, P2778, DOI [10.1002/etc.5620201217, 10.1897/1551-5028(2001)020&lt;2778:TAPICI&gt;2.0.CO;2]; Honkoop PJC, 1965, BIVALVE REPROD WADDE; Hurd H, 2001, P ROY SOC B-BIOL SCI, V268, P1749, DOI 10.1098/rspb.2001.1729; Ibrahim MM, 2006, EXP PARASITOL, V112, P31, DOI 10.1016/j.exppara.2005.08.012; JOHNSTON BR, 1982, Z PARASITENKD, V67, P31, DOI 10.1007/BF00929511; JOKELA J, 1993, FUNCT ECOL, V7, P332, DOI 10.2307/2390213; Jokela J, 2005, OIKOS, V108, P156, DOI 10.1111/j.0030-1299.2005.13185.x; Kim Y, 2006, B MAR SCI, V79, P83; KRAAK MHS, 1991, NETH J ZOOL, V41, P269; KURIS AM, 1974, Q REV BIOL, V49, P129, DOI 10.1086/408018; Lajtner J, 2008, ACTA PARASITOL, V53, P85, DOI 10.2478/s11686-008-0011-1; Laruelle F, 2002, J PARASITOL, V88, P856, DOI 10.1645/0022-3395(2002)088[0856:HAOTID]2.0.CO;2; Lion S, 2010, ECOL LETT, V13, P1245, DOI 10.1111/j.1461-0248.2010.01516.x; Marcogliese DJ, 2005, DIS AQUAT ORGAN, V63, P77, DOI 10.3354/dao063077; MASTITSKY SE, 2004, THESIS NATL ACAD SCI; MCCAHON CP, 1991, FRESHWATER BIOL, V25, P169, DOI 10.1111/j.1365-2427.1991.tb00482.x; McMahon RF, 1996, AM ZOOL, V36, P339; McVeigh A, 2006, MAR ENVIRON RES, V62, pS433, DOI 10.1016/j.marenvres.2006.04.021; Michalakis Y, 2007, ECOLOGIE EVOLUTION S, P129; MINCHELLA DJ, 1981, AM NAT, V118, P876, DOI 10.1086/283879; Minguez L, 2011, WATER RES, V45, P665, DOI 10.1016/j.watres.2010.08.028; Minguez L, 2009, ENVIRON RES, V109, P843, DOI 10.1016/j.envres.2009.07.012; Molloy Daniel P., 1997, Reviews in Fisheries Science, V5, P27; Molloy DP, 2005, DIS AQUAT ORGAN, V65, P237, DOI 10.3354/dao065237; Molloy DP, 2001, DIS AQUAT ORGAN, V44, P203, DOI 10.3354/dao044203; MOORE MN, 1988, MAR ECOL PROG SER, V46, P81, DOI 10.3354/meps046081; Morley NJ, 2010, AQUAT TOXICOL, V96, P27, DOI 10.1016/j.aquatox.2009.09.017; Morley NJ, 2006, MAR POLLUT BULL, V52, P1330, DOI 10.1016/j.marpolbul.2006.08.025; MOURITSEN KN, 1994, J EXP MAR BIOL ECOL, V181, P53, DOI 10.1016/0022-0981(94)90103-1; NELSON WG, 1995, ENVIRON TOXICOL CHEM, V14, P513, DOI 10.1002/etc.5620140321; OWEN G, 1972, SCI PROG, V60, P299; Palais F, 2011, CHEMOSPHERE, V83, P1062, DOI 10.1016/j.chemosphere.2011.01.060; Parker GA, 2003, NATURE, V425, P480, DOI 10.1038/nature02012; Paul-Pont I, 2010, ENVIRON POLLUT, V158, P3401, DOI 10.1016/j.envpol.2010.07.028; Paul-Pont I, 2010, MAR POLLUT BULL, V60, P515, DOI 10.1016/j.marpolbul.2009.11.013; Pearse A.G.E., 1972, HISTOCHEMISTRY THEOR, V2; Plaistow SJ, 2001, INT J PARASITOL, V31, P346, DOI 10.1016/S0020-7519(01)00115-1; POULIN R, 1998, EVOLUTIONARY ECOLOGY; Prenter J, 2004, WATER RES, V38, P2847, DOI 10.1016/j.watres.2004.03.042; PRICE PW, 1977, EVOLUTION, V31, P405, DOI [10.2307/2407761, 10.1111/j.1558-5646.1977.tb01021.x]; Sorensen RE, 2001, PARASITOLOGY, V123, pS3, DOI 10.1017/S0031182001007843; SPRUNG M, 1991, MALACOLOGIA, V33, P63; STANCZYKOWSKA A, 1977, Polskie Archiwum Hydrobiologii, V24, P461; Stoeckmann AM, 2001, J N AM BENTHOL SOC, V20, P486, DOI 10.2307/1468043; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Sures B, 2008, ENV PARASITOLOGY INT; TASKINEN J, 1991, SYST PARASITOL, V19, P81, DOI 10.1007/BF00009906; Taskinen J, 1992, BIOL RES REPORTS U J, P27; Thieltges DW, 2009, J MAR BIOL ASSOC UK, V89, P563, DOI 10.1017/S0025315408002294; Tourari A.L., 1988, Haliotis, V18, P85; Wegeberg AM, 1999, J SEA RES, V42, P325, DOI 10.1016/S1385-1101(99)00035-0; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P249, DOI 10.1016/S1050-4648(02)00164-X	66	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e34029	10.1371/journal.pone.0034029	http://dx.doi.org/10.1371/journal.pone.0034029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448287	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700078
J	Field, JJ; Burdick, MD; DeBaun, MR; Strieter, BA; Liu, L; Mehrad, B; Rose, CE; Linden, J; Strieter, RM				Field, Joshua J.; Burdick, Marie D.; DeBaun, Michael R.; Strieter, Brett A.; Liu, Ling; Mehrad, Borna; Rose, C. Edward, Jr.; Linden, Joel; Strieter, Robert M.			The Role of Fibrocytes in Sickle Cell Lung Disease	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; CIRCULATING FIBROCYTES; GROWTH-FACTOR; CHEMOKINE RECEPTOR-4; IFN-GAMMA; HYPERTENSION; RISK; INFLAMMATION; INHIBITION; EXPRESSION	Background: Interstitial lung disease is a frequent complication in sickle cell disease and is characterized by vascular remodeling and interstitial fibrosis. Bone marrow-derived fibrocytes have been shown to contribute to the pathogenesis of other interstitial lung diseases. The goal of this study was to define the contribution of fibrocytes to the pathogenesis of sickle cell lung disease. Methodology/Principal Findings: Fibrocytes were quantified and characterized in subjects with sickle cell disease or healthy controls, and in a model of sickle cell disease, the NY1DD mouse. The role of the chemokine ligand CXCL12 in trafficking of fibrocytes and phenotype of lung disease was examined in the animal model. We found elevated concentration of activated fibrocytes in the peripheral blood of subjects with sickle cell disease, which increased further during vaso-occlusive crises. There was a similar elevations in the numbers and activation phenotype of fibrocytes in the bone marrow, blood, and lungs of the NY1DD mouse, both at baseline and under conditions of hypoxia/re-oxygenation. In both subjects with sickle cell disease and the mouse model, fibrocytes expressed a hierarchy of chemokine receptors, with CXCR4 expressed on most fibrocytes, and CCR2 and CCR7 expressed on a smaller subset of cells. Depletion of the CXCR4 ligand, CXCL12, in the mouse model resulted in a marked reduction of fibrocyte trafficking into the lungs, reduced lung collagen content and improved lung compliance and histology. Conclusions: These data support the notion that activated fibrocytes play a significant role in the pathogenesis of sickle cell lung disease.	[Field, Joshua J.] Blood Res Inst, Blood Ctr Wisconsin, Milwaukee, WI USA; [Burdick, Marie D.; Strieter, Brett A.; Liu, Ling; Mehrad, Borna; Rose, C. Edward, Jr.; Strieter, Robert M.] Univ Virginia, Sch Med, Dept Med, Div Pulm & Crit Care Med, Charlottesville, VA 22908 USA; [DeBaun, Michael R.] Vanderbilt Univ, Sch Med, Dept Pediat, Div Hematol & Oncol, Nashville, TN 37212 USA; [DeBaun, Michael R.] Vanderbilt Univ, Sch Med, Dept Med, Div Hematol & Oncol, Nashville, TN 37212 USA; [Linden, Joel] La Jolla Inst Allergy & Immunol, La Jolla, CA USA	Versiti Blood Center of Wisconsin; University of Virginia; Vanderbilt University; Vanderbilt University; La Jolla Institute for Immunology	Field, JJ (corresponding author), Blood Res Inst, Blood Ctr Wisconsin, Milwaukee, WI USA.	mdb5b@virginia.edu	Mehrad, Borna/G-2659-2010; Linden, Joel/AAH-5690-2020; Linden, Joel/J-9259-2014; Mehrad, Borna/AAC-9876-2019; Mehrad, Borna/D-9363-2015	Linden, Joel/0000-0002-0689-1647; Mehrad, Borna/0000-0001-5198-065X; Mehrad, Borna/0000-0001-5198-065X	National Heart, Lung, and Blood Institute [HL08710, HL079937, HL073848, HL098329, HL066027, HL098526]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008710, R01HL098526, R01HL079937, R01HL073848, R01HL095704, R01HL098329, R01HL066027] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute HL08710 (JJF), HL079937 (MRD), HL073848 (BM), HL098329 (BM, RMS), HL066027 and HL098526 (RMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Anthi A, 2007, AM J RESP CRIT CARE, V175, P1272, DOI 10.1164/rccm.200610-1498OC; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Baran CP, 2007, AM J RESP CRIT CARE, V176, P78, DOI 10.1164/rccm.200609-1279OC; Blease K, 2002, AM J PATHOL, V160, P481, DOI 10.1016/S0002-9440(10)64867-5; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Burdick MD, 2005, AM J RESP CRIT CARE, V171, P261, DOI 10.1164/rccm.200409-1164OC; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; FUKUDA Y, 1987, AM J PATHOL, V126, P171; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gomperts BN, 2007, J LEUKOCYTE BIOL, V82, P449, DOI 10.1189/jlb.0906587; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Keane MP, 1999, J IMMUNOL, V163, P5686; Keeley EC, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-2; Keeley EC, 2010, INT J BIOCHEM CELL B, V42, P535, DOI 10.1016/j.biocel.2009.10.014; Klings ES, 2006, AM J RESP CRIT CARE, V173, P1264, DOI 10.1164/rccm.200601-125OC; Maeda A, 1996, CHEST, V109, P780, DOI 10.1378/chest.109.3.780; Marshall R, 1998, THORAX, V53, P815, DOI 10.1136/thx.53.10.815; McMillan TR, 2008, AM J RESP CRIT CARE, V177, P771, DOI 10.1164/rccm.200708-1184OC; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Mehrad B, 2009, INT J BIOCHEM CELL B, V41, P1708, DOI 10.1016/j.biocel.2009.02.020; Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Osarogiagbon UR, 2000, BLOOD, V96, P314, DOI 10.1182/blood.V96.1.314.013k39_314_320; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; POWARS D, 1988, MEDICINE, V67, P66, DOI 10.1097/00005792-198801000-00005; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Strieter RM, 2009, J LEUKOC BIOL; Strieter Robert M, 2008, Proc Am Thorac Soc, V5, P305, DOI 10.1513/pats.200710-160DR; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Strieter Robert M., 2001, Chest, V120, p77S, DOI 10.1378/chest.120.1_suppl.S77-a; van Deventer HW, 2008, AM J PATHOL, V173, P253, DOI 10.2353/ajpath.2008.070732; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492	41	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33702	10.1371/journal.pone.0033702	http://dx.doi.org/10.1371/journal.pone.0033702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442712	gold, Green Submitted, Green Published			2022-12-27	WOS:000303836500053
J	McGreevy, PD; Corken, RA; Salvin, H; Black, CM				McGreevy, Paul D.; Corken, Robert A.; Salvin, Hannah; Black, Celeste M.			Whip Use by Jockeys in a Sample of Australian Thoroughbred Races-An Observational Study	PLOS ONE			English	Article							PAIN	The use of whips by jockeys is an issue. The current study viewed opportunistic high-speed footage of 15 race finishes frame-by-frame to examine the outcomes of arm and wrist actions (n = 350) on 40 horses viewed from the left of the field. Any actions fully or partially obscured by infrastructure or other horses were removed from the database, leaving a total of 104 non-contact sweeps and 134 strikes. For all instances of arm actions that resulted in fully visible whip strikes behind the saddle (n = 109), the outcomes noted were area struck, percentage of unpadded section making contact, whether the seam made contact and whether a visible indentation was evident on impact. We also recorded use of clockwise or counter-clockwise arm action from each jockey's whip, whether the whip was held like a tennis racquet or a ski pole, whether the hind leg on the side of the impact was in stance or swing phase and whether the jockey's arm was seen traveling above shoulder height. The goal of the study was to characterize the area struck and the visual impact of whip use at the level of the horse. We measured the ways in which both padded and unpadded sections of the whip made impact. There was evidence of at least 28 examples, in 9 horses, of breaches of the whip rules (one seam contact, 13 contacts with the head, and 14 arm actions that rose above the height of the shoulder). The whip caused a visible indentation on 83% of impacts. The unpadded section of the whip made contact on 64% of impacts. The results call into question the ability of Stewards to effectively police the rules concerning whip use and, more importantly, challenge the notion that padding the distal section of whips completely safeguards horses from any possible whip-related pain.	[McGreevy, Paul D.; Corken, Robert A.; Salvin, Hannah] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Black, Celeste M.] Univ Sydney, Fac Law, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	McGreevy, PD (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	paul.mcgreevy@sydney.edu.au		McGreevy, Paul/0000-0001-7220-8378				Australian Racing Board, 2009, PADD WHIP SPEC; Australian Racing Board, 2011, AUSTR RUL RAC; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; British Horseracing Authority, 2011, RESP REG REV US WHIP; British Horseracing Authority, 2008, US WHIP HORS; Chen X, 2011, NEUROSCIENCE, V185, P166, DOI 10.1016/j.neuroscience.2011.04.020; Dina OA, 2011, EUR J PAIN, V15, P796, DOI 10.1016/j.ejpain.2011.02.005; Evans D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015622; Horseracing Regulatory Authority (HRA, 2006, INSTR DIR BRIT HORS; Jones B, 2010, J VET BEHAV, V5, P196, DOI 10.1016/j.jveb.2010.04.001; Le Bars D, 2009, PAIN, V142, P165, DOI 10.1016/j.pain.2009.01.009; LeBars D, 2009, PAIN, V140, P3; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Lewis T, 1936, CLIN SCI, V2, P373; Martin GS, 1996, J AM VET MED ASSOC, V209, P1900; McGreevy P., 2010, EQUITATION SCI, V1st ed.; McGreevy PD, 2012, J VET BEHAV, V7, P186, DOI 10.1016/j.jveb.2011.05.001; McGreevy PD, 2011, J VET BEHAV, V6, P287, DOI 10.1016/j.jveb.2011.02.010; McGreevy PD, 2004, EQUINE BEHAV GUIDE V, P50; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Mills P. C., 1996, Proceedings of the 11th International Conference of Racing Analysts and Veterinarians, Queensland, Australia, 1996, P305; Perl E R, 1976, Prog Brain Res, V43, P263; Rivat C, 2010, PAIN, V150, P358, DOI 10.1016/j.pain.2010.05.031; Sluka KA, 2010, PAIN, V148, P188, DOI 10.1016/j.pain.2009.07.001; Smith P, 2011, AUSTRALIAN      0409; Wall P D, 1979, Ciba Found Symp, P293; WALL PD, 1979, PAIN, V6, P253, DOI 10.1016/0304-3959(79)90047-2; Woolf C. J., 2006, TXB PAIN, P91	28	14	14	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33398	10.1371/journal.pone.0033398	http://dx.doi.org/10.1371/journal.pone.0033398			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442687	Green Published, gold			2022-12-27	WOS:000303836500028
J	Tremillon, N; Morello, E; Llull, D; Mazmouz, R; Gratadoux, JJ; Guillot, A; Chapot-Chartier, MP; Monlezun, L; Sole, V; Ginisty, H; Poquet, I				Tremillon, Nicolas; Morello, Eric; Llull, Daniel; Mazmouz, Rabia; Gratadoux, Jean-Jacques; Guillot, Alain; Chapot-Chartier, Marie-Pierre; Monlezun, Laura; Sole, Veronique; Ginisty, Herve; Poquet, Isabelle			PpiA, a Surface PPIase of the Cyclophilin Family in Lactococcus lactis	PLOS ONE			English	Article							PROLYL CIS/TRANS ISOMERASES; CIS-TRANS ISOMERASES; BACILLUS-SUBTILIS; LISTERIA-MONOCYTOGENES; STREPTOCOCCUS-PYOGENES; HETEROLOGOUS PROTEINS; MATURATION PROTEIN; ANTIBODY FRAGMENTS; CHAPERONE FUNCTION; MIP PROTEIN	Background: Protein folding in the envelope is a crucial limiting step of protein export and secretion. In order to better understand this process in Lactococcus lactis, a lactic acid bacterium, genes encoding putative exported folding factors like Peptidyl Prolyl Isomerases (PPIases) were searched for in lactococcal genomes. Results: In L. lactis, a new putative membrane PPIase of the cyclophilin subfamily, PpiA, was identified and characterized. ppiA gene was found to be constitutively expressed under normal and stress (heat shock, H2O2) conditions. Under normal conditions, PpiA protein was synthesized and released from intact cells by an exogenously added protease, showing that it was exposed at the cell surface. No obvious phenotype could be associated to a ppiA mutant strain under several laboratory conditions including stress conditions, except a very low sensitivity to H2O2. Induction of a ppiA copy provided in trans had no effect i) on the thermosensitivity of an mutant strain deficient for the lactococcal surface protease HtrA and ii) on the secretion and stability on four exported proteins (a highly degraded hybrid protein and three heterologous secreted proteins) in an otherwise wild-type strain background. However, a recombinant soluble form of PpiA that had been produced and secreted in L. lactis and purified from a culture supernatant displayed both PPIase and chaperone activities. Conclusions: Although L. lactis PpiA, a protein produced and exposed at the cell surface under normal conditions, displayed a very moderate role in vivo, it was found, as a recombinant soluble form, to be endowed with folding activities in vitro.	[Tremillon, Nicolas; Morello, Eric; Llull, Daniel; Mazmouz, Rabia; Gratadoux, Jean-Jacques; Guillot, Alain; Chapot-Chartier, Marie-Pierre; Poquet, Isabelle] INRA, Micalis Microbiol Alimentat Serv Sante UMR1319, Jouy En Josas, France; [Tremillon, Nicolas; Morello, Eric; Monlezun, Laura; Sole, Veronique; Ginisty, Herve] Prologue Biotech, GTP Technol, Labege, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Tremillon, N (corresponding author), INRA, Micalis Microbiol Alimentat Serv Sante UMR1319, Jouy En Josas, France.	isabelle.poquet@jouy.inra.fr	MORELLO, Eric/P-8087-2016; Isabelle, Poquet/AAA-7746-2021	MORELLO, Eric/0000-0002-2009-4919; Isabelle, Poquet/0000-0003-3514-6520; MONLEZUN, Laura/0000-0003-4661-3366; Sole-Jamault, Veronique/0000-0002-6221-7630; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	Association Nationale de la Recherche et de la Technologie (ANRT), Paris, France, CIFRE; European Commission; Fondation pour la Recherche Medicale (France)	Association Nationale de la Recherche et de la Technologie (ANRT), Paris, France, CIFRE(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale (France)(Fondation pour la Recherche Medicale)	This work was funded by Association Nationale de la Recherche et de la Technologie (ANRT), Paris, France [http://www.anrt.asso.fr/fr/espace_cifre/accueil.jsp] CIFRE PhD grants for NT and EM; a European Commission: Marie Curie Individual Fellowship [http://ec.europa.eu/research/fp6/mariecurie-actions/action/fellow_en.html] for DL; and a Fondation pour la Recherche Medicale (France): post-doctoral Fellowship [http://www.frm.org/] for DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; Audouy SAL, 2006, VACCINE, V24, P5434, DOI 10.1016/j.vaccine.2006.03.054; Bahey-El-Din M, 2008, VACCINE, V26, P5304, DOI 10.1016/j.vaccine.2008.07.047; Bahey-El-Din M, 2010, J MED MICROBIOL, V59, P904, DOI 10.1099/jmm.0.018770-0; Bahey-El-Din M, 2010, DISCOV MED, V9, P455; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Behrens-Kneip S, 2010, INT J MED MICROBIOL, V300, P421, DOI 10.1016/j.ijmm.2010.04.012; Bosma T, 2006, APPL ENVIRON MICROB, V72, P880, DOI 10.1128/AEM.72.1.880-889.2006; Bothmann H, 2000, J BIOL CHEM, V275, P17100, DOI 10.1074/jbc.M910233199; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Cortes-Perez NG, 2006, MICROBIOL-SGM, V152, P2611, DOI 10.1099/mic.0.28698-0; Dreisbach A, 2010, PROTEOMICS, V10, P3082, DOI 10.1002/pmic.201000062; Drouault S, 2002, APPL ENVIRON MICROB, V68, P3932, DOI 10.1128/AEM.68.8.3932-3942.2002; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Foucaud-Scheunemann C, 2003, FEMS MICROBIOL LETT, V224, P53, DOI 10.1016/S0378-1097(03)00419-1; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; HAANDRIKMAN AJ, 1991, J BACTERIOL, V173, P4517, DOI 10.1128/JB.173.14.4517-4525.1991; HAANDRIKMAN AJ, 1991, APPL ENVIRON MICROB, V57, P1899, DOI 10.1128/AEM.57.7.1899-1904.1991; Helbig JH, 2003, BIOL CHEM, V384, P125, DOI 10.1515/BC.2003.013; Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200; Hermans PWM, 2006, J BIOL CHEM, V281, P968, DOI 10.1074/jbc.M510014200; Hyyrylainen HL, 2010, MOL MICROBIOL, V77, P108, DOI 10.1111/j.1365-2958.2010.07188.x; Janowski B, 1997, ANAL BIOCHEM, V252, P299, DOI 10.1006/abio.1997.2330; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Justice SS, 2005, J BACTERIOL, V187, P7680, DOI 10.1128/JB.187.22.7680-7686.2005; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; KLEEREBEZEM M, 1995, MOL MICROBIOL, V18, P313, DOI 10.1111/j.1365-2958.1995.mmi_18020313.x; KNAPPIK A, 1993, BIO-TECHNOL, V11, P77, DOI 10.1038/nbt0193-77; Kohler R, 2003, INFECT IMMUN, V71, P4389, DOI 10.1128/IAI.71.8.4389-4397.2003; KONTINEN VP, 1993, MOL MICROBIOL, V8, P727, DOI 10.1111/j.1365-2958.1993.tb01616.x; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Le Loir Y, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-2; Leloup L, 1997, APPL ENVIRON MICROB, V63, P2117, DOI 10.1128/AEM.63.6.2117-2123.1997; Lindholm A, 2004, APPL ENVIRON MICROB, V70, P2061, DOI 10.1128/AEM.70.4.2061-2071.2004; Llull D, 2004, APPL ENVIRON MICROB, V70, P5398, DOI 10.1128/AEM.70.9.5398-5406.2004; Llull D, 2011, J BACTERIOL, V193, P1919, DOI 10.1128/JB.01109-10; Miyoshi A, 2002, APPL ENVIRON MICROB, V68, P3141, DOI 10.1128/AEM.68.6.3141-3146.2002; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Padmanabhan N, 2009, MOL BIOL CELL, V20, P68, DOI 10.1091/mbc.E08-02-0178; Poquet I, 2000, MOL MICROBIOL, V35, P1042, DOI 10.1046/j.1365-2958.2000.01757.x; Poquet I, 1998, J BACTERIOL, V180, P1904, DOI 10.1128/JB.180.7.1904-1912.1998; RAHFELD JU, 1994, FEBS LETT, V352, P180, DOI 10.1016/0014-5793(94)00932-5; Ramirez K, 2010, MUCOSAL IMMUNOL, V3, P159, DOI 10.1038/mi.2009.131; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Sevastsyanovich YR, 2010, BIOTECHNOL APPL BIOC, V55, P9, DOI 10.1042/BA20090174; Severin A, 2007, J BACTERIOL, V189, P1514, DOI 10.1128/JB.01132-06; Shoma S, 2010, EUR J CLIN MICROBIOL; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sriraman K, 2008, APPL ENVIRON MICROB, V74, P7442, DOI 10.1128/AEM.00638-08; Sydenham M, 2000, INFECT IMMUN, V68, P1109, DOI 10.1128/IAI.68.3.1109-1115.2000; Tremillon N, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-37; Vitikainen M, 2005, J APPL MICROBIOL, V99, P363, DOI 10.1111/j.1365-2672.2005.02572.x; Vitikainen M, 2004, J BIOL CHEM, V279, P19302, DOI 10.1074/jbc.M400861200; Vitikainen M, 2001, J BACTERIOL, V183, P1881, DOI 10.1128/JB.183.6.1881-1890.2001; VOS P, 1989, J BACTERIOL, V171, P2795, DOI 10.1128/jb.171.5.2795-2802.1989; Williams RC, 2003, J BIOL CHEM, V278, P18056, DOI 10.1074/jbc.M301244200; Yeh CM, 2008, APPL ENVIRON MICROB, V74, P1039, DOI 10.1128/AEM.01547-07	60	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33516	10.1371/journal.pone.0033516	http://dx.doi.org/10.1371/journal.pone.0033516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442694	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500035
J	Assareh, H; Mengersen, K				Assareh, Hassan; Mengersen, Kerrie			Change Point Estimation in Monitoring Survival Time	PLOS ONE			English	Article							WEIGHTED MOVING AVERAGE; FAST INITIAL RESPONSE; EWMA CONTROL CHARTS; RISK	Precise identification of the time when a change in a hospital outcome has occurred enables clinical experts to search for a potential special cause more effectively. In this paper, we develop change point estimation methods for survival time of a clinical procedure in the presence of patient mix in a Bayesian framework. We apply Bayesian hierarchical models to formulate the change point where there exists a step change in the mean survival time of patients who underwent cardiac surgery. The data are right censored since the monitoring is conducted over a limited follow-up period. We capture the effect of risk factors prior to the surgery using a Weibull accelerated failure time regression model. Markov Chain Monte Carlo is used to obtain posterior distributions of the change point parameters including location and magnitude of changes and also corresponding probabilistic intervals and inferences. The performance of the Bayesian estimator is investigated through simulations and the result shows that precise estimates can be obtained when they are used in conjunction with the risk-adjusted survival time CUSUM control charts for different magnitude scenarios. The proposed estimator shows a better performance where a longer follow-up period, censoring time, is applied. In comparison with the alternative built-in CUSUM estimator, more accurate and precise estimates are obtained by the Bayesian estimator. These superiorities are enhanced when probability quantification, flexibility and generalizability of the Bayesian change point detection model are also considered.	[Assareh, Hassan; Mengersen, Kerrie] Queensland Univ Technol, Fac Sci & Engn, Discipline Math Sci, Brisbane, Qld 4001, Australia; [Assareh, Hassan] St Andrews Med Inst, Brisbane, Qld, Australia	Queensland University of Technology (QUT)	Assareh, H (corresponding author), Queensland Univ Technol, Fac Sci & Engn, Discipline Math Sci, Brisbane, Qld 4001, Australia.	k.mengersen@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022; Assareh, Hassan/D-3718-2012	Mengersen, Kerrie/0000-0001-8625-9168	Queensland University of Technology; St. Andrew's Medical Institute, Brisbane, Australia, through ARC	Queensland University of Technology; St. Andrew's Medical Institute, Brisbane, Australia, through ARC	This study has been supported by Queensland University of Technology and St. Andrew's Medical Institute, Brisbane, Australia, through an ARC linkage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri A, 2011, QUALITY RELIABILITY; Assareh Hassan, 2011, IAENG International Journal of Computer Science, V38, P409; Assareh H., 2011, STAT METHODS MED RES; Assareh Hassan, 2011, Qual Manag Health Care, V20, P207, DOI 10.1097/QMH.0b013e318220897e; Biswas P, 2008, STAT MED, V27, P3382, DOI 10.1002/sim.3216; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cook D, 2004, THESIS U QUEENSLAND; Cook David A, 2008, Crit Care Resusc, V10, P239; Gelman A., 2004, BAYESIAN DATA ANAL; Grigg O, 2004, J R STAT SOC A STAT, V167, P523, DOI 10.1111/j.1467-985X.2004.0apm2.x; Grigg OA, 2006, J QUAL TECHNOL, V38, P124, DOI 10.1080/00224065.2006.11918598; Grigg O, 2007, J AM STAT ASSOC, V102, P140, DOI 10.1198/016214506000001121; Klein JP., 2003, SURVIVAL ANAL TECHNI; Knoth S, 2005, STAT PAP, V46, P47, DOI 10.1007/BF02762034; Liu J.S., 2008, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-76371-2, DOI 10.1007/978-0-387-76371-2]; Montgomery D. C., 2008, INTRO STAT QUALITY C; Nishina K., 1992, Quality and Reliability Engineering International, V8, P537, DOI 10.1002/qre.4680080605; Noorossana R, 2009, QUAL RELIAB ENG INT, V25, P875, DOI 10.1002/qre.1007; PAGE ES, 1961, TECHNOMETRICS, V3, P1, DOI 10.2307/1266472; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; PARSONNET V, 1989, CIRCULATION, V79, P3; Perry MB, 2005, INT J RELIAB QUAL SA, V12, P95, DOI 10.1142/S0218539305001719; Plummer M., 2010, PACKAGE CODA; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Samuel T, 2001, QUAL ENG, V13, P357; Sego L.H, 2006, THESIS VIRGINIA POLY; Sego LH, 2009, STAT MED, V28, P1386, DOI 10.1002/sim.3546; Spielgelhalter D., 2003, WINBUGS VERSION 1 4; Steiner S H, 2000, Biostatistics, V1, P441, DOI 10.1093/biostatistics/1.4.441; Steiner SH, 1999, J QUAL TECHNOL, V31, P75; Steiner SH, 2010, STAT MED, V29, P444, DOI 10.1002/sim.3788; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Xie M., 2002, STAT MODELS CONTROL	33	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33630	10.1371/journal.pone.0033630	http://dx.doi.org/10.1371/journal.pone.0033630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438969	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100075
J	Strassburg, S; Hodson, NW; Hill, PI; Richardson, SM; Hoyland, JA				Strassburg, Sandra; Hodson, Nigel W.; Hill, Patrick I.; Richardson, Stephen M.; Hoyland, Judith A.			Bi-Directional Exchange of Membrane Components Occurs during Co-Culture of Mesenchymal Stem Cells and Nucleus Pulposus Cells	PLOS ONE			English	Article							HIGH-DENSITY COCULTURE; INTERVERTEBRAL DISC; GENE-EXPRESSION; STROMAL CELLS; DIFFERENTIATION; TRANSPLANTATION; MICROVESICLES; PHENOTYPE; MECHANISM; CARDIOMYOCYTES	Mesenchymal stem cell (MSC)-based therapies have been proposed as novel treatments for intervertebral disc (IVD) degeneration. We have previously demonstrated that when MSCs are co-cultured with nucleus pulposus (NP) cells with direct cell-cell contact, they differentiate along the NP lineage and simultaneously stimulate the degenerate NP cell population to regain a normal (non-degenerate) phenotype, an effect which requires cell-cell communication. However, the mechanisms by which NP cells and MSCs interact in this system are currently unclear. Thus, in this study we investigated a range of potential mechanisms for exchange of cellular components or information that may direct these changes, including cell fusion, gap-junctional communication and exchange of membrane components by direct transfer or via microvesicle formation. Flow cytometry of fluorescently labeled MSCs and NP cells revealed evidence of some cell fusion and formation of gapjunctions, although at the three timepoints studied these phenomena were detectable only in a small proportion of cells. While these mechanisms may play a role in cell-cell communication, the data suggests they are not the predominant mechanism of interaction. However, flow cytometry of fluorescently dual-labeled cells showed that extensive bi-directional transfer of membrane components is operational during direct co-culture of MSCs and NP cells. Furthermore, there was also evidence for secretion and internalization of membrane-bound microvesicles by both cell types. Thus, this study highlights bi-directional intercellular transfer of membrane components as a possible mechanism of cellular communication between MSC and NP cells.	[Strassburg, Sandra; Hodson, Nigel W.; Richardson, Stephen M.; Hoyland, Judith A.] Univ Manchester, Sch Biomed, Fac Med & Human Sci, Manchester, Lancs, England; [Hill, Patrick I.] Univ Manchester, Sch Chem Engn, Fac Engn & Phys Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	Strassburg, S (corresponding author), Univ Manchester, Sch Biomed, Fac Med & Human Sci, Manchester, Lancs, England.	judith.a.hoyland@manchester.ac.uk	Richardson, Stephen/A-4124-2009; Hoyland, Judith A/P-5168-2014	Richardson, Stephen/0000-0002-7637-4135; Hoyland, Judith A/0000-0003-4876-5208; Hill, Patrick/0000-0002-4185-418X; Hodson, Nigel/0000-0002-7486-1976	The University of Manchester Medical School Strategic	The University of Manchester Medical School Strategic	This work was funded by The University of Manchester Medical School Strategic PhD Studentship award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Beeres SLMA, 2005, J AM COLL CARDIOL, V46, P1943, DOI 10.1016/j.jacc.2005.07.055; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c; Feng G, 2011, J NEUROSURG SPINE; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Henriksson HB, 2009, SPINE, V34, P141, DOI 10.1097/BRS.0b013e31818f8c20; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Niu XL, 2009, J CELL SCI, V122, P600, DOI 10.1242/jcs.031427; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Richardson SM, 2007, HISTOL HISTOPATHOL, V22, P1033, DOI 10.14670/HH-22.1033; Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205; Richardson SM, 2010, J CELL PHYSIOL, V222, P23, DOI 10.1002/jcp.21915; Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018; Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Sakai D, 2011, ORTHOP CLIN N AM, V42, P555, DOI 10.1016/j.ocl.2011.07.005; Schneider PRA, 2011, J ORTHOP RES, V29, P1351, DOI 10.1002/jor.21400; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Strassburg S, 2010, REGEN MED, V5, P701, DOI 10.2217/RME.10.59; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Vadala G, 2008, SPINE, V33, P870, DOI 10.1097/BRS.0b013e31816b4619; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wei AQ, 2009, J ORTHOP RES, V27, P374, DOI 10.1002/jor.20567; Yamamoto Y, 2004, SPINE, V29, P1508, DOI 10.1097/01.BRS.0000131416.90906.20; Yoon J, 2005, ANN HEMATOL, V84, P715, DOI 10.1007/s00277-005-1068-7	36	65	79	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33739	10.1371/journal.pone.0033739	http://dx.doi.org/10.1371/journal.pone.0033739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438989	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309000038
J	Yang, C; Wu, J; Zheng, YG				Yang, Chao; Wu, Jiang; Zheng, Y. George			Function of the Active Site Lysine Autoacetylation in Tip60 Catalysis	PLOS ONE			English	Article							HISTONE-ACETYLTRANSFERASE ACTIVITY; GENE-EXPRESSION; DNA-REPAIR; ACETYLATION; PROTEIN; COMPLEX; INTERACTS; DOMAIN; SUPERFAMILY; INVOLVEMENT	The 60-kDa HIV-Tat interactive protein (Tip60) is a key member of the MYST family of histone acetyltransferases (HATs) that plays critical roles in multiple cellular processes. We report here that Tip60 undergoes autoacetylation at several lysine residues, including a key lysine residue (i.e. Lys-327) in the active site of the MYST domain. The mutation of K327 to arginine led to loss of both the autoacetylation activity and the cognate HAT activity. Interestingly, deacetylated Tip60 still kept a substantial degree of HAT activity. We also investigated the effect of cysteine 369 and glutamate 403 in Tip60 autoacetylation in order to understand the molecular pathway of the autoacetylation at K327. Together, we conclude that the acetylation of K327 which is located in the active site of Tip60 regulates but is not obligatory for the catalytic activity of Tip60. Since acetylation at this key residue appears to be evolutionarily conserved amongst all MYST proteins, our findings provide an interesting insight into the regulatory mechanism of MYST activities.	[Yang, Chao; Wu, Jiang; Zheng, Y. George] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Yang, C (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	yzheng@gsu.edu	Zheng, Yujun/P-8975-2014; Wu, Jiang/J-7731-2013; Zheng, Yujun/H-9122-2012	Zheng, Yujun/0000-0001-7116-3067; Wu, Jiang/0000-0002-4124-5413; 	National Institutes of Health [GM086717]; Georgia Cancer Coalition Distinguished Cancer Scholar Award; GSU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition Distinguished Cancer Scholar Award; GSU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grant GM086717 and a Georgia Cancer Coalition Distinguished Cancer Scholar Award to YGZ. CY is supported by a Molecular Basis of Disease Fellowship at GSU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Wolffe, 1998, CHROMATIN STRUCTURE, Vxiv, P447; Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; An Woojin, 2007, Subcell Biochem, V41, P351; Anguera MC, 2006, COLD SPRING HARB SYM, V71, P429, DOI 10.1101/sqb.2006.71.012; Avvakumov Nikita, 2007, Subcell Biochem, V41, P295; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bhadra MP, 2005, GENETICS, V169, P2061, DOI 10.1534/genetics.104.036020; Blanco-Garcia N, 2009, J BIOL CHEM, V284, P1343, DOI 10.1074/jbc.M806075200; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Creaven M, 1999, BIOCHEMISTRY-US, V38, P8826, DOI 10.1021/bi9907274; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Halkidou K, 2004, NUCLEIC ACIDS RES, V32, P1654, DOI 10.1093/nar/gkh296; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kato Y, 2005, BIOESSAYS, V27, P1, DOI 10.1002/bies.20171; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; McGraw S, 2003, BIOL REPROD, V68, P383, DOI 10.1095/biolreprod.102.005991; Morrison AJ, 2005, CELL CYCLE, V4, P568; Morrison AJ, 2006, RES PRO CEL, V41, P109, DOI 10.1007/008; Nordentoft I, 2003, BIOCHEM J, V374, P165, DOI 10.1042/BJ20030087; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sapountzi V, 2011, CELL MOL LIFE SCI, V68, P1147, DOI 10.1007/s00018-010-0599-9; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith KT, 2009, NAT BIOTECHNOL, V27, P917, DOI 10.1038/nbt1009-917; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Stavropoulos P, 2008, P NATL ACAD SCI USA, V105, P12236, DOI 10.1073/pnas.0805813105; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sun BF, 2011, CELL RES, V21, P1262, DOI 10.1038/cr.2011.105; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng YG, 2008, MED RES REV, V28, P645, DOI 10.1002/med.20120	63	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32886	10.1371/journal.pone.0032886	http://dx.doi.org/10.1371/journal.pone.0032886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470428	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000010
J	Gamez-Pozo, A; Sanchez-Navarro, I; Calvo, E; Agullo-Ortuno, MT; Lopez-Vacas, R; Diaz, E; Camafeita, E; Nistal, M; Madero, R; Espinosa, E; Lopez, JA; Vara, JAF				Gamez-Pozo, Angelo; Sanchez-Navarro, Iker; Calvo, Enrique; Teresa Agullo-Ortuno, Maria; Lopez-Vacas, Rocio; Diaz, Esther; Camafeita, Emilio; Nistal, Manuel; Madero, Rosario; Espinosa, Enrique; Antonio Lopez, Juan; Fresno Vara, Juan Angel			PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; TRANSCRIPT RELEASE FACTOR; POLYMERASE-I; PHOSPHOPEPTIDE ENRICHMENT; FACTOR PTRF; EXPRESSION; CAVEOLAE; PHOSPHORYLATION; ADENOCARCINOMA; CHROMATOGRAPHY	With the completion of the human genome sequence, biomedical sciences have entered in the "omics'' era, mainly due to high-throughput genomics techniques and the recent application of mass spectrometry to proteomics analyses. However, there is still a time lag between these technological advances and their application in the clinical setting. Our work is designed to build bridges between high-performance proteomics and clinical routine. Protein extracts were obtained from fresh frozen normal lung and non-small cell lung cancer samples. We applied a phosphopeptide enrichment followed by LC-MS/MS. Subsequent label-free quantification and bioinformatics analyses were performed. We assessed protein patterns on these samples, showing dozens of differential markers between normal and tumor tissue. Gene ontology and interactome analyses identified signaling pathways altered on tumor tissue. We have identified two proteins, PTRF/cavin-1 and MIF, which are differentially expressed between normal lung and non-small cell lung cancer. These potential biomarkers were validated using western blot and immunohistochemistry. The application of discovery-based proteomics analyses in clinical samples allowed us to identify new potential biomarkers and therapeutic targets in non-small cell lung cancer.	[Gamez-Pozo, Angelo; Sanchez-Navarro, Iker; Lopez-Vacas, Rocio; Diaz, Esther; Fresno Vara, Juan Angel] Hosp Univ La Paz, Inst Genet Med & Mol, Lab Mol Pathol & Oncol, Madrid, Spain; [Calvo, Enrique; Camafeita, Emilio; Antonio Lopez, Juan] Ctr Nacl Invest Cardiovasc, Serv Prote, Madrid, Spain; [Teresa Agullo-Ortuno, Maria] Hosp Doce Octubre, Inst Invest Sanitaria I 12, Serv Oncol, Madrid, Spain; [Nistal, Manuel] Hosp Univ La Paz, Inst Invest Sanitaria IdiPAZ, Serv Pathol, Madrid, Spain; [Madero, Rosario] Hosp Univ La Paz, Inst Invest Sanitaria IdiPAZ, Dept Stat, Madrid, Spain; [Espinosa, Enrique] Hosp Univ La Paz, Inst Invest Sanitaria IdiPAZ, Med Oncol Serv, Madrid, Spain	Hospital Universitario La Paz; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital Universitario 12 de Octubre; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz	Gamez-Pozo, A (corresponding author), Hosp Univ La Paz, Inst Genet Med & Mol, Lab Mol Pathol & Oncol, Madrid, Spain.	juanangel.fresno@idipaz.es	Gamez-Pozo, Angelo/N-2506-2014; Fresno Vara, Juan Angel/F-6702-2010; Lopez, Juan Antonio/G-7750-2015; Agulló Ortuño, M. Teresa/T-1494-2017; Agulló-Ortuño, M. Teresa/ABA-3155-2021; Vara, Juan Ángel Fresno/Y-9928-2019	Gamez-Pozo, Angelo/0000-0002-8931-0624; Fresno Vara, Juan Angel/0000-0003-1527-1252; Lopez, Juan Antonio/0000-0002-9097-6060; Agulló Ortuño, M. Teresa/0000-0002-7617-6681; Agulló-Ortuño, M. Teresa/0000-0002-7617-6681; Vara, Juan Ángel Fresno/0000-0003-1527-1252	Red Tematica de Investigacion Cooperativa en Cancer (RTICC) from Carlos III Institute of Health (Spanish Ministry of Science and Innovation, Spain) [RD06-0020-1022]; Mutua Madrilena Foundation; Foundation for Biomedical Research of La Paz University Hospital; Carlos III Institute of Health [CA10/01447]; Spanish Ministry of Science and Innovation; ProCNIC Foundation; Carlos III Institute of Health, Spanish Health Ministry (RETIC) [RD09/0076/00073]; Farmaindustria, through the Cooperation Program in Clinical and Translational Research of the Community of Madrid;  [FIS CP05/00248];  [PS09/01597]	Red Tematica de Investigacion Cooperativa en Cancer (RTICC) from Carlos III Institute of Health (Spanish Ministry of Science and Innovation, Spain); Mutua Madrilena Foundation; Foundation for Biomedical Research of La Paz University Hospital; Carlos III Institute of Health(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ProCNIC Foundation; Carlos III Institute of Health, Spanish Health Ministry (RETIC); Farmaindustria, through the Cooperation Program in Clinical and Translational Research of the Community of Madrid; ; 	This research was supported by grants FIS CP05/00248, PS09/01597, Red Tematica de Investigacion Cooperativa en Cancer (RTICC, RD06-0020-1022) from Carlos III Institute of Health (Spanish Ministry of Science and Innovation, Spain) and research grants by the Mutua Madrilena Foundation. ISN is supported by Foundation for Biomedical Research of La Paz University Hospital. ED is supported by grant CA10/01447 from Carlos III Institute of Health. Spanish National Centre for Cardiovascular Research is supported by the Spanish Ministry of Science and Innovation and the ProCNIC Foundation. The IdiPAZ Biobank is supported by Carlos III Institute of Health, Spanish Health Ministry (RETIC RD09/0076/00073) and Farmaindustria, through the Cooperation Program in Clinical and Translational Research of the Community of Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Aryal UK, 2010, RAPID COMMUN MASS SP, V24, P219, DOI 10.1002/rcm.4377; Aung CS, 2011, EUR J CELL BIOL, V90, P136, DOI 10.1016/j.ejcb.2010.06.004; Bach JP, 2009, CANCER-AM CANCER SOC, V115, P2031, DOI 10.1002/cncr.24245; Bai L, 2012, J CELL BIOCHEM, V113, P322, DOI 10.1002/jcb.23358; Bai L, 2011, CELL RES, V21, P1088, DOI 10.1038/cr.2011.56; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Bremnes RM, 2011, J THORAC ONCOL, V6, P824, DOI 10.1097/JTO.0b013e3182037b76; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Conrad DH, 2008, J GEN INTERN MED, V23, P78, DOI 10.1007/s11606-007-0411-1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Gamez-Pozo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007731; Garai J, 2009, CURR MED CHEM, V16, P1091, DOI 10.2174/092986709787581842; Gazdar AF, 2010, CANCER METAST REV, V29, P37, DOI 10.1007/s10555-010-9201-z; Gould ML, 2010, PROSTATE, V70, P1609, DOI 10.1002/pros.21195; Groseclose MR, 2008, PROTEOMICS, V8, P3715, DOI 10.1002/pmic.200800495; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Han GH, 2008, PROTEOMICS, V8, P1346, DOI 10.1002/pmic.200700884; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jansa P, 1999, MOL GEN GENET, V262, P508, DOI 10.1007/s004380051112; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254; Lee H, 2008, AM J CLIN PATHOL, V129, P772, DOI 10.1309/GFCLLRH8A68XKMJN; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Marko-Varga G, 2007, J PROTEOME RES, V6, P2925, DOI 10.1021/pr070046s; McClelland M, 2009, AM J PATHOL, V174, P638, DOI 10.2353/ajpath.2009.080463; Mitchell RA, 2004, CELL SIGNAL, V16, P13, DOI 10.1016/j.cellsig.2003.07.002; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nagaraj N, 2010, J PROTEOME RES, V9, P6786, DOI 10.1021/pr100637q; Pastwa E, 2007, PROTEOM CLIN APPL, V1, P4, DOI 10.1002/prca.200600369; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shen J, 2006, CANCER RES, V66, P11194, DOI 10.1158/0008-5472.CAN-04-1444; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Volonte D, 2011, J BIOL CHEM, V286, P28657, DOI 10.1074/jbc.C111.235119; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	49	56	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e33752	10.1371/journal.pone.0033752	http://dx.doi.org/10.1371/journal.pone.0033752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461895	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900014
J	Teh, MT; Gemenetzidis, E; Patel, D; Tariq, R; Nadir, A; Bahta, AW; Waseem, A; Hutchison, IL				Teh, Muy-Teck; Gemenetzidis, Emilios; Patel, Deeviyaben; Tariq, Rameez; Nadir, Ayesha; Bahta, Adiam W.; Waseem, Ahmad; Hutchison, Iain L.			FOXM1 Induces a Global Methylation Signature That Mimics the Cancer Epigenome in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							STRESS-INDUCED SENESCENCE; PROMOTER METHYLATION; LUNG-CANCER; TRANSCRIPTION FACTOR; BMI-1 EXPRESSION; UP-REGULATION; FILAMIN-A; LIFE-SPAN; COMPLEX; LSH	The oncogene FOXM1 has been implicated in all major types of human cancer. We recently showed that aberrant FOXM1 expression causes stem cell compartment expansion resulting in the initiation of hyperplasia. We have previously shown that FOXM1 regulates HELLS, a SNF2/helicase involved in DNA methylation, implicating FOXM1 in epigenetic regulation. Here, we have demonstrated using primary normal human oral keratinocytes (NOK) that upregulation of FOXM1 suppressed the tumour suppressor gene p16(INK4A) (CDKN2A) through promoter hypermethylation. Knockdown of HELLS using siRNA reactivated the mRNA expression of p16(INK4A) and concomitant downregulation of two DNA methyltransferases DNMT1 and DNMT3B. The dose-dependent upregulation of endogenous FOXM1 (isoform B) expression during tumour progression across a panel of normal primary NOK strains (n = 8), dysplasias (n = 5) and head and neck squamous cell carcinoma (HNSCC) cell lines (n = 11) correlated positively with endogenous expressions of HELLS, BMI1, DNMT1 and DNMT3B and negatively with p16(INK4A) and involucrin. Bisulfite modification and methylation-specific promoter analysis using absolute quantitative PCR (MS-qPCR) showed that upregulation of FOXM1 significantly induced p16(INK4A) promoter hypermethylation (10-fold, P<0.05) in primary NOK cells. Using a non-bias genome-wide promoter methylation microarray profiling method, we revealed that aberrant FOXM1 expression in primary NOK induced a global hypomethylation pattern similar to that found in an HNSCC (SCC15) cell line. Following validation experiments using absolute qPCR, we have identified a set of differentially methylated genes, found to be inversely correlated with in vivo mRNA expression levels of clinical HNSCC tumour biopsy samples. This study provided the first evidence, using primary normal human cells and tumour tissues, that aberrant upregulation of FOXM1 orchestrated a DNA methylation signature that mimics the cancer methylome landscape, from which we have identified a unique FOXM1-induced epigenetic signature which may have clinical translational potentials as biomarkers for early cancer screening, diagnostic and/or therapeutic interventions.	[Teh, Muy-Teck; Gemenetzidis, Emilios; Patel, Deeviyaben; Tariq, Rameez; Nadir, Ayesha; Waseem, Ahmad] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England; [Gemenetzidis, Emilios; Bahta, Adiam W.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London, England; [Hutchison, Iain L.] St Bartholomews Hosp, Dept Oral & Maxillofacial Surg, London, England; [Hutchison, Iain L.] Royal London Hosp, Dept Oral & Maxillofacial Surg, London E1 1BB, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital	Teh, MT (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England.	m.t.teh@qmul.ac.uk	Teh, Muy-Teck/B-9284-2016	Teh, Muy-Teck/0000-0002-7725-8355; Umair, Ayesha/0000-0001-5714-5268; Hutchison, Iain/0000-0002-4894-4049	Wellcome Trust; Facial Surgery Research Foundation-Saving Faces; Institute of Dentistry; Barts and the London School of Medicine and Dentistry; Queen Mary University of London	Wellcome Trust(Wellcome TrustEuropean Commission); Facial Surgery Research Foundation-Saving Faces; Institute of Dentistry; Barts and the London School of Medicine and Dentistry; Queen Mary University of London	This work was co-funded by the Wellcome Trust (MTT, EG), the Facial Surgery Research Foundation-Saving Faces (MTT, AW) and the Institute of Dentistry (DP, RT, AN), Barts and the London School of Medicine and Dentistry, Queen Mary University of London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Ai JZ, 2011, CELL PHYSIOL BIOCHEM, V27, P207, DOI 10.1159/000327946; Angiero F, 2008, ANTICANCER RES, V28, P2535; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Burton ER, 2011, MOL CANCER RES, V9, P1126, DOI 10.1158/1541-7786.MCR-11-0162; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Gaballah K, 2008, J PATHOL, V215, P280, DOI 10.1002/path.2360; Gemenetzidis E, 2010, CANCER RES, V70, P9515, DOI 10.1158/0008-5472.CAN-10-2173; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Georgiou E, 2007, EUR J CANCER PREV, V16, P396, DOI 10.1097/01.cej.0000236260.26265.d6; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kalathas D, 2011, MOL MED REP, V4, P363, DOI 10.3892/mmr.2011.431; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Koo CY, 2011, BIOCH BIOPHYSICA ACT; KULKARNI PS, 1995, CARCINOGENESIS, V16, P2515, DOI 10.1093/carcin/16.10.2515; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Li CY, 2010, J BIOL CHEM, V285, P30328, DOI 10.1074/jbc.M110.147413; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Palmisano WA, 2000, CANCER RES, V60, P5954; REISS M, 1985, J NATL CANCER I, V74, P1015; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Ron-Bigger S, 2010, STEM CELLS, V28, P1349, DOI 10.1002/stem.468; Schilling B, 2005, FEBS LETT, V579, P2485, DOI 10.1016/j.febslet.2005.03.061; Sweeney KJ, 2000, MECH DEVELOP, V92, P263, DOI 10.1016/S0925-4773(00)00242-2; Teh MT, 2002, CANCER RES, V62, P4773; Teh MT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-45; Timmermann S, 1998, ONCOGENE, V17, P3445, DOI 10.1038/sj.onc.1202244; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Uramoto H, 2010, ANTICANCER RES, V30, P3939; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Wang Y, 2007, ONCOGENE, V26, P6061, DOI 10.1038/sj.onc.1210435; Wang Z, 2011, CANCER RES, DOI [10.1158/0008-5472.can-1110-4087, DOI 10.1158/0008-5472.CAN-1110-4087]; Waseem A, 2010, ORAL ONCOL, V46, P536, DOI 10.1016/j.oraloncology.2010.03.022; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xie ZQ, 2010, NUCLEIC ACIDS RES, V38, P8027, DOI 10.1093/nar/gkq715; Yamada Y, 2010, ADV GENET, V70, P177, DOI [10.1016/B978-0-12-380866-0.60007-1, 10.1016/S0065-2660(10)70007-9]; Yan W, 2003, P NATL ACAD SCI USA, V100, P7189, DOI 10.1073/pnas.1236145100; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108; Zhou R, 2009, NUCLEIC ACIDS RES, V37, P5183, DOI 10.1093/nar/gkp533	55	59	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e34329	10.1371/journal.pone.0034329	http://dx.doi.org/10.1371/journal.pone.0034329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22461910	Green Published, Green Submitted, gold			2022-12-27	WOS:000304118900028
J	Chang, ZY; Lu, DW; Yeh, MK; Chiang, CH				Chang, Zhi-Yang; Lu, Da-Wen; Yeh, Ming-Kung; Chiang, Chiao-Hsi			A Novel High-Content Flow Cytometric Method for Assessing the Viability and Damage of Rat Retinal Ganglion Cells	PLOS ONE			English	Article							ASPARTATE (NMDA)-INDUCED APOPTOSIS; OPTIC-NERVE FIBERS; EXPERIMENTAL GLAUCOMA; NEUROTROPHIC FACTOR; IN-VIVO; FUNCTIONAL LOSS; MESSENGER-RNA; DBA/2J MICE; MOUSE MODEL; DEATH	Purpose: The aim of the study was to develop a high-content flow cytometric method for assessing the viability and damage of small, medium, and large retinal ganglion cells (RGCs) in N-methyl-D-aspartic acid (NMDA)-injury model. Methods/Results: Retinal toxicity was induced in rats by intravitreal injection of NMDA and RGCs were retrogradely labeled with Fluoro-Gold (FG). Seven days post-NMDA injection, flatmount and flow cytometric methods were used to evaluate RGCs. In addition, the RGC area diameter (D-(a)) obtained from retinal flatmount imaging were plotted versus apparent volume diameter (D-(v)) obtained from flow cytometry for the same cumulative cell number (sequentially from small to large RGCs) percentile (Q) to establish their relationship for accurately determining RGC sizes. Good correlation (r = 0.9718) was found between D-(a) and apparent D-(v). Both flatmount and flow cytometric analyses of RGCs showed that 40 mM NMDA significantly reduced the numbers of small and medium RGCs but not large RGCs. Additionally, flow cytometry showed that the geometric means of FG and thy-1 intensities in three types of RGCs decreased to 90.966 +/- 2.24% (P<0.05) and 91.78 +/- 61.89% (P>0.05) for small, 69.626 +/- 2.11% (P<0.01) and 69.076 +/- 2.98% (P<0.01) for medium, and 69.68 +/- 66.48% (P<0.05) and 69.91 +/- 66.23% (P<0.05) for large as compared with the normal RGCs. Conclusion: The established flow cytometric method provides high-content analysis for differential evaluation of RGC number and status and should be useful for the evaluation of various models of optic nerve injury and the effects of potential neuroprotective agents.	[Chang, Zhi-Yang; Chiang, Chiao-Hsi] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lu, Da-Wen] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Yeh, Ming-Kung] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Chiang, Chiao-Hsi] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Chang, ZY (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	cch@mail.ndmctsgh.edu.tw	Chiang, Chiao-Hsi/AAS-9777-2021		National Science Council [NSC97-2320-B016-002, NSC98-2320-B016-003-MY3]; Tri-service General Hospital [TSGH-C97-1-S01]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-service General Hospital	This work was supported by grants from the National Science Council (NSC97-2320-B016-002 and NSC98-2320-B016-003-MY3) and a grant from Tri-service General Hospital (TSGH-C97-1-S01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari EA, 2002, BRIT J OPHTHALMOL, V86, P1131, DOI 10.1136/bjo.86.10.1131; Chidlow G, 2003, BRAIN RES, V963, P298, DOI 10.1016/S0006-8993(02)04052-0; Chidlow G, 2007, DRUGS, V67, P725, DOI 10.2165/00003495-200767050-00006; Danias J, 2002, INVEST OPHTH VIS SCI, V43, P587; Dibas A, 2010, MOL VIS, V16, P330; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Edwards BS, 2004, CURR OPIN CHEM BIOL, V8, P392, DOI 10.1016/j.cbpa.2004.06.007; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fortune B, 2004, INVEST OPHTH VIS SCI, V45, P1854, DOI 10.1167/iovs.03-1411; FUKUDA Y, 1977, BRAIN RES, V119, P327, DOI 10.1016/0006-8993(77)90314-6; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Grieshaber P, 2010, J NEUROSCI METH, V192, P233, DOI 10.1016/j.jneumeth.2010.07.037; Higashide T, 2006, INVEST OPHTH VIS SCI, V47, P2943, DOI 10.1167/iovs.05-0708; Huang W, 2006, CURR EYE RES, V31, P265, DOI 10.1080/02713680500545671; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; Ino-ue M, 2000, INVEST OPHTH VIS SCI, V41, P4055; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Kashiwagi F, 2000, INVEST OPHTH VIS SCI, V41, P2373; Kwong JMK, 2003, BRAIN RES, V970, P119, DOI 10.1016/S0006-8993(03)02298-4; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P2391; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Morgan JE, 2002, J GLAUCOMA, V11, P365, DOI 10.1097/00061198-200208000-00015; Murata H, 2008, INVEST OPHTH VIS SCI, V49, P5546, DOI 10.1167/iovs.07-1211; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Nash MS, 1999, INVEST OPHTH VIS SCI, V40, P1293; Ota T, 2002, J OCUL PHARMACOL TH, V18, P241, DOI 10.1089/108076802760116160; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; Peng PH, 2008, EXP EYE RES, V86, P637, DOI 10.1016/j.exer.2008.01.008; Porciatti V, 1997, VISION RES, V37, P1975, DOI 10.1016/S0042-6989(97)00018-7; Porciatti V, 2007, INVEST OPHTH VIS SCI, V48, P745, DOI 10.1167/iovs.06-0733; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Reichstein D, 2007, EXP EYE RES, V84, P13, DOI 10.1016/j.exer.2006.08.009; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schlamp CL, 2001, MOL VIS, V7, P192; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Vecino E, 2002, VISION RES, V42, P151, DOI 10.1016/S0042-6989(01)00251-6; Ventura LM, 2006, INVEST OPHTH VIS SCI, V47, P3904, DOI 10.1167/iovs.06-0161; VIDALSANZ M, 1988, EXP NEUROL, V102, P92, DOI 10.1016/0014-4886(88)90081-7; Vrabec JP, 2007, EYE, V21, pS11, DOI 10.1038/sj.eye.6702880; Yang JJ, 2000, CURR EYE RES, V21, P981, DOI 10.1076/ceyr.21.6.981.6991	41	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33983	10.1371/journal.pone.0033983	http://dx.doi.org/10.1371/journal.pone.0033983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457807	gold, Green Published, Green Submitted			2022-12-27	WOS:000304046900038
J	Wang, B; Li, Y; Tan, Y; Miao, X; Liu, XD; Shao, C; Yang, XH; Turdi, S; Ma, LJ; Ren, J; Cai, L				Wang, Bo; Li, Yang; Tan, Yi; Miao, Xiao; Liu, Xu-Dong; Shao, Chen; Yang, Xiao-Hui; Turdi, Subat; Ma, Li-Jie; Ren, Jun; Cai, Lu			Low-Dose Cd Induces Hepatic Gene Hypermethylation, along with the Persistent Reduction of Cell Death and Increase Cell Proliferation in Rats an Mice	PLOS ONE			English	Article							INDUCED MALIGNANT-TRANSFORMATION; C57BL/6J MALE-MICE; ACID-DEFINED DIET; HEPATOCELLULAR-CARCINOMA; DNA METHYLATION; CADMIUM CARCINOGENESIS; CHOLINE-DEFICIENT; CYTOKERATIN 8/18; HUMAN CANCER; APOPTOSIS	Background: Cadmium (Cd) is classified as a human carcinogen probably associated with epigenetic changes. DNA methylation is one of epigenetic mechanisms by which cells control gene expression. Therefore, the present study genome-widely screened the methylation-altered genes in the liver of rats previously exposed to low-dose Cd. Methodology Principal Findings: Rats were exposed to Cd at 20 nmol/kg every other day for 4 weeks and gene methylation was analyzed at the 48(th) week with methylated DNA immunoprecipitation-CpG island microarray. Among the 1629 altered genes, there were 675 genes whose promoter CpG islands (CGIs) were hypermethylated, 899 genes whose promoter CGIs were hypomethylated, and 55 genes whose promoter CGIs were mixed with hyper- and hypo-methylation. Caspase-8 gene promoter CGIs and TNF gene promoter CGIs were hypermethylated and hypomethylated, respectively, along with a low apoptosis rate in Cd-treated rat livers. To link the aberrant methylation of caspase-8 and TNF genes to the low apoptosis induced by low-dose Cd, mice were given chronic exposure to low-dose Cd with and without methylation inhibitor (5-aza-2'-deoxyctidene, 5-aza). At the 48th week after Cd exposure, livers from Cd-treated mice displayed the increased caspase-8 CGI methylation and decreased caspase-8 protein expression, along with significant increases in cell proliferation and overexpression of TGF-beta 1 and cytokeratin 8/18 (the latter is a new marker of mouse liver preneoplastic lesions), all which were prevented by 5-aza treatment. Conclusion/Significance: These results suggest that Cd-induced global gene hypermethylation, most likely caspase-8 gene promoter hypermethylation that down-regulated its expression, leading to the decreased hepatic apoptosis and increased preneoplastic lesions.	[Wang, Bo; Li, Yang; Shao, Chen] Jilin Univ, Dept Pathophysiol, Prostate Dis Prevent & Treatment Res Ctr, Norman Bethune Coll Med, Changchun 130023, Jilin, Peoples R China; [Wang, Bo] Inner Mongolia Forestry Gen Hosp, Dept Pathol, Yakeshi, Inner Mongolia, Peoples R China; [Wang, Bo; Tan, Yi; Miao, Xiao; Cai, Lu] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA; [Miao, Xiao] Jilin Univ, Hosp 2, Dept Ophthalmol, Changchun 130023, Jilin, Peoples R China; [Liu, Xu-Dong] Inner Mongolia Med Coll, Affiliated Hosp, Dept Emergency, Hohhot, Inner Mongolia, Peoples R China; [Yang, Xiao-Hui; Turdi, Subat; Ren, Jun] Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA; [Ma, Li-Jie] Inner Mongolia Med Coll, Dept Pharmacol, Hohhot, Inner Mongolia, Peoples R China; [Cai, Lu] Univ Louisville, Dept Radiat Oncol, Louisville, KY 40292 USA; [Cai, Lu] Univ Louisville, Dept Pharmacol, Louisville, KY 40292 USA; [Cai, Lu] Univ Louisville, Dept Toxicol, Louisville, KY 40292 USA	Jilin University; University of Louisville; Jilin University; Inner Mongolia Medical University; University of Wyoming; Inner Mongolia Medical University; University of Louisville; University of Louisville; University of Louisville	Wang, B (corresponding author), Jilin Univ, Dept Pathophysiol, Prostate Dis Prevent & Treatment Res Ctr, Norman Bethune Coll Med, Changchun 130023, Jilin, Peoples R China.	nmmalji@hotmail.com; l0cai001@louisville.edu	Cai, Lu/AAG-9920-2019; Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783	Natural Science Foundation of Inner Mongolia Autonomous Region of China [2011BS1102]; Bureua of Science and Technology Foundation of Jilin Provice, China [201115115]; NIEHS Center for Environment Genomics and Integrative Biology at the University of Louisville; National Institute of Health [RR016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	Natural Science Foundation of Inner Mongolia Autonomous Region of China; Bureua of Science and Technology Foundation of Jilin Provice, China; NIEHS Center for Environment Genomics and Integrative Biology at the University of Louisville; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work was supported in part by grants from Natural Science Foundation of Inner Mongolia Autonomous Region of China [grant: 2011BS1102, to LJM], Bureua of Science and Technology Foundation of Jilin Provice, China [grant: 201115115, to YL], from the CEGIB Pilot Project of the NIEHS Center for Environment Genomics and Integrative Biology at the University of Louisville [grant: 2007, to LC] and National Institute of Health [RR016474, to JR]. No additional external funding recieved for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 2001, CANCER RES, V61, P455; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Denda A, 2002, JPN J CANCER RES, V93, P125, DOI 10.1111/j.1349-7006.2002.tb01250.x; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gunawardana CG, 2006, AM J PHYSIOL-RENAL, V290, pF1074, DOI 10.1152/ajprenal.00067.2005; HANIGAN MH, 1990, CARCINOGENESIS, V11, P589, DOI 10.1093/carcin/11.4.589; Hashimoto E, 2012, HEPATOL RES, V42, P1, DOI 10.1111/j.1872-034X.2011.00872.x; Hill-Baskin AE, 2009, HUM MOL GENET, V18, P2975, DOI 10.1093/hmg/ddp236; Huang DJ, 2008, TOXICOL LETT, V179, P43, DOI 10.1016/j.toxlet.2008.03.018; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Jiang GF, 2008, TOXICOLOGY, V244, P49, DOI 10.1016/j.tox.2007.10.028; Kabukcuoglu S, 2010, EUR J GYNAECOL ONCOL, V31, P641; Kakehashi A, 2010, TOXICOL APPL PHARM, V242, P47, DOI 10.1016/j.taap.2009.09.013; Kakehashi A, 2009, TOXICOL APPL PHARM, V238, P71, DOI 10.1016/j.taap.2009.04.018; Kawai M, 2010, ARCH TOXICOL, V84, P155, DOI 10.1007/s00204-009-0498-8; Kawai M, 2010, J VET MED SCI, V72, P263, DOI 10.1292/jvms.09-0329; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; Kuo LJ, 2008, IN VIVO, V22, P305; Larson J, 2010, TOXICOL LETT, V199, P166, DOI 10.1016/j.toxlet.2010.08.020; Lehmann U, 2005, CLIN CANCER RES, V11, P3654, DOI 10.1158/1078-0432.CCR-04-2462; MAITANI T, 1986, TOXICOLOGY, V42, P121, DOI 10.1016/0300-483X(86)90003-X; Martinez R, 2007, CARCINOGENESIS, V28, P1264, DOI 10.1093/carcin/bgm014; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Misra UK, 2002, CELL SIGNAL, V14, P327, DOI 10.1016/S0898-6568(01)00268-6; Oh SH, 2006, TOXICOLOGY, V220, P1, DOI 10.1016/j.tox.2005.08.025; Pelizzola M, 2008, GENOME RES, V18, P1652, DOI 10.1101/gr.080721.108; Qu W, 2005, INT J CANCER, V114, P346, DOI 10.1002/ijc.20736; Shimada H, 1998, J TOXICOL ENV HEAL A, V54, P159; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; WAALKES MP, 1988, CANCER RES, V48, P4656; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wang B, 2011, J APPL TOXI IN PRESS; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Yamashiro Y, 2010, BIOCHEM BIOPH RES CO, V399, P365, DOI 10.1016/j.bbrc.2010.07.077; Yu J, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-29; Yuan C, 2000, TOXICOL APPL PHARM, V164, P321, DOI 10.1006/taap.2000.8921	39	53	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33853	10.1371/journal.pone.0033853	http://dx.doi.org/10.1371/journal.pone.0033853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457795	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900029
J	Wu, X; Cai, ZD; Chen, ZR; Yao, ZJ; Zhang, GJ				Wu, Xing; Cai, Zheng-dong; Chen, Zheng-rong; Yao, Zhen-jun; Zhang, Guang-jian			A Preliminary Evaluation of Limb Salvage Surgery for Osteosarcoma around Knee Joint	PLOS ONE			English	Article							BONE-TUMORS; SURVIVAL; OUTCOMES; GRAFT	Objective: To evaluate the effectiveness and drawbacks of diversified procedures of limb salvage surgery (LSS), providing a reference of rational surgical criterion of LSS. Methods: Fifty eight patients with stage IIB extremity osteosarcoma around knee joint area between 1992 and 2002 were studied retrospectively. Among them, 43 patients were treated by LSS followed by reconstruction. Reconstruction approaches included re-implantation of irradiation-devitalized tumor bone (n = 12), autoclaving-devitalized tumor bone (n = 8), prosthetic replacement (n = 11), allograft transplantation (n = 8) and vascularized fibula autograft implantation (n = 4). Amputations were performed in 15 patients. Patients were followed up for 6-16 years. Results: There were no significant difference between LSS and amputation groups regarding disease free survival and local recurrence rates. The actuarial 5-year continuous disease free survival and local recurrence rate were 30.0% and 25.0% in patients of devitalized LSS group, whereas those were 56.5% and 8.7% in patients of non-devitalized reconstruction group. The complication rate was significantly higher in LSS group compared to amputation group (P = 0.003). Conclusion: LSS with non-devitalized procedures is the optimal treatment for osteosarcoma around knee joint area. Prosthesis implantation is the preferred option for bone reconstruction following LSS. Prevention and treatment of postoperative complications should be paid more attention to get good long-term outcomes of surgery.	[Wu, Xing; Cai, Zheng-dong] Tongji Univ, Sch Med, Shanghai Tenth Peoples Hosp, Dept Orthopaed, Shanghai 200092, Peoples R China; [Chen, Zheng-rong; Yao, Zhen-jun; Zhang, Guang-jian] Fudan Univ, Sch Med, Shanghai Zhongshan Hosp, Dept Orthopaed, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Wu, X (corresponding author), Tongji Univ, Sch Med, Shanghai Tenth Peoples Hosp, Dept Orthopaed, Shanghai 200092, Peoples R China.	wuxinggood@163.com						Ayerza MA, 2006, CLIN ORTHOP RELAT R, P231, DOI 10.1097/01.blo.0000229314.58878.88; Bacci G, 2001, CLIN ORTHOP RELAT R, P186; Bacci G, 2008, J SURG ONCOL, V98, P415, DOI 10.1002/jso.21140; Bhangu AA, 2006, INT ORTHOP, V30, P465, DOI 10.1007/s00264-006-0186-8; Carty CP, 2009, KNEE, V16, P405, DOI 10.1016/j.knee.2009.02.006; Eiser C, 2009, EUR J CANCER, V45, P1744, DOI 10.1016/j.ejca.2009.02.025; Eralp L, 2009, ACTA ORTHOP TRAUMATO, V43, P219, DOI 10.3944/AOTT.2009.219; Fan QY, 2003, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000037439.23683.9c; Fan SW, 2000, CHINESE J ORTHOPAEDI, V20, P393; Federman N, 2009, CURR TREAT OPTION ON, V10, P82, DOI 10.1007/s11864-009-0087-3; Haidar R, 2008, PEDIATR BLOOD CANCER, V51, P787, DOI 10.1002/pbc.21696; Hatano H, 2005, J BONE JOINT SURG BR, V87B, P1006, DOI 10.1302/0301-620X.87B7.14822; Healey JH, 2009, CLIN ORTHOP RELAT R, V467, P1813, DOI 10.1007/s11999-008-0548-1; Heller L, 2006, J SURG ONCOL, V94, P479, DOI 10.1002/jso.20485; Kumta SM, 1998, J BONE JOINT SURG BR, V80B, P994, DOI 10.1302/0301-620X.80B6.8982; Li CX, 2009, CANCER BIOL THER, V8, P1102, DOI 10.4161/cbt.8.12.8556; Messerschmitt PJ, 2009, J AM ACAD ORTHOP SUR, V17, P515, DOI 10.5435/00124635-200908000-00005; Noguchi M, 2008, J RECONSTR MICROSURG, V24, P525, DOI 10.1055/s-0028-1088236; Ogawa Y, 2008, ONCOL REP, V19, P1389; Pakos EE, 2009, EUR J CANCER, V45, P2367, DOI 10.1016/j.ejca.2009.03.005; RUGGIERI P, 1993, CLIN ORTHOP RELAT R, P226; Sampo MM, 2008, ACTA ORTHOP, V79, P861, DOI 10.1080/17453670810016966; Tunn PU, 2008, INT ORTHOP, V32, P619, DOI 10.1007/s00264-007-0388-8; Wafa H, 2006, EXPERT REV ANTICANC, V6, P239, DOI 10.1586/14737140.6.2.239; Wilkins RM, 2003, ANN SURG ONCOL, V10, P498, DOI 10.1245/ASO.2003.03.061	25	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33492	10.1371/journal.pone.0033492	http://dx.doi.org/10.1371/journal.pone.0033492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457768	Green Submitted, Green Published, gold			2022-12-27	WOS:000304046900014
J	Zhang, LQ; Wang, J; Jiang, F; Xu, L; Liu, FY; Yin, R				Zhang, Lou Qian; Wang, Jun; Jiang, Feng; Xu, Lin; Liu, Fu Yin; Yin, Rong			Prognostic Value of Survivin in Patients with Non-Small Cell Lung Carcinoma: A Systematic Review with Meta-Analysis	PLOS ONE			English	Review							GENE-EXPRESSION; IMMUNOHISTOCHEMICAL ANALYSIS; NUCLEAR SURVIVIN; CANCER; MARKER; P53; ADENOCARCINOMA; BIOMARKERS; CASPASES; PROTEIN	Purpose: The potential prognostic value of survivin in resected non-small cell lung carcinoma (NSCLC) is variably reported. The objective of this study was to conduct a systematic review of literatures evaluating survivin expression in resected NSCLC as a prognostic indicator. Methods: Relevant literatures were identified using PubMed, EMBASE and Chinese Biomedicine Databases. We present the results of a meta-analysis of the association between survivin expression and overall survival (OS) in NSCLC patients. Studies were pooled and summary hazard ratios (HR) were calculated. Subgroup analyses and publication bias were also conducted. Results: We performed a final analysis of 2703 patients from 28 evaluable studies. Combined HRs suggested that survivin overexpression had an unfavorable impact on NSCLC patients' survival with no evidence of any significant publication bias (HR = 2.03, 95% CI: 1.78-2.33, Egger's test, P = 0.24) and no severe heterogeneity between studies (I-2 = 26.9%). Its effect also appeared significant when stratified according to the studies categorized by histological type, HR estimate, patient race, cutoff point (5%, 10%), detection methods and literature written language except for disease stage. Survivin was identified as a prognostic marker of advanced-stage NSCLC (HR = 1.93, 95% CI: 1.49-2.51), but not early-stage NSCLC (HR = 1.97, 95% CI: 0.76-5.14), in spite of the combined data being relatively small. Conclusion: This study shows that survivin expression appears to be a pejorative prognostic factor in terms of overall survival in surgically treated NSCLC. Large prospective studies are now needed to confirm the clinical utility of survivin as an independent prognostic marker.	[Zhang, Lou Qian; Jiang, Feng; Xu, Lin; Yin, Rong] Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China; [Wang, Jun; Liu, Fu Yin] Jiangsu Prov Official Hosp, Jiangsu Prov Geriatr Inst, Dept Chemotherapy, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhang, LQ (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China.	xulinjs@yeah.net						Akyurek N, 2006, VIRCHOWS ARCH, V449, P164, DOI 10.1007/s00428-006-0239-9; Atikcan S, 2006, RESP MED, V100, P2220, DOI 10.1016/j.rmed.2006.02.031; Bria E, 2008, EJSO-EUR J SURG ONC, V34, P593, DOI 10.1016/j.ejso.2007.06.002; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Chen P, 2010, RESPIROLOGY, V15, P501, DOI 10.1111/j.1440-1843.2010.01710.x; Chen X, 2009, CHINESE GERMAN J CLI, V8, P265; Dai CH, 2010, JPN J CLIN ONCOL, V40, P327, DOI 10.1093/jjco/hyp165; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falleni M, 2003, J PATHOL, V200, P620, DOI 10.1002/path.1388; Fan J, 2008, LUNG CANCER, V61, P91, DOI 10.1016/j.lungcan.2007.11.011; Grossi F, 2010, J THORAC ONCOL, V5, P1354, DOI 10.1097/JTO.0b013e3181e77a78; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoshil F, 2009, JAPANESE J LUNG CANC, V49, P12; Ikehara M, 2002, ONCOL REP, V9, P835; JACQUEMIER J, 1994, BRIT J CANCER, V69, P846, DOI 10.1038/bjc.1994.164; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karczmarek-Borowska B, 2005, FOLIA HISTOCHEM CYTO, V43, P237; Kim GY, 2011, MODERN PATHOLOGY; Kren L, 2004, APPL IMMUNOHISTO M M, V12, P44; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li Chenghui, 2008, Zhongguo Fei Ai Za Zhi, V11, P90, DOI 10.3779/j.issn.1009-3419.2008.01.020; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Lv XY, 2010, J CLIN PULMONARY MED, V15, P5; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mohamed S, 2009, EUR RESPIR J, V33, P127, DOI 10.1183/09031936.00068708; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; Nakashima N, 2010, INT J ONCOL, V37, P687, DOI 10.3892/ijo_00000718; Oldenhuis CNAM, 2008, EUR J CANCER, V44, P946, DOI 10.1016/j.ejca.2008.03.006; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Porebska Irena, 2010, Cancer Genomics & Proteomics, V7, P331; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Sah NK, 2006, CANCER LETT, V244, P164, DOI 10.1016/j.canlet.2006.03.007; Samuel T, 2005, CANCER RES, V65, P210; Shinohara ET, 2005, CANCER-AM CANCER SOC, V103, P1685, DOI 10.1002/cncr.20951; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Tamm I, 1998, CANCER RES, V58, P5315; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Tsuboi Masahiro, 2007, Ann Thorac Cardiovasc Surg, V13, P73; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wang Dao-Feng, 2006, Ai Zheng, V25, P359; Weng XW, 2010, CHINESE J CANC PREVE, V17, P198; Yamashita SI, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-22; Yang Dong-Xia, 2010, Chin J Cancer, V29, P396; Yie SM, 2009, LUNG CANCER, V63, P284, DOI 10.1016/j.lungcan.2008.05.024; Yoo J, 2007, J KOREAN MED SCI, V22, P318, DOI 10.3346/jkms.2007.22.2.318; Zhang JR, 2010, CHINESE CLIN ONCOLOG, V15, P789; [张强 Zhang Qiang], 2010, [肿瘤防治研究, Cancer Research on Prevention and Treatment], V37, P909; Zhou Jian-Mei, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P544; Zhu Zhi-Hua, 2007, Ai Zheng, V26, P1268	56	47	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e34100	10.1371/journal.pone.0034100	http://dx.doi.org/10.1371/journal.pone.0034100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457815	Green Published, Green Submitted, gold			2022-12-27	WOS:000304046900044
J	Fisher, BM; Van Bockern, J; Hart, J; Lynch, AM; Winn, VD; Gibbs, RS; Weinberg, A				Fisher, Barbra M.; Van Bockern, Janice; Hart, Jan; Lynch, Anne M.; Winn, Virginia D.; Gibbs, Ronald S.; Weinberg, Adriana			Pandemic Influenza A H1N1 2009 Infection versus Vaccination: A Cohort Study Comparing Immune Responses in Pregnancy	PLOS ONE			English	Article							ANTIBODY-RESPONSES; UNITED-STATES; VIRUS; IMMUNIZATION; VACCINES; WOMEN; PROTECTION; SAFETY	Background: With the emergence of H1N1 pandemic (pH1N1) influenza, the CDC recommended that pregnant women be one of five initial target groups to receive the 2009 monovalent H1N1 vaccine, regardless of prior infection with this influenza strain. We sought to compare the immune response of pregnant women to H1N1 infection versus vaccination and to determine the extent of passive immunity conferred to the newborn. Methods/Findings: During the 2009-2010 influenza season, we enrolled a cohort of women who either had confirmed pH1N1 infection during pregnancy, did not have pH1N1 during pregnancy but were vaccinated against pH1N1, or did not have illness or vaccination. Maternal and umbilical cord venous blood samples were collected at delivery. Hemagglutination inhibition assays (HAI) for pH1N1 were performed. Data were analyzed using linear regression analyses. HAIs were performed for matched maternal/cord blood pairs for 16 women with confirmed pH1N1 infection, 14 women vaccinated against pH1N1, and 10 women without infection or vaccination. We found that pH1N1 vaccination and wild-type infection during pregnancy did not differ with respect to (1) HAI titers at delivery, (2) HAI antibody decay slopes over time, and (3) HAI titers in the cord blood. Conclusions: Vaccination against pH1N1 confers a similar HAI antibody response as compared to pH1N1 infection during pregnancy, both in quantity and quality. Illness or vaccination during pregnancy confers passive immunity to the newborn.	[Weinberg, Adriana] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Weinberg, Adriana] Univ Colorado, Sch Med, Dept Pathol & Med, Aurora, CO USA; [Fisher, Barbra M.; Van Bockern, Janice; Hart, Jan; Lynch, Anne M.; Winn, Virginia D.; Gibbs, Ronald S.] Univ Colorado, Sch Med, Dept Obstet & Gynaecol, Sect Maternal Fetal Med, Aurora, CO USA; [Gibbs, Ronald S.] Novartis Diagnost & Therapeut, Emeryville, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Weinberg, A (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.	Adriana.Weinberg@ucdenver.edu		Winn, Virginia/0000-0003-1136-2907	Newborn Hope of Colorado; Department of Obstetrics and Gynecology at the University of Colorado School of Medicine	Newborn Hope of Colorado; Department of Obstetrics and Gynecology at the University of Colorado School of Medicine	This study is funded by Newborn Hope of Colorado and the Academic Enrichment Fund of the Department of Obstetrics and Gynecology at the University of Colorado School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Obstet Gynecol, V116, P1006, DOI 10.1097/AOG.0b013e3181fae845; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1100; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Blencowe H, 2010, INT J EPIDEMIOL S1, V30, P1102; Callaghan WM, 2010, OBSTET GYNECOL, V115, P919, DOI 10.1097/AOG.0b013e3181d99d85; Carlson Amanda, 2009, Rev Obstet Gynecol, V2, P139; Cox CM, 2011, CLIN INFECT DIS, V52, pS69, DOI 10.1093/cid/ciq011; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Demicheli V, 2005, COCHRANE DB SYST REV, V19; Englund JA, 2003, VACCINE, V21, P3460, DOI 10.1016/S0264-410X(03)00351-7; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fisher BM, 2011, AM J OBSTET GYNECOL, V204, pS107, DOI 10.1016/j.ajog.2011.02.041; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Gruber WC, 1997, VACCINE, V15, P1379, DOI 10.1016/S0264-410X(97)00032-7; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Jackson ML, 2011, CLIN INFECT DIS, V53, P455, DOI 10.1093/cid/cir437; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Levin MJ, 2008, VACCINE, V26, P4210, DOI 10.1016/j.vaccine.2008.05.054; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; MacDonald NE, 2009, OBSTET GYNECOL, V114, P365, DOI 10.1097/AOG.0b013e3181af6ce8; McElhaney JE, 2009, VACCINE, V27, P2418, DOI 10.1016/j.vaccine.2009.01.136; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; National Center for Immunization and Respiratory Diseases CDC, 2009, MMWR Recomm Rep, V58, P1; de la Tabla VO, 2010, CLIN MICROBIOL INFEC, V16, P1358, DOI 10.1111/j.1469-0691.2010.03159.x; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; von Kries R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023955; Walter EB, 2009, PEDIATR INFECT DIS J, V28, P1099, DOI 10.1097/INF.0b013e3181b0c0ca; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	30	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33048	10.1371/journal.pone.0033048	http://dx.doi.org/10.1371/journal.pone.0033048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457731	Green Submitted, Green Published, gold			2022-12-27	WOS:000303909200014
J	Kirkbride, JB; Errazuriz, A; Croudace, TJ; Morgan, C; Jackson, D; Boydell, J; Murray, RM; Jones, PB				Kirkbride, James B.; Errazuriz, Antonia; Croudace, Tim J.; Morgan, Craig; Jackson, Daniel; Boydell, Jane; Murray, Robin M.; Jones, Peter B.			Incidence of Schizophrenia and Other Psychoses in England, 1950-2009: A Systematic Review and Meta-Analyses	PLOS ONE			English	Review							1ST EPISODE PSYCHOSIS; SOUTH-EAST LONDON; CANNABIS USE; PSYCHIATRIC MORBIDITY; BIPOLAR DISORDER; RISK-FACTORS; 1ST-EPISODE PSYCHOSIS; 1ST-CONTACT INCIDENCE; GENDER-DIFFERENCES; ETHNIC-MINORITIES	Background: We conducted a systematic review of incidence rates in England over a sixty-year period to determine the extent to which rates varied along accepted (age, sex) and less-accepted epidemiological gradients (ethnicity, migration and place of birth and upbringing, time). Objectives: To determine variation in incidence of several psychotic disorders as above. Data Sources: Published and grey literature searches (MEDLINE, PSycINFO, EMBASE, CINAHL, ASSIA, HMIC), and identification of unpublished data through bibliographic searches and author communication. Study Eligibility Criteria: Published 1950-2009; conducted wholly or partially in England; original data on incidence of non-organic adult-onset psychosis or one or more factor(s) pertaining to incidence. Participants: People, 16-64 years, with first -onset psychosis, including non-affective psychoses, schizophrenia, bipolar disorder, psychotic depression and substance-induced psychosis. Study Appraisal and Synthesis Methods: Title, abstract and full-text review by two independent raters to identify suitable citations. Data were extracted to a standardized extraction form. Descriptive appraisals of variation in rates, including tables and forest plots, and where suitable, random-effects meta-analyses and meta-regressions to test specific hypotheses; rate heterogeneity was assessed by the I-2-statistic. Results: 83 citations met inclusion. Pooled incidence of all psychoses (N = 9) was 31.7 per 100,000 person-years (95% CI: 24.6-40.9), 23.2 (95% CI: 18.3-29.5) for non-affective psychoses (N = 8), 15.2 (95% CI: 11.9-19.5) for schizophrenia (N = 15) and 12.4 (95% CI: 9.0-17.1) for affective psychoses (N = 7). This masked rate heterogeneity (I-2: 0.54-0.97), possibly explained by socio-environmental factors; our review confirmed (via meta-regression) the typical age-sex interaction in psychosis risk, including secondary peak onset in women after 45 years. Rates of most disorders were elevated in several ethnic minority groups compared with the white (British) population. For example, for schizophrenia: black Caribbean (pooled RR: 5.6; 95% CI: 3.4-9.2; N = 5), black African (pooled RR: 4.7; 95% CI: 3.3-6.8; N = 5) and South Asian groups in England (pooled RR: 2.4; 95% CI: 1.3-4.5; N = 3). We found no evidence to support an overall change in the incidence of psychotic disorder over time, though diagnostic shifts (away from schizophrenia) were reported. Limitations: Incidence studies were predominantly cross-sectional, limiting causal inference. Heterogeneity, while evidencing important variation, suggested pooled estimates require interpretation alongside our descriptive systematic results. Conclusions and Implications of Key Findings: Incidence of psychotic disorders varied markedly by age, sex, place and migration status/ethnicity. Stable incidence over time, together with a robust socio-environmental epidemiology, provides a platform for developing prediction models for health service planning.	[Kirkbride, James B.; Errazuriz, Antonia; Croudace, Tim J.; Jones, Peter B.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Morgan, Craig; Boydell, Jane; Murray, Robin M.] Inst Psychiat, Dept Psychosis Studies, London, England; [Jackson, Daniel] Univ Cambridge, MRC Biostat Unit, Inst Publ Hlth, Cambridge, England	University of Cambridge; University of London; King's College London; MRC Biostatistics Unit; University of Cambridge	Kirkbride, JB (corresponding author), Univ Cambridge, Dept Psychiat, Herchel Smith Bldg Brain & Mind Sci, Cambridge, England.	jbk25@cam.ac.uk	Croudace, Tim/ABC-9681-2021; Kirkbride, James B./A-9345-2008; Errazuriz, Antonia/N-7327-2015; Murray, Robin M/F-8658-2012; Morgan, Craig/B-2100-2010	Kirkbride, James B./0000-0003-3401-0824; Murray, Robin M/0000-0003-0829-0519; Morgan, Craig/0000-0002-1386-2369; Croudace, Tim/0000-0001-8346-7463; Errazuriz, Antonia/0000-0001-9948-388X; Jones, Peter Brian/0000-0002-0387-880X; Jackson, Dan/0000-0002-4963-8123	Department of Health [PR-SC-0908-10009]; National Institute for Health Research [RP-PG-0606-1335]; Wellcome Trust [WT085540]; Medical Research Council [1052.00.006]; East of England Evidence Adoption Centre; Medical Research Council [MC_U105260558] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10215] Funding Source: researchfish; MRC [MC_U105260558] Funding Source: UKRI	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); East of England Evidence Adoption Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the Department of Health Policy Research Programme (PR-SC-0908-10009; www.ccf.nihr.ac.uk/Pages/Home.aspx). Peter Jones was partly supported by National Institute for Health Research grant RP-PG-0606-1335 (www.nihr.ac.uk/Pages/default.aspx). James Kirkbride was partly supported by a Sir Henry Wellcome Research Fellowship from the Wellcome Trust (WT085540; www.wellcome.org). Dan Jackson was partly supported by a Medical Research Council grant (1052.00.006; www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. As per standard operating procedure of the Department of Health, the authors had to submit to them a final version of this manuscript 28 days prior to submission to the journal. This manuscript was approved for submission to the journal without correction.; This project forms part of the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Cambridgeshire and Peterborough and was supported by the East of England Evidence Adoption Centre. The authors of this review were helped by many people. We are grateful to Professor John McGrath for his wise guidance during the planning and conduct of this review. His expertise allowed us to improve the final quality of this work. The CLAHRC Evidence Adoption Centre played a pivotal role in providing us with expert librarians and other resources when designing and conducting the systematic search strategy; we are indebted to them. We thank Anna Capasso for making this possible. Without the diligent, patient help and expertise of the librarians involved in this project, we would have been unable to develop such a comprehensive and systematic strategy to search the research literature. We therefore pass on our heartfelt thanks to Karen Rigby, Kerry Herbert and Margaret Bevan at the Education Library, Hinchingbrooke Health Care NHS Trust, as well as to Barbara Norrey from the Mid Essex PCT for her expert guidance on the grey literature. We are grateful to Ian White, MRC Biostatistics Unit, for providing access to expertise to conduct the analyses contained within this review. We would also like to thank the following researchers for providing timely clarifications or additional data for some studies and citations included in this report: Prof. Brian Cooper, Prof. Tom Burns, Prof. Francis Creed, Prof. Thomas Barnes, Prof. Peter Congdon, Prof. Philippa Garety, Prof. Joe Kai, Dr. Andrew Thompson, Dr. Emma Mitford, Dr. Martin Frisher, Prof. Ilana Crome and Kate Beaven and Ellie Smith from the Office for National Statistics. Finally, we are grateful to Alan Roach and the PRP team at the Department of Health for patiently guiding this review towards completion.	Allardyce J, 2005, BRIT J PSYCHIAT, V187, P401, DOI 10.1192/bjp.187.5.401; Allardyce J, 2001, BRIT J PSYCHIAT, V179, P335, DOI 10.1192/bjp.179.4.335; Amin S, 1999, BRIT J PSYCHIAT, V175, P537, DOI 10.1192/bjp.175.6.537; ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; BAMRAH JS, 1991, BRIT J PSYCHIAT, V159, P802, DOI 10.1192/bjp.159.6.802; Barnett JH, 2007, BRIT J PSYCHIAT, V190, P515, DOI 10.1192/bjp.bp.106.024448; Barraclough B M, 1967, Mon Bull Minist Health Public Health Lab Serv, V26, P63; BAUDIS P, 1977, SOC PSYCHIATR, V12, P185, DOI 10.1007/BF00578138; BEBBINGTON P, 1987, ACTA PSYCHIAT SCAND, V75, P640, DOI 10.1111/j.1600-0447.1987.tb02849.x; Bebbington PE, 2004, BRIT J PSYCHIAT, V185, P220, DOI 10.1192/bjp.185.3.220; BEBBINGTON PE, 1981, SOC PSYCHIATR, V16, P43, DOI 10.1007/BF00578068; Bhugra D, 1997, PSYCHOL MED, V27, P791, DOI 10.1017/S0033291797005369; Bhugra D, 1996, BRIT J PSYCHIAT, V169, P587, DOI 10.1192/bjp.169.5.587; Boydell J, 2006, PSYCHOL MED, V36, P1441, DOI 10.1017/S0033291706008440; Boydell J, 2004, SOC PSYCH PSYCH EPID, V39, P597, DOI 10.1007/s00127-004-0789-6; Boydell J, 2003, BRIT J PSYCHIAT, V182, P45, DOI 10.1192/bjp.182.1.45; Boydell J, 2001, BMJ-BRIT MED J, V323, P1336, DOI 10.1136/bmj.323.7325.1336; Bresnahan M, 2007, INT J EPIDEMIOL, V36, P751, DOI 10.1093/ije/dym041; Brewin J, 1997, BRIT J PSYCHIAT, V171, P140, DOI 10.1192/bjp.171.2.140; Brooke EM, 1959, 2 INT C PSYCH ZUR 19, P52; Brooke EM, MONTHLY B MINSITRY H, V17, P208; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Cantor-Graae E, 2003, BRIT J PSYCHIAT, V182, P117, DOI 10.1192/bjp.182.2.117; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; CARPENTER L, 1980, BRIT J PSYCHIAT, V137, P201, DOI 10.1192/bjp.137.3.201; CASTLE D, 1991, BRIT J PSYCHIAT, V159, P790, DOI 10.1192/bjp.159.6.790; CASTLE DJ, 1993, SCHIZOPHRENIA BULL, V19, P691, DOI 10.1093/schbul/19.4.691; Castle DJ, 1998, PSYCHOSIS INNER CITY, P83; Cheng F, 2011, PSYCHOL MED, V41, P949, DOI 10.1017/S0033291710002461; Chua Wan Lian LC, COCHRANE DATABASE SY; CLARE AW, 1974, BRIT J ADDICT, V69, P207; COCHRANE R, 1989, SOC PSYCH PSYCH EPID, V24, P2, DOI 10.1007/BF01788193; COCHRANE R, 1988, BRIT J PSYCHIAT, V153, P363, DOI 10.1192/bjp.153.3.363; Cohen A, 2008, SCHIZOPHRENIA BULL, V34, P229, DOI 10.1093/schbul/sbm105; Coid JW, 2009, ARCH GEN PSYCHIAT, V66, P161; Coid JW, 2008, ARCH GEN PSYCHIAT, V65, P1250, DOI 10.1001/archpsyc.65.11.1250; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; COOPER JE, 1987, BRIT J PSYCHIAT, V151, P619, DOI 10.1192/bjp.151.5.619; Corcoran C, 2009, SCHIZOPHRENIA BULL, V35, P596, DOI 10.1093/schbul/sbn089; Crebbin K, 2008, J AFFECT DISORDERS, V105, P117, DOI 10.1016/j.jad.2007.04.025; Crebbin K, 2009, SOC PSYCH PSYCH EPID, V44, P710, DOI 10.1007/s00127-008-0490-2; Croudace TJ, 2000, PSYCHOL MED, V30, P177, DOI 10.1017/S0033291799001464; DAUNCEY K, 1993, BRIT J PSYCHIAT, V163, P613, DOI 10.1192/bjp.163.5.613; DEALARCON J, 1993, J PUBLIC HEALTH MED, V15, P93, DOI 10.1093/oxfordjournals.pubmed.a042827; DEAN G, 1981, BRIT J PSYCHIAT, V139, P506, DOI 10.1192/bjp.139.6.506; DEAN G, 1981, BRIT MED J, V282, P1831, DOI 10.1136/bmj.282.6279.1831; Demjaha A, 2009, PSYCHOL MED, V39, P1943, DOI 10.1017/S0033291709990651; DER G, 1990, LANCET, V335, P513, DOI 10.1016/0140-6736(90)90745-Q; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EATON WW, 1991, EPIDEMIOL REV, V13, P320, DOI 10.1093/oxfordjournals.epirev.a036075; EATON WW, 1985, EPIDEMIOL REV, V7, P105, DOI 10.1093/oxfordjournals.epirev.a036278; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faris Robert E.L, 1939, MENTAL DISORDERS URB; Fearon P, 2006, PSYCHOL MED, V36, P1541, DOI 10.1017/S0033291706008774; Fisher H, 2009, BRIT J PSYCHIAT, V194, P319, DOI 10.1192/bjp.bp.107.047985; Frisher M, 2009, SCHIZOPHR RES, V113, P123, DOI 10.1016/j.schres.2009.05.031; GALDOS PM, 1993, SCHIZOPHR RES, V10, P7, DOI 10.1016/0920-9964(93)90071-P; GATER R, 1995, BRIT J PSYCHIAT, V166, P344, DOI 10.1192/bjp.166.3.344; GATER RA, 1989, PSYCHOL MED, V19, P719, DOI 10.1017/S0033291700024314; Giggs J, 1973, Nurs Times, V69, P1210; GIGGS JA, 1986, SOC SCI MED, V23, P945, DOI 10.1016/0277-9536(86)90252-2; GIGGS JA, 1987, BRIT J PSYCHIAT, V151, P627, DOI 10.1192/bjp.151.5.627; GIGGS JA, 1973, T I BRIT GEOGR, P55, DOI 10.2307/621712; Goater N, 1999, BRIT J PSYCHIAT, V175, P34, DOI 10.1192/bjp.175.1.34; GOLDACRE M, 1994, J EPIDEMIOL COMMUN H, V48, P318, DOI 10.1136/jech.48.3.318; GOLDBERG EM, 1963, BRIT J PSYCHIAT, V109, P785, DOI 10.1192/bjp.109.463.785; Gould M, 2006, PSYCHIATR BULL, V30, P243, DOI 10.1192/pb.30.7.243; GRADDEALARCON J, 1975, PSYCHOL MED, V5, P32, DOI 10.1017/S0033291700007200; Grigoriadis S, 2002, CAN J PSYCHIAT, V47, P437, DOI 10.1177/070674370204700504; HAFNER H, 1993, BRIT J PSYCHIAT, V162, P80, DOI 10.1192/bjp.162.1.80; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; HARE EH, 1956, J MENT SCI, V102, P349, DOI 10.1192/bjp.102.427.349; Harrison G, 1997, PSYCHOL MED, V27, P799, DOI 10.1017/S0033291796004643; HARRISON G, 1988, PSYCHOL MED, V18, P643, DOI 10.1017/S0033291700008321; HARRISON G, 1991, BRIT J PSYCHIAT, V159, P811, DOI 10.1192/bjp.159.6.811; HEMSI LK, 1967, SOC PSYCHIATR, V2, P95, DOI 10.1007/BF00578322; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; HICKLING FW, 1995, BRIT J PSYCHIAT, V167, P193, DOI 10.1192/bjp.167.2.193; Hickling FW, 1999, BRIT J PSYCHIAT, V175, P283, DOI 10.1192/bjp.175.3.283; Hickman M, 2007, ADDICTION, V102, P597, DOI 10.1111/j.1360-0443.2006.01710.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HITCH PJ, 1980, BRIT J PSYCHIAT, V137, P206, DOI 10.1192/bjp.137.3.206; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Ihara K, 2009, PSYCHOPATHOLOGY, V42, P81, DOI 10.1159/000203340; JABLENSKY A, 1992, PSYCHOL MED, P1; Jackson D, METAANALYTIC A UNPUB; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X; JONES SJ, 1991, EUR J PSYCHIAT, V5, P22; JOYCE PR, 1987, AUST NZ J PSYCHIAT, V21, P82, DOI 10.3109/00048678709160903; Kennedy N, 2005, AM J PSYCHIAT, V162, P257, DOI 10.1176/appi.ajp.162.2.257; Kennedy N, 2005, PSYCHOL MED, V35, P855, DOI 10.1017/S0033291704003307; KING M, 1994, BMJ-BRIT MED J, V309, P1115, DOI 10.1136/bmj.309.6962.1115; Kirkbride JB, 2008, PSYCHOL MED, V38, P1083, DOI 10.1017/S0033291707002085; Kirkbride JB, 2008, BRIT J PSYCHIAT, V193, P18, DOI 10.1192/bjp.bp.107.041566; Kirkbride JB, 2009, INT J EPIDEMIOL, V38, P1255, DOI 10.1093/ije/dyn168; Kirkbride JB, 2007, PSYCHOL MED, V37, P1413, DOI 10.1017/S0033291707000499; Kirkbride JB, 2007, SOC PSYCH PSYCH EPID, V42, P438, DOI 10.1007/s00127-007-0193-0; Kirkbride JB, 2011, SCHIZOPHRENIA BULL, V37, P262, DOI 10.1093/schbul/sbq120; Kirkbride JB, 2006, ARCH GEN PSYCHIAT, V63, P250, DOI 10.1001/archpsyc.63.3.250; Kirkbride JB, 2012, BRIT J PSYCHIAT; Kirkbride JB, SYSTEMATIC IN PRESS; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; LEFF JP, 1976, BRIT J PSYCHIAT, V129, P428, DOI 10.1192/bjp.129.5.428; LEWIS G, 1992, LANCET, V340, P137, DOI 10.1016/0140-6736(92)93213-7; LEWIS G, 1990, BRIT J PSYCHIAT, V157, P410, DOI 10.1192/bjp.157.3.410; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; LITTLEWOOD R, 1981, PSYCHOL MED, V11, P289, DOI 10.1017/S0033291700052119; LITTLEWOOD R, 1978, PSYCHIAT CLIN, V11, P15, DOI 10.1159/000283721; Lloyd T, 2005, BRIT J PSYCHIAT, V186, P126, DOI 10.1192/bjp.186.2.126; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mahmmood MA, 2006, SCHIZOPHR RES, V86, pS66, DOI 10.1016/S0920-9964(06)70198-0; Mahy GE, 1999, BRIT J PSYCHIAT, V175, P28, DOI 10.1192/bjp.175.1.28; MALZBERG B, 1964, MENT HYG, V48, P478; Marcelis M, 1998, PSYCHOL MED, V28, P871, DOI 10.1017/S0033291798006898; March D, 2008, EPIDEMIOL REV, V30, P84, DOI 10.1093/epirev/mxn006; Mazzoncini R, 2010, ACTA PSYCHIAT SCAND, V121, P351, DOI 10.1111/j.1600-0447.2009.01483.x; MCGOVERN D, 1987, SOC PSYCHIATR, V22, P139, DOI 10.1007/BF00583848; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; McGrath J, 2001, SOC PSYCH PSYCH EPID, V36, P533, DOI 10.1007/s001270170003; McGrath JJ, 2006, SCHIZOPHRENIA BULL, V32, P195, DOI 10.1093/schbul/sbi052; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; McGrath JJ, 2007, ARCH GEN PSYCHIAT, V64, P14, DOI 10.1001/archpsyc.64.1.14; McNaught AS, 1997, BRIT J PSYCHIAT, V170, P307, DOI 10.1192/bjp.170.4.307; Metzl Jonathan, 2010, PROTEST PSYCHOSIS SC; Mitford E, POPULATION ADJ UNPUB; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Morgan C, 2006, PSYCHOL MED, V36, P239, DOI 10.1017/S0033291705006604; Morgan C, 2010, PSYCHOL MED, V40, P705, DOI 10.1017/S0033291709005546; Morgan C, 2008, PSYCHOL MED, V38, P1701, DOI 10.1017/S0033291708004534; Morgan C, 2007, PSYCHOL MED, V37, P495, DOI 10.1017/S0033291706009330; Morgan C, 2006, WORLD PSYCHIATRY, V5, P40; Mortensen PB, 1999, NEW ENGL J MED, V340, P603, DOI 10.1056/NEJM199902253400803; MUNKJORGENSEN P, 1992, BRIT J PSYCHIAT, V161, P489, DOI 10.1192/bjp.161.4.489; MUNKJORGENSEN P, 1993, EUR ARCH PSY CLIN N, V242, P244, DOI 10.1007/BF02189970; Niendam TA, 2009, NEUROPSYCHOL REV, V19, P280, DOI 10.1007/s11065-009-9108-z; Nixon NL, 2005, PSYCHOL MED, V35, P1145, DOI 10.1017/S0033291705004939; Norm R., 2011, PSYCHOL MED, P1, DOI DOI 10.1017/S0033291711001140; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Odegaard O, 1932, ACTA PSYCH NEUROL SU, P11; Office for National Statistics, 2001, COUNT EV BIG CHALL F; OPCS/GRO(S), 1994, UND GREAT BRIT 1991; Pedersen CB, 2006, BIPOLAR DISORD, V8, P242, DOI 10.1111/j.1399-5618.2006.00307.x; Power P, 2007, EARLY INTERV PSYCHIA, V1, P97, DOI 10.1111/j.1751-7893.2007.00010.x; PRINCE MJ, 1990, LANCET, V335, P851; Proctor SE, 2004, J EVAL CLIN PRACT, V10, P539, DOI 10.1111/j.1365-2753.2003.00474.x; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; R Core Team, 2021, R LANGUAGE ENV STAT; Reay R, 2010, ACTA PSYCHIAT SCAND, V121, P315, DOI 10.1111/j.1600-0447.2009.01505.x; Reininghaus U, 2010, SCHIZOPHR RES, V124, P43, DOI 10.1016/j.schres.2010.08.038; RIECHERROSSLER A, 1994, BIOL PSYCHIAT, V36, P492, DOI 10.1016/0006-3223(94)90649-1; RING N, 1991, ACTA PSYCHIAT SCAND, V84, P489, DOI 10.1111/j.1600-0447.1991.tb03182.x; Rota M, 2010, STAT MED, V29, P2679, DOI 10.1002/sim.4041; Rowlands RP, 2001, INT J CLIN PRACT, V55, P669; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; RWEGELLERA GGC, 1977, PSYCHOL MED, V7, P317, DOI 10.1017/S0033291700029421; Saha S, 2008, INT J METH PSYCH RES, V17, P55, DOI 10.1002/mpr.240; SARTORIUS N, 1986, PSYCHOL MED, V16, P909, DOI 10.1017/S0033291700011910; Schofield P, 2011, PSYCHOL MED, V41, P1263, DOI 10.1017/S0033291710001649; Scully PJ, 2004, SCHIZOPHR RES, V67, P143, DOI 10.1016/S0920-9964(03)00194-4; Selten JP, 2002, AM J PSYCHIAT, V159, P669, DOI 10.1176/appi.ajp.159.4.669; SHEPHERD M, 1989, PSYCHOL MED, P1, DOI 10.1017/S026418010000059X; Silver E, 2002, SOC SCI MED, V55, P1457, DOI 10.1016/S0277-9536(01)00266-0; Singh S., 2003, PSYCHIAT B, V27, P254, DOI [10.1017/S0955603600002531, DOI 10.1017/S0955603600002531]; Singh SP, 2004, BRIT J PSYCHIAT, V185, P452, DOI 10.1192/bjp.185.6.452; Singh SP, 2006, BMJ-BRIT MED J, V333, P648, DOI 10.1136/bmj.38930.501516.BE; SPICER CC, 1973, BRIT J PSYCHIAT, V123, P535, DOI 10.1192/bjp.123.5.535; Sterne JAC, 2004, STATA J, V4, P127, DOI 10.1177/1536867X0400400204; Susser E, 1996, ARCH GEN PSYCHIAT, V53, P25; Suvisaari JM, 1999, ARCH GEN PSYCHIAT, V56, P733, DOI 10.1001/archpsyc.56.8.733; TAKEI N, 1995, J EPIDEMIOL COMMUN H, V49, P106, DOI 10.1136/jech.49.1.106; TAKEI N, 1992, SCHIZOPHR RES, V6, P102, DOI 10.1016/0920-9964(92)90114-K; TAKEI N, 1995, EUR PSYCHIAT, V10, P165, DOI 10.1016/0767-399X(96)80059-9; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; THOMAS CS, 1993, BRIT J PSYCHIAT, V163, P91, DOI 10.1192/bjp.163.1.91; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Torrey EF, 2001, SCHIZOPHR RES, V49, P295, DOI 10.1016/S0920-9964(00)00081-5; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; Van Os J, 2000, BRIT J PSYCHIAT, V176, P243, DOI 10.1192/bjp.176.3.243; VANOS J, 1995, SOC PSYCH PSYCH EPID, V30, P161, DOI 10.1007/BF00790654; VANOS J, 1993, BRIT MED J, V307, P489, DOI 10.1136/bmj.307.6902.489; VanOs J, 1996, PSYCHOL MED, V26, P203, DOI 10.1017/S0033291700033845; vanOs J, 1996, SOC PSYCH PSYCH EPID, V31, P129, DOI 10.1007/BF00785759; Veling W, 2008, SOC PSYCH PSYCH EPID, V43, P953, DOI 10.1007/s00127-008-0381-6; Veling W, 2008, AM J PSYCHIAT, V165, P66, DOI 10.1176/appi.ajp.2007.07030423; Veling W, 2007, INT J EPIDEMIOL, V36, P761, DOI 10.1093/ije/dym085; Veling W, 2010, SCHIZOPHRENIA BULL, V36, P1149, DOI 10.1093/schbul/sbp032; Weiser M, 2008, PSYCHOL MED, V38, P1113, DOI 10.1017/S003329170700205X; White IR, 2011, STATA J, V11, P255, DOI 10.1177/1536867X1101100206; White IR, 2009, STATA J, V9, P40, DOI 10.1177/1536867X0900900103; Wicks S, 2005, AM J PSYCHIAT, V162, P1652, DOI 10.1176/appi.ajp.162.9.1652; Wing JK, 1976, PSYCHIAT SERVICES CA; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101; Zolkowska K, 2001, PSYCHOL MED, V31, P669, DOI 10.1017/S0033291701003786	201	303	307	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e31660	10.1371/journal.pone.0031660	http://dx.doi.org/10.1371/journal.pone.0031660			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	940QX	22457710	Green Published, gold			2022-12-27	WOS:000303909200002
J	Payne, JD; Tucker, MA; Ellenbogen, JM; Wamsley, EJ; Walker, MP; Schacter, DL; Stickgold, R				Payne, Jessica D.; Tucker, Matthew A.; Ellenbogen, Jeffrey M.; Wamsley, Erin J.; Walker, Matthew P.; Schacter, Daniel L.; Stickgold, Robert			Memory for Semantically Related and Unrelated Declarative Information: The Benefit of Sleep, the Cost of Wake	PLOS ONE			English	Article							PROCEDURAL MEMORY; CONSOLIDATION; SPINDLES; SYSTEMS	Numerous studies have examined sleep's influence on a range of hippocampus-dependent declarative memory tasks, from text learning to spatial navigation. In this study, we examined the impact of sleep, wake, and time-of-day influences on the processing of declarative information with strong semantic links (semantically related word pairs) and information requiring the formation of novel associations (unrelated word pairs). Participants encoded a set of related or unrelated word pairs at either 9am or 9pm, and were then tested after an interval of 30 min, 12 hr, or 24 hr. The time of day at which subjects were trained had no effect on training performance or initial memory of either word pair type. At 12 hr retest, memory overall was superior following a night of sleep compared to a day of wakefulness. However, this performance difference was a result of a pronounced deterioration in memory for unrelated word pairs across wake; there was no sleep-wake difference for related word pairs. At 24 hr retest, with all subjects having received both a full night of sleep and a full day of wakefulness, we found that memory was superior when sleep occurred shortly after learning rather than following a full day of wakefulness. Lastly, we present evidence that the rate of deterioration across wakefulness was significantly diminished when a night of sleep preceded the wake period compared to when no sleep preceded wake, suggesting that sleep served to stabilize the memories against the deleterious effects of subsequent wakefulness. Overall, our results demonstrate that 1) the impact of 12 hr of waking interference on memory retention is strongly determined by word-pair type, 2) sleep is most beneficial to memory 24 hr later if it occurs shortly after learning, and 3) sleep does in fact stabilize declarative memories, diminishing the negative impact of subsequent wakefulness.	[Payne, Jessica D.] Univ Notre Dame, Dept Psychol, Indiana, PA USA; [Payne, Jessica D.; Tucker, Matthew A.; Wamsley, Erin J.; Stickgold, Robert] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Payne, Jessica D.; Tucker, Matthew A.; Wamsley, Erin J.; Stickgold, Robert] Ctr Sleep & Cognit, Boston, MA USA; [Ellenbogen, Jeffrey M.] Massachusetts Gen Hosp, Dept Neurol, Sleep Div, Boston, MA 02114 USA; [Ellenbogen, Jeffrey M.] Harvard Med Sch, Div Sleep Med, Boston, MA USA; [Walker, Matthew P.] Univ Calif, Dept Psychol, Berkeley, CA USA; [Payne, Jessica D.; Schacter, Daniel L.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Notre Dame; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Harvard University	Payne, JD (corresponding author), Univ Notre Dame, Dept Psychol, Indiana, PA USA.	jpayne7@nd.edu		Schacter, Daniel/0000-0002-2460-6061; Wamsley, Erin/0000-0003-4465-3890	National Institutes of Health [R01-MH48832]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048832, R01MH092638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health R01-MH48832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Backhaus J, 2008, NEUROBIOL LEARN MEM, V89, P76, DOI 10.1016/j.nlm.2007.08.010; BENSON K, 1977, PSYCHOPHYSIOLOGY, V14, P375, DOI 10.1111/j.1469-8986.1977.tb02967.x; BENSON K, 1975, PSYCHOPHYSIOLOGY, V12, P192, DOI 10.1111/j.1469-8986.1975.tb01275.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ebbinghaus, 1885, GEDACHTNIS; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fischer S, 2011, J SLEEP RES, V20, P267, DOI 10.1111/j.1365-2869.2010.00881.x; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Kerkhof GA, 2010, PROG BRAIN RES, V185, P49, DOI 10.1016/B978-0-444-53702-7.00004-X; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Payne JD, 2010, CURR DIR PSYCHOL SCI, V19, P290, DOI 10.1177/0963721410383978; Payne JD, 2011, SLEEP MED CLIN, V6, P15, DOI 10.1016/j.jsmc.2010.12.005; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; Saletin JM, 2011, CEREB CORTEX; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Schmidt C, 2006, J NEUROSCI, V26, P8976, DOI 10.1523/JNEUROSCI.2464-06.2006; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Stickgold R, 2004, SLEEP, V27, P1443, DOI 10.1093/sleep/27.8.1443; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Van der Werf YD, 2009, P NATL ACAD SCI USA, V106, P18926, DOI 10.1073/pnas.0901320106; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	33	75	76	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33079	10.1371/journal.pone.0033079	http://dx.doi.org/10.1371/journal.pone.0033079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	940QX	22457736	gold, Green Published, Green Submitted			2022-12-27	WOS:000303909200018
J	Robert-Gangneux, F; Drogoul, AS; Rostan, O; Piquet-Pellorce, C; Cayon, J; Lisbonne, M; Herbelin, A; Gascan, H; Guiguen, C; Samson, M; Gangneux, JP				Robert-Gangneux, Florence; Drogoul, Anne-Sophie; Rostan, Octavie; Piquet-Pellorce, Claire; Cayon, Jerome; Lisbonne, Mariette; Herbelin, Andre; Gascan, Hugues; Guiguen, Claude; Samson, Michel; Gangneux, Jean-Pierre			Invariant NKT Cells Drive Hepatic Cytokinic Microenvironment Favoring Efficient Granuloma Formation and Early Control of Leishmania donovani Infection	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; KILLER T-CELLS; IMMUNE-RESPONSES; BONE-MARROW; MYCOBACTERIAL INFECTIONS; DEFICIENT MICE; CUTTING EDGE; LIVER-INJURY; IFN-GAMMA; ALPHA	The development of inflammatory granulomas around infected Kupffer cells is necessary for hepatic parasite clearance during visceral leishmaniasis. Invariant NKT (iNKT) cells are predominant T cells in the mouse liver and can synthesize large quantities of IL-4 and IFN-gamma, two cytokines involved in granuloma formation. This study analyzed the role of iNKT cells in the hepatic immune response during Leishmania donovani infection, using a murine model of wild-type (WT) and iNKT cell-deficient (J alpha 18(-/-)) C57BL/6 mice sacrificed 15, 30 or 60 days post-infection. We recorded hepatic parasite loads, cytokine expression, and analyzed granulomatous response by immunohistochemistry and hepatic immune cell infiltration by flow cytometry. Whereas WT animals rapidly controlled the infection and developed an inflammatory response associated with a massive influx of iNKT cells observed by flow cytometry, J alpha 18(-/-) mice had significantly higher parasitic loads on all time points. This lack of control of parasite burden was associated with a delay in granuloma maturation (28.1% of large granulomas at day 60 versus 50.7% in WT). Cytokine transcriptome analysis showed that mRNA of 90/101 genes encoding chemokines, cytokines and their receptors, was underexpressed in J alpha 18(-/-) mice. Detection of IL-4 and TNF-alpha by ELISA in liver extracts was also significantly lower in J alpha 18(-/-) mice. Consistent with flow cytometry analysis, cytokinome profile in WT mice showed a bias of expression towards T cell-chemoattractant chemokines on D15, and displayed a switch towards expression of granulocytes and/or monocytes -chemoattractant chemokines on D60. In J alpha 18(-/-) mice, the significantly lower expression of CXCL5, MIP-2 and CCL2 mRNA was correlated with a defect in myeloperoxidase positive-cell attraction observed by immunohistochemistry and with a lower granulocyte and monocyte infiltration in the liver, as shown by flow cytometry. These data indicate that iNKT cells play a role in early and sustained pro-inflammatory cytokine response warranting efficient organization of hepatic granulomas and parasite clearance.	[Robert-Gangneux, Florence; Drogoul, Anne-Sophie; Guiguen, Claude; Gangneux, Jean-Pierre] Ctr Hosp Univ Rennes, Parasitol Lab, Rennes, France; [Robert-Gangneux, Florence; Drogoul, Anne-Sophie; Rostan, Octavie; Piquet-Pellorce, Claire; Lisbonne, Mariette; Samson, Michel; Gangneux, Jean-Pierre] Univ Rennes 1, INSERM U1085, IRSET, Rennes, France; [Cayon, Jerome; Gascan, Hugues] Univ Angers, INSERM U564, Angers, France; [Herbelin, Andre] Univ Paris 11, INSERM U935, Villejuif, France	CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Robert-Gangneux, F (corresponding author), Ctr Hosp Univ Rennes, Parasitol Lab, Rennes, France.	florence.robert-gangneux@univ-rennes1.fr	Gangneux, Jean-Pierre/J-2960-2015; Herbelin, Andre/D-3096-2017; PIQUET-PELLORCE, Claire SL/I-4195-2015; Samson, Michel/F-8356-2013; ROBERT-GANGNEUX, Florence/I-4692-2015	Herbelin, Andre/0000-0003-0193-7084; PIQUET-PELLORCE, Claire SL/0000-0003-3198-1975; ROBERT-GANGNEUX, Florence/0000-0003-4493-596X; Gangneux, Jean-Pierre/0000-0002-4974-5607	Faculte de Medecine, Universite Rennes 1 (COREC); CPER Bretagne [360b]	Faculte de Medecine, Universite Rennes 1 (COREC); CPER Bretagne	This work was supported by a grant from the Faculte de Medecine, Universite Rennes 1 (COREC 2007) and by a grant from the CPER Bretagne - 360b 2007-2013/European funding FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amprey JL, 2004, J EXP MED, V200, P895, DOI 10.1084/jem.20040704; Apostolou I, 1999, P NATL ACAD SCI USA, V96, P5141, DOI 10.1073/pnas.96.9.5141; Beattie L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000805; Beattie L, 2010, EUR J IMMUNOL, V40, P117, DOI 10.1002/eji.200939863; BRADLEY DJ, 1977, CLIN EXP IMMUNOL, V30, P119; Campanelli AP, 2010, HUM IMMUNOL, V71, P1220, DOI 10.1016/j.humimm.2010.09.002; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cotterell SEJ, 1999, EUR J IMMUNOL, V29, P203, DOI 10.1002/(SICI)1521-4141(199901)29:01&lt;203::AID-IMMU203&gt;3.0.CO;2-B; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Emoto M, 2010, EUR J IMMUNOL, V40, P1328, DOI 10.1002/eji.200939594; Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Gomes-Pereira S, 2004, FEMS IMMUNOL MED MIC, V41, P59, DOI 10.1016/j.femsim.2004.01.003; Hansen DS, 2004, INT J PARASITOL, V34, P15, DOI 10.1016/j.ijpara.2003.09.007; Ilgoutz SC, 2001, INT J PARASITOL, V31, P899, DOI 10.1016/S0020-7519(01)00197-7; Im JS, 2008, CLIN IMMUNOL, V127, P214, DOI 10.1016/j.clim.2007.12.005; Ishikawa H, 2000, INT IMMUNOL, V12, P1267, DOI 10.1093/intimm/12.9.1267; Karmakar S, 2011, EUR J IMMUNOL, V41, P1376, DOI 10.1002/eji.201040981; Kaye PM, 2004, IMMUNOL REV, V201, P239, DOI 10.1111/j.0105-2896.2004.00188.x; Lehmann J, 2000, J INTERF CYTOK RES, V20, P63, DOI 10.1089/107999000312748; Lisbonne M, 2011, EUR J IMMUNOL, V41, P1720, DOI 10.1002/eji.201041006; Mattner J, 2006, MICROBES INFECT, V8, P354, DOI 10.1016/j.micinf.2005.07.002; McFarlane E, 2008, INFECT IMMUN, V76, P532, DOI 10.1128/IAI.01388-07; Mielke MEA, 1997, IMMUNOL REV, V158, P79, DOI 10.1111/j.1600-065X.1997.tb00994.x; Miller ML, 2009, J IMMUNOL, V183, P32, DOI 10.4049/jimmunol.0900690; MURRAY HW, 1992, J IMMUNOL, V148, P1858; Murray HW, 2000, INFECT IMMUN, V68, P6294, DOI 10.1128/IAI.68.11.6294-6299.2000; Murray HW, 2000, INFECT IMMUN, V68, P6289, DOI 10.1128/IAI.68.11.6289-6293.2000; MURRAY HW, 1995, J EXP MED, V181, P387, DOI 10.1084/jem.181.1.387; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Murray HW, 2001, INT J EXP PATHOL, V82, P249, DOI 10.1046/j.1365-2613.2001.00199.x; Osman Y, 2000, EUR J IMMUNOL, V30, P1919, DOI 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; Rai AK, 2011, PARASITE IMMUNOL, V33, P688, DOI 10.1111/j.1365-3024.2011.01328.x; Rai AK, 2011, INT J PARASITOL, V41, P1069, DOI 10.1016/j.ijpara.2011.05.010; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Satoskar AR, 2000, EUR J IMMUNOL, V30, P834, DOI 10.1002/1521-4141(200003)30:3&lt;834::AID-IMMU834&gt;3.0.CO;2-9; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Smelt SC, 2000, J IMMUNOL, V164, P3681, DOI 10.4049/jimmunol.164.7.3681; Sprengers D, 2008, GASTROENTEROLOGY, V134, P2132, DOI 10.1053/j.gastro.2008.02.037; SQUIRES KE, 1989, J IMMUNOL, V143, P4244; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Stanley AC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000028; STERN JJ, 1988, J IMMUNOL, V140, P3971; Svensson M, 2005, INFECT IMMUN, V73, P7541, DOI 10.1128/IAI.73.11.7541-7547.2005; Taylor AP, 1997, J EXP MED, V185, P1231, DOI 10.1084/jem.185.7.1231; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; TUMANG MCT, 1994, J IMMUNOL, V153, P768; Uemura Y, 2009, J IMMUNOL, V183, P201, DOI 10.4049/jimmunol.0900873; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; vonderWeid T, 1996, J IMMUNOL, V157, P4421; Zhu R, 2007, J IMMUNOL, V178, P5435, DOI 10.4049/jimmunol.178.9.5435	57	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33413	10.1371/journal.pone.0033413	http://dx.doi.org/10.1371/journal.pone.0033413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457760	Green Published, gold			2022-12-27	WOS:000303909200029
J	Kumar, A; Shivashankar, GV				Kumar, Abhishek; Shivashankar, G. V.			Mechanical Force Alters Morphogenetic Movements and Segmental Gene Expression Patterns during Drosophila Embryogenesis	PLOS ONE			English	Article							CELL-SHAPE CHANGES; LEFT-RIGHT ASYMMETRY; FOLDED-GASTRULATION; I MYOSINS; DIFFERENTIATION; MIGRATION; DYNAMICS; NETWORK; PROTEIN; TWIST	The development of an organism is accompanied by various cellular morphogenetic movements, changes in cellular as well as nuclear morphology and transcription programs. Recent evidence suggests that intra and inter-cellular connections mediated by various adhesion proteins contribute to defining nuclear morphology. In addition, three dimensional organization of the cell nucleus regulate the transcription programs. However the link between cellular morphogenetic movements and its coupling to nuclear function in a developmental context is poorly understood. In this paper we use a point perturbation by tissue level laser ablation and sheet perturbation by application of force using magnetic tweezers to alter cellular morphogenetic movements and probe its impact on nuclear morphology and segmental gene expression patterns. Mechanical perturbations during blastoderm stage in a developing Drosophila embryo resulted in localized alterations in nuclear morphology and cellular movement. In addition, global defects in germ-band (GB) extension and retraction are observed when external force is applied during morphogenetic movements, suggesting a long-range physical coupling within the GB layer of cells. Further local application of force resulted in redistribution of non muscle myosin-II in the GB layer. Finally these perturbations lead to altered segmental gene (engrailed) expression patterns later during the development. Our observations suggest that there exists a tight regulation between nuclear morphology and cellular adhesive connections during morphogenetic movement of cells in the embryo. The observed spatial changes in patterning genes, with perturbation, highlight the importance of nuclear integrity to cellular movement in establishing gene expression program in a developmental system.	[Kumar, Abhishek; Shivashankar, G. V.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Kumar, Abhishek; Shivashankar, G. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Kumar, Abhishek; Shivashankar, G. V.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); National University of Singapore; National University of Singapore	Kumar, A (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bellary Rd, Bangalore, Karnataka, India.	shiva.gvs@gmail.com	Kumar, Abhishek/F-3498-2018	Kumar, Abhishek/0000-0003-3235-1916	Nanoscience Initiative of Department of Science and Technology (DST), India	Nanoscience Initiative of Department of Science and Technology (DST), India	Nanoscience Initiative of Department of Science and Technology (DST), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aracena J, 2006, J THEOR BIOL, V239, P49, DOI 10.1016/j.jtbi.2005.07.011; ARIAS AM, 1988, DEVELOPMENT, V103, P157; Baum B, 2006, CURR BIOL, V16, pR502, DOI 10.1016/j.cub.2006.06.011; Bhattacharya D, 2009, BIOPHYS J, V96, P3832, DOI 10.1016/j.bpj.2008.11.075; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Debarre D, 2004, OPT LETT, V29, P2881, DOI 10.1364/OL.29.002881; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; JIANG J, 1991, GENE DEV, V5, P265, DOI 10.1101/gad.5.2.265; Kahn J, 2009, DEV CELL, V16, P734, DOI 10.1016/j.devcel.2009.04.013; KARR TL, 1989, DEVELOPMENT, V105, P605; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Lawrence P.A., 1989, Ciba Foundation Symposium, P131; LAWRENCE PA, 1989, DEVELOPMENT, V105, P761; Leptin M, 1995, ANNU REV CELL DEV BI, V11, P189; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Speder P, 2007, CURR OPIN CELL BIOL, V19, P82, DOI 10.1016/j.ceb.2006.12.006; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; Supatto W, 2005, P NATL ACAD SCI USA, V102, P1047, DOI 10.1073/pnas.0405316102; Taniguchi K, 2007, FLY, V1, P287, DOI 10.4161/fly.5252; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Woolner S, 2007, CURR BIOL, V17, pR289, DOI 10.1016/j.cub.2007.02.016; YOUNG PE, 1991, DEVELOPMENT, V111, P1	33	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33089	10.1371/journal.pone.0033089	http://dx.doi.org/10.1371/journal.pone.0033089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470437	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100014
J	Rodo, AP; Vachova, L; Palkova, Z				Rodo, Albert Pineda; Vachova, Libuse; Palkova, Zdena			In Vivo Determination of Organellar pH Using a Universal Wavelength-Based Confocal Microscopy Approach	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; YEAST COLONY DEVELOPMENT; INTRACELLULAR PH; PLASMA-MEMBRANE; CYTOSOLIC PH; CELLS; ACIDIFICATION; EXPRESSION; GROWTH; IDENTIFICATION	Many essential cellular processes are affected by transmembrane H+ gradients and intracellular pH (pHi). The research of such metabolic events calls for a non-invasive method to monitor pHi within individual subcellular compartments. We present a novel confocal microscopy approach for the determination of organellar pHi in living cells expressing pH-dependent ratiometric fluorescent proteins. Unlike conventional intensity-based fluorometry, our method relies on emission wavelength scans at single-organelle resolution to produce wavelength-based pH estimates both accurate and robust to low-signal artifacts. Analyses of Ato1p-pHluorin and Ato1p-mCherry yeast cells revealed previously unreported wavelength shifts in pHluorin emission which, together with ratiometric mCherry, allowed for high-precision quantification of actual physiological pH values and evidenced dynamic pHi changes throughout the different stages of yeast colony development. Additionally, comparative pH quantification of Ato1p-pHluorin and Met17p-pHluorin cells implied the existence of a significant pHi gradient between peripheral and internal cytoplasm of cells from colonies occurring in the ammonia-producing alkali developmental phase. Results represent a step forward in the study of pHi regulation and subcellular metabolic functions beyond the scope of this study.	[Rodo, Albert Pineda; Vachova, Libuse; Palkova, Zdena] Charles Univ Prague, Dept Genet & Microbiol, Prague, Czech Republic; [Vachova, Libuse] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Palkova, Z (corresponding author), Charles Univ Prague, Dept Genet & Microbiol, Prague, Czech Republic.	zdenap@natur.cuni.cz	Palkova, Zdena/M-8692-2014; Vachova, Libuse/H-7620-2014	Palkova, Zdena/0000-0002-0864-8042; Vachova, Libuse/0000-0002-8143-6054	Grant Agency of the Czech Republic [204/08/0718]; Ministry of Education [LC06063, MSM0021620858]; Howard Hughes Medical Institute [55005623]; Charles University in Prague [UNCE 204013]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Charles University in Prague	This study was supported by the Grant Agency of the Czech Republic 204/08/0718, the Ministry of Education LC06063 and MSM0021620858, by the Howard Hughes Medical Institute International Research Award (#55005623 to Dr. Palkova) and by Charles University in Prague (UNCE 204013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Bagar T, 2009, EUKARYOT CELL, V8, P703, DOI 10.1128/EC.00333-08; Bizzarri R, 2006, BIOPHYS J, V90, P3300, DOI 10.1529/biophysj.105.074708; BOGONEZ E, 1983, BIOCHIM BIOPHYS ACTA, V733, P234, DOI 10.1016/0005-2736(83)90527-8; Bour-Dill C, 2000, CYTOMETRY, V39, P16, DOI 10.1002/(SICI)1097-0320(20000101)39:1<16::AID-CYTO4>3.0.CO;2-I; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; DAVIES L, 1993, CELL, V75, P321, DOI 10.1016/0092-8674(93)80073-N; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Desai MJ, 2003, MICROBIOL MOL BIOL R, V67, P38, DOI 10.1128/MMBR.67.1.38-51.2003; Disbrow GL, 2005, J VIROL, V79, P5839, DOI 10.1128/JVI.79.9.5839-5846.2005; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gori K, 2007, J DAIRY SCI, V90, P5032, DOI 10.3168/jds.2006-750; Granseth B, 2007, J PHYSIOL-LONDON, V585, P681, DOI 10.1113/jphysiol.2007.139022; IMAI T, 1995, J BIOTECHNOL, V38, P165, DOI 10.1016/0168-1656(94)00130-5; Jankowski A, 2001, J BIOL CHEM, V276, P48748, DOI 10.1074/jbc.M109003200; Karagiannis J, 2001, J CELL SCI, V114, P2929; Lasorsa FM, 2004, BIOCHEM J, V381, P581, DOI 10.1042/BJ20040856; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Mahon MJ, 2011, ADV BIOSCI BIOTECHNO, V2, P2156; Maresova L, 2010, YEAST, V27, P317, DOI 10.1002/yea.1755; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; McDonald NA, 2007, MOL CELL NEUROSCI, V35, P237, DOI 10.1016/j.mcn.2007.02.016; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moseyko N, 2001, PLANT CELL ENVIRON, V24, P557, DOI 10.1046/j.1365-3040.2001.00703.x; Mukherjee S, 2006, BIOCHEM J, V398, P97, DOI 10.1042/BJ20060388; Nehrke Keith, 2006, V351, P223; Olsen KN, 2002, APPL ENVIRON MICROB, V68, P4145, DOI 10.1128/AEM.68.8.4145-4147.2002; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Paiva S, 2002, BIOCHEM J, V363, P737, DOI 10.1042/0264-6021:3630737; Palkova Z, 2000, J CELL SCI, V113, P1923; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; Palkova Z, 2009, MOL MEMBR BIOL, V26, P228, DOI 10.1080/09687680902893130; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; PRESTON RA, 1989, P NATL ACAD SCI USA, V86, P7027, DOI 10.1073/pnas.86.18.7027; Ricicova M, 2007, BBA-BIOMEMBRANES, V1768, P1170, DOI 10.1016/j.bbamem.2007.02.011; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vachova L, 2009, ENVIRON MICROBIOL, V11, P494, DOI 10.1111/j.1462-2920.2008.01789.x; van Roermund CWT, 2004, J CELL SCI, V117, P4231, DOI 10.1242/jcs.01305; Varlamov O, 2010, AM J PHYSIOL-ENDOC M, V299, pE486, DOI 10.1152/ajpendo.00330.2010; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; Xiong G, 2007, ANALYST, V128, P581	50	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33229	10.1371/journal.pone.0033229	http://dx.doi.org/10.1371/journal.pone.0033229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470445	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100023
J	Reina-Bueno, M; Argandona, M; Salvador, M; Rodriguez-Moya, J; Iglesias-Guerra, F; Csonka, LN; Nieto, JJ; Vargas, C				Reina-Bueno, Mercedes; Argandona, Montserrat; Salvador, Manuel; Rodriguez-Moya, Javier; Iglesias-Guerra, Fernando; Csonka, Laszlo N.; Nieto, Joaquin J.; Vargas, Carmen			Role of Trehalose in Salinity and Temperature Tolerance in the Model Halophilic Bacterium Chromohalobacter salexigens	PLOS ONE			English	Article							ESCHERICHIA-COLI; HALOMONAS-ELONGATA; COMPATIBLE SOLUTES; DESICCATION TOLERANCE; GLYCINE BETAINE; BIOSYNTHESIS; CLONING; SYNTHASE; GENES; ACCUMULATION	The disaccharide trehalose is considered as a universal stress molecule, protecting cells and biomolecules from injuries imposed by high osmolarity, heat, oxidation, desiccation and freezing. Chromohalobacter salexigens is a halophilic and extremely halotolerant gamma-proteobacterium of the family Halomonadaceae. In this work, we have investigated the role of trehalose as a protectant against salinity, temperature and desiccation in C. salexigens. A mutant deficient in the trehalose-6-phosphate synthase gene (otsA::Omega) was not affected in its salt or heat tolerance, but double mutants ectoine-and trehalose-deficient, or hydroxyectoine-reduced and trehalose-deficient, displayed an osmo- and thermosensitive phenotype, respectively. This suggests a role of trehalose as a secondary solute involved in osmo-(at least at low salinity) and thermoprotection of C. salexigens. Interestingly, trehalose synthesis was osmoregulated at the transcriptional level, and thermoregulated at the post-transcriptional level, suggesting that C. salexigens cells need to be pre-conditioned by osmotic stress, in order to be able to quickly synthesize trehalose in response to heat stress. C. salexigens was more sensitive to desiccation than E. coli and desiccation tolerance was slightly improved when cells were grown at high temperature. Under these conditions, single mutants affected in the synthesis of trehalose or hydroxyectoine were more sensitive to desiccation than the wild-type strain. However, given the low survival rates of the wild type, the involvement of trehalose and hydroxyectoine in C. salexigens response to desiccation could not be firmly established.	[Reina-Bueno, Mercedes; Argandona, Montserrat; Salvador, Manuel; Rodriguez-Moya, Javier; Nieto, Joaquin J.; Vargas, Carmen] Univ Seville, Dept Microbiol & Parasitol, Seville, Spain; [Iglesias-Guerra, Fernando] Univ Seville, Dept Organ & Pharmaceut Chem, Seville, Spain; [Csonka, Laszlo N.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	University of Sevilla; University of Sevilla; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Reina-Bueno, M (corresponding author), Univ Seville, Dept Microbiol & Parasitol, Seville, Spain.	cvargas@us.es	/AAA-4450-2019; Vargas, Carmen/A-6283-2018; Salvador de Lara, Manuel/H-2960-2015; Argandoña, Montserrat/H-5531-2015; Gutiérrez, Joaquín José Nieto/K-9974-2014	/0000-0002-7203-5777; Vargas, Carmen/0000-0002-4094-4319; Salvador de Lara, Manuel/0000-0002-1966-2480; Gutiérrez, Joaquín José Nieto/0000-0001-8879-819X; Argandona, Montserrat/0000-0002-2635-1023	Spanish Ministerio de Ciencia e Innovacion [BIO2008-04117]; Junta de Andalucia [P08-CVI-03724]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia)	This research was financially supported by grants from the Spanish Ministerio de Ciencia e Innovacion (BIO2008-04117), and Junta de Andalucia (P08-CVI-03724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarico S, 2005, APPL ENVIRON MICROB, V71, P2460, DOI 10.1128/AEM.71.5.2460-2466.2005; Arahal DR, 2001, INT J SYST EVOL MICR, V51, P1443, DOI 10.1099/00207713-51-4-1443; Argandona M, 2010, APPL ENVIRON MICROB, V76, P3575, DOI 10.1128/AEM.03136-09; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; BLAZQUEZ MA, 1994, J BACTERIOL, V176, P3895; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROWN AD, 1976, BACTERIOL REV, V40, P803, DOI 10.1128/MMBR.40.4.803-846.1976; Calderon MI, 2004, MICROBIOL-SGM, V150, P3051, DOI 10.1099/mic.0.27122-0; Canovas D, 1996, J BACTERIOL, V178, P7221, DOI 10.1128/jb.178.24.7221-7226.1996; Canovas D, 1999, APPL ENVIRON MICROB, V65, P3774; Canovas D, 2001, J BACTERIOL, V183, P3365, DOI 10.1128/JB.183.11.3365-3371.2001; Canovas D, 2000, MICROBIOL-SGM, V146, P455, DOI 10.1099/00221287-146-2-455; Canovas D, 1997, J BIOL CHEM, V272, P25794, DOI 10.1074/jbc.272.41.25794; CSONKA LN, 1982, J BACTERIOL, V151, P1433, DOI 10.1128/JB.151.3.1433-1443.1982; Cytryn EJ, 2007, J BACTERIOL, V189, P6751, DOI 10.1128/JB.00533-07; da Costa M. S., 1998, V61, P117; de Castro AG, 2000, APPL ENVIRON MICROB, V66, P4142, DOI 10.1128/AEM.66.9.4142-4144.2000; De Smet KAL, 2000, MICROBIOL-UK, V146, P199, DOI 10.1099/00221287-146-1-199; DEVIRGILIO C, 1994, EUR J BIOCHEM, V219, P179; Dominguez-Ferreras A, 2009, J BACTERIOL, V191, P7490, DOI 10.1128/JB.00725-09; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Empadinhas N, 2006, INT MICROBIOL, V9, P199; Empadinhas N, 2011, ENVIRON MICROBIOL, V13, P2056, DOI 10.1111/j.1462-2920.2010.02390.x; Galinski E A, 1995, Adv Microb Physiol, V37, P272, DOI 10.1016/S0065-2911(08)60148-4; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harishchandra RK, 2010, BIOPHYS CHEM, V150, P37, DOI 10.1016/j.bpc.2010.02.007; KESSLER B, 1992, MOL GEN GENET, V233, P293, DOI 10.1007/BF00587591; Kraegeloh A, 2002, EXTREMOPHILES, V6, P453, DOI 10.1007/s00792-002-0277-4; LARSEN PI, 1987, ARCH MICROBIOL, V147, P1, DOI 10.1007/BF00492896; LeBlanc JC, 2008, APPL ENVIRON MICROB, V74, P2627, DOI 10.1128/AEM.02711-07; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; LOUIS P, 1994, APPL MICROBIOL BIOT, V41, P684; Manzanera M, 2004, FEMS MICROBIOL LETT, V233, P347, DOI 10.1016/j.femsle.2004.03.005; Manzanera M, 2002, APPL ENVIRON MICROB, V68, P4328, DOI 10.1128/AEM.68.9.4328-4333.2002; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Maruta K, 1996, BBA-GEN SUBJECTS, V1291, P177, DOI 10.1016/S0304-4165(96)00082-7; Maruta K, 1996, BIOSCI BIOTECH BIOCH, V60, P717, DOI 10.1271/bbb.60.717; Miller J.H., 1992, SHORT COURSE BACTERI, P150; NIETO JJ, 1989, APPL ENVIRON MICROB, V55, P2385, DOI 10.1128/AEM.55.9.2385-2390.1989; Nobre A, 2008, J BACTERIOL, V190, P7939, DOI 10.1128/JB.01055-08; Oren A, 2008, SALINE SYSTEMS, V15, P4; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Potts M, 2001, TRENDS MICROBIOL, V9, P553, DOI 10.1016/S0966-842X(01)02231-4; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Qu QH, 2004, J BIOL CHEM, V279, P47890, DOI 10.1074/jbc.M404955200; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryu SI, 2005, BIOCHEM BIOPH RES CO, V329, P429, DOI 10.1016/j.bbrc.2005.01.149; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; Saum Stephan H, 2008, Saline Syst, V4, P4, DOI 10.1186/1746-1448-4-4; Sawangwan T, 2010, BIOTECHNOL J, V5, P187, DOI 10.1002/biot.200900197; SEVERIN J, 1992, J GEN MICROBIOL, V138, P1629, DOI 10.1099/00221287-138-8-1629; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Tsusaki K, 1997, BBA-GEN SUBJECTS, V1334, P28, DOI 10.1016/S0304-4165(96)00103-1; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Vargas C, 2006, J APPL MICROBIOL, V100, P98, DOI 10.1111/j.1365-2672.2005.02757.x; Vargas C, 1997, SYST APPL MICROBIOL, V20, P173, DOI 10.1016/S0723-2020(97)80063-X; Vargas Carmen, 2008, Saline Syst, V4, P14, DOI 10.1186/1746-1448-4-14; Ventosa A, 1998, MICROBIOL MOL BIOL R, V62, P504, DOI 10.1128/MMBR.62.2.504-544.1998; VREELAND RH, 1980, INT J SYST BACTERIOL, V30, P485, DOI 10.1099/00207713-30-2-485; Wannet WJB, 1998, BBA-GEN SUBJECTS, V1425, P177, DOI 10.1016/S0304-4165(98)00066-X; WELSH DT, 1991, J GEN MICROBIOL, V137, P745, DOI 10.1099/00221287-137-4-745; Welsh DT, 1999, FEMS MICROBIOL LETT, V174, P57, DOI 10.1016/S0378-1097(99)00122-6; Welsh DT, 2000, FEMS MICROBIOL REV, V24, P263, DOI 10.1111/j.1574-6976.2000.tb00542.x	70	40	40	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33587	10.1371/journal.pone.0033587	http://dx.doi.org/10.1371/journal.pone.0033587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448254	gold, Green Published, Green Submitted			2022-12-27	WOS:000303855700045
J	Shao, LJ; Feng, W; Lee, KJ; Chen, BPC; Zhou, DH				Shao, Lijian; Feng, Wei; Lee, Kyung-Jong; Chen, Benjamin P. C.; Zhou, Daohong			A Sensitive and Quantitative Polymerase Chain Reaction-Based Cell Free In Vitro Non-Homologous End Joining Assay for Hematopoietic Stem Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE REPAIR; CANCER; PATHWAYS; ATM	Hematopoietic stem cells (HSCs) are responsible for sustaining hematopoietic homeostasis and regeneration after injury for the entire lifespan of an organism. Maintenance of genomic stability is crucial for the preservation of HSCs, which depends on their efficient repair of DNA damage, particularly DNA double strand breaks (DSBs). Because of the paucity of HSCs and lack of sensitive assays, directly measuring the ability of HSCs to repair DSBs has been difficult. Therefore, we developed a sensitive and quantitative cell free in vitro non-homologous end joining (NHEJ) assay using linearized plasmids as the substrates and quantitative polymerase chain reaction (qPCR) technique. This assay can sensitively detect DSB repair via NHEJ in less than 1 mu g 293T cell nuclear proteins or nuclear extracts from about 5,000 to 10,000 human BM CD34(+) hematopoietic cells. Using this assay, we confirmed that human bone marrow HSCs (CD34(+)CD38(-) cells) are less proficient in the repair of DSBs by NHEJ than HPCs (CD34(+)CD38(+) cells). In contrast, mouse quiescent HSCs (Pyronin-Y-low LKS+ cells) and cycling HSCs (Pyronin-Y-hi LKS+ cells) repaired the damage more efficiently than HPCs (LKS- cells). The difference in the abilities of human and mouse HSCs and HPCs to repair DSBs through NHEJ is likely attributed to their differential expression of key NHEJ DNA damage repair genes such as LIG4. These findings suggest that the qPCR-based cell free in vitro NHEJ assay can be used to sensitively measure the ability of human and mouse HSCs to repair DSBs.	[Shao, Lijian; Feng, Wei; Zhou, Daohong] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Lee, Kyung-Jong; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Texas System; University of Texas Southwestern Medical Center Dallas	Shao, LJ (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.	dzhou@uams.edu	Shao, Lijian/AAA-1074-2020		National Institutes of Health (US) [R01-CA086688, CA102558, AI080421]; Winthrop Rockefeller Endowment for Leukemia Research; Arkansas Science & Technology Authority; NATIONAL CANCER INSTITUTE [R01CA122023, R01CA102558, R01CA086860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080421] Funding Source: NIH RePORTER	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winthrop Rockefeller Endowment for Leukemia Research; Arkansas Science & Technology Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National Institutes of Health (US) R01-CA086688, CA102558, and AI080421; the Winthrop Rockefeller Endowment for Leukemia Research; and the Arkansas Research Alliance Scholarship from the Arkansas Science & Technology Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Lane AA, 2010, CELL, V142, P360, DOI 10.1016/j.cell.2010.07.030; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Phillips ER, 2007, ONCOGENE, V26, P7799, DOI 10.1038/sj.onc.1210877; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Seita J, 2010, CELL STEM CELL, V7, P145, DOI 10.1016/j.stem.2010.07.006; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Tomimatsu N, 2007, J BIOL CHEM, V282, P10138, DOI 10.1074/jbc.M611880200; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418	21	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33499	10.1371/journal.pone.0033499	http://dx.doi.org/10.1371/journal.pone.0033499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448248	Green Submitted, Green Published, gold			2022-12-27	WOS:000303855700039
J	Zaman, F; Chrysis, D; Huntjens, K; Fadeel, B; Savendahl, L				Zaman, Farasat; Chrysis, Dionisios; Huntjens, Kirsten; Fadeel, Bengt; Savendahl, Lars			Ablation of the Pro-Apoptotic Protein Bax Protects Mice from Glucocorticoid-Induced Bone Growth Impairment	PLOS ONE			English	Article							RAT METATARSAL BONES; CELL-DEATH; PLATE CHONDROCYTES; FEMALE MICE; DEXAMETHASONE; ACTIVATION; EXPRESSION; CARTILAGE; RETARDATION; RECEPTOR	Dexamethasone (Dexa) is a widely used glucocorticoid to treat inflammatory diseases; however, a multitude of undesired effects have been reported to arise from this treatment including osteoporosis, obesity, and in children decreased longitudinal bone growth. We and others have previously shown that glucocorticoids induce apoptosis in growth plate chondrocytes. Here, we hypothesized that Bax, a pro-apoptotic member of the Bcl-2 family, plays a key role in Dexa-induced chondrocyte apoptosis and bone growth impairment. Indeed, experiments in the human HCS-2/8 chondrocytic cell line demonstrated that silencing of Bax expression using small-interfering (si) RNA efficiently blocked Dexa-induced apoptosis. Furthermore, ablation of Bax in female mice protected against Dexa-induced bone growth impairment. Finally, Bax activation by Dexa was confirmed in human growth plate cartilage specimens cultured ex vivo. Our findings could therefore open the door for new therapeutic approaches to prevent glucocorticoid-induced bone growth impairment through specific targeting of Bax.	[Zaman, Farasat; Chrysis, Dionisios; Huntjens, Kirsten; Savendahl, Lars] Karolinska Inst, Pediat Endocrinol Unit, Dept Womens & Childrens Hlth, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Fadeel, Bengt] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Zaman, F (corresponding author), Karolinska Inst, Pediat Endocrinol Unit, Dept Womens & Childrens Hlth, Astrid Lindgren Childrens Hosp, Stockholm, Sweden.	Farasat.Zaman@ki.se	CHRYSIS, DIONISIOS/HGB-4107-2022; Zaman, Farasat/AAE-1144-2020	Savendahl, Lars/0000-0003-1067-4976	Swedish Research Council; Swedish Childhood Cancer Foundation; Sallskapet Barnavard; Stiftelsen Frimurare Barnhuset i Stockholm; HKH Kronprinsessan Lovisas Forening for Barnasjukvard	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Sallskapet Barnavard; Stiftelsen Frimurare Barnhuset i Stockholm; HKH Kronprinsessan Lovisas Forening for Barnasjukvard	The authors received support from the Swedish Research Council (www.vr.se), the Swedish Childhood Cancer Foundation (www.barncancerfonden.se/), Sallskapet Barnavard, Stiftelsen Frimurare Barnhuset i Stockholm (www.kungahuset.se), and HKH Kronprinsessan Lovisas Forening for Barnasjukvard (www.kronprinsessanlovisa.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Chagin AS, 2007, BONE, V40, P1415, DOI 10.1016/j.bone.2006.12.066; Chagin AS, 2010, J ENDOCRINOL, V204, P21, DOI 10.1677/JOE-09-0307; Chagin AS, 2004, J BONE MINER RES, V19, P72, DOI 10.1359/JBMR.0301203; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; Chrysis D, 2003, J ENDOCRINOL, V176, P331, DOI 10.1677/joe.0.1760331; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Del Poeta G, 2008, CURR CANCER DRUG TAR, V8, P207; Espina B, 2008, J CELL PHYSIOL, V215, P488, DOI 10.1002/jcp.21335; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Frankfurt O, 2004, CURR OPIN ONCOL, V16, P553, DOI 10.1097/01.cco.0000142072.22226.09; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hilbers I, 2003, RHEUMATOL INT, V23, P75, DOI 10.1007/s00296-002-0255-2; HUNZIKER EB, 1987, J BONE JOINT SURG AM, V69A, P162, DOI 10.2106/00004623-198769020-00002; Ishikawa S, 1997, ACTA MED OKAYAMA, V51, P279; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4; Lehmann K, 2006, EUR J HUM GENET, V14, P1248, DOI 10.1038/sj.ejhg.5201708; Li WZ, 2010, EUR J PHARMACOL, V628, P108, DOI 10.1016/j.ejphar.2009.11.045; Liang M, 2008, J BONE MINER RES, V23, P610, DOI [10.1359/jbmr.080106, 10.1359/JBMR.080106]; Liu Y, 2004, J BONE MINER RES, V19, P479, DOI 10.1359/JBMR.0301242; Lu YHCS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3456; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Malone MH, 2004, J BIOL CHEM, V279, P52850, DOI 10.1074/jbc.M408040200; Martensson K, 2004, J BONE MINER RES, V19, P1805, DOI 10.1359/JBMR.040805; Milosevic J, 2004, EXP CELL RES, V294, P9, DOI 10.1016/j.yexcr.2003.10.033; Mushtaq T, 2004, ENDOCRINOLOGY, V145, P2478, DOI 10.1210/en.2003-1435; Mushtaq T, 2002, J ENDOCRINOL, V175, P705, DOI 10.1677/joe.0.1750705; Mushtaq T, 2002, ARCH DIS CHILD, V87, P93, DOI 10.1136/adc.87.2.93; Oshima Y, 2004, MUSCLE NERVE, V30, P49, DOI 10.1002/mus.20036; Perez GI, 2007, P NATL ACAD SCI USA, V104, P5229, DOI 10.1073/pnas.0608557104; Purton JF, 2004, J IMMUNOL, V173, P3816, DOI 10.4049/jimmunol.173.6.3816; Rooman RPA, 2003, ENDOCRINOLOGY, V144, P2553, DOI 10.1210/en.2003-0062; Rundle CH, 2008, BONE, V43, P880, DOI 10.1016/j.bone.2008.07.239; Savendahl L, 2005, HORM RES, V64, P94, DOI 10.1159/000087764; Schulze J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010309; Siebler T, 2002, BONE, V31, P457, DOI 10.1016/S8756-3282(02)00855-4; Smink JJ, 2003, J ENDOCRINOL, V177, P381, DOI 10.1677/joe.0.1770381; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Tivesten A, 2004, J BONE MINER RES, V19, P1833, DOI 10.1359/JBMR.040819; Tome ME, 2004, BBA-MOL CELL RES, V1693, P57, DOI 10.1016/j.bbamcr.2004.05.004; Tsao CH, 2008, J GEN VIROL, V89, P1930, DOI 10.1099/vir.0.2008/000182-0; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Zaman F, 2007, CANCER RES, V67, P10078, DOI 10.1158/0008-5472.CAN-06-3982	48	24	25	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33168	10.1371/journal.pone.0033168	http://dx.doi.org/10.1371/journal.pone.0033168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442678	Green Published, Green Submitted, gold			2022-12-27	WOS:000303836500020
J	Zhao, JJ; Pan, K; Wang, W; Chen, JG; Wu, YH; Lv, L; Li, JJ; Chen, YB; Wang, DD; Pan, QZ; Li, XD; Xia, JC				Zhao, Jing-jing; Pan, Ke; Wang, Wei; Chen, Ju-gao; Wu, Yan-heng; Lv, Lin; Li, Jian-jun; Chen, Yi-bing; Wang, Dan-dan; Pan, Qiu-zhong; Li, Xiao-dong; Xia, Jian-chuan			The Prognostic Value of Tumor-Infiltrating Neutrophils in Gastric Adenocarcinoma after Resection	PLOS ONE			English	Article							PREDICTS POOR SURVIVAL; PREOPERATIVE NEUTROPHIL; ANGIOGENIC SWITCH; MOUSE MODEL; CANCER; CELLS; CARCINOGENESIS; CARCINOMA; RATIO; INFLAMMATION	Background: Several pieces of evidence indicate that tumor-infiltrating neutrophils (TINs) are correlated to tumor progression. In the current study, we explore the relationship between TINs and clinicopathological features of gastric adenocarcinoma patients. Furthermore, we investigated the prognostic value of TINs. Patients and Methods: The study was comprised of two groups, training group (115 patients) and test group (97 patients). Biomarkers (intratumoral CD15+ neutrophils) were assessed by immunohistochemistry. The relationship between clinicopathological features and patient outcome were evaluated using Cox regression and Kaplan-Meier analysis. Results: Immunohistochemical detection showed that the tumor-infiltrating neutrophils (TINs) in the training group ranged from 0.00-115.70 cells/high-power microscopic field (HPF) and the median number was 21.60 cells/HPF. Based on the median number, the patients were divided into high and low TINs groups. Chi-square test analysis revealed that the density of CD15+ TINs was positively associated with lymph node metastasis (p = 0.024), distance metastasis (p = 0.004) and UICC (International Union Against Cancer) staging (p = 0.028). Kaplan-Meier analysis showed that patients with a lower density of TINs had a better prognosis than patients with a higher density of TINs (p = 0.002). Multivariate Cox's analysis showed that the density of CD15+ TINs was an independent prognostic factor for overall survival of gastric adenocarcinoma patients. Using another 97 patients as a test group and basing on the median number of TINs (21.60 cells/HPF) coming from the training group, Kaplan-Meier analysis also showed that patients with a lower density of TINs had a better prognosis than patients with a higher density of TINs (p = 0.032). The results verify that the number of CD15+ TINs can predict the survival of gastric adenocarcinoma surgical patients. Conclusions: The presence of CD15+ TINs is an independent and unfavorable factor in the prognosis of gastric adenocarcinoma patients. Targeting CD15+ TINs may be a potential intervenient therapy in the future.	[Zhao, Jing-jing; Pan, Ke; Wang, Wei; Chen, Ju-gao; Lv, Lin; Li, Jian-jun; Chen, Yi-bing; Wang, Dan-dan; Pan, Qiu-zhong; Li, Xiao-dong; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Jing-jing; Pan, Ke; Wang, Wei; Chen, Ju-gao; Lv, Lin; Li, Jian-jun; Chen, Yi-bing; Wang, Dan-dan; Pan, Qiu-zhong; Li, Xiao-dong; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Li, Xiao-dong] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Yan-heng] Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Jinan University	Zhao, JJ (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	lixd@sysucc.org.cn; xiajch@mail.sysu.edu.cn			National Natural Science Foundation of China [u0772002, 30700985, 30973398]; Guangdong Natural Science Foundation [925100890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (u0772002, 30700985, 30973398) and Guangdong Natural Science Foundation (925100890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Benelli R, 2003, CHEM IMMUNOL, V83, P167; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Caruso RA, 2002, MODERN PATHOL, V15, P831, DOI 10.1097/01.MP.0000020391.98998.6B; Chen JG, 2011, INT J BIOL SCI, V7, P53, DOI 10.7150/ijbs.7.53; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daniel D, 2005, CANCER RES, V65, P2018, DOI 10.1158/0008-5472.CAN-04-3444; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Jung MR, 2011, J SURG ONCOL, V104, P504, DOI 10.1002/jso.21986; Kuang DM, 2010, J HEPATOL; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Li YW, 2011, J HEPATOL, V54, P497, DOI 10.1016/j.jhep.2010.07.044; Lv L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018219; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Paesmans M, 2000, CANCER, V89, P523, DOI 10.1002/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO;2-6; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Schmidt H, 2007, J CLIN ONCOL, V25, P1562, DOI 10.1200/JCO.2006.09.0274; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Strell C, 2010, EXP CELL RES, V316, P138, DOI 10.1016/j.yexcr.2009.09.003; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060	29	81	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33655	10.1371/journal.pone.0033655	http://dx.doi.org/10.1371/journal.pone.0033655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	22442706	Green Submitted, Green Published, gold			2022-12-27	WOS:000303836500047
J	Cardeal, LBD; Boccardo, E; Termini, L; Rabachini, T; Andreoli, MA; di Loreto, C; Longatto, A; Villa, LL; Maria-Engler, SS				da Silva Cardeal, Laura Beatriz; Boccardo, Enrique; Termini, Lara; Rabachini, Tatiana; Andreoli, Maria Antonieta; di Loreto, Celso; Longatto Filho, Adhemar; Villa, Luisa Lina; Maria-Engler, Silvya Stuchi			HPV16 Oncoproteins Induce MMPs/RECK-TIMP-2 Imbalance in Primary Keratinocytes: Possible Implications in Cervical Carcinogenesis	PLOS ONE			English	Article							CYSTEINE-RICH PROTEIN; MATRIX-METALLOPROTEINASE; TISSUE INHIBITOR; GENE-EXPRESSION; REGULATOR RECK; KAZAL MOTIFS; CARCINOMA; CANCER; MMP-2; MATRIX-METALLOPROTEINASE-9	Cervical cancer is the third most common cancer in women worldwide. Persistent infection with high-risk HPV types, principally HPV16 and 18 is the main risk factor for the development of this malignancy. However, the onset of invasive tumor occurs many years after initial exposure in a minority of infected women. This suggests that other factors beyond viral infection are necessary for tumor establishment and progression. Tumor progression is characterized by an increase in secretion and activation of matrix metalloproteinases (MMPs) produced by either the tumor cells themselves or tumor-associated fibroblasts or macrophages. Increased MMPs expression, including MMP-2, MMP-9 and MT1-MMP, has been observed during cervical carcinoma progression. These proteins have been associated with degradation of ECM components, tumor invasion, metastasis and recurrence. However, few studies have evaluated the interplay between HPV infection and the expression and activity of MMPs and their regulators in cervical cancer. We analyzed the effect of HPV16 oncoproteins on the expression and activity of MMP-2, MMP-9, MT1-MMP, and their inhibitors TIMP-2 and RECK in cultures of human keratinocytes. We observed that E7 expression is associated with increased pro-MMP-9 activity in the epithelial component of organotypic cultures, while E6 and E7 oncoproteins co-expression down-regulates RECK and TIMP-2 levels in organotypic and monolayers cultures. Finally, a study conducted in human cervical tissues showed a decrease in RECK expression levels in precancer and cancer lesions. Our results indicate that HPV oncoproteins promote MMPs/ RECK-TIMP-2 imbalance which may be involved in HPV-associated lesions outcome.	[da Silva Cardeal, Laura Beatriz; Maria-Engler, Silvya Stuchi] Univ Sao Paulo, Sch Pharmaceut Sci, Clin Chem & Toxicol Dept, Sao Paulo, Brazil; [Boccardo, Enrique; Termini, Lara; Rabachini, Tatiana; Andreoli, Maria Antonieta; Villa, Luisa Lina] Ludwig Inst Canc Res, Virol Grp, Sao Paulo, Brazil; [Boccardo, Enrique] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil; [Termini, Lara; Villa, Luisa Lina] HPV Inst INCT HPV, Sao Paulo, Brazil; [di Loreto, Celso] Nucleo Patol Inst Adolfo Lutz, Sao Paulo, Brazil; [Longatto Filho, Adhemar] Univ Sao Paulo, Sch Med, Lab Med Invest LIM 14, Sao Paulo, Brazil; [Longatto Filho, Adhemar] Barretos Canc Hosp, PIO XII Fdn, Barretos, Brazil; [Longatto Filho, Adhemar] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Longatto Filho, Adhemar] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal	Universidade de Sao Paulo; Ludwig Institute for Cancer Research; Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital de Cancer de Barretos; Universidade do Minho	Cardeal, LBD (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Clin Chem & Toxicol Dept, Sao Paulo, Brazil.	silvya@usp.br	Rabachini, Tatiana/B-1460-2014; Maria-Engler, Silvya/ABC-2016-2020; VILLA, LUISA/AAH-4761-2019; Termini, Lara/P-2387-2015; Filho, Adhemar Longatto/A-2889-2016; Engler, Silvya Stuchi Maria/K-5936-2016; Longatto-Filho, Adhemar/N-3397-2019; longatto-filho, adhemar/D-7039-2013; Boccardo, Enrique/A-3960-2012	Rabachini, Tatiana/0000-0003-0636-2558; Maria-Engler, Silvya/0000-0003-4771-6041; VILLA, LUISA/0000-0003-4074-2335; Termini, Lara/0000-0002-3588-8877; Engler, Silvya Stuchi Maria/0000-0003-4771-6041; Longatto-Filho, Adhemar/0000-0002-5779-9752; longatto-filho, adhemar/0000-0002-5779-9752; Boccardo, Enrique/0000-0003-1900-0273	FAPESP-Sao Paulo Research Foundation [2005/58885-1, 2008/58817-4, 2008/03232-1]; PRPG-USP: Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo; CNPq: Conselho Nacional de Pesquisa e Desenvolvimento	FAPESP-Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PRPG-USP: Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo; CNPq: Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by FAPESP-Sao Paulo Research Foundation: 2005/58885-1 (to LBSC), 2008/58817-4 (to SSME) and 2008/03232-1 (to LLV); and by PRPG-USP: Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo and CNPq: Conselho Nacional de Pesquisa e Desenvolvimento (to SSME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul B, 2011, MED MICROBIOL IMMUN, V200, P127, DOI 10.1007/s00430-011-0183-4; Boccardo E, 2004, VIROLOGY, V328, P233, DOI 10.1016/j.virol.2004.07.026; Branca M, 2006, ANTICANCER RES, V26, P1543; Brummer O, 2002, GYNECOL ONCOL, V84, P222, DOI 10.1006/gyno.2001.6413; Clark JCM, 2007, CANCER METAST REV, V26, P675, DOI 10.1007/s10555-007-9093-8; Cardeal LBD, 2006, BIOCHEM CELL BIOL, V84, P713, DOI 10.1139/O06-084; Dong QA, 2010, INT J EXP PATHOL, V91, P368, DOI 10.1111/j.1365-2613.2010.00724.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fejzo MS, 2011, GENE CHROMOSOME CANC, V50, P434, DOI 10.1002/gcc.20868; Furumoto K, 2001, HEPATOLOGY, V33, P189, DOI 10.1053/jhep.2001.21048; Gaiotto MAM, 2004, AM J OBSTET GYNECOL, V190, P1278, DOI 10.1016/j.ajog.2003.12.017; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P10978, DOI 10.1073/pnas.97.20.10978; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; International Agency for Research on Cancer/World Health Organization, 2007, IARC MON EV CARC RIS, V90; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Liu LT, 2003, ONCOGENE, V22, P8263, DOI 10.1038/sj.onc.1207157; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masui T, 2003, CLIN CANCER RES, V9, P1779; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; Min W, 2009, INT J GYNECOL CANCER, V19, P547, DOI 10.1111/IGC.0b013e3181a44c68; Morioka Y, 2009, ONCOGENE, V28, P1454, DOI 10.1038/onc.2008.486; Nair SA, 2003, J CANCER RES CLIN, V129, P123, DOI 10.1007/s00432-002-0411-9; NUOVO GJ, 1995, CANCER RES, V55, P267; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oh J, 2006, ONCOGENE, V25, P4230, DOI 10.1038/sj.onc.1209444; Oh J, 2004, CANCER RES, V64, P9062, DOI 10.1158/0008-5472.CAN-04-1981; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630; Sasahara RM, 2002, CANCER DETECT PREV, V26, P435, DOI 10.1016/S0361-090X(02)00123-X; Schlecht NF, 2001, JAMA-J AM MED ASSOC, V286, P3106, DOI 10.1001/jama.286.24.3106; Schroer N, 2011, CANCER RES, V71, P87, DOI 10.1158/0008-5472.CAN-10-2193; Shen BC, 2003, CANCER RES, V63, P6537; Correa TCS, 2010, J CELL BIOCHEM, V110, P52, DOI 10.1002/jcb.22472; Span PN, 2003, CANCER, V97, P2710, DOI 10.1002/cncr.11395; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Stetler-Stevenson WG, 2008, CANCER METAST REV, V27, P57, DOI 10.1007/s10555-007-9105-8; Takagi S, 2009, CANCER RES, V69, P1502, DOI 10.1158/0008-5472.CAN-08-2635; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Takenaka K, 2004, EUR J CANCER, V40, P1617, DOI 10.1016/j.ejca.2004.02.028; Takeuchi T, 2004, CLIN CANCER RES, V10, P5572, DOI 10.1158/1078-0432.CCR-03-0656; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Yoshida S, 2008, J VIROL, V82, P8820, DOI 10.1128/JVI.02363-07; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	45	43	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33585	10.1371/journal.pone.0033585	http://dx.doi.org/10.1371/journal.pone.0033585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438955	Green Submitted, gold, Green Published			2022-12-27	WOS:000303309100063
J	Li, WT; Wang, R; Yan, ZM; Bai, LF; Sun, ZR				Li, Wenting; Wang, Rui; Yan, Zhangming; Bai, Linfu; Sun, Zhirong			High Accordance in Prognosis Prediction of Colorectal Cancer across Independent Datasets by Multi-Gene Module Expression Profiles	PLOS ONE			English	Article							SUBNETWORK MARKERS; NETWORK TOPOLOGY; HUMAN GENES; IDENTIFICATION; MUTATIONS; FRAMEWORK	A considerable portion of patients with colorectal cancer have a high risk of disease recurrence after surgery. These patients can be identified by analyzing the expression profiles of signature genes in tumors. But there is no consensus on which genes should be used and the performance of specific set of signature genes varies greatly with different datasets, impeding their implementation in the routine clinical application. Instead of using individual genes, here we identified functional multi-gene modules with significant expression changes between recurrent and recurrence-free tumors, used them as the signatures for predicting colorectal cancer recurrence in multiple datasets that were collected independently and profiled on different microarray platforms. The multi-gene modules we identified have a significant enrichment of known genes and biological processes relevant to cancer development, including genes from the chemokine pathway. Most strikingly, they recruited a significant enrichment of somatic mutations found in colorectal cancer. These results confirmed the functional relevance of these modules for colorectal cancer development. Further, these functional modules from different datasets overlapped significantly. Finally, we demonstrated that, leveraging above information of these modules, our module based classifier avoided arbitrary fitting the classifier function and screening the signatures using the training data, and achieved more consistency in prognosis prediction across three independent datasets, which holds even using very small training sets of tumors.	[Li, Wenting; Yan, Zhangming; Bai, Linfu; Sun, Zhirong] Tsinghua Univ, Minist Educ Key Lab Bioinformat, State Key Lab Biomembrane & Membrane Biotechnol, Inst Bioinformat & Syst Biol,Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Rui] Duke Univ, Computat Biol & Bioinformat Program, Inst Genome Sci & Policy, Med Ctr, Durham, NC USA	Tsinghua University; Duke University	Li, WT (corresponding author), Tsinghua Univ, Minist Educ Key Lab Bioinformat, State Key Lab Biomembrane & Membrane Biotechnol, Inst Bioinformat & Syst Biol,Sch Life Sci, Beijing 100084, Peoples R China.	sunzhr@mail.tsinghua.edu.cn	Yan, Zhangming/N-1574-2018	Yan, Zhangming/0000-0001-5373-8496	973 project [2009CB918801, 2011CBA00802]; National Natural Science Foundation of China [31171274]	973 project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by 973 project No. 2009CB918801 and No. 2011CBA00802, http://www.most.gov.cn; National Natural Science Foundation of China fund No. 31171274, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrier A, 2006, J CLIN ONCOL, V24, P4685, DOI 10.1200/JCO.2005.05.0229; Cabusora L, 2005, BIOINFORMATICS, V21, P2898, DOI 10.1093/bioinformatics/bti440; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dao P, 2011, BIOINFORMATICS, V27, pI205, DOI 10.1093/bioinformatics/btr245; Dong D, 2007, CHINESE SCI BULL, V52, P2938, DOI 10.1007/s11434-007-0454-z; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Garman KS, 2008, P NATL ACAD SCI USA, V105, P19432, DOI 10.1073/pnas.0806674105; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hwang B, 2009, PROG BIOCHEM BIOPHYS, V36, P1415, DOI 10.3724/SP.J.1206.2009.00325; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lin YH, 2007, CLIN CANCER RES, V13, P498, DOI 10.1158/1078-0432.CCR-05-2734; Mi ZB, 2010, BIOINFORMATICS, V26, P2586, DOI 10.1093/bioinformatics/btq472; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Nacu S, 2007, BIOINFORMATICS, V23, P850, DOI 10.1093/bioinformatics/btm019; Newman M.E.J., 2004, PHYS REV E, V70; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ross JS, 2011, BIOMARK MED, V5, P319, DOI [10.2217/BMM.11.38, 10.2217/bmm.11.38]; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Su J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S8; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Torkamani A, 2009, GENOME RES, V19, P1570, DOI 10.1101/gr.092833.109; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zipin-Roitman A, 2007, CANCER RES, V67, P3396, DOI 10.1158/0008-5472.CAN-06-3087	40	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33653	10.1371/journal.pone.0033653	http://dx.doi.org/10.1371/journal.pone.0033653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438977	Green Published, gold, Green Submitted			2022-12-27	WOS:000303309100081
J	Bar Yaacov, D; Arbel-Thau, K; Zilka, Y; Ovadia, O; Bouskila, A; Mishmar, D				Bar Yaacov, Dan; Arbel-Thau, Karmit; Zilka, Yael; Ovadia, Ofer; Bouskila, Amos; Mishmar, Dan			Mitochondrial DNA Variation, but Not Nuclear DNA, Sharply Divides Morphologically Identical Chameleons along an Ancient Geographic Barrier	PLOS ONE			English	Article							CONTRASTING PATTERNS; EVOLUTIONARY; MICROSATELLITE; HYBRIDIZATION; HISTORIES; AFLP	The Levant is an important migration bridge, harboring border-zones between Afrotropical and palearctic species. Accordingly, Chameleo chameleon, a common species throughout the Mediterranean basin, is morphologically divided in the southern Levant (Israel) into two subspecies, Chamaeleo chamaeleon recticrista (CCR) and C. c. musae (CCM). CCR mostly inhabits the Mediterranean climate (northern Israel), while CCM inhabits the sands of the north-western Negev Desert (southern Israel). AFLP analysis of 94 geographically well dispersed specimens indicated moderate genetic differentiation (PhiPT = 0.097), consistent with the classical division into the two subspecies, CCR and CCM. In contrast, sequence analysis of a 637 bp coding mitochondrial DNA (mtDNA) fragment revealed two distinct phylogenetic clusters which were not consistent with the morphological division: one mtDNA cluster consisted of CCR specimens collected in regions northern of the Jezreel Valley and another mtDNA cluster harboring specimens pertaining to both the CCR and CCM subspecies but collected southern of the Jezreel Valley. AMOVA indicated clear mtDNA differentiation between specimens collected northern and southern to the Jezreel Valley (PhiPT = 0.79), which was further supported by a very low coalescent-based estimate of effective migration rates. Whole chameleon mtDNA sequencing (similar to 17,400 bp) generated from 11 well dispersed geographic locations revealed 325 mutations sharply differentiating the two mtDNA clusters, suggesting a long allopatric history further supported by BEAST. This separation correlated temporally with the existence of an at least 1 million year old marine barrier at the Jezreel Valley exactly where the mtDNA clusters meet. We discuss possible involvement of gender-dependent life history differences in maintaining such mtDNA genetic differentiation and suggest that it reflects (ancient) local adaptation to mitochondrial-related traits.	[Bar Yaacov, Dan; Arbel-Thau, Karmit; Zilka, Yael; Ovadia, Ofer; Bouskila, Amos; Mishmar, Dan] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University	Bar Yaacov, D (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	dmishmar@bgu.ac.il	Ovadia, Ofer OO/C-8292-2012; Bouskila, Amos/B-4847-2010; Mishmar, Dan/AAJ-6109-2020	Bouskila, Amos/0000-0002-6995-5070; Mishmar, Dan/0000-0003-3488-8792; Bar Yaacov, Dan/0000-0002-0599-5153; Ovadia, Ofer/0000-0002-4941-4947	Shulov Foundation; Israel Science Foundation (ISF); United States-Israel Binational Science Foundation (BSF)	Shulov Foundation; Israel Science Foundation (ISF)(Israel Science Foundation); United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation)	The authors thank the Shulov Foundation for partial funding of this study (through a grant to AM and DM). During this study DM was supported by the Israel Science Foundation (ISF) and AB by the United States-Israel Binational Science Foundation (BSF). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bolnick DA, 2006, MOL BIOL EVOL, V23, P2161, DOI 10.1093/molbev/msl088; Bouskila A, 2001, HDB AMPHIBIANS REPTI; Brito PH, 2007, MOL ECOL, V16, P3423, DOI 10.1111/j.1365-294X.2007.03401.x; Castellana S, 2011, GENOME BIOL EVOL; Creer S, 2004, J EVOLUTION BIOL, V17, P100, DOI 10.1046/j.1420-9101.2003.00642.x; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellison CK, 2006, EVOLUTION, V60, P1382, DOI 10.1111/j.0014-3820.2006.tb01217.x; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Garcia-Veigas J, 2009, CHEM GEOL, V265, P499, DOI 10.1016/j.chemgeo.2009.05.013; Gershoni M, 2010, J MOL BIOL, V404, P158, DOI 10.1016/j.jmb.2010.09.029; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Hoffman JI, 2009, MOL ECOL, V18, P2961, DOI 10.1111/j.1365-294X.2009.04246.x; HOOFIEN JH, 1964, ISRAEL J ZOOL, V13, P136; Horowitz A., 1979, QUATERNARY ISRAEL; Hudson AG, 2011, P ROY SOC B-BIOL SCI, V278, P58, DOI 10.1098/rspb.2010.0925; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Macey JR, 2008, MOL PHYLOGENET EVOL, V49, P1015, DOI 10.1016/j.ympev.2008.08.024; Marshall JC, 2001, MOL ECOL, V10, P435, DOI 10.1046/j.1365-294x.2001.01232.x; MELNICK DJ, 1992, INT J PRIMATOL, V13, P379, DOI 10.1007/BF02547824; Mila B, 2010, MOL ECOL, V19, P108, DOI 10.1111/j.1365-294X.2009.04441.x; Nachman MW, 1996, GENETICS, V142, P953; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Thaler R, 2008, MOL PHYLOGENET EVOL, V48, P838, DOI 10.1016/j.ympev.2008.05.027; Townsend T, 2002, MOL PHYLOGENET EVOL, V23, P22, DOI 10.1006/mpev.2001.1076; Vallender R, 2007, MOL ECOL, V16, P2017, DOI 10.1111/j.1365-294X.2007.03282.x; WRIGHT S, 1978, P580; Zelditch ML, 2004, GEOMETRIC MORPHOMETR	36	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e31372	10.1371/journal.pone.0031372	http://dx.doi.org/10.1371/journal.pone.0031372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22457709	gold, Green Published, Green Submitted			2022-12-27	WOS:000303129700003
J	Banerjee, ER; Laflamme, MA; Papayannopoulou, T; Kahn, M; Murry, CE; Henderson, WR				Banerjee, Ena Ray; Laflamme, Michael A.; Papayannopoulou, Thalia; Kahn, Michael; Murry, Charles E.; Henderson, William R., Jr.			Human Embryonic Stem Cells Differentiated to Lung Lineage-Specific Cells Ameliorate Pulmonary Fibrosis in a Xenograft Transplant Mouse Model	PLOS ONE			English	Article							EPITHELIAL PROGENITOR CELLS; BETA-CATENIN; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTOR; II CELLS; REPAIR; INHIBITION; EXPRESSION; DERIVATION; CBP	Background: Our aim was to differentiate human (h) embryonic stem (ES) cells into lung epithelial lineage-specific cells [i.e., alveolar epithelial type I (AEI) and type II (AEII) cells and Clara cells] as the first step in the development of cell-based strategies to repair lung injury in the bleomycin mouse model of idiopathic pulmonary fibrosis (IPF). A heterogeneous population of non-ciliated lung lineage-specific cells was derived by a novel method of embryoid body (EB) differentiation. This differentiated human cell population was used to modulate the profibrotic phenotype in transplanted animals. Methodology and Principal Findings: Omission or inclusion of one or more components in the differentiation medium skewed differentiation of H7 hES cells into varying proportions of AEI, AEII, and Clara cells. ICG-001, a small molecule inhibitor of Wnt/b-catenin/Creb-binding protein (CBP) transcription, changed marker expression of the differentiated ES cells from an AEII-like phenotype to a predominantly AEI-like phenotype. The differentiated cells were used in xenograft transplantation studies in bleomycin-treated Rag2 gamma C-/- mice. Human cells were detected in lungs of the transplanted groups receiving differentiated ES cells treated with or without ICG-001. The increased lung collagen content found in bleomycin-treated mice receiving saline was significantly reduced by transplantation with the lung-lineage specific epithelial cells differentiated from ES cells. A significant increase in progenitor number was observed in the airways of bleomycin-treated mice after transplantation of differentiated hES cells. Conclusions: This study indicates that ES cell-based therapy may be a powerful novel approach to ameliorate lung fibrosis.	[Banerjee, Ena Ray; Henderson, William R., Jr.] Univ Washington, Ctr Allergy & Inflammat, Seattle, WA 98195 USA; [Banerjee, Ena Ray; Papayannopoulou, Thalia; Henderson, William R., Jr.] Univ Washington, Dept Med, Inst Stem Cell & Regenerat Med, Seattle, WA USA; [Laflamme, Michael A.; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Laflamme, Michael A.; Murry, Charles E.] Univ Washington, Dept Pathol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Papayannopoulou, Thalia] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Kahn, Michael] Univ So Calif, Dept Biochem & Mol Biol, Ctr Stem Cell & Regenerat Med, Los Angeles, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Southern California	Banerjee, ER (corresponding author), Univ Calcutta, Dept Zool, Kolkata, India.	joangb@u.washington.edu	Laflamme, Michael/AAV-6791-2021	Laflamme, Michael/0000-0001-5908-880X	National Institutes of Health [R01 HL73722]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084642, R01HL073722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant R01 HL73722. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NN, 2002, TISSUE ENG, V8, P541, DOI 10.1089/107632702760240463; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Bishop AE, 2004, CELL PROLIFERAT, V37, P89, DOI 10.1111/j.1365-2184.2004.00302.x; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Chen ZM, 2004, BIOCHEM BIOPH RES CO, V319, P774, DOI 10.1016/j.bbrc.2004.05.048; Chistiakov DA, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-92; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Dahlin K, 2004, AM J RESP CELL MOL, V31, P309, DOI 10.1165/rcmb.2003-0423OC; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; EVANS MJ, 1978, LAB INVEST, V38, P648; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Germano D, 2009, AM J RESP CRIT CARE, V179, P939, DOI 10.1164/rccm.200809-1390OC; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kasper M, 1996, HISTOL HISTOPATHOL, V11, P463; Kolla V, 2007, AM J RESP CELL MOL, V36, P213, DOI 10.1165/rcmb.2006-0207OC; Kuwano Kazuyoshi, 2001, Current Molecular Medicine (Hilversum), V1, P551, DOI 10.2174/1566524013363401; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Leblond AL, 2009, HUM GENE THER, V20, P1329, DOI 10.1089/hum.2009.035; Lu Yun, 2008, Proc Am Thorac Soc, V5, P300, DOI 10.1513/pats.200710-162DR; Lukaszewicz AI, 2010, J MED CHEM, V53, P3439, DOI 10.1021/jm901361d; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; McMillan M, 2005, DRUG DISCOV TODAY, V10, P1467, DOI 10.1016/S1359-6446(05)03613-5; Miyabayashi K, 2006, BIOCHEM BIOPH RES CO, V350, P753, DOI 10.1016/j.bbrc.2006.09.117; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rippon HJ, 2006, STEM CELLS, V24, P1389, DOI 10.1634/stemcells.2005-0465; Rippon HJ, 2004, CLONING STEM CELLS, V6, P49, DOI 10.1089/1536230041372328; Samadikuchaksaraei A, 2006, TISSUE ENG, V12, P867, DOI 10.1089/ten.2006.12.867; Stripp BR, 2005, AM J RESP CELL MOL, V32, P85, DOI 10.1165/rcmb.F289; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031, DOI 10.1152/ajplung.1997.272.6.L1031; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Ware CB, 2005, BIOTECHNIQUES, V38, P879, DOI 10.2144/05386ST01; Weibel ER, 1984, PATHWAY OXYGEN STRUC, P231; Wetsel RA, 2011, ANNU REV MED, V62, P95, DOI 10.1146/annurev-med-052009-172110; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; WITSCHI H, 1991, CHEST, V99, pS22, DOI 10.1378/chest.99.3.22S; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367	50	62	64	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33165	10.1371/journal.pone.0033165	http://dx.doi.org/10.1371/journal.pone.0033165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470441	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000016
J	Lin, YS; Huang, KS; Yang, CH; Wang, CY; Yang, YS; Hsu, HC; Liao, YJ; Tsai, CW				Lin, Yung-Sheng; Huang, Keng-Shiang; Yang, Chih-Hui; Wang, Chih-Yu; Yang, Yuh-Shyong; Hsu, Hsiang-Chen; Liao, Yu-Ju; Tsai, Chia-Wen			Microfluidic Synthesis of Microfibers for Magnetic-Responsive Controlled Drug Release and Cell Culture	PLOS ONE			English	Article							DELIVERY; ALGINATE; FIBERS; NANOCARRIERS; SCAFFOLDS; CHITOSAN; SYSTEMS	This study demonstrated the fabrication of alginate microfibers using a modular microfluidic system for magnetic-responsive controlled drug release and cell culture. A novel two-dimensional fluid-focusing technique with multi-inlets and junctions was used to spatiotemporally control the continuous laminar flow of alginate solutions. The diameter of the manufactured microfibers, which ranged from 211 mm to 364 mm, could be well controlled by changing the flow rate of the continuous phase. While the model drug, diclofenac, was encapsulated into microfibers, the drug release profile exhibited the characteristic of a proper and steady release. Furthermore, the diclofenac release kinetics from the magnetic iron oxide-loaded microfibers could be controlled externally, allowing for a rapid drug release by applying a magnetic force. In addition, the successful culture of glioblastoma multiforme cells in the microfibers demonstrated a good structural integrity and environment to grow cells that could be applied in drug screening for targeting cancer cells. The proposed microfluidic system has the advantages of ease of fabrication, simplicity, and a fast and low-cost process that is capable of generating functional microfibers with the potential for biomedical applications, such as drug controlled release and cell culture.	[Lin, Yung-Sheng; Liao, Yu-Ju] Hungkuang Univ, Dept Appl Cosmetol, Taichung, Taiwan; [Lin, Yung-Sheng; Liao, Yu-Ju] Hungkuang Univ, Master Program Cosmet Sci, Taichung, Taiwan; [Huang, Keng-Shiang] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Yang, Chih-Hui] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Wang, Chih-Yu] I Shou Univ, Dept Biomed Engn, Kaohsiung, Taiwan; [Yang, Yuh-Shyong] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Hsu, Hsiang-Chen] I Shou Univ, Dept Mech & Automat Engn, Kaohsiung, Taiwan; [Tsai, Chia-Wen] Ming Chuan Univ, Dept Informat Management, Taipei, Taiwan	Hungkuang University; Hungkuang University; I Shou University; I Shou University; I Shou University; National Yang Ming Chiao Tung University; I Shou University; Ming Chuan University	Lin, YS (corresponding author), Hungkuang Univ, Dept Appl Cosmetol, Taichung, Taiwan.	huangks@isu.edu.tw; chyang@isu.edu.tw	HUANG, KENG-SHIANG/X-9893-2019; Yang, Yuh-Shyong/L-7401-2019	Yang, Yuh-Shyong/0000-0003-0177-473X; Huang, Keng-Shiang/0000-0002-7751-0223; Hsu, Hsiang-Chen/0000-0001-9841-580X	I-Shou University [ISU94-04-03, ISU 98-S-04, ISU 99-S-02]; National Science Council of Taiwan [NSC 100-2320-B-214-005, NSC 100-2622-E-241-002-CC3, NSC 100-3114-C-214-001-ES, NSC100-2320-B-214-003-MY2]	I-Shou University; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the I-Shou University (ISU94-04-03, ISU 98-S-04, and ISU 99-S-02) and the National Science Council of Taiwan (NSC 100-2320-B-214-005, NSC 100-2622-E-241-002-CC3, NSC 100-3114-C-214-001-ES, and NSC100-2320-B-214-003-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Allison SD, 2008, EXPERT OPIN DRUG DEL, V5, P615, DOI 10.1517/17425247.5.6.615 ; Basu J, 2010, TRENDS BIOTECHNOL, V28, P526, DOI 10.1016/j.tibtech.2010.07.007; Cinti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017132; Curtis JR, 2005, AM J MANAG CARE, V11, P537; Dandoy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020983; Delaney JT, 2010, SOFT MATTER, V6, P866, DOI 10.1039/b922888h; Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017; Gonzalez-Rodriguez ML, 2002, INT J PHARMACEUT, V232, P225, DOI 10.1016/S0378-5173(01)00915-2; Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005; Hess MW, 2010, METHOD CELL BIOL, V96, P649, DOI 10.1016/S0091-679X(10)96027-5; Hu SH, 2008, ADV FUNCT MATER, V18, P2946, DOI 10.1002/adfm.200800428; Hu SH, 2008, ADV MATER, V20, P2690, DOI 10.1002/adma.200800193; Hu SH, 2008, LANGMUIR, V24, P239, DOI 10.1021/la701570z; Huang KS, 2011, SOFT MATTER, V7, P6713, DOI 10.1039/c0sm01361g; Huang KS, 2009, J CONTROL RELEASE, V137, P15, DOI 10.1016/j.jconrel.2009.02.019; Hwang CM, 2008, LANGMUIR, V24, P6845, DOI 10.1021/la800253b; Jeong W, 2004, LAB CHIP, V4, P576, DOI 10.1039/b411249k; Jung JH, 2009, LAB CHIP, V9, P2596, DOI 10.1039/b901308c; Kang E, 2011, NAT MATER, V10, P877, DOI [10.1038/NMAT3108, 10.1038/nmat3108]; Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063; Kim YJ, 2005, BIOL PHARM BULL, V28, P394, DOI 10.1248/bpb.28.394; Kraitzer A, 2008, J CONTROL RELEASE, V126, P139, DOI 10.1016/j.jconrel.2007.11.011; Krishna ADS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007240; Kuehl KS, 2010, CLIN THER, V32, P1001, DOI 10.1016/j.clinthera.2010.06.001; Laurienzo P, 2006, J BIOMED MATER RES A, V78A, P523, DOI 10.1002/jbm.a.30763; Lee KH, 2010, LAB CHIP, V10, P1328, DOI 10.1039/b924987g; Lin YS, 2011, ELECTROPHORESIS, V32, P3157, DOI 10.1002/elps.201100343; Martins S, 2007, CARBOHYD POLYM, V69, P725, DOI 10.1016/j.carbpol.2007.02.012; Naing MW, 2011, CYTOTHERAPY, V13, P391, DOI 10.3109/14653249.2011.556352; Ntim WO, 2010, J AM COLL CARDIOL, V55, P171, DOI 10.1016/j.jacc.2009.08.043; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peter JF, 2010, PROTEOMICS, V10, P628, DOI [10.1002/pmic.200800535, 10.1002/pmic.200900535]; Saraf A, 2010, J CONTROL RELEASE, V143, P95, DOI 10.1016/j.jconrel.2009.12.009; Shin S, 2007, LANGMUIR, V23, P9104, DOI 10.1021/la700818q; Smith SC, 2011, NEOPLASIA, V13, P72, DOI 10.1593/neo.101214; Sundar S, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014104; Tiwari SK, 2010, INT J PHARMACEUT, V392, P209, DOI 10.1016/j.ijpharm.2010.03.021; Ulery BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017642; Veiga JP, 2011, J PHARMACOL TOX MET, V64, P226, DOI 10.1016/j.vascn.2011.04.006; Wan Y, 2008, ACTA BIOMATER, V4, P876, DOI 10.1016/j.actbio.2008.01.001; Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007; Williams PS, 2009, MOL PHARMACEUT, V6, P1290, DOI 10.1021/mp900018v; Woolfson DN, 2010, CHEM SOC REV, V39, P3464, DOI 10.1039/c0cs00032a; Xu CJ, 2009, DALTON T, P5583, DOI 10.1039/b900272n; Yang CH, 2009, LAB CHIP, V9, P961, DOI 10.1039/b814952f; Yang CH, 2009, LAB CHIP, V9, P145, DOI 10.1039/b807454b	49	39	40	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33184	10.1371/journal.pone.0033184	http://dx.doi.org/10.1371/journal.pone.0033184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470443	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000017
J	Khalil, S; Tan, GA; Giri, DD; Zhou, XK; Howe, LR				Khalil, Sara; Tan, Grace A.; Giri, Dilip D.; Zhou, Xi Kathy; Howe, Louise R.			Activation Status of Wnt/beta-Catenin Signaling in Normal and Neoplastic Breast Tissues: Relationship to HER2/neu Expression in Human and Mouse	PLOS ONE			English	Article							MAMMARY-TUMOR VIRUS; INFILTRATING DUCTAL BREAST; CYCLIN D1 EXPRESSION; BETA-CATENIN; E-CADHERIN; TRANSGENIC MICE; STEM-CELLS; IN-SITU; TRANSCRIPTIONAL ACTIVITY; NEU PROTOONCOGENE	Wnt/beta-catenin signaling is strongly implicated in neoplasia, but the role of this pathway in human breast cancer has been controversial. Here, we examined Wnt/beta-catenin pathway activation as a function of breast cancer progression, and tested for a relationship with HER2/neu expression, using a human tissue microarray comprising benign breast tissues, ductal carcinoma in situ (DCIS), and invasive carcinomas. Cores were scored for membranous beta-catenin, a key functional component of adherens junctions, and for nucleocytoplasmic beta-catenin, a hallmark of Wnt/beta-catenin pathway activation. Only 82% of benign samples exhibited membrane-associated beta-catenin, indicating a finite frequency of false-negative staining. The frequency of membrane positivity was similar in DCIS samples, but was significantly reduced in carcinomas (45%, P < 0.001), consistent with loss of adherens junctions during acquisition of invasiveness. Negative membrane status in cancers correlated with higher grade (P = 0.04) and estrogen receptor-negative status (P = 0.03), both indices of poor prognosis. Unexpectedly, a substantial frequency of nucleocytoplasmic beta-catenin was observed in benign breast tissues (36%), similar to that in carcinomas (35%). Positive-staining basal nuclei observed in benign breast may identify putative stem cells. An increased frequency of nucleocytoplasmic beta-catenin was observed in DCIS tumors (56%), suggesting that pathway activation may be an early event in human breast neoplasia. A correlation was observed between HER2/neu expression and nucleocytoplasmic beta-catenin in node-positive carcinomas (P = 0.02). Furthermore, cytoplasmic beta-catenin was detected in HER2/neu-induced mouse mammary tumors. The Axin2(NLSlacZ) mouse strain, a previously validated reporter of mammary Wnt/beta-catenin signaling, was utilized to define in vivo transcriptional consequences of HER2/neu-induced beta-catenin accumulation. Discrete hyperplastic foci observed in mammary glands from bigenic MMTV/neu, Axin2(NLSlacZ) mice, highlighted by robust beta-catenin/TCF signaling, likely represent the earliest stage of mammary intraepithelial neoplasia in MMTV/neu mice. Our study thus provides provocative evidence for Wnt/beta-catenin signaling as an early, HER2/neu-inducible event in breast neoplasia.	[Khalil, Sara; Tan, Grace A.; Howe, Louise R.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Giri, Dilip D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Zhou, Xi Kathy] Weill Cornell Med Coll, Dept Publ Hlth, Div Biostat & Epidemiol, New York, NY USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Khalil, S (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA.	lrhowe@med.cornell.edu		Howe, Louise/0000-0002-1468-7136	NIH [R01 CA131219]; Department of Defense [W81XWH-04-1-0619]; NATIONAL CANCER INSTITUTE [R01CA131219] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01 CA131219 (L. R. H.) and Department of Defense Breast Cancer Research Program grant W81XWH-04-1-0619 (L. R. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SC, 2002, HUM PATHOL, V33, P39, DOI 10.1053/hupa.2002.30196; Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Baker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008854; BARTKOVA J, 1990, HUM PATHOL, V21, P1164, DOI 10.1016/0046-8177(90)90154-W; Bertolo C, 2008, AM J CLIN PATHOL, V130, P414, DOI 10.1309/J3QV9763DYPV338D; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bonvini P, 2001, CANCER RES, V61, P1671; Bukholm IRK, 2001, INT J CANCER, V94, P148, DOI 10.1002/ijc.1432; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Candidus S, 1996, CANCER RES, V56, P49; Chung GG, 2004, CANCER, V100, P2084, DOI 10.1002/cncr.20232; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Clapper ML, 2004, MUTAT RES-FUND MOL M, V555, P97, DOI 10.1016/j.mrfmmm.2004.05.021; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Furuuchi K, 2000, AM J PATHOL, V156, P1997, DOI 10.1016/S0002-9440(10)65072-9; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gonzalez MA, 1999, J PATHOL, V187, P523, DOI 10.1002/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO;2-3; Graham NA, 2004, J BIOL CHEM, V279, P23517, DOI 10.1074/jbc.M314055200; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jonsson M, 2000, EUR J CANCER, V36, P242, DOI 10.1016/S0959-8049(99)00276-2; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Karayiannakis AJ, 2001, EUR J SURG ONCOL, V27, P31, DOI 10.1053/ejso.1999.1017; KASHIWABA M, 1994, J CANCER RES CLIN, V120, P727, DOI 10.1007/BF01194271; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Kurpios NA, 2009, DEV BIOL, V325, P106, DOI 10.1016/j.ydbio.2008.09.033; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Park K, 2006, HISTOPATHOLOGY, V48, P702, DOI 10.1111/j.1365-2559.2006.02403.x; PETERS G, 1983, CELL, V33, P369, DOI 10.1016/0092-8674(83)90418-X; Polakis P, 2000, GENE DEV, V14, P1837; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; RAMACHANDRA S, 1990, J PATHOL, V161, P7, DOI 10.1002/path.1711610104; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; Schroeder JA, 2002, J BIOL CHEM, V277, P22692, DOI 10.1074/jbc.M201975200; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; Smalley MJ, 2001, J MAMMARY GLAND BIOL, V6, P37, DOI 10.1023/A:1009564431268; Sorlie T, 1998, Hum Mutat, V12, P215; Sormunen RT, 1999, J PATHOL, V187, P416; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wang K, 2007, ONCOL REP, V17, P89; Webster MT, 2000, GENE CHROMOSOME CANC, V28, P443; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zschiesche W, 1997, ANTICANCER RES, V17, P561	72	39	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33421	10.1371/journal.pone.0033421	http://dx.doi.org/10.1371/journal.pone.0033421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457761	gold, Green Submitted, Green Published			2022-12-27	WOS:000304046900010
J	Zhang, QN; Gao, T; Luo, Y; Chen, XJ; Gao, G; Gao, XQ; Zhou, YW; Dai, JP				Zhang, Qinan; Gao, Teng; Luo, Yi; Chen, Xijuan; Gao, Ge; Gao, Xiaoqun; Zhou, Yiwu; Dai, Jiapei			Transient Focal Cerebral Ischemia/Reperfusion Induces Early and Chronic Axonal Changes in Rats: Its Importance for the Risk of Alzheimer's Disease	PLOS ONE			English	Article							MOUSE MODEL; TRANSPORT; AXONOPATHY; TAU; PATHOGENESIS; PATHOLOGY; DEMENTIA; ISCHEMIA; DEFICITS	The dementia of Alzheimer's type and brain ischemia are known to increase at comparable rates with age. Recent advances suggest that cerebral ischemia may contribute to the pathogenesis of Alzheimer's disease (AD), however, the neuropathological relationship between these two disorders is largely unclear. It has been demonstrated that axonopathy, mainly manifesting as impairment of axonal transport and swelling of the axon and varicosity, is a prominent feature in AD and may play an important role in the neuropathological mechanisms in AD. In this study, we investigated the early and chronic changes of the axons of neurons in the different brain areas (cortex, hippocampus and striatum) using in vivo tracing technique and grading analysis method in a rat model of transient focal cerebral ischemia/reperfusion (middle cerebral artery occlusion, MCAO). In addition, the relationship between the changes of axons and the expression of beta-amyloid 42 (A beta 42) and hyperphosphorylated Tau, which have been considered as the key neuropathological processes of AD, was analyzed by combining tracing technique with immunohistochemistry or western blotting. Subsequently, we found that transient cerebral ischemia/reperfusion produced obvious swelling of the axons and varicosities, from 6 hours after transient cerebral ischemia/reperfusion even up to 4 weeks. We could not observe A beta plaques or overexpression of A beta 42 in the ischemic brain areas, however, the site-specific hyperphosphorylated Tau could be detected in the ischemic cortex. These results suggest that transient cerebral ischemia/reperfusion induce early and chronic axonal changes, which may be an important mechanism affecting the clinical outcome and possibly contributing to the development of AD after stroke.	[Zhang, Qinan; Luo, Yi; Dai, Jiapei] S Cent Univ Nationalities, Wuhan Inst Neurosci & Neuroengn, Wuhan, Peoples R China; [Zhang, Qinan; Gao, Teng; Chen, Xijuan; Gao, Xiaoqun] Zhengzhou Univ, Coll Med, Dept Anat, Zhengzhou, Peoples R China; [Gao, Ge; Gao, Xiaoqun] Zhengzhou Univ, Coll Med, Brain Paralysis Res Ctr, Zhengzhou, Peoples R China; [Zhou, Yiwu] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan 430074, Peoples R China	South Central Minzu University; Zhengzhou University; Zhengzhou University; Huazhong University of Science & Technology	Zhang, QN (corresponding author), S Cent Univ Nationalities, Wuhan Inst Neurosci & Neuroengn, Wuhan, Peoples R China.	jdai@mail.scuec.edu.cn		Dai, Jiapei/0000-0002-1474-5754	China Ministry of Human Resources; Research Foundation for the Key Laboratory of Neuroscience and Neuroengineering from South-Central University for Nationalities [XJS09001]; Royal Netherlands Academy of Arts and Sciences [05CDP030]	China Ministry of Human Resources; Research Foundation for the Key Laboratory of Neuroscience and Neuroengineering from South-Central University for Nationalities; Royal Netherlands Academy of Arts and Sciences	This work was supported by a project of the China Ministry of Human Resources for Return Overseas Chinese Scholarship (2007) and the Research Foundation for the Key Laboratory of Neuroscience and Neuroengineering from South-Central University for Nationalities (XJS09001), and partly by a joint research project between China and the Netherlands, Royal Netherlands Academy of Arts and Sciences (05CDP030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong R. A, 2011, INT J ALZHEIMERS DIS, DOI [10.4061/2011/630865, DOI 10.4061/2011/630865]; Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082; Dai JP, 2002, BRAIN RES, V948, P138, DOI 10.1016/S0006-8993(02)03152-9; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kalaria R, 2002, J NEUROL SCI, V203, P29, DOI 10.1016/S0022-510X(02)00256-3; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Koistinaho M, 2005, BRAIN RES REV, V48, P240, DOI 10.1016/j.brainresrev.2004.12.014; Lazarov O, 2007, J NEUROSCI, V27, P7011, DOI 10.1523/JNEUROSCI.4272-06.2007; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Minoshima S, 2008, EUR J NUCL MED MOL I, V35, pS89, DOI 10.1007/s00259-007-0707-8; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Smith KDB, 2007, NEUROIMAGE, V35, P1401, DOI 10.1016/j.neuroimage.2007.01.046; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Troncoso JC, 2008, ANN NEUROL, V64, P168, DOI 10.1002/ana.21413; van de Nes JAP, 2008, BRAIN RES, V1213, P152, DOI 10.1016/j.brainres.2008.03.043; White L, 2002, ANN NY ACAD SCI, V977, P9, DOI 10.1111/j.1749-6632.2002.tb04794.x; Wirths O, 2006, ACTA NEUROPATHOL, V111, P312, DOI 10.1007/s00401-006-0041-4; Xiao AW, 2011, NEUROSCI BULL, V27, P287, DOI 10.1007/s12264-011-1736-7; Zhu XW, 2007, J NEUROL SCI, V257, P240, DOI 10.1016/j.jns.2007.01.039	24	36	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e33722	10.1371/journal.pone.0033722	http://dx.doi.org/10.1371/journal.pone.0033722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22457786	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900022
J	Schreinemacher, MH; Backes, WH; Slenter, JM; Xanthoulea, S; Delvoux, B; van Winden, L; Beets-Tan, RG; Evers, JLH; Dunselman, GAJ; Romano, A				Schreinemacher, Marc H.; Backes, Walter H.; Slenter, Jos M.; Xanthoulea, Sofia; Delvoux, Bert; van Winden, Larissa; Beets-Tan, Regina G.; Evers, Johannes L. H.; Dunselman, Gerard A. J.; Romano, Andrea			Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance Imaging	PLOS ONE			English	Article							DEEP PELVIC ENDOMETRIOSIS; ARTERY LIGATION MODEL; INFILTRATING ENDOMETRIOSIS; ANGIOGRAPHY; THERAPY; GROWTH; AGENTS; PREDICTION; ACCURACY; VESSELS	Endometriosis is defined as the presence of endometrial tissue outside the uterus. It affects 10-15% of women during reproductive age and has a big personal and social impact due to chronic pelvic pain, subfertility, loss of work-hours and medical costs. Such conditions are exacerbated by the fact that the correct diagnosis is made as late as 8-11 years after symptom presentation. This is due to the lack of a reliable non-invasive diagnostic test and the fact that the reference diagnostic standard is laparoscopy (invasive, expensive and not without risks). High-molecular weight gadofosveset-trisodium is used as contrast agent in Magnetic Resonance Imaging (MRI). Since it extravasates from hyperpermeable vessels more easily than from mature blood vessels, this contrast agent detects angiogenesis efficiently. Endometriosis has high angiogenic activity. Therefore, we have tested the possibility to detect endometriosis non-invasively using Dynamic Contrast-Enhanced MRI (DCE-MRI) and gadofosveset-trisodium as a contrast agent in a mouse model. Endometriotic lesions were surgically induced in nine mice by autologous transplantation. Three weeks after lesion induction, mice were scanned by DCE-MRI. Dynamic image analysis showed that the rates of uptake (inwash), persistence and outwash of the contrast agent were different between endometriosis and control tissues (large blood vessels and back muscle). Due to the extensive angiogenesis in induced lesions, the contrast agent persisted longer in endometriotic than control tissues, thus enhancing the MRI signal intensity. DCE-MRI was repeated five weeks after lesion induction, and contrast enhancement was similar to that observed three weeks after endometriosis induction. The endothelial-cell marker CD31 and the pericyte marker alpha-smooth- muscle-actin (mature vessels) were detected with immunohistochemistry and confirmed that endometriotic lesions had significantly higher prevalence of new vessels (CD31 only positive) than the uterus and control tissues. The diagnostic value of gadofosveset-trisodium to detect endometriosis should be tested in human settings.	[Schreinemacher, Marc H.; Xanthoulea, Sofia] Maastricht Univ & Med Ctr, Dept Surg, Maastricht, Netherlands; [Backes, Walter H.; Slenter, Jos M.; Beets-Tan, Regina G.] Maastricht Univ & Med Ctr, Dept Radiol, Maastricht, Netherlands; [Backes, Walter H.; Slenter, Jos M.] Maastricht Univ & Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Delvoux, Bert; Evers, Johannes L. H.; Dunselman, Gerard A. J.; Romano, Andrea] Maastricht Univ & Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Delvoux, Bert; van Winden, Larissa; Evers, Johannes L. H.; Dunselman, Gerard A. J.; Romano, Andrea] Maastricht Univ & Med Ctr, Dept Obstet & Gynaecol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Schreinemacher, MH (corresponding author), Maastricht Univ & Med Ctr, Dept Surg, Maastricht, Netherlands.	a.romano@maastrichtuniversity.nl	Beets-Tan, Regina/AAZ-9119-2020; Romano, Andrea/K-1373-2016; Evers, Johannes L/F-6000-2012	Romano, Andrea/0000-0002-5900-6883; Backes, Walter H/0000-0001-7905-0681; xanthoulea, sofia/0000-0003-4700-3404; Evers, Johannes/0000-0001-8079-1436				Aerts HJWL, 2008, MAGN RESON MED, V59, P1111, DOI 10.1002/mrm.21575; Bazot M, 2004, RADIOLOGY, V232, P379, DOI 10.1148/radiol.2322030762; Bazot M, 2007, HUM REPROD, V22, P1457, DOI 10.1093/humrep/dem008; Bazot M, 2011, EUR J RADIOL, V80, pE331, DOI 10.1016/j.ejrad.2010.12.006; Becker CM, 2011, AM J PATHOL, V178, P1782, DOI 10.1016/j.ajpath.2010.12.037; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Brosens I, 2004, BEST PRACT RES CL OB, V18, P285, DOI 10.1016/j.bpobgyn.2004.03.002; Coutinho A, 2011, RADIOGRAPHICS, V31, P549, DOI 10.1148/rg.312105144; Dassen H, 2010, AM J PATHOL, V177, P2495, DOI 10.2353/ajpath.2010.100026; de Graaff AA, 2012, HUM REPROD IN PRESS; de Graaff AA, 2010, FERTIL STERIL, V94, P1108, DOI 10.1016/j.fertnstert.2009.10.041; de Lussanet QG, 2006, NMR BIOMED, V19, P77, DOI 10.1002/nbm.1003; De Lussanet QG, 2005, INT J RADIAT ONCOL, V63, P1309, DOI 10.1016/j.ijrobp.2005.04.052; de Lussanet QG, 2005, RADIOLOGY, V235, P65, DOI 10.1148/radiol.2351040411; de Lussanet QG, 2007, NMR BIOMED, V20, P717, DOI 10.1002/nbm.1133; Delvoux B, 2009, J CLIN ENDOCR METAB, V94, P876, DOI 10.1210/jc.2008-2218; Essig M, 2007, EUR RADIOL, V17, pB30, DOI 10.1007/s10406-007-0211-z; Essig M, 2010, EUR RADIOL, V20, P218, DOI 10.1007/s00330-009-1530-3; Goyen M, 2008, VASC HEALTH RISK MAN, V4, P1, DOI 10.2147/vhrm.2008.04.01.1; Groothuis P. G., 2005, Angiogenesis, V8, P147, DOI 10.1007/s10456-005-9005-x; Grummer R, 2006, HUM REPROD UPDATE, V12, P641, DOI 10.1093/humupd/dml026; Hull ML, 2003, J CLIN ENDOCR METAB, V88, P2889, DOI 10.1210/jc.2002-021912; Izquierdo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008131; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Marcal L, 2010, ABDOM IMAGING, V35, P708, DOI 10.1007/s00261-010-9611-y; Nap AW, 2005, FERTIL STERIL, V83, P793, DOI 10.1016/j.fertnstert.2004.06.080; Nap AW, 2004, BEST PRACT RES CL OB, V18, P233, DOI 10.1016/j.bpobgyn.2004.01.005; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Rogers PAW, 2009, REPROD SCI, V16, P335, DOI 10.1177/1933719108330568; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Simoens S, 2011, GYNECOL OBSTET INVES, V71, P170, DOI 10.1159/000316055; Somigliana E, 2010, HUM REPROD, V25, P1863, DOI 10.1093/humrep/deq141; Stratton P, 2003, FERTIL STERIL, V79, P1078, DOI 10.1016/S0015-0282(03)00155-9; van Kaam KJAF, 2007, HUM REPROD, V22, P129, DOI 10.1093/humrep/del325; van Kaam KJAF, 2007, REPROD SCI, V14, P367, DOI 10.1177/1933719107303436; Vigano P, 2004, BEST PRACT RES CL OB, V18, P177, DOI 10.1016/j.bpobgyn.2004.01.007	36	16	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e33241	10.1371/journal.pone.0033241	http://dx.doi.org/10.1371/journal.pone.0033241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457748	Green Submitted, Green Published, gold			2022-12-27	WOS:000303909200026
J	Falter, CM; Elliott, MA; Bailey, AJ				Falter, Christine M.; Elliott, Mark A.; Bailey, Anthony J.			Enhanced Visual Temporal Resolution in Autism Spectrum Disorders	PLOS ONE			English	Article							PERCEPTION; CHILDREN; SIMULTANEITY; INDIVIDUALS; ATTENTION; DEFICITS; WINDOWS; ADULTS; ORDER	Cognitive functions that rely on accurate sequencing of events, such as action planning and execution, verbal and nonverbal communication, and social interaction rely on well-tuned coding of temporal event-structure. Visual temporal event-structure coding was tested in 17 high-functioning adolescents and adults with autism spectrum disorder (ASD) and mental-and chronological-age matched typically-developing (TD) individuals using a perceptual simultaneity paradigm. Visual simultaneity thresholds were lower in individuals with ASD compared to TD individuals, suggesting that autism may be characterised by increased parsing of temporal event-structure, with a decreased capability for integration over time. Lower perceptual simultaneity thresholds in ASD were also related to increased developmental communication difficulties. These results are linked to detail-focussed and local processing bias.	[Falter, Christine M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Falter, Christine M.] Univ Oxford, Dept Psychiat, Oxford, England; [Elliott, Mark A.] Kyushu Univ, Ctr Appl Perceptual Res, Fukuoka 812, Japan; [Elliott, Mark A.] Natl Univ Ireland, Sch Psychol, Galway, Ireland; [Bailey, Anthony J.] Univ British Columbia, Dept Psychiat, UBC Inst Mental Hlth, Vancouver, BC, Canada	University of Groningen; University of Oxford; Kyushu University; Ollscoil na Gaillimhe-University of Galway; University of British Columbia	Falter, CM (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	c.m.falter@rug.nl	Bailey, Anthony/J-2860-2014	Bailey, Anthony/0000-0003-4257-972X; Elliott, Mark/0000-0003-2560-8760	Baily Thomas Charitable Trust; German Research Council (DFG); TIMELY, a European Cooperation in Science and Technology action	Baily Thomas Charitable Trust; German Research Council (DFG)(German Research Foundation (DFG)); TIMELY, a European Cooperation in Science and Technology action	The authors thank the Baily Thomas Charitable Trust for financial support of this study. CMF was supported by a German Research Council (DFG) Fellowship. The collaboration between CMF and MAE was supported by TIMELY, a European Cooperation in Science and Technology action. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman MJ, 2011, AJIDD-AM J INTELLECT, V116, P165, DOI 10.1352/1944-7558-116.2.165; Allman MJ, BRAIN IN PRESS; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2003, INQ 3 COMP SOFTW; Arnold D., 2002, FITTING LOGISTIC CUR; Bennetto L, 1996, CHILD DEV, V67, P1816, DOI 10.2307/1131734; Boucher J, 2001, TIME MEMORY, P111, DOI DOI 10.1080/713659824; BRECHER GERHARD A., 1932, ZEITSCHR VERGLEICH PHYSIOL, V18, P204; Bryson J, 2001, BEHAV BRAIN SCI, V24, P878, DOI 10.1017/S0140525X0122010X; Cavallini F., 1993, COLL MATH J, V24, P247; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Elliott MA, 2007, PSYCHOL RES-PSYCH FO, V71, P687, DOI 10.1007/s00426-006-0057-3; Elliott MA, 2010, PSIHOLOGIJA, V43, P359, DOI 10.2298/PSI1004359E; Exner S., 1875, PFLUGERS ARCH GESAMT, V11, P403, DOI [10.1007/BF01659311, DOI 10.1007/BF01659311]; Falter CM, 2008, J AUTISM DEV DISORD, V38, P507, DOI 10.1007/s10803-007-0419-8; Falter CM, SUBJECTIVE IN PRESS; Foss-Feig JH, 2010, EXP BRAIN RES, V203, P381, DOI 10.1007/s00221-010-2240-4; Foucher JR, 2007, SCHIZOPHR RES, V97, P118, DOI 10.1016/j.schres.2007.08.013; Giersch A, 2009, SCHIZOPHRENIA BULL, V35, P816, DOI 10.1093/schbul/sbn016; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Husserl E., 1928, VORLESUNGEN PHANOMEN; Jones CRG, 2009, NEUROPSYCHOLOGIA, V47, P2850, DOI 10.1016/j.neuropsychologia.2009.06.015; Kwakye LD, 2011, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00129; Laasonen M, 2001, COGN AFFECT BEHAV NE, V1, P394, DOI 10.3758/CABN.1.4.394; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Martin JS, 2010, J AUTISM DEV DISORD, V40, P640, DOI 10.1007/s10803-009-0904-3; Mostofsky SH, 2000, J INT NEUROPSYCH SOC, V6, P752, DOI 10.1017/S1355617700677020; Mottron L, 1999, J CHILD PSYCHOL PSYC, V40, P203, DOI 10.1111/1469-7610.00433; Nakano T, 2010, P R SOC B, V277, P1027, DOI 10.1098/rspb.2009.1713; Plaisted K, 1999, J CHILD PSYCHOL PSYC, V40, P733, DOI 10.1111/1469-7610.00489; Pockett S., 2003, PHENOMENOL COGN SCI, V2, P55, DOI [10.1023/A:1022960122740, DOI 10.1023/A:1022960122740]; Poppel E, 2009, PHILOS T R SOC B, V364, P1887, DOI 10.1098/rstb.2009.0015; Poppel E., 1988, MINDWORKS TIME CONSC; Schmidt H, 2011, J ABNORM PSYCHOL, V120, P476, DOI 10.1037/a0023387; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; STELMACH LB, 1991, J EXP PSYCHOL HUMAN, V17, P539, DOI 10.1037/0096-1523.17.2.539; Szelag E, 2004, BRIT J PSYCHOL, V95, P269, DOI 10.1348/0007126041528167; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Trevarthen C, 2005, BRAIN DEV-JPN, V27, pS25, DOI 10.1016/j.braindev.2005.03.016; Wallace GL, 2008, RES AUTISM SPECT DIS, V2, P447, DOI 10.1016/j.rasd.2007.09.005; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wimpory D, 2002, J INTELL DISABIL RES, V46, P352, DOI 10.1046/j.1365-2788.2002.00423.x	47	38	38	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e32774	10.1371/journal.pone.0032774	http://dx.doi.org/10.1371/journal.pone.0032774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939YN	22470425	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100005
J	Glas, J; Wagner, J; Seiderer, J; Olszak, T; Wetzke, M; Beigel, F; Tillack, C; Stallhofer, J; Friedrich, M; Steib, C; Goke, B; Ochsenkuhn, T; Karbalai, N; Diegelmann, J; Czamara, D; Brand, S				Glas, Juergen; Wagner, Johanna; Seiderer, Julia; Olszak, Torsten; Wetzke, Martin; Beigel, Florian; Tillack, Cornelia; Stallhofer, Johannes; Friedrich, Matthias; Steib, Christian; Goeke, Burkhard; Ochsenkuhn, Thomas; Karbalai, Nazanin; Diegelmann, Julia; Czamara, Darina; Brand, Stephan			PTPN2 Gene Variants Are Associated with Susceptibility to Both Crohn's Disease and Ulcerative Colitis Supporting a Common Genetic Disease Background	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; PROTEIN-TYROSINE-PHOSPHATASE; INSULIN-RECEPTOR; CELIAC-DISEASE; LOCI; ATG16L1; CARD15; IL23R; IDENTIFICATION	Background: Genome-wide association studies identified PTPN2 (protein tyrosine phosphatase, non-receptor type 2) as susceptibility gene for inflammatory bowel diseases (IBD). However, the exact role of PTPN2 in Crohn's disease (CD) and ulcerative colitis (UC) and its phenotypic effect are unclear. We therefore performed a detailed genotype-phenotype and epistasis analysis of PTPN2 gene variants. Methodology/Principal Findings: Genomic DNA from 2131 individuals of Caucasian origin (905 patients with CD, 318 patients with UC, and 908 healthy, unrelated controls) was analyzed for two SNPs in the PTPN2 region (rs2542151, rs7234029) for which associations with IBD were found in previous studies in other cohorts. Our analysis revealed a significant association of PTPN2 SNP rs2542151 with both susceptibility to CD (p = 1.95 x 10(-5); OR 1.49 [1.34-1.79]) and UC (p = 3.87 x 10(-2), OR 1.31 [1.02-1.68]). Moreover, PTPN2 SNP rs7234029 demonstrated a significant association with susceptibility to CD (p = 1.30 x 10(-3); OR 1.35 [1.13-1.62]) and a trend towards association with UC (p = 7.53 x 10(-2); OR 1.26 [0.98-1.62]). Genotype-phenotype analysis revealed an association of PTPN2 SNP rs7234029 with a stricturing disease phenotype (B2) in CD patients (p = 6.62 x 10(-3)). Epistasis analysis showed weak epistasis between the ATG16L1 SNP rs2241879 and PTPN2 SNP rs2542151 (p = 0.024) in CD and between ATG16L1 SNP rs4663396 and PTPN2 SNP rs7234029 (p = 4.68 x 10(-3)) in UC. There was no evidence of epistasis between PTPN2 and NOD2 and PTPN2 and IL23R. In silico analysis revealed that the SNP rs7234029 modulates potentially the binding sites of several transcription factors involved in inflammation including GATA-3, NF-kappa B, C/EBP, and E4BP4. Conclusions/Significance: Our data confirm the association of PTPN2 variants with susceptibility to both CD and UC, suggesting a common disease pathomechanism for these diseases. Given recent evidence that PTPN2 regulates autophagosome formation in intestinal epithelial cells, the potential link between PTPN2 and ATG16L1 should be further investigated.	[Glas, Juergen; Wagner, Johanna; Seiderer, Julia; Olszak, Torsten; Wetzke, Martin; Beigel, Florian; Tillack, Cornelia; Stallhofer, Johannes; Friedrich, Matthias; Steib, Christian; Goeke, Burkhard; Ochsenkuhn, Thomas; Diegelmann, Julia; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Wagner, Johanna; Wetzke, Martin; Friedrich, Matthias; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Sch Med, Gastrointestinal Div, Boston, MA 02115 USA; [Wetzke, Martin] Hannover Med Sch, Dept Pediat, Hannover, Germany; [Karbalai, Nazanin; Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Hannover Medical School; Max Planck Society	Glas, J (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Mirza-Schreiber, Nazanin/AAD-1563-2022; Mirza-Schreiber, Nazanin/AAD-1558-2022; Wetzke, Martin/HDM-2614-2022	Mirza-Schreiber, Nazanin/0000-0003-0836-8267; Stallhofer, Johannes/0000-0001-8698-6103	Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich [422]; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung [81/08//EKMS08/01]; DFG German research Foundation [BR 1912/6-1]; Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium) [2010_ EKES.32]; Ludwig-Maximilians-University Munich	Broad Medical Foundation; Ludwig-Maximilians-University Munich; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung; DFG German research Foundation(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium); Ludwig-Maximilians-University Munich	Dr. Glas was supported by a grant from the Broad Medical Foundation (IBD-0126R2). Dr. Seiderer and Dr. Diegelmann were supported by grants from the Ludwig-Maximilians-University Munich (FoFoLe Nr. 422; Habilitationsstipendium, LMUExcellent to Dr. Stallhofer and Promotionsstipendium to Dr. Diegelmann); Dr. Seiderer was also supported by the Robert-Bosch-Foundation and the Else Kroner-Fresenius-Stiftung (81/08//EKMS08/01). Dr. Brand was supported by grants from the DFG German research Foundation (BR 1912/6-1), the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_ EKES.32), and by grants of Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FoFoLe program). This work contains parts of the unpublished doctoral theses of Dr. Wagner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Colli ML, 2010, HUM MOL GENET, V19, P135, DOI 10.1093/hmg/ddp474; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029309; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019319; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Kobayashi T, 2011, J IMMUNOL, V186, P4649, DOI 10.4049/jimmunol.1003888; Latiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022688; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; LENNARDJONES JE, 1989, SCAND J GASTROENTE S, V170, P16, DOI DOI 10.3109/00365528909091339; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Massey DCO, 2007, AUTOPHAGY, V3, P649, DOI 10.4161/auto.5075; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Morgan AR, 2010, TISSUE ANTIGENS, V76, P119, DOI 10.1111/j.1399-0039.2010.01493.x; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Scharl M, 2012, INFLAMM BOWEL DIS, V18, P1287, DOI 10.1002/ibd.21891; Scharl M, 2012, INFLAMM BOWEL DIS, V18, P900, DOI 10.1002/ibd.21913; Scharl M, 2011, GUT, V60, P189, DOI 10.1136/gut.2010.216606; Scharl M, 2009, GASTROENTEROLOGY, V137, P2030, DOI 10.1053/j.gastro.2009.07.078; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Simoncic PD, 2006, CAN J PHYSIOL PHARM, V84, P667, DOI 10.1139/Y06-012; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Thompson SD, 2010, ARTHRITIS RHEUM-US, V62, P3265, DOI 10.1002/art.27688; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; van der Heide F, 2010, AM J GASTROENTEROL, V105, P1165, DOI 10.1038/ajg.2009.659; Walchli S, 2000, J BIOL CHEM, V275, P9792, DOI 10.1074/jbc.275.13.9792; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	53	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33682	10.1371/journal.pone.0033682	http://dx.doi.org/10.1371/journal.pone.0033682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22457781	gold, Green Submitted, Green Published			2022-12-27	WOS:000303857100036
J	Costantino, CM; Gupta, A; Yewdall, AW; Dale, BM; Devi, LA; Chen, BK				Costantino, Cristina Maria; Gupta, Achla; Yewdall, Alice W.; Dale, Benjamin M.; Devi, Lakshmi A.; Chen, Benjamin K.			Cannabinoid Receptor 2-Mediated Attenuation of CXCR4-Tropic HIV Infection in Primary CD4+T Cells	PLOS ONE			English	Article							CD4(+) T-CELLS; DOWN-REGULATION; CORECEPTOR USE; CXCR4; CCR5; INHIBITION; CB2; OLIGOMERIZATION; MARIJUANA; IMMUNITY	Agents that activate cannabinoid receptor pathways have been tested as treatments for cachexia, nausea or neuropathic pain in HIV-1/AIDS patients. The cannabinoid receptors (CB1R and CB2R) and the HIV-1 co-receptors, CCR5 and CXCR4, all signal via Gai-coupled pathways. We hypothesized that drugs targeting cannabinoid receptors modulate chemokine coreceptor function and regulate HIV-1 infectivity. We found that agonism of CB2R, but not CB1R, reduced infection in primary CD4+ T cells following cell-free and cell-to-cell transmission of CXCR4-tropic virus. As this change in viral permissiveness was most pronounced in unstimulated T cells, we investigated the effect of CB2R agonism on to CXCR4-induced signaling following binding of chemokine or virus to the co-receptor. We found that CB2R agonism decreased CXCR4-activation mediated G-protein activity and MAPK phosphorylation. Furthermore, CB2R agonism altered the cytoskeletal architecture of resting CD4+ T cells by decreasing F-actin levels. Our findings suggest that CB2R activation in CD4+ T cells can inhibit actin reorganization and impair productive infection following cell-free or cell-associated viral acquisition of CXCR4-tropic HIV-1 in resting cells. Therefore, the clinical use of CB2R agonists in the treatment of AIDS symptoms may also exert beneficial adjunctive antiviral effects against CXCR4-tropic viruses in late stages of HIV-1 infection.	[Costantino, Cristina Maria; Yewdall, Alice W.; Dale, Benjamin M.; Chen, Benjamin K.] Mt Sinai Sch Med, Dept Infect Dis, Dept Med, Inst Immunol, New York, NY 10029 USA; [Costantino, Cristina Maria; Gupta, Achla; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Costantino, CM (corresponding author), Mt Sinai Sch Med, Dept Infect Dis, Dept Med, Inst Immunol, New York, NY 10029 USA.	Lakshmi.Devi@mssm.edu; Ben.Chen@mssm.edu	Devi P, Lakshmi/GXM-5982-2022	Devi P, Lakshmi/0000-0001-9274-4776; Costantino, Cristina/0000-0002-3705-8519; Chen, Benjamin K/0000-0002-5404-1997	United States National Institutes of Health [R01AI074420, DP1DA028866]; NIH [DA008863, DA019521]; NIH CTSA [UL1RR029887]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008863, R37DA008863, DP1DA028866, K05DA019521, R56DA008863] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by United States National Institutes of Health grants R01AI074420 and DP1DA028866 awarded to BKC and NIH grants DA008863 and DA019521 awarded to LAD. CMC is further supported by NIH CTSA grant UL1RR029887 awarded to the Mount Sinai School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DI, 2007, NEUROLOGY, V68, P515, DOI 10.1212/01.wnl.0000253187.66183.9c; Abrams DI, 2003, ANN INTERN MED, V139, P258, DOI 10.7326/0003-4819-139-4-200308190-00008; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Amar MB, 2006, J ETHNOPHARMACOL, V105, P1, DOI 10.1016/j.jep.2006.02.001; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Borner C, 2007, J LEUKOCYTE BIOL, V81, P336, DOI 10.1189/jlb.0306224; Bredt BM, 2002, J CLIN PHARMACOL, V42, p82S, DOI 10.1002/j.1552-4604.2002.tb06007.x; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Bukrinsky M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-85; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Doranz BJ, 1997, J EXP MED, V186, P1395, DOI 10.1084/jem.186.8.1395; Downer EJ, 2011, J BIOL CHEM, V286, P10316, DOI 10.1074/jbc.M110.188599; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; ElSohly MA, 2001, J ANAL TOXICOL, V25, P565, DOI 10.1093/jat/25.7.565; Fenyo EM, 1996, ANTIBIOT CHEMOTHER, V48, P49; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; Gomes I, 2003, METH MOLEC MED, V84, P157; Hoffmann DE, 2010, NEW ENGL J MED, V362, P1453, DOI 10.1056/NEJMp1000695; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Huffman JW, 1999, CURR MED CHEM, V6, P705; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Jiang SX, 2010, J BIOL CHEM, V285, P35471, DOI 10.1074/jbc.M110.144758; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Klein TW, 2007, ADV EXP MED BIOL, V601, P395; Klein TW, 2000, J IMMUNOL, V164, P6461, DOI 10.4049/jimmunol.164.12.6461; Lovinger DM, 2008, PRESYNAPTIC MODULATI; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Molina PE, 2011, AIDS RES HUM RETROVI; Moreira FA, 2009, BEST PRACT RES CL EN, V23, P133, DOI 10.1016/j.beem.2008.09.003; NEWELL GR, 1985, PREV MED, V14, P81, DOI 10.1016/0091-7435(85)90023-4; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Rock RB, 2007, J NEUROIMMUNE PHARM, V2, P178, DOI 10.1007/s11481-006-9040-4; Rodriguez-Frade JM, 2004, EMBO J, V23, P66, DOI 10.1038/sj.emboj.7600020; Saleh S, 2007, BLOOD, V110, P4161, DOI 10.1182/blood-2007-06-097907; Simmons G, 2000, IMMUNOL REV, V177, P112, DOI 10.1034/j.1600-065X.2000.17719.x; TINDALL B, 1988, AUST NZ J MED, V18, P8, DOI 10.1111/j.1445-5994.1988.tb02232.x; Vasiliver-Shamis G, 2008, J VIROL, V82, P9445, DOI 10.1128/JVI.00835-08; Vila-Coro AJ, 2000, P NATL ACAD SCI USA, V97, P3388, DOI 10.1073/pnas.050457797; Vorster PJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182238; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Wu YT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-95; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhu LX, 2000, J IMMUNOL, V165, P373, DOI 10.4049/jimmunol.165.1.373	59	47	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33961	10.1371/journal.pone.0033961	http://dx.doi.org/10.1371/journal.pone.0033961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448282	gold, Green Published, Green Submitted			2022-12-27	WOS:000303855700073
J	Noto, H; Goto, A; Tsujimoto, T; Noda, M				Noto, Hiroshi; Goto, Atsushi; Tsujimoto, Tetsuro; Noda, Mitsuhiko			Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis	PLOS ONE			English	Review							COLORECTAL-CANCER; PANCREATIC-CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; INSULIN-RESISTANCE; METABOLIC SYNDROME; INCIDENT CANCER; BLADDER-CANCER; REDUCED RISK	Background: A growing body of evidence has suggested that metformin potentially reduces the risk of cancer. Our objective was to enhance the precision of estimates of the effect of metformin on the risk of any-site and site-specific cancers in patients with diabetes. Methods/Principal Findings: We performed a search of MEDLINE, EMBASE, ISI Web of Science, Cochrane Library, and ClinicalTrials.gov for pertinent articles published as of October 12, 2011, and included them in a systematic review and meta-analysis. We calculated pooled risk ratios (RRs) for overall cancer mortality and cancer incidence. Of the 21,195 diabetic patients reported in 6 studies (4 cohort studies, 2 RCTs), 991 (4.5%) cases of death from cancer were reported. A total of 11,117 (5.3%) cases of incident cancer at any site were reported among 210,892 patients in 10 studies (2 RCTs, 6 cohort studies, 2 case-control studies). The risks of cancer among metformin users were significantly lower than those among non-metformin users: the pooled RRs (95% confidence interval) were 0.66 (0.49-0.88) for cancer mortality, 0.67 (0.53-0.85) for all-cancer incidence, 0.68 (0.53-0.88) for colorectal cancer (n = 6), 0.20 (0.07-0.59) for hepatocellular cancer (n = 4), 0.67 (0.45-0.99) for lung cancer (n = 3). Conclusion/Significance: The use of metformin in diabetic patients was associated with significantly lower risks of cancer mortality and incidence. However, this analysis is mainly based on observational studies and our findings underscore the more need for long-term RCTs to confirm this potential benefit for individuals with diabetes.	[Noto, Hiroshi; Goto, Atsushi; Tsujimoto, Tetsuro; Noda, Mitsuhiko] Ctr Hosp, Natl Ctr Global Hlth & Med, Dept Diabet & Metab Med, Tokyo, Japan; [Noto, Hiroshi; Goto, Atsushi; Tsujimoto, Tetsuro; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Res Inst, Dept Diabet Res, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Noto, H (corresponding author), Ctr Hosp, Natl Ctr Global Hlth & Med, Dept Diabet & Metab Med, Tokyo, Japan.	noto-tky@umin.net	Noda, Mitsuhiko/W-3905-2019	Noda, Mitsuhiko/0000-0003-0413-4631; Goto, Atsushi/0000-0003-0669-654X	Ministry of Health, Labour and Welfare of Japan [H22-019]; Japan Diabetes Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Diabetes Foundation	This study was supported by a Health Sciences Research Grant (Comprehensive Research on Diabetes/Cardiovascular and Life-Style Related Diseases H22-019) from the Ministry of Health, Labour and Welfare of Japan and by a grant from Japan Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2008, CURR PHARM DESIGN, V14, P940, DOI 10.2174/138161208784139765; Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252; Azoulay L, 2011, CANCER EPIDEM BIOMAR, V20, P337, DOI 10.1158/1055-9965.EPI-10-0940; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Barone BB, 2010, DIABETES CARE, V33, P931, DOI 10.2337/dc09-1721; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Bonovas S, 2004, DIABETOLOGIA, V47, P1071, DOI 10.1007/s00125-004-1415-6; Bosco JLF, 2011, CANCER EPIDEM BIOMAR, V20, P101, DOI 10.1158/1055-9965.EPI-10-0817; Bowker SL, 2010, DIABETOLOGIA, V53, P1631, DOI 10.1007/s00125-010-1750-8; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; BRUNING PF, 1992, INT J CANCER, V52, P511, DOI 10.1002/ijc.2910520402; Chao C, 2008, AM J EPIDEMIOL, V168, P471, DOI 10.1093/aje/kwn160; Chen TM, 2011, J GASTROEN HEPATOL, V26, P858, DOI 10.1111/j.1440-1746.2011.06664.x; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Dhindsa S, 2004, J CLIN ENDOCR METAB, V89, P5462, DOI 10.1210/jc.2004-0804; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Donadon V, 2010, LIVER INT, V30, P750, DOI 10.1111/j.1478-3231.2010.02223.x; Donadon V, 2009, WORLD J GASTROENTERO, V15, P2506, DOI 10.3748/wjg.15.2506; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; GIOVANNUCCI E, 1995, CANCER CAUSE CONTROL, V6, P164, DOI 10.1007/BF00052777; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Grossmann M, 2008, J CLIN ENDOCR METAB, V93, P1834, DOI 10.1210/jc.2007-2177; Hassan MM, 2010, CANCER-AM CANCER SOC, V116, P1938, DOI 10.1002/cncr.24982; He XX, 2011, ANN ONCOL, V22, P2640, DOI 10.1093/annonc/mdr020; Hense HW, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-15; Home PD, 2010, DIABETOLOGIA, V53, P1838, DOI 10.1007/s00125-010-1804-y; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hosono K, 2010, MOL CARCINOGEN, V49, P662, DOI 10.1002/mc.20637; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Inoue M, 2009, CANCER CAUSE CONTROL, V20, P741, DOI 10.1007/s10552-008-9287-6; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Johnson JA, 2010, DIABETES, V59, P1129, DOI 10.2337/db10-0334; Kaaks R, 1996, CANCER CAUSE CONTROL, V7, P605, DOI 10.1007/BF00051703; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Kim YI, 1998, NUTR REV, V56, P275; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Larsson SC, 2006, DIABETOLOGIA, V49, P2819, DOI 10.1007/s00125-006-0468-0; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McFarland MS, 2010, PHARMACOTHERAPY, V30, P1159, DOI 10.1592/phco.30.11.1159; Mellbin LG, 2011, DIABETOLOGIA, V54, P1308, DOI 10.1007/s00125-011-2084-x; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Mitri J, 2008, DIABETES CARE, V31, P2391, DOI 10.2337/dc08-1034; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Monami M, 2011, DIABETES CARE, V34, P129, DOI 10.2337/dc10-1287; Monami M, 2009, ACTA DIABETOL, V46, P279, DOI 10.1007/s00592-008-0083-2; Morden NE, 2011, DIABETES CARE, V34, P1965, DOI 10.2337/dc11-0699; Morss AS, 2007, J BIOL CHEM, V282, P14635, DOI 10.1074/jbc.M608565200; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nkontchou G, 2011, J CLIN ENDOCR METAB, V96, P2601, DOI 10.1210/jc.2010-2415; Noto H, J DIABETES IN PRESS; Noto H, 2011, ENDOCR PRACT, V17, P616, DOI 10.4158/EP10357.RA; Noto H, 2010, J DIABETES COMPLICAT, V24, P345, DOI 10.1016/j.jdiacomp.2010.06.004; Patel T, 2010, UROLOGY, V76, P1240, DOI 10.1016/j.urology.2010.03.059; Piccinni C, 2011, DIABETES CARE; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Richardson LC, 2005, NAT CLIN PRACT ONCOL, V2, P48, DOI 10.1038/ncponc0062; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Seow A, 2006, JNCI-J NATL CANCER I, V98, P135, DOI 10.1093/jnci/djj015; Silverman DT, 1999, BRIT J CANCER, V80, P1830, DOI 10.1038/sj.bjc.6690607; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tseng CH, 2011, DIABETOLOGIA, V54, P2009, DOI 10.1007/s00125-011-2171-z; Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; van Staa TP, 2011, DIABETOLOGIA    1130; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Wolf I, 2005, LANCET ONCOL, V6, P103, DOI 10.1016/S1470-2045(05)01736-5; Wotton CJ, 2011, DIABETOLOGIA, V54, P527, DOI 10.1007/s00125-010-1987-2; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yang XL, 2011, DIABETES CARE, V34, P375, DOI 10.2337/dc10-1509; Yang XL, 2010, DIABETES RES CLIN PR, V90, P343, DOI 10.1016/j.diabres.2010.08.022; Yang YX, 2009, GASTROENTEROLOGY, V137, P412, DOI 10.1053/j.gastro.2009.06.022; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; Yu H, 1999, J La State Med Soc, V151, P218; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081; Zhang W, 1998, J NUTR, V128, P158, DOI 10.1093/jn/128.2.158; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512	98	406	423	48	519	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e33411	10.1371/journal.pone.0033411	http://dx.doi.org/10.1371/journal.pone.0033411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	22448244	Green Published, gold, Green Submitted			2022-12-27	WOS:000303855700034
J	Glover, LE; Tajiri, N; Lau, T; Kaneko, Y; van Loveren, H; Borlongan, CV				Glover, Loren E.; Tajiri, Naoki; Lau, Tsz; Kaneko, Yuji; van Loveren, Harry; Borlongan, Cesario V.			Immediate, but Not Delayed, Microsurgical Skull Reconstruction Exacerbates Brain Damage in Experimental Traumatic Brain Injury Model	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; DECOMPRESSIVE CRANIECTOMY; EARLY CRANIOPLASTY; MICE; AQUAPORIN-4; COMPLICATIONS; EXPRESSION; MANAGEMENT; EDEMA; DEATH	Moderate to severe traumatic brain injury (TBI) often results in malformations to the skull. Aesthetic surgical maneuvers may offer normalized skull structure, but inconsistent surgical closure of the skull area accompanies TBI. We examined whether wound closure by replacement of skull flap and bone wax would allow aesthetic reconstruction of the TBI-induced skull damage without causing any detrimental effects to the cortical tissue. Adult male Sprague-Dawley rats were subjected to TBI using the controlled cortical impact (CCI) injury model. Immediately after the TBI surgery, animals were randomly assigned to skull flap replacement with or without bone wax or no bone reconstruction, then were euthanized at five days post-TBI for pathological analyses. The skull reconstruction provided normalized gross bone architecture, but 2,3,5-triphenyltetrazolium chloride and hematoxylin and eosin staining results revealed larger cortical damage in these animals compared to those that underwent no surgical maneuver at all. Brain swelling accompanied TBI, especially the severe model, that could have relieved the intracranial pressure in those animals with no skull reconstruction. In contrast, the immediate skull reconstruction produced an upregulation of the edema marker aquaporin-4 staining, which likely prevented the therapeutic benefits of brain swelling and resulted in larger cortical infarcts. Interestingly, TBI animals introduced to a delay in skull reconstruction (i.e., 2 days post-TBI) showed significantly reduced edema and infarcts compared to those exposed to immediate skull reconstruction. That immediate, but not delayed, skull reconstruction may exacerbate TBI-induced cortical tissue damage warrants a careful consideration of aesthetic repair of the skull in TBI.	[Glover, Loren E.; Tajiri, Naoki; Lau, Tsz; Kaneko, Yuji; van Loveren, Harry; Borlongan, Cesario V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Glover, LE (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012; Tajiri, Naoki/K-1230-2012	Borlongan, Cesar/0000-0002-2966-9782; Tajiri, Naoki/0000-0003-2189-662X	National Institutes of Health; National Institute of Neurological Disorders and Stroke [1R01NS071956-01]; James and Esther King Foundation; SanBio Inc.; Celgene Cellular Therapeutics; KM Pharmaceutical Consulting; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); James and Esther King Foundation; SanBio Inc.; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); KM Pharmaceutical Consulting; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CVB is supported by the National Institutes of Health, the National Institute of Neurological Disorders and Stroke 1R01NS071956-01, the James and Esther King Foundation for Biomedical Research Program, SanBio Inc., Celgene Cellular Therapeutics, KM Pharmaceutical Consulting, and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorini AM, 2003, ACT NEUR S, V86, P261; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bolkvadze T, 2011, J NEUROTRAUMA; Borlongan CV, 2000, FASEB J, V14, P1307, DOI 10.1096/fj.14.10.1307; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Dempsey RJ, 2003, J NEUROSURG, V98, P867, DOI 10.3171/jns.2003.98.4.0867; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Ho KM, 2011, CRITICAL CARE MED; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Huang X, 2010, INT J MED SCI, V7, P385; Lethaus B, J NEUROTRAUMA; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Lund-Johansen M, 2011, WORLD NEUROSURG, V75, P454, DOI 10.1016/j.wneu.2011.01.020; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Minardi J, 2009, MT SINAI J MED, V76, P138, DOI 10.1002/msj.20105; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Petersen K, 2011, J TRAUMA, V71, pS264, DOI 10.1097/TA.0b013e318227ad9a; Piero C, 2009, J CRANIOFAC SURG, V20, P498, DOI 10.1097/SCS.0b013e31819b9e14; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; SCHIETROMA M, 1992, Annali Italiani di Chirurgia, V63, P163; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Thavarajah D, 2011, BRIT J NEUROSURGERY, P1; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Walberer M, 2008, AGGRAVATION INFARCT; Walcott BP, 2011, NEUROTHERAPEUTICS, P1; Wang P, 2011, GENET MOL RES, V10, P2165, DOI 10.4238/vol10-3gmr1212; Wurm G, 2004, SURG NEUROL, V62, P510, DOI 10.1016/j.surneu.2004.01.025; Xia CF, 2006, HYPERTENSION, V47, P752, DOI 10.1161/01.HYP.0000214867.35632.0e; Yanagawa Y, 2000, NEUROL MED-CHIR, V40, P133, DOI 10.2176/nmc.40.133; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yu GL, 2004, BRAIN RES, V1015, P50, DOI 10.1016/j.brainres.2004.04.055; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zweckberger K, 2011, NEUROSCIENCE LETT	53	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33646	10.1371/journal.pone.0033646	http://dx.doi.org/10.1371/journal.pone.0033646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438975	gold, Green Published, Green Submitted			2022-12-27	WOS:000303309100080
J	Huang, L; Lin, JX; Yu, YH; Zhang, MY; Wang, HY; Zheng, M				Huang, Long; Lin, Jia-Xin; Yu, Yan-Hong; Zhang, Mei-Yin; Wang, Hui-Yun; Zheng, Min			Downregulation of Six MicroRNAs Is Associated with Advanced Stage, Lymph Node Metastasis and Poor Prognosis in Small Cell Carcinoma of the Cervix	PLOS ONE			English	Article							COLON-CANCER CELLS; HEPATOCELLULAR-CARCINOMA; UTERINE CERVIX; LUNG-CANCER; NEUROENDOCRINE CARCINOMA; COLORECTAL-CANCER; BREAST-CANCER; EXPRESSION; SURVIVAL; TARGETS	Background: Small cell carcinoma of the cervix (SCCC) is very rare, and due to the long time period required to recruit sufficient numbers of patients, there is a paucity of information regarding the prognostic factors associated with survival. MicroRNAs (miRNAs) have been used as cancer-related biomarkers in a variety of tumor types, and the objective of this study was to determine whether microRNA expression profiles can predict clinical outcome in SCCC. Methodology/Principal Findings: Forty-four patients with SCCC who underwent radical hysterectomy between January 2000 and October 2009 were enrolled. Using the GeneCopoeia All-in-One (TM) Customized Human qPCR Primer Array, the expression profiles of 30 miRNAs associated with tumor metastasis was obtained from the formalin-fixed paraffin embedded samples of all 44 patients. Seven miRNAs, has-let-7c, has-miR-10b, has-miR-100, has-miR-125b, has-miR-143, has-miR-145 and has-miR-199a-5p were significantly down-regulated in advanced stage SCCCpatients (FIGO IB2-IV) compared to early stage SCCC patients (FIGOIB1). Among, downregulation of six miRNAs, has-let-7c, has-miR-100, has-miR-125b, has-miR-143, has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC. Kaplan-Meier survival analyses revealed that SCCC patients with low expression of has-miR-100 (P = 0.019) and has-miR-125b (P = 0.020) projected a significant tendency towards poorer prognosis. Conclusions/Significance: This study demonstrates that downregulation of 7 miRNA associated with advanced stage, 6 miRNAs with metastasis and 2 with poor prognosis in SCCC. Functional analysis of these miRNAs may enhance our understanding of SCCC, as altered expression of specific miRNAs may regulate the metastatic pathway and provide novel targets for therapy.	[Huang, Long; Lin, Jia-Xin; Zhang, Mei-Yin; Wang, Hui-Yun; Zheng, Min] Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Long; Lin, Jia-Xin; Zheng, Min] Sun Yat Sen Univ, Dept Gynecol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Yan-Hong] So Med Univ, Dept Obstet & Gynecol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China	Huang, L (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	wanghyun@mail.sysu.edu.cn; zheng_min_2006@yahoo.com.cn	Yu, Yan/GYV-4514-2022		National Natural Science Foundation of China [81171948]; Science and Technology Planning Project of Guangdong Province [2009B030801018]; Research Fund of State Key Laboratory of Oncology in Southern China [030041060004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Research Fund of State Key Laboratory of Oncology in Southern China	This study was supported by grants from the National Natural Science Foundation of China (No. 81171948), the Science and Technology Planning Project of Guangdong Province (No. 2009B030801018) and the Research Fund of State Key Laboratory of Oncology in Southern China (No. 030041060004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Balderston KD, 1998, GYNECOL ONCOL, V71, P128, DOI 10.1006/gyno.1998.5104; Chan JK, 2003, CANCER, V97, P568, DOI 10.1002/cncr.11086; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chung HH, 2006, INT J GYNECOL CANCER, V16, P1833, DOI 10.1111/j.1525-1438.2006.00708.x; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Crowder S, 2007, SEMIN ONCOL, V34, P57, DOI 10.1053/j.seminoncol.2006.10.028; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; GERSELL DJ, 1988, AM J SURG PATHOL, V12, P684, DOI 10.1097/00000478-198809000-00005; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Kim YB, 1996, GYNECOL ONCOL, V62, P411, DOI 10.1006/gyno.1996.0259; Korcum AF, 2008, ARCH GYNECOL OBSTET, V277, P367, DOI 10.1007/s00404-007-0463-9; Kulda V, 2010, CANCER GENET CYTOGEN, V200, P154, DOI 10.1016/j.cancergencyto.2010.04.015; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; PAZDUR R, 1981, GYNECOL ONCOL, V12, P120, DOI 10.1016/0090-8258(81)90103-7; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sevin BU, 1996, CANCER-AM CANCER SOC, V77, P1489, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1489::AID-CNCR10>3.0.CO;2-W; SHEETS EE, 1988, OBSTET GYNECOL, V71, P10; Shen QL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-227; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Tsunoda S, 2005, INT J GYNECOL CANCER, V15, P295, DOI 10.1111/j.1525-1438.2005.15219.x; VANNAGELL JR, 1977, CANCER, V40, P2243, DOI 10.1002/1097-0142(197711)40:5<2243::AID-CNCR2820400534>3.0.CO;2-H; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Viswanathan AN, 2004, GYNECOL ONCOL, V93, P27, DOI 10.1016/j.ygyno.2003.12.027; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	41	93	101	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33762	10.1371/journal.pone.0033762	http://dx.doi.org/10.1371/journal.pone.0033762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438992	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309100094
J	Li, XY; Mai, JT; Virtue, A; Yin, Y; Gong, R; Sha, XJ; Gutchigian, S; Frisch, A; Hodge, I; Jiang, XH; Wang, H; Yang, XF				Li, Xinyuan; Mai, Jietang; Virtue, Anthony; Yin, Ying; Gong, Ren; Sha, Xiaojin; Gutchigian, Stefanie; Frisch, Andrew; Hodge, Imani; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng			IL-35 Is a Novel Responsive Anti-inflammatory Cytokine - A New System of Categorizing Anti-inflammatory Cytokines	PLOS ONE			English	Article							REGULATORY T-CELLS; DNA METHYLATION; GENE-EXPRESSION; PROTEIN; ATHEROSCLEROSIS; INDUCTION; IDENTIFICATION; PROLIFERATION; HOMOCYSTEINE; INFLAMMATION	It remains unknown whether newly identified anti-inflammatory/immunosuppressive cytokine interleukin-35 (IL-35) is different from other anti-inflammatory cytokines such as IL-10 and transforming growth factor (TGF)-beta in terms of inhibition of inflammation initiation and suppression of full-blown inflammation. Using experimental database mining and statistical analysis methods we developed, we examined the tissue expression profiles and regulatory mechanisms of IL-35 in comparison to other anti-inflammatory cytokines. Our results suggest that in contrast to TGF-beta, IL-35 is not constitutively expressed in human tissues but it is inducible in response to inflammatory stimuli. We also provide structural evidence that AU-rich element (ARE) binding proteins and microRNAs target IL-35 subunit transcripts, by which IL-35 may achieve non-constitutive expression status. Furthermore, we propose a new system to categorize anti-inflammatory cytokines into two groups: (1) the house-keeping cytokines, such as TGF-beta, inhibit the initiation of inflammation whereas (2) the responsive cytokines including IL-35 suppress inflammation in full-blown stage. Our in-depth analyses of molecular events that regulate the production of IL-35 as well as the new categorization system of anti-inflammatory cytokines are important for the design of new strategies of immune therapies.	[Li, Xinyuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA; Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Li, XY (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA.	xfyang@temple.edu	Li, Xinyuan/B-1139-2015; Li, Xinyuan/Z-6299-2019	Li, Xinyuan/0000-0002-6746-8367; Li, Xinyuan/0000-0002-6746-8367; Frisch, Andrew/0000-0002-0080-9147	National Institutes of Health [HL094451, HL108910, HL67033, HL82774, HL77288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082774, R01HL094451, R01HL117654, R01HL077288, R01HL067033, R01HL108910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants HL094451 and HL108910 (XFY), HL67033, HL82774 and HL77288 (HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; Chen NC, 2010, FASEB J, V24, P2804, DOI 10.1096/fj.09-143651; Chiu IM, 2001, PROG NUCLEIC ACID RE, V70, P155, DOI 10.1016/S0079-6603(01)70016-5; Collison L.W., 2012, NAT IMMUNOL; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cua DJ, 1999, J EXP MED, V189, P1005, DOI 10.1084/jem.189.6.1005; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; Holloway Dustin T, 2005, Genome Inform, V16, P83; Homma Y, 2007, J INTERF CYTOK RES, V27, P799, DOI 10.1089/jir.2007.0006; Huang CH, 2011, J IMMUNOL, V187, P462, DOI 10.4049/jimmunol.1100259; Ikushima H, 2011, CELL TISSUE RES; Jalonen U, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/40691; Jamaluddin MS, 2007, CLIN CHEM LAB MED, V45, P1660, DOI 10.1515/CCLM.2007.350; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; KUBIN M, 1994, J EXP MED, V180, P211, DOI 10.1084/jem.180.1.211; LI J, 2009, GENES NUTR; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Mai JT, 2010, FRONT BIOSCI-LANDMRK, V15, P986, DOI 10.2741/3657; Medzhitov R, 2011, NAT REV IMMUNOL, V11, P693, DOI 10.1038/nri3063; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Narverud I, 2011, ATHEROSCLEROSIS, V214, P163, DOI 10.1016/j.atherosclerosis.2010.10.002; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Poleganov MA, 2008, MOL IMMUNOL, V45, P2869, DOI 10.1016/j.molimm.2008.01.021; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sahoo A, 2010, INT REV IMMUNOL, V29, P77, DOI 10.3109/08830180903349651; Salmaggi A, 1996, J NEUROL, V243, P13; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Szyf M, 2010, CLIN REV ALLERG IMMU, V39, P62, DOI 10.1007/s12016-009-8172-8; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; UELAND PM, 1984, J BIOL CHEM, V259, P2360; Virtue A, 2011, FRONT BIOSCI-LANDMRK, V16, P3133, DOI 10.2741/3901; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wirtz S, 2011, GASTROENTEROLOGY; Xiong Z, 2008, FRONT BIOSCI-LANDMRK, V13, P7143, DOI 10.2741/3217; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Yamashita H, 2003, AM J CARDIOL, V91, P133, DOI 10.1016/S0002-9149(02)03097-7; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208; Zandian M, 2011, GENE THER; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211; Zill P, 2002, NEUROPSYCHOPHARMACOL, V26, P489, DOI 10.1016/S0893-133X(01)00386-4	67	178	200	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33628	10.1371/journal.pone.0033628	http://dx.doi.org/10.1371/journal.pone.0033628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438968	Green Published, gold			2022-12-27	WOS:000303309100074
J	Liu, ZY; Owen, T; Fang, J; Zuo, J				Liu, Zhiyong; Owen, Thomas; Fang, Jie; Zuo, Jian			Overactivation of Notch1 Signaling Induces Ectopic Hair Cells in the Mouse Inner Ear in an Age-Dependent Manner	PLOS ONE			English	Article							OTIC PLACODE; SUPPORTING CELLS; REGULATES DEVELOPMENT; FATE SPECIFICATION; PROSENSORY PATCHES; SENSORY EPITHELIA; MAMMALIAN COCHLEA; EXPRESSION; MATH1; FGF	Background: During mouse inner ear development, Notch1 signaling first specifies sensory progenitors, and subsequently controls progenitors to further differentiate into either hair cells (HCs) or supporting cells (SCs). Overactivation of NICD (Notch1 intracellular domain) at early embryonic stages leads to ectopic HC formation. However, it remains unclear whether such an effect can be elicited at later embryonic or postnatal stages, which has important implications in mouse HC regeneration by reactivation of Notch1 signaling. Methodology/Principal Findings: We performed comprehensive in vivo inducible overactivation of NICD at various developmental stages. In CAG(CreER+); Rosa26-NICDloxp/+ mice, tamoxifen treatment at embryonic day 10.5 (E10.5) generated ectopic HCs in the non-sensory regions in both utricle and cochlea, whereas ectopic HCs only appeared in the utricle when tamoxifen was given at E13. When tamoxifen was injected at postnatal day 0 (P0) and P1, no ectopic HCs were observed in either utricle or cochlea. Interestingly, Notch1 signaling induced new HCs in a non-cell-autonomous manner, because the new HCs did not express NICD. Adjacent to the new HCs were cells expressing the SC marker Sox10 (either NICD+ or NICD-negative). Conclusions/Significance: Our data demonstrate that the developmental stage determines responsiveness of embryonic otic precursors and neonatal non-sensory epithelial cells to NICD overactivation, and that Notch 1 signaling in the wild type, postnatal inner ear is not sufficient for generating new HCs. Thus, our genetic mouse model is suitable to test additional pathways that could synergistically interact with Notch1 pathway to produce HCs at postnatal ages.	[Liu, Zhiyong; Owen, Thomas; Fang, Jie; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Liu, Zhiyong] Univ Tennessee, Ctr Hlth Sci, Integrated Program Biomed Sci, Memphis, TN 38163 USA; [Owen, Thomas] Univ Bath, Bath BA2 7AY, Avon, England	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Bath	Liu, ZY (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org			National Institutes of Health [DC06471, DC05168, DC008800, CA21765]; Office of Naval Research [N000140911014]; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; Hartwell Individual Biomedical Research Award; NOHR; St. Jude Children's Research Hospital; University of Tennessee Health Science Center; Society of Developmental Biology; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006471, R21DC005168, R21DC008800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Hartwell Individual Biomedical Research Award; NOHR; St. Jude Children's Research Hospital; University of Tennessee Health Science Center; Society of Developmental Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by the National Institutes of Health (DC06471, DC05168, DC008800 and CA21765), the Office of Naval Research (N000140911014), the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital, The Hartwell Individual Biomedical Research Award, NOHR, Travel Awards from Academic Programs of St. Jude Children's Research Hospital, the University of Tennessee Health Science Center, and the Society of Developmental Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bok J, 2007, DEVELOPMENT, V134, P1713, DOI 10.1242/dev.000760; Breuskin I, 2009, DEV BIOL, V335, P327, DOI 10.1016/j.ydbio.2009.09.007; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Burns J, 2008, J COMP NEUROL, V511, P396, DOI 10.1002/cne.21849; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chen P, 2002, DEVELOPMENT, V129, P2495; Collado MS, 2008, CURR OPIN OTOLARYNGO, V16, P465, DOI 10.1097/MOO.0b013e32830f4ab5; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Driver EC, 2008, J NEUROSCI, V28, P7350, DOI 10.1523/JNEUROSCI.0312-08.2008; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Fekete DM, 1998, J NEUROSCI, V18, P7811; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Freyer L, 2010, DEV DYNAM, V239, P1708, DOI 10.1002/dvdy.22308; Groves AK, 2000, DEVELOPMENT, V127, P3489; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hatch EP, 2007, DEVELOPMENT, V134, P3615, DOI 10.1242/dev.006627; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hayashi T, 2008, J NEUROSCI, V28, P5991, DOI 10.1523/JNEUROSCI.1690-08.2008; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Huh SH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001231; Hwang CH, 2010, DEV DYNAM, V239, P505, DOI 10.1002/dvdy.22200; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly MC, 2009, CURR OPIN NEUROBIOL, V19, P395, DOI 10.1016/j.conb.2009.07.010; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kwan T, 2009, ANN NY ACAD SCI, V1170, P28, DOI 10.1111/j.1749-6632.2009.04484.x; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Li HW, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-16; Liu ZY, 2010, DEV DYNAM, V239, P1674, DOI 10.1002/dvdy.22302; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; Morsli H, 1998, J NEUROSCI, V18, P3327; Murata J, 2006, J COMP NEUROL, V497, P502, DOI 10.1002/cne.20997; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Mustapha M, 2009, J NEUROSCI, V29, P1212, DOI 10.1523/JNEUROSCI.4957-08.2009; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Ohyama T, 2007, INT J DEV BIOL, V51, P463, DOI 10.1387/ijdb.072320to; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Pan W, 2010, P NATL ACAD SCI USA, V107, P15798, DOI 10.1073/pnas.1003089107; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Sweet EM, 2011, DEV BIOL, V358, P113, DOI 10.1016/j.ydbio.2011.07.019; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Tsai H, 2001, HUM MOL GENET, V10, P507, DOI 10.1093/hmg/10.5.507; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Wright TJ, 2003, CURR TOP DEV BIOL, V57, P225, DOI 10.1016/S0070-2153(03)57008-9; Yamamoto N, 2006, J MOL MED, V84, P37, DOI 10.1007/s00109-005-0706-9; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	72	41	44	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e34123	10.1371/journal.pone.0034123	http://dx.doi.org/10.1371/journal.pone.0034123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	23251366	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700080
J	Sun, Y; Lian, ZQ; Jiang, CY; Wang, YH; Zhu, HB				Sun, Yang; Lian, Zeqin; Jiang, Chunying; Wang, Yinghong; Zhu, Haibo			Beneficial Metabolic Effects of 2',3',5'-tri-acetyl-N-6-(3-Hydroxylaniline) Adenosine in the Liver and Plasma of Hyperlipidemic Hamsters	PLOS ONE			English	Article							H-1-NMR SPECTROSCOPY; DISEASE DIAGNOSIS; NMR-SPECTROSCOPY; INBORN-ERRORS; LINOLEIC-ACID; PLS-DA; METABONOMICS; URINE; SERUM; H-1	Background: Pharmaceutical research of hyperlipidemia has been commonly pursued using traditional approaches. However, unbiased metabonomics attempts to explore the metabolic signature of hyperlipidemia in a high-throughput manner to understand pathophysiology of the disease process. Methodology/Principal Findings: As a new way, we performed H-3 NMR-based metabonomics to evaluate the beneficial effects of 2',3',5'-tri-acetyl-N-6-(3-hydroxylaniline) adenosine (WS070117) on plasma and liver from hyperlipidemic Syrian golden hamsters. Both plasma and liver profiles provided a clearer distinction between the control and hyperlipidemic hamsters. Compared to control animals, hyperlipidemic hamsters showed a higher content of lipids (triglyceride and cholesterol), lactate and alanine together with a lower content of choline-containing compounds (e. g., phosphocholine, phosphatidylcholine, and glycerophosphocholine) and betaine. As a result, metabonomics-based findings such as the PCA and OPLS-DA plotting of metabolic state and analysis of potential biomarkers in plasma and liver correlated well to the assessment of biochemical assays, Oil Red O staining and in vivo ultrasonographic imaging suggesting that WS070117 was able to regulate lipid content and displayed more beneficial effects on plasma and liver than simvastatin. Conclusions/Significance: This work demonstrates the promise of applying H-1 NMR metabonomics to evaluate the beneficial effects of WS070117 which may be a good drug candidate for hyperlipidemia.	[Sun, Yang] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Sun, Y (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	wyh@imm.ac.cn; zhuhaibo@imm.ac.cn	lian, zeqin/AAG-8595-2019	lian, zeqin/0000-0003-2068-6604	National Natural Sciences Foundation of China (NSFC) [30873063, 30973527]; Natural Sciences Foundation of Beijing [7092068, 7102115]; National Science and Technology [2009ZX09103-034, 2009ZX09301-003, 2009ZX09303-003, 2008ZX09401, 2009ZX09311-004]	National Natural Sciences Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Beijing(Beijing Natural Science Foundation); National Science and Technology	This study was supported by grants from the National Natural Sciences Foundation of China (NSFC, Grant Number: 30873063, 30973527) and the Natural Sciences Foundation of Beijing (Grant Number: 7092068, 7102115). The authors are also grateful for grants from the National Science and Technology Major Project (Grant Number: 2009ZX09103-034, 2009ZX09301-003, 2009ZX09303-003, 2008ZX09401, 2009ZX09311-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Beckwith-Hall BM, 2003, ANALYST, V128, P814, DOI 10.1039/b302360p; Bertram HC, 2007, ANAL CHEM, V79, P168, DOI 10.1021/ac061322+; Bollard ME, 2000, MAGNET RESON MED, V44, P201, DOI 10.1002/1522-2594(200008)44:2<201::AID-MRM6>3.0.CO;2-5; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Colli A, 2003, RADIOLOGY, V227, P89, DOI 10.1148/radiol.2272020193; Duarte IF, 2007, NMR BIOMED, V20, P401, DOI 10.1002/nbm.1073; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; FELIG P, 1971, J CLIN INVEST, V50, P2703, DOI 10.1172/JCI106771; Gavaghan CL, 2002, FEBS LETT, V530, P191, DOI 10.1016/S0014-5793(02)03476-2; Kang J, 2008, J AGR FOOD CHEM, V56, P11589, DOI 10.1021/jf802088a; Kim SH, 2009, ANAL BIOANAL CHEM, V395, P1117, DOI 10.1007/s00216-009-3054-8; Lian ZQ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-67; Liang X, J PROTEOME RES, V10, P790; Lindon JC, 2005, PHARMACOGENOMICS, V6, P691, DOI 10.2217/14622416.6.7.691; Lindon JC, 2004, BIOMARKERS, V9, P1, DOI 10.1080/13547500410001668379; Lindon JC, 2004, EXPERT REV MOL DIAGN, V4, P189, DOI 10.1586/14737159.4.2.189; Liu ML, 2002, MAGN RESON CHEM, V40, pS83, DOI 10.1002/mrc.1121; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P539, DOI 10.1007/s00216-006-0546-7; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; SINTA G, 2005, SCIENCE, V310, P965; Valeille K, 2006, J NUTR, V136, P1305, DOI 10.1093/jn/136.5.1305; Valeille K, 2005, AM J PHYSIOL-HEART C, V289, pH652, DOI 10.1152/ajpheart.00130.2005; van Doorn M, 2007, BRIT J CLIN PHARMACO, V63, P562, DOI 10.1111/j.1365-2125.2006.02816.x; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Willker W, 1998, MAGN RESON CHEM, V36, pS79, DOI 10.1002/(SICI)1097-458X(199806)36:13<S79::AID-OMR294>3.3.CO;2-Q; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wu QF, 2010, J PHARMACEUT BIOMED, V51, P698, DOI 10.1016/j.jpba.2009.09.042; Yang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016641	31	70	80	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e32115	10.1371/journal.pone.0032115	http://dx.doi.org/10.1371/journal.pone.0032115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	23071695	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000003
J	Xiao, D; Bommareddy, A; Kim, SH; Sehrawat, A; Hahm, ER; Singh, SV				Xiao, Dong; Bommareddy, Ajay; Kim, Su-Hyeong; Sehrawat, Anuradha; Hahm, Eun-Ryeong; Singh, Shivendra V.			Benzyl Isothiocyanate Causes FoxO1-Mediated Autophagic Death in Human Breast Cancer Cells	PLOS ONE			English	Article							PROSTATE-CANCER; INDUCED APOPTOSIS; INHIBITION; CONSTITUENT; MTOR; PREVENTION; INDUCTION; TARGET; GROWTH; CHAIN	Benzyl isothiocyanate (BITC), a constituent of edible cruciferous vegetables, inhibits growth of breast cancer cells but the mechanisms underlying growth inhibitory effect of BITC are not fully understood. Here, we demonstrate that BITC treatment causes FoxO1-mediated autophagic death in cultured human breast cancer cells. The BITC-treated breast cancer cells (MDA-MB-231, MCF-7, MDA-MB-468, BT-474, and BRI-JM04) and MDA-MB-231 xenografts from BITC-treated mice exhibited several features characteristic of autophagy, including appearance of double-membrane vacuoles (transmission electron microscopy) and acidic vesicular organelles (acridine orange staining), cleavage of microtubule-associated protein 1 light chain 3 (LC3), and/or suppression of p62 (p62/SQSTM1 or sequestosome 1) expression. On the other hand, a normal human mammary epithelial cell line (MCF-10A) was resistant to BITC-induced autophagy. BITC-mediated inhibition of MDA-MB-231 and MCF-7 cell viability was partially but statistically significantly attenuated in the presence of autophagy inhibitors 3-methyl adenine and bafilomycin A1. Stable overexpression of Mn-superoxide dismutase, which was fully protective against apoptosis, conferred only partial protection against BITC-induced autophagy. BITC treatment decreased phosphorylation of mTOR and its downstream targets (P70s6k and 4E-BP1) in cultured MDA-MB-231 and MCF-7 cells and MDA-MB-231 xenografts, but activation of mTOR by transient overexpression of its positive regulator Rheb failed to confer protection against BITC-induced autophagy. Autophagy induction by BITC was associated with increased expression and acetylation of FoxO1. Furthermore, autophagy induction and cell growth inhibition resulting from BITC exposure were significantly attenuated by small interfering RNA knockdown of FoxO1. In conclusion, the present study provides novel insights into the molecular circuitry of BITC-induced cell death involving FoxO1-mediated autophagy.	[Xiao, Dong; Kim, Su-Hyeong; Sehrawat, Anuradha; Hahm, Eun-Ryeong; Singh, Shivendra V.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15260 USA; [Bommareddy, Ajay] Wilkes Univ, Sch Pharm, Dept Pharmaceut Sci, Wilkes Barre, PA USA; [Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wilkes University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, SV (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15260 USA.	singhs@upmc.edu			National Cancer Institute at the National Institutes of Health [RO1 CA129347-05, P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA129347] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by a grant from the National Cancer Institute at the National Institutes of Health (RO1 CA129347-05). This research project used the Cell and Tissue Imaging Facility, and Tissue and Research Pathology Facility supported by a grant from the National Cancer Institute at the National Institutes of Health (P30CA047904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; DeMasters G, 2006, MOL CANCER THER, V5, P2786, DOI 10.1158/1535-7163.MCT-06-0316; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fowke JH, 2003, CANCER RES, V63, P3980; Gibson SB, 2010, AUTOPHAGY, V6, P835, DOI 10.4161/auto.6.7.13335; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; HULKA BS, 1995, LANCET, V346, P883, DOI 10.1016/S0140-6736(95)92713-1; Iwamaru A, 2007, ONCOGENE, V26, P1840, DOI 10.1038/sj.onc.1209992; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2003, CANCER RES, V63, P2103; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Kim SH, 2011, CARCINOGENESIS, V32, P359, DOI 10.1093/carcin/bgq267; Kim SH, 2010, CANCER PREV RES, V3, P718, DOI 10.1158/1940-6207.CAPR-10-0048; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Obiorah I, 2011, MATURITAS, V70, P315, DOI 10.1016/j.maturitas.2011.09.006; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scherz-Shouval R, 2007, AUTOPHAGY, V3, P371, DOI 10.4161/auto.4214; Singh SV, 2008, CANCER RES, V68, P9503, DOI 10.1158/0008-5472.CAN-08-1677; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tseng E, 2004, EXP BIOL MED, V229, P835, DOI 10.1177/153537020422900817; Warin R, 2010, MOL CARCINOGEN, V49, P500, DOI 10.1002/mc.20600; Warin R, 2009, CANCER RES, V69, P9473, DOI 10.1158/0008-5472.CAN-09-2960; WATTENBERG LW, 1977, J NATL CANCER I, V58, P395, DOI 10.1093/jnci/58.2.395; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Xiao D, 2008, J BIOL CHEM, V283, P30151, DOI 10.1074/jbc.M802529200; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Zhang YS, 2003, MOL CANCER THER, V2, P1045; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	39	56	62	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e32597	10.1371/journal.pone.0032597	http://dx.doi.org/10.1371/journal.pone.0032597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457718	gold, Green Submitted, Green Published			2022-12-27	WOS:000303909200005
J	Qi, YF; Fu, XQ; Xiong, ZG; Zhang, HT; Hill, SM; Rowan, BG; Dong, Y				Qi, Yanfeng; Fu, Xueqi; Xiong, Zhenggang; Zhang, Haitao; Hill, Steven M.; Rowan, Brian G.; Dong, Yan			Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; IN-VIVO; SELENIUM; APOPTOSIS; CELLS; PHOSPHORYLATION; DOXORUBICIN; SURVIVAL; MODEL	A major challenge in breast cancer therapy is the lack of an effective therapeutic option for a particularly aggressive subtype of breast cancer, triple-negative breast cancer. Here we provide the first preclinical evidence that a second-generation selenium compound, methylseleninic acid, significantly enhances the anticancer efficacy of paclitaxel in triple-negative breast cancer. Through combination-index value calculation, we demonstrated that methylseleninic acid synergistically enhanced the growth inhibitory effect of paclitaxel in triple-negative breast cancer cells. The synergism was attributable to more pronounced induction of caspase-mediated apoptosis, arrest of cell cycle progression at the G2/M checkpoint, and inhibition of cell proliferation. Treatment of SCID mice bearing MDA-MB-231 triple-negative breast cancer xenografts for four weeks with methylseleninic acid (4.5 mg/kg/day, orally) and paclitaxel (10 mg/kg/week, through intraperitoneal injection) resulted in a more pronounced inhibition of tumor growth compared with either agent alone. The attenuated tumor growth correlated with a decrease in tumor cell proliferation and an induction of apoptosis. The in vivo study also indicated the safety of using methylseleninic acid in the combination regime. Our findings thus provide strong justification for the further development of methylseleninic acid and paclitaxel combination therapy for the treatment of triple-negative breast cancer.	[Qi, Yanfeng; Hill, Steven M.; Rowan, Brian G.; Dong, Yan] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Biol Struct, New Orleans, LA 70112 USA; [Qi, Yanfeng; Hill, Steven M.; Rowan, Brian G.; Dong, Yan] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Cellular Biol, New Orleans, LA 70112 USA; [Zhang, Haitao; Dong, Yan] Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China; [Xiong, Zhenggang; Zhang, Haitao] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Pathol & Lab Med, New Orleans, LA 70112 USA	Tulane University; Tulane University; Jilin University; Tulane University	Qi, YF (corresponding author), Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Biol Struct, 1430 Tulane Ave, New Orleans, LA 70112 USA.	ydong@tulane.edu	Qi, Yanfeng/G-5311-2013	Dong, Yan/0000-0003-1622-5354	National Cancer Institute [K01CA114252]; American Cancer Society [RSG-07-218-01-TBE]; Mary Kay Foundation [019-11]; Louisiana Cancer Research Consortium; Tulane Cancer Center; Department of Structural and Cellular Biology, Tulane University School of Medicine; NATIONAL CANCER INSTITUTE [K01CA114252] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Mary Kay Foundation; Louisiana Cancer Research Consortium; Tulane Cancer Center; Department of Structural and Cellular Biology, Tulane University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute grant K01CA114252 (YD), American Cancer Society grant RSG-07-218-01-TBE (YD), Mary Kay Foundation grant 019-11 (YD), Louisiana Cancer Research Consortium Start-up Fund (YD and HZ), Tulane Cancer Center Developmental Fund (YD), and Departmental Seed Fund from the Department of Structural and Cellular Biology, Tulane University School of Medicine (YD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LS, 2011, J NUTR; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Dong Y, 2003, CANCER RES, V63, P52; Fost C, 2011, ONCOL REP, V25, P1481, DOI 10.3892/or.2011.1188; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Hu HB, 2005, CLIN CANCER RES, V11, P2379, DOI 10.1158/1078-0432.CCR-04-2084; Hu H, 2008, CLIN CANCER RES, V14, P1150, DOI 10.1158/1078-0432.CCR-07-4037; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Ip C, 2000, CANCER RES, V60, P2882; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang WQ, 2009, MOL CANCER THER, V8, P682, DOI 10.1158/1535-7163.MCT-08-0908; Kotsopoulos J, 2010, CANCER CAUSE CONTROL, V21, P679, DOI 10.1007/s10552-009-9495-8; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1832; Li GX, 2008, CARCINOGENESIS, V29, P1005, DOI 10.1093/carcin/bgn007; Li HJ, 2004, JNCI-J NATL CANCER I, V96, P696, DOI 10.1093/jnci/djh125; Li S, 2007, ANTICANCER RES, V27, P3075; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Liu SA, 2008, MOL CANCER RES, V6, P306, DOI 10.1158/1541-7786.MCR-07-0159; Liu SA, 2010, MOL CANCER THER, V9, P2016, DOI 10.1158/1535-7163.MCT-09-0924; Matsuyoshi S, 2006, BRIT J CANCER, V94, P532, DOI 10.1038/sj.bjc.6602955; Matsuyoshi S, 2006, PATHOBIOLOGY, V73, P205, DOI 10.1159/000096022; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohta Y, 2009, CHEM RES TOXICOL, V22, P1795, DOI 10.1021/tx900202m; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Reid ME, 2004, J TRACE ELEM MED BIO, V18, P69, DOI 10.1016/j.jtemb.2004.03.004; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Suzana S, 2009, SINGAP MED J, V50, P265; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vogt TM, 2007, AM J EPIDEMIOL, V166, P280, DOI 10.1093/aje/kwm075; Wang L, 2009, CANCER PREV RES, V2, P484, DOI 10.1158/1940-6207.CAPR-08-0173; Yamanaka K, 2011, INT J ONCOL, V39, P569, DOI 10.3892/ijo.2011.1077; Zeng Q, 2010, EUR J CANCER, V46, P1132, DOI 10.1016/j.ejca.2010.01.014	38	83	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31539	10.1371/journal.pone.0031539	http://dx.doi.org/10.1371/journal.pone.0031539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22448277	Green Submitted, Green Published, gold			2022-12-27	WOS:000302737400031
J	He, L; Wang, Q; Jin, XK; Wang, Y; Chen, LL; Liu, LH; Wang, Y				He, Lin; Wang, Qun; Jin, Xinkun; Wang, Ying; Chen, Lili; Liu, Lihua; Wang, Yang			Transcriptome Profiling of Testis during Sexual Maturation Stages in Eriocheir sinensis Using Illumina Sequencing	PLOS ONE			English	Article							CHINESE MITTEN CRAB; HEAT-SHOCK PROTEINS; CDC2 KINASE; SPERMATOGENESIS; EXPRESSION; ACROSOME; DYNAMICS; HSP70-2; TOOL; HEPATOPANCREAS	The testis is a highly specialized tissue that plays dual roles in ensuring fertility by producing spermatozoa and hormones. Spermatogenesis is a complex process, resulting in the production of mature sperm from primordial germ cells. Significant structural and biochemical changes take place in the seminiferous epithelium of the adult testis during spermatogenesis. The gene expression pattern of testis in Chinese mitten crab (Eriocheir sinensis) has not been extensively studied, and limited genetic research has been performed on this species. The advent of high-throughput sequencing technologies enables the generation of genomic resources within a short period of time and at minimal cost. In the present study, we performed de novo transcriptome sequencing to produce a comprehensive transcript dataset for testis of E. sinensis. In two runs, we produced 25,698,778 sequencing reads corresponding with 2.31 Gb total nucleotides. These reads were assembled into 342,753 contigs or 141,861 scaffold sequences, which identified 96,311 unigenes. Based on similarity searches with known proteins, 39,995 unigenes were annotated based on having a Blast hit in the non-redundant database or ESTscan results with a cut-off E-value above 10(-5). This is the first report of a mitten crab transcriptome using high-throughput sequencing technology, and all these testes transcripts can help us understand the molecular mechanisms involved in spermatogenesis and testis maturation.	[He, Lin; Wang, Qun; Jin, Xinkun; Wang, Ying; Chen, Lili; Liu, Lihua; Wang, Yang] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	He, L (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	qwang@bio.ecnu.edu.cn	Jin, Xingkun/H-4366-2013; Wang, Qun/I-7778-2013	Jin, Xingkun/0000-0003-2454-1621; Wang, Qun/0000-0001-7929-7692; Wen, Daizong/0000-0002-4551-2646; HUA, YANJUN/0000-0001-6461-3576; Savini, Giacomo/0000-0003-0075-3582	National Natural Science Foundation of China [31172393]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 31172393) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1994, MOL BIOL CELL, P787; Alekseev OM, 2009, BIOL REPROD, V81, P739, DOI 10.1095/biolreprod.109.076497; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dix DJ, 1997, CELL STRESS CHAPERON, V2, P73, DOI 10.1379/1466-1268(1997)002<0073:HEAFDG>2.3.CO;2; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Ecroyd H, 2003, BIOL REPROD, V69, P1801, DOI 10.1095/biolreprod.103.017350; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1999, REV REPROD, V4, P23, DOI 10.1530/revreprod/4.1.23; Fan YS, 2012, MOL BIOL REP, V39, P4727, DOI 10.1007/s11033-011-1265-5; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Griveau JF, 1997, INT J ANDROL, V20, P61, DOI 10.1046/j.1365-2605.1997.00044.x; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Herborg LM, 2006, J EXP MAR BIOL ECOL, V329, P1, DOI 10.1016/j.jembe.2005.08.001; Huang SY, 2005, THERIOGENOLOGY, V64, P1940, DOI 10.1016/j.theriogenology.2005.04.024; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Jiang H, 2009, MAR BIOTECHNOL, V11, P317, DOI 10.1007/s10126-008-9146-1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kierszenbaum AL, 2006, MOL REPROD DEV, V73, P939, DOI 10.1002/mrd.20536; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WW, 2010, FISH SHELLFISH IMMUN, V29, P1010, DOI 10.1016/j.fsi.2010.08.007; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Lie PPY, 2009, TRENDS BIOCHEM SCI, V34, P366, DOI 10.1016/j.tibs.2009.03.005; Linschooten JO, 2011, REPROD TOXICOL, V32, P106, DOI 10.1016/j.reprotox.2011.05.004; Lu W, 2011, PEPTIDES, DOI [10.1016/j.physletb.2003.10.071, DOI 10.1016/J.PHYSLETB.2003.10.071]; Lui WY, 2003, J ANDROL, V24, P1; Luk JM, 2006, J CELL PHYSIOL, V209, P755, DOI 10.1002/jcp.20746; Ma PP, 2006, MOL REPROD DEV, V73, P774, DOI 10.1002/mrd.20468; Maier B, 2003, BIOL REPROD, V68, P67, DOI 10.1095/biolreprod.102.004143; Manandhar G, 2009, BIOL REPROD, V80, P1168, DOI 10.1095/biolreprod.108.071738; Merlo E, 2007, NEUROSCIENCE, V147, P46, DOI 10.1016/j.neuroscience.2007.04.022; Neuer A, 2000, HUM REPROD UPDATE, V6, P149, DOI 10.1093/humupd/6.2.149; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; Obermann H, 2005, MOL HUM REPROD, V11, P53, DOI 10.1093/molehr/gah132; Qiu GF, 2008, ANIM REPROD SCI, V105, P209, DOI 10.1016/j.anireprosci.2007.03.005; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Rudnick DA, 2003, BASIC APPL ECOL, V4, P249, DOI 10.1078/1439-1791-00152; Sandmann T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r76; Sasagawa I, 2001, EUR J BIOCHEM, V268, P3053, DOI 10.1046/j.1432-1327.2001.02200.x; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; Seli E, FERTILITY PRESERVATI, P245, DOI [10.1007/978-1-4419-1783-6_19, DOI 10.1007/978-1-4419-1783-6_19]; Shen BL, 2009, MOL BIOL REP, V36, P1149, DOI 10.1007/s11033-008-9291-7; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; Shrivastava V, 2010, REPRODUCTION, V139, P999, DOI 10.1530/REP-09-0492; Stewart MJ, 2010, TISSUE CELL, V42, P137, DOI 10.1016/j.tice.2010.03.002; Sui L, 2007, AQUACULTURE, V273, P139, DOI 10.1016/j.aquaculture.2007.09.016; Takenaka K, 1997, J CELL BIOL, V136, P1091, DOI 10.1083/jcb.136.5.1091; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wang DH, 2010, COMP BIOCHEM PHYS A, V157, P123, DOI 10.1016/j.cbpa.2010.05.015; Wang HZ, 2006, AQUACULTURE, V255, P456, DOI 10.1016/j.aquaculture.2006.01.005; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wu YJ, 2011, CELL TISSUE RES, V344, P355, DOI 10.1007/s00441-011-1151-4; Xiao Xiang, 2007, Journal of Zhejiang University-Science B, V8, P498, DOI 10.1631/jzus.2007.B0498; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhu DH, 1997, DEVELOPMENT, V124, P3007	65	108	111	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33735	10.1371/journal.pone.0033735	http://dx.doi.org/10.1371/journal.pone.0033735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	23049823	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500061
J	Yu, HL; Zhang, ZL; Chen, J; Pei, AJ; Hua, F; Qian, XC; He, JJ; Liu, CF; Xu, XS				Yu, Hailong; Zhang, Zeng-Li; Chen, Jing; Pei, Aijie; Hua, Fang; Qian, Xuanchen; He, Jinjiang; Liu, Chun-Feng; Xu, Xingshun			Carvacrol, a Food-Additive, Provides Neuroprotection on Focal Cerebral Ischemia/Reperfusion Injury in Mice	PLOS ONE			English	Article							ESSENTIAL OILS; HUMANIN; 5-ISOPROPYL-2-METHYLPHENOL; ACETYLCHOLINESTERASE; INFLAMMATION; INVOLVEMENT; MECHANISMS; ISCHEMIA; THYMOL; ACETYL	Carvacrol (CAR), a naturally occurring monoterpenic phenol and food additive, has been shown to have antimicrobials, antitumor, and antidepressant-like activities. A previous study demonstrated that CAR has the ability to protect liver against ischemia/reperfusion injury in rats. In this study, we investigated the protective effects of CAR on cerebral ischemia/reperfusion injury in a middle cerebral artery occlusion mouse model. We found that CAR (50 mg/kg) significantly reduced infarct volume and improved neurological deficits after 75 min of ischemia and 24 h of reperfusion. This neuroprotection was in a dose-dependent manner. Post-treatment with CAR still provided protection on infarct volume when it was administered intraperitoneally at 2 h after reperfusion; however, intracerebroventricular post-treatment reduced infarct volume even when the mice were treated with CAR at 6 h after reperfusion. These findings indicated that CAR has an extended therapeutic window, but delivery strategies may affect the protective effects of CAR. Further, we found that CAR significantly decreased the level of cleaved caspase-3, a marker of apoptosis, suggesting the anti-apoptotic activity of CAR. Finally, our data indicated that CAR treatment increased the level of phosphorylated Akt and the neuroprotection of CAR was reversed by a PI3K inhibitor LY-294002, demonstrating the involvement of the PI3K/Akt pathway in the anti-apoptotic mechanisms of CAR. Due to its safety and wide use in the food industry, CAR is a promising agent to be translated into clinical trials.	[Yu, Hailong; Chen, Jing; Qian, Xuanchen; Liu, Chun-Feng; Xu, Xingshun] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China; [Yu, Hailong; Chen, Jing; Pei, Aijie; Qian, Xuanchen; Liu, Chun-Feng; Xu, Xingshun] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Zhang, Zeng-Li; He, Jinjiang] Soochow Univ, Dept Toxicol, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China; [Hua, Fang] Emory Univ, Sch Med, Dept Emergency Med, Brain Res Lab, Atlanta, GA USA	Soochow University - China; Soochow University - China; Soochow University - China; Emory University	Yu, HL (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China.	liucf@suda.edu.cn; Xingshunxu@suda.edu.cn	Xu, Xingshun/AAF-8183-2020	Lee, Peter P./0000-0002-2660-4377; Holmes, Susan/0000-0002-2208-8168; Xu, Xingshun/0000-0003-0205-6342	National Natural Science Foundation of China [81071095, 81120108011]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions of China	This study was supported by grants 81071095 and 81120108011 from the National Natural Science Foundation of China (to XX) and the Priority Academic Program Development of Jiangsu Higher Education Institutions of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, EUR J CLIN MICROBIOL, V30, P41, DOI 10.1007/s10096-010-1050-8; Amiri H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/728065; [Anonymous], 2006, INT J TOXICOL, V25, P29, DOI 10.1080/10915810600716653; Arunasree KM, 2010, PHYTOMEDICINE, V17, P581, DOI 10.1016/j.phymed.2009.12.008; Auriel E, 2010, J CELL MOL MED, V14, P2200, DOI 10.1111/j.1582-4934.2010.01135.x; Boskabady MH, 2011, PHYTOTHER RES, V25, P530, DOI 10.1002/ptr.3290; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Canbek M, 2008, PHYTOMEDICINE, V15, P447, DOI 10.1016/j.phymed.2007.11.022; Melo FHC, 2011, FUND CLIN PHARMACOL, V25, P362, DOI 10.1111/j.1472-8206.2010.00850.x; Melo FHC, 2010, FUND CLIN PHARMACOL, V24, P437, DOI 10.1111/j.1472-8206.2009.00788.x; Cho S, 2012, J NUTR BIOCHEM, V23, P192, DOI 10.1016/j.jnutbio.2010.11.016; Coimbra M, 2011, J CONTROL RELEASE; Dambolena JS, 2011, INT J FOOD MICROBIOL, V145, P140, DOI 10.1016/j.ijfoodmicro.2010.12.001; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Garcia-Garcia R, 2011, J FOOD SCI, V76, pM95, DOI 10.1111/j.1750-3841.2010.02005.x; Guimaraes A. G., 2011, NAUNYN SCHMIEDEBERGS; Guimaraes AG, 2010, BASIC CLIN PHARMACOL, V107, P949, DOI 10.1111/j.1742-7843.2010.00609.x; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Jayakumar S, 2012, MOL CELL BIOCHEM, V360, P51, DOI 10.1007/s11010-011-1043-7; Jukic M, 2007, PHYTOTHER RES, V21, P259, DOI 10.1002/ptr.2063; Kaufmann D, 2011, J PHARM PHARMACOL, V63, P1368, DOI 10.1111/j.2042-7158.2011.01344.x; Lee J, 2008, J DERMATOL SCI, V52, P160, DOI 10.1016/j.jdermsci.2008.06.007; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Nostro A., 2011, RECENT PAT ANTIINFEC; Orhan I, 2008, Z NATURFORSCH C, V63, P547; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Savelev SU, 2004, PHYTOTHER RES, V18, P315, DOI 10.1002/ptr.1451; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tang XR, 2011, NAT PROD RES, V25, P320, DOI 10.1080/14786419.2010.532796; Trabace L, 2011, TOXICOL APPL PHARM, V255, P169, DOI 10.1016/j.taap.2011.06.011; Ultee A, 1999, APPL ENVIRON MICROB, V65, P4606; Virmani Renu, 2006, Neurosurgery, V59, pS219; Wieten L, 2010, ARTHRITIS RHEUM-US, V62, P1026, DOI 10.1002/art.27344; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Yin QH, 2012, CYTOTECHNOLOGY, V64, P43, DOI 10.1007/s10616-011-9389-y; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	40	84	88	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33584	10.1371/journal.pone.0033584	http://dx.doi.org/10.1371/journal.pone.0033584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	23251464	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100062
J	Liu, YJ; Ding, YC; Alonas, E; Zhao, WL; Santangelo, PJ; Jin, DY; Piper, JA; Teng, JL; Ren, QS; Xi, P				Liu, Yujia; Ding, Yichen; Alonas, Eric; Zhao, Wenli; Santangelo, Philip J.; Jin, Dayong; Piper, James A.; Teng, Junlin; Ren, Qiushi; Xi, Peng			Achieving lambda/10 Resolution CW STED Nanoscopy with a Ti:Sapphire Oscillator	PLOS ONE			English	Article							STIMULATED-EMISSION-DEPLETION; 2-PHOTON EXCITATION; MICROSCOPY; BREAKING; REVEALS; LIMIT	In this report, a Ti: Sapphire oscillator was utilized to realize synchronization-free stimulated emission depletion (STED) microscopy. With pump power of 4.6 W and sample irradiance of 310 mW, we achieved super-resolution as high as 71 nm. With synchronization-free STED, we imaged 200 nm nanospheres as well as all three cytoskeletal elements (microtubules, intermediate filaments, and actin filaments), clearly demonstrating the resolving power of synchronization-free STED over conventional diffraction limited imaging. It also allowed us to discover that, Dylight 650, exhibits improved performance over ATTO647N, a fluorophore frequently used in STED. Furthermore, we applied synchronization-free STED to image fluorescently-labeled intracellular viral RNA granules, which otherwise cannot be differentiated by confocal microscopy. Thanks to the widely available Ti:Sapphire oscillators in multiphoton imaging system, this work suggests easier access to setup super-resolution microscope via the synchronization-free STED.	[Liu, Yujia; Ren, Qiushi] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Liu, Yujia; Ding, Yichen; Ren, Qiushi; Xi, Peng] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Alonas, Eric; Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Alonas, Eric; Santangelo, Philip J.] Emory Univ, Atlanta, GA 30322 USA; [Jin, Dayong; Piper, James A.] Macquarie Univ, Adv Cytometry Labs, MQphoton Res Ctr, Sydney, NSW 2109, Australia; [Zhao, Wenli; Teng, Junlin] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Shanghai Jiao Tong University; Peking University; University System of Georgia; Georgia Institute of Technology; Emory University; Macquarie University; Peking University	Liu, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	xipeng@pku.edu.cn	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	"973" Major State Basic Research Development Program of China [2011CB809101, 2010CB933901, 2011CB707502]; National Natural Science Foundation of China [61178076]; PKU-GT/Emory University BME Seed Grant; Wallace H. Coulter Foundation; Olympus Australia; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	"973" Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PKU-GT/Emory University BME Seed Grant; Wallace H. Coulter Foundation; Olympus Australia; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research is supported by the "973" Major State Basic Research Development Program of China (2011CB809101, 2010CB933901, 2011CB707502), the National Natural Science Foundation of China (61178076), PKU-GT/Emory University BME Seed Grant funded by Wallace H. Coulter Foundation, and seed fund support from Olympus Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Cao YY, 2011, OPT EXPRESS, V19, P19486, DOI 10.1364/OE.19.019486; Diaspro A, 2005, Q REV BIOPHYS, V38, P97, DOI 10.1017/S0033583505004129; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; Hell SW, 2010, SPRINGER SER CHEM PH, V96, P365, DOI 10.1007/978-3-642-02597-6_19; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hirvonen LM, 2011, AUST J CHEM, V64, P41, DOI 10.1071/CH10333; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hyeon C, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2364190; Kasper R, 2010, SMALL, V6, P1379, DOI 10.1002/smll.201000203; Keller J, 2007, OPT EXPRESS, V15, P3361, DOI 10.1364/OE.15.003361; Moneron G, 2010, OPT EXPRESS, V18, P1302, DOI 10.1364/OE.18.001302; Moneron G, 2009, OPT EXPRESS, V17, P14567, DOI 10.1364/OE.17.014567; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Rankin BR, 2009, OPT EXPRESS, V17, P15679, DOI 10.1364/OE.17.015679; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Santangelo PJ, 2009, NAT METHODS, V6, P347, DOI [10.1038/nmeth.1316, 10.1038/NMETH.1316]; Scheul T, 2011, OPT EXPRESS, V19, P18036, DOI 10.1364/OE.19.018036; Schrof S, 2011, OPT EXPRESS, V19, P8066, DOI 10.1364/OE.19.008066; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wang WC, 2010, APPL OPTICS, V49, P6703, DOI 10.1364/AO.49.006703; Westphal V, 2003, APPL PHYS LETT, V82, P3125, DOI 10.1063/1.1571656; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wurm CA, 2010, METHODS MOL BIOL, V591, P185, DOI 10.1007/978-1-60761-404-3_11; Xi P, 2008, OPT COMMUN, V281, P1841, DOI 10.1016/j.optcom.2007.09.066; Xi P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3059629	38	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40003	10.1371/journal.pone.0040003	http://dx.doi.org/10.1371/journal.pone.0040003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22615852	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800086
J	Fu, WX; Liu, Y; Lu, X; Niu, XY; Ding, XD; Liu, JF; Zhang, Q				Fu, Wei-Xuan; Liu, Yang; Lu, Xin; Niu, Xiao-Yan; Ding, Xiang-Dong; Liu, Jian-Feng; Zhang, Qin			A Genome-Wide Association Study Identifies Two Novel Promising Candidate Genes Affecting Escherichia coli F4ab/F4ac Susceptibility in Swine	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; POPULATION STRATIFICATION; INTESTINAL RECEPTOR; EPITHELIAL-CELLS; MILK-PRODUCTION; DAIRY-CATTLE; INTEGRIN; BINDING; PROTEIN; F4AC	Enterotoxigenic Escherichia coli (ETEC) expressing F4 fimbria is the major pathogenic bacteria causing diarrhoea in neonatal and post-weaning piglets. Previous studies have revealed that the susceptibility to ETEC F4ab/F4ac is an autosomal Mendelian dominant trait and the loci controlling the F4ab/F4ac receptor are located on SSC13q41, between markers SW207 and S0283. To pinpoint these loci and further validate previous findings, we performed a genome-wide association study (GWAS) using a two generation family-based population, consisting of 301 piglets with phenotypes of susceptibility to ETEC F4ab/F4ac by the vitro adhesion test. The DNA of all piglets and their parents was genotyped using the Illumina PorcineSNP60 BeadChip, and 50,972 and 50,483 SNPs were available for F4ab and F4ac susceptibility, respectively, in the association analysis after quality control. In summary, 28 and 18 significant SNPs (p < 0.05) were detected associated with F4ab and F4ac susceptibility respectively at genome-wide significance level. From these significant findings, two novel candidate genes, HEG1 and ITGB5, were firstly identified as the most promising genes underlying F4ab/F4ac susceptibility in swine according to their functions and positions. Our findings herein provide a novel evidence for unravelling genetic mechanism of diarrhoea risk in piglets.	[Fu, Wei-Xuan; Liu, Yang; Lu, Xin; Niu, Xiao-Yan; Ding, Xiang-Dong; Liu, Jian-Feng; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China; [Lu, Xin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Fu, WX (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China.	liujf@cau.edu.cn; qzhang@cau.edu.cn	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	National Natural Science Foundations of China [30972092, 30800776]; National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms [2009ZX08009-146B]; Natural Science Foundations of Beijing [6102016]; New-Century Training Programme Foundation for the Talents by the State Education Commission of China [NETC-10-0783]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms; Natural Science Foundations of Beijing; New-Century Training Programme Foundation for the Talents by the State Education Commission of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Natural Science Foundations of China (30972092, 30800776), the National High Technology Research and Development Program of China (863 Program 2011AA100302), the National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms (2009ZX08009-146B), the Natural Science Foundations of Beijing (6102016), New-Century Training Programme Foundation for the Talents by the State Education Commission of China (NETC-10-0783) and Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Aplin JD, 1996, MOL HUM REPROD, V2, P527, DOI 10.1093/molehr/2.7.527; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIJLSMA IGW, 1987, VET RES COMMUN, V11, P509, DOI 10.1007/BF00396368; Billey LO, 1998, VET MICROBIOL, V59, P203, DOI 10.1016/S0378-1135(97)00193-4; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; de Koning DJ, 1999, GENETICS, V152, P1679; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; EDFORSLILJA I, 1995, ANIM GENET, V26, P237, DOI 10.1111/j.1365-2052.1995.tb03250.x; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GEORGES M, 1995, GENETICS, V139, P907; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Jacobsen M, 2010, ANIM GENET, V41, P21, DOI 10.1111/j.1365-2052.2009.01952.x; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Joller D, 2009, ANIM GENET, V40, P749, DOI 10.1111/j.1365-2052.2009.01881.x; Joller D, 2009, COMP MOL APPROACHES; Jorgensen CB, 2003, CYTOGENET GENOME RES, V102, P157, DOI 10.1159/000075742; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kasuga I, 2009, RESP MED, V103, P1672, DOI 10.1016/j.rmed.2009.05.008; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Lagarrigue S, 2006, GENET SEL EVOL, V38, P85, DOI 10.1051/gse:2005028; Lang TG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-197; Li Yuhua, 2007, Journal of Genetics and Genomics, V34, P591, DOI 10.1016/S1673-8527(07)60067-8; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Marquardt RR, 1999, FEMS IMMUNOL MED MIC, V23, P283, DOI 10.1016/S0928-8244(98)00147-3; Memmo LM, 1998, J CELL SCI, V111, P425; Mousa SA, 1999, J CELL BIOCHEM, V74, P135, DOI 10.1002/(SICI)1097-4644(19990701)74:1<135::AID-JCB15>3.3.CO;2-R; Pongpanich M, 2010, BIOINFORMATICS, V26, P1731, DOI 10.1093/bioinformatics/btq272; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Python P, 2005, J ANIM BREED GENET, V122, P5, DOI 10.1111/j.1439-0388.2005.00490.x; Python P, 2002, ANIM GENET, V33, P441, DOI 10.1046/j.1365-2052.2002.00915.x; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rampoldi A, 2011, MAMM GENOME, V22, P122, DOI 10.1007/s00335-010-9305-3; Ren J, 2009, J ANIM BREED GENET, V126, P30, DOI 10.1111/j.1439-0388.2008.00751.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; WANG YK, 1993, MOL CELL BIOL, V13, P5691, DOI 10.1128/MCB.13.9.5691; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x; Zhang B, 2008, ANIM GENET, V39, P258, DOI 10.1111/j.1365-2052.2008.01721.x	46	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e32127	10.1371/journal.pone.0032127	http://dx.doi.org/10.1371/journal.pone.0032127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22615852	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900001
J	Liu, Y; Costa, MB; Gerhardinger, C				Liu, Yang; Costa, Montserrat Biarnes; Gerhardinger, Chiara			IL-1 beta Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1 beta Autostimulation	PLOS ONE			English	Article							PROTEIN-KINASE-C; INTERLEUKIN-1 INDUCES INTERLEUKIN-1; MULLER CELLS; MICROGLIAL ACTIVATION; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; GENE-EXPRESSION; RETINOPATHY; BRAIN; INDUCTION	Many molecular and cellular abnormalities detected in the diabetic retina support a role for IL-1 beta-driven neuroinflammation in the pathogenesis of diabetic retinopathy. IL-1 beta is well known for its role in the induction and, through autostimulation, amplification of neuroinflammation. Upregulation of IL-1 beta has been consistently detected in the diabetic retina; however, the mechanisms and cellular source of IL-1 beta overexpression are poorly understood. The aim of this study was to investigate the effect of high glucose and IL-1 beta itself on IL-1 beta expression in microglial, macroglial (astrocytes and Muller cells) and retinal vascular endothelial cells; and to study the effect of diabetes on the expression of IL-1 beta in isolated retinal vessels and on the temporal pattern of IL-1 beta upregulation and glial reactivity in the retina of streptozotocin-diabetic rats. IL-1 beta was quantified by RealTime RT-PCR and ELISA, glial fibrillar acidic protein, alpha 2-macroglobulin, and ceruloplasmin by immunoblotting. We found that high glucose induced a 3-fold increase of IL-1 beta expression in retinal endothelial cells but not in macroglia and microglia. IL-1 beta induced its own synthesis in endothelial and macroglial cells but not in microglia. In retinal endothelial cells, the high glucose-induced IL-1 beta overexpression was prevented by calphostin C, a protein kinase C inhibitor. The retinal vessels of diabetic rats showed increased IL-1 beta expression as compared to non-diabetic rats. Retinal expression of IL-1 beta increased early after the induction of diabetes, continued to increase with progression of the disease, and was temporally associated with upregulation of markers of glial activation. These findings point to hyperglycemia as the trigger and to the endothelium as the origin of the initial retinal upregulation of IL-1 beta in diabetes; and to IL-1 beta itself, via autostimulation in endothelial and macroglial cells, as the mechanism of sustained IL-1 beta overexpression. Interrupting the vicious circle triggered by IL-1 beta autostimulation could limit the progression of diabetic retinopathy.	[Liu, Yang] Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School	Liu, Y (corresponding author), Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA 02115 USA.	chiara.gerhardinger@schepens.harvard.edu	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	National Institutes of Health [R01EY016206]; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (R01EY016206). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Asakawa H, 1997, J DIABETES COMPLICAT, V11, P176, DOI 10.1016/S1056-8727(97)00004-4; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; CAGLIERO E, 1991, J BIOL CHEM, V266, P14244; Carmo A, 2000, NITRIC OXIDE-BIOL CH, V4, P590, DOI 10.1006/niox.2000.0312; Chakrabarti S, 2000, DIABETES-METAB RES, V16, P393, DOI 10.1002/1520-7560(0000)9999:9999<::AID-DMRR157>3.0.CO;2-G; Dagher Z, 2004, DIABETES, V53, P2404, DOI 10.2337/diabetes.53.9.2404; DALTON BJ, 1989, ARTHRITIS RHEUM, V32, P279, DOI 10.1002/anr.1780320309; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gerhardinger C, 2009, DIABETES, V58, P1659, DOI 10.2337/db08-1008; GIULIAN D, 1988, J NEUROSCI, V8, P2485; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; HURME M, 1990, BLOOD, V76, P2198; Ibrahim AS, 2011, DIABETES, V60, P1122, DOI 10.2337/db10-1160; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Kowluru RA, 2004, BRIT J OPHTHALMOL, V88, P1343, DOI 10.1136/bjo.2003.038133; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; LEE SC, 1993, J IMMUNOL, V150, P2659; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Ramsauer M, 2002, FASEB J, V16, P1274, DOI 10.1096/fj.01-0814fje; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SHIBA T, 1993, AM J PHYSIOL, V265, pE783, DOI 10.1152/ajpendo.1993.265.5.E783; Sun W, 2005, DIABETES, V54, P3418, DOI 10.2337/diabetes.54.12.3418; Tham CS, 2003, INT J DEV NEUROSCI, V21, P431, DOI 10.1016/j.ijdevneu.2003.09.003; Toda Y, 2002, J IMMUNOL, V168, P1984, DOI 10.4049/jimmunol.168.4.1984; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; WARNER SJC, 1987, J EXP MED, V165, P1316, DOI 10.1084/jem.165.5.1316; WARNER SJC, 1987, J IMMUNOL, V139, P1911; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang L, 2011, INVEST OPHTH VIS SCI, V50, P2319; Yego ECK, 2009, INVEST OPHTH VIS SCI, V50, P1920, DOI 10.1167/iovs.08-2082; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zhang ZG, 1998, BRAIN RES, V784, P210, DOI 10.1016/S0006-8993(97)01317-6	52	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36949	10.1371/journal.pone.0036949	http://dx.doi.org/10.1371/journal.pone.0036949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615852	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300046
